PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Luo, JJ; Wang, J; Ma, TM; Sun, ZR				Luo, Junjie; Wang, Jun; Ma, Ting Martin; Sun, Zhirong			Reverse Engineering of Bacterial Chemotaxis Pathway via Frequency Domain Analysis	PLOS ONE			English	Article							BEHAVIORAL VARIABILITY; ESCHERICHIA-COLI; SINGLE-CELL; ADAPTATION; MODEL; ROBUSTNESS; RESPONSES; NOISE	Chemotaxis is defined as a behavior involving organisms sensing attractants or repellents and leading towards or away from them. Therefore, it is possible to reengineer chemotaxis network to control the movement of bacteria to our advantage. Understanding the design principles of chemotaxis pathway is a prerequisite and an important topic in synthetic biology. Here, we provide guidelines for chemotaxis pathway design by employing control theory and reverse engineering concept on pathway dynamic design. We first analyzed the mathematical models for two most important kinds of E. coli chemotaxis pathway-adaptive and non-adaptive pathways, and concluded that the control units of the pathway de facto function as a band-pass filter and a low-pass filter, respectively, by abstracting the frequency response properties of the pathways. The advantage of the band-pass filter is established, and we demonstrate how to tune the three key parameters of it-A (max amplification), omega(1) (down cut-off frequency) and omega(2) (up cut-off frequency) to optimize the chemotactic effect. Finally, we hypothesized a similar but simpler version of the dynamic pathway model based on the principles discovered and show that it leads to similar properties with native E. coli chemotactic behaviors. Our study provides an example of simulating and designing biological dynamics in silico and indicates how to make use of the native pathway's features in this process. Furthermore, the characteristics we discovered and tested through reverse engineering may help to understand the design principles of the pathway and promote the design of artificial chemotaxis pathways.	[Luo, Junjie; Ma, Ting Martin; Sun, Zhirong] Tsinghua Univ, Minist Educ Key Lab Bioinformat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Wang, Jun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Luo, JJ (corresponding author), Tsinghua Univ, Minist Educ Key Lab Bioinformat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	sunzhr@mail.tsinghua.edu.cn	Luo, Junjie/L-3285-2019	Long, Yicheng/0000-0002-0714-2322; Long, Yicheng/0000-0003-3578-5197	Hi-Tech Research and Development 863 Program of China [2006AA02003]; 973 project [2009CB918801]; National Science Foundation of China [30770498]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); 973 project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech Research and Development 863 Program of China (No. 2006AA02003), Foundational Science Research Grant from the 973 project (No. 2009CB918801) and National Science Foundation of China Grant (No. 30770498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; CHIKOFSKY EJ, 1990, IEEE SOFTWARE, V7, P13, DOI 10.1109/52.43044; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; HOSNI YA, 1994, COMPUT IND ENG, V26, P341, DOI 10.1016/0360-8352(94)90066-3; Ingolia NT, 2008, NATURE, V454, P1059, DOI 10.1038/4541059a; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; LAUB AJ, 1981, IEEE T AUTOMAT CONTR, V26, P407, DOI 10.1109/TAC.1981.1102602; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Liu ZW, 1996, BIOTECHNOL BIOENG, V51, P120, DOI 10.1002/(SICI)1097-0290(19960705)51:1<120::AID-BIT14>3.0.CO;2-U; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Soyer OS, 2006, J THEOR BIOL, V241, P223, DOI 10.1016/j.jtbi.2005.11.024; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	33	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9182	10.1371/journal.pone.0009182	http://dx.doi.org/10.1371/journal.pone.0009182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231879	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300001
J	de Souza, D; Kelly-Hope, L; Lawson, B; Wilson, M; Boakye, D				de Souza, Dziedzom; Kelly-Hope, Louise; Lawson, Bernard; Wilson, Michael; Boakye, Daniel			Environmental Factors Associated with the Distribution of Anopheles gambiae s.s in Ghana; an Important Vector of Lymphatic Filariasis and Malaria	PLOS ONE			English	Article							WEST-AFRICA; GENETIC DIFFERENTIATION; INSECTICIDE RESISTANCE; ECOLOGICAL ZONES; MOLECULAR-FORMS; BORNE DISEASE; COMPLEX; ABUNDANCE; IRRIGATION; KENYA	Anopheles gambiae s.s mosquitoes are important vectors of lymphatic filariasis (LF) and malaria in Ghana. To better understand their ecological aspects and influence on disease transmission, we examined the spatial distribution of the An. gambiae (M and S) molecular forms and associated environmental factors, and determined their relationship with disease prevalence. Published and current data available on the An. gambiae species in Ghana were collected in a database for analysis, and the study sites were georeferenced and mapped. Using the An. gambiae s.s sites, environmental data were derived from climate, vegetation and remote-sensed satellite sources, and disease prevalence data from existing LF and malaria maps in the literature. The data showed that An. gambiae M and S forms were sympatric in most locations. However, the S form predominated in the central region, while the Mformpredominated in the northern and coastal savanna regions. Bivariate and multiple regression analyses identified temperature as a key factor distinguishing their distributions. An. gambiae M was significantly correlated with LF, and 2.5 to 3 times more prevalent in the high LF zone than low to medium zones. There were no significant associations between high prevalence An. gambiae s.s locations and malaria. The distribution of the An. gambiae M and S forms and the diseases they transmit in Ghana appear to be distinct, driven by different environmental factors. This study provides useful baseline information for disease control, and future work on the An. gambiae s.s in Ghana.	[de Souza, Dziedzom; Wilson, Michael; Boakye, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [de Souza, Dziedzom; Lawson, Bernard] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [Kelly-Hope, Louise] Univ Liverpool, Ctr Neglected Trop Dis, Liverpool L69 3BX, Merseyside, England	University of Ghana; Kwame Nkrumah University Science & Technology; University of Liverpool	de Souza, D (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana.	dboakye@noguchi.mimcom.org	de Souza, Dziedzom/ABC-8432-2021	de Souza, Dziedzom/0000-0001-5000-6177; Kelly-Hope, Louise/0000-0002-3330-7629	JRS Biodiversity Foundation	JRS Biodiversity Foundation	This study was supported by the JRS Biodiversity Foundation (http://www.jrsbdf.org/v2/home.asp) grant to Prof Boakye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoulaye D, 2003, J MED ENTOMOL, V40, P195, DOI 10.1603/0022-2585-40.2.195; Afari Edwin A., 1995, Afr J Health Sci, V2, P312; Appawu MA, 2001, AFR ENTOMOL, V9, P59; Appawu MA, 2001, TROP MED INT HEALTH, V6, P511, DOI 10.1046/j.1365-3156.2001.00737.x; APPAWU MA, 1994, ACTA TROP, V56, P15, DOI 10.1016/0001-706X(94)90036-1; Bayoh MN, 2001, MED VET ENTOMOL, V15, P267, DOI 10.1046/j.0269-283x.2001.00298.x; Boakye DA, 2004, ANN TROP MED PARASIT, V98, P501, DOI 10.1179/000349804225003514; Calzetta M, 2008, AM J TROP MED HYG, V78, P169, DOI 10.4269/ajtmh.2008.78.169; Carnevale P, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P273; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coluzzi M., 1993, Parassitologia (Rome), V35, P23; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dunyo SK, 1996, T ROY SOC TROP MED H, V90, P634, DOI 10.1016/S0035-9203(96)90414-9; Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUNTER JM, 1992, SOC SCI MED, V35, P627, DOI 10.1016/0277-9536(92)90001-7; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; *IRI, 2008, IRI LDEO CLIM DAT LI; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly-Hope LA, 2006, TROP MED INT HEALTH, V11, P129, DOI 10.1111/j.1365-3156.2005.01558.x; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Lariviere M, 1966, Bull Soc Med Afr Noire Lang Fr, V11, P670; Lenhart Audrey, 2007, Filaria J, V6, P14, DOI 10.1186/1475-2883-6-14; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Love T, 2002, CLIMATE PREDICTION C; Molyneux DH, 2003, T ROY SOC TROP MED H, V97, P129, DOI 10.1016/S0035-9203(03)90097-6; Muturi EJ, 2007, J MED ENTOMOL, V44, P336, DOI 10.1603/0022-2585(2007)44[336:MSSAPF]2.0.CO;2; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; *NOAA, 2008, DAILY DIAGN GROUND Q; *NOAA, 2008, DAILY DIAGN AB GROUN; *NOAA, 2008, NCEP CPC FEWS AFR DA; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; *USGS, 2008, NORM DIFF VEG IND LA; WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121; WHO, 2004, WHOCDSCPEPVC200410; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; DIRECTORY CITIES TOW	46	68	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9927	10.1371/journal.pone.0009927	http://dx.doi.org/10.1371/journal.pone.0009927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360950	Green Published, Green Accepted, gold			2022-12-27	WOS:000276163100019
J	Scott, JJ; Budsberg, KJ; Suen, G; Wixon, DL; Balser, TC; Currie, CR				Scott, Jarrod J.; Budsberg, Kevin J.; Suen, Garret; Wixon, Devin L.; Balser, Teri C.; Currie, Cameron R.			Microbial Community Structure of Leaf-Cutter Ant Fungus Gardens and Refuse Dumps	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACID; CUTTING ANTS; SOIL; BACTERIA; POPULATION; DYNAMICS; BIOMASS; NESTS; LIPOPOLYSACCHARIDES; METAGENOMICS	Background: Leaf-cutter ants use fresh plant material to grow a mutualistic fungus that serves as the ants' primary food source. Within fungus gardens, various plant compounds are metabolized and transformed into nutrients suitable for ant consumption. This symbiotic association produces a large amount of refuse consisting primarily of partly degraded plant material. A leaf-cutter ant colony is thus divided into two spatially and chemically distinct environments that together represent a plant biomass degradation gradient. Little is known about the microbial community structure in gardens and dumps or variation between lab and field colonies. Methodology/Principal Findings: Using microbial membrane lipid analysis and a variety of community metrics, we assessed and compared the microbiota of fungus gardens and refuse dumps from both laboratory-maintained and field-collected colonies. We found that gardens contained a diverse and consistent community of microbes, dominated by Gram-negative bacteria, particularly gamma-Proteobacteria and Bacteroidetes. These findings were consistent across lab and field gardens, as well as host ant taxa. In contrast, dumps were enriched for Gram-positive and anaerobic bacteria. Broad-scale clustering analyses revealed that community relatedness between samples reflected system component (gardens/dumps) rather than colony source (lab/field). At finer scales samples clustered according to colony source. Conclusions/Significance: Here we report the first comparative analysis of the microbiota from leaf-cutter ant colonies. Our work reveals the presence of two distinct communities: one in the fungus garden and the other in the refuse dump. Though we find some effect of colony source on community structure, our data indicate the presence of consistently associated microbes within gardens and dumps. Substrate composition and system component appear to be the most important factor in structuring the microbial communities. These results thus suggest that resident communities are shaped by the plant degradation gradient created by ant behavior, specifically their fungiculture and waste management.	[Scott, Jarrod J.; Budsberg, Kevin J.; Suen, Garret; Balser, Teri C.; Currie, Cameron R.] Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Scott, Jarrod J.; Suen, Garret; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Scott, Jarrod J.; Currie, Cameron R.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Budsberg, Kevin J.; Balser, Teri C.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Wixon, Devin L.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Scott, JJ (corresponding author), Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	currie@bact.wisc.edu	Suen, Garret/AAF-2080-2019	Suen, Garret/0000-0002-6170-711X; Scott, Jarrod/0000-0001-9863-1318; Wixon, Devin/0000-0002-5206-4650	National Science Foundation [DEB-0747002, MCB-0702025, MCB-0731822]; DOE Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; Direct For Biological Sciences [0747002] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); DOE Great Lakes Bioenergy Research Center(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation [grants DEB-0747002 (to CRC), MCB-0702025 (to CRC and TCB), and MCB-0731822 (to CRC)] and the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494, to (CRC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baath E, 2003, MICROBIAL ECOL, V45, P373, DOI 10.1007/s00248-003-2002-y; BACCI M, 1995, BRAZ J MED BIOL RES, V28, P79; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Belt T., 1874, NATURALIST NICARAGUA; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bull ID, 2000, NATURE, V405, P175, DOI 10.1038/35012061; Carreiro SC, 1997, ANTON LEEUW INT J G, V71, P243, DOI 10.1023/A:1000182108648; Colwell R.K., 2006, ESTIMATES STAT ESTIM; CRAVEN SE, 1970, SCIENCE, V169, P184, DOI 10.1126/science.169.3941.184; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Epstein E., 1997, SCI COMPOSTING; Farji-Brener AG, 2000, BIOTROPICA, V32, P120, DOI 10.1646/0006-3606(2000)032[0120:TIOWTD]2.0.CO;2; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fritze H, 2000, EUR J SOIL SCI, V51, P565, DOI 10.1046/j.1365-2389.2000.00346.x; Frostegard A, 1997, APPL ENVIRON MICROB, V63, P2224; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hallmann C, 2008, NAT GEOSCI, V1, P588, DOI 10.1038/ngeo260; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; HENDRICK D, 2005, MANUAL SOIL ANAL MON, P251; Herz H, 2007, BIOTROPICA, V39, P476, DOI 10.1111/j.1744-7429.2007.00283.x; Herz H, 2007, BIOTROPICA, V39, P482, DOI 10.1111/j.1744-7429.2007.00284.x; Holldobler B., 1990, pi; Hudson TM, 2009, SOIL BIOL BIOCHEM, V41, P1088, DOI 10.1016/j.soilbio.2009.02.014; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Keith-Roach MJ, 2002, BIOGEOCHEMISTRY, V60, P77, DOI 10.1023/A:1016553225977; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Little AEF, 2003, NATURWISSENSCHAFTEN, V90, P558, DOI 10.1007/s00114-003-0480-x; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Mentzer JL, 2006, PLANT SOIL, V284, P85, DOI 10.1007/s11104-006-0032-1; Midi I, 2001, SHERLOCK MICROBIAL I; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; MOSER JOHN C., 1963, ANN ENTOMOL SOC AMER, V56, P286, DOI 10.1093/aesa/56.3.286; Oravecz O, 2004, FOLIA MICROBIOL, V49, P83, DOI 10.1007/BF02931652; Petersen SO, 2002, SOIL SCI SOC AM J, V66, P826, DOI 10.2136/sssaj2002.0826; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Poulsen M, 2003, NATURWISSENSCHAFTEN, V90, P406, DOI 10.1007/s00114-003-0450-3; Ramsey PW, 2006, PEDOBIOLOGIA, V50, P275, DOI 10.1016/j.pedobi.2006.03.003; ROCKWOOD LL, 1976, ECOLOGY, V57, P48, DOI 10.2307/1936397; *SAS I INC, 2007, JMP; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Smithwick EAH, 2005, SOIL BIOL BIOCHEM, V37, P1546, DOI 10.1016/j.soilbio.2005.01.016; Srinivasan BS, 2005, NAT BIOTECHNOL, V23, P691, DOI 10.1038/nbt1098; Sternberg LD, 2007, P ROY SOC B-BIOL SCI, V274, P315, DOI 10.1098/rspb.2006.3746; SUEN G, 2010, INSECT HERBIVO UNPUB; Suen G, 2006, J BACTERIOL, V188, P7999, DOI 10.1128/JB.01195-06; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Weber N. A., 1972, GARDENING ANTS ATTIN; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; Wirth R, 2003, HERBIVORY LEAF CUTTI, P230; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zar, 2011, BIOSTAT ANAL; ZELLES L, 1992, SOIL BIOL BIOCHEM, V24, P317, DOI 10.1016/0038-0717(92)90191-Y; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	61	65	69	6	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9922	10.1371/journal.pone.0009922	http://dx.doi.org/10.1371/journal.pone.0009922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360970	gold, Green Published, Green Submitted			2022-12-27	WOS:000276163100015
J	Dheda, K; Davids, V; Lenders, L; Roberts, T; Meldau, R; Ling, D; Brunet, L; Smit, RV; Peter, J; Green, C; Badri, M; Sechi, L; Sharma, S; Hoelscher, M; Dawson, R; Whitelaw, A; Blackburn, J; Pai, M; Zumla, A				Dheda, Keertan; Davids, Virginia; Lenders, Laura; Roberts, Teri; Meldau, Richard; Ling, Daphne; Brunet, Laurence; Smit, Richard van Zyl; Peter, Jonathan; Green, Clare; Badri, Motasim; Sechi, Leonardo; Sharma, Surendra; Hoelscher, Michael; Dawson, Rodney; Whitelaw, Andrew; Blackburn, Jonathan; Pai, Madhukar; Zumla, Alimuddin			Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples	PLOS ONE			English	Article							MYCOBACTERIAL LIPOARABINOMANNAN; ACTIVE TUBERCULOSIS; BURDEN; TECHNOLOGIES	Background: The accurate diagnosis of TB in HIV-infected patients, particularly with advanced immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) assay (Clearview-TB (R)-ELISA) may have some utility for the diagnosis of TB in HIV-infected patients; however, the precise subgroup that may benefit from this technology requires clarification. The utility of LAM in sputum samples has, hitherto, not been evaluated. Methods: LAM was measured in sputum and urine samples obtained from 500 consecutively recruited ambulant patients, with suspected TB, from 2 primary care clinics in South Africa. Culture positivity for M. tuberculosis was used as the reference standard for TB diagnosis. Results: Of 440 evaluable patients 120/387 (31%) were HIV-infected. Urine-LAM positivity was associated with HIV positivity (p = 0.007) and test sensitivity, although low, was significantly higher in HIV-infected compared to uninfected patients (21% versus 6%; p<0.001), and also in HIV-infected participants with a CD4 <200 versus <200 cells/mm(3) (37% versus 0%; p = 0.003). Urine-LAM remained highly specific in all 3 subgroups (95%-100%). 25% of smear-negative but culture-positive HIV-infected patients with a CD4 <200 cells/mm(3) were positive for urine-LAM. Sputum-LAM had good sensitivity (86%) but poor specificity (15%) likely due to test cross-reactivity with several mouth-residing organisms including actinomycetes and nocardia species. Conclusions: These preliminary data indicate that in a high burden primary care setting the diagnostic usefulness of urine-LAM is limited, as a rule-in test, to a specific patient subgroup i.e. smear-negative HIV-infected TB patients with a CD4 count <200 cells/mm(3), who would otherwise have required further investigation. However, even in this group sensitivity was modest. Future and adequately powered studies in a primary care setting should now specifically target patients with suspected TB who have advanced HIV infection.	[Dheda, Keertan; Davids, Virginia; Lenders, Laura; Meldau, Richard; Smit, Richard van Zyl; Peter, Jonathan; Dawson, Rodney] Univ Cape Town, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Davids, Virginia; Lenders, Laura; Meldau, Richard; Smit, Richard van Zyl; Peter, Jonathan; Dawson, Rodney] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Roberts, Teri; Blackburn, Jonathan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Badri, Motasim] Univ Cape Town, Dept Med, Clin Res Support Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Green, Clare; Zumla, Alimuddin] UCL, Sch Med, Dept Infect, Ctr Infect Dis & Int Hlth, London W1N 8AA, England; [Blackburn, Jonathan] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Ling, Daphne; Brunet, Laurence; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Sechi, Leonardo] Univ Sardinia, Dipartimento Sci Biomed, Sassari, Italy; [Sharma, Surendra] All India Inst Med Sci, Dept Med, Div Pulm Crit Care & Sleep Med, New Delhi 110029, India; [Whitelaw, Andrew] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Hoelscher, Michael] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School; University of Cape Town; McGill University; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Cape Town; University of Munich	Dheda, K (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Hoelscher, Michael/D-3436-2012; ZUMLA, Alimuddin/ABA-8208-2020; Pai, Madhukar/AAX-9901-2021; Sechi, Leonardo Antonio/Y-3109-2018; PAL, MRINAL/ABG-9676-2020; Brunet, Laurence/J-7099-2014; Badri, Motasim/E-1141-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Brunet, Laurence/0000-0001-8467-4835; sechi, leonardo antonio/0000-0003-0566-2049; Whitelaw, Andrew/0000-0001-9070-5247; Peter, Jonathan/0000-0002-2658-0723; van Zyl-Smit, Richard/0000-0002-4115-5362; Badri, Motasim/0000-0002-5268-6492	European Commission [EU-FP7]; Europe AID ADAT; EDCTP; UK Cambridge Biomedical Research Centre (CBRC); National Institute for Health Research (NIHR); Canadian Institutes of Health Research (CIHR) [MOP-89918]; Medical Research Council (MRC) Career Development Award; NRF/SARChI award; CIHR New Investigator Award	European Commission(European CommissionEuropean Commission Joint Research Centre); Europe AID ADAT; EDCTP; UK Cambridge Biomedical Research Centre (CBRC); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medical Research Council (MRC) Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF/SARChI award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This study was supported by a TBsusgent grant from the European Commission (EU-FP7; K. D., M. P., M. H.), Europe AID ADAT grant (A. Z. and M. H.), EDCTP (M. H., K. D. and A. Z.), UK Cambridge Biomedical Research Centre (CBRC), National Institute for Health Research (NIHR) (A. Z.), and in by part by the Canadian Institutes of Health Research (CIHR) grant MOP-89918; M. P., K. D.). K. D. is also supported by a Medical Research Council (MRC) Career Development Award and a NRF/SARChI award, and M. P. by a CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Esquivel C, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-1; Arias-Bouda LMP, 2000, J CLIN MICROBIOL, V38, P2278; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Burman William J, 2003, Semin Respir Infect, V18, P263; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Daley P, 2009, INT J TUBERC LUNG D, V13, P989; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Doublier S, 2007, AIDS, V21, P423, DOI 10.1097/QAD.0b013e328012c522; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; LAWN SD, 2009, URINE LIPOARABINOMAN; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; MUTETWA R, 2009, INT J TUBERCULOSIS L; New Diagnostics Working Group of the Stop TB Partnership, 2009, PATHW BETT DIAGN TUB; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Quaggin SE, 2009, J CLIN INVEST, V119, P1085, DOI 10.1172/JCI39254; REITHER K, 2009, LOW SENSITIVITY URIN; Shah M, 2009, J ACQ IMMUN DEF SYND; Sittampalam GS, 1996, J IMMUNOL METHODS, V190, P151, DOI 10.1016/0022-1759(95)00262-6; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; *WHO, 2006, STOP TB PARTN; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; World Health Organization, 2008, GLOB TUB CONTR SURV	28	109	113	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9848	10.1371/journal.pone.0009848	http://dx.doi.org/10.1371/journal.pone.0009848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352098	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894500016
J	Jung, RE; Segall, JM; Grazioplene, RG; Qualls, C; Sibbitt, WL; Roldan, CA				Jung, Rex E.; Segall, Judith M.; Grazioplene, Rachael G.; Qualls, Clifford; Sibbitt, Wilmer L., Jr.; Roldan, Carlos A.			Cortical Thickness and Subcortical Gray Matter Reductions in Neuropsychiatric Systemic Lupus Erythematosus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; PROTON MR SPECTROSCOPY; SURFACE-BASED ANALYSIS; ANTIPHOSPHOLIPID ANTIBODIES; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; RHESUS-MONKEY; BRAIN-LESIONS	Within systemic lupus erythematosus (SLE) patients can be divided into groups with and without central nervous system involvement, the latter being subcategorized as neuropsychiatric systemic lupus erythematosus (NPSLE). While a number of research groups have investigated NPSLE, there remains a lack of consistent application of this diagnostic criteria within neuroimaging studies. Previous neuroimaging research suggests that SLE patients have reduced subcortical and regional gray matter volumes when compared to controls, and that these group differences may be driven by SLE patients with neuropsychiatric symptoms. The current study sought to compare measures of cortical thickness and subcortical structure volume between NPSLE, SLE, and healthy controls. We hypothesized that patients with NPSLE (N = 21) would have thinner cortex and reduced subcortical gray matter volumes when compared to SLE (N = 16) and control subjects (N = 21). All subjects underwent MRI examinations on a 1.5 Tesla Siemens Sonata scanner. Anatomical reconstruction and segmentation were performed using the FreeSurfer image analysis suite. Cortical and subcortical volumes were extracted from FreeSurfer and analyzed for group differences, controlling for age. The NPSLE group exhibited decreased cortical thickness in clusters of the left frontal and parietal lobes as well as in the right parietal and occipital lobes compared to control subjects. Compared to the SLE group, the NPSLE group exhibited comparable thinning in clusters of the frontal and temporal lobes. Controlling for age, we found that between group effects for subcortical gray matter structures were significant for the thalamus (F = 3.06, p = .04), caudate nucleus (F = 3.19, p = .03), and putamen (F = 4.82, p = .005). These results clarify previous imaging work identifying cortical atrophy in a mixed SLE and NPSLE group, and suggest that neuroanatomical abnormalities are specific to SLE patients diagnosed with neuropsychiatric symptoms. Future work should help elucidate the underlying mechanisms underlying the emerging neurobiological profile seen in NPSLE, as well as clarify the apparent lack of overlap between cortical thinning and functional activation results and other findings pointing to increased functional activation during cognitive tasks.	[Jung, Rex E.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Jung, Rex E.; Segall, Judith M.; Grazioplene, Rachael G.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Dept Math, Albuquerque, NM 87131 USA; [Sibbitt, Wilmer L., Jr.; Roldan, Carlos A.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Jung, RE (corresponding author), Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.	rjung@salud.unm.edu	Sibbitt, Wilmer/AAI-7746-2020	Sibbitt, Wilmer/0000-0001-5872-160X; Jung, Rex/0000-0003-3718-0597	NIH-NHLBI (National Institutes of Health-National Heart, Lung, and Blood Institute) [R01HL077422-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077422] Funding Source: NIH RePORTER	NIH-NHLBI (National Institutes of Health-National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research supported by grant number R01HL077422-01A1 - NIH-NHLBI (National Institutes of Health-National Heart, Lung, and Blood Institute), to Carlos A. Roldan, M. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Appenzeller S, 2006, ANN RHEUM DIS, V65, P1585, DOI 10.1136/ard.2005.049486; Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; Appenzeller S, 2004, NEUROLOGY, V63, P1808, DOI 10.1212/01.WNL.0000144178.32208.4F; Appenzeller S, 2007, NEUROIMAGE, V34, P694, DOI 10.1016/j.neuroimage.2006.09.029; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BAUM KA, 1993, CLIN NEUROL NEUROSUR, V95, P29, DOI 10.1016/0303-8467(93)90088-X; BENNETT R, 1972, BRIT MED J, V4, P342, DOI 10.1136/bmj.4.5836.342; BLUESTEIN HG, 1987, NEW ENGL J MED, V317, P309, DOI 10.1056/NEJM198707303170509; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bosma GPT, 2002, ARTHRITIS RHEUM, V46, P2665, DOI 10.1002/art.10574; Bosma GPT, 2000, ARTHRITIS RHEUM-US, V43, P48, DOI 10.1002/1529-0131(200001)43:1<48::AID-ANR7>3.0.CO;2-H; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Brooks WM, 1997, J RHEUMATOL, V24, P2323; CARETTE S, 1982, J RHEUMATOL, V9, P855; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chinn RJS, 1997, ARTHRITIS RHEUM-US, V40, P36, DOI 10.1002/art.1780400107; Cotton F, 2004, REV MED INTERNE, V25, P8, DOI 10.1016/S0248-8663(03)00265-0; Csepany T, 2003, J NEUROL, V250, P1348, DOI 10.1007/s00415-003-0223-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FEELY RH, 1976, IRISH MED J, V69, P255; FEINGLASS EJ, 1976, MEDICINE, V55, P323, DOI 10.1097/00005792-197607000-00004; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgibbon BM, 2008, RHEUMATOLOGY, V47, P50, DOI 10.1093/rheumatology/kem287; Friedman SD, 1998, RADIOLOGY, V209, P79, DOI 10.1148/radiology.209.1.9769816; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hachulla E, 1998, LUPUS, V7, P124, DOI 10.1191/096120398678919868; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; Hanly JG, 2004, LUPUS, V13, P861, DOI 10.1191/0961203304lu2024oa; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hughes M, 2007, ACTA RADIOL, V48, P213, DOI 10.1080/02841850601105825; ISHIKAWA O, 1994, J RHEUMATOL, V21, P87; JAREK MJ, 1994, ARTHRITIS RHEUM-US, V37, P1609, DOI 10.1002/art.1780371108; JUNG RE, 2009, HUM BRAIN MAPP; Juranek J, 2008, NEUROIMAGE, V40, P1516, DOI 10.1016/j.neuroimage.2008.01.043; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; LU LH, 2009, CEREB CORTEX; MCCUNE WJ, 1988, ARTHRITIS RHEUM-US, V31, P159, DOI 10.1002/art.1780310202; OMDAL R, 1989, SCAND J RHEUMATOL, V18, P283, DOI 10.3109/03009748909095031; Otte A, 1997, EUR J NUCL MED, V24, P787; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rocca MA, 2006, NEUROIMAGE, V30, P478, DOI 10.1016/j.neuroimage.2005.09.047; Rocca MA, 2002, ANN NEUROL, V51, P330, DOI 10.1002/ana.10120; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sabet A, 1998, STROKE, V29, P2254, DOI 10.1161/01.STR.29.11.2254; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sanna G, 2003, J RHEUMATOL, V30, P985; SCHMAHMANN JD, 1990, J COMP NEUROL, V295, P299, DOI 10.1002/cne.902950212; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sibbitt Jr W.L., 2009, SEMIN ARTHRITIS RHEU; Sibbitt WL, 1997, AM J NEURORADIOL, V18, P1271; SIBBITT WL, 1994, AM J NEURORADIOL, V15, P923; Sibbitt WL, 1999, ARTHRITIS RHEUM-US, V42, P2026, DOI 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J; SIBBITT WL, 1995, ARTHRITIS RHEUM-US, V38, P810, DOI 10.1002/art.1780380615; SIBBITT WL, 1989, ANN RHEUM DIS, V48, P1014, DOI 10.1136/ard.48.12.1014; Sibbitt WL, 2002, J RHEUMATOL, V29, P1536; Sundgren PC, 2005, NEURORADIOLOGY, V47, P576, DOI 10.1007/s00234-005-1371-y; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wartenburger I, 2009, NEUROIMAGE, V48, P291, DOI 10.1016/j.neuroimage.2009.06.025; Waterloo K, 1999, J NEUROL, V246, P706, DOI 10.1007/s004150050436; Weiner SM, 2000, ANN RHEUM DIS, V59, P377, DOI 10.1136/ard.59.5.377; WEISBERG LA, 1986, COMPUT RADIOL, V10, P63, DOI 10.1016/0730-4862(86)90022-3; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Zanardi VA, 2001, CLIN RHEUMATOL, V20, P245, DOI 10.1007/s100670170037; 1999, ARTHRITIS RHEUM, V42, P599	77	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9302	10.1371/journal.pone.0009302	http://dx.doi.org/10.1371/journal.pone.0009302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352085	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500002
J	Genovart, M; Negre, N; Tavecchia, G; Bistuer, A; Parpal, L; Oro, D				Genovart, Meritxell; Negre, Nieves; Tavecchia, Giacomo; Bistuer, Ana; Parpal, Luis; Oro, Daniel			The Young, the Weak and the Sick: Evidence of Natural Selection by Predation	PLOS ONE			English	Article							SUBSTANDARD INDIVIDUALS; SOCKEYE-SALMON; RISK; SIZE; POPULATIONS; GULLS; BEARS; MASS; VULNERABILITY; RECRUITMENT	It is assumed that predators mainly prey on substandard individuals, but even though some studies partially support this idea, evidence with large sample sizes, exhaustive analysis of prey and robust analysis is lacking. We gathered data from a culling program of yellow-legged gulls killed by two methods: by the use of raptors or by shooting at random. We compared both data sets to assess whether birds of prey killed randomly or by relying on specific individual features of the prey. We carried out a meticulous post-mortem examination of individuals, and analysing multiple prey characteristics simultaneously we show that raptors did not hunt randomly, but rather preferentially predate on juveniles, sick gulls, and individuals with poor muscle condition. Strikingly, gulls with an unusually good muscle condition were also predated more than expected, supporting the mass-dependent predation risk theory. This article provides a reliable example of how natural selection may operate in the wild and proves that predators mainly prey on substandard individuals.	[Genovart, Meritxell; Tavecchia, Giacomo; Oro, Daniel] IMEDEA CSIC UIB, Dept Biodivers & Conservat, Populat Ecol Grp, Esporles, Spain; [Bistuer, Ana] Consell Mallorca, Serv Gestio Residus, Palma de Mallorca, Spain; [Negre, Nieves] Fdn Nat Parc, Santa Eugenia, Spain; [Parpal, Luis] Consorci Recuperacio Fauna Illes Balears COFIB, Santa Eugenia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Genovart, M (corresponding author), IMEDEA CSIC UIB, Dept Biodivers & Conservat, Populat Ecol Grp, Esporles, Spain.	m.genovart@uib.es	Tavecchia, Giacomo/N-3961-2014; Oro, Daniel/H-4208-2012; Genovart, Meritxell/L-4873-2014	Tavecchia, Giacomo/0000-0001-5435-2691; Oro, Daniel/0000-0003-4782-3007; Genovart, Meritxell/0000-0003-2919-1288	EMAYA (Empresa Municipal de Agua y Alcantarillado); Spanish Ministry of Science [CGL2006-04325/BOS]; I3P-CSIC fellowship	EMAYA (Empresa Municipal de Agua y Alcantarillado); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); I3P-CSIC fellowship	The authors acknowledge support mainly from TIRME, S. A. and also from EMAYA (Empresa Municipal de Agua y Alcantarillado) and the Spanish Ministry of Science (grant ref. CGL2006-04325/BOS). M. G. was supported by an I3P-CSIC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 1877, DIFFERENT FORMS FLOW; BLOKPOEL H, 1991, ACT 20 C INT ORN CHR; Bosch M, 2000, J APPL ECOL, V37, P369, DOI 10.1046/j.1365-2664.2000.00501.x; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Carlson SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001286; Carlson SM, 2009, EVOLUTION, V63, P1244, DOI 10.1111/j.1558-5646.2009.00643.x; Curio E., 1976, ETHOLOGY PREDATION; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Duffy MA, 2005, LIMNOL OCEANOGR, V50, P412, DOI 10.4319/lo.2005.50.2.0412; Endler J.A., 1986, Monographs in Population Biology, pviii; ERRINGTON PL, 1946, Q REV BIOL, V21, P144, DOI 10.1086/395220; FEARE CJ, 1991, BIRD POPULATION STUD, P463; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Hatch Jeremy J., 1996, International Journal of Environmental Health Research, V6, P5, DOI 10.1080/09603129609356867; HEITMEYER ME, 1993, J WILDLIFE MANAGE, V57, P733, DOI 10.2307/3809073; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; MacLeod R, 2007, P ROY SOC B-BIOL SCI, V274, P2587, DOI 10.1098/rspb.2007.0786; MacLeod R, 2006, BIOL LETT-UK, V2, P43, DOI 10.1098/rsbl.2005.0421; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Moller AP, 2000, OECOLOGIA, V122, P500, DOI 10.1007/s004420050972; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Penteriani V, 2008, J AVIAN BIOL, V39, P215, DOI 10.1111/j.0908-8857.2008.04280.x; Quinn TP, 1999, OECOLOGIA, V121, P273, DOI 10.1007/s004420050929; Quinn TP, 2001, EVOL ECOL RES, V3, P917; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RICKLEFS RE, 1969, NATURE, V223, P922, DOI 10.1038/223922a0; Sanz-Aguilar A, 2009, ECOGRAPHY, V32, P637, DOI 10.1111/j.1600-0587.2009.05596.x; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; TEMPLE SA, 1987, ECOLOGY, V68, P669, DOI 10.2307/1938472; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578	39	80	80	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9774	10.1371/journal.pone.0009774	http://dx.doi.org/10.1371/journal.pone.0009774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333305	gold, Green Published			2022-12-27	WOS:000275809700013
J	Cestari, I; Ramirez, MI				Cestari, Igor; Ramirez, Marcel I.			Inefficient Complement System Clearance of Trypanosoma cruzi Metacyclic Trypomastigotes Enables Resistant Strains to Invade Eukaryotic Cells	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; MEDIATED LYSIS; MOLECULAR-BASIS; BLOOD-DONORS; ANTIBODIES; PATHWAY; ACTIVATION; INFECTION; SURFACE; SUSCEPTIBILITY	The complement system is the main arm of the vertebrate innate immune system against pathogen infection. For the protozoan Trypanosoma cruzi, the causative agent of Chagas disease, subverting the complement system and invading the host cells is crucial to succeed in infection. However, little attention has focused on whether the complement system can effectively control T. cruzi infection. To address this question, we decided to analyse: 1) which complement pathways are activated by T. cruzi using strains isolated from different hosts, 2) the capacity of these strains to resist the complement-mediated killing at nearly physiological conditions, and 3) whether the complement system could limit or control T. cruzi invasion of eukaryotic cells. The complement activating molecules C1q, C3, mannan-binding lectin and ficolins bound to all strains analysed; however, C3b and C4b deposition assays revealed that T. cruzi activates mainly the lectin and alternative complement pathways in non-immune human serum. Strikingly, we detected that metacyclic trypomastigotes of some T. cruzi strains were highly susceptible to complement-mediated killing in non-immune serum, while other strains were resistant. Furthermore, the rate of parasite invasion in eukaryotic cells was decreased by non-immune serum. Altogether, these results establish that the complement system recognizes T. cruzi metacyclic trypomastigotes, resulting in killing of susceptible strains. The complement system, therefore, acts as a physiological barrier which resistant strains have to evade for successful host infection.	[Cestari, Igor; Ramirez, Marcel I.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Cestari, I (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	marcelr@fiocruz.br			National Council for Scientific and Technological Development (CNPq) [476737/2004-4]; CNPq [141757/2006-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PDEE4261/06-2]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by The National Council for Scientific and Technological Development (CNPq) (476737/2004-4); I. S. Cestari was a recipient of CNPq (141757/2006-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PDEE4261/06-2) scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA IC, 1991, J IMMUNOL, V146, P2394; ALMEIDA IC, 1994, BIOCHEM J, V304, P793, DOI 10.1042/bj3040793; Ambrosio AR, 2005, PARASITE IMMUNOL, V27, P333, DOI 10.1111/j.1365-3024.2005.00782.x; Atayde VD, 2004, INT J PARASITOL, V34, P851, DOI 10.1016/j.ijpara.2004.03.003; Bahia Maria Terezinha, 2002, Rev. Soc. Bras. Med. Trop., V35, P339, DOI 10.1590/S0037-86822002000400010; Barrett VJ, 1997, AM J CLIN PATHOL, V108, P499; Barros VC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006047; BIJOVSKY AT, 1984, ACTA TROP, V41, P207; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Cestari ID, 2008, J INFECT DIS, V198, P1276, DOI 10.1086/592167; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; DECASTRO SL, 1993, ACTA TROP, V53, P83, DOI 10.1016/0001-706X(93)90021-3; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Ferreira V, 2004, J IMMUNOL, V172, P3042, DOI 10.4049/jimmunol.172.5.3042; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000447; ISH C, 1993, SCAND J IMMUNOL, V38, P113, DOI 10.1111/j.1365-3083.1993.tb01701.x; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; JOINER K, 1986, P NATL ACAD SCI USA, V83, P6593, DOI 10.1073/pnas.83.17.6593; JOINER K, 1985, J EXP MED, V161, P1196, DOI 10.1084/jem.161.5.1196; Kipnis T L, 1992, Mediators Inflamm, V1, P309, DOI 10.1155/S0962935192000450; KIPNIS TL, 1985, SCAND J IMMUNOL, V22, P217, DOI 10.1111/j.1365-3083.1985.tb01874.x; KOENE RAP, 1973, J IMMUNOL, V111, P1894; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kollien Astrid H., 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P335; KRETTLI AU, 1979, CLIN EXP IMMUNOL, V37, P416; KRETTLI AU, 1985, CLIN EXP IMMUNOL, V62, P270; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Leon-Perez F, 2007, VECTOR-BORNE ZOONOT, V7, P330, DOI 10.1089/vbz.2006.0604; Moreno I, 2007, MICROBES INFECT, V9, P1574, DOI 10.1016/j.micinf.2007.09.009; Munoz J, 2009, CLIN INFECT DIS, V48, P1736, DOI 10.1086/599223; Negrette OS, 2005, PEDIATRICS, V115, pE668, DOI 10.1542/peds.2004-1732; Norris KA, 1998, INFECT IMMUN, V66, P2460, DOI 10.1128/IAI.66.6.2460-2465.1998; Parmentier HK, 2004, VET IMMUNOL IMMUNOP, V100, P25, DOI 10.1016/j.vetimm.2004.02.009; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; PEARSON RD, 1980, J IMMUNOL, V125, P2195; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Peters NC, 2009, CELL MICROBIOL, V11, P1290, DOI 10.1111/j.1462-5822.2009.01348.x; Piron M, 2008, TRANSFUSION, V48, P1862, DOI 10.1111/j.1537-2995.2008.01789.x; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; Roellig DM, 2009, INT J PARASITOL, V39, P1603, DOI 10.1016/j.ijpara.2009.06.007; Roellig DM, 2009, J PARASITOL, V95, P360, DOI 10.1645/GE-1740.1; SAMANOVIC M, 2009, PLOS PATHOG, V5, P1; Schuster JP, 2000, INT J PARASITOL, V30, P1475, DOI 10.1016/S0020-7519(00)00119-3; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; TAMBOURGI DV, 1993, INFECT IMMUN, V61, P3656, DOI 10.1128/IAI.61.9.3656-3663.1993; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018; Turner M W, 2000, Rev Immunogenet, V2, P305; WIRTZ GH, 1967, IMMUNOCHEMISTRY, V4, P61, DOI 10.1016/0019-2791(67)90198-X; YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; YOSHIDA N, 1987, PARASITE IMMUNOL, V9, P389, DOI 10.1111/j.1365-3024.1987.tb00516.x; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008	57	39	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9721	10.1371/journal.pone.0009721	http://dx.doi.org/10.1371/journal.pone.0009721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300530	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400019
J	Kessel, L; Eskildsen, L; van der Poel, M; Larsen, M				Kessel, Line; Eskildsen, Lars; van der Poel, Mike; Larsen, Michael			Non-Invasive Bleaching of the Human Lens by Femtosecond Laser Photolysis	PLOS ONE			English	Article							HUMAN EYE LENS; PROTEIN INTERACTIONS; DAMAGE; SENSITIVITY; ULTRAVIOLET; THRESHOLDS; DEPENDENCE; LESIONS; PULSES	Background: Globally, cataract is the leading cause of blindness and impaired vision. Cataract surgery is an attractive treatment option but it remains unavailable in sufficient quantity for the vast majority of the world population living in areas without access to specialized health care. Reducing blindness from cataract requires solutions that can be applied outside operating theatres. Cataract is a protein conformational disease characterized by accumulation of light absorbing, fluorescent and scattering protein aggregates. The aim of the study was to investigate whether these compounds were susceptible to photobleaching by a non-invasive procedure and whether this would lead to optical rejuvenation of the lens. Methodology/Principal Findings: Nine human donor lenses were treated with an 800 nm infra-red femtosecond pulsed laser in a treatment zone measuring 1 x 1 x 0.52 mm. After laser treatment the age-induced yellow discoloration of the lens was markedly reduced and the transmission of light was increased corresponding to an optical rejuvenation of 3 to 7 years. Conclusions/Significance: The results demonstrate that the age-induced yellowing of the human lens can be bleached by a non-invasive procedure based on femtosecond laser photolysis. Cataract is a disease associated with old age. At the current technological stage, lens aging is delayed but with a treatment covering the entire lens volume complete optical rejuvenation is expected. Thus, femtosecond photolysis has the potential clinical value of replacing invasive cataract surgery by a non-invasive treatment modality that can be placed in mobile units, thus breaking down many of the barriers impeding access to treatment in remote and poor regions of the world.	[Kessel, Line; Eskildsen, Lars; Larsen, Michael] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, Glostrup, Denmark; [Eskildsen, Lars; van der Poel, Mike] Tech Univ Denmark, Dept Photon Engn, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Kessel, L (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, Glostrup, Denmark.	line.kessel@dadlnet.dk	Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891; Kessel, Line/0000-0002-9375-1510	Danish Medical Research Council [721-06-0664]; Danish National Advanced Technology Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Advanced Technology Foundation	The study received financial support from the Danish Medical Research Council (grant # 721-06-0664) and the Danish National Advanced Technology Foundation (Hoejteknologifonden). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argirov OK, 2005, ANN NY ACAD SCI, V1043, P166, DOI 10.1196/annals.1333.021; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CAIN CP, 1995, INVEST OPHTH VIS SCI, V36, P879; Cain CP, 1999, INVEST OPHTH VIS SCI, V40, P2343; Cain CP, 2002, HEALTH PHYS, V82, P855, DOI 10.1097/00004032-200206000-00014; Cain CP, 2001, J LASER APPL, V13, P125, DOI 10.2351/1.1356421; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Friedlaender Mitchell H., 2006, International Ophthalmology Clinics, V46, P145, DOI 10.1097/00004397-200604630-00013; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; HAM WT, 1979, PHOTOCHEM PHOTOBIOL, V29, P735, DOI 10.1111/j.1751-1097.1979.tb07759.x; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; Heisterkamp A, 2005, OPT EXPRESS, V13, P3690, DOI 10.1364/OPEX.13.003690; Hermans EA, 2008, OPTOMETRY VISION SCI, V85, P1179, DOI 10.1097/OPX.0b013e31818e8d57; Kessel L, 2005, ACTA OPHTHALMOL SCAN, V83, P221, DOI 10.1111/j.1600-0420.2005.00388.x; Kessel L, 2011, ACTA OPHTHALMOL, V89, pe289, DOI 10.1111/j.1755-3768.2009.01839.x; Kessel L, 2010, J CATARACT REFR SURG, V36, P308, DOI 10.1016/j.jcrs.2009.08.035; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Ortwerth BJ, 2002, EXP EYE RES, V74, P217, DOI 10.1006/exer.2001.1114; Ponce A, 2006, MOL VIS, V12, P879; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rockwell BA, 1999, J LASER APPL, V11, P42, DOI 10.2351/1.521879; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; STRADNER A, 2007, PHYS REV LETT, V99; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; TOTH CA, 1995, INVEST OPHTH VIS SCI, V36, P1910; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; *WHO, 2007, VIS 2020 RIGHT SIGHT, P7	30	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9711	10.1371/journal.pone.0009711	http://dx.doi.org/10.1371/journal.pone.0009711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300521	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400009
J	Stark, MS; Tyagi, S; Nancarrow, DJ; Boyle, GM; Cook, AL; Whiteman, DC; Parsons, PG; Schmidt, C; Sturm, RA; Hayward, NK				Stark, Mitchell S.; Tyagi, Sonika; Nancarrow, Derek J.; Boyle, Glen M.; Cook, Anthony L.; Whiteman, David C.; Parsons, Peter G.; Schmidt, Christopher; Sturm, Richard A.; Hayward, Nicholas K.			Characterization of the Melanoma miRNAome by Deep Sequencing	PLOS ONE			English	Article							CELL-PROLIFERATION; TUMOR INVASION; EXPRESSION; MICRORNAS; MELANOCYTES; PROGRESSION; METASTASIS; REPRESSION; REVEALS; MARKER	Background: MicroRNAs (miRNAs) are 18-23 nucleotide non-coding RNAs that regulate gene expression in a sequence specific manner. Little is known about the repertoire and function of miRNAs in melanoma or the melanocytic lineage. We therefore undertook a comprehensive analysis of the miRNAome in a diverse range of pigment cells including: melanoblasts, melanocytes, congenital nevocytes, acral, mucosal, cutaneous and uveal melanoma cells. Methodology/Principal Findings: We sequenced 12 small RNA libraries using Illumina's Genome Analyzer II platform. This massively parallel sequencing approach of a diverse set of melanoma and pigment cell libraries revealed a total of 539 known mature and mature-star sequences, along with the prediction of 279 novel miRNA candidates, of which 109 were common to 2 or more libraries and 3 were present in all libraries. Conclusions/Significance: Some of the novel candidate miRNAs may be specific to the melanocytic lineage and as such could be used as biomarkers to assist in the early detection of distant metastases by measuring the circulating levels in blood. Follow up studies of the functional roles of these pigment cell miRNAs and the identification of the targets should shed further light on the development and progression of melanoma.	[Stark, Mitchell S.; Tyagi, Sonika; Nancarrow, Derek J.; Hayward, Nicholas K.] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia; [Boyle, Glen M.; Parsons, Peter G.] Queensland Inst Med Res, Drug Discovery Lab, Brisbane, Qld 4006, Australia; [Whiteman, David C.] Queensland Inst Med Res, Canc Control Grp, Brisbane, Qld 4006, Australia; [Cook, Anthony L.; Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Melanogenix Grp, St Lucia, Qld, Australia; [Schmidt, Christopher] Queensland Inst Med Res, Canc Immunotherapy Grp, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute	Stark, MS (corresponding author), Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia.	Nick.Hayward@qimr.edu.au	hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-3874-2019; Sturm, Richard A/C-9943-2009; Whiteman, David C/P-2728-2014; Parsons, Peter/J-4683-2013; Cook, Anthony/K-9489-2018; Stark, Mitchell S/E-3542-2010; Boyle, Glen/G-1347-2013; Parsons, Peter G/H-8163-2015; hayward, nick/AAV-8802-2020; Stark, Mitchell/K-6794-2019; Schmidt, Christopher W/A-4353-2009; Tyagi, Sonika/L-2256-2019	hayward, nicholas k/0000-0003-4760-1033; Sturm, Richard A/0000-0003-1301-0294; Whiteman, David C/0000-0003-2563-9559; Parsons, Peter/0000-0002-0473-3346; Cook, Anthony/0000-0003-1770-7910; Stark, Mitchell S/0000-0002-4510-2161; Boyle, Glen/0000-0002-1385-529X; Parsons, Peter G/0000-0002-0473-3346; Stark, Mitchell/0000-0002-4510-2161; Schmidt, Christopher W/0000-0002-3955-5076; Tyagi, Sonika/0000-0003-0181-6258	National Health and Medical Research Council of Australia (NHMRC); Cancer Council Queensland	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC)(www.nhmrc.gov.au), and the Cancer Council Queensland (www.cancerqld.org.au). NKH is the recipient of a Senior Principal Research Fellowship from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leonard JH, 2003, PIGM CELL RES, V16, P198, DOI 10.1034/j.1600-0749.2003.00033.x; Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pollock PM, 2002, MELANOMA RES, V12, P565, DOI 10.1097/00008390-200212000-00006; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681	34	163	280	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9685	10.1371/journal.pone.0009685	http://dx.doi.org/10.1371/journal.pone.0009685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300190	gold, Green Published, Green Submitted			2022-12-27	WOS:000275620900017
J	Karakasiliotis, I; Vashist, S; Bailey, D; Abente, EJ; Green, KY; Roberts, LO; Sosnovtsev, SV; Goodfellow, IG				Karakasiliotis, Ioannis; Vashist, Surender; Bailey, Dalan; Abente, Eugenio J.; Green, Kim Y.; Roberts, Lisa O.; Sosnovtsev, Stanislav V.; Goodfellow, Ian G.			Polypyrimidine Tract Binding Protein Functions as a Negative Regulator of Feline Calicivirus Translation	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; NUCLEAR-PORE COMPLEX; VIRUS GENOMIC RNA; MOUTH-DISEASE VIRUS; CELLULAR-PROTEINS; MAMMALIAN-CELLS; CAPSID PROTEIN; INFECTED-CELLS; NONSTRUCTURAL POLYPROTEIN; POLY(A)-BINDING PROTEIN	Background: Positive strand RNA viruses rely heavily on host cell RNA binding proteins for various aspects of their life cycle. Such proteins interact with sequences usually present at the 59 or 39 extremities of the viral RNA genome, to regulate viral translation and/or replication. We have previously reported that the well characterized host RNA binding protein polypyrimidine tract binding protein (PTB) interacts with the 5'end of the feline calicivirus (FCV) genomic and subgenomic RNAs, playing a role in the FCV life cycle. Principal Findings: We have demonstrated that PTB interacts with at least two binding sites within the 5'end of the FCV genome. In vitro translation indicated that PTB may function as a negative regulator of FCV translation and this was subsequently confirmed as the translation of the viral subgenomic RNA in PTB siRNA treated cells was stimulated under conditions in which RNA replication could not occur. We also observed that PTB redistributes from the nucleus to the cytoplasm during FCV infection, partially localizing to viral replication complexes, suggesting that PTB binding may be involved in the switch from translation to replication. Reverse genetics studies demonstrated that synonymous mutations in the PTB binding sites result in a cell-type specific defect in FCV replication. Conclusions: Our data indicates that PTB may function to negatively regulate FCV translation initiation. To reconcile this with efficient virus replication in cells, we propose a putative model for the function of PTB in the FCV life cycle. It is possible that during the early stages of infection, viral RNA is translated in the absence of PTB, however, as the levels of viral proteins increase, the nuclear-cytoplasmic shuttling of PTB is altered, increasing the cytoplasmic levels of PTB, inhibiting viral translation. Whether PTB acts directly to repress translation initiation or via the recruitment of other factors remains to be determined but this may contribute to the stimulation of viral RNA replication via clearance of ribosomes from viral RNA.	[Karakasiliotis, Ioannis; Vashist, Surender; Bailey, Dalan; Goodfellow, Ian G.] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England; [Abente, Eugenio J.; Green, Kim Y.; Sosnovtsev, Stanislav V.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Abente, Eugenio J.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Roberts, Lisa O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland College Park; University of Surrey	Karakasiliotis, I (corresponding author), BSRC Alexander Fleming, Lab Post Transcript Control, Vari, Greece.	I.Goodfellow@imperial.ac.uk	Roberts, Lisa/E-6365-2010; Vashist, Surender/H-5879-2013; Karakasiliotis, Ioannis/ABG-9709-2021; Karakasiliotis, Yannis/AAP-5973-2021	Vashist, Surender/0000-0003-1343-8514; Karakasiliotis, Ioannis/0000-0003-3004-8104; Goodfellow, Ian/0000-0002-9483-510X; Bailey, Dalan/0000-0002-5640-2266; Abente, Eugenio/0000-0002-3390-2786	Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, US; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897] Funding Source: NIH RePORTER; BBSRC [BB/D007755/1, BB/D007607/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D007607/1, BB/D007755/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, Biotechnology and Biological Sciences Research Council (BBSRC) and in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, US. I.G. is a Wellcome Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABENTE EJ, 2010, VIROLOGY IN PRESS; Al-Molawi N, 2003, J GEN VIROL, V84, P1237, DOI 10.1099/vir.0.18840-0; Anwar A, 2000, J BIOL CHEM, V275, P34231, DOI 10.1074/jbc.M006343200; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Asanaka M, 2005, P NATL ACAD SCI USA, V102, P10327, DOI 10.1073/pnas.0408529102; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Barton DJ, 1999, J VIROL, V73, P10104, DOI 10.1128/JVI.73.12.10104-10112.1999; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Brocard M, 2007, VIRUS GENES, V35, P5, DOI 10.1007/s11262-006-0038-z; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DREW J, 1994, J VIROL, V68, P697, DOI 10.1128/JVI.68.2.697-703.1994; Fahrenkrog B, 2006, CAN J PHYSIOL PHARM, V84, P279, DOI 10.1139/Y05-100; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Geissler K, 1999, J VIROL, V73, P834, DOI 10.1128/JVI.73.1.834-838.1999; Geissler K, 1999, VET MICROBIOL, V69, P63, DOI 10.1016/S0378-1135(99)00089-9; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Green KY, 2002, J VIROL, V76, P8582, DOI 10.1128/JVI.76.17.8582-8595.2002; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Guest S, 2004, J VIROL, V78, P11097, DOI 10.1128/JVI.78.20.11097-11107.2004; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Gutierrez AL, 1997, J VIROL, V71, P3826; Gutierrez-Escolano AL, 2003, BIOCHEM BIOPH RES CO, V311, P759, DOI 10.1016/j.bbrc.2003.10.066; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; Henics T, 2006, CELL BIOL INT, V30, P480, DOI 10.1016/j.cellbi.2006.01.001; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HONDA M, 2004, BIOMEDICAL REV, V15, P37; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kafasla P, 2009, MOL CELL, V34, P556, DOI 10.1016/j.molcel.2009.04.015; Kaminski A, 1998, RNA, V4, P626, DOI 10.1017/S1355838298971898; Karakasiliotis I, 2006, J GEN VIROL, V87, P3339, DOI 10.1099/vir.0.82153-0; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Niepmann M, 1997, J VIROL, V71, P8330, DOI 10.1128/JVI.71.11.8330-8339.1997; Perez I, 1997, RNA, V3, P764; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Pilipenko EV, 2001, EMBO J, V20, P6899, DOI 10.1093/emboj/20.23.6899; Sandoval-Jaime C, 2009, VIROLOGY, V387, P322, DOI 10.1016/j.virol.2009.02.041; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; SOSNOVTSEV S, 1995, VIROLOGY, V210, P383, DOI 10.1006/viro.1995.1354; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2002, J VIROL, V76, P7060, DOI 10.1128/JVI.76.14.7060-7072.2002; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Vashist S, 2009, FUTURE VIROL, V4, P353, DOI 10.2217/FVL.09.18; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133; Zuniga S, 2009, VIRUS RES, V139, P253, DOI 10.1016/j.virusres.2008.06.015	64	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9562	10.1371/journal.pone.0009562	http://dx.doi.org/10.1371/journal.pone.0009562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224775	Green Submitted, gold, Green Published			2022-12-27	WOS:000275328800009
J	Martin, CM; Wagner, WE				Martin, Cassandra M.; Wagner, William E., Jr.			Female Field Crickets Incur Increased Parasitism Risk When Near Preferred Song	PLOS ONE			English	Article							ACOUSTICALLY-ORIENTING PARASITOIDS; MALE CALLING SONG; MATE CHOICE; ORMIA-OCHRACEA; UNPARASITIZED POPULATIONS; RELATIVE IMPORTANCE; SEASONAL-VARIATION; PREDATION RISK; AGE STRUCTURE; TELEOGRYLLUS	Female animals often prefer males with conspicuous traits because these males provide direct or indirect benefits. Conspicuous male traits, however, can attract predators. This not only increases the risk of predation for conspicuous males but also for the females that prefer them. In the variable field cricket, Gryllus lineaticeps, males that produce preferred song types provide females with greater material benefits, but they are also more likely to attract lethal parasitoid flies. First, we conducted a field experiment that tested the hypothesis that females have a greater risk of fly parasitism when in association with preferred high chirp rate males. Females were nearly twice as likely to be parasitized when caged with high chirp rate song than when caged with low chirp rate song. Females may thus be forced to trade off the quality of the benefits they receive from mating with preferred males and the risk of being killed by a predator when near these males. Second, we assessed female parasitism rates in a natural population. Up to 6% of the females were parasitized in field samples. Because the females we collected could have become parasitized had they not been collected, this provides a minimum estimate of the female parasitism rate in the field. In a laboratory study, we found no difference in the proportion of time parasitized and unparasitized females spent hiding under shelters; thus, differences in activity patterns do not appear to have biased our estimate of female parasitism rates. Overall, our results suggest that female association costs have the potential to shape the evolution of female mating preferences.	[Martin, Cassandra M.; Wagner, William E., Jr.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Martin, CM (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	cassiem@unlserve.unl.edu	Wagner, William E./H-5709-2019; Wagner, William/B-6865-2009	Wagner, William E./0000-0001-6306-7964; Wagner, William/0000-0001-6306-7964	Sigma Xi; American Philosophical Society; Orthopterists' Society; School of Biological Sciences at UNL; US Department of Education; NSF [IOB 0521743, IOS 0818116]; Division Of Integrative Organismal Systems [0818116] Funding Source: National Science Foundation	Sigma Xi; American Philosophical Society; Orthopterists' Society; School of Biological Sciences at UNL; US Department of Education(US Department of Education); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a Grant-In-Aid of Research from Sigma Xi, a Lewis and Clark Award for Exploration and Field Research from the American Philosophical Society, a grant from the Orthopterists' Society, two grants from the School of Biological Sciences at UNL, and two GAANN awards from the US Department of Education to C. M. M., and by NSF grants IOB 0521743 and IOS 0818116 to W. E. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, BEHAV ECOL SOCIOBIOL, V36, P111, DOI 10.1007/BF00170716; ADAMO SA, 1995, J INSECT PHYSIOL, V41, P269, DOI 10.1016/0022-1910(94)00095-X; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Allen GR, 1999, J INSECT BEHAV, V12, P67, DOI 10.1023/A:1020929231430; Andersson Malte, 1994; Bernal XE, 2006, BEHAV ECOL, V17, P709, DOI 10.1093/beheco/arl003; Bertram SM, 2004, ETHOLOGY, V110, P963, DOI 10.1111/j.1439-0310.2004.01031.x; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; Cade WH, 1996, CAN J ZOOL, V74, P393, DOI 10.1139/z96-046; CADE WH, 1984, BEHAVIOUR, V88, P61, DOI 10.1163/156853984X00489; Endler J.A., 1986, Monographs in Population Biology, pviii; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Gong A, 1996, ANIM BEHAV, V52, P1007, DOI 10.1006/anbe.1996.0248; Gray DA, 1999, P ROY SOC B-BIOL SCI, V266, P707, DOI 10.1098/rspb.1999.0693; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; Johnson JB, 2003, BEHAV ECOL, V14, P619, DOI 10.1093/beheco/arg046; Kim TW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000422; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kolluru GR, 1999, J INSECT BEHAV, V12, P611, DOI 10.1023/A:1020923602780; Kolluru GR, 2002, BEHAV ECOL, V13, P607, DOI 10.1093/beheco/13.5.607; Lehmann GUC, 2006, ANIM BEHAV, V71, P1103, DOI 10.1016/j.anbehav.2005.08.009; Lehmann GUC, 2001, ENTOMOL GEN, V25, P135; MURRAY AM, 1995, CAN J ZOOL, V73, P1207, DOI 10.1139/z95-144; POCKLINGTON R, 1995, ANIM BEHAV, V49, P1122, DOI 10.1006/anbe.1995.0141; Ramsauer N, 2000, NATURWISSENSCHAFTEN, V87, P315, DOI 10.1007/s001140050729; SAKALUK SK, 1984, ANIM BEHAV, V32, P659, DOI 10.1016/S0003-3472(84)80141-4; SIMMONS LW, 1994, ETHOLOGY, V98, P333; SLAGSVOLD T, 1995, ANIM BEHAV, V50, P1109, DOI 10.1016/0003-3472(95)80110-3; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; Velez MJ, 2006, ETHOLOGY, V112, P1041, DOI 10.1111/j.1439-0310.2006.01262.x; Velez MJ, 2006, ANIM BEHAV, V72, P439, DOI 10.1016/j.anbehav.2006.02.002; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; Wagner WE, 2003, EVOLUTION, V57, P2054, DOI 10.1111/j.0014-3820.2003.tb00385.x; Wagner WE, 2007, ECOL ENTOMOL, V32, P478, DOI 10.1111/j.1365-2311.2007.00898.x; Wagner WE, 2007, EVOLUTION, V61, P617, DOI 10.1111/j.1558-5646.2007.00062.x; WALKER TJ, 1991, FLA ENTOMOL, V74, P554, DOI 10.2307/3495408; Zuk M, 1995, ECOL ENTOMOL, V20, P380, DOI 10.1111/j.1365-2311.1995.tb00471.x; Zuk M, 1998, EVOLUTION, V52, P166, DOI 10.2307/2410931; ZUK M, 1993, BEHAV ECOL SOCIOBIOL, V33, P339; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	43	21	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9592	10.1371/journal.pone.0009592	http://dx.doi.org/10.1371/journal.pone.0009592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231888	gold, Green Published			2022-12-27	WOS:000275328300010
J	Krieglstein, J; Kewitz, T; Kirchhefer, U; Hofnagel, O; Weissen-Plenz, G; Reinbold, M; Klumpp, S				Krieglstein, Josef; Kewitz, Tobias; Kirchhefer, Uwe; Hofnagel, Oliver; Weissen-Plenz, Gabriele; Reinbold, Michael; Klumpp, Susanne			Damage of Guinea Pig Heart and Arteries by a Trioleate-Enriched Diet and of Cultured Cardiomyocytes by Oleic Acid	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; PHOSPHATASE TYPE 2C; FATTY-ACIDS; LIPOPROTEIN; CHOLESTEROL; EXPRESSION; 2C-ALPHA; 2C-BETA	Background: Mono-unsaturated fatty acids (MUFAs) like oleic acid have been shown to cause apoptosis of cultured endothelial cells by activating protein phosphatase type 2C alpha and beta (PP2C). The question arises whether damage of endothelial or other cells could be observed in intact animals fed with a trioleate-enriched diet. Methodology/Principal Findings: Dunkin-Hartley guinea pigs were fed with a trioleate-enriched diet for 5 months. Advanced atherosclerotic changes of the aorta and the coronary arteries could not be seen but the arteries appeared in a pre-atherosclerotic stage of vascular remodelling. However, the weight and size of the hearts were lower than in controls and the number of apoptotic myocytes increased in the hearts of trioleate-fed animals. To confirm the idea that oleic acid may have caused this apoptosis by activation of PP2C, cultured cardiomyocytes from guinea pigs and mice were treated with various lipids. It was demonstrable that oleic acid dose-dependently caused apoptosis of cardiomyocytes from both species, yet, similar to previous experiments with cultured neurons and endothelial cells, stearic acid, elaidic acid and oleic acid methylester did not. The apoptotic effect caused by oleic acid was diminished when PP2C alpha and beta were downregulated by siRNA showing that PP2C was causally involved in apoptosis caused by oleic acid. Conclusions/Significance: The glycerol trioleate diet given to guinea pigs for 5 months did not cause marked atherosclerosis but clearly damaged the hearts by activating PP2C alpha and beta. The diet used with 24% (wt/wt) glycerol trioleate is not comparable to human diets. The detrimental role of MUFAs for guinea pig heart tissue in vivo is shown for the first time. Whether it is true for humans remains to be shown.	[Krieglstein, Josef; Kewitz, Tobias; Reinbold, Michael; Klumpp, Susanne] Univ Munster, Inst Pharmazut & Med Chem, Munster, Germany; [Kirchhefer, Uwe] Univ Klinikum Muenster, Inst Pharmakol & Toxikol, Munster, Germany; [Hofnagel, Oliver; Weissen-Plenz, Gabriele] Univ Klinikum Munster, Leibniz Inst Fuer Arterioskleroseforsch, Munster, Germany	University of Munster; University of Munster; University of Munster	Krieglstein, J (corresponding author), Univ Munster, Inst Pharmazut & Med Chem, Munster, Germany.	krieglst@uni-muenster.de			Deutsche Forschungsgemeinschaft [KR 354/17-1, KL 601/9-3, KI 653/13-1,2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Studies were supported by grants from the Deutsche Forschungsgemeinschaft (DFG: KR 354/17-1, KL 601/9-3 and KI 653/13-1,2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Cos E, 2001, LIPIDS, V36, P1209, DOI 10.1007/s11745-001-0834-1; Cullen P, 2005, HANDB EXP PHARM, V170, P3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FERNANDEZ ML, 1989, METABOLISM, V38, P1094, DOI 10.1016/0026-0495(89)90046-2; Fernandez ML, 2001, J NUTR, V131, P10, DOI 10.1093/jn/131.1.10; Hufnagel B, 2005, ATHEROSCLEROSIS, V180, P245, DOI 10.1016/j.atherosclerosis.2004.12.021; KEYS A, 1970, CIRCULATION, V41, P191; Kliche K, 2006, CELL PHYSIOL BIOCHEM, V18, P265, DOI 10.1159/000097673; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; Klumpp S, 2000, METHOD ENZYMOL, V315, P570; Klumpp S, 2002, NEUROCHEM INT, V41, P251, DOI 10.1016/S0197-0186(02)00020-7; Klumpp S, 1998, FEBS LETT, V437, P229, DOI 10.1016/S0014-5793(98)01237-X; Krieglstein J, 2008, EUR J PHARM SCI, V35, P397, DOI 10.1016/j.ejps.2008.08.007; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marley AE, 1998, FEBS LETT, V431, P121, DOI 10.1016/S0014-5793(98)00708-X; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Reinbold M, 2008, MOL NUTR FOOD RES, V52, P581, DOI 10.1002/mnfr.200700321; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; STINS MF, 1992, ARTERIOSCLER THROMB, V12, P1437, DOI 10.1161/01.ATV.12.12.1437; Thijssen MA, 2005, HANDB EXP PHARM, V170, P165; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A61	A70	e9561	10.1371/journal.pone.0009561	http://dx.doi.org/10.1371/journal.pone.0009561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221399	Green Submitted, gold, Green Published			2022-12-27	WOS:000275328200006
J	Segu, L; Lecomte, MJ; Wolff, M; Santamaria, J; Hen, R; Dumuis, A; Berrard, S; Bockaert, J; Buhot, MC; Compan, V				Segu, Luis; Lecomte, Marie-Jose; Wolff, Mathieu; Santamaria, Julie; Hen, Rene; Dumuis, Aline; Berrard, Sylvie; Bockaert, Joel; Buhot, Marie-Christine; Compan, Valerie			Hyperfunction of Muscarinic Receptor Maintains Long-Term Memory in 5-HT4 Receptor Knock-Out Mice	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; RAT FRONTAL-CORTEX; ACETYLCHOLINE-RELEASE; PARTIAL AGONIST; WORKING-MEMORY; SPATIAL MEMORY; WATER-MAZE; DIFFERENTIAL MODULATION; HIPPOCAMPAL-NEURONS; DORSAL HIPPOCAMPUS	Patients suffering from dementia of Alzheimer's type express less serotonin 4 receptors (5-HTR4), but whether an absence of these receptors modifies learning and memory is unexplored. In the spatial version of the Morris water maze, we show that 5-HTR4 knock-out (KO) and wild-type (WT) mice performed similarly for spatial learning, short-and long-term retention. Since 5-HTR4 control mnesic abilities, we tested whether cholinergic system had circumvented the absence of 5-HTR4. Inactivating muscarinic receptor with scopolamine, at an ineffective dose (0.8 mg/kg) to alter memory in WT mice, decreased long-term but not short-term memory of 5-HTR4 KO mice. Other changes included decreases in the activity of choline acetyltransferase (ChAT), the required enzyme for acetylcholine synthesis, in the septum and the dorsal hippocampus in 5-HTR4 KO under baseline conditions. Training- and scopolamine-induced increase and decrease, respectively in ChAT activity in the septum in WT mice were not detected in the 5-HTR4 KO animals. Findings suggest that adaptive changes in cholinergic systems may circumvent the absence of 5-HTR4 to maintain long-term memory under baseline conditions. In contrast, despite adaptive mechanisms, the absence of 5-HTR4 aggravates scopolamine-induced memory impairments. The mechanisms whereby 5-HTR4 mediate a tonic influence on ChAT activity and muscarinic receptors remain to be determined.	[Segu, Luis; Wolff, Mathieu; Buhot, Marie-Christine] Bordeaux Univ, CNRS, UMR5228, Ctr Neurosci Integrat & Cognit, Talence, France; [Lecomte, Marie-Jose; Santamaria, Julie; Berrard, Sylvie] CNRS, UMR7225, INSERM, Inst Cerveau & Moelle Epiniere,Ctr Rech,UMR S975, Paris, France; [Hen, Rene] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Dumuis, Aline; Bockaert, Joel; Compan, Valerie] Nimes Univ, Montpellier Univ 1&2, INSERM, CNRS,UMR5203,U661,Inst Genom Fonct, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier		Valerie.Compan@igf.cnrs.fr	INCIA, NeurexTeam/D-6197-2014; Wolff, Mathieu/F-2276-2013	Wolff, Mathieu/0000-0003-3037-3038; COMPAN, Valerie/0000-0002-4634-2765	CNRS; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	CNRS and INSERM provided the financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiko J, 1997, BEHAV BRAIN RES, V88, P201, DOI 10.1016/S0166-4328(97)02298-5; Bert B, 2005, NEUROBIOL LEARN MEM, V84, P57, DOI 10.1016/j.nlm.2005.03.005; Bickmeyer U, 2002, EUR J NEUROSCI, V16, P209, DOI 10.1046/j.1460-9568.2002.02072.x; Bijak M, 1997, NEUROSCIENCE, V78, P1017, DOI 10.1016/S0306-4522(96)00666-5; Bockaert J, 2004, CNS NEUROL DISORD-DR, V3, P39, DOI 10.2174/1568007043482615; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; BRILEY M, 1990, PSYCHOPHARMACOLOGY, V101, P187, DOI 10.1007/BF02244124; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; BUHOT MC, 1991, BEHAV BRAIN RES, V44, P67, DOI 10.1016/S0166-4328(05)80240-2; Cachard-Chastel M, 2008, BEHAV BRAIN RES, V187, P455, DOI 10.1016/j.bbr.2007.10.008; Cai X, 2002, J PHYSIOL-LONDON, V540, P743; Carli M, 1999, BRIT J PHARMACOL, V128, P1207, DOI 10.1038/sj.bjp.0702915; Chapin EM, 2002, NEUROSCI LETT, V324, P1; Compan V, 1996, EUR J NEUROSCI, V8, P2591, DOI 10.1111/j.1460-9568.1996.tb01553.x; Compan V, 2004, J NEUROSCI, V24, P412, DOI 10.1523/JNEUROSCI.2806-03.2004; Compan V, 2007, FRONT NEUROSCI, P157; Conductier G, 2006, EUR J NEUROSCI, V24, P1053, DOI 10.1111/j.1460-9568.2006.04943.x; CONSOLO S, 1994, NEUROREPORT, V5, P1230, DOI 10.1097/00001756-199406020-00018; Cornea-Hebert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P; Egashira N, 2006, BRAIN RES, V1069, P54, DOI 10.1016/j.brainres.2005.10.103; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Fontana DJ, 1997, NEUROPHARMACOLOGY, V36, P689, DOI 10.1016/S0028-3908(97)00055-5; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Inui K, 2004, NEUROTOX RES, V6, P153, DOI 10.1007/BF03033218; JAFFARD R, 1993, HIPPOCAMPUS, V3, P203; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lamirault L, 2003, PROG NEURO-PSYCHOPH, V27, P185, DOI 10.1016/S0278-5846(02)00351-2; Lamirault L, 2001, NEUROPHARMACOLOGY, V41, P844, DOI 10.1016/S0028-3908(01)00123-X; Lelong V, 2003, N-S ARCH PHARMACOL, V367, P621, DOI 10.1007/s00210-003-0743-2; Levallet G, 2009, PSYCHOPHARMACOLOGY, V202, P125, DOI 10.1007/s00213-008-1283-8; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Manuel-Apolinar L, 2004, BEHAV BRAIN RES, V148, P179, DOI 10.1016/S0166-4328(03)00186-4; Marchetti E, 2000, NEUROPHARMACOLOGY, V39, P2017, DOI 10.1016/S0028-3908(00)00038-1; Matsumoto M, 2001, J PHARMACOL EXP THER, V296, P676; Moser PC, 2002, J PHARMACOL EXP THER, V302, P731, DOI 10.1124/jpet.102.034249; OHNO M, 1993, EUR J PHARMACOL, V234, P29; OKEEFE J, 1975, EXP NEUROL, V48, P152, DOI 10.1016/0014-4886(75)90230-7; PATEL S, 1995, NEUROSCIENCE, V69, P1159, DOI 10.1016/0306-4522(95)00314-9; Ruotsalainen S, 1998, J PSYCHOPHARMACOL, V12, P177, DOI 10.1177/026988119801200210; Santamaria J, 2009, J NEUROSCI RES, V87, P532, DOI 10.1002/jnr.21866; Terry AV, 1998, PSYCHOPHARMACOLOGY, V135, P407, DOI 10.1007/s002130050529; Topic B, 2007, HIPPOCAMPUS, V17, P68, DOI 10.1002/hipo.20246; Torres GE, 1996, MOL PHARMACOL, V50, P1316; Vilaro MT, 2005, J COMP NEUROL, V484, P418, DOI 10.1002/cne.20447; WAEBER C, 1994, NEUROPHARMACOLOGY, V33, P527, DOI 10.1016/0028-3908(94)90084-1; Warburton EC, 1997, BEHAV BRAIN RES, V84, P247; Yamaguchi T, 1997, N-S ARCH PHARMACOL, V356, P712, DOI 10.1007/PL00005110	48	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9529	10.1371/journal.pone.0009529	http://dx.doi.org/10.1371/journal.pone.0009529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209108	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100014
J	Jung, AG; Labarerra, C; Jansen, AM; Qvortrup, K; Wild, K; Kjaerulff, O				Jung, Anita G.; Labarerra, Christina; Jansen, Anna M.; Qvortrup, Klaus; Wild, Klemens; Kjaerulff, Ole			A Mutational Analysis of the Endophilin-A N-BAR Domain Performed in Living Flies	PLOS ONE			English	Article							MEMBRANE CURVATURE; STRUCTURAL BASIS; DROSOPHILA; ENDOCYTOSIS; INVAGINATION; SYNAPTOJANIN; PATHWAY; MECHANISMS; DYNAMIN	Background: Endophilin is a cytoplasmic protein with an important function in clathrin-dependent endocytosis at synapses and elsewhere. Endophilin has a BAR (Bin/Amphiphysin/Rvs-homology) domain, which is implicated in the sensing and induction of membrane curvature. Previous structure-function studies of the endophilin-A BAR domain have almost exclusively been made in reduced systems, either in vitro or ex vivo in cultured cells. To extend and complement this work, we have analyzed the role played by the structural features of the endophilin-A BAR domain in Drosophila in vivo. Methodology/Principal Findings: The study is based on genetic rescue of endophilin-A (endoA) null mutants with wild type or mutated endoA transgenes. We evaluated the viability of the rescuants, the locomotor behavior in adult flies and the neurotransmission at the larval neuromuscular junction. Whereas mutating the endophilin BAR domain clearly affected adult flies, larval endophilin function was surprisingly resistant to mutagenesis. Previous reports have stressed the importance of a central appendage on the convex BAR surface, which forms a hydrophobic ridge able to directly insert into the lipid bilayer. We found that the charge-negative substitution A66D, which targets the hydrophobic ridge and was reported to completely disrupt the ability of endophilin-BAR to tubulate liposomes in vitro, rescued viability and neurotransmission with the same efficiency as wild type endoA transgenes, even in adults. A similar discrepancy was found for the hydrophilic substitutions A63S/A66S and A63S/A66S/M70Q. The A66W mutation, which introduces a bulky hydrophobic side chain and induces massive vesiculation of liposomes in vitro, strongly impeded eye development, even in presence of the endogenous endoA gene. Substantial residual function was observed in larvae rescued with the EndoA(Arf) transgene, which encodes a form of endophilin-A that completely lacks the central appendage. Whereas a mutation (D151P) designed to increase the BAR curvature was functional, another mutation (P143A, DLEN) designed to decrease the curvature was not. Conclusions/Significance: Our results provide novel insight into the structure/function relationship of the endophilin-A BAR domain in vivo, especially with relation to synaptic function.	[Jung, Anita G.; Labarerra, Christina; Jansen, Anna M.; Kjaerulff, Ole] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Wild, Klemens] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany	University of Copenhagen; University of Copenhagen; Ruprecht Karls University Heidelberg	Jung, AG (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	o.kjaerulff@mfi.ku.dk	Kjaerulff, Ole/Q-6996-2018	Kjaerulff, Ole/0000-0002-8654-1435; Qvortrup, Klaus/0000-0001-8811-0260	Danish MRC; Lundbeck Foundation; Novo Nordisk Foundation; Faculty of Health, University of Copenhagen	Danish MRC(Danish Medical Research Council); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Faculty of Health, University of Copenhagen	Funded by the Danish MRC, the Lundbeck Foundation, the Novo Nordisk Foundation and the Faculty of Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1999, PRACTICAL STAT MED R, pXII; Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; BRAND AH, 1993, DEVELOPMENT, V118, P401; Craft GE, 2008, MOL CELL PROTEOMICS, V7, P1146, DOI 10.1074/mcp.M700351-MCP200; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Eun SH, 2007, GENETICS, V175, P1163, DOI 10.1534/genetics.106.067959; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FLEISS JL, 2003, STAT METHODS RATES P, pR27; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Huttner WB, 2002, TRENDS CELL BIOL, V12, P155, DOI 10.1016/S0962-8924(02)02252-3; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Powell K, 2009, NATURE, V460, P318, DOI 10.1038/460318a; Rikhy R, 2002, J NEUROSCI, V22, P7478; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weber U, 2000, DEVELOPMENT, V127, P3619; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Zar J.H., 2009, BIOSTATISTICAL ANAL	39	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9492	10.1371/journal.pone.0009492	http://dx.doi.org/10.1371/journal.pone.0009492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209138	gold, Green Published			2022-12-27	WOS:000275063400007
J	Stegmann, CM; Luhrmann, R; Wahl, MC				Stegmann, Christian M.; Luehrmann, Reinhard; Wahl, Markus C.			The Crystal Structure of PPIL1 Bound to Cyclosporine A Suggests a Binding Mode for a Linear Epitope of the SKIP Protein	PLOS ONE			English	Article							CYCLOPHILIN; COREGULATOR; SPLICEOSOME; MOLECULES; INSIGHTS; SNW/SKIP; COMPLEX	Background: The removal of introns from pre-mRNA is carried out by a large macromolecular machine called the spliceosome. The peptidyl-prolyl cis/trans isomerase PPIL1 is a component of the human spliceosome and binds to the spliceosomal SKIP protein via a binding site distinct from its active site. Principal Findings: Here, we have studied the PPIL1 protein and its interaction with SKIP biochemically and by X-ray crystallography. A minimal linear binding epitope derived from the SKIP protein could be determined using a peptide array. A 36-residue region of SKIP centred on an eight-residue epitope suffices to bind PPIL1 in pull-down experiments. The crystal structure of PPIL1 in complex with the inhibitor cyclosporine A (CsA) was obtained at a resolution of 1.15 angstrom and exhibited two bound Cd2+ ions that enabled SAD phasing. PPIL1 residues that have previously been implicated in binding of SKIP are involved in the coordination of Cd2+ ions in the present crystal structure. Employing the present crystal structure, the determined minimal binding epitope and previously published NMR data [1], a molecular docking study was performed. In the docked model of the PPIL1-SKIP interaction, a proline residue of SKIP is buried in a hydrophobic pocket of PPIL1. This hydrophobic contact is encircled by several hydrogen bonds between the SKIP peptide and PPIL1. Conclusion: We characterized a short, linear epitope of SKIP that is sufficient to bind the PPIL1 protein. Our data indicate that this SKIP peptide could function in recruiting PPIL1 into the core of the spliceosome. We present a molecular model for the binding mode of SKIP to PPIL1 which emphasizes the versatility of cyclophilin-type PPIases to engage in additional interactions with other proteins apart from active site contacts despite their limited surface area.	[Stegmann, Christian M.; Luehrmann, Reinhard; Wahl, Markus C.] Max Planck Inst Biophys Chem, Gottingen, Germany; [Stegmann, Christian M.; Wahl, Markus C.] Free Univ Berlin, Max Planck Inst Biophys Chem, AG Strukturbiochem, Inst Chem & Biochem, D-1000 Berlin, Germany	Max Planck Society; Free University of Berlin; Max Planck Society	Stegmann, CM (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	mwahl@gwdg.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307	German National Academic Foundation; VW Foundation [VW I/81 649]; Max Planck Society	German National Academic Foundation; VW Foundation(Volkswagen); Max Planck Society(Max Planck Society)	C. M. S. was supported by a fellowship of the German National Academic Foundation (Studienstiftung). This research was supported by a grant from the VW Foundation (VW I/81 649) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mesa A, 2008, FEBS LETT, V582, P2345, DOI 10.1016/j.febslet.2008.06.006; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; REES DC, 1983, J MOL BIOL, V168, P367, DOI 10.1016/S0022-2836(83)80024-2; Reidt U, 2003, J MOL BIOL, V331, P45, DOI 10.1016/S0022-2836(03)00684-3; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skruzny M, 2001, BBA-GENE STRUCT EXPR, V1521, P146, DOI 10.1016/S0167-4781(01)00301-3; Stegmann CM, 2009, ANGEW CHEM INT EDIT, V48, P5207, DOI 10.1002/anie.200900481; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thai V, 2008, J MOL BIOL, V378, P71, DOI 10.1016/j.jmb.2007.08.051; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang XS, 2010, J BIOL CHEM, V285, P4951, DOI 10.1074/jbc.M109.087528; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200	26	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10013	10.1371/journal.pone.0010013	http://dx.doi.org/10.1371/journal.pone.0010013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368803	Green Submitted, gold, Green Published			2022-12-27	WOS:000276419900013
J	Schreuder, M; Blankertz, B; Tangermann, M				Schreuder, Martijn; Blankertz, Benjamin; Tangermann, Michael			A New Auditory Multi-Class Brain-Computer Interface Paradigm: Spatial Hearing as an Informative Cue	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; P300; P3A; COMMUNICATION; LOCALIZATION; PROBABILITY; ATTENTION; MEMORY	Most P300-based brain-computer interface (BCI) approaches use the visual modality for stimulation. For use with patients suffering from amyotrophic lateral sclerosis (ALS) this might not be the preferable choice because of sight deterioration. Moreover, using a modality different from the visual one minimizes interference with possible visual feedback. Therefore, a multi-class BCI paradigm is proposed that uses spatially distributed, auditory cues. Ten healthy subjects participated in an offline oddball task with the spatial location of the stimuli being a discriminating cue. Experiments were done in free field, with an individual speaker for each location. Different inter-stimulus intervals of 1000 ms, 300 ms and 175 ms were tested. With averaging over multiple repetitions, selection scores went over 90% for most conditions, i.e., in over 90% of the trials the correct location was selected. One subject reached a 100% correct score. Corresponding information transfer rates were high, up to an average score of 17.39 bits/minute for the 175 ms condition (best subject 25.20 bits/minute). When presenting the stimuli through a single speaker, thus effectively canceling the spatial properties of the cue, selection scores went down below 70% for most subjects. We conclude that the proposed spatial auditory paradigm is successful for healthy subjects and shows promising results that may lead to a fast BCI that solely relies on the auditory sense.	[Schreuder, Martijn; Blankertz, Benjamin; Tangermann, Michael] Berlin Inst Technol, Machine Learning Dept, Berlin, Germany; [Blankertz, Benjamin] Fraunhofer FIRST, Intelligent Data Anal Grp, Berlin, Germany	Technical University of Berlin; Fraunhofer Gesellschaft; Fraunhofer Institute Center Schloss Birlinghoven	Schreuder, M (corresponding author), Berlin Inst Technol, Machine Learning Dept, Berlin, Germany.	martijn@cs.tu-berlin.de	Schreuder, Martijn/E-2476-2013; Tangermann, Michael/ABE-4178-2020	Tangermann, Michael/0000-0001-6729-0290; Blankertz, Benjamin/0000-0002-2437-4846; Schreuder, Evert-Jan Martijn/0000-0002-7239-9909	European Information and Communication Technologies (ICT) Programme Project [FP7-224631, 216886]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-1]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01IB001A, 01GQ0850]; European Community [ICT-216886]	European Information and Communication Technologies (ICT) Programme Project; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community(European Commission)	This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631 and 216886, by grants of the Deutsche Forschungsgemeinschaft (DFG) (MU 987/3-1) and Bundesministerium fur Bildung und Forschung (BMBF) (FKZ 01IB001A, 01GQ0850) and by the FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence, ICT-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1908, BIOMETRIKA, V6, P1; Bayliss JD, 2004, CYBERPSYCHOL BEHAV, V7, P694, DOI 10.1089/cpb.2004.7.694; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer AM, 2008, P 4 INT BRAIN COMP I, P280; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Chatterjee A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-40; CINCOTTI F, 2007, COMPUT INTELL NEUROS; Conroy MA, 2007, J PSYCHOPHYSIOL, V21, P22, DOI 10.1027/0269-8803.21.1.22; Deouell LY, 2006, EUR J NEUROSCI, V24, P1488, DOI 10.1111/j.1460-9568.2006.05025.x; DESAIN P, 2006, P 3 INT BRAIN COMP I, P98; Duda R.O., 2006, PATTERN CLASSIFICATI; Farquhar J., 2008, P 4 INT BCI WORKSH T, P50; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Green M D, 1966, SIGNAL DETECTION THE; Hill N.J., 2005, ADV NEURAL INFORM PR, V17, P569; Hinterberger T, 2004, EXP BRAIN RES, V154, P521, DOI 10.1007/s00221-003-1690-3; Kanoh S, 2008, IEEE ENG MED BIO, P642, DOI 10.1109/IEMBS.2008.4649234; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lenhardt A, 2008, IEEE T NEUR SYS REH, V16, P121, DOI 10.1109/TNSRE.2007.912816; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; Muller-Putz GR, 2006, IEEE T NEUR SYS REH, V14, P30, DOI 10.1109/TNSRE.2005.863842; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Rader SK, 2008, CLIN NEUROPHYSIOL, V119, P1176, DOI 10.1016/j.clinph.2008.01.014; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Teder-Salejarvi WA, 1998, PERCEPT PSYCHOPHYS, V60, P1228, DOI 10.3758/BF03206172; Teder-Salejarvi WA, 1999, COGNITIVE BRAIN RES, V8, P213, DOI 10.1016/S0926-6410(99)00023-3; TOMIAKA R, 2008, P 4 INT BRAIN COMP I, P232; TREDER M, 2009, BBCI WORKSH ADV NEUR; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	46	193	199	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9813	10.1371/journal.pone.0009813	http://dx.doi.org/10.1371/journal.pone.0009813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368976	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200004
J	Tajima, S; Okada, M				Tajima, Satohiro; Okada, Masato			Discriminating Natural Image Statistics from Neuronal Population Codes	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; BAND-LIMITED CONTRAST; AMPLITUDE SPECTRA; RECEPTIVE-FIELD; CONTEXTUAL MODULATION; PERCEIVED CONTRAST; CORTICAL-NEURONS; SIMPLE CELLS; FACILITATION	The power law provides an efficient description of amplitude spectra of natural scenes. Psychophysical studies have shown that the forms of the amplitude spectra are clearly related to human visual performance, indicating that the statistical parameters in natural scenes are represented in the nervous system. However, the underlying neuronal computation that accounts for the perception of the natural image statistics has not been thoroughly studied. We propose a theoretical framework for neuronal encoding and decoding of the image statistics, hypothesizing the elicited population activities of spatial-frequency selective neurons observed in the early visual cortex. The model predicts that frequency-tuned neurons have asymmetric tuning curves as functions of the amplitude spectra falloffs. To investigate the ability of this neural population to encode the statistical parameters of the input images, we analyze the Fisher information of the stochastic population code, relating it to the psychophysically measured human ability to discriminate natural image statistics. The nature of discrimination thresholds suggested by the computational model is consistent with experimental data from previous studies. Of particular interest, a reported qualitative disparity between performance in fovea and parafovea can be explained based on the distributional difference over preferred frequencies of neurons in the current model. The threshold shows a peak at a small falloff parameter when the neuronal preferred spatial frequencies are narrowly distributed, whereas the threshold peak vanishes for a neural population with a more broadly distributed frequency preference. These results demonstrate that the distributional property of neuronal stimulus preference can play a crucial role in linking microscopic neurophysiological phenomena and macroscopic human behaviors.	[Tajima, Satohiro; Okada, Masato] Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan; [Tajima, Satohiro] NHK Japan Broadcasting Corp, Nagano Stn, Nagano, Japan; [Okada, Masato] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	University of Tokyo; NHK Japan Broadcasting Corp; RIKEN	Tajima, S (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan.	tajima@mns.k.u-tokyo.ac.jp	Tajima, Satohiro/I-7100-2013	Tajima, Satohiro/0000-0002-9597-1381	Ministry of Education, Culture, Sports, Science and Technology of Japan [20650019];  [18079003];  [20240020]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was partially supported by Grants-in-Aid for Scientific Research on Priority Areas (Grant No. 18079003), Grants-in-Aid for Scientific Research (A) (Grant No. 20240020) and Grants-in-Aid for Exploratory Research (Grant No. 20650019) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; BEX PJ, 2007, J VIS, V7; Billock VA, 2000, PHYSICA D, V137, P379, DOI 10.1016/S0167-2789(99)00197-9; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; BRADY N, 1995, VISION RES, V35, P739, DOI 10.1016/0042-6989(94)00172-I; Brady N, 1997, PERCEPTION, V26, P1089, DOI 10.1068/p261089; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Carandini M, 1997, J NEUROSCI, V17, P8621; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Dayan P, 2001, COMPUTATIONAL NEUROS; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FIELD DJ, 1986, PROC R SOC SER B-BIO, V228, P379, DOI 10.1098/rspb.1986.0060; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Hansen BC, 2003, NETWORK-COMP NEURAL, V14, P501, DOI 10.1088/0954-898X/14/3/307; Hansen BC, 2006, J VISION, V6, P696, DOI 10.1167/6.7.3; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KNILL DC, 1990, J OPT SOC AM A, V7, P1113, DOI 10.1364/JOSAA.7.001113; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Liu RuoWei, 2008, China Vegetables, P1; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Meese TS, 2007, J VISION, V7, DOI 10.1167/7.4.7; Mizobe K, 2001, VISUAL NEUROSCI, V18, P377, DOI 10.1017/S0952523801183045; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Parraga CA, 2005, VISION RES, V45, P3145, DOI 10.1016/j.visres.2005.08.006; Parraga CA, 2000, PERCEPTION, V29, P1101, DOI 10.1068/p2904; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; Thomson MGA, 1997, J OPT SOC AM A, V14, P2081, DOI 10.1364/JOSAA.14.002081; Tolhurst DJ, 1997, PERCEPTION, V26, P1011, DOI 10.1068/p261011; Tolhurst DJ, 1997, VISION RES, V37, P3203, DOI 10.1016/S0042-6989(97)00119-3; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zemel RS, 1999, ADV NEUR IN, V11, P174; Zipser K, 1996, J NEUROSCI, V16, P7376	61	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9704	10.1371/journal.pone.0009704	http://dx.doi.org/10.1371/journal.pone.0009704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360849	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969500001
J	Cox, LE; Ferraiuolo, L; Goodall, EF; Heath, PR; Higginbottom, A; Mortiboys, H; Hollinger, HC; Hartley, JA; Brockington, A; Burness, CE; Morrison, KE; Wharton, SB; Grierson, AJ; Ince, PG; Kirby, J; Shaw, PJ				Cox, Laura E.; Ferraiuolo, Laura; Goodall, Emily F.; Heath, Paul R.; Higginbottom, Adrian; Mortiboys, Heather; Hollinger, Hannah C.; Hartley, Judith A.; Brockington, Alice; Burness, Christine E.; Morrison, Karen E.; Wharton, Stephen B.; Grierson, Andrew J.; Ince, Paul G.; Kirby, Janine; Shaw, Pamela J.			Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; COMMON-CAUSE; ESCRT-III; CELLULAR PATHWAYS; MUSCULAR-ATROPHY; MOUSE MODEL; PROTEIN; AUTOPHAGY; COMPLEX; PHOSPHORYLATION	Background: Amyotrophic lateral sclerosis (ALS), a common late-onset neurodegenerative disease, is associated with fronto-temporal dementia (FTD) in 3-10% of patients. A mutation in CHMP2B was recently identified in a Danish pedigree with autosomal dominant FTD. Subsequently, two unrelated patients with familial ALS, one of whom also showed features of FTD, were shown to carry missense mutations in CHMP2B. The initial aim of this study was to determine whether mutations in CHMP2B contribute more broadly to ALS pathogenesis. Methodology/Principal Findings: Sequencing of CHMP2B in 433 ALS cases from the North of England identified 4 cases carrying 3 missense mutations, including one novel mutation, p. Thr104Asn, none of which were present in 500 neurologically normal controls. Analysis of clinical and neuropathological data of these 4 cases showed a phenotype consistent with the lower motor neuron predominant (progressive muscular atrophy (PMA)) variant of ALS. Only one had a recognised family history of ALS and none had clinically apparent dementia. Microarray analysis of motor neurons from CHMP2B cases, compared to controls, showed a distinct gene expression signature with significant differential expression predicting disassembly of cell structure; increased calcium concentration in the ER lumen; decrease in the availability of ATP; down-regulation of the classical and p38 MAPK signalling pathways, reduction in autophagy initiation and a global repression of translation. Transfection of mutant CHMP2B into HEK-293 and COS-7 cells resulted in the formation of large cytoplasmic vacuoles, aberrant lysosomal localisation demonstrated by CD63 staining and impairment of autophagy indicated by increased levels of LC3-II protein. These changes were absent in control cells transfected with wild-type CHMP2B. Conclusions/Significance: We conclude that in a population drawn from North of England pathogenic CHMP2B mutations are found in approximately 1% of cases of ALS and 10% of those with lower motor neuron predominant ALS. We provide a body of evidence indicating the likely pathogenicity of the reported gene alterations. However, absolute confirmation of pathogenicity requires further evidence, including documentation of familial transmission in ALS pedigrees which might be most fruitfully explored in cases with a LMN predominant phenotype.	[Cox, Laura E.; Ferraiuolo, Laura; Goodall, Emily F.; Heath, Paul R.; Higginbottom, Adrian; Mortiboys, Heather; Hollinger, Hannah C.; Hartley, Judith A.; Brockington, Alice; Burness, Christine E.; Wharton, Stephen B.; Grierson, Andrew J.; Ince, Paul G.; Kirby, Janine; Shaw, Pamela J.] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Morrison, Karen E.] Univ Birmingham, Dept Neurol, Birmingham, East Midlands, England	University of Sheffield; University of Birmingham	Cox, LE (corresponding author), Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England.	pamela.shaw@sheffield.ac.uk	Shaw, Pamela/E-6193-2010; Mortiboys, Heather/E-8838-2010; Ferraiuolo, Laura/E-5834-2010; Heath, Paul/B-4778-2009; Shaw, Pamela J/A-7620-2010; Brockington, Alice R/B-5122-2009; Grierson, Andy/A-5067-2009; Goodall, Emily F/B-4781-2009; Ince, Paul G/A-5064-2009; Kirby, Janine/B-3980-2009	Mortiboys, Heather/0000-0001-6439-0579; Ferraiuolo, Laura/0000-0001-9118-5714; Grierson, Andy/0000-0001-7039-6731; Ince, Paul G/0000-0001-6677-8753; Kirby, Janine/0000-0002-7468-5917; Hollinger, Hannah/0000-0002-8557-7727; Shaw, Pamela/0000-0002-8925-2567; Goodall, Emily/0000-0002-1002-6541; Morrison, Karen Elaine/0000-0003-0216-5717; Wharton, Stephen B/0000-0003-2785-333X	Wellcome Trust [069388/Z/02/Z]; MRC [G0900652, G0400074, G0502157] Funding Source: UKRI; Medical Research Council [G0502157, G0400074, G0900652] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (grant number 069388/Z/02/Z) (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Blair IP, 2008, J NEUROL NEUROSUR PS, V79, P849, DOI 10.1136/jnnp.2007.140541; Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758; Brockington A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-23; Cannon A, 2006, NEUROSCI LETT, V398, P83, DOI 10.1016/j.neulet.2005.12.056; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Cummins MM, 2002, PFLUG ARCH EUR J PHY, V444, P644, DOI 10.1007/s00424-002-0856-3; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gijselinck I, 2009, NEUROBIOL AGING, V30, P1329, DOI 10.1016/j.neurobiolaging.2007.11.002; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Guerreiro RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002450; GUERREIRO RJ, 2009, HUM MUTAT; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Jackson M, 1997, ANN NEUROL, V42, P803, DOI 10.1002/ana.410420518; JONES CT, 1994, MOL CELL PROBE, V8, P329, DOI 10.1006/mcpr.1994.1046; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SHAW PJ, 1991, J NEUROL NEUROSUR PS, V54, P993, DOI 10.1136/jnnp.54.11.993; SIDDIQUE N, 2008, PHYS MED REH CLIN N, V19, pR7; Siddique N, 2008, PHYS MED REH CLIN N, V19, P429, DOI 10.1016/j.pmr.2008.05.001; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; VANES MA, 2009, J NEUROL NEUROSURG P; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663	68	176	182	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9872	10.1371/journal.pone.0009872	http://dx.doi.org/10.1371/journal.pone.0009872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352044	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000275894500025
J	Menalled, LB; Patry, M; Ragland, N; Lowden, PAS; Goodman, J; Minnich, J; Zahasky, B; Park, L; Leeds, J; Howland, D; Signer, E; Tobin, AJ; Brunner, D				Menalled, Liliana B.; Patry, Monica; Ragland, Natalie; Lowden, Phillip A. S.; Goodman, Jennifer; Minnich, Jennie; Zahasky, Benjamin; Park, Larry; Leeds, Janet; Howland, David; Signer, Ethan; Tobin, Allan J.; Brunner, Daniela			Comprehensive Behavioral Testing in the R6/2 Mouse Model of Huntington's Disease Shows No Benefit from CoQ10 or Minocycline	PLOS ONE			English	Article							COENZYME Q(10); COMBINATION THERAPY; MOTOR DEFICITS; INDUCED LUPUS; TETRACYCLINE; PARKINSONS; MICE; NEUROPROTECTION; MITOCHONDRIAL; TRANSLATION	Previous studies of the effects of coenzyme Q10 and minocycline on mouse models of Huntington's disease have produced conflicting results regarding their efficacy in behavioral tests. Using our recently published best practices for husbandry and testing for mouse models of Huntington's disease, we report that neither coenzyme Q10 nor minocycline had significant beneficial effects on measures of motor function, general health (open field, rotarod, grip strength, rearing-climbing, body weight and survival) in the R6/2 mouse model. The higher doses of minocycline, on the contrary, reduced survival. We were thus unable to confirm the previously reported benefits for these two drugs, and we discuss potential reasons for these discrepancies, such as the effects of husbandry and nutrition.	[Menalled, Liliana B.; Patry, Monica; Ragland, Natalie; Goodman, Jennifer; Minnich, Jennie; Zahasky, Benjamin; Brunner, Daniela] PsychoGenics Inc, Tarrytown, NY USA; [Lowden, Phillip A. S.] Birkbeck Coll, Sch Biomed & Chem Sci, London, England; [Park, Larry; Leeds, Janet] CHDI Management CHDI Fdn, Los Angeles, CA USA; [Howland, David] CHDI Management CHDI Fdn, Princeton, NJ USA; [Signer, Ethan; Tobin, Allan J.] CHDI Management CHDI Fdn, New York, NY USA; [Brunner, Daniela] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA	University of London; Birkbeck University London; Columbia University; New York State Psychiatry Institute	Menalled, LB (corresponding author), PsychoGenics Inc, Tarrytown, NY USA.	liliana.menalled@psychogenics.com	Longo, Kenneth A/A-5631-2010		CHDI Foundation; Psychogenics	CHDI Foundation; Psychogenics	The study was founded by the CHDI Foundation. Members of that organization are co-authors of this work. They have contributed to the conception of the study as well as the design, provided the mouse line, the data interpretation, decision to publish and the writing of the manuscript. The authors employed by Psychogenics Inc. received salaried funding by Psychogenics. Daniela Brunner in addition was a consultant for CHDI. The authors employed by Psychogenics Inc. contributed to the manuscript by conceiving and designing the experiments, performing the experiments, analyzing the data, contributing reagents/materials/analysis tools, and writing the paper.	Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061; Attur MG, 1999, J IMMUNOL, V162, P3160; Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Bantubungi K, 2005, NEUROBIOL DIS, V18, P206, DOI 10.1016/j.nbd.2004.09.017; Beal F, 2004, METHOD ENZYMOL, V382, P473; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Bonelli RM, 2007, EXPERT OPIN PHARMACO, V8, P141, DOI 10.1517/14656566.8.2.141; Bonelli RM, 2004, INT CLIN PSYCHOPHARM, V19, P337, DOI 10.1097/00004850-200411000-00004; Bonelli RM, 2003, NEUROLOGY, V60, P883, DOI 10.1212/01.WNL.0000049936.85487.7A; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; DONNET A, 1992, BIOMED PHARMACOTHER, V46, P171, DOI 10.1016/0753-3322(92)90026-4; DRAGATSIS I, 2009, NEUROBIOLOGY DIS; Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Good ML, 2003, BRIT J DERMATOL, V149, P237, DOI 10.1046/j.1365-2133.2003.05497.x; GORDON P, 2004, PLACEBOCONTROLLED PH, P1845; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Goulden V, 1996, BRIT J DERMATOL, V134, P693, DOI 10.1111/j.1365-2133.1996.tb06972.x; GUERIN C, 1992, BIOCHEM BIOPH RES CO, V188, P740, DOI 10.1016/0006-291X(92)91118-A; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Hersch Steven M, 2004, NeuroRx, V1, P298, DOI 10.1007/BF03206614; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Ibrahim WH, 2000, J NUTR, V130, P2343, DOI 10.1093/jn/130.9.2343; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Ioannidis JPA, 2007, EUR J CLIN INVEST, V37, P340, DOI 10.1111/j.1365-2362.2007.01794.x; Kamzalov S, 2003, J NUTR, V133, P3175, DOI 10.1093/jn/133.10.3175; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Lawrenson RA, 2000, DRUG SAFETY, V23, P333, DOI 10.2165/00002018-200023040-00006; Lawson TM, 2001, RHEUMATOLOGY, V40, P329, DOI 10.1093/rheumatology/40.3.329; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Lin SZ, 2003, LIFE SCI, V72, P1635, DOI 10.1016/S0024-3205(02)02442-6; Lonnrot K, 1998, BIOCHEM MOL BIOL INT, V44, P727; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marshall FJ, 2006, NEUROLOGY, V66, P366, DOI 10.1212/01.wnl.0000198586.85250.13; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; MENALLED L, 2009, NEUROBIOL DIS; Mievis S, 2007, NEUROMOL MED, V9, P47, DOI 10.1385/NMM:9:1:47; MORALES LM, 1989, AM J CLIN NUTR, V50, P145, DOI 10.1093/ajcn/50.1.145; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PALLIER P, 2008, BRAIN RES B; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Schilling G, 2004, EXP NEUROL, V187, P137, DOI 10.1016/j.expneurol.2004.01.003; Schilling G, 2001, NEUROSCI LETT, V315, P149, DOI 10.1016/S0304-3940(01)02326-6; Schlienger RG, 2000, DERMATOLOGY, V200, P223, DOI 10.1159/000018387; Seaman HE, 2001, J CLIN PHARMACOL, V41, P852, DOI 10.1177/00912700122010753; Settgast AM, 2003, INT J DERMATOL, V42, P316, DOI 10.1046/j.1365-4362.2003.01778.x; Shapiro LE, 1997, ARCH DERMATOL, V133, P1224, DOI 10.1001/archderm.133.10.1224; Shults CW, 2004, EXP NEUROL, V188, P491, DOI 10.1016/j.expneurol.2004.05.003; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Teitelbaum JE, 1998, ARCH PEDIAT ADOL MED, V152, P1132; Thomas M, 2004, MOVEMENT DISORD, V19, P692, DOI 10.1002/mds.20018; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; WAGNER LA, 2008, ANIMAL TRANSLATIONAL; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	77	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9793	10.1371/journal.pone.0009793	http://dx.doi.org/10.1371/journal.pone.0009793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339553	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000275894300019
J	Bradley, LH; Fuqua, J; Richardson, A; Turchan-Cholewo, J; Ai, Y; Kelps, KA; Glass, JD; He, XQ; Zhang, ZM; Grondin, R; Littrell, OM; Huettl, P; Pomerleau, F; Gash, DM; Gerhardt, GA				Bradley, Luke H.; Fuqua, Josh; Richardson, April; Turchan-Cholewo, Jadwiga; Ai, Yi; Kelps, Kristen A.; Glass, John D.; He, Xiuquan; Zhang, Zhiming; Grondin, Richard; Littrell, O. Meagan; Huettl, Peter; Pomerleau, Francois; Gash, Don M.; Gerhardt, Greg A.			Dopamine Neuron Stimulating Actions of a GDNF Propeptide	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; IN-VIVO; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FUNCTIONAL RECOVERY; SUBSTANTIA-NIGRA; FACTOR PRECURSOR; RAT STRIATUM; CELL-DEATH	Background: Neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), have shown great promise for protection and restoration of damaged or dying dopamine neurons in animal models and in some Parkinson's disease (PD) clinical trials. However, the delivery of neurotrophic factors to the brain is difficult due to their large size and poor bio-distribution. In addition, developing more efficacious trophic factors is hampered by the difficulty of synthesis and structural modification. Small molecules with neurotrophic actions that are easy to synthesize and modify to improve bioavailability are needed. Methods and Findings: Here we present the neurobiological actions of dopamine neuron stimulating peptide-11 (DNSP-11), an 11-mer peptide from the proGDNF domain. In vitro, DNSP-11 supports the survival of fetal mesencephalic neurons, increasing both the number of surviving cells and neuritic outgrowth. In MN9D cells, DNSP-11 protects against dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA)-induced cell death, significantly decreasing TUNEL-positive cells and levels of caspase-3 activity. In vivo, a single injection of DNSP-11 into the normal adult rat substantia nigra is taken up rapidly into neurons and increases resting levels of dopamine and its metabolites for up to 28 days. Of particular note, DNSP-11 significantly improves apomorphine-induced rotational behavior, and increases dopamine and dopamine metabolite tissue levels in the substantia nigra in a rat model of PD. Unlike GDNF, DNSP-11 was found to block staurosporine- and gramicidin-induced cytotoxicity in nutrient-deprived dopaminergic B65 cells, and its neuroprotective effects included preventing the release of cytochrome c from mitochondria. Conclusions: Collectively, these data support that DNSP-11 exhibits potent neurotrophic actions analogous to GDNF, making it a viable candidate for a PD therapeutic. However, it likely signals through pathways that do not directly involve the GFR alpha 1 receptor.	[Bradley, Luke H.; Fuqua, Josh; Richardson, April; Turchan-Cholewo, Jadwiga; Ai, Yi; Kelps, Kristen A.; He, Xiuquan; Zhang, Zhiming; Grondin, Richard; Littrell, O. Meagan; Huettl, Peter; Pomerleau, Francois; Gash, Don M.; Gerhardt, Greg A.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Bradley, Luke H.; Fuqua, Josh; Richardson, April; Turchan-Cholewo, Jadwiga; Ai, Yi; Kelps, Kristen A.; He, Xiuquan; Zhang, Zhiming; Grondin, Richard; Littrell, O. Meagan; Huettl, Peter; Pomerleau, Francois; Gash, Don M.; Gerhardt, Greg A.] Univ Kentucky, Morris K Udall Parkinsons Dis Res Ctr Excellence, Coll Med, Lexington, KY 40536 USA; [Bradley, Luke H.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Bradley, Luke H.] Univ Kentucky, Struct Biol Ctr, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Bradley, LH (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA.	lhbradley@uky.edu		Bradley, Luke/0000-0003-1870-0796	NIDA [T32 DA022738]; NIA [T32 AG000242, AG013494]; University of Kentucky College of Medicine; NIH [P20RR20171]; PhRMA Foundation; NINDS [NS039787]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000242, P01AG013494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022738] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Kentucky College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support was provided by training research fellowships from NIDA (T32 DA022738, J.F. & K. A. K.) and NIA (T32 AG000242, J.T.-C.). This work was also supported by University of Kentucky College of Medicine Start-up Funds (L. H. B.), NIH COBRE Pilot (P20RR20171, L. H. B.), PhRMA Foundation (L. H. B.), NINDS (NS039787, G. A. G., D. M. G., L. H. B., F. P., P. H., J.F., Y.A., Z.Z., R. G.) and NIA (AG013494, D. M. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; CARLILE GW, MOL PHARM, V57, P2; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dicou E, 1997, J CELL BIOL, V136, P389, DOI 10.1083/jcb.136.2.389; Dicou E, 2006, BIOCHEM BIOPH RES CO, V347, P833, DOI 10.1016/j.bbrc.2006.06.171; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Goldstein NES, 2005, ASSESSMENT, V12, P462, DOI 10.1177/1073191105283065; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; HALL ME, 1989, LC GC-MAG SEP SCI, V7, P258; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; Hebert MA, 1996, J PHARMACOL EXP THER, V279, P1181; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1997, EXP NEUROL, V147, P130, DOI 10.1006/exnr.1997.6571; Hornykiewicz O, 1987, Adv Neurol, V45, P19; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Ibanez CF, 1998, TRENDS NEUROSCI, V21, P438, DOI 10.1016/S0166-2236(98)01266-1; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Immonen T, 2008, EXP NEUROL, V210, P793, DOI 10.1016/j.expneurol.2007.12.018; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2009, EXP NEUROL, V219, P197, DOI 10.1016/j.expneurol.2009.05.013; Schapira AHV, 1998, ANN NEUROL, V44, pS89, DOI 10.1002/ana.410440714; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatton W, 2003, J NEURAL TRANSM, V110, P509, DOI 10.1007/s00702-002-0827-z; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Winkler C, 1996, J NEUROSCI, V16, P7206; York B, 2005, FASEB J, V19, P1202, DOI 10.1096/fj.04-3142fje; Yu LY, 2008, J NEUROSCI, V28, P7467, DOI 10.1523/JNEUROSCI.1877-08.2008; Yu LY, 2003, J CELL BIOL, V163, P987, DOI 10.1083/jcb.200305083	52	25	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9752	10.1371/journal.pone.0009752	http://dx.doi.org/10.1371/journal.pone.0009752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305789	Green Published, gold, Green Submitted			2022-12-27	WOS:000276456300006
J	Rutledge, RG; Stewart, D				Rutledge, Robert G.; Stewart, Don			Assessing the Performance Capabilities of LRE-Based Assays for Absolute Quantitative Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYSTEMATIC VALIDATION; COPY NUMBER; DNA; STANDARD; QUANTIFICATION; RELIABILITY; GENES	Background: Linear regression of efficiency or LRE introduced a new paradigm for conducting absolute quantification, which does not require standard curves, can generate absolute accuracies of +/- 25% and has single molecule sensitivity. Derived from adapting the classic Boltzmann sigmoidal function to PCR, target quantity is calculated directly from the fluorescence readings within the central region of an amplification profile, generating 4-8 determinations from each amplification reaction. Findings: Based on generating a linear representation of PCR amplification, the highly visual nature of LRE analysis is illustrated by varying reaction volume and amplification efficiency, which also demonstrates how LRE can be used to model PCR. Examining the dynamic range of LRE further demonstrates that quantitative accuracy can be maintained down to a single target molecule, and that target quantification below ten molecules conforms to that predicted by Poisson istribution. Essential to the universality of optical calibration, the fluorescence intensity generated by SYBR Green I (FU/bp) is shown to be independent of GC content and amplicon size, further verifying that absolute scale can be established using a single quantitative standard. Two high-performance lambda amplicons are also introduced that in addition to producing highly precise optical calibrations, can be used as benchmarks for performance testing. The utility of limiting dilution assay for conducting platform-independent absolute quantification is also discussed, along with the utility of defining assay performance in terms of absolute accuracy. Conclusions: Founded on the ability to exploit lambda gDNA as a universal quantitative standard, LRE provides the ability to conduct absolute quantification using few resources beyond those needed for sample preparation and amplification. Combined with the quantitative and quality control capabilities of LRE, this kinetic-based approach has the potential to fundamentally transform how real-time qPCR is conducted.	[Rutledge, Robert G.; Stewart, Don] Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Rutledge, RG (corresponding author), Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada.	Bob.Rutledge@NRCan.gc.ca			Canadian Biotechnology Strategy	Canadian Biotechnology Strategy	The research was supported in part by a grant to RGR from the Canadian Biotechnology Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle B, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-75; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Garson JA, 2009, AIDS RES HUM RETROV, V25, P377, DOI 10.1089/aid.2008.0270; Gentle A, 2001, BIOTECHNIQUES, V31, P502, DOI 10.2144/01313st03; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; Kang J J, 2000, Nucleic Acids Res, V28, pe2, DOI 10.1093/nar/28.2.e2; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rasoolizadeh A, 2009, J GEN VIROL, V90, P1505, DOI 10.1099/vir.0.008664-0; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Skern R, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-10; Spadoro J., 1998, GENE QUANTIFICATION, P31; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	32	51	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9731	10.1371/journal.pone.0009731	http://dx.doi.org/10.1371/journal.pone.0009731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305810	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809600004
J	Zhou, JN; Zhao, L; Qin, LP; Wang, J; Jia, YL; Yao, HL; Sang, C; Hu, QH; Shi, SS; Nan, X; Yue, W; Zhuang, FY; Yang, C; Wang, YF; Pei, XT				Zhou, Junnian; Zhao, Lei; Qin, Lipeng; Wang, Jing; Jia, Yali; Yao, Hailei; Sang, Chen; Hu, Qinghua; Shi, Shuangshuang; Nan, Xue; Yue, Wen; Zhuang, Fengyuan; Yang, Chun; Wang, Yunfang; Pei, Xuetao			Epimorphin Regulates Bile Duct Formation via Effects on Mitosis Orientation in Rat Liver Epithelial Stem-Like Cells	PLOS ONE			English	Article							MORPHOGENIC PROTEIN; SPINDLE ORIENTATION; DIFFERENTIATION; INTEGRINS; GROWTH; EXPRESSION; SUBSTRATUM; ADHESION; SHAPE	Understanding how hepatic precursor cells can generate differentiated bile ducts is crucial for studies on epithelial morphogenesis and for development of cell therapies for hepatobiliary diseases. Epimorphin (EPM) is a key morphogen for duct morphogenesis in various epithelial organs. The role of EPM in bile duct formation (DF) from hepatic precursor cells, however, is not known. To address this issue, we used WB-F344 rat epithelial stem-like cells as model for bile duct formation. A micropattern and a uniaxial static stretch device was used to investigate the effects of EPM and stress fiber bundles on the mitosis orientation (MO) of WB cells. Immunohistochemistry of liver tissue sections demonstrated high EPM expression around bile ducts in vivo. In vitro, recombinant EPM selectively induced DF through upregulation of CK19 expression and suppression of HNF3 alpha and HNF6, with no effects on other hepatocytic genes investigated. Our data provide evidence that EPM guides MO of WB-F344 cells via effects on stress fiber bundles and focal adhesion assembly, as supported by blockade EPM, beta 1 integrin, and F-actin assembly. These blockers can also inhibit EPM-induced DF. These results demonstrate a new biophysical action of EPM in bile duct formation, during which determination of MO plays a crucial role.	[Zhou, Junnian; Qin, Lipeng; Jia, Yali; Yao, Hailei; Shi, Shuangshuang; Nan, Xue; Yue, Wen; Wang, Yunfang; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China; [Zhao, Lei; Wang, Jing; Sang, Chen; Hu, Qinghua; Zhuang, Fengyuan; Yang, Chun] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China	Beihang University	Zhou, JN (corresponding author), Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China.	yangchun@tsinghua.edu.cn; wangyf1972@gmail.com; peixt@nic.bmi.ac.cn	Jia, Yali/AAH-1668-2022; Jia, Yali/AFL-9551-2022; Zhou, Junnian/CAI-2072-2022; Yang, Chun/A-7467-2008	Zhou, Junnian/0000-0002-7782-234X; Jia, Yali/0000-0002-2896-6021; Yang, Chun/0000-0003-1191-7642	National High Technology Research and Development Program of China [2006AA02A107]; Major State Basic Research Program of China [2005CB522702]; National Nature Science Foundation of China [30671098, 30870602]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (No: 2006AA02A107), the Major State Basic Research Program of China (No: 2005CB522702), and the National Nature Science Foundation of China (No: 30671098 No: 30870602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Chapman L, 1999, FASEB J, V13, pA160; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLARK P, 1993, J CELL SCI, V105, P203; Coffinier C, 2002, DEVELOPMENT, V129, P1829; COLEMAN WB, 1993, AM J PATHOL, V142, P1373; COLEMAN WB, 1998, LIVER GROWTH REPAIR, P50; Couchie D, 2002, DIFFERENTIATION, V69, P209, DOI 10.1046/j.1432-0436.2002.690414.x; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Fan JH, 2009, J CELL PHYSIOL, V220, P72, DOI 10.1002/jcp.21731; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; GERMAIN L, 1988, CANCER RES, V48, P368; GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270; HAMMARBACK JA, 1986, DEV BIOL, V117, P655, DOI 10.1016/0012-1606(86)90334-9; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; HIRAI Y, 1994, EUR J BIOCHEM, V225, P1133, DOI 10.1111/j.1432-1033.1994.1133b.x; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Hirose M, 1996, BIOCHEM BIOPH RES CO, V225, P155, DOI 10.1006/bbrc.1996.1146; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Lemaigre FP, 2003, MECH DEVELOP, V120, P81; LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559; Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Oka Y, 1996, EXP CELL RES, V222, P189, DOI 10.1006/excr.1996.0024; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711; Segawa D, 2005, J GASTROEN HEPATOL, V20, P1769, DOI 10.1111/j.1440-1746.2005.03944.x; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Simian M, 2001, DEVELOPMENT, V128, P3117; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yanai M, 2008, DEV DYNAM, V237, P1268, DOI 10.1002/dvdy.21520; Yao HL, 2009, DIFFERENTIATION, V77, P154, DOI 10.1016/j.diff.2008.09.017; Yoshino R, 2006, HEPATOL RES, V34, P238, DOI 10.1016/j.hepres.2005.12.011; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zhang LY, 1998, HISTOCHEM J, V30, P903, DOI 10.1023/A:1003485503117	55	14	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9732	10.1371/journal.pone.0009732	http://dx.doi.org/10.1371/journal.pone.0009732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305811	Green Submitted, Green Published, gold			2022-12-27	WOS:000275809600005
J	Sharma, D; Bhattacharya, J				Sharma, Deepak; Bhattacharya, Jayanta			Evolutionary Constraints Acting on DDX3X Protein Potentially Interferes with Rev-Mediated Nuclear Export of HIV-1 RNA	PLOS ONE			English	Article							SEQUENCE; HELICASE; FAMILY; SITES	Differential host-pathogen interactions direct viral replication in infected cells. In HIV-1 infected cells, nuclear export of viral RNA transcripts into cellular cytoplasm is governed by interaction of HIV-1 Rev, Exportin-1 (CRM-1) and DDX3X. Knock down of DDX3X has been shown to drastically impair HIV replication. Here we show that evolutionary forces are responsible for demarking previously unidentified critical functionally important residues on the surface of DDX3X. Using computational approaches, we show that these functional residues, depending on their location, are capable of regulating ATPase and RNA helicase functions of DDX3X. The potential of these residues in designing better blockers against HIV-1 replication was also assessed. Also, using stepwise docking simulations, we could identify DDX3X-CRM-1 interface and its critical functional residues. Our data would help explain the role of DDX3X in HIV-1 Rev function with potential to design new intervention strategies against HIV-1 replication.	[Sharma, Deepak; Bhattacharya, Jayanta] Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Sharma, D (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India.	jbhattacharya@nariindia.org	Sharma, Deepak/GPT-1692-2022	Sharma, Deepak/0000-0001-8436-1759				Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOHM H, 2003, CRYST STRC SYMM, V31, P1069; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Harris ME, 2000, ESSAYS BIOCHEM, V36, P115, DOI 10.1042/bse0360115; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JOY S, 2006, SILICO BIOL, V6, P48; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ritchie DW, 2005, J APPL CRYSTALLOGR, V38, P808, DOI 10.1107/S002188980502474X; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON MA, ARGUSLAB 4 0 1 ARGUS; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9613	10.1371/journal.pone.0009613	http://dx.doi.org/10.1371/journal.pone.0009613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300618	gold, Green Published, Green Submitted			2022-12-27	WOS:000275621000002
J	Snyder, CM; Allan, JE; Bonnett, EL; Doom, CM; Hill, AB				Snyder, Christopher M.; Allan, Jane E.; Bonnett, Elizabeth L.; Doom, Carmen M.; Hill, Ann B.			Cross-Presentation of a Spread-Defective MCMV Is Sufficient to Prime the Majority of Virus-Specific CD8+T Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS-INFECTION; UL115 GENE-PRODUCT; MAMMALIAN-CELLS; RESPONSES; ANTIGEN; EXPRESSION; PROTECTION; DISTINCT; GENOME	CD8+ T cells can be primed by peptides derived from endogenous proteins (direct presentation), or exogenously acquired protein (cross-presentation). However, the relative ability of these two pathways to prime CD8+ T cells during a viral infection remains controversial. Cytomegaloviruses (CMVs) can infect professional antigen presenting cells (APCs), including dendritic cells, thus providing peptides for direct presentation. However, the viral immune evasion genes profoundly impair recognition of infected cells by CD8+ T cells. Nevertheless, CMV infection elicits a very strong CD8+ T cell response, prompting its recent use as a vaccine vector. We have shown previously that deleting the immune evasion genes from murine cytomegalovirus (MCMV) that target class I MHC presentation, has no impact on the size or breadth of the CD8+ T cell response elicited by infection, suggesting that the majority of MCMV-specific CD8+ T cells in vivo are not directly primed by infected professional APCs. Here we use a novel spread-defective mutant of MCMV, lacking the essential glycoprotein gL, to show that cross-presentation alone can account for the majority of MCMV-specific CD8+ T cell responses to the virus. Our data support the conclusion that cross-presentation is the primary mode of antigen presentation by which CD8+ T cells are primed during MCMV infection.	[Snyder, Christopher M.; Bonnett, Elizabeth L.; Doom, Carmen M.; Hill, Ann B.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Allan, Jane E.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia	Oregon Health & Science University; University of Western Australia	Snyder, CM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	hillan@ohsu.edu	Allan, Jane E/D-3101-2013	Allan, Jane E/0000-0003-2572-9773; Snyder, Christopher/0000-0003-1370-7198	National Institutes of Health (NIH) [RO1 A I47206]; American Heart Association; National Health and Medical Research Council of Australia [9934711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047206] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) RO1 A I47206 and an American Heart Association GIA awarded to A. B. H., a National Health and Medical Research Council of Australia Grant 9934711 to J.E.A., and a post-doctoral training grant from the American Heart Association (# 0725786Z) awarded to C. M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Goodrum F, 2004, BLOOD, V104, P687, DOI 10.1182/blood-2003-12-4344; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hobom U, 2000, J VIROL, V74, P7720, DOI 10.1128/JVI.74.17.7720-7729.2000; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; JORDAN MC, 1983, INFECT IMMUN, V41, P841, DOI 10.1128/IAI.41.2.841-843.1983; KAYE JF, 1992, J GEN VIROL, V73, P2693, DOI 10.1099/0022-1317-73-10-2693; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; Loewendorf A, 2004, J VIROL, V78, P13062, DOI 10.1128/JVI.78.23.13062-13071.2004; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smith LM, 2008, J VIROL, V82, P6689, DOI 10.1128/JVI.00160-08; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; SPAETE RR, 1993, VIROLOGY, V193, P853, DOI 10.1006/viro.1993.1194; Streblow DN, 2007, J VIROL, V81, P3816, DOI 10.1128/JVI.02425-06; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	34	58	67	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9681	10.1371/journal.pone.0009681	http://dx.doi.org/10.1371/journal.pone.0009681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300633	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900014
J	Vaiyapuri, S; Harrison, RA; Bicknell, AB; Gibbins, JM; Hutchinson, G				Vaiyapuri, Sakthivel; Harrison, Robert A.; Bicknell, Andrew B.; Gibbins, Jonathan M.; Hutchinson, Gail			Purification and Functional Characterisation of Rhinocerase, a Novel Serine Protease from the Venom of Bitis gabonica rhinoceros	PLOS ONE			English	Article							THROMBIN-LIKE ENZYME; SNAKE-VENOM; PLASMINOGEN-ACTIVATOR; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; COAGULANT ENZYME; PROTEINASES; SEQUENCE; SPECIFICITY; FIBRINOGEN	Background: Serine proteases are a major component of viper venoms and are thought to disrupt several distinct elements of the blood coagulation system of envenomed victims. A detailed understanding of the functions of these enzymes is important both for acquiring a fuller understanding of the pathology of envenoming and because these venom proteins have shown potential in treating blood coagulation disorders. Methodology/Principal Findings: In this study a novel, highly abundant serine protease, which we have named rhinocerase, has been isolated and characterised from the venom of Bitis gabonica rhinoceros using liquid phase isoelectric focusing and gel filtration. Like many viper venom serine proteases, this enzyme is glycosylated; the estimated molecular mass of the native enzyme is approximately 36kDa, which reduces to 31kDa after deglycosylation. The partial amino acid sequence shows similarity to other viper venom serine proteases, but is clearly distinct from the sequence of the only other sequenced serine protease from Bitis gabonica. Other viper venom serine proteases have been shown to exert distinct biological effects, and our preliminary functional characterization of rhinocerase suggest it to be multifunctional. It is capable of degrading alpha and beta chains of fibrinogen, dissolving plasma clots and of hydrolysing a kallikrein substrate. Conclusions/Significance: A novel multifunctional viper venom serine protease has been isolated and characterised. The activities of the enzyme are consistent with the known in vivo effects of Bitis gabonica envenoming, including bleeding disorders, clotting disorders and hypotension. This study will form the basis for future research to understand the mechanisms of serine protease action, and examine the potential for rhinocerase to be used clinically to reduce the risk of human haemostatic disorders such as heart attacks and strokes.	[Vaiyapuri, Sakthivel; Bicknell, Andrew B.; Gibbins, Jonathan M.; Hutchinson, Gail] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Harrison, Robert A.] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England; [Gibbins, Jonathan M.] King Saud Univ, Blood Transfus Res Grp, Riyadh, Saudi Arabia	University of Reading; Liverpool School of Tropical Medicine; University of Liverpool; King Saud University	Vaiyapuri, S (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	e.g.hutchinson@reading.ac.uk	Vaiyapuri, Sakthivel/M-4198-2013	Gibbins, Jonathan/0000-0002-0372-5352; Vaiyapuri, Sakthivel/0000-0002-6006-6517	Felix Trust, London; British Heart Foundation [PG/08/100/26125] Funding Source: researchfish	Felix Trust, London; British Heart Foundation(British Heart Foundation)	This research was funded by the Felix Trust, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY GS, 1976, BIOCHEM J, V153, P409, DOI 10.1042/bj1530409; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714; Castro HC, 2004, CELL MOL LIFE SCI, V61, P843, DOI 10.1007/s00018-003-3325-z; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Gao R, 1998, TOXICON, V36, P457, DOI 10.1016/S0041-0101(97)00150-5; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; HATTON MWC, 1973, BIOCHEM J, V131, P799, DOI 10.1042/bj1310799; Hubbard GP, 2003, J THROMB HAEMOST, V1, P1079, DOI 10.1046/j.1538-7836.2003.00212.x; ITOH N, 1987, J BIOL CHEM, V262, P3132; Komori Y, 2002, J NAT TOXINS, V11, P205; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; MARKLAND FS, 1982, P NATL ACAD SCI-BIOL, V79, P1688, DOI 10.1073/pnas.79.6.1688; MARSH NA, 1974, BRIT J HAEMATOL, V26, P295, DOI 10.1111/j.1365-2141.1974.tb00474.x; MEIER J, 1991, CRIT REV TOXICOL, V21, P171, DOI 10.3109/10408449109089878; Muanpasitporn C, 2007, TOXICON, V49, P1083, DOI 10.1016/j.toxicon.2007.01.015; Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PIRKLE H, 1986, J BIOL CHEM, V261, P8830; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; VILJOEN CC, 1979, TOXICON, V17, P145, DOI 10.1016/0041-0101(79)90293-9; Wagstaff SC, 2006, PLOS MED, V3, P832, DOI 10.1371/journal.pmed.0030184; Zhang SJ, 2001, J NAT TOXINS, V10, P221; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246; Zhu ZL, 2005, J BIOL CHEM, V280, P10524, DOI 10.1074/jbc.M412900200	29	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9687	10.1371/journal.pone.0009687	http://dx.doi.org/10.1371/journal.pone.0009687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300193	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000275620900018
J	Yamashita, A; Nishikawa, S; Rancourt, DE				Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.			Microenvironment Modulates Osteogenic Cell Lineage Commitment in Differentiated Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO; ES CELLS; OSTEOBLASTS; MARROW; MASS	Background: Due to their self-renewal, embryonic stem cells (ESCs) are attractive cells for applications in regenerative medicine and tissue engineering. Although ESC differentiation has been used as a platform for generating bone in vitro and in vivo, the results have been unsatisfactory at best. It is possible that the traditional culture methods, which have been used, are not optimal and that other approaches must be explored. Methodology/Principal Findings: ESCs were differentiated into osteoblast lineage using a micro-mass approach. In response to osteogenic differentiation medium, many cells underwent apoptosis, while others left the micro-mass, forming small aggregates in suspension. These aggregates were cultured in three different culture conditions (adhesion, static suspension, and stirred suspension), then examined for osteogenic potential in vitro and in vivo. In adhesion culture, ESCs primed to become osteoblasts recommitted to the adipocyte lineage in vitro. In a static suspension culture, resulting porous aggregates expressed osteoblasts markers and formed bone in vivo via intermembranous ossification. In a stirred suspension culture, resulting non-porous aggregates suppressed osteoblast differentiation in favor of expanding progenitor cells. Conclusions/Significance: We demonstrate that microenvironment modulates cell fate and subsequent tissue formation during ESC differentiation. For effective tissue engineering using ESCs, it is important to develop optimized cell culture/differentiation conditions based upon the influence of microenvironment.	[Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary	Yamashita, A (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	rancourt@ucalgary.ca			Canadian Institutes of Health Research [200605RMF-163344-RMA-CBBA-27639]; Alberta Heritage Foundation of Medical Research; Japanese Society for the Promotion of Science	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation of Medical Research(Alberta Heritage Foundation for Medical Research); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Canadian Institutes of Health Research 200605RMF-163344-RMA-CBBA-27639. AY was supported by postdoctoral fellowships from the Alberta Heritage Foundation of Medical Research and the Japanese Society for the Promotion of Science. DER is an Alberta Heritage Foundation of Medical Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERESFORD JN, 1992, J CELL SCI, V102, P341; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; SARBER R, 1981, MECH AGEING DEV, V17, P107, DOI 10.1016/0047-6374(81)90077-4; Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759; TAIANI J, 2009, STEM CELLS IN PRESS; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Yamashita A, 2005, CLONING STEM CELLS, V7, P232, DOI 10.1089/clo.2005.7.232; Yamashita A, 2006, CLONING STEM CELLS, V8, P3, DOI 10.1089/clo.2006.8.3; Yamashita A, 2009, CELL DEATH DIFFER, V16, P278, DOI 10.1038/cdd.2008.149; Yamashita A, 2006, FEBS LETT, V580, P4121, DOI 10.1016/j.febslet.2006.06.057; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	23	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9663	10.1371/journal.pone.0009663	http://dx.doi.org/10.1371/journal.pone.0009663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300192	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900004
J	O'Connor, AM; Auvermann, B; Bickett-Weddle, D; Kirkhorn, S; Sargeant, JM; Ramirez, A; Von Essen, SG				O'Connor, Annette M.; Auvermann, Brent; Bickett-Weddle, Danelle; Kirkhorn, Steve; Sargeant, Jan M.; Ramirez, Alejandro; Von Essen, Susanna G.			The Association between Proximity to Animal Feeding Operations and Community Health: A Systematic Review	PLOS ONE			English	Review							QUALITY-OF-LIFE; GEOGRAPHICAL-DISTRIBUTION; ENVIRONMENTAL EXPOSURE; AIR-POLLUTION; PUBLIC-HEALTH; LUNG-FUNCTION; ODOR; EPIDEMIOLOGY; PREVALENCE; SYMPTOMS	Background: A systematic review was conducted for the association between animal feeding operations (AFOs) and the health of individuals living near AFOs. Methodology/Principal Findings: The review was restricted to studies reporting respiratory, gastrointestinal and mental health outcomes in individuals living near AFOs in North America, European Union, United Kingdom, and Scandinavia. From June to September 2008 searches were conducted in PUBMED, CAB, Web-of-Science, and Agricola with no restrictions. Hand searching of narrative reviews was also used. Two reviewers independently evaluated the role of chance, confounding, information, selection and analytic bias on the study outcome. Nine relevant studies were identified. The studies were heterogeneous with respect to outcomes and exposures assessed. Few studies reported an association between surrogate clinical outcomes and AFO proximity. A negative association was reported when odor was the measure of exposure to AFOs and self-reported disease, the measure of outcome. There was evidence of an association between self-reported disease and proximity to AFO in individuals annoyed by AFO odor. Conclusions/Significance: There was inconsistent evidence of a weak association between self-reported disease in people with allergies or familial history of allergies. No consistent dose response relationship between exposure and disease was observable.	[O'Connor, Annette M.; Ramirez, Alejandro] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50011 USA; [Auvermann, Brent] Texas AgriLife Res, Amarillo, TX USA; [Bickett-Weddle, Danelle] Iowa State Univ, Ctr Food Secur Publ Hlth, Coll Vet Med, Ames, IA USA; [Kirkhorn, Steve] Marshfield Clin Fdn Med Res & Educ, Natl Farm Med Ctr, Marshfield, WI USA; [Sargeant, Jan M.] Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada; [Sargeant, Jan M.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [Von Essen, Susanna G.] Univ Nebraska, Med Ctr, Dept Environm Agr & Occupat Hlth, Coll Publ Hlth, Omaha, NE USA	Iowa State University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Iowa State University; Marshfield Clinic; University of Guelph; University of Guelph; University of Nebraska System; University of Nebraska Medical Center	O'Connor, AM (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50011 USA.	oconnor@iastate.edu	O'Connor, A/AFK-8069-2022; Auvermann, Brent W/D-3466-2017; O'Connor, Annette/GRX-1453-2022; O'Connor, A/E-5591-2010; O'Connor, A/AFY-4688-2022	O'Connor, A/0000-0003-0604-7822; Auvermann, Brent W/0000-0001-6506-2921; O'Connor, Annette/0000-0003-0604-7822; O'Connor, A/0000-0003-0604-7822; O'Connor, A/0000-0003-0604-7822	United Soybean Board; National Pork Board [Q 8126]	United Soybean Board; National Pork Board	This study was funded by the United Soybean Board, (www.unitedsoybean.org) and the National Pork Board (www.pork.org), Grant #Q 8126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acad. Med. Sci, 2007, ID ENV CAUS DIS SHOU; ANDERSEN JK, 1991, INT J FOOD MICROBIOL, V13, P231, DOI 10.1016/0168-1605(91)90007-C; [Anonymous], 2008, CONCENTRATED ANIMAL; [Anonymous], 2008, PUTTING MEAT TABLE I; Avery RC, 2004, ARCH ENVIRON HEALTH, V59, P101, DOI 10.3200/AEOH.59.2.101-108; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bullers S, 2005, HUM ECOL, V33, P1, DOI 10.1007/s10745-005-1653-3; Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839; Chang MC, 2008, J INST MATH JUSSIEU, V7, P1, DOI 10.1017/S1474748007000126; Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Donham KJ, 2007, ENVIRON HEALTH PERSP, V115, P317, DOI 10.1289/ehp.8836; Donham Kelley J, 2006, J Agromedicine, V11, P15, DOI 10.1300/J096v11n03_03; DONHAM KJ, 1995, AM J IND MED, V27, P405, DOI 10.1002/ajim.4700270309; Eichholzer M, 1998, NUTR REV, V56, P95; Ghosh R, 2007, ENVIRON RES, V105, P400, DOI 10.1016/j.envres.2007.03.009; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Goetghebeur MM, 2008, BMC HEALTH SERV RES, V8, P270, DOI DOI 10.1186/1472-6963-8-270; HANSELMAN TA, 2008, ENVIRON SCI TECHNOL, V37, P5471; Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835; Hoopmann M, 2006, GESUNDHEITSWESEN, V68, P575, DOI 10.1055/s-2006-926987; HRUDEY SE, 2000, REV DOCUMENTS PERTAI; Innocent GT, 2005, EPIDEMIOL INFECT, V133, P1033, DOI 10.1017/S0950268805003687; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jaime PC, 2009, PREV MED, V48, P45, DOI 10.1016/j.ypmed.2008.10.018; Jongbloed AW, 1998, J ANIM SCI, V76, P2641; Kirkhorn SR, 2000, ENVIRON HEALTH PERSP, V108, P705, DOI 10.2307/3454407; Kirkhorn Steven R, 2002, Minn Med, V85, P38; Kistemann T, 2004, EPIDEMIOL INFECT, V132, P495, DOI 10.1017/S0950268803001729; LARSSON K, 1992, CHEST, V101, P767, DOI 10.1378/chest.101.3.767; MCLACHLAN JA, 1995, ENV HLTH PERSPECT, P3; Michel P, 1999, EPIDEMIOL INFECT, V122, P193, DOI 10.1017/S0950268899002083; Mirabelli MC, 2006, PEDIATRICS, V118, pE66, DOI 10.1542/peds.2005-2812; Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; NATTABI B, 2009, AIDS BEHAV; Naylor C D, 1995, J Eval Clin Pract, V1, P127, DOI 10.1111/j.1365-2753.1995.tb00018.x; Nimmermark S, 2004, ANN AGR ENV MED, V11, P163; Nygard K, 2004, EPIDEMIOL INFECT, V132, P317, DOI 10.1017/S0950268803001900; Odoi A, 2004, EPIDEMIOL INFECT, V132, P967, DOI 10.1017/S0950268804002481; Odoi Agricola, 2004, Int J Health Geogr, V3, P11, DOI 10.1186/1476-072X-3-11; Ottenbacher KJ, 2004, J CLIN EPIDEMIOL, V57, P1147, DOI 10.1016/j.jclinepi.2003.05.003; Parfrey Patrick, 2009, V473, P1, DOI 10.1007/978-1-59745-385-1_1; Radon K, 2004, ANN AGR ENV MED, V11, P59; Radon K, 2005, Pneumologie, V59, P897, DOI 10.1055/s-2005-915572; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; Rudek J., 2008, ADVERSE HLTH EFFECTS; Schiffman SS, 2005, ENVIRON HEALTH PERSP, V113, P567, DOI 10.1289/ehp.6814; SCHIFFMAN SS, 2008, J ANIM SCI, V76, P1345; SCHIFFMAN SS, 2008, HLTH EFFECTS AERIAL; SHOEMAKERNAWAS P, 1982, WESTERN J MED, V137, P436; SHUSTERMAN D, 1992, ARCH ENVIRON HEALTH, V47, P76, DOI 10.1080/00039896.1992.9935948; Sigurdarson ST, 2006, CHEST, V129, P1486, DOI 10.1378/chest.129.6.1486; Sigurdarson ST, 2004, AM J IND MED, V46, P345, DOI 10.1002/ajim.20055; Sneeringer S, 2009, AM J AGR ECON, V91, P124, DOI 10.1111/j.1467-8276.2008.01161.x; Tajik M, 2008, NEW SOLUT, V18, P193, DOI 10.2190/NS.18.2.i; Thorne PS, 2007, ENVIRON HEALTH PERSP, V115, P296, DOI 10.1289/ehp.8831; Thu K., 1997, Journal of Agricultural Safety and Health, V3, P13; Valcour JE, 2002, EMERG INFECT DIS, V8, P252, DOI 10.3201/eid0803.010159; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vogelzang PFJ, 1998, AM J RESP CRIT CARE, V157, P15, DOI 10.1164/ajrccm.157.1.9703087; Von Essen Susanna G, 2005, J Agromedicine, V10, P55, DOI 10.1300/J096v10n04_08; Wing S, 2002, ENVIRON HEALTH PERSP, V110, P437, DOI 10.1289/ehp.02110437; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439; Wing S, 2008, AM J PUBLIC HEALTH, V98, P1390, DOI 10.2105/AJPH.2007.110486; World Health Organization, 2000, EV US EP EV ENV HLTH; 2008, OCCUPATIONAL COMMUNI; 2008, COMMUNITY SOCIAL IMP; 2009, REGULATORY DEFINITIO	71	30	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9530	10.1371/journal.pone.0009530	http://dx.doi.org/10.1371/journal.pone.0009530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	565XE	20224825	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800003
J	Sarafian, TA; Montes, C; Imura, T; Qi, JW; Coppola, G; Geschwind, DH; Sofroniew, MV				Sarafian, Theodore A.; Montes, Cindy; Imura, Tetsuya; Qi, Jingwei; Coppola, Giovanni; Geschwind, Daniel H.; Sofroniew, Michael V.			Disruption of Astrocyte STAT3 Signaling Decreases Mitochondrial Function and Increases Oxidative Stress In Vitro	PLOS ONE			English	Article							UP-REGULATION; GLUTATHIONE BIOSYNTHESIS; SUPEROXIDE; GLIA; ASTROGLIOSIS; ACTIVATION; EXPRESSION; PROTECTION; NEURONS; TRANSCRIPTION-3	Background: Astrocytes exert a wide variety of functions in health and disease and respond to a wide range of signaling pathways, including members of the Janus-kinase signal transducers and activators of transcription (Jak-STAT) family. We have recently shown that STAT3 is an important regulator of astrocyte reactivity after spinal cord injury in vivo [1]. Methodology/Principal Findings: Here, we used both a conditional gene deletion strategy that targets the deletion of STAT3 selectively to astrocytes (STAT3-CKO), and a pharmacological inhibitor of JAK-2, AG490, in cultured astrocytes in vitro, to investigate potential functions and molecules influenced by STAT3 signaling in relation to mitochondrial function and oxidative stress. Our findings show that the absence of STAT3 signaling in astrocytes leads to (i) increased production of superoxide anion and other reactive oxygen species and decreased level of glutathione, (ii) decreased mitochondrial membrane potential and decreased ATP production, and (iii) decreased rate of cell proliferation. Many of the differences observed in STAT3-CKO astrocytes were distinctly altered by exposure to rotenone, suggesting a role for complex I of the mitochondrial electron transport chain. Gene expression microarray studies identified numerous changes in STAT3-CKO cells that may have contributed to the identified deficits in cell function. Conclusions/Significance: Taken together, these STAT3-dependent alterations in cell function and gene expression have relevance to both reactive gliosis and to the support and protection of surrounding cells in neural tissue.	[Sarafian, Theodore A.; Montes, Cindy; Imura, Tetsuya; Qi, Jingwei; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sarafian, TA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	tsarafian@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020		National Institutes of Health [5R01NS057624, DA021580]; Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants 5R01NS057624 (MVS) and DA021580 (TS) and by the Adelson Medical Research Foundation (www.adelsonfoundation.org) (Adelson Program in Neural Rehabilitation and Repair). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, JPN J PHARMACOL, V72, P299, DOI 10.1254/jjp.72.299; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Aschner M, 1997, ANN NY ACAD SCI, V825, P334, DOI 10.1111/j.1749-6632.1997.tb48445.x; BASS DA, 1983, J IMMUNOL, V130, P1910; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brown DR, 2000, MOL CELL NEUROSCI, V15, P465, DOI 10.1006/mcne.2000.0840; Carpentier PA, 2008, VIROLOGY, V375, P24, DOI 10.1016/j.virol.2008.01.024; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Corley SM, 2001, GLIA, V36, P281, DOI 10.1002/glia.1116; Damiani CL, 2007, J NEUROCHEM, V100, P720, DOI 10.1111/j.1471-4159.2006.04321.x; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P1792, DOI 10.1016/j.biocel.2008.01.012; GENTLEMAN R, BIOINFORMATICS COMPU; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Han YH, 2009, LUNG CANCER, V63, P201, DOI 10.1016/j.lungcan.2008.05.005; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Imura T, 2003, J NEUROSCI, V23, P2824; Lamarche F, 2004, ALCOHOL, V33, P127, DOI 10.1016/S0741-8329(04)00100-4; Lamigeon C, 2001, J NEUROCHEM, V77, P598, DOI 10.1046/j.1471-4159.2001.00278.x; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milner PI, 2007, OSTEOARTHR CARTILAGE, V15, P735, DOI 10.1016/j.joca.2007.01.008; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sarafian TA, 2003, AM J PHYSIOL-LUNG C, V284, pL298, DOI 10.1152/ajplung.00157.2002; SARAFIAN TA, 1994, TOXICOL LETT, V74, P149, DOI 10.1016/0378-4274(94)90093-0; Scacco Salvatore, 2006, Ital J Biochem, V55, P254; Sengupta A, 2007, NEUROTOXICOLOGY, V28, P478, DOI 10.1016/j.neuro.2006.10.005; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Smyth GK, BIOINFORMATICS COMPU; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sortino MA, 2004, ENDOCRINOLOGY, V145, P5080, DOI 10.1210/en.2004-0973; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Sugimoto K, 2008, WORLD J GASTROENTERO, V14, P5110, DOI 10.3748/wjg.14.5110; Terui K, 2004, J HEPATOL, V41, P957, DOI 10.1016/j.jhep.2004.08.019; TRAVIS J, 1994, SCIENCE, V266, P970, DOI 10.1126/science.7973679; Tretter L, 2007, NEUROCHEM INT, V50, P139, DOI 10.1016/j.neuint.2006.07.010; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vila M, 2001, CURR OPIN NEUROL, V14, P483, DOI 10.1097/00019052-200108000-00009; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Yajima D, 2009, CELL BIOCHEM FUNCT, V27, P338, DOI 10.1002/cbf.1578	53	129	133	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9532	10.1371/journal.pone.0009532	http://dx.doi.org/10.1371/journal.pone.0009532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224768	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800005
J	Brunoni, AR; Tadini, L; Fregni, F				Brunoni, Andre R.; Tadini, Laura; Fregni, Felipe			Changes in Clinical Trials Methodology Over Time: A Systematic Review of Six Decades of Research in Psychopharmacology	PLOS ONE			English	Review							DOUBLE-BLIND TRIAL; LITHIUM MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIALS; CONTROLLED 18-MONTH TRIAL; CHRONIC-SCHIZOPHRENIA; AFFECTIVE-DISORDERS; PROPHYLACTIC LITHIUM; CONSORT STATEMENT; NATIONAL-INSTITUTE; GERIATRIC-PATIENTS	Background: There have been many changes in clinical trials methodology since the introduction of lithium and the beginning of the modern era of psychopharmacology in 1949. The nature and importance of these changes have not been fully addressed to date. As methodological flaws in trials can lead to false-negative or false-positive results, the objective of our study was to evaluate the impact of methodological changes in psychopharmacology clinical research over the past 60 years. Methodology/Principal Findings: We performed a systematic review from 1949 to 2009 on MEDLINE and Web of Science electronic databases, and a hand search of high impact journals on studies of seven major drugs (chlorpromazine, clozapine, risperidone, lithium, fluoxetine and lamotrigine). All controlled studies published 100 months after the first trial were included. Ninety-one studies met our inclusion criteria. We analyzed the major changes in abstract reporting, study design, participants' assessment and enrollment, methodology and statistical analysis. Our results showed that the methodology of psychiatric clinical trials changed substantially, with quality gains in abstract reporting, results reporting, and statistical methodology. Recent trials use more informed consent, periods of washout, intention-to-treat approach and parametric tests. Placebo use remains high and unchanged over time. Conclusions/Significance: Clinical trial quality of psychopharmacological studies has changed significantly in most of the aspects we analyzed. There was significant improvement in quality reporting and internal validity. These changes have increased study efficiency; however, there is room for improvement in some aspects such as rating scales, diagnostic criteria and better trial reporting. Therefore, despite the advancements observed, there are still several areas that can be improved in psychopharmacology clinical trials.	[Brunoni, Andre R.] Univ Sao Paulo, Dept & Inst Psychiat, Sao Paulo, Brazil; [Tadini, Laura] Osped Maggiore Policlin Mangiagalli & Regina Elen, Fdn IRCCS, Ctr Clin Neuronanotecnol & Neurostimolaz, Milan, Italy; [Tadini, Laura; Fregni, Felipe] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	Universidade de Sao Paulo; IRCCS Ca Granda Ospedale Maggiore Policlinico; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Brunoni, AR (corresponding author), Univ Sao Paulo, Dept & Inst Psychiat, Sao Paulo, Brazil.	ffregni@bidmc.harvard.edu	Brunoni, Andre R./H-8394-2012	Brunoni, Andre R./0000-0002-6310-3571; Fregni, Felipe/0000-0001-9359-8643				ABSE DW, 1960, JAMA-J AM MED ASSOC, V174, P2036, DOI 10.1001/jama.1960.03030160022006; Adam D, 2005, EUR ARCH PSY CLIN N, V255, P258, DOI 10.1007/s00406-004-0555-5; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Andreasen NC, 2007, SCHIZOPHRENIA BULL, V33, P108, DOI 10.1093/schbul/sbl054; ASHCROFT GW, 1961, J MENT SCI, V107, P287, DOI 10.1192/bjp.107.447.287; Azorin JM, 2001, AM J PSYCHIAT, V158, P1305, DOI 10.1176/appi.ajp.158.8.1305; BAASTRUP PC, 1970, LANCET, V2, P326; Ban TA, 2006, PROG NEURO-PSYCHOPH, V30, P599, DOI 10.1016/j.pnpbp.2006.01.014; Barbosa L, 2003, J CLIN PSYCHIAT, V64, P403, DOI 10.4088/JCP.v64n0407; Bauer Michael, 2004, Evid Based Ment Health, V7, P72; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; BOARDMAN RH, 1956, LANCET, V271, P487; Bondolfi G, 1998, AM J PSYCHIAT, V155, P499, DOI 10.1176/ajp.155.4.499; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392; BREIER A, 1994, AM J PSYCHIAT, V151, P20; Breier AF, 1999, AM J PSYCHIAT, V156, P294; BREMNER JD, 1984, J CLIN PSYCHIAT, V45, P414; Calabrese JR, 2003, J CLIN PSYCHIAT, V64, P1013, DOI 10.4088/JCP.v64n0906; Calabrese JR, 2000, J CLIN PSYCHIAT, V61, P841, DOI 10.4088/JCP.v61n1106; CALABRESE JR, 1999, J CLIN PSYCHIAT, V60; CAPSTICK NS, 1965, BRIT J PSYCHIAT, V111, P517, DOI 10.1192/bjp.111.475.517; CASEY JF, 1960, AM J PSYCHIAT, V117, P97, DOI 10.1176/ajp.117.2.97; CASEY JF, 1960, ARCH GEN PSYCHIAT, V2, P210; CASEY JF, 1961, AM J PSYCHIAT, V117, P997, DOI 10.1176/ajp.117.11.997; CHOUINARD G, 1985, J CLIN PSYCHIAT, V46, P32; COHN JB, 1985, J CLIN PSYCHIAT, V46, P26; Conley RR, 2001, AM J PSYCHIAT, V158, P765, DOI 10.1176/appi.ajp.158.5.765; COPPEN A, 1976, BRIT J PSYCHIAT, V128, P479, DOI 10.1192/bjp.128.5.479; COPPEN A, 1971, LANCET, V2, P275; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DEBUS JR, 1988, J CLIN PSYCHIAT, V49, P422; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; DRANSFIELD GA, 1958, J MENT SCI, V104, P1183, DOI 10.1192/bjp.104.437.1183; Duffy FF, 2008, PSYCHIAT SERV, V59, P1148, DOI 10.1176/appi.ps.59.10.1148; DUNNER DL, 1976, ARCH GEN PSYCHIAT, V33, P117; FABRE LF, 1987, J CLIN PSYCHIAT, V48, P406; FEIGHNER JP, 1985, J CLIN PSYCHIAT, V46, P20; FEIGHNER JP, 1991, J CLIN PSYCHIAT, V52, P329; FEIGHNER JP, 1985, J CLIN PSYCHIAT, V46, P369; Feinman RD, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-1; FIEVE RR, 1968, AM J PSYCHIAT, V125, P492, DOI 10.1176/ajp.125.4.492; FIEVE RR, 1975, ARCH GEN PSYCHIAT, V32, P1541; FINK M, 1958, JAMA-J AM MED ASSOC, V166, P1846, DOI 10.1001/jama.1958.02990150042009; FLEMING BG, 1959, J MENT SCI, V105, P349, DOI 10.1192/bjp.105.439.349; FLEMING BG, 1958, J MENT SCI, V104, P749, DOI 10.1192/bjp.104.436.749; FOOTE ES, 1958, J MENT SCI, V104, P201, DOI 10.1192/bjp.104.434.201; GELENBERG AJ, 1979, J CLIN PSYCHIAT, V40, P238; Gelenberg AJ, 2008, J CLIN PSYCHIAT, V69, P1513, DOI 10.4088/JCP.v69n1001; GILMORE TH, 1959, J MENT SCI, V105, P508, DOI 10.1192/bjp.105.439.508; GIUSTI P, 1993, PHARMACOL RES, V27, P201, DOI 10.1006/phrs.1993.1019; Glasser SP, 2006, J CLIN PHARMACOL, V46, P1106, DOI 10.1177/0091270006290336; GOOD WW, 1958, AM J PSYCHIAT, V115, P443, DOI 10.1176/ajp.115.5.443; HAIDER I, 1971, BRIT J PSYCHIAT, V119, P599, DOI 10.1192/bjp.119.553.599; HAMILTON M, 1960, J MENT SCI, V106, P40, DOI 10.1192/bjp.106.442.40; HIMWICH HE, 1958, SCIENCE, V127, P59, DOI 10.1126/science.127.3289.59; Ho BC, 1999, J CLIN PSYCHIAT, V60, P658, DOI 10.4088/JCP.v60n1003; HOLLISTER LE, 1971, ARCH GEN PSYCHIAT, V24, P273; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; HURST L, 1960, J MENT SCI, V106, P726, DOI 10.1192/bjp.106.443.726; JOHNSON G, 1971, BRIT J PSYCHIAT, V119, P267, DOI 10.1192/bjp.119.550.267; Johnson T, 1998, Stat Methods Med Res, V7, P209; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; KAY DWK, 1970, BRIT J PSYCHIAT, V117, P667, DOI 10.1192/bjp.117.541.667; Kim SYH, 2003, PSYCHOPHARMACOLOGY, V171, P13, DOI 10.1007/s00213-003-1458-2; KING PD, 1958, AM J PSYCHIAT, V115, P354, DOI 10.1176/ajp.115.4.354; KING PD, 1959, AM J PSYCHIAT, V115, P1026, DOI 10.1176/ajp.115.11.1026; LAAKMANN G, 1988, BRIT J PSYCHIAT, V153, P64, DOI 10.1192/S0007125000297316; Lecrubier Y, 2008, EUR ARCH PSY CLIN N, V258, P6, DOI 10.1007/s00406-007-1003-0; Leucht S, 2008, SCHIZOPHRENIA BULL, V34, P275, DOI 10.1093/schbul/sbm159; LEVINE S, 1987, BRIT J PSYCHIAT, V150, P653, DOI 10.1192/bjp.150.5.653; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindenmayer JP, 1998, J CLIN PSYCHIAT, V59, P521, DOI 10.4088/JCP.v59n1005; LITTLE JC, 1958, J MENT SCI, V104, P334, DOI 10.1192/bjp.104.435.334; LOMAS J, 1957, BRIT MED J, V2, P78, DOI 10.1136/bmj.2.5036.78; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MAGGS R, 1963, BRIT J PSYCHIAT, V109, P56, DOI 10.1192/bjp.109.458.56; March JS, 2005, AM J PSYCHIAT, V162, P836, DOI 10.1176/appi.ajp.162.5.836; MARDER SR, 1994, AM J PSYCHIAT, V151, P825; MARKS IM, 1972, BRIT J PSYCHIAT, V121, P493, DOI 10.1192/bjp.121.5.493; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McDougle CJ, 2000, ARCH GEN PSYCHIAT, V57, P794, DOI 10.1001/archpsyc.57.8.794; MCDOWALL A, 1966, BRIT J PSYCHIAT, V112, P629, DOI 10.1192/bjp.112.487.629; MELIA PI, 1970, BRIT J PSYCHIAT, V116, P621, DOI 10.1192/bjp.116.535.621; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2005, EXPLORE-NY, V1, P40, DOI 10.1016/j.explore.2004.11.001; MONTGOMERY SA, 1988, BRIT J PSYCHIAT, V153, P69; Muller MJ, 2003, J AFFECT DISORDERS, V77, P65, DOI 10.1016/S0165-0327(02)00097-6; NAYLOR GJ, 1974, BRIT J PSYCHIAT, V124, P52, DOI 10.1192/bjp.124.1.52; Normann C, 2002, J CLIN PSYCHIAT, V63, P337, DOI 10.4088/JCP.v63n0411; PERRY PJ, 1989, J CLIN PSYCHIAT, V50, P290; PEUSKENS J, 1995, BRIT J PSYCHIAT, V166, P712, DOI 10.1192/bjp.166.6.712; PICKAR D, 1992, ARCH GEN PSYCHIAT, V49, P345; PIGOTT TA, 1990, ARCH GEN PSYCHIAT, V47, P926; PLATMAN SR, 1970, AM J PSYCHIAT, V127, P351, DOI 10.1176/ajp.127.3.351; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; PRIEN RF, 1972, ARCH GEN PSYCHIAT, V26, P146; PRIEN RF, 1973, ARCH GEN PSYCHIAT, V28, P337; PRIEN RF, 1974, AM J PSYCHIAT, V131, P198, DOI 10.1176/ajp.131.2.198; REES WL, 1955, J MENT SCI, V101, P834, DOI 10.1192/bjp.101.425.834; RICKELS K, 1985, J CLIN PSYCHIAT, V46, P38; ROBINSON DB, 1959, ARCH GEN PSYCHIAT, V1, P41; SALISBURY BJ, 1957, J MENT SCI, V103, P830, DOI 10.1192/bjp.103.433.830; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Schwartz SJ, 1996, ARCH PHYS MED REHAB, V77, P497, DOI 10.1016/S0003-9993(96)90040-4; SHOPSIN B, 1979, ARCH GEN PSYCHIAT, V36, P657; SHOPSIN B, 1975, ARCH GEN PSYCHIAT, V32, P34; SMITH JA, 1958, AM J PSYCHIAT, V115, P253, DOI 10.1176/ajp.115.3.253; SPRING G, 1970, AM J PSYCHIAT, V126, P1306, DOI 10.1176/ajp.126.9.1306; STOKES PE, 1971, LANCET, V1, P1319; TAKAHASHI R, 1975, ARCH GEN PSYCHIAT, V32, P1310; Tansella M, 2006, PSYCHOL MED, V36, P711, DOI 10.1017/S003329170600715X; Thase ME, 2002, J CLIN PSYCHIAT, V63, P24; Todd S, 2007, STAT MED, V26, P237, DOI 10.1002/sim.2763; USHER RW, 1991, J CLIN PSYCHIAT, V52, P134; VANPRAAG HM, 1976, BRIT J PSYCHIAT, V129, P547, DOI 10.1192/bjp.129.6.547; WADZISZ FJ, 1972, BRIT J PSYCHIAT, V121, P507, DOI 10.1192/bjp.121.5.507; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; WALSH GP, 1959, J MENT SCI, V105, P199, DOI 10.1192/bjp.105.438.199; WATANABE S, 1975, ARCH GEN PSYCHIAT, V32, P659; Weisler RH, 2008, J AFFECT DISORDERS, V108, P1, DOI 10.1016/j.jad.2007.09.012; WHITEHEAD PL, 1970, AM J PSYCHIAT, V127, P824, DOI 10.1176/ajp.127.6.824; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; WILSON IC, 1961, J MENT SCI, V107, P90, DOI 10.1192/bjp.107.446.90; Wirshing DA, 1999, AM J PSYCHIAT, V156, P1374; Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821; YOUNG JPR, 1987, BRIT J PSYCHIAT, V151, P337, DOI 10.1192/bjp.151.3.337; Zimmerman M, 1999, COMPR PSYCHIAT, V40, P182, DOI 10.1016/S0010-440X(99)90001-9; Zlowodzki M, 2006, MED PRIN PRACT, V15, P1, DOI 10.1159/000089379; 1968, DSM 2	134	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9479	10.1371/journal.pone.0009479	http://dx.doi.org/10.1371/journal.pone.0009479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209133	gold, Green Published, Green Submitted			2022-12-27	WOS:000275063400003
J	Chen, CS; Bellier, A; Kao, CY; Yang, YL; Chen, HD; Los, FCO; Aroian, RV				Chen, Chang-Shi; Bellier, Audrey; Kao, Cheng-Yuan; Yang, Ya-Luen; Chen, Huan-Da; Los, Ferdinand C. O.; Aroian, Raffi V.			WWP-1 Is a Novel Modulator of the DAF-2 Insulin-Like Signaling Network Involved in Pore-Forming Toxin Cellular Defenses in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; LIFE-SPAN; PROTEIN TOXINS; CRYSTAL PROTEINS; STRESS-RESPONSE; BACTERIAL; LONGEVITY; IMMUNITY; MUTANTS; LONG	Pore-forming toxins (PFTs) are the single largest class of bacterial virulence factors. The DAF-2 insulin/insulin-like growth factor-1 signaling pathway, which regulates lifespan and stress resistance in Caenorhabditis elegans, is known to mutate to resistance to pathogenic bacteria. However, its role in responses against bacterial toxins and PFTs is as yet unexplored. Here we reveal that reduction of the DAF-2 insulin-like pathway confers the resistance of Caenorhabditis elegans to cytolitic crystal (Cry) PFTs produced by Bacillus thuringiensis. In contrast to the canonical DAF-2 insulin-like signaling pathway previously defined for aging and pathogenesis, the PFT response pathway diverges at 3-phosphoinositide-dependent kinase 1 (PDK-1) and appears to feed into a novel insulin-like pathway signal arm defined by the WW domain Protein 1 (WWP-1). In addition, we also find that WWP-1 not only plays an important role in the intrinsic cellular defense (INCED) against PFTs but also is involved in innate immunity against pathogenic bacteria Pseudomonas aeruginosa and in lifespan regulation. Taken together, our data suggest that WWP-1 and DAF-16 function in parallel within the fundamental DAF-2 insulin/IGF-1 signaling network to regulate fundamental cellular responses in C. elegans.	[Chen, Chang-Shi; Chen, Huan-Da] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chen, Chang-Shi; Yang, Ya-Luen] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Bellier, Audrey; Kao, Cheng-Yuan; Los, Ferdinand C. O.; Aroian, Raffi V.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	National Cheng Kung University; National Cheng Kung University; University of California System; University of California San Diego	Chen, CS (corresponding author), Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	raroian@ucsd.edu	KAO, CHENG-YUAN/A-7531-2010; bellier, audrey/D-7649-2015; Chen, Chang-Shi/B-9251-2009	KAO, CHENG-YUAN/0000-0003-0946-9270; bellier, audrey/0000-0002-3106-4547; Chen, Chang-Shi/0000-0002-8201-3635	NIH [AI056189, GM071603]; NSF [MCB0517718]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant AI056189 (CSC, AB), NSF grant MCB0517718 (CSC), and NIH grant GM071603 (CYK, FCOL) to RVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; BELLIER A, 2009, PLOS PATHOG IN PRESS; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof Larry J., 2006, V351, P139; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; BRENNER S, 1974, GENETICS, V77, P71; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Finney D.J., 1980, PROBIT ANAL, V3rd; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Huang K, 2000, GENE, V252, P137, DOI 10.1016/S0378-1119(00)00216-X; Huffman DL, 2004, INT J MED MICROBIOL, V293, P599, DOI 10.1078/1438-4221-00303; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Marroquin LD, 2000, GENETICS, V155, P1693; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wiles TJ, 2008, MOL BIOL CELL, V19, P1427, DOI 10.1091/mbc.E07-07-0638; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; Zhang YM, 2008, DEV BIOL, V315, P290, DOI 10.1016/j.ydbio.2007.12.032	47	35	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9494	10.1371/journal.pone.0009494	http://dx.doi.org/10.1371/journal.pone.0009494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209166	Green Published, gold, Green Submitted			2022-12-27	WOS:000275063300010
J	Hsu, YH; Traugh, JA				Hsu, Yuan-Hao; Traugh, Jolinda A.			Reciprocally Coupled Residues Crucial for Protein Kinase Pak2 Activity Calculated by Statistical Coupling Analysis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GAMMA-PAK; CATALYTIC SUBUNIT; PEPTIDE INHIBITOR; C-SRC; ACTIVATION; AUTOPHOSPHORYLATION; CONFORMATION; CDC42; DOMAIN	Regulation of Pak2 activity involves at least two mechanisms: (i) phosphorylation of the conserved Thr(402) in the activation loop and (ii) interaction of the autoinhibitory domain (AID) with the catalytic domain. We collected 482 human protein kinase sequences from the kinome database and globally mapped the evolutionary interactions of the residues in the catalytic domain with Thr(402) by sequence-based statistical coupling analysis (SCA). Perturbation of Thr(402) (34.6%) suggests a communication pathway between Thr(402) in the activation loop, and Phe(387) (Delta Delta E(387F,402T) = 2.80) in the magnesium positioning loop, Trp(427) (Delta Delta E(427W),(402T) = 3.12) in the F-helix, and Val(404) (Delta Delta E(404V,402T) = 4.43) and Gly(405) (Delta Delta E(405G,402T) = 2.95) in the peptide positioning loop. When compared to the cAMP-dependent protein kinase (PKA) and Src, the perturbation pattern of threonine phosphorylation in the activation loop of Pak2 is similar to that of PKA, and different from the tyrosine phosphorylation pattern of Src. Reciprocal coupling analysis by SCA showed the residues perturbed by Thr(402) and the reciprocal coupling pairs formed a network centered at Trp(427) in the F-helix. Nine pairs of reciprocal coupling residues crucial for enzymatic activity and structural stabilization were identified. Pak2, PKA and Src share four pairs. Reciprocal coupling residues exposed to the solvent line up as an activation groove. This is the inhibitor (PKI) binding region in PKA and the activation groove for Pak2. This indicates these evolutionary conserved residues are crucial for the catalytic activity of PKA and Pak2.	[Hsu, Yuan-Hao; Traugh, Jolinda A.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hsu, YH (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	y2hsu@ucsd.edu	hsu, yuan-hao/B-5744-2009		National Institutes of Health (NIH) [GM26738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026738] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health (NIH) grant GM26738 to Jolinda A. Traugh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; KARLSSON R, 1993, ACTA CRYSTALLOGR D, V49, P381, DOI 10.1107/S0907444993002306; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Roig J, 2001, VITAM HORM, V62, P167, DOI 10.1016/S0083-6729(01)62004-1; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Tu H, 1999, MOL CELL BIOL, V19, P602; Tuazon PT, 1998, BIOCHEMISTRY-US, V37, P17024, DOI 10.1021/bi982103o; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wu H, 2003, BIOCHEMISTRY-US, V42, P1129, DOI 10.1021/bi026857l; Xu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005913; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9455	10.1371/journal.pone.0009455	http://dx.doi.org/10.1371/journal.pone.0009455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209159	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997100005
J	Zeng, J; Parvanova, IA; Howard, JC				Zeng, Jia; Parvanova, Iana Angelova; Howard, Jonathan C.			A Dedicated Promoter Drives Constitutive Expression of the Cell-Autonomous Immune Resistance GTPase, Irga6 (IIGP1) in Mouse Liver	PLOS ONE			English	Article								Background: In general, immune effector molecules are induced by infection. Methodology and Principal Findings: However, strong constitutive expression of the cell-autonomous resistance GTPase, Irga6 (IIGP1), was found in mouse liver, contrasting with previous evidence that expression of this protein is exclusively dependent on induction by IFN gamma. Constitutive and IFN gamma-inducible expression of Irga6 in the liver were shown to be dependent on transcription initiated from two independent untranslated 5' exons, which splice alternatively into the long exon encoding the full-length protein sequence. Irga6 is expressed constitutively in freshly isolated hepatocytes and is competent in these cells to accumulate on the parasitophorous vacuole membrane of infecting Toxoplasma gondii tachyzoites. Conclusions and Significance: The role of constitutive hepatocyte expression of Irga6 in resistance to parasites invading from the gut via the hepatic portal system is discussed.			Zeng, J (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds, W Yorkshire, England.	j.howard@uni-koeln.de		Howard, Jonathan/0000-0003-2756-5143				Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boehm U, 1998, J IMMUNOL, V161, P6715; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUNN JP, 2008, EMBO J; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; Kaiser F, 2004, J CELL SCI, V117, P1747, DOI 10.1242/jcs.01039; Kawakubo K, 1999, VIROLOGY, V264, P106, DOI 10.1006/viro.1999.9995; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Liesenfeld O, 1999, IMMUNOBIOLOGY, V201, P229, DOI 10.1016/S0171-2985(99)80063-1; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; MELZER T, 2008, INFECT IMMUN; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; PARVANOVA I, 2005, ANAL ROLE P47 GTPASE; Samadani U, 1996, GENE EXPRESSION, V6, P23; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6787	10.1371/journal.pone.0006787	http://dx.doi.org/10.1371/journal.pone.0006787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	20368812	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000029
J	Shimshek, DR; Mueller, M; Wiessner, C; Schweizer, T; van der Putten, PH				Shimshek, Derya R.; Mueller, Matthias; Wiessner, Christoph; Schweizer, Tatjana; van der Putten, P. Herman			The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of alpha-synucleinopathy	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; PROTEIN; AGGREGATION; TOXICITY; MUTATION; MICE; DEGENERATION	Background: Aggregation and misfolded alpha-synuclein is thought to be central in the pathogenesis of Parkinson's disease (PD). Heat-shock proteins (HSPs) that are involved in refolding and degradation processes could lower the aggregate load of alpha-synuclein and thus be beneficial in alpha-synucleinopathies. Methodology/Principal Findings: We co-overexpressed human A53T point-mutated alpha-synuclein and human HSP70 in mice, both under the control of Thy1 regulatory sequences. Behavior read-outs showed no beneficial effect of HSP70 expression in mice. In contrast, motor coordination, grip strength and weight were even worse in the alpha-synucleinopathy model in the presence of HSP70 overexpression. Biochemical analyses revealed no differences in alpha-synuclein oligomers/aggregates, truncations and phosphorylation levels and alpha-synuclein localization was unchanged in immunostainings. Conclusion/Significance: Overexpressing HSP70 in a mouse model of alpha-synucleinopathy did not lower the toxic load of alpha-synuclein species and had no beneficial effect on alpha-synuclein-related motor deficits.	[Shimshek, Derya R.; Mueller, Matthias] Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways Model Dis Ctr, Basel, Switzerland	Novartis	Shimshek, DR (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways Model Dis Ctr, Basel, Switzerland.	derya.shimshek@novartis.com		Shimshek, Derya/0000-0001-8602-7850	Novartis Pharma AG	Novartis Pharma AG	The work was funded by the Novartis Pharma AG (www.novartis.com). The company had a role in this study due to employment of one or more authors of this study.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Dedeoglu A, 2002, EXP NEUROL, V176, P262, DOI 10.1006/exnr.2002.7933; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; Douglas Michael R, 2007, Expert Rev Neurother, V7, P657, DOI 10.1586/14737175.7.6.657; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Muchowski PJ, 2008, J BIOL CHEM, V283, P6330, DOI 10.1074/jbc.M709678200; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	24	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10014	10.1371/journal.pone.0010014	http://dx.doi.org/10.1371/journal.pone.0010014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368804	gold, Green Published, Green Submitted			2022-12-27	WOS:000276419900014
J	Mulle, JG; Patel, VC; Warren, ST; Hegde, MR; Cutler, DJ; Zwick, ME				Mulle, Jennifer G.; Patel, Viren C.; Warren, Stephen T.; Hegde, Madhuri R.; Cutler, David J.; Zwick, Michael E.			Empirical Evaluation of Oligonucleotide Probe Selection for DNA Microarrays	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COPY NUMBER; GENOME; DESIGN; IDENTIFICATION; MAP	DNA-based microarrays are increasingly central to biomedical research. Selecting oligonucleotide sequences that will behave consistently across experiments is essential to the design, production and performance of DNA microarrays. Here our aim was to improve on probe design parameters by empirically and systematically evaluating probe performance in a multivariate context. We used experimental data from 19 array CGH hybridizations to assess the probe performance of 385,474 probes tiled in the Duchenne muscular dystrophy (DMD) region of the X chromosome. Our results demonstrate that probe melting temperature, single nucleotide polymorphisms (SNPs), and homocytosine motifs all have a strong effect on probe behavior. These findings, when incorporated into future microarray probe selection algorithms, may improve microarray performance for a wide variety of applications.	[Mulle, Jennifer G.; Patel, Viren C.; Warren, Stephen T.; Hegde, Madhuri R.; Cutler, David J.; Zwick, Michael E.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Mulle, JG (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	jmulle@emory.edu	Warren, Stephen T/A-2498-2012		Kirschstein National Research Service Award (NRSA); NARSAD Young Investigator	Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator(NARSAD)	G. M. was supported by a Kirschstein National Research Service Award (NRSA) fellowship and a NARSAD Young Investigator award (http://www.narsad.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1992, No To Hattatsu, V24, P127; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; BERTHET N, 2008, MICROBIAL BIOTECHNOL; Bertone P, 2006, GENOME RES, V16, P271, DOI 10.1101/gr.4455906; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Flibotte S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-497; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Graf S, 2007, BIOINFORMATICS, V23, pI195, DOI 10.1093/bioinformatics/btm200; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HARTMANN A, 2008, HUM MUTAT; Hegde MR, 2008, HUM MUTAT, V29, P1091, DOI 10.1002/humu.20831; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; MAITRA A, 2004, HUMAN MITOCHIP HIGH; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; *NIMBLEGEN SYST IN, 2007, ROCH NIMBLEGEN PROB, P1; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Patil Nila, 2001, SCIENCE; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rouleau E, 2007, CLIN GENET, V72, P199, DOI 10.1111/j.1399-0004.2007.00849.x; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sharp AJ, 2007, HUM MOL GENET, V16, P2770, DOI 10.1093/hmg/ddm234; Vainrub A, 2004, BIOPOLYMERS, V73, P614, DOI 10.1002/bip.20008; ZWICK KMP, 2008, PLOS ONE; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	31	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9921	10.1371/journal.pone.0009921	http://dx.doi.org/10.1371/journal.pone.0009921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360966	Green Submitted, gold, Green Published			2022-12-27	WOS:000276163100014
J	Turner, H; Lieshout, N; Van Ginkel, WE; Menken, SBJ				Turner, Hubert; Lieshout, Niek; Van Ginkel, Wil E.; Menken, Steph B. J.			Molecular Phylogeny of the Small Ermine Moth Genus Yponomeuta (Lepidoptera, Yponomeutidae) in the Palaearctic	PLOS ONE			English	Article							LENGTH DIFFERENCE TEST; MULTIPLE SEQUENCE ALIGNMENT; CYTOCHROME-OXIDASE-I; MITOCHONDRIAL-DNA; NUCLEOTIDE-SEQUENCE; PLANT RELATIONSHIPS; MIXED MODELS; CLUSTAL-X; INSECT; INCONGRUENCE	Background: The small ermine moth genus Yponomeuta (Lepidoptera, Yponomeutidae) contains 76 species that are specialist feeders on hosts from Celastraceae, Rosaceae, Salicaceae, and several other plant families. The genus is a model for studies in the evolution of phytophagous insects and their host-plant associations. Here, we reconstruct the phylogeny to provide a solid framework for these studies, and to obtain insight into the history of host-plant use and the biogeography of the genus. Methodology/Principal Findings: DNA sequences from an internal transcribed spacer region (ITS-1) and from the 16S rDNA (16S) and cytochrome oxidase (COII) mitochondrial genes were collected from 20-23 (depending on gene) species and two outgroup taxa to reconstruct the phylogeny of the Palaearctic members of this genus. Sequences were analysed using three different phylogenetic methods (parsimony, likelihood, and Bayesian inference). Conclusions/Significance: Roughly the same patterns are retrieved irrespective of the method used, and they are similar among the three genes. Monophyly is well supported for a clade consisting of the Japanese (but not the Dutch) population of Yponomeuta sedellus and Y. yanagawanus, a Y. kanaiellus-polystictus clade, and a Rosaceae-feeding, western Palaearctic clade (Y. cagnagellus-irrorellus clade). Within these clades, relationships are less well supported, and the patterns between the different gene trees are not so similar. The position of the remaining taxa is also variable among the gene trees and rather weakly supported. The phylogenetic information was used to elucidate patterns of biogeography and resource use. In the Palaearctic, the genus most likely originated in the Far East, feeding on Celastraceae, dispersing to the West concomitant with a shift to Rosaceae and further to Salicaceae. The association of Y. cagnagellus with Euonymus europaeus (Celastraceae), however, is a reversal. The only oligophagous species, Y. padellus, belongs to the derived western Palaearctic clade, evidence that specialisation is reversible.	[Turner, Hubert; Lieshout, Niek; Van Ginkel, Wil E.; Menken, Steph B. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Turner, Hubert] Netherlands Ctr Biodivers Nat, Sect Natl Herbarium Nederland, Leiden, Netherlands	University of Amsterdam; Naturalis Biodiversity Center	Turner, H (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	turner@nhn.leidenuniv.nl	Turner, Hubert/A-7360-2010	Turner, Hubert/0000-0001-8052-8988	Netherlands Organization for Scientific Research [441.041]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Niek Lieshout was supported by the Netherlands Organization for Scientific Research (NWO; SLW grant 441.041) http://www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AC, 2008, ENTOMOL EXP APPL, V128, P240, DOI 10.1111/j.1570-7458.2008.00684.x; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; BROWN JM, 1994, MOL BIOL EVOL, V11, P128; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Cossentine JE, 2000, CAN ENTOMOL, V132, P685, DOI 10.4039/Ent132685-5; CROZIER RH, 1989, MOL BIOL EVOL, V6, P399; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Dowton M, 2002, SYST BIOL, V51, P19, DOI 10.1080/106351502753475853; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; *GEN COMP GROUP, 1991, PROGR MAN GCG PACK V; Gershenson Z.S., 1998, YPONOMEUTIDAE LEPIDO; HARRISON RG, 1987, MOL BIOL EVOL, V4, P144; Herrebout W.M., 1976, Symposia Biologica Hungarica, V16, P91; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; JERMY T, 1993, ENTOMOL EXP APPL, V66, P3, DOI 10.1007/BF02381541; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kolsch G, 2008, MOL PHYLOGENET EVOL, V48, P936, DOI 10.1016/j.ympev.2008.05.035; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Menken SBJ, 1996, ENTOMOL EXP APPL, V80, P297, DOI 10.1007/BF00194779; MENKEN SBJ, 1992, ANNU REV ENTOMOL, V37, P41, DOI 10.1146/annurev.en.37.010192.000353; Menken SBJ, 1998, ENDLESS FORMS, P145; MENKEN SBJ, 1982, Z ZOOL SYST EVOL, V20, P131; MENKEN SBJ, 1987, EVOLUTION, V41, P630, DOI 10.1111/j.1558-5646.1987.tb05834.x; Moriuti S, 1977, FAUNA JAPONICA YPONO; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pellmyr O, 1999, P NATL ACAD SCI USA, V96, P9178, DOI 10.1073/pnas.96.16.9178; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; POVEL GDE, 1987, P K NED AKAD C BIOL, V90, P367; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roessingh P, 2000, CHEMOECOLOGY, V10, P41, DOI 10.1007/s000490050006; ROESSINGH P, 1989, ENTOMOL EXP APPL, V51, P49, DOI 10.1007/BF00343443; Roessingh P, 2007, J COMP PHYSIOL A, V193, P635, DOI 10.1007/s00359-007-0218-x; Rokas A, 2001, HEREDITY, V87, P294, DOI 10.1046/j.1365-2540.2001.00872.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Southwood TRE, 1996, ENTOMOL EXP APPL, V80, P320, DOI 10.1007/BF00194783; SPERLING FAH, 1995, ANN ENTOMOL SOC AM, V88, P155, DOI 10.1093/aesa/88.2.155; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2002, PAUP PHYL AN US PARS; Teasdale BW, 2009, EUR J PHYCOL, V44, P171, DOI 10.1080/09670260802590877; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ulenberg Sandrine A., 2009, Tijdschrift voor Entomologie, V152, P187; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WILGENBUSCH JC, AWTY SYST GRAPH EXPL; XIONG B, 1990, GENOME, V34, P3006; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801	62	12	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9933	10.1371/journal.pone.0009933	http://dx.doi.org/10.1371/journal.pone.0009933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360968	Green Submitted, gold, Green Published			2022-12-27	WOS:000276163100022
J	Bhan, U; Ballinger, MN; Zeng, XY; Newstead, MJ; Cornicelli, MD; Standiford, TJ				Bhan, Urvashi; Ballinger, Megan N.; Zeng, Xianying; Newstead, Michael J.; Cornicelli, Matthew D.; Standiford, Theodore J.			Cooperative Interactions between TLR4 and TLR9 Regulate Interleukin 23 and 17 Production in a Murine Model of Gram Negative Bacterial Pneumonia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; PROTECTIVE INNATE IMMUNITY; CONTAINING ADAPTER PROTEIN; KLEBSIELLA-PNEUMONIAE; HOST-DEFENSE; PSEUDOMONAS-AERUGINOSA; MACROPHAGE ACTIVATION; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; DENDRITIC CELLS	Toll like receptors play an important role in lung host defense against bacterial pathogens. In this study, we investigated independent and cooperative functions of TLR4 and TLR9 in microbial clearance and systemic dissemination during Gram-negative bacterial pneumonia. To access these responses, wildtype Balb/c mice, mice with defective TLR4 signaling (TLR4 lps-d), mice deficient in TLR9 (TLR9(-/-)) and TLR4/9 double mutant mice (TLR4(lps-d)/TLR9(-/-)) were challenged with K. pneumoniae, then time-dependent lung bacterial clearance and systemic dissemination determined. We found impaired lung bacterial clearance in TLR4 and TLR9 single mutant mice, whereas the greatest impairment in clearance was observed in TLR4(lps-d)/TLR9(-/-) double mutant mice. Early lung expression of TNF-alpha, IL-12, and chemokines was TLR4 dependent, while IFN-gamma production and the later expression of TNF-alpha and IL-12 was dependent on TLR9. Classical activation of lung macrophages and maximal induction of IL-23 and IL-17 required both TLR4 and TLR9. Finally, the i.t. instillation of IL-17 partially restored anti-bacterial immunity in TLR4(lps-d)/TLR9(-/-) double mutant mice. In conclusion, our studies indicate that TLR4 and TLR9 have both non-redundant and cooperative roles in lung innate responses during Gram-negative bacterial pneumonia and are both critical for IL-17 driven antibacterial host response.	[Bhan, Urvashi; Ballinger, Megan N.; Zeng, Xianying; Newstead, Michael J.; Cornicelli, Matthew D.; Standiford, Theodore J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bhan, U (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	ubhan@med.umich.edu		Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [K08HL094762, P50 HL074024, HL25243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094762, R01HL057243, P50HL074024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health Grants: K08HL094762 (UB), P50 HL074024 and HL25243 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; Elkins KL, 2009, MICROBES INFECT, V11, P49, DOI 10.1016/j.micinf.2008.10.005; Gikas A, 1998, INFECTION, V26, P155, DOI 10.1007/BF02771841; Gordon DJ, 2003, BIOCHEMISTRY-US, V42, P475, DOI 10.1021/bi0259857; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Heiman AS, 2005, J INTERF CYTOK RES, V25, P82, DOI 10.1089/jir.2005.25.82; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Jeyaseelan S, 2005, J IMMUNOL, V175, P7484, DOI 10.4049/jimmunol.175.11.7484; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Sjolinder H, 2008, INFECT IMMUN, V76, P5421, DOI 10.1128/IAI.00615-08; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Suzuki K, 2005, AM J RESP CRIT CARE, V171, P707, DOI 10.1164/rccm.200408-1078OC; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhou XP, 2008, CURR NANOSCI, V4, P88, DOI 10.2174/157341308783591870	35	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9896	10.1371/journal.pone.0009896	http://dx.doi.org/10.1371/journal.pone.0009896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360853	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600006
J	Dolatshad, H; Cary, AJ; Davis, FC				Dolatshad, Hamid; Cary, Andrew J.; Davis, Fred C.			Differential Expression of the Circadian Clock in Maternal and Embryonic Tissues of Mice	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; MOUSE PERIPHERAL-TISSUES; GENE-EXPRESSION; MESSENGER-RNA; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; MOLECULAR CLOCK; NURSING MOTHERS; CELL-CYCLE; FETAL	Background: Molecular feedback loops involving transcription and translation and several key genes are at the core of circadian regulatory cycles affecting cellular pathways and metabolism. These cycles are active in most adult animal cells but little is known about their expression or influence during development. Methodology/Principal Findings: To determine if circadian cycles are active during mammalian development we measured the expression of key circadian genes during embryogenesis in mice using quantitative real-time RT-PCR. All of the genes examined were expressed in whole embryos beginning at the earliest age examined, embryonic day 10. In contrast to adult tissues, circadian variation was absent for all genes at all of the embryonic ages examined in either whole embryos or individual tissues. Using a bioluminescent fusion protein that tracks translation of the circadian gene, per2, we also analyzed protein levels. Similar to mRNA, a protein rhythm was observed in adult tissue but not in embryonic tissues collected in-vivo. In contrast, when tissues were placed in culture for the continuous assay of bioluminescence, rhythms were observed in embryonic (E18) tissues. We found that placing embryonic tissues in culture set the timing (phase) of these rhythms, suggesting the importance of a synchronizing signal for the expression of circadian cycles in developing tissues. Conclusions/Significance: These results show that embryonic tissues express key circadian genes and have the capacity to express active circadian regulatory cycles. In vivo, circadian cycles are not expressed in embryonic tissues as they are in adult tissues. Individual cells might express oscillations, but are not synchronized until later in development.	[Dolatshad, Hamid; Cary, Andrew J.; Davis, Fred C.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Dolatshad, H (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	f.davis@neu.edu		Dolatshad, Hamid/0000-0002-4724-1720	National Institutes of Health [1 R01 MH068796]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant 1 R01 MH068796 to FCD (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; BARR M, 1973, TERATOLOGY, V7, P283, DOI 10.1002/tera.1420070309; BATSCHELET E, 1972, ANIMAL ORIENTATION N, P61; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; DAVIS FC, 2001, HDB BEHAV NEUROBIOLO, P247; DAVIS FC, 1988, AM J PHYSIOL, V255, P439; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; DUNCAN MJ, 1993, DEV BRAIN RES, V73, P205, DOI 10.1016/0165-3806(93)90140-6; El-Hennamy R, 2008, J BIOL RHYTHM, V23, P435, DOI 10.1177/0748730408322635; ENDO A, 1989, GAMETE RES, V22, P435, DOI 10.1002/mrd.1120220409; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fujimoto Y, 2006, GENES CELLS, V11, P525, DOI 10.1111/j.1365-2443.2006.00960.x; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Gozeri E, 2008, NEUROENDOCRINOL LETT, V29, P87; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HASTINGS MH, 1999, J NEUROSCI, V11, P1; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Johnson Martin H, 2002, Reprod Biomed Online, V4, P140; Johnson MH, 2000, BIOESSAYS, V22, P57, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;57::AID-BIES10&gt;3.0.CO;2-L; Kennaway DJ, 2005, HUM REPROD UPDATE, V11, P91, DOI 10.1093/humupd/dmh054; Kiessling AA, 2009, J ASSIST REPROD GEN, V26, P187, DOI 10.1007/s10815-009-9306-x; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Li XD, 2005, DEV BRAIN RES, V158, P31, DOI 10.1016/j.devbrainres.2005.05.005; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; MOORE RY, 1989, J NEUROSCI, V9, P2151; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Ripperger JA, 2000, GENE DEV, V14, P679; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Sakamoto K, 2002, NEUROREPORT, V13, P1239, DOI 10.1097/00001756-200207190-00003; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Saxena MT, 2007, MOL IMAGING, V6, P68, DOI 10.2310/7290.2007.00003; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimomura H, 2001, EUR J NEUROSCI, V13, P687, DOI 10.1046/j.0953-816x.2000.01438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	70	53	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9855	10.1371/journal.pone.0009855	http://dx.doi.org/10.1371/journal.pone.0009855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352049	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894500021
J	van Baarle, S; Bramkamp, M				van Baarle, Suey; Bramkamp, Marc			The MinCDJ System in Bacillus subtilis Prevents Minicell Formation by Promoting Divisome Disassembly	PLOS ONE			English	Article							BACTERIAL-CELL DIVISION; SITE SELECTION SYSTEM; ESCHERICHIA-COLI; Z-RING; POLAR LOCALIZATION; CORRECT PLACEMENT; PROPER PLACEMENT; MIND PROTEIN; FTSZ; SPECIFICITY	Background: Cell division in Bacillus subtilis takes place precisely at midcell, through the action of Noc, which prevents division from occurring over the nucleoids, and the Min system, which prevents cell division from taking place at the poles. Originally it was thought that the Min system acts directly on FtsZ, preventing the formation of a Z-ring and, therefore, the formation of a complete cytokinetic ring at the poles. Recently, a new component of the B. subtilis Min system was identified, MinJ, which acts as a bridge between DivIVA and MinCD. Methodology/Principal Findings: We used fluorescence microscopy and molecular genetics to examine the molecular role of MinJ. We found that in the absence of a functional Min system, FtsA, FtsL and PBP-2B remain associated with completed division sites. Evidence is provided that MinCDJ are responsible for the failure of these proteins to localize properly, indicating that MinCDJ can act on membrane integral components of the divisome. Conclusions/Significance: Taken together, we postulate that the main function of the Min system is to prevent minicell formation adjacent to recently completed division sites by promoting the disassembly of the cytokinetic ring, thereby ensuring that cell division occurs only once per cell cycle. Thus, the role of the Min system in rod-shaped bacteria seems not to be restricted to an inhibitory function on FtsZ polymerization, but can act on different levels of the divisome.	[van Baarle, Suey; Bramkamp, Marc] Univ Cologne, Inst Biochem, Cologne, Germany	University of Cologne	van Baarle, S (corresponding author), Univ Cologne, Inst Biochem, Cologne, Germany.	marc.bramkamp@uni-koeln.de		Bramkamp, Marc/0000-0002-7704-3266	Max Planck Society; European Union	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was funded by the Max Planck Society and a European Union Marie-Curie ADOPT program (fellowship for SvB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Feucht A, 2001, GENE, V264, P289, DOI 10.1016/S0378-1119(01)00338-9; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Harry E., 2006, INT REV CYTOL, V253, P27; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Karoui ME, 2001, MOL MICROBIOL, V42, P1211, DOI 10.1046/j.1365-2958.2001.02710.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENARCIC R, 2009, EMBO J; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mukherjee A, 1998, METHOD ENZYMOL, V298, P296, DOI 10.1016/S0076-6879(98)98026-0; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Yu XC, 2000, J BACTERIOL, V182, P6203, DOI 10.1128/JB.182.21.6203-6213.2000	47	41	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9850	10.1371/journal.pone.0009850	http://dx.doi.org/10.1371/journal.pone.0009850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352045	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500018
J	Bahia, AC; Kubota, MS; Tempone, AJ; Pinheiro, WD; Tadei, WP; Secundino, NFC; Traub-Cseko, YM; Pimenta, PFP				Bahia, Ana C.; Kubota, Marina S.; Tempone, Antonio J.; Pinheiro, Waleria D.; Tadei, Wanderli P.; Secundino, Nagila F. C.; Traub-Csekoe, Yara M.; Pimenta, Paulo F. P.			Anopheles aquasalis Infected by Plasmodium vivax Displays Unique Gene Expression Profiles when Compared to Other Malaria Vectors and Plasmodia	PLOS ONE			English	Article							MOSQUITO; GAMBIAE; MIDGUT; IMMUNITY; STIMULATION; MECHANISM; RESPONSES; CLONING; PCR	Malaria affects 300 million people worldwide every year and is endemic in 22 countries in the Americas where transmission occurs mainly in the Amazon Region. Most malaria cases in the Americas are caused by Plasmodium vivax, a parasite that is almost impossible to cultivate in vitro, and Anopheles aquasalis is an important malaria vector. Understanding the interactions between this vector and its parasite will provide important information for development of disease control strategies. To this end, we performed mRNA subtraction experiments using A. aquasalis 2 and 24 hours after feeding on blood and blood from malaria patients infected with P. vivax to identify changes in the mosquito vector gene induction that could be important during the initial steps of infection. A total of 2,138 clones of differentially expressed genes were sequenced and 496 high quality unique sequences were obtained. Annotation revealed 36% of sequences unrelated to genes in any database, suggesting that they were specific to A. aquasalis. A high number of sequences (59%) with no matches in any databases were found 24 h after infection. Genes related to embryogenesis were down-regulated in insects infected by P. vivax. Only a handful of genes related to immune responses were detected in our subtraction experiment. This apparent weak immune response of A. aquasalis to P. vivax infection could be related to the susceptibility of this vector to this important human malaria parasite. Analysis of some genes by real time PCR corroborated and expanded the subtraction results. Taken together, these data provide important new information about this poorly studied American malaria vector by revealing differences between the responses of A. aquasalis to P. vivax infection, in relation to better studied mosquito-Plasmodium pairs. These differences may be important for the development of malaria transmission-blocking strategies in the Americas.	[Bahia, Ana C.; Kubota, Marina S.; Tempone, Antonio J.; Traub-Csekoe, Yara M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil; [Pinheiro, Waleria D.; Tadei, Wanderli P.] Inst Nacl de Pesquisas da Amazonia, Lab Malaria & Dengue, Manaus, Amazonas, Brazil; [Secundino, Nagila F. C.; Pimenta, Paulo F. P.] Fiocruz MS, Inst Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Institute Nacional de Pesquisas da Amazonia; Fundacao Oswaldo Cruz	Bahia, AC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	ytraub@ioc.fiocruz.br; pimenta@cpqrr.fiocruz.br	Nascimento, Ana Cristina Bahia/G-2372-2015; Traub-Cseko, Yara M/F-2723-2015; Tadei, Wanderli Pedro/N-4486-2018; Secundino, Nagila/AAM-4553-2020; Pimenta, Paulo/AAH-1502-2020; Tempone, Antonio J/E-5118-2011	Nascimento, Ana Cristina Bahia/0000-0002-4584-1888; Tadei, Wanderli Pedro/0000-0002-0612-3285; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Apoio a Nucleos de Excelencia (PRONEX, MG); Fundacacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia (PRONEX, MG); Fundacacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Apoio a Nucleos de Excelencia (PRONEX, MG), Fundacacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; BERTI J, 1993, MEM I OSWALDO CRUZ, V88, P363, DOI 10.1590/S0074-02761993000300004; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; CHADEE DD, 1992, ANN TROP MED PARASIT, V86, P583, DOI 10.1080/00034983.1992.11812713; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; GASS RF, 1979, ACTA TROP, V36, P243; Gentile C, 2005, Mem. Inst. Oswaldo Cruz, V100, P545, DOI 10.1590/S0074-02762005000600008; Giannoni F, 2001, J BIOL CHEM, V276, P700, DOI 10.1074/jbc.M005540200; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gupta L, 2005, P NATL ACAD SCI USA, V102, P4010, DOI 10.1073/pnas.0409642102; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Jahan N, 1999, PARASITOLOGY, V119, P535, DOI 10.1017/S0031182099005090; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Lavazec C, 2007, INFECT IMMUN, V75, P1635, DOI 10.1128/IAI.00864-06; Lavazec C, 2005, INSECT MOL BIOL, V14, P163, DOI 10.1111/j.1365-2583.2004.00541.x; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200; Povoa MM, 2003, J MED ENTOMOL, V40, P379, DOI 10.1603/0022-2585-40.4.379; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shi L, 2004, INSECT MOL BIOL, V13, P387, DOI 10.1111/j.0962-1075.2004.00496.x; Sodja A, 2007, J INSECT PHYSIOL, V53, P833, DOI 10.1016/j.jinsphys.2007.03.017; Somboon Pradya, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P691; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100	42	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9795	10.1371/journal.pone.0009795	http://dx.doi.org/10.1371/journal.pone.0009795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339545	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894300020
J	Jung, RE; Grazioplene, R; Caprihan, A; Chavez, RS; Haier, RJ				Jung, Rex E.; Grazioplene, Rachael; Caprihan, Arvind; Chavez, Robert S.; Haier, Richard J.			White Matter Integrity, Creativity, and Psychopathology: Disentangling Constructs with Diffusion Tensor Imaging	PLOS ONE			English	Article							BIPOLAR DISORDER; COGNITIVE NEUROSCIENCE; NEUREGULIN-1; BRAIN; SCHIZOPHRENIA; CONNECTIVITY; PERSONALITY; ABNORMALITIES; INTELLIGENCE; ARCHITECTURE	That creativity and psychopathology are somehow linked remains a popular but controversial idea in neuroscience research. Brain regions implicated in both psychosis-proneness and creative cognition include frontal projection zones and association fibers. In normal subjects, we have previously demonstrated that a composite measure of divergent thinking (DT) ability exhibited significant inverse relationships in frontal lobe areas with both cortical thickness and metabolite concentration of N-acetyl-aspartate (NAA). These findings support the idea that creativity may reside upon a continuum with psychopathology. Here we examine whether white matter integrity, assessed by Fractional Anisotropy ( FA), is related to two measures of creativity ( Divergent Thinking and Openness to Experience). Based on previous findings, we hypothesize inverse correlations within fronto-striatal circuits. Seventy-two healthy, young adult (18-29 years) subjects were scanned on a 3 Tesla scanner with Diffusion Tensor Imaging. DT measures were scored by four raters (alpha = .81) using the Consensual Assessment Technique, from which a composite creativity index (CCI) was derived. We found that the CCI was significantly inversely related to FA within the left inferior frontal white matter (t = 5.36, p = .01), and Openness as inversely related to FA within the right inferior frontal white matter (t = 4.61, p = .04). These findings demonstrate an apparent overlap in specific white matter architecture underlying the normal variance of divergent thinking, openness, and psychotic-spectrum traits, consistent with the idea of a continuum.	[Jung, Rex E.; Grazioplene, Rachael; Caprihan, Arvind; Chavez, Robert S.; Haier, Richard J.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Jung, Rex E.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Jung, Rex E.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Jung, RE (corresponding author), Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA.	rjung@mrn.org	Chavez, Robert S./ABE-9303-2021	Chavez, Robert S./0000-0001-7877-299X; Jung, Rex/0000-0003-3718-0597	The John Templeton Foundation (www.templeton.org)	The John Templeton Foundation (www.templeton.org)	The John Templeton Foundation (www.templeton.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; AMABILE TM, 1982, J PERS SOC PSYCHOL, V43, P997, DOI 10.1037/0022-3514.43.5.997; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Cummings JL, 2008, CNS SPECTRUMS, V13, P1; Dietrich A, 2004, PSYCHON B REV, V11, P1011, DOI 10.3758/BF03196731; Dietrich A, 2007, METHODS, V42, P22, DOI 10.1016/j.ymeth.2006.12.009; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Guilford J.P., 1967, NATURE HUMAN INTELLI; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Han DH, 2008, J PSYCHIATR RES, V42, P399, DOI 10.1016/j.jpsychires.2007.03.002; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; HASENFUS N, 1976, BRIT J PSYCHIAT, V129, P346, DOI 10.1192/bjp.129.4.346; Haznedar MM, 2005, BIOL PSYCHIAT, V57, P733, DOI 10.1016/j.biopsych.2005.01.002; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; JAMISON KR, 1989, PSYCHIATRY, V52, P125, DOI 10.1080/00332747.1989.11024436; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung RE, 2009, J NEUROSCI, V29, P5319, DOI 10.1523/JNEUROSCI.0588-09.2009; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhn T., 1970, STRUCTURE SCI REVOLU; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Luders E, 2007, NEUROIMAGE, V37, P1457, DOI 10.1016/j.neuroimage.2007.06.028; Ludwig AM, 1998, CREATIVITY RES J, V11, P93, DOI 10.1207/s15326934crj1102_1; McIntosh AM, 2008, BIOL PSYCHIAT, V64, P1088, DOI 10.1016/j.biopsych.2008.07.026; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Miller GF, 2007, SCHIZOPHR RES, V93, P317, DOI 10.1016/j.schres.2007.02.007; Nakamura M, 2005, BIOL PSYCHIAT, V58, P468, DOI 10.1016/j.biopsych.2005.04.016; NESSE RM, 2005, EVOLUTIONARY PSYCHOL, P903; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; RINGMAN JM, 2007, BRAIN; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Simonton DK, 2009, PERSPECT PSYCHOL SCI, V4, P441, DOI 10.1111/j.1745-6924.2009.01152.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sprooten E, 2009, MOL PSYCHIATR, V14, P237, DOI 10.1038/mp.2008.136; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STERNBERG RJ, 2005, HDB CREATIVITY, P490; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thomson PA, 2007, MOL PSYCHIATR, V12, P94, DOI 10.1038/sj.mp.4001889; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x	56	83	85	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9818	10.1371/journal.pone.0009818	http://dx.doi.org/10.1371/journal.pone.0009818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FR	20339554	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894300031
J	Balyasnikova, IV; Ferguson, SD; Sengupta, S; Han, Y; Lesniak, MS				Balyasnikova, Irina V.; Ferguson, Sherise D.; Sengupta, Sadhak; Han, Yu; Lesniak, Maciej S.			Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma	PLOS ONE			English	Article							FACTOR RECEPTOR-VIII; EXPRESSION; GENES; DELIVERY; ANGIOGENESIS; SUPPRESSION; CETUXIMAB; BREAST; ALPHA	Background: Glioblastoma multiforme is the most lethal brain tumor with limited therapeutic options. Antigens expressed on the surface of malignant cells are potential targets for antibody-mediated gene/drug delivery. Principal Findings: In this study, we investigated the ability of genetically modified human mesenchymal stem cells (hMSCs) expressing a single-chain antibody (scFv) on their surface against a tumor specific antigen, EGFRvIII, to enhance the therapy of EGFRvIII expressing glioma cells in vivo. The growth of U87-EGFRvIII was specifically delayed in co-culture with hMSC-scFvEGFRvIII. A significant down-regulation was observed in the expression of pAkt in EGFRvIII expressing glioma cells upon culture with hMSC-scFvEGFRvIII vs. controls as well as in EGFRvIII expressing glioma cells from brain tumors co-injected with hMSC-scFvEGFRvIII in vivo. hMSC expressing scFvEGFRvIII also demonstrated several fold enhanced retention in EGFRvIII expressing flank and intracranial glioma xenografts vs. control hMSCs. The growth of U87-EGFRvIII flank xenografts was inhibited by 50% in the presence of hMSC-scFvEGFRvIII (p<0.05). Moreover, animals co-injected with U87-EGFRvIII and hMSC-scFvEGFRvIII intracranially showed significantly improved survival compared to animals injected with U87-EGFRvIII glioma cells alone or with control hMSCs. This survival was further improved when the same animals received an additional dosage of hMSC-scFvEGFRvIII two weeks after initial tumor implantation. Of note, EGFRvIII expressing brain tumors co-injected with hMSCs had a lower density of CD31 expressing blood vessels in comparison with control tumors, suggesting a possible role in tumor angiogenesis. Conclusions/Significance: The results presented in this study illustrate that genetically modified MSCs may function as a novel therapeutic vehicle for malignant brain tumors.	[Balyasnikova, Irina V.; Ferguson, Sherise D.; Sengupta, Sadhak; Han, Yu; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA	University of Chicago	Balyasnikova, IV (corresponding author), Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA.	mlesniak@surgery.bsd.uchicago.edu	Han, Yu/GZA-9220-2022; Sengupta, Sadhak/D-2526-2009		National Cancer Institute [R01-CA122930, R01-CA138587, R21-CA135728]; National Institute of Neurological Disorders and Stroke [K08-NS046430]; Alliance for Cancer Gene Therapy Young Investigator Award; American Cancer Society [RSG-07-276-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA138587, R01CA122930, R21CA135728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS046430] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alliance for Cancer Gene Therapy Young Investigator Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute (R01-CA122930, R01-CA138587, R21-CA135728), the National Institute of Neurological Disorders and Stroke (K08-NS046430), The Alliance for Cancer Gene Therapy Young Investigator Award, and the American Cancer Society (RSG-07-276-01-MGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALYASNIKOVA IV, 2009, J TISSUE ENG RE 1124; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Emrich JG, 2002, AM J CLIN ONCOL-CANC, V25, P541, DOI 10.1097/00000421-200212000-00001; Frank RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008314; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; GARCIA DP, 1993, CANCER RES, V53, P3217; Han W, 2006, CANCER BIOL THER, V5, P1361, DOI 10.4161/cbt.5.10.3226; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Jost M, 2001, J BIOL CHEM, V276, P6320, DOI 10.1074/jbc.M008210200; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kuan CT, 2000, INT J CANCER, V88, P962, DOI 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U; Kuan CT, 1999, CLIN CANCER RES, V5, P1539; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Lal A, 2002, CANCER RES, V62, P3335; LIBERMANN TA, 1984, CANCER RES, V44, P753; LUETZKENDORF J, 2009, J CELL MOL MED; Luwor RB, 2001, CANCER RES, V61, P5355; Mishima K, 2001, CANCER RES, V61, P5349; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Neyns B, 2009, ANN ONCOL, V20, P1596, DOI 10.1093/annonc/mdp032; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Patel D, 2007, ANTICANCER RES, V27, P3355; Sampson JH, 2000, P NATL ACAD SCI USA, V97, P7503, DOI 10.1073/pnas.130166597; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Schmidt M, 1999, ONCOGENE, V18, P1711, DOI 10.1038/sj.onc.1202489; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wu JL, 2004, NEUROL RES, V26, P785, DOI 10.1179/016164104225014139; Yang BJ, 2009, NEUROSURGERY, V65, P610, DOI 10.1227/01.NEU.0000350227.61132.A7; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181	46	56	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9750	10.1371/journal.pone.0009750	http://dx.doi.org/10.1371/journal.pone.0009750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305783	Green Published, gold, Green Submitted			2022-12-27	WOS:000276456300004
J	Wang, YX; Khaing, ZZ; Li, N; Hall, B; Schmidt, CE; Ellington, AD				Wang, Yuxuan; Khaing, Zin Z.; Li, Na; Hall, Brad; Schmidt, Christine E.; Ellington, Andrew D.			Aptamer Antagonists of Myelin-Derived Inhibitors Promote Axon Growth	PLOS ONE			English	Article							NOGO-RECEPTOR; OUTGROWTH INHIBITOR; EMERGING CLASS; RNA APTAMERS; GLYCOPROTEIN; IDENTIFICATION; REGENERATION; RHO; ANTIBODIES; PEGAPTANIB	Myelin of the adult central nervous system (CNS) is one of the major sources of inhibitors of axon regeneration following injury. The three known myelin-derived inhibitors (Nogo, MAG, and OMgp) bind with high affinity to the Nogo-66 receptor (NgR) on axons and limit neurite outgrowth. Here we show that RNA aptamers can be generated that bind with high affinity to NgR, compete with myelin-derived inhibitors for binding to NgR, and promote axon elongation of neurons in vitro even in the presence of these inhibitors. Aptamers may have key advantages over protein antagonists, including low immunogenicity and the possibility of ready modification during chemical synthesis for stability, signaling, or immobilization. This first demonstration that aptamers can directly influence neuronal function suggests that aptamers may prove useful for not only healing spinal cord and other neuronal damage, but may be more generally useful as neuromodulators.	[Wang, Yuxuan; Li, Na; Hall, Brad; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Khaing, Zin Z.; Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Schmidt, Christine E.] Univ Texas Austin, Cockrell Sch Engn, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wang, YX (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	andy.ellington@mail.utexas.edu	Schmidt, Christine E/P-1613-2016	Khaing, Zin/0000-0001-5652-5891	National Science Foundation; Howard Hughes Medical Institute through the Freshman Research Initiative; Texas Institute for Drug and Diagnostics Development; Gillson Longenbaugh Foundation; Welch Foundation [F-1654]	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute through the Freshman Research Initiative; Texas Institute for Drug and Diagnostics Development; Gillson Longenbaugh Foundation; Welch Foundation(The Welch Foundation)	This work was funded in part by the National Science Foundation, the Howard Hughes Medical Institute through the Freshman Research Initiative, the Texas Institute for Drug and Diagnostics Development, the Gillson Longenbaugh Foundation, and by the Welch Foundation (F-1654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Burmeister PE, 2006, OLIGONUCLEOTIDES, V16, P337, DOI 10.1089/oli.2006.16.337; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Dupuis L, 2008, P NATL ACAD SCI USA, V105, P740, DOI 10.1073/pnas.0703842105; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fiedler M, 2002, PROTEIN ENG, V15, P931, DOI 10.1093/protein/15.11.931; Fish G, 2003, OPHTHALMOLOGY, V110, P979, DOI 10.1016/S0161-6420(03)00085-X; Fournier AE, 2002, PROG BRAIN RES, V137, P361; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lee SW, 1997, NAT BIOTECHNOL, V15, P41, DOI 10.1038/nbt0197-41; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Martin DF, 2002, RETINA-J RET VIT DIS, V22, P143; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Ng EWM, 2005, CAN J OPHTHALMOL, V40, P352, DOI 10.1016/S0008-4182(05)80078-X; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; PENDERGRAST PS, 2006, GTC BIO 4 ANN C CYT, P109; Rentmeister A, 2006, RNA, V12, P1650, DOI 10.1261/rna.126306; Rimmele M, 2003, CHEMBIOCHEM, V4, P963, DOI 10.1002/cbic.200300648; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Seo HS, 2000, J MICROBIOL BIOTECHN, V10, P707; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; Takei Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000062; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354	41	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9726	10.1371/journal.pone.0009726	http://dx.doi.org/10.1371/journal.pone.0009726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300533	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400020
J	Moustafa, A; Evans, AN; Kulis, DM; Hackett, JD; Erdner, DL; Anderson, DM; Bhattacharya, D				Moustafa, Ahmed; Evans, Andrew N.; Kulis, David M.; Hackett, Jeremiah D.; Erdner, Deana L.; Anderson, Donald M.; Bhattacharya, Debashish			Transcriptome Profiling of a Toxic Dinoflagellate Reveals a Gene-Rich Protist and a Potential Impact on Gene Expression Due to Bacterial Presence	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; GENOME; ALEXANDRIUM; SEQUENCE; BIOSYNTHESIS; PHAGOTROPHY; CHLOROPHYLL; DISCOVERY; DINOPHYTA; PROTEINS	Background: Dinoflagellates are unicellular, often photosynthetic protists that play a major role in the dynamics of the Earth's oceans and climate. Sequencing of dinoflagellate nuclear DNA is thwarted by their massive genome sizes that are often several times that in humans. However, modern transcriptomic methods offer promising approaches to tackle this challenging system. Here, we used massively parallel signature sequencing (MPSS) to understand global transcriptional regulation patterns in Alexandrium tamarense cultures that were grown under four different conditions. Methodology/Principal Findings: We generated more than 40,000 unique short expression signatures gathered from the four conditions. Of these, about 11,000 signatures did not display detectable differential expression patterns. At a p-value, < 1E-10, 1,124 signatures were differentially expressed in the three treatments, xenic, nitrogen-limited, and phosphorus-limited, compared to the nutrient-replete control, with the presence of bacteria explaining the largest set of these differentially expressed signatures. Conclusions/Significance: Among microbial eukaryotes, dinoflagellates contain the largest number of genes in their nuclear genomes. These genes occur in complex families, many of which have evolved via recent gene duplication events. Our expression data suggest that about 73% of the Alexandrium transcriptome shows no significant change in gene expression under the experimental conditions used here and may comprise a "core'' component for this species. We report a fundamental shift in expression patterns in response to the presence of bacteria, highlighting the impact of biotic interaction on gene expression in dinoflagellates.	[Moustafa, Ahmed; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Evans, Andrew N.; Erdner, Deana L.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Kulis, David M.; Anderson, Donald M.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Hackett, Jeremiah D.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Austin; Woods Hole Oceanographic Institution; University of Arizona	Moustafa, A (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	bhattacharya@aesop.rutgers.edu	Moustafa, Ahmed/AAZ-3991-2020; Erdner, Deana L/C-4981-2008; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Erdner, Deana L/0000-0002-1736-8835; Moustafa, Ahmed/0000-0002-0111-3555; Evans, Andrew/0000-0002-5366-9942	National Institutes of Health [R01 ES 013679-01A2]; NIEHS [P50 ES 012742]; NSF [OCE-043072, EF-0732440]; Institutional NRSA [T 32 GM98629]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679, P50ES012742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629, T32GM008629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NSF(National Science Foundation (NSF)); Institutional NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily funded by a collaborative grant from the National Institutes of Health (R01 ES 013679-01A2) awarded to DB, DMA, and M. Bento Soares. Funding support for DMA and DLE was also provided from the Woods Hole Center for Oceans and Human Health from the NSF/NIEHS Centers for Oceans and Human Health program, NIEHS (P50 ES 012742) and (NSF OCE-043072). Additional support came from the National Science Foundation (EF-0732440) in a grant awarded to F. Gerald Plumley, DB, JDH, and DMA. AM was supported by an Institutional NRSA (T 32 GM98629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi M, 2001, ENVIRON MICROBIOL, V3, P380, DOI 10.1046/j.1462-2920.2001.00207.x; Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2522, DOI 10.1016/j.dsr2.2005.06.014; ANDERSON DM, 1985, LIMNOL OCEANOGR, V30, P1000, DOI 10.4319/lo.1985.30.5.1000; ANDERSON DM, 1985, J PHYCOL, V21, P200; ANDERSON DM, 1984, J PHYCOL, V20, P418, DOI 10.1111/j.0022-3646.1984.00418.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Bhaud Y, 2000, J CELL SCI, V113, P1231; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CALVIN M, 1948, SCIENCE, V107, P476, DOI 10.1126/science.107.2784.476; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Choi JY, 1997, J EUKARYOT MICROBIOL, V44, P412, DOI 10.1111/j.1550-7408.1997.tb05717.x; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; DELAHABA G, 1959, J BIOL CHEM, V234, P603; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Doucette Gregory J., 1995, Natural Toxins, V3, P65, DOI 10.1002/nt.2620030202; DREBES G, 1982, HELGOLANDER MEERESUN, V35, P501, DOI 10.1007/BF01999138; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Fagerberg T, 2009, HARMFUL ALGAE, V8, P823, DOI 10.1016/j.hal.2009.02.002; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; FUKAMI K, 1992, NIPPON SUISAN GAKK, V58, P1073; Gallacher S, 1997, APPL ENVIRON MICROB, V63, P239, DOI 10.1128/AEM.63.1.239-245.1997; GALLERON C, 1978, BIOCHIMIE, V60, P1235; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; HAIDAK DJ, 1966, SCIENCE, V152, P212, DOI 10.1126/science.152.3719.212; HAN JH, 1980, J BACTERIOL, V141, P1466, DOI 10.1128/JB.141.3.1466-1469.1980; HAXO FT, 1976, PLANT PHYSIOL, V57, P297, DOI 10.1104/pp.57.2.297; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Hold GL, 2001, FEMS MICROBIOL ECOL, V36, P223, DOI 10.1111/j.1574-6941.2001.tb00843.x; HOLMHANSEN O, 1969, SCIENCE, V163, P87, DOI 10.1126/science.163.3862.87; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacobson DM, 1996, J PHYCOL, V32, P279, DOI 10.1111/j.0022-3646.1996.00279.x; JEON KW, 1967, EXP CELL RES, V48, P236, DOI 10.1016/0014-4827(67)90313-8; Jeong HJ, 2005, AQUAT MICROB ECOL, V40, P133, DOI 10.3354/ame040133; JEONG HJ, 1994, MAR ECOL PROG SER, V106, P173, DOI 10.3354/meps106173; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Legrand C, 1998, AQUAT MICROB ECOL, V15, P65, DOI 10.3354/ame015065; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mayali X, 2008, J PHYCOL, V44, P923, DOI 10.1111/j.1529-8817.2008.00549.x; Mayali X, 2008, APPL ENVIRON MICROB, V74, P2595, DOI 10.1128/AEM.02191-07; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Pfannschmidt T, 2009, ANN BOT-LONDON, V103, P599, DOI 10.1093/aob/mcn081; Pfiester L. A., 1987, BIOL DINOFLAGELLATES, P611; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Scheetz TE, 2004, GENOME RES, V14, P733, DOI 10.1101/gr.1414204; SHIMIZU Y, 1986, ANN NY ACAD SCI, V479, P24, DOI 10.1111/j.1749-6632.1986.tb15558.x; SHIMIZU Y, 1984, J AM CHEM SOC, V106, P6433, DOI 10.1021/ja00333a062; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Trivedi N, 2002, FUTURE GENER COMP SY, V18, P863, DOI 10.1016/S0167-739X(02)00059-6; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	63	113	115	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9688	10.1371/journal.pone.0009688	http://dx.doi.org/10.1371/journal.pone.0009688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300646	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900019
J	Sol, D; Garcia, N; Iwaniuk, A; Davis, K; Meade, A; Boyle, WA; Szekely, T				Sol, Daniel; Garcia, Nuria; Iwaniuk, Andrew; Davis, Katie; Meade, Andrew; Boyle, W. Alice; Szekely, Tamas			Evolutionary Divergence in Brain Size between Migratory and Resident Birds	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; PHYLOGENETIC ANALYSIS; DISCRETE CHARACTERS; COGNITION; PATTERNS; ECOLOGY; INTELLIGENCE; PREDICTS; COSTS; WORLD	Despite important recent progress in our understanding of brain evolution, controversy remains regarding the evolutionary forces that have driven its enormous diversification in size. Here, we report that in passerine birds, migratory species tend to have brains that are substantially smaller (relative to body size) than those of resident species, confirming and generalizing previous studies. Phylogenetic reconstructions based on Bayesian Markov chain methods suggest an evolutionary scenario in which some large brained tropical passerines that invaded more seasonal regions evolved migratory behavior and migration itself selected for smaller brain size. Selection for smaller brains in migratory birds may arise from the energetic and developmental costs associated with a highly mobile life cycle, a possibility that is supported by a path analysis. Nevertheless, an important fraction (over 68%) of the correlation between brain mass and migratory distance comes from a direct effect of migration on brain size, perhaps reflecting costs associated with cognitive functions that have become less necessary in migratory species. Overall, our results highlight the importance of retrospective analyses in identifying selective pressures that have shaped brain evolution, and indicate that when it comes to the brain, larger is not always better.	[Sol, Daniel; Garcia, Nuria] Autonomous Univ Barcelona, Ctr Ecol Res & Appl Forestries CREAF, Bellaterra, Catalonia, Spain; [Sol, Daniel] CEAB CSIC Ctr Adv Studies Blanes Spanish Natl Res, Blanes, Catalonia, Spain; [Iwaniuk, Andrew] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Davis, Katie] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Meade, Andrew] Univ Glasgow, Div Ecol & Evolutionary Biol, Glasgow, Lanark, Scotland; [Boyle, W. Alice] Univ Western Ontario, Dept Biol, London, ON, Canada; [Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Lethbridge; University of Reading; University of Glasgow; Western University (University of Western Ontario); University of Bath	Sol, D (corresponding author), Autonomous Univ Barcelona, Ctr Ecol Res & Appl Forestries CREAF, Bellaterra, Catalonia, Spain.	d.sol@creaf.uab.es	Sol, Daniel/A-5238-2008; Szekely, Tamas/I-7089-2016; Boyle, W. Alice/G-1872-2010; Iwaniuk, Andrew/H-7255-2019	Sol, Daniel/0000-0001-6346-6949; Szekely, Tamas/0000-0003-2093-0056; Boyle, W. Alice/0000-0002-2880-142X; Iwaniuk, Andrew/0000-0001-9273-3655	Proyecto de Investigacion [CGL2007-66257]; Consolider project [CSD 2008-00040]	Proyecto de Investigacion; Consolider project(Spanish Government)	This work was supported by a Proyecto de Investigacion (CGL2007-66257) and a Consolider project (CSD 2008-00040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J.M., 2000, EVOLVING BRAINS; [Anonymous], 2002, CAUSE CORRELATION BI; Arbuckle J. L., 2007, AMOS USERS GUIDE VER; BENNETT PM, 1985, J ZOOL, V207, P151; BERTHOLD P, 1991, ANNU REV ECOL SYST, V22, P357, DOI 10.1146/annurev.es.22.110191.002041; Bininda-Emonds O.R., 2004, COMPU BIOL, P267; Boerner M, 2008, EVOLUTION, V62, P3157, DOI 10.1111/j.1558-5646.2008.00490.x; Boyle WA, 2007, AM NAT, V169, P344, DOI 10.1086/511335; Chesser RT, 1998, AM NAT, V152, P311, DOI 10.1086/286171; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Cristol DA, 2003, ANIM BEHAV, V66, P317, DOI 10.1006/anbe.2003.2194; Darwin C., 1871, P423; Davis KE, 2008, THESIS U GLASGOW GLA; Deaner Robert O., 2003, P233; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Francis RC, 2005, TRENDS ECOL EVOL, V20, P476, DOI 10.1016/j.tree.2005.07.002; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gibson KR, 2002, BRAIN BEHAV EVOLUT, V59, P10, DOI 10.1159/000063730; Goloboff P, 2008, CLADISTICS, V24, P91; Grace JB., 2015, STRUCTURAL EQUATION; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Li C., 1975, PATH ANAL A PRIMER; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann Claudia, 2005, P114; Newton I, 1996, J ANIM ECOL, V65, P137, DOI 10.2307/5716; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; PAGEL M, 1994, P ROY SOC LOND B, V144; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Paradis E, 2006, ANAL PHYLOGENETICS E; Perez-Barberia FJ, 2007, EVOLUTION, V61, P2811, DOI 10.1111/j.1558-5646.2007.00229.x; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Phillimore AB, 2006, AM NAT, V168, P220, DOI 10.1086/505763; Pravosudov VV, 2007, ANIM BEHAV, V73, P535, DOI 10.1016/j.anbehav.2006.10.005; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Safi K, 2005, BIOL LETT-UK, V1, P283, DOI 10.1098/rsbl.2005.0333; Schuck-Paim C, 2008, BRAIN BEHAV EVOLUT, V71, P200, DOI 10.1159/000119710; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol Daniel, 2003, P63; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; Winkler H, 2004, J ORNITHOL, V145, P238, DOI 10.1007/s10336-004-0040-y; WINKLER H, 2003, BIRDS 2 WORLDS; Zink RM, 2002, J AVIAN BIOL, V33, P433, DOI 10.1034/j.1600-048X.2002.03081.x; [No title captured]	66	58	59	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9617	10.1371/journal.pone.0009617	http://dx.doi.org/10.1371/journal.pone.0009617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224776	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800015
J	Morris, SK; Bassani, DG; Kumar, R; Awasthi, S; Paul, VK; Jha, P				Morris, Shaun K.; Bassani, Diego G.; Kumar, Rajesh; Awasthi, Shally; Paul, Vinod K.; Jha, Prabhat			Factors Associated with Physician Agreement on Verbal Autopsy of over 27000 Childhood Deaths in India	PLOS ONE			English	Article							ADULT DEATHS; SEX-RATIO; VALIDATION; MORTALITY; VALIDITY	Introduction: Each year, more than 10 million children younger than five years of age die. The large majority of these deaths occur in the developing world. The verbal autopsy (VA) is a tool designed to ascertain cause of death in such settings. While VA has been validated against hospital diagnosed cause of death, there has been no research conducted to better understand the factors that may influence individual physicians in determining cause of death from VA. Methodology/Principal Findings: This study uses data from over 27,000 neonatal and childhood deaths from The Million Death Study in which 6.3 million people in India were monitored for vital status between 1998 and 2003. The main outcome variable was physician agreement or disagreement of category of death and the variables were assessed for association using the kappa statistic, univariate and multivariate logistic regression using a conceptual hierarchical model, and a sensitivity and specificity analysis using the final VA category of mortality as the gold standard. The main variables found to be significantly associated with increased physician agreement included older ages and male gender of the deceased. When taking into account confounding factors in the multivariate analysis, we did not find consistent significant differences in physician agreement based on the death being in a rural or urban area, at home or in a health care facility, registered or not, or the respondent's gender, religion, relationship to the deceased, or whether or not the respondent lived with the deceased. Conclusions/Significance: Factors influencing physician agreement/disagreement to the greatest degree are the gender and age of the deceased; specifically, physicians tend to be less likely to agree on a common category of death in female children and in younger ages, particularly neonates. Additional training of physician reviewers and continued adaptation of the VA itself, with a focus on gender and age of the deceased, may be useful in increasing rates of physician agreement in these groups.	[Morris, Shaun K.; Bassani, Diego G.; Jha, Prabhat] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kumar, Rajesh] Post Grad Inst Med Educ, Sch Publ Hlth, Chandigarh, India; [Awasthi, Shally] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Paul, Vinod K.] All India Inst Med Sci, Dept Pediat, New Delhi, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; King George's Medical University; All India Institute of Medical Sciences (AIIMS) New Delhi	Morris, SK (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, 30 Bond St, Toronto, ON M5B 1W8, Canada.	shaun.morris@utoronto.ca	Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820	Canada Research Chair program; United Nations Children's Fund [50140]; Fogarty International Centre of the United States National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research [IEG-53506]; International Research Development Centre [102172]; Li Ka Shing Knowledge Institute and Keenan Research Centre at St. Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	Canada Research Chair program(Canada Research Chairs); United Nations Children's Fund; Fogarty International Centre of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); International Research Development Centre; Li Ka Shing Knowledge Institute and Keenan Research Centre at St. Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Shaun K. Morris is a Fellow of the Pediatric Scientist Development Program. The project described was supported by grants the Sick Kids Foundation and Paediatric Chairs of Canada. Prabhat Jha is supported by the Canada Research Chair program. External funding is from the United States Fund for the The United Nations Children's Fund (UNICEF; sub-grant 50140), Fogarty International Centre of the United States National Institutes of Health (NIH; grant R01 TW05991-01]), Canadian Institute of Health Research (CIHR; IEG-53506), International Research Development Centre (Grant 102172), and Li Ka Shing Knowledge Institute and Keenan Research Centre at St. Michael's Hospital, University of Toronto (Centre for Global Health Research [CGHR] support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arokiasamy P, 2008, J BIOSOC SCI, V40, P183, DOI 10.1017/S0021932007002623; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Byass P, 2003, SCAND J PUBLIC HEALT, V31, P32, DOI 10.1080/14034950310015086; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; *CTR GLOB HLTH RES, 2009, MILL DEATH STUDY 200; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P, 2007, INT J EPIDEMIOL, V36, P651, DOI 10.1093/ije/dym108; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404; Sahni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002224; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; SETEL PW, 2007, SCANDAL INVISIBILITY; StataCorp L, 2007, STAT DAT AN STAT SOF; Thatte N, 2009, J PERINATOL, V29, P187, DOI 10.1038/jp.2008.138; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; World Health Organization, 2007, VERB AUT STAND ASC A	26	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A170	A177	e9583	10.1371/journal.pone.0009583	http://dx.doi.org/10.1371/journal.pone.0009583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221398	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200016
J	Rippe, V; Dittberner, L; Lorenz, VN; Drieschner, N; Nimzyk, R; Sendt, W; Junker, K; Belge, G; Bullerdiek, J				Rippe, Volkhard; Dittberner, Lea; Lorenz, Verena N.; Drieschner, Norbert; Nimzyk, Rolf; Sendt, Wolfgang; Junker, Klaus; Belge, Gazanfer; Bullerdiek, Joern			The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas	PLOS ONE			English	Article							CYTOGENETIC INVESTIGATIONS; EXPRESSION; TUMORS; DNA; DIFFERENTIATION; IDENTIFICATION; BREAKPOINTS; INVASION; CANCER	Thyroid adenomas are common benign human tumors with a high prevalence of about 5% of the adult population even in iodine sufficient areas. Rearrangements of chromosomal band 19q13.4 represent a frequent clonal cytogenetic deviation in these tumors making them the most frequent non-random chromosomal translocations in human epithelial tumors at all. Two microRNA (miRNA) gene clusters i.e. C19MC and miR-371-3 are located in close proximity to the breakpoint region of these chromosomal rearrangements and have been checked for a possible up-regulation due to the genomic alteration. In 4/5 cell lines established from thyroid adenomas with 19q13.4 rearrangements and 5/5 primary adenomas with that type of rearrangement both the C19MC and miR-371-3 cluster were found to be significantly overexpressed compared to controls lacking that particular chromosome abnormality. In the remaining cell line qRT-PCR revealed overexpression of members of the miR-371-3 cluster only which might be due to a deletion accompanying the chromosomal rearrangement in that case. In depth molecular characterization of the breakpoint in a cell line from one adenoma of this type reveals the existence of large Pol-II mRNA fragments as the most likely source of up-regulation of the C19MC cluster. The up-regulation of the clusters is likely to be causally associated with the pathogenesis of the corresponding tumors. Of note, the expression of miRNAs miR-520c and miR-373 is known to characterize stem cells and in terms of molecular oncology has been implicated in invasive growth of epithelial cells in vitro and in vivo thus allowing to delineate a distinct molecular subtype of thyroid adenomas. Besides thyroid adenomas rearrangements of 19q13.4 are frequently found in other human neoplasias as well, suggesting that activation of both clusters might be a more general phenomenon in human neoplasias.	[Rippe, Volkhard; Dittberner, Lea; Lorenz, Verena N.; Drieschner, Norbert; Nimzyk, Rolf; Belge, Gazanfer; Bullerdiek, Joern] Univ Bremen, Ctr Human Genet, Bremen, Germany; [Sendt, Wolfgang] St Joseph Stift, Dept Gen & Visceral Surg, Bremen, Germany; [Junker, Klaus] Hosp Bremen Mitte, Dept Pathol, Bremen, Germany; [Bullerdiek, Joern] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Bullerdiek, Joern] Univ Vet Med, Res Cluster Excellence REBIRTH, Hannover, Germany	University of Bremen; Klinikum Bremen-Mitte; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Rippe, V (corresponding author), Univ Bremen, Ctr Human Genet, Bremen, Germany.	bullerd@uni-bremen.de	Rippe, Volkhard/I-1927-2013	Rippe, Volkhard/0000-0001-8758-6013	University of Bremen	University of Bremen	The work was supported by the University of Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELGE G, 1992, CELL BIOL INT REP, V16, P339, DOI 10.1016/S0309-1651(06)80139-6; Belge G, 1998, CANCER GENET CYTOGEN, V101, P42, DOI 10.1016/S0165-4608(97)00057-5; Belge G, 1997, GENE CHROMOSOME CANC, V20, P201, DOI 10.1002/(SICI)1098-2264(199710)20:2<201::AID-GCC11>3.0.CO;2-T; Belge G, 2001, CYTOGENET CELL GENET, V93, P48, DOI 10.1159/000056947; Bol S, 2001, CYTOGENET CELL GENET, V95, P189, DOI 10.1159/000059344; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; DELELLIS RA, 2004, ED CONS C LYON FRANC; Fehr A, 2008, CANCER GENET CYTOGEN, V180, P135, DOI 10.1016/j.cancergencyto.2007.10.007; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; KIEVITS T, 1990, CYTOMETRY, V11, P105, DOI 10.1002/cyto.990110112; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li SSL, 2009, J CELL BIOCHEM, V106, P1020, DOI 10.1002/jcb.22084; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMELIN D, 2009, GENOME RES; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; ROQUE L, 1993, CANCER GENET CYTOGEN, V67, P1, DOI 10.1016/0165-4608(93)90036-L; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; SPELEMAN F, 1989, CANCER GENET CYTOGEN, V40, P29, DOI 10.1016/0165-4608(89)90142-8; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	31	88	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9485	10.1371/journal.pone.0009485	http://dx.doi.org/10.1371/journal.pone.0009485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209130	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400005
J	Ezak, MJ; Ferkey, DM				Ezak, Meredith J.; Ferkey, Denise M.			The C. elegans D2-Like Dopamine Receptor DOP-3 Decreases Behavioral Sensitivity to the Olfactory Stimulus 1-Octanol	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; ARACHIDONIC-ACID RELEASE; HAMSTER OVARY CELLS; IN-VIVO; CHEMOSENSORY RECEPTORS; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; AMINE RECEPTORS; PHOSPHOLIPASE-D; ASH NEURONS	We previously found that dopamine signaling modulates the sensitivity of wild-type C. elegans to the aversive odorant 1-octanol. C. elegans lacking the CAT-2 tyrosine hydroxylase enzyme, which is required for dopamine biosynthesis, are hypersensitive in their behavioral avoidance of dilute concentrations of octanol. Dopamine can also modulate the context-dependent response of C. elegans lacking RGS-3 function, a negative regulator of G alpha signaling. rgs-3 mutant animals are defective in their avoidance of 100% octanol when they are assayed in the absence of food (E. coli bacterial lawn), but their response is restored when they are assayed in the presence of food or exogenous dopamine. However, it is not known which receptor might be mediating dopamine's effects on octanol avoidance. Herein we describe a role for the C. elegans D2-like receptor DOP-3 in the regulation of olfactory sensitivity. We show that DOP-3 is required for the ability of food and exogenous dopamine to rescue the octanol avoidance defect of rgs-3 mutant animals. In addition, otherwise wild-type animals lacking DOP-3 function are hypersensitive to dilute octanol, reminiscent of cat-2 mutants. Furthermore, we demonstrate that DOP-3 function in the ASH sensory neurons is sufficient to rescue the hypersensitivity of dop-3 mutant animals, while dop-3 RNAi knockdown in ASH results in octanol hypersensitivity. Taken together, our data suggest that dopaminergic signaling through DOP-3 normally acts to dampen ASH signaling and behavioral sensitivity to octanol.	[Ezak, Meredith J.; Ferkey, Denise M.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ezak, MJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	dmferkey@buffalo.edu			Ellison Medical Foundation [AG0380-07]	Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by a New Scholar in Aging Award from The Ellison Medical Foundation (http://www.ellisonfoundation.org/index.jsp, AG0380-07 to D. M. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BRENNER S, 1974, GENETICS, V77, P71; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; CHIO CL, 1994, J BIOL CHEM, V269, P11813; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Ferkey DM, 2007, NEURON, V53, P39, DOI 10.1016/j.neuron.2006.11.015; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gonon F, 1997, J NEUROSCI, V17, P5972; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; KANTERMAN RY, 1991, MOL PHARMACOL, V39, P364; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Lints R, 1999, DEVELOPMENT, V126, P5819; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Nilsson CL, 1999, LIFE SCI, V64, P939, DOI 10.1016/S0024-3205(99)00020-X; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; RANKIN CH, 1992, BEHAV NEUROSCI, V106, P239, DOI 10.1037/0735-7044.106.2.239; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rios M, 1999, J NEUROSCI, V19, P3519; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Senogles SE, 2000, MOL PHARMACOL, V58, P455, DOI 10.1124/mol.58.2.455; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VIAL D, 1995, J NEUROCHEM, V64, P2765; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; White JG, 1986, PHILOS T R SOC LON B, P1, DOI [10.1098/rstb.1986.0056, DOI 10.1098/RSTB.1986.0056]; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	73	33	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9487	10.1371/journal.pone.0009487	http://dx.doi.org/10.1371/journal.pone.0009487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209143	Green Published, gold, Green Submitted			2022-12-27	WOS:000275063300007
J	Soebiyanto, RP; Adimi, F; Kiang, RK				Soebiyanto, Radina P.; Adimi, Farida; Kiang, Richard K.			Modeling and Predicting Seasonal Influenza Transmission in Warm Regions Using Climatological Parameters	PLOS ONE			English	Article							EPIDEMICS	Background: Influenza transmission is often associated with climatic factors. As the epidemic pattern varies geographically, the roles of climatic factors may not be unique. Previous in vivo studies revealed the direct effect of winter-like humidity on air-borne influenza transmission that dominates in regions with temperate climate, while influenza in the tropics is more effectively transmitted through direct contact. Methodology/Principal Findings: Using time series model, we analyzed the role of climatic factors on the epidemiology of influenza transmission in two regions characterized by warm climate: Hong Kong (China) and Maricopa County (Arizona, USA). These two regions have comparable temperature but distinctly different rainfall. Specifically we employed Autoregressive Integrated Moving Average (ARIMA) model along with climatic parameters as measured from ground stations and NASA satellites. Our studies showed that including the climatic variables as input series result in models with better performance than the univariate model where the influenza cases depend only on its past values and error signal. The best model for Hong Kong influenza was obtained when Land Surface Temperature (LST), rainfall and relative humidity were included as input series. Meanwhile for Maricopa County we found that including either maximum atmospheric pressure or mean air temperature gave the most improvement in the model performances. Conclusions/Significance: Our results showed that including the environmental variables generally increases the prediction capability. Therefore, for countries without advanced influenza surveillance systems, environmental variables can be used for estimating influenza transmission at present and in the near future.	[Soebiyanto, Radina P.; Adimi, Farida; Kiang, Richard K.] NASA, Goddard Space Flight Ctr, Global Change Data Ctr, Greenbelt, MD 20771 USA; [Soebiyanto, Radina P.] Univ Maryland Baltimore Cty, Goddard Earth Sci & Technol Ctr, Baltimore, MD 21228 USA; [Adimi, Farida] Wyle Int, Mclean, VA USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County	Soebiyanto, RP (corresponding author), NASA, Goddard Space Flight Ctr, Global Change Data Ctr, Greenbelt, MD 20771 USA.	richard.kiang@nasa.gov			NASA Applied Sciences Public Health Program	NASA Applied Sciences Public Health Program	This study is supported by NASA Applied Sciences Public Health Program (http://nasascience.nasa.gov/earth-science/applied-sciences). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Box G.E.P., 2009, TIME SERIES ANAL FOR, Vthird; Chatfield C., 2000, TIME SERIES FORECAST; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chumkiew S, 2007, PROC WRLD ACAD SCI E, V19, P364; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Flood Control District of Maricopa, 2009, WEATH INF; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; *HONG KONG DEP HLT, HONG KONG DEP HLTH F; *HONG KONG OBS, HONG KONG OBS EXTR M; Kiang R, 2006, GEOSPATIAL HEALTH, V1, P71, DOI 10.4081/gh.2006.282; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; *MAR DEP PUBL HLTH, MAR DEP PUBL HLTH MA; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; *NASA GODD EARTH S, GES DISC INT ONL VIS; *NASA GODD SPAC FL, 2009, MODIS; *NASA GODD SPAC FL, 2009, GLOB PREC MEAS; *NASA GODD SPAC FL, 2009, TROP RAINF MEAS MISS; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Sagripanti JL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1278, DOI 10.1111/j.1751-1097.2007.00177.x; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; SMITH E, 2006, MEASURING PRECIPITAT; Urashima M, 2003, JPN J INFECT DIS, V56, P43; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO, 2009, INFL SEAS; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; XIAO X, 2007, J WILDLIFE DIS, V43	33	124	129	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9450	10.1371/journal.pone.0009450	http://dx.doi.org/10.1371/journal.pone.0009450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209164	Green Submitted, Green Published, gold			2022-12-27	WOS:000274997100003
J	Takao, K; Tanda, K; Nakamura, K; Kasahara, J; Nakao, K; Katsuki, M; Nakanishi, K; Yamasaki, N; Toyama, K; Adachi, M; Umeda, M; Araki, T; Fukunaga, K; Kondo, H; Sakagami, H; Miyakawa, T				Takao, Keizo; Tanda, Koichi; Nakamura, Kenji; Kasahara, Jiro; Nakao, Kazuki; Katsuki, Motoya; Nakanishi, Kazuo; Yamasaki, Nobuyuki; Toyama, Keiko; Adachi, Minami; Umeda, Masahiro; Araki, Tsutomu; Fukunaga, Kohji; Kondo, Hisatake; Sakagami, Hiroyuki; Miyakawa, Tsuyoshi			Comprehensive Behavioral Analysis of Calcium/Calmodulin-Dependent Protein Kinase IV Knockout Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; RAT HIPPOCAMPAL-NEURONS; ELEVATED PLUS-MAZE; SYNAPTIC PLASTICITY; DEFICIENT MICE; FEAR MEMORY; PPP3CC GENE; SCHIZOPHRENIA; CALCINEURIN; TRANSCRIPTION	Calcium-calmodulin dependent protein kinase IV (CaMKIV) is a protein kinase that activates the transcription factor CREB, the cyclic AMP-response element binding protein. CREB is a key transcription factor in synaptic plasticity and memory consolidation. To elucidate the behavioral effects of CaMKIV deficiency, we subjected CaMKIV knockout (CaMKIV KO) mice to a battery of behavioral tests. CaMKIV KO had no significant effects on locomotor activity, motor coordination, social interaction, pain sensitivity, prepulse inhibition, attention, or depression-like behavior. Consistent with previous reports, CaMKIV KO mice exhibited impaired retention in a fear conditioning test 28 days after training. In contrast, however, CaMKIV KO mice did not show any testing performance deficits in passive avoidance, one of the most commonly used fear memory paradigms, 28 days after training, suggesting that remote fear memory is intact. CaMKIV KO mice exhibited intact spatial reference memory learning in the Barnes circular maze, and normal spatial working memory in an eight-arm radial maze. CaMKIV KO mice also showed mildly decreased anxiety-like behavior, suggesting that CaMKIV is involved in regulating emotional behavior. These findings indicate that CaMKIV might not be essential for fear memory or spatial memory, although it is possible that the activities of other neural mechanisms or signaling pathways compensate for the CaMKIV deficiency.	[Takao, Keizo; Tanda, Koichi; Nakanishi, Kazuo; Yamasaki, Nobuyuki; Toyama, Keiko; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Genet Engn & Funct Genom Grp, Kyoto, Japan; [Takao, Keizo; Toyama, Keiko; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan; [Takao, Keizo; Toyama, Keiko; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan; [Nakamura, Kenji] Mitsubishi Kagaku Inst Life Sci, Mouse Genome Technol Lab, Tokyo, Japan; [Kasahara, Jiro; Adachi, Minami; Umeda, Masahiro; Araki, Tsutomu] Univ Tokushima, Grad Sch Hlth Biosci, Dept Neurobiol & Therapeut, Tokushima 770, Japan; [Kasahara, Jiro; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Nakao, Kazuki] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo, Japan; [Katsuki, Motoya] Natl Inst Nat Sci, Minato Ku, Tokyo 1050001, Japan; [Kondo, Hisatake] Tohoku Bunka Gakuen Univ, Fac Med Sci & Welf, Dept Rehabil, Sendai, Miyagi, Japan; [Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 228, Japan	Kyoto University; Fujita Health University; Japan Science & Technology Agency (JST); Mitsubishi Kagaku Institute of Life Sciences (MITILS); Tokushima University; Tohoku University; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Kitasato University	Takao, K (corresponding author), Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Genet Engn & Funct Genom Grp, Kyoto, Japan.	miyakawa@fujita-hu.ac.jp	Takao, Keizo/B-9527-2008; Fukunaga, Kohji/AAI-8811-2021; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200; zhong wei, he gui/0000-0002-3066-3564; Fukunaga, Kohji/0000-0001-8526-2824	KAKENHI [20016013, 20023017, 16680015, 19653081]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; National Institute of Biomedical Innovation (NIBIO); Neuroinformatics Japan Center (NIJC); CREST & BIRD of Japan Science and Technology Agency (JST)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Neuroinformatics Japan Center (NIJC); CREST & BIRD of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' (20016013), on Priority Areas "Pathomechanisms of Brain Disorders'' (20023017), Young Scientists A (16680015), Exploratory Research (19653081), and Integrative Brain Research (IBR-shien) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Neuroinformatics Japan Center (NIJC), and by grants from CREST & BIRD of Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P11309; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; Fukushima H, 2008, J NEUROSCI, V28, P9910, DOI 10.1523/JNEUROSCI.2625-08.2008; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Horiuchi Y, 2007, MOL PSYCHIATR, V12, P891, DOI 10.1038/sj.mp.4002019; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kasahara J, 1999, J BIOL CHEM, V274, P9061, DOI 10.1074/jbc.274.13.9061; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Ko SW, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-10; Komada M., 2008, J VIS EXP, V1088; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mathieu F, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-2; Matsuo N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.003.2009; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Sakagami H, 2004, EUR J NEUROSCI, V19, P863, DOI 10.1111/j.0953-816X.2004.03195.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Shum FWF, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-22; Takao K., 2006, J VIS EXP, V104; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tiraboschi E, 2004, NEUROPSYCHOPHARMACOL, V29, P1831, DOI 10.1038/sj.npp.1300488; Uezu A, 2002, J NEUROCHEM, V82, P585, DOI 10.1046/j.1471-4159.2002.00984.x; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Wu LJ, 2008, EUR J NEUROSCI, V27, P1923, DOI 10.1111/j.1460-9568.2008.06183.x; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	49	55	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9460	10.1371/journal.pone.0009460	http://dx.doi.org/10.1371/journal.pone.0009460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209163	Green Submitted, Green Published, gold			2022-12-27	WOS:000274997100007
J	Donadoni, C; Bisighini, C; Scotti, L; Diomede, L; Ngyen, M; Nouhin, J; DeSantis, L; Zambon, A; Ferrari, D; Gallotta, G; Corrao, G; Pancino, G; Lopalco, L				Donadoni, Carla; Bisighini, Cinzia; Scotti, Lorenza; Diomede, Lorenzo; Ngyen, Marie; Nouhin, Janin; DeSantis, Lucia; Zambon, Antonella; Ferrari, Davide; Gallotta, Giulia; Corrao, Giovanni; Pancino, Gianfranco; Lopalco, Lucia			Setting of Methods for Analysis of Mucosal Antibodies in Seminal and Vaginal Fluids of HIV Seropositive Subjects from Cambodian and Italian Cohorts	PLOS ONE			English	Article							EXPOSED SERONEGATIVE INDIVIDUALS; NEUTRALIZING ANTIBODIES; 1-INFECTED INDIVIDUALS; HUMORAL IMMUNITY; MENSTRUAL-CYCLE; GENITAL-TRACT; SECRETIONS; IGA; INFECTION; WOMEN	Background: Genital mucosae play a key role in protection from STD and HIV infection, due to their involvement in both horizontal and vertical disease transmission. High variability of published observations concerning IgA isolation and quantification underlies the strong requirement of specific methods able to maximize investigation on HIV-specific IgA. Methodology: Genital fluids from 109 subjects, including male and female cohorts from Italy and Cambodia, were collected, aliquoted and processed with different techniques, to assess optimal conditions maximizing mucosal antibody recovery. Three sampling techniques, up to sixteen preservation conditions, six ELISA methods and four purifications protocols were compared. Principal Findings: The optimal method here described took advantage of Weck-Cel sampling of female mucosal fluids. Immediate processing of genital fluids, with the addition of antibiotics and EDTA, improved recovery of vaginal IgA, while the triple addition of EDTA, antibiotics and protease inhibitors provided the highest amount of seminal IgA. Due to low amount of IgA in mucosal fluids, a high sensitive sandwich ELISA assay was set; sensitivity was enhanced by milk-based overcoating buffer and by a two-step biotin-streptavidin signal amplification. Indeed, commercial antisera to detect human immunoglobulins showed weak cross-reactivity to different antibody types. Three-step affinity purification provided reproducible immunoglobulin recovery from genital specimens, while conventional immuno-affinity IgA purification was found poorly manageable. Affinity columns were suitable to isolate mucosal IgA, which are ten-fold less concentrated than IgG in genital specimens, and provided effective separation of IgA monomers, dimers, and J-chains. Jacalin-bound resin successfully separated IgA1 from IgA2 subfraction. Conclusions/Significance: Specific, effective and reliable methods to study local immunity are key items in understanding host mucosal response. The sequence of methods here described is effective and reliable in analysing humoral local responses, and may provide a solid advance to identify and measure the effective mucosal responses to HIV.	[Donadoni, Carla; Bisighini, Cinzia; Diomede, Lorenzo; Lopalco, Lucia] Ist Sci San Raffaele, Div Immunol Infect Dis & Trasplantat, I-20132 Milan, Italy; [Scotti, Lorenza; Zambon, Antonella; Corrao, Giovanni] Univ Milanobicocca, Dept Stat, Milan, Italy; [Ngyen, Marie; Nouhin, Janin] Inst Pasteur Cambodge, HIV Hepatitis Lab, Phnom Penh, Cambodia; [DeSantis, Lucia] Univ Vita Salute, San Raffaele Sci Inst, Dept Obstet & Gynaecol, Milan, Italy; [Ferrari, Davide] Ist Sci San Raffaele, Dept Obstet & Gynaecol, I-20132 Milan, Italy; [Gallotta, Giulia] Ist Sci San Raffaele, Dept Infect Dis, I-20132 Milan, Italy; [Pancino, Gianfranco] Inst Pasteur, Regulat Retroviral Infect Unit, Paris, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Donadoni, C (corresponding author), Univ Milanobicocca, Dept Clin Med & Prevent, Milan, Italy.	lopalco.lucia@hsr.it	Nouhin, Janin/AAM-2322-2021; Nouhin, Janin/AAS-6946-2020; De Santis, Lucia/ABI-2166-2020; , Lopalco/AAN-2429-2020; Scotti, Lorenza/AAB-9544-2019; Pancino, Gianfranco/A-5519-2010	Nouhin, Janin/0000-0003-4985-8377; Nouhin, Janin/0000-0003-4985-8377; Scotti, Lorenza/0000-0002-3861-9058; Lopalco, Lucia/0000-0003-3812-1759; Zambon, Antonella/0000-0001-6443-3858	European Commission [201433]; National Institutes of Health (NIH) [1 U19 AI062150]; Bill and Melinda Gates Foundation [53030, PP1008144]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062150] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by Grant no 201433 from European Commission/Seventh Framework Programme (URL:www.ngin.eu), Grant no 1 U19 AI062150 from National Institutes of Health (NIH) and Grant GCE no 53030 and PP1008144 from the Bill and Melinda Gates Foundation; the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R, 2007, CURR HIV RES, V5, P588, DOI 10.2174/157016207782418452; Barassi C, 2004, BLOOD, V104, P2205, DOI 10.1182/blood-2004-06-2134; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; GREGORY RL, 1987, J IMMUNOL METHODS, V99, P101, DOI 10.1016/0022-1759(87)90037-8; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Hocini H, 2000, J IMMUNOL METHODS, V235, P53, DOI 10.1016/S0022-1759(99)00214-8; Jackson S, 2000, AIDS RES HUM RETROV, V16, P595, DOI 10.1089/088922200309016; JEA M, 1999, MANUAL COLLECTION PR; KAETZEL CM, 2005, IMMUNOGLOBULIN TRANS, P211; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; LEHNER T, 1992, SCIENCE, V258, P1365, DOI 10.1126/science.1360702; Lehner T, 2003, VACCINE, V21, pS68, DOI 10.1016/S0264-410X(03)00204-4; Lopalco L, 2004, CURR HIV RES, V2, P127, DOI 10.2174/1570162043484951; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Moldoveanu Z, 2005, J IMMUNOL, V175, P4127, DOI 10.4049/jimmunol.175.6.4127; PACK TD, 2001, CURR PROTOC IMMUNOL, P1; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Ruprecht RM, 2001, TRANSFUS CLIN BIOL, V8, P350, DOI 10.1016/S1246-7820(01)00187-2; RUSSELL M, 2005, BIOL ACTIVITIES, P267; TJOKRONEGORO A, 1974, J REPROD FERTIL, V38, P221; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Veazey RS, 2001, TRENDS IMMUNOL, V22, P626, DOI 10.1016/S1471-4906(01)02039-7; Westfall PH, 1997, J AM STAT ASSOC, V92, P299, DOI 10.2307/2291474; WILK MB, 1968, BIOMETRIKA, V55, P1; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334	32	11	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9920	10.1371/journal.pone.0009920	http://dx.doi.org/10.1371/journal.pone.0009920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360961	Green Published, gold			2022-12-27	WOS:000276163100013
J	Rahman, FZ; Smith, AM; Hayee, B; Marks, DJB; Bloom, SL; Segal, AW				Rahman, Farooq Z.; Smith, Andrew M.; Hayee, Bu'Hussain; Marks, Daniel J. B.; Bloom, Stuart L.; Segal, Anthony W.			Delayed Resolution of Acute Inflammation in Ulcerative Colitis Is Associated with Elevated Cytokine Release Downstream of TLR4	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CD4(+) T-CELLS; CROHNS-DISEASE; BOWEL-DISEASE; TRIF; PATHOGENESIS; LOCI; MICE; INTERFERON-BETA-1A; INHIBITION	Background: Ulcerative colitis (UC) is widely viewed as a leukocyte-mediated disorder. Although strong evidence implicates an exuberant response to microbial components in its pathogenesis, no intrinsic immune defect has been identified and the underlying pathogenic mechanisms remain obscure. Methodology/Principal Findings: The acute immune response to bacterial injection was determined in UC patients with quiescent disease and directly compared to healthy control subjects. Monocyte-derived macrophages were used to investigate bacterial recognition mechanisms in vitro. An exuberant and protracted acute inflammatory response to bacteria was evident in patients with UC, which coincides with increased systemic levels of CXCL10. Macrophages stimulated with bacteria and Toll-like receptor (TLR) ligands revealed a specific defect in the TLR4 response in UC. The defect resulted in the over-expression of a number of pro-inflammatory molecules under transcriptional control of the adaptor TIR-domain containing adaptor inducing interferon-b (TRIF). Conclusion: These findings highlight a dysregulated innate immune response with over-expression of molecules associated with leukocyte recruitment and activation that may eventuate in the hallmark chronic immune-mediated inflammation of UC.	[Rahman, Farooq Z.; Smith, Andrew M.; Hayee, Bu'Hussain; Marks, Daniel J. B.; Segal, Anthony W.] UCL, Dept Med, London, England; [Bloom, Stuart L.] Univ Coll London Hosp, Dept Gastroenterol, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Rahman, FZ (corresponding author), UCL, Dept Med, London, England.	andrew.m.smith@ucl.ac.uk		Segal, Anthony/0000-0001-7602-9043; Hayee, Bu'Hussain/0000-0003-1670-8815; Smith, Andrew/0000-0002-4691-5973	Wellcome Trust; Broad Medical Research Program	Wellcome Trust(Wellcome TrustEuropean Commission); Broad Medical Research Program	This work was supported by The Wellcome Trust (GHACB) (www.wellcome.ac.uk) and The Broad Medical Research Program (GHADY) (www.broadmedical.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari N, 2006, J CLIN PATHOL, V59, P1066, DOI 10.1136/jcp.2005.034983; Brain O, 2008, CURR OPIN GASTROEN, V24, P469, DOI 10.1097/MOG.0b013e3282ff0dd5; CEKIC C, 2009, J BIOL CHEM; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Eri R, 2008, INFLAMM BOWEL DIS, V14, P458, DOI 10.1002/ibd.20344; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Mavrogiannis C, 2001, J HEPATOL, V34, P964, DOI 10.1016/S0168-8278(01)00022-8; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Noguchi A, 2007, J GASTROENTEROL, V42, P947, DOI 10.1007/s00535-007-2118-9; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pena-Rossi C, 2008, ALIMENT PHARM THER, V28, P758, DOI 10.1111/j.1365-2036.2008.03778.x; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Scarpa M, 2004, DIGEST DIS SCI, V49, P1738, DOI 10.1007/s10620-004-9562-7; Schott E, 2007, WORLD J GASTROENTERO, V13, P3638, DOI 10.3748/wjg.v13.i26.3638; Seow CH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006790.pub2; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Singh UP, 2008, J INTERF CYTOK RES, V28, P31, DOI 10.1089/jir.2007.0059; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Tursi A, 2007, INFLAMM BOWEL DIS, V13, P1189, DOI 10.1002/ibd.20152; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Youn HS, 2005, J IMMUNOL, V175, P3339, DOI 10.4049/jimmunol.175.5.3339	37	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9891	10.1371/journal.pone.0009891	http://dx.doi.org/10.1371/journal.pone.0009891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360984	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600005
J	Tsuchiya, K; Hayashi, F				Tsuchiya, Kaori; Hayashi, Fumio			Factors Affecting Sperm Quality Before and After Mating of Calopterygid Damselflies	PLOS ONE			English	Article							PRUINOSA SELYS ODONATA; COPULATION DURATION; WING PIGMENTATION; SUCCESS; VIABILITY; REMOVAL; FEMALES; TACTICS; CHOICE; AGE	Damselflies (Odonata: Zygoptera) have a more complex sperm transfer system than other internally ejaculating insects. Males translocate sperm from the internal reproductive organs to the specific sperm vesicles, a small cavity on the body surface, and then transfer them into the female. To examine how the additional steps of sperm transfer contribute to decreases in sperm quality, we assessed sperm viability (the proportion of live sperm) at each stage of mating and after different storage times in male and female reproductive organs in two damselfly species, Mnais pruinosa and Calopteryx cornelia. Viability of stored sperm in females was lower than that of male stores even just after copulation. Male sperm vesicles were not equipped to maintain sperm quality for longer periods than the internal reproductive organs. However, the sperm vesicles were only used for short-term storage; therefore, this process appeared unlikely to reduce sperm viability when transferred to the female. Males remove rival sperm prior to transfer of their own ejaculate using a peculiar-shaped aedeagus, but sperm removal by males is not always complete. Thus, dilution occurs between newly received sperm and aged sperm already stored in the female, causing lower viability of sperm inside the female than that of sperm transferred by males. If females do not remate, sperm viability gradually decreases with the duration of storage. Frequent mating of females may therefore contribute to the maintenance of high sperm quality.	[Tsuchiya, Kaori; Hayashi, Fumio] Tokyo Metropolitan Univ, Dept Biol, Tokyo 158, Japan	Tokyo Metropolitan University	Tsuchiya, K (corresponding author), Tokyo Metropolitan Univ, Dept Biol, Setagaya Ku, Tokyo 158, Japan.	fhayashi@tmu.ac.jp			Japan Society for the Promotion of Science [13640632, 15570019]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by Grant-in-Aid for Scientific Research ( C) from the Japan Society for the Promotion of Science (13640632 and 15570019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordoba-Aguilar A, 2005, J EVOLUTION BIOL, V18, P132, DOI 10.1111/j.1420-9101.2004.00796.x; Cordoba-Aguilar A, 2002, ANIM BEHAV, V63, P759, DOI 10.1006/anbe.2001.1974; Damiens D, 2002, PHYSIOL ENTOMOL, V27, P97, DOI 10.1046/j.1365-3032.2002.00274.x; den Boer SPA, 2009, P ROY SOC B-BIOL SCI, V276, P3945, DOI 10.1098/rspb.2009.1184; Fedina TY, 2004, P ROY SOC B-BIOL SCI, V271, P1393, DOI 10.1098/rspb.2004.2731; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Hayashi F, 2005, ENTOMOL SCI, V8, P245, DOI 10.1111/j.1479-8298.2005.00123.x; HIGASHI K, 1982, Odonatologica, V11, P129; HIGASHI K, 1987, DRAGONFLY MATING SYS; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Lodesani M, 2004, J APICULT RES, V43, P27, DOI 10.1080/00218839.2004.11101105; NOMAKUCHI S, 1988, Ecological Research, V3, P75, DOI 10.1007/BF02346931; NOMAKUCHI S, 1985, Odonatologica, V14, P301; Plaistow SJ, 2000, P ROY SOC B-BIOL SCI, V267, P969, DOI 10.1098/rspb.2000.1098; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Reinhardt K, 2010, GENETICA, V138, P119, DOI 10.1007/s10709-009-9360-4; Simmons L. W., 2001, MG BEH ECOL; Siva-Jothy MT, 1999, BEHAVIOUR, V136, P1365, DOI 10.1163/156853999500776; SIVAJOTHY MT, 1989, BEHAV ECOL SOCIOBIOL, V25, P261, DOI 10.1007/BF00300052; SIVAJOTHY MT, 1989, BEHAV ECOL SOCIOBIOL, V24, P39, DOI 10.1007/BF00300116; SIVAJOTHY MT, 1995, P ROY SOC B-BIOL SCI, V259, P313, DOI 10.1098/rspb.1995.0046; SIVAJOTHY MT, 1995, BEHAV ECOL SOCIOBIOL, V37, P39, DOI 10.1007/s002650050171; Sugimura M, 1999, DRAGONFLIES JAPANESE; SUZUKI K, 1981, J COLL LIB ARTS TOYA, V14, P25; TSUCHIYA K, 2005, THESIS TOKYO METROPO; Tsuchiya K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1417, DOI 10.1007/s00265-008-0571-y; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916; WAAGE JK, 1987, BEHAV ECOL SOCIOBIOL, V20, P439, DOI 10.1007/BF00302987; WATANABE M, 1990, J ETHOL, V8, P129, DOI 10.1007/BF02350283; Zar JH, 1999, BIOSTATISTICAL ANAL	34	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9904	10.1371/journal.pone.0009904	http://dx.doi.org/10.1371/journal.pone.0009904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361037	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600010
J	Thalmann, J; Janik, K; May, M; Sommer, K; Ebeling, J; Hofmann, F; Genth, H; Klos, A				Thalmann, Jessica; Janik, Katrin; May, Martin; Sommer, Kirsten; Ebeling, Jenny; Hofmann, Fred; Genth, Harald; Klos, Andreas			Actin Re-Organization Induced by Chlamydia trachomatis Serovar D - Evidence for a Critical Role of the Effector Protein CT166 Targeting Rac	PLOS ONE			English	Article							DIFFICILE TOXIN-B; CLOSTRIDIUM-DIFFICILE; RHO-GTPASES; HELA-CELLS; ENTRY; GLYCOSYLTRANSFERASES; ACTIVATION; INVASION; CNF1; CYTOSKELETON	The intracellular bacterium Chlamydia trachomatis causes infections of urogenital tract, eyes or lungs. Alignment reveals homology of CT166, a putative effector protein of urogenital C. trachomatis serovars, with the N-terminal glucosyltransferase domain of clostridial glucosylating toxins (CGTs). CGTs contain an essential DXD-motif and mono-glucosylate GTP-binding proteins of the Rho/Ras families, the master regulators of the actin cytoskeleton. CT166 is preformed in elementary bodies of C. trachomatis D and is detected in the host-cell shortly after infection. Infection with high MOI of C. trachomatis serovar D containing the CT166 ORF induces actin re-organization resulting in cell rounding and a decreased cell diameter. A comparable phenotype was observed in HeLa cells treated with the Rho-GTPase-glucosylating Toxin B from Clostridium difficile (TcdB) or HeLa cells ectopically expressing CT166. CT166 with a mutated DXD-motif (CT166-mut) exhibited almost unchanged actin dynamics, suggesting that CT166-induced actin re-organization depends on the glucosyltransferase motif of CT166. The cytotoxic necrotizing factor 1 (CNF1) from E. coli deamidates and thereby activates Rho-GTPases and transiently protects them against TcdB-induced glucosylation. CNF1-treated cells were found to be protected from TcdB- and CT166-induced actin re-organization. CNF1 treatment as well as ectopic expression of non-glucosylable Rac1-G12V, but not RhoA-G14A, reverted CT166-induced actin re-organization, suggesting that CT166-induced actin re-organization depends on the glucosylation of Rac1. In accordance, over-expression of CT166-mut diminished TcdB induced cell rounding, suggesting shared substrates. Cell rounding induced by high MOI infection with C. trachomatis D was reduced in cells expressing CT166-mut or Rac1-G12V, and in CNF1 treated cells. These observations indicate that the cytopathic effect of C. trachomatis D is mediated by CT166-induced Rac1 glucosylation. Finally, chlamydial uptake was impaired in CT166 over-expressing cells. Our data strongly suggest CT166's participation as an effector protein during host-cell entry, ensuring a balanced uptake into host-cells by interfering with Rac-dependent cytoskeletal changes.	[Thalmann, Jessica] Hannover Med Sch, Dept Nephrol, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany; [May, Martin; Hofmann, Fred; Genth, Harald] Hannover Med Sch, Inst Toxicol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School	Thalmann, J (corresponding author), Hannover Med Sch, Dept Nephrol, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany.	klos.andreas@mh-hannover.de	Genth, Harald/HHS-0118-2022; Janik, Katrin/U-2525-2019	Janik, Katrin/0000-0003-0878-7402; May, Martin/0000-0002-8335-6699	German Research Foundation [SFB587/A16]; International Research Training Group [1273]; Center of Infection Biology (ZIB)	German Research Foundation(German Research Foundation (DFG)); International Research Training Group; Center of Infection Biology (ZIB)	This project was partially supported by a grant of the German Research Foundation (DFG)-SFB587/A16 and partially also by the International Research Training Group 1273 funded by the DFG and the Center of Infection Biology (ZIB) at the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Ando Y, 2007, MOL BIOL CELL, V18, P3752, DOI 10.1091/mbc.E07-03-0281; Barth H, 1999, J BIOL CHEM, V274, P27407, DOI 10.1074/jbc.274.39.27407; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; Busch C, 2000, J BIOL CHEM, V275, P13228, DOI 10.1074/jbc.275.18.13228; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Dreger SC, 2009, BIOCHEMISTRY-US, V48, P1785, DOI 10.1021/bi800708b; Fiorentini C, 1997, J BIOL CHEM, V272, P19532, DOI 10.1074/jbc.272.31.19532; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Halabi-Cabezon I, 2008, FEBS LETT, V582, P3751, DOI 10.1016/j.febslet.2008.10.003; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Herrmann C, 1998, J BIOL CHEM, V273, P16134, DOI 10.1074/jbc.273.26.16134; Hoffmann C, 2005, REV PHYSIOL BIOCH P, V152, P49, DOI 10.1007/s10254-004-0026-4; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Huelsenbeck SC, 2009, CELL MOTIL CYTOSKEL, V66, P967, DOI 10.1002/cm.20390; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; MAJEED M, 1991, INFECT IMMUN, V59, P4465, DOI 10.1128/IAI.59.12.4465-4472.1991; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stoll T, 2009, TOXICON, V54, P745, DOI 10.1016/j.toxicon.2009.05.038; Subtil A, 2004, J CELL SCI, V117, P3923, DOI 10.1242/jcs.01247; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	36	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9887	10.1371/journal.pone.0009887	http://dx.doi.org/10.1371/journal.pone.0009887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360858	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500014
J	D'Aiuto, L; Marzulli, M; Mohan, KN; Borowczyk, E; Saporiti, F; VanDemark, A; Chaillet, JR				D'Aiuto, Leonardo; Marzulli, Marco; Mohan, K. Naga; Borowczyk, Ewa; Saporiti, Federica; VanDemark, Andrew; Chaillet, J. Richard			Dissection of Structure and Function of the N-Terminal Domain of Mouse DNMT1 Using Regional Frame-Shift Mutagenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MAMMALIAN DNA METHYLTRANSFERASE; METHYLATED DNA; EPIGENETIC INHERITANCE; REGULATORY DOMAIN; REPLICATION FOCI; GENE; BINDING; RECOGNITION; MAINTENANCE	Deletion analysis of mouse DNMT1, the primary maintenance methyltransferase in mammals, showed that most of the N-terminal regulatory domain (amino acid residues 412-1112) is required for its enzymatic activity. Although analysis of deletion mutants helps to identify regions of a protein sequence required for a particular activity, amino acid deletions can have drastic effects on protein structure and/or stability. Alternative approaches represented by rational design and directed evolution are resource demanding, and require high-throughput selection or screening systems. We developed Regional Frame-shift Mutagenesis (RFM) as a new approach to identify portions required for the methyltransferase activity of DNMT1 within the N-terminal 89-905 amino acids. In this method, a short stretch of amino acids in the wild-type protein is converted to a different amino acid sequence. The resultant mutant protein retains the same amino acid length as the wild type, thereby reducing physical constrains on normal folding of the mutant protein. Using RFM, we identified three small regions in the amino-terminal one-third of the protein that are essential for DNMT1 function. Two of these regions (amino acids 124-160 and 341-368) border a large disordered region that regulates maintenance methylation activity. This organization of DNMT1's amino terminus suggests that the borders define the position of the disordered region within the DNMT1 protein, which in turn allows for its proper function.	[D'Aiuto, Leonardo; Marzulli, Marco; Mohan, K. Naga; Borowczyk, Ewa; Chaillet, J. Richard] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [VanDemark, Andrew] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Saporiti, Federica] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Aiuto, L (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	Chaillet@pitt.edu	Mohan, Kommu Naga/HIK-1746-2022	SAPORITI, FEDERICA/0000-0003-2647-3212; D'Aiuto, Leonardo/0000-0002-7102-2093; VanDemark, Andrew/0000-0003-3424-4831	National Institutes of Health USA [R01HD044133]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044133] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by Grant R01HD044133 from the National Institutes of Health USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antikainen NM, 2005, BIOORGAN MED CHEM, V13, P2701, DOI 10.1016/j.bmc.2005.01.059; Araujo FD, 2001, J BIOL CHEM, V276, P6930, DOI 10.1074/jbc.M009037200; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Borowczyk E, 2009, P NATL ACAD SCI USA, V106, P20806, DOI 10.1073/pnas.0905668106; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chan MF, 2001, MOL CELL BIOL, V21, P7587, DOI 10.1128/MCB.21.22.7587-7600.2001; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; D'Aiuto L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-52; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Flores-Ramirez Gabriela, 2007, BMC Chemical Biology, V7, P1, DOI 10.1186/1472-6769-7-1; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Margot JB, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-7; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pradhan S, 2000, EMBO J, V19, P2103, DOI 10.1093/emboj/19.9.2103; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sajedi E, 2008, BBA-MOL CELL RES, V1783, P131, DOI 10.1016/j.bbamcr.2007.08.010; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suetake I, 2006, J BIOCHEM, V140, P763, DOI 10.1093/jb/mvj210; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; Zhao HM, 2007, BIOTECHNOL BIOENG, V98, P313, DOI 10.1002/bit.21455	34	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9831	10.1371/journal.pone.0009831	http://dx.doi.org/10.1371/journal.pone.0009831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352123	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000275894400030
J	Dorsten, JN; Varughese, BE; Karmo, S; Seeger, MA; VanBerkum, MFA				Dorsten, Joy N.; Varughese, Bridget E.; Karmo, Stephanie; Seeger, Mark A.; VanBerkum, Mark F. A.			In the Absence of Frazzled Over-Expression of Abelson Tyrosine Kinase Disrupts Commissure Formation and Causes Axons to Leave the Embryonic CNS	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; LONG-RANGE GUIDANCE; RHO FAMILY GTPASES; NETRIN-RECEPTOR; ROBO RECEPTORS; DROSOPHILA CNS; GENETIC-ANALYSIS; COLORECTAL-CANCER; CELL-ADHESION; ABL-FAMILY	Background: In the Drosophila embryonic nerve cord, the formation of commissures require both the chemoattractive Netrin receptor Frazzled (Fra) and the Abelson (Abl) cytoplasmic tyrosine kinase. Abl binds to the cytoplasmic domain of Fra and loss-of-function mutations in abl enhance fra-dependent commissural defects. To further test Abl's role in attractive signaling, we over-expressed Abl in Fra mutants anticipating rescue of commissures. Methodology/Principal Findings: The Gal4-UAS system was used to pan-neurally over-express Abl in homozygous fra embryos. Surprisingly, this led to a significant decrease in both posterior and anterior commissure formation and induced some commissural and longitudinal axons to project beyond the CNS/PNS border. Re-expressing wild-type Fra, or Fra mutants with a P-motif deleted, revert both commissural and exiting phenotypes, indicating that Fra is required but not a specific P-motif. This is supported by S2 cell experiments demonstrating that Abl binds to Fra independent of any specific P-motif and that Fra continues to be phosphorylated when individual P-motifs are removed. Decreasing midline repulsion by reducing Robo signaling had no effect on the Abl phenotype and the phenotypes still occur in a Netrin mutant. Pan-neural over-expression of activated Rac or Cdc42 in a fra mutant also induced a significant loss in commissures, but axons did not exit the CNS. Conclusion/Significance: Taken together, these data suggest that Fra activity is required to correctly regulate Abl-dependent cytoskeletal dynamics underlying commissure formation. In the absence of Fra, increased Abl activity appears to be incorrectly utilized downstream of other guidance receptors resulting in a loss of commissures and the abnormal projections of some axons beyond the CNS/PNS border.	[Dorsten, Joy N.; Varughese, Bridget E.; Karmo, Stephanie; VanBerkum, Mark F. A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Seeger, Mark A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Seeger, Mark A.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Wayne State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Dorsten, JN (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mvanberk@biology.biosci.wayne.edu			National Science Foundation [0416472]; Wayne State University; William Turner Memorial Foundation Scholarship	National Science Foundation(National Science Foundation (NSF)); Wayne State University; William Turner Memorial Foundation Scholarship	This work was funded by the National Science Foundation (# 0416472) to M. VanBerkum. J. D. was partially supported by a Rumble Graduate Fellowship from Wayne State University and was a recipient of the William Turner Memorial Foundation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-31; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2001, J CELL BIOL, V155, P1117, DOI 10.1083/jcb.200110077; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dorsten JN, 2008, INT J DEV NEUROSCI, V26, P753, DOI 10.1016/j.ijdevneu.2008.07.004; Dorsten JN, 2007, DEV BIOL, V308, P120, DOI 10.1016/j.ydbio.2007.05.012; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fogerty FJ, 1999, ONCOGENE, V18, P219, DOI 10.1038/sj.onc.1202239; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Georgiou M, 2003, MECH DEVELOP, V120, P1009, DOI 10.1016/S0925-4773(03)00179-5; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hiramoto M, 2006, NAT NEUROSCI, V9, P58, DOI 10.1038/nn1612; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hu S, 1998, J NEUROBIOL, V35, P77, DOI 10.1002/(SICI)1097-4695(199804)35:1<77::AID-NEU7>3.0.CO;2-8; Huang CH, 2007, J BIOL CHEM, V282, P32442, DOI 10.1074/jbc.M702583200; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jeon M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-3; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kidd T, 2009, SCIENCE, V324, P893, DOI 10.1126/science.1174216; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Ku HY, 2009, MOL CELL BIOL, V29, P3623, DOI 10.1128/MCB.00229-09; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li WQ, 2006, J CELL SCI, V119, P47, DOI 10.1242/jcs.02697; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liebl EC, 2003, DEVELOPMENT, V130, P3217, DOI 10.1242/dev.00545; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; McGovern VL, 2003, DEV GENES EVOL, V213, P500, DOI 10.1007/s00427-003-0349-1; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Schindelholz B, 2001, DEVELOPMENT, V128, P4371; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Song JK, 2008, MECH DEVELOP, V125, P247, DOI 10.1016/j.mod.2007.11.005; Stevens TL, 2008, MOL BIOL CELL, V19, P378, DOI 10.1091/mbc.E07-01-0008; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104	95	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9822	10.1371/journal.pone.0009822	http://dx.doi.org/10.1371/journal.pone.0009822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352105	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894400022
J	Matos, PM; Castanho, MARB; Santos, NC				Matos, Pedro M.; Castanho, Miguel A. R. B.; Santos, Nuno C.			HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes	PLOS ONE			English	Article							MULTIFUNCTIONAL DOMAINS; GP41; CELLS; ENTRY; BIOMEMBRANES; MECHANISMS; FLUIDITY; RECEPTOR; BINDING; AIDS	Enfuvirtide and T-1249 are two HIV-1 fusion inhibitor peptides that bind to gp41 and prevent its fusogenic conformation, inhibiting viral entry into host cells. Previous studies established the relative preferences of these peptides for membrane model systems of defined lipid compositions. We aimed to understand the interaction of these peptides with the membranes of erythrocytes and peripheral blood mononuclear cells. The peptide behavior toward cell membranes was followed by di-8-ANEPPS fluorescence, a lipophilic probe sensitive to the changes in membrane dipole potential. We observed a fusion inhibitor concentration-dependent decrease on the membrane dipole potential. Quantitative analysis showed that T-1249 has an approximately eight-fold higher affinity towards cells, when compared with enfuvirtide. We also compared the binding towards di-8-ANEPPS labeled lipid vesicles that model cell membranes and obtained concordant results. We demonstrated the distinct enfuvirtide and T-1249 membranotropism for circulating blood cells, which can be translated to a feasible in vivo scenario. The enhanced interaction of T-1249 with cell membranes correlates with its higher efficacy, as it can increase and accelerate the drug binding to gp41 in its pre-fusion state.	[Matos, Pedro M.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal	Universidade de Lisboa	Matos, PM (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal.	nsantos@fm.ul.pt	Santos, Nuno/N-7248-2013; Matos, Pedro/B-4718-2010	Santos, Nuno/0000-0002-0580-0475; Matos, Pedro/0000-0002-8386-6613; Castanho, Miguel/0000-0001-7891-7562; FCCN, Bogus/0000-0001-6282-8004; FCCN, Bogus/0000-0003-1034-3552	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science, Technology and Higher Education (MCTES) [PTDC/QUI-BIQ/104787/2008, SFRH/BD/42205/2007]	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science, Technology and Higher Education (MCTES)(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT, http://www.fct.mctes.pt) of the Portuguese Ministry of Science, Technology and Higher Education (MCTES), including project PTDC/QUI-BIQ/104787/2008. P. M. M. was funded by the FCT-MCTES PhD grant SFRH/BD/42205/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; Banki Z, 2006, J IMMUNOL, V177, P3469, DOI 10.4049/jimmunol.177.5.3469; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Clarke RJ, 1997, BBA-BIOMEMBRANES, V1323, P223, DOI 10.1016/S0005-2736(96)00188-5; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Greene WC, 2007, EUR J IMMUNOL, V37, pS94, DOI 10.1002/eji.200737441; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Martin-Carbonero L, 2004, AIDS REV, V6, P61; Matos PM, 2008, J PEPT SCI, V14, P407, DOI 10.1002/psc.1005; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Peisajovich SG, 2003, J BIOL CHEM, V278, P21012, DOI 10.1074/jbc.M212773200; Qi Z, 2008, J BIOL CHEM, V283, P30376, DOI 10.1074/jbc.M804672200; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Veiga AS, 2004, J AM CHEM SOC, V126, P14758, DOI 10.1021/ja0459882; Veiga S, 2004, BIOCHEM J, V377, P107, DOI 10.1042/BJ20031350; Vitha MF, 2007, BBA-BIOMEMBRANES, V1768, P107, DOI 10.1016/j.bbamem.2006.06.022; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Zhang HY, 2008, ORG PROCESS RES DEV, V12, P101, DOI 10.1021/op7002198	38	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9830	10.1371/journal.pone.0009830	http://dx.doi.org/10.1371/journal.pone.0009830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352107	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400029
J	Deo, AJ; Costa, R; DeLisi, LE; DeSalle, R; Haghighi, F				Deo, Anthony J.; Costa, Ramiro; DeLisi, Lynn E.; DeSalle, Rob; Haghighi, Fatemeh			A Novel Analytical Framework for Dissecting the Genetic Architecture of Behavioral Symptoms in Neuropsychiatric Disorders	PLOS ONE			English	Article							GENOME-WIDE SCAN; SCHIZOAFFECTIVE DISORDER; DEPRESSIVE-DISORDERS; MAJOR DEPRESSION; BIPOLAR-DISORDER; LINKAGE ANALYSIS; EARLY-ONSET; SCHIZOPHRENIA SUSCEPTIBILITY; PSYCHIATRIC-DISORDERS; LOCI	Background: For diagnosis of neuropsychiatric disorders, a categorical classification system is often utilized as a simple way for conceptualizing an often complex clinical picture. This approach provides an unsatisfactory model of mental illness, since in practice patients do not conform to these prototypical diagnostic categories. Family studies show notable familial co-aggregation between schizophrenia and bipolar illness and between schizoaffective disorders and both bipolar disorder and schizophrenia, revealing that mental illness does not conform to such categorical models and is likely to follow a continuum encompassing a spectrum of behavioral symptoms. Results and Methodology: We introduce an analytic framework to dissect the phenotypic heterogeneity present in complex psychiatric disorders based on the conceptual paradigm of a continuum of psychosis. The approach identifies subgroups of behavioral symptoms that are likely to be phenotypically and genetically homogenous. We have evaluated this approach through analysis of simulated data with simulated behavioral traits and predisposing genetic factors. We also apply this approach to a psychiatric dataset of a genome scan for schizophrenia for which extensive behavioral information was collected for each individual patient and their families. With this approach, we identified significant evidence for linkage among depressed individuals with two distinct symptom profiles, that is individuals with sleep disturbance symptoms with linkage on chromosome 2q13 and also a mutually exclusive group of individuals with symptoms of concentration problems with linkage on chromosome 2q35. In addition we identified a subset of individuals with schizophrenia defined by language disturbances with linkage to chromosome 2p25.1 and a group of patients with a phenotype intermediate between those of schizophrenia and schizoaffective disorder with linkage to chromosome 2p21. Conclusions: The findings presented are novel and demonstrate the efficacy of this approach in detection of genes underlying such complex human disorders as schizophrenia and depression.	[Deo, Anthony J.] NYU, Dept Biol, New York, NY 10003 USA; [Deo, Anthony J.; DeSalle, Rob] Amer Museum Nat Hist, Ctr Comparat Genom, New York, NY 10024 USA; [Deo, Anthony J.; DeSalle, Rob] Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA; [Deo, Anthony J.; Haghighi, Fatemeh] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Costa, Ramiro; Haghighi, Fatemeh] New York State Psychiat Inst & Hosp, Div Mol Imaging & Neuropathol, New York, NY 10032 USA; [DeLisi, Lynn E.] Harvard Univ, Sch Med, VA Boston Healthcare Syst, Brockton, MA 02401 USA	New York University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Columbia University; New York State Psychiatry Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Deo, AJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.	fgh3@columbia.edu			NSF [DEB0508584]; National Science Foundation;  [HG002915];  [MH074118]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG002915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074118] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by HG002915, MH074118, and NSF DEB0508584. The analyses were conducted on computing resources supported by the National Science Foundation under the following NSF programs: Partnerships for Advanced Computational Infrastructure, Distributed Terascale Facility (DTF) and Terascale Extensions: Enhancements to the Extensible Terascale Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; ANDREASEN NC, 1979, ARCH GEN PSYCHIAT, V36, P1325; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Bramon E, 2001, Curr Psychiatry Rep, V3, P332; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Camp NJ, 2001, AM J HUM GENET, V69, P1278, DOI 10.1086/324590; Chen CH, 1998, HUM GENET, V103, P702, DOI 10.1007/s004390050894; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; CROW TJ, 1990, PROG PSYCH, P81; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; DELISI LE, 1998, OXFORD S BROOK GENET; Docherty NM, 2006, AM J PSYCHIAT, V163, P2111, DOI 10.1176/appi.ajp.163.12.2111; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Francks C, 2003, HUM MOL GENET, V12, P3225, DOI 10.1093/hmg/ddg362; GOLOBOFF P, 2000, TNT TREE ANAL USING; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Greenberg DA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S3; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; HODGE SE, 1983, AM J HUM GENET, V35, P1139; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li XB, 2002, EUR J PHARMACOL, V441, P151, DOI 10.1016/S0014-2999(02)01441-3; LIPSCOMB DL, 1992, PARSIMONY HOMOLOGY A, P45; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Marengo J, 2000, PSYCHIAT RES, V97, P61, DOI 10.1016/S0165-1781(00)00218-3; Mowry BJ, 2000, AM J MED GENET, V96, P864, DOI 10.1002/1096-8628(20001204)96:6<864::AID-AJMG35>3.3.CO;2-4; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Oulis P, 1999, PSYCHOPATHOLOGY, V32, P187, DOI 10.1159/000029089; Pato CN, 2004, AM J MED GENET B, V127B, P30, DOI 10.1002/ajmg.b.30001; Pickard BS, 2006, MOL PSYCHIATR, V11, P847, DOI 10.1038/sj.mp.4001867; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAYLOR MA, 1994, COMPR PSYCHIAT, V35, P420, DOI 10.1016/0010-440X(94)90224-0; TEMPLETON AR, 1987, GENETICS, V117, P343; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Terwilliger JD, 2001, ADV GENET, V42, P351, DOI 10.1016/S0065-2660(01)42032-3; TSUANG MT, 1995, SCHIZOPHR RES, V17, P161, DOI 10.1016/0920-9964(95)00057-S; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Wijsman EM, 2003, MOL PSYCHIATR, V8, P695, DOI 10.1038/sj.mp.4001356; Zubenko GS, 2003, MOL PSYCHIATR, V8, P611, DOI 10.1038/sj.mp.4001354; Zubenko GS, 2003, AM J PSYCHIAT, V160, P857, DOI 10.1176/appi.ajp.160.5.857; Zubenko GS, 2002, AM J MED GENET, V114, P980, DOI 10.1002/ajmg.b.10933; Zubenko GS, 2002, AM J MED GENET, V114, P413, DOI 10.1002/ajmg.10381; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9714	10.1371/journal.pone.0009714	http://dx.doi.org/10.1371/journal.pone.0009714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300526	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400012
J	Widenmaier, SB; Kim, SJ; Yang, GK; De Los Reyes, T; Nian, C; Asadi, A; Seino, Y; Kieffer, TJ; Kwok, YN; McIntosh, CHS				Widenmaier, Scott B.; Kim, Su-Jin; Yang, Gary K.; De Los Reyes, Thomas; Nian, Cuilan; Asadi, Ali; Seino, Yutaka; Kieffer, Timothy J.; Kwok, Yin Nam; McIntosh, Christopher H. S.			A GIP Receptor Agonist Exhibits beta-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved beta-Cell Function and Glycemic Control	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; ACTIVATED PROTEIN-KINASE; DOWN-REGULATION; GLUCOSE-INTOLERANCE; ENTEROINSULAR AXIS; BAX EXPRESSION; ANALOGS; RESISTANCE	Aims: The gastrointestinal hormone GIP promotes pancreatic islet function and exerts pro-survival actions on cultured beta-cells. However, GIP also promotes lipogenesis, thus potentially restricting its therapeutic use. The current studies evaluated the effects of a truncated GIP analog, D-Ala(2)-GIP(1-30) (D-GIP(1-30)), on glucose homeostasis and beta-cell mass in rat models of diabetes. Materials and Methods: The insulinotropic and pro-survival potency of D-GIP(1-30) was evaluated in perfused pancreas preparations and cultured INS-1 beta-cells, respectively, and receptor selectivity evaluated using wild type and GIP receptor knockout mice. Effects of D-GIP(1-30) on beta-cell function and glucose homeostasis, in vivo, were determined using Lean Zucker rats, obese Vancouver diabetic fatty rats, streptozotocin treated rats, and obese Zucker diabetic fatty rats, with effects on beta-cell mass determined in histological studies of pancreatic tissue. Lipogenic effects of D-GIP(1-30) were evaluated on cultured 3T3-L1 adipocytes. Results: Acutely, D-GIP(1-30) improved glucose tolerance and insulin secretion. Chronic treatment with D-GIP(1-30) reduced levels of islet pro-apoptotic proteins in Vancouver diabetic fatty rats and preserved beta-cell mass in streptozotocin treated rats and Zucker diabetic fatty rats, resulting in improved insulin responses and glycemic control in each animal model, with no change in body weight. In in vitro studies, D-GIP(1-30) exhibited equivalent potency to GIP(1-42) on beta-cell function and survival, but greatly reduced action on lipoprotein lipase activity in 3T3-L1 adipocytes. Conclusions: These findings demonstrate that truncated forms of GIP exhibit potent anti-diabetic actions, without pro-obesity effects, and that the C-terminus contributes to the lipogenic actions of GIP.	[Widenmaier, Scott B.; Kim, Su-Jin; Yang, Gary K.; De Los Reyes, Thomas; Nian, Cuilan; Asadi, Ali; Kieffer, Timothy J.; Kwok, Yin Nam; McIntosh, Christopher H. S.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Widenmaier, Scott B.; Kim, Su-Jin; Yang, Gary K.; De Los Reyes, Thomas; Nian, Cuilan; Asadi, Ali; Kieffer, Timothy J.; Kwok, Yin Nam; McIntosh, Christopher H. S.] Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V5Z 1M9, Canada; [Seino, Yutaka] Kansai Elect Power Hosp, Dept Diabet & Clin Nutr, Osaka, Japan	University of British Columbia; University of British Columbia	Widenmaier, SB (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	mcintoch@interchange.ubc.ca		Widenmaier, Scott/0000-0001-5684-2707; De los Reyes, Thomas/0000-0002-8649-0965; Yang, Gary/0000-0002-3039-4392	Canadian Institutes of Health Research and the Canadian Diabetes Association to CHMc; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council of Canada; MSFHR	Canadian Institutes of Health Research and the Canadian Diabetes Association to CHMc(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MSFHR(Michael Smith Foundation for Health Research)	These studies were generously supported by funding from the Canadian Institutes of Health Research and the Canadian Diabetes Association to CHMc, the Michael Smith Foundation for Health Research (MSFHR) to CHMc and TJK and scholarships from the Natural Sciences and Engineering Research Council of Canada and MSFHR to SBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Ding KH, 2008, J BONE MINER RES, V23, P536, DOI 10.1359/JBMR.071202; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; FUJITA Y, GASTROENTER IN PRESS; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hanke J, 2000, ANAT EMBRYOL, V202, P303, DOI 10.1007/s004290000112; Hanke J, 2001, CELLS TISSUES ORGANS, V169, P113, DOI 10.1159/000047869; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin N, 2005, BIOL CHEM, V386, P679, DOI 10.1515/BC.2005.079; Irwin N, 2006, BIOCHEM PHARMACOL, V72, P719, DOI 10.1016/j.bcp.2006.06.013; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kerr BD, 2009, BIOCHEM PHARMACOL, V78, P1008, DOI 10.1016/j.bcp.2009.05.037; Kerr BD, 2009, PEPTIDES, V30, P219, DOI 10.1016/j.peptides.2008.10.017; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kuhn-Wache K, 2000, ADV EXP MED BIOL, V477, P187; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; MAIDA A, 2009, GASTROENTEROLOGY; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; McIntosh CHS, 2006, INT J BIOCHEM CELL B, V38, P860, DOI 10.1016/j.biocel.2005.12.013; Meier JJ, 2004, HORM METAB RES, V36, P859, DOI 10.1055/s-2004-826176; MENEILLY GS, 1993, DIABETES CARE, V16, P110, DOI 10.2337/diacare.16.1.110; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mizuno N, 1998, ENDOCRINOLOGY, V139, P1429, DOI 10.1210/en.139.3.1429; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; PEDERSON RA, 1982, REGUL PEPTIDES, V5, P53, DOI 10.1016/0167-0115(82)90075-1; Piteau S, 2007, BIOCHEM BIOPH RES CO, V362, P1007, DOI 10.1016/j.bbrc.2007.08.115; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; ROSSOWSKI WJ, 1992, REGUL PEPTIDES, V39, P9, DOI 10.1016/0167-0115(92)90003-D; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Topp BG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1730, DOI 10.1152/ajpendo.00572.2007; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Widenmaier SB, 2009, J BIOL CHEM, V284, P30372, DOI 10.1074/jbc.M109.060178; Widenmaier SB, 2009, J BIOL CHEM, V284, P10764, DOI 10.1074/jbc.M809116200; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033	60	78	86	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9590	10.1371/journal.pone.0009590	http://dx.doi.org/10.1371/journal.pone.0009590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231880	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328300008
J	Kucerova, E; Clifton, SW; Xia, XQ; Long, F; Porwollik, S; Fulton, L; Fronick, C; Minx, P; Kyung, K; Warren, W; Fulton, R; Feng, DY; Wollam, A; Shah, N; Bhonagiri, V; Nash, WE; Hallsworth-Pepin, K; Wilson, RK; McClelland, M; Forsythe, SJ				Kucerova, Eva; Clifton, Sandra W.; Xia, Xiao-Qin; Long, Fred; Porwollik, Steffen; Fulton, Lucinda; Fronick, Catrina; Minx, Patrick; Kyung, Kim; Warren, Wesley; Fulton, Robert; Feng, Dongyan; Wollam, Aye; Shah, Neha; Bhonagiri, Veena; Nash, William E.; Hallsworth-Pepin, Kymberlie; Wilson, Richard K.; McClelland, Michael; Forsythe, Stephen J.			Genome Sequence of Cronobacter sakazakii BAA-894 and Comparative Genomic Hybridization Analysis with Other Cronobacter Species	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ENTEROBACTER-SAKAZAKII; ESCHERICHIA-COLI; O-ANTIGEN; VISUALIZATION TOOLS; MOLECULAR ANALYSIS; VIBRIO-CHOLERAE; INFANT FORMULA; BRAIN-ABSCESS; GENE LOCUS	Background: The genus Cronobacter (formerly called Enterobacter sakazakii) is composed of five species; C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, and C. dublinensis. The genus includes opportunistic human pathogens, and the first three species have been associated with neonatal infections. The most severe diseases are caused in neonates and include fatal necrotizing enterocolitis and meningitis. The genetic basis of the diversity within the genus is unknown, and few virulence traits have been identified. Methodology/Principal Findings: We report here the first sequence of a member of this genus, C. sakazakii strain BAA-894. The genome of Cronobacter sakazakii strain BAA-894 comprises a 4.4 Mb chromosome (57% GC content) and two plasmids; 31 kb (51% GC) and 131 kb (56% GC). The genome was used to construct a 387,000 probe oligonucleotide tiling DNA microarray covering the whole genome. Comparative genomic hybridization (CGH) was undertaken on five other C. sakazakii strains, and representatives of the four other Cronobacter species. Among 4,382 annotated genes inspected in this study, about 55% of genes were common to all C. sakazakii strains and 43% were common to all Cronobacter strains, with 10-17% absence of genes. Conclusions/Significance: CGH highlighted 15 clusters of genes in C. sakazakii BAA-894 that were divergent or absent in more than half of the tested strains; six of these are of probable prophage origin. Putative virulence factors were identified in these prophage and in other variable regions. A number of genes unique to Cronobacter species associated with neonatal infections (C. sakazakii, C. malonaticus and C. turicensis) were identified. These included a copper and silver resistance system known to be linked to invasion of the blood-brain barrier by neonatal meningitic strains of Escherichia coli. In addition, genes encoding for multidrug efflux pumps and adhesins were identified that were unique to C. sakazakii strains from outbreaks in neonatal intensive care units.	[Kucerova, Eva; Forsythe, Stephen J.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Xia, Xiao-Qin; Long, Fred; Porwollik, Steffen; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Clifton, Sandra W.; Fulton, Lucinda; Fronick, Catrina; Minx, Patrick; Kyung, Kim; Warren, Wesley; Fulton, Robert; Feng, Dongyan; Wollam, Aye; Shah, Neha; Bhonagiri, Veena; Nash, William E.; Hallsworth-Pepin, Kymberlie; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO USA	Nottingham Trent University; Washington University (WUSTL)	Kucerova, E (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	mcclelland.michael@gmail.com	McClelland, Michael/A-8583-2011; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; xia, xiao qin/0000-0002-8034-1096; McClelland, Michael/0000-0003-1788-9347; Forsythe, Stephen/0000-0002-6709-0712	National Institutes of Health (NIH) [R01AI52237, R01AI075093, R01AI073971]; Nottingham Trent University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052237, R01AI073971, R01AI075093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nottingham Trent University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants R01AI52237, R01AI075093, and R01AI073971, and by a grant from Nottingham Trent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 1998, CURR OPIN MICROBIOL, V1, P75, DOI 10.1016/S1369-5274(98)80145-8; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burdette JH, 2000, PEDIATR RADIOL, V30, P33, DOI 10.1007/s002470050009; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Collyn F, 2004, INFECT IMMUN, V72, P4784, DOI 10.1128/IAI.72.8.4784-4790.2004; CZERWICKA M, 2010, CARBOHYDRAT IN PRESS; Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Florea L, 2000, NUCLEIC ACIDS RES, V28, P3486, DOI 10.1093/nar/28.18.3486; Florea L, 2003, NUCLEIC ACIDS RES, V31, P3527, DOI 10.1093/nar/gkg551; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gurtler JB, 2005, INT J FOOD MICROBIOL, V104, P1, DOI 10.1016/j.ijfoodmicro.2005.02.013; Himelright I, 2002, JAMA-J AM MED ASSOC, V287, P2204; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kandhai MC, 2004, LANCET, V363, P39, DOI 10.1016/S0140-6736(03)15169-0; Kaper JB, 1998, JPN J MED SCI BIOL, V51, pS101, DOI 10.7883/yoken1952.51.Supplement1_S101; Kim CC, 2002, GENOME BIOL, V3; Kim KP, 2008, INFECT IMMUN, V76, P562, DOI 10.1128/IAI.00937-07; KLINE MW, 1988, J PEDIATR-US, V113, P430, DOI 10.1016/S0022-3476(88)80623-1; Kothary MH, 2007, APPL ENVIRON MICROB, V73, P4142, DOI 10.1128/AEM.02729-06; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; LAZDUNSKI CJ, 1988, BIOCHIMIE, V70, P1291, DOI 10.1016/0300-9084(88)90197-6; Lehner A, 2006, FEMS MICROBIOL LETT, V265, P244, DOI 10.1111/j.1574-6968.2006.00500.x; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; MacLean LL, 2009, BIOCHEM CELL BIOL, V87, P927, DOI 10.1139/O09-059; MacLean LL, 2009, BIOCHEM CELL BIOL, V87, P459, DOI 10.1139/O09-004; MacLean LL, 2009, CARBOHYD RES, V344, P667, DOI 10.1016/j.carres.2009.01.020; Mougous JD, 2006, P NATL ACAD SCI USA, V103, P4258, DOI 10.1073/pnas.0510861103; Mullane N, 2008, APPL ENVIRON MICROB, V74, P3783, DOI 10.1128/AEM.02302-07; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; Osaili T, 2009, INT J FOOD MICROBIOL, V136, P214, DOI 10.1016/j.ijfoodmicro.2009.08.006; Pagotto FJ, 2003, J FOOD PROTECT, V66, P370, DOI 10.4315/0362-028X-66.3.370; Pickard D, 2008, J BACTERIOL, V190, P2580, DOI 10.1128/JB.01654-07; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Townsend S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-64; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Van Acker J, 2001, J CLIN MICROBIOL, V39, P293, DOI 10.1128/JCM.39.1.293-297.2001; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; WILLIS J, 1988, PEDIATR INFECT DIS J, V7, P196, DOI 10.1097/00006454-198803000-00012; WORKMAN C, 2002, GENOME BIOL, V3; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430	58	164	800	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A51	A60	e9556	10.1371/journal.pone.0009556	http://dx.doi.org/10.1371/journal.pone.0009556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221447	gold, Green Published			2022-12-27	WOS:000275328200005
J	Buron, N; Porceddu, M; Brabant, M; Desgue, D; Racoeur, C; Lassalle, M; Pechoux, C; Rustin, P; Jacotot, E; Borgne-Sanchez, A				Buron, Nelly; Porceddu, Mathieu; Brabant, Magali; Desgue, Diana; Racoeur, Cindy; Lassalle, Myriam; Pechoux, Christine; Rustin, Pierre; Jacotot, Etienne; Borgne-Sanchez, Annie			Use of Human Cancer Cell Lines Mitochondria to Explore the Mechanisms of BH3 Peptides and ABT-737-Induced Mitochondrial Membrane Permeabilization	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY PROTEINS; MIMETIC ABT-737; OUTER-MEMBRANE; CASPASE ACTIVATION; BAX; APOPTOSIS; DEATH; INHIBITORS; DOMAINS	Current limitations of chemotherapy include toxicity on healthy tissues and multidrug resistance of malignant cells. A number of recent anti-cancer strategies aim at targeting the mitochondrial apoptotic machinery to induce tumor cell death. In this study, we set up protocols to purify functional mitochondria from various human cell lines to analyze the effect of peptidic and xenobiotic compounds described to harbour either Bcl-2 inhibition properties or toxic effects related to mitochondria. Mitochondrial inner and outer membrane permeabilization were systematically investigated in cancer cell mitochondria versus non-cancerous mitochondria. The truncated (t-) Bid protein, synthetic BH3 peptides from Bim and Bak, and the small molecule ABT-737 induced a tumor-specific and OMP-restricted mitochondrio-toxicity, while compounds like HA-14.1, YC-137, Chelerythrine, Gossypol, TW-37 or EM20-25 did not. We found that ABT-737 can induce the Bax-dependent release of apoptotic proteins (cytochrome c, Smac/Diablo and Omi/HtrA2 but not AIF) from various but not all cancer cell mitochondria. Furthermore, ABT-737 addition to isolated cancer cell mitochondria induced oligomerization of Bax and/or Bak monomers already inserted in the mitochondrial membrane. Finally immunoprecipatations indicated that ABT-737 induces Bax, Bak and Bim desequestration from Bcl-2 and Bcl-xL but not from Mcl-1L. This study investigates for the first time the mechanism of action of ABT-737 as a single agent on isolated cancer cell mitochondria. Hence, this method based on MOMP (mitochondrial outer membrane permeabilization) is an interesting screening tool, tailored for identifying Bcl-2 antagonists with selective toxicity profile against cancer cell mitochondria but devoid of toxicity against healthy mitochondria.	[Buron, Nelly; Porceddu, Mathieu; Brabant, Magali; Desgue, Diana; Racoeur, Cindy; Lassalle, Myriam; Jacotot, Etienne; Borgne-Sanchez, Annie] THERAPTOSIS SA, Dept Oncol, Romainville, France; [Buron, Nelly; Porceddu, Mathieu; Borgne-Sanchez, Annie] MITOLOGICS SAS, Mitol Res Lab, Hop Robert Debre, Paris, France; [Pechoux, Christine] INRA, Plateau Microscopie Elect MIMA2, UR Genom & Physiol Lactat 1196, Jouy En Josas, France; [Rustin, Pierre] Hop Robert Debre, Inserm U676, F-75019 Paris, France; [Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, Paris, France; [Jacotot, Etienne] Univ London Imperial Coll Sci Technol & Med, Canc Div, Dept Reprod Biol, Hammersmith Hosp, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London	Buron, N (corresponding author), THERAPTOSIS SA, Dept Oncol, Biocitech Technol Pk, Romainville, France.	aborgne.sanchez@mitologics.com		/0000-0002-5301-1569	Agence Nationale pour la Valorisation de la Recherche; Theraptosis SA; Mitologics SAS	Agence Nationale pour la Valorisation de la Recherche; Theraptosis SA; Mitologics SAS	This study was supported by Agence Nationale pour la Valorisation de la Recherche (http://www.agence-nationale-recherche.fr) to Theraptosis SA (http://www.theraptosis.com), by Theraptosis SA and Mitologics SAS (http://www.mitologics.com). The Agence Nationale pour la Valorisation de la Recherche had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; AOUACHERIA A, 2007, GENE SEQUENCES, V1, P43; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bombrun A, 2003, J MED CHEM, V46, P4365, DOI 10.1021/jm034107j; BRENNER D, 2009, CURR OPIN CELL BIOL; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cartron PF, 2008, FEBS LETT, V582, P3045, DOI 10.1016/j.febslet.2008.07.047; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; CHEN S, 2009, MOL CELL BIOL; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Fu GF, 2005, CANCER BIOL THER, V4, P822, DOI 10.4161/cbt.4.8.1889; GALLUZZI L, 2009, MOL ASPECTS MED; Goldsmith KC, 2006, ONCOGENE, V25, P4525, DOI 10.1038/sj.onc.1209489; GOLDSMITH KC, 2009, CELL DEATH DIFFER; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hermanson D, 2009, MOL PHARMACOL, V76, P667, DOI 10.1124/mol.109.055830; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lecoeur H, 2004, EXP CELL RES, V294, P106, DOI 10.1016/j.yexcr.2003.10.030; Letai A, 2005, J CLIN INVEST, V115, P2648, DOI 10.1172/JCI26250; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai A, 2006, CANCER CELL, V10, P343, DOI 10.1016/j.ccr.2006.10.014; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; Polster BM, 2003, J NEUROSCI, V23, P2735; Polster BM, 2001, J BIOL CHEM, V276, P37887; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	49	40	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9924	10.1371/journal.pone.0009924	http://dx.doi.org/10.1371/journal.pone.0009924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360986	Green Published, gold			2022-12-27	WOS:000276163200006
J	Boal, F; Stephens, DJ				Boal, Frederic; Stephens, David J.			Specific Functions of BIG1 and BIG2 in Endomembrane Organization	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; PROTEIN-KINASE-A; BREFELDIN-A; MEMBRANE-TRAFFICKING; ENDOPLASMIC-RETICULUM; RECYCLING ENDOSOMES; DISTINCT FUNCTIONS; MAMMALIAN-CELLS	Background: Transport of molecules from one subcellular compartment to another involves the recruitment of cytosolic coat protein complexes to a donor membrane to concentrate cargo, deform the membrane and ultimately to form an independent carrier. Small-GTP-binding proteins of the Arf family are central to many membrane trafficking events. Arfs are activated by guanine nucleotide exchange factors (GEFs) which results in their recruitment to membranes and subsequent engagement with Arf-effectors, many of which are coat proteins. Among the human BFA-sensitive large Arf-GEFs, the function of the two closely related BIG1 and BIG2 is still not clear, and recent studies have raised the question of functional redundancy between the two proteins. Methodology/Principal Findings: Here we have used small-interfering RNA on human cells and a combination of fixed and live-cell imaging to investigate the differential functions of BIG1 and BIG2 in endomembrane organization and function. Importantly, in this direct comparative study, we show discrete functions for BIG1 and BIG2. Our results show that depletion of BIG2 but not of BIG1 induces a tubulation of the recycling endosomal compartment, consistent with a specific role for BIG2 here. In contrast, suppression of BIG1 induces the formation of Golgi mini-stacks still polarized and functional in terms of cargo export. Conclusions: A key finding from our work is that suppression of BIG1 expression results in a fragmentation of the Golgi apparatus. Our data indicate that the human BFA-sensitive large Arf-GEFs have non-redundant functions in cell organization and membrane trafficking. BIG1 is required to maintain the normal morphology of the Golgi; BIG2 is important for endosomal compartment integrity and cannot replace the function of BIG1 in Golgi organization.	[Boal, Frederic; Stephens, David J.] Univ Bristol, Sch Med Sci, Cell Biol Labs, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Boal, F (corresponding author), Univ Bristol, Sch Med Sci, Cell Biol Labs, Dept Biochem, Bristol BS8 1TD, Avon, England.	fred.boal@bristol.ac.uk	Boal, Frédéric/O-6306-2018	Boal, Frédéric/0000-0001-7607-4573; Stephens, David/0000-0001-5297-3240	Biotechnology and Biological Sciences Research Council [E012450]; Biotechnology and Biological Sciences Research Council [BB/E012450/1] Funding Source: researchfish; Medical Research Council [G117/554] Funding Source: researchfish; BBSRC [BB/E012450/1] Funding Source: UKRI; MRC [G117/554] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by a research grant from the Biotechnology and Biological Sciences Research Council [E012450]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Bejarano E, 2006, J CELL SCI, V119, P3764, DOI 10.1242/jcs.03146; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Citterio C, 2006, P NATL ACAD SCI USA, V103, P2683, DOI 10.1073/pnas.0510571103; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kuroda F, 2007, P NATL ACAD SCI USA, V104, P3201, DOI 10.1073/pnas.0611696104; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Padilla PI, 2004, P NATL ACAD SCI USA, V101, P2752, DOI 10.1073/pnas.0307345101; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saeki N, 2005, J BIOL CHEM, V280, P10128, DOI 10.1074/jbc.M413415200; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	57	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9898	10.1371/journal.pone.0009898	http://dx.doi.org/10.1371/journal.pone.0009898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360857	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500018
J	Dawood, FS; Hope, KG; Durrheim, DN; Givney, R; Fry, AM; Dalton, CB				Dawood, Fatimah S.; Hope, Kirsty G.; Durrheim, David N.; Givney, Rodney; Fry, Alicia M.; Dalton, Craig B.			Estimating the Disease Burden of Pandemic (H1N1) 2009 Virus Infection in Hunter New England, Northern New South Wales, Australia, 2009	PLOS ONE			English	Article							INFLUENZA; HOSPITALIZATIONS	Introduction: On May 26, 2009, the first confirmed case of Pandemic (H1N1) 2009 virus (pH1N1) infection in Hunter New England (HNE), New South Wales (NSW), Australia (population 866,000) was identified. We used local surveillance data to estimate pH1N1-associated disease burden during the first wave of pH1N1 circulation in HNE. Methods: Surveillance was established during June 1-August 30, 2009, for: 1) laboratory detection of pH1N1 at HNE and NSW laboratories, 2) pH1N1 community influenza-like illness (ILI) using an internet survey of HNE residents, and 3) pH1N1-associated hospitalizations and deaths using respiratory illness International Classification of Diseases 10 codes at 35 HNE hospitals and mandatory reporting of confirmed pH1N1-associated hospitalizations and deaths to the public health service. The proportion of pH1N1 positive specimens was applied to estimates of ILI, hospitalizations, and deaths to estimate disease burden. Results: Of 34,177 specimens tested at NSW laboratories, 4,094 (12%) were pH1N1 positive. Of 1,881 specimens from patients evaluated in emergency departments and/or hospitalized, 524 (26%) were pH1N1 positive. The estimated number of persons with pH1N1-associated ILI in the HNE region was 53,383 (range 37,828-70,597) suggesting a 6.2% attack rate (range 4.4-8.2%). An estimated 509 pH1N1-associated hospitalizations (range 388-630) occurred (reported: 184), and up to 10 pH1N1-associated deaths (range 8-13) occurred (reported: 5). The estimated case hospitalization ratio was 1% and case fatality ratio was 0.02%. Discussion: The first wave of pH1N1 activity in HNE resulted in symptomatic infection in a small proportion of the population, and the number of HNE pH1N1-associated hospitalizations and deaths is likely higher than officially reported.	[Dawood, Fatimah S.; Fry, Alicia M.] Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA 30333 USA; [Hope, Kirsty G.] Univ Newcastle, Hunter New England Populat Hlth & Newcastle Inst, Wallsend, Tyne & Wear, England; [Durrheim, David N.; Dalton, Craig B.] Hunter New England Populat Hlth & Hunter Med Res, Wallsend, Tyne & Wear, England; [Givney, Rodney] John Hunter Hosp, Hunter Area Pathol Serv, Newcastle, NSW, Australia	Centers for Disease Control & Prevention - USA; Newcastle University - UK; John Hunter Hospital	Dawood, FS (corresponding author), Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA 30333 USA.	fdawood@cdc.gov						[Anonymous], 2009, PREVALENCE FLU LIKE; *AUSTR INFL, 2009, 11 AUSTR INFL; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mathews JD, 2009, INFLUENZA OTHER RESP, V3, P143, DOI 10.1111/j.1750-2659.2009.00089.x; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; *NSW, WEEKL INFL EP REP; PARRELLA A, 2009, AUSTR FAMILY PHYS, V39; REED C, 2009, EMERG INFECT DIS APR; Wilson N, 2009, EUROSURVEILLANCE, V14; 2009 VICTORIAN INFLU; 2009, ECDC INTERIM RISK AS; PANDEMIC INFLUENZA P, P1; ASSESSMENT 2009 INFL	15	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9880	10.1371/journal.pone.0009880	http://dx.doi.org/10.1371/journal.pone.0009880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360868	Green Submitted, Green Published, gold			2022-12-27	WOS:000275969500012
J	Liang, B; Ferguson, K; Kadyk, L; Watts, JL				Liang, Bin; Ferguson, Kim; Kadyk, Lisa; Watts, Jennifer L.			The Role of Nuclear Receptor NHR-64 in Fat Storage Regulation in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; HORMONE-RECEPTOR; BETA-OXIDATION; ACID; SREBP; DROSOPHILA; PATHWAY; DOMAIN; IDENTIFICATION; DESATURASE	Nuclear hormone receptors (NHRs) play vital roles in the regulation of metabolism, reproduction, and development. We found that inactivation of a C. elegans HNF4 homologue nhr-64 by RNA interference (RNAi) suppresses low fat stores in stearoyl-CoA desaturase-deficient fat-6; fat-7 double mutants and sterol regulatory element binding protein (SREBP) sbp-1 mutants. Furthermore, inactivation of nhr-64 improves the growth rate of the fat-6; fat-7and sbp-1 strains. While nhr-64RNAi subtly affects fatty acid composition and fat storage in wild-type C. elegans, its effects on lipid metabolism are most apparent in the background of stearoyl-CoA desaturase or SREBP deficiency. NHR-64 displays transcriptional activating activity when expressed in yeast, and inactivation of nhr-64 affects the expression of at least 14 metabolic genes. Wild-type worms treated with nhr-64 RNAi display increased expression of acetyl-CoA carboxylase as well as increased abundance of de novo synthesized monomethyl branched chain fatty acids, suggesting an increase in fat synthesis. However, reduced expression of the acetyl-CoA synthetase gene acs-2 and an acyl-CoA oxidase gene indicates that a key role of NHR-64 may be to promote fatty acid oxidation in mitochondria and peroxisomes. These studies reveal that NHR-64 is an important regulator of fat storage in C. elegans.	[Liang, Bin; Watts, Jennifer L.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Ferguson, Kim; Kadyk, Lisa] Exelixis Inc, San Francisco, CA USA	Washington State University; Exelixis, Inc.	Liang, B (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jwatts@wsu.edu	Watts, Jennifer/AAC-7425-2020; Kadyk, Lisa/W-5243-2019	Watts, Jennifer/0000-0003-4349-0639	National Institutes of Health (NIH) [R01DK74114]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by National Institutes of Health (NIH) (R01DK74114). Exelixis provided support in terms of employment of Lisa Kadyk and Kim Ferguson, who generated the sbp-1(ep79) mutant strain and did the analysis that is shown in supplemental Figure S1A. Other than that, the funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of the C. elegans strains used in this work were obtained from the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Antebi A, 2000, GENE DEV, V14, P1512; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	43	43	48	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9869	10.1371/journal.pone.0009869	http://dx.doi.org/10.1371/journal.pone.0009869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360843	gold, Green Published, Green Submitted			2022-12-27	WOS:000275969500008
J	Hung, AY; Sung, CC; Brito, IL; Sheng, M				Hung, Albert Y.; Sung, Clifford C.; Brito, Ilana L.; Sheng, Morgan			Degradation of Postsynaptic Scaffold GKAP and Regulation of Dendritic Spine Morphology by the TRIM3 Ubiquitin Ligase in Rat Hippocampal Neurons	PLOS ONE			English	Article							RING FINGER PROTEIN; EXCITATORY SYNAPSES; SYNAPTIC PROTEIN; DIFFERENTIAL EXPRESSION; PROTEASOME SYSTEM; DENSITY PROTEINS; SHANK FAMILY; MYOSIN-V; COMPLEX; PSD-95	Changes in neuronal activity modify the structure of dendritic spines and alter the function and protein composition of synapses. Regulated degradation of postsynaptic density (PSD) proteins by the ubiquitin-proteasome system is believed to play an important role in activity-dependent synaptic remodeling. Stimulating neuronal activity in vitro and in vivo induces the ubiquitination and degradation of GKAP/SAPAP and Shank, major scaffold proteins of the PSD. However, the specific ubiquitin ligases that regulate postsynaptic protein composition have not been identified. Here we identify the RING finger-containing protein TRIM3 as a specific E3 ubiquitin ligase for the PSD scaffold GKAP/SAPAP1. Present in PSD fractions from rat brain, TRIM3 stimulates ubiquitination and proteasome-dependent degradation of GKAP, and induces the loss of GKAP and associated scaffold Shank1 from postsynaptic sites. Suppression of endogenous TRIM3 by RNA interference (RNAi) results in increased accumulation of GKAP and Shank1 at synapses, as well as enlargement of dendritic spine heads. RNAi of TRIM3 also prevented the loss of GKAP induced by synaptic activity. Thus, TRIM3 is a novel E3 ligase that mediates activity-dependent turnover of PSD scaffold proteins and is a negative regulator of dendritic spine morphology.	[Hung, Albert Y.; Sung, Clifford C.; Brito, Ilana L.; Sheng, Morgan] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hung, Albert Y.; Sung, Clifford C.; Brito, Ilana L.; Sheng, Morgan] MIT, Dept Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hung, Albert Y.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts General Hospital	Hung, AY (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	msheng@mit.edu	; Brito, Ilana/W-1827-2017	Sheng, Morgan/0000-0002-8703-5366; Brito, Ilana/0000-0002-2250-3480	National Institutes of Health [K08 Award NS41411]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS041411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by National Institutes of Health K08 Award NS41411 (A. Y. H.). M. S. was an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohkawa N, 2001, J NEUROCHEM, V78, P75, DOI 10.1046/j.1471-4159.2001.00373.x; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	52	76	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9842	10.1371/journal.pone.0009842	http://dx.doi.org/10.1371/journal.pone.0009842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352094	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894500011
J	You, H; Zhang, WB; Jones, MK; Gobert, GN; Mulvenna, J; Rees, G; Spanevello, M; Blair, D; Duke, M; Brehm, K; McManus, DP				You, Hong; Zhang, Wenbao; Jones, Malcolm K.; Gobert, Geoffrey N.; Mulvenna, Jason; Rees, Glynn; Spanevello, Mark; Blair, David; Duke, Mary; Brehm, Klaus; McManus, Donald P.			Cloning and Characterisation of Schistosoma japonicum Insulin Receptors	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE KINASES; HOST-PARASITE INTERPLAY; DIFFERENTIAL REGULATION; LIGAND SPECIFICITY; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GLUCOSE-UPTAKE; BLOOD FLUKES	Background: Schistosomes depend for growth and development on host hormonal signals, which may include the insulin signalling pathway. We cloned and assessed the function of two insulin receptors from Schistosoma japonicum in order to shed light on their role in schistosome biology. Methodology/Principal Findings: We isolated, from S. japonicum, insulin receptors 1 (SjIR-1) and 2 (SjIR-2) sharing close sequence identity to their S. mansoni homologues (SmIR-1 and SmIR-2). SjIR-1 is located on the tegument basal membrane and the internal epithelium of adult worms, whereas SjIR-2 is located in the parenchyma of males and the vitelline tissue of females. Phylogenetic analysis showed that SjIR-2 and SmIR-2 are close to Echinococcus multilocularis insulin receptor (EmIR), suggesting that SjIR-2, SmIR-2 and EmIR share similar roles in growth and development in the three taxa. Structure homology modelling recovered the conserved structure between the SjIRs and Homo sapiens IR (HIR) implying a common predicted binding mechanism in the ligand domain and the same downstream signal transduction processing in the tyrosine kinase domain as in HIR. Two-hybrid analysis was used to confirm that the ligand domains of SjIR-1 and SjIR-2 contain the insulin binding site. Incubation of adult worms in vitro, both with a specific insulin receptor inhibitor and anti-SjIRs antibodies, resulted in a significant decrease in worm glucose levels, suggesting again the same function for SjIRs in regulating glucose uptake as described for mammalian cells. Conclusions: Adult worms of S. japonicum possess insulin receptors that can specifically bind to insulin, indicating that the parasite can utilize host insulin for development and growth by sharing the same pathway as mammalian cells in regulating glucose uptake. A complete understanding of the role of SjIRs in the biology of S. japonicum may result in their use as new targets for drug and vaccine development against schistosomiasis.	[You, Hong; Zhang, Wenbao; Jones, Malcolm K.; Gobert, Geoffrey N.; Mulvenna, Jason; Rees, Glynn; Spanevello, Mark; Duke, Mary; McManus, Donald P.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [You, Hong] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Blair, David] James Cook Univ, Sch Trop Biol, Townsville, Qld, Australia; [Brehm, Klaus] Univ Wurzburg, Inst Hyg & Mikrobiol, Wurzburg, Germany	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; James Cook University; University of Wurzburg	You, H (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	donM@qimr.edu.au	You, Hong/AAB-4649-2020; Mulvenna, Jason/H-7110-2014; Blair, David/O-2786-2019; Jones, Malcolm K/A-1097-2009; Gobert, Geoffrey/A-1468-2011; McManus, Donald P./G-2678-2013; Blair, David/G-6052-2011; Gobert, Geoffrey/V-2985-2019; McManus, Don/AAC-5394-2020	You, Hong/0000-0002-8790-7793; Mulvenna, Jason/0000-0003-3521-8061; Blair, David/0000-0002-4658-3251; Jones, Malcolm K/0000-0002-0035-6141; Blair, David/0000-0002-4658-3251; McManus, Don/0000-0001-6443-1449; Gobert, Geoffrey/0000-0001-5884-6453	National Health and Medical Research Council of Australia [ID 290238, ID 496600]; Wellcome Trust [ID071657MA]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the National Health and Medical Research Council of Australia (ID 290238 and ID 496600, http://www.nhmrc.gov.au/), and the Wellcome Trust (ID071657MA, http://www.wellcome.ac.uk/). H. Y. is a recipient of a University of Queensland postgraduate scholarship (Endeavour IPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahier A, 2008, PARASITE, V15, P573, DOI 10.1051/parasite/2008154573; ALBERTS GF, 1994, CIRC RES, V75, P261, DOI 10.1161/01.RES.75.2.261; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Bahia D, 2006, MEM I OSWALDO CRUZ, V101, P137, DOI 10.1590/S0074-02762006000900022; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Bealla MJ, 2002, INT J PARASITOL, V32, P399, DOI 10.1016/S0020-7519(01)00348-4; Bergquist NR, 2005, TRENDS PARASITOL, V21, P112, DOI 10.1016/j.pt.2005.01.001; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Damian RT, 1997, PARASITOLOGY, V115, pS169, DOI 10.1017/S0031182097002357; Davies SJ, 1998, J BIOL CHEM, V273, P11234, DOI 10.1074/jbc.273.18.11234; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Dissous C, 2007, BIOESSAYS, V29, P1281, DOI 10.1002/bies.20662; Dissous C, 2006, FEBS LETT, V580, P2968, DOI 10.1016/j.febslet.2006.03.046; Dozio N, 2001, J INVEST MED, V49, P85, DOI 10.2310/6650.2001.34094; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; ESCOBEDO G, 2009, J HELMINTHOL, P1; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; HAN ZG, 2009, ANN REV GENOMICS HUM; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hu W, 2004, TRENDS MOL MED, V10, P217, DOI 10.1016/j.molmed.2004.03.002; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulstijn M, 2003, PARASITOLOGY, V126, P53, DOI 10.1017/S0031182002002512; Hulstijn M, 2001, MEM I OSWALDO CRUZ, V96, P393, DOI 10.1590/S0074-02762001000300020; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Khayath N, 2007, FEBS J, V274, P659, DOI 10.1111/j.1742-4658.2006.05610.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; Knobloch J, 2006, INT J PARASITOL, V36, P1261, DOI 10.1016/j.ijpara.2006.06.004; KOIVISTO UM, 1991, J BIOL CHEM, V266, P2615; Konrad C, 2003, INT J PARASITOL, V33, P301, DOI 10.1016/S0020-7519(02)00265-5; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leenstra T, 2006, INFECT IMMUN, V74, P6398, DOI 10.1128/IAI.00757-06; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; LoVerde PT, 2009, CURR OPIN MICROBIOL, V12, P422, DOI 10.1016/j.mib.2009.06.005; MALCOLM KJ, 2007, INT J BIOCHEM CELL B, V39, P1551; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MCLAREN DJ, 1977, NATURE, V269, P147, DOI 10.1038/269147a0; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Sambrook J., 2001, MOL CLONING; SAPERSTEIN R, 1989, BIOCHEMISTRY-US, V28, P5694, DOI 10.1021/bi00439a053; SHOEMAKER CB, 1992, MOL BIOCHEM PARASIT, V53, P17, DOI 10.1016/0166-6851(92)90003-3; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; YOU H, 2009, INT J PARASITOL; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	71	61	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9868	10.1371/journal.pone.0009868	http://dx.doi.org/10.1371/journal.pone.0009868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352052	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000275894500024
J	Caljon, G; De Ridder, K; De Baetselier, P; Coosemans, M; Van Den Abbeele, J				Caljon, Guy; De Ridder, Karin; De Baetselier, Patrick; Coosemans, Marc; Van Den Abbeele, Jan			Identification of a Tsetse Fly Salivary Protein with Dual Inhibitory Action on Human Platelet Aggregation	PLOS ONE			English	Article							EXTRACELLULAR ATP; ESCHERICHIA-COLI; DENDRITIC CELLS; GLAND EXTRACTS; APYRASE; EXPRESSION; 5'-NUCLEOTIDASE; RECEPTOR; ACTIVATION; CHEMOTAXIS	Background: Tsetse flies (Glossina sp.), the African trypanosome vectors, rely on anti-hemostatic compounds for efficient blood feeding. Despite their medical importance, very few salivary proteins have been characterized and functionally annotated. Methodology/Principal Findings: Here we report on the functional characterisation of a 5'nucleotidase-related (5'Nuc) saliva protein of the tsetse fly Glossina morsitans morsitans. This protein is encoded by a 1668 bp cDNA corresponding at the genomic level with a single-copy 4 kb gene that is exclusively transcribed in the tsetse salivary gland tissue. The encoded 5'Nuc protein is a soluble 65 kDa glycosylated compound of tsetse saliva with a dual anti-hemostatic action that relies on its combined apyrase activity and fibrinogen receptor (GPIIb/IIIa) antagonistic properties. Experimental evidence is based on the biochemical and functional characterization of recombinant protein and on the successful silencing of the 5'nuc translation in the salivary gland by RNA interference (RNAi). Refolding of a 5'Nuc/SUMO-fusion protein yielded an active apyrase enzyme with K-m and V-max values of 43+/-4 mM and 684+/-49 nmol Pi/minxmg for ATPase and 49+/-11 mu M and 177+/-37 nmol Pi/minxmg for the ADPase activity. In addition, recombinant 5'Nuc was found to bind to GPIIb/IIIa with an apparent K-D of 92+/-25 nM. Consistent with these features, 5'Nuc potently inhibited ADP-induced thrombocyte aggregation and even caused disaggregation of ADP-triggered human platelets. The importance of 5'Nuc for the tsetse fly hematophagy was further illustrated by specific RNAi that reduced the anti-thrombotic activities in saliva by approximately 50% resulting in a disturbed blood feeding process. Conclusions/Significance: These data show that this 5'nucleotidase-related apyrase exhibits GPIIb/IIIa antagonistic properties and represents a key thromboregulatory compound of tsetse fly saliva.	[Caljon, Guy; De Ridder, Karin; Coosemans, Marc; Van Den Abbeele, Jan] Inst Trop Med Antwerp ITM, Unit Entomol, Antwerp, Belgium; [Caljon, Guy; De Baetselier, Patrick] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy; De Baetselier, Patrick] VIB, Dept Mol & Cellular Interact, Ghent, Belgium	Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Caljon, G (corresponding author), Inst Trop Med Antwerp ITM, Unit Entomol, Antwerp, Belgium.	jvdabbeele@itg.be	De Baetselier, Patrick/D-3866-2014; Caljon, Guy/E-1310-2017	Caljon, Guy/0000-0002-4870-3202; Van Den Abbeele, Jan/0000-0002-4533-4480	InterUniversity Attraction Pole [IUAP, P6/15]	InterUniversity Attraction Pole(Belgian Federal Science Policy Office)	This project was supported by InterUniversity Attraction Pole fundings (IUAP, P6/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVESSILVA J, 2010, BMC GENOMIC IN PRESS; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Caljon G, 2006, INFECT IMMUN, V74, P6324, DOI 10.1128/IAI.01046-06; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Cappello M, 1996, AM J TROP MED HYG, V54, P475, DOI 10.4269/ajtmh.1996.54.475; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Champagne Donald E., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P375, DOI 10.2174/1568006043335862; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Faudry E, 2004, J BIOL CHEM, V279, P19607, DOI 10.1074/jbc.M401681200; Fini C, 2000, EUR J BIOCHEM, V267, P4978, DOI 10.1046/j.1432-1327.2000.01545.x; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Gounaris K, 2005, TRENDS PARASITOL, V21, P17, DOI 10.1016/j.pt.2004.10.005; GREVELINK SA, 1993, P NATL ACAD SCI USA, V90, P9155, DOI 10.1073/pnas.90.19.9155; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; LERNER EA, 1991, J BIOL CHEM, V266, P11234; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; Lombardo F, 2000, J BIOL CHEM, V275, P23861, DOI 10.1074/jbc.M909547199; MANT MJ, 1981, BRIT J HAEMATOL, V48, P601, DOI 10.1111/j.1365-2141.1981.00601.x; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Reddy VB, 2000, J BIOL CHEM, V275, P15861, DOI 10.1074/jbc.275.21.15861; Reno HE, 2005, AM J TROP MED HYG, V73, P541, DOI 10.4269/ajtmh.2005.73.541; Ribeiro JMC, 1999, J EXP BIOL, V202, P1551; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Sevigny J, 2000, J BIOL CHEM, V275, P5640, DOI 10.1074/jbc.275.8.5640; Sun DF, 2006, PLATELETS, V17, P178, DOI 10.1080/09537100500460234; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; Valenzuela JG, 2001, J EXP BIOL, V204, P229; Van Den Abbeele J, 2007, INSECT BIOCHEM MOLEC, V37, P1075, DOI 10.1016/j.ibmb.2007.06.006; Zebisch M, 2007, BIOCHEMISTRY-US, V46, P11945, DOI 10.1021/bi701103y	45	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9671	10.1371/journal.pone.0009671	http://dx.doi.org/10.1371/journal.pone.0009671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351782	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400007
J	Ramsgaard, L; Englert, JM; Tobolewski, J; Tomai, L; Fattman, CL; Leme, AS; Kaynar, AM; Shapiro, SD; Enghild, JJ; Oury, TD				Ramsgaard, Lasse; Englert, Judson M.; Tobolewski, Jacob; Tomai, Lauren; Fattman, Cheryl L.; Leme, Adriana S.; Kaynar, A. Murat; Shapiro, Steven D.; Enghild, Jan J.; Oury, Tim D.			The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis	PLOS ONE			English	Article							INDUCED LUNG INJURY; EXTRACELLULAR-SUPEROXIDE DISMUTASE; IDIOPATHIC PULMONARY-FIBROSIS; SOLUBLE RECEPTOR; CELL-SURFACE; RAGE; BLEOMYCIN; PATHOGENESIS; PROTEIN; TISSUE	Background: The role of the receptor for advanced glycation end-products (RAGE) has been shown to differ in two different mouse models of asbestos and bleomycin induced pulmonary fibrosis. RAGE knockout (KO) mice get worse fibrosis when challenged with asbestos, whereas in the bleomycin model they are largely protected against fibrosis. In the current study the role of RAGE in a mouse model of silica induced pulmonary fibrosis was investigated. Methodology/Principal Findings: Wild type (WT) and RAGE KO mice received a single intratracheal (i.t.) instillation of silica in saline or saline alone as vehicle control. Fourteen days after treatment mice were subjected to a lung mechanistic study and the lungs were lavaged and inflammatory cells, protein and TGF-beta levels in lavage fluid determined. Lungs were subsequently either fixed for histology or excised for biochemical assessment of fibrosis and determination of RAGE protein- and mRNA levels. There was no difference in the inflammatory response or degree of fibrosis (hydroxyproline levels) in the lungs between WT and RAGE KO mice after silica injury. However, histologically the fibrotic lesions in the RAGE KO mice had a more diffuse alveolar septal fibrosis compared to the nodular fibrosis in WT mice. Furthermore, RAGE KO mice had a significantly higher histologic score, a measure of affected areas of the lung, compared to WT silica treated mice. A lung mechanistic study revealed a significant decrease in lung function after silica compared to control, but no difference between WT and RAGE KO. While a dose response study showed similar degrees of fibrosis after silica treatment in the two strains, the RAGE KO mice had some differences in the inflammatory response compared to WT mice. Conclusions/Significance: Aside from the difference in the fibrotic pattern, these studies showed no indicators of RAGE having an effect on the severity of pulmonary fibrosis following silica injury.	[Ramsgaard, Lasse; Englert, Judson M.; Tobolewski, Jacob; Tomai, Lauren; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Fattman, Cheryl L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Leme, Adriana S.; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Kaynar, A. Murat] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Kaynar, A. Murat] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramsgaard, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	tdoury@pitt.edu	Kaynar, Ata Murat/ABI-6877-2020	Kaynar, Ata Murat/0000-0001-8847-0450; Enghild, Jan Johannes/0000-0001-9292-9172	National Institutes of Health [R01HL110166, R21ES013986, F30ES016973]; The Lundbeck Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013986, F30ES016973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was received from the National Institutes of Health R01HL110166 and R21ES013986 to Tim D. Oury, F30ES016973 to Judson M. Englert, and The Lundbeck Foundation (www.lundbeck.com) grant to Lasse Ramsgaard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N; BROWN RFR, 1988, TOXICOLOGY, V51, P101, DOI 10.1016/0300-483X(88)90084-4; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Gefter JV, 2009, CELL TISSUE RES, V337, P79, DOI 10.1007/s00441-009-0791-0; Gongora MC, 2008, AM J PATHOL, V173, P915, DOI 10.2353/ajpath.2008.080119; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kim W, 2005, ANN NY ACAD SCI, V1043, P553, DOI 10.1196/annals.1338.063; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; *NAT I OCC SAF HLT, 2008, SIL NUMB DEATHS CRUD; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; TAM PE, 1993, PCR METH APPL, V3, P71; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; VANBARNEVELD PWC, 1987, AM REV RESPIR DIS, V135, P48; *WHO, 2000, 238 WHO G; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	40	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9604	10.1371/journal.pone.0009604	http://dx.doi.org/10.1371/journal.pone.0009604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333255	Green Published, Green Accepted, gold			2022-12-27	WOS:000275809700002
J	Kraus, VB; Kepler, TB; Stabler, T; Renner, J; Jordan, J				Kraus, Virginia B.; Kepler, Thomas B.; Stabler, Thomas; Renner, Jordan; Jordan, Joanne			First Qualification Study of Serum Biomarkers as Indicators of Total Body Burden of Osteoarthritis	PLOS ONE			English	Article							BIOCHEMICAL MARKERS; KNEE OSTEOARTHRITIS; RADIOGRAPHIC SUBTYPES; POSTMENOPAUSAL WOMEN; HIP OSTEOARTHRITIS; CARTILAGE TURNOVER; MOLECULAR MARKERS; DISEASE-ACTIVITY; MULTIPLE SITES; JOINT DAMAGE	Background: Osteoarthritis (OA) is a debilitating chronic multijoint disease of global proportions. OA presence and severity is usually documented by x-ray imaging but whole body imaging is impractical due to radiation exposure, time and cost. Systemic (serum or urine) biomarkers offer a potential alternative method of quantifying total body burden of disease but no OA-related biomarker has ever been stringently qualified to determine the feasibility of this approach. The goal of this study was to evaluate the ability of three OA-related biomarkers to predict various forms or subspecies of OA and total body burden of disease. Methodology/Principal Findings: Female participants (461) with clinical hand OA underwent radiography of hands, hips, knees and lumbar spine; x-rays were comprehensively scored for OA features of osteophyte and joint space narrowing. Three OA-related biomarkers, serum hyaluronan (sHA), cartilage oligomeric matrix protein (sCOMP), and urinary C-telopeptide of type II collagen (uCTX2), were measured by ELISA. sHA, sCOMP and uCTX2 correlated positively with total osteophyte burden in models accounting for demographics (age, weight, height): R-2 = 0.60, R-2 = 0.47, R-2 = 0.51 (all p < 10(-6)); sCOMP correlated negatively with total joint space narrowing burden: R 2 = 0.69 (p, 10 26). Biomarkers and demographics predicted 35-38% of variance in total burden of OA (total joint space narrowing or osteophyte). Joint size did not determine the contribution to the systemic biomarker concentration. Biomarker correlation with disease in the lumbar spine resembled that in the rest of the skeleton. Conclusions/Significance: We have suspected that the correlation of systemic biomarkers with disease has been hampered by the inability to fully phenotype the burden of OA in a patient. These results confirm the hypothesis, revealed upon adequate patient phenotyping, that systemic joint tissue concentrations of several biomarkers can be quantitative indicators of specific subspecies of OA and of total body burden of disease.	[Kraus, Virginia B.; Stabler, Thomas] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kepler, Thomas B.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Kepler, Thomas B.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Renner, Jordan; Jordan, Joanne] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Kraus, VB (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	vbk@acpub.duke.edu		Kepler, Thomas/0000-0002-1383-6865	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases [UO1 AR050898]; National Institutes of Health/National Institute of Aging [2P60 AG11268, MO1-RR-30]; National Center for Research Resources; General Clinical Research Centers Program; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR050898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health/National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases UO1 AR050898; National Institutes of Health/National Institute of Aging Claude D. Pepper Older Americans Independence Centers 2P60 AG11268; MO1-RR-30, National Center for Research Resources, General Clinical Research Centers Program, National Institutes of Health where this study was conducted; and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Aurich M, 2005, ARTHRITIS RHEUM-US, V52, P112, DOI 10.1002/art.20740; Bauer DC, 2006, OSTEOARTHR CARTILAGE, V14, P723, DOI 10.1016/j.joca.2006.04.001; Birmingham JD, 2006, BIOMARK INSIGHTS, V1, P61; Bruyere O, 2006, ANN RHEUM DIS, V65, P1050, DOI 10.1136/ard.2005.045914; Burnett S, 1994, RADIOGRAPHIC ATLAS O; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Christgau S, 2004, MENOPAUSE, V11, P508, DOI 10.1097/01.WCB.0000121484.18437.98; Christgau S, 2004, CLIN EXP RHEUMATOL, V22, P36; CHUA SD, 2008, OSTEOARTHRITIS CARTI; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Dam EB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2774; Davis CR, 2007, ARTHRITIS RHEUM, V56, P4038, DOI 10.1002/art.23129; Elliott AL, 2005, ARTHRITIS RHEUM-US, V52, P105, DOI 10.1002/art.20724; Garnero P, 2008, OSTEOARTHR CARTILAGE, V16, P660, DOI 10.1016/j.joca.2007.10.002; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576; Garnero P, 2001, ANN RHEUM DIS, V60, P619, DOI 10.1136/ard.60.6.619; Garnero P, 2005, J RHEUMATOL, V32, P697; Garnero P, 2004, ARTHRITIS RHEUM-US, V50, P3137, DOI 10.1002/art.20493; Garnero P, 2003, CURR OPIN RHEUMATOL, V15, P641, DOI 10.1097/00002281-200309000-00020; Gordon CD, 2008, CLIN CHIM ACTA, V398, P21, DOI 10.1016/j.cca.2008.07.031; Hunter DJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2314; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kraus VB, 2007, OSTEOARTHR CARTILAGE, V15, P120, DOI 10.1016/j.joca.2006.10.002; Manicourt DH, 2006, ARTHRITIS RHEUM, V54, P3205, DOI 10.1002/art.22075; March LM, 1997, BAILLIERE CLIN RHEUM, V11, P817, DOI 10.1016/S0950-3579(97)80011-8; Meulenbelt I, 2007, OSTEOARTHR CARTILAGE, V15, P379, DOI 10.1016/j.joca.2006.09.007; Meulenbelt I, 2006, ANN RHEUM DIS, V65, P360, DOI 10.1136/ard.2005.040642; NAGELKERKE N, 2002, BIOMETRIKA, V78, P691; NELSON A, 2007, CURR PRIM CARE REP, V2, P109; Otterness IG, 2000, OSTEOARTHR CARTILAGE, V8, P180, DOI 10.1053/joca.1999.0288; Pavelka K, 2004, OSTEOARTHR CARTILAGE, V12, P277, DOI 10.1016/j.joca.2004.01.001; Rousseau JC, 2007, NAT CLIN PRACT RHEUM, V3, P346, DOI 10.1038/ncprheum0508; TABASSI NC, 2007, CURR RHEUMATOL REP, V9, P16; VALDES AM, 2008, ANN RHEUM DIS   1203; Vilim V, 2002, OSTEOARTHR CARTILAGE, V10, P707, DOI 10.1053/joca.2002.0819; Wagner JA, 2007, CLIN PHARMACOL THER, V81, P104, DOI 10.1038/sj.clpt.6100017; Young-Min SA, 2001, ANN RHEUM DIS, V60, P545; Zhang YQ, 2008, RHEUM DIS CLIN N AM, V34, P515, DOI 10.1016/j.rdc.2008.05.007	40	60	63	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9739	10.1371/journal.pone.0009739	http://dx.doi.org/10.1371/journal.pone.0009739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305824	Green Submitted, Green Published, gold			2022-12-27	WOS:000275809600011
J	Buckingham, G; Goodale, MA				Buckingham, Gavin; Goodale, Melvyn A.			Lifting without Seeing: The Role of Vision in Perceiving and Acting upon the Size Weight Illusion	PLOS ONE			English	Article							PERCEPTION; CUES; HEAVINESS; OBJECTS	Background: Our expectations of an object's heaviness not only drive our fingertip forces, but also our perception of heaviness. This effect is highlighted by the classic size-weight illusion (SWI), where different-sized objects of identical mass feel different weights. Here, we examined whether these expectations are sufficient to induce the SWI in a single wooden cube when lifted without visual feedback, by varying the size of the object seen prior to the lift. Methodology/Principal Findings: Participants, who believed that they were lifting the same object that they had just seen, reported that the weight of the single, standard-sized cube that they lifted on every trial varied as a function of the size of object they had just seen. Seeing the small object before the lift made the cube feel heavier than it did after seeing the large object. These expectations also affected the fingertip forces that were used to lift the object when vision was not permitted. The expectation-driven errors made in early trials were not corrected with repeated lifting, and participants failed to adapt their grip and load forces from the expected weight to the object's actual mass in the same way that they could when lifting with vision. Conclusions/Significance: Vision appears to be crucial for the detection, and subsequent correction, of the ostensibly non-visual grip and load force errors that are a common feature of this type of object interaction. Expectations of heaviness are not only powerful enough to alter the perception of a single object's weight, but also continually drive the forces we use to lift the object when vision is unavailable.	[Buckingham, Gavin; Goodale, Melvyn A.] Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada	Western University (University of Western Ontario)	Buckingham, G (corresponding author), Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada.	gbucking@uwo.ca	Buckingham, Gavin/A-8715-2008; Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Lauwereyns, Jan/0000-0003-0551-2550; Buckingham, Gavin/0000-0002-6950-5504	Department of Foreign Affairs and International Trade (DFAIT) Canada	Department of Foreign Affairs and International Trade (DFAIT) Canada	This work was supported by a Department of Foreign Affairs and International Trade (DFAIT) Canada postdoctoral fellowship, awarded to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1970, PERCEPT PSYCHOPHYS, V8, P1, DOI 10.3758/BF03208919; Bridgeman B, 2005, PSYCHON B REV, V12, P549, DOI 10.3758/BF03193803; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; GRANIT R, 1972, BRAIN, V95, P451; Haffenden AM, 1998, J COGNITIVE NEUROSCI, V10, P122, DOI 10.1162/089892998563824; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; KOSELEFF P, 1957, ACTA PSYCHOL, V13, P242, DOI 10.1016/0001-6918(57)90023-9; MASIN CM, 1988, PERCEPT PSYCHOPHYS, V44, P309; Streit M, 2007, PSYCHON B REV, V14, P1001, DOI 10.3758/BF03194135; Valdez AB, 2008, PERCEPT PSYCHOPHYS, V70, P647, DOI 10.3758/PP.70.4.647; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	19	76	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9709	10.1371/journal.pone.0009709	http://dx.doi.org/10.1371/journal.pone.0009709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	569SM	20300575	Green Published, Green Submitted, gold			2022-12-27	WOS:000275621000019
J	Rezaee, F; Rellick, SL; Piedimonte, G; Akers, SM; O'Leary, HA; Martin, K; Craig, MD; Gibson, LF				Rezaee, Fariba; Rellick, Stephanie L.; Piedimonte, Giovanni; Akers, Stephen M.; O'Leary, Heather A.; Martin, Karen; Craig, Michael D.; Gibson, Laura F.			Neurotrophins Regulate Bone Marrow Stromal Cell IL-6 Expression through the MAPK Pathway	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-6 TRANSGENIC MICE; BRONCHIAL EPITHELIAL-CELLS; FACTOR ENHANCES SURVIVAL; SUBSTANCE-P; GRANULOCYTE-MACROPHAGE; TRANSCRIPTION FACTOR; PC12 CELLS	Background: The host's response to infection is characterized by altered levels of neurotrophins and an influx of inflammatory cells to sites of injured tissue. Progenitor cells that give rise to the differentiated cellular mediators of inflammation are derived from bone marrow progenitor cells where their development is regulated, in part, by cues from bone marrow stromal cells (BMSC). As such, alteration of BMSC function in response to elevated systemic mediators has the potential to alter their function in biologically relevant ways, including downstream alteration of cytokine production that influences hematopoietic development. Methodology/Principal Findings: In the current study we investigated BMSC neurotrophin receptor expression by flow cytometric analysis to determine differences in expression as well as potential to respond to NGF or BDNF. Intracellular signaling subsequent to neurotrophin stimulation of BMSC was analyzed by western blot, microarray analysis, confocal microscopy and real-time PCR. Analysis of BMSC Interleukin-6 (IL-6) expression was completed using ELISA and real-time PCR. Conclusion: BMSC established from different individuals had distinct expression profiles of the neurotrophin receptors, TrkA, TrkB, TrkC, and p75(NTR). These receptors were functional, demonstrated by an increase in Akt-phosphorylation following BMSC exposure to recombinant NGF or BDNF. Neurotrophin stimulation of BMSC resulted in increased IL-6 gene and protein expression which required activation of ERK and p38 MAPK signaling, but was not mediated by the NFkB pathway. BMSC response to neurotrophins, including the up-regulation of IL-6, may alter their support of hematopoiesis and regulate the availability of inflammatory cells for migration to sites of injury or infection. As such, these studies are relevant to the growing appreciation of the interplay between neurotropic mediators and the regulation of hematopoiesis.	[Rezaee, Fariba; Piedimonte, Giovanni] W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA; [Martin, Karen] W Virginia Univ, Sch Med, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Rellick, Stephanie L.; Akers, Stephen M.; O'Leary, Heather A.; Martin, Karen; Craig, Michael D.; Gibson, Laura F.] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Gibson, Laura F.] W Virginia Univ, Sch Med, Dept Microbiol & Immunol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Rezaee, F (corresponding author), W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA.	lgibson@hsc.wvu.edu	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Gibson, Laura/0000-0002-7291-9046; Martin, Karen/0000-0001-8916-4092; O'Leary, Heather/0000-0003-1321-1520	National Institutes of Health [R01 HL056888, R01 CA134573, P20 RR016440, R01HL61007]; Microscope Imaging Facility [P20 RR016440]; West Virginia University Flow Cytometry Core Facility [P20 RR016440, S10 RR020866]; NATIONAL CANCER INSTITUTE [R01CA134573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440, S10RR020866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007, R01HL056888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microscope Imaging Facility; West Virginia University Flow Cytometry Core Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was received from the National Institutes of Health R01 HL056888 (LFG), NIH R01 CA134573 (LFG), P20 RR016440 (LFG) and NIH R01HL61007 (GP), Microscope Imaging Facility (P20 RR016440), and West Virginia University Flow Cytometry Core Facility (P20 RR016440 and S10 RR020866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOE L, 1993, GROWTH FACTORS, V9, P149, DOI 10.3109/08977199309010830; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; Boissiere F, 1997, EXP NEUROL, V145, P245, DOI 10.1006/exnr.1997.6443; Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; BOYLE MDP, 1985, J IMMUNOL, V134, P564; Bracci-Laudiero L, 2005, BLOOD, V106, P3507, DOI 10.1182/blood-2004-10-4055; BRACCI-LAUDIERO L, 1992, NEUROSCI LETT, V147, P9; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Calza L, 1997, MOL BRAIN RES, V51, P60, DOI 10.1016/S0169-328X(97)00213-1; CANEVA L, 1995, BLOOD CELL MOL DIS, V21, P73, DOI 10.1006/bcmd.1995.0011; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; FATTORI E, 1994, BLOOD, V83, P2570; Freund-Michel V, 2006, CELL SIGNAL, V18, P621, DOI 10.1016/j.cellsig.2005.06.007; Furuno T, 2006, NEUROSCI LETT, V392, P240, DOI 10.1016/j.neulet.2005.09.031; Gibson L F, 1997, Biol Blood Marrow Transplant, V3, P122; GORDON M Y, 1983, International Journal of Cell Cloning, V1, P429; GORDON MY, 1983, BRIT J HAEMATOL, V53, P317, DOI 10.1111/j.1365-2141.1983.tb02026.x; Hamada A, 1996, BRIT J HAEMATOL, V93, P299, DOI 10.1046/j.1365-2141.1996.5151055.x; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hirano T, 1998, Int Rev Immunol, V16, P249; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; KANNAN Y, 1993, INT ARCH ALLERGY IMM, V102, P362, DOI 10.1159/000236584; KANNAN Y, 1991, BLOOD, V77, P1320; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KHAIR OA, 1994, EUR RESPIR J, V7, P2109, DOI 10.1183/09031936.94.07122109; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Kobayashi H, 2001, NEUROSCI LETT, V305, P157, DOI 10.1016/S0304-3940(01)01854-7; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li N, 2007, BIOCHEM BIOPH RES CO, V356, P561, DOI 10.1016/j.bbrc.2007.03.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markel TA, 2008, AM J PHYSIOL-REG I, V294, pR1491, DOI 10.1152/ajpregu.00031.2008; MATSUDA H, 1988, P NATL ACAD SCI USA, V85, P6508, DOI 10.1073/pnas.85.17.6508; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Nakayama T, 2007, J NATL CANCER I, V99, P223, DOI 10.1093/jnci/djk031; NOMA T, 1987, IMMUNOL LETT, V15, P249, DOI 10.1016/0165-2478(87)90032-0; Nowicki M, 2006, J CLIN PATHOL, V59, P935, DOI 10.1136/jcp.2005.034629; Nowicki M, 2007, J CLIN PATHOL, V60, P749, DOI 10.1136/jcp.2006.041475; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Rameshwar P, 2001, J NEUROIMMUNOL, V121, P22, DOI 10.1016/S0165-5728(01)00443-X; Raychaudhuri SP, 2004, PROG BRAIN RES, V146, P433; Raychaudhuri SP, 1998, ACTA DERM-VENEREOL, V78, P84; Rodriguez MDC, 2004, BLOOD, V103, P3349, DOI 10.1182/blood-2003-10-3438; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schonhoff CM, 2001, J NEUROCHEM, V78, P631, DOI 10.1046/j.1471-4159.2001.00432.x; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Scicchitano MS, 2008, BLOOD CELL MOL DIS, V40, P370, DOI 10.1016/j.bcmd.2007.10.009; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Simone MD, 1999, HEMATOL ONCOL, V17, P1; Sio SWS, 2008, J IMMUNOL, V180, P8333, DOI 10.4049/jimmunol.180.12.8333; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Washiyama K, 1996, AM J PATHOL, V148, P929; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z; Yamaguchi M, 2008, AM J ORTHOD DENTOFAC, V133, P690, DOI 10.1016/j.ajodo.2006.03.043; Yoon SO, 1998, J NEUROSCI, V18, P3273; Yu M, 2002, TOXICOL SCI, V68, P488, DOI 10.1093/toxsci/68.2.488; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	69	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9690	10.1371/journal.pone.0009690	http://dx.doi.org/10.1371/journal.pone.0009690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300619	Green Published, gold, Green Submitted			2022-12-27	WOS:000275621000008
J	Poage, GM; Christensen, BC; Houseman, EA; McClean, MD; Wiencke, JK; Posner, MR; Clark, JR; Nelson, HH; Marsit, CJ; Kelsey, KT				Poage, Graham M.; Christensen, Brock C.; Houseman, E. Andres; McClean, Michael D.; Wiencke, John K.; Posner, Marshall R.; Clark, John R.; Nelson, Heather H.; Marsit, Carmen J.; Kelsey, Karl T.			Genetic and Epigenetic Somatic Alterations in Head and Neck Squamous Cell Carcinomas Are Globally Coordinated but Not Locally Targeted	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; COPY NUMBER; PROMOTER METHYLATION; HIGH-RESOLUTION; CANCER PATIENTS; POOR-PROGNOSIS; BREAST-CANCER; SURVIVAL; ARRAY	Background: Solid tumors, including head and neck squamous cell carcinomas (HNSCC), arise as a result of genetic and epigenetic alterations in a sustained stress environment. Little work has been done that simultaneously examines the spectrum of both types of changes in human tumors on a genome-wide scale and results so far have been limited and mixed. Since it has been hypothesized that epigenetic alterations may act by providing the second carcinogenic hit in gene silencing, we sought to identify genome-wide DNA copy number alterations and CpG dinucleotide methylation events and examine the global/local relationships between these types of alterations in HNSCC. Methodology/Principal Findings: We have extended a prior analysis of 1,413 cancer-associated loci for epigenetic changes in HNSCC by integrating DNA copy number alterations, measured at 500,000 polymorphic loci, in a case series of 19 primary HNSCC tumors. We have previously demonstrated that local copy number does not bias methylation measurements in this array platform. Importantly, we found that the global pattern of copy number alterations in these tumors was significantly associated with tumor methylation profiles (p<0.002). However at the local level, gene promoter regions did not exhibit a correlation between copy number and methylation (lowest q = 0.3), and the spectrum of genes affected by each type of alteration was unique. Conclusion/Significance: This work, using a novel and robust statistical approach demonstrates that, although a "second hit'' mechanism is not likely the predominant mode of action for epigenetic dysregulation in cancer, the patterns of methylation events are associated with the patterns of allele loss. Our work further highlights the utility of integrative genomics approaches in exploring the driving somatic alterations in solid tumors.	[Poage, Graham M.; Kelsey, Karl T.] Brown Univ, Dept Mol Pharmacol, Providence, RI 02912 USA; [Poage, Graham M.; Kelsey, Karl T.] Brown Univ, Dept Physiol, Providence, RI 02912 USA; [Christensen, Brock C.; Marsit, Carmen J.; Kelsey, Karl T.] Brown Univ, Dept Pathol, Providence, RI 02912 USA; [Christensen, Brock C.; Marsit, Carmen J.; Kelsey, Karl T.] Brown Univ, Dept Lab Med, Providence, RI 02912 USA; [Christensen, Brock C.; Houseman, E. Andres; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Ctr Environm Hlth & Technol, Providence, RI 02912 USA; [Houseman, E. Andres] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [McClean, Michael D.] Boston Univ, Dept Environm Hlth, Boston, MA 02215 USA; [Wiencke, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Posner, Marshall R.] Dana Farber Canc Inst, Dept Med Oncol Solid Tumor Oncol, Boston, MA 02115 USA; [Clark, John R.] Massachusetts Gen Hosp, Dept Med Hematol Oncol, Boston, MA 02114 USA; [Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Brown University; Brown University; Brown University; Brown University; Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Poage, GM (corresponding author), Brown Univ, Dept Mol Pharmacol, Providence, RI 02912 USA.	Karl_Kelsey@Brown.edu	McClean, Michael D/J-2934-2015; Kelsey, Karl T/I-1252-2014; Christensen, Brock/B-8460-2009	McClean, Michael/0000-0002-3902-8823; Houseman, Eugene Andres/0000-0003-0703-1830; Marsit, Carmen/0000-0003-4566-150X; Nelson, Heather/0000-0003-1901-9513	Flight Attendant Medical Research Institute; National Institutes of Health [5R01CA078609-10, 2R01CA100679-06A1, 5RO1ES006717-13]; NATIONAL CANCER INSTITUTE [R01CA100679, R01CA078609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006717] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Flight Attendant Medical Research Institute (C. M. and M. M.), and the National Institutes of Health (5R01CA078609-10, 2R01CA100679-06A1, 5RO1ES006717-13) (K.K. and J.W.). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Andrews J, PLOS ONE, V5, pe8665; Arnold CN, 2004, CANCER BIOL THER, V3, P960, DOI 10.4161/cbt.3.10.1113; Ashman JNE, 2003, BRIT J CANCER, V89, P864, DOI 10.1038/sj.bjc.6601199; Bauer VL, 2008, J MOL MED, V86, P1353, DOI 10.1007/s00109-008-0397-0; Bergamo NA, 2005, CLIN CANCER RES, V11, P621; Bockmuhl U, 2000, AM J PATHOL, V157, P369, DOI 10.1016/S0002-9440(10)64549-X; Bockmuhl U, 2001, OTOLARYNG HEAD NECK, V124, P451, DOI 10.1067/mhn.2001.114794; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Christensen BC, 2009, CANCER RES, V69, P227, DOI 10.1158/0008-5472.CAN-08-2586; Costello Joseph F., 2009, V507, P131, DOI 10.1007/978-1-59745-522-0_11; Dikshit RP, 2007, CANCER-AM CANCER SOC, V110, P1745, DOI 10.1002/cncr.22975; Ell SR, 2002, LARYNGOSCOPE, V112, P1094, DOI 10.1097/00005537-200206000-00029; Furniss CS, 2007, INT J CANCER, V120, P2386, DOI 10.1002/ijc.22633; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Hassan KMA, 2001, HUM GENET, V109, P452; Hogg RP, 2002, EUR J CANCER, V38, P1585, DOI 10.1016/S0959-8049(01)00422-1; Houseman EA, 2009, BIOINFORMATICS, V25, P1999, DOI 10.1093/bioinformatics/btp364; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Huang Jing, 2004, Human Genomics, V1, P287; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jun P, 2009, NEURO-ONCOLOGY, V11, P414, DOI 10.1215/15228517-2008-096; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Li XH, 2008, CANCER PREV RES, V1, P413, DOI 10.1158/1940-6207.CAPR-08-0121; Lin LJ, 2008, ONCOLOGY-BASEL, V75, P102, DOI 10.1159/000155813; Marsit CJ, 2008, CANCER-AM CANCER SOC, V113, P1566, DOI 10.1002/cncr.23770; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Miracca EC, 1999, BRIT J CANCER, V81, P677, DOI 10.1038/sj.bjc.6690747; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Ohta S, 2009, ORAL SURG ORAL MED O, V107, P81, DOI 10.1016/j.tripleo.2008.08.027; Park JJ, 2008, GENE, V407, P139, DOI 10.1016/j.gene.2007.10.011; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Singh B, 2001, CANCER RES, V61, P4506; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Wolff E, 1998, ORAL ONCOL, V34, P186, DOI 10.1016/S1368-8375(97)00079-1; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang QF, 2002, CLIN CANCER RES, V8, P2890; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739	53	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9651	10.1371/journal.pone.0009651	http://dx.doi.org/10.1371/journal.pone.0009651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300172	Green Submitted, Green Published, gold			2022-12-27	WOS:000275620600007
J	Sintchenko, V; Anthony, S; Phan, XH; Lin, F; Coiera, EW				Sintchenko, Vitali; Anthony, Stephen; Phan, Xuan-Hieu; Lin, Frank; Coiera, Enrico W.			A PubMed-Wide Associational Study of Infectious Diseases	PLOS ONE			English	Article							GENOME; INTEGRATION; FEATURES; GENES	Background: Computational discovery is playing an ever-greater role in supporting the processes of knowledge synthesis. A significant proportion of the more than 18 million manuscripts indexed in the PubMed database describe infectious disease syndromes and various infectious agents. This study is the first attempt to integrate online repositories of text-based publications and microbial genome databases in order to explore the dynamics of relationships between pathogens and infectious diseases. Methodology/Principal Findings: Herein we demonstrate how the knowledge space of infectious diseases can be computationally represented and quantified, and tracked over time. The knowledge space is explored by mapping of the infectious disease literature, looking at dynamics of literature deposition, zooming in from pathogen to genome level and searching for new associations. Syndromic signatures for different pathogens can be created to enable a new and clinically focussed reclassification of the microbial world. Examples of syndrome and pathogen networks illustrate how multilevel network representations of the relationships between infectious syndromes, pathogens and pathogen genomes can illuminate unexpected biological similarities in disease pathogenesis and epidemiology. Conclusions/Significance: This new approach based on text and data mining can support the discovery of previously hidden associations between diseases and microbial pathogens, clinically relevant reclassification of pathogenic microorganisms and accelerate the translational research enterprise.	[Sintchenko, Vitali; Anthony, Stephen; Phan, Xuan-Hieu; Lin, Frank; Coiera, Enrico W.] Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia; [Sintchenko, Vitali] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch, Sydney, NSW 2006, Australia; [Sintchenko, Vitali] Westmead Hosp, Inst Clin Pathol & Med Res, Sydney W Area Hlth Serv, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Sintchenko, V (corresponding author), Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia.	vitali.sintchenko@sydney.edu.au	Lin, Frank/R-1275-2019	Lin, Frank/0000-0001-9250-6874; Sintchenko, Vitali/0000-0002-9261-3650; Coiera, Enrico/0000-0002-6444-6584; Phan, Xuan-Hieu/0000-0002-7640-9190	Australian Research Council [LP0667531]; National Health and Medical Research Council; Cerebral Palsy Institute	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cerebral Palsy Institute	We acknowledge the financial support from the Australian Research Council (LP0667531), National Health and Medical Research Council and the Cerebral Palsy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; [Anonymous], 2005, PRINCIPLES PRACTICE; Arakawa K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-31; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Browne Allen C, 2003, AMIA Annu Symp Proc, P798; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Chagoyen M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-41; Chaussabel Damien, 2004, Am J Pharmacogenomics, V4, P383, DOI 10.2165/00129785-200404060-00005; Davies V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006948; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; *DOE, DOE FUND GEN ENC BAC; *EUR BIOINF I, EUR BIOINF I DAT; Fielding AH, 2007, CLUSTER AND CLASSIFICATION TECHNIQUES FOR THE BIOSCIENCES, P1, DOI 10.2277/ 0521618002; Garner HR, 2007, IEEE ENG MED BIOL, V26, P73, DOI 10.1109/MEMB.2007.364934; Goh CS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-257; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Hanks P., 1990, COMPUT LINGUIST, V16, P22, DOI DOI 10.3115/981623.981633; Hickey TBM, 2009, INFECT IMMUN, V77, P3389, DOI 10.1128/IAI.00143-09; Hu YH, 2003, J PROTEOME RES, V2, P405, DOI 10.1021/pr0340227; Jelier R, 2005, BIOINFORMATICS, V21, P2049, DOI 10.1093/bioinformatics/bti268; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Koshland DE, 2007, SCIENCE, V317, P761, DOI 10.1126/science.1147166; KRALLINGER M, 2008, GENOME BIOL S2, V9, P58; Liu Y, 2006, PLOS COMPUT BIOL, V2, P1419, DOI 10.1371/journal.pcbi.0020159; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; R Development Core Team, 2005, R LANG ENV STAT COMP; Rodriguez-Esteban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000597; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; Slayden RA, 2009, J ANTIMICROB CHEMOTH, V63, P451, DOI 10.1093/jac/dkn507; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Vargas-Quesada B., 2007, VISUALIZING STRUCTUR; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xiang ZS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r150; Yu S, 2008, BIOINFORMATICS, V24, pI119, DOI 10.1093/bioinformatics/btn291; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zaremba S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-177	46	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9535	10.1371/journal.pone.0009535	http://dx.doi.org/10.1371/journal.pone.0009535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224767	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800007
J	Moore, M; Walsh, M; Bailey, J; Brunson, D; Gulland, F; Landry, S; Mattila, D; Mayo, C; Slay, C; Smith, J; Rowles, T				Moore, Michael; Walsh, Michael; Bailey, James; Brunson, David; Gulland, Frances; Landry, Scott; Mattila, David; Mayo, Charles; Slay, Christopher; Smith, Jamison; Rowles, Teresa			Sedation at Sea of Entangled North Atlantic Right Whales (Eubalaena glacialis) to Enhance Disentanglement	PLOS ONE			English	Article								Background: The objective of this study was to enhance removal of fishing gear from right whales (Eubalaena glacialis) at sea that evade disentanglement boat approaches. Titrated intra muscular injections to achieve sedation were undertaken on two free swimming right whales. Methodology/Principal Findings: Following initial trials with beached whales, a sedation protocol was developed for right whales. Mass was estimated from sighting and necropsy data from comparable right whales. Midazolam (0.01 to 0.025 mg/ kg) was first given alone or with meperidine (0.17 to 0.25 mg/kg) either once or four times over two hours to whale # 1102 by cantilevered pole syringe. In the last attempt on whale # 1102 there appeared to be a mild effect in 20-30 minutes, with duration of less than 2 hours that included exhalation before the blowhole fully cleared the water. Boat avoidance, used as a measure of sedation depth, was not reduced. A second severely entangled animal in 2009, whale # 3311, received midazolam (0.03 mg/kg) followed by butorphanol (0.03 mg/kg) an hour later, delivered ballistically. Two months later it was then given midazolam (0.07 mg/kg) and butorphanol (0.07 mg/kg) simultaneously. The next day both drugs at 0.1 mg/kg were given as a mixture in two darts 10 minutes apart. The first attempt on whale # 3311 showed increased swimming speed and boat avoidance was observed after a further 20 minutes. The second attempt on whale # 3311 showed respiration increasing mildly in frequency and decreasing in strength. The third attempt on whale # 3311 gave a statistically significant increase in respiratory frequency an hour after injection, with increased swimming speed and marked reduction of boat evasion that enabled decisive cuts to entangling gear. Conclusions/Significance: We conclude that butorphanol and midazolam delivered ballistically in appropriate dosages and combinations may have merit in future refractory free swimming entangled right whale cases until other entanglement solutions are developed.	[Moore, Michael] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Walsh, Michael; Bailey, James] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Brunson, David] Pfizer Inc, Vet Specialty Team Sedat Pain Management & Anesth, Madison, WI USA; [Gulland, Frances] Marine Mammal Ctr, Sausalito, CA USA; [Landry, Scott; Mayo, Charles] Provincetown Ctr Coastal Studies, Provincetown, MA USA; [Mattila, David] Natl Oceanog Atmospher Adm, Hawaiian Islands Humpback Whale Natl Marine Sanct, Natl Ocean Serv, Kihei, HI USA; [Slay, Christopher] Coastwise Consulting Inc, Athens, GA USA; [Smith, Jamison] Natl Oceanog Atmospher Adm, Protected Resources Div, Natl Marine Fisheries Serv, Gloucester, MA USA; [Rowles, Teresa] Natl Oceanog Atmospher Adm, Marine Mammal Conservat Div, Natl Marine Fisheries Serv, Silver Spring, MD USA	Woods Hole Oceanographic Institution; State University System of Florida; University of Florida; Pfizer; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Moore, M (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mmoore@whoi.edu	Moore, Michael/E-1707-2015	Moore, Michael/0000-0003-3074-6631	Cecil H; Ida M. Green Technology Innovation Program (WHOI); North Pond Foundation; Sloan and Wick Simmonds; Northeast Consortium; National Oceanic Atmospheric Administration (NOAA); Georgia Department of Natural Resources; Florida Fish and Wildlife Conservation Commission; Provincetown Center for Coastal Studies; Coastwise Consulting; Atlantic Large Whale Disentanglement Network; Aquatic Animal Health Program; University of Florida	Cecil H; Ida M. Green Technology Innovation Program (WHOI); North Pond Foundation; Sloan and Wick Simmonds; Northeast Consortium; National Oceanic Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Georgia Department of Natural Resources; Florida Fish and Wildlife Conservation Commission; Provincetown Center for Coastal Studies; Coastwise Consulting; Atlantic Large Whale Disentanglement Network; Aquatic Animal Health Program; University of Florida(University of Florida)	This work was funded by Cecil H. and Ida M. Green Technology Innovation Program (WHOI), North Pond Foundation, Sloan and Wick Simmonds, Northeast Consortium, National Oceanic Atmospheric Administration (NOAA), Georgia Department of Natural Resources, Florida Fish and Wildlife Conservation Commission, Provincetown Center for Coastal Studies, Coastwise Consulting, the Atlantic Large Whale Disentanglement Network, and Aquatic Animal Health Program, University of Florida. NOAA was centrally involved in the permitting and undertaking of the work. The Marine Mammal Protection Act of 1972 demands that this be so. The paper was drafted by all of the authors with no influence from NOAA as an agency in terms of how it was written. Coastwise Consulting provided logistic support for the 2009 field work. Provincetown Center for Coastal Studies provided support for ballistic technology development. Woods Hole Oceanographic Institution funded initial concept development. University of Florida funded drug acquisition. Despite some of the authors being employees of the above sources of funds, the administrators of the funds so granted had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Inc. had no financial involvement in the project.	BRUNSON D, 2002, P AM ASS ZOO VET, P320; CHITTICK E, 2006, P INT ASS AQ AN MED, P144; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gulland Frances M. D., 2008, Aquatic Mammals, V34, P182, DOI 10.1578/AM.34.2.2008.182; Haulena M, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P655; JOSEPH BE, 1988, J WILDLIFE DIS, V24, P691, DOI 10.7589/0090-3558-24.4.691; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lien J., 1986, Whalewatcher, V20, P3; Moore M.J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P301; Moore Michael J., 2004, Journal of Cetacean Research and Management, V6, P199; Reidarson TH, 1998, J ZOO WILDLIFE MED, V29, P451; SCHEVILL WE, 1967, SCIENCE, V157, P630, DOI 10.1126/science.157.3789.630; WALSH M, 2006, P AM ASS ZOO VET	13	24	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9597	10.1371/journal.pone.0009597	http://dx.doi.org/10.1371/journal.pone.0009597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231895	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300014
J	Bain, JM; Ziegler, A; Yang, ZG; Levison, SW; Sen, E				Bain, Jennifer M.; Ziegler, Amber; Yang, Zhengang; Levison, Steven W.; Sen, Ellora			TGF beta 1 Stimulates the Over-Production of White Matter Astrocytes from Precursors of the "Brain Marrow'' in a Rodent Model of Neonatal Encephalopathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEUKEMIA INHIBITORY FACTOR; HYPOXIC-ISCHEMIC INJURY; PERINATAL SUBVENTRICULAR ZONE; STEM-CELLS; TGF-BETA; OLIGODENDROCYTE PROGENITORS; IMMATURE OLIGODENDROCYTES; DEVELOPMENTAL-CHANGES; GLIAL RESPONSES	Background: In children born prematurely and those surviving cerebral ischemia there are white matter abnormalities that correlate with neurological dysfunction. Since this injury occurs in the immature brain, when the majority of subventricular zone (SVZ) cells generate white matter oligodendrocytes, we sought to study the effect this injury has on gliogenesis from the SVZ. We hypothesized that there is aberrant glial cell generation from the SVZ after neonatal hypoxia ischemia (H/I) that contributes to an increased astrogliogenesis with concomitant oligodendroglial insufficiency. Mechanistically we hypothesized that an increase in specific locally produced cytokines during recovery from injury were modifying the differentiation of glial progenitors towards astrocytes at the expense of the more developmentally-appropriate oligodendrocytes. Methodology/Principal Finding: For these studies we used the Vannucci H/I rat model where P6 rats are subjected to unilateral common carotid ligation followed by 75 min of systemic hypoxia. Retroviral lineage tracing studies combined with morphological and immunohistochemical analyses revealed the preferential generation of SVZ-derived white matter astrocytes instead of oligodendrocytes post hypoxia/ischemia. Microarray and QRT-PCR analyses of the damaged SVZ showed increased expression of several cytokines and receptors that are known to promote astrocyte differentiation, such as EGF, LIF and TGF beta signaling components. Using gliospheres to model the neonatal SVZ, we evaluated the effects of these cytokines on signal transduction pathways regulating astrocyte generation, proliferation and differentiation. These studies demonstrated that combinations of EGF, LIF and TGF beta 1 reconstituted the increased astrogliogenesis. TGF beta 1-induced Smad 2/3 phosphorylation and the combination of EGF, LIF and TGF beta 1 synergistically increased STAT3 phosphorylation over single or double cytokine combinations. Pharmacologically inhibiting ALK5 signaling in vitro antagonized the TGF beta 1-induced increase in astrocyte generation and antagonizing ALK5 signaling in vivo similarly inhibited astrogliogenesis within the SVZ during recovery from H/I. Conclusion/Significance: Altogether, these data indicate that there is aberrant specification of glial precursors within the neonatal SVZ during recovery from neonatal H/I that is a consequence of altered cytokine signaling. Our studies further suggest that antagonizing the ALK5 receptor will restore the normal pattern of cell differentiation after injury to the immature brain.	[Bain, Jennifer M.; Ziegler, Amber; Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, UH Canc Ctr, Newark, NJ 07103 USA; [Bain, Jennifer M.; Ziegler, Amber; Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Sen, Ellora] Natl Brain Res Ctr, Manesar, Haryana, India; [Yang, Zhengang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Yang, Zhengang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Fudan University; Fudan University	Bain, JM (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, UH Canc Ctr, 185 S Orange Ave, Newark, NJ 07103 USA.	steve.levison@umdnj.edu; ellora@nbrc.ac.in	Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Sen, Ellora/0000-0001-6842-7850	National Institute of Neurological Disorders and Stroke [F31NS062629]; National Institute of Mental Health [MH59950]; Department of Biotechnology, Government of India [BT/PR6615/MED/14/857/2005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062629] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke #F31NS062629 awarded to JMB, the National Institute of Mental Health #MH59950 awarded to SWL, and the Department of Biotechnology #BT/PR6615/MED/14/857/2005, Government of India, awarded to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Back SA, 1998, J NEUROSCI, V18, P6241; BAIN J, 2009, GLIAL DYSGENESIS CAU; Basu A, 2002, J NEUROSCI, V22, P6071; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Brazel CY, 2004, DEV NEUROSCI-BASEL, V26, P266, DOI 10.1159/000082143; BRAZEL CY, 2003, THESIS PENNSYLVANIA; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; BURTRUM D, 1994, EXP NEUROL, V126, P112, DOI 10.1006/exnr.1994.1047; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; CHAO CC, 1992, J CLIN INVEST, V90, P1786, DOI 10.1172/JCI116053; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Covey MV, 2007, NEUROSCIENCE, V148, P501, DOI 10.1016/j.neuroscience.2007.06.015; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Graham EM, 2004, NEUROBIOL DIS, V17, P89, DOI 10.1016/j.nbd.2004.05.007; GRESSENS P, 1992, BIOL NEONATE, V61, P4; HUNTER KE, 1993, GLIA, V7, P203, DOI 10.1002/glia.440070303; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; LAZAR LM, 1992, J NEUROSCI, V12, P1688; Levison SW, 2002, DEV NEUROSCI-BASEL, V24, P459; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Levison SW, 2001, DEV NEUROSCI-BASEL, V23, P234, DOI 10.1159/000046149; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LEVISON SW, 1999, J NEUROCHEMISTRY, V70; LOO DT, 1994, NEUROREPORT, V5, P1585, DOI 10.1097/00001756-199408150-00011; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Ness JK, 2002, MOL CELL NEUROSCI, V20, P476, DOI 10.1006/mcne.2002.1149; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Northington FJ, 2001, DEV NEUROSCI-BASEL, V23, P186, DOI 10.1159/000046141; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plane JM, 2004, NEUROBIOL DIS, V16, P585, DOI 10.1016/j.nbd.2004.04.003; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; RIVKIN MJ, 1995, ANN NEUROL, V38, P92, DOI 10.1002/ana.410380116; Robe PA, 2000, NEUROREPORT, V11, P2837, DOI 10.1097/00001756-200009110-00003; ROESSMANN U, 1986, ACTA NEUROPATHOL, V70, P302, DOI 10.1007/BF00686088; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; ROMANKO MJ, 2000, SOC NEUR ABST, V26, P281; RONALDSON PT, 2009, J CEREB BLOOD FLOW M; Saliba E, 2001, BIOL NEONATE, V79, P224; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Sun PZ, 2003, J MAGN RESON, V161, P168, DOI 10.1016/S1090-7807(02)00199-4; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; VANNUCCI RC, 1988, STROKE, V19, P245, DOI 10.1161/01.STR.19.2.245; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Viti J, 2003, J NEUROSCI, V23, P3385; WELSH FA, 1982, J CEREBR BLOOD F MET, V2, P221, DOI 10.1038/jcbfm.1982.22; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Yang ZG, 2007, DEV NEUROSCI-BASEL, V29, P331, DOI 10.1159/000105474; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068; Young GM, 1997, J NEUROSCI METH, V77, P163, DOI 10.1016/S0165-0270(97)00123-4; YOUNG GM, 1996, SOC NEUR ABST, V22; Zaidi AU, 2004, GLIA, V46, P380, DOI 10.1002/glia.20013; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024	82	30	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9567	10.1371/journal.pone.0009567	http://dx.doi.org/10.1371/journal.pone.0009567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221422	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197200016
J	Boyer, JG; Bhanot, K; Kothary, R; Boudreau-Lariviere, C				Boyer, Justin G.; Bhanot, Kunal; Kothary, Rashmi; Boudreau-Lariviere, Celine			Hearts of Dystonia musculorum Mice Display Normal Morphological and Histological Features but Show Signs of Cardiac Stress	PLOS ONE			English	Article							BULLOUS PEMPHIGOID ANTIGEN-1; CROSS-LINKING FACTOR; MUSCLE CYTOARCHITECTURE; INTERMEDIATE-FILAMENTS; SKELETAL-MUSCLE; BPAG1 LOCUS; ACTIN; PLECTIN; HYPERTROPHY; INTEGRITY	Dystonin is a giant cytoskeletal protein belonging to the plakin protein family and is believed to crosslink the major filament systems in contractile cells. Previous work has demonstrated skeletal muscle defects in dystonin-deficient dystonia musculorum (dt) mice. In this study, we show that the dystonin muscle isoform is localized at the Z-disc, the H zone, the sarcolemma and intercalated discs in cardiac tissue. Based on this localization pattern, we tested whether dystonin-deficiency leads to structural defects in cardiac muscle. Desmin intermediate filament, microfilament, and microtubule subcellular organization appeared normal in dt hearts. Nevertheless, increased transcript levels of atrial natriuretic factor (ANF, 66%) beta-myosin heavy chain (beta-MHC, 95%) and decreased levels of sarcoplasmic reticulum calcium pump isoform 2A (SERCA2a, 26%), all signs of cardiac muscle stress, were noted in dt hearts. Hearts from two-week old dt mice were assessed for the presence of morphological and histological alterations. Heart to body weight ratios as well as left ventricular wall thickness and left chamber volume measurements were similar between dt and wild-type control mice. Hearts from dt mice also displayed no signs of fibrosis or calcification. Taken together, our data provide new insights into the intricate structure of the sarcomere by situating dystonin in cardiac muscle fibers and suggest that dystonin does not significantly influence the structural organization of cardiac muscle fibers during early postnatal development.	[Boyer, Justin G.; Boudreau-Lariviere, Celine] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada; [Boudreau-Lariviere, Celine] Laurentian Univ, Sch Human Kinet, Sudbury, ON P3E 2C6, Canada; [Boudreau-Lariviere, Celine] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Boyer, Justin G.; Bhanot, Kunal; Kothary, Rashmi] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Boyer, Justin G.; Bhanot, Kunal; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Laurentian University; Laurentian University; Laurentian University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Boyer, JG (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	cboudreaulariviere@laurentian.ca		Kothary, Rashmi/0000-0002-9239-7310	National Science and Engineering Research Council of Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by research grants from the National Science and Engineering Research Council of Canada (C. B.- L.) and Canadian Institutes of Health Research (R. K.). J. G. B. was a recipient of a Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada at the time this study was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Boudreau-Lariviere C, 2002, DIFFERENTIATION, V70, P247, DOI 10.1046/j.1432-0436.2002.700603.x; BOYER JG, 2009, PLAKINS STRIATED MUS; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367; DUCHEN LW, 1962, J PHYS, V165, P7; FRANCH HA, 1988, CIRC RES, V62, P31, DOI 10.1161/01.RES.62.1.31; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jefferson JJ, 2006, EXP CELL RES, V312, P2712, DOI 10.1016/j.yexcr.2006.04.025; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Konieczny P, 2008, ADV EXP MED BIOL, V642, P165; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Lin CM, 2005, J CELL SCI, V118, P3727, DOI 10.1242/jcs.02510; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Steiner-Champliaud MF, 2010, EXP CELL RES, V316, P297, DOI 10.1016/j.yexcr.2009.11.010; TANAKA T, 1991, J BIOL CHEM, V266, P12555; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Young KG, 2008, EXP CELL RES, V314, P2750, DOI 10.1016/j.yexcr.2008.06.021; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235; Young KG, 2005, EXP CELL RES, V312, P121, DOI 10.1016/j.yexcr.2005.10.002; Young KG, 2003, J CELL SCI, V116, P4543, DOI 10.1242/jcs.00764	35	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9465	10.1371/journal.pone.0009465	http://dx.doi.org/10.1371/journal.pone.0009465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209123	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997100012
J	Keckeis, M; Lattova, Z; Maurovich-Horvat, E; Beitinger, PA; Birkmann, S; Lauer, CJ; Wetter, TC; Wilde-Frenz, J; Pollmacher, T				Keckeis, Marietta; Lattova, Zuzana; Maurovich-Horvat, Eszter; Beitinger, Pierre A.; Birkmann, Steffen; Lauer, Christoph J.; Wetter, Thomas C.; Wilde-Frenz, Johanna; Pollmaecher, Thomas			Impaired Glucose Tolerance in Sleep Disorders	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; FASTING PLASMA-GLUCOSE; OBESITY; INDEX; APNEA; RISK; EPIDEMIOLOGY; ASSOCIATION	Background: Recent epidemiological and experimental data suggest a negative influence of shortened or disturbed night sleep on glucose tolerance. Due to the high prevalence of sleep disorders this might be a major health issue. However, no comparative studies of carbohydrate metabolism have been conducted in clinical sleep disorders. Methodology/Principal Findings: We performed oral glucose tolerance tests (OGTT) and assessed additional parameters of carbohydrate metabolism in patients suffering from obstructive sleep apnea syndrome (OSAS, N = 25), restless legs syndrome (RLS, N = 18) or primary insomnia (N = 21), and in healthy controls (N = 33). Compared to controls, increased rates of impaired glucose tolerance were found in OSAS (OR: 4.9) and RLS (OR: 4.7) patients, but not in primary insomnia patients (OR: 1.6). In addition, HbA1c values were significantly increased in the same two patient groups. Significant positive correlations were found between 2-h plasma glucose values measured during the OGTT and the apnea-arousal-index in OSAS (r = 0.56; p < 0.05) and the periodic leg movement-arousal-index in RLS (r = 0.56, p, 0.05), respectively. Sleep duration and other quantitative aspects of sleep were similar between patient groups. Conclusions/Significance: Our findings suggest that some, but not all sleep disorders considerably compromise glucose metabolism. Repeated arousals during sleep might be a pivotal causative factor deserving further experimental investigations to reveal potential novel targets for the prevention of metabolic diseases.	[Keckeis, Marietta; Lattova, Zuzana; Maurovich-Horvat, Eszter; Beitinger, Pierre A.; Wetter, Thomas C.; Pollmaecher, Thomas] Max Planck Inst Psychiat, Munich, Germany; [Keckeis, Marietta; Lattova, Zuzana; Maurovich-Horvat, Eszter; Birkmann, Steffen; Lauer, Christoph J.; Wilde-Frenz, Johanna; Pollmaecher, Thomas] Klinikum Ingolstadt, Ctr Mental Hlth, Ingolstadt, Germany	Max Planck Society	Keckeis, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	thomas.pollmaecher@klinikum-ingolstadt.de			European Union Framework 6 [MCRTN-CT-2004-512362]	European Union Framework 6(European Commission)	This study was supported by the European Union Framework 6 (MCRTN-CT-2004-512362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; BONNET M, 1993, SLEEP, V16, P748; BONNET MH, 1992, SLEEP, V15, P526; Bosco D, 2009, J NEUROL SCI, V287, P60, DOI 10.1016/j.jns.2009.09.008; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Gao X, 2009, NEUROLOGY, V72, P1255, DOI 10.1212/01.wnl.0000345673.35676.1c; Garcia-Borreguero D, 2006, EUR J NEUROL, V13, P15, DOI 10.1111/j.1468-1331.2006.01587.x; Genuth S, 2003, DIABETES CARE, V26, P3160; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Heidemann C, 2009, EUR J EPIDEMIOL, V24, P281, DOI 10.1007/s10654-009-9338-7; Hornyak M, 2007, SLEEP, V30, P861, DOI 10.1093/sleep/30.7.861; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Inoue K, 2007, DIABETES RES CLIN PR, V77, P451, DOI 10.1016/j.diabres.2007.01.024; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Ko GTC, 2000, DIABETES CARE, V23, P1290, DOI 10.2337/diacare.23.9.1290; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merlino G, 2007, SLEEP, V30, P866, DOI 10.1093/sleep/30.7.866; Narkiewicz K, 2003, ACTA PHYSIOL SCAND, V177, P385, DOI 10.1046/j.1365-201X.2003.01091.x; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Pollmacher T, 2007, SLEEP MED CLIN, V2, P293, DOI 10.1016/j.jsmc.2007.03.002; Rechtschaffen A., MANUAL STANDARDIZED; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Takahashi Masaki, 2001, Journal of the Japan Diabetes Society, V44, P745; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; Walters AS, 2009, SLEEP, V32, P589, DOI 10.1093/sleep/32.5.589; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; WOLEVER TMS, 1986, AM J CLIN NUTR, V43, P167, DOI 10.1093/ajcn/43.1.167	35	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9444	10.1371/journal.pone.0009444	http://dx.doi.org/10.1371/journal.pone.0009444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209158	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997100002
J	Chou, KC; Shen, HB				Chou, Kuo-Chen; Shen, Hong-Bin			A New Method for Predicting the Subcellular Localization of Eukaryotic Proteins with Both Single and Multiple Sites: Euk-mPLoc 2.0	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; LOCATION PREDICTION; APOPTOSIS PROTEINS; GENE ONTOLOGY; DOMAIN; DATABASE; BIOINFORMATICS; CLASSIFICATION; DISCRIMINANT	Information of subcellular locations of proteins is important for in-depth studies of cell biology. It is very useful for proteomics, system biology and drug development as well. However, most existing methods for predicting protein subcellular location can only cover 5 to 12 location sites. Also, they are limited to deal with single-location proteins and hence failed to work for multiplex proteins, which can simultaneously exist at, or move between, two or more location sites. Actually, multiplex proteins of this kind usually posses some important biological functions worthy of our special notice. A new predictor called "Euk-mPLoc 2.0'' is developed by hybridizing the gene ontology information, functional domain information, and sequential evolutionary information through three different modes of pseudo amino acid composition. It can be used to identify eukaryotic proteins among the following 22 locations: (1) acrosome, (2) cell wall, (3) centriole, (4) chloroplast, (5) cyanelle, (6) cytoplasm, (7) cytoskeleton, (8) endoplasmic reticulum, (9) endosome, (10) extracell, (11) Golgi apparatus, (12) hydrogenosome, (13) lysosome, (14) melanosome, (15) microsome (16) mitochondria, (17) nucleus, (18) peroxisome, (19) plasma membrane, (20) plastid, (21) spindle pole body, and (22) vacuole. Compared with the existing methods for predicting eukaryotic protein subcellular localization, the new predictor is much more powerful and flexible, particularly in dealing with proteins with multiple locations and proteins without available accession numbers. For a newly-constructed stringent benchmark dataset which contains both single- and multiple-location proteins and in which none of proteins has >= 25% pairwise sequence identity to any other in a same location, the overall jackknife success rate achieved by Euk-mPLoc 2.0 is more than 24% higher than those by any of the existing predictors. As a user-friendly web-server, Euk-mPLoc 2.0 is freely accessible at http://www.csbio.sjtu.edu.cn/bioinf/euk-multi-2/. For a query protein sequence of 400 amino acids, it will take about 15 seconds for the web-server to yield the predicted result; the longer the sequence is, the more time it may usually need. It is anticipated that the novel approach and the powerful predictor as presented in this paper will have a significant impact to Molecular Cell Biology, System Biology, Proteomics, Bioinformatics, and Drug Development.	[Chou, Kuo-Chen; Shen, Hong-Bin] Gordon Life Sci Inst, San Diego, CA USA; [Chou, Kuo-Chen; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chou, KC (corresponding author), Gordon Life Sci Inst, San Diego, CA USA.	kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60704047]; Science and Technology Commission of Shanghai Municipality [08ZR1410600, 08JC1410600]; Shanghai Municipal Education Commission [10ZZ17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the National Natural Science Foundation of China (Grant No. 60704047), Science and Technology Commission of Shanghai Municipality (Grant No. 08ZR1410600, 08JC1410600), sponsored by Shanghai Pujiang Program and Innovation Program of Shanghai Municipal Education Commission (10ZZ17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Gonzalez-Diaz H, 2009, CURR PROTEOMICS, V6, P214, DOI 10.2174/157016409789973789; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; Jahandideh S, 2007, J THEOR BIOL, V249, P785, DOI 10.1016/j.jtbi.2007.09.002; Jahandideh S, 2007, BIOPHYS CHEM, V128, P87, DOI 10.1016/j.bpc.2007.03.006; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; JIANG Y, 2008, J COMPUT CHEM; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Murvai J, 2001, NUCLEIC ACIDS RES, V29, P58, DOI 10.1093/nar/29.1.58; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Nanni L, 2009, PROTEIN PEPTIDE LETT, V16, P163, DOI 10.2174/092986609787316199; Perez-Montoto LG, 2009, CURR PROTEOMICS, V6, P246, DOI 10.2174/157016409789973761; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SMITH C, 2008, SUBCELLULAR TARGETIN; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vilar S, 2009, J THEOR BIOL, V261, P449, DOI 10.1016/j.jtbi.2009.07.031; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	68	300	310	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9931	10.1371/journal.pone.0009931	http://dx.doi.org/10.1371/journal.pone.0009931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368981	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200009
J	Oleksiak, A; Manko, M; Postma, A; van der Ham, IJM; van den Berg, AV; van Wezel, RJA				Oleksiak, Anna; Manko, Miroslawa; Postma, Albert; van der Ham, Ineke J. M.; van den Berg, Albert V.; van Wezel, Richard J. A.			Distance Estimation Is Influenced by Encoding Conditions	PLOS ONE			English	Article							RECEPTIVE-FIELD SIZE; VISUAL-SPATIAL INFORMATION; PSYCHOPHYSICS TOOLBOX; STRIATE CORTEX; SERIAL MEMORY; EYE-MOVEMENTS; FOVEAL BIAS; REPULSION; POSITION; ECCENTRICITY	Background: It is well established that foveating a behaviorally relevant part of the visual field improves localization performance as compared to the situation where the gaze is directed elsewhere. Reduced localization performance in the peripheral encoding conditions has been attributed to an eccentricity-dependent increase in positional uncertainty. It is not known, however, whether and how the foveal and peripheral encoding conditions can influence spatial interval estimation. In this study we compare observers' estimates of a distance between two co-planar dots in the condition where they foveate the two sample dots and where they fixate a central dot while viewing the sample dots peripherally. Methodology/Principal Findings: Observers were required to reproduce, after a short delay, a distance between two sample dots based on a stationary reference dot and a movable mouse pointer. When both sample dots are foveated, we find that the distance estimation error is small but consistently increases with the dots-separation size. In comparison, distance judgment in peripheral encoding condition is significantly overestimated for smaller separations and becomes similar to the performance in foveal trials for distances from 10 to 16 degrees. Conclusions/Significance: Although we find improved accuracy of distance estimation in the foveal condition, the fact that the difference is related to the reduction of the estimation bias present in the peripheral conditon, challenges the simple account of reducing the eccentricity-dependent positional uncertainty. Contrary to this, we present evidence for an explanation in terms of neuronal populations activated by the two sample dots and their inhibitory interactions under different visual encoding conditions. We support our claims with simulations that take into account receptive fields size differences between the two encoding conditions.	[Oleksiak, Anna; Manko, Miroslawa; van Wezel, Richard J. A.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Oleksiak, Anna; van den Berg, Albert V.; van Wezel, Richard J. A.] Univ Utrecht, Funct Neurobiol & Helmholtz Inst, Utrecht, Netherlands; [Postma, Albert; van der Ham, Ineke J. M.] Univ Utrecht, Expt Psychol & Helmholtz Inst, Utrecht, Netherlands; [van Wezel, Richard J. A.] Univ Twente, Biomed Signals & Syst Grp, NL-7500 AE Enschede, Netherlands	Utrecht University; Utrecht University; Utrecht University; University of Twente	Oleksiak, A (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	a.oleksiak@uu.nl	van den Berg, Albert/G-3108-2012; van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069; van den Berg, Albert Victor/0000-0002-1543-5408; van der Ham, Ineke/0000-0003-2520-7422	Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant of the Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl/NWOHome.nsf/pages/NWOP_5T8EXB) (Evolution and Behaviour: 051-14-027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; ANDREWS DP, 1978, VISION RES, V18, P615, DOI 10.1016/0042-6989(78)90140-2; BLAKEMOR.C, 1970, NATURE, V228, P37, DOI 10.1038/228037a0; BOUMA H, 1970, VISION RES, V10, P333, DOI 10.1016/0042-6989(70)90104-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURBECK CA, 1987, VISION RES, V27, P417, DOI 10.1016/0042-6989(87)90090-3; Carandini M, 1997, VISION RES, V37, P3061, DOI 10.1016/S0042-6989(97)00100-4; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; DOW BM, 1981, EXP BRAIN RES, V44, P213; FISCHER B, 1970, EXP BRAIN RES, V11, P448; FISCHER B, 1973, VISION RES, V13, P2113, DOI 10.1016/0042-6989(73)90188-0; HESS RF, 1994, VISION RES, V34, P625, DOI 10.1016/0042-6989(94)90018-3; Hiris E, 1996, VISUAL NEUROSCI, V13, P187, DOI 10.1017/S0952523800007227; INUI T, 1981, J OPT SOC AM, V71, P151, DOI 10.1364/JOSA.71.000151; ISRAEL I, 1992, EXP BRAIN RES, V90, P221; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kerzel D, 2002, VISION RES, V42, P159, DOI 10.1016/S0042-6989(01)00274-7; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; KINGSTONE A, 1993, J EXP PSYCHOL HUMAN, V19, P1251, DOI 10.1037/0096-1523.19.6.1251; LEVI DM, 1990, VISION RES, V30, P557, DOI 10.1016/0042-6989(90)90068-V; LEVI DM, 1988, VISION RES, V28, P597, DOI 10.1016/0042-6989(88)90109-5; MARSHAK W, 1979, SCIENCE, V205, P1399, DOI 10.1126/science.472756; MATEEFF S, 1983, BIOL CYBERN, V49, P111, DOI 10.1007/BF00320391; Mikaelian S, 2000, VISION RES, V40, P2999, DOI 10.1016/S0042-6989(00)00143-7; OEHLER R, 1985, EXP BRAIN RES, V59, P217; OTOOLE B, 1977, VISION RES, V17, P367, DOI 10.1016/0042-6989(77)90025-6; OYAMA T, 1978, PSYCHOL RES-PSYCH FO, V40, P101, DOI 10.1007/BF00308406; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poirier FJAM, 2005, VISION RES, V45, P2436, DOI 10.1016/j.visres.2005.03.007; Polimeni JR, 2006, VISION RES, V46, P3336, DOI 10.1016/j.visres.2006.03.006; Rauber HJ, 1999, VISION RES, V39, P3187, DOI 10.1016/S0042-6989(99)00025-5; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; Rijpkema M, 2008, BRAIN RES, V1189, P90, DOI 10.1016/j.brainres.2007.10.100; Saint-Aubin J, 2007, EXP PSYCHOL, V54, P264, DOI 10.1027/1618-3169.54.4.264; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; STEVENSON SB, 1991, VISION RES, V31, P805, DOI 10.1016/0042-6989(91)90148-X; TAM WJ, 1994, PERCEPT PSYCHOPHYS, V56, P251, DOI 10.3758/BF03209759; Terao Y, 2002, J NEUROPHYSIOL, V88, P1716, DOI 10.1152/jn.2002.88.4.1716; TOET A, 1988, VISION RES, V28, P535, DOI 10.1016/0042-6989(88)90175-7; Tremblay S, 2006, PSYCHON B REV, V13, P452, DOI 10.3758/BF03193869; TRUJILLIORTIZ A, 2004, RMAOV2 2 WAY REPEATE; Uddin MK, 2005, VISION RES, V45, P3301, DOI 10.1016/j.visres.2005.03.006; WESTHEIMER G, 1977, VISION RES, V17, P941, DOI 10.1016/0042-6989(77)90069-4; Westheimer G, 1998, VISION RES, V38, P487, DOI 10.1016/S0042-6989(97)00192-2; WHITE JM, 1992, VISION RES, V32, P513, DOI 10.1016/0042-6989(92)90243-C; WILSON ME, 1970, J PHYSIOL-LONDON, V207, P611, DOI 10.1113/jphysiol.1970.sp009083; YAP YL, 1989, VISION RES, V29, P789, DOI 10.1016/0042-6989(89)90091-6; Yazdanbakhsh A, 2008, NEUROSCI LETT, V438, P246, DOI 10.1016/j.neulet.2008.04.040	53	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9918	10.1371/journal.pone.0009918	http://dx.doi.org/10.1371/journal.pone.0009918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360953	Green Published, gold			2022-12-27	WOS:000276163100011
J	Weimerskirch, H; Bertrand, S; Silva, J; Marques, JC; Goya, E				Weimerskirch, Henri; Bertrand, Sophie; Silva, Jaime; Carlos Marques, Jose; Goya, Elisa			Use of Social Information in Seabirds: Compass Rafts Indicate the Heading of Food Patches	PLOS ONE			English	Article							PUBLIC INFORMATION; COLONIES; BEHAVIOR; CENTERS; BIRD; PERU	Ward and Zahavi suggested in 1973 that colonies could serve as information centres, through a transfer of information on the location of food resources between unrelated individuals (Information Centre Hypothesis). Using GPS tracking and observations on group movements, we studied the search strategy and information transfer in two of the most colonial seabirds, Guanay cormorants (Phalacrocorax bougainvillii) and Peruvian boobies (Sula variegata). Both species breed together and feed on the same prey. They do return to the same feeding zone from one trip to the next indicating high unpredictability in the location of food resources. We found that the Guanay cormorants use social information to select their bearing when departing the colony. They form a raft at the sea surface whose position is continuously adjusted to the bearing of the largest returning columns of cormorants. As such, the raft serves as a compass signal that gives an indication on the location of the food patches. Conversely, Peruvian boobies rely mainly on personal information based on memory to take heading at departure. They search for food patches solitarily or in small groups through network foraging by detecting the white plumage of congeners visible at long distance. Our results show that information transfer does occur and we propose a new mechanism of information transfer based on the use of rafts off colonies. The use of rafts for information transfer may be common in central place foraging colonial seabirds that exploit short lasting and/or unpredictably distributed food patches. Over the past decades Guanay cormorants have declined ten times whereas Peruvian boobies have remained relatively stable. We suggest that the decline of the cormorants could be related to reduced social information opportunities and that social behaviour and search strategies have the potential to play an important role in the population dynamics of colonial animals.	[Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Bertrand, Sophie] Ctr Rech Halieuth, Inst Rech Dev, Sete, France; [Bertrand, Sophie; Silva, Jaime; Carlos Marques, Jose; Goya, Elisa] Inst Mar Peru, Direcc Recursos Pelag, Callao, Peru	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; bertrand, sophie/F-4161-2012	Weimerskirch, Henri/0000-0002-0457-586X; bertrand, sophie/0000-0003-1976-3799	CNRS-INEE (Centre National de la Recherche Scientifique - Institut National Ecologie et Environnement); IRD (Institut de Recherche pour le Developpement) and IMARPE (Institut del Mar del Peru)	CNRS-INEE (Centre National de la Recherche Scientifique - Institut National Ecologie et Environnement); IRD (Institut de Recherche pour le Developpement) and IMARPE (Institut del Mar del Peru)	This study was funded by CNRS-INEE (Centre National de la Recherche Scientifique - Institut National Ecologie et Environnement), IRD (Institut de Recherche pour le Developpement) and IMARPE (Institut del Mar del Peru). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; BRETAGNOLLE V, 1993, AM NAT, V142, P141, DOI 10.1086/285532; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Burger AE, 1997, COLON WATERBIRD, V20, P55, DOI 10.2307/1521764; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; EVANS RM, 1982, AUK, V99, P24, DOI 10.2307/4086018; GASTON A.J., 1981, WILDLIFE MONOGRAPH, V6; Giraldeau L.A., 2000, MG BEH ECOL; Goya E., 2000, B I MAR PERU, V19, P125; GREENE E, 1987, NATURE, V329, P239, DOI 10.1038/329239a0; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jahncke J., 1998, B I MAR PERU, V17, P15; JORDAN R, 1967, REP CALIF COOP OCEAN, V11, P105; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Lack D., 1968, pvii; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; MILINSKI M, 1994, ECOLOGY, V75, P1150, DOI 10.2307/1939438; MOCK DW, 1988, ORNIS SCAND, V19, P231, DOI 10.2307/3676564; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; NEVITT G, 1999, BIRDLIFE S AFRICA, P2072; Orians G.H., 1979, P155; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; TOVAR H, 1987, ICLARM REV STUDIES; VALONE T, 1989, GROUP FORAGING PUBLI, P357; WAGNER R, 2009, OIKOS, P9999; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wittenberger J.F., 1985, Avian Biology, V8, P1; Zavalaga CB, 1999, S AFR J MARINE SCI, V21, P251	40	94	94	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9928	10.1371/journal.pone.0009928	http://dx.doi.org/10.1371/journal.pone.0009928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360959	gold, Green Published, Green Submitted			2022-12-27	WOS:000276163100020
J	Ding, ZY; Liang, JY; Li, J; Lu, YL; Ariyaratna, V; Lu, ZM; Davies, MA; Westwick, JK; Mills, GB				Ding, Zhiyong; Liang, Jiyong; Li, Jin; Lu, Yiling; Ariyaratna, Vathsala; Lu, Zhimin; Davies, Michael A.; Westwick, John K.; Mills, Gordon B.			Physical Association of PDK1 with AKT1 Is Sufficient for Pathway Activation Independent of Membrane Localization and Phosphatidylinositol 3 Kinase	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; RICTOR-MTOR COMPLEX; FLUORESCENT PROTEIN; PH DOMAIN; PHOSPHORYLATION; AKT/PKB; IDENTIFICATION; TRANSLOCATION; INHIBITION; MECHANISM	Frequent activation of the AKT serine-threonine kinase in cancer confers resistance to therapy. AKT is activated by a multistep process involving phosphatidylinositide (PtdIns) phosphate-mediated recruitment of AKT and its upstream kinases, including 3-Phosphoinositide-dependent kinase 1 (PDK1), to the inner surface of the cell membrane. PDK1 in the appropriate context phosphorylates AKT at threonine 308 (T308) to activate AKT. Whether PtdIns(3,4,5) Ps (PtdInsP3) binding and AKT membrane translocation mediate functions other than formation of a functional PDK1:: AKT complex have not been fully elucidated. We fused complementary fragments of intensely fluorescent protein (IFP) to AKT1 and PDK1 to induce a stable complex to study the prerequisites of AKT1 phosphorylation and function. In the stabilized PDK1-IFPC::IFPN-AKT1 complex, AKT1 T308 phosphorylation was independent of PtdIns, as demonstrated by treatment with Phosphatidylinositol 3 Kinase (PI3K) inhibitors. Further when interaction with PtdIns and the cell membrane was prevented by creating PH-domain mutants of AKT1 (R25A) and PDK1 (R474A), AKT1 phosphorylation on T308 was maintained in the PDK1-IFPC::IFPN-AKT1 complex. The PDK1-IFPC::IFPN-AKT1 complex was sufficient for phosphorylation of known AKT substrates, and conferred resistance to inhibitors of PI3K (LY294002, PI103, GDC0941 and TGX286) but not inhibitors of the downstream TORC1 complex (rapamycin). Thus the locus of action of targeted therapeutics can be elucidated by the constitutively active AKT1 complex. Our data indicate that PtdIns and membrane localization are not required for AKT phosphorylation and activation, but rather serve to induce a functional physical interaction between PDK1 and AKT. The PDK1-IFPC::IFPN-AKT1 complex provides a cell-based platform to examine specificity of drugs targeting PI3K pathway components.	[Ding, Zhiyong; Liang, Jiyong; Li, Jin; Lu, Yiling; Ariyaratna, Vathsala; Davies, Michael A.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Westwick, John K.] Odyssey Thera Inc, San Ramon, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ding, ZY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	zding@mdanderson.org	Davies, Michael/GWV-2527-2022		National Institutes of Health (NIH) [5R21CA126700]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, R21CA126700] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Innovative Molecular Analysis Technologies (IMAT) grant 5R21CA126700 to Z.D. http://innovation.cancer.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson E.W., 1998, J SERV RES-US, V1, P5, DOI DOI 10.1177/109467059800100102; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Howe CJ, 2002, J BIOL CHEM, V277, P30469, DOI 10.1074/jbc.M205036200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; KERPPOLA TK, 2006, NAT REV MOL CELL BIO; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; LaHair MM, 2006, ANTIOXID REDOX SIGN, V8, P1749, DOI 10.1089/ars.2006.8.1749; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; MACDONALD ML, 2006, NAT CHEM BIOL; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Saji M, 2005, BIOCHEM BIOPH RES CO, V332, P167, DOI 10.1016/j.bbrc.2005.04.109; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	32	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9910	10.1371/journal.pone.0009910	http://dx.doi.org/10.1371/journal.pone.0009910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361045	Green Submitted, Green Published, gold			2022-12-27	WOS:000275969600016
J	Evans-Roberts, KM; Breuer, C; Wall, MK; Sugimoto-Shirasu, K; Maxwell, A				Evans-Roberts, Katherine M.; Breuer, Christian; Wall, Melisa K.; Sugimoto-Shirasu, Keiko; Maxwell, Anthony			Arabidopsis thaliana GYRB3 Does Not Encode a DNA Gyrase Subunit	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING DOMAIN; ARABIDOPSIS; TOPOISOMERASES; SEQUENCES; ALIGNMENT; COMPLEX; ENERGY; SERVER	Background: DNA topoisomerases are enzymes that control the topology of DNA in all cells. DNA gyrase is unique among the topoisomerases in that it is the only enzyme that can actively supercoil DNA using the free energy of ATP hydrolysis. Until recently gyrase was thought to be unique to bacteria, but has now been discovered in plants. The genome of the model plant, Arabidopsis thaliana, is predicted to encode four gyrase subunits: AtGyrA, AtGyrB1, AtGyrB2 and AtGyrB3. Methodology/Principal Findings: We found, contrary to previous data, that AtGyrB3 is not essential to the survival of A. thaliana. Bioinformatic analysis suggests AtGyrB3 is considerably shorter than other gyrase B subunits, lacking part of the ATPase domain and other key motifs found in all type II topoisomerases; but it does contain a putative DNA-binding domain. Partially purified AtGyrB3 cannot bind E. coli GyrA or support supercoiling. AtGyrB3 cannot complement an E. coli gyrB temperature-sensitive strain, whereas AtGyrB2 can. Yeast two-hybrid analysis suggests that AtGyrB3 cannot bind to AtGyrA or form a dimer. Conclusions/Significance: These data strongly suggest that AtGyrB3 is not a gyrase subunit but has another unknown function. One possibility is that it is a nuclear protein with a role in meiosis in pollen.	[Evans-Roberts, Katherine M.; Breuer, Christian; Wall, Melisa K.; Maxwell, Anthony] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Breuer, Christian; Sugimoto-Shirasu, Keiko] RIKEN, Plant Sci Ctr, Kanagawa, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; RIKEN	Evans-Roberts, KM (corresponding author), Papworth Hosp, Hlth Enterprise E Ltd, Papworth Everard, Everard, England.	tony.maxwell@bbsrc.ac.uk	Sugimoto, Keiko/B-3368-2010; Breuer, Christian/A-8977-2011	Sugimoto, Keiko/0000-0002-9209-8230; Maxwell, Anthony/0000-0002-5756-6430	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC); KMER was funded jointly by a studentship from BBSRC and Syngenta (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Bates A. D., 2005, DNA TOPOLOGY; Bates AD, 2007, BIOCHEMISTRY-US, V46, P7929, DOI 10.1021/bi700789g; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Caron P R, 1994, Adv Pharmacol, V29B, P271; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Costenaro L, 2007, STRUCTURE, V15, P329, DOI 10.1016/j.str.2007.01.013; Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249; DONG KC, 2008, PROTEIN NUCL ACID IN; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim OK, 2001, EXPERT OPIN INV DRUG, V10, P199, DOI 10.1517/13543784.10.2.199; Maxwell A, 1999, METH MOL B, V94, P135; Maxwell A, 1999, BIOCHEM SOC T, V27, P48, DOI 10.1042/bst0270048; Maxwell A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gk1054; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Morgante CV, 2009, MOL GENET GENOMICS, V281, P525, DOI 10.1007/s00438-009-0429-7; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; Wall MK, 2004, P NATL ACAD SCI USA, V101, P7821, DOI 10.1073/pnas.0400836101; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; YAMAGISHI J, 1986, MOL GEN GENET, V204, P367, DOI 10.1007/BF00331012; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9899	10.1371/journal.pone.0009899	http://dx.doi.org/10.1371/journal.pone.0009899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360860	Green Submitted, Green Published, gold			2022-12-27	WOS:000275969600007
J	Thariani, R; Yager, P				Thariani, Rahber; Yager, Paul			Imaging of Surfaces by Concurrent Surface Plasmon Resonance and Surface Plasmon Resonance-Enhanced Fluorescence	PLOS ONE			English	Article							SPECTROSCOPY; IMMUNOASSAY; MICROSCOPE; KINETICS; HEALTH; ADSORPTION; DEPENDENCE; FILMS; ACID; CARE	Surface plasmon resonance imaging and surface plasmon induced fluorescent are sensitive tools for surface analysis. However, existing instruments in this area have provided limited capability for concurrent detection, and may be large and expensive. We demonstrate a highly cost-effective system capable of concurrent surface plasmon resonance microscopy (SPRM) and surface plasmon resonance-enhanced fluorescence (SPRF) imaging, allowing for simultaneous monitoring of reflectivity and fluorescence from discrete spatial regions. The instrument allows for high performance imaging and quantitative measurements with surface plasmon resonance, and surface plasmon induced fluorescence, with inexpensive off-the-shelf components.	[Thariani, Rahber; Yager, Paul] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Thariani, R (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	thariani@u.washington.edu			Bill & Melinda Gates Foundation's [37884]; National Institutes of Health (NIH) [T32EB001650]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation's; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Support for this project was provided through funding from The Bill & Melinda Gates Foundation's Grand Challenges in Global Health Initiative under Grant Number 37884, "A Point-of-Care Diagnostic System for the Developing World,'' awarded to the UW-led consortium: Dr. Paul Yager, PI (UW) and collaborators at Micronics Inc., Nanogen Inc., PATH, and the Stayton Group (UW). The views expressed by the authors do not necessarily reflect the views of the funding agency. Additional support was also provided by National Institutes of Health (NIH) Cardiovascular Training Grant No. T32EB001650 through Dr. Michael Regnier (UW). No funding or assistance in kind was received from commercial sources including Micronics Inc. and Nanogen Inc. The authors declare their full adherence to all PLOSOne data sharing and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell B, 2004, CLIN CHEM, V50, P1942, DOI 10.1373/clinchem.2004.036830; Carlsson J, 2008, BIOSENS BIOELECTRON, V24, P876, DOI 10.1016/j.bios.2008.07.018; Fang S, 2005, ANAL CHEM, V77, P6528, DOI 10.1021/ac051283m; Fu E, 2004, REV SCI INSTRUM, V75, P2300, DOI 10.1063/1.1764608; Fu E, 2003, REV SCI INSTRUM, V74, P3182, DOI 10.1063/1.1574603; Huang B, 2007, ANAL CHEM, V79, P2979, DOI 10.1021/ac062284x; Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b; Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569; Kurita R, 2006, ANAL CHEM, V78, P5525, DOI 10.1021/ac060480y; Leonard P, 2005, J FOOD PROTECT, V68, P728, DOI 10.4315/0362-028X-68.4.728; Liebermann T, 2000, COLLOID SURFACE A, V171, P115, DOI 10.1016/S0927-7757(99)00550-6; Munson MS, 2004, LAB CHIP, V4, P438, DOI 10.1039/b407765b; Pan T, 2009, J LUMIN, V129, P741, DOI 10.1016/j.jlumin.2009.02.006; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Raether H., 1988, SURFACE PLASMONS SMO, DOI 10.1007/BFb0048319; Robelek R, 2004, ANAL CHEM, V76, P6160, DOI 10.1021/ac049351c; ROTHENHAUSLER B, 1988, NATURE, V332, P615, DOI 10.1038/332615a0; Roy S, 2002, LANGMUIR, V18, P6319, DOI 10.1021/la025578w; SASIAN JM, 1992, OPT ENG, V31, P527, DOI 10.1117/12.56085; Tawa K, 2005, BIOPHYS J, V89, P2750, DOI 10.1529/biophysj.105.065482; Tawa K, 2005, BIOSENS BIOELECTRON, V21, P322, DOI 10.1016/j.bios.2004.10.024; Tawa K, 2004, NUCLEIC ACIDS RES, V32, P2372, DOI 10.1093/nar/gkh572; Thariani R, 2008, SENSOR ACTUAT B-CHEM, V130, P765, DOI 10.1016/j.snb.2007.10.065; Vareiro MMLM, 2008, ANAL BIOCHEM, V377, P243, DOI 10.1016/j.ab.2008.03.033; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	26	3	3	17	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9833	10.1371/journal.pone.0009833	http://dx.doi.org/10.1371/journal.pone.0009833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360841	Green Submitted, gold, Green Published			2022-12-27	WOS:000275969500003
J	Campos, Y; Qiu, XH; Zanoteli, E; Moshiach, S; Vergani, N; Bongiovanni, A; Harris, AJ; d'Azzo, A				Campos, Yvan; Qiu, Xiaohui; Zanoteli, Edmar; Moshiach, Simon; Vergani, Naja; Bongiovanni, Antonella; Harris, A. John; d'Azzo, Alessandra			Ozz-E3 Ubiquitin Ligase Targets Sarcomeric Embryonic Myosin Heavy Chain during Muscle Development	PLOS ONE			English	Article							SKELETAL-MUSCLE; CHAPERONE UNC-45; THICK FILAMENTS; CARDIOTOXIN INJURY; PROTEIN; EXPRESSION; DEGRADATION; REGENERATION; ISOFORMS; SYSTEM	Muscle contractile proteins are expressed as a series of developmental isoforms that are in constant dynamic remodeling during embryogenesis, but how obsolete molecules are recognized and removed is not known. Ozz is a developmentally regulated protein that functions as the adaptor component of a RING-type ubiquitin ligase complex specific to striated muscle. Ozz(-/-) mutants exhibit defects in myofibrillogenesis and myofiber differentiation. Here we show that Ozz targets the rod portion of embryonic myosin heavy chain and preferentially recognizes the sarcomeric rather than the soluble pool of myosin. We present evidence that Ozz binding to the embryonic myosin isoform within sarcomeric thick filaments marks it for ubiquitination and proteolytic degradation, allowing its replacement with neonatal or adult isoforms. This unique function positions Ozz within a system that facilitates sarcomeric myosin remodeling during muscle maturation and regeneration. Our findings identify Ozz-E3 as the ubiquitin ligase complex that interacts with and regulates myosin within its fully assembled cytoskeletal structure.	[Campos, Yvan; Qiu, Xiaohui; Zanoteli, Edmar; Moshiach, Simon; Vergani, Naja; d'Azzo, Alessandra] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Bongiovanni, Antonella] CNR, Ist Biomed & Immunol Mol, Palermo, Italy; [Harris, A. John] Univ Otago, Sch Med, Dept Physiol, Dunedin, New Zealand	St Jude Children's Research Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Otago	Campos, Y (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	sandra.dazzo@stjude.org	Bongiovanni, Antonella/AAX-5051-2020	Bongiovanni, Antonella/0000-0002-0307-4043	National Institutes of Health [R01 AR049867]; Cancer Center Support [CA021765]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health grants R01 AR049867, the Cancer Center Support Grant CA021765, the Assisi Foundation of Memphis, and the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BANDMAN E, 1992, DEV BIOL, V154, P273, DOI 10.1016/0012-1606(92)90067-Q; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; BROZANSKI BS, 1991, AM J PHYSIOL, V261, pL49, DOI 10.1152/ajplung.1991.261.2.L49; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; DAVIS JS, 1993, BIOCHEMISTRY-US, V32, P4035, DOI 10.1021/bi00066a026; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; DUXSON MJ, 1989, DEVELOPMENT, V107, P743; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; HARRIS AJ, 1989, DEVELOPMENT, V107, P751; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; KELLY AM, 1969, J CELL BIOL, V42, P135, DOI 10.1083/jcb.42.1.135; Kim J, 2008, TRENDS CELL BIOL, V18, P264, DOI 10.1016/j.tcb.2008.03.007; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; LOUGHNA PT, 1990, DEVELOPMENT, V109, P217; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; SAAD AD, 1986, P NATL ACAD SCI USA, V83, P9483, DOI 10.1073/pnas.83.24.9483; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sun YM, 2003, J MUSCLE RES CELL M, V24, P561, DOI 10.1023/B:JURE.0000009895.03111.b3; TRINICK JA, 1982, METHOD ENZYMOL, V85, P17; Wanek LJ, 2000, ANAT REC, V258, P176; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9866	10.1371/journal.pone.0009866	http://dx.doi.org/10.1371/journal.pone.0009866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352047	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894500023
J	Chang, MY; Kim, D; Kim, CH; Kang, HC; Yang, E; Moon, JI; Ko, S; Park, J; Park, KS; Lee, KA; Hwang, DY; Chung, Y; Lanza, R; Kim, KS				Chang, Mi-Yoon; Kim, Dohoon; Kim, Chun-Hyung; Kang, Hoon-Chul; Yang, Eungi; Moon, Jung-Il; Ko, Sanghyeok; Park, Junpil; Park, Kyung-Soon; Lee, Kyung-Ah; Hwang, Dong-Youn; Chung, Young; Lanza, Robert; Kim, Kwang-Soo			Direct Reprogramming of Rat Neural Precursor Cells and Fibroblasts into Pluripotent Stem Cells	PLOS ONE			English	Article							SOMATIC-CELLS; GENERATION; NEURONS; DIFFERENTIATION; TRANSPLANTATION; INDUCTION; DISEASE	Background: Given the usefulness of rats as an experimental system, an efficient method for generating rat induced pluripotent stem (iPS) cells would provide researchers with a powerful tool for studying human physiology and disease. Here, we report direct reprogramming of rat neural precursor (NP) cells and rat embryonic fibroblasts (REF) into iPS cells by retroviral transduction using either three (Oct3/4, Sox2, and Klf4), four (Oct3/4, Sox2, Klf4, and c-Myc), or five (Oct3/4, Sox2, Klf4, c-Myc, and Nanog) genes. Methodology and Principal Findings: iPS cells were generated from both NP and REF using only three (Oct3/4, Sox2, and Klf4) genes without c-Myc. Two factors were found to be critical for efficient derivation and maintenance of rat iPS cells: the use of rat instead of mouse feeders, and the use of small molecules specifically inhibiting mitogen-activated protein kinase and glycogen synthase kinase 3 pathways. In contrast, introduction of embryonic stem cell (ESC) extracts induced partial reprogramming, but failed to generate iPS cells. However, when combined with retroviral transduction, this method generated iPS cells with significantly higher efficiency. Morphology, gene expression, and epigenetic status confirmed that these rat iPS cells exhibited ESC-like properties, including the ability to differentiate into all three germ layers both in vitro and in teratomas. In particular, we found that these rat iPS cells could differentiate to midbrain-like dopamine neurons with a high efficiency. Conclusions/Significance: Given the usefulness of rats as an experimental system, our optimized method would be useful for generating rat iPS cells from diverse tissues and provide researchers with a powerful tool for studying human physiology and disease.	[Chang, Mi-Yoon; Kim, Dohoon; Kim, Chun-Hyung; Kang, Hoon-Chul; Yang, Eungi; Moon, Jung-Il; Ko, Sanghyeok; Park, Junpil; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab, Belmont, MA 02178 USA; [Kim, Kwang-Soo] Harvard Stem Cell Inst, Cambridge, MA USA; [Chung, Young; Lanza, Robert] Stem Cell Int Inc, Worcester, MA USA; [Park, Kyung-Soon; Lee, Kyung-Ah; Hwang, Dong-Youn; Kim, Kwang-Soo] Pochon CHA Univ, Coll Med, CHA Stem Cell Inst, Seoul, South Korea	Harvard University; McLean Hospital; Harvard University; Pochon Cha University	Chang, MY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab, Belmont, MA 02178 USA.	kskim@mclean.harvard.edu	Chung, Young Gie/AAC-8149-2020	Lanza, Robert/0000-0002-3047-3074	National Institute of Health [MH48866, MH087903]; Korean Stem Cell Research Center; Korean Government (MOEFRD) [KRF-2006-214-H00004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048866, R29MH048866, R33MH087903, R21MH087903] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Stem Cell Research Center; Korean Government (MOEFRD)(Korean Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Health grants MH48866 and MH087903 and by International Collaboration Grants from Korean Stem Cell Research Center and the CHA Stem Cell Institute of the Pochon CHA University; Mi-Yoon Chang was supported by the fellowship from Korea Research Foundation Grant funded by the Korean Government (MOEFRD) (KRF-2006-214-H00004). Stem Cell International, Inc., played a role as a funder due to employment of two of the authors of this study. Dr. Young Chung and Dr. Robert Lanza are employed by Stem Cell International, Inc. The funders therefore had a role in data collection and analysis. The funders had no role in decision to publish or preparation of the manuscript.	Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; BRUNDIN P, 1987, EXP BRAIN RES, V69, P183; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chang MY, 2004, DEV BRAIN RES, V153, P89, DOI 10.1016/j.devbrainres.2004.08.003; CHANG MY, 2008, INT S IPS RES KYOT J; CHANG MY, 2008, SFN ANN M WASH DC; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAHASHI K, 2009, PLOS ONE, V4, P1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	31	51	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9838	10.1371/journal.pone.0009838	http://dx.doi.org/10.1371/journal.pone.0009838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352099	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894500010
J	Drake, KR; Kang, M; Kenworthy, AK				Drake, Kimberly R.; Kang, Minchul; Kenworthy, Anne K.			Nucleocytoplasmic Distribution and Dynamics of the Autophagosome Marker EGFP-LC3	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-1; LASER-SCANNING MICROSCOPES; NUCLEAR EXPORT SIGNAL; SMOOTH-MUSCLE-CELLS; LIGHT-CHAIN 3; FLUORESCENCE RECOVERY; MONITORING AUTOPHAGY; MAMMALIAN-CELLS; LIVING CELLS; IN-VIVO	The process of autophagy involves the formation of autophagosomes, double-membrane structures that encapsulate cytosol. Microtubule-associated protein light chain 3 (LC3) was the first protein shown to specifically label autophagosomal membranes in mammalian cells, and subsequently EGFP-LC3 has become one of the most widely utilized reporters of autophagy. Although LC3 is currently thought to function primarily in the cytosol, the site of autophagosome formation, EGFP-LC3 often appears to be enriched in the nucleoplasm relative to the cytoplasm in published fluorescence images. However, the nuclear pool of EGFP-LC3 has not been specifically studied in previous reports, and mechanisms by which LC3 shuttles between the cytoplasm and nucleoplasm are currently unknown. In this study, we therefore investigated the regulation of the nucleo-cytoplasmic distribution of EGFP-LC3 in living cells. By quantitative fluorescence microscopy analysis, we demonstrate that soluble EGFP-LC3 is indeed enriched in the nucleus relative to the cytoplasm in two commonly studied cell lines, COS-7 and HeLa. Although LC3 contains a putative nuclear export signal (NES), inhibition of active nuclear export or mutation of the NES had no effect on the nucleo-cytoplasmic distribution of EGFP-LC3. Furthermore, FRAP analysis indicates that EGFP-LC3 undergoes limited passive nucleo-cytoplasmic transport under steady state conditions, and that the diffusional mobility of EGFP-LC3 was substantially slower in the nucleus and cytoplasm than predicted for a freely diffusing monomer. Induction of autophagy led to a visible decrease in levels of soluble EGFP-LC3 relative to autophagosome-bound protein, but had only modest effects on the nucleo-cytoplasmic ratio or diffusional mobility of the remaining soluble pools of EGFP-LC3. We conclude that the enrichment of soluble EGFP-LC3 in the nucleus is maintained independently of active nuclear export or induction of autophagy. Instead, incorporation of soluble EGFP-LC3 into large macromolecular complexes within both the cytoplasm and nucleus may prevent its rapid equilibrium between the two compartments.	[Drake, Kimberly R.; Kang, Minchul; Kenworthy, Anne K.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37203 USA; [Kenworthy, Anne K.] Vanderbilt Univ Sch Med, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Drake, KR (corresponding author), Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37203 USA.	Anne.kenworthy@vanderbilt.edu		Kenworthy, Anne/0000-0001-6567-9059	NIH [R01 GM073846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM073846 (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Furuta S, 2002, ONCOGENE, V21, P7060, DOI 10.1038/sj.onc.1205790; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Houtsmuller AB, 2005, ADV BIOCHEM ENG BIOT, V95, P177, DOI 10.1007/b102214; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Liang XH, 2001, CANCER RES, V61, P3443; LIPPINCOTTSCHWA.J, 2001, MOL CELL BIOL, V2, P444; MANN SS, 1994, J BIOL CHEM, V269, P11492; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Meyer T, 2007, FEBS J, V274, P815, DOI 10.1111/j.1742-4658.2006.05626.x; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Seldenbecher CI, 2004, J MOL BIOL, V336, P957, DOI 10.1016/j.jmb.2003.12.054; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stavreva DA, 2004, METHOD ENZYMOL, V375, P443; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Wachsmuth M, 2003, BIOPHYS J, V84, P3353, DOI 10.1016/S0006-3495(03)70059-9; Wei XB, 2003, BIOPHYS J, V84, P1317, DOI 10.1016/S0006-3495(03)74947-9; Zhou B, 1997, J CLIN INVEST, V100, P3070, DOI 10.1172/JCI119862; Zhou B, 1998, CIRC RES, V83, P481, DOI 10.1161/01.RES.83.5.481	61	71	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9806	10.1371/journal.pone.0009806	http://dx.doi.org/10.1371/journal.pone.0009806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352102	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400012
J	Rao, SS; Kong, WP; Wei, CJ; Van Hoeven, N; Gorres, JP; Nason, M; Andersen, H; Tumpey, TM; Nabel, GJ				Rao, Srinivas S.; Kong, Wing-Pui; Wei, Chih-Jen; Van Hoeven, Neal; Gorres, J. Patrick; Nason, Martha; Andersen, Hanne; Tumpey, Terrence M.; Nabel, Gary J.			Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret	PLOS ONE			English	Article							CD8(+) T-CELLS; RECEPTOR SPECIFICITY; VIRUS-REPLICATION; A VACCINE; NEUTRALIZING ANTIBODIES; EXTRACELLULAR DOMAIN; PROTECTIVE IMMUNITY; LETHAL CHALLENGE; PLASMID DNA; M2 PROTEIN	Efforts to develop a broadly protective vaccine against the highly pathogenic avian influenza A (HPAI) H5N1 virus have focused on highly conserved influenza gene products. The viral nucleoprotein (NP) and ion channel matrix protein (M2) are highly conserved among different strains and various influenza A subtypes. Here, we investigate the relative efficacy of NP and M2 compared to HA in protecting against HPAI H5N1 virus. In mice, previous studies have shown that vaccination with NP and M2 in recombinant DNA and/or adenovirus vectors or with adjuvants confers protection against lethal challenge in the absence of HA. However, we find that the protective efficacy of NP and M2 diminishes as the virulence and dose of the challenge virus are increased. To explore this question in a model relevant to human disease, ferrets were immunized with DNA/rAd5 vaccines encoding NP, M2, HA, NP+M2 or HA+NP+M2. Only HA or HA+NP+M2 vaccination conferred protection against a stringent virus challenge. Therefore, while gene-based vaccination with NP and M2 may provide moderate levels of protection against low challenge doses, it is insufficient to confer protective immunity against high challenge doses of H5N1 in ferrets. These immunogens may require combinatorial vaccination with HA, which confers protection even against very high doses of lethal viral challenge.	[Rao, Srinivas S.; Kong, Wing-Pui; Wei, Chih-Jen; Gorres, J. Patrick; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Van Hoeven, Neal; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Nason, Martha] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Andersen, Hanne] BIOQUAL Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); BIOQUAL Inc.	Rao, SS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022	Elyard, Hanne/0000-0003-1103-9608	National Institutes of Allergy; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	National Institutes of Allergy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the intramural research program of the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGARANO G, 1984, EUR J CLIN MICROBIOL, V3, P516, DOI 10.1007/BF02013610; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Butman BT, 2006, DEV BIOLOGICALS, V123, P225; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; CRAFT JE, 1984, J INFECT DIS, V149, P789, DOI 10.1093/infdis/149.5.789; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Graham DA, 1997, J VET DIAGN INVEST, V9, P24, DOI 10.1177/104063879700900105; HOKE CH, 1979, REV INFECT DIS, V1, P946; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; PIAZZA FM, 1991, AM J RESP CELL MOL, V4, P82, DOI 10.1165/ajrcmb/4.1.82; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Rasmussen H, 2002, CANCER GENE THER, V9, P951, DOI 10.1038/sj.cgt.7700518; REED LJ, 1938, AM J HYG, V27; RICHMOND JY, 1999, BIOSAFETY MICROBIOLO, P17; Robinson Harriet L., 1997, Journal of Infectious Diseases, V176, pS50, DOI 10.1086/514176; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WHO, 2009, WHO MAN AN INFL DIAG; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; YANKAUCKAS MA, 1993, DNA CELL BIOL, V12, P771, DOI 10.1089/dna.1993.12.771; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	54	72	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9812	10.1371/journal.pone.0009812	http://dx.doi.org/10.1371/journal.pone.0009812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352112	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400015
J	Stuelten, CH; Busch, JI; Tang, BW; Flanders, KC; Oshima, A; Sutton, E; Karpova, TS; Roberts, AB; Wakefield, LM; Niederhuber, JE				Stuelten, Christina H.; Busch, Johanna I.; Tang, Binwu; Flanders, Kathleen C.; Oshima, Akira; Sutton, Emily; Karpova, Tatiana S.; Roberts, Anita B.; Wakefield, Lalage M.; Niederhuber, John E.			Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-beta Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ENHANCES TUMORIGENESIS; MAMMARY ADENOCARCINOMA; SUPPRESSES METASTASIS; STROMAL FIBROBLASTS; INVASION; HOMEOSTASIS; EXPRESSION; PROSTATE; PROMOTE	Carcinoma are complex societies of mutually interacting cells in which there is a progressive failure of normal homeostatic mechanisms, causing the parenchymal component to expand inappropriately and ultimately to disseminate to distant sites. When a cancer cell metastasizes, it first will be exposed to cancer associated fibroblasts in the immediate tumor microenvironment and then to normal fibroblasts as it traverses the underlying connective tissue towards the bloodstream. The interaction of tumor cells with stromal fibroblasts influences tumor biology by mechanisms that are not yet fully understood. Here, we report a role for normal stroma fibroblasts in the progression of invasive tumors to metastatic tumors. Using a coculture system of human metastatic breast cancer cells (MCF10CA1a) and normal murine dermal fibroblasts, we found that medium conditioned by cocultures of the two cell types (CoCM) increased migration and scattering of MCF10CA1a cells in vitro, whereas medium conditioned by homotypic cultures had little effect. Transient treatment of MCF10CA1a cells with CoCM in vitro accelerated tumor growth at orthotopic sites in vivo, and resulted in an expanded pattern of metastatic engraftment. The effects of CoCM on MCF10CA1a cells were dependent on small amounts of active TGF-beta 1 secreted by fibroblasts under the influence of the tumor cells, and required intact ALK5-, p38-, and JNK signaling in the tumor cells. In conclusion, these results demonstrate that transient interactions between tumor cells and normal fibroblasts can modify the acellular component of the local microenvironment such that it induces long-lasting increases in tumorigenicity and alters the metastatic pattern of the cancer cells in vivo. TGF-beta appears to be a key player in this process, providing further rationale for the development of anti-cancer therapeutics that target the TGF-beta pathway.	[Stuelten, Christina H.; Busch, Johanna I.; Sutton, Emily; Niederhuber, John E.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Tang, Binwu; Flanders, Kathleen C.; Oshima, Akira; Roberts, Anita B.; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Karpova, Tatiana S.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stuelten, CH (corresponding author), NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA.	chrisstu@mail.nih.gov	Wakefield, Lalage M/M-1963-2017	Wakefield, Lalage M/0000-0003-4124-5250; Stuelten, Christina/0000-0002-2850-5399; Karpova, Tatiana/0000-0001-6025-2128	National Cancer Institute, NIH, Bethesda, USA; NATIONAL CANCER INSTITUTE [ZIABC010929, ZIABC010796, ZIABC010797, ZIABC005785] Funding Source: NIH RePORTER	National Cancer Institute, NIH, Bethesda, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, NIH, Bethesda, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHENG N, 2005, ONCOGENE; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Jechlinger M, 2002, J MAMMARY GLAND BIOL, V7, P415, DOI 10.1023/A:1024090116451; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kawai N, 2002, GASTROENTEROLOGY, V122, P331, DOI 10.1053/gast.2002.31023; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Proia DA, 2005, CELL CYCLE, V4, P1022, DOI 10.4161/cc.4.8.1903; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rosen E M, 1993, EXS, V65, P301; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Stuelten CH, 2005, J CELL SCI, V118, P2143, DOI 10.1242/jcs.02334; Stuelten CH, 2008, CANCER RES, V68, P7278, DOI 10.1158/0008-5472.CAN-08-1842; Stuelten CH, 2007, BIOTECHNIQUES, V43, P289, DOI 10.2144/000112549; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thomas GJ, 2002, BRIT J CANCER, V87, P859, DOI 10.1038/sj.bjc.6600545; Tian F, 2004, CANCER RES, V64, P4523, DOI 10.1158/0008-5472.CAN-04-0030; Tian F, 2003, CANCER RES, V63, P8284; TIMME TL, 1994, ENDOCRINOLOGY, V134, P1039, DOI 10.1210/en.134.3.1039; VanWaarde MAWH, 1997, ANAL BIOCHEM, V247, P45, DOI 10.1006/abio.1997.2026; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	48	67	71	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9832	10.1371/journal.pone.0009832	http://dx.doi.org/10.1371/journal.pone.0009832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352126	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894400031
J	Bousset, L; Bonnefoy, J; Sourigues, Y; Wien, F; Melki, R				Bousset, Luc; Bonnefoy, Jonathan; Sourigues, Yannick; Wien, Frank; Melki, Ronald			Structure and Assembly Properties of the N-Terminal Domain of the Prion Ure2p in Isolation and in Its Natural Context	PLOS ONE			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; PROTEIN FIBRILS; ALPHA-SYNUCLEIN; YEAST PRIONS; PROPAGATION; HSP70; PSI+; NANOPARTICLES; CONFORMATION	Background: The aggregation of the baker's yeast prion Ure2p is at the origin of the [URE3] trait. The Q- and N-rich N-terminal part of the protein is believed to drive Ure2p assembly into fibrils of amyloid nature and the fibrillar forms of full-length Ure2p and its N-terminal part generated in vitro have been shown to induce [URE3] occurrence when introduced into yeast cells. This has led to the view that the fibrillar form of the N-terminal part of the protein is sufficient for the recruitment of constitutive Ure2p and that it imprints its amyloid structure to full-length Ure2p. Results: Here we generate a set of Ure2p N-terminal fragments, document their assembly and structural properties and compare them to that of full-length Ure2p. We identify the minimal region critical for the assembly of Ure2p N-terminal part into amyloids and show that such fibrils are unable to seed the assembly of full length Ure2p unlike fibrils made of intact Ure2p. Conclusion: Our results clearly indicate that fibrillar Ure2p shares no structural similarities with the amyloid fibrils made of Ure2p N-terminal part. Our results further suggest that the induction of [URE3] by fibrils made of full-length Ure2p is likely the consequence of fibrils growth by depletion of cytosolic Ure2p while it is the consequence of de novo formation of prion particles following, for example, titration within the cells of a specific set of molecular chaperones when fibrils made of Ure2p N-terminal domain are introduced within the cytoplasm.	[Bousset, Luc; Bonnefoy, Jonathan; Sourigues, Yannick; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Wien, Frank] Synchrotron Soleil, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Bousset, L (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr	Wien, Frank/B-7846-2012	Wien, Frank/0000-0002-0752-8735; bousset, luc/0000-0002-0433-4337	Agence Nationale de la Recherche [ANR-06-BLAN-0266]; Centre National de la Recherche Scientifique	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Agence Nationale de la Recherche (ANR-06-BLAN-0266) and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bousset L, 2004, BIOCHEMISTRY-US, V43, P5022, DOI 10.1021/bi049828e; Bousset L, 2003, J STRUCT BIOL, V141, P132, DOI 10.1016/S1047-8477(02)00606-8; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2008, CURR ALZHEIMER RES, V5, P251, DOI 10.2174/156720508784533303; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Colvin VL, 2007, P NATL ACAD SCI USA, V104, P8679, DOI 10.1073/pnas.0703194104; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 1997, GENETICS, V147, P507; Evans P, 2007, EXP EYE RES, V84, P1001, DOI 10.1016/j.exer.2007.01.016; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; GEIGE R, 1992, CRYSTALLIZATION NUCL, P1; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; Leslie A, 1992, NEWSLETTER PROTEIN C; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Loovers HM, 2007, GENETICS, V175, P621, DOI 10.1534/genetics.106.066019; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; SANDSTROM J, 2000, CIRCULAR DICHROISM P, P459; Savistchenko J, 2008, J BIOL CHEM, V283, P15732, DOI 10.1074/jbc.M800728200; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9760	10.1371/journal.pone.0009760	http://dx.doi.org/10.1371/journal.pone.0009760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339590	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894300007
J	Harms, KM; Li, L; Cunningham, LA				Harms, Kate M.; Li, Lu; Cunningham, Lee Anna			Murine Neural Stem/Progenitor Cells Protect Neurons against Ischemia by HIF-1 alpha-Regulated VEGF Signaling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; STROKE-INDUCED NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; RAT-BRAIN; IN-VITRO	Focal cerebral ischemia following middle cerebral artery occlusion (MCAO) stimulates a robust cytogenic response from the adult subventricular zone (SVZ) that includes massive proliferation of neural stem/progenitor cells (NSPCs) and cellular migration into the injury area. To begin to explore beneficial roles of NSPCs in this response, we investigated the ability of embryonic and postnatal NSPCs to promote neuronal survival under conditions of in vivo and in vitro ischemia. Intracerebral transplantation of NSPCs attenuated neuronal apoptosis in response to focal ischemia induced by transient MCAO, and prevented neuronal cell death of cortical neurons in response to oxygen-glucose deprivation (OGD) in culture. NSPC-mediated neuroprotection was blocked by the pharmacological inhibitors of vascular endothelial growth factor (VEGF), SU1498 and Flt-1Fc. Embryonic and postnatal NSPCs were both intrinsically resistant to brief OGD exposure, and constitutively expressed both hypoxia-inducible factor 1 alpha (HIF-1 alpha) transcription factor and its downstream target, VEGF. Genomic deletion of HIF-1 alpha by Cre-mediated excision of exon 2 in NSPC cultures resulted in >50% reduction of VEGF production and ablation of NSPC-mediated neuroprotection. These findings indicate that NSPCs promote neuronal survival under ischemic conditions via HIF-1 alpha-VEGF signaling pathways and support a role for NSPCs in promotion of neuronal survival following stroke.	[Harms, Kate M.; Li, Lu; Cunningham, Lee Anna] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Harms, KM (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA.	LeeAnna@salud.unm.edu			American Heart Association [0810071Z, 09GRNT2290178]; University of New Mexico School of Medicine [C-2310-RAC/Bridge]	American Heart Association(American Heart Association); University of New Mexico School of Medicine	This work was supported by grants from the American Heart Association (www.americanheart.org), 0810071Z (KMH) and 09GRNT2290178 (LAC), and Dedicated Health Research Funds from the University of New Mexico School of Medicine (http://hsc.unm.edu/som/), C-2310-RAC/Bridge (LAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Birk DM, 2008, VASC ENDOVASC SURG, V42, P517, DOI 10.1177/1538574408322755; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwai M, 2003, J CEREBR BLOOD F MET, V23, P331, DOI 10.1097/01.WCB.0000050060.57184.E7; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Marti Hugo H., 1999, Thrombosis and Haemostasis, V82, P44; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; McColl BK, 2004, APMIS, V112, P463, DOI 10.1111/j.1600-0463.2004.apm11207-0807.x; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHWEIKI D, 1992, NATURE, V359, P845; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Taoufik E, 2008, P NATL ACAD SCI USA, V105, P6185, DOI 10.1073/pnas.0801447105; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Xiong L, 2009, CELL STRESS CHAPERON, V14, P183, DOI 10.1007/s12192-008-0071-z; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang ZJ, 2002, J NEUROSCI RES, V70, P140, DOI 10.1002/jnr.10380; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	70	77	83	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9767	10.1371/journal.pone.0009767	http://dx.doi.org/10.1371/journal.pone.0009767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339541	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300011
J	Land, T; Warner, D; Paskowsky, M; Cammaerts, A; Wetherell, L; Kaufmann, R; Zhang, L; Malarcher, A; Pechacek, T; Keithly, L				Land, Thomas; Warner, Donna; Paskowsky, Mark; Cammaerts, Ayesha; Wetherell, LeAnn; Kaufmann, Rachel; Zhang, Lei; Malarcher, Ann; Pechacek, Terry; Keithly, Lois			Medicaid Coverage for Tobacco Dependence Treatments in Massachusetts and Associated Decreases in Smoking Prevalence	PLOS ONE			English	Article								Background: Approximately 50% of smokers die prematurely from tobacco-related diseases. In July 2006, the Massachusetts health care reform law mandated tobacco cessation coverage for the Massachusetts Medicaid population. The new benefit included behavioral counseling and all medications approved for tobacco cessation treatment by the U. S. Food and Drug Administration (FDA). Between July 1, 2006 and December 31, 2008, a total of 70,140 unique Massachusetts Medicaid subscribers used the newly available benefit, which is approximately 37% of all Massachusetts Medicaid smokers. Given the high utilization rate, the objective of this study is to determine if smoking prevalence decreased significantly after the initiation of tobacco cessation coverage. Methods and Findings: Smoking prevalence was evaluated pre- to post-benefit using 1999 through 2008 data from the Massachusetts Behavioral Risk Factor Survey (BRFSS). The crude smoking rate decreased from 38.3% (95% C. I. 33.6%-42.9%) in the pre-benefit period compared to 28.3% (95% C. I.: 24.0%-32.7%) in the post-benefit period, representing a decline of 26 percent. A demographically adjusted smoking rate showed a similar decrease in the post-benefit period. Trend analyses reflected prevalence decreases that accrued over time. Specifically, a joinpoint analysis of smoking prevalence among Massachusetts Medicaid benefit-eligible members (age 18-64) from 1999 through 2008 found a decreasing trend that was coincident with the implementation of the benefit. Finally, a logistic regression that controlled for demographic factors also showed that the trend in smoking decreased significantly from July 1, 2006 to December 31, 2008. Conclusion: These findings suggest that a tobacco cessation benefit that includes coverage for medications and behavioral treatments, has few barriers to access, and involves broad promotion can significantly reduce smoking prevalence.	[Land, Thomas; Warner, Donna; Paskowsky, Mark; Keithly, Lois] Massachusetts Tobacco Control Program, Boston, MA USA; [Cammaerts, Ayesha; Wetherell, LeAnn] Off Medicaid Commonwealth Massachusetts, Boston, MA USA; [Kaufmann, Rachel; Zhang, Lei; Malarcher, Ann; Pechacek, Terry] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Land, T (corresponding author), Massachusetts Tobacco Control Program, Boston, MA USA.	Thomas.Land@state.ma.us			U.S. Centers for Disease Control and Prevention (CDC) [U58/CCU122821]	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The U.S. Centers for Disease Control and Prevention (CDC) has supported this work under the CDC Grant/Cooperative Agreement Number: U58/CCU122821. The study design, data collection instruments, data analysis, decision to publish, and preparation of the manuscript was a collaborative effort between the CDC, the Massachusetts Tobacco Control Program, and the Massachusetts Office of Medicaid.	ARMOUR BS, 2009, PREVENTING CHRONIC D, V6, P3; BLACKWELL DL, 2002, VITAL HLTH STAT, V10, P205; Blumberg S. J., 2008, WIRELESS SUBSTITUTIO; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 2009, HLTH RISKS US BEH RI; Fiore MC, 2008, TREATING TOBACCO USE; *I MED, 2007, END TOB PROBL BLUEPR; *KAIS COMM MED UN, 2009, MASS HLTH REF 3 YEAR; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; Pleis JR, 2009, VITAL HLTH STAT, V10, P240; U. S. Department of Health and Human Services, 2004, HLTH CONS SOM REP SU; *WHO, 2008, MPOWER	12	95	99	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9770	10.1371/journal.pone.0009770	http://dx.doi.org/10.1371/journal.pone.0009770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305787	gold, Green Submitted, Green Published			2022-12-27	WOS:000276456300010
J	Nakajima, M; Takahashi, A; Kou, I; Rodriguez-Fontenla, C; Gomez-Reino, JJ; Furuichi, T; Dai, J; Sudo, A; Uchida, A; Fukui, N; Kubo, M; Kamatani, N; Tsunoda, T; Malizos, KN; Tsezou, A; Gonzalez, A; Nakamura, Y; Ikegawa, S				Nakajima, Masahiro; Takahashi, Atsushi; Kou, Ikuyo; Rodriguez-Fontenla, Cristina; Gomez-Reino, Juan J.; Furuichi, Tatsuya; Dai, Jin; Sudo, Akihiro; Uchida, Atsumasa; Fukui, Naoshi; Kubo, Michiaki; Kamatani, Naoyuki; Tsunoda, Tatsuhiko; Malizos, Konstantinos N.; Tsezou, Aspasia; Gonzalez, Antonio; Nakamura, Yusuke; Ikegawa, Shiro			New Sequence Variants in HLA Class II/III Region Associated with Susceptibility to Knee Osteoarthritis Identified by Genome-Wide Association Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; INCREASES SUSCEPTIBILITY; ARTICULAR CHONDROCYTES; OSTEO-ARTHRITIS; GENE; JAPANESE; PHENOTYPES; ANTIGENS; HLA-DQA2; BTNL2	Osteoarthritis (OA) is a common disease that has a definite genetic component. Only a few OA susceptibility genes that have definite functional evidence and replication of association have been reported, however. Through a genome-wide association study and a replication using a total of similar to 4,800 Japanese subjects, we identified two single nucleotide polymorphisms (SNPs) (rs7775228 and rs10947262) associated with susceptibility to knee OA. The two SNPs were in a region containing HLA class II/III genes and their association reached genome-wide significance (combined P = 2.43x10(-8) for rs7775228 and 6.73x10(-8) for rs10947262). Our results suggest that immunologic mechanism is implicated in the etiology of OA.	[Nakajima, Masahiro; Kou, Ikuyo; Furuichi, Tatsuya; Dai, Jin; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Tokyo, Japan; [Rodriguez-Fontenla, Cristina; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Lab Invest 10, Santiago De Compostela, Spain; [Rodriguez-Fontenla, Cristina; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Rheumatol Unit, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain; [Dai, Jin] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Peoples R China; [Sudo, Akihiro; Uchida, Atsumasa] Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Fukui, Naoshi] Natl Hosp Org Sagamihara Natl Hosp, Clin Res Ctr Rheumatol & Allergy, Dept Pathomech, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Kanagawa, Japan; [Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Kanagawa, Japan; [Malizos, Konstantinos N.] Univ Thessaly, Dept Orthopaed, Larisa, Greece; [Malizos, Konstantinos N.] Inst Biomed Res & Technol, Larisa, Greece; [Tsezou, Aspasia] Univ Thessaly, Sch Med, Dept Biol, Larisa, Greece; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	RIKEN; RIKEN; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Nanjing University; Mie University; RIKEN; RIKEN; University of Thessaly; University of Thessaly; University of Tokyo	Nakajima, M (corresponding author), RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Dai, Jin/GVT-2414-2022; Gonzalez, Antonio/C-4444-2008; Ikegawa, Shiro/N-6895-2015; Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015; Gomez-Reino, Juan/ABI-2853-2020	Dai, Jin/0000-0003-3063-746X; Gonzalez, Antonio/0000-0002-2624-0606; Ikegawa, Shiro/0000-0003-0316-2147; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Gomez-Reino, Juan/0000-0001-5229-6294; Rodriguez Fontenla, Maria Cristina/0000-0002-9829-6393	Ministry of Education, Culture, Sports, Science and Technology; Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional); Foundation Mutua Madrile (Madrid)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional); Foundation Mutua Madrile (Madrid)	The Japanese study is supported by the Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology. The European study is supported by Instituto de Salud Carlos III from the Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional), the Foundation Mutua Madrile (Madrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2007, MOL BIOL CELL, P1577; Andrieu N, 1998, EPIDEMIOL REV, V20, P137, DOI 10.1093/oxfordjournals.epirev.a017976; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CLAYTON J, 1997, GENETIC DIVERSITY HL, P665; Dai J, 2010, J HUM GENET, V55, P77, DOI 10.1038/jhg.2009.137; Evans TI, 1995, ARTHRITIS RHEUM, V38, P1754, DOI 10.1002/art.1780381208; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; LANCE EM, 1993, CLIN ORTHOP RELAT R, P266; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Moos V, 2002, RHEUMATOLOGY, V41, P666, DOI 10.1093/rheumatology/41.6.666; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Mototani H, 2008, HUM MOL GENET, V17, P1790, DOI 10.1093/hmg/ddn069; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; PATTRICK M, 1989, ANN RHEUM DIS, V48, P470, DOI 10.1136/ard.48.6.470; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; REVELL PA, 1988, ANN RHEUM DIS, V47, P300, DOI 10.1136/ard.47.4.300; Rodriguez-Lopez J, 2009, OSTEOARTHR CARTILAGE, V17, P321, DOI 10.1016/j.joca.2008.07.012; Rudy GB, 1997, J IMMUNOL, V158, P2116; Sakata M, 2003, CLIN EXP RHEUMATOL, V21, P704; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Spector TD, 2006, ARTHRITIS RHEUM-US, V54, P524, DOI 10.1002/art.21624; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wakitani S, 2001, CLIN RHEUMATOL, V20, P417, DOI 10.1007/s100670170006; YU LP, 1991, J IMMUNOL, V147, P4393	28	77	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9723	10.1371/journal.pone.0009723	http://dx.doi.org/10.1371/journal.pone.0009723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305777	gold, Green Submitted, Green Published			2022-12-27	WOS:000276456300012
J	Losel, RM; Schnetzke, U; Brinkkoetter, PT; Song, H; Beck, G; Schnuelle, P; Hoger, S; Wehling, M; Yard, BA				Loesel, Ralf M.; Schnetzke, Ulf; Brinkkoetter, Paul T.; Song, Hui; Beck, Grietje; Schnuelle, Peter; Hoeger, Simone; Wehling, Martin; Yard, Benito A.			N-Octanoyl Dopamine, a Non-Hemodyanic Dopamine Derivative, for Cell Protection during Hypothermic Organ Preservation	PLOS ONE			English	Article							COLD-PRESERVATION; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; ENDOTHELIAL-CELLS; GRAFT-SURVIVAL; RAT-LIVER; INJURY; PRETREATMENT; CATECHOLAMINES; CALCIUM	Background: Although donor dopamine treatment reduces the requirement for post transplantation dialysis in renal transplant recipients, implementation of dopamine in donor management is hampered by its hemodynamic side-effects. Therefore novel dopamine derivatives lacking any hemodynamic actions and yet are more efficacious in protecting tissue from cold preservation injury are warranted. We hypothesized that variation of the molecular structure would yield more efficacious compounds avoid of any hemodynamic effects. Methodology/Principal Findings: To this end, we assessed protection against cold preservation injury in HUVEC by the attenuation of lactate dehydrogenase (LDH) release. Modification of dopamine by an alkanoyl group increased cellular uptake and significantly improved efficacy of protection. Further variation revealed that only compounds bearing two hydroxy groups in ortho or para position at the benzene nucleus, i.e. strong reductants, were protective. However, other reducing agents like N-acetyl cysteine and ascorbate, or NADPH oxidase inhibition did not prevent cellular injury following cold storage. Unlike dopamine, a prototypic novel compound caused no hemodynamic side-effects. Conclusions/Significance: In conclusion, we demonstrate that protection against cold preservation injury by catecholamines is exclusively governed by strong reducing capacity and sufficient lipophilicity. The novel dopamine derivatives might be of clinical relevance in donor pre-conditioning as they are completely devoid of hemodynamic action, their increased cellular uptake would reduce time of treatment and therefore also may have a potential use for non-heart beating donors.	[Loesel, Ralf M.; Wehling, Martin] Univ Med Ctr Mannheim, Dept Clin Pharmacol, Mannheim, Germany; [Schnetzke, Ulf; Brinkkoetter, Paul T.; Song, Hui; Schnuelle, Peter; Hoeger, Simone; Yard, Benito A.] Univ Med Ctr Mannheim, Dept Nephrol, Mannheim, Germany; [Beck, Grietje] Univ Med Ctr Mannheim, Dept Anaesthesiol, Mannheim, Germany; [Song, Hui] Shandong Univ, Sch Dent, Jinan 250100, Peoples R China; [Brinkkoetter, Paul T.] Univ Cologne, Dept Med, Ctr Mol Med & Cologne Excellence Cluster Cellular, Cologne, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Shandong University; University of Cologne	Losel, RM (corresponding author), Univ Med Ctr Mannheim, Dept Clin Pharmacol, Mannheim, Germany.	ralf.loesel@ohm-hochschule.de		Losel, Ralf/0000-0001-9010-5217	Else-Kroener-Stiftung; Medical School Mannheim	Else-Kroener-Stiftung; Medical School Mannheim	The author's laboratories were supported by grants from the Else-Kroener-Stiftung to B. A. Y. and funds from the Medical School Mannheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkkoetter PT, 2008, CELL PHYSIOL BIOCHEM, V22, P195, DOI 10.1159/000149797; Brinkkoetter PT, 2006, TRANSPLANTATION, V82, P534, DOI 10.1097/01.tp.0000229396.34362.e2; Dragun D, 2001, KIDNEY INT, V60, P1173, DOI 10.1046/j.1523-1755.2001.0600031173.x; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Gottmann U, 2005, TRANSPLANTATION, V79, P1344, DOI 10.1097/01.TP.0000159030.86574.6C; Haddad P, 1999, CRYOBIOLOGY, V39, P69, DOI 10.1006/cryo.1999.2186; Hoeger S, 2009, TRANSPLANTATION, V87, P52, DOI 10.1097/TP.0b013e318191b2ca; Juste RN, 1998, INTENS CARE MED, V24, P1217, DOI 10.1007/s001340050747; Kouwenhoven EA, 2001, KIDNEY INT, V59, P1142; Rauen U, 2006, CORNEA, V25, P68, DOI 10.1097/01.ico.0000167880.96439.c6; Salahudeen AA, 2001, TRANSPLANTATION, V72, P1498, DOI 10.1097/00007890-200111150-00005; Schnuelle P, 2004, AM J TRANSPLANT, V4, P419, DOI 10.1111/j.1600-6143.2004.00331.x; Schnuelle P, 1999, KIDNEY INT, V56, P738, DOI 10.1046/j.1523-1755.1999.00567.x; Schnuelle P, 2001, TRANSPLANTATION, V72, P455, DOI 10.1097/00007890-200108150-00017; SCHNUELLE P, 2009, JAMA IN PRESS; Shoskes DA, 1996, J UROLOGY, V155, P1831, DOI 10.1016/S0022-5347(01)66023-3; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Wyllie S, 2003, LIVER TRANSPLANT, V9, P401, DOI 10.1053/jlts.2003.50065; Yard B, 2004, AM J TRANSPLANT, V4, P22, DOI 10.1046/j.1600-6143.2003.00268.x	19	28	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9713	10.1371/journal.pone.0009713	http://dx.doi.org/10.1371/journal.pone.0009713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300525	gold, Green Published, Green Submitted			2022-12-27	WOS:000275716400011
J	Manful, T; Mulindwa, J; Frank, FM; Clayton, CE; Matovu, E				Manful, Theresa; Mulindwa, Julius; Frank, Fernanda M.; Clayton, Christine E.; Matovu, Enock			A Search for Trypanosoma brucei rhodesiense Diagnostic Antigens by Proteomic Screening and Targeted Cloning	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS; RECOMBINANT ANTIGENS; TRYPTECT CIATT(R); ANTIBODY-ELISA; INFECTION; IDENTIFICATION; MELARSOPROL; GLYCOSOMES; CANDIDATE	Background: The only available diagnostic method for East African trypanosomiasis is light microscopy of blood samples. A simple immunodiagnostic would greatly aid trypanosomiasis control. Methodology and Principal Findings: To find trypanosome proteins that are specifically recognised by sera from human sleeping sickness patients, we have screened the Trypanosoma brucei brucei proteome by Western blotting. Using cytosolic, cytoskeletal and glycosomal fractions, we found that the vast majority of abundant trypanosome proteins is not specifically recognised by patient sera. We identified phosphoglycerate kinase (PGKC), heat shock protein (HSP70), and histones H2B and H3 as possible candidate diagnostic antigens. These proteins, plus paraflagellar rod protein 1, rhodesain (a cysteine protease), and an extracellular fragment of the Trypanosoma brucei nucleoside transporter TbNT10, were expressed in E. coli and tested for reactivity with patient and control sera. Only TbHSP70 was preferentially recognized by patient sera, but the sensitivity and specificity were insufficient for use of TbHSP70 alone as a diagnostic. Immunoprecipitation using a native protein extract revealed no specifically reacting proteins. Conclusions: No abundant T. brucei soluble, glycosomal or cytoskeletal protein is likely to be useful in diagnosis. To find useful diagnostic antigens it will therefore be necessary to use more sophisticated proteomic methods, or to test a very large panel of candidate proteins.	[Manful, Theresa; Mulindwa, Julius; Clayton, Christine E.] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany; [Mulindwa, Julius; Matovu, Enock] Makerere Univ, Fac Vet Med, Kampala, Uganda; [Frank, Fernanda M.] Catedra Inmunol IDEHU UBA CONICET, Fac Farm & Bioquim UBA, Buenos Aires, DF, Argentina	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Makerere University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Manful, T (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019; Mulindwa, Julius/AAX-6204-2020	Matovu, Enock/0000-0003-0714-7032; Clayton, Christine/0000-0002-6384-0731; Fernanda M., Frank/0000-0003-4521-1306; Mulindwa, Julius/0000-0002-5419-2760	World Health Organisation/World Bank/United Nations [A60193, A50367]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) (DFG)	World Health Organisation/World Bank/United Nations(World Health Organization); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) (DFG)(German Research Foundation (DFG))	This study was partially supported by the World Health Organisation/World Bank/United Nations special programme for research and training in tropical diseases (TDR) grants A60193 to CC and ID A50367 to EM and FF. JM is supported in Heidelberg by a fellowship from the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akol MN, 1999, E AFR MED J, V76, P38; Asonganyi T, 1998, ANN TROP MED PARASIT, V92, P837, DOI 10.1080/00034989858871; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; BROCKMOLLER J, 1985, BIOL CHEM H-S, V366, P901, DOI 10.1515/bchm3.1985.366.2.901; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; Clayton CE, 1987, J CELL BIOL; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Desquesnes M, 2009, PREV VET MED, V90, P233, DOI 10.1016/j.prevetmed.2009.04.011; Desquesnes M, 2009, VET PARASITOL, V162, P214, DOI 10.1016/j.vetpar.2009.03.033; Flechas ID, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-186; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P60, DOI 10.1002/elps.1150090112; Hutchinson OC, 2004, TRENDS PARASITOL, V20, P519, DOI 10.1016/j.pt.2004.08.007; Jannin J, 2004, CURR OPIN INFECT DIS, V17, P565, DOI 10.1097/00001432-200412000-00009; Lalmanach G, 2002, BIOL CHEM, V383, P739, DOI 10.1515/BC.2002.077; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; MAINA NW, 2007, T R SOC TROP MED HYG; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; MULLER N, 1993, PARASITOLOGY, V107, P411, DOI 10.1017/S0031182000067767; Nantulya VM, 1997, T ROY SOC TROP MED H, V91, P551, DOI 10.1016/S0035-9203(97)90023-7; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; Radwanska M, 2002, AM J TROP MED HYG, V67, P684, DOI 10.4269/ajtmh.2002.67.684; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; Umezawa ES, 2003, TRANSFUSION, V43, P91, DOI 10.1046/j.1537-2995.2003.00279.x	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9630	10.1371/journal.pone.0009630	http://dx.doi.org/10.1371/journal.pone.0009630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224787	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800025
J	Kim, D; Shu, S; Coppola, MD; Kaneko, S; Yuan, ZQ; Cheng, JQ				Kim, Donghwa; Shu, Shaokun; Coppola, Marc D.; Kaneko, Satoshi; Yuan, Zeng-qiang; Cheng, Jin Q.			Regulation of Proapoptotic Mammalian ste20-Like Kinase MST2 by the IGF1-Akt Pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTES APOPTOSIS; PROTEIN-KINASE; PROTEOLYTIC ACTIVATION; AKT PHOSPHORYLATES; HIPPO PATHWAY; DROSOPHILA; GROWTH; TRANSCRIPTION; SURVIVAL	Background: Hippo, a Drosophila serine/threonine kinase, promotes apoptosis and restricts cell growth and proliferation. Its mammalian homolog MST2 has been shown to play similar role and be regulated by Raf-1 via a kinase-independent mechanism and by RASSF family proteins through forming complex with MST2. However, regulation of MST2 by cell survival signal remains largely unknown. Methodology/Principal Findings: Using immunoblotting, in vitro kinase and in vivo labeling assays, we show that IGF1 inhibits MST2 cleavage and activation induced by DNA damage through the phosphatidylinosotol 3-kinase (PI3K)/Akt pathway. Akt phosphorylates a highly conserved threonine-117 residue of MST2 in vitro and in vivo, which leads to inhibition of MST2 cleavage, nuclear translocation, autophosphorylation-Thr180 and kinase activity. As a result, MST2 proapoptotic and growth arrest function was significantly reduced. Further, inverse correlation between pMST2-T117/pAkt and pMST2-T180 was observed in human breast tumors. Conclusions/Significance: Our findings demonstrate for the first time that extracellular cell survival signal IGF1 regulates MST2 and that Akt is a key upstream regulator of MST2.	[Kim, Donghwa; Shu, Shaokun; Coppola, Marc D.; Kaneko, Satoshi; Yuan, Zeng-qiang; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Kim, D (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [CA107078, CA137041]; Department of Defense [W81XWH-08-2-0101]; Bankhead-Coley [ID 09BB-05]; NATIONAL CANCER INSTITUTE [R01CA137041, R01CA107078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health CA107078 and CA137041, Department of Defense W81XWH-08-2-0101 and Bankhead-Coley Grant ID 09BB-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; O'Neill E, 2005, CELL CYCLE, V4, P365, DOI 10.4161/cc.4.3.1531; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	42	36	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9616	10.1371/journal.pone.0009616	http://dx.doi.org/10.1371/journal.pone.0009616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231902	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328300023
J	Bachler, E; Hahn, S; Schaub, M; Arlettaz, R; Jenni, L; Fox, JW; Afanasyev, V; Liechti, F				Baechler, Erich; Hahn, Steffen; Schaub, Michael; Arlettaz, Raphael; Jenni, Lukas; Fox, James W.; Afanasyev, Vsevolod; Liechti, Felix			Year-Round Tracking of Small Trans-Saharan Migrants Using Light-Level Geolocators	PLOS ONE			English	Article							MIGRATION; BIRDS; ACCURACY	Since 1899 ringing (or banding) remained the most important source of information about migration routes, stopover sites and wintering grounds for birds that are too small to carry satellite-based tracking systems. Despite the large quantity of migrating birds ringed in their breeding areas in Europe, the number of ring recoveries from sub-Saharan Africa is very low and therefore the whereabouts of most small bird species outside the breeding season remain a mystery. With new miniaturized light-level geolocators it is now possible to look beyond the limits of ring recovery data. Here we show for the first time year round tracks of a near passerine trans-Saharan migrant, the European Hoopoe (Upupa epops epops). Three birds wintered in the Sahel zone of Western Africa where they remained stationary for most of the time. One bird chose a south-easterly route following the Italian peninsula. Birds from the same breeding population used different migration routes and wintering sites, suggesting a low level of migratory connectivity between breeding and wintering areas. Our tracking of a near passerine bird, the European Hoopoe, with light-level geolocators opens a new chapter in the research of Palaearctic-African bird migration as this new tool revolutionizes our ability to discover migration routes, stopover sites and wintering grounds of small birds.	[Baechler, Erich; Hahn, Steffen; Schaub, Michael; Arlettaz, Raphael; Jenni, Lukas; Liechti, Felix] Swiss Ornithol Inst, Sempach, Switzerland; [Schaub, Michael; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Fox, James W.; Afanasyev, Vsevolod] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Swiss Ornithological Institute; University of Bern; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Bachler, E (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	erich.baechler@vogelwarte.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Schaub, Michael/0000-0003-2745-0557; Hahn, Steffen/0000-0002-4924-495X	Swiss Ornithological Institute; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish; NERC [bas0100025, bas010011] Funding Source: UKRI	Swiss Ornithological Institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Swiss Ornithological Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, AVIAN MIGRATION, P253; Bairlein F, 2001, ARDEA, V89, P7; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Hill Roger D., 1994, P227; Hobson K. A., 2008, TRACKING ANIMAL MIGR, P144; Moreau R., 1972, PALAEARCTIC AFRICAN; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P333; Norris D. Ryan, 2006, Ornithological Monographs, V61, P79; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Reichlin TS, 2009, J ORNITHOL, V150, P393, DOI 10.1007/s10336-008-0361-3; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wendeln Helmut, 1999, Ringing and Migration, V19, P210; ZINK G, 1995, ATLAS WIEDERFUNDE BE, V3	20	129	139	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9566	10.1371/journal.pone.0009566	http://dx.doi.org/10.1371/journal.pone.0009566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221266	Green Published, Green Accepted, gold			2022-12-27	WOS:000275197200015
J	Brorsson, C; Hansen, NT; Bergholdt, R; Brunak, S; Pociot, F				Brorsson, Caroline; Hansen, Niclas Tue; Bergholdt, Regine; Brunak, Soren; Pociot, Flemming			The Type 1 Diabetes - HLA Susceptibility Interactome - Identification of HLA Genotype-Specific Disease Genes for Type 1 Diabetes	PLOS ONE			English	Article							PROTEIN-KINASE CK2; T1D SUSCEPTIBILITY; HUMAN MACROPHAGES; COMPLEX; REGION; HSP70; EXPRESSION; INHIBITOR; MELLITUS; NETWORKS	Background: The individual contribution of genes in the HLA region to the risk of developing type 1 diabetes (T1D) is confounded by the high linkage disequilibrium (LD) in this region. Using a novel approach we have combined genetic association data with information on functional protein-protein interactions to elucidate risk independent of LD and to place the genetic association into a functional context. Methodology/Principal Findings: Genetic association data from 2300 single nucleotide polymorphisms (SNPs) in the HLA region was analysed in 2200 T1D family trios divided into six risk groups based on HLA-DRB1 genotypes. The best SNP signal in each gene was mapped to proteins in a human protein interaction network and their significance of clustering in functional network modules was evaluated. The significant network modules identified through this approach differed between the six HLA risk groups, which could be divided into two groups based on carrying the DRB1*0301 or the DRB1*0401 allele. Proteins identified in networks specific for DRB1*0301 carriers were involved in stress response and inflammation whereas in DRB1*0401 carriers the proteins were involved in antigen processing and presentation. Conclusions/Significance: In this study we were able to hypothesise functional differences between individuals with T1D carrying specific DRB1 alleles. The results point at candidate proteins involved in distinct cellular processes that could not only help the understanding of the pathogenesis of T1D, but also the distinction between individuals at different genetic risk for developing T1D.	[Brorsson, Caroline; Bergholdt, Regine; Pociot, Flemming] Hagedorn Res Inst, Gentofte, Denmark; [Brorsson, Caroline; Bergholdt, Regine; Pociot, Flemming] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Niclas Tue; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pociot, Flemming] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pociot, Flemming] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Technical University of Denmark; Lund University; University of Copenhagen	Brorsson, C (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	cbss@hagedorn.dk	; Brunak, Soren/O-6621-2016	Brorsson, Caroline Anna/0000-0003-3473-1744; Brunak, Soren/0000-0003-0316-5866; Pociot, Flemming/0000-0003-3274-5448	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF) [U01 DK062418]; EFSD/JDRF/Novo Nordisk; Danish Medical Research Council [271-05-0672]; Juvenile Diabetes Research Foundation [33-2008-391]; Novo Nordisk A/S; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); EFSD/JDRF/Novo Nordisk(Novo NordiskJuvenile Diabetes Research Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk A/S(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study was funded by research grants from EFSD/JDRF/Novo Nordisk, the Danish Medical Research Council (271-05-0672), the Juvenile Diabetes Research Foundation (33-2008-391) and Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia-Lapid R, 2003, J AUTOIMMUN, V20, P313, DOI 10.1016/S0896-8411(03)00038-6; Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Bergholdt R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r253; Berka N, 2007, J NATL MED ASSOC, V99, P715; BRAY P, 1991, P NATL ACAD SCI USA, V88, P9563, DOI 10.1073/pnas.88.21.9563; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; CAPLEN NJ, 1990, IMMUNOGENETICS, V32, P427; Chen KG, 2005, PIGM CELL RES, V18, P102, DOI 10.1111/j.1600-0749.2005.00214.x; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Eike MC, 2009, GENES IMMUN, V10, P56, DOI 10.1038/gene.2008.74; EIKE MC, 2008, GENES IMMUN; Eisemann J, 2009, IMMUNOBIOLOGY, V214, P861, DOI 10.1016/j.imbio.2009.06.020; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Gaudreault N, 2004, DIABETOLOGIA, V47, P2081, DOI 10.1007/s00125-004-1583-4; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HELQVIST S, 1991, DIABETOLOGIA, V34, P150, DOI 10.1007/BF00418268; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Inoue S, 2009, CLIN EXP IMMUNOL, V156, P172, DOI 10.1111/j.1365-2249.2008.03872.x; Johansson S, 2003, GENES IMMUN, V4, P46, DOI 10.1038/sj.gene.6363917; KAWAGUCHI Y, 1993, DIABETES RES CLIN PR, V21, P103, DOI 10.1016/0168-8227(93)90056-B; Kerr JR, 2005, J VET MED B, V52, P335, DOI 10.1111/j.1439-0450.2005.00859.x; Kimura HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007857; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; Lindfors K, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-53; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Matsuyama W, 2004, J IMMUNOL, V172, P2332, DOI 10.4049/jimmunol.172.4.2332; Mehta JL, 1998, BIOCHEM BIOPH RES CO, V248, P511, DOI 10.1006/bbrc.1998.9004; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; NERUP J, 1974, LANCET, V2, P864; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Palazzo M, 2008, J IMMUNOL, V181, P3126, DOI 10.4049/jimmunol.181.5.3126; POCIOT F, 1993, SCAND J IMMUNOL, V38, P491, DOI 10.1111/j.1365-3083.1993.tb02593.x; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebbeck TR, 2008, INT J CANCER, V123, P1385, DOI 10.1002/ijc.23687; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; Sia Charles, 2005, Rev Diabet Stud, V2, P40, DOI 10.1900/RDS.2005.2.40; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; TU L, 2009, EUR J IMMUNOL; Valdes AM, 2009, DIABETES OBES METAB, V11, P46, DOI 10.1111/j.1463-1326.2008.01002.x; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Valdes AM, 2005, TISSUE ANTIGENS, V65, P115, DOI 10.1111/j.1399-0039.2005.00348.x; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; WELSH N, 1991, AUTOIMMUNITY, V9, P33, DOI 10.3109/08916939108997121; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009	69	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9576	10.1371/journal.pone.0009576	http://dx.doi.org/10.1371/journal.pone.0009576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221424	Green Submitted, Green Published, gold			2022-12-27	WOS:000275197200019
J	MacLeod, IJ; Minson, T				MacLeod, Iain J.; Minson, Tony			Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry	PLOS ONE			English	Article							NF-KAPPA-B; EPSTEIN-BARR-VIRUS; GLYCOPROTEIN-H; HUMAN CYTOMEGALOVIRUS; MONOCLONAL-ANTIBODIES; ENVELOPED VIRIONS; KINASE-ACTIVITY; CELL-GROWTH; C-MYC; ALPHA	The envelope of HSV-1 contains a number of glycoproteins, four of which are essential for virus entry. Virus particles lacking gB, gD, gH or gL are entry-defective, although these viruses retain the ability to bind to the plasma membrane via the remaining glycoproteins. Soluble forms of gD have been shown to trigger the nuclear translocation of the NF-kappa B transcriptional complex in addition to stimulating the production of Type I interferon. By taking advantage of the entry-defective phenotype of glycoprotein-deficient HSV-1 virus particles, the results presented here show that binding of virions to cellular receptors on the plasma membrane is sufficient to stimulate a change in cellular gene expression. Preliminary microarray studies, validated by quantitative real-time PCR, identified the differential expression of cellular genes associated with the NF-kappa B, PI3K/Akt, Jak/Stat and related Jak/Src pathways by virions lacking gB or gH but not gD. Gene induction occurred at a few particles per cell, corresponding to physiological conditions during primary infection. Reporter assay studies determined that NF-kappa B transcriptional activity is stimulated within an hour of HSV-1 binding, peaks between two and three hours post-binding and declines to background levels by five hours after induction. The immediate, transient nature of these signalling events suggests that HSV-1 glycoproteins, particularly gD, may alter the cellular environment pre-entry so as to condition the cell for viral replication.	[MacLeod, Iain J.; Minson, Tony] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	MacLeod, IJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	imacleod@hsph.harvard.edu	Li, Chia Cheng/D-9906-2015	MacLeod, Iain/0000-0001-5608-634X	Wellcome Trust [WT073049MA]; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grant WT073049MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SJ, 2000, J VIROL, V74, P7842, DOI 10.1128/JVI.74.17.7842-7850.2000; Amici C, 2006, J BIOL CHEM, V281, P7110, DOI 10.1074/jbc.M512366200; Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; Aubert M, 2003, GENE THER, V10, P1437, DOI 10.1038/sj.gt.3302004; Babic N, 1999, J GEN VIROL, V80, P2403, DOI 10.1099/0022-1317-80-9-2403; Beier R, 2000, EMBO J, V19, P5813, DOI 10.1093/emboj/19.21.5813; Boursnell MEG, 1997, J INFECT DIS, V175, P16, DOI 10.1093/infdis/175.1.16; Browne H, 1996, J VIROL, V70, P4311, DOI 10.1128/JVI.70.7.4311-4316.1996; Browne HM, 2009, PROTEIN PEPTIDE LETT, V16, P760, DOI 10.2174/092986609788681850; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; D'Addario M, 2001, J MOL BIOL, V308, P501, DOI 10.1006/jmbi.2001.4589; D'Addario M, 2000, J MOL BIOL, V298, P765, DOI 10.1006/jmbi.2000.3717; Dang CV, 1999, MOL CELL BIOL, V19, P1; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Gregory D, 2004, J VIROL, V78, P13582, DOI 10.1128/JVI.78.24.13582-13590.2004; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hossain A, 1997, J GEN VIROL, V78, P3341, DOI 10.1099/0022-1317-78-12-3341; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; LAUDE H, 1992, J VIROL, V66, P743, DOI 10.1128/JVI.66.2.743-749.1992; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; MCLEAN C, 1982, J GEN VIROL, V63, P297, DOI 10.1099/0022-1317-63-2-297; Medici MA, 2003, J BIOL CHEM, V278, P36059, DOI 10.1074/jbc.M306198200; MINSON AC, 1986, J GEN VIROL, V67, P1001, DOI 10.1099/0022-1317-67-6-1001; Naldinho-Souto R, 2006, J VIROL, V80, P2582, DOI 10.1128/JVI.80.5.2582-2584.2006; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Paludan SR, 2001, J VIROL, V75, P10170, DOI 10.1128/JVI.75.21.10170-10178.2001; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Patel A, 1998, VIROLOGY, V247, P212, DOI 10.1006/viro.1998.9243; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; Rodger G, 2001, J VIROL, V75, P710, DOI 10.1128/JVI.75.2.710-716.2001; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Rozen S, 2000, Methods Mol Biol, V132, P365; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Schang LM, 1998, J VIROL, V72, P5626, DOI 10.1128/JVI.72.7.5626-5637.1998; Sciortino MT, 2007, ANN NY ACAD SCI, V1096, P89, DOI 10.1196/annals.1397.074; Sciortino MT, 2008, BIOCHEM PHARMACOL, V76, P1522, DOI 10.1016/j.bcp.2008.07.030; Simmen KA, 2001, P NATL ACAD SCI USA, V98, P7140, DOI 10.1073/pnas.121177598; Taddeo B, 2002, P NATL ACAD SCI USA, V99, P17031, DOI 10.1073/pnas.252588599; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; WATSON DH, 1963, VIROLOGY, V19, P250, DOI 10.1016/0042-6822(63)90062-X	47	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9560	10.1371/journal.pone.0009560	http://dx.doi.org/10.1371/journal.pone.0009560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221426	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197200012
J	Chen, G; League, GP; Nam, SC				Chen, Geng; League, Garrett P.; Nam, Sang-Chul			Role of Spastin in Apical Domain Control along the Rhabdomere Elongation in Drosophila Photoreceptor	PLOS ONE			English	Article							MICROTUBULE STABILITY; RETINITIS-PIGMENTOSA; NUCLEAR MIGRATION; PROTEIN; CRUMBS; GENE; MORPHOGENESIS; EYE; PARAPLEGIA; MUTATIONS	Background: Mutations in spastin are the most common cause of hereditary spastin paraplegia, a neurodegenerative disease. In this study, the role of spastin was examined in Drosophila photoreceptor development. Methodology/Principal Findings: The spastin mutation in developing pupal eyes causes a mild mislocalization of the apical membrane domain at the distal section, but the apical domain was dramatically reduced at the proximal section of the developing pupal eye. Since the rhabdomeres in developing pupal eyes grow from distal to proximal, this phenotype strongly suggests that spastin is required for apical domain maintenance during rhabdomere elongation. This role of spastin in apical domain modulation was further supported by spastin's gain-of-function phenotype. Spastin overexpression in photoreceptors caused the expansion of the apical membrane domain from apical to basolateral in the developing photoreceptor. Although the localizations of the apical domain and adherens junctions (AJs) were severely expanded, there were no defects in cell polarity. Conclusions/Significance: These results strongly suggest that spastin is essential for apical domain biogenesis during rhabdomere elongation in Drosophila photoreceptor morphogenesis.	[Chen, Geng; League, Garrett P.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X	Baylor University	Baylor University	The authors thank Manzoor Bhat, Hugo Bellen, Kendal Broadie, KwangWook Choi, Kyung-Ok Cho, Yang Hong, Yuh-Nung Jan, Nina Tang Sherwood, Kai Zinn, Developmental Studies Hybridoma Bank, Bloomington Stock Center for fly stocks and reagents, and Alicia Rogers for technical assistance. Confocal Microscopy was supported by Baylor University.	Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Charvin D, 2003, HUM MOL GENET, V12, P71, DOI 10.1093/hmg/ddg004; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; Choi KW, 2007, FLY, V1, P235, DOI 10.4161/fly.4954; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fan SS, 1997, DEVELOPMENT, V124, P1497; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; WOLF N, 1988, DEVELOPMENT, V102, P311; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; XU T, 1993, DEVELOPMENT, V117, P1223	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9480	10.1371/journal.pone.0009480	http://dx.doi.org/10.1371/journal.pone.0009480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209135	gold, Green Published, Green Submitted			2022-12-27	WOS:000275063400004
J	de Meis, L; Ketzer, LA; da Costa, RM; de Andrade, IR; Benchimol, M				de Meis, Leopoldo; Ketzer, Luisa A.; da Costa, Rodrigo Madeiro; de Andrade, Ivone Rosa; Benchimol, Marlene			Fusion of the Endoplasmic Reticulum and Mitochondrial Outer Membrane in Rats Brown Adipose Tissue: Activation of Thermogenesis by Ca2+	PLOS ONE			English	Article							HEAT-PRODUCTION; CA2+-ATPASE; ATPASE; ENERGY; WATER; IDENTIFICATION; TEMPERATURE; HYDROLYSIS; LIVER	Brown adipose tissue (BAT) mitochondria thermogenesis is regulated by uncoupling protein 1 (UCP 1), GDP and fatty acids. In this report, we observed fusion of the endoplasmic reticulum (ER) membrane with the mitochondrial outer membrane of rats BAT. Ca2+-ATPase (SERCA 1) was identified by immunoelectron microscopy in both ER and mitochondria. This finding led us to test the Ca2+ effect in BAT mitochondria thermogenesis. We found that Ca2+ increased the rate of respiration and heat production measured with a microcalorimeter both in coupled and uncoupled mitochondria, but had no effect on the rate of ATP synthesis. The Ca2+ concentration needed for half-maximal activation varied between 0.08 and 0.11 mu M. The activation of respiration was less pronounced than that of heat production. Heat production and ATP synthesis were inhibited by rotenone and KCN. Liver mitochondria have no UCP1 and during respiration synthesize a large amount of ATP, produce little heat, GDP had no effect on mitochondria coupling, Ca2+ strongly inhibited ATP synthesis and had little or no effect on the small amount of heat released. These finding indicate that Ca2+ activation of thermogenesis may be a specific feature of BAT mitochondria not found in other mitochondria such as liver.	[de Meis, Leopoldo; Ketzer, Luisa A.; da Costa, Rodrigo Madeiro] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, Rio De Janeiro, Brazil; [de Andrade, Ivone Rosa; Benchimol, Marlene] Univ Santa Ursula, Lab Ultraestrutura Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	de Meis, L (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, Rio De Janeiro, Brazil.	demeis@bioqmed.ufrj.br	Ketzer, Luisa Andrea/J-1652-2015	Ketzer, Luisa Andrea/0000-0002-1127-116X	PRONEX - Financiadora de Estudos e Projetos (FINEP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	PRONEX - Financiadora de Estudos e Projetos (FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from PRONEX - Financiadora de Estudos e Projetos (FINEP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). LAK and RMC are recipients of post doctoral fellowships from CNPq and FAPERJ, respectively. IRA is PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200; BAFFY G, 2009, HEPATOLOGY, V50, P1204; Bedeaux D, 2008, PHYS CHEM CHEM PHYS, V10, P7304, DOI 10.1039/b810374g; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; BRACKER CE, 1971, PROTOPLASMA, V73, P15, DOI 10.1007/BF01286408; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1988, METHOD ENZYMOL, V157, P190; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FRANKE WW, 1971, PROTOPLASMA, V73, P35, DOI 10.1007/BF01286409; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; JUNGALWA.FB, 1970, BIOCHEM J, V117, P481, DOI 10.1042/bj1170481; JURGEN AW, 2009, J STRUCT BIOL, V166, P1; KLINGENBERG M, 2006, BIOCHIM BIOPHYS ACTA, V1778, P1978; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaver EV, 2002, AM J PHYSIOL-CELL PH, V282, pC1016, DOI 10.1152/ajpcell.00204.2001; LICHTENBELT WDM, 2009, NEW ENGL J MED, V360, P1518; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MORRE DJ, 1971, PROTOPLASMA, V73, P43, DOI 10.1007/BF01286410; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; NICHOLLS DG, 1999, J BIOENERGETIC BIOME, V3, P166; NICHOLLS JG, 1984, RES MOTIVATION ED ST, V1, P64; RICQUIER D, 1979, FEBS LETT, V99, P203, DOI 10.1016/0014-5793(79)80279-3; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; SPACEK J, 1980, J CELL SCI, V46, P129; STAUFFER CE, 1975, ANAL BIOCHEM, V69, P646, DOI 10.1016/0003-2697(75)90172-4; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	43	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9439	10.1371/journal.pone.0009439	http://dx.doi.org/10.1371/journal.pone.0009439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209153	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300002
J	Marshall, AK; Barrett, OPT; Cullingford, TE; Shanmugasundram, A; Sugden, PH; Clerk, A				Marshall, Andrew K.; Barrett, Oliver P. T.; Cullingford, Timothy E.; Shanmugasundram, Achchuthan; Sugden, Peter H.; Clerk, Angela			ERK1/2 Signaling Dominates Over RhoA Signaling in Regulating Early Changes in RNA Expression Induced by Endothelin-1 in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; VENTRICULAR MYOCYTES; GENE-EXPRESSION; GROWTH; STIMULATION; HYPERTROPHY; INHIBITION; ACTIVATE; RECEPTOR; HEART	Background: Cardiomyocyte hypertrophy is associated with changes in gene expression. Extracellular signal-regulated kinases 1/2 (ERK1/2) and RhoA [activated by hypertrophic agonists (e. g. endothelin-1)] regulate gene expression and are implicated in the response, but their relative significance in regulating the cardiomyocyte transcriptome is unknown. Our aim was to establish the significance of ERK1/2 and/or RhoA in the early cardiomyocyte transcriptomic response to endothelin-1. Methods/Principal Findings: Cardiomyocytes were exposed to endothelin-1 (1 h) with/without PD184352 (to inhibit ERK1/2) or C3 transferase (C3T, to inhibit RhoA). RNA expression was analyzed using microarrays and qPCR. ERK1/2 signaling positively regulated similar to 65% of the early gene expression response to ET-1 with a small (similar to 2%) negative effect, whereas RhoA signaling positively regulated similar to 10% of the early gene expression response to ET-1 with a greater (similar to 14%) negative contribution. Of RNAs non-responsive to endothelin-1, 66 or 448 were regulated by PD184352 or C3T, respectively, indicating that RhoA had a more significant effect on baseline RNA expression. mRNAs upregulated by endothelin-1 encoded a number of receptor ligands (e. g. Ereg, Areg, Hbegf) and transcription factors (e. g. Abra/Srf) that potentially propagate the response. Conclusions/Significance: ERK1/2 dominates over RhoA in the early transcriptomic response to endothelin-1. RhoA plays a major role in maintaining baseline RNA expression but, with upregulation of Abra/Srf by endothelin-1, RhoA may regulate changes in RNA expression over longer times. Our data identify ERK1/2 as a more significant node than RhoA in regulating the early stages of cardiomyocyte hypertrophy.	[Marshall, Andrew K.; Barrett, Oliver P. T.; Cullingford, Timothy E.; Shanmugasundram, Achchuthan; Sugden, Peter H.; Clerk, Angela] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England	Imperial College London	Marshall, AK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England.	a.clerk@imperial.ac.uk		Clerk, Angela/0000-0002-5658-0708	British Heart Foundation [FS/07/005, PG/07/074/23445, PG/07/018/22411]; Fondation Leducq	British Heart Foundation(British Heart Foundation); Fondation Leducq(Leducq Foundation)	A. K. M., O. P. T. B and T. E. C. were supported by grants from the British Heart Foundation (FS/07/005, PG/07/074/23445, PG/07/018/22411). The work was also supported by the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710; Bromann PA, 2005, J BIOL CHEM, V280, P10253, DOI 10.1074/jbc.M413806200; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Clerk A, 1996, BIOCHEM J, V317, P109, DOI 10.1042/bj3170109; Clerk A, 2001, MOL CELL BIOL, V21, P1173, DOI 10.1128/MCB.21.4.1173-1184.2001; Clerk A, 1998, J CELL BIOL, V142, P523, DOI 10.1083/jcb.142.2.523; Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Fischer P, 2008, BRIT J PHARMACOL, V153, pS414, DOI 10.1038/bjp.2008.1; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Kennedy RA, 2006, J MOL CELL CARDIOL, V41, P236, DOI 10.1016/j.yjmcc.2006.04.011; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266	28	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10027	10.1371/journal.pone.0010027	http://dx.doi.org/10.1371/journal.pone.0010027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368814	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000276419900021
J	Hayles, B; Yellaboina, S; Wang, DG				Hayles, Brewster; Yellaboina, Sailu; Wang, Degeng			Comparing Transcription Rate and mRNA Abundance as Parameters for Biochemical Pathway and Network Analysis	PLOS ONE			English	Article							PHYLOGENETIC PROFILES; ESCHERICHIA-COLI; GENE-EXPRESSION; GENOME; GENERATION; PREDICTION; SEQUENCE; DATABASE; OPERONS; BIOLOGY	The cells adapt to extra- and intra-cellular signals by dynamic orchestration of activities of pathways in the biochemical networks. Dynamic control of the gene expression process represents a major mechanism for pathway activity regulation. Gene expression has thus been routinely measured, most frequently at steady-state mRNA abundance level using microarray technology. The results are widely used in statistical inference of the structures of underlying biochemical networks, with the assumption that functionally related genes exhibit similar dynamic profiles. Steady-state mRNA abundance, however, is a composite of two factors: transcription rate and mRNA degradation rate. The question being asked here is therefore whether steady-state mRNA abundance or any of two factors is a more informative measurement target for studying network dynamics. The yeast S. cerevisiae was used as model organism and transcription rate was chosen out of the two factors in this study, because genome-wide determination of transcription rates has been reported for several physiological processes in this species. Our strategy is to test which one is a better measurement of functional relatedness between genes. The analysis was performed on those S. cerevisiae genes that have bacterial orthologs as identified by reciprocal BLAST analysis, so that functional relatedness of a gene pair can be measured by the frequency at which their bacterial orthologs co-occur in the same operon in the collection of bacterial genomes. It is found that transcription rate data is generally a better parameter for functional relatedness than steady state mRNA abundance, suggesting transcription rate data is more informative to use in deciphering the logics used by the cells in dynamic regulation of biochemical network behaviors. The significance of this finding for network and systems biology, as well as biomedical research in general, is discussed.	[Hayles, Brewster; Yellaboina, Sailu; Wang, Degeng] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hayles, B (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA.	dwang1@cas.usf.edu			University of South Florida (USF) Foundation	University of South Florida (USF) Foundation	This work was supported by the University of South Florida (USF) Foundation and a USF New Researcher Grant to D. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Karimpour-Fard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-393; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1; McGuire AM, 2000, NUCLEIC ACIDS RES, V28, P4523, DOI 10.1093/nar/28.22.4523; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Moreno-Hagelsieb G, 2008, PROTEINS, V70, P344, DOI 10.1002/prot.21564; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Teng XK, 2009, SCI CHINA SER C, V52, P7, DOI 10.1007/s11427-009-0012-9; Tissot B, 2009, FEBS LETT, V583, P1728, DOI 10.1016/j.febslet.2009.03.049; Wu Hongwei, 2005, Genome Inform, V16, P247; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Yuan Y, 2007, PLOS COMPUT BIOL, V3, P2391, DOI 10.1371/journal.pcbi.0030243	30	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9908	10.1371/journal.pone.0009908	http://dx.doi.org/10.1371/journal.pone.0009908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361042	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600014
J	Pemberton, AD; Brown, JK				Pemberton, Alan D.; Brown, Jeremy K.			In Vitro Interactions of Extracellular Histones with LDL Suggest a Potential Pro-Atherogenic Role	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PLASMA-PROTEOME; HEPARAN-SULFATE; RETENTION; BINDING; ATHEROSCLEROSIS; PROLIFERATION; COMPLEXES; PERLECAN; PROTEINS	Background: Nuclear histones have previously been shown to aggregate LDL in vitro, suggestive of a possible proatherogenic role. Recent studies indicate that histones are released during acute inflammation, and therefore might interact with circulating lipoproteins in vivo. In view of the associative link between inflammation and cardiovascular disease, the behaviour of histones was investigated using in vitro models of LDL retention and foam cell formation. Methodology/Principal Findings: Heparin agarose beads were used as a model of a matrix rich in sulphated glycosaminoglycans, to which histones bind strongly. Histone-modified beads were observed to pull down more LDL from solution than untreated beads, indicating that histones can function as bridging molecules, enhancing LDL retention. Furthermore, addition of heparin inhibited histone-induced aggregation of LDL. To model foam cell formation, murine RAW 264.7 macrophages were incubated for 24 h in the presence of LDL, histones, LDL plus histones or vehicle control. Cells incubated with LDL in the presence of histones accumulated significantly more intracellular lipid than with LDL or histone alone. Conclusions/Significance: These results are consistent with a potential pro-atherogenic role for extracellular histones, which should be investigated further.	[Pemberton, Alan D.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Pemberton, AD (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	alan.pemberton@ed.ac.uk			University of Edinburgh Development Fund; Biotechnology and Biological Sciences Research Council [BBE01867X1]	University of Edinburgh Development Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of Edinburgh Development Fund. JKB was funded by the Biotechnology and Biological Sciences Research Council (Grant no. BBE01867X1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILOZUR ME, 1990, J BIOL CHEM, V265, P19697; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; COURVALIN JC, 1982, J BIOL CHEM, V257, P456; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; GONIAS SL, 1985, THROMB RES, V39, P97, DOI 10.1016/0049-3848(85)90125-2; Gustafsson M, 2007, CIRC RES, V101, P777, DOI 10.1161/CIRCRESAHA.107.149666; Henriquez JP, 2002, J CELL SCI, V115, P2041; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; PEMBERTON AD, 2010, PROTEOMICS IN PRESS; PEREIRA LF, 1994, CLIN EXP IMMUNOL, V97, P175; SKRZYDLEWSKI Z, 1976, ACTA BIOL ACAD SCI H, V27, P291; SKRZYDLEWSKI Z, 1977, B ACAD POL SCI BIOL, V25, P71; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Wilson PWF, 2008, AM J MED, V121, P15, DOI 10.1016/j.amjmed.2008.06.012; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zheng XY, 2009, J CHROMATOGR A, V1216, P3538, DOI 10.1016/j.chroma.2009.01.063	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9884	10.1371/journal.pone.0009884	http://dx.doi.org/10.1371/journal.pone.0009884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360839	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500013
J	Gelling, M; Montes, I; Moorhouse, TP; Macdonald, DW				Gelling, Merryl; Montes, Inigo; Moorhouse, Tom P.; Macdonald, David W.			Captive Housing during Water Vole (Arvicola terrestris) Reintroduction: Does Short-Term Social Stress Impact on Animal Welfare?	PLOS ONE			English	Article							PLASMA-CORTICOSTERONE CONCENTRATIONS; LEUKOCYTE COPING CAPACITY; NEUTROPHIL ACTIVATION; IMMUNE FUNCTION; WILD; BEHAVIOR; DENSITY; RATS; TRANSLOCATION; RESTRAINT	Background: Animals captive bred for reintroduction are often housed under conditions which are not representative of their preferred social structure for at least part of the reintroduction process. Specifically, this is most likely to occur during the final stages of the release programme, whilst being housed during transportation to the release site. The degree of social stress experienced by individuals during this time may negatively impact upon their immunocompetence. Methodology/Principal Findings: We examined two measure of stress-body weight and Leukocyte Coping Capacity (LCC) - to investigate the effects of group size upon captive-bred water voles destined for release within a reintroduction program. Water voles were housed in laboratory cages containing between one and eight individuals. LCC scores were negatively correlated with group size, suggesting that individuals in larger groups experienced a larger degree of immunosuppression than did individuals housed in smaller groups or individually. During the course of the study mean body weights increased, in contrast to expectations from a previous study. This was attributed to the individuals sampled being sub-adults and thus growing in length and weight during the course of the investigation. Conclusions/Significance: The reintroduction process will inevitably cause some stress to the release cohort. However, for water voles we conclude that the stress experienced may be reduced by decreasing group size within captive colony and/or transportation housing practises. These findings are of significance to other species' reintroductions, in highlighting the need to consider life-history strategies when choosing housing systems for animals being maintained in captivity prior to release to the wild. A reduction in stress experienced at the pre-release stage may improve immunocompetence and thus animal welfare and initial survival post-release.	[Gelling, Merryl; Montes, Inigo; Moorhouse, Tom P.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England	University of Oxford	Gelling, M (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	merryl.gelling@zoo.ox.ac.uk	Gelling, Merryl/I-8448-2012	Moorhouse, Tom/0000-0002-8889-2175	Environment Agency and Peoples Trust for Endangered Species (PTES); Holly Hill Trust; PTES	Environment Agency and Peoples Trust for Endangered Species (PTES); Holly Hill Trust; PTES	M. Gelling was funded by the Environment Agency and Peoples Trust for Endangered Species (PTES) with contributions from D. Gow Consultancies. PTES also funded I. Montes for the duration of the study. T. Moorhouse was funded by the Holly Hill Trust and PTES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altholtz LY, 2006, J AM ASSOC LAB ANIM, V45, P17; Armstrong DP, 1999, BIOL CONSERV, V89, P329, DOI 10.1016/S0006-3207(99)00012-9; BOND M, 1997, ORANGUTAN SPECIES SU, P77; Burman O, 2008, PHYSIOL BEHAV, V93, P89, DOI 10.1016/j.physbeh.2007.08.001; Calvete C, 2005, J WILDLIFE MANAGE, V69, P1063, DOI 10.2193/0022-541X(2005)069[1063:QLASOT]2.0.CO;2; CODDINGTON EJ, 1995, GEN COMP ENDOCR, V100, P33, DOI 10.1006/gcen.1995.1129; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Egger G, 2001, INFLAMMATION, V25, P129, DOI 10.1023/A:1007174723608; Ford WCL, 1997, INT J ANDROL, V20, P44; Gelling M, 2009, ANIM WELFARE, V18, P1; Gregory LF, 1996, GEN COMP ENDOCR, V104, P312, DOI 10.1006/gcen.1996.0176; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; Honess PE, 2005, ANIM WELFARE, V14, P291; Hu TH, 1999, CELL SIGNAL, V11, P355, DOI 10.1016/S0898-6568(99)00007-8; JEFFERIES DJ, 1989, MAMMAL REV, V19, P111, DOI 10.1111/j.1365-2907.1989.tb00406.x; KOFKE WA, 1995, J NEUROSURG ANESTH, V7, P280, DOI 10.1097/00008506-199510000-00007; Kunz-Ebrecht SR, 2003, BRAIN BEHAV IMMUN, V17, P373, DOI 10.1016/S0889-1591(03)00029-1; Laber K, 2008, J AM ASSOC LAB ANIM, V47, P16; Letty J, 2000, ANIM CONSERV, V3, P211, DOI 10.1017/S1367943000000925; Mathews F, 2002, VET REC, V150, P785, DOI 10.1136/vr.150.25.785; McLaren Graeme, 2006, P120; McLaren GW, 2004, ANIM WELFARE, V13, P337; McLaren GW, 2003, EXP PHYSIOL, V88, P541, DOI 10.1113/eph8802571; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Montes I, 2004, ANIM WELFARE, V13, P355; Moorhouse TP, 2007, J ZOOL, V271, P19, DOI 10.1111/j.1469-7998.2006.00175.x; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; Moorhouse TP, 2008, J ANIM ECOL, V77, P1288, DOI 10.1111/j.1365-2656.2008.01431.x; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Mugnai C, 2009, APPL ANIM BEHAV SCI, V118, P91, DOI 10.1016/j.applanim.2009.02.007; O'Malley J, 2008, J AM ASSOC LAB ANIM, V47, P9; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Ostrakhovitch EA, 2001, BIOCHEM PHARMACOL, V62, P743, DOI 10.1016/S0006-2952(01)00707-9; PENG X, 1989, LAB ANIM, V23, P302, DOI 10.1258/002367789780746042; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Sanidas D, 2000, EXP PHYSIOL, V85, P263, DOI 10.1111/j.1469-445X.2000.02023.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Strachan R, 1993, WATER VOLE ARVICOLA; STRACHAN R, 2006, WATERVOLE CONSERVATI; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Yildiz A, 2007, ASIAN AUSTRAL J ANIM, V20, P263; Zhou J, 1999, AM J PHYSIOL-REG I, V277, pR757, DOI 10.1152/ajpregu.1999.277.3.R757	44	14	14	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9791	10.1371/journal.pone.0009791	http://dx.doi.org/10.1371/journal.pone.0009791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352093	Green Published, gold			2022-12-27	WOS:000275894500006
J	Lind, J; Lindenfors, P				Lind, Johan; Lindenfors, Patrik			The Number of Cultural Traits Is Correlated with Female Group Size but Not with Male Group Size in Chimpanzee Communities	PLOS ONE			English	Article							PAN-TROGLODYTES; EVOLUTION	What determines the number of cultural traits present in chimpanzee (Pan troglodytes) communities is poorly understood. In humans, theoretical models suggest that the frequency of cultural traits can be predicted by population size. In chimpanzees, however, females seem to have a particularly important role as cultural carriers. Female chimpanzees use tools more frequently than males. They also spend more time with their young, skewing the infants' potential for social learning towards their mothers. In Gombe, termite fishing has been shown to be transmitted from mother to offspring. Lastly, it is female chimpanzees that transfer between communities and thus have the possibility of bringing in novel cultural traits from other communities. From these observations we predicted that females are more important cultural carriers than males. Here we show that the reported number of cultural traits in chimpanzee communities correlates with the number of females in chimpanzee communities, but not with the number of males. Hence, our results suggest that females are the carriers of chimpanzee culture.	[Lind, Johan] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Lind, J (corresponding author), Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden.	johan.lind@zoologi.su.se	Lindenfors, Patrik/G-6401-2011; Lindenfors, Patrik/N-2801-2019	Lindenfors, Patrik/0000-0003-3245-0850; Lindenfors, Patrik/0000-0003-3245-0850	Swedish Research Council (PL); CULTAPTATION [FP6-2004-NEST-PATH-043434]	Swedish Research Council (PL)(Swedish Research Council); CULTAPTATION	This study was funded through a research grant from the Swedish Research Council (PL) and it was also supported by the CULTAPTATION project (European Commission contract FP6-2004-NEST-PATH-043434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Enquist M, 2008, THEOR POPUL BIOL, V74, P46, DOI 10.1016/j.tpb.2008.04.007; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; HANNAH AC, 1987, PRIMATES, V28, P31, DOI 10.1007/BF02382181; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; IUCN, 2014, IUCN RED LIST THREAT; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Lycett SJ, 2009, J HUM EVOL, V57, P337, DOI 10.1016/j.jhevol.2009.05.015; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Nishida T., 1987, P165; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; R Core Team, 2018, R LANG ENV STAT COMP; Strimling P, 2009, THEOR POPUL BIOL, V76, P77, DOI 10.1016/j.tpb.2009.04.006; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Wrangham R. W, 2000, PRIMATE MALES CAUSES	23	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9241	10.1371/journal.pone.0009241	http://dx.doi.org/10.1371/journal.pone.0009241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352086	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894500001
J	Cepeda-Cornejo, V; Dirzo, R				Cepeda-Cornejo, Veronica; Dirzo, Rodolfo			Sex-Related Differences in Reproductive Allocation, Growth, Defense and Herbivory in Three Dioecious Neotropical Palms	PLOS ONE			English	Article							RAIN-FOREST; RESOURCE-ALLOCATION; BIOMASS ALLOCATION; ILEX-AQUIFOLIUM; PLANT TOLERANCE; TREE; PATTERNS; COSTS; SHRUB; CHAMAEDOREA	Background: Frequently, in dioecious plants, female plants allocate more resources to reproduction than male plants. Therefore it is expected that asymmetrical allocation to reproduction may lead to a reproduction-growth tradeoff, whereby female plants grow less than male plants, but invest more in defenses and thus experience lower herbivory than male plants. Methodology/Principal Findings: We tested these expectations by comparing resource allocation to reproduction, growth and defense and its consequences on herbivory in three sympatric dioecious Chamaedorea palms (C. alternans, C. pinnatifrons and C. ernesti-augusti) using a pair-wise design (replicated male/female neighboring plants) in a Mexican tropical rain forest. Our findings support the predictions. Biomass allocation to reproduction in C. pinnatifrons was 3-times higher in female than male plants, consistent with what is known in C. alternans and C. ernesti-augusti. Growth (height and leaf production rate and biomass production) was higher in male plants of all three species. Female plants of the three species had traits that suggest greater investment in defense, as they had 4-16% tougher leaves, and 8-18% higher total phenolic compounds concentration. Accordingly, female plants sustained 53-78% lower standing herbivory and 49-87% lower herbivory rates than male plants. Conclusions/Significance: Our results suggests that resource allocation to reproduction in the studied palms is more costly to female plants and this leads to predictable intersexual differences in growth, defense and herbivory. We conclude that resource allocation to reproduction in plants can have important consequences that influence their interaction with herbivores. Since herbivory is recognized as an important selective force in plants, these results are of significance to our understanding of plant defense evolution.	[Cepeda-Cornejo, Veronica; Dirzo, Rodolfo] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidad Nacional Autonoma de Mexico; Stanford University	Cepeda-Cornejo, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	vcepeda@ecologia.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN229002]; National Council of Science and Technology of Mexico (CONACYT); Posgrado en Ciencias Biologicas; Universidad Nacional Autonoma de Mexico (UNAM); Instituto de Ecologia (UNAM); Direccion general de Estudios de Posgrado (DGEP-UNAM)	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); National Council of Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado en Ciencias Biologicas; Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Instituto de Ecologia (UNAM)(Universidad Nacional Autonoma de Mexico); Direccion general de Estudios de Posgrado (DGEP-UNAM)(Universidad Nacional Autonoma de Mexico)	This study was supported by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) IN229002 (http://www.unam.mx). The National Council of Science and Technology of Mexico (CONACYT), the Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico (UNAM), the Instituto de Ecologia (UNAM) and the Direccion general de Estudios de Posgrado (DGEP-UNAM), provided financial support for graduate studies to V. C. C. Field work of R. D was supported by a CONACYT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Antos JA, 1999, J ECOL, V87, P77, DOI 10.1046/j.1365-2745.1999.00331.x; Araújo Ana Paula A., 2003, Rev. Bras. entomol., V47, P483, DOI 10.1590/S0085-56262003000400001; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BULLOCK SH, 1984, OECOLOGIA, V63, P426, DOI 10.1007/BF00390677; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; DELPH LF, 1990, ECOLOGY, V71, P1342, DOI 10.2307/1938271; DELPH LF, 1993, AM J BOT, V80, P607, DOI 10.2307/2445429; Delph LF, 1999, GENDER SEXUAL DIMORP, P149, DOI DOI 10.1007/978-3-662-03908-3_6; Dudley LS, 2006, AM J BOT, V93, P1775, DOI 10.3732/ajb.93.12.1775; ELMQVIST T, 1991, OIKOS, V61, P65, DOI 10.2307/3545407; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; FEENY P, 1976, COEVOLUTION ANIMALS, P3; FEENY PP, 1976, ANAL PHENOLIC PLANT; Fincher RM, 2008, J CHEM ECOL, V34, P558, DOI 10.1007/s10886-008-9432-4; Fordyce JA, 2001, J ANIM ECOL, V70, P997, DOI 10.1046/j.0021-8790.2001.00568.x; GONZALEZSORIANO E, HISTORIA NATURAL TUX; GOVAERTS R, 2006, WORLD CHECKLIST AREC; GROSS KL, 1981, AM J BOT, V68, P801, DOI 10.2307/2443186; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HJALTEN J, 1992, OECOLOGIA, V89, P253, DOI 10.1007/BF00317225; HUNT R, 1982, CONCEPTS PLANT GROWT, P14; IBARRAMANRIQUEZ G, 1992, AM J BOT, V79, P383, DOI 10.2307/2445150; JING SW, 1990, OIKOS, V58, P369, DOI 10.2307/3545228; Karlsson P. Staffan, 2005, P1, DOI 10.1016/B978-012088386-8/50001-6; KRISCHIK VA, 1990, OECOLOGIA, V83, P182, DOI 10.1007/BF00317750; LEVINS RICHARD, 1968; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; Montesinos D, 2006, ANN BOT-LONDON, V98, P885, DOI 10.1093/aob/mcl172; Obeso JR, 1997, J ECOL, V85, P159, DOI 10.2307/2960648; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Obeso JR, 2002, REV CHIL HIST NAT, V75, P67; Otero-Arnaiz A, 2001, J TROP ECOL, V17, P745, DOI 10.1017/S0266467401001559; OYAMA K, 1991, Principes, V35, P86; OYAMA K, 1988, Plant Species Biology, V3, P27, DOI 10.1111/j.1442-1984.1988.tb00168.x; OYAMA K, 1990, J ECOL, V78, P648, DOI 10.2307/2260890; OYAMA K, 1992, TROPICS, V2, P23; POPP JW, 1988, AM J BOT, V75, P1732, DOI 10.2307/2444688; Quero H.J., 1994, FLORA VERACRUZ; Ramos A, 2008, HORTIC BRAS, V26, P138, DOI 10.1590/S0102-05362008000200002; REEKIE EG, 1987, AM NAT, V129, P876, DOI 10.1086/284681; Rocheleau AF, 2001, AM J BOT, V88, P659, DOI 10.2307/2657066; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; SAGERS CL, 1995, ECOLOGY, V76, P1835, DOI 10.2307/1940715; Soto M., 1997, HIST NATURAL TUXTLAS, P7; Stearns SC, 1992, TRADE OFFS EVOLUTION, P72; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Suzuki AA, 2005, AM J BOT, V92, P2003, DOI 10.3732/ajb.92.12.2003; Thomas MM, 2006, MOL PHYLOGENET EVOL, V38, P398, DOI 10.1016/j.ympev.2005.08.019; Torimaru T, 2006, CAN J BOT, V84, P1860, DOI 10.1139/B06-129; Turcotte J, 2001, ECOSCIENCE, V8, P506, DOI 10.1080/11956860.2001.11682682; Ueno N, 2006, CAN J BOT, V84, P1852, DOI 10.1139/B06-142	55	57	62	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9824	10.1371/journal.pone.0009824	http://dx.doi.org/10.1371/journal.pone.0009824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352113	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894400024
J	Gosoniu, L; Veta, AM; Vounatsou, P				Gosoniu, Laura; Veta, Andre Mia; Vounatsou, Penelope			Bayesian Geostatistical Modeling of Malaria Indicator Survey Data in Angola	PLOS ONE			English	Article							TRANSMISSION	The 2006-2007 Angola Malaria Indicator Survey (AMIS) is the first nationally representative household survey in the country assessing coverage of the key malaria control interventions and measuring malaria-related burden among children under 5 years of age. In this paper, the Angolan MIS data were analyzed to produce the first smooth map of parasitaemia prevalence based on contemporary nationwide empirical data in the country. Bayesian geostatistical models were fitted to assess the effect of interventions after adjusting for environmental, climatic and socio-economic factors. Non-linear relationships between parasitaemia risk and environmental predictors were modeled by categorizing the covariates and by employing two non-parametric approaches, the B-splines and the P-splines. The results of the model validation showed that the categorical model was able to better capture the relationship between parasitaemia prevalence and the environmental factors. Model fit and prediction were handled within a Bayesian framework using Markov chain Monte Carlo (MCMC) simulations. Combining estimates of parasitaemia prevalence with the number of children under 5 we obtained estimates of the number of infected children in the country. The population-adjusted prevalence ranges from 3.76% in Namibe province to 32.65% in Malanje province. The odds of parasitaemia in children living in a household with at least 0.2 ITNs per person was by 41% lower (CI: 14%, 60%) than in those with fewer ITNs. The estimates of the number of parasitaemic children produced in this paper are important for planning and implementing malaria control interventions and for monitoring the impact of prevention and control activities.	[Gosoniu, Laura; Vounatsou, Penelope] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Veta, Andre Mia] LDA, COSEP Consultoria, Luanda, Angola	University of Basel; Swiss Tropical & Public Health Institute	Gosoniu, L (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	laura.gosoniu@unibas.ch		Vounatsou, Penelope/0000-0002-4904-5352	United States Agency for International Development (USAID)/Angola; President's Malaria Initiative (PMI); United Nations Development Programme (UNDP); Swiss National Science Foundation (SNF) [IZLSZ3 122926]	United States Agency for International Development (USAID)/Angola(United States Agency for International Development (USAID)); President's Malaria Initiative (PMI)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); United Nations Development Programme (UNDP); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Funding for the Angola Malaria Indicator Survey (MIS) was provided by the United States Agency for International Development (USAID)/Angola, the President's Malaria Initiative (PMI) and the United Nations Development Programme (UNDP)-managed Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). This investigation received financial support from the Swiss National Science Foundation (SNF) (Project No. IZLSZ3 122926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2009, COMPUT STAT DATA AN, V53, P3358, DOI 10.1016/j.csda.2009.02.022; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; *PMI, 2006, PRES MAL IN; RUEBUSH TK, 2005, PRESIDENTS INITIATIV; UNICEF, 2008, PROGR REP MAL NO MOR; *UNICEF, 2003, MICS MULT IND CLUST; WHO/UNICEF, 2005, WORLD MAL REP; *WHO UNICEF, 2005, SUMM COUNTR PROF HIV; 2007, ANGOLA MALARIA INDIC	15	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9322	10.1371/journal.pone.0009322	http://dx.doi.org/10.1371/journal.pone.0009322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351775	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894400002
J	Zhao, SX; Pan, CM; Cao, HM; Han, B; Shi, JY; Liang, J; Gao, GQ; Peng, YD; Su, Q; Chen, JL; Zhao, JJ; Song, HD				Zhao, Shuang-Xia; Pan, Chun-Ming; Cao, Huang-Ming; Han, Bing; Shi, Jing-Yi; Liang, Jun; Gao, Guan-Qi; Peng, Yong-De; Su, Qing; Chen, Jia-Lun; Zhao, Jia-Jun; Song, Huai-Dong			Association of the CTLA4 Gene with Graves' Disease in the Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTOIMMUNE THYROID-DISEASE; SUSCEPTIBILITY; POLYMORPHISM; SNPS; REGION; ANTIBODIES; VARIANTS; PROMOTER; RECEPTOR	To determine whether genetic heterogeneity exists in patients with Graves' disease (GD), the cytotoxic T-lymphocyte associated 4 (CTLA-4) gene, which is implicated a susceptibility gene for GD by considerable genetic and immunological evidence, was used for association analysis in a Chinese Han cohort recruited from various geographic regions. Our association study for the SNPs in the CTLA4 gene in 2640 GD patients and 2204 control subjects confirmed that CTLA4 is the susceptibility gene for GD in the Chinese Han population. Moreover, the logistic regression analysis in the combined Chinese Han cohort revealed that SNP rs231779 (allele frequencies p = 2.81 x 10(-9), OR = 1.35, and genotype distributions p = 2.75 x 10(-9), OR = 1.42) is likely the susceptibility variant for GD. Interestingly, the logistic regression analysis revealed that SNP rs35219727 may be the susceptibility variant to GD in the Shandong population; however, SNP, rs231779 in the CTLA4 gene probably independently confers GD susceptibility in the Xuzhou and southern China populations. These data suggest that the susceptibility variants of the CTLA4 gene varied between the different geographic populations with GD.	[Zhao, Shuang-Xia; Pan, Chun-Ming; Cao, Huang-Ming; Han, Bing; Shi, Jing-Yi; Chen, Jia-Lun; Song, Huai-Dong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Inst Endocrinol, State Key Lab Med Genom,Mol Med Ctr, Shanghai 200030, Peoples R China; [Liang, Jun] Fourth Hosp Xuzhou, Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; [Gao, Guan-Qi] Peoples Hosp Linyi, Dept Endocrinol, Linyi, Shandong, Peoples R China; [Peng, Yong-De] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Endocrinol, Shanghai 200030, Peoples R China; [Su, Qing] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Endocrinol, Shanghai 200030, Peoples R China; [Zhao, Jia-Jun] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhao, SX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Inst Endocrinol, State Key Lab Med Genom,Mol Med Ctr, Shanghai 200030, Peoples R China.	jjzhao@medmail.com.cn; huaidong_s1966@163.com	Song, Huai-Dong/G-8961-2011; Zhao, Jiajun/W-2963-2018	Zhao, Jiajun/0000-0003-3267-9292; Song, Huai-Dong/0000-0002-9609-5803	National Natural Science Foundation of China [30971595, 30771017, 30971383]; Chinese High Tech Program (863) [2006AA02Z175]; Commission for Science and Technology of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese High Tech Program (863)(National High Technology Research and Development Program of China); Commission for Science and Technology of Shanghai	This work was supported in part by the National Natural Science Foundation of China (30971595, 30771017 and 30971383), Chinese High Tech Program (863)(2006AA02Z175), and Commission for Science and Technology of Shanghai. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; BRIX TH, 2001, EVIDENCE MAJOR ROLE, P930; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chen X., 2000, CHIN J ENDOCRINOL ME, V18, P342; Chistyakov DA, 2000, MOL GENET METAB, V70, P214, DOI 10.1006/mgme.2000.3007; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; GU LQ, 2009, CLIN ENDOCR IN PRESS; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; KOCHI Y, 2005, FUNCTIONAL VARIANT F, P478; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; ONODERA T, 1990, IMMUNOLOGY, V71, P581; Petrone A, 2005, THYROID, V15, P232, DOI 10.1089/thy.2005.15.232; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song HD, 2009, HUM MOL GENET, V18, P1156, DOI 10.1093/hmg/ddn442; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Tomer Y, 2007, J AUTOIMMUN, V29, P69, DOI 10.1016/j.jaut.2007.05.006; Tsai ST, 2008, J PEDIATR ENDOCR MET, V21, P665; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang PW, 2007, J CLIN ENDOCR METAB, V92, P2513, DOI 10.1210/jc.2006-2761; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yanagawa T, 1997, THYROID, V7, P843, DOI 10.1089/thy.1997.7.843; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41	34	34	43	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9821	10.1371/journal.pone.0009821	http://dx.doi.org/10.1371/journal.pone.0009821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352109	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400021
J	Panova, M; Bostrom, J; Hofving, T; Areskoug, T; Eriksson, A; Mehlig, B; Makinen, T; Andre, C; Johannesson, K				Panova, Marina; Bostrom, Johan; Hofving, Tobias; Areskoug, Therese; Eriksson, Anders; Mehlig, Bernhard; Makinen, Tuuli; Andre, Carl; Johannesson, Kerstin			Extreme Female Promiscuity in a Non-Social Invertebrate Species	PLOS ONE			English	Article							MICROSATELLITE DNA MARKERS; MULTIPLE PATERNITY; GENETIC BENEFITS; LITTORINA-SAXATILIS; NATURAL-POPULATION; MATING FREQUENCY; SEXUAL CONFLICT; NUPTIAL GIFTS; MATE CHOICE; POLYANDRY	Background: While males usually benefit from as many matings as possible, females often evolve various methods of resistance to matings. The prevalent explanation for this is that the cost of additional matings exceeds the benefits of receiving sperm from a large number of males. Here we demonstrate, however, a strongly deviating pattern of polyandry. Methodology/Principal Findings: We analysed paternity in the marine snail Littorina saxatilis by genotyping large clutches (53-79) of offspring from four females sampled in their natural habitats. We found evidence of extreme promiscuity with 15-23 males having sired the offspring of each female within the same mating period. Conclusions/Significance: Such a high level of promiscuity has previously only been observed in a few species of social insects. We argue that genetic bet-hedging (as has been suggested earlier) is unlikely to explain such extreme polyandry. Instead we propose that these high levels are examples of convenience polyandry: females accept high numbers of matings if costs of refusing males are higher than costs of accepting superfluous matings.	[Panova, Marina; Bostrom, Johan; Hofving, Tobias; Areskoug, Therese; Eriksson, Anders; Andre, Carl; Johannesson, Kerstin] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden; [Eriksson, Anders; Mehlig, Bernhard] Univ Gothenburg, Dept Phys, Gothenburg, Sweden; [Makinen, Tuuli] Univ Alaska Museum N, Fairbanks, AK USA	University of Gothenburg; University of Gothenburg; University of Alaska System; University of Alaska Fairbanks	Panova, M (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden.	Marina.Panova@marecol.gu.se	Mehlig, Bernhard/N-6491-2013; Eriksson, Anders/C-9767-2010; Johannesson, Kerstin/B-5528-2013; Panova, Marina/D-2633-2015; Panova, Marina/V-3533-2019; Johannesson, Kerstin/X-7994-2019; Hofving, Tobias/AAK-9174-2021; Andre, Carl/B-4237-2010	Eriksson, Anders/0000-0003-3436-3726; Johannesson, Kerstin/0000-0003-0176-7986; Panova, Marina/0000-0002-4147-6473; Panova, Marina/0000-0002-4147-6473; Johannesson, Kerstin/0000-0003-0176-7986; Andre, Carl/0000-0003-4404-7292; Makinen, Tuuli Elina/0000-0001-5163-8459; Mehlig, Bernhard/0000-0002-3672-6538; Hofving, Tobias/0000-0002-9855-4268	Swedish Research Council; Linnaeus Centre for Marine Evolutionary Biology; Thorden Foundation; Centre for Theoretical Biology at Gothenburg University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Centre for Marine Evolutionary Biology; Thorden Foundation; Centre for Theoretical Biology at Gothenburg University	This study was supported by the Swedish Research Council (grants to KJ, CA), the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se/), the Thorden Foundation and the Centre for Theoretical Biology at Gothenburg University (http://www.ctbio.science.gu.se/theoretical_biology/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G., 2005, SEXUAL CONFLICT, P360; Balloux F, 2003, GENETICS, V165, P2313; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Blyth JE, 2005, HEREDITY, V95, P174, DOI 10.1038/sj.hdy.6800713; Blyth JE, 2006, J INSECT BEHAV, V19, P447, DOI 10.1007/s10905-006-9034-3; Buckland-Nicks J, 1999, INVERTEBR REPROD DEV, V36, P145, DOI 10.1080/07924259.1999.9652691; Buckland-Nicks J, 1998, MICRON, V29, P267, DOI 10.1016/S0968-4328(97)00064-4; COHEN AC, 1960, BIOMETRICS, V16, P203, DOI 10.2307/2527552; Denny AJ, 2004, NATURWISSENSCHAFTEN, V91, P396, DOI 10.1007/s00114-004-0546-4; Dibattista JD, 2008, MOL ECOL, V17, P783, DOI 10.1111/j.1365-294X.2007.03623.x; Dunn DW, 2005, BEHAV ECOL SOCIOBIOL, V58, P128, DOI 10.1007/s00265-005-0922-x; Engqvist L, 2006, BEHAV ECOL, V17, P435, DOI 10.1093/beheco/arj046; Eriksson A, 2010, MOL ECOL RESOUR, V10, P282, DOI 10.1111/j.1755-0998.2009.02753.x; Fox CW, 2003, EVOL ECOL RES, V5, P273; Garant D, 2005, BEHAV ECOL SOCIOBIOL, V57, P240, DOI 10.1007/s00265-004-0854-x; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Hollander J, 2005, ANIM BEHAV, V70, P1209, DOI 10.1016/j.anbehav.2005.03.014; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JOHANNESSON B, 1986, J EXP MAR BIOL ECOL, V102, P183, DOI 10.1016/0022-0981(86)90175-9; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; Karl SA, 2008, MOL ECOL, V17, P3973, DOI 10.1111/j.1365-294X.2008.03902.x; Madsen T, 2005, MOL ECOL, V14, P1783, DOI 10.1111/j.1365-294X.2005.02505.x; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Mikhailova N, 1998, HYDROBIOLOGIA, V378, P33, DOI 10.1023/A:1003221117784; Pai A, 2002, J EVOLUTION BIOL, V15, P1076, DOI 10.1046/j.1420-9101.2002.00456.x; Panova M, 2008, J MOLLUS STUD, V74, P111, DOI 10.1093/mollus/eym052; Paterson IG, 2001, BIOL BULL-US, V200, P261, DOI 10.2307/1543508; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rivera A Cordero, 2002, J Insect Sci, V2, P14; SAUR M, 1990, DEV HYDROB, V56, P261, DOI 10.1007/BF00028082; Sherman PW, 1998, AM NAT, V151, P392, DOI 10.1086/286127; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Sokolov EP, 2002, MOL ECOL NOTES, V2, P27, DOI 10.1046/j.1471-8278 .2001.00133.x; Song SD, 2007, MOL ECOL, V16, P2353, DOI 10.1111/j.1365-294X.2007.03277.x; Tarpy DR, 2000, AM NAT, V155, P820, DOI 10.1086/303358; Thiel M, 2003, BEHAV ECOL SOCIOBIOL, V55, P113, DOI 10.1007/s00265-003-0677-1; Thornhill R., 1983, pi; Tie AD, 2000, MOL ECOL, V9, P108, DOI 10.1046/j.1365-294x.2000.00764-2.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Trontti K, 2007, BEHAV ECOL, V18, P298, DOI 10.1093/beheco/arl083; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Van Gossum H, 2001, BEHAV ECOL SOCIOBIOL, V51, P69; Voigt CC, 2008, BIOL LETTERS, V4, P476, DOI 10.1098/rsbl.2008.0282; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Wedell N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-204; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	52	47	48	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9640	10.1371/journal.pone.0009640	http://dx.doi.org/10.1371/journal.pone.0009640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300171	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620600005
J	Bueno, LL; Morais, CG; Araujo, FF; Gomes, JAS; Correa-Oliveira, R; Soares, IS; Lacerda, MV; Fujiwara, RT; Braga, EM				Bueno, Lilian Lacerda; Morais, Cristiane Guimaraes; Araujo, Fernanda Fortes; Silva Gomes, Juliana Assis; Correa-Oliveira, Rodrigo; Soares, Irene Silva; Lacerda, Marcus Vinicius; Fujiwara, Ricardo Toshio; Braga, Erika Martins			Plasmodium vivax: Induction of CD4(+)CD25(+)FoxP3(+) Regulatory T Cells during Infection Are Directly Associated with Level of Circulating Parasites	PLOS ONE			English	Article							IN-VITRO EXPANSION; TGF-BETA; DENDRITIC CELLS; MALARIA; FALCIPARUM; RESPONSES; ANTIGEN; CTLA-4; FOXP3; GITR	Circulation CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) have been associated with the delicate balancing between control of overwhelming acute malaria infection and prevention of immune pathology due to disproportionate inflammatory responses to erythrocytic stage of the parasite. While the role of Tregs has been well-documented in murine models and P. falciparum infection, the phenotype and function of Tregs in P. vivax infection is still poorly characterized. In the current study, we demonstrated that patients with acute P. vivax infection presented a significant augmentation of circulating Tregs producing anti-inflammatory (IL-10 and TGF-beta) as well as pro-inflammatory (IFN-gamma, IL-17) cytokines, which was further positively correlated with parasite burden. Surface expression of GITR molecule and intracellular expression of CTLA-4 were significantly upregulated in Tregs from infected donors, presenting also a positive association between either absolute numbers of CD4(+)CD25(+)FoxP3(+)GITR(+) or CD4(+)CD25(+)FoxP3(+)CTLA-4(+) and parasite load. Finally, we demonstrate a suppressive effect of Treg cells in specific T cell proliferative responses of P. vivax infected subjects after antigen stimulation with Pv-AMA-1. Our findings indicate that malaria vivax infection lead to an increased number of activated Treg cells that are highly associated with parasite load, which probably exert an important contribution to the modulation of immune responses during P. vivax infection.	[Bueno, Lilian Lacerda; Morais, Cristiane Guimaraes; Fujiwara, Ricardo Toshio; Braga, Erika Martins] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Araujo, Fernanda Fortes; Silva Gomes, Juliana Assis; Correa-Oliveira, Rodrigo; Fujiwara, Ricardo Toshio] Fiocruz MS, Lab Imunol Celular & Mol, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Silva Gomes, Juliana Assis] Univ Fed Minas Gerais, Dept Morfol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Soares, Irene Silva] Univ Sao Paulo, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Lacerda, Marcus Vinicius] Fundacao Med Trop Amazonas, Manaus, Amazonas, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade de Sao Paulo	Bueno, LL (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Soares, Irene/GQF-1984-2022; Gomes, Juliana A. S./M-4083-2017; Braga, Erika Martins/A-6776-2008; Bueno, Lilian/AAQ-1939-2020; Soares, Irene Silva/C-5974-2012; Fujiwara, Ricardo Toshio/J-7579-2012	Gomes, Juliana A. S./0000-0002-8332-2907; Braga, Erika Martins/0000-0001-5550-7157; Bueno, Lilian/0000-0003-3510-4590; Soares, Irene Silva/0000-0002-3336-6856; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG [CBB APQ-0997-4.01/07]; Brazilian National Research Council (CNPq/Brazil)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian National Research Council (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG (Grant # CBB APQ-0997-4.01/07). Lilian Bueno is supported by a Doctoral degree fellowship from Brazilian National Research Council (CNPq/Brazil). Irene Soares, Ricardo Fujiwara, Rodrigo Correa-Oliveira and Erika Braga are supported by CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; Braga EM, 2002, AM J TROP MED HYG, V66, P299, DOI 10.4269/ajtmh.2002.66.299; Bueno LL, 2008, VACCINE, V26, P1204, DOI 10.1016/j.vaccine.2007.12.031; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hisaeda H, 2005, EUR J IMMUNOL, V35, P3516, DOI 10.1002/eji.200526073; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hougardy JM, 2007, MICROBES INFECT, V9, P1325, DOI 10.1016/j.micinf.2007.06.004; Ing R, 2006, J IMMUNOL, V176, P441, DOI 10.4049/jimmunol.176.1.441; Jacobs P, 1996, INFECT IMMUN, V64, P44, DOI 10.1128/IAI.64.1.44-49.1996; Jacobs T, 2002, J IMMUNOL, V169, P2323, DOI 10.4049/jimmunol.169.5.2323; Jangpatarapongsa K, 2008, EUR J IMMUNOL, V38, P2697, DOI 10.1002/eji.200838186; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Levings MK, 2002, INT ARCH ALLERGY IMM, V129, P263, DOI 10.1159/000067596; Long TTA, 2003, INT J PARASITOL, V33, P175, DOI 10.1016/S0020-7519(02)00261-8; Matera G, 2008, DIAGN MICR INFEC DIS, V62, P280, DOI 10.1016/j.diagmicrobio.2008.06.015; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Nishioka T, 2008, IMMUNOL LETT, V121, P97, DOI 10.1016/j.imlet.2008.09.003; Nocentini G, 2007, EUR J IMMUNOL, V37, P1165, DOI 10.1002/eji.200636933; Prakash J, 2003, J Assoc Physicians India, V51, P265; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Scopel KKG, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-8; Shevach EM, 2008, EUR J IMMUNOL, V38, P915, DOI 10.1002/eji.200738111; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Watanabe K, 2009, PARASITE IMMUNOL, V31, P440, DOI 10.1111/j.1365-3024.2009.01127.x; Wu Y, 2007, EXP PARASITOL, V115, P301, DOI 10.1016/j.exppara.2006.09.015; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	66	63	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9623	10.1371/journal.pone.0009623	http://dx.doi.org/10.1371/journal.pone.0009623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224778	Green Published, gold			2022-12-27	WOS:000275328800018
J	Di Pasquale, G; Kaludov, N; Agbandje-McKenna, M; Chiorini, JA				Di Pasquale, Giovanni; Kaludov, Nikola; Agbandje-McKenna, Mavis; Chiorini, John A.			BAAV Transcytosis Requires an Interaction with beta-1-4 Linked-Glucosamine and gp96	PLOS ONE			English	Article							BOVINE ADENOASSOCIATED VIRUS; GROWTH-FACTOR RECEPTOR; BLOOD-BRAIN-BARRIER; ESCHERICHIA-COLI; TYPE-2 INFECTION; EPITHELIAL-CELLS; INNER-EAR; PROTEIN; BINDING; CORECEPTOR	Cell surface carbohydrates play an important role in virus entry and intracellular trafficking. Bovine Adeno-Associated Virus (BAAV) uses plasma membrane gangliosides for transduction and infection. In addition, independent of the infectious pathway, BAAV also has the ability to pass through barrier epithelia and endothelia using a transcytosis pathway dependent upon the presence of cell surface carbohydrates. Thus, in order to better define the carbohydrate interactions that are necessary for BAAV infection or transcytosis, a glycan microarray composed of both natural and synthetic carbohydrates was probed with HA-tagged BAAV particles. This identified chitotriose, a trimer of beta-1-4-linked N-acetyl glucosamine, as having an interaction with BAAV. Competition experiments showed that the BAAV interaction with this carbohydrate is not necessary for infection but is instead important in the transcytosis pathway. The beta-1-4-linked N-acetyl glucosamine modification has been reported on gp96, a glycoprotein involved in the transcytosis of bacteria and toxins. Significantly, immunoprecipitation and competition experiments with an anti-gp96 antibody and a soluble form of gp96, respectively, showed this glycoprotein can also interact with BAAV to serve as a receptor for its transcytosis.	[Di Pasquale, Giovanni; Kaludov, Nikola; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Agbandje-McKenna, Mavis] Univ Florida, Coll Med, Dept Biochem & Mol Biol, McKnight Brain Inst, Gainesville, FL 32610 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); State University System of Florida; University of Florida	Di Pasquale, G (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov			National Institutes of Health [R01 GM082946]; NIH National Institute of Dental and Craniofacial Research; National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is also supported by National Institutes of Health R01 GM082946 to MAM and an NIH National Institute of Dental and Craniofacial Research intramural grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Consortium for Functional Glycomics is funded by National Institute of General Medical Sciences grant GM62116.	Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Di Pasquale G, 2005, MOL THER, V11, P849, DOI 10.1016/j.ymthe.2005.02.004; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duque S., 2009, MOL THER; ETZIER M, 1970, BIOCHEMISTRY-US, V9, P869; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Lopez-Bueno A, 2008, J VIROL, V82, P1195, DOI 10.1128/JVI.01692-07; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Palermo LM, 2006, J VIROL, V80, P8482, DOI 10.1128/JVI.00683-06; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Schmidt M, 2004, J VIROL, V78, P6509, DOI 10.1128/JVI.78.12.6509-6516.2004; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; SHIBATA S, 2009, GENE THER IN PRESS; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Warrington KH, 2004, J VIROL, V78, P6595, DOI 10.1128/JVI.78.12.6595-6609.2004; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	40	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9336	10.1371/journal.pone.0009336	http://dx.doi.org/10.1371/journal.pone.0009336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231878	Green Submitted, gold, Green Published			2022-12-27	WOS:000275328300002
J	Muller, MP; McGeer, AJ; Hassan, K; Marshall, J; Christian, M				Muller, Matthew P.; McGeer, Allison J.; Hassan, Kazi; Marshall, John; Christian, Michael		Toronto Invasive Bacterial Dis	Evaluation of Pneumonia Severity and Acute Physiology Scores to Predict ICU Admission and Mortality in Patients Hospitalized for Influenza	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CRITICAL-CARE; UNITED-STATES; VALIDATION; TRIAGE; RULE; DERIVATION; RESOURCES; NEED; TOOL	Background: The demand for inpatient medical services increases during influenza season. A scoring system capable of identifying influenza patients at low risk death or ICU admission could help clinicians make hospital admission decisions. Methods: Hospitalized patients with laboratory confirmed influenza were identified over 3 influenza seasons at 25 Ontario hospitals. Each patient was assigned a score for 6 pneumonia severity and 2 sepsis scores using the first data available following their registration in the emergency room. In-hospital mortality and ICU admission were the outcomes. Score performance was assessed using the area under the receiver operating characteristic curve (AUC) and the sensitivity and specificity for identifying low risk patients (risk of outcome < 5%). Results: The cohort consisted of 607 adult patients. Mean age was 76 years, 12% of patients died (71/607) and 9% required ICU care (55/607). None of the scores examined demonstrated good discriminatory ability (AUC >= 0.80). The Pneumonia Severity Index (AUC 0.78, 95% CI 0.72-0.83) and the Mortality in Emergency Department Sepsis score (AUC 0.77, 95% 0.71-0.83) demonstrated fair predictive ability (AUC >= 0.70) for in-hospital mortality. The best predictor of ICU admission was SMART-COP (AUC 0.73, 95% CI 0.67-0.79). All other scores were poor predictors (AUC < 0.70) of either outcome. If patients classified as low risk for in-hospital mortality using the PSI were discharged, 35% of admissions would have been avoided. Conclusions: None of the scores studied were good predictors of in-hospital mortality or ICU admission. The PSI and MEDS score were fair predictors of death and if these results are validated, their use could reduce influenza admission rates significantly.	[Muller, Matthew P.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [McGeer, Allison J.] Univ Toronto, Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5B 1W8, Canada; [Marshall, John] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Christian, Michael] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Christian, Michael] Univ Toronto, Univ Hlth Network, Toronto, ON M5B 1W8, Canada; [Christian, Michael] Canadian Forces Hlth Serv, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Muller, MP (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	mullerm@smh.toronto.on.ca; Michael.christian@utoronto.ca	Christian, Michael/AAZ-4452-2020; mcgeer, allison/H-7747-2014; McGeer, Allison/AAB-6885-2020; Christian, Mike/AAO-6338-2020	Christian, Michael/0000-0001-9644-9950; mcgeer, allison/0000-0001-5647-6137; McGeer, Allison/0000-0001-5647-6137; Christian, Mike/0000-0001-9644-9950	Canadian Institutes for Health Research (CIHR) [CAT 86859]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research (CIHR) grant # CAT 86859 (http://www.cihr-irsc.gc.ca/e/193.html). The CIHR had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; *BRIT THOR SOC STA, 2001, THORAX S4, V56, pS1; Capelastegul A, 2006, EUR RESPIR J, V27, P151, DOI 10.1183/09031936.06.00062505; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Conte HA, 1999, AM J MED, V106, P20, DOI 10.1016/S0002-9343(98)00369-6; Devereaux AV, 2008, CHEST, V133, p51S, DOI 10.1378/chest.07-2693; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Naughton BJ, 2000, J AM GERIATR SOC, V48, P1292, DOI 10.1111/j.1532-5415.2000.tb02604.x; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Talmor D, 2007, CRIT CARE MED, V35, P1251, DOI 10.1097/01.CCM.0000262385.95721.CC; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; ZWEIG MH, 1993, CLIN CHEM, V39, P561	25	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9563	10.1371/journal.pone.0009563	http://dx.doi.org/10.1371/journal.pone.0009563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221431	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197200013
J	Margeli, M; Cirauqui, B; Castella, E; Tapia, G; Costa, C; Gimenez-Capitan, A; Barnadas, A; Ronco, MS; Benlloch, S; Taron, M; Rosell, R				Margeli, Mireia; Cirauqui, Beatriz; Castella, Eva; Tapia, Gustavo; Costa, Carlota; Gimenez-Capitan, Ana; Barnadas, Agusti; Sanchez Ronco, Maria; Benlloch, Susana; Taron, Miquel; Rosell, Rafael			The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer	PLOS ONE			English	Article							LUNG-CANCER; INCREASED SENSITIVITY; SPORADIC BREAST; CHEMORESISTANCE; PROMOTER; SURVIVAL; SUBTYPES; MARKERS; PREDICT; AGENTS	Background: A fraction of sporadic breast cancers has low BRCA1 expression. BRCA1 mutation carriers are more likely to achieve a pathological complete response with DNA-damage-based chemotherapy compared to non-mutation carriers. Furthermore, sporadic ovarian cancer patients with low levels of BRCA1 mRNA have longer survival following platinum-based chemotherapy than patients with high levels of BRCA1 mRNA. Methodology/Principal Findings: Tumor biopsies were obtained from 86 breast cancer patients who were candidates for neoadjuvant chemotherapy, treated with four cycles of neoadjuvant fluorouracil, epirubicin and cyclophosphamide. Estrogen receptor (ER), progesterone receptor (PR), HER2, cytokeratin 5/6 and vimentin were examined by tissue microarray. HER2 were also assessed by chromogenic in situ hybridization, and BRCA1 mRNA was analyzed in a subset of 41 patients for whom sufficient tumor tissue was available by real-time quantitative PCR. Median time to progression was 42 months and overall survival was 55 months. In the multivariate analysis for time to progression and overall survival for 41 patients in whom BRCA1 could be assessed, low levels of BRCA1 mRNA, positive PR and negative lymph node involvement predicted a significantly lower risk of relapse, low levels of BRCA1 mRNA and positive PR were the only variables associated with significantly longer survival. Conclusions/Significance: We provide evidence for a major role for BRCA1 mRNA expression as a marker of time to progression and overall survival in sporadic breast cancers treated with anthracycline-based chemotherapy. These findings can be useful for customizing chemotherapy.	[Margeli, Mireia; Cirauqui, Beatriz; Taron, Miquel; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Dept Med, Catalan Inst Oncol, Med Oncol Serv, Badalona, Spain; [Margeli, Mireia; Cirauqui, Beatriz; Taron, Miquel; Rosell, Rafael] Autonomous Univ Barcelona, Badalona, Spain; [Castella, Eva; Tapia, Gustavo] Hosp Badalona Germans Trias & Pujol, Pathol Serv, Badalona, Spain; [Costa, Carlota; Gimenez-Capitan, Ana; Benlloch, Susana; Taron, Miquel; Rosell, Rafael] USP Dexeus Univ Inst, Pangaea Biotech SA, Barcelona, Spain; [Sanchez Ronco, Maria] Univ Alcala de Henares, Madrid, Spain; [Barnadas, Agusti] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain	Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universidad de Alcala; Hospital of Santa Creu i Sant Pau	Margeli, M (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Med, Catalan Inst Oncol, Med Oncol Serv, Badalona, Spain.	33198mmv@comb.es; rrosell@ico.scs.es	Tapia, Gustavo/M-9938-2017; Giménez-Capitán, Ana/AAX-1433-2021; Castellà, Eva/K-4140-2017	Tapia Melendo, Gustavo/0000-0003-1882-0368	Redes de Cancer [RD06/0056/0020]	Redes de Cancer	This study was partially supported by a grant from Redes de Cancer (RD06/0056/0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; BYRSKI T, 2007, BREAST CANC RES TREA; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chapppuis PO, 2002, J MED GENET, V39, P608, DOI 10.1136/jmg.39.8.608; Einspahr JG, 2003, CANCER RES, V63, P3891; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Fedier A, 2003, INT J ONCOL, V22, P1169; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Font A, 2008, J CLIN ONCOL, V26; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; Husain A, 1998, CANCER RES, V58, P1120; Kirova YM, 2005, EUR J CANCER, V41, P2304, DOI 10.1016/j.ejca.2005.02.037; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; LIEDTKE C, 2006, AACR M; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Maione P, 2005, J CLIN ONCOL, V23, P6865, DOI 10.1200/JCO.2005.02.527; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quinn JE, 2003, CANCER RES, V63, P6221; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Rosell R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005133; Rosell Rafael, 2008, P231, DOI 10.1007/978-1-60327-088-5_13; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; SALEH EM, 2009, CELL BIOCH BIOPHYS; Scholl SM, 1995, EUR J CANCER, V31A, P1969, DOI 10.1016/0959-8049(95)00454-8; Sgagias MK, 2004, CELL CYCLE, V3, P1451, DOI 10.4161/cc.3.11.1211; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tanner M, 2000, AM J PATHOL, V157, P1467, DOI 10.1016/S0002-9440(10)64785-2; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987	40	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9499	10.1371/journal.pone.0009499	http://dx.doi.org/10.1371/journal.pone.0009499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209131	Green Submitted, gold, Green Published			2022-12-27	WOS:000275063400009
J	Hauser, PV; Pippin, JW; Kaiser, C; Krofft, RD; Brinkkoetter, PT; Hudkins, KL; Kerjaschki, D; Reiser, J; Alpers, CE; Shankland, SJ				Hauser, Peter V.; Pippin, Jeffrey W.; Kaiser, Cora; Krofft, Ronald D.; Brinkkoetter, Paul T.; Hudkins, Kelly L.; Kerjaschki, Dontscho; Reiser, Jochen; Alpers, Charles E.; Shankland, Stuart J.			Novel siRNA Delivery System to Target Podocytes In Vivo	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PARIETAL EPITHELIAL-CELLS; DOUBLE-STRANDED-RNA; GLOMERULAR PODOCYTES; INTERFERING RNAS; ANGIOTENSIN-II; MICE; EXPRESSION; APOPTOSIS; DIFFERENTIATION	Podocytes are injured in several glomerular diseases. To alter gene expression specifically in podocytes in vivo, we took advantage of their active endocytotic machinery and developed a method for the targeted delivery of small interfering ribonucleic acids (siRNA). We generated an anti-mouse podocyte antibody that binds to rat and mouse podocytes in vivo. The polyclonal IgG antibody was cleaved into monovalent fragments, while preserving the antigen recognition sites. One Neutravidin molecule was linked to each monovalent IgG via the available sulfohydryl group. Protamine, a polycationic nuclear protein and universal adaptor for anionic siRNA, was linked to the neutravidin via biotin. The delivery system was named shamporter (sheep antimouse podocyte transporter). Injection of shamporter coupled with either nephrin siRNA or TRPC6 siRNA via tail vein into normal rats substantially reduced the protein levels of nephrin or TRPC6 respectively, measured by western blot analysis and immunostaining. The effect was target specific because other podocyte-specific genes remained unchanged. Shamporter + nephrin siRNA induced transient proteinuria in rats. Control rats injected with shamporter coupled to control-siRNA showed no changes. These results show for the first time that siRNA can be delivered efficiently and specifically to podocytes in vivo using an antibody-delivery system.	[Hauser, Peter V.; Pippin, Jeffrey W.; Kaiser, Cora; Krofft, Ronald D.; Brinkkoetter, Paul T.; Shankland, Stuart J.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Hudkins, Kelly L.; Alpers, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kerjaschki, Dontscho] Vienna Med Univ, Dept Clin Pathol, Vienna, Austria; [Reiser, Jochen] Univ Miami, Div Nephrol & Hypertens, Miami, FL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Medical University of Vienna; University of Miami	Hauser, PV (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	scooby@u.washington.edu	Hauser, Peter Viktor/D-4255-2009	Hauser, Peter Viktor/0000-0003-1168-034X	National Institute of Health [DK60525, DK56799, DK51096, F32 DK070434, K08DK076970]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056799, K08DK076970, R01DK051096, R01DK060525, F32DK070434] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health (DK60525, DK56799, DK51096; F32 DK070434 and K08DK076970), and by the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADLER S, 1993, KIDNEY INT, V44, P278, DOI 10.1038/ki.1993.242; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bao LH, 2009, J CLIN INVEST, V119, P1264, DOI 10.1172/JCI36000; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; Davidson I., 1969, CLIN DIAGNOSIS LAB M; Done S, 2008, KIDNEY INT, V73, P697, DOI 10.1038/sj.ki.5002707; Durvasula RV, 2003, METH MOLEC MED, V86, P47; Durvasula RV, 2006, CURR OPIN NEPHROL HY, V15, P1, DOI 10.1097/01.mnh.0000199012.79670.0b; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gawlik A, 2005, CURR MOL MED, V5, P527, DOI 10.2174/1566524054553522; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Grippo PJ, 2002, GENESIS, V32, P277, DOI 10.1002/gene.10080; Harlow E, 1998, ANTIBODIES LAB MANUA; HAUSER PV, 2006, NOVEL ANTIPODOCYTES; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hiromura K, 2002, KIDNEY INT, V61, P1312, DOI 10.1046/j.1523-1755.2002.00257.x; Hiromura K, 2001, KIDNEY INT, V60, P2235, DOI 10.1046/j.1523-1755.2001.00057.x; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Ingelfinger JR, 1999, AM J PHYSIOL-RENAL, V276, pF218, DOI 10.1152/ajprenal.1999.276.2.F218; Isaka Yoshitaka, 2006, Clin Exp Nephrol, V10, P229, DOI 10.1007/s10157-006-0442-7; Junghans M, 2005, EUR J PHARM BIOPHARM, V60, P287, DOI 10.1016/j.ejpb.2005.01.006; Junghans M, 2000, Nucleic Acids Res, V28, pE45, DOI 10.1093/nar/28.10.e45; Kawachi H, 2002, MICROSC RES TECHNIQ, V57, P236, DOI 10.1002/jemt.10081; Kirkman T. W., 1996, STAT USE; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Logar CM, 2007, KIDNEY INT, V72, P489, DOI 10.1038/sj.ki.5002362; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyer TN, 2007, KIDNEY INT, V72, P841, DOI 10.1038/sj.ki.5002450; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; *NAT I DIAB DIG KI, 2006, NIDDK USRDS ANN DAT; O'Neal Kelly R, 2007, Methods Mol Biol, V366, P309; Ohse T, 2009, AM J PHYSL RENAL PHY; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; PAGTALUNAN ME, 1995, AM J PHYSIOL-RENAL, V268, pF82, DOI 10.1152/ajprenal.1995.268.1.F82; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; RUSK N, 2007, NATURE METHODS, V4, P196; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SEEGAN GW, 1979, P NATL ACAD SCI USA, V76, P907, DOI 10.1073/pnas.76.2.907; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; WIEDERMANN G, 1963, P SOC EXP BIOL MED, V113, P609; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	54	44	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9463	10.1371/journal.pone.0009463	http://dx.doi.org/10.1371/journal.pone.0009463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209128	gold, Green Submitted, Green Published			2022-12-27	WOS:000274997100010
J	Zautner, AE; Krause, M; Stropahl, G; Holtfreter, S; Frickmann, H; Maletzki, C; Kreikemeyer, B; Pau, HW; Podbielski, A				Zautner, Andreas E.; Krause, Merit; Stropahl, Gerhard; Holtfreter, Silva; Frickmann, Hagen; Maletzki, Claudia; Kreikemeyer, Bernd; Pau, Hans Wilhelm; Podbielski, Andreas			Intracellular Persisting Staphylococcus aureus Is the Major Pathogen in Recurrent Tonsillitis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; FINE-NEEDLE-ASPIRATION; STREPTOCOCCUS-PYOGENES; PERITONSILLAR ABSCESS; BIOFILM FORMATION; CORE CULTURES; BACTERIOLOGY; CHILDREN; SURFACE; INTERNALIZATION	Background: The two major indications for tonsillectomy are recurrent tonsillitis (RT) and peritonsillar abscess (PTA). Unlike PTAs, which are primarily treated surgically, RT is often cured by tonsillectomy only after a series of failed drug therapy attempts. Although the bacteriological background of RT has been studied, the reason for the lack of success of conservative therapeutic approaches is not well understood. Methods: In a prospective study, tonsil specimens from 130 RT patients and 124 PTA patients were examined for the presence of extra-and intracellular bacteria using antibiotic protection assays. Staphylococcus aureus isolates from RT patients were characterized by pulsed-field gel electrophoresis (PFGE), spa-typing and MSCRAMM-gene-PCR. Their ability for biofilm formation was tested and their cell invasiveness was confirmed by a flow cytometric invasion assay (FACS), fluorescent in situ hybridization (FISH) and immunohistochemistry. Findings: S. aureus was the predominant species (57.7%) in RT patients, whereas Streptococcus pyogenes was most prevalent (20.2%) in PTA patients. Three different assays (FACS, FISH, antibiotic protection assay) showed that nearly all RT-associated S. aureus strains were located inside tonsillar cells. Correspondingly, the results of the MSCRAMM-gene-PCRs confirmed that 87% of these S. aureus isolates were invasive strains and not mere colonizers. Based upon PFGE analyses of genomic DNA and on spa-gene typing the vast majority of the S. aureus isolates belonged to different clonal lineages. Conclusions: Our results demonstrate that intracellular residing S. aureus is the most common cause of RT and indicate that S. aureus uses this location to survive the effects of antibiotics and the host immune response. A German translation of the Abstract is provided as supplementary material (Abstract S1).	[Zautner, Andreas E.; Frickmann, Hagen; Maletzki, Claudia; Kreikemeyer, Bernd; Podbielski, Andreas] Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Krause, Merit; Pau, Hans Wilhelm] Otto Korner, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Stropahl, Gerhard] Univ Hosp Rostock, Inst Pathol, Rostock, Germany; [Holtfreter, Silva] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany	University of Rostock; Ernst Moritz Arndt Universitat Greifswald	Zautner, AE (corresponding author), Inst Med Microbiol Virol & Hyg, Rostock, Germany.	azautne@gwdg.de	Zautner, Andreas Erich/AAE-7425-2019; Zautner, Andreas Erich/ABA-9655-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Holtfreter, Silva/0000-0002-2672-8230; Kreikemeyer, Bernd/0000-0001-9527-5098	University of Rostock	University of Rostock	The study was exclusively funded by the regular research budget of the University of Rostock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, BRIT J DERMATOL, V148, P526, DOI 10.1046/j.1365-2133.2003.05162.x; Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baldassarri L, 2007, J CLIN MICROBIOL, V45, P1284, DOI 10.1128/JCM.02119-06; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brojerdian S, 2000, Acta Otorhinolaryngol Belg, V54, P459; BROOK I, 1995, CLIN INFECT DIS, V21, P171, DOI 10.1093/clinids/21.1.171; Brook I, 2000, LARYNGOSCOPE, V110, P994, DOI 10.1097/00005537-200006000-00021; BROOK I, 1989, AM J OTOLARYNG, V10, P227, DOI 10.1016/0196-0709(89)90001-X; Brook I, 2005, INT J PEDIATR OTORHI, V69, P9, DOI 10.1016/j.ijporl.2004.08.007; Brook I, 2004, J ORAL MAXIL SURG, V62, P1545, DOI 10.1016/j.joms.2003.12.043; Cherukuri S, 2002, LARYNGOSCOPE, V112, P18, DOI 10.1097/00005537-200201000-00003; Chole RA, 2003, ARCH OTOLARYNGOL, V129, P634, DOI 10.1001/archotol.129.6.634; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Courvalin P, 2001, CLIN INFECT DIS, V33, pS138, DOI 10.1086/321840; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Endo LH, 1996, ACTA OTO-LARYNGOL, P130; Gaffney RJ, 1998, CLIN OTOLARYNGOL, V23, P181; GAFFNEY RJ, 1991, RESP MED, V85, P383, DOI 10.1016/S0954-6111(06)80182-4; Galli J, 2007, Acta Otorhinolaryngol Ital, V27, P134; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gavriel H, 2008, MEDICINE, V87, P33, DOI 10.1097/MD.0b013e318162a0fb; Guarner J, 2006, HUM PATHOL, V37, P1482, DOI 10.1016/j.humpath.2006.05.011; Gul M, 2007, AM J OTOLARYNG, V28, P173, DOI 10.1016/j.amjoto.2006.08.010; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Inci E, 2003, J INT MED RES, V31, P307; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Jeong JH, 2007, LARYNGOSCOPE, V117, P2146, DOI 10.1097/MLG.0b013e31814543c8; Kania RE, 2007, ARCH OTOLARYNGOL, V133, P115, DOI 10.1001/archotol.133.2.115; Kasenomm P, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-7; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Krimmer V, 1999, J CLIN MICROBIOL, V37, P2667, DOI 10.1128/JCM.37.8.2667-2673.1999; KUHN JJ, 1995, ANN OTO RHINOL LARYN, V104, P646, DOI 10.1177/000348949510400810; Lemaire S, 2008, CLIN MICROBIOL INFEC, V14, P766, DOI 10.1111/j.1469-0691.2008.02035.x; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Lindroos R, 2000, ACTA OTO-LARYNGOL, P206; Loganathan A., 2006, SMJ Singapore Medical Journal, V47, P271; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Mahakit CP, 2006, CLIN THER, V28, P99, DOI 10.1016/j.clinthera.2006.01.006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MITCHELMORE IJ, 1994, EUR J CLIN MICROBIOL, V13, P542, DOI 10.1007/BF01971304; Niederfuhr A, 2008, ALLERGY, V63, P1359, DOI 10.1111/j.1398-9995.2008.01798.x; Niederfuhr A, 2009, ARCH OTOLARYNGOL, V135, P131, DOI 10.1001/archoto.2008.531; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Orrling A, 1997, ACTA OTO-LARYNGOL, V117, P618, DOI 10.3109/00016489709113448; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; Payne SC, 2007, CLIN INFECT DIS, V45, pE121, DOI 10.1086/522763; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Pichichero ME, 2007, OTOLARYNG HEAD NECK, V137, P851, DOI 10.1016/j.otohns.2007.07.033; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Podbielski A, 2003, INT J MED MICROBIOL, V293, P179, DOI 10.1078/1438-4221-00253; Post J Christopher, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P347, DOI 10.1097/MOO.0b013e3282b97327; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Sandberg A, 2009, ANTIMICROB AGENTS CH, V53, P1874, DOI 10.1128/AAC.01605-07; Schraff S, 2001, INT J PEDIATR OTORHI, V57, P213, DOI 10.1016/S0165-5876(00)00447-X; Sclafani AP, 1998, PEDIATRICS, V101, P675, DOI 10.1542/peds.101.4.675; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Skoulakis C, 2008, SCAND J INFECT DIS, V40, P899, DOI 10.1080/00365540802419048; Stenz L, 2008, FEMS MICROBIOL LETT, V287, P149, DOI 10.1111/j.1574-6968.2008.01316.x; Stepanovic S, 2001, EUR J CLIN MICROBIOL, V20, P502; Stjernquist-Desatnik A, 1999, ACTA OTO-LARYNGOL, V119, P102; Summers AO, 2002, CLIN INFECT DIS, V34, pS85, DOI 10.1086/340245; Swidsinski A, 2007, J CLIN PATHOL, V60, P253, DOI 10.1136/jcp.2006.037309; Szuhay G, 1998, J OTOLARYNGOL, V27, P206; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TIMON CI, 1990, RESP MED, V84, P395, DOI 10.1016/S0954-6111(08)80074-1; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; van der Veen EL, 2006, EUR ARCH OTO-RHINO-L, V263, P750, DOI 10.1007/s00405-006-0046-6; van Staaij BK, 2003, ACTA OTO-LARYNGOL, V123, P873, DOI 10.1080/00016480310000395; VandenBergh MFQ, 1999, J LAB CLIN MED, V133, P525, DOI 10.1016/S0022-2143(99)90181-6; WOLF M, 1995, INT J PEDIATR OTORHI, V31, P43, DOI 10.1016/0165-5876(94)01072-6; Woolford TJ, 1999, INT J CLIN PRACT, V53, P96	80	72	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9452	10.1371/journal.pone.0009452	http://dx.doi.org/10.1371/journal.pone.0009452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209109	gold, Green Submitted, Green Published			2022-12-27	WOS:000274997100004
J	Pacini, S; Carnicelli, V; Trombi, L; Montali, M; Fazzi, R; Lazzarini, E; Giannotti, S; Petrini, M				Pacini, Simone; Carnicelli, Vittoria; Trombi, Luisa; Montali, Marina; Fazzi, Rita; Lazzarini, Edoardo; Giannotti, Stefano; Petrini, Mario			Constitutive Expression of Pluripotency-Associated Genes in Mesodermal Progenitor Cells (MPCs)	PLOS ONE			English	Article							NEURAL STEM-CELLS; GENERATION; OCT-4; SOX2	Background: We recently characterized a progenitor of mesodermal lineage (MPCs) from the human bone marrow of adults or umbilical cord blood. These cells are progenitors able to differentiate toward mesenchymal, endothelial and cardiomyogenic lineages. Here we present an extensive molecular characterization of MPCs, from bone marrow samples, including 39 genes involved in stem cell machinery, differentiation and cell cycle regulation. Methodology/Principal Findings: MPCs are cytofluorimetrically characterized and quantitative RT-PCR was performed to evaluate the gene expression profile, comparing it with MSCs and hESCs lines. Immunofluorescence and dot-blot analysis confirm qRT-PCR data. MPCs exhibit an increased expression of OCT4, NANOG, SALL4, FBX15, SPP1 and to a lesser extent c-MYC and KLF4, but lack LIN28 and SOX2. MPCs highly express SOX15. Conclusions/Significance: MPCs express many pluripotency-associated genes and show a peculiar Oct-4 molecular circuit. Understanding this unique molecular mechanism could lead to identifying MPCs as feasible, long telomeres, target cells for reprogramming with no up-regulation of the p53 pathway. Furthermore MPCs are easily and inexpensively harvested from human bone marrow.	[Pacini, Simone; Trombi, Luisa; Montali, Marina; Fazzi, Rita; Lazzarini, Edoardo; Petrini, Mario] Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy; [Carnicelli, Vittoria] Univ Pisa, Dipartimento Sci Uomo & Ambiente, Pisa, Italy; [Giannotti, Stefano] Univ Pisa, Dipartimento Endocrinol & Metab Ortopedia & Traum, Pisa, Italy	University of Pisa; University of Pisa; University of Pisa	Pacini, S (corresponding author), Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy.	s.pacini@med.unipi.it	Pacini, Simone/H-3318-2019; Lazzarini, Edoardo/J-8459-2018	Pacini, Simone/0000-0003-1701-6001; Lazzarini, Edoardo/0000-0001-6369-5442; Montali, Marina/0000-0001-8804-4320	Department of Oncology; Transplants and New Advances in Medicine; University of Pisa	Department of Oncology; Transplants and New Advances in Medicine; University of Pisa	The work was exclusively supported by institutional funds of the Department of Oncology, Transplants and New Advances in Medicine, University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Beltrami AP, 2009, PHARMACOL THERAPEUT, V124, P23, DOI 10.1016/j.pharmthera.2009.06.003; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Petrini M, 2009, STEM CELLS DEV, V18, P857, DOI 10.1089/scd.2008.0291; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2008, CELL STEM CELL, V2, P295, DOI 10.1016/j.stem.2008.03.015; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Trombi L, 2009, STEM CELLS DEV, V18, P1227, DOI 10.1089/scd.2009.0054; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	33	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9861	10.1371/journal.pone.0009861	http://dx.doi.org/10.1371/journal.pone.0009861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360837	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969500007
J	Souslova, V; Townsend, PA; Mann, J; van der Loos, CM; Motterle, A; D'Acquisto, F; Mann, DA; Ye, S				Souslova, Veronika; Townsend, Paul A.; Mann, Jelena; van der Loos, Chris M.; Motterle, Anna; D'Acquisto, Fulvio; Mann, Derek A.; Ye, Shu			Allele-Specific Regulation of Matrix Metalloproteinase-3 Gene by Transcription Factor NF kappa B	PLOS ONE			English	Article							STROMELYSIN-1 MMP3 GENE; CORONARY ATHEROSCLEROSIS; 5A/6A POLYMORPHISM; PROMOTER; EXPRESSION; RISK; INTERLEUKIN-6; DETERMINANTS; MACROPHAGES; ACTIVATION	Background: Matrix metalloproteinase-3 (MMP3) is implicated in the pathogenesis and progression of atherosclerotic lesions. Previous studies suggested that MMP3 expression is influenced by a polymorphism (known as the 5A/6A polymorphism) in the promoter of the MMP3 gene and that this polymorphism is located within a cis-element that interacts with the transcription factor NF kappa B. In the present study, we sought to investigate whether MMP3 and NF kappa B were co-localized in atherosclerotic lesions and whether NF kappa B had differential effects on the two alleles of the MMP3 5A/6A polymorphism. Methodology/Principal Findings: Immunohistochemical examination showed that MMP3 and both the NF kappa B p50 and p65 subunits were expressed abundantly in macrophages in atherosclerotic lesions and that MMP3 expression was co-localized with p50 and p65. Chromatin immunoprecipitation experiments showed interaction of p50 and p65 with the MMP3 promoter in macrophages, with greater binding to the 5A allele than to the 6A allele. Reporter gene assays in transiently transfected macrophages showed that the 5A allele had greater transcriptional activity than the 6A allele, and that this allele-specific effect was augmented when the cells were treated with the NF kappa B activator lipopolysaccharides or co-transfected with p50 and/or p65 expressing plasmids, but was reduced when the cells were treated with the NF kappa B inhibitor 6-Amino-4-(4-phenoxyphenylethylamino)-quinazoline or transfected with a dominant negative mutant of IkB kinase-beta. Conclusion: These results corroborate an effect of the 5A/6A polymorphism on MMP3 transcription and indicate that NF kappa B has differential effects on the 5A and 6A alleles.	[Souslova, Veronika; Motterle, Anna; D'Acquisto, Fulvio; Ye, Shu] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Townsend, Paul A.] Univ Southampton, Sch Med, Div Human Genet, Southampton, Hants, England; [Mann, Jelena; Mann, Derek A.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [van der Loos, Chris M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of London; Queen Mary University London; University of Southampton; Newcastle University - UK; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Souslova, V (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.	s.ye@qmul.ac.uk	Townsend, Paul/AAF-8234-2020; Ye, Shu/C-4067-2009; D'Acquisto, Fulvio/E-7204-2018; Ye, Shu/R-6384-2017	D'Acquisto, Fulvio/0000-0002-4513-1608; Ye, Shu/0000-0002-4126-4278; Mann, Derek/0000-0003-0950-243X; Townsend, Paul/0000-0001-8956-9508	British Heart Foundation [PG/08/051/25141, FS/07/021]; National Institute of Health Research	British Heart Foundation(British Heart Foundation); National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (PG/08/051/25141, FS/07/021) www.bhf.org.uk. It forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2006, J MED GENET, V43, P897, DOI 10.1136/jmg.2006.040808; Beyzade S, 2003, J AM COLL CARDIOL, V41, P2130, DOI 10.1016/S0735-1097(03)00482-0; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bond M, 1999, BIOCHEM BIOPH RES CO, V264, P561, DOI 10.1006/bbrc.1999.1551; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Bondeson J, 2007, J RHEUMATOL, V34, P523; Borghaei RC, 2004, BIOCHEM BIOPH RES CO, V316, P182, DOI 10.1016/j.bbrc.2004.02.030; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gnasso A, 2000, ARTERIOSCL THROM VAS, V20, P1600, DOI 10.1161/01.ATV.20.6.1600; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hoppmann P, 2004, EUR HEART J, V25, P335, DOI 10.1016/j.ehj.2003.12.004; Humphries S, 2002, EUR HEART J, V23, P721, DOI 10.1053/euhj.2001.2895; Humphries SE, 2002, ANN HUM GENET, V66, P343, DOI 10.1017/S0003480002001264; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lamblin N, 2002, J AM COLL CARDIOL, V40, P43, DOI 10.1016/S0735-1097(02)01909-5; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lichtinghagen R, 2003, CLIN SCI, V105, P373, DOI 10.1042/CS20030098; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Medley TL, 2003, CIRC RES, V92, P1254, DOI 10.1161/01.RES.0000076891.24317.CA; Mizon-Gerard F, 2004, EUR HEART J, V25, P688, DOI 10.1016/j.ehj.2004.01.015; Nagase H, 1998, BIOL EXTRAC, P43; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Rauramaa R, 2000, ARTERIOSCL THROM VAS, V20, P2657, DOI 10.1161/01.ATV.20.12.2657; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Silence J, 2001, ARTERIOSCL THROM VAS, V21, P1440, DOI 10.1161/hq0901.097004; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Terashima M, 1999, CIRCULATION, V99, P2717, DOI 10.1161/01.CIR.99.21.2717; van der Loos CM, 2008, J HISTOTECHNOL, V31, P119, DOI 10.1179/his.2008.31.3.119; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Ye S, 2006, CARDIOVASC RES, V69, P636, DOI 10.1016/j.cardiores.2005.07.015; Zhu CY, 2006, BIOCHEM BIOPH RES CO, V348, P1150, DOI 10.1016/j.bbrc.2006.07.174	45	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9902	10.1371/journal.pone.0009902	http://dx.doi.org/10.1371/journal.pone.0009902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360864	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000275969500020
J	Barnett, DJ; Levine, R; Thompson, CB; Wijetunge, GU; Oliver, AL; Bentley, MA; Neubert, PD; Pirrallo, RG; Links, JM; Balicer, RD				Barnett, Daniel J.; Levine, Roger; Thompson, Carol B.; Wijetunge, Gamunu U.; Oliver, Anthony L.; Bentley, Melissa A.; Neubert, Patrick D.; Pirrallo, Ronald G.; Links, Jonathan M.; Balicer, Ran D.			Gauging US Emergency Medical Services Workers' Willingness to Respond to Pandemic Influenza Using a Threat- and Efficacy-Based Assessment Framework	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PUBLIC-HEALTH; PREPAREDNESS; DUTY; WILL	Background: Emergency Medical Services workers' willingness to report to duty in an influenza pandemic is essential to healthcare system surge amidst a global threat. Application of Witte's Extended Parallel Process Model (EPPM) has shown utility for revealing influences of perceived threat and efficacy on non-EMS public health providers' willingness to respond in an influenza pandemic. We thus propose using an EPPM-informed assessment of EMS workers' perspectives toward fulfilling their influenza pandemic response roles. Methodology/Principal Findings: We administered an EPPM-informed snapshot survey about attitudes and beliefs toward pandemic influenza response, to a nationally representative, stratified random sample of 1,537 U. S. EMS workers from May-June 2009 (overall response rate: 49%). Of the 586 respondents who met inclusion criteria (currently active EMS providers in primarily EMS response roles), 12% indicated they would not voluntarily report to duty in a pandemic influenza emergency if asked, 7% if required. A majority (52%) indicated their unwillingness to report to work if risk of disease transmission to family existed. Confidence in personal safety at work (OR = 3.3) and a high threat/high efficacy ("concerned and confident'') EPPM profile (OR = 4.7) distinguished those who were more likely to voluntarily report to duty. Although 96% of EMS workers indicated that they would probably or definitely report to work if they were guaranteed a pandemic influenza vaccine, only 59% had received an influenza immunization in the preceding 12 months. Conclusions/Significance: EMS workers' response willingness gaps pose a substantial challenge to prehospital surge capacity in an influenza pandemic. "Concerned and confident'' EMS workers are more than four times as likely to fulfill pandemic influenza response expectations. Confidence in workplace safety is a positively influential modifier of their response willingness. These findings can inform insights into interventions for enhancing EMS workers' willingness to respond in the face of a global infectious disease threat.	[Barnett, Daniel J.; Links, Jonathan M.] Johns Hopkins Preparedness & Emergency Response R, Baltimore, MD USA; [Barnett, Daniel J.; Links, Jonathan M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Levine, Roger] Amer Inst Res, San Mateo, CA USA; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Wijetunge, Gamunu U.; Oliver, Anthony L.; Neubert, Patrick D.] US Dept Transportat, Off Emergency Med Serv, Natl Highway Traff Safety Adm, Washington, DC USA; [Oliver, Anthony L.; Neubert, Patrick D.] Assoc Sch Publ Hlth, Washington, DC USA; [Bentley, Melissa A.] Natl Registry Emergency Med Technicians, Columbus, OH USA; [Pirrallo, Ronald G.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Pirrallo, Ronald G.] Milwaukee Cty Emergency Med Serv, Milwaukee Cty, WI USA; [Balicer, Ran D.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; American Institutes for Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical College of Wisconsin; Ben Gurion University	Barnett, DJ (corresponding author), Johns Hopkins Preparedness & Emergency Response R, Baltimore, MD USA.	dbarnett@jhsph.edu		Oliver, Anthony/0000-0002-7968-5975; Barnett, Daniel/0000-0003-1382-6197; Pirrallo, Ronald/0000-0002-8321-3866	Preparedness & Emergency Response Research Center [1P01tP00288-01, 104264]	Preparedness & Emergency Response Research Center	Preparedness & Emergency Response Research Center (PERRC)[CDC/Grant# 1P01tP00288-01; Grant# 104264]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99; Barnett DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006365; BISH A, 2010, BR J HLTH PSYCHOL; Brown William E Jr, 2002, Prehosp Emerg Care, V6, P433, DOI 10.1080/10903120290938085; Chaffee Mary, 2009, Disaster Med Public Health Prep, V3, P42, DOI 10.1097/DMP.0b013e31818e8934; Cone David C, 2006, Am J Disaster Med, V1, P28; Cowan AE, 2005, BIOSECUR BIOTERROR, V3, P16, DOI 10.1089/bsp.2005.3.16; Damery S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-142; Dawson Drew E, 2003, Prehosp Emerg Care, V7, P114, DOI 10.1080/10903120390937210; DiMaggio C, 2005, BIOSECUR BIOTERROR, V3, P331, DOI 10.1089/bsp.2005.3.331; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Ehrenstein BP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-311; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; *I MED, 2007, EM MED SERV CROSSR, P1; *I MED, 2008, RES PRIOR EM PREP RE, P1; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Katz AR, 2006, J AM DENT ASSOC, V137, P461, DOI 10.14219/jada.archive.2006.0217; National Highway Traffic Safety Administration, 2007, NAT EMS SCOP PRACT M; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Reilly MJ, 2007, PREHOSP DISASTER MED, V22, P297, DOI 10.1017/S1049023X00004908; SHAPIRA Y, 1991, ISRAEL J MED SCI, V27, P704; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P., 1985, PERILOUS PROGR MANAG, P91; *WHO, 2009, PREP 2 WAV LESS CURR; *WHO, 2009, INFL A H1N1 UPD 29; WHO (World Health Organization), 2009, CLIN FEAT SEV CAS PA; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; World Health Organization, 2009, INFL A H1N1 STAT WHO	31	44	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9856	10.1371/journal.pone.0009856	http://dx.doi.org/10.1371/journal.pone.0009856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FT	20352050	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894500022
J	Kim, K; Kim, KH; Cheong, J				Kim, KyeongJin; Kim, Kook Hwan; Cheong, JaeHun			Hepatitis B Virus X Protein Impairs Hepatic Insulin Signaling Through Degradation of IRS1 and Induction of SOCS3	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL ACTIVATION; TRANSGENIC MICE; FATTY LIVER; IN-VIVO; RESISTANCE; INFECTION; RECEPTOR; PATHWAYS; INFLAMMATION	Background: Hepatitis B virus (HBV) is a major cause of chronic liver diseases, and frequently results in hepatitis, cirrhosis, and ultimately hepatocellular carcinoma. The role of HCV in associations with insulin signaling has been elucidated. However, the pathogenesis of HBV-associated insulin signaling remains to be clearly characterized. Therefore, we have attempted to determine the mechanisms underlying the HBV-associated impairment of insulin signaling. Methodology: The expressions of insulin signaling components were investigated in HBx-transgenic mice, HBx-constitutive expressing cells, and transiently HBx-transfected cells. Protein and gene expression was examined by Western blot, immunohistochemistry, RT-PCR, and promoter assay. Protein-protein interaction was detected by coimmunoprecipitation. Principal Findings: HBx induced a reduction in the expression of IRS1, and a potent proteasomal inhibitor blocked the downregulation of IRS1. Additionally, HBx enhanced the expression of SOCS3 and induced IRS1 ubiquitination. Also, C/EBP alpha and STAT3 were involved in the HBx-induced expression of SOCS3. HBx interfered with insulin signaling activation and recovered the insulin-mediated downregulation of gluconeogenic genes. Conclusions/Significance: These results provide direct experimental evidences for the contribution of HBx in the impairment of insulin signaling.	[Kim, KyeongJin; Kim, Kook Hwan; Cheong, JaeHun] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea	Pusan National University	Kim, K (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea.	molecule85@pusan.ac.kr		Kim, Kook Hwan/0000-0003-2702-9156	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080907]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Barclay JL, 2007, MOL ENDOCRINOL, V21, P2503, DOI 10.1210/me.2006-0498; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Custro N, 2001, DIABETES METAB, V27, P476; Dandri M, 1996, J VIROL, V70, P5246, DOI 10.1128/JVI.70.8.5246-5254.1996; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fan JG, 2008, J GASTROEN HEPATOL, V23, P679, DOI 10.1111/j.1440-1746.2008.05361.x; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Hajjou M, 2005, J MED VIROL, V77, P57, DOI 10.1002/jmv.20427; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim K, 2008, BIOCHEM J, V416, P219, DOI 10.1042/BJ20081336; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Kong HJ, 2003, HEPATOLOGY, V38, P1258, DOI 10.1053/jhep.2003.50451; Krebs DL, 2000, J CELL SCI, V113, P2813; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lee YH, 1998, J BIOL CHEM, V273, P25510, DOI 10.1074/jbc.273.39.25510; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Mohammad Alizadeh Amir Houshang, 2006, Indian J Gastroenterol, V25, P286; Murakami S, 1999, INTERVIROLOGY, V42, P81, DOI 10.1159/000024969; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park MJ, 2007, BIOCHEM J, V402, P567, DOI 10.1042/BJ20061549; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sangiorgio L, 2000, DIABETES RES CLIN PR, V48, P147, DOI 10.1016/S0168-8227(99)00135-7; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; SHIMADA M, 2000, GEOMECH RES SER, V2, P1; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; WHITE MF, 1994, J BIOL CHEM, V269, P1; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yang J.J., 2004, SHAANXI AGR SCI, V1, P6; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X	51	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e8649	10.1371/journal.pone.0008649	http://dx.doi.org/10.1371/journal.pone.0008649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351777	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400001
J	Nakamura, KJ; Gach, JS; Jones, L; Semrau, K; Walter, J; Bibollet-Ruche, F; Decker, JM; Heath, L; Decker, WD; Sinkala, M; Kankasa, C; Thea, D; Mullins, J; Kuhn, L; Zwick, MB; Aldrovandi, GM				Nakamura, Kyle J.; Gach, Johannes S.; Jones, Laura; Semrau, Katherine; Walter, Jan; Bibollet-Ruche, Frederic; Decker, Julie M.; Heath, Laura; Decker, William D.; Sinkala, Moses; Kankasa, Chipepo; Thea, Donald; Mullins, James; Kuhn, Louise; Zwick, Michael B.; Aldrovandi, Grace M.			4E10-Resistant HIV-1 Isolated from Four Subjects with Rare Membrane-Proximal External Region Polymorphisms	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; FUSION INHIBITOR T-20; NEUTRALIZING ANTIBODY; ENVELOPE GLYCOPROTEIN; PASSIVE-IMMUNIZATION; GP41 ECTODOMAIN; CRAC SEGMENT; VACCINE; EPITOPE	Human antibody 4E10 targets the highly conserved membrane-proximal external region (MPER) of the HIV-1 transmembrane glycoprotein, gp41, and has extraordinarily broad neutralizing activity. It is considered by many to be a prototype for vaccine development. In this study, we describe four subjects infected with viruses carrying rare MPER polymorphisms associated with resistance to 4E10 neutralization. In one case resistant virus carrying a W680G substitution was transmitted from mother to infant. We used site-directed mutagenesis to demonstrate that the W680G substitution is necessary for conferring the 4E10-resistant phenotype, but that it is not sufficient to transfer the phenotype to a 4E10-sensitive Env. Our third subject carried Envs with a W680R substitution causing variable resistance to 4E10, indicating that residues outside the MPER are required to confer the phenotype. A fourth subject possessed a F673L substitution previously associated with 4E10 resistance. For all three subjects with W680 polymorphisms, we observed additional residues in the MPER that co-varied with position 680 and preserved charged distributions across this region. Our data provide important caveats for vaccine development targeting the MPER. Naturally occurring Env variants described in our study also represent unique tools for probing the structure-function of HIV-1 envelope.	[Nakamura, Kyle J.; Jones, Laura; Walter, Jan; Decker, William D.; Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Nakamura, Kyle J.] Univ So Calif, Keck Sch Med, Syst Biol & Dis Program, Los Angeles, CA 90033 USA; [Gach, Johannes S.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA; [Semrau, Katherine; Thea, Donald] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA; [Bibollet-Ruche, Frederic; Decker, Julie M.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Heath, Laura; Mullins, James] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Sinkala, Moses] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Kankasa, Chipepo] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia; [Mullins, James] Univ Washington, Dept Med, Seattle, WA USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, New York, NY USA	Children's Hospital Los Angeles; University of Southern California; Scripps Research Institute; Boston University; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Zambia; University of Washington; University of Washington Seattle; Columbia University	Nakamura, KJ (corresponding author), Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA.	galdrovandi@chla.usc.edu		Gach, Johannes/0000-0002-5043-5710; Semrau, Katherine/0000-0002-8360-1391; Thea, Donald/0000-0002-6933-1030; Walter, Jan/0000-0003-2247-5560	National Institutes of Health Cellular, Biochemical and Molecular Sciences Training Program [T 32 067587]; National Institute of Child Health and Human Development [HD 57161, HD 39611, HD 40777]; National Institute of Allergy and Immunology [AI69993]; International Maternal Pediatric Adolescent AIDS Trials Group [U01 AI068632]; Austrian Science Fund [J2845-B13]; NIH AIDS Research and Reference Reagent; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040777, R01HD039611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069993, P30AI027757, U01AI068632] Funding Source: NIH RePORTER	National Institutes of Health Cellular, Biochemical and Molecular Sciences Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Immunology; International Maternal Pediatric Adolescent AIDS Trials Group; Austrian Science Fund(Austrian Science Fund (FWF)); NIH AIDS Research and Reference Reagent; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program Grant (T 32 067587), National Institute of Child Health and Human Development (HD 57161, HD 39611, and HD 40777), National Institute of Allergy and Immunology (AI69993), International Maternal Pediatric Adolescent AIDS Trials Group U01 AI068632 and Austrian Science Fund Grant J2845-B13. GMA is an Elizabeth Glaser Pediatric AIDS Foundation Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Hessell and D. Burton (TSRI) for IgG DEN3 and S. Ingale and P. Dawson (TSRI) for MPER peptide 179-4. We also thank the NIH AIDS Research and Reference Reagent program and Drs. M. Sharp and D. Finzi for their support of this project.	Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burke B, 2007, CURR HIV RES, V5, P625, DOI 10.2174/157016207782418533; Burton DR, 2006, NATURE, V441, P817, DOI 10.1038/441817a; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dimitrov AS, 2003, BIOCHEMISTRY-US, V42, P14150, DOI 10.1021/bi035154g; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2008, J VIROL, V82, P2367, DOI 10.1128/JVI.02161-07; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HESSELL AJ, J VIROL, V84, P1302; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Levine AJ, 2008, J VIROL, V82, P11998, DOI 10.1128/JVI.01953-08; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; LU M, 2009, BIOCHEMISTRY; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montefiori DC, 2005, NAT MED, V11, P593, DOI 10.1038/nm0605-593; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Nakowitsch S, 2005, AIDS, V19, P1957, DOI 10.1097/01.aids.0000189856.13817.76; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Perez LG, 2009, J VIROL, V83, P7397, DOI 10.1128/JVI.00656-09; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Safrit JT, 2004, JAIDS-J ACQ IMM DEF, V35, P169, DOI 10.1097/00126334-200402010-00012; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Xu WD, 2002, VACCINE, V20, P1956, DOI 10.1016/S0264-410X(02)00077-4; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	61	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9786	10.1371/journal.pone.0009786	http://dx.doi.org/10.1371/journal.pone.0009786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352106	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894400010
J	Zimic, M; Velazco, A; Comina, G; Coronel, J; Fuentes, P; Luna, CG; Sheen, P; Gilman, RH; Moore, DAJ				Zimic, Mirko; Velazco, Abner; Comina, German; Coronel, Jorge; Fuentes, Patricia; Luna, Carmen G.; Sheen, Patricia; Gilman, Robert H.; Moore, David A. J.			Development of Low-Cost Inverted Microscope to Detect Early Growth of Mycobacterium tuberculosis in MODS Culture	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY ASSAY	Background: The microscopic observation drug susceptibility (MODS) assay for rapid, low-cost detection of tuberculosis and multidrug resistant tuberculosis depends upon visualization of the characteristic cording colonies of Mycobacterium tuberculosis in liquid media. This has conventionally required an inverted light microscope in order to inspect the MODS culture plates from below. Few tuberculosis laboratories have this item and the capital cost of $5,000 for a high-end microscope could be a significant obstacle to MODS roll-out. Methodology: We hypothesized that the precise definition provided by costly high-specification inverted light microscopes might not be necessary for pattern recognition. Significance: In this work we describe the development of a low-cost artesenal inverted microscope that can operate in both a standard or digital mode to effectively replace the expensive commercial inverted light microscope, and an integrated system that could permit a local and remote diagnosis of tuberculosis.	[Zimic, Mirko; Coronel, Jorge; Fuentes, Patricia; Luna, Carmen G.; Sheen, Patricia; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Unidad Bioinformat, Lima, Peru; [Zimic, Mirko; Coronel, Jorge; Fuentes, Patricia; Luna, Carmen G.; Sheen, Patricia; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lab Enfermedades Infecciosas, Lima, Peru; [Velazco, Abner; Comina, German] Univ Nacl Ingn, Fac Ciencias, Lab Peliculas Delgadas, Lima, Peru; [Gilman, Robert H.; Moore, David A. J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, Fac Med, Dept Infect Dis & Immun, London, England; [Moore, David A. J.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, Clin Res Unit, London WC1, England	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University Nacional de Ingenieria Lima; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Zimic, M (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Unidad Bioinformat, Lima, Peru.	mzimic@jhsph.edu		Coronel, Jorge/0000-0002-4580-6716; Comina, German/0000-0003-2114-0486	Wellcome Trust Career Development Fellowship [078067/Z/05]; Peruvian FINCYT Proyecto de Interes Nacional [PIN 061]; National Institutes of Health [5D43TW006581]; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER	Wellcome Trust Career Development Fellowship(Wellcome Trust); Peruvian FINCYT Proyecto de Interes Nacional; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was funded by the Wellcome Trust Career Development Fellowship [078067/Z/05], by the Peruvian FINCYT Proyecto de Interes Nacional [PIN 061] and by the National Institutes of Health award 5D43TW006581 "Infectious Diseases Training Program in Peru''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias M, 2007, CLIN INFECT DIS, V44, P674, DOI 10.1086/511639; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Zimic M, 2009, T ROY SOC TROP MED H, V103, P638, DOI 10.1016/j.trstmh.2008.10.015	8	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9577	10.1371/journal.pone.0009577	http://dx.doi.org/10.1371/journal.pone.0009577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351778	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400005
J	Carrasco, DI; Bichler, EK; Seburn, KL; Pinter, MJ				Carrasco, Dario I.; Bichler, Edyta K.; Seburn, Kevin L.; Pinter, Martin J.			Nerve Terminal Degeneration Is Independent of Muscle Fiber Genotype in SOD1(G93A) Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; NEUROMUSCULAR-JUNCTION; MOUSE MODEL; MOTONEURON DISEASE; EXTEND SURVIVAL; IN-VIVO; CELLS; UNIT; SUBSETS	Background: Motor neuron degeneration in SOD1(G93A) transgenic mice begins at the nerve terminal. Here we examine whether this degeneration depends on expression of mutant SOD1 in muscle fibers. Methodology/Principal Findings: Hindlimb muscles were transplanted between wild-type and SOD1(G93A) transgenic mice and the innervation status of neuromuscular junctions (NMJs) was examined after 2 months. The results showed that muscles from SOD1(G93A) mice did not induce motor terminal degeneration in wildtype mice and that muscles from wildtype mice did not prevent degeneration in SOD1(G93A) transgenic mice. Control studies demonstrated that muscles transplanted from SOD1(G93A) mice continued to express mutant SOD1 protein. Experiments on wildtype mice established that the host supplied terminal Schwann cells (TSCs) at the NMJs of transplanted muscles. Conclusions/Significance: These results indicate that expression of the mutant protein in muscle is not needed to cause motor terminal degeneration in SOD1(G93A) transgenic mice and that a combination of motor terminals, motor axons and Schwann cells, all of which express mutant protein may be sufficient.	[Carrasco, Dario I.; Bichler, Edyta K.; Pinter, Martin J.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Seburn, Kevin L.] Jackson Lab, Bar Harbor, ME 04609 USA	Emory University; Jackson Laboratory	Carrasco, DI (corresponding author), Emory Univ, Dept Physiol, Atlanta, GA 30322 USA.	mpinter@emory.edu			National Institutes of Health (NIH) [NS31621]; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031621] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant NS31621 (M.J.P.) and by generous funding provided by the ALS Association (K.L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; CARLSON BM, 1976, EXP NEUROL, V52, P421, DOI 10.1016/0014-4886(76)90214-4; Carrasco DI, 2004, J NEUROPHYSIOL, V92, P1175, DOI 10.1152/jn.00157.2004; CARRASCO DI, 2006, 6784 SOC NEUR; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Colomar A, 2004, GLIA, V47, P284, DOI 10.1002/glia.20086; COTE C, 1986, AM J PHYSIOL, V250, pC828, DOI 10.1152/ajpcell.1986.250.6.C828; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frankel WN, 1998, NEURON, V20, P183, DOI 10.1016/S0896-6273(00)80447-X; Frey D, 2000, J NEUROSCI, V20, P2534; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1994; HANSENSMITH FM, 1979, J NEUROL SCI, V41, P149, DOI 10.1016/0022-510X(79)90035-2; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Miller SW, 1998, J APPL PHYSIOL, V84, P1865, DOI 10.1152/jappl.1998.84.6.1865; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; MORGAN JE, 1989, MUSCLE NERVE, V12, P401, DOI 10.1002/mus.880120511; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; Pinter MJ, 2001, METH NE FRO NEUROSCI, P231; PINTER MJ, 1995, J NEUROSCI, V15, P3447; Pinter MJ, 1997, J NEUROSCI, V17, P4500; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Reddy LV, 2003, NEURON, V40, P563, DOI 10.1016/S0896-6273(03)00682-2; Sanes JR, 1998, J PHYSIOLOGY-PARIS, V92, P167, DOI 10.1016/S0928-4257(98)80004-1; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; SUGIURA Y, 2004, INVOLVEMENT SKELETAL; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	33	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9802	10.1371/journal.pone.0009802	http://dx.doi.org/10.1371/journal.pone.0009802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339550	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300024
J	Ross, JV; House, T; Keeling, MJ				Ross, Joshua V.; House, Thomas; Keeling, Matt J.			Calculation of Disease Dynamics in a Population of Households	PLOS ONE			English	Article							EPIDEMIC MODELS; SIR EPIDEMICS; NETWORK; COMMUNITY; TRANSMISSION; INTEGRALS; INVASION; NUMBERS; SIZE	Early mathematical representations of infectious disease dynamics assumed a single, large, homogeneously mixing population. Over the past decade there has been growing interest in models consisting of multiple smaller subpopulations (households, workplaces, schools, communities), with the natural assumption of strong homogeneous mixing within each subpopulation, and weaker transmission between subpopulations. Here we consider a model of SIRS (susceptible-infectious-recovered-susceptible) infection dynamics in a very large (assumed infinite) population of households, with the simplifying assumption that each household is of the same size (although all methods may be extended to a population with a heterogeneous distribution of household sizes). For this households model we present efficient methods for studying several quantities of epidemiological interest: (i) the threshold for invasion; (ii) the early growth rate; (iii) the household offspring distribution; (iv) the endemic prevalence of infection; and (v) the transient dynamics of the process. We utilize these methods to explore a wide region of parameter space appropriate for human infectious diseases. We then extend these results to consider the effects of more realistic gamma-distributed infectious periods. We discuss how all these results differ from standard homogeneous-mixing models and assess the implications for the invasion, transmission and persistence of infection. The computational efficiency of the methodology presented here will hopefully aid in the parameterisation of structured models and in the evaluation of appropriate responses for future disease outbreaks.	[Ross, Joshua V.] Univ Cambridge, Kings Coll, Cambridge, England; [House, Thomas; Keeling, Matt J.] Univ Warwick, Biol Sci & Math Inst, Coventry CV4 7AL, W Midlands, England	University of Cambridge; University of Warwick	Ross, JV (corresponding author), Univ Cambridge, Kings Coll, Cambridge, England.	jvr25@cam.ac.uk	Ross, Joshua V/C-2761-2009; Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765; House, Thomas/0000-0001-5835-8062; Ross, Joshua/0000-0002-9918-8167	Medical Research Council [G0701256]; Wellcome Trust; EPSRC [EP/H016139/1] Funding Source: UKRI; MRC [G0701256] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H016139/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been supported by funding from the Medical Research Council (Grant Number G0701256; www.mrc.ac.uk), and the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY CL, 1991, BIOMETRICS, V47, P961, DOI 10.2307/2532652; ALTMANN M, 1995, J MATH BIOL, V33, P661, DOI 10.1007/BF00298647; ANDERSON R M, 1991; Andersson H, 2000, SPRINGER LECT NOTES, V151; Bailey NTJ, 1957, MATH THEORY EPIDEMIC; BALL F, 1986, ADV APPL PROBAB, V18, P289, DOI 10.2307/1427301; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2001, ADV APPL PROBAB, V33, P99, DOI 10.1017/S000186780001065X; Ball F, 1999, MATH BIOSCI, V156, P41, DOI 10.1016/S0025-5564(98)10060-3; Ball F, 1997, ANN APPL PROBAB, V7, P46; Ball F, 2009, ADV APPL PROBAB, V41, P765, DOI 10.1239/aap/1253281063; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Becker NG, 1998, MATH BIOSCI, V147, P23, DOI 10.1016/S0025-5564(97)00079-5; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Dangerfield CE, 2009, J R SOC INTERFACE, V6, P761, DOI 10.1098/rsif.2008.0410; DANIELS HE, 1967, 5TH P BERK S MATH ST, V4, P281; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Ghoshal G, 2004, MATH BIOSCI, V190, P71, DOI 10.1016/j.mbs.2004.02.006; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; House T, 2008, MATH BIOSCI, V213, P29, DOI 10.1016/j.mbs.2008.01.011; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; James A, 2007, P ROY SOC B-BIOL SCI, V274, P741, DOI 10.1098/rspb.2006.0219; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Keeling MJ, 1997, P ROY SOC B-BIOL SCI, V264, P1149, DOI 10.1098/rspb.1997.0159; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klovdahl AS, 2001, SEX TRANSM DIS, V28, P25, DOI 10.1097/00007435-200101000-00006; Koopman JS, 2002, MATH BIOSCI, V180, P49, DOI 10.1016/S0025-5564(02)00124-4; KURTZ TG, 1970, J APPL PROBAB, V7, P49, DOI 10.2307/3212147; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Pollett PK, 2003, MATH BIOSCI, V182, P213, DOI 10.1016/S0025-5564(02)00161-X; Pollett PK, 2002, J APPL PROBAB, V39, P901, DOI 10.1017/S0021900200022142; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Ross JV, 2009, THEOR POPUL BIOL, V75, P123, DOI 10.1016/j.tpb.2008.12.002; WATTS D, 1998, COLLECTIVE DYNAMICS; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	51	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9666	10.1371/journal.pone.0009666	http://dx.doi.org/10.1371/journal.pone.0009666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305791	Green Published, Green Submitted, gold			2022-12-27	WOS:000276456300001
J	Amdam, GV; Fennern, E; Baker, N; Rascon, B				Amdam, Gro V.; Fennern, Erin; Baker, Nicholas; Rascon, Brenda			Honeybee Associative Learning Performance and Metabolic Stress Resilience Are Positively Associated	PLOS ONE			English	Article							DIVISION-OF-LABOR; SUCROSE RESPONSIVENESS; PROBOSCIS EXTENSION; SOCIAL-ROLE; MORTALITY; TACTILE; BEES; LIFE; IQ; PLASTICITY	Background: Social-environmental influences can affect animal cognition and health. Also, human socio-economic status is a covariate factor connecting psychometric test-performance (a measure of cognitive ability), educational achievement, lifetime health, and survival. The complimentary hypothesis, that mechanisms in physiology can explain some covariance between the same traits, is disputed. Possible mechanisms involve metabolic biology affecting integrity and stability of physiological systems during development and ageing. Knowledge of these relationships is incomplete, and underlying processes are challenging to reveal in people. Model animals, however, can provide insights into connections between metabolic biology and physiological stability that may aid efforts to reduce human health and longevity disparities. Results: We document a positive correlation between a measure of associative learning performance and the metabolic stress resilience of honeybees. This relationship is independent of social factors, and may provide basic insights into how central nervous system (CNS) function and metabolic biology can be associated. Controlling for social environment, age, and learning motivation in each bee, we establish that learning in Pavlovian conditioning to an odour is positively correlated with individual survival time in hyperoxia. Hyperoxia induces oxidative metabolic damage, and provides a measure of metabolic stress resistance that is often related to overall lifespan in laboratory animals. The positive relationship between Pavlovian learning ability and stress resilience in the bee is not equally established in other model organisms so far, and contrasts with a genetic cost of improved associative learning found in Drosophila melanogaster. Conclusions: Similarities in the performances of different animals need not reflect common functional principles. A correlation of honeybee Pavlovian learning and metabolic stress resilience, thereby, is not evidence of a shared biology that will give insight about systems integrity in people. Yet, the means to resolve difficult research questions often come from findings in distant areas of science while the model systems that turn out to be valuable are sometimes the least predictable. Our results add to recent findings indicating that honeybees can become instrumental to understanding how metabolic biology influences life outcomes.	[Amdam, Gro V.; Fennern, Erin; Baker, Nicholas] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amdam, Gro V.; Rascon, Brenda] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Amdam, GV (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Gro.Amdam@asu.edu		Fennern, Erin/0000-0002-7501-3354	Research Council of Norway [175413, 180504, 185306, 191699]; National Institute on Aging (NIA) [P01 AG22500]; The PEW Charitable Trust; Wissenschaftskolleg zu Berlin; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The PEW Charitable Trust; Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Research Council of Norway (# 175413, 180504, 185306, and 191699), the National Institute on Aging (NIA P01 AG22500), The PEW Charitable Trust, and the Wissenschaftskolleg zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Amdam GV, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1003; Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BITTERMAN ME, 1975, SCIENCE, V188, P699, DOI 10.1126/science.188.4189.699; Burger JMS, 2008, EVOLUTION, V62, P1294, DOI 10.1111/j.1558-5646.2008.00376.x; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Douglas RM, 2008, PHYSIOLOGY, V23, P333, DOI 10.1152/physiol.00023.2008; Espinoza SE, 2008, J AM GERIATR SOC, V56, P1744, DOI 10.1111/j.1532-5415.2008.01845.x; FINCH CE, 1990, LONGEVITY SENESCENCE, P67; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; GOLSTEIN P, 2003, MOL CELL BIOL, V4, P1; Hall PA, 2009, PSYCHOSOM MED, V71, P196, DOI 10.1097/PSY.0b013e318190d7f0; Hemmingsson T, 2009, J EPIDEMIOL COMMUN H, V63, P697, DOI 10.1136/jech.2008.079160; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Jokela M, 2009, PSYCHOSOM MED, V71, P322, DOI 10.1097/PSY.0b013e31819b69f6; Kanazawa Satoshi, 2008, Biodemography Soc Biol, V54, P200, DOI 10.1080/19485565.2008.9989142; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; Mery F, 2004, ANIM BEHAV, V68, P589, DOI 10.1016/j.anbehav.2003.12.005; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Montgomery DC., 2017, DESIGN ANAL EXPT, V9th edn; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nelson F.C., 1927, AM BEE J, V67, P242; Ramsden E, 2007, J HIST BEHAV SCI, V43, P109, DOI 10.1002/jhbs.20219; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; ROTHENBUHLER WC, 1989, APIDOLOGIE, V20, P433, DOI 10.1051/apido:19890508; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Scheiner R, 2010, APIDOLOGIE, V41, P29, DOI 10.1051/apido/2009040; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Sloan FA, 2010, AM J PUBLIC HEALTH, V100, P357, DOI 10.2105/AJPH.2008.158188; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WHALLEY LJ, 2001, BMJ-BRIT MED J, V322, pE819; Winston M.L., 1987, BIOL HONEY BEE, P296; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5	59	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9740	10.1371/journal.pone.0009740	http://dx.doi.org/10.1371/journal.pone.0009740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305818	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809600012
J	Kadir, SHSA; Miragoli, M; Abu-Hayyeh, S; Moshkov, AV; Xie, QL; Keitel, V; Nikolaev, VO; Williamson, C; Gorelik, J				Kadir, Siti H. Sheikh Abdul; Miragoli, Michele; Abu-Hayyeh, Shadi; Moshkov, Alexey V.; Xie, Qilian; Keitel, Verena; Nikolaev, Viacheslav O.; Williamson, Catherine; Gorelik, Julia			Bile Acid-Induced Arrhythmia Is Mediated by Muscarinic M-2 Receptors in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; INTRAHEPATIC CHOLESTASIS; OBSTETRIC CHOLESTASIS; PREGNANCY; IDENTIFICATION; INHIBITION; ACTIVATION; EXPRESSION; FAMILY	Background: Intrahepatic cholestasis of pregnancy (ICP) is a common disease affecting up to 5% of pregnancies and which can cause fetal arrhythmia and sudden intrauterine death. We previously demonstrated that bile acid taurocholate (TC), which is raised in the bloodstream of ICP, can acutely alter the rate and rhythm of contraction and induce abnormal calcium destabilization in cultured neonatal rat cardiomyocytes (NRCM). Apart from their hepatic functions bile acids are ubiquitous signalling molecules with diverse systemic effects mediated by either the nuclear receptor FXR or by a recently discovered G-protein coupled receptor TGR5. We aim to investigate the mechanism of bile-acid induced arrhythmogenic effects in an in-vitro model of the fetal heart. Methods and Results: Levels of bile acid transporters and nuclear receptor FXR were studied by quantitative real time PCR, western blot and immunostaining, which showed low levels of expression. We did not observe functional involvement of the canonical receptors FXR and TGR5. Instead, we found that TC binds to the muscarinic M-2 receptor in NRCM and serves as a partial agonist of this receptor in terms of inhibitory effect on intracellular cAMP and negative chronotropic response. Pharmacological inhibition and siRNA-knockdown of the M-2 receptor completely abolished the negative effect of TC on contraction, calcium transient amplitude and synchronisation in NRCM clusters. Conclusion: We conclude that in NRCM the TC-induced arrhythmia is mediated by the partial agonism at the M2 receptor. This mechanism might serve as a promising new therapeutic target for fetal arrhythmia.	[Kadir, Siti H. Sheikh Abdul; Miragoli, Michele; Moshkov, Alexey V.; Xie, Qilian; Nikolaev, Viacheslav O.; Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kadir, Siti H. Sheikh Abdul; Abu-Hayyeh, Shadi; Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Keitel, Verena] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Kadir, Siti H. Sheikh Abdul] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia; [Xie, Qilian] Hebei Med Univ, Hosp 1, Ctr Heart, Shijiazhuang, Hebei Province, Peoples R China	Imperial College London; Imperial College London; Heinrich Heine University Dusseldorf; Universiti Teknologi MARA; Hebei Medical University	Kadir, SHSA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	j.gorelik@imperial.ac.uk	Moshkov, Alexey/C-2825-2014; Nikolaev, Vyacheslav/AAT-7746-2020; Keitel, Verena/AAF-3471-2019; Keitel, Verena/AAH-9016-2021; Moshkov, Alexey/AAO-9902-2020; Sheikh Abdul Kadir, Siti Hamimah/ABA-7769-2021; Miragoli, Michele/K-6418-2016	Moshkov, Alexey/0000-0002-1858-6738; Keitel, Verena/0000-0003-1383-7662; Moshkov, Alexey/0000-0002-1858-6738; Sheikh Abdul Kadir, Siti Hamimah/0000-0002-1671-4839; Miragoli, Michele/0000-0002-4058-4368; Williamson, Catherine/0000-0002-6226-7611; Gorelik, Julia/0000-0003-1148-9158	Action Medical Research; Institute of Obstetrics and Gynaecology Trust; Universiti Teknologi MARA in Malaysia; Biomedical Research Centre at Imperial College Healthcare NHS Trust	Action Medical Research; Institute of Obstetrics and Gynaecology Trust; Universiti Teknologi MARA in Malaysia; Biomedical Research Centre at Imperial College Healthcare NHS Trust	This work was supported by Action Medical Research, the Institute of Obstetrics and Gynaecology Trust, Universiti Teknologi MARA in Malaysia and the Biomedical Research Centre at Imperial College Healthcare NHS Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin P, 1999, Ethn Health, V4, P35; Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; CAULFIELD MP, 1993, PROGR BRAIN RES, V98, P293; CLARK WA, 1991, AM J PHYSIOL, V261, P530; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; DANIELSSON H, 1975, ANNU REV BIOCHEM, V44, P233, DOI 10.1146/annurev.bi.44.070175.001313; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Dhein S, 2001, PHARMACOL RES, V44, P161, DOI 10.1006/phrs.2001.0835; Eloranta JJ, 2008, PHYSIOLOGY, V23, P286, DOI 10.1152/physiol.00020.2008; FISK NM, 1988, BRIT J OBSTET GYNAEC, V95, P1137, DOI 10.1111/j.1471-0528.1988.tb06791.x; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Gorelik J, 2002, CLIN SCI, V103, P191, DOI 10.1042/cs1030191; Gorelik J, 2006, CARDIOVASC RES, V72, P422, DOI 10.1016/j.cardiores.2006.09.009; Guo GL, 2006, BBA-MOL CELL BIOL L, V1761, P1401, DOI 10.1016/j.bbalip.2006.09.018; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; IACONO G, 1989, AM J PHYSIOL, V256, pH1407, DOI 10.1152/ajpheart.1989.256.5.H1407; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; KHLKAMP V, 1985, PFLUGERS ARCH, V403, P266; KORTH M, 1988, CIRC RES, V62, P1080, DOI 10.1161/01.RES.62.6.1080; LAATIKAINEN T, 1984, INT J GYNECOL OBSTET, V22, P91, DOI 10.1016/0020-7292(84)90019-5; LAATIKAINEN TJ, 1975, AM J OBSTET GYNECOL, V122, P852, DOI 10.1016/0002-9378(75)90727-9; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; Otte K, 2003, MOL CELL BIOL, V23, P864, DOI 10.1128/MCB.23.3.864-872.2003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Raufman JP, 2003, DIGEST DIS SCI, V48, P1431, DOI 10.1023/A:1024733500950; Raufman JP, 2002, EUR J PHARMACOL, V457, P77, DOI 10.1016/S0014-2999(02)02690-0; REID R, 1976, BRIT MED J, V1, P870, DOI 10.1136/bmj.1.6014.870; REYES H, 1982, HEPATOLOGY, V2, P87; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; Stengel PW, 2002, AM J PHYSIOL-REG I, V282, pR1443, DOI 10.1152/ajpregu.00486.2001; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164	44	85	87	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9689	10.1371/journal.pone.0009689	http://dx.doi.org/10.1371/journal.pone.0009689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300620	Green Published, Green Submitted, gold			2022-12-27	WOS:000275621000007
J	Badzakova-Trajkov, G; Haberling, IS; Roberts, RP; Corballis, MC				Badzakova-Trajkov, Gjurgjica; Haeberling, Isabelle S.; Roberts, Reece P.; Corballis, Michael C.			Cerebral Asymmetries: Complementary and Independent Processes	PLOS ONE			English	Article							LANGUAGE LATERALIZATION; HANDEDNESS; GENE; FMRI; EVOLUTION	Most people are right-handed and left-cerebrally dominant for speech, leading historically to the general notion of left-hemispheric dominance, and more recently to genetic models proposing a single lateralizing gene. This hypothetical gene can account for higher incidence of right-handers in those with left cerebral dominance for speech. It remains unclear how this dominance relates to the right-cerebral dominance for some nonverbal functions such as spatial or emotional processing. Here we use functional magnetic resonance imaging with a sample of 155 subjects to measure asymmetrical activation induced by speech production in the frontal lobes, by face processing in the temporal lobes, and by spatial processing in the parietal lobes. Left-frontal, right-temporal, and right- parietal dominance were all intercorrelated, suggesting that right- cerebral biases may be at least in part complementary to the left-hemispheric dominance for language. However, handedness and parietal asymmetry for spatial processing were uncorrelated, implying independent lateralizing processes, one producing a leftward bias most closely associated with handedness, and the other a rightward bias most closely associated with spatial attention.	[Badzakova-Trajkov, Gjurgjica; Haeberling, Isabelle S.; Roberts, Reece P.; Corballis, Michael C.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Auckland	Badzakova-Trajkov, G (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	g.badzakova@auckland.ac.nz		Corballis, Michael/0000-0002-3126-6114; Roberts, Reece/0000-0001-6760-0981	Marsden Fund [07-UOA-015]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The study was supported by the Marsden Fund to M. C. C. administered by the Royal Society of New Zealand 07-UOA-015 (http://marsden.rsnz.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock JE, 2003, NEUROIMAGE, V18, P423, DOI 10.1016/S1053-8119(02)00013-7; Annett M, 2002, HANDEDNESS BRAIN ASY; Bourne VJ, 2008, NEUROPSYCHOLOGY, V22, P350, DOI 10.1037/0894-4105.22.3.350; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; BRYDEN MP, 1983, BRAIN LANG, V20, P249, DOI 10.1016/0093-934X(83)90044-5; BRYDEN MP, 1990, CAN PSYCHOL, V31, P297, DOI 10.1037/h0078949; Cicek M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.007.2009; Corballis M. C., 1993, LOPSIDED APE; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; CORBALLIS MC, 2001, HAND MOUTH; Crow TJ, 2009, LATERALITY, V14, P3, DOI 10.1080/13576500802574984; Crow Tim J., 2002, VVolume 106, P197; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; DRIVER J, 2001, COGNITIVE NEUROSCIEN, P39; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Floel A, 2005, BEHAV BRAIN RES, V158, P269, DOI 10.1016/j.bbr.2004.09.016; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Francks C, 2009, LATERALITY, V14, P11, DOI 10.1080/13576500802536439; Gaillard WD, 2004, NEUROLOGY, V63, P1403, DOI 10.1212/01.wnl.0000141852.65175.a7; Harrison RM, 2008, FOLIA PRIMATOL, V79, P253, DOI 10.1159/000113539; HARVEY M, 1995, BRAIN COGNITION, V27, P59, DOI 10.1006/brcg.1995.1004; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P659, DOI 10.1037/0735-7044.118.3.659; Isaacs KL, 2006, NEUROLOGY, V66, P1855, DOI 10.1212/01.wnl.0000219623.28769.74; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Laland KN, 2008, PHILOS T R SOC B, V363, P3577, DOI 10.1098/rstb.2008.0132; MCMANUS C, 2002, RIGHT HAND LEFT HAND; McManus IC, 2004, P ROY SOC B-BIOL SCI, V271, P2579, DOI 10.1098/rspb.2004.2881; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Shimoda N, 2008, NEUROSCI LETT, V430, P43, DOI 10.1016/j.neulet.2007.10.016; SMEELE PMT, 2004, J EXP PSYCHOL HUMAN, V24, P1232; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; Whitehouse AJO, 2009, NEUROPSYCHOLOGIA, V47, P1938, DOI 10.1016/j.neuropsychologia.2009.03.005; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilkinson D, 2009, NEUROPSYCHOLOGIA, V47, P1701, DOI 10.1016/j.neuropsychologia.2009.02.008; Woermann FG, 2003, NEUROLOGY, V61, P699, DOI 10.1212/01.WNL.0000078815.03224.57; Yovel G, 2008, NEUROPSYCHOLOGIA, V46, P3061, DOI 10.1016/j.neuropsychologia.2008.06.017	44	124	125	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9682	10.1371/journal.pone.0009682	http://dx.doi.org/10.1371/journal.pone.0009682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300635	Green Published, gold			2022-12-27	WOS:000275620900015
J	Koethe, JR; Westfall, AO; Luhanga, DK; Clark, GM; Goldman, JD; Mulenga, PL; Cantrell, RA; Chi, BH; Zulu, I; Saag, MS; Stringer, JSA				Koethe, John R.; Westfall, Andrew O.; Luhanga, Dora K.; Clark, Gina M.; Goldman, Jason D.; Mulenga, Priscilla L.; Cantrell, Ronald A.; Chi, Benjamin H.; Zulu, Isaac; Saag, Michael S.; Stringer, Jeffrey S. A.			A Cluster Randomized Trial of Routine HIV-1 Viral Load Monitoring in Zambia: Study Design, Implementation, and Baseline Cohort Characteristics	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; INFECTED ADULTS; SOUTH-AFRICA; HEALTH-CARE; OUTCOMES; COUNTRIES	Background: The benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use of routine VL testing at ART-initiation and at 3, 6, 12, and 18 months, versus our local standard of care (which uses immunological and clinical criteria to diagnose treatment failure, with discretionary VL testing when the two do not agree). Methodology: Dedicated study personnel were integrated into public-sector ART clinics. We collected participant information in a dedicated research database. Twelve ART clinics in Lusaka, Zambia constituted the units of randomization. Study clinics were stratified into pairs according to matching criteria (historical mortality rate, size, and duration of operation) to limit the effect of clustering, and independently randomized to the intervention and control arms. The study was powered to detect a 36% reduction in mortality at 18 months. Principal Findings: From December 2006 to May 2008, we completed enrollment of 1973 participants. Measured baseline characteristics did not differ significantly between the study arms. Enrollment was staggered by clinic pair and truncated at two matched sites. Conclusions: A large clinical trial of routing VL monitoring was successfully implemented in a dynamic and rapidly growing national ART program. Close collaboration with local health authorities and adequate reserve staff were critical to success. Randomized controlled trials such as this will likely prove valuable in determining long-term outcomes in resource-constrained settings.	[Koethe, John R.; Westfall, Andrew O.; Luhanga, Dora K.; Clark, Gina M.; Goldman, Jason D.; Mulenga, Priscilla L.; Cantrell, Ronald A.; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Koethe, John R.] Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN 37212 USA; [Chi, Benjamin H.; Stringer, Jeffrey S. A.] Univ Alabama, Dept Obstet & Gynecol, Sch Med, Birmingham, AL 35294 USA; [Zulu, Isaac] Univ Teaching Hosp, Dept Internal Med, Lusaka, Zambia; [Saag, Michael S.] Univ Alabama, Sch Med, Div Infect Dis, Birmingham, AL USA	Vanderbilt University; University of Alabama System; University of Alabama Birmingham; University of Zambia; University of Alabama System; University of Alabama Birmingham	Koethe, JR (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	john.r.koethe@vanderbilt.edu	Stringer, Jeffrey S. A./AAU-2342-2021; Goldman, Jason D./AAD-9419-2020	Goldman, Jason D./0000-0002-3825-6832; Westfall, Andrew/0000-0002-0468-4695; Stringer, Jeffrey/0000-0002-9590-7216	National Institutes of Health [U01-AI069452]; University of Alabama at Birmingham Center for AIDS Research [P30-AI027767]; Fogarty International Center [R24-TW007988, K01-TW06670]; Doris Duke Charitable Foundation [2007061]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center for AIDS Research; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	The Viral Load Study is supported by a National Institutes of Health grant (U01-AI069452; http://grants.nih.gov/grants) and the University of Alabama at Birmingham Center for AIDS Research (P30-AI027767; http://www.uabcfar.org/). Investigator salary or trainee support is provided by the Fogarty International Center (R24-TW007988, K01-TW06670; www.fic.nih.gov) and a Clinical Scientist Development Award from the Doris Duke Charitable Foundation (2007061; www.ddcf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-89; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Gazzard B, 2006, HIV MED, V7, P487, DOI 10.1111/j.1468-1293.2006.00424.x; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Koenig SP, 2006, BMJ-BRIT MED J, V332, P602, DOI 10.1136/bmj.332.7541.602; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; REYNOLDS SJ, 2009, FAILURE IMMUNOLOGIC; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; *UN DEP PROGR ZAMB, 2007, HUM DEV REP; UNAIDS, 2008, REP GLOB AIDS EP; *WHO JOINT UN PROG, 2008, UN ACC SCAL PRIOR HI; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2006, ANT THER HIV INF AD	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9680	10.1371/journal.pone.0009680	http://dx.doi.org/10.1371/journal.pone.0009680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300631	gold, Green Published			2022-12-27	WOS:000275620900013
J	Gardner, RL				Gardner, Richard L.			Normal Bias in the Direction of Fetal Rotation Depends on Blastomere Composition during Early Cleavage in the Mouse	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; EMBRYO CULTURE; 4-CELL STAGE; BLASTOCYST; AXIS; FLOW; ORIENTATION; HANDEDNESS; REVERSAL; POLARITY	Interest in establishing the basis of left/right asymmetry during embryogenesis has burgeoned in recent years. Relevant studies in mammals, focused largely on the mouse, have revealed involvement of a variety of genes that are common to the process in other animals. In the mouse, lateral differences in gene expression are first evident late in gastrulation when directional rotation of nodal cilia has been implicated in effecting the normally very strong bias in handedness. Reconstructing cleavage stages with correspondingly positioned blastomeres from appropriate numbers of conceptuses with similar division planes provides a way of testing whether they differ in potency without the confounding effects of reduced cell number. In a study using this strategy, 4-cell stage conceptuses reconstructed from blastomeres produced by equatorial as opposed to meridional second cleavage were found to be compromised in their ability to support normal development. Here, in more refined reconstructions undertaken at both the 4- and 8-cell stage, no significant impairment of development to the 9(th) or 12(th) day of gestation was found for products of equatorial second cleavage or their 8-cell stage progeny. Most surprisingly, however, a significant increase in reversal of the direction of axial rotation was found specifically among fetuses developing from conceptuses reconstructed from 8-cell stage progeny of products of equatorial second cleavage. Hence, manipulations during early cleavage some 6 days before fetal asymmetries are first evident can perturb the normally very strong bias in specification of a facet of left-right asymmetry.	Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Gardner, RL (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	rlg534@york.ac.uk			Royal Society; March of Dimes [1-FY03-84]	Royal Society(Royal Society of London); March of Dimes(March of Dimes)	This work was funded by personal support from the Royal Society (http://www.google.com/search?client=safari&rls=en&rls=en&q=royal+society+of+london&ie=UTF-8&ie=UTF-8&oe=UTF-8) - no grant number - and a project grant from the March of Dimes (http://www.google.com/search?client= safari&rls=en&rls=en&q=march+of+dimes+foundation&ie=UTF-8&ie=UTF-8&oe=UTF-8) Grant1-FY03-84. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; ENDO A, 1987, ANAT EMBRYOL, V176, P133, DOI 10.1007/BF00309761; FUJINAGA M, 1995, TOXICOL IN VITRO, V9, P593, DOI 10.1016/0887-2333(95)00068-J; Gardner RL, 2007, HUM REPROD, V22, P798, DOI 10.1093/humrep/del424; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Gardner RL, 2006, REPROD BIOMED ONLINE, V12, P144, DOI 10.1016/S1472-6483(10)60853-X; Gardner RL, 2003, PHILOS T ROY SOC B, V358, P1331, DOI 10.1098/rstb.2003.1322; Hadjantonakis AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002511; Hibino T, 2006, DEV GENES EVOL, V216, P265, DOI 10.1007/s00427-005-0051-6; Hiiragi T, 2006, REPROD BIOMED ONLINE, V12, P150, DOI 10.1016/S1472-6483(10)60854-1; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; KITAZAWA C, 2007, J EXP ZOOL PART A, V307, P1; Kuroda R, 2009, NATURE, V462, P790, DOI 10.1038/nature08597; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; McCarthy A, 1998, REPROD TOXICOL, V12, P177, DOI 10.1016/S0890-6238(97)00150-0; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; SUZUKI H, 1995, BIOL REPROD, V53, P78, DOI 10.1095/biolreprod53.1.78; Takaoka K, 2007, CURR OPIN GENET DEV, V17, P344, DOI 10.1016/j.gde.2007.06.001; WOOD WB, 1991, NATURE, V349, P536, DOI 10.1038/349536a0; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011	28	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9610	10.1371/journal.pone.0009610	http://dx.doi.org/10.1371/journal.pone.0009610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224769	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800013
J	Levesque, MV; Levesque, D; Briere, FP; Perreault, JP				Levesque, Michel V.; Levesque, Dominique; Briere, Francis P.; Perreault, Jean-Pierre			Investigating a New Generation of Ribozymes in Order to Target HCV	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SMALL INTERFERING RNAS; DELTA-RIBOZYME; IN-VITRO; INTRACELLULAR-LOCALIZATION; REPLICATION COMPLEX; MAMMALIAN-CELLS; VIRAL-RNA; GENE; INHIBITION	For a long time nucleic acid-based approaches directed towards controlling the propagation of Hepatitis C Virus (HCV) have been considered to possess high potential. Towards this end, ribozymes (i.e. RNA enzymes) that specifically recognize and subsequently catalyze the cleavage of their RNA substrate present an attractive molecular tool. Here, the unique properties of a new generation of ribozymes are taken advantage of in order to develop an efficient and durable ribozyme-based technology with which to target HCV (+) RNA strands. These ribozymes resulted from the coupling of a specific on/off adaptor (SOFA) to the ribozyme domain derived from the Hepatitis Delta Virus (HDV). The former switches cleavage activity "on" solely in the presence of the desired RNA substrate, while the latter was the first catalytic RNA reported to function naturally in human cells, specifically in hepatocytes. In order to maximize the chances for success, a step-by-step approach was used for both the design and the selection of the ribozymes. This approach included the use of both bioinformatics and biochemical methods for the identification of the sites possessing the greatest potential for targeting, and the subsequent in vitro testing of the cleavage activities of the corresponding SOFA-HDV ribozymes. These efforts led to a significant improvement in the ribozymes' designs. The ability of the resulting SOFA-HDV ribozymes to inhibit HCV replication was further examined using a luciferase-based replicon. Although some of the ribozymes exhibited high levels of cleavage activity in vitro, none appears to be a potential long term inhibitor in cellulo. Analysis of recent discoveries in the cellular biology of HCV might explain this failure, as well as provide some ideas on the potential limits of using nucleic acid-based drugs to control the propagation of HCV. Finally, the above conclusions received support from experiments performed using a collection of SOFA-HDV ribozymes directed against HCV (-) strands.	[Levesque, Michel V.; Levesque, Dominique; Briere, Francis P.; Perreault, Jean-Pierre] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Levesque, MV (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Pierre.Perreault@USherbrooke.ca			Canadian Institute of Health Research (CIHR) [EOP-38322]; Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institute of Health Research (CIHR; grant number EOP-38322) to JPP. The RNA group is supported by grants from both CIHR (Resource program) and Universite de Sherbrooke. ML is the recipient of a predoctoral fellowship from the Fonds de Recherche en Sante du Quebec. JPP holds the Canada Research Chairs in genomics and catalytic RNAs, and is a member of the Centre de Recherche Clinique Etienne Lebel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anouti F, 2002, ANTISENSE NUCLEIC A, V12, P275, DOI 10.1089/108729002320351593; Alaoui-Ismaili MH, 2000, ANTIVIR RES, V46, P181, DOI 10.1016/S0166-3542(00)00085-1; Ananvoranich S, 1999, NUCLEIC ACIDS RES, V27, P1473, DOI 10.1093/nar/27.6.1473; Ananvoranich S, 1998, J BIOL CHEM, V273, P13182, DOI 10.1074/jbc.273.21.13182; Asif-Ullah M, 2007, CURR GENE THER, V7, P205, DOI 10.2174/156652307780859008; Beaulieu Pierre L, 2004, Curr Opin Investig Drugs, V5, P838; Bergeron LJ, 2005, RNA, V11, P1858, DOI 10.1261/rna.2112705; Bergeron LJ, 2005, NUCLEIC ACIDS RES, V33, P1240, DOI 10.1093/nar/gki278; Bergeron LJ, 2003, CURR MED CHEM, V10, P2589, DOI 10.2174/0929867033456486; Bergeron LJ, 2002, NUCLEIC ACIDS RES, V30, P4682, DOI 10.1093/nar/gkf598; Bertrand E, 1997, RNA, V3, P75; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; D'Anjou FO, 2004, J BIOL CHEM, V279, P14232, DOI 10.1074/jbc.M310632200; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Deschenes P, 2000, ANTISENSE NUCLEIC A, V10, P53, DOI 10.1089/oli.1.2000.10.53; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Fiola K, 2006, APPL ENVIRON MICROB, V72, P869, DOI 10.1128/AEM.72.1.869-879.2006; FONG TL, 1991, J CLIN INVEST, V88, P1058, DOI 10.1172/JCI115368; Griffiths J, 2002, HEPATOLOGY, V35, P709, DOI 10.1053/jhep.2002.31258; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Kato Y, 2001, J BIOL CHEM, V276, P15378, DOI 10.1074/jbc.M010570200; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; KROKE J, 2004, J VIROL, V78, P3436; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Levesque D, 2002, RNA, V8, P464, DOI 10.1017/S1355838202020289; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Macejak DG, 2000, HEPATOLOGY, V31, P769, DOI 10.1002/hep.510310331; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Moradpour D, 2002, TRENDS MOL MED, V8, P476, DOI 10.1016/S1471-4914(02)02395-X; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Ohkawa K, 1997, J HEPATOL, V27, P78, DOI 10.1016/S0168-8278(97)80283-8; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; Peracchi A, 2004, REV MED VIROL, V14, P47, DOI 10.1002/rmv.415; Pereira AA, 2009, NAT REV GASTRO HEPAT, V6, P403, DOI 10.1038/nrgastro.2009.92; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100; Robichaud GA, 2008, NUCLEIC ACIDS RES, V36, P4609, DOI 10.1093/nar/gkn432; Sakamoto N, 2008, J GASTROEN HEPATOL, V23, P1437, DOI 10.1111/j.1440-1746.2007.05076.x; Seo MY, 2003, J VIROL, V77, P810, DOI 10.1128/JVI.77.1.810-812.2003; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smith RM, 2007, J VIRAL HEPATITIS, V14, P194, DOI 10.1111/j.1365-2893.2006.00794.x; Smith RM, 2002, J VIROL, V76, P9563, DOI 10.1128/JVI.76.19.9563-9574.2002; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Trepanier J, 2006, J VIRAL HEPATITIS, V13, P131, DOI 10.1111/j.1365-2893.2005.00684.x; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Watanabe T, 2007, J HEPATOL, V47, P744, DOI 10.1016/j.jhep.2007.06.015; Welch PJ, 1996, GENE THER, V3, P994; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840	57	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9627	10.1371/journal.pone.0009627	http://dx.doi.org/10.1371/journal.pone.0009627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224783	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800022
J	Emerson, KJ; Bradshaw, WE; Holzapfel, CM				Emerson, Kevin J.; Bradshaw, William E.; Holzapfel, Christina M.			Microarrays Reveal Early Transcriptional Events during the Termination of Larval Diapause in Natural Populations of the Mosquito, Wyeomyia smithii	PLOS ONE			English	Article							PITCHER-PLANT MOSQUITO; MAMMALIAN SORBITOL DEHYDROGENASE; PHOTOPERIODIC TIME MEASUREMENT; DROSOPHILA-MELANOGASTER; EVOLUTIONARY DIVERGENCE; GENE-EXPRESSION; SEASONAL PHOTOPERIODISM; CLIMATE-CHANGE; PEA APHID; PROTEIN	Background: The mosquito Wyeomyia smithii overwinters in a larval diapause that is initiated, maintained and terminated by day length (photoperiod). We use a forward genetic approach to investigate transcriptional events involved in the termination of diapause following exposure to long-days. Methods/Principal Findings: We incorporate a novel approach that compares two populations that differentially respond to a single day length. We identify 30 transcripts associated with differential response to day length. Most genes with a previously annotated function are consistent with their playing a role in the termination of diapause, in downstream developmental events, or in the transition from potentially oxygen-poor to oxygen-rich environments. One gene emerges from three separate forward genetic screens as a leading candidate for a gene contributing to the photoperiodic timing mechanism itself (photoperiodic switch). We name this gene photoperiodic response gene 1 (ppdrg1). WsPpdrg1 is up-regulated under long-day response conditions, is located under a QTL for critical photoperiod and is associated with critical photoperiod after 25 generations of recombination from a cross between extreme phenotypes. Conclusions: Three independent forward genetic approaches identify WsPpdrg1 as a gene either involved in the photoperiodic switch mechanism or very tightly linked to a gene that is. We conclude that continued forward genetic approaches will be central to understanding not only the molecular basis of photoperiodism and diapause, but also the evolutionary potential of temperate and polar animal populations when confronted with rapid climate change.	[Emerson, Kevin J.; Bradshaw, William E.; Holzapfel, Christina M.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Emerson, KJ (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	kemerson@uoregon.edu	Emerson, Kevin/AAC-8207-2020	Emerson, Kevin/0000-0003-3283-0693	National Science Foundation (NSF) [DEB-0413573, DEB-0917827, IOB-0445710, IOB-0839998, DGE-0504727]; National Institutes of Health (NIH) Genetics Training Grant [5-T32-GMO7413]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH) Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by generous funding through National Science Foundation (NSF) Grants DEB-0413573, DEB-0917827, IOB-0445710, and IOB-0839998 to WEB. During this research KJE was supported by an National Institutes of Health (NIH) Genetics Training Grant 5-T32-GMO7413 to George Sprague and an National Science Foundation (NSF) IGERT Training Grant DGE-0504727 to John Postlethwait, Patrick Phillips and Karen Guilleman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Bradshaw WE, 2005, GENETICS, V169, P485, DOI 10.1534/genetics.104.031971; BRADSHAW WE, 1976, NATURE, V262, P384, DOI 10.1038/262384b0; Bradshaw WE, 2004, EVOLUTION, V58, P1748, DOI 10.1111/j.0014-3820.2004.tb00458.x; Bradshaw WE, 2003, AM NAT, V161, P735, DOI 10.1086/374344; BRADSHAW WE, 1977, EVOLUTION, V31, P546, DOI [10.2307/2407521, 10.1111/j.1558-5646.1977.tb01044.x]; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; BRADSHAW WE, 2010, ANN REV PHY IN PRESS; Bradshaw W, 2007, SCIENCE, V316, P1851, DOI 10.1126/science.1145053; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks HV, 1987, INSECT DORMANCY ECOL; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Emerson KJ, 2008, J COMP PHYSIOL A, V194, P611, DOI 10.1007/s00359-008-0334-2; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P385, DOI 10.1007/s00359-009-0416-9; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Goto SG, 2002, J INSECT PHYSIOL, V48, P803, DOI 10.1016/S0022-1910(02)00108-7; HARD JJ, 1993, AM NAT, V142, P457, DOI 10.1086/285549; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; Hoy M.A., 1978, P101; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Kim E, 2008, INSECT MOL BIOL, V17, P537, DOI 10.1111/j.1365-2583.2008.00822.x; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Kyriacou CP, 2008, TRENDS GENET, V24, P124, DOI 10.1016/j.tig.2007.12.003; Lair KP, 1997, GENETICS, V147, P1873; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-456; Leather S. R., 1993, ECOLOGY INSECT OVERW; Luque T, 1998, J BIOL CHEM, V273, P34293, DOI 10.1074/jbc.273.51.34293; Mathias D, 2006, J BIOL RHYTHM, V21, P132, DOI [10.1177/0748730406286320, 10.1177/0748730405286320]; Mathias D, 2005, J INSECT PHYSIOL, V51, P661, DOI 10.1016/j.jinsphys.2005.03.011; Mathias D, 2007, GENETICS, V176, P391, DOI 10.1534/genetics.106.068726; NIIMI T, 1993, COMP BIOCHEM PHYS B, V106, P437, DOI 10.1016/0305-0491(93)90326-Z; NIIMI T, 1993, EUR J BIOCHEM, V213, P1125, DOI 10.1111/j.1432-1033.1993.tb17862.x; PATERSON CG, 1971, CAN J ZOOLOG, V49, P1455, DOI 10.1139/z71-214; Pratt C. W., 2004, ESSENTIAL BIOCH, V3rd; R Development Core Team, 2007, R LANG ENV STAT COMP; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Saunders DS, 2002, INSECT CLOCKS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokal RR, 1995, BIOMETRY; Stehlik J, 2008, J BIOL RHYTHM, V23, P129, DOI 10.1177/0748730407313364; Tan CG, 2003, DEVELOPMENT, V130, P671, DOI 10.1242/dev.00298; Tauber E, 2008, FUNCT ECOL, V22, P19, DOI 10.1111/j.1365-2435.2007.01343.x; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAYLOR F, 1980, THEOR POPUL BIOL, V18, P125, DOI 10.1016/0040-5809(80)90044-1; Torok I, 1999, MOL CELL BIOL, V19, P2308; Verras M, 2004, ARCH INSECT BIOCHEM, V56, P133, DOI 10.1002/arch.20004	58	43	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9574	10.1371/journal.pone.0009574	http://dx.doi.org/10.1371/journal.pone.0009574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221437	Green Submitted, Green Published, gold			2022-12-27	WOS:000275197200018
J	Heymans, F; Fischer, A; Stow, NW; Girard, M; Vourexakis, Z; Des Courtis, A; Renzi, G; Huggler, E; Vlaminck, S; Bonfils, P; Mladina, R; Lund, V; Schrenzel, J; Francois, P; Lacroix, JS				Heymans, Frederic; Fischer, Adrien; Stow, Nicholas W.; Girard, Myriam; Vourexakis, Zacharias; Des Courtis, Antoine; Renzi, Gesuele; Huggler, Elzbieta; Vlaminck, Stefan; Bonfils, Pierre; Mladina, Ranko; Lund, Valerie; Schrenzel, Jacques; Francois, Patrice; Lacroix, Jean Silvain			Screening for Staphylococcal Superantigen Genes Shows No Correlation with the Presence or the Severity of Chronic Rhinosinusitis and Nasal Polyposis	PLOS ONE			English	Article							AUREUS RHINOSINUSITIS; ENTEROTOXIN; INFECTIONS; RECURRENT; CLUSTER; SHOCK; PREVALENCE; MUCOSA; FOOD; EGC	Background: Staphylococcus aureus secretes numerous exotoxins which may exhibit superantigenic properties. Whereas the virulence of several of them is well documented, their exact biological effects are not fully understood. Exotoxins may influence the immune and inflammatory state of various organs, including the sinonasal mucosa: their possible involvement in chronic rhinosinusitis has been suggested and is one of the main trends in current research. The aim of this study was to investigate whether the presence of any of the 22 currently known staphylococcal exotoxin genes could be correlated with chronic rhinosinusitis. Methodology/Principal Findings: We conducted a prospective, multi-centred European study, analysing 93 Staphylococcus aureus positive swabs taken from the middle meatus of patients suffering from chronic rhinosinusitis, with or without nasal polyposis, and controls. Strains were systematically tested for the presence of the 22 currently known exotoxin genes and genotyped according to their agr groups. No direct correlation was observed between chronic rhinosinusitis, with or without nasal polyposis, and either agr groups or the presence of the most studied exotoxins genes (egc, sea, seb, pvl, exfoliatins or tsst-1). However, genes for enterotoxins P and Q were frequently observed in nasal polyposis for the first time, but absent in the control group. The number of exotoxin genes detected was not statistically different among the 3 patient groups. Conclusions/Significance: Unlike many previous studies have been suggesting, we did not find any evident correlation between staphylococcal exotoxin genes and the presence or severity of chronic rhinosinusitis with or without nasal polyposis.	[Heymans, Frederic; Stow, Nicholas W.; Vourexakis, Zacharias; Des Courtis, Antoine; Lacroix, Jean Silvain] Univ Hosp Geneva, Dept Otorhinolaryngol & ENT Surg, Rhinol Olfactol Unit, Geneva, Switzerland; [Fischer, Adrien; Girard, Myriam; Huggler, Elzbieta; Schrenzel, Jacques; Francois, Patrice] Univ Hosp Geneva, Genom Res Lab, Infect Dis Unit, Dept Internal Med, Geneva, Switzerland; [Renzi, Gesuele; Schrenzel, Jacques] Univ Hosp Geneva, Dept Med Genet & Lab Med, Cent Lab Bacteriol, Geneva, Switzerland; [Vlaminck, Stefan] Acad Hosp St Jan, Brugge, Belgium; [Bonfils, Pierre] Georges Pompidou European Hosp, Dept ENT Head & Neck Surg, Paris, France; [Mladina, Ranko] Clin Hosp Ctr, Dept ENT Head & Neck Surg, Zagreb, Croatia; [Lund, Valerie] UCL EAR Inst Laryngol & Otol, London, England	University of Geneva; University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Heymans, F (corresponding author), Univ Hosp Geneva, Dept Otorhinolaryngol & ENT Surg, Rhinol Olfactol Unit, Geneva, Switzerland.	silvain.lacroix@hcuge.ch	Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Fischer, adrien/0000-0002-5437-4804; francois, patrice/0000-0002-0540-750X	Swiss National Science Foundation [3100A0-116075/1, 3100A0-112370/1]; European Commission 6th Framework Program [37957]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission 6th Framework Program(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Swiss National Science Foundation 3100A0-116075/1 (PF), 3100A0-112370/1 (JS), and the European Commission 6th Framework Program (MagRSA project #37957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2003, CURR ALLERGY ASTHM R, V3, P523, DOI 10.1007/s11882-003-0065-y; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bania J, 2006, INT J FOOD MICROBIOL, V108, P36, DOI 10.1016/j.ijfoodmicro.2005.10.013; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; Bernstein Joel M, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P39, DOI 10.1097/00020840-200502000-00010; Chen B, 2007, AM J RHINOL, V21, P346, DOI 10.2500/ajr.2007.21.3029; Chen B, 2006, AM J RHINOL, V20, P325, DOI 10.2500/ajr.2006.20.2870; Chiang YC, 2008, INT J FOOD MICROBIOL, V121, P66, DOI 10.1016/j.ijfoodmicro.2007.10.005; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB S S; Conley DB, 2006, AM J RHINOL, V20, P451, DOI 10.2500/ajr.2006.20.2880; Delagranda A, 2008, RHINOLOGY, V46, P125; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Ferry T, 2005, CLIN INFECT DIS, V41, P771, DOI 10.1086/432798; FISCHER A, 2009, J MICROBIOL; Floret D, 2001, ARCH PEDIATRIE, V8, p762S, DOI 10.1016/S0929-693X(01)80194-9; Fokkens W, 2007, RHINOLOGY, P1; Francois P, 2006, J CLIN MICROBIOL, V44, P1892, DOI 10.1128/JCM.44.5.1892-1895.2006; Francois P, 2005, J CLIN MICROBIOL, V43, P3346, DOI 10.1128/JCM.43.7.3346-3355.2005; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; Koessler T, 2006, J CLIN MICROBIOL, V44, P1040, DOI 10.1128/JCM.44.3.1040-1048.2006; KOS MI, 2009, INFECTION; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lee, 2007, J MICROBIOL BIOTECHN, V17, P1504; Letertre C, 2003, J APPL MICROBIOL, V95, P38, DOI 10.1046/j.1365-2672.2003.01957.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malm L, 1997, ACTA OTO-LARYNGOL, V117, P465, DOI 10.3109/00016489709113422; Min YG, 2006, ACTA OTO-LARYNGOL, V126, P941, DOI 10.1080/00016480500469016; Mushtaq F, 2008, ACTA PAEDIATR, V97, P985, DOI 10.1111/j.1651-2227.2008.00797.x; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; PINTO J, 2008, LARYNGOSCOPE; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Schleucher RD, 2008, J TRAVEL MED, V15, P137, DOI 10.1111/j.1708-8305.2008.00194.x; Seiberling KA, 2005, LARYNGOSCOPE, V115, P1580, DOI 10.1097/01.mlg.0000168111.11802.9c; STENZ L, 2008, FEMS MICROBIOL LETT; Thomas DY, 2006, INFECT IMMUN, V74, P4724, DOI 10.1128/IAI.00132-06; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Van Zele T, 2008, AM J RHINOL, V22, P223, DOI 10.2500/ajr.2008.22.3161; WAYOFF M, ANNA OTOLARYNGOLOGIE, V96, P229; ZEITZ HJ, 1988, CLIN CHEST MED, V9, P567	43	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9525	10.1371/journal.pone.0009525	http://dx.doi.org/10.1371/journal.pone.0009525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221434	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197200006
J	Kawabe, T; Shirai, N; Wada, Y; Miura, K; Kanazawa, S; Yamaguchi, MK				Kawabe, Takahiro; Shirai, Nobu; Wada, Yuji; Miura, Kayo; Kanazawa, So; Yamaguchi, Masami K.			The Audiovisual Tau Effect in Infancy	PLOS ONE			English	Article							VISUAL-MOTION PERCEPTION; SOUND; ILLUSIONS; VISION; ATTENTION; OBJECTS; FUSION; SPACE	Background: Perceived spatial intervals between successive flashes can be distorted by varying the temporal intervals between them (the "tau effect''). A previous study showed that a tau effect for visual flashes could be induced when they were accompanied by auditory beeps with varied temporal intervals (an audiovisual tau effect). Methodology/Principal Findings: We conducted two experiments to investigate whether the audiovisual tau effect occurs in infancy. Forty-eight infants aged 5-8 months took part in this study. In Experiment 1, infants were familiarized with audiovisual stimuli consisting of three pairs of two flashes and three beeps. The onsets of the first and third pairs of flashes were respectively matched to those of the first and third beeps. The onset of the second pair of flashes was separated from that of the second beep by 150 ms. Following the familiarization phase, infants were exposed to a test stimulus composed of two vertical arrays of three static flashes with different spatial intervals. We hypothesized that if the audiovisual tau effect occurred in infancy then infants would preferentially look at the flash array with spatial intervals that would be expected to be different from the perceived spatial intervals between flashes they were exposed to in the familiarization phase. The results of Experiment 1 supported this hypothesis. In Experiment 2, the first and third beeps were removed from the familiarization stimuli, resulting in the disappearance of the audiovisual tau effect. This indicates that the modulation of temporal intervals among flashes by beeps was essential for the audiovisual tau effect to occur (Experiment 2). Conclusions/Significance: These results suggest that the cross-modal processing that underlies the audiovisual tau effect occurs even in early infancy. In particular, the results indicate that audiovisual modulation of temporal intervals emerges by 5-8 months of age.	[Kawabe, Takahiro] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; [Shirai, Nobu] Niigata Univ, Dept Psychol, Niigata, Japan; [Wada, Yuji] Natl Food Res Inst, Sensory & Cognit Food Sci Lab, Tsukuba, Ibaraki 305, Japan; [Kawabe, Takahiro; Miura, Kayo] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki Ku, Kanagawa, Japan; [Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Tokyo 112, Japan; [Yamaguchi, Masami K.] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Kyushu University; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Kyushu University; Japan Womens University; Chuo University; Japan Science & Technology Agency (JST)	Kawabe, T (corresponding author), Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan.	tkawabe@hes.kyushu-u.ac.jp			Japan Society for the Promotion of Science [18000090, 19-1464]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by the Kyushu University Superstar Program (http://www. srp. kyushu-u. ac. jp/ssp_ home/e_ top. html) to T. K.; the Foundation of Technology Supporting the Creation of Digital Media Contents from the Japan Science and Technology Agency (http://www. media. jst. go. jp/ english/index. html) to M. K. Y; and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (http://www. jsps. go. jp/english/index. html) 18000090 to M. K. Y and 19-1464 to N. S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; BAHRICK LE, 1994, DEV INTERSENSORY PER, P165; Benussi V, 1913, ARCH GES PSYCHOL, V36, P59; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Goldreich D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000333; Helson H, 1930, Science, V71, P536, DOI 10.1126/science.71.1847.536; Helson H, 1931, J EXP PSYCHOL, V14, P202, DOI 10.1037/h0071164; Kawabe T, 2008, ACTA PSYCHOL, V128, P249, DOI 10.1016/j.actpsy.2008.01.004; Kawabe T, 2009, EXP BRAIN RES, V198, P195, DOI 10.1007/s00221-009-1877-3; Kawabe T, 2006, PERCEPT PSYCHOPHYS, V68, P750, DOI 10.3758/BF03193698; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; LEWKOWICZ DJ, 1980, DEV PSYCHOL, V16, P597; LEWKOWICZ DJ, 1994, DEV PSYCHOL, V30, P880, DOI 10.1037/0012-1649.30.6.880; Lewkowicz DJ, 1994, DEV INTERSENSORY PER, P165; MAURER D, 2004, ATTENTION PERFORM, V21, P193; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mishra J, 2008, BRAIN RES, V1242, P102, DOI 10.1016/j.brainres.2008.05.023; Neil PA, 2006, DEVELOPMENTAL SCI, V9, P454, DOI 10.1111/j.1467-7687.2006.00512.x; Quinn PC, 1996, J EXP CHILD PSYCHOL, V63, P189, DOI 10.1006/jecp.1996.0047; Roder BJ, 2000, INFANCY, V1, P491, DOI 10.1207/S15327078IN0104_9; Sarrazin JC, 2007, PSYCHOL RES-PSYCH FO, V71, P201, DOI 10.1007/s00426-005-0019-1; Scheier C, 2003, DEVELOPMENTAL SCI, V6, P233, DOI 10.1111/1467-7687.00276; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Spector F, 2009, DEV PSYCHOL, V45, P175, DOI 10.1037/a0014171; SPELKE ES, 1983, PERCEPTION, V12, P719, DOI 10.1068/p120719; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Wada Y, 2009, J EXP CHILD PSYCHOL, V102, P315, DOI 10.1016/j.jecp.2008.07.002; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9503	10.1371/journal.pone.0009503	http://dx.doi.org/10.1371/journal.pone.0009503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209137	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400011
J	Brouwer, IA; Wanders, AJ; Katan, MB				Brouwer, Ingeborg A.; Wanders, Anne J.; Katan, Martijn B.			Effect of Animal and Industrial Trans Fatty Acids on HDL and LDL Cholesterol Levels in Humans - A Quantitative Review	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; CORONARY-HEART-DISEASE; MODERATELY HYPERLIPIDEMIC SUBJECTS; HYDROGENATED SOYBEAN OIL; HEALTHY-HUMAN SUBJECTS; MIDDLE-AGED MEN; PLASMA-LIPIDS; CARDIOVASCULAR-DISEASE; INSULIN SENSITIVITY; SERUM-LIPOPROTEINS	Background: Trans fatty acids are produced either by industrial hydrogenation or by biohydrogenation in the rumens of cows and sheep. Industrial trans fatty acids lower HDL cholesterol, raise LDL cholesterol, and increase the risk of coronary heart disease. The effects of conjugated linoleic acid and trans fatty acids from ruminant animals are less clear. We reviewed the literature, estimated the effects trans fatty acids from ruminant sources and of conjugated trans linoleic acid (CLA) on blood lipoproteins, and compared these with industrial trans fatty acids. Methodology/Principal Findings: We searched Medline and scanned reference lists for intervention trials that reported effects of industrial trans fatty acids, ruminant trans fatty acids or conjugated linoleic acid on LDL and HDL cholesterol in humans. The 39 studies that met our criteria provided results of 29 treatments with industrial trans fatty acids, 6 with ruminant trans fatty acids and 17 with CLA. Control treatments differed between studies; to enable comparison between studies we recalculated for each study what the effect of trans fatty acids on lipoprotein would be if they isocalorically replaced cis mono unsaturated fatty acids. In linear regression analysis the plasma LDL to HDL cholesterol ratio increased by 0.055 (95% CI 0.044-0.066) for each % of dietary energy from industrial trans fatty acids replacing cis monounsaturated fatty acids The increase in the LDL to HDL ratio for each % of energy was 0.038 (95% CI 0.012-0.065) for ruminant trans fatty acids, and 0.043 (95% CI 0.012-0.074) for conjugated linoleic acid (p = 0.99 for difference between CLA and industrial trans fatty acids; p = 0.37 for ruminant versus industrial trans fatty acids). Conclusions/Significance: Published data suggest that all fatty acids with a double bond in the trans configuration raise the ratio of plasma LDL to HDL cholesterol.	[Brouwer, Ingeborg A.; Wanders, Anne J.; Katan, Martijn B.] Vrije Univ Amsterdam, EMGO Inst Hlth Care Res, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Wanders, Anne J.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Vrije Universiteit Amsterdam; Wageningen University & Research	Brouwer, IA (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth Care Res, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.	Ingeborg.Brouwer@falw.vu.nl	Katan, Martijn/ABB-6613-2021	Brouwer, Ingeborg/0000-0002-8762-382X	Netherlands Heart Foundation [2006B176]; Foundation for Nutrition and Health Research; Royal Netherlands Academy of Arts and Sciences	Netherlands Heart Foundation(Netherlands Heart Foundation); Foundation for Nutrition and Health Research; Royal Netherlands Academy of Arts and Sciences	This study was supported by the Netherlands Heart Foundation (Grant No. 2006B176), the Foundation for Nutrition and Health Research, and the Royal Netherlands Academy of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMENDINGEN K, 1995, J LIPID RES, V36, P1370; ANDERSON JT, 1957, J CLIN INVEST, V36, P81, DOI 10.1172/JCI103413; Aro A., 1998, Journal of Food Composition and Analysis, V11, P150, DOI 10.1006/jfca.1998.0570; Aro A, 1997, AM J CLIN NUTR, V65, P1419, DOI 10.1093/ajcn/65.5.1419; ASCHERIO A, 1994, CIRCULATION, V89, P94, DOI 10.1161/01.CIR.89.1.94; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Benito P, 2001, LIPIDS, V36, P229, DOI 10.1007/s11745-001-0712-x; Berven G, 2000, EUR J LIPID SCI TECH, V102, P455, DOI 10.1002/1438-9312(200008)102:7<455::AID-EJLT455>3.3.CO;2-M; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; BRUSSAARD JH, 1982, ATHEROSCLEROSIS, V42, P205, DOI 10.1016/0021-9150(82)90151-4; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; de Roos NM, 2001, J NUTR, V131, P242, DOI 10.1093/jn/131.2.242; DENKE MA, 1995, AM J CLIN NUTR, V62; Desroches S, 2005, AM J CLIN NUTR, V82, P309, DOI 10.1093/ajcn/82.2.309; Dyerberg J, 2004, EUR J CLIN NUTR, V58, P1062, DOI 10.1038/sj.ejcn.1601934; Elgersma A, 2006, ANIM FEED SCI TECH, V131, P207, DOI 10.1016/j.anifeedsci.2006.06.012; Food and Drug Administration, 2003, FED REGISTER, V68, P41434; FRENCH MA, 2002, ASIA PACIFIC J CL S7, V11; Gaullier JM, 2007, BRIT J NUTR, V97, P550, DOI 10.1017/S0007114507381324; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Han SN, 2002, J LIPID RES, V43, P445; Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692; Iwata Toshio, 2007, J Oleo Sci, V56, P517; Jakobsen MU, 2008, INT J EPIDEMIOL, V37, P173, DOI 10.1093/ije/dym243; Judd JT, 2002, LIPIDS, V37, P123, DOI 10.1007/s11745-002-0871-9; JUDD JT, 1994, AM J CLIN NUTR, V59, P861, DOI 10.1093/ajcn/59.4.861; KEYS A, 1957, LANCET, V270, P959; Lambert EV, 2007, BRIT J NUTR, V97, P1001, DOI 10.1017/S0007114507172822; Lichtenstein AH, 1999, NEW ENGL J MED, V340, P1933, DOI 10.1056/NEJM199906243402501; LICHTENSTEIN AH, 1993, ARTERIOSCLER THROMB, V13, P154, DOI 10.1161/01.ATV.13.2.154; Lichtenstein AH, 2006, AM J CLIN NUTR, V84, P497, DOI 10.1093/ajcn/84.3.497; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Louheranta AM, 1999, METABOLISM, V48, P870, DOI 10.1016/S0026-0495(99)90221-4; Lovejoy JC, 2002, DIABETES CARE, V25, P1283, DOI 10.2337/diacare.25.8.1283; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Motard-Belanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Muller H, 1998, LIPIDS, V33, P879, DOI 10.1007/s11745-998-0284-9; Muller H, 1998, BRIT J NUTR, V80, P243, DOI 10.1017/S0007114598001299; Naumann E, 2006, ATHEROSCLEROSIS, V188, P167, DOI 10.1016/j.atherosclerosis.2005.10.019; NESTEL P, 1992, J LIPID RES, V33, P1029; Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; PARODI PW, 1976, J DAIRY SCI, V59, P1870, DOI 10.3168/jds.S0022-0302(76)84455-4; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Precht D, 1996, INT DAIRY J, V6, P791, DOI 10.1016/0958-6946(96)00004-0; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Sluijs I, 2010, AM J CLIN NUTR, V91, P175, DOI 10.3945/ajcn.2009.28192; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Steck SE, 2007, J NUTR, V137, P1188, DOI 10.1093/jn/137.5.1188; SUNDRAM K, 1997, J NUTR, V127; SUNDRAM K, 2007, NUTR METABOLISM, V4; Tholstrup T, 2006, AM J CLIN NUTR, V83, P237; Tricon S, 2006, AM J CLIN NUTR, V83, P744, DOI 10.1093/ajcn/83.4.744; Tricon S, 2004, AM J CLIN NUTR, V80, P614; Turpeinen AM, 2002, AM J CLIN NUTR, V76, P504, DOI 10.1093/ajcn/76.3.504; Vega-Lopez S, 2006, AM J CLIN NUTR, V84, P54, DOI 10.1093/ajcn/84.1.54; Vermunt SHF, 2001, BRIT J NUTR, V85, P387, DOI 10.1079/BJN2000270; Wanders AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009000; Whigham LD, 2004, FOOD CHEM TOXICOL, V42, P1701, DOI 10.1016/j.fct.2004.06.008; Whigham LD, 2007, AM J CLIN NUTR, V85, P1203; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; ZOCK PL, 1992, J LIPID RES, V33, P399	65	197	201	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9434	10.1371/journal.pone.0009434	http://dx.doi.org/10.1371/journal.pone.0009434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209147	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300001
J	Shahaf, G; Cancro, MP; Mehr, R				Shahaf, Gitit; Cancro, Michael P.; Mehr, Ramit			Kinetic Modeling Reveals a Common Death Niche for Newly Formed and Mature B Cells	PLOS ONE			English	Article							VITRO TOLERANCE INDUCTION; BONE-MARROW; LYMPHOCYTE DEVELOPMENT; CLONAL DELETION; SELF-TOLERANCE; MATURATION; SELECTION; DIFFERENTIATION; REPERTOIRE; ANTIBODY	Background: B lymphocytes are subject to elimination following strong BCR ligation in the absence of appropriate second signals, and this mechanism mediates substantial cell losses during late differentiation steps in the bone marrow and periphery. Mature B cells may also be eliminated through this mechanism as well as through normal turnover, but the population containing mature cells destined for elimination has not been identified. Herein, we asked whether the transitional 3 (T3) subset, which contains most newly formed cells undergoing anergic death, could also include mature B cells destined for elimination. Methodology/Principal Findings: To interrogate this hypothesis and its implications, we applied mathematical models to previously generated in vivo labeling data. Our analyses reveal that the death rate of T3 B cells is far higher than the death rates of all other splenic B cell subpopulations. Further, the model, in which the T3 pool includes both newly formed and mature primary B cells destined for apoptotic death, shows that this cell loss may account for nearly all mature B cell turnover. Conclusions/Significance: This finding has implications for the mechanism of normal mature B cell turnover.	[Shahaf, Gitit; Mehr, Ramit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Cancro, Michael P.] Univ Penn, Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA	Bar Ilan University; University of Pennsylvania	Shahaf, G (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	mehrra@mail.biu.ac.il		Cancro, Michael/0000-0002-8659-3227; Mehr, Ramit/0000-0002-4303-6834	Israel Science Foundation [759/01-1, 546]; Israel Cancer Research Fund; Human Frontiers Science Program; Swedish Foundation for Strategic Research; Mina and Everard Goodman Faculty of Life Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073939] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Human Frontiers Science Program(Human Frontier Science Program); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Mina and Everard Goodman Faculty of Life Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the following grants (to R. M.): Israel Science Foundation grants number 759/01-1 and 546; Israel Cancer Research Fund project grant; and indirectly by a Human Frontiers Science Program grant and a Swedish Foundation for Strategic Research grant funding the Strategic Research Center for studies on Integrative Recognition in the Immune System, Karolinska Institute, Stockholm, Sweden. G. S. was supported by a Dean's excellence PhD scholarship of The Mina and Everard Goodman Faculty of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 1997, EUR J IMMUNOL, V27, P1801, DOI 10.1002/eji.1830270731; Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; BASTEN A, 1991, IMMUNOL REV, V122, P5, DOI 10.1111/j.1600-065X.1991.tb00593.x; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Cancro MP, 2004, IMMUNOL REV, V197, P89, DOI 10.1111/j.0105-2896.2004.0099.x; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Gorfine M, 2003, B MATH BIOL, V65, P1131, DOI 10.1016/S0092-8240(03)00062-4; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Mehr R, 2003, INT IMMUNOL, V15, P301, DOI 10.1093/intimm/dxg025; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; METCALF ES, 1977, J IMMUNOL, V118, P2111; METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327; Monroe JG, 2003, IMMUNOL RES, V27, P427, DOI 10.1385/IR:27:2-3:427; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1975, J EXP MED, V141, P904; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; Osmond D G, 1990, Semin Immunol, V2, P173; OSMOND DG, 1976, NATURE, V260, P328, DOI 10.1038/260328a0; Rolink A, 1996, IMMUNOL LETT, V54, P157, DOI 10.1016/S0165-2478(96)02666-1; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Shahaf G, 2006, INT IMMUNOL, V18, P31, DOI 10.1093/intimm/dxh346; Shahaf G, 2004, INT IMMUNOL, V16, P1081, DOI 10.1093/intimm/dxh109; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038	33	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9497	10.1371/journal.pone.0009497	http://dx.doi.org/10.1371/journal.pone.0009497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209168	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300013
J	Cairns, M; Gosling, R; Carneiro, I; Gesase, S; Mosha, JF; Hashim, R; Kaur, H; Lemnge, M; Mosha, FW; Greenwood, B; Chandramohan, D				Cairns, Matthew; Gosling, Roly; Carneiro, Ilona; Gesase, Samwel; Mosha, Jacklin F.; Hashim, Ramadhan; Kaur, Harparkash; Lemnge, Martha; Mosha, Frank W.; Greenwood, Brian; Chandramohan, Daniel			Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ANTIMALARIAL-DRUG RESISTANCE; SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM; CHLORPROGUANIL-DAPSONE; THERAPEUTIC-EFFICACY; ROUTINE VACCINATIONS; DOUBLE-BLIND; IN-VIVO; TRANSMISSION	Background: Intermittent preventive treatment in infants (IPTi) is a new malaria control tool. However, it is uncertain whether IPTi works mainly through chemoprophylaxis or treatment of existing infections. Understanding the mechanism is essential for development of replacements for sulfadoxine-pyrimethamine (SP) where it is no longer effective. This study investigated how protection against malaria given by SP, chlorproguanil-dapsone (CD) and mefloquine (MQ), varied with time since administration of IPTi. Methods and Findings: A secondary analysis of data from a randomised, placebo-controlled trial in an area of high antifolate resistance in Tanzania was conducted. IPTi using SP, CD, MQ or placebo was given to 1280 infants at 2, 3 and 9 months of age. Poisson regression with random effects to adjust for potential clustering of malaria episodes within children was used to calculate incidence rate ratios for clinical malaria in defined time strata following IPTi. The short-acting antimalarial CD gave no protection against clinical malaria, whereas long-acting MQ gave two months of substantial protection (protective efficacy (PE) 73.1% (95% CI: 23.9, 90.5) and 73.3% (95% CI: 0, 92.9) in the first and second month respectively). SP gave some protection in the first month after treatment (PE 64.5% (95% CI: 10.6, 85.9)) although it did not reduce the incidence of malaria up to 12 months of age. There was no evidence of either long-term protection or increased risk of malaria for any of the regimens. Conclusion: Post-treatment chemoprophylaxis appears to be the main mechanism by which IPTi protects children against malaria. Long-acting antimalarials are therefore likely to be the most effective drugs for IPTi, but as monotherapies could be vulnerable to development of drug resistance. Due to concerns about tolerability, the mefloquine formulation used in this study is not suitable for IPTi. Further investigation of combinations of long-acting antimalarials for IPTi is needed.	[Cairns, Matthew] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Gosling, Roly; Carneiro, Ilona; Kaur, Harparkash; Greenwood, Brian; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Gesase, Samwel; Hashim, Ramadhan; Lemnge, Martha] Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania; [Mosha, Jacklin F.; Mosha, Frank W.] Kilimanjaro Christian Med Coll, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Cairns, M (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	matthew.cairns@lshtm.ac.uk		Mosha, Jacklin/0000-0001-7940-8903	IPTi Consortium; Bill and Melinda Gates Foundation; United Kingdom Medical Research Council (MRC)	IPTi Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Kilimanjaro IPTi Drug Options Trial was funded by the IPTi Consortium which is supported by the Bill and Melinda Gates Foundation. GSK provided the chlorproguanil-dapsone and Roche the sulfadoxine-pyrimethamine and mefloquine. MC is funded by the United Kingdom Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Aubouy A, 2007, TROP MED INT HEALTH, V12, P886, DOI 10.1111/j.1365-3156.2007.01859.x; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; *COMM PERSP ROL IN, 2008, ASS ROL INT PREV TRE; Dzinjalamala FK, 2005, ANTIMICROB AGENTS CH, V49, P3601, DOI 10.1128/AAC.49.9.3601-3606.2005; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hills, 1993, STAT MODELS EPIDEMIO; KARBWANG J, 1990, CLIN PHARMACOKINET, V19, P264, DOI 10.2165/00003088-199019040-00002; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; May J, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-198; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Simpson JA, 2006, BRIT J CLIN PHARMACO, V61, P289, DOI 10.1111/j.1365-2125.2005.02567.x; Smith T, 1999, T ROY SOC TROP MED H, V93, pS59; Stepniewska K, 2008, ANTIMICROB AGENTS CH, V52, P1589, DOI 10.1128/AAC.00903-07; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5	34	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9467	10.1371/journal.pone.0009467	http://dx.doi.org/10.1371/journal.pone.0009467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209126	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000274997100014
J	Peron, J; Le Jeune, F; Haegelen, C; Dondaine, T; Drapier, D; Sauleau, P; Reymann, JM; Drapier, S; Rouaud, T; Millet, B; Verin, M				Peron, Julie; Le Jeune, Florence; Haegelen, Claire; Dondaine, Thibaut; Drapier, Dominique; Sauleau, Paul; Reymann, Jean-Michel; Drapier, Sophie; Rouaud, Tiphaine; Millet, Bruno; Verin, Marc			Subthalamic Nucleus Stimulation Affects Theory of Mind Network: A PET Study in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VARIANT FRONTOTEMPORAL DEMENTIA; FRONTAL VARIANT; BASAL GANGLIA; FDG-PET; EXPRESSION RECOGNITION; EMOTION RECOGNITION; ALZHEIMERS-DISEASE; SOCIAL COGNITION; SCHIZOPHRENIA	Background: There appears to be an overlap between the limbic system, which is modulated by subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD), and the brain network that mediates theory of mind (ToM). Accordingly, the aim of the present study was to investigate the effects of STN DBS on ToM of PD patients and to correlate ToM modifications with changes in glucose metabolism. Methodology/Principal Findings: To this end, we conducted (18)FDG-PET scans in 13 PD patients in pre- and post-STN DBS conditions and correlated changes in their glucose metabolism with modified performances on the Eyes test, a visual ToM task requiring them to describe thoughts or feelings conveyed by photographs of the eye region. Postoperative PD performances on this emotion recognition task were significantly worse than either preoperative PD performances or those of healthy controls (HC), whereas there was no significant difference between preoperative PD and HC. Conversely, PD patients in the postoperative condition performed within the normal range on the gender attribution task included in the Eyes test. As far as the metabolic results are concerned, there were correlations between decreased cerebral glucose metabolism and impaired ToM in several cortical areas: the bilateral cingulate gyrus (BA 31), right middle frontal gyrus (BA 8, 9 and 10), left middle frontal gyrus (BA 6), temporal lobe (fusiform gyrus, BA 20), bilateral parietal lobe (right BA 3 and right and left BA 7) and bilateral occipital lobe (BA 19). There were also correlations between increased cerebral glucose metabolism and impaired ToM in the left superior temporal gyrus (BA 22), left inferior frontal gyrus (BA 13 and BA 47) and right inferior frontal gyrus (BA 47). All these structures overlap with the brain network that mediates ToM. Conclusion/Significance: These results seem to confirm that STN DBS hinders the ability to infer the mental states of others and modulates a distributed network known to subtend ToM.	[Peron, Julie; Dondaine, Thibaut; Drapier, Sophie; Rouaud, Tiphaine; Verin, Marc] CHU Rennes, Hop Pontchaillou, Neurol Clin, Rennes, France; [Peron, Julie; Le Jeune, Florence; Haegelen, Claire; Dondaine, Thibaut; Drapier, Dominique; Sauleau, Paul; Reymann, Jean-Michel; Drapier, Sophie; Rouaud, Tiphaine; Millet, Bruno; Verin, Marc] Univ Rennes 1, Hop Pontchaillou, CHU Rennes, Unite Rech Univ EM Behav & Basal Ganglia 425, Rennes, France; [Le Jeune, Florence] Ctr Anticanc Eugene Marquis Rennes, Nucl Med Serv, Rennes, France; [Haegelen, Claire] CHU Rennes, Hop Pontchaillou, Serv Neurochirurg, Rennes, France; [Dondaine, Thibaut; Drapier, Dominique; Millet, Bruno] Ctr Hosp Guillaume Regnier Rennes, Serv Hosp Univ Psychiat Adulte, Rennes, France; [Sauleau, Paul] CHU Rennes, Hop Pontchaillou, Serv Explorat Fonct, Rennes, France; [Reymann, Jean-Michel] CHU Rennes, Hop Pontchaillou, Ctr Invest Clin, Rennes, France	CHU Rennes; CHU Rennes; Universite de Rennes; UNICANCER; Centre Eugene Marquis; CHU Rennes; CHU Rennes; CHU Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Peron, J (corresponding author), CHU Rennes, Hop Pontchaillou, Neurol Clin, Rennes, France.	marc.verin@chu-rennes.fr	Verin, Marc/ABC-6924-2020; Haegelen, Claire CH/J-5332-2016; Sauleau, Paul/ABC-4459-2020; Péron, Julie/C-5658-2013; Le Jeune, Florence/ABC-6983-2020	Péron, Julie/0000-0002-6579-4011; Dondaine, Thibaut/0000-0002-8778-5079	Neurology Unit of Pontchaillou University Hospital in Rennes, France	Neurology Unit of Pontchaillou University Hospital in Rennes, France	This study was funded by the Neurology Unit of Pontchaillou University Hospital in Rennes, France (Prof. G. Edan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Benabid AL, 2000, NEUROLOGY, V55, pS40; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Biseul I, 2005, NEUROPSYCHOLOGIA, V43, P1054, DOI 10.1016/j.neuropsychologia.2004.10.006; Bora E, 2007, EUR ARCH PSY CLIN N, V257, P104, DOI 10.1007/s00406-006-0681-3; Bora E, 2006, PSYCHIAT RES, V145, P95, DOI 10.1016/j.psychres.2005.11.003; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; COHEN R, 2006, FRENCH ADAPATION 3 T; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Drapier D, 2008, NEUROPSYCHOLOGIA, V46, P2796, DOI 10.1016/j.neuropsychologia.2008.05.006; Dujardin K, 2004, J NEUROL NEUROSUR PS, V75, P202; Fahn S., 1987, RECENT DEV PARKINSON, P153; Farrant A, 2005, EPILEPSY BEHAV, V7, P506, DOI 10.1016/j.yebeh.2005.07.018; Finton MJ, 1998, J CLIN EXP NEUROPSYC, V20, P186, DOI 10.1076/jcen.20.2.186.1167; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geday J, 2006, NEUROIMAGE, V33, P706, DOI 10.1016/j.neuroimage.2006.06.056; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hilker R, 2004, J CEREBR BLOOD F MET, V24, P7, DOI 10.1097/01.WCB.0000092831.44769.09; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Howard K, 1992, PYRAMIDS PALM TREES; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Irani F, 2006, SCHIZOPHR RES, V88, P151, DOI 10.1016/j.schres.2006.07.016; Joel D, 1997, BRAIN RES REV, V23, P62, DOI 10.1016/S0165-0173(96)00018-5; Kalbe E, 2009, NEUROLOGY, V72, P42, DOI 10.1212/01.wnl.0000338536.31388.f0; Kelemen O, 2005, NEUROPSYCHOLOGY, V19, P494, DOI 10.1037/0894-4105.19.4.494; Kington JM, 2000, J PSYCHIAT RES, V34, P341, DOI 10.1016/S0022-3956(00)00029-7; Kleiner-Fisman G, 2004, MOVEMENT DISORD, V19, P1209, DOI 10.1002/mds.20151; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Le Jeune F, 2008, BRAIN, V131, P1599, DOI 10.1093/brain/awn084; Le Jeune F, 2009, NEUROLOGY, V73, P1746, DOI 10.1212/WNL.0b013e3181c34b34; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; LOZANO AM, 1995, LANCET, V346, P1383, DOI 10.1016/S0140-6736(95)92404-3; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; MANDAL MK, 1991, CORTEX, V27, P247, DOI 10.1016/S0010-9452(13)80129-3; Mattis S, 1988, DEMENTIA RATING SCAL; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Peron J, 2010, NEUROPSYCHOLOGIA, V48, P1053, DOI 10.1016/j.neuropsychologia.2009.12.003; Peron J, 2010, NEUROPSYCHOLOGY, V24, P1, DOI 10.1037/a0017433; Peron J, 2009, NEUROPSYCHOLOGIA, V47, P406, DOI 10.1016/j.neuropsychologia.2008.09.008; Pourfar M, 2009, J NEUROSURG, V110, P1278, DOI 10.3171/2008.12.JNS08991; PREMACK D, 1978, SCIENCE, V202, P532, DOI 10.1126/science.705342; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Schroeder U, 2004, J NEUROL NEUROSUR PS, V75, P648, DOI 10.1136/jnnp.2003.019794; Schroeder U, 2003, ANN NEUROL, V54, P445, DOI 10.1002/ana.10683; Schroeder U, 2002, BRAIN, V125, P1995, DOI 10.1093/brain/awf199; Schwab R.S., 1969, 3 S PARK DIS, P152; Spielberger C. D., 1993, MANUEL INVENTAIRE AN; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALAIRACH J, 1988, COPLANAR STERETOXIC; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Thobois S, 2007, J CEREBR BLOOD F MET, V27, P1173, DOI 10.1038/sj.jcbfm.9600425; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104	68	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9919	10.1371/journal.pone.0009919	http://dx.doi.org/10.1371/journal.pone.0009919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360963	Green Published, gold, Green Submitted			2022-12-27	WOS:000276163100012
J	Amitay, S; Halliday, L; Taylor, J; Sohoglu, E; Moore, DR				Amitay, Sygal; Halliday, Lorna; Taylor, Jenny; Sohoglu, Ediz; Moore, David R.			Motivation and Intelligence Drive Auditory Perceptual Learning	PLOS ONE			English	Article							VERNIER DISCRIMINATION TASK; FREQUENCY DISCRIMINATION; IDENTICAL STIMULI; FEEDBACK; ORIENTATION; IMPROVEMENT; PLASTICITY; CHILDREN; BRAIN; SPECIFICITY	Background: Although feedback on performance is generally thought to promote perceptual learning, the role and necessity of feedback remain unclear. We investigated the effect of providing varying amounts of positive feedback while listeners attempted to discriminate between three identical tones on learning frequency discrimination. Methodology/Principal Findings: Using this novel procedure, the feedback was meaningless and random in relation to the listeners' responses, but the amount of feedback provided (or lack thereof) affected learning. We found that a group of listeners who received positive feedback on 10% of the trials improved their performance on the task (learned), while other groups provided either with excess (90%) or with no feedback did not learn. Superimposed on these group data, however, individual listeners showed other systematic changes of performance. In particular, those with lower non-verbal IQ who trained in the no feedback condition performed more poorly after training. Conclusions/Significance: This pattern of results cannot be accounted for by learning models that ascribe an external teacher role to feedback. We suggest, instead, that feedback is used to monitor performance on the task in relation to its perceived difficulty, and that listeners who learn without the benefit of feedback are adept at self-monitoring of performance, a trait that also supports better performance on non-verbal IQ tests. These results show that ` perceptual' learning is strongly influenced by top-down processes of motivation and intelligence.	[Amitay, Sygal; Halliday, Lorna; Taylor, Jenny; Sohoglu, Ediz; Moore, David R.] Inst Hearing Res, MRC, Nottingham, England		Amitay, S (corresponding author), Inst Hearing Res, MRC, Nottingham, England.	sygal@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012; Sohoglu, Ediz/B-7682-2013	Amitay, Sygal/0000-0001-9482-3435; Halliday, Lorna/0000-0003-1883-7741; Sohoglu, Ediz/0000-0002-0755-6445	Medical Research Council (MRC), United Kingdom; MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_U135097130] Funding Source: researchfish	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council (MRC), United Kingdom. All authors were MRC employees at the time the research was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Calero MD, 2007, LEARN INDIVID DIFFER, V17, P328, DOI 10.1016/j.lindif.2007.03.012; CAMPBELL RA, 1963, J ACOUST SOC AM, V35, P1511, DOI 10.1121/1.1918738; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; DEARY IJ, 1994, INTELLIGENCE, V18, P189, DOI 10.1016/0160-2896(94)90027-2; DEARY IJ, 1995, DEV PSYCHOL, V31, P237, DOI 10.1037/0012-1649.31.2.237; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Ferdinand NK, 2008, J COGNITIVE NEUROSCI, V20, P629, DOI 10.1162/jocn.2008.20046; Green DM, 1966, SIGNAL DETECTION THE; Hebb Donald O., 1949, ORG BEHAV; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Herzog MH, 1998, BIOL CYBERN, V78, P107, DOI 10.1007/s004220050418; Herzog MH, 1999, VISION RES, V39, P4232, DOI 10.1016/S0042-6989(99)00138-8; Hinton G. E., 1999, UNSUPERVISED LEARNIN; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KNUDSEN EI, 1994, J NEUROSCI, V14, P3985; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUKASZEWSKI JS, 1962, J ACOUST SOC AM, V34, P223, DOI 10.1121/1.1909173; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; Micheyl C, 2009, ATTEN PERCEPT PSYCHO, V71, P5, DOI 10.3758/APP.71.1.5; Petrov AA, 2006, VISION RES, V46, P3177, DOI 10.1016/j.visres.2006.03.022; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Psychological Corp, 1999, WASI WECHSL ABBR SCA; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2006, J VISION, V6, P966, DOI 10.1167/6.9.9; Shibata K, 2009, VISION RES, V49, P2574, DOI 10.1016/j.visres.2009.06.009; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Swets JA, 1964, SIGNAL DETECTION REC; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; ZWISLOCKI J, 1958, J ACOUST SOC AM, V30, P254, DOI 10.1121/1.1909559	44	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9816	10.1371/journal.pone.0009816	http://dx.doi.org/10.1371/journal.pone.0009816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FS	20352121	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000275894400018
J	Voelckel, C; Borevitz, JO; Kramer, EM; Hodges, SA				Voelckel, Claudia; Borevitz, Justin O.; Kramer, Elena M.; Hodges, Scott A.			Within and between Whorls: Comparative Transcriptional Profiling of Aquilegia and Arabidopsis	PLOS ONE			English	Article							MADS-BOX GENES; HETEROTOPIC EXPRESSION; FLOWER DEVELOPMENT; ABC MODEL; EVOLUTION; DEFENSE; ANGIOSPERMS; RADIATION; SUPPORTS; ECOLOGY	Background: The genus Aquilegia is an emerging model system in plant evolutionary biology predominantly because of its wide variation in floral traits and associated floral ecology. The anatomy of the Aquilegia flower is also very distinct. There are two whorls of petaloid organs, the outer whorl of sepals and the second whorl of petals that form nectar spurs, as well as a recently evolved fifth whorl of staminodia inserted between stamens and carpels. Methodology/Principal Findings: We designed an oligonucleotide microarray based on EST sequences from a mixed tissue, normalized cDNA library of an A. formosa x A. pubescens F2 population representing 17,246 unigenes. We then used this array to analyze floral gene expression in late pre-anthesis stage floral organs from a natural A. formosa population. In particular, we tested for gene expression patterns specific to each floral whorl and to combinations of whorls that correspond to traditional and modified ABC model groupings. Similar analyses were performed on gene expression data of Arabidopsis thaliana whorls previously obtained using the Ath1 gene chips (data available through The Arabidopsis Information Resource). Conclusions/Significance: Our comparative gene expression analyses suggest that 1) petaloid sepals and petals of A. formosa share gene expression patterns more than either have organ-specific patterns, 2) petals of A. formosa and A. thaliana may be independently derived, 3) staminodia express B and C genes similar to stamens but the staminodium genetic program has also converged on aspects of the carpel program and 4) staminodia have unique up-regulation of regulatory genes and genes that have been implicated with defense against microbial infection and herbivory. Our study also highlights the value of comparative gene expression profiling and the Aquilegia microarray in particular for the study of floral evolution and ecology.	[Voelckel, Claudia] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand; [Borevitz, Justin O.] Univ Chicago, Chicago, IL 60637 USA; [Kramer, Elena M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hodges, Scott A.] Univ Calif Santa Barbara, Dept Ecol & Evolut, Santa Barbara, CA 93106 USA	Massey University; University of Chicago; Harvard University; University of California System; University of California Santa Barbara	Voelckel, C (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	c.voelckel@massey.ac.nz	Borevitz, Justin/B-5423-2012; Voelckel, Claudia/F-2693-2011	Borevitz, Justin/0000-0001-8408-3699; Hodges, Scott/0000-0002-0401-6072	National Science Foundation [0412727]; Alexander von Humboldt Foundation	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was funded under a National Science Foundation grant to SA Hodges (http://www.nsf.gov/awardsearch/showAward. do? Award Number = 0412727). C Voelckel acknowledges funding from the Alexander von Humboldt Foundation through a Feodor Lynen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XZ, 2004, PLANT CELL, V16, P1478, DOI 10.1105/tpc.021147; Baum DA, 1998, CURR OPIN PLANT BIOL, V1, P79, DOI 10.1016/S1369-5266(98)80132-5; Bhuiyan NH, 2009, J EXP BOT, V60, P509, DOI 10.1093/jxb/ern290; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bowman JL, 1997, J BIOSCIENCE, V22, P515, DOI 10.1007/BF02703197; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Chanderbali AS, 2009, P NATL ACAD SCI USA, V106, P8929, DOI 10.1073/pnas.0811476106; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cooper EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008655; De Craene LPR, 2007, ANN BOT-LONDON, V100, P621, DOI 10.1093/aob/mcm076; Erbar C, 1999, FLORA, V194, P317; Gould B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-6; Hodges SA, 2009, P NATL ACAD SCI USA, V106, P9947, DOI 10.1073/pnas.0901594106; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; Kalivas A, 2007, DNA SEQUENCE, V18, P120, DOI 10.1080/10425170601060582; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kramer EM, 2007, PLANT CELL, V19, P750, DOI 10.1105/tpc.107.050385; Kramer EM, 2010, PHILOS T R SOC B, V365, P477, DOI 10.1098/rstb.2009.0230; Kramer EM, 2009, ANNU REV PLANT BIOL, V60, P261, DOI 10.1146/annurev.arplant.043008.092051; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kramer EM, 2005, J EXP ZOOL PART B, V304B, P526, DOI 10.1002/jez.b.21046; Laitinen RAE, 2005, GENOME RES, V15, P475, DOI 10.1101/gr.3043705; Laitinen RAE, 2007, PLANTA, V226, P347, DOI 10.1007/s00425-007-0486-2; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Peiffer JA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-43; Ralph SG, 2006, PLANT CELL ENVIRON, V29, P1545, DOI 10.1111/j.1365-3040.2006.01532.x; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Soltis DE, 2007, ANN BOT-LONDON, V100, P155, DOI 10.1093/aob/mcm117; TAKHTAJAN, 1991, EVOLUTIONARY TRENDS; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Tucker SC, 2005, INT J PLANT SCI, V166, P557, DOI 10.1086/429848; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang W, 2007, TAXON, V56, P811, DOI 10.2307/25065864; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Whittall JB, 2006, MOL ECOL, V15, P4645, DOI 10.1111/j.1365-294X.2006.03114.x; Yu LF, 2009, PLANTA, V229, P693, DOI 10.1007/s00425-008-0867-1; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032	49	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9735	10.1371/journal.pone.0009735	http://dx.doi.org/10.1371/journal.pone.0009735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352114	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400008
J	Seidel, A; Ye, Y; de Armas, LR; Soto, M; Yarosh, W; Marcsisin, RA; Tran, D; Selsted, ME; Camerini, D				Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Tran, Dat; Selsted, Michael E.; Camerini, David			Cyclic and Acyclic Defensins Inhibit Human Immunodeficiency Virus Type-1 Replication by Different Mechanisms	PLOS ONE			English	Article							ALPHA-DEFENSINS; THETA-DEFENSINS; HIV-1 INFECTION; ANTIMICROBIAL PEPTIDES; CELLS; BETA-DEFENSIN-2; RETROCYCLIN; EXPRESSION; BINDING; FUSION	Defensins are antimicrobial peptides expressed by plants and animals. In mammals there are three subfamilies of defensins, distinguished by structural features: alpha, beta and theta. Alpha and beta-defensins are linear peptides with broad anti-microbial activity that are expressed by many mammals including humans. In contrast, theta-defensins are cyclic anti-microbial peptides made by several non-human primates but not humans. All three defensin types have anti-HIV-1 activity, but their mechanisms of action differ. We studied the anti-HIV-1 activity of one defensin from each group, HNP-1 (alpha), HBD-2 (beta) and RTD-1 (theta). We examined how each defensin affected HIV-1 infection and demonstrated that the cyclic defensin RTD-1 inhibited HIV-1 entry, while acyclic HNP-1 and HBD-2 inhibited HIV-1 replication even when added 12 hours post-infection and blocked viral replication after HIV-1 cDNA formation. We further found that all three defensins downmodulated CXCR4. Moreover, RTD-1 inactivated X4 HIV-1, while HNP-1 and HBD-2 inactivated both X4 and R5 HIV-1. The data presented here show that acyclic and cyclic defensins block HIV-1 replication by shared and diverse mechanisms. Moreover, we found that HNP-1 and RTD-1 directly inhibited firefly luciferase enzymatic activity, which may affect the interpretation of previously published data.	[Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Camerini, David] Univ Calif Irvine, Dept Mol Biol & Biochem, Sch Biol Sci, Irvine, CA 92717 USA; [Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Camerini, David] Univ Calif Irvine, Ctr Virus Res, Irvine, CA USA; [Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Tran, Dat; Selsted, Michael E.; Camerini, David] Univ Calif Irvine, Ctr Immunol, Irvine, CA USA; [Tran, Dat; Selsted, Michael E.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Seidel, A (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Sch Biol Sci, Irvine, CA 92717 USA.	david.camerini@uci.edu			National Institutes of Health (NIH) [AI 60438, AI 22931, DE 15517]; George and Dottie Hewitt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022931, R37AI022931, R21AI060438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015517] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Dottie Hewitt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH) grants AI 60438 awarded to DC and AI 22931 and DE 15517 awarded to MES. DT was supported by a George and Dottie Hewitt Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp S, 2005, EUR J MED RES, V10, P1; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Ayabe T, 2004, TRENDS MICROBIOL, V12, P394, DOI 10.1016/j.tim.2004.06.007; Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb; Camerini D, 2000, J VIROL, V74, P3196, DOI 10.1128/JVI.74.7.3196-3204.2000; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Jia HP, 2001, GENE, V263, P211; Jia HP, 2001, J PEDIATR-US, V138, P109, DOI 10.1067/mpd.2001.109375; Jotwani R, 2004, J DENT RES, V83, P371, DOI 10.1177/154405910408300504; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Owen SM, 2004, J PEPT RES, V63, P469, DOI 10.1111/j.1399-3011.2004.00155.x; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Sawaki K, 2002, ANTICANCER RES, V22, P2103; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J BIOL CHEM, V260, P4579; SHIOMI K, 1993, BIOCHEM BIOPH RES CO, V195, P1336, DOI 10.1006/bbrc.1993.2190; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Trabattoni D, 2004, JAIDS-J ACQ IMM DEF, V35, P455, DOI 10.1097/00126334-200404150-00003; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tunzi CR, 2000, PEDIATR RES, V48, P30, DOI 10.1203/00006450-200007000-00008; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Yang BL, 2005, T NONFERR METAL SOC, V15, P1; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Zaharatos GJ, 2004, JAIDS-J ACQ IMM DEF, V36, P993, DOI 10.1097/00126334-200408150-00001; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185; Zhang LQ, 2004, SCIENCE, V303, P467	49	50	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9737	10.1371/journal.pone.0009737	http://dx.doi.org/10.1371/journal.pone.0009737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305815	gold, Green Published			2022-12-27	WOS:000275809600009
J	Potdar, VA; Chadha, MS; Jadhav, SM; Mullick, J; Cherian, SS; Mishra, AC				Potdar, Varsha A.; Chadha, Mandeep S.; Jadhav, Santosh M.; Mullick, Jayati; Cherian, Sarah S.; Mishra, Akhilesh C.			Genetic Characterization of the Influenza A Pandemic (H1N1) 2009 Virus Isolates from India	PLOS ONE			English	Article							MAMMALIAN-CELLS; HEMAGGLUTININ; EMERGENCE; OUTBREAK; POULTRY	Background: The Influenza A pandemic H1N1 2009 (H1N1pdm) virus appeared in India in May 2009 and thereafter outbreaks with considerable morbidity and mortality have been reported from many parts of the country. Continuous monitoring of the genetic makeup of the virus is essential to understand its evolution within the country in relation to global diversification and to track the mutations that may affect the behavior of the virus. Methods: H1N1pdm viruses were isolated from both recovered and fatal cases representing major cities and sequenced. Phylogenetic analyses of six concatenated whole genomes and the hemagglutinin (HA) gene of seven more isolates from May-September 2009 was performed with reference to 685 whole genomes of global isolates available as of November 24, 2009. Molecular characterization of all the 8 segments was carried out for known pathogenic markers. Results: The first isolate of May 2009 belonged to clade 5. Although clade 7 was the dominant H1N1pdm lineage in India, both clades 6 and 7 were found to be co-circulating. The neuraminidase of all the Indian isolates possessed H275, the marker for sensitivity to the neuraminidase inhibitor Oseltamivir. Some of the mutations in HA are at or in the vicinity of antigenic sites and may therefore be of possible antigenic significance. Among these a D222G mutation in the HA receptor binding domain was found in two of the eight Indian isolates obtained from fatal cases. Conclusions: The majority of the 13 Indian isolates grouped in the globally most widely circulating H1N1pdm clade 7. Further, correlations of the mutations specific to clade 7 Indian isolates to viral fitness and adaptability in the country remains to be understood. The D222G mutation in HA from isolates of fatal cases needs to be studied for pathogenicity.	[Potdar, Varsha A.; Chadha, Mandeep S.; Jadhav, Santosh M.; Mullick, Jayati; Cherian, Sarah S.; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Potdar, VA (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	acm1750@rediffmail.com	Jadhav, Santoshkumar/AAB-7634-2021; Potdar, Varsha/ABA-3799-2021; Cherian, /411001/H-1332-2016; Cherian, Sarah/ABA-6207-2021	Potdar, Varsha/0000-0002-7535-7878; 	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gupta R., 2017, DTU HLTH TECH; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; KIBOURNE ED, 2006, EMERG INFECT DIS, V12, P9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mishra AC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-26; NELSON M, 2009, EARLY DIVERSIFICATIO; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; *WHO, PAND H1N1 2009 24 AP; World Health Organization, 2009, CDC PROT REAL TIM RT; World Health Organization, PAND H1N1 2009 UPD 7; [No title captured]	30	95	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9693	10.1371/journal.pone.0009693	http://dx.doi.org/10.1371/journal.pone.0009693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300625	Green Submitted, Green Published, gold			2022-12-27	WOS:000275621000011
J	Chandrasekar, G; Archer, A; Gustafsson, JA; Lendahl, MA				Chandrasekar, Gayathri; Archer, Amena; Gustafsson, Jan-Ake; Lendahl, Monika Andersson			Levels of 17 beta-Estradiol Receptors Expressed in Embryonic and Adult Zebrafish Following In Vivo Treatment of Natural or Synthetic Ligands	PLOS ONE			English	Article							HUMAN ESTROGEN-RECEPTOR; TROUT ONCORHYNCHUS-MYKISS; DANIO-RERIO; GENES; 4-NONYLPHENOL; NONYLPHENOL; BINDING; BRAIN; CHEMICALS; ALPHA	The nuclear receptors encompass a group of regulatory proteins involved in a number of physiological processes. The estrogen receptors (ERs), of which one alpha and one beta form exist in mammals function as transcription factors in response to 17 beta-estradiol (E2). In zebrafish there are three gene products of estrogen receptors and they are denoted esr1 (ERalpha), esr2a (ERbeta2) and esr2b (ERbeta1). Total RNA of zebrafish early life stages (<3, 6, 12, 24, 48, 72, 96 and 120 hours post fertilization) and of adult fish (liver, intestine, eye, heart, brain, ovary, testis, gill, swim bladder and kidney) were isolated following in vivo exposures. Using specific primers for each of the three zebrafish ERs the expression levels were quantified using real time PCR methodology. It was shown that in absence of exposure all three estrogen receptors were expressed in adult fish. The levels of expression of two of these three ER genes, the esr1 and esr2a were altered in organs such as liver, intestine, brain and testis in response to ligand (E2, diethylstilbestrol or 4-nonylphenol). During embryogenesis two of the three receptor genes, esr1 and esr2b were expressed, and in presence of ligand the mRNA levels of these two genes increased. The conclusions are i) estrogen receptor genes are expressed during early development ii) altered expression of esr genes in response to ligand is dependent on the cellular context; iii) the estrogenic ligand 4-nonylphenol, a manufactured compound commonly found in sewage of water treatment plants, acts as an agonist of the estrogen receptor during development and has both agonist and antagonist properties in tissues of adult fish. This knowledge of esr gene function in development and in adult life will help to understand mechanisms of interfering mimicking endocrine chemicals in vivo.	[Chandrasekar, Gayathri; Archer, Amena; Gustafsson, Jan-Ake; Lendahl, Monika Andersson] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet	Chandrasekar, G (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	Monika.Andersson.Lendahl@ki.se	Andersson Lendahl, Monika/ABE-5981-2021	Archer, Amena/0000-0002-0400-4151; Andersson Lendahl, Monika/0000-0002-5690-8515	Karolinska Institutet; Center of Biosciences; Swedish Society of Medicine	Karolinska Institutet(Karolinska Institutet); Center of Biosciences; Swedish Society of Medicine	This project is supported by funds at Karolinska Institutet, Center of Biosciences and by The Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademollo N, 2008, ENVIRON INT, V34, P984, DOI 10.1016/j.envint.2008.03.001; AMORES A, 1998, DEV DYNAMICS SCI, P1711; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Chiang EFL, 2001, MOL BIOL EVOL, V18, P542, DOI 10.1093/oxfordjournals.molbev.a003833; Costache AD, 2005, MOL ENDOCRINOL, V19, P2979, DOI 10.1210/me.2004-0435; Cristofaro PA, 2006, CRIT CARE MED, V34, P2188, DOI 10.1097/01.CCM.0000227173.13497.56; Del Giacco L, 2000, DEV GENES EVOL, V210, P41, DOI 10.1007/PL00008187; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; GIGER W, 1984, SCIENCE, V225, P623, DOI 10.1126/science.6740328; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI [10.1897/1551-5028(1997)016&lt;0534:EAIFUK&gt;2.3.CO;2, 10.1002/etc.5620160320]; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ishibashi H, 2006, CHEMOSPHERE, V65, P1019, DOI 10.1016/j.chemosphere.2006.03.034; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kinnberg K, 2000, MAR ENVIRON RES, V50, P169, DOI 10.1016/S0141-1136(00)00078-7; KORACH KS, 1987, J STEROID BIOCHEM, V27, P281, DOI 10.1016/0022-4731(87)90319-0; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lahnsteiner F, 2005, AQUAT TOXICOL, V71, P297, DOI 10.1016/j.aquatox.2004.11.007; Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liedtke A, 2008, ENVIRON TOXICOL, V23, P59, DOI 10.1002/tox.20305; Liu RZ, 2005, FEBS J, V272, P3561, DOI 10.1111/j.1742-4658.2005.04775.x; Liu RZ, 2004, GENE EXPR PATTERNS, V4, P379, DOI 10.1016/j.modgep.2004.01.010; Luo Q, 2005, COMP BIOCHEM PHYS C, V140, P123, DOI 10.1016/j.cca.2005.01.008; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Meucci V, 2006, AQUAT TOXICOL, V77, P167, DOI 10.1016/j.aquatox.2005.11.008; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069; Muncke J, 2007, ENVIRON TOXICOL, V22, P185, DOI 10.1002/tox.20255; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Sabo-Attwood T, 2007, J MOL ENDOCRINOL, V39, P223, DOI 10.1677/JME-07-0038; Sawyer SJ, 2006, GEN COMP ENDOCR, V147, P108, DOI 10.1016/j.ygcen.2005.12.010; Seo JS, 2006, BIOCHEM BIOPH RES CO, V346, P213, DOI 10.1016/j.bbrc.2006.05.123; Shelby MD, 1996, ENVIRON HEALTH PERSP, V104, P1296, DOI 10.2307/3432965; Shrader EA, 2003, ECOTOXICOLOGY, V12, P485, DOI 10.1023/B:ECTX.0000003034.69538.eb; Sumpter JP, 2008, WATER SCI TECHNOL, V57, P125, DOI 10.2166/wst.2008.796; Tingaud-Sequeira A, 2004, GENE EXPR PATTERNS, V4, P561, DOI 10.1016/j.modgep.2004.02.002; Ton C, 2006, BIRTH DEFECTS RES A, V76, P553, DOI 10.1002/bdra.20281; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Xia YY, 2008, BIOMED ENVIRON SCI, V21, P1, DOI 10.1016/S0895-3988(08)60001-X; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	54	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9678	10.1371/journal.pone.0009678	http://dx.doi.org/10.1371/journal.pone.0009678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300630	Green Submitted, Green Published, gold			2022-12-27	WOS:000275620900012
J	Ferrer-i-Cancho, R; Elvevag, B				Ferrer-i-Cancho, Ramon; Elvevag, Brita			Random Texts Do Not Exhibit the Real Zipf's Law-Like Rank Distribution	PLOS ONE			English	Article							POWER LAWS	Background: Zipf's law states that the relationship between the frequency of a word in a text and its rank ( the most frequent word has rank 1, the 2nd most frequent word has rank 2,...) is approximately linear when plotted on a double logarithmic scale. It has been argued that the law is not a relevant or useful property of language because simple random texts-constructed by concatenating random characters including blanks behaving as word delimiters-exhibit a Zipf's law-like word rank distribution. Methodology/Principal Findings: In this article, we examine the flaws of such putative good fits of random texts. We demonstrate-by means of three different statistical tests-that ranks derived from random texts and ranks derived from real texts are statistically inconsistent with the parameters employed to argue for such a good fit, even when the parameters are inferred from the target real text. Our findings are valid for both the simplest random texts composed of equally likely characters as well as more elaborate and realistic versions where character probabilities are borrowed from a real text. Conclusions/Significance: The good fit of random texts to real Zipf's law-like rank distributions has not yet been established. Therefore, we suggest that Zipf's law might in fact be a fundamental law in natural languages.	[Ferrer-i-Cancho, Ramon] Univ Politecn Cataluna, Dept Llenguatges & Sistemes Informat, Barcelona, Catalonia, Spain; [Elvevag, Brita] NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20892 USA	Universitat Politecnica de Catalunya; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ferrer-i-Cancho, R (corresponding author), Univ Politecn Cataluna, Dept Llenguatges & Sistemes Informat, Barcelona, Catalonia, Spain.	rferrericancho@lsi.upc.edu	Ferrer-i-Cancho, Ramon/A-5424-2011; Elvevåg, Brita/ABC-1835-2021	Ferrer-i-Cancho, Ramon/0000-0002-7820-923X; Elvevåg, Brita/0000-0003-0441-3729	Spanish Ministry of Science [TIN2008-06582-C03-01]; National Institute of Mental Health Intramural Research Program (NIMH-IRP); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002711] Funding Source: NIH RePORTER	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Mental Health Intramural Research Program (NIMH-IRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by the project Secuencias Simbolicas: Analisis, Aprendizaje, Mineria y Evolucion, Barcelona (SESAAME-BAR) (TIN2008-06582-C03-01) of the Spanish Ministry of Science and Innovation, http://web.micinn.es/ (RFC); and the National Institute of Mental Health Intramural Research Program (NIMH-IRP), http://intramural.nimh.nih.gov/ (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancho RFI, 2005, EUR PHYS J B, V47, P449, DOI 10.1140/epjb/e2005-00340-y; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen A, 1997, FRACTALS, V5, P95, DOI 10.1142/S0218348X97000103; Conrad B, 2004, IEEE T INFORM THEORY, V50, P1403, DOI 10.1109/TIT.2004.830752; Cormen T.H., 1990, INTRO ALGORITHMS 2 V; DAGPUNAR J, 1988, PRINCIPLES RANDOM VA; DeGroot M. H., 1989, PROBABILITY STAT; Devroye L., 1986, NONUNIFORM RANDOM VA; Ferrer-I-Cancho R, 2009, J AM SOC INF SCI TEC, V60, P837, DOI 10.1002/asi.21033; Herdan G., 1964, QUANTITATIVE LINGUIS; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Mandelbrot B., 1966, READINGS MATH SOCIAL, P151; Manin D, 2008, COGNITIVE SCI, V32, P1075, DOI 10.1080/03640210802020003; Manning C.D., 1999, FDN STAT NATURAL LAN; MILLER GA, 1957, AM J PSYCHOL, V70, P311, DOI 10.2307/1419346; Miller George A., 1963, HDB MATH PSYCHOL, P419; MITZENMACHER M, 2002, INTERNET MATH, V0001, P00226, DOI DOI 10.1080/15427951.2004.10129088; Naranan S., 1996, J QUANT LINGUIST, V3, P177, DOI DOI 10.1080/09296179608599629; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nicolis J. S., 1991, CHAOS INFORM PROCESS; RAPOPORT A, 1982, STUD ZIPFS LAW, V1, P1; Wolfram S., 2002, NEW KIND SCI; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293; Zipf G. K., 1972, HUMAN BEHAV PRINCIPL; ZIPF GK, 1935, PSYCHOBIOL LANGUAGE; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	34	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9411	10.1371/journal.pone.0009411	http://dx.doi.org/10.1371/journal.pone.0009411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231884	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300004
J	Pan, CE; Cheung, B; Tan, SY; Li, CL; Li, L; Liu, SW; Jiang, SB				Pan, Chungen; Cheung, Byron; Tan, Suiyi; Li, Chunling; Li, Lin; Liu, Shuwen; Jiang, Shibo			Genomic Signature and Mutation Trend Analysis of Pandemic (H1N1) 2009 Influenza A Virus	PLOS ONE			English	Article							NS1 PROTEIN; ORIGIN; OSELTAMIVIR; HOST; INTERFERON; ACTIVATION; RESPONSES; MUTANTS	A novel swine-origin pandemic influenza A(H1N1) virus (H1N1pdm, also referred to as S-OIV) was identified as the causative agent of the 21(st) century's first influenza pandemic, but molecular features conferring its ability of human-to-human transmission has not been identified. Here we compared the protein sequences of 2009 H1N1pdm strains with those causing other pandemics and the viruses isolated from humans, swines and avians, and then analyzed the mutation trend of the residues at the signature and non-signature positions, which are species-and non-species-associated, respectively, in the proteins of H1N1pdm during the pandemic of 2009. We confirmed that the host-specific genomic signatures of 2009 H1N1pdm, which are mainly swine-like, were highly identical to those of the 1918 H1N1pdm. During the short period of time when the pandemic alert level was raised from phase 4 to phase 6, one signature residue at the position of NP-100 mutated from valine to isoleucine. Four non-signature residues, at positions NA-91, NA-233, HA-206, and NS1-123, also changed during the epidemic in 2009. All these mutant residues, except that at NA-91, are located in the viral functional domains, suggesting that they may play roles in the human adaption and virulence of 2009 H1N1pdm.	[Pan, Chungen; Cheung, Byron; Tan, Suiyi; Li, Lin; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Pan, Chungen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Tan, Suiyi; Li, Lin; Liu, Shuwen; Jiang, Shibo] So Med Univ, Guangzhou, Guangdong, Peoples R China; [Li, Chunling] Guangdong Acad Agr Sci, Inst Vet Med, Guangzhou, Guangdong, Peoples R China	New York Blood Center; Peking University; Southern Medical University - China; Guangdong Academy of Agricultural Sciences	Pan, CE (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	sjiang@nybloodcenter.org	Jiang, Shibo/L-4500-2014; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022	Jiang, Shibo/0000-0001-8283-7135; Liu, Shuwen/0000-0001-6346-5006; Pan, Chungen/0000-0003-0359-533X	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Chungen Pan is partly supported by a scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; *CDC, 2009, MMWR-MORBID MORTAL W, V58, P402; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; CHEN GW, 2009, VIRUS EMERG INFECT D, V15, P1897; Chen HL, 2009, EMERG INFECT DIS, V15, P1970, DOI 10.3201/eid1512.091057; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; DeLano W.L., PYMOL MOL GRAPHICS S; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Pan CE, 2009, BIOCHEM BIOPH RES CO, V385, P402, DOI 10.1016/j.bbrc.2009.05.064; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Vana G, 2008, MOL PHYLOGENET EVOL, V47, P1100, DOI 10.1016/j.ympev.2008.02.003; VON IM, 1993, NATURE, V363, P418; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	29	77	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A31	A37	e9549	10.1371/journal.pone.0009549	http://dx.doi.org/10.1371/journal.pone.0009549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221396	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328200003
J	Soulsbury, CD				Soulsbury, Carl D.			Genetic Patterns of Paternity and Testes Size in Mammals	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; SPERM COMPETITION; MULTIPLE PATERNITY; OVULATION MODE; EVOLUTION; BIRDS; QUALITY; POPULATIONS; SELECTION; QUANTITY	Background: Testes size is used as a proxy of male intrasexual competition, with larger testes indicative of greater competition. It has been shown that in some taxa, social mating systems reflect variance in testes size, but results are not consistent, and instead it has been suggested that genetic patterns of mating may reflect testes size. However, there are different measures of genetic patterns of mating. Multiple paternity rates are the most widely used measure but are limited to species that produce multi-offspring litters, so, at least for group living species, other measures such as loss of paternity to males outside the social group (extra group paternity) or the proportion of offspring sired by the dominant male (alpha paternity) might be appropriate. This study examines the relationship between testes size and three genetic patterns of mating: multiple paternity, extragroup paternity and alpha paternity. Methodology/Principal Findings: Using data from mammals, phylogenetically corrected general linear models demonstrate that both multiple paternity and alpha paternity, but not extra group paternity, relate to testes size. Testes size is greater in species with high multiple paternity rates, whereas the converse is found for alpha paternity. Additionally, length of mating season, ovulation mode and litter size significantly influenced testes size in one model. Conclusions/Significance: These results demonstrate that patterns of mating (multiple paternity and alpha paternity rates) determined by genetic analysis can provide reliable indicators of male postcopulatory intrasexual competition (testes size), and that other variables (length of mating season, ovulation mode, litter size) may also be important.	Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Soulsbury, CD (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	carl.soulsbury@bristol.ac.uk	Soulsbury, Carl D./F-3137-2010; Soulsbury, Carl/P-1492-2019	Soulsbury, Carl D./0000-0001-8808-5210; Soulsbury, Carl/0000-0001-8808-5210				Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead T. R., 1996, PARTNERSHIPS BIRDS S, P323; BIRKHEAD TR, 1987, BEHAVIOUR, V101, P101, DOI 10.1163/156853987X00396; BIRKHEAD TR, 1999, MALE FERTILITY INFER, P18; Bryja J, 2008, BEHAV ECOL SOCIOBIOL, V63, P251, DOI 10.1007/s00265-008-0656-7; Calhim S, 2007, BEHAV ECOL, V18, P271, DOI 10.1093/beheco/arl076; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Cohas A, 2009, BIOL LETTERS, V5, P313, DOI 10.1098/rsbl.2008.0760; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daly-Engel TS, 2006, ENVIRON BIOL FISH, V76, P419, DOI 10.1007/s10641-006-9008-5; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; Eccard JA, 2009, ANIM BEHAV, V78, P563, DOI 10.1016/j.anbehav.2009.04.008; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; GULLBERG A, 1992, HEREDITAS, V117, P103, DOI 10.1111/j.1601-5223.1992.tb00164.x; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HESKE EJ, 1990, J MAMMAL, V71, P510, DOI 10.2307/1381789; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; Iossa G, 2008, FUNCT ECOL, V22, P655, DOI 10.1111/j.1365-2435.2008.01409.x; Iossa G, 2009, BEHAV ECOL, V20, P385, DOI 10.1093/beheco/arn149; Isvaran K, 2007, P ROY SOC B-BIOL SCI, V274, P219, DOI 10.1098/rspb.2006.3723; Kappeler PM, 1997, BEHAV ECOL, V8, P10, DOI 10.1093/beheco/8.1.10; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Lack D., 1968, pvii; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Myers EM, 2004, MOL ECOL, V13, P1951, DOI 10.1111/j.1365-294X.2004.02208.x; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Parker GA, 2005, BIOL LETTERS, V1, P235, DOI 10.1098/rsbl.2004.0273; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARKER GA, 1998, SPERM COMPETITION SE, P1; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; RIBBLE DO, 1992, FUNCT ECOL, V6, P455, DOI 10.2307/2389283; SAY L, 2006, BIOL LETT, V43, P41; Schulke O, 2004, BEHAV ECOL SOCIOBIOL, V55, P293, DOI 10.1007/s00265-003-0709-x; Simmons L. W., 2001, MG BEH ECOL; Soulsbury CD, 2010, EVOL ECOL, V24, P879, DOI 10.1007/s10682-009-9344-y; Soulsbury CD, 2010, BIOL LETTERS, V6, P39, DOI 10.1098/rsbl.2009.0703; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wink Michael, 1999, Acta Ornithologica (Warsaw), V34, P91; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Zuur Alain F., 2009, P1	59	101	102	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A152	A157	e9581	10.1371/journal.pone.0009581	http://dx.doi.org/10.1371/journal.pone.0009581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221392	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000275328200014
J	Yang, L; Chen, J; Shi, LM; Hudock, MP; Wang, KJ; He, L				Yang, Lun; Chen, Jian; Shi, Leming; Hudock, Michael P.; Wang, Kejian; He, Lin			Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HUMAN ACETYLCHOLINESTERASE; DOCKING; LIGAND; IDENTIFICATION; SYSTEM; VISUALIZATION; PHARMACOLOGY; STRATEGIES; RESIDUES	Drug medications inevitably affect not only their intended protein targets but also other proteins as well. In this study we examined the hypothesis that drugs that share the same therapeutic effect also share a common therapeutic mechanism by targeting not only known drug targets, but also by interacting unexpectedly on the same cryptic targets. By constructing and mining an Alzheimer's disease (AD) drug-oriented chemical-protein interactome (CPI) using a matrix of 10 drug molecules known to treat AD towards 401 human protein pockets, we found that such cryptic targets exist. We recovered from CPI the only validated therapeutic target of AD, acetylcholinesterase (ACHE), and highlighted several other putative targets. For example, we discovered that estrogen receptor (ER) and histone deacetylase (HDAC), which have recently been identified as two new therapeutic targets of AD, might already have been targeted by the marketed AD drugs. We further established that the CPI profile of a drug can reflect its interacting character towards multi-protein sets, and that drugs with the same therapeutic attribute will share a similar interacting profile. These findings indicate that the CPI could represent the landscape of chemical-protein interactions and uncover "behind-the-scenes" aspects of the therapeutic mechanisms of existing drugs, providing testable hypotheses of the key nodes for network pharmacology or brand new drug targets for one-target pharmacology paradigm.	[Yang, Lun; Chen, Jian; Hudock, Michael P.; Wang, Kejian; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio Ctr X, Shanghai 200030, Peoples R China; [Yang, Lun; Chen, Jian; He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University; US Food & Drug Administration (FDA); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, L (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio Ctr X, Shanghai 200030, Peoples R China.	lunyang@gmail.com; helinhelin@gmail.com	Yang, Lun/B-4859-2012; Shi, Leming/B-3150-2010	Shi, Leming/0000-0002-7143-2033	National Natural Science Foundation of China [30900841]; Postdoctoral Science Foundation of China [200902243]; China Postdoctoral Science Foundation [20070420660]; Shanghai Postdoctoral Science Foundation [61444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China [ 30900841], Special Reward Funding from Postdoctoral Science Foundation of China (200902243), China Postdoctoral Science Foundation (20070420660) and Shanghai Postdoctoral Science Foundation (No. 61444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carageorgiou H, 2005, BASIC CLIN PHARMACOL, V97, P320, DOI 10.1111/j.1742-7843.2005.pto_174.x; Carswell HVO, 2004, AM J PHYSIOL-HEART C, V287, pH1501, DOI 10.1152/ajpheart.00227.2004; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fang H, 2008, CURR DRUG METAB, V9, P1038, DOI 10.2174/138920008786927802; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji ZL, 2003, DRUG SAFETY, V26, P685, DOI 10.2165/00002018-200326100-00002; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li CY, 2007, CELL RES, V17, P357, DOI 10.1038/cr.2007.27; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nacasch N, 1998, CLIN NEUROPHARMACOL, V21, P132; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich RL, 2001, ANAL BIOCHEM, V296, P197, DOI 10.1006/abio.2001.5314; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schatz RA, 2003, ANN PHARMACOTHER, V37, P1321, DOI 10.1345/aph.1D050; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vigers GPA, 2004, J MED CHEM, V47, P80, DOI 10.1021/jm030161o; von Rechenberg M, 2005, PROTEOMICS, V5, P1764, DOI 10.1002/pmic.200301088; VURAL H, 2008, BIOL TRACE ELEM RES; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; YANG L, 2009, PLOS COMPUT IN PRESS; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312; Zhang JX, 2007, BIOINFORMATICS, V23, P1710, DOI 10.1093/bioinformatics/btm139	48	40	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A71	A81	e9568	10.1371/journal.pone.0009568	http://dx.doi.org/10.1371/journal.pone.0009568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221449	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328200007
J	Miller, BG; Stamatoyannopoulos, JA				Miller, Brady G.; Stamatoyannopoulos, John A.			Integrative Meta-Analysis of Differential Gene Expression in Acute Myeloid Leukemia	PLOS ONE			English	Article							EOSINOPHIL-DERIVED NEUROTOXIN; HOMEOBOX GENE; NORMAL KARYOTYPE; DOWN-REGULATION; HOX EXPRESSION; DISTINCT; MUTATIONS; AML; PROFILES; CANCER	Background: Acute myeloid leukemia (AML) is a heterogeneous disease with an overall poor prognosis. Gene expression profiling studies of patients with AML has provided key insights into disease pathogenesis while exposing potential diagnostic and prognostic markers and therapeutic targets. A systematic comparison of the large body of gene expression profiling studies in AML has the potential to test the extensibility of conclusions based on single studies and provide further insights into AML. Methodology/Principal Findings: In this study, we systematically compared 25 published reports of gene expression profiling in AML. There were a total of 4,918 reported genes of which one third were reported in more than one study. We found that only a minority of reported prognostically-associated genes (9.6%) were replicated in at least one other study. In a combined analysis, we comprehensively identified both gene sets and functional gene categories and pathways that exhibited significant differential regulation in distinct prognostic categories, including many previously unreported associations. Conclusions/Significance: We developed a novel approach for granular, cross-study analysis of gene-by-gene data and their relationships with established prognostic features and patient outcome. We identified many robust novel prognostic molecular features in AML that were undetected in prior studies, and which provide insights into AML pathogenesis with potential diagnostic, prognostic, and therapeutic implications. Our database and integrative analysis are available online (http://gat. stamlab. org).	[Miller, Brady G.] Univ Washington, Dept Hematol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, BG (corresponding author), Univ Washington, Dept Hematol, Seattle, WA 98195 USA.	jstam@uw.edu			NIH [5T32HL007093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIH (5T32HL007093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; ANDREEFF M, 2008, HOX EXPRESSION PATTE; Appleton CTG, 2006, J CELL PHYSIOL, V207, P735, DOI 10.1002/jcp.20615; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BORRESEN B, 1996, P 10 INT S MOLT SALT, V7, P11; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Bullinger L, 2007, BLOOD, V110, P1291, DOI 10.1182/blood-2006-10-049783; Cahan P, 2005, GENE, V360, P78, DOI 10.1016/j.gene.2005.07.008; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Cheong JW, 2003, LEUKEMIA RES, V27, P1159, DOI 10.1016/S0145-2126(03)00102-4; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P5327, DOI 10.1093/nar/26.23.5327; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Eisele L, 2007, ACTA HAEMATOL-BASEL, V117, P8, DOI 10.1159/000096854; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Fruchart C, 1996, AM J HEMATOL, V53, P175, DOI 10.1002/(SICI)1096-8652(199611)53:3<175::AID-AJH5>3.0.CO;2-W; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; GELLER RB, 1990, BRIT J HAEMATOL, V76, P340, DOI 10.1111/j.1365-2141.1990.tb06365.x; GIAMPAOLO A, 1994, BLOOD, V84, P3637, DOI 10.1182/blood.V84.11.3637.bloodjournal84113637; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; GRUBACH L, 2008, EUR J HAEMATOL; Guillemin R, 2005, J ENDOCRINOL, V184, P11, DOI 10.1677/joe.1.05883; Haferlach T, 2005, GENE CHROMOSOME CANC, V43, P113, DOI 10.1002/gcc.20175; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Hatfield KJ, 2008, LEUKEMIA, V22, P287, DOI 10.1038/sj.leu.2404985; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Heuser M, 2005, HAEMATOLOGICA, V90, P1484; Huang H, 2005, J NEUROPATH EXP NEUR, V64, P891, DOI 10.1097/01.jnen.0000183345.19447.8e; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; INOUE K, 1994, BLOOD, V84, P2672, DOI 10.1182/blood.V84.8.2672.bloodjournal8482672; Joshi N, 2006, CANCER RES, V66, P6851, DOI 10.1158/0008-5472.CAN-06-0662; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Kohlmann A, 2003, GENE CHROMOSOME CANC, V37, P396, DOI 10.1002/gcc.10225; Kreuter M, 2006, LEUKEMIA, V20, P1950, DOI 10.1038/sj.leu.2404384; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lacayo NJ, 2004, BLOOD, V104, P2646, DOI 10.1182/blood-2003-12-4449; Larsson O, 2006, NAT BIOTECHNOL, V24, P1322, DOI 10.1038/nbt1106-1322; Lee S, 2006, P NATL ACAD SCI USA, V103, P1030, DOI 10.1073/pnas.0509878103; Liu ZJ, 2004, LEUKEMIA, V18, P880, DOI 10.1038/sj.leu.2403300; Lopez-Pedrera C, 2006, PROTEOMICS, V6, pS293, DOI 10.1002/pmic.200500384; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Moratz C, 2004, METHOD ENZYMOL, V389, P15; Moussa O, 2008, ONCOGENE, V27, P55, DOI 10.1038/sj.onc.1210629; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Mullighan CG, 2007, LEUKEMIA, V21, P2000, DOI 10.1038/sj.leu.2404808; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Neben K, 2005, ONCOGENE, V24, P1580, DOI 10.1038/sj.onc.1208344; Neben K, 2004, ONCOGENE, V23, P2379, DOI 10.1038/sj.onc.1207401; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Okabe-Kado J, 2002, LEUKEMIA LYMPHOMA, V43, P859, DOI 10.1080/10428190290017006; Okutsu J, 2002, MOL CANCER THER, V1, P1035; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Park MH, 2007, ONCOL REP, V18, P1395; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Roche J, 2004, LEUKEMIA, V18, P1059, DOI 10.1038/sj.leu.2403366; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Rusiniak ME, 2000, CANCER RES, V60, P1824; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Schlenk RF, 2009, CURR OPIN HEMATOL, V16, P98, DOI 10.1097/MOH.0b013e3283257adb; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; Shimamoto A, 1996, P NATL ACAD SCI USA, V93, P10913, DOI 10.1073/pnas.93.20.10913; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; Smid M, 2003, BIOINFORMATICS, V19, P2065, DOI 10.1093/bioinformatics/btg282; Stapnes C, 2007, INT J ONCOL, V31, P1529; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Thompson A, 2003, BLOOD, V101, P1558, DOI 10.1182/blood.V101.4.1558; Thornhill S, 1997, PHYS WORLD, V10, P17; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Ulrich Cornelia M, 2005, Hum Mutat, V26, P394, DOI 10.1002/humu.9371; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van den Plas D, 2004, BIOL CELL, V96, P463, DOI 10.1016/j.biolcel.2004.04.007; Van den Plas D, 2004, CELL BIOL INT, V28, P199, DOI 10.1016/j.cellbi.2003.11.019; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Vey N, 2004, ONCOGENE, V23, P9381, DOI 10.1038/sj.onc.1207910; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Voso MT, 2004, BLOOD, V103, P698, DOI 10.1182/blood-2003-07-2249; Wheatley K, 1999, BRIT J HAEMATOL, V107, P69, DOI 10.1046/j.1365-2141.1999.01684.x; Whitman SP, 2008, BLOOD, V111, P1552, DOI 10.1182/blood-2007-08-107946; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239; Xie P, 2008, LEUKEMIA RES, V32, P475, DOI 10.1016/j.leukres.2007.07.006; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Yang D, 2003, BLOOD, V102, P3396, DOI 10.1182/blood-2003-01-0151	96	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9466	10.1371/journal.pone.0009466	http://dx.doi.org/10.1371/journal.pone.0009466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209125	Green Submitted, gold, Green Published			2022-12-27	WOS:000274997100013
J	Cermeno, P; de Vargas, C; Abrantes, F; Falkowski, PG				Cermeno, Pedro; de Vargas, Colomban; Abrantes, Fatima; Falkowski, Paul G.			Phytoplankton Biogeography and Community Stability in the Ocean	PLOS ONE			English	Article							MARINE-PHYTOPLANKTON; MASS-SPECTROMETRY; ATLANTIC; DIVERSITY; ASSEMBLAGES; VARIABILITY; MICROBES; TIME	Background: Despite enormous environmental variability linked to glacial/interglacial climates of the Pleistocene, we have recently shown that marine diatom communities evolved slowly through gradual changes over the past 1.5 million years. Identifying the causes of this ecological stability is key for understanding the mechanisms that control the tempo and mode of community evolution. Methodology/Principal Findings: If community assembly were controlled by local environmental selection rather than dispersal, environmental perturbations would change community composition, yet, this could revert once environmental conditions returned to previous-like states. We analyzed phytoplankton community composition across >10(4) km latitudinal transects in the Atlantic Ocean and show that local environmental selection of broadly dispersed species primarily controls community structure. Consistent with these results, three independent fossil records of marine diatoms over the past 250,000 years show cycles of community departure and recovery tightly synchronized with the temporal variations in Earth's climate. Conclusions/Significance: Changes in habitat conditions dramatically alter community structure, yet, we conclude that the high dispersal of marine planktonic microbes erases the legacy of past environmental conditions, thereby decreasing the tempo of community evolution.	[Cermeno, Pedro; Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08903 USA; [de Vargas, Colomban] CNRS, Biol Stn, Roscoff, France; [de Vargas, Colomban] UPMC, Roscoff, France; [Abrantes, Fatima] LNEG, Marine Geol Dept, Alfragide, Portugal; [Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Laboratorio Nacional de Energia e Geologia IP (LNEG); Rutgers State University New Brunswick	Cermeno, P (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	pedro@uvigo.es	Abrantes, Fatima F G/B-5985-2013; Abrantes, Fatima/N-7253-2019	Abrantes, Fatima F G/0000-0002-9110-0212; Abrantes, Fatima/0000-0002-9110-0212; de Vargas, Colomban/0000-0002-6476-6019; Cermeno, Pedro/0000-0002-3902-3475	European Union; UK Natural Environmental Research Council [NER/O/S/2001/00680]; Natural Environment Research Council [NER/O/S/2001/00680] Funding Source: researchfish	European Union(European Commission); UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was funded by the European Union through a Marie Curie project within 6th European Community framework Program. http://cordis.europa.eu/mariecurie-actions/.Atlantic Meridional Transect data collection was supported by the UK Natural Environmental Research Council through the Atlantic Meridional Transect consortium (NER/O/S/2001/00680). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This is AMT contribution number 189.	ABRANTES F, 1988, MAR MICROPALEONTOL, V13, P79, DOI 10.1016/0377-8398(88)90013-8; Abrantes F, 2000, EARTH PLANET SC LETT, V176, P7, DOI 10.1016/S0012-821X(99)00312-X; ABRANTES F, 1994, CARBON CYCLING GLACI, P425; Abrantes FF, 1991, PALEOCEANOGRAPHY, V6, P431, DOI 10.1029/91PA00049; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BATTARBE.RW, 1973, LIMNOL OCEANOGR, V18, P647, DOI 10.4319/lo.1973.18.4.0647; Bennett, 1997, EVOLUTION ECOLOGY PA; Bown P, 2009, MAR MICROPALEONTOL, V71, P60, DOI 10.1016/j.marmicro.2009.01.005; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cermeno P, 2008, LIMNOL OCEANOGR, V53, P312, DOI 10.4319/lo.2008.53.1.0312; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; De Vargas C, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P271; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; Dolan JR, 2005, AQUAT MICROB ECOL, V41, P39, DOI 10.3354/ame041039; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Falkowski PG, 2002, SCI AM, V287, P54, DOI 10.1038/scientificamerican0802-54; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hayward BW, 2001, GEOLOGY, V29, P599, DOI 10.1130/0091-7613(2001)029<0599:GDSEDT>2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUGHESMARTINY JB, 2006, NATURE REV MICROBIOL, V4, P101, DOI DOI 10.1038/NRMICRO1341; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; JACKSON JBC, 1999, TRENDS ECOLOGY EVOLU, V14; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Koroleff F., 1976, METHODS SEAWATER ANA, P117; Legendre L., 1983, DEV ENV MODELLING; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MAC ARTHUR ROBERT H., 1967; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; MARTENS R., 1987, SPORT PSYCHOL, V1, P29, DOI [10.1123/tsp.1.1.29, DOI 10.1123/TSP.1.1.29]; MCINTYRE A, 1967, SCIENCE, V158, P1314, DOI 10.1126/science.158.3806.1314; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pichevin L, 2005, MAR GEOL, V218, P81, DOI 10.1016/j.margeo.2005.04.003; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Robinson C, 2006, DEEP-SEA RES PT II, V53, P1483, DOI 10.1016/j.dsr2.2006.06.002; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; Roy Kaustuv, 2005, P160; SCHULMAN NM, 1992, J POP FILM TV, V20, P2; Sluijs A, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P323; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Sokal RR, 1995, BIOMETRY; Stanley S. M., 1979, MACROEVOLUTION; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WEI KY, 1988, PALEOBIOLOGY, V14, P345, DOI 10.1017/S0094837300012094; Weinbauer Markus G., 2007, Endangered Species Research, V3, P205, DOI 10.3354/esr003205; West S, 2004, MAR MICROPALEONTOL, V51, P321, DOI 10.1016/j.marmicro.2004.01.004; WESTERHAUSEN L, 1993, DEEP-SEA RES PT I, V40, P1087, DOI 10.1016/0967-0637(93)90091-G	51	38	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10037	10.1371/journal.pone.0010037	http://dx.doi.org/10.1371/journal.pone.0010037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368810	Green Published, gold			2022-12-27	WOS:000276419900023
J	Nakajima, Y; Yamazaki, T; Nishii, S; Noguchi, T; Hoshino, H; Niwa, K; Viviani, VR; Ohmiya, Y				Nakajima, Yoshihiro; Yamazaki, Tomomi; Nishii, Shigeaki; Noguchi, Takako; Hoshino, Hideto; Niwa, Kazuki; Viviani, Vadim R.; Ohmiya, Yoshihiro			Enhanced Beetle Luciferase for High-Resolution Bioluminescence Imaging	PLOS ONE			English	Article							IN-VIVO; GENE-EXPRESSION; COENZYME-A; CLOCK; EMISSION; SPECTRA; CLONING; ALPHA; CDNA	We developed an enhanced green-emitting luciferase (ELuc) to be used as a bioluminescence imaging (BLI) probe. ELuc exhibits a light signal in mammalian cells that is over 10-fold stronger than that of the firefly luciferase (FLuc), which is the most widely used luciferase reporter gene. We showed that ELuc produces a strong light signal in primary cells and tissues and that it enables the visualization of gene expression with high temporal resolution at the single-cell level. Moreover, we successfully imaged the nucleocytoplasmic shuttling of importin alpha by fusing ELuc at the intracellular level. These results demonstrate that the use of ELuc allows a BLI spatiotemporal resolution far greater than that provided by FLuc.	[Nakajima, Yoshihiro; Noguchi, Takako; Hoshino, Hideto; Niwa, Kazuki; Ohmiya, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Osaka, Japan; [Yamazaki, Tomomi; Nishii, Shigeaki] TOYOBO Co Ltd, Tsuruga Inst Biotechnol, Fukui, Japan; [Viviani, Vadim R.] Univ Fed Sao Carlos, Lab Bioquim & Biotecnol Sistemas Bioluminescentes, Sao Paulo, Brazil	National Institute of Advanced Industrial Science & Technology (AIST); Toyobo Co., Ltd; Universidade Federal de Sao Carlos	Nakajima, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Osaka, Japan.	y-nakajima@aist.go.jp; y-ohmiya@aist.go.jp	Ohmiya, Yoshihiro/J-7143-2013; Nakajima, Yoshihiro/M-6935-2018; Viviani, Vadim R/D-5314-2012; Niwa, Kazuki/L-7576-2018	Ohmiya, Yoshihiro/0000-0002-4944-509X; Nakajima, Yoshihiro/0000-0002-7422-730X; Niwa, Kazuki/0000-0002-3367-3127	Japan Society for the Promotion of Science (JSPS) [21590266]; New Energy and Industrial Technology Development Organization (NEDO); Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP, Brazil)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by a Grant-in-Aid for Scientific Research (No. 21590266 to YN) from Japan Society for the Promotion of Science (JSPS), New Energy and Industrial Technology Development Organization (NEDO), and Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP, Brazil) for funding the basic research. TY and SN are employed at TOYOBO Corporation. Thus, although TOYOBO Corporation did not provide direct financial support, it can be consider as an indirect funder for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRTH RL, 1958, BIOCHIM BIOPHYS ACTA, V27, P519, DOI 10.1016/0006-3002(58)90381-0; Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Fontes R, 1997, BIOCHEM BIOPH RES CO, V237, P445, DOI 10.1006/bbrc.1997.7161; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hageman J, 2007, J BIOL CHEM, V282, P34334, DOI 10.1074/jbc.M703876200; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nakajima Y, 2004, FEBS LETT, V565, P122, DOI 10.1016/j.febslet.2004.03.083; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P948, DOI 10.1271/bbb.68.948; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Nakajima Y, 1996, J BIOL CHEM, V271, P17383, DOI 10.1074/jbc.271.29.17383; Noguchi T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-40; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; SELIGER HH, 1964, J GEN PHYSIOL, V48, P95, DOI 10.1085/jgp.48.1.95; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; SILVANETO AJ, 2009, PHOTOCHEM PHOTOBIOL, V8, P1748; Viviani V, 2001, BIOCHEM BIOPH RES CO, V280, P1286, DOI 10.1006/bbrc.2001.4254; Viviani VR, 1999, PHOTOCHEM PHOTOBIOL, V70, P254, DOI 10.1111/j.1751-1097.1999.tb07997.x; Welsh DK, 2005, METHOD ENZYMOL, V393, P269, DOI 10.1016/S0076-6879(05)93011-5; Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006; WIDDER EA, 1982, BIOL BULL-US, V162, P423, DOI 10.2307/1540994; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	31	93	93	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10011	10.1371/journal.pone.0010011	http://dx.doi.org/10.1371/journal.pone.0010011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368807	Green Submitted, Green Published, gold			2022-12-27	WOS:000276419900012
J	Yue, P; Chen, ZJ; Nassir, F; Bernal-Mizrachi, C; Finck, B; Azhar, S; Abumrad, NA				Yue, Pin; Chen, Zhouji; Nassir, Fatiha; Bernal-Mizrachi, Carlos; Finck, Brian; Azhar, Salman; Abumrad, Nada A.			Enhanced Hepatic apoA-I Secretion and Peripheral Efflux of Cholesterol and Phospholipid in CD36 Null Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR BI; APOLIPOPROTEIN-A-I; LIPID DROPLETS; SR-BI; SELECTIVE UPTAKE; CELLULAR UPTAKE; OXIDIZED LDL; FATTY-ACID; CLEARANCE	CD36 facilitates oxidized low density lipoprotein uptake and is implicated in development of atherosclerotic lesions. CD36 also binds unmodified high and very low density lipoproteins (HDL, VLDL) but its role in the metabolism of these particles is unclear. Several polymorphisms in the CD36 gene were recently shown to associate with serum HDL cholesterol. To gain insight into potential mechanisms for these associations we examined HDL metabolism in CD36 null (CD36(-/-)) mice. Feeding CD36(-/-) mice a high cholesterol diet significantly increased serum HDL, cholesterol and phospholipids, as compared to wild type mice. HDL apolipoproteins apoA-I and apoA-IV were increased and shifted to higher density HDL fractions suggesting altered particle maturation. Clearance of dual-labeled HDL was unchanged in CD36(-/-) mice and cholesterol uptake from HDL or LDL by isolated CD36(-/-) hepatocytes was unaltered. However, CD36(-/-) hepatocytes had higher cholesterol and phospholipid efflux rates. In addition, expression and secretion of apoA-I and apoA-IV were increased reflecting enhanced PXR. Similar to hepatocytes, cholesterol and phospholipid efflux were enhanced in CD36(-/-) macrophages without changes in protein levels of ABCA1, ABCG1 or SR-B1. However, biotinylation assays showed increased surface ABCA1 localization in CD36(-/-) cells. In conclusion, CD36 influences reverse cholesterol transport and hepatic ApoA-I production. Both pathways are enhanced in CD36 deficiency, increasing HDL concentrations, which suggests the potential benefit of CD36 inhibition.	[Yue, Pin; Chen, Zhouji; Nassir, Fatiha; Finck, Brian; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Sch Med, Dept Med, Div Endocrinol, St Louis, MO 63110 USA; [Azhar, Salman] Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Dept Vet Affairs, Palo Alto, CA USA; [Azhar, Salman] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Yue, P (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA.	pyue@DOM.wustl.edu		Finck, Brian/0000-0001-5411-3674; Nassir, Fatiha/0000-0002-3653-3621; Bernal-Mizrachi, Carlos/0000-0002-8991-7522	National Institutes of Health [R01 DK33301, R01 DK60022, R01 HL092271]; Nutrition Obesity Research Center [P30DK056341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881, R01HL092473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060022, P30DK056341, R01DK033301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institutes of Health grants R01 DK33301, R01 DK60022 and R01 HL092271 and by the Nutrition Obesity Research Center grant P30DK056341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050; AZHAR S, 1990, BIOCHIM BIOPHYS ACTA, V1047, P148, DOI 10.1016/0005-2760(90)90041-U; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; BUERS I, 2009, ARTERIOSCLER THROMB; Calvo D, 1998, J LIPID RES, V39, P777; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chroni A, 2005, BIOCHEMISTRY-US, V44, P13132, DOI 10.1021/bi051029o; Collot-Teixeira S, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/813236; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; de Villiers WJS, 2001, J LIPID RES, V42, P1231; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Johnson LA, 2008, ARTERIOSCL THROM VAS, V28, P1745, DOI 10.1161/ATVBAHA.108.169680; Jones C, 2007, J CLIN INVEST, V117, P165, DOI 10.1172/JCI29415; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Linder MD, 2009, ARTERIOSCL THROM VAS, V29, P883, DOI 10.1161/ATVBAHA.108.179481; Liu PS, 2008, METHOD ENZYMOL, V439, P327, DOI 10.1016/S0076-6879(07)00424-7; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Luangrath V, 2008, ARTERIOSCL THROM VAS, V28, P1290, DOI 10.1161/ATVBAHA.107.161653; Malik S, 2003, FRONT BIOSCI, V8, pD360, DOI 10.2741/1005; MEHRDAD H, 1995, ATHEROSCLEROSIS, V117, P199; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Nicholson AC, 2000, ANN NY ACAD SCI, V902, P128; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Srivastava RAK, 2000, MOL CELL BIOCHEM, V209, P125, DOI 10.1023/A:1007107712725; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Sviridov D, 2009, J LIPID RES, V50, P1257, DOI 10.1194/jlr.E900003-JLR200; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Waddington EI, 2005, METHODS, V36, P196, DOI 10.1016/j.ymeth.2004.12.002; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9906	10.1371/journal.pone.0009906	http://dx.doi.org/10.1371/journal.pone.0009906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360851	Green Published, gold			2022-12-27	WOS:000275969600012
J	Macatangay, BJC; Szajnik, ME; Whiteside, TL; Riddler, SA; Rinaldo, CR				Macatangay, Bernard J. C.; Szajnik, Marta E.; Whiteside, Theresa L.; Riddler, Sharon A.; Rinaldo, Charles R.			Regulatory T Cell Suppression of Gag-Specific CD8(+) T Cell Polyfunctional Response After Therapeutic Vaccination of HIV-1-Infected Patients on ART	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; TYPE-1 INFECTION; IMMUNODEFICIENCY; SUBSETS; DESIGN	We tested the hypothesis that therapeutic vaccination against HIV-1 can increase the frequency and suppressive function of regulatory, CD4(+) T cells (Treg), thereby masking enhancement of HIV-1-specific CD8(+) T cell response. HIV-1-infected subjects on antiretroviral therapy (N = 17) enrolled in a phase I therapeutic vaccine trial received 2 doses of autologous dendritic cells (DC) loaded with HIV-1 peptides. The frequency of CD4(+)CD25(hi)FOXP3(+) Treg in blood was determined prior to and after vaccination in subjects and normal controls. Polyfunctional CD8(+) T cell responses were determined pre- and post-vaccine (N = 7) for 5 immune mediators after in vitro stimulation with Gag peptide, staphylococcal enterotoxin B (SEB), or medium alone. Total vaccine response (post-vaccine-pre-vaccine) was compared in the Treg(+) and Treg-depleted (Treg-) sets. After vaccination, 12/17 subjects showed a trend of increased Treg frequency (P = 0.06) from 0.74% to 1.2%. The increased frequency did not correlate with CD8(+) T cell vaccine response by enzyme linked immunosorbent assay for interferon gamma production. Although there was no significant change in CD8(+) T cell polyfunctional response after vaccination, Treg depletion increased the polyfunctionality of the total vaccine response (P = 0.029), with a >2-fold increase in the percentage of CD8(+) T cells producing multiple immune mediators. In contrast, depletion of Treg did not enhance polyfunctional T cell response to SEB, implying specificity of suppression to HIV-1 Gag. Therapeutic immunization with a DC-based vaccine against HIV-1 caused a modest increase in Treg frequency and a significant increase in HIV-1-specific, Treg suppressive function. The Treg suppressive effect masked an increase in the vaccine-induced anti-HIV-1-specific polyfunctional response. The role of Treg should be considered in immunotherapeutic trials of HIV-1 infection.	[Macatangay, Bernard J. C.; Riddler, Sharon A.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Szajnik, Marta E.; Whiteside, Theresa L.] Univ Pittsburgh, Dept Pathol, Inst Canc, Pittsburgh, PA USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Pathol, Pittsburgh, PA USA; [Rinaldo, Charles R.] Univ Pittsburgh, Sch Med, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Rinaldo, Charles R.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Macatangay, BJC (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	macatangaybj@upmc.edu		Macatangay, Bernard/0000-0002-0405-0991	NIH [U19-AI55794, PO1-DE12321, R37-AI41870]; NIR/NCRR/GCRC [MO1-RR-000056]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI055794, R37AI041870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012321] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIR/NCRR/GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by NIH grants: U19-AI55794, PO1-DE12321, R37-AI41870, and NIR/NCRR/GCRC grant MO1-RR-000056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld MA, 2001, J VIROL, V75, P1301, DOI 10.1128/JVI.75.3.1301-1311.2001; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Baker CAR, 2007, CLIN EXP IMMUNOL, V147, P533, DOI 10.1111/j.1365-2249.2006.03319.x; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Connolly NC, 2008, CLIN VACCINE IMMUNOL, V15, P284, DOI 10.1128/CVI.00221-07; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Huang XL, 2009, CLIN VACCINE IMMUNOL, V16, P1504, DOI 10.1128/CVI.00104-09; Ivars Fredrik, 2007, Chem Immunol Allergy, V93, P137, DOI 10.1159/000100862; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Lopez M, 2006, IMMUNOBIOLOGY, V211, P127, DOI 10.1016/j.imbio.2005.11.003; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Peretz Y, 2007, CLIN IMMUNOL, V124, P57, DOI 10.1016/j.clim.2007.04.004; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Rinaldo CR, 2000, J VIROL, V74, P4127, DOI 10.1128/JVI.74.9.4127-4138.2000; Seddiki Nabila, 2008, Curr HIV/AIDS Rep, V5, P20, DOI 10.1007/s11904-008-0004-6; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	27	47	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9852	10.1371/journal.pone.0009852	http://dx.doi.org/10.1371/journal.pone.0009852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352042	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500019
J	Saari, S; Sundell, J; Huitu, O; Helander, M; Ketoja, E; Ylonen, H; Saikkonen, K				Saari, Susanna; Sundell, Janne; Huitu, Otso; Helander, Marjo; Ketoja, Elise; Ylonen, Hannu; Saikkonen, Kari			Fungal-Mediated Multitrophic Interactions - Do Grass Endophytes in Diet Protect Voles from Predators?	PLOS ONE			English	Article							PERFORMANCE; CONSUMPTION; COMMUNITY; WEASELS	Plant-associated micro-organisms such as mycotoxin-producing endophytes commonly have direct negative effects on herbivores. These effects may be carried over to natural enemies of the herbivores, but this has been rarely explored. We examined how feeding on Neotyphodium endophyte infected (E+) and endophyte free (E-) meadow ryegrass (Scherodonus pratensis) affects body mass, population size and mobility of sibling voles (Microtus levis), and whether the diet mediates the vulnerability of voles to least weasel (Mustela nivalis nivalis) predation. Because least weasels are known to be olfactory hunters, we also examined whether they are able to distinguish olfactory cues of voles fed on E+ and E- diets. Neither body mass of voles nor population size differed between diets. However, contrary to our prediction, least weasels preyed more often on voles fed with E- grass than on voles fed with E+ grass. The mobility of voles fed on E+ grass was reduced compared to voles fed on E- grass, but this effect was unrelated to risk of predation. Least weasels appeared unable to distinguish between excrement odours of voles between the two treatments. Our results suggest that consumption of endophytic grass is not directly deleterious to sibling voles. What's more, consumption of endophytes appears to be advantageous to voles by reducing risk of mammalian predation. Our study is thus the first to demonstrate an effect of plant-associated microbial symbionts on herbivore-predator interactions in vertebrate communities.	[Saari, Susanna; Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland; [Saari, Susanna; Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Sundell, Janne; Ylonen, Hannu] Univ Jyvaskyla, Dept Biol & Environm Sci, Konnevesi Res Stn, Konnevesi, Finland; [Huitu, Otso] Finnish Forest Res Inst, Suonenjoki Res Unit, Suonenjoki, Finland; [Ketoja, Elise] MTT Agrifood Res Finland, Serv Unit, Jokioinen, Finland; [Sundell, Janne] Univ Helsinki, Lammi Biol Stn, Lammi, Finland	Natural Resources Institute Finland (Luke); University of Turku; University of Jyvaskyla; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Helsinki	Saari, S (corresponding author), MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland.	susanna.saari@mtt.fi	Saari, Susanna/A-1677-2016	Saari, Susanna/0000-0002-3746-4728; Helander, Marjo/0000-0002-9759-4321	Academy of Finland; Marjatta and Eino Kolli Foundation; Olvi Foundation	Academy of Finland(Academy of Finland); Marjatta and Eino Kolli Foundation; Olvi Foundation	This study is part of Endophytic Fungi in Ecological Plant Production Programme no. 110658, funded by the Academy of Finland, Niemi Foundation, Marjatta and Eino Kolli Foundation and Olvi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.aka.fi/fi/A/, http://www.olvisaatio.fi/web/olvisaatio/, https://www.kollinsaatio.com/. There is no URL for Niemi Foundation.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; BACON CW, 1977, APPL ENVIRON MICROB, V34, P576, DOI 10.1128/AEM.34.5.576-581.1977; Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Barker GM, 1996, BIOL CONTROL, V7, P281, DOI 10.1006/bcon.1996.0095; Bultman TL, 2003, OIKOS, V102, P491, DOI 10.1034/j.1600-0706.2003.11477.x; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1990, ANNU REV ECOL SYST, V21, P275, DOI 10.1146/annurev.es.21.110190.001423; COLEY AB, 1995, J ENV QUAL, V24; Conover MR, 1998, J MAMMAL, V79, P457, DOI 10.2307/1382976; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Durham WF, 1998, CAN J ZOOL, V76, P960, DOI 10.1139/cjz-76-5-960; Harri SA, 2008, OECOLOGIA, V157, P399, DOI 10.1007/s00442-008-1094-y; HAMETAHTI L, 1988, RETKEILYKASVIO FIELD; HIRJI KF, 1987, J AM STAT ASSOC, V82, P1110, DOI 10.2307/2289388; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; Huitu O, 2008, OECOLOGIA, V156, P333, DOI 10.1007/s00442-008-0984-3; Justus M, 1997, PHYTOCHEMISTRY, V44, P51, DOI 10.1016/S0031-9422(96)00535-3; KORPIMAKI E, 1991, OECOLOGIA, V88, P552, DOI 10.1007/BF00317719; KREBS CJ, 1999, ECOLOGICAL METHODOLO, P94; Leuchtmann Adrian, 1992, Natural Toxins, V1, P150, DOI 10.1002/nt.2620010303; Little T, 1978, AGR EXPT DESIGN ANAL; NORRDAHL K, 1995, P ROY SOC B-BIOL SCI, V261, P49, DOI 10.1098/rspb.1995.0116; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2000, ECOGRAPHY, V23, P360, DOI 10.1034/j.1600-0587.2000.d01-1645.x; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sundell J, 2004, BEHAV ECOL SOCIOBIOL, V56, P263, DOI 10.1007/s00265-004-0777-6; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; WOLDEMICHAEL GM, 2002, BIOCH SYST ECOL, V30, P264; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461; Ylonen H, 2003, ECOLOGY, V84, P1447, DOI 10.1890/0012-9658(2003)084[1447:WMNNPF]2.0.CO;2	32	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9845	10.1371/journal.pone.0009845	http://dx.doi.org/10.1371/journal.pone.0009845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352096	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894500013
J	Uemura, M; Niwa, Y; Kakazu, N; Adachi, N; Kinoshita, K				Uemura, Munehiro; Niwa, Youko; Kakazu, Naoki; Adachi, Noritaka; Kinoshita, Kazuo			Chromosomal Manipulation by Site-Specific Recombinases and Fluorescent Protein-Based Vectors	PLOS ONE			English	Article							CRE-LOXP; TRANSLOCATION; GENOME; RANGE	Feasibility of chromosomal manipulation in mammalian cells was first reported 15 years ago. Although this technique is useful for precise understanding of gene regulation in the chromosomal context, a limited number of laboratories have used it in actual practice because of associated technical difficulties. To overcome the practical hurdles, we developed a Cre-mediated chromosomal recombination system using fluorescent proteins and various site-specific recombinases. These techniques enabled quick construction of targeting vectors, easy identification of chromosome-rearranged cells, and rearrangement leaving minimum artificial elements at junctions. Applying this system to a human cell line, we successfully recapitulated two types of pathogenic chromosomal translocations in human diseases: MYC/IgH and BCR/ABL1. By inducing recombination between two loxP sites targeted into the same chromosome, we could mark cells harboring deletion or duplication of the inter-loxP segments with different colors of fluorescence. In addition, we demonstrated that the intrachromosomal recombination frequency is inversely proportional to the distance between two recombination sites, implicating a future application of this frequency as a proximity sensor. Our method of chromosomal manipulation can be employed for particular cell types in which gene targeting is possible (e. g. embryonic stem cells). Experimental use of this system would open up new horizons in genome biology, including the establishment of cellular and animal models of diseases caused by translocations and copy-number variations.	[Uemura, Munehiro; Niwa, Youko; Kinoshita, Kazuo] Shiga Med Ctr, Res Inst, Moriyama, Japan; [Kakazu, Naoki] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan; [Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan	Shimane University; Yokohama City University	Uemura, M (corresponding author), Shiga Med Ctr, Res Inst, Moriyama, Japan.	kkinoshi.shigamed@mac.com		Kakazu, Naoki/0000-0001-7251-069X	Japanese Society for the Promotion of Science [KAKENHI 20590326]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (KAKENHI 20590326) from Japanese Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Golic KG, 1996, GENETICS, V144, P1693; Golic MM, 1996, GENETICS, V143, P385; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HOZIER J, 1980, INT J CANCER, V26, P281, DOI 10.1002/ijc.2910260305; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu PT, 1998, GENETICS, V150, P1155; MATSUZAKI H, 1990, J BACTERIOL, V172, P610, DOI 10.1128/jb.172.2.610-618.1990; QIN MM, 1994, P NATL ACAD SCI USA, V91, P1706, DOI 10.1073/pnas.91.5.1706; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Smith AJH, 2002, ONCOGENE, V21, P4521, DOI 10.1038/sj.onc.1205530; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	23	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9846	10.1371/journal.pone.0009846	http://dx.doi.org/10.1371/journal.pone.0009846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352097	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894500014
J	Chun, JN; Choi, B; Lee, KW; Lee, DJ; Kang, DH; Lee, JY; Song, IS; Kim, HI; Lee, SH; Kim, HS; Lee, NK; Lee, SY; Lee, KJ; Kim, J; Kang, SW				Chun, Jung Nyeo; Choi, Boae; Lee, Kyung Wha; Lee, Doo Jae; Kang, Dong Hoon; Lee, Joo Young; Song, In Sung; Kim, Hye In; Lee, Sang-Hee; Kim, Hyeon Soo; Lee, Na Kyung; Lee, Soo Young; Lee, Kong-Joo; Kim, Jaesang; Kang, Sang Won			Cytosolic Hsp60 Is Involved in the NF-kappa B-Dependent Survival of Cancer Cells via IKK Regulation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN; KINASE-ALPHA; OSTEOCLAST DIFFERENTIATION; GENE-EXPRESSION; CHAPERONIN GROEL; SERINE-PROTEASE; ACTIVATION; APOPTOSIS; COMPLEX	Cytoplasmic presence of Hsp60, which is principally a nuclear gene-encoded mitochondrial chaperonin, has frequently been stated, but its role in intracellular signaling is largely unknown. In this study, we demonstrate that the cytosolic Hsp60 promotes the TNF-alpha-mediated activation of the IKK/NF-kappa B survival pathway via direct interaction with IKK alpha/beta in the cytoplasm. Selective loss or blockade of cytosolic Hsp60 by specific antisense oligonucleotide or neutralizing antibody diminished the IKK/NF-kappa B activation and the expression of NF-kappa B target genes, such as Bfl-1/A1 and MnSOD, which thus augmented intracellular ROS production and ASK1-dependent cell death, in response to TNF-alpha. Conversely, the ectopic expression of cytosol-targeted Hsp60 enhanced IKK/NF-kappa B activation. Mechanistically, the cytosolic Hsp60 enhanced IKK activation via upregulating the activation-dependent serine phosphorylation in a chaperone-independent manner. Furthermore, transgenic mouse study showed that the cytosolic Hsp60 suppressed hepatic cell death induced by diethylnitrosamine in vivo. The cytosolic Hsp60 is likely to be a regulatory component of IKK complex and it implicates the first mitochondrial factor that regulates cell survival via NF-kappa B pathway.	[Chun, Jung Nyeo; Choi, Boae; Lee, Kyung Wha; Lee, Doo Jae; Kang, Dong Hoon; Lee, Joo Young; Song, In Sung; Kim, Hye In; Lee, Na Kyung; Lee, Soo Young; Lee, Kong-Joo; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Chun, Jung Nyeo; Choi, Boae; Lee, Kyung Wha; Lee, Doo Jae; Kang, Dong Hoon; Lee, Joo Young; Song, In Sung; Kim, Hye In; Lee, Na Kyung; Lee, Soo Young; Lee, Kong-Joo; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Lee, Soo Young; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Lee, Soo Young; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Coll Nat Sci, Seoul, South Korea; [Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Lee, Sang-Hee] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea; [Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Korea Basic Science Institute (KBSI); Korea University; Korea University Medicine (KU Medicine)	Chun, JN (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	kangsw@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Ministry of Education, Science Technology; KOSEF [R15-2006-020]; National R&D Program for Cancer Control, Ministry of Health Welfare [0420190]; Korea Ministry of Education, Science Technology	Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); KOSEF(Korea Science and Engineering Foundation); National R&D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by 21C Frontier Functional Proteomics Project (FPR08-B1-190) funded by the Ministry of Education, Science & Technology and by KOSEF through the Center for Cell Signaling & Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans University. This study was also supported in part by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare (0420190). J.N. Chun, K. W. Lee, J.Y. Lee, B. A. Choi, and H. I. Kim were supported by Brain Korea 21 grant from the Korea Ministry of Education, Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozner P, 2002, J ALZHEIMERS DIS, V4, P479; Briones P, 1997, J INHERIT METAB DIS, V20, P569, DOI 10.1023/A:1005303008439; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; CAPPELLO F, 2008, CANC BIOL THER, V7; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hehner SP, 2000, MOL CELL BIOL, V20, P2556, DOI 10.1128/MCB.20.7.2556-2568.2000; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lai HC, 2007, AM J PHYSIOL-ENDOC M, V292, pE292, DOI 10.1152/ajpendo.00189.2006; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Park SG, 2003, J BIOL CHEM, V278, P39851, DOI 10.1074/jbc.M301618200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771; STEINHOFF U, 1994, P NATL ACAD SCI USA, V91, P5085, DOI 10.1073/pnas.91.11.5085; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WHITE ZW, 1995, J BIOL CHEM, V270, P20404, DOI 10.1074/jbc.270.35.20404; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	71	81	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9422	10.1371/journal.pone.0009422	http://dx.doi.org/10.1371/journal.pone.0009422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351780	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400003
J	Cook, TR; Kato, A; Tanaka, H; Ropert-Coudert, Y; Bost, CA				Cook, Timothee R.; Kato, Akiko; Tanaka, Hideji; Ropert-Coudert, Yan; Bost, Charles-Andre			Buoyancy under Control: Underwater Locomotor Performance in a Deep Diving Seabird Suggests Respiratory Strategies for Reducing Foraging Effort	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; GREAT CORMORANTS; ENERGETIC COSTS; METABOLIC-RATE; DEPTH; BIRDS; PENGUINS; STROKE; PATTERNS; MAMMALS	Background: Because they have air stored in many body compartments, diving seabirds are expected to exhibit efficient behavioural strategies for reducing costs related to buoyancy control. We study the underwater locomotor activity of a deep-diving species from the Cormorant family (Kerguelen shag) and report locomotor adjustments to the change of buoyancy with depth. Methodology/Principal Findings: Using accelerometers, we show that during both the descent and ascent phases of dives, shags modelled their acceleration and stroking activity on the natural variation of buoyancy with depth. For example, during the descent phase, birds increased swim speed with depth. But in parallel, and with a decay constant similar to the one in the equation explaining the decrease of buoyancy with depth, they decreased foot-stroke frequency exponentially, a behaviour that enables birds to reduce oxygen consumption. During ascent, birds also reduced locomotor cost by ascending passively. We considered the depth at which they started gliding as a proxy to their depth of neutral buoyancy. This depth increased with maximum dive depth. As an explanation for this, we propose that shags adjust their buoyancy to depth by varying the amount of respiratory air they dive with. Conclusions/Significance: Calculations based on known values of stored body oxygen volumes and on deep-diving metabolic rates in avian divers suggest that the variations of volume of respiratory oxygen associated with a respiration mediated buoyancy control only influence aerobic dive duration moderately. Therefore, we propose that an advantage in cormorants - as in other families of diving seabirds - of respiratory air volume adjustment upon diving could be related less to increasing time of submergence, through an increased volume of body oxygen stores, than to reducing the locomotor costs of buoyancy control.	[Cook, Timothee R.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Ctr Excellence, DST,NRF, ZA-7925 Cape Town, South Africa; [Cook, Timothee R.; Bost, Charles-Andre] CNRS, CEBC, UPR 1934, Villiers En Bois, France; [Kato, Akiko] Natl Inst Polar Res, Tokyo, Japan; [Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, CNRS, IPHC, DEPE, Strasbourg, France; [Tanaka, Hideji] Hokkaido Univ, Grad Sch Fisheries Sci, COE Neosci Nat Hist, Hakodate, Hokkaido, Japan	National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hokkaido University	Cook, TR (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Ctr Excellence, DST,NRF, ZA-7925 Cape Town, South Africa.	timothee.cook@gmail.com	Kato, Akiko/W-2447-2019	Cook, Timothee/0000-0003-2354-824X; Kato, Akiko/0000-0002-8947-3634	French Polar Institute [394]	French Polar Institute	This research was funded by program no. 394 of the French Polar Institute (Institut Paul Emile Victor - IPEV, URL: http://www.institut-polaire.fr/), with the logistical help of the Terres Australes et Antarctiques Francaises (TAAF, URL: http://www.taaf.fr/spip/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNASCH R, 1994, J EXP BIOL, V194, P83; Boyd IL, 1997, TRENDS ECOL EVOL, V12, P213, DOI 10.1016/S0169-5347(97)01054-9; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Butler PJ, 2001, NEWS PHYSIOL SCI, V16, P222; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Cook TR, 2008, MAR BIOL, V154, P383, DOI 10.1007/s00227-008-0939-6; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; COOK TR, 2008, THESIS LA ROCHELLE U; Davis RW, 2001, COMP BIOCHEM PHYS A, V129, P759, DOI 10.1016/S1095-6433(01)00345-2; Duncker H.-R., 1985, Biona Report, V3, P361; ECKERT R, 1999, ANIMAL PHYSL MECH AD, P727; Enstipp MR, 2005, J EXP BIOL, V208, P3451, DOI 10.1242/jeb.01791; Green JA, 2005, PHYSIOL BIOCHEM ZOOL, V78, P766, DOI 10.1086/432423; Gremillet D, 2005, J AVIAN BIOL, V36, P57, DOI 10.1111/j.0908-8857.2005.03331.x; Hansen ES, 2004, AM NAT, V163, P358, DOI 10.1086/381943; Hays GC, 2007, MAR BIOL, V150, P1003, DOI 10.1007/s00227-006-0412-3; Hooker SK, 2005, P ROY SOC B-BIOL SCI, V272, P355, DOI 10.1098/rspb.2004.2964; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Insley S. J., 2008, Endangered Species Research, V4, P147, DOI 10.3354/esr00050; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Laich Agustina Gomez, 2010, Endangered Species Research, V10, P29, DOI 10.3354/esr00091; Lovvorn JR, 2004, J EXP BIOL, V207, P4679, DOI 10.1242/jeb.01331; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Ribak G, 2005, J EXP BIOL, V208, P3835, DOI 10.1242/jeb.01856; Ribak G, 2005, J AVIAN BIOL, V36, P89, DOI 10.1111/j.0908-8857.2005.03499.x; Ribak G, 2004, J EXP BIOL, V207, P2101, DOI 10.1242/jeb.00997; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2006, MAR BIOL, V149, P415, DOI 10.1007/s00227-005-0242-8; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2002, J EXP BIOL, V205, P1189; SCHMID D, 1995, MAR BIOL, V123, P875, DOI 10.1007/BF00349133; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639; Watanuki Y, 2003, P ROY SOC B-BIOL SCI, V270, P483, DOI 10.1098/rspb.2002.2252; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson Rory P., 1992, Marine Ornithology, V20, P7; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; Wilson RP, 2004, MAR ECOL PROG SER, V278, P303, DOI 10.3354/meps278303; Wilson RP, 2003, MAR BIOL, V142, P537, DOI 10.1007/s00227-002-0964-9; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305	44	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9839	10.1371/journal.pone.0009839	http://dx.doi.org/10.1371/journal.pone.0009839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352122	Green Submitted, gold, Green Published			2022-12-27	WOS:000275894400033
J	Sheward, WJ; Naylor, E; Knowles-Barley, S; Armstrong, JD; Brooker, GA; Seckl, JR; Turek, FW; Holmes, MC; Zee, PC; Harmar, AJ				Sheward, W. John; Naylor, Erik; Knowles-Barley, Seymour; Armstrong, J. Douglas; Brooker, Gillian A.; Seckl, Jonathan R.; Turek, Fred W.; Holmes, Megan C.; Zee, Phyllis C.; Harmar, Anthony J.			Circadian Control of Mouse Heart Rate and Blood Pressure by the Suprachiasmatic Nuclei: Behavioral Effects Are More Significant than Direct Outputs	PLOS ONE			English	Article							VPAC(2) RECEPTOR; CLOCK GENE; SLEEP; RHYTHMICITY; MICE; VARIABILITY; ONSET; RESPONSIVENESS; ASSOCIATION; HOMEOSTASIS	Background: Diurnal variations in the incidence of events such as heart attack and stroke suggest a role for circadian rhythms in the etiology of cardiovascular disease. The aim of this study was to assess the influence of the suprachiasmatic nucleus (SCN) circadian clock on cardiovascular function. Methodology/Principal Findings: Heart rate (HR), blood pressure (BP) and locomotor activity (LA) were measured in circadian mutant (Vipr2(-/-)) mice and wild type littermates, using implanted radio-telemetry devices. Sleep and wakefulness were studied in similar mice implanted with electroencephalograph (EEG) electrodes. There was less diurnal variation in the frequency and duration of bouts of rest/activity and sleep/wake in Vipr2(-/-) mice than in wild type (WT) and short "ultradian" episodes of arousal were more prominent, especially in constant conditions (DD). Activity was an important determinant of circadian variation in BP and HR in animals of both genotypes; altered timing of episodes of activity and rest (as well as sleep and wakefulness) across the day accounted for most of the difference between Vipr2(-/-) mice and WT. However, there was also a modest circadian rhythm of resting HR and BP that was independent of LA. Conclusions/Significance: If appropriate methods of analysis are used that take into account sleep and locomotor activity level, mice are a good model for understanding the contribution of circadian timing to cardiovascular function. Future studies of the influence of sleep and wakefulness on cardiovascular physiology may help to explain accumulating evidence linking disrupted sleep with cardiovascular disease in man.	[Sheward, W. John; Brooker, Gillian A.; Seckl, Jonathan R.; Holmes, Megan C.; Harmar, Anthony J.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Naylor, Erik; Zee, Phyllis C.] Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Knowles-Barley, Seymour; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Turek, Fred W.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Edinburgh; Northwestern University; University of Edinburgh; Northwestern University	Sheward, WJ (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	tony.harmar@ed.ac.uk	Seckl, Jonathan R/C-3555-2013; Zee, Phyllis C/GPF-3704-2022	Armstrong, Douglas/0000-0002-5397-3864; Naylor, Erik/0000-0002-7508-9244; Harmar, Anthony/0000-0002-3838-9264	Medical Research Council [G9719726]; Wellcome Trust; British Heart Foundation Centre of Research Excellence Award [RE/08/001]; National Institutes of Health (NIH) [T32 AG020506-02]; EPSRC; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER; Medical Research Council [G0700704B] Funding Source: researchfish; MRC [G9719726] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation Centre of Research Excellence Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (G9719726) and the Wellcome Trust. The authors also acknowledge the support of the British Heart Foundation Centre of Research Excellence Award RE/08/001. E.N. was supported by National Institutes of Health (NIH) training grant T32 AG020506-02 and S.K.-B. by the EPSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZ HR, 1993, CIRCULATION, V88, P2284, DOI 10.1161/01.CIR.88.5.2284; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Ibuka N, 1980, Waking Sleeping, V4, P167; JANSSEN BJA, 1994, PHYSIOL BEHAV, V55, P307, DOI 10.1016/0031-9384(94)90138-4; Kerkhof GA, 1998, AM J HYPERTENS, V11, P373, DOI 10.1016/S0895-7061(97)00461-5; Kim SM, 2008, AM J PHYSIOL-REG I, V294, pR1427, DOI 10.1152/ajpregu.00074.2008; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; KRAUCHI K, 1994, AM J PHYSIOL, V267, pR819, DOI 10.1152/ajpregu.1994.267.3.R819; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Laposky AD, 2008, AM J PHYSIOL-REG I, V295, pR2059, DOI 10.1152/ajpregu.00026.2008; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; LEHMANN U, 1976, INT J CHRONOBIOL, V4, P223; Malhotra A, 2009, PROG CARDIOVASC DIS, V51, P279, DOI 10.1016/j.pcad.2008.10.004; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Naylor E, 2000, J NEUROSCI, V20, P8138; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; SANO H, 1995, JPN CIRC J, V59, P565, DOI 10.1253/jcj.59.565; Scheer FAJL, 1999, J BIOL RHYTHM, V14, P202, DOI 10.1177/074873099129000614; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Sei H, 2008, ENDOCRINOLOGY, V149, P3576, DOI 10.1210/en.2007-1714; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Swoap SJ, 2004, AM J PHYSIOL-REG I, V286, pR108, DOI 10.1152/ajpregu.00405.2003; Turek FW DC, 2005, PRINCIPLES PRACTICE, P318; Van Dongen HPA, 2001, CHRONOBIOL INT, V18, P85, DOI 10.1081/CBI-100001178; Van Vliet BN, 2003, J PHYSIOL-LONDON, V549, P313, DOI 10.1113/jphysiol.2003.041897; Vandewalle G, 2007, J SLEEP RES, V16, P148, DOI 10.1111/j.1365-2869.2007.00581.x; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; WELSH DK, 1986, J COMP PHYSIOL A, V158, P827, DOI 10.1007/BF01324824; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20	51	57	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9783	10.1371/journal.pone.0009783	http://dx.doi.org/10.1371/journal.pone.0009783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339544	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894300016
J	Hartman, AL; Norais, C; Badger, JH; Delmas, S; Haldenby, S; Madupu, R; Robinson, J; Khouri, H; Ren, QH; Lowe, TM; Maupin-Furlow, J; Pohlschroder, M; Daniels, C; Pfeiffer, F; Allers, T; Eisen, JA				Hartman, Amber L.; Norais, Cedric; Badger, Jonathan H.; Delmas, Stephane; Haldenby, Sam; Madupu, Ramana; Robinson, Jeffrey; Khouri, Hoda; Ren, Qinghu; Lowe, Todd M.; Maupin-Furlow, Julie; Pohlschroder, Mecky; Daniels, Charles; Pfeiffer, Friedhelm; Allers, Thorsten; Eisen, Jonathan A.			The Complete Genome Sequence of Haloferax volcanii DS2, a Model Archaeon	PLOS ONE			English	Article							HALOBACTERIUM SPECIES NRC-1; HALOPHILIC ARCHAEON; ESCHERICHIA-COLI; IN-VIVO; PHOSPHOTRANSFERASE SYSTEM; HALOARCULA-HISPANICA; RNA POLYADENYLATION; SIGNAL-TRANSDUCTION; PYROCOCCUS-ABYSSI; BACTERIAL GENOMES	Background: Haloferax volcanii is an easily culturable moderate halophile that grows on simple defined media, is readily transformable, and has a relatively stable genome. This, in combination with its biochemical and genetic tractability, has made Hfx. volcanii a key model organism, not only for the study of halophilicity, but also for archaeal biology in general. Methodology/Principal Findings: We report here the sequencing and analysis of the genome of Hfx. volcanii DS2, the type strain of this species. The genome contains a main 2.848 Mb chromosome, three smaller chromosomes pHV1, 3, 4 (85, 438, 636 kb, respectively) and the pHV2 plasmid (6.4 kb). Conclusions/Significance: The completed genome sequence, presented here, provides an invaluable tool for further in vivo and in vitro studies of Hfx. volcanii.	[Hartman, Amber L.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Hartman, Amber L.; Badger, Jonathan H.; Madupu, Ramana; Robinson, Jeffrey; Khouri, Hoda; Ren, Qinghu; Eisen, Jonathan A.] J Craig Venter Inst, Inst Genom Res, Rockville, MD USA; [Norais, Cedric] Univ Paris Sud, Inst Genet & Microbiol, Paris, France; [Lowe, Todd M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Maupin-Furlow, Julie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Pohlschroder, Mecky] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Delmas, Stephane; Haldenby, Sam; Allers, Thorsten] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England; [Daniels, Charles] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Hartman, Amber L.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Pfeiffer, Friedhelm] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Norais, Cedric] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	Johns Hopkins University; J. Craig Venter Institute; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; University of Pennsylvania; University of Nottingham; University System of Ohio; Ohio State University; University of California System; University of California Davis; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Hartman, AL (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	jaeisen@ucdavis.edu	Maupin-Furlow, Julie/AAW-4035-2020; Uthandi, Sivakumar/C-3277-2018; Allers, Thorsten/G-5503-2010; Eisen, Jonathan A./H-2706-2019; Pfeiffer, Friedhelm/K-1757-2019; Lowe, Todd Michael/ABJ-5261-2022; Pohlschroder, Mechy/P-3206-2019	Maupin-Furlow, Julie/0000-0001-6105-0923; Uthandi, Sivakumar/0000-0002-7116-1317; Allers, Thorsten/0000-0002-7308-3332; Eisen, Jonathan A./0000-0002-0159-2197; Pfeiffer, Friedhelm/0000-0003-4691-3246; Scholz, Amber/0000-0002-3461-0881; Delmas, Stephane/0000-0001-5523-7548	National Science Foundation [EF-024349, EF-0949453]; Biotechnology and Biological Sciences Research Council [BB/C501641/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The genome sequencing and initial analysis of the data was supported by grant EF-024349 from the National Science Foundation. Later work was supported in part by grant EF-0949453 from the National Science Foundation. Additional funding came from multiple sources supporting the work in labs other than the Eisen lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Alloing G, 2006, J BACTERIOL, V188, P6308, DOI 10.1128/JB.00585-06; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beard SJ, 2002, FEMS MICROBIOL LETT, V213, P149, DOI 10.1111/j.1574-6968.2002.tb11299.x; Bertani G, 1999, J BACTERIOL, V181, P2992, DOI 10.1128/JB.181.10.2992-3002.1999; Bidle KA, 2008, MICROBIOL-SGM, V154, P1436, DOI 10.1099/mic.0.2007/015586-0; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brenneis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004484; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; CHARLEBOIS RL, 1991, J MOL BIOL, V222, P509, DOI 10.1016/0022-2836(91)90493-P; CHARLEBOIS RL, 1987, P NATL ACAD SCI USA, V84, P8530, DOI 10.1073/pnas.84.23.8530; CHARLEBOIS RL, 1989, CAN J MICROBIOL, V35, P21, DOI 10.1139/m89-004; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; CLINE SW, 1992, J BACTERIOL, V174, P1076, DOI 10.1128/jb.174.3.1076-1080.1992; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; COHEN A, 1992, P NATL ACAD SCI USA, V89, P1602, DOI 10.1073/pnas.89.5.1602; Crowley David J, 2006, Saline Syst, V2, P11, DOI 10.1186/1746-1448-2-11; DasSarma S, 2001, PHOTOSYNTH RES, V70, P3, DOI 10.1023/A:1013879706863; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; DOOLITTLE WF, 1992, BIOCHEM SOC SYMP, P73; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Eisen JA, 1997, NAT MED, V3, P1076, DOI 10.1038/nm1097-1076; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; EISEN JA, 1999, EVOLUTION DNA REPAIR; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Ferrer C, 1996, J BACTERIOL, V178, P309, DOI 10.1128/jb.178.1.309-313.1996; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; Guy CP, 2006, J MOL BIOL, V358, P46, DOI 10.1016/j.jmb.2006.02.010; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hand NJ, 2006, J BACTERIOL, V188, P1251, DOI 10.1128/JB.188.4.1251-1259.2006; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Helm RA, 2003, GENETICS, V165, P951; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; HOFMAN JD, 1986, NUCLEIC ACIDS RES, V14, P6983, DOI 10.1093/nar/14.17.6983; Holmes ML, 2000, MOL MICROBIOL, V36, P114, DOI 10.1046/j.1365-2958.2000.01832.x; HOLMES ML, 1991, J BACTERIOL, V173, P3807, DOI 10.1128/JB.173.12.3807-3813.1991; HOLMES ML, 1991, J BACTERIOL, V173, P642, DOI 10.1128/jb.173.2.642-648.1991; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jokela M, 2004, NUCLEIC ACIDS RES, V32, P2430, DOI 10.1093/nar/gkh558; Karadzic IM, 2005, PROTEOMICS, V5, P354, DOI 10.1002/pmic.200400950; Kirkland PA, 2008, J PROTEOME RES, V7, P5033, DOI 10.1021/pr800517a; Kirkland PA, 2006, ANAL BIOCHEM, V351, P254, DOI 10.1016/j.ab.2006.01.017; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; Konrad Z, 2002, FEMS MICROBIOL LETT, V209, P197, DOI 10.1111/j.1574-6968.2002.tb11131.x; Konrad Z, 2002, BIOCHEM J, V366, P959, DOI 10.1042/BJ20020757; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurz Matthias, 2006, Saline Syst, V2, P10, DOI 10.1186/1746-1448-2-10; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; LOPEZGARCIA P, 1995, J BACTERIOL, V177, P1405, DOI 10.1128/jb.177.5.1405-1408.1995; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACKWAN RR, 2006, GENETICS; MacNeill SA, 2009, BIOCHEM SOC T, V37, P108, DOI 10.1042/BST0370108; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; McCready S, 1996, MUTAT RES-DNA REPAIR, V364, P25, DOI 10.1016/0921-8777(96)00018-3; McGeoch AT, 2008, NAT REV MOL CELL BIO, V9, P569, DOI 10.1038/nrm2426; Mesiet-Cladiere L, 2007, J MOL BIOL, V372, P1137, DOI 10.1016/j.jmb.2007.06.056; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; MEVARECH M, 1985, J BACTERIOL, V162, P461, DOI 10.1128/JB.162.1.461-462.1985; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; MOJICA FJM, 1994, J BACTERIOL, V176, P4966, DOI 10.1128/jb.176.16.4966-4973.1994; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; MORIMOTO S, 2007, GENOME LEVEL T UNPUB; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; Nandi Tannistha, 2004, In Silico Biology, V4, P573; Ng SYM, 2008, J BACTERIOL, V190, P6039, DOI 10.1128/JB.00546-08; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; OREN A, 2008, CORRECT NAMES TAXA F; Ortenberg R, 2000, MOL MICROBIOL, V35, P1493, DOI 10.1046/j.1365-2958.2000.01815.x; PALMER JR, 1995, J BACTERIOL, V177, P1844, DOI 10.1128/jb.177.7.1844-1849.1995; PFEIFER F, 1985, MOL GEN GENET, V198, P449, DOI 10.1007/BF00332938; PFEIFER F, 1990, NUCLEIC ACIDS RES, V18, P6921, DOI 10.1093/nar/18.23.6921; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Reuter CJ, 2004, APPL ENVIRON MICROB, V70, P7530, DOI 10.1128/AEM.70.12.7530-7538.2004; Robinson JL, 2005, J BACTERIOL, V187, P923, DOI 10.1128/JB.187.3.923-929.2005; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; ROBINSON NP, 2007, P NATL ACAD SCI US; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rochette PJ, 2003, NUCLEIC ACIDS RES, V31, P2786, DOI 10.1093/nar/gkg402; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rose RW, 2002, J BACTERIOL, V184, P3260, DOI 10.1128/JB.184.12.3260-3267.2002; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Sandler SJ, 1999, J BACTERIOL, V181, P907, DOI 10.1128/JB.181.3.907-915.1999; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; SAPIENZA C, 1982, NATURE, V299, P182, DOI 10.1038/299182a0; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schneider M, 2004, PLANT PHYSIOL BIOCH, V42, P1013, DOI 10.1016/j.plaphy.2004.10.009; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Shingaki R, 2003, CAN J MICROBIOL, V49, P313, DOI 10.1139/W03-041; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; SIMSEK M, 1982, P NATL ACAD SCI-BIOL, V79, P7268, DOI 10.1073/pnas.79.23.7268; Soppa J, 2009, BIOCHEM SOC T, V37, P133, DOI 10.1042/BST0370133; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; TRIESELMANN BA, 1992, J BACTERIOL, V174, P30, DOI 10.1128/jb.174.1.30-34.1992; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; VOLCANI BE, 1936, NATURE; Ward N, 2001, NATURE, V414, P148, DOI 10.1038/35102737; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wimmer F, 2008, FEBS LETT, V582, P3771, DOI 10.1016/j.febslet.2008.10.004; Woods WG, 1999, J BACTERIOL, V181, P7140, DOI 10.1128/JB.181.22.7140-7142.1999; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Wuichet K, 2007, METHOD ENZYMOL, V422, P3, DOI 10.1016/S0076-6879(06)22001-9; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; YURISTDOUTSCH S, 2009, J BACTERIOL; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041; Zhao A, 2006, MOL MICROBIOL, V59, P743, DOI 10.1111/j.1365-2958.2005.04975.x; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	164	183	378	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9605	10.1371/journal.pone.0009605	http://dx.doi.org/10.1371/journal.pone.0009605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333302	Green Submitted, Green Published, gold			2022-12-27	WOS:000275809700003
J	Mahajan, K; Coppola, D; Challa, S; Fang, B; Chen, YA; Zhu, WW; Lopez, AS; Koomen, J; Engelman, RW; Rivera, C; Muraoka-Cook, RS; Cheng, JQ; Schonbrunn, E; Sebti, SM; Earp, HS; Mahajan, NP				Mahajan, Kiran; Coppola, Domenico; Challa, Sridevi; Fang, Bin; Chen, Y. Ann; Zhu, Weiwei; Lopez, Alexis S.; Koomen, John; Engelman, Robert W.; Rivera, Charlene; Muraoka-Cook, Rebecca S.; Cheng, Jin Q.; Schoenbrunn, Ernst; Sebti, Said M.; Earp, H. Shelton; Mahajan, Nupam P.			Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation	PLOS ONE			English	Article							PROTEIN-KINASE-B; PLECKSTRIN HOMOLOGY DOMAIN; FOXO TRANSCRIPTION FACTORS; CANCER DRUG DISCOVERY; BREAST-CANCER; ONCOGENIC TRANSFORMATION; PHOSPHATIDIC-ACID; PI3K/AKT PATHWAY; AKT PATHWAY; GENE	The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development. Most studies have focused on its activation by Receptor Tyrosine Kinase (RTK) mediated Phosphatidylinositol-3-OH kinase (PI3K) activation or loss of Phosphatase and Tensin homolog (PTEN). We have uncovered that growth factors binding to RTKs lead to activation of a non-receptor tyrosine kinase, Ack1 (also known as ACK or TNK2), which directly phosphorylates AKT at an evolutionarily conserved tyrosine 176 in the kinase domain. Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation. Mice expressing activated Ack1 specifically in the prostate exhibit AKT Tyr176-phosphorylation and develop murine prostatic intraepithelial neoplasia (mPINs). Further, expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1 were positively correlated with the severity of disease progression, and inversely correlated with the survival of breast cancer patients. Thus, RTK/Ack1/AKT pathway provides a novel target for drug discovery.	[Mahajan, Kiran; Challa, Sridevi; Schoenbrunn, Ernst; Sebti, Said M.; Mahajan, Nupam P.] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL USA; [Coppola, Domenico; Lopez, Alexis S.; Engelman, Robert W.] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL USA; [Fang, Bin; Koomen, John] H Lee Moffitt Canc Ctr & Res Inst, Prote Facil, Tampa, FL USA; [Chen, Y. Ann; Zhu, Weiwei] H Lee Moffitt Canc Ctr & Res Inst, Div Biostat, Tampa, FL USA; [Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Rivera, Charlene; Muraoka-Cook, Rebecca S.; Earp, H. Shelton] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Mahajan, K (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL USA.	nupam.mahajan@moffitt.org	Mahajan, Kiran/ABA-3013-2020; Koomen, John/D-1844-2013	Mahajan, Kiran/0000-0001-7192-396X; Chen, yian/0000-0003-1468-3490; CHALLA, SRIDEVI/0000-0002-5308-9243; Schonbrunn, Ernst/0000-0002-3589-3510	Moffitt Support Grant; National Institutes of Health (NIH) [R01CA120304]; Department of Defense [W81XWH-09-1-0187]; NATIONAL CANCER INSTITUTE [R01CA120304] Funding Source: NIH RePORTER	Moffitt Support Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was funded by Moffitt Support Grant (to N. P. M.). This work was partially supported by grants from National Institutes of Health (NIH) (R01CA120304 to H. S. E.) and the Department of Defense (W81XWH-09-1-0187 to C. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kiyono M, 2000, J BIOL CHEM, V275, P29788, DOI 10.1074/jbc.M001378200; MAHAJAN K, 2010, PROSTATE MA IN PRESS; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Matsumoto J, 2002, JPN J CANCER RES, V93, P1317, DOI 10.1111/j.1349-7006.2002.tb01240.x; Panigrahi AR, 2004, J PATHOL, V204, P93, DOI 10.1002/path.1611; Sakurada A, 1997, JPN J CANCER RES, V88, P1025, DOI 10.1111/j.1349-7006.1997.tb00324.x; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SANTI SA, 2009, AM J PHYSL CELL PHYS; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Tibes R, 2008, BRIT J HAEMATOL, V140, P344, DOI 10.1111/j.1365-2141.2007.06920.x; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	45	106	124	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9646	10.1371/journal.pone.0009646	http://dx.doi.org/10.1371/journal.pone.0009646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333297	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809700005
J	Cai, QL; Verma, SC; Kumar, P; Ma, M; Robertson, ES				Cai, Qiliang; Verma, Suhbash C.; Kumar, Pankaj; Ma, Michelle; Robertson, Erle S.			Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification	PLOS ONE			English	Article							HIPPEL-LINDAU GENE; KAPPA-B ACTIVATION; TRANSCRIPTIONAL ACTIVITY; FIBRONECTIN MATRIX; NUCLEAR EXPORT; P53 ACTIVITY; DNA-BINDING; IN-VIVO; PROTEIN; PVHL	The hypoxic microenvironment contributes to embryonic development and tumor progression through stabilization of the potent transcriptional factor HIF alpha. In normoxia, the tumor suppressor protein VHL acts as an E3 ubiquitin ligase to target HIFa for proteolytic destruction. Increasing evidence shows that VHL is a multifunctional adaptor involved in inhibition of HIF alpha-dependent and independent cellular processes. However, the molecular effect of hypoxic stress on VHL functions remains elusive. Here we report that PIASy, a SUMO E3 ligase upregulated in hypoxia, interacts with VHL and induces VHL SUMOylation on lysine residue 171. Moreover, PIASy-mediated SUMO1 modification induces VHL oligomerization and abrogates its inhibitory function on tumor cell growth, migration and clonogenicity. Knockdown of PIASy by small interfering RNA leads to reduction of VHL oligomerization and increases HIF1 alpha degradation. These findings reveal a unique molecular strategy for inactivation of VHL under hypoxic stress.	[Cai, Qiliang] Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Cai, QL (corresponding author), Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA.	erle@upenn.edu			National Cancer Institute [5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01, 1R01CA138434-01A209]; National Institute of Allergy and Infectious Diseases [5R01AI067037-04]; National Institute of Dental and Craniofacial Research [5R01DE017338-03]; NATIONAL CANCER INSTITUTE [R01CA108461, R00CA126182, R01CA137894, R01CA091792, R01CA138434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Cancer Institute 5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01 and 1R01CA138434-01A209; National Institute of Allergy and Infectious Diseases 5R01AI067037-04 and National Institute of Dental and Craniofacial Research 5R01DE017338-03 (to ESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lieubeau-Teillet B, 1998, CANCER RES, V58, P4957; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Patocs A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-29; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; RUSSELL RC, 2008, EMBO REP; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; VANHAGEN M, 2009, NUCL ACIDS RES; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010	52	74	78	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9720	10.1371/journal.pone.0009720	http://dx.doi.org/10.1371/journal.pone.0009720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300531	Green Published, Green Submitted, gold			2022-12-27	WOS:000275716400018
J	Onum, H; Tabara, Y; Kawamura, R; Tanaka, T; Ohashi, J; Nishida, W; Takata, Y; Ochi, M; Yamada, K; Kawamoto, R; Kohara, K; Miki, T; Makino, H; Osawa, H				Onum, Hiroshi; Tabara, Yasuharu; Kawamura, Ryoichi; Tanaka, Takashi; Ohashi, Jun; Nishida, Wataru; Takata, Yasunori; Ochi, Masaaki; Yamada, Kazuya; Kawamoto, Ryuichi; Kohara, Katsuhiko; Miki, Tetsuro; Makino, Hideichi; Osawa, Haruhiko			A at Single Nucleotide Polymorphism-358 Is Required for G at-420 to Confer the Highest Plasma Resistin in the General Japanese Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; SERUM RESISTIN; MESSENGER-RNA; ASSOCIATION; PROMOTER; MACROPHAGES; GENOTYPE; GLUCOSE; OBESITY	Insulin resistance is a feature of type 2 diabetes. Resistin, secreted from adipocytes, causes insulin resistance in mice. We previously reported that the G/G genotype of single nucleotide polymorphism (SNP) at 2420 (rs1862513) in the human resistin gene (RETN) increased susceptibility to type 2 diabetes by enhancing its promoter activity. Plasma resistin was highest in Japanese subjects with G/G genotype, followed by C/G, and C/C. In this study, we cross-sectionally analyzed plasma resistin and SNPs in the RETN region in 2,019 community-dwelling Japanese subjects. Plasma resistin was associated with SNP-638 (rs34861192), SNP-537 (rs34124816), SNP-420, SNP-358 (rs3219175), SNP+299 (rs3745367), and SNP+1263 (rs3745369) (P, 10(-13) in all cases). SNP-638, SNP -420, SNP-358, and SNP+157 were in the same linkage disequilibrium (LD) block. SNP-358 and SNP-638 were nearly in complete LD (r(2) = 0.98), and were tightly correlated with SNP-420 (r(2) = 0.50, and 0.51, respectively). The correlation between either SNP-358 (or SNP-638) or SNP-420 and plasma resistin appeared to be strong (risk alleles for high plasma resistin; A at SNP-358, r(2) = 0.5224, P = 4.94610 2324; G at SNP-420, r(2) = 0.2616, P = 1.71610(-133)). In haplotypes determined by SNP-420 and SNP-358, the estimated frequencies for C-G, G-A, and G-G were 0.6700, 0.2005, and 0.1284, respectively, and C-A was rare (0.0011), suggesting that subjects with A at 2358, generally had G at -420. This G-A haplotype conferred the highest plasma resistin (8.24 ng/ml difference/allele compared to C-G, P < 0.0001). In THP-1 cells, the RETN promoter with the G-A haplotype showed the highest activity. Nuclear proteins specifically recognized one base difference at SNP-358, but not at SNP-638. Therefore, A at -358 is required for G at 2420 to confer the highest plasma resistin in the general Japanese population. In Caucasians, the association between SNP-420 and plasma resistin is not strong, and A at 2358 may not exist, suggesting that SNP-358 could explain this ethnic difference.	[Onum, Hiroshi; Kawamura, Ryoichi; Nishida, Wataru; Takata, Yasunori; Ochi, Masaaki; Makino, Hideichi; Osawa, Haruhiko] Ehime Univ, Dept Mol & Genet Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Onum, Hiroshi; Tabara, Yasuharu; Kohara, Katsuhiko; Miki, Tetsuro; Osawa, Haruhiko] Ehime Univ, Ehime Proteomed Res Ctr, Matsuyama, Ehime 790, Japan; [Tabara, Yasuharu] Ehime Univ, Dept Basic Med Res & Educ, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Tanaka, Takashi] Osaka Ohtani Univ, Fac Pharm, Mol Biol Lab, Osaka, Japan; [Ohashi, Jun] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Life Syst Med Sci, Ibaraki, Japan; [Yamada, Kazuya] Matsumoto Univ, Fac Human Hlth Sci, Dept Hlth & Nutr Sci, Nagano, Japan; [Kawamoto, Ryuichi] Ehime Univ, Dept Community Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Kohara, Katsuhiko; Miki, Tetsuro] Ehime Univ, Dept Geriatr Med, Grad Sch Med, Matsuyama, Ehime 790, Japan	Ehime University; Ehime University; Ehime University; University of Tsukuba; Ehime University; Ehime University	Onum, H (corresponding author), Ehime Univ, Dept Mol & Genet Med, Grad Sch Med, Matsuyama, Ehime 790, Japan.	harosawa@m.ehime-u.ac.jp	OHASHI, JUN/G-5907-2015		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ehime University; Takeda Science Foundation; Setsuro Fujii Memorial; Osaka Foundation for Promotion of Fundamental Medical Research; Mr. Takashi Ikeda	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ehime University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Setsuro Fujii Memorial; Osaka Foundation for Promotion of Fundamental Medical Research; Mr. Takashi Ikeda	This work was supported by grants from Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Ehime University, Takeda Science Foundation, Setsuro Fujii Memorial, the Osaka Foundation for Promotion of Fundamental Medical Research, and by a fund from Mr. Takashi Ikeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO H, 2009, DIABETOLOGIA; Azuma K, 2004, HORM METAB RES, V36, P564, DOI 10.1055/s-2004-825762; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cho YM, 2004, DIABETOLOGIA, V47, P559, DOI 10.1007/s00125-003-1319-x; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; GERBER M, 2005, J CLIN ENDOCRINOL ME; Hivert MF, 2009, DIABETES, V58, P750, DOI 10.2337/db08-1339; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; McCarthy Mark I, 2006, Curr Diab Rep, V6, P147, DOI 10.1007/s11892-006-0026-7; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Osawa H, 2005, BIOCHEM BIOPH RES CO, V335, P596, DOI 10.1016/j.bbrc.2005.07.122; Osawa H, 2002, DIABETES, V51, P863, DOI 10.2337/diabetes.51.3.863; Osawa H, 2007, DIABETES CARE, V30, P1501, DOI 10.2337/dc06-1936; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; QATANANI M, 2009, J CLIN INVEST; Rangwala SM, 2004, DIABETES, V53, P1937, DOI 10.2337/diabetes.53.8.1937; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tejero ME, 2008, HEREDITY, V101, P60, DOI 10.1038/hdy.2008.28	29	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9718	10.1371/journal.pone.0009718	http://dx.doi.org/10.1371/journal.pone.0009718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300528	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400016
J	Parnell, AC; Inger, R; Bearhop, S; Jackson, AL				Parnell, Andrew C.; Inger, Richard; Bearhop, Stuart; Jackson, Andrew L.			Source Partitioning Using Stable Isotopes: Coping with Too Much Variation	PLOS ONE			English	Article							MIXING MODELS; TROPHIC STRUCTURE; CONSUMER-DIET; ECOLOGY; NICHE; UNCERTAINTY	Background: Stable isotope analysis is increasingly being utilised across broad areas of ecology and biology. Key to much of this work is the use of mixing models to estimate the proportion of sources contributing to a mixture such as in diet estimation. Methodology: By accurately reflecting natural variation and uncertainty to generate robust probability estimates of source proportions, the application of Bayesian methods to stable isotope mixing models promises to enable researchers to address an array of new questions, and approach current questions with greater insight and honesty. Conclusions: We outline a framework that builds on recently published Bayesian isotopic mixing models and present a new open source R package, SIAR. The formulation in R will allow for continued and rapid development of this core model into an all-encompassing single analysis suite for stable isotope research.	[Parnell, Andrew C.] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland; [Inger, Richard; Bearhop, Stuart] Univ Exeter, Ctr Ecol & Conservat, Sch Biosci, Penryn, Cornwall, England; [Jackson, Andrew L.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland	University College Dublin; University of Exeter; Trinity College Dublin	Parnell, AC (corresponding author), Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland.	A.Jackson@tcd.ie	Parnell, Andrew/C-7284-2014; Jackson, Andrew L/D-3441-2009; Bearhop, Stuart/G-3105-2012; Inger, Richard/D-3445-2009	Parnell, Andrew/0000-0001-7956-7939; Jackson, Andrew L/0000-0001-7334-0434; Bearhop, Stuart/0000-0002-5864-0129; Inger, Richard/0000-0003-1660-3706	NERC [NE/ F021690/1]; Natural Environment Research Council [NE/F021690/1] Funding Source: researchfish; NERC [NE/F021690/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Authors AJ, AP and SB hold faculty positions in their respective institutions. No other funds are directly linked to the work described in this manuscript. RI is funded as a postdoctoral researcher on NERC standard grant NE/ F021690/1 http://www.nerc.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Cremona F, 2009, BIOGEOCHEMISTRY, V94, P81, DOI 10.1007/s10533-009-9309-9; Evans M., 1993, STAT DISTRIBUTIONS; Gibbs MM, 2008, ESTUAR COAST, V31, P344, DOI 10.1007/s12237-007-9012-9; Hall-Aspland SA, 2005, OECOLOGIA, V143, P143, DOI 10.1007/s00442-004-1783-0; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Parnell A., 2008, SIAR STABLE ISOTOPE; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Samelius G, 2007, J ANIM ECOL, V76, P873, DOI 10.1111/j.1365-2656.2007.01278.x; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Semmens BX, 2009, ECOL LETT, V12, pE6, DOI 10.1111/j.1461-0248.2009.01283.x; Soto-Jimenez MF, 2008, MAR ENVIRON RES, V66, P451, DOI 10.1016/j.marenvres.2008.07.009; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wilson RM, 2009, ESTUAR COAST, V32, P999, DOI 10.1007/s12237-009-9183-7; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	26	1981	2076	48	666	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9672	10.1371/journal.pone.0009672	http://dx.doi.org/10.1371/journal.pone.0009672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300637	Green Published, gold			2022-12-27	WOS:000275620900007
J	Hsieh, PJ; Tse, PU				Hsieh, Po-Jang; Tse, Peter U.			BOLD Signal in Both Ipsilateral and Contralateral Retinotopic Cortex Modulates with Perceptual Fading	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; FILLING-IN; VISUOMOTOR CONTROL; DISTINCT MODES; ATTENTION; BRIGHTNESS; AREAS; FIELD; TASK; REPRESENTATION	Under conditions of visual fixation, perceptual fading occurs when a stationary object, though present in the world and continually casting light upon the retina, vanishes from visual consciousness. The neural correlates of the consciousness of such an object will presumably modulate in activity with the onset and cessation of perceptual fading. Method: In order to localize the neural correlates of perceptual fading, a green disk that had been individually set to be equiluminant with the orange background, was presented in one of the four visual quadrants; Subjects indicated with a button press whether or not the disk was subjectively visible as it perceptually faded in and out. Results: Blood oxygen-level dependent (BOLD) signal in V1 and ventral retinotopic areas V2v and V3v decreases when the disk subjectively disappears, and increases when it subjectively reappears. This effect occurs in early visual areas both ipsilaterally and contralaterally to the fading figure. That is, it occurs regardless of whether the fading stimulus is presented inside or outside of the corresponding portion of visual field. In addition, we find that the microsaccade rate rises before and after perceptual transitions from not seeing to seeing the disk, and decreases before perceptual transitions from seeing to not seeing the disk. These BOLD signal changes could be driven by a global process that operates across contralateral and ipsilateral visual cortex or by a confounding factor, such as microsaccade rate.	[Hsieh, Po-Jang; Tse, Peter U.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Hsieh, PJ (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	pjh@mit.edu			NIH [R03 MH0609660-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by NIH R03 MH0609660-01 grant to PUT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; ANSTIS S, COLOUR VISION PHYSL, P156; ARRINGTON KF, 1994, VISION RES, V34, P3371, DOI 10.1016/0042-6989(94)90071-X; Binsted G, 2005, EXP BRAIN RES, V162, P89, DOI 10.1007/s00221-004-2108-6; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BREWER AA, 2004, SOC NEUR M; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Caplovitz GR, 2008, HUM BRAIN MAPP, V29, P651, DOI 10.1002/hbm.20429; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Danckert J, 2001, EXP BRAIN RES, V137, P303; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GERRITS HJM, 1966, VISION RES, V6, P427, DOI 10.1016/0042-6989(66)90051-4; GERRITS HJM, 1970, EXPT BRAIN RES, V72, P279; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hagenbeek RF, 2002, BRAIN COGNITION, V49, P34, DOI 10.1006/brcg.2001.1481; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hsieh PJ, 2009, VISION RES, V49, P439, DOI 10.1016/j.visres.2008.12.004; Hsieh PJ, 2006, VISION RES, V46, P2251, DOI 10.1016/j.visres.2005.11.030; HSIEH PJ, 2010, HUMAN BRAIN MAPPING; Hsieh PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005163; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Khan MA, 2005, EXP BRAIN RES, V164, P395, DOI 10.1007/s00221-005-2325-7; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Krigolson A, 2006, EXP BRAIN RES, V170, P127, DOI 10.1007/s00221-006-0386-x; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Macknik S. L., 2009, COGNITIVE NEUROSCIEN; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2007, SCI AM, V297, P56, DOI 10.1038/scientificamerican0807-56; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Neumann H, 2001, BIOL CYBERN, V85, P355, DOI 10.1007/s004220100258; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; Previc F H, 1995, Int J Neurosci, V80, P247, DOI 10.3109/00207459508986103; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Spillmann L., 2003, FILLING IN PERCEPTUA, P81, DOI DOI 10.1093/ACPROF:OSO/9780195140132.003.0005; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; Tse PU, 2010, NEUROIMAGE, V49, P805, DOI 10.1016/j.neuroimage.2009.07.052; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; VONGRUNAU M, 1994, PERCEPT PSYCHOPHYS, V56, P211, DOI 10.3758/BF03213899; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WHISHAW IQ, 1994, BEHAV BRAIN SCI, V17, P173, DOI 10.1017/S0140525X00033884	67	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9638	10.1371/journal.pone.0009638	http://dx.doi.org/10.1371/journal.pone.0009638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300177	Green Submitted, gold, Green Published			2022-12-27	WOS:000275620600003
J	Leeansyah, E; Zhou, JL; Paukovics, G; Lewin, SR; Crowe, SM; Jaworowski, A				Leeansyah, Edwin; Zhou, Jingling; Paukovics, Geza; Lewin, Sharon R.; Crowe, Suzanne M.; Jaworowski, Anthony			Decreased NK Cell FcR gamma in HIV-1 Infected Individuals Receiving Combination Antiretroviral Therapy: a Cross Sectional Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD8 T-LYMPHOCYTES; HIV-1 INFECTION; IMMUNE ACTIVATION; SIGNALING CHAIN; ZETA MOLECULES; EXPRESSION; DEPLETION; CD3-ZETA; PHAGOCYTOSIS	Background: FcR gamma is an immunoreceptor tyrosine-based activation motif (ITAM)-signalling protein essential for immunoreceptor signaling and monocyte, macrophage and NK cell function. Previous study from our laboratory showed that FcR gamma is down-regulated in HIV-infected macrophages in vitro. FcR gamma expression in immune cells present in HIV-infected individuals is unknown. Methodology/Principal Findings: We compared FcR gamma expression in peripheral blood mononuclear cells isolated from HIV-1-infected individuals receiving combination antiretroviral therapy and healthy, HIV-1-uninfected individuals. FcR gamma mRNA and protein levels were measured using quantitative real-time PCR and immunoblotting, respectively. CD56(+) CD94(+) lymphocytes isolated from blood of HIV-1 infected individuals had reduced FcR gamma protein expression compared to HIV-uninfected individuals (decrease = 76.8%, n = 18 and n = 12 respectively, p = 0.0036). In a second group of patients, highly purified NK cells had reduced FcR gamma protein expression compared to uninfected controls (decrease = 50.2%, n = 9 and n = 8 respectively, p = 0.021). Decreased FcR gamma expression in CD56(+) CD94(+) lymphocytes was associated with reduced mRNA (51.7%, p = 0.021) but this was not observed for the smaller group of patients analysed for NK cell expression (p = 0.36). Conclusion/Significance: These data suggest biochemical defects in ITAM-dependent signalling within NK cells in HIV-infected individuals which is present in the context of treatment with combination antiretroviral therapy.	[Leeansyah, Edwin; Zhou, Jingling; Paukovics, Geza; Lewin, Sharon R.; Crowe, Suzanne M.; Jaworowski, Anthony] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia; [Leeansyah, Edwin; Lewin, Sharon R.; Crowe, Suzanne M.; Jaworowski, Anthony] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Alfred Hosp, Infect Dis Unit, Melbourne, Vic 3181, Australia	Burnet Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Leeansyah, E (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia.	anthonyj@burnet.edu.au	Lewin, Sharon/Z-3297-2019; Leeansyah, Edwin/J-1017-2019	Leeansyah, Edwin/0000-0003-0505-4967; Lewin, Sharon Ruth/0000-0002-0330-8241; jaworowski, anthony/0000-0002-3844-805X	National Health and Medical Research Council (NHMRC) [358399, 543137]; Australian Postgraduate Award; NHMRC	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Grants 358399 and 543137. EL was a recipient of an Australian Postgraduate Award and SMC is of an NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram C.L., 2007, SCI STKE, V2007, pre2; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL, V173, P5305, DOI 10.4049/jimmunol.173.8.5305; Arase H, 2001, J IMMUNOL, V166, P21, DOI 10.4049/jimmunol.166.1.21; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Geertsma MF, 1999, J INFECT DIS, V180, P649, DOI 10.1086/314941; Geertsma MF, 1999, FEMS IMMUNOL MED MIC, V26, P249, DOI 10.1016/S0928-8244(99)00151-0; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gomez G, 2005, J IMMUNOL, V174, P5987, DOI 10.4049/jimmunol.174.10.5987; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Juang YT, 2007, J IMMUNOL, V179, P4884, DOI 10.4049/jimmunol.179.7.4884; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Leeansyah E, 2007, J IMMUNOL, V178, P1096, DOI 10.4049/jimmunol.178.2.1096; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Rellahan BL, 1998, J IMMUNOL, V160, P2794; Solomon A, 2003, J INFECT DIS, V187, P1915, DOI 10.1086/375351; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tarazona R, 2002, J CLIN IMMUNOL, V22, P176, DOI 10.1023/A:1015476114409; Tridandapani S, 2003, J IMMUNOL, V170, P4572, DOI 10.4049/jimmunol.170.9.4572; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9643	10.1371/journal.pone.0009643	http://dx.doi.org/10.1371/journal.pone.0009643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224795	Green Published, gold			2022-12-27	WOS:000275328800034
J	Erhardt, M; Wegrzyn, RD; Deuerling, E				Erhardt, Marc; Wegrzyn, Renee D.; Deuerling, Elke			Extra N-Terminal Residues Have a Profound Effect on the Aggregation Properties of the Potential Yeast Prion Protein Mca1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; URE2 PROTEIN; PROPAGATION; INHERITANCE; HSP104; PSI; CHAPERONE; FEATURES; ELEMENT; SYSTEM	The metacaspase Mca1 from Saccharomyces cerevisiae displays a Q/N-rich region at its N-terminus reminiscent of yeast prion proteins. In this study, we show that the ability of Mca1 to form insoluble aggregates is modulated by a peptide stretch preceding its putative prion-forming domain. Based on its genomic locus, three potential translational start sites of Mca1 can give rise to two slightly different long Mca1 proteins or a short version, Mca1(451/453) and Mca1(432), respectively, although under normal physiological conditions Mca1(432) is the predominant form expressed. All Mca1 variants exhibit the Q/N-rich regions, while only the long variants Mca1(451/453) share an extra stretch of 19 amino acids at their N-terminal end. Strikingly, only long versions of Mca1 but not Mca1(432) revealed pronounced aggregation in vivo and displayed prion-like properties when fused to the C-terminal domain of Sup35 suggesting that the N-terminal peptide element promotes the conformational switch of Mca1 protein into an insoluble state. Transfer of the 19 N-terminal amino acid stretch of Mca1(451) to the N-terminus of firefly luciferase resulted in increased aggregation of luciferase, suggesting a protein destabilizing function of the peptide element. We conclude that the aggregation propensity of the potential yeast prion protein Mca1 in vivo is strongly accelerated by a short peptide segment preceding its Q/N-rich region and we speculate that such a conformational switch might occur in vivo via the usage of alternative translational start sites.	[Erhardt, Marc; Deuerling, Elke] Univ Konstanz, Fachbereich Biol, Constance, Germany; [Wegrzyn, Renee D.] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany	University of Konstanz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Erhardt, M (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	elke.deuerling@uni-konstanz.de		Erhardt, Marc/0000-0001-6292-619X	HFSP (Human Frontier Science Program); DFG (German Science Foundation) [DE-783/3-1]	HFSP (Human Frontier Science Program)(Human Frontier Science Program); DFG (German Science Foundation)(German Research Foundation (DFG))	M. E. gratefully acknowledges scholarship support of the Boehringer Ingelheim Fonds. This work was supported by an Alexander von Humboldt Postdoctoral Fellowship for R. D. W. and grants of the HFSP (Human Frontier Science Program) and of the DFG (German Science Foundation, DE-783/3-1) to E. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Allen KD, 2007, J BIOL CHEM, V282, P3004, DOI 10.1074/jbc.M609597200; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 1996, GENETICS, V144, P1375; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fernandez-Bellot E, 1999, BIOCHEM J, V338, P403, DOI 10.1042/0264-6021:3380403; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Komar AA, 2003, EMBO J, V22, P1199, DOI 10.1093/emboj/cdg103; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	32	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9929	10.1371/journal.pone.0009929	http://dx.doi.org/10.1371/journal.pone.0009929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360952	Green Published, Green Submitted, gold			2022-12-27	WOS:000276163100021
J	Herberich, E; Sikorski, J; Hothorn, T				Herberich, Esther; Sikorski, Johannes; Hothorn, Torsten			A Robust Procedure for Comparing Multiple Means under Heteroscedasticity in Unbalanced Designs	PLOS ONE			English	Article							BACILLUS-SIMPLEX; EVOLUTION CANYON; ANOVA; ADAPTATION	Investigating differences between means of more than two groups or experimental conditions is a routine research question addressed in biology. In order to assess differences statistically, multiple comparison procedures are applied. The most prominent procedures of this type, the Dunnett and Tukey-Kramer test, control the probability of reporting at least one false positive result when the data are normally distributed and when the sample sizes and variances do not differ between groups. All three assumptions are non-realistic in biological research and any violation leads to an increased number of reported false positive results. Based on a general statistical framework for simultaneous inference and robust covariance estimators we propose a new statistical multiple comparison procedure for assessing multiple means. In contrast to the Dunnett or Tukey-Kramer tests, no assumptions regarding the distribution, sample sizes or variance homogeneity are necessary. The performance of the new procedure is assessed by means of its familywise error rate and power under different distributions. The practical merits are demonstrated by a reanalysis of fatty acid phenotypes of the bacterium Bacillus simplex from the "Evolution Canyons" I and II in Israel. The simulation results show that even under severely varying variances, the procedure controls the number of false positive findings very well. Thus, the here presented procedure works well under biologically realistic scenarios of unbalanced group sizes, non-normality and heteroscedasticity.	[Herberich, Esther; Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Sikorski, Johannes] Deutsch Sammlung Mikroorganismen & Zellkulturen G, Braunschweig, Germany	University of Munich; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Herberich, E (corresponding author), Univ Munich, Inst Stat, Munich, Germany.	torsten.hothorn@stat.uni-muenchen.de	Hothorn, Torsten/A-3639-2010; Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020	Hothorn, Torsten/0000-0001-8301-0471; Sikorski, Johannes/0000-0002-1890-5540	Deutsche Forschungsgemeinschaft [SI 1352/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	J.S. received funding from Deutsche Forschungsgemeinschaft, grant number SI 1352/1-2 (http://www.dfg.de). E. H. and T. H. were supported by the Ludwig-Maximilians-Universitat Munchen LMUinnovative project "BioMed-S" (http://www.biomed-s.uni-muenchen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathke AC, 2009, AM STAT, V63, P239, DOI 10.1198/tast.2009.08187; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Boyd WA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001259; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hothorn T., 2009, MULTCOMP SIMULTANEOU; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lee S, 2003, COMMUN STAT-SIMUL C, V32, P987, DOI 10.1081/SAC-120023874; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; MACKINNON JG, 1985, J ECONOMETRICS, V29, P305, DOI 10.1016/0304-4076(85)90158-7; R Core Team, 2020, R LANG ENV STAT COMP; Sarantseva S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008191; Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102; Sikorski J, 2008, FEMS MICROBIOL ECOL, V66, P38, DOI 10.1111/j.1574-6941.2008.00574.x; Sikorski J, 2008, MICROBIOL-SGM, V154, P2416, DOI 10.1099/mic.0.2007/016105-0; TUKEY J. W, 1953, PROBLEM MULTIPLE COM; WEERAHANDI S, 1995, BIOMETRICS, V51, P589, DOI 10.2307/2532947; XU J, 2008, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000294; Xu LW, 2008, COMMUN STAT-THEOR M, V37, P1002, DOI 10.1080/03610920701713252; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	23	205	208	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9788	10.1371/journal.pone.0009788	http://dx.doi.org/10.1371/journal.pone.0009788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360960	Green Published, Green Submitted, gold			2022-12-27	WOS:000276163100001
J	MacLean, D; Elina, N; Havecker, ER; Heimstaedt, SB; Studholme, DJ; Baulcombe, DC				MacLean, Daniel; Elina, Nataliya; Havecker, Ericka R.; Heimstaedt, Susanne B.; Studholme, David J.; Baulcombe, David C.			Evidence for Large Complex Networks of Plant Short Silencing RNAs	PLOS ONE			English	Article							SIRNA BIOGENESIS; EXPANSION; PATHWAY; FAMILY; SET	Background: In plants and animals there are many classes of short RNAs that carry out a wide range of functions within the cell; short silencing RNAs (ssRNAs) of 21-25 nucleotides in length are produced from double-stranded RNA precursors by the protein Dicer and guide nucleases and other proteins to their RNA targets through base pairing interactions. The consequence of this process is degradation of the targeted RNA, suppression of its translation or initiation of secondary ssRNA production. The secondary ssRNAs in turn could then initiate further layers of ssRNA production to form extensive cascades and networks of interacting RNA [1]. Previous empirical analysis in plants established the existence of small secondary ssRNA cascade [2], in which a single instance of this event occurred but it was not known whether there are other more extensive networks of secondary sRNA production. Methodology/Principal Findings: We generated a network by predicting targets of ssRNA populations obtained from high-throughput sequencing experiments. The topology of the network shows it to have power law connectivity distribution, to be dissortative, highly clustered and composed of multiple components. We also identify protein families, PPR and ULP1, that act as hubs within the network. Comparison of the repetition of genomic sub-sequences of ssRNA length between Arabidopsis and E. coli suggest that the network structure is made possible by the underlying repetitiveness in the genome sequence. Conclusions/Significance: Together our results provide good evidence for the existence of a large, robust ssRNA interaction network with distinct regulatory function. Such a network could have a massive effect on the regulation of gene expression via mediation of transcript levels.	[MacLean, Daniel; Heimstaedt, Susanne B.; Studholme, David J.] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Elina, Nataliya] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London, England; [Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Imperial College London; University of Cambridge	MacLean, D (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	dan.maclean@sainsbury-laboratory.ac.uk	Studholme, David/H-6790-2019; MacLean, Dan/C-7046-2013	Studholme, David/0000-0002-3010-6637; MacLean, Dan/0000-0003-1032-0887; Baulcombe, David/0000-0003-0780-6878; Yelina (Elina), Natasha (Nataliya)/0000-0001-9863-1414	Gatsby Charitable Foundation [MEST-CT2004-404273]	Gatsby Charitable Foundation	The work was funded by the Gatsby Charitable Foundation (www.gatsby.org); S. H. was supported by a studentship from Gatsby Charitable Foundation and a Marie Curie Fellowship (MEST-CT2004-404273)(http://mcfa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alon U, 2007, INTRO SYSTEMS BIOL D; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baulcombe DC, 2006, COLD SPRING HARB SYM, V71, P13, DOI 10.1101/sqb.2006.71.052; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Hofacker Ivo L, 2009, Curr Protoc Bioinformatics, VChapter 12, DOI [10.1002/0471250953.bi1202s04, 10.1002/0471250953.bi1202s26]; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Luscombe NM, 2002, GENOME BIOL, V3; MILO R, 2002, SCIENCE, V5594, P763; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; R Development Core Team, 2007, R LANG ENV STAT COMP; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	31	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9901	10.1371/journal.pone.0009901	http://dx.doi.org/10.1371/journal.pone.0009901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360863	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600008
J	Bertaso, F; Roussignol, G; Worley, P; Bockaert, J; Fagni, L; Ango, F				Bertaso, Federica; Roussignol, Gautier; Worley, Paul; Bockaert, Joel; Fagni, Laurent; Ango, Fabrice			Homer1a-Dependent Crosstalk Between NMDA and Metabotropic Glutamate Receptors in Mouse Neurons	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; BETA-GAMMA-SUBUNITS; CHANNEL FUNCTION; CA2+ CHANNELS; MODULATION; HOMER; PROTEINS; ACTIVATION; EXPRESSION; MEMBRANE	Background: A large number of evidences suggest that group-I metabotropic glutamate receptors (mGluR1a, 1b, 1c, 5a, 5b) can modulate NMDA receptor activity. Interestingly, a physical link exists between these receptors through a Homer-Shank multi-protein scaffold that can be disrupted by the immediate early gene, Homer1a. Whether such a versatile link supports functional crosstalk between the receptors is unknown. Methodology/Principal Findings: Here we used biochemical, electrophysiological and molecular biological approaches in cultured mouse cerebellar neurons to investigate this issue. We found that Homer1a or dominant negative Shank3 mutants that disrupt the physical link between the receptors allow inhibition of NMDA current by group-I mGluR agonist. This effect is antagonized by pertussis toxin, but not thapsigargin, suggesting the involvement of a G protein, but not intracellular calcium stores. Also, this effect is voltage-sensitive, being present at negative, but not positive membrane potentials. In the presence of DHPG, an apparent NMDA "tail current'' was evoked by large pulse depolarization, only in neurons transfected with Homer1a. Co-immunoprecipitation experiments showed interaction between G-protein beta gamma subunits and NMDA receptor in the presence of Homer1a and group-I mGluR agonist. Conclusions/Significance: Altogether these results suggest a direct inhibition of NMDA receptor-channel by Gbetagamma subunits, following disruption of the Homer-Shank3 complex by the immediate early gene Homer1a. This study provides a new molecular mechanism by which group-I mGluRs could dynamically regulate NMDA receptor function.	[Bertaso, Federica; Roussignol, Gautier; Bockaert, Joel; Fagni, Laurent; Ango, Fabrice] Univ Montpellier 1 & 2, INSERM U661, CNRS UMR 5203, Dept Neurobiol,Inst Genom Fonct, Montpellier, France; [Worley, Paul] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Johns Hopkins University	Bertaso, F (corresponding author), Univ Montpellier 1 & 2, INSERM U661, CNRS UMR 5203, Dept Neurobiol,Inst Genom Fonct, Montpellier, France.	laurent.fagni@igf.cnrs.fr	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Ango, Fabrice/0000-0002-5548-209X	Agence Nationale pour la Recherche (French National agency for Research) [ANR-08-MNPS-037-01 - SynGen]; European Commission [222918]	Agence Nationale pour la Recherche (French National agency for Research)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Agence Nationale pour la Recherche (French National agency for Research, ANR-08-MNPS-037-01 - SynGen) and European Commission (contract number 222918 - REPLACES - FP7 - Thematic priority HEALTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarsamy S, 2001, CURR OPIN NEUROBIOL, V11, P357, DOI 10.1016/S0959-4388(00)00219-1; Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Blaabjerg M, 2003, EXP NEUROL, V183, P573, DOI 10.1016/S0014-4886(03)00204-8; Chavis P, 1998, EUR J NEUROSCI, V10, P2322, DOI 10.1046/j.1460-9568.1998.00243.x; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016/j.tips.2005.06.008; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; SHIGEMOTO R, 1993, J NEUROCHEM, V61; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Yu SP, 1997, J PHYSIOL-LONDON, V499, P721, DOI 10.1113/jphysiol.1997.sp021964; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	20	73	76	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9755	10.1371/journal.pone.0009755	http://dx.doi.org/10.1371/journal.pone.0009755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305784	gold, Green Submitted, Green Published			2022-12-27	WOS:000276456300015
J	Csaszar, NBM; Ralph, PJ; Frankham, R; Berkelmans, R; van Oppen, MJH				Csaszar, Nikolaus B. M.; Ralph, Peter J.; Frankham, Richard; Berkelmans, Ray; van Oppen, Madeleine J. H.			Estimating the Potential for Adaptation of Corals to Climate Warming	PLOS ONE			English	Article							GREAT-BARRIER-REEF; GENE-EXPRESSION; EXCITATION-ENERGY; BLEACHING EVENTS; HEAT; DIVERSITY; STRESS; SYMBIODINIUM; TEMPERATURE; ENVIRONMENTS	The persistence of tropical coral reefs is threatened by rapidly increasing climate warming, causing a functional breakdown of the obligate symbiosis between corals and their algal photosymbionts (Symbiodinium) through a process known as coral bleaching. Yet the potential of the coral-algal symbiosis to genetically adapt in an evolutionary sense to warming oceans is unknown. Using a quantitative genetics approach, we estimated the proportion of the variance in thermal tolerance traits that has a genetic basis (i.e. heritability) as a proxy for their adaptive potential in the widespread Indo-Pacific reef-building coral Acropora millepora. We chose two physiologically different populations that associate respectively with one thermo-tolerant (Symbiodinium clade D) and one less tolerant symbiont type (Symbiodinium C2). In both symbiont types, pulse amplitude modulated (PAM) fluorometry and high performance liquid chromatography (HPLC) analysis revealed significant heritabilities for traits related to both photosynthesis and photoprotective pigment profile. However, quantitative real-time polymerase chain reaction (qRT-PCR) assays showed a lack of heritability in both coral host populations for their own expression of fundamental stress genes. Coral colony growth, contributed to by both symbiotic partners, displayed heritability. High heritabilities for functional key traits of algal symbionts, along with their short clonal generation time and high population sizes allow for their rapid thermal adaptation. However, the low overall heritability of coral host traits, along with the corals' long generation time, raise concern about the timely adaptation of the coral-algal symbiosis in the face of continued rapid climate warming.	[Csaszar, Nikolaus B. M.; Ralph, Peter J.] Univ Technol Sydney, Dept Environm Sci, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Frankham, Richard] Macquarie Univ, Sydney, NSW 2109, Australia; [Frankham, Richard] Australian Museum, Sydney, NSW 2000, Australia; [Csaszar, Nikolaus B. M.; Berkelmans, Ray; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Technology Sydney; Macquarie University; Australian Museum; Australian Institute of Marine Science	Csaszar, NBM (corresponding author), Univ Technol Sydney, Dept Environm Sci, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia.	m.vanoppen@aims.gov.au	Ralph, Peter/L-1527-2019; Ralph, Peter J/C-5029-2009; van Oppen, Madeleine JH/C-3261-2008	Ralph, Peter/0000-0002-3103-7346; Ralph, Peter J/0000-0002-3103-7346; van Oppen, Madeleine/0000-0003-4607-0744	Marine Tropical Sciences Research Facility [2.5i.2]; Australian Institute of Marine Science; University of Technology Sydney; Australian Coral Reef Society	Marine Tropical Sciences Research Facility; Australian Institute of Marine Science; University of Technology Sydney; Australian Coral Reef Society	This work was funded by the Marine Tropical Sciences Research Facility (project 2.5i.2), the Australian Institute of Marine Science, the University of Technology Sydney, and the Australian Coral Reef Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cammack KM, 2009, THERIOGENOLOGY, V71, P651, DOI 10.1016/j.theriogenology.2008.09.029; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawford DL, 2007, J EXP BIOL, V210, P1613, DOI 10.1242/jeb.005454; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; DAVIES PS, 1989, MAR BIOL, V101, P389; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Falconer D.S., 1996, INTRO QUANTITATIVE G, P464; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gattuso JP, 1999, AM ZOOL, V39, P160; GLEASON DF, 1993, NATURE, V365, P836, DOI 10.1038/365836a0; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Halliwell B., 1989, FREE RADICAL BIO MED, P86; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 1996, PLANT CELL ENVIRON, V19, P1359, DOI 10.1111/j.1365-3040.1996.tb00014.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Hohenboken WD, 2004, NEW ZEAL J AGR RES, V47, P119, DOI 10.1080/00288233.2004.9513579; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kellermann VM, 2006, EVOLUTION, V60, P1104, DOI 10.1554/05-710.1; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 1999, AM ZOOL, V39, P146; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krebs RA, 1998, EVOLUTION, V52, P841, DOI 10.1111/j.1558-5646.1998.tb03708.x; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Nicholls RJ, 2007, CLIMATIC CHANGE 2007, P315, DOI 10.2134/jeq2008.0015br; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Parry M. L., 2007, CLIMATE CHANGE 2007, P23; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Richmond Robert H., 1997, P175; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Turner P, 2002, MAR TECHNOL SOC J, V36, P70, DOI 10.4031/002533202787914160; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; WILKERSON FP, 1988, CORAL REEFS, V7, P29, DOI 10.1007/BF00301979; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Young AJ, 1997, PURE APPL CHEM, V69, P2125, DOI 10.1351/pac199769102125	71	96	99	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9751	10.1371/journal.pone.0009751	http://dx.doi.org/10.1371/journal.pone.0009751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305781	Green Published, gold			2022-12-27	WOS:000276456300005
J	Lombaert, E; Guillemaud, T; Cornuet, JM; Malausa, T; Facon, B; Estoup, A				Lombaert, Eric; Guillemaud, Thomas; Cornuet, Jean-Marie; Malausa, Thibaut; Facon, Benoit; Estoup, Arnaud			Bridgehead Effect in the Worldwide Invasion of the Biocontrol Harlequin Ladybird	PLOS ONE			English	Article							HARMONIA-AXYRIDIS PALLAS; BIOLOGICAL INVASION; COLEOPTERA; COCCINELLIDAE; HISTORY; PATHWAYS; ABC	Recent studies of the routes of worldwide introductions of alien organisms suggest that many widespread invasions could have stemmed not from the native range, but from a particularly successful invasive population, which serves as the source of colonists for remote new territories. We call here this phenomenon the invasive bridgehead effect. Evaluating the likelihood of such a scenario is heuristically challenging. We solved this problem by using approximate Bayesian computation methods to quantitatively compare complex invasion scenarios based on the analysis of population genetics (microsatellite variation) and historical (first observation dates) data. We applied this approach to the Harlequin ladybird Harmonia axyridis (HA), a coccinellid native to Asia that was repeatedly introduced as a biocontrol agent without becoming established for decades. We show that the recent burst of worldwide invasions of HA followed a bridgehead scenario, in which an invasive population in eastern North America acted as the source of the colonists that invaded the European, South American and African continents, with some admixture with a biocontrol strain in Europe. This demonstration of a mechanism of invasion via a bridgehead has important implications both for invasion theory (i. e., a single evolutionary shift in the bridgehead population versus multiple changes in case of introduced populations becoming invasive independently) and for ongoing efforts to manage invasions by alien organisms (i. e., heightened vigilance against invasive bridgeheads).	[Lombaert, Eric; Guillemaud, Thomas; Malausa, Thibaut] Univ Nice Sophia Antipolis, Equipe Biol Populat & Interact, CNRS, INRA,IBSV,UMR 1301, Sophia Antipolis, France; [Cornuet, Jean-Marie; Facon, Benoit; Estoup, Arnaud] Montpellier SupAgro, Cirad, INRA, IRD,Ctr Biol & Gest Populat,UMR, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Lombaert, E (corresponding author), Univ Nice Sophia Antipolis, Equipe Biol Populat & Interact, CNRS, INRA,IBSV,UMR 1301, Sophia Antipolis, France.	estoup@supagro.inra.fr	Malausa, Thibaut/X-1614-2018; guillemaud, thomas/B-4899-2012	Malausa, Thibaut/0000-0003-1681-7958; guillemaud, thomas/0000-0003-0451-1644	Agence Nationale de la Recherche [ANR-06-BDIV-008-01, ANR-09-BLAN-0145-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Agence Nationale de la Recherche (ANR-06-BDIV-008-01 and ANR-09-BLAN-0145-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens T, 2003, BELG J ZOOL, V133, P195; Beaumont MA, 2002, GENETICS, V162, P2025; CHAPIN JB, 1991, P ENTOMOL SOC WASH, V93, P630; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hanfling B, 2002, MAR ECOL PROG SER, V238, P307, DOI 10.3354/meps238307; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Koch R L, 2003, J Insect Sci, V3, P32; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Krafsur ES, 1997, BIOL CONTROL, V8, P207, DOI 10.1006/bcon.1997.0508; LaMana ML, 1996, BIOL CONTROL, V6, P232, DOI 10.1006/bcon.1996.0029; Loiseau A, 2009, MOL ECOL RESOUR, V9, P934, DOI 10.1111/j.1755-0998.2009.02517.x; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; ONGAGNA P, 1993, ENTOMOPHAGA, V38, P125, DOI 10.1007/BF02373146; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saini E. D., 2004, RIA, Revista de Investigaciones Agropecuarias, V33, P151; Stals R, 2007, S AFR J SCI, V103, P123; Tavare S, 1997, GENETICS, V145, P505; TEDDERS WL, 1994, ENTOMOL NEWS, V105, P228; Vila Montserrat, 2009, V3, P265; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	29	315	334	2	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9743	10.1371/journal.pone.0009743	http://dx.doi.org/10.1371/journal.pone.0009743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305822	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809600015
J	Lundholm, J; MacIvor, JS; MacDougall, Z; Ranalli, M				Lundholm, Jeremy; MacIvor, J. Scott; MacDougall, Zachary; Ranalli, Melissa			Plant Species and Functional Group Combinations Affect Green Roof Ecosystem Functions	PLOS ONE			English	Article							RETENTION; URBAN; BIODIVERSITY; DIVERSITY; PRODUCTIVITY; BUILDINGS; RUNOFF	Background: Green roofs perform ecosystem services such as summer roof temperature reduction and stormwater capture that directly contribute to lower building energy use and potential economic savings. These services are in turn related to ecosystem functions performed by the vegetation layer such as radiation reflection and transpiration, but little work has examined the role of plant species composition and diversity in improving these functions. Methodology/Principal Findings: We used a replicated modular extensive (shallow growing-medium) green roof system planted with monocultures or mixtures containing one, three or five life-forms, to quantify two ecosystem services: summer roof cooling and water capture. We also measured the related ecosystem properties/processes of albedo, evapotranspiration, and the mean and temporal variability of aboveground biomass over four months. Mixtures containing three or five life-form groups, simultaneously optimized several green roof ecosystem functions, outperforming monocultures and single life-form groups, but there was much variation in performance depending on which life-forms were present in the three life-form mixtures. Some mixtures outperformed the best monocultures for water capture, evapotranspiration, and an index combining both water capture and temperature reductions. Combinations of tall forbs, grasses and succulents simultaneously optimized a range of ecosystem performance measures, thus the main benefit of including all three groups was not to maximize any single process but to perform a variety of functions well. Conclusions/Significance: Ecosystem services from green roofs can be improved by planting certain life-form groups in combination, directly contributing to climate change mitigation and adaptation strategies. The strong performance by certain mixtures of life-forms, especially tall forbs, grasses and succulents, warrants further investigation into niche complementarity or facilitation as mechanisms governing biodiversity-ecosystem functioning relationships in green roof ecosystems.	[Lundholm, Jeremy; MacIvor, J. Scott; MacDougall, Zachary; Ranalli, Melissa] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Saint Marys University - Canada	Lundholm, J (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	jlundholm@smu.ca	Lundholm, Jeremy T/G-2638-2010		National Sciences and Engineering Research Council of Canada (NSERC); CGS; Saint Mary's University; Mountain Equipment Co-op	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CGS; Saint Mary's University; Mountain Equipment Co-op	Funding was provided by National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to J.L., IPS to S.M. and CGS to M.R. (www.nserc-crsng.gc.ca), Saint Mary's University, and Mountain Equipment Co-op (http://www.mec.ca/Main/explore.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Alexandria E, 2008, BUILD ENVIRON, V43, P480, DOI 10.1016/j.buildenv.2006.10.055; [Anonymous], 1996, BOUNDARY LAYER CLIMA; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Banting D., 2005, REPORT ENV BENEFITS; BASS B, 2002, NRCC46737 I RES CONS; Brenneisen Stephan, 2006, Urban Habitats, V4, P27; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carter T, 2008, J ENVIRON MANAGE, V87, P350, DOI 10.1016/j.jenvman.2007.01.024; Carter T, 2007, LANDSCAPE URBAN PLAN, V80, P84, DOI 10.1016/j.landurbplan.2006.06.005; Darlington AB, 2001, ENVIRON SCI TECHNOL, V35, P240, DOI 10.1021/es0010507; Dietz ME, 2006, ENVIRON SCI TECHNOL, V40, P1335, DOI 10.1021/es051644f; Dunnett Nigel, 2008, Urban Ecosystems, V11, P385, DOI 10.1007/s11252-008-0064-9; Eumorfopoulou E, 1998, ENERG BUILDINGS, V27, P29, DOI 10.1016/S0378-7788(97)00023-6; FOGARTY C, 2009, NOVA WEATHER; Frumkin H, 2002, PUBLIC HEALTH REP, V117, P201, DOI 10.1093/phr/117.3.201; *GREEN ROOFS HLTH, 2009, 2008 GREEN ROOF IND; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Knapp AK, 1998, AM J BOT, V85, P940, DOI 10.2307/2446360; Kohler M., 2002, Environmental Management and Health, V13, P382, DOI 10.1108/09566160210439297; Kohler M., 2006, URBAN HABITATS, V4, P3; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lazzarin RA, 2005, ENERG BUILDINGS, V37, P1260, DOI 10.1016/j.enbuild.2005.02.001; LIU K, 2005, 3 N AM GREEN ROOF C; Lundholm J., 2006, URBAN HABITATS, V4, P87; Maneewan S, 2005, SOL ENERGY, V78, P495, DOI 10.1016/j.solener.2004.08.003; Mentens J, 2006, LANDSCAPE URBAN PLAN, V77, P217, DOI 10.1016/j.landurbplan.2005.02.010; Miltner RJ, 2004, LANDSCAPE URBAN PLAN, V69, P87, DOI 10.1016/j.landurbplan.2003.10.032; MITSCH WJ, 1995, ECOL APPL, V5, P830, DOI 10.2307/1941991; Monterusso MA, 2005, HORTSCIENCE, V40, P391, DOI 10.21273/HORTSCI.40.2.391; Mueller KE, 2006, ENVIRON SCI TECHNOL, V40, P6662, DOI 10.1021/es060776l; Niachou A, 2001, ENERG BUILDINGS, V33, P719, DOI 10.1016/S0378-7788(01)00062-7; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Onmura S, 2001, ENERG BUILDINGS, V33, P653, DOI 10.1016/S0378-7788(00)00134-1; PACALA S, 2002, BIODIVERSITY COMPOSI, P151; Perez-Lombard L, 2008, ENERG BUILDINGS, V40, P394, DOI 10.1016/j.enbuild.2007.03.007; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Ranalli M., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, DOI 10.1079/PAVSNNR20083034; Ridgwell A, 2009, CURR BIOL, V19, P146, DOI 10.1016/j.cub.2008.12.025; SLATTERTHWAITE D, 2008, ENVIRON URBAN, V20, P539; Spolek Graig, 2008, Urban Ecosystems, V11, P349, DOI 10.1007/s11252-008-0061-z; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; THURING C, 2007, NATIVE PLANT SOC B C, V12, P3; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 2002, BIODIVERSITY COMPOSI, P9; *US GEN SERV ADM, 2008, SUST MATT; *USDA, 2009, NAT RES CONS SERV PL; VanWoert ND, 2005, J ENVIRON QUAL, V34, P1036, DOI 10.2134/jeq2004.0364; Villarreal EL, 2005, ECOL ENG, V25, P1, DOI 10.1016/j.ecoleng.2004.11.008; Wolf D, 2008, ECOL ENG, V33, P179, DOI 10.1016/j.ecoleng.2008.02.008; 2009, SHEFFIELD WEATHER ST; 2009, BBC WEATHER AVERAGE; 2009, NATL OCEANIC ATMOSPH; 2009, BIZEE DEGREE DAYS WE	57	205	210	6	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9677	10.1371/journal.pone.0009677	http://dx.doi.org/10.1371/journal.pone.0009677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300196	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900011
J	Baran, R; Castelblanco, L; Tang, G; Shapiro, I; Goncharov, A; Jin, YS				Baran, Renee; Castelblanco, Liliana; Tang, Garland; Shapiro, Ian; Goncharov, Alexandr; Jin, Yishi			Motor Neuron Synapse and Axon Defects in a C. elegans Alpha-Tubulin Mutant	PLOS ONE			English	Article							PRESYNAPTIC ACTIVE ZONES; CAENORHABDITIS-ELEGANS; MICROTUBULE DYNAMICS; BETA-TUBULIN; NERVOUS-SYSTEM; GENE; MUTATIONS; PROTEIN; DOUBLECORTIN; TRANSPORT	Regulation of microtubule dynamics underlies many fundamental cellular mechanisms including cell division, cell motility, and transport. In neurons, microtubules play key roles in cell migration, axon outgrowth, control of axon and synapse growth, and the regulated transport of vesicles and structural components of synapses. Loss of synapse and axon integrity and disruption of axon transport characterize many neurodegenerative diseases. Recently, mutations that specifically alter the assembly or stability of microtubules have been found to directly cause neurodevelopmental defects or neurodegeneration in vertebrates. We report here the characterization of a missense mutation in the C-terminal domain of C. elegans alpha-tubulin, tba-1(ju89), that disrupts motor neuron synapse and axon development. Mutant ju89 animals exhibit reduction in the number and size of neuromuscular synapses, altered locomotion, and defects in axon extension. Although null mutations of tba-1 show a nearly wild-type pattern, similar axon outgrowth defects were observed in animals lacking the beta-tubulin TBB-2. Genetic analysis reveals that tba-1(ju89) affects synapse development independent of its role in axon outgrowth. tba-1(ju89) is an altered function allele that most likely perturbs interactions between TBA-1 and specific microtubule-associated proteins that control microtubule dynamics and transport of components needed for synapse and axon growth.	[Baran, Renee; Castelblanco, Liliana; Tang, Garland; Shapiro, Ian] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA; [Goncharov, Alexandr; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, San Diego, CA 92103 USA; [Goncharov, Alexandr; Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA	Occidental College; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Baran, R (corresponding author), Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA.	baran@oxy.edu		Jin, Yishi/0000-0002-9371-9860	NIH [NS35546]; Occidental College Undergraduate Research Center; NSF [RUI 064227]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035546, R37NS035546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Occidental College Undergraduate Research Center; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: NIH NS35546 to YJ (www.nih.gov). AG is an HHMI associate, and YJ is an HHMI investigator (www.hhmi.org). LC and GT were supported by the Occidental College Undergraduate Research Center (www.oxy.edu/urc) and NSF RUI 064227 to RB (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bamber BA, 1999, J NEUROSCI, V19, P5348; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; BRENNER S, 1974, GENETICS, V77, P71; Brown MA, 2009, MED J AUSTRALIA, V190, P3, DOI 10.5694/j.1326-5377.2009.tb02249.x; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Ellis GC, 2004, J CELL SCI, V117, P457, DOI 10.1242/jcs.00869; ERRICO A, 2002, HUM MOL GENET, V11, P183; Fallet-Bianco C, 2008, BRAIN, V131, P2304, DOI 10.1093/brain/awn155; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; FUKUSHIGE T, 1993, J MOL BIOL, V234, P1290, DOI 10.1006/jmbi.1993.1685; FUKUSHIGE T, 1995, BBA-GENE STRUCT EXPR, V1261, P401, DOI 10.1016/0167-4781(95)00028-F; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Imai Y, 2004, CURR OPIN NEUROBIOL, V14, P384, DOI 10.1016/j.conb.2004.04.002; Jin S, 2009, DEVELOPMENT, V136, P1571, DOI 10.1242/dev.029983; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jin YS, 1999, J NEUROSCI, V19, P539; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Lu CG, 2005, GENETICS, V170, P115, DOI 10.1534/genetics.104.030106; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Moccia R, 2003, J NEUROSCI, V23, P9409; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schaefer MKE, 2007, J NEUROSCI, V27, P8779, DOI 10.1523/JNEUROSCI.1599-07.2007; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Szymanski D, 2002, CURR BIOL, V12, pR767, DOI 10.1016/S0960-9822(02)01288-5; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	68	22	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9655	10.1371/journal.pone.0009655	http://dx.doi.org/10.1371/journal.pone.0009655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300184	Green Published, gold			2022-12-27	WOS:000275620600010
J	Creighton, CJ; Benham, AL; Zhu, HF; Khan, MF; Reid, JG; Nagaraja, AK; Fountain, MD; Dziadek, O; Han, D; Ma, L; Kim, J; Hawkins, SM; Anderson, ML; Matzuk, MM; Gunaratne, PH				Creighton, Chad J.; Benham, Ashley L.; Zhu, Huifeng; Khan, Mahjabeen F.; Reid, Jeffrey G.; Nagaraja, Ankur K.; Fountain, Michael D., Jr.; Dziadek, Olivia; Han, Derek; Ma, Lang; Kim, Jong; Hawkins, Shannon M.; Anderson, Matthew L.; Matzuk, Martin M.; Gunaratne, Preethi H.			Discovery of Novel MicroRNAs in Female Reproductive Tract Using Next Generation Sequencing	PLOS ONE			English	Article							EXPRESSION PROFILES; RNA; IDENTIFICATION; GENES	MicroRNAs (miRNAs) are small non-coding RNAs that mediate post-transcriptional gene silencing. Over 700 human miRNAs have currently been identified, many of which are mutated or de-regulated in diseases. Here we report the identification of novel miRNAs through deep sequencing the small RNAome (<30 nt) of over 100 tissues or cell lines derived from human female reproductive organs in both normal and disease states. These specimens include ovarian epithelium and ovarian cancer, endometrium and endometriomas, and uterine myometrium and uterine smooth muscle tumors. Sequence reads not aligning with known miRNAs were each mapped to the genome to extract flanking sequences. These extended sequence regions were folded in silico to identify RNA hairpins. Sequences demonstrating the ability to form a stem loop structure with low minimum free energy (<-225 kcal) and predicted Drosha and Dicer cut sites yielding a mature miRNA sequence matching the actual sequence were considered putative novel miRNAs. Additional confidence was achieved when putative novel hairpins assembled a collection of sequences highly similar to the putative mature miRNA but with heterogeneous 3'-ends. A confirmed novel miRNA fulfilled these criteria and had its "star" sequence in our collection. We found 7 distinct confirmed novel miRNAs, and 51 additional novel miRNAs that represented highly confident predictions but without detectable star sequences. Our novel miRNAs were detectable in multiple samples, but expressed at low levels and not specific to any one tissue or cell type. To date, this study represents the largest set of samples analyzed together to identify novel miRNAs.	[Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Khan, Mahjabeen F.; Nagaraja, Ankur K.; Fountain, Michael D., Jr.; Dziadek, Olivia; Han, Derek; Ma, Lang; Anderson, Matthew L.; Matzuk, Martin M.; Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Reid, Jeffrey G.; Gunaratne, Preethi H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Nagaraja, Ankur K.; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Benham, Ashley L.; Zhu, Huifeng; Kim, Jong; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Hawkins, Shannon M.; Anderson, Matthew L.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Fountain, Michael D., Jr.; Matzuk, Martin M.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Creighton, CJ (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	phgunaratne@uh.edu	Hawkins, Shannon/AAX-5216-2020; Hawkins, Shannon M/B-7095-2015; Anderson, Matthew/C-4755-2019	Hawkins, Shannon/0000-0002-0727-3971; Hawkins, Shannon M/0000-0002-0727-3971; Anderson, Matthew/0000-0002-2081-4672	Ovarian Cancer Research Fund; Young Texans Against Cancer; National Institutes of Health [CA60651, P30 CA125123, K12 HD01426-02]; Specialized Cooperative Centers in Reproductive & Infertility Research [U54HD07495]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001426] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, P50CA083639, R01CA060651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; Young Texans Against Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Cooperative Centers in Reproductive & Infertility Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Program Project Development Grant from the Ovarian Cancer Research Fund (CJC, JGR, MLA, MMM, PHG), the Young Texans Against Cancer (MLA, MMM), and National Institutes of Health Grants CA60651 (MMM), P30 CA125123 (CJC), and K12 HD01426-02 (MLA), and the Specialized Cooperative Centers in Reproductive & Infertility Research U54HD07495 (CJC, SMH, MMM, PHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; CREIGHTON C, CANC RES IN PRESS; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GISH W, COMMUNICATION; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	29	76	150	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9637	10.1371/journal.pone.0009637	http://dx.doi.org/10.1371/journal.pone.0009637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224791	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800031
J	Leidner, AK; Haddad, NM; Lovejoy, TE				Leidner, Allison K.; Haddad, Nick M.; Lovejoy, Thomas E.			Does Tropical Forest Fragmentation Increase Long-Term Variability of Butterfly Communities?	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; HABITAT FRAGMENTATION; DEFORESTATION; EXTINCTIONS; LANDSCAPE; ABUNDANCE; RESPONSES; DECAY; BIRDS	Habitat fragmentation is a major driver of biodiversity loss. Yet, the overall effects of fragmentation on biodiversity may be obscured by differences in responses among species. These opposing responses to fragmentation may be manifest in higher variability in species richness and abundance (termed hyperdynamism), and in predictable changes in community composition. We tested whether forest fragmentation causes long-term hyperdynamism in butterfly communities, a taxon that naturally displays large variations in species richness and community composition. Using a dataset from an experimentally fragmented landscape in the central Amazon that spanned 11 years, we evaluated the effect of fragmentation on changes in species richness and community composition through time. Overall, adjusted species richness (adjusted for survey duration) did not differ between fragmented forest and intact forest. However, spatial and temporal variation of adjusted species richness was significantly higher in fragmented forests relative to intact forest. This variation was associated with changes in butterfly community composition, specifically lower proportions of understory shade species and higher proportions of edge species in fragmented forest. Analysis of rarefied species richness, estimated using indices of butterfly abundance, showed no differences between fragmented and intact forest plots in spatial or temporal variation. These results do not contradict the results from adjusted species richness, but rather suggest that higher variability in butterfly adjusted species richness may be explained by changes in butterfly abundance. Combined, these results indicate that butterfly communities in fragmented tropical forests are more variable than in intact forest, and that the natural variability of butterflies was not a buffer against the effects of fragmentation on community dynamics.	[Leidner, Allison K.; Haddad, Nick M.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Lovejoy, Thomas E.] H John Heinz III Ctr Sci Econ & Environm, Washington, DC USA; [Lovejoy, Thomas E.] Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Lovejoy, Thomas E.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil; [Lovejoy, Thomas E.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	University of North Carolina; North Carolina State University; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; George Mason University	Leidner, AK (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	Leidner@umd.edu			Andrew W. Mellon Foundation; CitiCorp; Smithsonian Institution; Man and the Biosphere Program (MAB); World Wildlife Fund	Andrew W. Mellon Foundation; CitiCorp; Smithsonian Institution(Smithsonian Institution); Man and the Biosphere Program (MAB); World Wildlife Fund	The Andrew W. Mellon Foundation, CitiCorp, the Smithsonian Institution, the Man and the Biosphere Program (MAB), and World Wildlife Fund helped fund the Biological Dynamics of Forest Fragments Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez-Malvido J, 2003, CONSERV BIOL, V17, P389, DOI 10.1046/j.1523-1739.2003.01120.x; Boulinier T, 1998, P NATL ACAD SCI USA, V95, P7497, DOI 10.1073/pnas.95.13.7497; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brown Keith S. Jr., 1997, P91; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; ERWIN TL, 1997, BIODIVERSITY, V2; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Laurance W.F., 1997, TROPICAL FOREST REMN, V1st; Laurance WF, 2002, J VEG SCI, V13, P595, DOI 10.1111/j.1654-1103.2002.tb02086.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Malcolm Jay R., 1997, P207; Morris W. F., 2002, QUANTITATIVE CONSERV; Pimm S.L., 1991, BALANCE NATURE; Samways MJ, 1996, BIODIVERS CONSERV, V5, P1047, DOI 10.1007/BF00052715; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Shahabuddin G, 2005, BIODIVERS CONSERV, V14, P1137, DOI 10.1007/s10531-004-7842-3; Steffan-Dewenter I, 2000, ECOL LETT, V3, P449, DOI 10.1046/j.1461-0248.2000.00175.x; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; Stratford JA, 1999, CONSERV BIOL, V13, P1416, DOI 10.1046/j.1523-1739.1999.98494.x; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; TOUCHER MD, 1997, TROPICAL FOREST REMN; Uehara-Prado M, 2007, GLOBAL ECOL BIOGEOGR, V16, P43, DOI 10.1111/j.1466-8238.2006.00267.x; WOLDA H, 1992, OECOLOGIA, V89, P47, DOI 10.1007/BF00319014; WOLDA H, 1978, AM NAT, V112, P1017, DOI 10.1086/283344; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Yamamoto N, 2007, P NATL ACAD SCI USA, V104, P10524, DOI 10.1073/pnas.0701583104	36	34	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9534	10.1371/journal.pone.0009534	http://dx.doi.org/10.1371/journal.pone.0009534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224772	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800006
J	Bourgeas, R; Basse, MJ; Morelli, X; Roche, P				Bourgeas, Raphael; Basse, Marie-Jeanne; Morelli, Xavier; Roche, Philippe			Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; CRYSTAL-STRUCTURE; X-RAY; DRUG DISCOVERY; BINDING-SITES; COMPLEX; TARGETS; DOMAIN; RECOGNITION; PRINCIPLES	Background: In the last decade, the inhibition of protein-protein interactions (PPIs) has emerged from both academic and private research as a new way to modulate the activity of proteins. Inhibitors of these original interactions are certainly the next generation of highly innovative drugs that will reach the market in the next decade. However, in silico design of such compounds still remains challenging. Methodology/Principal Findings: Here we describe this particular PPI chemical space through the presentation of 2P2I(DB), a hand-curated database dedicated to the structure of PPIs with known inhibitors. We have analyzed protein/protein and protein/inhibitor interfaces in terms of geometrical parameters, atom and residue properties, buried accessible surface area and other biophysical parameters. The interfaces found in 2P2IDB were then compared to those of representative datasets of heterodimeric complexes. We propose a new classification of PPIs with known inhibitors into two classes depending on the number of segments present at the interface and corresponding to either a single secondary structure element or to a more globular interacting domain. 2P2IDB complexes share global shape properties with standard transient heterodimer complexes, but their accessible surface areas are significantly smaller. No major conformational changes are seen between the different states of the proteins. The interfaces are more hydrophobic than general PPI's interfaces, with less charged residues and more non-polar atoms. Finally, fifty percent of the complexes in the 2P2IDB dataset possess more hydrogen bonds than typical protein-protein complexes. Potential areas of study for the future are proposed, which include a new classification system consisting of specific families and the identification of PPI targets with high druggability potential based on key descriptors of the interaction. Conclusions: 2P2I database stores structural information about PPIs with known inhibitors and provides a useful tool for biologists to assess the potential druggability of their interfaces. The database can be accessed at http://2p2idb.cnrs-mrs.fr.	[Bourgeas, Raphael] CNRS, Lab Interact & Modulateurs Reponses, UPR3243, Marseille, France; Aix Marseille Univ, IMM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bourgeas, R (corresponding author), CNRS, Lab Interact & Modulateurs Reponses, UPR3243, Marseille, France.	morelli@ifr88.cnrs-mrs.fr; proche@ifr88.cnrs-mrs.fr	ROCHE, Philippe/E-5661-2010; morelli, xavier/A-9218-2016	ROCHE, Philippe/0000-0002-5580-0588; morelli, xavier/0000-0001-8101-7901; Bourgeas, Raphael/0000-0002-8564-6155				Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Arumugam S, 2003, BIOCHEMISTRY-US, V42, P7950, DOI 10.1021/bi034545s; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Douguet D, 2006, BIOINFORMATICS, V22, P2612, DOI 10.1093/bioinformatics/btl447; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; Fry DC, 2008, CURR PROTEIN PEPT SC, V9, P240, DOI 10.2174/138920308784533989; Fry DC, 2006, BIOPOLYMERS, V84, P535, DOI 10.1002/bip.20608; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Hartigan JA, 1979, J ROYAL STAT SOC C, V28, P100, DOI DOI 10.2307/2346830; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Horn JR, 2003, J MOL BIOL, V331, P497, DOI 10.1016/S0022-2836(03)00783-6; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P9146, DOI 10.1021/bi0009690; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Novak W, 2009, J COMPUT AID MOL DES, V23, P49, DOI 10.1007/s10822-008-9237-0; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Pagliaro L, 2004, CURR OPIN CHEM BIOL, V8, P442, DOI 10.1016/j.cbpa.2004.06.006; Pal A, 2007, J BIOSCIENCES, V32, P101, DOI 10.1007/s12038-007-0010-7; Patel S, 2008, EXPERT OPIN INV DRUG, V17, P1865, DOI 10.1517/13543780802493366 ; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Redzynia I, 2009, FEBS J, V276, P793, DOI 10.1111/j.1742-4658.2008.06824.x; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; ROCHE P, 2010, IN PRESS; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; THIOULOUSE J, 1997, ADE 4 MULTIVARIATE A, P75; Toogood PL, 2002, J MED CHEM, V45, P1543, DOI 10.1021/jm010468s; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	41	99	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9598	10.1371/journal.pone.0009598	http://dx.doi.org/10.1371/journal.pone.0009598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231898	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300015
J	Ilsar, R; Chawantanpipat, C; Chan, KH; Dobbins, TA; Waugh, R; Hennessy, A; Celermajer, DS; Ng, MKC				Ilsar, Rahn; Chawantanpipat, Chirapan; Chan, Kim H.; Dobbins, Timothy A.; Waugh, Richard; Hennessy, Annemarie; Celermajer, David S.; Ng, Martin K. C.			Measurement of Pulmonary Flow Reserve and Pulmonary Index of Microcirculatory Resistance for Detection of Pulmonary Microvascular Obstruction	PLOS ONE			English	Article							IDEAL CORONARY VASODILATOR; ARTERIAL-HYPERTENSION; INTRACORONARY PAPAVERINE; EXPERIMENTAL VALIDATION; CARDIAC-OUTPUT; BLOOD-FLOW; THERMODILUTION; ADENOSINE; DISEASE; REPRODUCIBILITY	Background: The pulmonary microcirculation is the chief regulatory site for resistance in the pulmonary circuit. Despite pulmonary microvascular dysfunction being implicated in the pathogenesis of several pulmonary vascular conditions, there are currently no techniques for the specific assessment of pulmonary microvascular integrity in humans. Peak hyperemic flow assessment using thermodilution-derived mean transit-time (T-mn) facilitate accurate coronary microcirculatory evaluation, but remain unvalidated in the lung circulation. Using a high primate model, we aimed to explore the use of T-mn as a surrogate of pulmonary blood flow for the purpose of measuring the novel indices Pulmonary Flow Reserve [PFR = (maximum hyperemic)/(basal flow)] and Pulmonary Index of Microcirculatory Resistance [PIMR = (maximum hyperemic distal pulmonary artery pressure) 6(maximum hyperemic T-mn)]. Ultimately, we aimed to investigate the effect of progressive pulmonary microvascular obstruction on PFR and PIMR. Methods and Results: Temperature-and pressure-sensor guidewires (TPSG) were placed in segmental pulmonary arteries (SPA) of 13 baboons and intravascular temperature measured. T-mn and hemodynamics were recorded at rest and following intra-SPA administration of the vasodilator agents adenosine (10-400 mu g/kg/min) and papaverine (3-24 mg). Temperature did not vary with intra-SPA sensor position (0.010 +/- 0.009 v 0.010 +/- 0.009 degrees C; distal v proximal; p = 0.1), supporting T-mn use in lung for the purpose of hemodynamic indices derivation. Adenosine (to 200 mu g/kg/min) & papaverine (to 24 mg) induced dose-dependent flow augmentations (40 +/- 67% & 35 +/- 13% T-mn reductions v baseline, respectively; p < 0.0001). PFR and PIMR were then calculated before and after progressive administration of ceramic microspheres into the SPA. Cumulative microsphere doses progressively reduced PFR (1.41 +/- 0.06, 1.26 +/- 0.19, 1.17 +/- 0.07 & 1.01 +/- 0.03; for 0, 10(4), 10(5) & 10(6) microspheres; p = 0.009) and increased PIMR (5.7 +/- 0.6, 6.3 +/- 1.0, 6.8 +/- 0.6 & 7.6 +/- 0.6 mmHg. sec; p = 0.0048). Conclusions: Thermodilution-derived mean transit time can be accurately and reproducibly measured in the pulmonary circulation using TPSG. Mean transit time-derived PFR and PIMR can be assessed using a TPSG and adenosine or papaverine as hyperemic agents. These novel indices detect progressive pulmonary microvascular obstruction and thus have with a potential role for pulmonary microcirculatory assessment in humans.	[Ilsar, Rahn; Chawantanpipat, Chirapan; Chan, Kim H.; Waugh, Richard; Celermajer, David S.; Ng, Martin K. C.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Ilsar, Rahn; Celermajer, David S.; Ng, Martin K. C.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Dobbins, Timothy A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Hennessy, Annemarie] Univ Western Sydney, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Western Sydney University	Ilsar, R (corresponding author), Royal Prince Alfred Hosp, Sydney, NSW, Australia.	mkcng@med.usyd.edu.au	Dobbins, Timothy A/I-5819-2013; Dobbins, Timothy/AAS-1422-2020; Hennessy, Annemarie/HGB-5049-2022	Dobbins, Timothy A/0000-0003-1841-9056; Dobbins, Timothy/0000-0003-1841-9056; Hennessy, Annemarie/0000-0002-5975-2843	National Health and Medical Research Council of Australia [512404]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by a National Health and Medical Research Council of Australia (www.nhmrc.gov.au), Project Grant #512404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger WR, 2007, CLIN CHEST MED, V28, P255, DOI 10.1016/j.ccm.2006.11.009; Barbato E, 2004, EUR HEART J, V25, P219, DOI 10.1016/j.ehj.2003.11.009; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; BHATTACHARYA J, 1980, SCIENCE, V210, P327, DOI 10.1126/science.7423192; Bressollette E, 2001, CHEST, V120, P809, DOI 10.1378/chest.120.3.809; BUSH A, 1989, BRIT J CLIN PHARMACO, V27, P165, DOI 10.1111/j.1365-2125.1989.tb05347.x; CELERMAJER DS, 1993, CIRCULATION, V87, P440, DOI 10.1161/01.CIR.87.2.440; De Bruyne B, 2001, CIRCULATION, V104, P2003, DOI 10.1161/hc4201.099223; DOUCETTE JW, 1992, CIRCULATION, V85, P1899, DOI 10.1161/01.CIR.85.5.1899; Fearon WF, 2004, CIRCULATION, V109, P2269, DOI 10.1161/01.CIR.0000128669.99355.CB; Fearon WF, 2003, CIRCULATION, V108, P2198, DOI 10.1161/01.CIR.0000099521.31396.9D; Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1; Fearon WF, 2008, J AM COLL CARDIOL, V51, P560, DOI 10.1016/j.jacc.2007.08.062; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie Nazzareno, 2006, Proc Am Thorac Soc, V3, P571, DOI 10.1513/pats.200605-113LR; Glenny RW, 1999, J APPL PHYSIOL, V86, P623, DOI 10.1152/jappl.1999.86.2.623; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Ilsar R, 2009, CLIN EXP PHARMACOL P, V36, P797, DOI 10.1111/j.1440-1681.2009.05160.x; Johnson BD, 2000, J APPL PHYSIOL, V88, P1650, DOI 10.1152/jappl.2000.88.5.1650; Kern MJ, 2000, CIRCULATION, V101, P1344, DOI 10.1161/01.CIR.101.11.1344; Lovering AT, 2007, AM J PHYSIOL-HEART C, V292, pH1777, DOI 10.1152/ajpheart.01024.2006; LUMB A, 2000, APPL RESP PHYSL; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522; Ogawa K, 2001, ANESTHESIOLOGY, V94, P668, DOI 10.1097/00000542-200104000-00022; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Pijls NHJ, 2002, CIRCULATION, V105, P2482, DOI 10.1161/01.CIR.0000017199.09457.3D; Radegran G, 2001, ACTA PHYSIOL SCAND, V171, P177, DOI 10.1046/j.1365-201x.2001.00796.x; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; WEST JB, 1964, J APPL PHYSIOL, V19, P713, DOI 10.1152/jappl.1964.19.4.713; WHITE PF, 1982, ANESTHESIOLOGY, V56, P119, DOI 10.1097/00000542-198202000-00007; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595; WILSON RF, 1986, CIRCULATION, V73, P444, DOI 10.1161/01.CIR.73.3.444; ZIJLSTRA F, 1986, CATHETER CARDIO DIAG, V12, P298, DOI 10.1002/ccd.1810120505	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9601	10.1371/journal.pone.0009601	http://dx.doi.org/10.1371/journal.pone.0009601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231900	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300017
J	Galmbacher, K; Heisig, M; Hotz, C; Wischhusen, J; Galmiche, A; Bergmann, B; Gentschev, I; Goebel, W; Rapp, UR; Fensterle, J				Galmbacher, Katharina; Heisig, Martin; Hotz, Christian; Wischhusen, Joerg; Galmiche, Antoine; Bergmann, Birgit; Gentschev, Ivaylo; Goebel, Werner; Rapp, Ulf R.; Fensterle, Joachim			Shigella Mediated Depletion of Macrophages in a Murine Breast Cancer Model Is Associated with Tumor Regression	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM; THERAPY; PROGRESSION; FLEXNERI; VIRULENCE; PLASMID; CELLS; ACCUMULATION; APOPTOSIS; PROTEINS	A tumor promoting role of macrophages has been described for a transgenic murine breast cancer model. In this model tumor-associated macrophages (TAMs) represent a major component of the leukocytic infiltrate and are associated with tumor progression. Shigella flexneri is a bacterial pathogen known to specificly induce apotosis in macrophages. To evaluate whether Shigella-induced removal of macrophages may be sufficient for achieving tumor regression we have developed an attenuated strain of S. flexneri (M90T Delta aroA) and infected tumor bearing mice. Two mouse models were employed, xenotransplantation of a murine breast cancer cell line and spontanous breast cancer development in MMTV-HER2 transgenic mice. Quantitative analysis of bacterial tumor targeting demonstrated that attenuated, invasive Shigella flexneri primarily infected TAMs after systemic administration. A single i.v. injection of invasive M90TDaroA resulted in caspase-1 dependent apoptosis of TAMs followed by a 74% reduction in tumors of transgenic MMTV-HER-2 mice 7 days post infection. TAM depletion was sustained and associated with complete tumor regression. These data support TAMs as useful targets for antitumor therapy and highlight attenuated bacterial pathogens as potential tools.	[Galmbacher, Katharina; Heisig, Martin; Hotz, Christian; Galmiche, Antoine; Bergmann, Birgit; Gentschev, Ivaylo; Rapp, Ulf R.; Fensterle, Joachim] Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, Wurzburg, Germany; [Heisig, Martin; Bergmann, Birgit; Goebel, Werner] Univ Wurzburg, Biozentrum, Inst Mikrobiol, Wurzburg, Germany; [Wischhusen, Joerg] Univ Frauen Klin Wurzburg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Galmbacher, K (corresponding author), INTERLAB Cent Lab Serv GmbH, Munich, Germany.	jfensterle@aezsinc.com	Gentschev, Ivaylo/F-9454-2011; Gentschev, Ivaylo/AAJ-5819-2021	Gentschev, Ivaylo/0000-0003-3743-6329; Hotz, Christian/0000-0001-6148-9821	International DFG Research Training Group [1141]; Franco-German University [ED-31-04]; Aeterna Zentaris	International DFG Research Training Group; Franco-German University; Aeterna Zentaris	KG, CH and MH were supported by the International DFG Research Training Group 1141 Wuerzburg/Nice (GCWN. de) and the Franco-German University (ED-31-04;http://www.dfh-ufa.org/). This work was supported in part by Aeterna Zentaris (http://www.aeternazentaris.com/) and in part by the Bavarian Research Cooperations Abayfor (Foringen; http://www.bayfor.org/de/geschaeftsbereiche/forschungsverbuende/welt-des-lebens/foringen.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JF is currently employed by Aeterna Zentaris and during this study he was the group leader in the unit and supervisor of Mrs. Galmbacher.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng HL, 2002, J CLIN ONCOL, V20, P1544, DOI 10.1200/JCO.20.6.1544; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Fensterle J, 2008, CANCER GENE THER, V15, P85, DOI 10.1038/sj.cgt.7701109; Forbes NS, 2003, CANCER RES, V63, P5188; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; KURAHARA H, 2009, J SURG RES; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Loessner H, 2008, INT J MED MICROBIOL, V298, P21, DOI 10.1016/j.ijmm.2007.07.005; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pawelek JM, 1997, CANCER RES, V57, P4537; Pilgrim S, 2003, GENE THER, V10, P2036, DOI 10.1038/sj.gt.3302105; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; RYMSA B, 1990, RES COMMUN CHEM PATH, V68, P263; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Van Mellaert L, 2006, TRENDS MICROBIOL, V14, P190, DOI 10.1016/j.tim.2006.02.002; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Volpers C, 2003, J VIROL, V77, P2093, DOI 10.1128/JVI.77.3.2093-2104.2003; WEIBEL S, 2008, CELL MICROBIOL; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	38	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A93	A103	e9572	10.1371/journal.pone.0009572	http://dx.doi.org/10.1371/journal.pone.0009572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221397	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200009
J	Ghosh, R; Lipson, KL; Sargent, KE; Mercurio, AM; Hunt, JS; Ron, D; Urano, F				Ghosh, Rajarshi; Lipson, Kathryn L.; Sargent, Karen E.; Mercurio, Arthur M.; Hunt, Joan S.; Ron, David; Urano, Fumihiko			Transcriptional Regulation of VEGF-A by the Unfolded Protein Response Pathway	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; FACTOR MESSENGER-RNA; PLACENTAL DEVELOPMENT; ER STRESS; MAMMALIAN-CELLS; TUMOR-GROWTH; KINASE IRE1; ACGT CORE; IN-VIVO; HYPOXIA	Background: Angiogenesis is crucial to many physiological and pathological processes including development and cancer cell survival. Vascular endothelial growth factor-A (VEGFA) is the predominant mediator of angiogenesis in the VEGF family. During development, adverse environmental conditions like nutrient deprivation, hypoxia and increased protein secretion occur. IRE1 alpha, PERK, and ATF6 alpha, master regulators of the unfolded protein response (UPR), are activated under these conditions and are proposed to have a role in mediating angiogenesis. Principal Findings: Here we show that IRE1 alpha, PERK, and ATF6 alpha powerfully regulate VEGFA mRNA expression under various stress conditions. In Ire1 alpha(-/-) and Perk(-/-) mouse embryonic fibroblasts and ATF6 alpha-knockdown HepG2 cells, induction of VEGFA mRNA by endoplasmic reticulum stress is attenuated as compared to control cells. Embryonic lethality of Ire1 alpha(-/-) mice is due to the lack of VEGFA induction in labyrinthine trophoblast cells of the developing placenta. Rescue of IRE1 alpha and PERK in Ire1 alpha(-/-) and Perk(-/-) cells respectively, prevents VEGFA mRNA attenuation. We further report that the induction of VEGFA by IRE1 alpha, PERK and ATF6 involves activation of transcription factors, spliced-XBP-1, ATF4 and cleaved ATF6 respectively. Conclusions/Significance: Our results reveal that the IRE1 alpha-XBP-1, PERK-ATF4, and ATF6a pathways constitute novel upstream regulatory pathways of angiogenesis by modulating VEGF transcription. Activation of these pathways helps the rapidly growing cells to obtain sufficient nutrients and growth factors for their survival under the prevailing hostile environmental conditions. These results establish an important role of the UPR in angiogenesis.	[Ghosh, Rajarshi; Lipson, Kathryn L.; Sargent, Karen E.; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Lipson, Kathryn L.] Western New England Coll, Dept Phys & Biol Sci, Springfield, MA USA; [Hunt, Joan S.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Ron, David] NYU, Sch Med, Skirball Inst, New York, NY USA; [Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Western New England University; University of Kansas; University of Kansas Medical Center; New York University; University of Cambridge	Ghosh, R (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Fumihiko.Urano@umassmed.edu	Urano, Fumihiko/AAF-4492-2020; Longo, Kenneth A/A-5631-2010	Ron, David/0000-0002-3014-5636; Ghosh, Rajarshi/0000-0002-5780-8241	National Institutes of Health (NIH) [R01DK067493]; Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School [DK032520]; Juvenile Diabetes Research Foundation [1-2008-593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067493, P30DK032520] Funding Source: NIH RePORTER; Medical Research Council [G0600717B] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research in the laboratory of F. Urano is supported by a National Institutes of Health (NIH) R01DK067493 grant, a grant from the Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School (DK032520), and a Juvenile Diabetes Research Foundation Regular Research Grant (1-2008-593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Koumenis C, 2007, METHOD ENZYMOL, V435, P275, DOI 10.1016/S0076-6879(07)35014-3; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Rinkenberger J, 2000, NAT GENET, V25, P248, DOI 10.1038/76985; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selesniemi K, 2005, STEM CELLS DEV, V14, P697, DOI 10.1089/scd.2005.14.697; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; SHWEIKI D, 1992, NATURE, V359, P845; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	36	185	197	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A104	A115	e9575	10.1371/journal.pone.0009575	http://dx.doi.org/10.1371/journal.pone.0009575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221394	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200010
J	Teramoto, T; Sternick, LA; Kage-Nakadai, E; Sajjadi, S; Siembida, J; Mitani, S; Iwasaki, K; Lambie, EJ				Teramoto, Takayuki; Sternick, Laura A.; Kage-Nakadai, Eriko; Sajjadi, Shirine; Siembida, Jakub; Mitani, Shohei; Iwasaki, Kouichi; Lambie, Eric J.			Magnesium Excretion in C. elegans Requires the Activity of the GTL-2 TRPM Channel	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CATION CHANNEL; FUNCTIONAL-CHARACTERIZATION; SECONDARY HYPOCALCEMIA; MG2+ TRANSPORTER; NEURONS; GENE; ABSORPTION; INTESTINE; CELLS	Systemic magnesium homeostasis in mammals is primarily governed by the activities of the TRPM6 and TRPM7 cation channels, which mediate both uptake by the intestinal epithelial cells and reabsorption by the distal convoluted tubule cells in the kidney. In the nematode, C. elegans, intestinal magnesium uptake is dependent on the activities of the TRPM channel proteins, GON-2 and GTL-1. In this paper we provide evidence that another member of the TRPM protein family, GTL-2, acts within the C. elegans excretory cell to mediate the excretion of excess magnesium. Thus, the activity of GTL-2 balances the activities of the paralogous TRPM channel proteins, GON-2 and GTL-1.	[Teramoto, Takayuki] Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 812, Japan; [Sternick, Laura A.; Sajjadi, Shirine; Lambie, Eric J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Siembida, Jakub; Iwasaki, Kouichi] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan	Kyushu University; Dartmouth College; Northwestern University; Feinberg School of Medicine; Tokyo Women's Medical University	Teramoto, T (corresponding author), Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 812, Japan.	eric.j.lambie@dartmouth.edu	Lambie, Eric/K-5657-2014	Lambie, Eric/0000-0002-7371-128X; Teramoto, Takayuki/0000-0001-7060-7148	Ministry of Education; NIH National Center for Research Resources; Northwestern University; National Institutes of Health [GM49785, GM082133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082133] Funding Source: NIH RePORTER	Ministry of Education; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Northwestern University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The allele tm1463 was isolated by the National Bioresource Project for the Experimental Animal C. elegans, which is funded by the Ministry of Education (http://www. mext. go. jp/english/). Some strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (http://www. ncrr. nih. gov/). This work was supported by funds from Northwestern University (http://www. northwestern. edu/) (to K. I.) and the National Institutes of Health (http://www. nih. gov/) to E. J. L. (GM49785) and K. I. (GM082133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Church DL, 2003, GENETICS, V165, P563; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Estevez AY, 2005, J PHYSIOL-LONDON, V567, P239, DOI 10.1113/jphysiol.2005.091900; Estevez AY, 2003, J GEN PHYSIOL, V122, P207, DOI 10.1085/jgp.200308804; FINE KD, 1991, J CLIN INVEST, V88, P396, DOI 10.1172/JCI115317; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Gadsby DC, 2009, PHILOS T R SOC B, V364, P229, DOI 10.1098/rstb.2008.0243; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KAYNE LH, 1993, MINER ELECTROL METAB, V19, P210; Kemp BJ, 2009, GENETICS, V181, P581, DOI 10.1534/genetics.108.094870; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Levitt MD, 1996, J CLIN INVEST, V97, P2308, DOI 10.1172/JCI118673; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2007, MAGNESIUM RES, V20, P6; Schweigel M, 2000, FRONT BIOSCI-LANDMRK, V5, pD666, DOI 10.2741/Schweigel; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0; Xing J, 2008, J GEN PHYSIOL, V131, P245, DOI 10.1085/jgp.200709914	37	23	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A228	A235	e9589	10.1371/journal.pone.0009589	http://dx.doi.org/10.1371/journal.pone.0009589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221407	Green Submitted, gold, Green Published			2022-12-27	WOS:000275328200021
J	Kobayashi, H; Huang, JH; Ye, F; Shyr, Y; Blackwell, TS; Lin, PC				Kobayashi, Hanako; Huang, Jianhua; Ye, Fei; Shyr, Yu; Blackwell, Timothy S.; Lin, P. Charles			Interleukin-32 beta Propagates Vascular Inflammation and Exacerbates Sepsis in a Mouse Model	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TUMOR ANGIOGENESIS; T-CELLS; IL-32; RECEPTOR; ALPHA; TIE2; IL-1-BETA; CYTOKINE; MEDIATOR	Background: Inflammation is associated with most diseases, which makes understanding the mechanisms of inflammation vitally important. Methodology/Principal Findings: Here, we demonstrate a critical function of interleukin-32 beta (IL-32 beta) in vascular inflammation. IL-32 beta is present in tissues from humans, but is absent in rodents. We found that the gene is highly expressed in endothelial cells. Three isoforms of IL-32, named IL-32 alpha, beta, and e, were cloned from human endothelial cells, with IL-32 beta being the major isoform. Pro-inflammatory cytokines (TNF alpha and IL-1 beta) induced IL-32 beta expression through NF-kappa B. Conversely, IL-32 beta propagated vascular inflammation via induction of vascular cell adhesion molecules and inflammatory cytokines. Accordingly, IL-32 beta increased adhesion of inflammatory cells to activated endothelial cells, a paramount process in inflammation. These results illustrate a positive feedback regulation that intensifies and prolongs inflammation. Importantly, endothelial/hematopoietic expression of IL-32 beta in transgenic mice elevated inflammation and worsened sepsis. This was demonstrated by significant elevation of leukocyte infiltration and serum levels of TNF alpha and IL-1 beta, increased vascular permeability and lung damage, and accelerated animal death. Together, our results reveal an important function of IL-32 in vascular inflammation and sepsis development. Conclusions/Significance: Our results reveal an important function of IL-32 in vascular inflammation and sepsis development.	[Kobayashi, Hanako; Huang, Jianhua; Lin, P. Charles] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37235 USA; [Ye, Fei; Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Blackwell, Timothy S.; Lin, P. Charles] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Blackwell, Timothy S.; Lin, P. Charles] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Kobayashi, H (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37235 USA.	Charles.lin@vanderbilt.edu		Kobayashi, Hanako/0000-0001-5064-2616	National Institutes of Health [CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [ZIABC011390, R01CA108856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants from the National Institutes of Health (CA108856, NS45888 and AR053718) to PCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2004, CRIT CARE MED, V32, pS271, DOI 10.1097/01.CCM.0000129669.21649.40; BAKER CC, 1983, SURGERY, V94, P331; DAHL CA, 1992, J IMMUNOL, V148, P597; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeBusk LM, 2003, ARTHRITIS RHEUM-US, V48, P2461, DOI 10.1002/art.11213; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kobayashi H, 2009, CYTOKINE, V46, P351, DOI 10.1016/j.cyto.2009.03.007; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; STOCKINGER H, 1990, J IMMUNOL, V145, P3889	20	54	56	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9458	10.1371/journal.pone.0009458	http://dx.doi.org/10.1371/journal.pone.0009458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221440	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197200001
J	Stelzer, RJ; Chittka, L; Carlton, M; Ings, TC				Stelzer, Ralph J.; Chittka, Lars; Carlton, Marc; Ings, Thomas C.			Winter Active Bumblebees (Bombus terrestris) Achieve High Foraging Rates in Urban Britain	PLOS ONE			English	Article							HYMENOPTERA; PATTERNS; SUCCESS; POLLEN; NECTAR	Background: Foraging bumblebees are normally associated with spring and summer in northern Europe. However, there have been sightings of the bumblebee Bombus terrestris during the warmer winters in recent years in southern England. But what floral resources are they relying upon during winter and how much winter forage can they collect? Methodology/Principal Findings: To test if urban areas in the UK provide a rich foraging niche for bees we set up colonies of B. terrestris in the field during two late winter periods (2005/6 & 2006/7) in London, UK, and measured their foraging performance. Fully automatic radio-frequency identification (RFID) technology was used in 2006/7 to enable us to record the complete foraging activity of individually tagged bees. The number of bumblebees present during winter (October 2007 to March 2008) and the main plants they visited were also recorded during transect walks. Queens and workers were observed throughout the winter, suggesting a second generation of bee colonies active during the winter months. Mass flowering shrubs such as Mahonia spp. were identified as important food resources. The foraging experiments showed that bees active during the winter can attain nectar and pollen foraging rates that match, and even surpass, those recorded during summer. Conclusions/Significance: B. terrestris in the UK are now able to utilise a rich winter foraging resource in urban parks and gardens that might at present still be under-exploited, opening up the possibility of further changes in pollinator phenology.	[Stelzer, Ralph J.; Chittka, Lars; Ings, Thomas C.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Carlton, Marc] London Nat Hist Soc, London, England	University of London; Queen Mary University London	Stelzer, RJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	t.c.ings@qmul.ac.uk	Chittka, Lars/C-3110-2012; Ings, Thomas C/J-3439-2012	Chittka, Lars/0000-0001-8153-1732; Ings, Thomas C/0000-0002-7496-1977	Westfield Trust; University of London [CRFT1C7R]; Natural Environment Research Council [NE/D012813/1]; Leverhulme Early Career Fellowship [ECF/2009/0180]; NERC [NE/D012813/1] Funding Source: UKRI	Westfield Trust; University of London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Early Career Fellowship(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been supported by a Westfield Trust (http://www.qmul.ac.uk/) Studentship (RS), a University of London (http://www.lon.ac.uk/) Central Research Fund grant CRFT1C7R (TI), Natural Environment Research Council (http://www.nerc.ac.uk/) Grant NE/D012813/1 (TI & LC) and a Leverhulme Early Career Fellowship (http://www.leverhulme.ac.uk/) ECF/2009/0180 (TI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford DV, 1975, BUMBLEBEES; BENTON T, 2008, BUMBLEBEES; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; CUMBER RA, 1949, T R ENT SOC LOND, P1; EDWARDS M, 2006, BWARS NEWSLETTER SPR, P20; Farmer S, 2006, BWARS NEWSLETTER, P21; FERTON C, 1901, COMPT AFAS C AJ; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Gurel F, 2008, INSECT SOC, V55, P123, DOI 10.1007/s00040-008-0984-7; HEINRICH B, 1979, J EXP BIOL, V80, P217; Heinrich B., 1979, BUMBLEBEE EC; Ings TC, 2006, J APPL ECOL, V43, P940, DOI 10.1111/j.1365-2664.2006.01199.x; Ings TC, 2005, ENTOMOL GEN, V28, P233; Ings TC, 2005, OECOLOGIA, V144, P508, DOI 10.1007/s00442-005-0081-9; INGS TC, 2007, THESIS U LONDON LOND; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PRYSJONES O, 1982, THESIS U CAMBRIDGE C; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; ROBERTSON A, 1991, Entomologist's Monthly Magazine, V127, P165; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Roth M., 2002, EFFECTS CITIES LOCAL, P1; SLADEN FWL, 1912, HUMBLE BEE ITS LIFE; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Streit S, 2003, ZOOLOGY, V106, P169, DOI 10.1078/0944-2006-00113; Wilson E.O., 1975, P1; Yeninar H, 2000, J APICULT RES, V39, P107, DOI 10.1080/00218839.2000.11101030	31	68	70	7	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9559	10.1371/journal.pone.0009559	http://dx.doi.org/10.1371/journal.pone.0009559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221445	Green Submitted, gold, Green Published			2022-12-27	WOS:000275197200011
J	Odhiambo, FO; Hamel, MJ; Williamson, J; Lindblade, K; ter Kuile, FO; Peterson, E; Otieno, P; Kariuki, S; Vulule, J; Slutsker, L; Newman, RD				Odhiambo, Frank O.; Hamel, Mary J.; Williamson, John; Lindblade, Kim; ter Kuile, Feiko O.; Peterson, Elizabeth; Otieno, Peter; Kariuki, Simon; Vulule, John; Slutsker, Laurence; Newman, Robert D.			Intermittent Preventive Treatment in Infants for the Prevention of Malaria in Rural Western Kenya: A Randomized, Double-Blind Placebo-Controlled Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; TREATED BED NETS; CHLORPROGUANIL-DAPSONE; UNCOMPLICATED MALARIA; AFRICAN CHILDREN; AMODIAQUINE-ARTESUNATE; ANTIMALARIAL TREATMENT; ROUTINE VACCINATIONS; TANZANIAN CHILDREN	Background: Intermittent preventive treatment in infants (IPTi) with sulphadoxine-pyrimethamine (SP) for the prevention of malaria has shown promising results in six trials. However, resistance to SP is rising and alternative drug combinations need to be evaluated to better understand the role of treatment versus prophylactic effects. Methods: Between March 2004 and March 2008, in an area of western Kenya with year round malaria transmission with high seasonal intensity and high usage of insecticide-treated nets, we conducted a randomized, double-blind placebo-controlled trial with SP plus 3 days of artesunate (SP-AS3), 3 days of amodiaquine-artesunate (AQ3-AS3), or 3 days of short-acting chlorproguanil-dapsone (CD3) administered at routine expanded programme of immunization visits (10 weeks, 14 weeks and 9 months). Principal Findings: 1,365 subjects were included in the analysis. The incidence of first or only episode of clinical malaria during the first year of life (primary endpoint) was 0.98 episodes/person-year in the placebo group, 0.74 in the SP-AS3 group, 0.76 in the AQ3-AS3 group, and 0.82 in the CD3 group. The protective efficacy (PE) and 95% confidence intervals against the primary endpoint were: 25.7% (6.3, 41.1); 25.9% (6.8, 41.0); and 16.3% (-5.2, 33.5) in the SP-AS3, AQ3-AS3, and CD3 groups, respectively. The PEs for moderate-to-severe anaemia were: 27.5% (-6.9, 50.8); 23.1% (-11.9, 47.2); and 11.4% (-28.6, 39.0). The duration of the protective effect remained significant for up to 5 to 8 weeks for SP-AS3 and AQ3-AS3. There was no evidence for a sustained beneficial or rebound effect in the second year of life. All regimens were well tolerated. Conclusions: These results support the view that IPTi with long-acting regimens provide protection against clinical malaria for up to 8 weeks even in the presence of high ITN coverage, and that the prophylactic rather than the treatment effect of IPTi appears central to its protective efficacy.	[Odhiambo, Frank O.; Hamel, Mary J.; Otieno, Peter; Kariuki, Simon; Vulule, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Hamel, Mary J.; Williamson, John; Lindblade, Kim; Slutsker, Laurence; Newman, Robert D.] Ctr Dis Control & Prevent, Div Parasit Dis, Malaria Branch, Atlanta, GA USA; [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Peterson, Elizabeth] Vermont Dept Hlth, Burlington, VT 05402 USA	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool	Odhiambo, FO (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	fodhiambo@ke.cdc.gov	Kuile, Feiko ter/ABD-6681-2020; Kariuki, Simon/AFT-6596-2022	Kuile, Feiko ter/0000-0003-3663-5617; Lindblade, Kim/0000-0002-5593-0470	Bill & Melinda Gates Foundation Global Health Program [28578]	Bill & Melinda Gates Foundation Global Health Program	Bill & Melinda Gates Foundation Global Health Program, Grant ID# 28578. http://www.gatesfoundation.org/global-health/Pages/overview.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; BEIER JC, 1990, J MED ENTOMOL, V27, P570, DOI 10.1093/jmedent/27.4.570; BEUTLER E, 1989, BLOOD, V74, P2550; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; *CDC, 2005, SAS PROGR CDC GROWTH; *CENTR BOSK, 2004, KEN DEM HLTH SURV 20; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; COX DR, 1972, J R STAT SOC B, V34, P187; D'Alessandro U, 2006, LANCET, V368, P1306, DOI 10.1016/S0140-6736(06)69532-9; Doherty JF, 1999, T ROY SOC TROP MED H, V93, P543, DOI 10.1016/S0035-9203(99)90376-0; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Fanello CI, 2006, TROP MED INT HEALTH, V11, P589, DOI 10.1111/j.1365-3156.2006.01610.x; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Gupta S, 2002, EXP PARASITOL, V100, P28, DOI 10.1006/expr.2001.4659; Hietala SF, 2007, J PHARMACOKINET PHAR, V34, P669, DOI 10.1007/s10928-007-9064-2; Hills, 1993, STAT MODELS EPIDEMIO; *IOM, 2008, ASS ROL INT PREV TRE; *KENYAMOH, 2006, NAT GUID DIAGN TREAT; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; May J, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-198; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Obonyo CO, 2003, T ROY SOC TROP MED H, V97, P585, DOI 10.1016/S0035-9203(03)80038-X; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P3, DOI 10.4269/ajtmh.2003.68.3; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; Shiff C, 1996, T ROY SOC TROP MED H, V90, P262, DOI 10.1016/S0035-9203(96)90240-0; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; Thwing JI, 2009, TROP MED INT HEALTH, V14, P294, DOI 10.1111/j.1365-3156.2009.02222.x; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; Vreugdenhil CJ, 2004, AM J TROP MED HYG, V71, P537, DOI 10.4269/ajtmh.2004.71.537; WATKINS WM, 1988, T ROY SOC TROP MED H, V82, P398, DOI 10.1016/0035-9203(88)90133-2; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; WHO UNICEF, 2005, WORLD MALARIA REPORT; Winstanley P, 1997, T ROY SOC TROP MED H, V91, P322, DOI 10.1016/S0035-9203(97)90093-6	59	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10016	10.1371/journal.pone.0010016	http://dx.doi.org/10.1371/journal.pone.0010016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368815	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000276419900016
J	Gottstein, B; Wittwer, M; Schild, M; Merli, M; Leib, SL; Muller, N; Muller, J; Jaggi, R				Gottstein, Bruno; Wittwer, Matthias; Schild, Marc; Merli, Michael; Leib, Stephen L.; Mueller, Norbert; Mueller, Joachim; Jaggi, Rolf			Hepatic Gene Expression Profile in Mice Perorally Infected with Echinococcus multilocularis Eggs	PLOS ONE			English	Article							EOSINOPHIL-DERIVED NEUROTOXIN; GUANYLATE-BINDING PROTEIN-1; IN-VIVO TREATMENT; IMMUNE-RESPONSE; T-CELLS; ALVEOLAR ECHINOCOCCOSIS; INFLAMMATORY RESPONSES; INTERFERON-GAMMA; PROTECTS MICE; LIVER	Background: Alveolar echinococcosis (AE) is a severe chronic hepatic parasitic disease currently emerging in central and eastern Europe. Untreated AE presents a high mortality (>90%) due to a severe hepatic destruction as a result of parasitic metacestode proliferation which behaves like a malignant tumor. Despite this severe course and outcome of disease, the genetic program that regulates the host response leading to organ damage as a consequence of hepatic alveolar echinococcosis is largely unknown. Methodology/Principal Findings: We used a mouse model of AE to assess gene expression profiles in the liver after establishment of a chronic disease status as a result of a primary peroral infection with eggs of the fox tapeworm Echinococcus multilocularis. Among 38 genes differentially regulated (false discovery rate adjusted p <= 0.05), 35 genes were assigned to the functional gene ontology group < immune response >, while 3 associated with the functional group < intermediary metabolism >. Upregulated genes associated with, immune response. could be clustered into functional subgroups including < macrophages >, < APCs >, < lymphocytes, chemokines and regulation >, < B-cells > and < eosinophils >. Two downregulated genes related to < lymphocytes, chemokines and regulation > and < intermediary metabolism >, respectively. The < immune response > genes either associated with an < immunosupression > or an < immunostimulation > pathway. From the overexpressed genes, 18 genes were subsequently processed with a Custom Array microfluidic card system in order to assess respective expression status at the mRNA level relative to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37) selected upon a constitutive and stable expression level. The results generated by the two independent tools used for the assessment of gene expression, i.e., microarray and microfluidic card system, exhibited a high level of congruency (Spearman correlation rho = 0.81, p = 7.87e-5) and thus validated the applied methods. Conclusions/Significance: Based on this set of biomarkers, new diagnostic targets have been made available to predict disease status and progression. These biomarkers may also offer new targets for immuno-therapeutic intervention.	[Gottstein, Bruno; Schild, Marc; Mueller, Norbert; Mueller, Joachim] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Wittwer, Matthias; Leib, Stephen L.] Univ Bern, Fac Med, Inst Infect Dis, Bern, Switzerland; [Merli, Michael] Univ Hohenheim, Dept Parasitol, D-7000 Stuttgart, Germany; [Jaggi, Rolf] Univ Bern, Dept Clin Res, Fac Med, Bern, Switzerland	University of Bern; University of Bern; University of Geneva; University Hohenheim; University of Bern; University of Geneva	Gottstein, B (corresponding author), Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland.	bruno.gottstein@ipa.unibe.ch	Leib, Stephen/M-3786-2019; Kummer, Juerg/B-3322-2011; Leib, Stephen L/A-7866-2011; Wittwer, Matthias/K-4512-2014	Leib, Stephen/0000-0002-1106-6123; Leib, Stephen L/0000-0002-1106-6123; Wittwer, Matthias/0000-0003-4713-8392; Muller, Joachim/0000-0001-8189-9270				Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; Amiot F, 1999, PARASITE IMMUNOL, V21, P475, DOI 10.1046/j.1365-3024.1999.00245.x; Asefa B, 2006, FEBS LETT, V580, P1205, DOI 10.1016/j.febslet.2006.01.032; Bandyopadhyay SK, 2008, AM J PATHOL, V173, P1361, DOI 10.2353/ajpath.2008.080444; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; BARON RW, 1976, INT J PARASITOL, V6, P37, DOI 10.1016/0020-7519(76)90008-4; Bauder B, 1999, PARASITE IMMUNOL, V21, P409, DOI 10.1046/j.1365-3024.1999.00241.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernthaler P, 2009, INFECT IMMUN, V77, P5564, DOI 10.1128/IAI.00653-09; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; Dai WJ, 2003, IMMUNOLOGY, V108, P238, DOI 10.1046/j.1365-2567.2003.01567.x; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; DEVOUGE M, 1983, TROPENMED PARASITOL, V34, P15; Emery I, 1998, PARASITE IMMUNOL, V20, P81, DOI 10.1046/j.1365-3024.1998.00131.x; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Fujii C, 2005, INT J CANCER, V114, P209, DOI 10.1002/ijc.20719; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gauci C, 2002, INFECT IMMUN, V70, P3969, DOI 10.1128/IAI.70.7.3969-3972.2002; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godot V, 2003, GASTROENTEROLOGY, V124, P1441, DOI 10.1016/S0016-5085(03)00273-7; Gottstein B, 2008, PARASITE, V15, P291, DOI 10.1051/parasite/2008153291; GOTTSTEIN B, 2009, MANSONS TROPICAL DIS, P1549; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Jenne L, 1998, CLIN INFECT DIS, V26, P492, DOI 10.1086/516316; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; KIZAKI T, 1993, IMMUNOLOGY, V79, P412; Koniaris LG, 2001, J IMMUNOL, V167, P399, DOI 10.4049/jimmunol.167.1.399; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Liance M, 1998, PARASITE, V5, P231, DOI 10.1051/parasite/1998053231; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Manicone AM, 2008, EXP LUNG RES, V34, P391, DOI 10.1080/01902140802221987; McManus DP, 2009, PARASITOLOGY, V136, P1643, DOI 10.1017/S0031182009005666; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mejri N, 2006, PARASITE IMMUNOL, V28, P373, DOI 10.1111/j.1365-3024.2006.00836.x; MEJRI N, 2009, PARASITOL RES   0702; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Nakajima M, 2001, INT ARCH ALLERGY IMM, V125, P241, DOI 10.1159/000053822; Nakamichi K, 2004, J VIROL, V78, P9376, DOI 10.1128/JVI.78.17.9376-9388.2004; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; PATER C, 1998, INTESTINAL SYSTEMIC; Pennock JL, 2006, CHEM IMMUNOL ALLERGY, V90, P128, DOI 10.1159/000088885; PLAYFORD MC, 1992, JPN J VET RES, V40, P113; PLAYFORD MC, 1992, INT J PARASITOL, V22, P975, DOI 10.1016/0020-7519(92)90056-Q; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Sailer M, 1997, J PEDIATR-US, V130, P320, DOI 10.1016/S0022-3476(97)70364-0; Santiago HD, 2004, INFECT IMMUN, V72, P4918, DOI 10.1128/IAI.72.8.4918-4923.2004; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Siles-Lucas M, 2003, VACCINE, V21, P431, DOI 10.1016/S0264-410X(02)00517-0; SILESLUCAS M, 2003, PARASITE IMMUNOL, V20, P623; STANLEY AC, 2008, PLOS PATHOG, V19; Stanley AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000158; Vuitton DA, 2006, PARASITOL INT, V55, pS51, DOI 10.1016/j.parint.2005.11.007; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Xiao H, 2002, J BIOL CHEM, V277, P8091, DOI 10.1074/jbc.M106650200; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340; Yang D, 2003, BLOOD, V102, P3396, DOI 10.1182/blood-2003-01-0151; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Zhai YA, 2008, HEPATOLOGY, V47, P207, DOI 10.1002/hep.21986; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190; Zingg W, 2004, INFECTION, V32, P299, DOI 10.1007/s15010-004-3134-9	74	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9779	10.1371/journal.pone.0009779	http://dx.doi.org/10.1371/journal.pone.0009779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368974	gold, Green Submitted, Green Published			2022-12-27	WOS:000276418200003
J	Singh, AK; Battu, A; Mohareer, K; Hasnain, SE; Ehtesham, NZ				Singh, Anil K.; Battu, Aruna; Mohareer, Krishnaveni; Hasnain, Seyed E.; Ehtesham, Nasreen Z.			Transcription of Human Resistin Gene Involves an Interaction of Sp1 with Peroxisome Proliferator-Activating Receptor Gamma (PPAR gamma)	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; 30-KDA PROTEIN-BINDING; SMOOTH-MUSCLE CELLS; IN-VITRO; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; DIABETIC SUBJECTS; CONTROL ELEMENT; EXPRESSION; PROMOTER	Background: Resistin is a cysteine rich protein, mainly expressed and secreted by circulating human mononuclear cells. While several factors responsible for transcription of mouse resistin gene have been identified, not much is known about the factors responsible for the differential expression of human resistin. Methodology/Principal Finding: We show that the minimal promoter of human resistin lies within similar to 80 bp sequence upstream of the transcriptional start site (-240) whereas binding sites for cRel, CCAAT enhancer binding protein alpha (C/EBP-alpha), activating transcription factor 2 (ATF-2) and activator protein 1 (AP-1) transcription factors, important for induced expression, are present within sequences up to -619. Specificity Protein 1(Sp1) binding site (-276 to -295) is also present and an interaction of Sp1 with peroxisome proliferator activating receptor gamma (PPAR gamma) is necessary for constitutive expression in U937 cells. Indeed co-immunoprecipitation assay demonstrated a direct physical interaction of Sp1 with PPAR gamma in whole cell extracts of U937 cells. Phorbol myristate acetate (PMA) upregulated the expression of resistin mRNA in U937 cells by increasing the recruitment of Sp1, ATF-2 and PPAR gamma on the resistin gene promoter. Furthermore, PMA stimulation of U937 cells resulted in the disruption of Sp1 and PPAR gamma interaction. Chromatin immunoprecipitation (ChIP) assay confirmed the recruitment of transcription factors phospho ATF-2, Sp1, Sp3, PPAR gamma, chromatin modifier histone deacetylase 1 (HDAC1) and the acetylated form of histone H3 but not cRel, C/EBP-alpha and phospho c-Jun during resistin gene transcription. Conclusion: Our findings suggest a complex interplay of Sp1 and PPAR gamma along with other transcription factors that drives the expression of resistin in human monocytic U937 cells.	[Singh, Anil K.; Hasnain, Seyed E.; Ehtesham, Nasreen Z.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Battu, Aruna; Ehtesham, Nasreen Z.] Indian Council Med Res, Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	University of Hyderabad; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Singh, AK (corresponding author), Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India.	nasreen_e1@hotmail.com	EHTESHAM, NASREEN ZAFAR/AAI-3169-2020; Singh, Anil K/H-6225-2019	Singh, Anil K/0000-0002-4102-2420; Battu, Aruna/0000-0001-7878-8983; Hasnain, Seyed/0000-0002-2967-0791	Indian Council of Medical Research and Council of Scientific and Industrial Research	Indian Council of Medical Research and Council of Scientific and Industrial Research	This work was supported by the Indian Council of Medical Research and Council of Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun H, 1998, J BIOL CHEM, V273, P9821, DOI 10.1074/jbc.273.16.9821; BURMA S, 1994, J BIOL CHEM, V269, P2750; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ehtesham NZ, 2002, CURR SCI INDIA, V83, P1190; Ehtesham NZ, 2001, CURR SCI INDIA, V80, P1369; Ghosh S, 2003, GENE, V305, P27, DOI 10.1016/S0378-1119(02)01213-1; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Hata Y, 1998, J BIOL CHEM, V273, P19294, DOI 10.1074/jbc.273.30.19294; Heilbronn LK, 2004, J CLIN ENDOCR METAB, V89, P1844, DOI 10.1210/jc.2003-031410; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hoppe KL, 1998, J LIPID RES, V39, P969; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jonke J, 2002, OBES RES, V10, P1; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; Lee YW, 2001, J MOL CELL CARDIOL, V33, P83, DOI 10.1006/jmcc.2000.1278; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; LI BY, 1994, J BIOL CHEM, V269, P7756; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; MUKHERJEE B, 1995, J BIOL CHEM, V270, P4405, DOI 10.1074/jbc.270.9.4405; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nielsen SJ, 1998, BIOCHEM J, V333, P511, DOI 10.1042/bj3330511; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Rajakumar RA, 1998, J BIOL CHEM, V273, P27474, DOI 10.1074/jbc.273.42.27474; Ramachandran A, 2001, J BIOL CHEM, V276, P23440, DOI 10.1074/jbc.M101537200; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; Song HY, 2002, BIOCHEM BIOPH RES CO, V299, P291, DOI 10.1016/S0006-291X(02)02551-2; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Tanaka T, 2000, ARTERIOSCL THROM VAS, V20, P392, DOI 10.1161/01.ATV.20.2.392; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vines CR, 2000, ENDOCRINOLOGY, V141, P938, DOI 10.1210/en.141.3.938; Yajima S, 1998, DNA CELL BIOL, V17, P471, DOI 10.1089/dna.1998.17.471; Zhou L, 2006, DOMEST ANIM ENDOCRIN, V30, P98, DOI 10.1016/j.domaniend.2005.06.004; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	68	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9912	10.1371/journal.pone.0009912	http://dx.doi.org/10.1371/journal.pone.0009912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360975	Green Published, gold			2022-12-27	WOS:000276163100007
J	Hadorn, M; Hotz, PE				Hadorn, Maik; Hotz, Peter Eggenberger			DNA-Mediated Self-Assembly of Artificial Vesicles	PLOS ONE			English	Article							LIPID VESICLES; BIOTIN INTERACTIONS; BILAYER VESICLES; LATERAL MOBILITY; LIPOSOMES; ADHESION; BINDING; AGGREGATION; RECOGNITION; FUSION	Background: Although multicompartment systems made of single unilamellar vesicles offer the potential to outperform single compartment systems widely used in analytic, synthetic, and medical applications, their use has remained marginal to date. On the one hand, this can be attributed to the binary character of the majority of the current tethering protocols that impedes the implementation of real multicomponent or multifunctional systems. On the other hand, the few tethering protocols theoretically providing multicompartment systems composed of several distinct vesicle populations suffer from the readjustment of the vesicle formation procedure as well as from the loss of specificity of the linking mechanism over time. Methodology/Principal Findings: In previous studies, we presented implementations of multicompartment systems and resolved the readjustment of the vesicle formation procedure as well as the loss of specificity by using linkers consisting of biotinylated DNA single strands that were anchored to phospholipid-grafted biotinylated PEG tethers via streptavidin as a connector. The systematic analysis presented herein provides evidences for the incorporation of phospholipid-grafted biotinylated PEG tethers to the vesicle membrane during vesicle formation, providing specific anchoring sites for the streptavidin loading of the vesicle membrane. Furthermore, DNA-mediated vesicle-vesicle self-assembly was found to be sequence-dependent and to depend on the presence of monovalent salts. Conclusions/Significance: This study provides a solid basis for the implementation of multi-vesicle assemblies that may affect at least three distinct domains. (i) Analysis. Starting with a minimal system, the complexity of a bottom-up system is increased gradually facilitating the understanding of the components and their interaction. (ii) Synthesis. Consecutive reactions may be implemented in networks of vesicles that outperform current single compartment bioreactors in versatility and productivity. (iii) Personalized medicine. Transport and targeting of long-lived, pharmacologically inert prodrugs and their conversion to short-lived, active drug molecules directly at the site of action may be accomplished if multi-vesicle assemblies of predefined architecture are used.	[Hadorn, Maik] Univ Zurich, Dept Informat, Artificial Intelligence Lab, Zurich, Switzerland; [Hotz, Peter Eggenberger] Univ So Denmark, Maersk Mc Kinney Moller Inst, Odense, Denmark	University of Zurich; University of Southern Denmark	Hadorn, M (corresponding author), Univ Zurich, Dept Informat, Artificial Intelligence Lab, Zurich, Switzerland.	hadorn@ifi.uzh.ch	Hadorn, Maik/I-8909-2012	Hadorn, Maik/0000-0003-4530-9346	Swiss National Foundation [200020-118127]; European Community [FP7/2007-2013, 249032]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Community(European Commission)	Maik Hadorn was partly funded by the Swiss National Foundation Project 200020-118127: 'Embryogenic Evolution: From Simulations to Robotic Applications' (http://www. projectdb.snf.ch/WebForms/Frameset.aspx). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 249032 (http://cordis.europa.eu/fetch?CALLER= PROJ_ICT&ACTION=D&CAT=PROJ&RCN= 92864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Beales PA, 2007, J PHYS CHEM A, V111, P12372, DOI 10.1021/jp075792z; Benkoski JJ, 2005, J PHYS CHEM B, V109, P9773, DOI 10.1021/jp044947p; Berti D, 1998, J PHYS CHEM B, V102, P303, DOI 10.1021/jp972954q; Biancaniello PL, 2007, LANGMUIR, V23, P2688, DOI 10.1021/la062885j; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Bolinger PY, 2008, ANGEW CHEM INT EDIT, V47, P5544, DOI 10.1002/anie.200801606; Bonacucina G, 2009, J PHARM SCI-US, V98, P1, DOI 10.1002/jps.21423; Boyer C, 2007, ACS NANO, V1, P176, DOI 10.1021/nn7002025; Burridge KA, 2004, LANGMUIR, V20, P10252, DOI 10.1021/la0489099; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; CHIRUVOLU S, 1994, SCIENCE, V264, P1753, DOI 10.1126/science.8209255; Chiu DT, 1999, SCIENCE, V283, P1892, DOI 10.1126/science.283.5409.1892; Cobbe S, 2003, J PHYS CHEM B, V107, P470, DOI 10.1021/jp021503p; Constable EC, 1999, CHEM COMMUN, P1483, DOI 10.1039/a904665h; Coussaert T, 2001, BIOPHYS J, V80, P2004, DOI 10.1016/S0006-3495(01)76170-X; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Farbman-Yogev I, 1998, J PHYS CHEM A, V102, P9586, DOI 10.1021/jp9823300; Gomez-Hens A, 2005, TRAC-TREND ANAL CHEM, V24, P9, DOI 10.1016/j.trac.2004.07.017; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HADORN M, 2010, 3 INT JOINT IN PRESS; Hadorn M, 2009, LECT NOTES ARTIF INT, V5865, P126, DOI 10.1007/978-3-642-10427-5_13; Hadorn M, 2009, LECT NOTES ARTIF INT, V5865, P169, DOI 10.1007/978-3-642-10427-5_17; HAN HK, 2002, AAPS J, V2, P48; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Kisak ET, 2004, CURR MED CHEM, V11, P199, DOI 10.2174/0929867043456197; Kisak ET, 2000, LANGMUIR, V16, P2825, DOI 10.1021/la990787a; Lasic DD., 1993, LIPOSOMES PHYS APPL; Li WM, 2001, BBA-BIOMEMBRANES, V1513, P193, DOI 10.1016/S0005-2736(01)00351-0; Licata NA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041406; Lynch NJ, 1996, BIOTECHNOL BIOENG, V50, P151; Marchi-Artzner V, 2001, CHEMPHYSCHEM, V2, P367, DOI 10.1002/1439-7641(20010618)2:6<367::AID-CPHC367>3.0.CO;2-#; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; Menger FM, 2002, ANGEW CHEM INT EDIT, V41, P1350, DOI 10.1002/1521-3773(20020415)41:8<1350::AID-ANIE1350>3.0.CO;2-#; Michel M, 2004, LANGMUIR, V20, P6127, DOI 10.1021/la049862u; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; NopplSimson DA, 1996, BIOPHYS J, V70, P1391, DOI 10.1016/S0006-3495(96)79697-2; Owen RL, 2005, ELECTROPHORESIS, V26, P735, DOI 10.1002/elps.200410288; Paleos CM, 1996, J PHYS CHEM-US, V100, P13898, DOI 10.1021/jp961424b; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pfeiffer I, 2006, ANAL CHEM, V78, P7493, DOI 10.1021/ac061280p; Ratanabanangkoon P, 2003, LANGMUIR, V19, P1054, DOI 10.1021/la026251y; Ratanabanangkoon P, 2002, LANGMUIR, V18, P4270, DOI 10.1021/la025568v; RECORD MT, 1967, BIOPOLYMERS, V5, P975, DOI 10.1002/bip.1967.360051010; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sideratou Z, 2002, LANGMUIR, V18, P5036, DOI 10.1021/la020150i; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stadler B, 2004, LANGMUIR, V20, P11348, DOI 10.1021/la0482305; Stengel G, 2007, J AM CHEM SOC, V129, P9584, DOI 10.1021/ja073200k; Svedhem S, 2003, CHEMBIOCHEM, V4, P339, DOI 10.1002/cbic.200390055; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; Vermette P, 2002, LANGMUIR, V18, P505, DOI 10.1021/la0109967; Walker SA, 1997, NATURE, V387, P61, DOI 10.1038/387061a0; Wang CZ, 2003, LANGMUIR, V19, P7676, DOI 10.1021/la0345946; Weikl TR, 2002, EUROPHYS LETT, V59, P916, DOI 10.1209/epl/i2002-00130-3; Wiedmer SK, 2004, TRAC-TREND ANAL CHEM, V23, P562, DOI 10.1016/j.trac.2004.03.001; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yoshina-Ishii C, 2003, J AM CHEM SOC, V125, P3696, DOI 10.1021/ja029783+	65	50	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9886	10.1371/journal.pone.0009886	http://dx.doi.org/10.1371/journal.pone.0009886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360854	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969600004
J	Lindsey, R; Ha, Y; Momany, M				Lindsey, Rebecca; Ha, Youngsil; Momany, Michelle			A Septin from the Filamentous Fungus A. nidulans Induces Atypical Pseudohyphae in the Budding Yeast S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; GENE FAMILY; BUD NECK; GROWTH; ROLES; LOCALIZATION; ORGANIZATION; CYTOKINESIS; EMERGENCE	Background: Septins, novel cytoskeletal proteins, form rings at the bases of emerging round buds in yeasts and at the bases of emerging elongated hyphal initials in filamentous fungi. Methodology/Principal Findings: When introduced into the yeast Saccharomyces cerevisiae, the septin AspC from the filamentous fungus Aspergillus nidulans induced highly elongated atypical pseudohyphae and spore-producing structures similar to those of hyphal fungi. AspC induced atypical pseudohyphae when S. cerevisiae pseudohyphal or haploid invasive genes were deleted, but not when the CDC10 septin gene was deleted. AspC also induced atypical pseudohyphae when S. cerevisiae genes encoding Cdc12-interacting proteins Bem4, Cla4, Gic1 and Gic2 were deleted, but not when BNI1, a Cdc12-interacting formin gene, was deleted. AspC localized to bud and pseudohypha necks, while its S. cerevisiae ortholog, Cdc12, localized only to bud necks. Conclusions/Significance: Our results suggest that AspC competes with Cdc12 for incorporation into the yeast septin scaffold and once there alters cell shape by altering interactions with the formin Bni1. That introduction of the A. nidulans septin AspC into S. cerevisiae induces a shift from formation of buds to formation of atypical pseudohyphae suggests that septins play an important role in the morphological plasticity of fungi.	[Lindsey, Rebecca; Ha, Youngsil; Momany, Michelle] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Lindsey, R (corresponding author), USDA, ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, Richard B Russell Agr Res Ctr, Athens, GA USA.	momany@plantbio.uga.edu	Momany, Michelle/L-2327-2016	Lindsey, Rebecca/0000-0002-2149-7971; Momany, Michelle/0000-0001-7110-063X	NSF [MCB0211787]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant MCB0211787 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Burke D., 2000, METHODS YEAST GENETI; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; DeVirgilio C, 1996, MICROBIOL-SGM, V142, P2897, DOI 10.1099/13500872-142-10-2897; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fares H, 1996, J CELL BIOL, V132, P399, DOI 10.1083/jcb.132.3.399; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Liu HP, 1996, GENETICS, V144, P967; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Momany M, 2001, GENETICS, V157, P969; OZSARAC N, 1995, GENE, V164, P157, DOI 10.1016/0378-1119(95)00438-C; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; RUOHONEN L, 1995, J BIOTECHNOL, V39, P193, DOI 10.1016/0168-1656(95)00024-K; RUOHONEN L, 1991, YEAST, V7, P337, DOI 10.1002/yea.320070404; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SIKORSKI RS, 1989, GENETICS, V122, P19; VERSELE M, 2004, MOL BIOL CELL; Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	33	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9858	10.1371/journal.pone.0009858	http://dx.doi.org/10.1371/journal.pone.0009858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360845	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500005
J	Fink, P; Ornbol, E; Christensen, KS				Fink, Per; Ornbol, Eva; Christensen, Kaj Sparle			The Outcome of Health Anxiety in Primary Care. A Two-Year Follow-up Study on Health Care Costs and Self-Rated Health	PLOS ONE			English	Article							III-R HYPOCHONDRIASIS; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; TRANSIENT HYPOCHONDRIASIS; PSYCHIATRIC COMORBIDITY; GENERAL-POPULATION; SOMATIZATION; PREVALENCE; DISORDERS; ILLNESS	Background: Hypochondriasis is prevalent in primary care, but the diagnosis is hampered by its stigmatizing label and lack of valid diagnostic criteria. Recently, new empirically established criteria for Health anxiety were introduced. Little is known about Health anxiety's impact on longitudinal outcome, and this study aimed to examine impact on self-rated health and health care costs. Methodology/Principal Findings: 1785 consecutive primary care patients aged 18-65 consulting their family physicians (FPs) for a new illness were followed-up for two years. A stratified subsample of 701 patients was assessed by the Schedules for Clinical Assessment in Neuropsychiatry interview. Patients with mild (N = 21) and severe Health anxiety (N = 81) and Hypochondriasis according to the DSM-IV (N = 59) were compared with a comparison group of patients who had a well-defined medical condition according to their FPs and a low score on the screening questionnaire (N = 968). Self-rated health was measured by questionnaire at index and at three, 12, and 24 months, and health care use was extracted from patient registers. Compared with the 968 patients with well-defined medical conditions, the 81 severe Health anxiety patients and the 59 DSM-IV Hypochondriasis patients continued during follow-up to manifest significantly more Health anxiety (Whiteley-7 scale). They also continued to have significantly worse self-rated functioning related to physical and mental health (component scores of the SF-36). The severe Health anxiety patients used about 41-78% more health care per year in total, both during the 3 years preceding inclusion and during follow-up, whereas the DSM-IV Hypochondriasis patients did not have statistically significantly higher total use. A poor outcome of Health anxiety was not explained by comorbid depression, anxiety disorder or well-defined medical condition. Patients with mild Health anxiety did not have a worse outcome on physical health and incurred significantly less health care costs than the group of patients with a well-defined medical condition. Conclusions/Significance: Severe Health anxiety was found to be a disturbing and persistent condition. It is costly for the health care system and must be taken seriously, i.e. diagnosed and treated. This study supports the validity of recently introduced new criteria for Health anxiety.	[Fink, Per; Ornbol, Eva] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, DK-8000 Aarhus, Denmark; [Christensen, Kaj Sparle] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark	Aarhus University; Aarhus University	Fink, P (corresponding author), Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, DK-8000 Aarhus, Denmark.	aarhus.ffl@rm.dk	Christensen, Kaj Sparle/M-9994-2014; Fink, Per/AAA-2297-2021	Christensen, Kaj Sparle/0000-0002-0409-2702; Fink, Per/0000-0003-2921-4099				Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; BARSKY AJ, 1990, ARCH GEN PSYCHIAT, V47, P746; Barsky AJ, 1998, ARCH GEN PSYCHIAT, V55, P737, DOI 10.1001/archpsyc.55.8.737; Barsky AJ, 2004, JAMA-J AM MED ASSOC, V291, P1464, DOI 10.1001/jama.291.12.1464; BARSKY AJ, 1992, ARCH GEN PSYCHIAT, V49, P101; Barsky AJ, 2001, MED CARE, V39, P705, DOI 10.1097/00005650-200107000-00007; BARSKY AJ, 1993, AM J PSYCHIAT, V150, P484; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Conroy RM, 1999, J PSYCHOSOM RES, V46, P45, DOI 10.1016/S0022-3999(98)00066-X; Creed F, 2004, J PSYCHOSOM RES, V56, P391, DOI 10.1016/S0022-3999(03)00622-6; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; Dickinson WP, 2003, GEN HOSP PSYCHIAT, V25, P1, DOI 10.1016/S0163-8343(02)00247-5; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eaton WW, 2000, ARCH GEN PSYCHIAT, V57, P217, DOI 10.1001/archpsyc.57.3.217; Efron B., 2003, INTRO BOOTSTRAP; ESCOBAR JI, 1987, AM J PUBLIC HEALTH, V77, P837, DOI 10.2105/AJPH.77.7.837; Escobar JI, 1998, GEN HOSP PSYCHIAT, V20, P155, DOI 10.1016/S0163-8343(98)00018-8; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FINK P, 1992, PSYCHOL MED, V22, P173, DOI 10.1017/S0033291700032827; Fink P, 1999, J PSYCHOSOM RES, V46, P261, DOI 10.1016/S0022-3999(98)00092-0; Fink P, 2004, J PSYCHOSOM RES, V57, P17, DOI 10.1016/S0022-3999(03)00374-X; Fink P, 2004, AM J PSYCHIAT, V161, P1680, DOI 10.1176/appi.ajp.161.9.1680; Fink P, 1995, ACTA PSYCHIAT SCAND, V92, P409, DOI 10.1111/j.1600-0447.1995.tb09605.x; Fink P, 1999, PSYCHOSOMATICS, V40, P330, DOI 10.1016/S0033-3182(99)71228-4; Fink P, 2002, PSYCHOSOMATICS, V43, P93, DOI 10.1176/appi.psy.43.2.93; Greeven A, 2007, AM J PSYCHIAT, V164, P91, DOI 10.1176/appi.ajp.164.1.91; Gureje O, 1997, PSYCHOL MED, V27, P1001, DOI 10.1017/S0033291797005345; Hansen MS, 2005, GEN HOSP PSYCHIAT, V27, P119, DOI 10.1016/j.genhosppsych.2004.10.005; KENDELL RE, 1989, PSYCHOL MED, V19, P45, DOI 10.1017/S0033291700011016; Looper KJ, 2001, PSYCHOL MED, V31, P577, DOI 10.1017/S0033291701003737; Lucock MP, 1997, BRIT MED J, V315, P572; Martin A, 2006, PSYCHOSOM MED, V68, P770, DOI 10.1097/01.psy.0000238213.04984.b0; Noyes R, 1999, GEN HOSP PSYCHIAT, V21, P8, DOI 10.1016/S0163-8343(98)00063-2; NOYES R, 1994, GEN HOSP PSYCHIAT, V16, P78, DOI 10.1016/0163-8343(94)90049-3; NOYES R, 1994, PSYCHOSOMATICS, V35, P533, DOI 10.1016/S0033-3182(94)71722-9; NOYES R, 1993, ARCH GEN PSYCHIAT, V50, P961; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Simon GE, 2001, GEN HOSP PSYCHIAT, V23, P51, DOI 10.1016/S0163-8343(01)00115-3; SMITH GR, 1986, ARCH INTERN MED, V146, P69, DOI 10.1001/archinte.146.1.69; SORENSEN HT, 1996, DAN MED B, V463; *STATA CORP, 2003, STATA VERS 8 0 COMP; Toft T, 2005, PSYCHOL MED, V35, P1175, DOI 10.1017/S0033291705004459; TOFT T, 2009, PRAGMATIC RAND UNPUB; TOFT T, 2009, PSYCHOTHERA IN PRESS; Ware JE, 2005, SF 36 HLTH SURVEY MA; Wareing PW, 2001, INT J FOOD SCI TECH, V36, P1, DOI 10.1046/j.1365-2621.2001.00419.x; World Health Organization (WHO), 1998, SCAN SCHED CLIN ASS	47	128	132	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9873	10.1371/journal.pone.0009873	http://dx.doi.org/10.1371/journal.pone.0009873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FT	20352043	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500026
J	Devillard, R; Galvani, S; Thiers, JC; Guenet, JL; Hannun, Y; Bielawski, J; Negre-Salvayre, A; Salvayre, R; Auge, N				Devillard, Raphael; Galvani, Sylvain; Thiers, Jean-Claude; Guenet, Jean-Louis; Hannun, Yusuf; Bielawski, Jacek; Negre-Salvayre, Anne; Salvayre, Robert; Auge, Nathalie			Stress-Induced Sphingolipid Signaling: Role of Type-2 Neutral Sphingomyelinase in Murine Cell Apoptosis and Proliferation (Publication with Expression of Concern. See vol. 13, 2018)	PLOS ONE			English	Article; Publication with Expression of Concern							TUMOR-NECROSIS-FACTOR; LOW-DENSITY LIPOPROTEINS; FACTOR-ALPHA; INDUCED ACTIVATION; CERAMIDE PATHWAY; DEATH; SMPD3; PATHOPHYSIOLOGY; RECEPTORS; GROWTH	Background: Sphingomyelin hydrolysis in response to stress-inducing agents, and subsequent ceramide generation, are implicated in various cellular responses, including apoptosis, inflammation and proliferation, depending on the nature of the different acidic or neutral sphingomyelinases. This study was carried out to investigate whether the neutral Mg2+-dependent neutral sphingomyelinase-2 (nSMase2) plays a role in the cellular signaling evoked by TNFalpha and oxidized LDLs, two stress-inducing agents, which are mitogenic at low concentrations and proapoptotic at higher concentrations. Methodology and Principal Findings: For this purpose, we used nSMase2-deficient cells from homozygous fro/fro (fragilitas ossium) mice and nSMase2-deficient cells reconstituted with a V5-tagged nSMase2. We report that the genetic defect of nSMase2 (in fibroblasts from fro/fro mice) does not alter the TNFalpha and oxidized LDLs-mediated apoptotic response. Likewise, the hepatic toxicity of TNFalpha is similar in wild type and fro mice, thus is independent of nSMase2 activation. In contrast, the mitogenic response elicited by low concentrations of TNFalpha and oxidized LDLs (but not fetal calf serum) requires nSMase2 activation. Conclusion and Significance: nSMase2 activation is not involved in apoptosis mediated by TNFalpha and oxidized LDLs in murine fibroblasts, and in the hepatotoxicity of TNFalpha in mice, but is required for the mitogenic response to stress-inducing agents.	[Devillard, Raphael; Galvani, Sylvain; Thiers, Jean-Claude; Negre-Salvayre, Anne; Salvayre, Robert; Auge, Nathalie] CHU Rangueil, INSERM, U858, F-31054 Toulouse, France; [Galvani, Sylvain; Thiers, Jean-Claude; Negre-Salvayre, Anne; Salvayre, Robert; Auge, Nathalie] Univ Toulouse 3, Fac Med, F-31062 Toulouse, France; [Devillard, Raphael] Univ Bordeaux 2, UFR Odontol, F-33076 Bordeaux, France; [Guenet, Jean-Louis] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; [Hannun, Yusuf; Bielawski, Jacek] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Medical University of South Carolina	Devillard, R (corresponding author), CHU Rangueil, INSERM, U858, F-31054 Toulouse, France.	nathalie.auge@inserm.fr	Devillard, Raphael/K-9279-2019	Devillard, Raphael/0000-0002-2962-2044; Negre-Salvayre, Anne/0000-0003-2136-5706; Auge, Nathalie/0000-0003-2088-7211	INSERM; Universite Toulouse-3; Institut Francais pour la Recherche Odontologique (IFRO); Fondation pour la Recherche Medicale; Fondation Coeur et Arteres; NIH [GM 43825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Toulouse-3; Institut Francais pour la Recherche Odontologique (IFRO); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Coeur et Arteres; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	INSERM, Universite Toulouse-3, Institut Francais pour la Recherche Odontologique (IFRO), Fondation pour la Recherche Medicale, Fondation Coeur et Arteres, and NIH-GM 43825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Auge N, 2000, PROG LIPID RES, V39, P207, DOI 10.1016/S0163-7827(00)00007-2; Auge N, 2002, ARTERIOSCL THROM VAS, V22, P1990, DOI 10.1161/01.ATV.0000043453.21629.3B; AUGE N, 1995, BIOCHEM J, V309, P1015, DOI 10.1042/bj3091015; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BROUCKAERT P, 1993, IMMUNOBIOLOGY, V187, P317, DOI 10.1016/S0171-2985(11)80347-5; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Coatrieux C, 2007, FREE RADICAL BIO MED, V43, P80, DOI 10.1016/j.freeradbiomed.2007.03.036; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Escargueil-Blanc I, 1998, J BIOL CHEM, V273, P27389, DOI 10.1074/jbc.273.42.27389; ESCARGUEILBLANC I, 1994, FASEB J, V8, P1075, DOI 10.1096/fasebj.8.13.7926374; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; KITTRELL FS, 1992, CANCER RES, V52, P1924; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Porn-Ares MI, 2003, BIOCHEM J, V374, P403, DOI 10.1042/BJ20021955; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002	44	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9826	10.1371/journal.pone.0009826	http://dx.doi.org/10.1371/journal.pone.0009826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352118	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400026
J	Fernandes, F; Ansari, IUH; Striker, R				Fernandes, Fiona; Ansari, Israr-ul H.; Striker, Rob			Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; RNA-POLYMERASE; CELL-CULTURE; REPLICATION; PROTEIN; GENOME; BINDING; STRAIN; DOMAIN	Background: Hepatitis C Virus (HCV) infection is a leading indication for liver transplantation. HCV infection reoccurs almost universally post transplant, decreasing both graft longevity and patient survival. The immunosuppressant, cyclosporine A (CsA) has potent anti-HCV activity towards both HCV replicons and the genotype 2a cell culture infectious virus. Previously, we isolated mutations in the 1bN replicon with less sensitivity to CsA that mapped to both NS5A and NS5B regions of the virus. Mutations in NS5A alone conferred decreased CsA susceptibility regardless of NS5B mutations. Methodology/Principal Findings: We examined the mechanisms by which NS5A mutations contribute to CsA resistance and if they are strain dependent. Using in vitro mutagenesis, the amino acid position 321 mutation of NS5A was restored to the wild-type tyrosine residue conferring partial CsA susceptibility on the mutant replicon. The 321 mutation also alters CsA susceptibility of the JFH cell culture virus. Additionally, we demonstrated a novel CsA-sensitive interaction between NS5A and both cyclophilin A and B. Both the mutant NS5A and wild type NS5A bind cyclophilin in vitro. The NS5A: cyclophilin interaction requires both the NS5A region identified by the resistance mutants and cyclophilin catalytic residues. In cell culture, NS5A from CsA resistant mutant has an enhanced interaction with cyclophilin B. Additionally; NS5B facilitates a stronger binding of mutant NS5A to endogenous cyclophilin B than wild-type in cell culture. Conclusions/Significance: Collectively, this data suggests direct interactions between cyclophilins and NS5A are critical to understand for optimal use of cyclophilin inhibitors in anti-HCV therapy.	[Fernandes, Fiona; Ansari, Israr-ul H.; Striker, Rob] Univ Wisconsin, Dept Med, Madison, WI USA; [Striker, Rob] Univ Wisconsin Hosp & Clin, William S Middleton Mem Vet Adm Hosp, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Fernandes, F (corresponding author), SUNY Stony Brook, Dept Microbiol & Mol Genet, Stony Brook, NY 11794 USA.	tstriker@wisc.edu		Striker, Rob/0000-0002-0454-895X; ANSARI, Israrul/0000-0003-0326-0329	American Cancer Society Research Scholar [07-077-01]; Office of Research and Development; Biomedical Laboratory R&D Service, Department of Veterans Affairs; University of Wisconsin Institute for Clinical and Translational Research; NIH Clinical and Translational Science [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	American Cancer Society Research Scholar(American Cancer Society); Office of Research and Development; Biomedical Laboratory R&D Service, Department of Veterans Affairs(US Department of Veterans Affairs); University of Wisconsin Institute for Clinical and Translational Research; NIH Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the American Cancer Society Research Scholar Grant (07-077-01) to R. S., by the Office of Research and Development, Biomedical Laboratory R&D Service, Department of Veterans Affairs, and by the University of Wisconsin Institute for Clinical and Translational Research, funded through an NIH Clinical and Translational Science Award, grant number 1UL1RR025011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari IH, 2004, J VIROL, V78, P9612, DOI 10.1128/JVI.78.18.9612-9623.2004; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Castro APV, 2003, J VIROL, V77, P9052, DOI 10.1128/JVI.77.16.9052-9068.2003; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Dietrich L, 2001, J VIROL, V75, P4721, DOI 10.1128/JVI.75.10.4721-4733.2001; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; GAITHER LA, VIROLOGY, V397, P43; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HECK JA, 2009, BIOCH PHARM; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu TW, 2009, ACTA MATH APPL SIN-E, V25, P33, DOI 10.1007/s10255-004-4100-0; LIU X, 2009, CELL MICROBIOL; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; SAMBROOK J, 2001, MOLECULAR CLONING LA; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652	38	74	76	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9815	10.1371/journal.pone.0009815	http://dx.doi.org/10.1371/journal.pone.0009815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352119	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400017
J	Arias, P; Cudeiro, J				Arias, Pablo; Cudeiro, Javier			Effect of Rhythmic Auditory Stimulation on Gait in Parkinsonian Patients with and without Freezing of Gait	PLOS ONE			English	Article							ATTENTIONAL COST; DISEASE PATIENTS; VARIABILITY; WALKING; MOTOR; CUES; METRONOME; PEOPLE; ONSET; TASK	Freezing of gait (FOG) in Parkinson's disease (PD) rises in prevalence when the effect of medications decays. It is known that auditory rhythmic stimulation improves gait in patients without FOG (PD-FOG), but its putative effect on patients with FOG (PD+FOG) at the end of dose has not been evaluated yet. This work evaluates the effect of auditory rhythmic stimulation on PD+FOG at the end of dose. 10 PD+ FOG and 9 PD-FOG patients both at the end of dose periods, and 10 healthy controls were asked to perform several walking tasks. Tasks were performed in the presence and absence of auditory sensory stimulation. All PD+ FOG suffered FOG during the task. The presence of auditory rhythmic stimulation (10% above preferred walking cadence) led PD+ FOG to significantly reduce FOG. Velocity and cadence were increased, and turn time reduced in all groups. We conclude that auditory stimulation at the frequency proposed may be useful to avoid freezing episodes in PD+ FOG.	[Arias, Pablo; Cudeiro, Javier] Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, Dept Med, INEF, La Coruna, Spain	Universidade da Coruna	Arias, P (corresponding author), Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, Dept Med, INEF, La Coruna, Spain.	jcud@udc.es	Arias, Pablo/C-7926-2015; Arias, Pablo/AAP-9721-2021	Arias, Pablo/0000-0002-9029-5310; Cudeiro, Javier/0000-0002-6597-6077	Xunta de Galicia, Spain [2007/000140-0, PGIDIT06PXIC137004PN]	Xunta de Galicia, Spain(Xunta de Galicia)	Work was supported by Xunta de Galicia (Conselleria de Educacion-2007/000140-0 and Direccion Xeral de I+D+i; PGIDIT06PXIC137004PN), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Bartels AL, 2003, J CLIN NEUROSCI, V10, P584, DOI 10.1016/S0967-5868(03)00192-9; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Cubo E, 2004, PARKINSONISM RELAT D, V10, P507, DOI 10.1016/j.parkreldis.2004.05.001; Del Olmo M, 2006, PARKINSONISM RELAT D, V12, P155, DOI 10.1016/j.parkreldis.2005.11.002; Ebersbach G, 1999, MOVEMENT DISORD, V14, P619, DOI 10.1002/1531-8257(199907)14:4<619::AID-MDS1011>3.0.CO;2-X; Enzensberger W, 1996, LANCET, V347, P1337, DOI 10.1016/S0140-6736(96)90987-3; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 2003, PHYSICA A, V321, P565, DOI 10.1016/S0378-4371(02)01744-2; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hong M, 2009, NEUROREHAB NEURAL RE, V23, P166, DOI 10.1177/1545968308320639; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Jankovic J, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20458; Kompoliti K, 2000, MOVEMENT DISORD, V15, P309, DOI 10.1002/1531-8257(200003)15:2<309::AID-MDS1016>3.0.CO;2-P; Kuo SH, 2008, MOVEMENT DISORD, V23, P616, DOI 10.1002/mds.21917; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miller RA, 1996, ELECTROMYOGR MOTOR C, V101, P1, DOI 10.1016/0013-4694(95)00209-X; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Nieuwboer A, 1997, Physiother Res Int, V2, P125, DOI 10.1002/pri.94; Nieuwboer A, 2000, PHYS THER, V80, P1087, DOI 10.1093/ptj/80.11.1087; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nieuwboer A, 2004, BRAIN, V127, P1650, DOI 10.1093/brain/awh189; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Okuma Y, 2006, J NEUROL, V253, P27, DOI 10.1007/s00415-006-7007-2; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Rochester L, 2007, J NEURAL TRANSM, V114, P1243, DOI 10.1007/s00702-007-0756-y; Rochester L, 2005, ARCH PHYS MED REHAB, V86, P999, DOI 10.1016/j.apmr.2004.10.040; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Willems AM, 2007, MOVEMENT DISORD, V22, P1871, DOI 10.1002/mds.21445	43	102	103	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9675	10.1371/journal.pone.0009675	http://dx.doi.org/10.1371/journal.pone.0009675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339591	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894300003
J	Jones, DR; Taylor, WA; Bate, C; David, M; Tayebi, M				Jones, Daryl Rhys; Taylor, William Alexander; Bate, Clive; David, Monique; Tayebi, Mourad			A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODY; SCRAPIE AGENT; MONOCLONAL-ANTIBODIES; SIGNAL-TRANSDUCTION; PROTEIN; DISEASE; MICE; BRAIN; DELAYS; INFECTION	The development of antibodies effective in crossing the blood brain barrier (BBB), capable of accessing the cytosol of affected cells and with higher affinity for PrPSc would be of paramount importance in arresting disease progression in its late stage and treating individuals with prion diseases. Antibody-based therapy appears to be the most promising approach following the exciting report from White and colleagues, establishing the "proof-of-principle'' for prion-immunotherapy. After passive transfer, anti-prion antibodies were shown to be very effective in curing peripheral but not central rodent prion disease, due to the fact that these anti-prion antibodies are relatively large molecules and cannot therefore cross the BBB. Here, we show that an anti-prion antibody derived from camel immunised with murine scrapie material adsorbed to immunomagnetic beads is able to prevent infection of susceptible N2a cells and cure chronically scrapie-infected neuroblastoma cultures. This antibody was also shown to transmigrate across the BBB and cross the plasma membrane of neurons to target cytosolic PrPC. In contrast, treatment with a conventional anti- prion antibody derived from mouse immunised with recombinant PrP protein was unable to prevent recurrence of PrPSc replication. Furthermore, our camelid antibody did not display any neurotoxic effects following treatment of susceptible N2a cells as evidenced by TUNEL staining. These findings demonstrate the potential use of anti- prion camelid antibodies for the treatment of prion and other related diseases via non-invasive means.	[Jones, Daryl Rhys; Taylor, William Alexander; Bate, Clive; Tayebi, Mourad] Royal Vet Coll, Dept Pathol & Infect Dis, Hertford, England; [David, Monique] Multiple Sclerosis Res Ctr New York, New York, NY USA	University of London; University of London Royal Veterinary College	Jones, DR (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hertford, England.	mtayebi@rvc.ac.uk	TAYEBI, MOURAD/F-7404-2010	TAYEBI, MOURAD/0000-0001-8664-6918	UK Royal Society; The Royal Veterinary College	UK Royal Society(Royal Society of London); The Royal Veterinary College	This study was supported by the UK Royal Society and The Royal Veterinary College Internal Grant Scheme to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; ADJOU KT, 1995, ANTIMICROB AGENTS CH, V39, P2810, DOI 10.1128/AAC.39.12.2810; Adjou KT, 2000, J COMP PATHOL, V122, P3, DOI 10.1053/jcpa.1999.0338; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campana V, 2009, BIOCHEM J, V418, P507, DOI 10.1042/BJ20081541; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DIRINGER H, 1991, J GEN VIROL, V72, P457, DOI 10.1099/0022-1317-72-2-457; Dumoulin M, 2004, BIOCHIMIE, V86, P589, DOI 10.1016/j.biochi.2004.09.012; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Goni F, 2008, NEUROSCIENCE, V153, P679, DOI 10.1016/j.neuroscience.2008.02.051; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mazzoni IE, 2005, BIOCHEM CELL BIOL, V83, P644, DOI 10.1139/o05-058; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Pilon J, 2007, NEUROSCI LETT, V429, P161, DOI 10.1016/j.neulet.2007.10.015; PRUSINER SB, 1994, ANNU REV MICROBIOL, V48, P655, DOI 10.1146/annurev.mi.48.100194.003255; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Regina A, 1999, J NEUROCHEM, V73, P1954; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Speare JO, 2003, J BIOL CHEM, V278, P12522, DOI 10.1074/jbc.M211599200; Tayebi M, 2004, MOL MED, V10, P104, DOI 10.2119/2004-00027.Tayebi; Tayebi M, 2006, IMMUNOL LETT, V105, P123, DOI 10.1016/j.imlet.2006.03.001; Tayebi M, 2009, J GEN VIROL, V90, P777, DOI 10.1099/vir.0.005041-0; Tayebi M, 2007, EXPERT REV ANTI-INFE, V5, P631, DOI 10.1586/14787210.5.4.631; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wuertzer CA, 2008, MOL THER, V16, P481, DOI 10.1038/sj.mt.6300387	49	27	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9804	10.1371/journal.pone.0009804	http://dx.doi.org/10.1371/journal.pone.0009804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339552	Green Published, gold			2022-12-27	WOS:000275894300026
J	Madar, A; Greenfield, A; Vanden-Eijnden, E; Bonneau, R				Madar, Aviv; Greenfield, Alex; Vanden-Eijnden, Eric; Bonneau, Richard			DREAM3: Network Inference Using Dynamic Context Likelihood of Relatedness and the Inferelator	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; ESCHERICHIA-COLI; EXPRESSION DATA; GENE NETWORKS; INFORMATION; MODEL; CHALLENGES; SELECTION; SYSTEMS	Background: Many current works aiming to learn regulatory networks from systems biology data must balance model complexity with respect to data availability and quality. Methods that learn regulatory associations based on unit-less metrics, such as Mutual Information, are attractive in that they scale well and reduce the number of free parameters (model complexity) per interaction to a minimum. In contrast, methods for learning regulatory networks based on explicit dynamical models are more complex and scale less gracefully, but are attractive as they may allow direct prediction of transcriptional dynamics and resolve the directionality of many regulatory interactions. Methodology: We aim to investigate whether scalable information based methods (like the Context Likelihood of Relatedness method) and more explicit dynamical models (like Inferelator 1.0) prove synergistic when combined. We test a pipeline where a novel modification of the Context Likelihood of Relatedness (mixed-CLR, modified to use time series data) is first used to define likely regulatory interactions and then Inferelator 1.0 is used for final model selection and to build an explicit dynamical model. Conclusions/Significance: Our method ranked 2nd out of 22 in the DREAM3 100-gene in silico networks challenge. Mixed-CLR and Inferelator 1.0 are complementary, demonstrating a large performance gain relative to any single tested method, with precision being especially high at low recall values. Partitioning the provided data set into four groups (knock-down, knock-out, time-series, and combined) revealed that using comprehensive knock-out data alone provides optimal performance. Inferelator 1.0 proved particularly powerful at resolving the directionality of regulatory interactions, i.e. "who regulates who" (approximately 93% of identified true positives were correctly resolved). Performance drops for high in-degree genes, i.e. as the number of regulators per target gene increases, but not with out-degree, i.e. performance is not affected by the presence of regulatory hubs.	[Madar, Aviv; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Greenfield, Alex; Vanden-Eijnden, Eric; Bonneau, Richard] NYU, Sch Med, Computat Biol Program, New York, NY 10003 USA; [Vanden-Eijnden, Eric] NYU, Courant Inst Math Sci, Dept Math, New York, NY 10003 USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10003 USA	New York University; New York University; New York University; New York University	Madar, A (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	Bonneau@nyu.edu	Bonneau, Richard/GZL-2900-2022; Madar, Aviv/AAO-1540-2020; Bonneau, Richard/ABD-6737-2021; Madar, Aviv/D-1023-2013		National Science Foundation (NSF) [DMS02-09959, DMS02-39625, DMS07959, DMS07-08140, DBI-08207]; Office of Naval Research (ONR) [N00014-04-1-0565]; Department of Defense (DOD) [USAMRAA W81XWH-04-1-0307]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Department of Defense (DOD)(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work of E.V.-E. was partially supported by National Science Foundation (NSF) grants DMS02-09959, DMS02-39625 and DMS07959, DMS02-39625 and DMS07-08140, and Office of Naval Research (ONR) grant N00014-04-1-0565. The work of R. B. was partially supported by NSF grant DBI-08207, and Department of Defense (DOD) grant USAMRAA W81XWH-04-1-0307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Babu M. Madan, 2009, V541, P163, DOI 10.1007/978-1-59745-243-4_8; Bansal M., 2007, MOL SYSTEMS BIOL, V3; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Chang WC, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-44; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Cover T. M., 1991, ELEMENTS INFORM THEO; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N., 1999, LEARNING BAYESIAN NE, P206; Gilchrist M, 2008, NATURE, V451, P1022, DOI 10.1038/nature06779; Gowda T, 2009, ANN NY ACAD SCI, V1158, P276, DOI 10.1111/j.1749-6632.2008.03763.x; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Herrgard MJ, 2004, CURR OPIN BIOTECH, V15, P70, DOI 10.1016/j.copbio.2003.11.002; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lauria M, 2009, ANN NY ACAD SCI, V1158, P257, DOI 10.1111/j.1749-6632.2008.03761.x; Madar A, 2009, IEEE ENG MED BIO, P5448, DOI 10.1109/IEMBS.2009.5334018; Madar Aviv, 2009, V541, P181, DOI 10.1007/978-1-59745-243-4_9; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; R Core Team, 2018, R LANG ENV STAT COMP; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Scheinine A, 2009, ANN NY ACAD SCI, V1158, P287, DOI 10.1111/j.1749-6632.2008.04100.x; Shannon C.E., 1948, BELL SYST TECH J, V27, P623, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang RS, 2007, BIOINFORMATICS, V23, P3056, DOI 10.1093/bioinformatics/btm465; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Zhao WT, 2008, IEEE ACM T COMPUT BI, V5, P262, DOI 10.1109/TCBB.2007.1067; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	48	66	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9803	10.1371/journal.pone.0009803	http://dx.doi.org/10.1371/journal.pone.0009803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339551	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894300025
J	Qiu, AQ; Oishi, K; Miller, MI; Lyketsos, CG; Mori, S; Albert, M				Qiu, Anqi; Oishi, Kenichi; Miller, Michael I.; Lyketsos, Constantine G.; Mori, Susumu; Albert, Marilyn			Surface-Based Analysis on Shape and Fractional Anisotropy of White Matter Tracts in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; FIBER TRACTS; HUMAN BRAIN; DIFFUSION; REGISTRATION; HIPPOCAMPAL; DEMENTIA; IMAGES; ATLAS; HYPOMETABOLISM	Background: White matter disruption has been suggested as one of anatomical features associated with Alzheimer's disease (AD). Diffusion tensor imaging (DTI), which has been widely used in AD studies, obtains new insights into the white matter structure. Methods: We introduced surface-based geometric models of the deep white matter tracts extracted from DTI, allowing the characterization of their shape variations relative to an atlas as well as fractional anisotropy (FA) variations on the atlas surface through large deformation diffeomorphic metric mapping (LDDMM). We applied it to assess local shapes and FA variations of twenty-three deep white matter tracts in 13 patients with AD and 19 healthy control subjects. Results: Our results showed regionally-specific shape abnormalities and FA reduction in the cingulum tract and the sagittal stratum tract in AD, suggesting that disruption in the white matter tracts near the temporal lobe may represent the secondary consequence of the medial temporal lobe pathology in AD. Moreover, the regionally-specific patterns of FA and shape of the white matter tracts were shown to be of sufficient sensitivity to robustly differentiate patients with AD from healthy comparison controls when compared with the mean FA and volumes within the regions of the white matter tracts. Finally, greater FA or deformation abnormalities of the white matter tracts were associated with lower MMSE scores. Conclusion: The regionally-specific shape and FA patterns could be potential imaging markers for differentiating AD from normal aging.	[Qiu, Anqi] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Oishi, Kenichi; Mori, Susumu] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD USA; [Albert, Marilyn] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Qiu, AQ (corresponding author), Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011; Oishi, Kenichi/H-1371-2013; Miller, Michael I./A-3213-2010	Qiu, Anqi/0000-0002-0215-6338; Oishi, Kenichi/0000-0002-1200-8611; 	National University of Singapore [R-397-000-058-133]; Agency for Science, Technology and Research's (A*STAR) Science and Engineering Research Council (SERC) [082-101-0025]; A* STAR's Singapore Institute for Clinical Sciences (SICS) [SICS-09/1/1/001]; National Institute on Aging [P50-AG005146, P50-AG 021334]; National Institute of Research Resources, NCRR [P41-RR15241]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000975, R01EB008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334, P50AG005146] Funding Source: NIH RePORTER	National University of Singapore(National University of Singapore); Agency for Science, Technology and Research's (A*STAR) Science and Engineering Research Council (SERC)(Agency for Science Technology & Research (A*STAR)); A* STAR's Singapore Institute for Clinical Sciences (SICS)(Agency for Science Technology & Research (A*STAR)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Research Resources, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National University of Singapore: start-up grant R-397-000-058-133 (AQ); the Agency for Science, Technology and Research's (A*STAR) Science and Engineering Research Council (SERC) 082-101-0025 ( AQ); A* STAR's Singapore Institute for Clinical Sciences (SICS) SICS-09/1/1/001 (AQ); the National Institute on Aging (P50-AG005146 and P50-AG 021334); and the National Institute of Research Resources (NCRR, P41-RR15241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2006, ALZ DIS ASSOC DIS, V20, P224, DOI 10.1097/01.wad.0000213857.89613.10; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cao Y, 2005, IEEE T MED IMAGING, V24, P1216, DOI 10.1109/TMI.2005.853923; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Chiang MC, 2008, IEEE T MED IMAGING, V27, P442, DOI 10.1109/TMI.2007.907326; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Csernansky JG, 2004, AM J PSYCHIAT, V161, P896, DOI 10.1176/appi.ajp.161.5.896; Duda R.O., 2006, PATTERN CLASSIFICATI; Dupuis P, 1998, Q APPL MATH, V56, P587, DOI 10.1090/qam/1632326; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Glaunes J, 2008, INT J COMPUT VISION, V80, P317, DOI 10.1007/s11263-008-0141-9; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Huang H, 2008, MAGN RESON IMAGING, V26, P1294, DOI 10.1016/j.mri.2008.03.005; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Irfanoglu MO, 2008, LECT NOTES COMPUT SC, V5242, P1014, DOI 10.1007/978-3-540-85990-1_122; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Lenglet C, 2006, IEEE T MED IMAGING, V25, P685, DOI 10.1109/TMI.2006.873299; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2007, LECT NOTES COMPUT SC, V4792, P161; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Qiu AQ, 2007, LECT NOTES COMPUT SC, V4791, P186; Qiu AQ, 2006, IEEE T MED IMAGING, V25, P1296, DOI 10.1109/TMI.2006.882143; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; ROSS ED, 1980, ARCH NEUROL-CHICAGO, V37, P193, DOI 10.1001/archneur.1980.00500530031001; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Thompson PM, 2003, J NEUROSCI, V23, P994; Vaillant M, 2005, LECT NOTES COMPUT SC, V3565, P381; Vaillant M, 2007, NEUROIMAGE, V34, P1149, DOI 10.1016/j.neuroimage.2006.08.053; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang YQ, 2005, ENVIRON SCI POLICY, V8, P179, DOI 10.1016/j.envsci.2004.09.005	54	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9811	10.1371/journal.pone.0009811	http://dx.doi.org/10.1371/journal.pone.0009811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339558	gold, Green Published			2022-12-27	WOS:000275894300030
J	Caldara, R; Zhou, XY; Miellet, S				Caldara, Roberto; Zhou, Xinyue; Miellet, Sebastien			Putting Culture Under the 'Spotlight' Reveals Universal Information Use for Face Recognition	PLOS ONE			English	Article							EYE-MOVEMENTS; PERCEPTUAL SPAN; FIXATION; AREA; OWN; FEATURES; SALIENCY; GAZE	Background: Eye movement strategies employed by humans to identify conspecifics are not universal. Westerners predominantly fixate the eyes during face recognition, whereas Easterners more the nose region, yet recognition accuracy is comparable. However, natural fixations do not unequivocally represent information extraction. So the question of whether humans universally use identical facial information to recognize faces remains unresolved. Methodology/Principal Findings: We monitored eye movements during face recognition of Western Caucasian (WC) and East Asian (EA) observers with a novel technique in face recognition that parametrically restricts information outside central vision. We used 'Spotlights' with Gaussian apertures of 2 degrees, 5 degrees or 8 degrees dynamically centered on observers' fixations. Strikingly, in constrained Spotlight conditions (2 degrees and 5 degrees) observers of both cultures actively fixated the same facial information: the eyes and mouth. When information from both eyes and mouth was simultaneously available when fixating the nose (8 degrees), as expected EA observers shifted their fixations towards this region. Conclusions/Significance: Social experience and cultural factors shape the strategies used to extract information from faces, but these results suggest that external forces do not modulate information use. Human beings rely on identical facial information to recognize conspecifics, a universal law that might be dictated by the evolutionary constraints of nature and not nurture.	[Caldara, Roberto; Miellet, Sebastien] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland; [Caldara, Roberto; Miellet, Sebastien] Univ Glasgow, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland; [Zhou, Xinyue] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	University of Glasgow; University of Glasgow; Sun Yat Sen University	Caldara, R (corresponding author), Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland.	r.caldara@psy.gla.ac.uk	Miellet, Sebastien/AFL-6215-2022; Miellet, Sebastien/H-5101-2011; Caldara, Roberto/H-1929-2011	Miellet, Sebastien/0000-0002-3519-033X; Caldara, Roberto/0000-0002-8260-9949; Lauwereyns, Jan/0000-0003-0551-2550	Economic and Social Research Council and Medical Research Council [ESRC/RES-060-25-0010]; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish; Medical Research Council [MC_G1001214] Funding Source: researchfish; ESRC [ES/E020933/1] Funding Source: UKRI; MRC [MC_G1001214] Funding Source: UKRI	Economic and Social Research Council and Medical Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by The Economic and Social Research Council and Medical Research Council (ESRC/RES-060-25-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Argyle M., 1976, GAZE MUTUAL GAZE; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caldara R, 2006, PERCEPTION, V35, P659, DOI 10.1068/p5360; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Caldara R, 2003, CLIN NEUROPHYSIOL, V114, P515, DOI 10.1016/S1388-2457(02)00407-8; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Caldara R, 2009, HUM BRAIN MAPP, V30, P1615, DOI 10.1002/hbm.20626; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; CROVITZ HF, 1962, AM J PSYCHOL, V75, P271, DOI 10.2307/1419611; DAVIDOFF J, 2008, COGNITION; DAVIES G, 1977, PERCEPTION, V6, P263, DOI 10.1068/p060263; Evans K, 2009, Q J EXP PSYCHOL, V62, P276, DOI 10.1080/17470210802373720; FRASER IH, 1990, PERCEPTION, V19, P661, DOI 10.1068/p190661; Galton Francis, 1883, INQUIRIES HUMAN FACU, DOI DOI 10.1037/14178-000; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P191, DOI 10.3758/BF03335056; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P187, DOI 10.3758/BF03335055; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Groner R, 1984, THEORETICAL APPL ASP, P523; GRONWALL DM, 1971, BRIT J PSYCHOL, V62, P175, DOI 10.1111/j.2044-8295.1971.tb02028.x; HAIG ND, 1986, PERCEPTION, V15, P235, DOI 10.1068/p150235; Hall E.T., 1966, HIDDEN DIMENSION; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HENDERSON JM, 2001, FRAGMENTS OBJECTS SE, P463, DOI DOI 10.1016/S0166-4115(01)80034-0; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; JACK RE, 2009, CULTURAL CONFUSIONS; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KELLY D, FRONTIERS P IN PRESS; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kuhn G, 2005, PERCEPTION, V34, P1155, DOI 10.1068/p3409bn1; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Michel C, 2007, COGNITIVE SCI, V31, P911, DOI 10.1080/03640210701530805; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; Miellet S, 2004, BRAIN LANG, V90, P299, DOI 10.1016/S0093-934X(03)00442-5; Miellet S, 2009, PSYCHOL SCI, V20, P721, DOI 10.1111/j.1467-9280.2009.02364.x; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; PORTA DG, 1593, REFRACTIONE OPTICES; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Rayner K, 2009, J EXP PSYCHOL LEARN, V35, P254, DOI 10.1037/a0013508; Rowley HA, 1998, IEEE T PATTERN ANAL, V20, P23, DOI 10.1109/34.655647; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; Triandis HC, 1995, INDIVIDUALISM COLLEC; Turati C, 2002, J EXP CHILD PSYCHOL, V83, P239, DOI 10.1016/S0022-0965(02)00148-0; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V	69	111	114	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9708	10.1371/journal.pone.0009708	http://dx.doi.org/10.1371/journal.pone.0009708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580NO	20305776	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000276456300011
J	Curnow, SJ; Fairclough, M; Schmutz, C; Kissane, S; Denniston, AKO; Nash, K; Buckley, CD; Lord, JM; Salmon, M				Curnow, S. John; Fairclough, Marianne; Schmutz, Caroline; Kissane, Steve; Denniston, Alastair K. O.; Nash, Kate; Buckley, Christopher D.; Lord, Janet M.; Salmon, Mike			Distinct Types of Fibrocyte Can Differentiate from Mononuclear Cells in the Presence and Absence of Serum	PLOS ONE			English	Article							CIRCULATING FIBROCYTES; MONOCYTES; FIBROBLASTS; TISSUE	Background: Fibrocytes are bone-marrow derived cells, expressing both haematopoietic and stromal cell markers, which contribute to tissue repair as well as pathological fibrosis. The differentiation of fibrocytes remains poorly characterised and this has limited understanding of their biology and function. In particular two methods are used to generate fibrocytes in vitro that differ fundamentally by the presence or absence of serum. Methodology/Principal Findings: We show here that fibrocytes grown in the absence of serum (SF) differentiate more efficiently from peripheral blood mononuclear cells than CD14(+) monocytes, and respond to serum by losing their spindle-shaped fibrocyte morphology. Although fibrocytes generated in the presence of serum (SC) express the same range of markers, they differentiate more efficiently from CD14(+) monocytes and do not change their morphology in response to serum. Transcriptional analysis revealed that both types of fibrocyte are distinct from each other, fibroblasts and additional monocyte-derived progeny. The gene pathways that differ significantly between SF and SC fibrocytes include those involved in cell migration, immune responses and response to wounding. Conclusions/Significance: These data show that SF and SC fibrocytes are distinct but related cell types, and suggest that they will play different roles during tissue repair and fibrosis where changes in serum proteins may occur.	[Curnow, S. John; Fairclough, Marianne; Schmutz, Caroline; Kissane, Steve; Denniston, Alastair K. O.; Nash, Kate; Buckley, Christopher D.; Lord, Janet M.; Salmon, Mike] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Curnow, SJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England.	s.j.curnow@bham.ac.uk	Denniston, Alastair/ABD-1238-2020; Buckley, Christopher/AAN-6378-2021	Denniston, Alastair/0000-0001-7849-0087; Buckley, Christopher/0000-0001-6924-6402; Lord, Janet/0000-0003-1030-6786; Curnow, John/0000-0002-2660-0392	Arthritis Research Campaign [16390]; Wellcome Trust [VS/06/BIR/A6]; Medical Research Council UK [G0600416]; Birmingham Eye Foundation [257549]; Medical Research Council [G9818340, G9818340B, G0600416] Funding Source: researchfish; National Institute for Health Research [CL-2009-09-002] Funding Source: researchfish; MRC [G9818340, G0600416] Funding Source: UKRI	Arthritis Research Campaign(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Birmingham Eye Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Arthritis Research Campaign (16390), The Wellcome Trust (VS/06/BIR/A6), Medical Research Council UK (Clinical Training Fellowship to AD; G0600416) and the Birmingham Eye Foundation (Registered [UK] Charity 257549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bahnelli C, 2007, IMMUNOBIOLOGY, V212, P693, DOI 10.1016/j.imbio.2007.09.009; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Filer A, 2009, ARTHRITIS RHEUM, V60, P1604, DOI 10.1002/art.24574; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Hong KM, 2005, FASEB J, V19, P2029, DOI 10.1096/fj.05-4295fje; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Uehara H, 2010, DIGEST DIS SCI, V55, P253, DOI 10.1007/s10620-009-0730-7	21	47	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9730	10.1371/journal.pone.0009730	http://dx.doi.org/10.1371/journal.pone.0009730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305780	Green Published, gold, Green Submitted			2022-12-27	WOS:000276456300013
J	Kleinau, G; Jaeschke, H; Worth, CL; Mueller, S; Gonzalez, J; Paschke, R; Krause, G				Kleinau, Gunnar; Jaeschke, Holger; Worth, Catherine L.; Mueller, Sandra; Gonzalez, Jorge; Paschke, Ralf; Krause, Gerd			Principles and Determinants of G-Protein Coupling by the Rhodopsin-Like Thyrotropin Receptor	PLOS ONE			English	Article							LUTEINIZING-HORMONE RECEPTOR; 2ND INTRACELLULAR LOOP; HETEROTRIMERIC G-PROTEIN; HUMAN FSH RECEPTOR; PHOSPHOLIPASE-C; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURES; LUTROPIN-RECEPTOR; ALPHA-SUBUNIT; GONADOTROPIN RECEPTORS	In this study we wanted to gain insights into selectivity mechanisms between G-protein-coupled receptors (GPCR) and different subtypes of G-proteins. The thyrotropin receptor (TSHR) binds G-proteins promiscuously and activates both Gs (cAMP) and Gq (IP). Our goal was to dissect selectivity patterns for both pathways in the intracellular region of this receptor. We were particularly interested in the participation of poorly investigated receptor parts. We systematically investigated the amino acids of intracellular loop (ICL) 1 and helix 8 using site-directed mutagenesis alongside characterization of cAMP and IP accumulation. This approach was guided by a homology model of activated TSHR in complex with heterotrimeric Gq, using the X-ray structure of opsin with a bound G-protein peptide as a structural template. We provide evidence that ICL1 is significantly involved in G-protein activation and our model suggests potential interactions with subunits G alpha as well as G beta gamma. Several amino acid substitutions impaired both IP and cAMP accumulation. Moreover, we found a few residues in ICL1 (L440, T441, H443) and helix 8 (R687) that are sensitive for Gq but not for Gs activation. Conversely, not even one residue was found that selectively affects cAMP accumulation only. Together with our previous mutagenesis data on ICL2 and ICL3 we provide here the first systematically completed map of potential interfaces between TSHR and heterotrimeric G-protein. The TSHR/Gq-heterotrimer complex is characterized by more selective interactions than the TSHR/Gs complex. In fact the receptor interface for binding Gs is a subset of that for Gq and we postulate that this may be true for other GPCRs coupling these G-proteins. Our findings support that G-protein coupling and preference is dominated by specific structural features at the intracellular region of the activated GPCR but is completed by additional complementary recognition patterns between receptor and G-protein subtypes.	[Kleinau, Gunnar; Worth, Catherine L.; Krause, Gerd] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Jaeschke, Holger; Mueller, Sandra; Gonzalez, Jorge; Paschke, Ralf] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Leipzig, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Leipzig University	Kleinau, G (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	GKrause@FMP-Berlin.de	Kleinau, Gunnar/GPX-6330-2022	Kleinau, Sandra/0000-0002-9729-2286; Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft [KL2334/2-1, PA423/14-1, KR1273/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (KL2334/2-1; PA423/14-1; KR1273/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier A, 1997, MOL CELL ENDOCRINOL, V127, P81, DOI 10.1016/S0303-7207(96)03996-2; Angelova K, 2008, MOL ENDOCRINOL, V22, P126, DOI 10.1210/me.2007-0352; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Bhatia J, 1996, J PHOTOCH PHOTOBIO B, V35, P19, DOI 10.1016/1011-1344(96)07309-5; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Cetani F, 1996, FEBS LETT, V378, P27, DOI 10.1016/0014-5793(95)01384-9; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; Claus M, 2006, J MOL MED, V84, P943, DOI 10.1007/s00109-006-0087-8; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Evans PD, 1995, PROG BRAIN RES, V106, P259; Feng XY, 2008, ENDOCRINOLOGY, V149, P1705, DOI 10.1210/en.2007-1341; Fernandez LM, 1997, MOL CELL ENDOCRINOL, V128, P161, DOI 10.1016/S0303-7207(97)04035-5; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Herrlich A, 1996, J BIOL CHEM, V271, P16764, DOI 10.1074/jbc.271.28.16764; Horn F, 2000, PROTEINS, V41, P448, DOI 10.1002/1097-0134(20001201)41:4<448::AID-PROT30>3.0.CO;2-C; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2008, CELL MOL LIFE SCI, V65, P4028, DOI 10.1007/s00018-008-8530-3; Jeoung M, 2007, MOL CELL ENDOCRINOL, V260, P137, DOI 10.1016/j.mce.2005.09.015; Joost P, 2002, GENOME BIOL, V3; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; KOSUGI S, 1994, FEBS LETT, V341, P162, DOI 10.1016/0014-5793(94)80449-4; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Kuhn B, 1999, BIOCHEMISTRY-US, V38, P12490, DOI 10.1021/bi990755m; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; Minegishi T, 1997, LIFE SCI, V60, P2043, DOI 10.1016/S0024-3205(97)00191-4; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mueller S, 2009, THYROID, V19, P765, DOI 10.1089/thy.2009.0006; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagashima T, 2001, THYROID, V11, P551, DOI 10.1089/105072501750302859; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; QUINTANA J, 1994, J BIOL CHEM, V269, P8772; RAYMOND JR, 1995, AM J PHYSIOL-RENAL, V269, pF141, DOI 10.1152/ajprenal.1995.269.2.F141; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schoneberg T, 2002, REV PHYSIOL BIOCH P, V144, P143; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Timossi C, 2002, MOL CELL ENDOCRINOL, V189, P157, DOI 10.1016/S0303-7207(01)00720-1; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Van Durme J, 2006, MOL ENDOCRINOL, V20, P2247, DOI 10.1210/me.2006-0020; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; van Koppen CJ, 2008, N-S ARCH PHARMACOL, V378, P503, DOI 10.1007/s00210-008-0318-3; Van Sande J, 2006, J CLIN ENDOCR METAB, V91, P1099, DOI 10.1210/jc.2005-1324; WANG Z, 1993, MOL ENDOCRINOL, V7, P85, DOI 10.1210/me.7.1.85; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	76	38	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9745	10.1371/journal.pone.0009745	http://dx.doi.org/10.1371/journal.pone.0009745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305779	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000276456300014
J	Segal, BH; Han, W; Bushey, JJ; Joo, M; Bhatti, Z; Feminella, J; Dennis, CG; Vethanayagam, RR; Yull, FE; Capitano, M; Wallace, PK; Minderman, H; Christman, JW; Sporn, MB; Chan, J; Vinh, DC; Holland, SM; Romani, LR; Gaffen, SL; Freeman, ML; Blackwell, TS				Segal, Brahm H.; Han, Wei; Bushey, Jennifer J.; Joo, Myungsoo; Bhatti, Zahida; Feminella, Joy; Dennis, Carly G.; Vethanayagam, R. Robert; Yull, Fiona E.; Capitano, Maegan; Wallace, Paul K.; Minderman, Hans; Christman, John W.; Sporn, Michael B.; Chan, Jefferson; Vinh, Donald C.; Holland, Steven M.; Romani, Luigina R.; Gaffen, Sarah L.; Freeman, Michael L.; Blackwell, Timothy S.			NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NF-KAPPA-B; SMOKE-INDUCED EMPHYSEMA; CUL3-BASED E3 LIGASE; CDDO-IMIDAZOLIDE; HOST-DEFENSE; DEFICIENT MICE; ENHANCES SUSCEPTIBILITY; SYNTHETIC TRITERPENOIDS; INFLAMMATORY RESPONSES	Background: Chronic granulomatous disease (CGD), an inherited disorder of the NADPH oxidase in which phagocytes are defective in generating superoxide anion and downstream reactive oxidant intermediates (ROIs), is characterized by recurrent bacterial and fungal infections and by excessive inflammation (e. g., inflammatory bowel disease). The mechanisms by which NADPH oxidase regulates inflammation are not well understood. Methodology/Principal Findings: We found that NADPH oxidase restrains inflammation by modulating redox-sensitive innate immune pathways. When challenged with either intratracheal zymosan or LPS, NADPH oxidase-deficient p47(phox-/-) mice and gp91(phox)-deficient mice developed exaggerated and progressive lung inflammation, augmented NF-kappa B activation, and elevated downstream pro-inflammatory cytokines (TNF-alpha, IL-17, and G-CSF) compared to wildtype mice. Replacement of functional NADPH oxidase in bone marrow-derived cells restored the normal lung inflammatory response. Studies in vivo and in isolated macrophages demonstrated that in the absence of functional NADPH oxidase, zymosan failed to activate Nrf2, a key redox-sensitive anti-inflammatory regulator. The triterpenoid, CDDO-Im, activated Nrf2 independently of NADPH oxidase and reduced zymosan-induced lung inflammation in CGD mice. Consistent with these findings, zymosan-treated peripheral blood mononuclear cells from X-linked CGD patients showed impaired Nrf2 activity and increased NF-kB activation. Conclusions/Significance: These studies support a model in which NADPH oxidase-dependent, redox-mediated signaling is critical for termination of lung inflammation and suggest new potential therapeutic targets for CGD.	[Segal, Brahm H.; Bushey, Jennifer J.; Feminella, Joy; Dennis, Carly G.; Vethanayagam, R. Robert; Minderman, Hans] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Segal, Brahm H.; Capitano, Maegan] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Segal, Brahm H.; Bhatti, Zahida] Univ Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA; [Han, Wei; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Joo, Myungsoo] Pusan Natl Univ, Sch Oriental Med, Div Appl Med, Yangsan, South Korea; [Yull, Fiona E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Wallace, Paul K.; Minderman, Hans] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Christman, John W.] Univ Illinois, Sect Pulm Crit Care & Sleep Med, Chicago, IL USA; [Sporn, Michael B.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Chan, Jefferson] Univ So Calif, Sch Med, Dept Pathol, Irvine, CA USA; [Vinh, Donald C.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Romani, Luigina R.] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Freeman, Michael L.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Blackwell, Timothy S.] Dept Vet Affairs, Nashville, TN USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Vanderbilt University; Pusan National University; Vanderbilt University; Roswell Park Cancer Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Dartmouth College; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Perugia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University	Segal, BH (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	brahm.segal@roswellpark.org	Romani, Luigina/O-9987-2018; Segal, Brahm/AAW-2706-2020; Wallace, PK/ABB-7704-2022	Wallace, PK/0000-0001-7823-9917; Romani, Luigina/0000-0002-1356-525X; Freeman, Michael/0000-0003-1881-366X; VINH, DONALD/0000-0003-1347-7767	Chronic Granulomatous Disorder Research Trust; NIH/NIAID [R01AI079253]; NIH/NCI [CA115556]; NIH [HL61419]; U.S. Department of Veterans Affairs (TSB); Korea Healthcare Technology RD [A084891]; NCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [R01CA115556, P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103643, R01HL061419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, R01AI079253] Funding Source: NIH RePORTER	Chronic Granulomatous Disorder Research Trust; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs (TSB)(US Department of Veterans Affairs); Korea Healthcare Technology RD; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Chronic Granulomatous Disorder Research Trust and NIH/NIAID R01AI079253 (BHS), NIH/NCI CA115556 (MLF), NIH HL61419 (TSB), the U.S. Department of Veterans Affairs (TSB), and Korea Healthcare Technology R&D Project A084891 (MJ). This research was supported, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BROWN KL, 2008, CLIN IMMUNOL; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; GALLIN JI, 1983, INFLAMMATION, V7, P227, DOI 10.1007/BF00917259; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; George-Chandy A, 2008, EUR J IMMUNOL, V38, P1118, DOI 10.1002/eji.200737348; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Ji Y, 2006, MOL CANCER THER, V5, P1452, DOI 10.1158/1535-7163.MCT-06-0136; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; KENSLER TW, 2006, ANN REV PHARM TOXICO; Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Mardiney M, 1997, BLOOD, V89, P2268, DOI 10.1182/blood.V89.7.2268; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rahman I, 2006, CURR DRUG TARGETS, V7, P707, DOI 10.2174/138945006777435254; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Rusyn I, 2000, CANCER RES, V60, P4798; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Schappi MG, 2008, J PATHOL, V214, P434, DOI 10.1002/path.2298; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Sekhar KR, 2003, CANCER RES, V63, P5636; Siddiqui S, 2007, CLIN INFECT DIS, V45, P673, DOI 10.1086/520985; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Tasaka S, 2008, ANTIOXID REDOX SIGN, V10, P739, DOI 10.1089/ars.2007.1940; Thimmulappa R. K., 2006, BIOCH BIOPHYS RES CO; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; Wei Y, 2009, AM J PHYSIOL-CELL PH, V297, pC907, DOI 10.1152/ajpcell.00536.2008; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zhu LX, 2008, AM J PHYSIOL-LUNG C, V294, pL469, DOI 10.1152/ajplung.00310.2007; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	65	136	138	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9631	10.1371/journal.pone.0009631	http://dx.doi.org/10.1371/journal.pone.0009631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300512	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000275716400001
J	McGaughran, A; Holland, BR				McGaughran, Angela; Holland, Barbara R.			Testing the Effect of Metabolic Rate on DNA Variability at the Intra-Specific Level	PLOS ONE			English	Article							CYTOCHROME-B EVOLUTION; MITOCHONDRIAL-DNA; MOLECULAR EVOLUTION; GENERATION TIME; BODY-SIZE; NUCLEOTIDE SUBSTITUTION; SPONTANEOUS MUTATION; TEMPERATURE; TEMPO; TURTLES	We tested the metabolic rate hypothesis (whereby rates of mtDNA evolution are postulated to be mediated primarily by mutagenic by-products of respiration) by examining whether mass-specific metabolic rate was correlated with root-to-tip distance on a set of mtDNA trees for the springtail Cryptopygus antarcticus travei from sub-Antarctic Marion Island. Using Bayesian analyses and a novel application of the comparative phylogenetic method, we did not find significant evidence that contemporary metabolic rates directly correlate with mutation rate (i.e., root-to-tip distance) once the underlying phylogeny is taken into account. However, we did find significant evidence that metabolic rate is dependent on the underlying mtDNA tree, or in other words, lineages with related mtDNA also have similar metabolic rates. We anticipate that future analyses which apply this methodology to datasets with longer sequences, more taxa, or greater variability will have more power to detect a significant direct correlation between metabolic rate and mutation rate. We conclude with suggestions for future analyses that would extend the preliminary approach applied here, in particular highlighting ways to tease apart oxidative stress effects from the effects of population size and/or selection coefficients operating on the molecular evolutionary rate.	[McGaughran, Angela; Holland, Barbara R.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand; [Holland, Barbara R.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University	McGaughran, A (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	ang.mcgaughran@gmail.com	Holland, Barbara/G-1646-2013; McGaughran, Angela/C-5916-2014	Holland, Barbara/0000-0002-4628-7938; McGaughran, Angela/0000-0002-3429-8699	New Zealand Tertiary Education Commission Top Achievers Doctoral Scholarship	New Zealand Tertiary Education Commission Top Achievers Doctoral Scholarship	AM was supported by a New Zealand Tertiary Education Commission Top Achievers Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI J, 1993, J MOL EVOL, V36, P270, DOI 10.1007/BF00160483; Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; [Anonymous], 2014, TRACER V1 6; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1992, MOL BIOL EVOL, V9, P457; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Barraclough TG, 1996, P ROY SOC B-BIOL SCI, V263, P589, DOI 10.1098/rspb.1996.0088; Bleiweiss R, 1998, MOL BIOL EVOL, V15, P481, DOI 10.1093/oxfordjournals.molbev.a025947; BLOCK W, 1975, OIKOS, V26, P15, DOI 10.2307/3543271; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; BOWEN BW, 1993, P NATL ACAD SCI USA, V90, P5574, DOI 10.1073/pnas.90.12.5574; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; DESALLE R, 1988, EVOLUTION, V42, P1076, DOI 10.1111/j.1558-5646.1988.tb02525.x; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gillooly JF, 2007, BIOL LETTERS, V3, P655, DOI 10.1098/rsbl.2007.0403; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Gissi C, 2000, MOL BIOL EVOL, V17, P1022, DOI 10.1093/oxfordjournals.molbev.a026383; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Lanfear R, 2007, P NATL ACAD SCI USA, V104, P15388, DOI 10.1073/pnas.0703359104; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; MARTIN AP, 1995, MOL BIOL EVOL, V12, P1124; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Martin AP, 1999, MOL BIOL EVOL, V16, P996, DOI 10.1093/oxfordjournals.molbev.a026189; MASON JM, 1985, ENVIRON MUTAGEN, V7, P663, DOI 10.1002/em.2860070506; McGaughran A, 2009, J INSECT PHYSIOL, V55, P129, DOI 10.1016/j.jinsphys.2008.10.009; MCGAUGHRAN A, 2010, METABOLIC RATE GENET, DOI DOI 10.1007/S00300-010-0767-2; McGaughran A, 2008, MOL PHYLOGENET EVOL, V46, P606, DOI 10.1016/j.ympev.2007.10.003; Mindell DP, 1996, ANNU REV ECOL SYST, V27, P279, DOI 10.1146/annurev.ecolsys.27.1.279; Mindell DP, 1996, MOL BIOL EVOL, V13, P422, DOI 10.1093/oxfordjournals.molbev.a025601; MINDELL DP, 1989, CLADISTICS, V5, P49, DOI 10.1111/j.1096-0031.1989.tb00482.x; MOOERS AO, 1994, MOL PHYLOGENET EVOL, V3, P344, DOI 10.1006/mpev.1994.1040; NOTHEL H, 1987, P NATL ACAD SCI USA, V84, P1045, DOI 10.1073/pnas.84.4.1045; Nunn GB, 1998, MOL BIOL EVOL, V15, P1360, DOI 10.1093/oxfordjournals.molbev.a025864; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; Spradling TA, 2001, J MAMMAL, V82, P65, DOI 10.1644/1545-1542(2001)082<0065:DIROCB>2.0.CO;2; TEMPLETON AR, 1992, GENETICS, V132, P619; WOODRUFF RC, 1984, HEREDITY, V53, P223, DOI 10.1038/hdy.1984.78; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; Zhang GY, 1995, P INT C BAS, V4, P297	53	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9686	10.1371/journal.pone.0009686	http://dx.doi.org/10.1371/journal.pone.0009686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300626	Green Published, gold, Green Submitted			2022-12-27	WOS:000275621000006
J	Zhu, WY; Wang, LH; Yang, YL; Jia, J; Fu, SH; Feng, Y; He, Y; Li, JP; Liang, GD				Zhu, Wuyang; Wang, Lihua; Yang, Yiliang; Jia, Juan; Fu, Shihong; Feng, Yun; He, Ying; Li, Jin-Ping; Liang, Guodong			Interaction of E2 Glycoprotein with Heparan Sulfate Is Crucial for Cellular Infection of Sindbis Virus	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; BINDING; CELLS; PROTEOGLYCAN; ATTACHMENT; GLYCOSAMINOGLYCANS; ALPHAVIRUSES; REPLICATION; ASSOCIATION; ADAPTATION	Cell culture-adapted strains of Sindbis virus (SINV) initially attach to cells by the ability to interact with heparan sulfate (HS) through selective mutation for positively charged amino acid (aa) scattered in E2 glycoprotein (W. B. Klimstra, K. D. Ryman, and R. E. Johnston, J. Virol. 72: 7357-7366, 1998). Here we have further confirmed that interaction of E2 protein with HS is crucial for cellular infection of SINV based on the reverse genetic system of XJ-160 virus, a Sindbis-like virus (SINLV). Both SINV YN87448 and SINLV XJ-160 displayed similar infectivity on BHK-21, Vero, or C6/36 cells, but XJ-160 failed to infect mouse embryonic fibroblast (MEF) cells. The molecular mechanisms underlying the selective infectivity of XJ-160 were approached by substituting the E1, E2, or both genes of XJ-160 with that of YN87448, and the chimeric virus was denominated as XJ-160/E1, XJ-160/E2, or XJ-160/E1E2, respectively. In contrast to the parental XJ-160, all chimeric viruses became infectious to wild-type MEF cells (MEF-wt). While MEF-Ext(-/-) cells, producing shortened HS chains, were resistant not only to XJ-160, but also to YN87448 as well as the chimeric viruses, indicating that the inability of XJ-160 to infect MEF-wt cells likely due to its incompetent discrimination of cellular HS. Treatment with heparin or HS-degrading enzyme resulted in a substantial decrease in plaque formation by YN87448, XJ-160/E2, and XJ-160/E1E2, but had marginal effect on XJ-160 and XJ-160/E1, suggesting that E2 glycoprotein from YN87448 plays a more important role than does E1 in mediating cellular HS-related cell infection. In addition, the peptide containing 145-150 aa from E2 gene of YN87448 specifically bound to heparin, while the corresponding peptide from the E2 gene of XJ-160 essentially showed no binding to heparin. As a new dataset, these results clearly confirm an essential role of E2 glycoprotein, especially the domain of 145-150 aa, in SINV cellular infection through the interaction with HS.	[Zhu, Wuyang; Wang, Lihua; Yang, Yiliang; Fu, Shihong; Feng, Yun; He, Ying; Liang, Guodong] Chinese Ctr Dis Control & Prevent, IVDC, China CDC,Inst Viral Dis Control & Prevent, Dept Viral Encephalitis, Beijing, Peoples R China; [Zhu, Wuyang; Wang, Lihua; Yang, Yiliang; Fu, Shihong; Feng, Yun; He, Ying; Liang, Guodong] State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China; [Jia, Juan; Li, Jin-Ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Chinese Center for Disease Control & Prevention; Uppsala University	Zhu, WY (corresponding author), Chinese Ctr Dis Control & Prevent, IVDC, China CDC,Inst Viral Dis Control & Prevent, Dept Viral Encephalitis, Beijing, Peoples R China.	gdliang@hotmail.com			National Natural Science Foundation of China [30170046, 30970160]; Major Science and Technology Project for Infectious Disease [2008ZX10004-001, 2009ZX10004-705]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]; Swedish Research Council [K2009-67X-21128-01-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project for Infectious Disease; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the grants from the National Natural Science Foundation of China (No. 30170046; 30970160), the Major Science and Technology Project for Infectious Disease (No. 2008ZX10004-001; 2009ZX10004-705), the Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105) and the Swedish Research Council (K2009-67X-21128-01-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JS, 2006, VIROLOGY, V347, P183, DOI 10.1016/j.virol.2005.11.034; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Deardorff ER, 2009, EMERG INFECT DIS, V15, P519, DOI 10.3201/eid1504.081008; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; Griffin D.E., 2001, FIELDS VIROLOGY, P917; Heil ML, 2001, J VIROL, V75, P6303, DOI 10.1128/JVI.75.14.6303-6309.2001; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Klimstra WB, 1999, J VIROL, V73, P10387, DOI 10.1128/JVI.73.12.10387-10398.1999; Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998; Knight RL, 2009, J VIROL, V83, P5640, DOI 10.1128/JVI.02427-08; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Lin CS, 2000, J MOL BIOL, V303, P7, DOI 10.1006/jmbi.2000.4121; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu LM, 2003, MOL CELL BIOCHEM, V245, P121, DOI 10.1023/A:1022870128494; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; RICE CM, 1982, J MOL BIOL, V154, P325, DOI 10.1016/0022-2836(82)90067-5; Ryman KD, 2007, J VIROL, V81, P3563, DOI 10.1128/JVI.02494-06; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; SHIVELY JE, 1970, BIOCHEMISTRY-US, V9, P33, DOI 10.1021/bi00803a005; Smit JM, 2002, J VIROL, V76, P10128, DOI 10.1128/JVI.76.20.10128-10137.2002; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Yang Y, 2005, MOL CELLS, V20, P173; Young DS, 2008, EMERG INFECT DIS, V14, P454, DOI 10.3201/eid1403.070816; ZHOU GL, 1998, ZHONGHUA SHI YAN HE, V12, P81; Zhu WY, 2009, VIRUS RES, V142, P204, DOI 10.1016/j.virusres.2009.01.017; Zhu WY, 2009, ARCH VIROL, V154, P245, DOI 10.1007/s00705-008-0298-0	40	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9656	10.1371/journal.pone.0009656	http://dx.doi.org/10.1371/journal.pone.0009656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300181	gold, Green Published, Green Submitted			2022-12-27	WOS:000275620600011
J	Heinlen, LD; McClain, MT; Ritterhouse, LL; Bruner, BF; Edgerton, CC; Keith, MP; James, JA; Harley, JB				Heinlen, Latisha D.; McClain, Micah T.; Ritterhouse, Lauren L.; Bruner, Benjamin F.; Edgerton, Colin C.; Keith, Michael P.; James, Judith A.; Harley, John B.			60 kD Ro and nRNP A Frequently Initiate Human Lupus Autoimmunity	PLOS ONE			English	Article							ANTI-SM ANTIBODIES; CLINICAL-SIGNIFICANCE; PEPTIDE IMMUNIZATION; HUMORAL AUTOIMMUNITY; SURFACE-STRUCTURES; REVISED CRITERIA; ERYTHEMATOSUS; AUTOANTIBODIES; DIAGNOSIS; NEPHRITIS	Systemic lupus erythematosus (SLE) is a clinically heterogeneous, humoral autoimmune disorder. The unifying feature among SLE patients is the production of large quantities of autoantibodies. Serum samples from 129 patients collected before the onset of SLE and while in the United States military were evaluated for early pre-clinical serologic events. The first available positive serum sample frequently already contained multiple autoantibody specificities (65%). However, in 34 SLE patients the earliest pre-clinical serum sample positive for any detectable common autoantibody bound only a single autoantigen, most commonly 60 kD Ro (29%), nRNP A (24%), anti-phospholipids (18%) or rheumatoid factor (15%). We identified several recurrent patterns of autoantibody onset using these pre-diagnostic samples. In the serum samples available, anti-nRNP A appeared before or simultaneously with anti-nRNP 70 K in 96% of the patients who had both autoantibodies at diagnosis. Anti-60 kD Ro antibodies appeared before or simultaneously with anti-La (98%) or anti-52 kD Ro (95%). The autoantibody response in SLE patients begins simply, often binding a single specific autoantigen years before disease onset, followed by epitope spreading to additional autoantigenic specificities that are accrued in recurring patterns.	[Heinlen, Latisha D.; McClain, Micah T.; Ritterhouse, Lauren L.; Bruner, Benjamin F.; James, Judith A.] Oklahoma Med Res Fdn, Dept Clin Immunol, Oklahoma City, OK 73104 USA; [Heinlen, Latisha D.; Ritterhouse, Lauren L.; James, Judith A.; Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK USA; [Heinlen, Latisha D.; Ritterhouse, Lauren L.; James, Judith A.; Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Edgerton, Colin C.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Keith, Michael P.] Natl Naval Med Ctr, Bethesda, MD USA; [Harley, John B.] US Dept Vet Affairs, Oklahoma City, OK USA; [Harley, John B.] Oklahoma Med Res Fdn, Dept Arthrit & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; US Department of Veterans Affairs; Oklahoma Medical Research Foundation	Heinlen, LD (corresponding author), Oklahoma Med Res Fdn, Dept Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	harley@omrf.org			National Institutes of Health [AI31584, AR48045, AR49084, AR45084, AR45451, RR15577, AR48940, RR20143, AI62629, AI50350]; Kirkland Scholar Awards; United States Department of Veterans Affairs; Lou Kerr Chair in Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577, P20RR020143, P30RR031152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031584, U19AI062629, R01AI024717, R41AI050350, R37AI024717, T32AI007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR048940, R29AR045451, P30AR053483, R01AR048045, P01AR049084, R01AR045451, R03AR045084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirkland Scholar Awards; United States Department of Veterans Affairs(US Department of Veterans Affairs); Lou Kerr Chair in Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (AI31584, AR48045, AR49084, AR45084, AR45451, RR15577, AR48940, RR20143, AI62629, AI50350), Kirkland Scholar Awards (JBH and JAJ) and the United States Department of Veterans Affairs. This work was also supported in part by the Lou Kerr Chair in Biomedical Research to JAJ. Bio-Rad provided the ANA test kits and selected the laboratory as a beta-test site for their commercial bead based assay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 1999, SCAND J IMMUNOL, V50, P447; Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Arbuckle MR, 2001, SCAND J IMMUNOL, V54, P211, DOI 10.1046/j.1365-3083.2001.00959.x; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, J RHEUMATOL, V15, P1773; Binder SR, 2006, LUPUS, V15, P412, DOI 10.1191/0961203306lu2326oa; Binder SR, 2005, CLIN DIAGN LAB IMMUN, V12, P1353, DOI 10.1128/CDLI.12.12.1353-1357.2005; CLOTET B, 1984, SCAND J RHEUMATOL, V13, P15, DOI 10.3109/03009748409102662; FIELD M, 1988, ANN RHEUM DIS, V47, P820, DOI 10.1136/ard.47.10.820; FISHER DE, 1985, ARTHRITIS RHEUM-US, V28, P1348, DOI 10.1002/art.1780281206; Gomez-Puerta JA, 2008, AUTOIMMUN REV, V7, P606, DOI 10.1016/j.autrev.2008.06.005; Greidinger EL, 2001, ARTHRITIS RHEUM, V44, P368; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; James JA, 1996, J IMMUNOL, V156, P4018; James JA, 1997, ANN NY ACAD SCI, V815, P124, DOI 10.1111/j.1749-6632.1997.tb52054.x; James JA, 1998, IMMUNOL REV, V164, P185, DOI 10.1111/j.1600-065X.1998.tb01220.x; JAMES JA, 1995, CLIN EXP RHEUMATOL, V13, P299; JAMES JA, 1992, J IMMUNOL, V148, P2074; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; KRISHNAN C, 1967, J CLIN INVEST, V46, P569, DOI 10.1172/JCI105558; MADDISON PJ, 1977, ARTHRITIS RHEUM, V20, P819, DOI 10.1002/art.1780200310; MARCHINI B, 1994, J AUTOIMMUN, V7, P179, DOI 10.1006/jaut.1994.1014; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; McClain MT, 2002, J IMMUNOL, V168, P2054, DOI 10.4049/jimmunol.168.4.2054; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; McCluskey J, 1998, IMMUNOL REV, V164, P209, DOI 10.1111/j.1600-065X.1998.tb01222.x; Moder KG, 2007, J RHEUMATOL, V34, P978; POOLE BD, 2009, ARTHRITIS R IN PRESS; Poole BD, 2008, J AUTOIMMUN, V31, P362, DOI 10.1016/j.jaut.2008.08.007; Reichlin M, 2003, CLIN IMMUNOL, V108, P69, DOI 10.1016/S1521-6616(03)00063-9; Scofield RH, 1997, CLIN EXP IMMUNOL, V109, P480, DOI 10.1046/j.1365-2249.1997.4791374.x; Scofield RH, 1999, ARTHRITIS RHEUM, V42, P1017, DOI 10.1002/1529-0131(199905)42:5<1017::AID-ANR22>3.0.CO;2-7; Shovman O, 2005, ANN NY ACAD SCI, V1050, P380, DOI 10.1196/annals.1313.120; Sundar K, 2004, J AUTOIMMUN, V23, P127, DOI 10.1016/j.jaut.2004.06.001; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tseng CE, 2006, ARTHRITIS RHEUM-US, V54, P3623, DOI 10.1002/art.22198; Yung S, 2008, AUTOIMMUN REV, V7, P317, DOI 10.1016/j.autrev.2007.12.001	39	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9599	10.1371/journal.pone.0009599	http://dx.doi.org/10.1371/journal.pone.0009599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224770	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328800012
J	Price, MN; Dehal, PS; Arkin, AP				Price, Morgan N.; Dehal, Paramvir S.; Arkin, Adam P.			FastTree 2-Approximately Maximum-Likelihood Trees for Large Alignments	PLOS ONE			English	Article							DNA-SEQUENCES; ALGORITHM; PHYLOGENIES; ACCURATE; RECONSTRUCTION; CONFIDENCE; PRINCIPLE; DATABASE; NUMBER; MOVES	Background: We recently described FastTree, a tool for inferring phylogenies for alignments with up to hundreds of thousands of sequences. Here, we describe improvements to FastTree that improve its accuracy without sacrificing scalability. Methodology/Principal Findings: Where FastTree 1 used nearest-neighbor interchanges (NNIs) and the minimum-evolution criterion to improve the tree, FastTree 2 adds minimum-evolution subtree-pruning-regrafting (SPRs) and maximum-likelihood NNIs. FastTree 2 uses heuristics to restrict the search for better trees and estimates a rate of evolution for each site (the "CAT" approximation). Nevertheless, for both simulated and genuine alignments, FastTree 2 is slightly more accurate than a standard implementation of maximum-likelihood NNIs (PhyML 3 with default settings). Although FastTree 2 is not quite as accurate as methods that use maximum-likelihood SPRs, most of the splits that disagree are poorly supported, and for large alignments, FastTree 2 is 100-1,000 times faster. FastTree 2 inferred a topology and likelihood-based local support values for 237,882 distinct 16S ribosomal RNAs on a desktop computer in 22 hours and 5.8 gigabytes of memory. Conclusions/Significance: FastTree 2 allows the inference of maximum-likelihood phylogenies for huge alignments. FastTree 2 is freely available at http://www.microbesonline.org/fasttree.	[Price, Morgan N.; Dehal, Paramvir S.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Price, Morgan N.; Dehal, Paramvir S.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Price, MN (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	MorganNPrice@yahoo.com	Puigbò, Pere/A-2214-2008; Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Price, Morgan/0000-0002-4251-0362	US Department of Energy Genomics [DE-AC02-05CH11231]	US Department of Energy Genomics(United States Department of Energy (DOE))	This work was supported by a grant from the US Department of Energy Genomics: GTL program (DE-AC02-05CH11231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bordewich M, 2009, IEEE ACM T COMPUT BI, V6, P110, DOI 10.1109/TCBB.2008.37; BRADLEY RK, 2009, PLOS COMPUT BIOL, V5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desper R, 2004, MOL BIOL EVOL, V21, P587, DOI 10.1093/molbev.msh049; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galtier N, 2004, J COMPUT BIOL, V11, P727, DOI 10.1089/cmb.2004.11.727; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUINDON S, 2010, SYST BIOL IN PRESS; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nei M, 1998, P NATL ACAD SCI USA, V95, P12390, DOI 10.1073/pnas.95.21.12390; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Roch S, 2006, IEEE ACM T COMPUT BI, V3, P92, DOI 10.1109/TCBB.2006.4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Stamatakis A., 2006, P 20 INT PAR DISTR P; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; STUDIER JA, 1988, MOL BIOL EVOL, V5, P729; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; WHEELER TJ, 2009, P 9 WORKSH ALG BIOIN; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	34	6807	6889	27	470	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9490	10.1371/journal.pone.0009490	http://dx.doi.org/10.1371/journal.pone.0009490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224823	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800002
J	Pfannkuche, K; Fatima, A; Gupta, MK; Dieterich, R; Hescheler, J				Pfannkuche, Kurt; Fatima, Azra; Gupta, Manoj K.; Dieterich, Rebecca; Hescheler, Juergen			Initial Colony Morphology-Based Selection for iPS Cells Derived from Adult Fibroblasts Is Substantially Improved by Temporary UTF1-Based Selection	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; INDUCTION; OCT4; UTF1; DIFFERENTIATION; EXPRESSION; MAINTAIN; OCT-3/4; GENE	Background: Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells. Recently, selection of fully reprogrammed cells was achieved based on colony morphology reminiscent of embryonic stem (ES) cells. The maintenance of pluripotency was analysed. Methodology/Principal Findings: Clonal murine iPS cell line TiB7-4, which was derived from adult fibroblasts, was analysed for maintenance of pluripotency. Colony morphology, expression of pluripotency factors and stage specific embryonic antigen 1 (SSEA1) were analysed by real time PCR and flow cytometry. We found the iPS cell line TiB7-4 and its subclones to be rather diverse and exhibiting a tendency towards spontaneous differentiation and loss of pluripotency independent of their initial colony morphology. In contrast an undifferentiated transcription factor 1 (UTF1) promoter-driven G418 (Neo) resistance significantly improved the quality of these iPS cells. After selection with UTF-Neo for two weeks iPS subclones could be stably maintained for at least 40 passages in culture and differentiate into all three germ layers. As control, a construct expressing G418 resistance under the control of the ubiquitously active SV40 early promoter formed subclones with different colony morphology. Some of these subclones could be cultured for at least 12 passages without loosing their pluripotency, but loss of pluripotency eventually occured in an unpredictable manner and was independent of the subclones' initial morphology and SSEA1 expression. A UTF-Neo-based selection of a whole population of TiB7-4 without further subcloning resulted in the generation of cultures with up to 99% SSEA1 positive cells under stringent selection conditions. Conclusions: Our data indicate that temporary selection using a genetic UTF1-based system can generate homogenous pluripotent iPS cells that can be maintained without permanent selection pressure.	[Pfannkuche, Kurt; Fatima, Azra; Gupta, Manoj K.; Dieterich, Rebecca; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, Cologne, Germany; [Hescheler, Juergen] Ctr Mol Med Cologne, Cologne, Germany	University of Cologne; University of Cologne	Pfannkuche, K (corresponding author), Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, Cologne, Germany.	Kurt.Pfannkuche@uni-koeln.de		Pfannkuche, Kurt Paul/0000-0002-4284-774X	North Rhine Westphalian Stem Cell Network [314-40000808]	North Rhine Westphalian Stem Cell Network	This project was supported by a grant from the North Rhine Westphalian Stem Cell Network (Grant No. 314-40000808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Nishimoto M, 2001, BIOCHEM BIOPH RES CO, V285, P945, DOI 10.1006/bbrc.2001.5265; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; YU J, 2009, SCIENCE; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	29	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A140	A151	e9580	10.1371/journal.pone.0009580	http://dx.doi.org/10.1371/journal.pone.0009580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221450	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200013
J	Carr, K; Murray, E; Armah, E; He, RL; Yau, SST				Carr, Kareem; Murray, Eleanor; Armah, Ebenezer; He, Rong L.; Yau, Stephen S. -T.			A Rapid Method for Characterization of Protein Relatedness Using Feature Vectors	PLOS ONE			English	Article							HEMOGLOBIN; MYOGLOBIN; SEQUENCES; FAMILY	We propose a feature vector approach to characterize the variation in large data sets of biological sequences. Each candidate sequence produces a single feature vector constructed with the number and location of amino acids or nucleic acids in the sequence. The feature vector characterizes the distance between the actual sequence and a model of a theoretical sequence based on the binomial and uniform distributions. This method is distinctive in that it does not rely on sequence alignment for determining protein relatedness, allowing the user to visualize the relationships within a set of proteins without making a priori assumptions about those proteins. We apply our method to two large families of proteins: protein kinase C, and globins, including hemoglobins and myoglobins. We interpret the high-dimensional feature vectors using principal components analysis and agglomerative hierarchical clustering. We find that the feature vector retains much of the information about the original sequence. By using principal component analysis to extract information from collections of feature vectors, we are able to quickly identify the nature of variation in a collection of proteins. Where collections are phylogenetically or functionally related, this is easily detected. Hierarchical agglomerative clustering provides a means of constructing cladograms from the feature vector output.	[Carr, Kareem; Armah, Ebenezer; Yau, Stephen S. -T.] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA; [Murray, Eleanor] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [He, Rong L.] Chicago State Univ, Dept Biol Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University; Chicago State University	Carr, K (corresponding author), Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA.	yau@uic.edu	Murray, Eleanor/I-6996-2019	Murray, Eleanor/0000-0003-0043-4901				Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; CHAPMAN BS, 1980, J BIOL CHEM, V255, P9051; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Downie JA, 2005, CURR BIOL, V15, pR196, DOI 10.1016/j.cub.2005.03.007; EVERITT BS, 2001, CLUSTER ANAL, P59; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; JOLLIFFE IT, 2004, SPRINGER SERIES STAT, P80; Karp G., 1999, CELL MOL BIOL CONCEP; Kruse M, 1996, J MOL EVOL, V43, P374; Kundu S, 2003, TRENDS PLANT SCI, V8, P387, DOI 10.1016/S1360-1385(03)00163-8; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Liu LB, 2006, MOL PHYLOGENET EVOL, V41, P64, DOI 10.1016/j.ympev.2006.05.019; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; Royer WE, 2000, P NATL ACAD SCI USA, V97, P7107, DOI 10.1073/pnas.97.13.7107; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; WHITAKER TL, 1995, BIOCHEMISTRY-US, V34, P8221, DOI 10.1021/bi00026a002	25	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9550	10.1371/journal.pone.0009550	http://dx.doi.org/10.1371/journal.pone.0009550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221427	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197200008
J	Balaji, V; Daley, P; Anand, AA; Sudarsanam, T; Michael, JS; Sahni, RD; Chordia, P; George, IA; Thomas, K; Ganesh, A; John, KR; Mathai, D				Balaji, V.; Daley, Peter; Anand, Alok Azad; Sudarsanam, Thambu; Michael, Joy Sarojini; Sahni, Rani Diana; Chordia, Poorvi; George, Ige Abraham; Thomas, Kurien; Ganesh, Alka; John, K. R.; Mathai, Dilip			Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; TREATMENT OUTCOMES	Background: India has a high burden of drug resistant TB, although there are few data on XDR-TB. Although XDR-TB has existed previously in India, the definition has not been widely applied, and surveillance using second line drug susceptibility testing has not been performed. Our objective was to analyze clinical and demographic risk factors associated with isolation of MDR and XDR-TB as compared to susceptible controls, at a tertiary center. Methodology/Findings: Retrospective chart review based on positive cultures isolated in a high volume mycobacteriology laboratory between 2002 and 2007. 47 XDR, 30 MDR and 117 susceptible controls were examined. Drug resistant cases were less likely to be extrapulmonary, and had received more previous treatment regimens. Significant risk factors for XDR-TB included residence outside the local state (OR 7.43, 3.07-18.0) and care costs subsidized (OR 0.23, 0.097-0.54) in bivariate analysis and previous use of a fluoroquinolone and injectable agent (other than streptomycin) (OR 7.00, 95% C.I. 1.14-43.03) and an initial treatment regimen which did not follow national guidelines (OR 5.68, 1.24-25.96) in multivariate analysis. Cavitation and HIV did not influence drug resistance. Conclusions/Significance: There is significant selection bias in the sample available. Selection pressure from previous treatment and an inadequate initial regimen increases risk of drug resistance. Local patients and those requiring financial subsidies may be at lower risk of XDR-TB.	[Balaji, V.; Michael, Joy Sarojini; Sahni, Rani Diana] Christian Med Coll Vellore, Dept Microbiol, Vellore, Tamil Nadu, India; [Daley, Peter; Sudarsanam, Thambu; Chordia, Poorvi; George, Ige Abraham; Thomas, Kurien; Ganesh, Alka; Mathai, Dilip] Christian Med Coll Vellore, Dept Med, Vellore, Tamil Nadu, India; [Anand, Alok Azad] Tufts Univ, Sch Med, Boston, MA 02111 USA; [John, K. R.] Christian Med Coll Vellore, Dept Community Med, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Tufts University; Christian Medical College & Hospital (CMCH) Vellore	Balaji, V (corresponding author), Christian Med Coll Vellore, Dept Microbiol, Vellore, Tamil Nadu, India.	daleyp@cmcvellore.ac.in	SAHNI, RANI DIANA/AAB-1007-2022; Daley, Peter/J-8908-2017	Daley, Peter/0000-0001-7068-8056				[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; [Anonymous], 2008, 4 WHO; Atre SR, 2005, J PUBLIC HEALTH POL, V26, P96, DOI 10.1057/palgrave.jphp.3200014; *CENTR TB DIV, 2006, DOTSPLUS GUID; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; JAIN S, 2007, HIGH PREVALENCE XDR, pA510; Johnson Jasmin, 2003, Indian J Chest Dis Allied Sci, V45, P105; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; MONDAL R, 2007, EMERG INFECT DIS; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; *REV NAT TB CONTR, 2008, TB IND 2008 RNTCP ST; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Sharma SK, 2003, INFECT GENET EVOL, V3, P183, DOI 10.1016/S1567-1348(03)00086-8; Singh A, 2007, EUR RESPIR J, V30, P178, DOI 10.1183/09031936.00025407; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; SUAREZGARCIA I, 2008, EUR J CLIN MICROBIOL; Thomas Aleyamma, 2007, Indian J Tuberc, V54, P117; Udwadia ZF, 2007, LANCET INFECT DIS, V7, P441, DOI 10.1016/S1473-3099(07)70141-X; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; WHO, 2009, GLOB TUB CONTR 2009; World Health Organization, 2006, GUID PROGR MAN DRUG; 2006, MMWR MORB MORTAL WKL, V55, P301	27	36	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9527	10.1371/journal.pone.0009527	http://dx.doi.org/10.1371/journal.pone.0009527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209106	Green Submitted, gold, Green Published			2022-12-27	WOS:000275197100012
J	Drenos, F; Kirkwood, TBL				Drenos, Fotios; Kirkwood, Thomas B. L.			Selection on Alleles Affecting Human Longevity and Late-Life Disease: The Example of Apolipoprotein E	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; E POLYMORPHISM; E GENOTYPE; E GENE; RELATIVE RISK; BLOOD-PRESSURE; APOE; ASSOCIATION; EVOLUTION	It is often claimed that genes affecting health in old age, such as cardiovascular and Alzheimer diseases, are beyond the reach of natural selection. We show in a simulation study based on known genetic (apolipoprotein E) and non-genetic risk factors (gender, diet, smoking, alcohol, exercise) that, because there is a statistical distribution of ages at which these genes exert their influence on morbidity and mortality, the effects of selection are in fact non-negligible. A gradual increase with each generation of the epsilon 2 and epsilon 3 alleles of the gene at the expense of the epsilon 4 allele was predicted from the model. The epsilon 2 allele frequency was found to increase slightly more rapidly than that for epsilon 3, although there was no statistically significant difference between the two. Our result may explain the recent evolutionary history of the epsilon 2, 3 and 4 alleles of the apolipoprotein E gene and has wider relevance for genes affecting human longevity.	[Drenos, Fotios; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Drenos, F (corresponding author), UCL, Dept Med, Div Cardiovasc Genet, London, England.	F.Drenos@ucl.ac.uk	; Stefanadis, Christodoulos/ABH-2232-2020	Drenos, Fotios/0000-0003-2469-5516; Stefanadis, Christodoulos/0000-0001-5974-6454	Dr Hadwen Trust; Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: researchfish; Medical Research Council [G0700718B] Funding Source: researchfish	Dr Hadwen Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the Dr Hadwen Trust for financial support (http://www.drhadwentrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bernstein MS, 2002, ARTERIOSCL THROM VAS, V22, P133, DOI 10.1161/hq0102.101819; Blanche H, 2001, CR ACAD SCI III-VIE, V324, P129, DOI 10.1016/S0764-4469(00)01274-9; Charlesworth B, 1996, CURR BIOL, V6, P20, DOI 10.1016/S0960-9822(02)00411-6; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CORBO RM, 1995, ANN HUM GENET, V59, P197, DOI 10.1111/j.1469-1809.1995.tb00741.x; Corbo RM, 2004, MOL HUM REPROD, V10, P617, DOI 10.1093/molehr/gah082; Corbo RM, 2004, FERTIL STERIL, V81, P104, DOI 10.1016/j.fertnstert.2003.05.029; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Corella D, 2001, AM J CLIN NUTR, V73, P736; Cournil A, 2000, P ROY SOC B-BIOL SCI, V267, P1021, DOI 10.1098/rspb.2000.1105; DeCarli C, 2001, ARCH NEUROL-CHICAGO, V58, P643, DOI 10.1001/archneur.58.4.643; DONG LM, 1994, J BIOL CHEM, V269, P22358; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Frisoni GB, 2001, J GERONTOL A-BIOL, V56, pM75, DOI 10.1093/gerona/56.2.M75; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Gerdes LU, 1996, HUM GENET, V98, P239, DOI 10.1007/s004390050200; Gerdes LU, 1996, HUM GENET, V98, P546, DOI 10.1007/s004390050257; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; HAWKES K, 2002, GRANDMOTHERS EVOLUTI, P380; Henneman P, 2009, EUR J HUM GENET, V17, P620, DOI 10.1038/ejhg.2008.202; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Kauma H, 1998, AM J HYPERTENS, V11, P1334, DOI 10.1016/S0895-7061(98)00163-0; Kennedy GE, 2003, J ROY ANTHROPOL INST, V9, P549, DOI 10.1111/1467-9655.00163; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kolovou G, 2002, CURR MED RES OPIN, V18, P118, DOI 10.1185/030079902125000444; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; Lewis SJ, 2004, INT J EPIDEMIOL, V33, P962, DOI 10.1093/ije/dyh214; Ljungquist B, 1998, J GERONTOL A-BIOL, V53, pM441, DOI 10.1093/gerona/53A.6.M441; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, NEUROBIOL AGING, V20, P429, DOI 10.1016/S0197-4580(99)00081-0; Martin GM, 1999, NEUROBIOL AGING, V20, P441, DOI 10.1016/S0197-4580(99)00078-0; Marz W, 1998, J LIPID RES, V39, P658; Masson LF, 2003, AM J CLIN NUTR, V77, P1098, DOI 10.1093/ajcn/77.5.1098; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Medawar P., 1952, UNSOLVED PROBLEM BIO; Millen BE, 2002, PREV MED, V35, P540, DOI 10.1006/pmed.2002.1116; Millen BE, 2001, J AM DIET ASSOC, V101, P187, DOI 10.1016/S0002-8223(01)00051-7; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; MILTON K, CRITICAL ROLE PLAYED, pS3886; Ordovas JM, 1999, P NUTR SOC, V58, P171, DOI 10.1079/PNS19990023; Ordovas JM, 1995, ATHEROSCLEROSIS, V118, pS11; Panagiotakos DB, 2002, PREV MED, V35, P548, DOI 10.1006/pmed.2002.1108; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; PETERSEN S, 2002, CORONARY HEART STAT; PRENTICE AM, INSIGHTS DEV WORLD T, P153; Puddey IB, 1999, AM J HYPERTENS, V12, P946; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; RALL SC, 1982, J BIOL CHEM, V257, P4171; Rea IM, 2001, MECH AGEING DEV, V122, P1367, DOI 10.1016/S0047-6374(01)00278-0; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Roses AD, 1997, NEUROBIOL DIS, V4, P170, DOI 10.1006/nbdi.1997.0161; Sapolsky RM, 2000, ANN NY ACAD SCI, V924, P99; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stengard JH, 1996, HUM GENET, V97, P677; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Twisk JWR, 2001, ANN EPIDEMIOL, V11, P157, DOI 10.1016/S1047-2797(00)00202-7; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; van der Meer IM, 2002, J HYPERTENS, V20, P2327, DOI 10.1097/00004872-200212000-00003; VANBOCKXMEER FM, 1994, NAT GENET, V6, P4, DOI 10.1038/ng0194-4; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	85	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10022	10.1371/journal.pone.0010022	http://dx.doi.org/10.1371/journal.pone.0010022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368805	Green Submitted, gold, Green Published			2022-12-27	WOS:000276419900019
J	Said-Sadier, N; Padilla, E; Langsley, G; Ojcius, DM				Said-Sadier, Najwane; Padilla, Eduardo; Langsley, Gordon; Ojcius, David M.			Aspergillus fumigatus Stimulates the NLRP3 Inflammasome through a Pathway Requiring ROS Production and the Syk Tyrosine Kinase	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; INVASIVE ASPERGILLOSIS; HOST-DEFENSE; CASPASE-1 ACTIVATION; FUNGAL-INFECTIONS; CANDIDA-ALBICANS; RECEPTORS; DECTIN-1; PROTEIN; CELLS	Invasive aspergillosis (IA) is a life-threatening disease that occurs in immunodepressed patients when infected with Aspergillus fumigatus. This fungus is the second most-common causative agent of fungal disease after Candida albicans. Nevertheless, much remains to be learned about the mechanisms by which A. fulmigatus activates the innate immune system. We investigated the inflammatory response to conidia and hyphae of A. fumigatus and specifically, their capacity to trigger activation of an inflammasome. Our results show that in contrast to conidia, hyphal fragments induce NLRP3 inflammasome assembly, caspase-1 activation and IL-1 beta release from a human monocyte cell line. The ability of Aspergillus hyphae to activate the NLRP3 inflammasome in the monocytes requires K+ efflux and ROS production. In addition, our data show that NLRP3 inflammasome activation as well as pro-IL-1 beta expression relies on the Syk tyrosine kinase, which is downstream from the pathogen recognition receptor Dectin-1, reinforcing the importance of Dectin-1 in the innate immune response against fungal infection. Furthermore, we show that treatment of monocytes with corticosteroids inhibits transcription of the gene encoding IL-1 beta. Thus, our data demonstrate that the innate immune response against A. fumigatus infection involves a two step activation process, with a first signal promoting expression and synthesis of pro-IL-1 beta; and a second signal, involving Syk-induced activation of the NLRP3 inflammasome and caspase-1, allowing processing and secretion of the mature cytokine.	[Said-Sadier, Najwane; Padilla, Eduardo; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Said-Sadier, Najwane; Padilla, Eduardo; Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Said-Sadier, Najwane; Langsley, Gordon] Univ Paris Diderot, Grad Grp Biochim Biotherapies Biol Mol & Infectio, Paris, France; [Langsley, Gordon] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,INSERM,U1016, Paris, France	University of California System; University of California Merced; University of California System; University of California Merced; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Said-Sadier, N (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA.	david.ojcius@gmail.com	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495	University of California	University of California(University of California System)	Experiments for this study were funded by the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, DRUG TODAY, V45, P105; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Almyroudis NG, 2005, MED MYCOL, V43, pS247, DOI 10.1080/13693780400025203; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Carneiro LAM, 2004, MICROBES INFECT, V6, P609, DOI 10.1016/j.micinf.2004.01.012; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Herbrecht R, 2005, MED MYCOL, V43, pS239, DOI 10.1080/13693780400025161; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ito JI, 2006, INFECT IMMUN, V74, P5075, DOI 10.1128/IAI.00815-06; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MEDOFF G, 1991, HOSP PRACT, V26, P41; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Silveira F, 2005, CURR OPIN PULM MED, V11, P242, DOI 10.1097/01.mcp.0000159832.20648.70; Simitsopoulou M, 2007, ANTIMICROB AGENTS CH, V51, P1048, DOI 10.1128/AAC.01095-06; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wiederhold NP, 2003, PHARMACOTHERAPY, V23, P1592, DOI 10.1592/phco.23.15.1592.31965; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	45	216	229	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10008	10.1371/journal.pone.0010008	http://dx.doi.org/10.1371/journal.pone.0010008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368800	Green Submitted, Green Published, gold			2022-12-27	WOS:000276419900011
J	Gordon, RL; Schon, D; Magne, C; Astesano, C; Besson, M				Gordon, Reyna L.; Schoen, Daniele; Magne, Cyrille; Astesano, Corine; Besson, Mireille			Words and Melody Are Intertwined in Perception of Sung Words: EEG and Behavioral Evidence	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; SCALP DISTRIBUTIONS; MUSIC; LANGUAGE; MEMORY; ERP; INTEGRATION; TEXT; EXPECTANCY	Language and music, two of the most unique human cognitive abilities, are combined in song, rendering it an ecological model for comparing speech and music cognition. The present study was designed to determine whether words and melodies in song are processed interactively or independently, and to examine the influence of attention on the processing of words and melodies in song. Event-Related brain Potentials (ERPs) and behavioral data were recorded while non-musicians listened to pairs of sung words (prime and target) presented in four experimental conditions: same word, same melody; same word, different melody; different word, same melody; different word, different melody. Participants were asked to attend to either the words or the melody, and to perform a same/different task. In both attentional tasks, different word targets elicited an N400 component, as predicted based on previous results. Most interestingly, different melodies (sung with the same word) elicited an N400 component followed by a late positive component. Finally, ERP and behavioral data converged in showing interactions between the linguistic and melodic dimensions of sung words. The finding that the N400 effect, a well-established marker of semantic processing, was modulated by musical melody in song suggests that variations in musical features affect word processing in sung language. Implications of the interactions between words and melody are discussed in light of evidence for shared neural processing resources between the phonological/semantic aspects of language and the melodic/harmonic aspects of music.	[Gordon, Reyna L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Gordon, Reyna L.; Schoen, Daniele; Astesano, Corine; Besson, Mireille] CNRS, Inst Neurosci Cognit Mediterranee, Marseille, France; [Gordon, Reyna L.; Schoen, Daniele; Astesano, Corine; Besson, Mireille] Univ Mediterranee, Marseille, France; [Magne, Cyrille] Middle Tennessee State Univ, Dept Psychol, Murfreesboro, TN 37132 USA; [Astesano, Corine] Univ Toulouse 2, Toulouse, France	State University System of Florida; Florida Atlantic University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Middle Tennessee State University; Universite de Toulouse; Universite de Toulouse - Jean Jaures	Gordon, RL (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	reyna.gordon@alumni.usc.edu	Schön, Daniele/B-2484-2013; Besson, Mireille/H-5110-2015	Schön, Daniele/0000-0003-4472-4150; Besson, Mireille/0000-0002-9549-5274; Gordon, Reyna/0000-0003-1643-6979	Human Frontier Science Program (HFSP) [RGP0053]; French Ministry of Research; American Academy of University Women	Human Frontier Science Program (HFSP)(Human Frontier Science Program); French Ministry of Research(Ministry of Research, FranceEuropean Commission); American Academy of University Women	This research was supported by a grant from the Human Frontier Science Program "An interdisciplinary approach to the problem of language and music specificity" (HFSP#RGP0053) to M. Besson and was conducted at the Institut de Neurosciences Cognitives de la Mediterranee, while R. L. Gordon was a graduate student. D. Schon and C. Astesano were supported by the HFSP grant; C. Magne benefitted from a "Cognitive Science" Fellowship from the French Ministry of Research; and R. L. Gordon benefited from a Fellowship from the American Academy of University Women. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S. O., 2006, PSYCHOL MUSIC, V34, P511, DOI DOI 10.1177/0305735606067168; ARAMAKI M, J COGNITIVE IN PRESS; Astesano C, 2004, COGNITIVE BRAIN RES, V18, P172, DOI 10.1016/j.cogbrainres.2003.10.002; Astesano C., 2001, RYTHME ACCENTUATION; BARTHOLOMEUS B, 1974, Cortex, V10, P215; BENTIN S, 1993, PSYCHOPHYSIOLOGY, V30, P161, DOI 10.1111/j.1469-8986.1993.tb01729.x; Bergeson TR, 1999, INFANT BEHAV DEV, V22, P51, DOI 10.1016/S0163-6383(99)80005-8; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; BESSON M, 1987, PSYCHOPHYSIOLOGY, V24, P14, DOI 10.1111/j.1469-8986.1987.tb01853.x; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Brown S, 2000, ORIGINS OF MUSIC, P271; Carrion RE, 2008, PSYCHOPHYSIOLOGY, V45, P759, DOI 10.1111/j.1469-8986.2008.00687.x; Cunningham WA, 2005, NEUROIMAGE, V28, P827, DOI 10.1016/j.neuroimage.2005.04.044; Daltrozzo J, 2009, BRAIN RES, V1270, P88, DOI 10.1016/j.brainres.2009.03.019; de l'Etoile SK, 2006, INFANT BEHAV DEV, V29, P456, DOI 10.1016/j.infbeh.2006.03.002; Digeser FM, 2009, EAR HEARING, V30, P704, DOI 10.1097/AUD.0b013e3181b1d42d; Dissanayake E., 2008, MUSIC SCI, V12, P169, DOI [DOI 10.1177/1029864908012001081, 10.1177/1029864908012001081]; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Fedorenko E, 2009, MEM COGNITION, V37, P1, DOI 10.3758/MC.37.1.1; FREY A, 2009, TEMPORAL SEMIOTIC UN, P247; GARNER WR, 1970, COGNITIVE PSYCHOL, V1, P225, DOI 10.1016/0010-0285(70)90016-2; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; GOODGLASS H, 1977, NEUROPSYCHOLOGIA, V15, P397, DOI 10.1016/0028-3932(77)90091-4; GORDON RL, 2006, MUSIC MOTOR CONTROL; Gregg MK, 2009, ATTEN PERCEPT PSYCHO, V71, P607, DOI 10.3758/APP.71.3.607; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hebert S, 2001, BRAIN COGNITION, V46, P169, DOI 10.1016/S0278-2626(01)80058-0; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hohlfeld A, 2005, COGNITIVE BRAIN RES, V24, P500, DOI 10.1016/j.cogbrainres.2005.03.001; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Ibanez A, 2006, BRAIN LANG, V98, P264, DOI 10.1016/j.bandl.2006.05.005; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; JOHNSON R, 1978, ELECTROEN CLIN NEURO, V44, P424, DOI 10.1016/0013-4694(78)90027-5; Kilgour AR, 2000, MEM COGNITION, V28, P700, DOI 10.3758/BF03198404; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2003, ANN NY ACAD SCI, V999, P15, DOI 10.1196/annals.1284.002; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; Lidji P, 2009, ANN NY ACAD SCI, V1169, P481, DOI 10.1111/j.1749-6632.2009.04770.x; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Magne C, 2007, CEREB CORTEX, V17, P2659, DOI 10.1093/cercor/bhl174; MCCALLUM WC, 1984, ELECTROEN CLIN NEURO, V59, P477, DOI 10.1016/0168-5597(84)90006-6; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mietz A, 2008, BRAIN LANG, V104, P159, DOI 10.1016/j.bandl.2007.03.005; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Mithen S., 2005, SINGING NEANDERTHALS; Nakata T, 2004, INFANT BEHAV DEV, V27, P455, DOI 10.1016/j.infbeh.2004.03.002; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Nguyen N., 2005, PHONOLOGIE PHONETIQU, P425; Nguyen N, 2008, J PHONETICS, V36, P1, DOI 10.1016/j.wocn.2007.07.001; NI V. J., 1984, ADV PSYCHOL, V19, P71, DOI [10.1016/S0166-4115(08)62346-8, DOI 10.1016/S0166-4115(08)62346-8]; Norton A, 2009, ANN NY ACAD SCI, V1169, P431, DOI 10.1111/j.1749-6632.2009.04859.x; PACHELLA RG, 1976, PERCEPT PSYCHOPHYS, V19, P29; PALLER KA, 1992, PSYCHOPHYSIOLOGY, V29, P202, DOI 10.1111/j.1469-8986.1992.tb01686.x; Pastor MC, 2008, BRAIN RES, V1189, P145, DOI 10.1016/j.brainres.2007.10.072; Patel A. D., 1997, PERCEPTION COGNITION, P191; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Peretz I, 2004, MEM COGNITION, V32, P142, DOI 10.3758/BF03195827; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; Perrin F, 2003, COGNITIVE BRAIN RES, V17, P36, DOI 10.1016/S0926-6410(03)00078-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; Racette A, 2006, BRAIN, V129, P2571, DOI 10.1093/brain/awl250; Rainey DW, 2002, MUSIC PERCEPT, V20, P173, DOI 10.1525/mp.2002.20.2.173; Relander K, 2009, J COGNITIVE NEUROSCI, V21, P1511, DOI 10.1162/jocn.2009.21127; Russo, 2004, POLSKIE FORUM PSYCHO, V9, P51; Schmidt-Kassow M, 2009, J COGNITIVE NEUROSCI, V21, P1693, DOI 10.1162/jocn.2008.21153; Schmithorst VJ, 2005, NEUROIMAGE, V25, P444, DOI 10.1016/j.neuroimage.2004.12.006; SCHON D, NEUROIMAGE IN PRESS; SCHON D, J COGNITIVE IN PRESS; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; SERAFINE ML, 1986, J MEM LANG, V25, P123, DOI 10.1016/0749-596X(86)90025-2; SERAFINE ML, 1984, COGNITION, V16, P285, DOI 10.1016/0010-0277(84)90031-3; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; Spreckelmeyer KN, 2006, BRAIN RES, V1070, P160, DOI 10.1016/j.brainres.2005.11.075; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Stratton V.N., 1994, EMPIR STUD ARTS, V12, P173, DOI DOI 10.2190/35T0-U4DT-N09Q-LQHW; Thiessen ED, 2009, ANN NY ACAD SCI, V1169, P225, DOI 10.1111/j.1749-6632.2009.04547.x; Thomas RD, 2006, J MATH PSYCHOL, V50, P441, DOI 10.1016/j.jmp.2006.05.006; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; van Besouw Rachel M, 2005, Logoped Phoniatr Vocol, V30, P129, DOI 10.1080/14015430500262160; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; VERLEGER R, 1990, INT J NEUROSCI, V55, P171, DOI 10.3109/00207459008985972; WALLACE WT, 1994, J EXP PSYCHOL LEARN, V20, P1471, DOI 10.1037/0278-7393.20.6.1471	103	37	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9889	10.1371/journal.pone.0009889	http://dx.doi.org/10.1371/journal.pone.0009889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360991	Green Submitted, Green Published, gold			2022-12-27	WOS:000276163200005
J	Clement, CC; Cannizzo, ES; Nastke, MD; Sahu, R; Olszewski, W; Miller, NE; Stern, LJ; Santambrogio, L				Clement, Cristina C.; Cannizzo, Elvira S.; Nastke, Maria-Dorothea; Sahu, Ranjit; Olszewski, Waldemar; Miller, Norman E.; Stern, Lawrence J.; Santambrogio, Laura			An Expanded Self-Antigen Peptidome Is Carried by the Human Lymph As Compared to the Plasma	PLOS ONE			English	Article							DENDRITIC CELLS; EXTRACELLULAR-MATRIX; STEM-CELLS; T-CELLS; RHEUMATOID-ARTHRITIS; II PRESENTATION; AFFERENT LYMPH; LEG LYMPH; IMMUNOTHERAPY; NODE	Background: The pre-nodal afferent lymph is the fluid which directly derives from the extracellular milieu from every parenchymal organ and, as it continues to circulate between the cells, it collects products deriving from the organ metabolism/catabolism. A comprehensive qualitative and quantitative investigation of the self-antigenic repertoire transported by the human lymph is still missing. Methodology/Principal Findings: A major difference between lymph and plasma could be visualized by FPLC and 2D gel in the amount of low molecular weight products corresponding to peptide fragments. Naturally processed peptides in normal pre-nodal human lymph were then fractionated by HPLC and characterized by multidimensional mass spectrometry. Analysis of more then 300 sequences identified self-peptides derived from both intracellular and extracellular proteins revealing the variety of catabolic products transported by human lymph. Quantitative analysis established that at least some of these peptides are present in the circulating lymph in nanomolar concentration. Conclusions/Significance: The peptidome, generated by physiological tissue catabolism and transported by the pre-nodal lymph, is in addition to the self-peptidome generated in endosomal compartment. Unlike self antigen processed by local or nodal APC, which mostly produce epitopes constrained by the endosomal processing activity, self antigens present in the lymph could derived from a wider variety of processing pathways; including caspases, involved in cellular apoptosis, and ADAM and other metalloproteinases involved in surface receptor editing, cytokines processing and matrix remodeling. Altogether, expanding the tissue-specific self-repertoire available for the maintenance of immunological tolerance.	[Clement, Cristina C.; Cannizzo, Elvira S.; Sahu, Ranjit; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Nastke, Maria-Dorothea; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Olszewski, Waldemar] Polish Acad Sci, Dept Surg Res & Transplantol, Warsaw, Poland; [Miller, Norman E.] Univ Oxford Magdalen Coll, Oxford OX1 4AU, England; [Santambrogio, Laura] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Yeshiva University; University of Massachusetts System; University of Massachusetts Worcester; Polish Academy of Sciences; University of Oxford; Yeshiva University	Clement, CC (corresponding author), Albert Einstein Coll Med, Dept Pathol, New York, NY USA.	laura.santambrogio@einstein.yu.edu	Miller, Norman E/P-6032-2017; Clement, Cristina/ABG-4525-2021	Miller, Norman E/0000-0001-7087-3390; Clement, Cristina/0000-0003-1464-407X; Cannizzo, Elvira stefania/0000-0001-9623-3041	National Institutes of Health [AI48832, AI-48833]; Irene Diamond Professorships in Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048833, R01AI048832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Professorships in Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI48832 to LS and grant AI-48833 to LJS) and Irene Diamond Professorships in Immunology (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FR, 2005, EXPERT REV VACCINES, V4, P881, DOI 10.1586/14760584.4.6.881; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; BAXTER AG, 1994, LANCET, V343, P1169; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Burke ZD, 2007, BIOCHEM J, V404, P169, DOI 10.1042/BJ20070167; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; Fugger L, 1996, EUR J IMMUNOL, V26, P928, DOI 10.1002/eji.1830260431; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hochweller K, 2006, CURR MOL MED, V6, P631, DOI 10.2174/156652406778194982; Hunger RE, 2001, ARCH DERMATOL RES, V293, P420, DOI 10.1007/s004030100253; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Interewicz B, 2004, LYMPHOLOGY, V37, P65; Jackson L, 2007, J POSTGRAD MED, V53, P121; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kavanaugh A, 2003, J RHEUMATOL, V30, P449; KIRSCHMANN DA, 1995, J IMMUNOL, V155, P5655; Kogawa K, 2002, IMMUNOL LETT, V80, P195, DOI 10.1016/S0165-2478(01)00314-5; Korbling M, 2003, BONE MARROW TRANSPL, V32, pS23, DOI 10.1038/sj.bmt.1703939; Korpos E, 2009, CURR PHARM DESIGN, V15, P1349, DOI 10.2174/138161209787846685; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Leak LV, 2004, PROTEOMICS, V4, P753, DOI 10.1002/pmic.200300573; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Nanjee MN, 2000, J LIPID RES, V41, P1317; Oehrl W, 2008, CONNECT TISSUE RES, V49, P145, DOI 10.1080/03008200802148629; Olszewski WL, 2001, LYMPHOLOGY, V34, P179; Pabst O, 2007, J LEUKOCYTE BIOL, V82, P795, DOI 10.1189/jlb.0307144; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; REED RK, 1994, INT J MICROCIRC, V14, P56, DOI 10.1159/000178207; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Satpute SR, 2008, SEMIN ARTHRITIS RHEU, V38, P195, DOI 10.1016/j.semarthrit.2007.10.002; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sohn RL, 2007, EXPERT REV CARDIOVAS, V5, P507, DOI 10.1586/14779072.5.3.507; Tanabe S, 2007, CURR PROTEIN PEPT SC, V8, P109, DOI 10.2174/138920307779941569; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Virtanen T, 2006, CURR OPIN ALLERGY CL, V6, P461, DOI 10.1097/01.all.0000246615.40085.2f; Zheng XC, 2004, EUR J IMMUNOL, V34, P3126, DOI 10.1002/eji.200425177	50	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9863	10.1371/journal.pone.0009863	http://dx.doi.org/10.1371/journal.pone.0009863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360855	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969600002
J	Arking, DE; Reinier, K; Post, W; Jui, J; Hilton, G; O'Connor, A; Prineas, RJ; Boerwinkle, E; Psaty, BM; Tomaselli, GF; Rea, T; Sotoodehnia, N; Siscovick, DS; Burke, GL; Marban, E; Spooner, PM; Chakravarti, A; Chugh, SS				Arking, Dan E.; Reinier, Kyndaron; Post, Wendy; Jui, Jonathan; Hilton, Gina; O'Connor, Ashley; Prineas, Ronald J.; Boerwinkle, Eric; Psaty, Bruce M.; Tomaselli, Gordon F.; Rea, Thomas; Sotoodehnia, Nona; Siscovick, David S.; Burke, Gregory L.; Marban, Eduardo; Spooner, Peter M.; Chakravarti, Aravinda; Chugh, Sumeet S.			Genome-Wide Association Study Identifies GPC5 as a Novel Genetic Locus Protective against Sudden Cardiac Arrest	PLOS ONE			English	Article							GOLABI-BEHMEL-SYNDROME; QT INTERVAL; ATHEROSCLEROSIS RISK; UNEXPECTED DEATH; HEPARAN-SULFATE; POPULATION; EPIDEMIOLOGY; COMMUNITIES; REGULATOR; GLYPICAN	Background: Existing studies indicate a significant genetic component for sudden cardiac arrest (SCA) and genome-wide association studies (GWAS) provide an unbiased approach for identification of novel genes. We performed a GWAS to identify genetic determinants of SCA. Methodology/Principal Findings: We used a case-control design within the ongoing Oregon Sudden Unexpected Death Study (Oregon-SUDS). Cases (n = 424) were SCAs with coronary artery disease (CAD) among residents of Portland, OR (2002-07, population similar to 1,000,000) and controls (n = 226) were residents with CAD, but no history of SCA. All subjects were of White-European ancestry and GWAS was performed using Affymetrix 500K/5.0 and 6.0 arrays. High signal markers were genotyped in SCA cases (n = 521) identified from the Atherosclerosis Risk in Communities Study (ARIC) and the Cardiovascular Health Study (CHS) (combined n = 19,611). No SNPs reached genome-wide significance (p < 5x10(-8)). SNPs at 6 loci were prioritized for follow-up primarily based on significance of p < 10(-4) and proximity to a known gene (CSMD2, GPR37L1, LIN9, B4GALNT3, GPC5, and ZNF592). The minor allele of GPC5 (GLYPICAN 5, rs3864180) was associated with a lower risk of SCA in Oregon-SUDS, an effect that was also observed in ARIC/CHS whites (p < 0.05) and blacks (p < 0.04). In a combined Cox proportional hazards model analysis that adjusted for race, the minor allele exhibited a hazard ratio of 0.85 (95% CI 0.74 to 0.98; p < 0.01). Conclusions/Significance: A novel genetic locus for SCA, GPC5, was identified from Oregon-SUDS and successfully validated in the ARIC and CHS cohorts. Three other members of the Glypican family have been previously implicated in human disease, including cardiac conditions. The mechanism of this specific association requires further study.	[Reinier, Kyndaron; Marban, Eduardo; Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Arking, Dan E.; Hilton, Gina; O'Connor, Ashley; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Post, Wendy; Tomaselli, Gordon F.; Spooner, Peter M.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Jui, Jonathan] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Prineas, Ronald J.; Burke, Gregory L.] Wake Forest Univ, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; [Psaty, Bruce M.; Rea, Thomas; Sotoodehnia, Nona; Siscovick, David S.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA	Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins University; Oregon Health & Science University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Washington; University of Washington Seattle	Arking, DE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	aravinda@jhmi.edu; sumeet.chugh@cshs.org	Marban, Eduardo/GWC-8514-2022	Ballantyne, Christie/0000-0002-6432-1730	Donald W. Reynolds Cardiovascular Clinical Research Center; National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI [R01 HL088416, R01 HL088456]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, N01-HC-85086, N01 HC-15103, N01 HC-55222, U01 HL080295]; National Human Genome Research Institute [U01HG004402]; NIH [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; National Center for Research Resources (NCRR) [1UL1RR025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC045133, N01HC055016, N01HC015103, N01HC085079, N01HC085086, N01HC075150, N01HC055222, N01HC055015, N01HC055020, N01HC035129, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R42HL055018, R01HL059367, R01HL088456, R01HL087641, R41HL055019, R01HL088416, U01HL080295, R41HL055018] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	Donald W. Reynolds Cardiovascular Clinical Research Center; National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Donald W. Reynolds Cardiovascular Clinical Research Center at the Johns Hopkins University School of Medicine; and National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) grant R01 HL088416 (to S. S. C) and R01 HL088456 (to N.S.). S.S.C. is the Pauline and Harold Price Professor at Cedars-Sinai Medical Center, Los Angeles, California. The Atherosclerosis Risk in Communities Study (ARIC) is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and NIH contract HHSN268200625226C. Infrastructure was partly supported by grant number UL1RR025005, a component of the NIH and NIH Roadmap for Medical Research. The Cardiovascular Heart Study is supported by contracts N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through N01-HC-85086, N01 HC-15103, N01 HC-55222, and U01 HL080295 from the NHLBI, with additional contribution from the National Institute of Neurological Disorders and Stroke. This publication was made possible by grant number 1UL1RR025005 from the National Center for Research Resources (NCRR), a component of the NIH, and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, BRLMM IMPR GEN CALL; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1985, J AM COLL CARDIOL S6, V0005; KANNEL WB, 1990, CAN J CARDIOL, V6, P439; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; KONIG R, 1991, AM J MED GENET, V38, P244, DOI 10.1002/ajmg.1320380215; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kuller L, 2002, ARTERIOSCL THROM VAS, V22, P1175, DOI 10.1161/01.ATV.0000022015.97341.3A; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Stecker EC, 2006, J AM COLL CARDIOL, V47, P1161, DOI 10.1016/j.jacc.2005.11.045; Veugelers M, 1998, GENOMICS, V53, P1, DOI 10.1006/geno.1998.5465; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	31	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9879	10.1371/journal.pone.0009879	http://dx.doi.org/10.1371/journal.pone.0009879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360844	gold, Green Published, Green Submitted			2022-12-27	WOS:000275969500011
J	Martin, CD; Thierry, G; Demonet, JF				Martin, Clara D.; Thierry, Guillaume; Demonet, Jean-Francois			ERP Characterization of Sustained Attention Effects in Visual Lexical Categorization	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; EVENT-RELATED POTENTIALS; WORD RECOGNITION; PREFRONTAL CORTEX; WORKING-MEMORY; READING ALOUD; SLOW WAVES; TASK; BRAIN; BLINK	As our understanding of the basic processes underlying reading is growing, the key role played by attention in this process becomes evident. Two research topics are of particular interest in this domain: (1) it is still undetermined whether sustained attention affects lexical decision tasks; (2) the influence of attention on early visual processing (i.e., before orthographic or lexico-semantic processing stages) remains largely under-specified. Here we investigated early perceptual modulations by sustained attention using an ERP paradigm adapted from Thierry et al. [1]. Participants had to decide whether visual stimuli presented in pairs pertained to a pre-specified category (lexical categorization focus on word or pseudoword pairs). Depending on the lexical category of the first item of a pair, participants either needed to fully process the second item (hold condition) or could release their attention and make a decision without full processing of the second item (release condition). The P1 peak was unaffected by sustained attention. The N1 was delayed and reduced after the second item of a pair when participants released their attention. Release of sustained attention also reduced a P3 wave elicited by the first item of a pair and abolished the P3 wave elicited by the second. Our results are consistent with differential effects of sustained attention on early processing stages and working memory. Sustained attention modulated early processing stages during a lexical decision task without inhibiting the process of stimulus integration. On the contrary, working memory involvement/updating was highly dependent upon the allocation of sustained attention. Moreover, the influence of sustained attention on both early and late cognitive processes was independent of lexical categorization focus.	[Martin, Clara D.] Univ Pompeu Fabra, Dept Technol, Barcelona, Spain; [Martin, Clara D.; Demonet, Jean-Francois] Hop Purpan, INSERM, U825, Toulouse, France; [Martin, Clara D.; Thierry, Guillaume] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Thierry, Guillaume] Bangor Univ, Ctr Res Bilingualism Theory & Practice, Econ & Social Res Council, Bangor, Wales	Pompeu Fabra University; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Bangor University; Bangor University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Martin, CD (corresponding author), Univ Pompeu Fabra, Dept Technol, Barcelona, Spain.	Claramartin3@gmail.com	Demonet, Jean-Francois/E-6725-2010; Thierry, Guillaume/C-2688-2008; Martin, Clara/B-4563-2012	Thierry, Guillaume/0000-0003-1325-2656; Martin, Clara/0000-0003-2701-5045; Demonet, Jean-Francois/0000-0003-0100-6175	Spanish government [2008-01191/PSIC, CE-CSD2007-00121]; Economic and Social Research Council [ES/E024556/1]; European Research Council [ERC-SG-209704]; ESRC [ES/E024556/1] Funding Source: UKRI	Spanish government(Spanish GovernmentEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	M. was funded by the Spanish government (PSI 2008-01191/PSIC and Consolider Ingenio 2010 CE-CSD2007-00121). G. T. is supported by the Economic and Social Research Council (ES/E024556/1) and the European Research Council (ERC-SG-209704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1987, ELECTROEN CLIN NEURO, V68, P458, DOI 10.1016/0168-5597(87)90057-8; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Croft RJ, 2003, PSYCHOPHYSIOLOGY, V40, P322, DOI 10.1111/1469-8986.00036; CURRY SH, 1984, ANN NY ACAD SCI, V425, P171, DOI 10.1111/j.1749-6632.1984.tb23529.x; Doallo S, 2004, CLIN NEUROPHYSIOL, V115, P199, DOI 10.1016/S1388-2457(03)00317-1; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DOUROS C, 1987, BIOFEEDBACK SELF-REG, V12, P39, DOI 10.1007/BF01000077; EASON RG, 1969, PHYSIOL BEHAV, V4, P283, DOI 10.1016/0031-9384(69)90176-0; Filipovic SR, 2001, CLIN NEUROPHYSIOL, V112, P1307, DOI 10.1016/S1388-2457(01)00558-2; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guillaume T, 2003, COGNITIVE BRAIN RES, V17, P535, DOI 10.1016/S0926-6410(03)00168-X; Hillyard S.A., 1987, HDB PHYSL 1, V5, P519; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Johnson Jr. R., 1988, ADV PSYCHOPHYSIOLOGY, V3, P69; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Lien MC, 2006, PSYCHOL AGING, V21, P431, DOI 10.1037/0882-7974.21.3.431; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Martin CD, 2006, BRAIN RES, V1098, P153, DOI 10.1016/j.brainres.2006.04.097; McCann RS, 2000, J EXP PSYCHOL HUMAN, V26, P1352, DOI 10.1037//0096-1523.26.4.1352; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; NAATANEN R, 1992, NEUROREPORT, V3, P493; Naatanen R., 1987, KNOWLEDGE AIDED INFO, P241; NAZIR TA, 1991, PERCEPT PSYCHOPHYS, V49, P373, DOI 10.3758/BF03205995; O'Malley S, 2008, J EXP PSYCHOL LEARN, V34, P422, DOI 10.1037/0278-7393.34.2.422; OREGAN JK, 1984, J EXP PSYCHOL HUMAN, V10, P250, DOI 10.1037/0096-1523.10.2.250; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Rabovsky M, 2008, BRAIN RES, V1222, P156, DOI 10.1016/j.brainres.2008.05.066; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Rosazza C, 2009, BRAIN RES, V1272, P32, DOI 10.1016/j.brainres.2009.03.033; RUCHKIN DS, 1988, PSYCHOPHYSIOLOGY, V25, P339, DOI 10.1111/j.1469-8986.1988.tb01253.x; RUGG MD, 1984, BRAIN LANG, V23, P225, DOI 10.1016/0093-934X(84)90065-8; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TECCE JJ, 1993, ELECTROENCEPHALOGRAP, P887; Telford CW, 1931, J EXP PSYCHOL, V14, P1, DOI 10.1037/h0073262; Thierry G, 1998, NEUROIMAGE, V8, P391, DOI 10.1006/nimg.1998.0371; Thierry G, 2003, HUM BRAIN MAPP, V19, P37, DOI 10.1002/hbm.10101; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Weisz N, 2002, INT J PSYCHOPHYSIOL, V45, P253, DOI 10.1016/S0167-8760(02)00032-6	54	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9892	10.1371/journal.pone.0009892	http://dx.doi.org/10.1371/journal.pone.0009892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574DS	20361039	Green Submitted, gold, Green Published			2022-12-27	WOS:000275969500016
J	Takeuchi, K; Abe, M; Hiasa, M; Oda, A; Amou, H; Kido, S; Harada, T; Tanaka, O; Miki, H; Nakamura, S; Nakano, A; Kagawa, K; Yata, K; Ozaki, S; Matsumoto, T				Takeuchi, Kyoko; Abe, Masahiro; Hiasa, Masahiro; Oda, Asuka; Amou, Hiroe; Kido, Shinsuke; Harada, Takeshi; Tanaka, Osamu; Miki, Hirokazu; Nakamura, Shingen; Nakano, Ayako; Kagawa, Kumiko; Yata, Kenichiro; Ozaki, Shuji; Matsumoto, Toshio			TGF-beta Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth	PLOS ONE			English	Article							INFLAMMATORY PROTEIN (MIP)-1-ALPHA; BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; I RECEPTOR KINASE; RESISTANCE CAM-DR; OSTEOLYTIC LESIONS; VICIOUS CYCLE; ACTIVATION; ADHESION; CANCER	Background: Multiple myeloma (MM) expands almost exclusively in the bone marrow and generates devastating bone lesions, in which bone formation is impaired and osteoclastic bone resorption is enhanced. TGF-beta, a potent inhibitor of terminal osteoblast (OB) differentiation, is abundantly deposited in the bone matrix, and released and activated by the enhanced bone resorption in MM. The present study was therefore undertaken to clarify the role of TGF-beta and its inhibition in bone formation and tumor growth in MM. Methodology/Principal Findings: TGF-beta suppressed OB differentiation from bone marrow stromal cells and MC3T3-E1 preosteoblastic cells, and also inhibited adipogenesis from C3H10T1/2 immature mesenchymal cells, suggesting differentiation arrest by TGF-beta. Inhibitors for a TGF-beta type I receptor kinase, SB431542 and Ki26894, potently enhanced OB differentiation from bone marrow stromal cells as well as MC3T3-E1 cells. The TGF-beta inhibition was able to restore OB differentiation suppressed by MM cell conditioned medium as well as bone marrow plasma from MM patients. Interestingly, TGF-beta inhibition expedited OB differentiation in parallel with suppression of MM cell growth. The anti-MM activity was elaborated exclusively by terminally differentiated OBs, which potentiated the cytotoxic effects of melphalan and dexamethasone on MM cells. Furthermore, TGF-beta inhibition was able to suppress MM cell growth within the bone marrow while preventing bone destruction in MM-bearing animal models. Conclusions/Significance: The present study demonstrates that TGF-beta inhibition releases stromal cells from their differentiation arrest by MM and facilitates the formation of terminally differentiated OBs, and that terminally differentiated OBs inhibit MM cell growth and survival and enhance the susceptibility of MM cells to anti-MM agents to overcome the drug resistance mediated by stromal cells. Therefore, TGF-beta appears to be an important therapeutic target in MM bone lesions.	[Takeuchi, Kyoko; Abe, Masahiro; Oda, Asuka; Amou, Hiroe; Kido, Shinsuke; Harada, Takeshi; Tanaka, Osamu; Miki, Hirokazu; Nakamura, Shingen; Nakano, Ayako; Kagawa, Kumiko; Yata, Kenichiro; Matsumoto, Toshio] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Hiasa, Masahiro] Univ Tokushima, Grad Sch Oral Sci, Dept Biomat & Bioengn, Tokushima 770, Japan; [Ozaki, Shuji] Tokushima Univ Hosp, Div Transfus Med, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University	Takeuchi, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan.	masabe@clin.med.tokushima-u.ac.jp	日浅, 雅博/S-1537-2019; HIASA, MASAHIRO/ABB-3885-2021; Tanaka, Osamu/AAS-9252-2020	HIASA, MASAHIRO/0000-0002-4830-6274; 	Ministry of Education, Culture, Science and Sports of Japan; Ministry of Health, Labor and Welfare of Japan [17-16]	Ministry of Education, Culture, Science and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-aid for Scientific Research (A) to T. M. and (C) to M. A., and for the 21st Century Center of Excellence Program from the Ministry of Education, Culture, Science and Sports of Japan, and a Grant-in-aid for Cancer Research (17-16) to M. A. from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Abe M, 2009, J BONE MINER METAB, V27, P16, DOI 10.1007/s00774-008-0012-z; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Date T, 2004, J ORTHOP SCI, V9, P503, DOI 10.1007/s00776-004-0815-2; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Giuliani N, 2007, CANCER RES, V67, P7665, DOI 10.1158/0008-5472.CAN-06-4666; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hashimoto T, 2004, BRIT J HAEMATOL, V125, P38, DOI 10.1111/j.1365-2141.2004.04864.x; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Hiraga T, 2001, CANCER RES, V61, P4418; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Matsumoto T, 2006, ANN NY ACAD SCI, V1068, P319, DOI 10.1196/annals.1346.035; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Oyajobi B. O., 2004, J BONE MINER RES, V19, P1011; Ozaki S, 2007, INT J HEMATOL, V86, P180, DOI 10.1532/IJH97.07030; Pennisi A, 2006, BLOOD, V108, p154A; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Qiang YW, 2008, BLOOD; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tassone P, 2005, BLOOD, V106, P713, DOI 10.1182/blood-2005-01-0373; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zangari M, 2005, BRIT J HAEMATOL, V131, P71, DOI 10.1111/j.1365-2141.2005.05733.x; Zangari M, 2006, CLIN LYMPHOMA MYELOM, V7, P109, DOI 10.3816/CLM.2006.n.047	49	99	101	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9870	10.1371/journal.pone.0009870	http://dx.doi.org/10.1371/journal.pone.0009870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360846	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969500009
J	Zakharova, E; Grandhi, J; Wewers, MD; Gavrilin, MA				Zakharova, Ekaterina; Grandhi, Jaykumar; Wewers, Mark D.; Gavrilin, Mikhail A.			Mycoplasma Suppression of THP-1 Cell TLR Responses Is Corrected with Antibiotics	PLOS ONE			English	Article							INDUCED SIGNAL-TRANSDUCTION; CHRONIC-FATIGUE-SYNDROME; GENE-EXPRESSION; HUMAN MONOCYTES; MESSENGER-RNA; KAPPA-B; LIPOPOLYSACCHARIDE; MACROPHAGES; FERMENTANS; FRANCISELLA	Mycoplasma contamination of cultured cell lines is a serious problem in research, altering cellular response to different stimuli thus compromising experimental results. We found that chronic mycoplasma contamination of THP-1 cells suppresses responses of THP-1 cells to TLR stimuli. For example, E. coli LPS induced IL-1 beta was suppressed by 6 fold and IL-8 by 10 fold in mycoplasma positive THP-1 cells. Responses to live F. novicida challenge were suppressed by 50-fold and 40-fold respectively for IL-1 beta and IL-8. Basal TLR4 expression level in THP-1 cells was decreased by mycoplasma by 2.4-fold (p = 0.0003). Importantly, cell responses to pathogen associated molecular patterns are completely restored by mycoplasma clearance with Plasmocin. Thus, routine screening of cell lines for mycoplasma is important for the maintenance of reliable experimental data and contaminated cell lines can be restored to their baseline function with antibiotic clearance of mycoplasma.	[Zakharova, Ekaterina; Grandhi, Jaykumar; Wewers, Mark D.; Gavrilin, Mikhail A.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zakharova, E (corresponding author), Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	wewers.2@osu.edu; gavrilin.1@osu.edu	Wewers, Mark/AAB-6202-2021	Gavrilin, Mikhail/0000-0003-2003-768X	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID); NIH [5-U54-AI-057153, R01-HL089440, HL076278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076278, R01HL089440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V Great Lakes RCE (NIH award 5-U54-AI-057153). This work was also supported by NIH grants R01-HL089440 and HL076278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Choppa PC, 1998, MOL CELL PROBE, V12, P301, DOI 10.1006/mcpr.1998.0186; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DEMCZUK S, 1988, J BIOL CHEM, V263, P13039; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Kaufmann A, 2000, EUR J IMMUNOL, V30, P1562, DOI 10.1002/1521-4141(200006)30:6<1562::AID-IMMU1562>3.0.CO;2-Q; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Seya T, 2002, INT J BIOCHEM CELL B, V34, P901, DOI 10.1016/S1357-2725(01)00164-9; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Vojdani A, 1998, FEMS IMMUNOL MED MIC, V22, P355; Wewers MD, 1997, J IMMUNOL, V159, P5964	21	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9900	10.1371/journal.pone.0009900	http://dx.doi.org/10.1371/journal.pone.0009900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360862	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500019
J	Citrome, L				Citrome, Leslie			Citability of Original Research and Reviews in Journals and Their Sponsored Supplements	PLOS ONE			English	Article							MEDICAL JOURNALS; ADDING KNOWLEDGE; PUBLICATION; ARTICLES; CITATIONS; QUALITY; POLICY; DRUG	Background: The contents of pharmaceutical industry sponsored supplements to medical journals are perceived to be less credible than the contents of their parent journals. It is unknown if their contents are cited as often. The objective of this study was to quantify the citability of original research and reviews contained in supplements and compare it with that for the parent journal. Methodology/Principal Findings: This was a cohort study of 446 articles published in the Journal of Clinical Psychiatry (JCP) and its supplements for calendar years 2000 and 2005. The total citation counts for each article up to October 5, 2009 were retrieved from the ISI Web of Science database. The main outcome measure was the number of citations received by an article since publication. Regular journal articles included 114 from calendar year 2000 and 190 from 2005. Articles from supplements included 90 from 2000 and 52 from 2005. The median citation counts for the 3 years post-publication were 10 (interquartile range [IQR], 4-20), 14 (IQR, 8-20), 13.5 (IQR, 8-23), and 13.5 (IQR, 8-20), for the 2000 parent journal, 2000 supplements, 2005 parent journal, and 2005 supplements, respectively. Citation counts were higher for the articles in the supplements than the parent journal for the cohorts from 2000 (p=.02), and no different for the year 2005 cohorts (p=.88). The 2005 parent journal cohort had higher citation counts than the 2000 cohort (p=.007), in contrast to the supplements where citation counts remained the same (p=.94). Conclusions/Significance: Articles published in JCP supplements are robustly cited and thus can be influential in guiding clinical and research practice, as well as shaping critical thinking. Because they are printed under the sponsorship of commercial interests, they may be perceived as less than objective. A reasonable step to help improve this perception would be to ensure that supplements are peer-reviewed in the same way as regular articles in the parent journal.	[Citrome, Leslie] NYU, Sch Med, Dept Psychiat, New York, NY 10003 USA; [Citrome, Leslie] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; Nathan Kline Institute for Psychiatric Research	Citrome, L (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY 10003 USA.	citrome@nki.rfmh.org	CITROME, LESLIE/G-6428-2012	CITROME, LESLIE/0000-0002-6098-9266				ABRAMSON J, 2008, EXPERT REPORT J ABRA; Berger M, 1998, DIABETIC MED, V15, P85, DOI 10.1002/(SICI)1096-9136(199801)15:1<85::AID-DIA539>3.0.CO;2-Y; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; Block AJ, 2000, CHEST, V117, P927, DOI 10.1378/chest.117.4.927; CAELLEIGH AS, 1993, B MED LIBR ASSOC, V81, P237; CARLAT D, 2009, CARLAT PSYCHIAT BLOG; Carlat D, 2008, J CLIN PSYCHIAT, V69, P1020, DOI 10.4088/JCP.v69n0620d; CAVALLI F, 1993, ANN ONCOL, V4, P99, DOI 10.1093/oxfordjournals.annonc.a058445; Charatan F, 2006, BRIT MED J, V333, P277, DOI 10.1136/bmj.333.7562.277-a; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Citrome Leslie, 2007, Psychiatry (Edgmont), V4, P54; DAYA S, 2004, EVIDENCE BASED OBSTE, V6, P159; Fassoulaki A, 2000, BRIT J ANAESTH, V84, P266, DOI 10.1093/oxfordjournals.bja.a013418; Fields D, 2006, J AM GERIATR SOC, V54, P1296, DOI 10.1111/j.1532-5415.2006.00822.x; Finucane TE, 2006, J AM GERIATR SOC, V54, P170, DOI 10.1111/j.1532-5415.2005.00575_1.x; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Frisch E, 2002, CLEV CLIN J MED, V69, P568, DOI 10.3949/ccjm.69.7.568; Gami AS, 2004, CAN MED ASSOC J, V170, P1925, DOI 10.1503/cmaj.1031879; Jureidini JN, 2008, MED J AUSTRALIA, V188, P260, DOI 10.5694/j.1326-5377.2008.tb01604.x; Kahn JM, 2006, CHEST, V129, P1387, DOI 10.1378/chest.129.5.1387; Kruse MW, 2008, AM J HEALTH-SYST PH, V65, P2328, DOI 10.2146/ajhp080453; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Lexchin J, 2001, Can J Clin Pharmacol, V8, P162; LURIE P, 1993, BRIT MED J, V307, P1140, DOI 10.1136/bmj.307.6912.1140-a; MILLER RD, 1995, ANESTH ANALG, V81, P886, DOI 10.1097/00000539-199510000-00050; MILLER RD, 1993, ANESTH ANALG, V77, P651; OPIE LH, 1993, CARDIOVASC DRUG THER, V7, P491, DOI 10.1007/BF00877611; *PHYS POSTGR PRESS, 2009, J CLIN PSYCHIAT MAST; *PHYS POSTGR PRESS, 2009, J CLIN PSYCHIAT REV; Picus D, 1995, J VASC INTERV RADIOL, V6, P839, DOI 10.1016/S1051-0443(95)71195-2; Place F, 1934, Bull Med Libr Assoc, V22, P209; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Seglen PO, 1997, BRIT MED J, V314, P498; SHELDON TA, 1993, LANCET, V341, P100, DOI 10.1016/0140-6736(93)92569-F; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Wolf R, 1999, J AM ACAD DERMATOL, V40, P282, DOI 10.1016/S0190-9622(99)70208-2; Yoshikawa TT, 2006, J AM GERIATR SOC, V54, P1, DOI 10.1111/j.1532-5415.2005.00574.x; 1994, BMJ, V308, P1692; 2009, THOMSON REUTERS	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9876	10.1371/journal.pone.0009876	http://dx.doi.org/10.1371/journal.pone.0009876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FT	20352048	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894500027
J	Holzbauer, SM; DeVries, AS; Sejvar, JJ; Lees, CH; Adjemian, J; McQuiston, JH; Medus, C; Lexau, CA; Harris, JR; Recuenco, SE; Belay, ED; Howell, JF; Buss, BF; Hornig, M; Gibbins, JD; Brueck, SE; Smith, KE; Danila, RN; Lipkin, WI; Lachance, DH; Dyck, PJB; Lynfield, R				Holzbauer, Stacy M.; DeVries, Aaron S.; Sejvar, James J.; Lees, Christine H.; Adjemian, Jennifer; McQuiston, Jennifer H.; Medus, Carlota; Lexau, Catherine A.; Harris, Julie R.; Recuenco, Sergio E.; Belay, Ermias D.; Howell, James F.; Buss, Bryan F.; Hornig, Mady; Gibbins, John D.; Brueck, Scott E.; Smith, Kirk E.; Danila, Richard N.; Lipkin, W. Ian; Lachance, Daniel H.; Dyck, P. James. B.; Lynfield, Ruth			Epidemiologic Investigation of Immune-Mediated Polyradiculoneuropathy among Abattoir Workers Exposed to Porcine Brain	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SEMPLE RABIES VACCINE; AUTOANTIBODIES; NEURITIS	Background: In October 2007, a cluster of patients experiencing a novel polyradiculoneuropathy was identified at a pork abattoir (Plant A). Patients worked in the primary carcass processing area (warm room); the majority processed severed heads (head-table). An investigation was initiated to determine risk factors for illness. Methods and Results: Symptoms of the reported patients were unlike previously described occupational associated illnesses. A case-control study was conducted at Plant A. A case was defined as evidence of symptoms of peripheral neuropathy and compatible electrodiagnostic testing in a pork abattoir worker. Two control groups were used - randomly selected non-ill warm-room workers (n = 49), and all non-ill head-table workers (n = 56). Consenting cases and controls were interviewed and blood and throat swabs were collected. The 26 largest U. S. pork abattoirs were surveyed to identify additional cases. Fifteen cases were identified at Plant A; illness onsets occurred during May 2004 - November 2007. Median age was 32 years (range, 21-55 years). Cases were more likely than warm-room controls to have ever worked at the head-table (adjusted odds ratio [AOR], 6.6; 95% confidence interval [CI], 1.6-26.7), removed brains or removed muscle from the backs of heads (AOR, 10.3; 95% CI, 1.5-68.5), and worked within 0-10 feet of the brain removal operation (AOR, 9.9; 95% CI, 1.2-80.0). Associations remained when comparing head-table cases and head-table controls. Workers removed brains by using compressed air that liquefied brain and generated aerosolized droplets, exposing themselves and nearby workers. Eight additional cases were identified in the only two other abattoirs using this technique. The three abattoirs that used this technique have stopped brain removal, and no new cases have been reported after 24 months of follow up. Cases compared to controls had higher median interferon-gamma (IFN gamma) levels (21.7 pg/ml; vs 14.8 pg/ml, P < 0.001). Discussion: This novel polyradiculoneuropathy was associated with removing porcine brains with compressed air. An autoimmune mechanism is supported by higher levels of IFN gamma in cases than in controls consistent with other immune mediated illnesses occurring in association with neural tissue exposure. Abattoirs should not use compressed air to remove brains and should avoid procedures that aerosolize CNS tissue. This outbreak highlights the potential for respiratory or mucosal exposure to cause an immune-mediated illness in an occupational setting.	[Holzbauer, Stacy M.; DeVries, Aaron S.; Lees, Christine H.; Medus, Carlota; Lexau, Catherine A.; Smith, Kirk E.; Danila, Richard N.; Lynfield, Ruth] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA; [Holzbauer, Stacy M.; Adjemian, Jennifer; Harris, Julie R.; Buss, Bryan F.; Gibbins, John D.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Sejvar, James J.; McQuiston, Jennifer H.; Recuenco, Sergio E.; Belay, Ermias D.] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA USA; [Howell, James F.] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Buss, Bryan F.] Nebraska Dept Hlth & Human Serv, Div Publ Hlth, Lincoln, NE USA; [Hornig, Mady; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Gibbins, John D.; Brueck, Scott E.] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA; [Lachance, Daniel H.; Dyck, P. James. B.] Mayo Clin, Dept Neurol, Rochester, MN USA	Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Columbia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Mayo Clinic	Holzbauer, SM (corresponding author), Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA.	Aaron.DeVries@state.mn.us	Belay, Ermias/A-8829-2013; Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; DeVries, Aaron/0000-0001-9211-0722; Belay, Ermias/0000-0002-9837-0960; Recuenco-Cabrera, Sergio/0000-0002-8446-7411	National Institutes of Health [U54AI5758]; Emerging Infections Program [5U01CI000313]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerging Infections Program; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Laboratory work performed by W. I. Lipkin and M. Hornig at the Columbia University Northeast Biodefense Center was funded by the National Institutes of Health award U54AI5758. Epidemiologic investigation was supported by the Emerging Infections Program Grant CFDA Number 93-283 Grant # 5U01CI000313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY O, 1977, EUR J IMMUNOL, V7, P213, DOI 10.1002/eji.1830070405; Adjemian JZ, 2009, INT J OCCUP ENV HEAL, V15, P331; Bour-Jordan W, 2005, J IMMUNOL, V175, P5649, DOI 10.4049/jimmunol.175.9.5649; *CDCP, 2008, MMWR-MORBID MORTAL W, V57, P122; Csurhes PA, 2005, J NEUROL NEUROSUR PS, V76, P1431, DOI 10.1136/jnnp.2004.052282; DICKER R, 2008, FIELD EPIDEMIOLOGY, P138; Elkarim RA, 1998, CLIN IMMUNOL IMMUNOP, V88, P241, DOI 10.1006/clin.1998.4573; FULLER C, 2008, 6 INT C EM INF DIS A; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; HEMACHUDHA T, 1988, NEUROLOGY, V38, P375, DOI 10.1212/WNL.38.3.375; HEMACHUDHA T, 1987, NEUROLOGY, V37, P550, DOI 10.1212/WNL.37.4.550; Jander S, 2001, J NEUROIMMUNOL, V114, P253, DOI 10.1016/S0165-5728(00)00460-4; JAVIER RS, 1989, J NEUROL SCI, V93, P221, DOI 10.1016/0022-510X(89)90192-5; Kieseier BC, 2002, BRAIN, V125, P823, DOI 10.1093/brain/awf070; Lachance DH, 2010, LANCET NEUROL, V9, P55, DOI 10.1016/S1474-4422(09)70296-0; LISAK RP, 1975, BIOMEDICINE, V22, P81; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; Piyasirisilp S, 1999, ANN NEUROL, V45, P595, DOI 10.1002/1531-8249(199905)45:5<595::AID-ANA7>3.0.CO;2-M; Prabhakar U, 2002, J IMMUNOL METHODS, V260, P207, DOI 10.1016/S0022-1759(01)00543-9; SMITH ME, 1979, J NEUROPATH EXP NEUR, V38, P377, DOI 10.1097/00005072-197907000-00003; Udawat H, 2001, J Assoc Physicians India, V49, P384; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YVES R, 2008, ARTHRIT CARE RES, V59, P1341	23	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9782	10.1371/journal.pone.0009782	http://dx.doi.org/10.1371/journal.pone.0009782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333310	Green Published, gold			2022-12-27	WOS:000275809700017
J	Inskeep, WP; Rusch, DB; Jay, ZJ; Herrgard, MJ; Kozubal, MA; Richardson, TH; Macur, RE; Hamamura, N; Jennings, RD; Fouke, BW; Reysenbach, AL; Roberto, F; Young, M; Schwartz, A; Boyd, ES; Badger, JH; Mathur, EJ; Ortmann, AC; Bateson, M; Geesey, G; Frazier, M				Inskeep, William P.; Rusch, Douglas B.; Jay, Zackary J.; Herrgard, Markus J.; Kozubal, Mark A.; Richardson, Toby H.; Macur, Richard E.; Hamamura, Natsuko; Jennings, Ryan deM.; Fouke, Bruce W.; Reysenbach, Anna-Louise; Roberto, Frank; Young, Mark; Schwartz, Ariel; Boyd, Eric S.; Badger, Jonathan H.; Mathur, Eric J.; Ortmann, Alice C.; Bateson, Mary; Geesey, Gill; Frazier, Marvin			Metagenomes from High-Temperature Chemotrophic Systems Reveal Geochemical Controls on Microbial Community Structure and Function	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; ARCHAEON PYROCOCCUS-FURIOSUS; MAMMOTH HOT-SPRINGS; HYPERTHERMOPHILIC ARCHAEON; GEOTHERMAL SPRINGS; GENOME SEQUENCE; SP NOV.; MOLECULAR CHARACTERIZATION; BACTERIAL COMMUNITIES; DEPOSITIONAL FACIES	The Yellowstone caldera contains the most numerous and diverse geothermal systems on Earth, yielding an extensive array of unique high-temperature environments that host a variety of deeply-rooted and understudied Archaea, Bacteria and Eukarya. The combination of extreme temperature and chemical conditions encountered in geothermal environments often results in considerably less microbial diversity than other terrestrial habitats and offers a tremendous opportunity for studying the structure and function of indigenous microbial communities and for establishing linkages between putative metabolisms and element cycling. Metagenome sequence (14-15,000 Sanger reads per site) was obtained for five high-temperature (>65 degrees C) chemotrophic microbial communities sampled from geothermal springs (or pools) in Yellowstone National Park (YNP) that exhibit a wide range in geochemistry including pH, dissolved sulfide, dissolved oxygen and ferrous iron. Metagenome data revealed significant differences in the predominant phyla associated with each of these geochemical environments. Novel members of the Sulfolobales are dominant in low pH environments, while other Crenarchaeota including distantly-related Thermoproteales and Desulfurococcales populations dominate in suboxic sulfidic sediments. Several novel archaeal groups are well represented in an acidic (pH 3) Fe-oxyhydroxide mat, where a higher O-2 influx is accompanied with an increase in archaeal diversity. The presence or absence of genes and pathways important in S oxidation-reduction, H-2-oxidation, and aerobic respiration (terminal oxidation) provide insight regarding the metabolic strategies of indigenous organisms present in geothermal systems. Multiple-pathway and protein-specific functional analysis of metagenome sequence data corroborated results from phylogenetic analyses and clearly demonstrate major differences in metabolic potential across sites. The distribution of functional genes involved in electron transport is consistent with the hypothesis that geochemical parameters (e.g., pH, sulfide, Fe, O-2) control microbial community structure and function in YNP geothermal springs.	[Inskeep, William P.; Jay, Zackary J.; Kozubal, Mark A.; Macur, Richard E.; Jennings, Ryan deM.; Young, Mark; Boyd, Eric S.; Bateson, Mary; Geesey, Gill] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA; [Inskeep, William P.; Jay, Zackary J.; Kozubal, Mark A.; Macur, Richard E.; Jennings, Ryan deM.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Rusch, Douglas B.; Badger, Jonathan H.; Frazier, Marvin] J Craig Venter Inst, Rockville, MD USA; [Herrgard, Markus J.; Richardson, Toby H.; Schwartz, Ariel; Mathur, Eric J.] Synthet Genom Inc, La Jolla, CA USA; [Hamamura, Natsuko; Reysenbach, Anna-Louise] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Fouke, Bruce W.] Univ Illinois, Urbana, IL 61801 USA; [Roberto, Frank] Idaho Natl Lab, Idaho Falls, ID USA; [Young, Mark; Bateson, Mary] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Boyd, Eric S.; Geesey, Gill] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Ortmann, Alice C.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; Ehime University; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Idaho National Laboratory; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of South Alabama	Inskeep, WP (corresponding author), Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA.	binskeep@montana.edu; drusch@jcvi.org	Roberto, Frank F/GWC-2615-2022; Hamamura, Natsuko/D-8837-2013; Hamamura, Natsuko/AAY-9454-2021	Roberto, Frank F/0000-0001-5459-0892; Hamamura, Natsuko/0000-0002-6641-1975; Jay, Zackary/0000-0003-3062-4933	U.S. National Aeronautics and Space Administration [NAG5-8807, NNG04GR46G]; U.S. National Science Foundation [BIO 0342269]; Montana Agricultural Experiment Station [911398]	U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); U.S. National Science Foundation(National Science Foundation (NSF)); Montana Agricultural Experiment Station	This work was supported by the Thermal Biology Institute via projects from the U.S. National Aeronautics and Space Administration (Exobiology Program NAG5-8807, NNG04GR46G), Dr. William Apel (Idaho National Laboratory, Idaho Falls, Idaho, USA), the U.S. National Science Foundation Research Coordination Network (BIO 0342269) focused on Yellowstone National Park, and the Montana Agricultural Experiment Station (Project 911398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Anderson IJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-145; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P682, DOI 10.1128/AEM.02019-07; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Ball J.W., 2002, 02382 US GEOL SURV, P104; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Boyd ES, 2007, APPL ENVIRON MICROB, V73, P6669, DOI 10.1128/AEM.01321-07; Boyd ES, 2009, ENVIRON MICROBIOL, V11, P950, DOI 10.1111/j.1462-2920.2008.01820.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brugger Kim, 2007, Archaea, V2, P127, DOI 10.1155/2007/745987; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Cozen AE, 2009, J BACTERIOL, V191, P782, DOI 10.1128/JB.00965-08; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dhillon A, 2005, APPL ENVIRON MICROB, V71, P4592, DOI 10.1128/AEM.71.8.4592-4601.2005; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Fouke BW, 2003, CAN J EARTH SCI, V40, P1531, DOI 10.1139/E03-067; Fouke BW, 2000, J SEDIMENT RES, V70, P565, DOI 10.1306/2DC40929-0E47-11D7-8643000102C1865D; Fournier R. O., 2005, GEOTHERMAL BIOL GEOC, P3; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; FUCHS G, 2007, SCIENCE, V318, P1782; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gonzalez JM, 2000, FEMS MICROBIOL LETT, V191, P243, DOI 10.1111/j.1574-6968.2000.tb09346.x; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; Griesbeck C, 2002, BIOCHEMISTRY-US, V41, P11552, DOI 10.1021/bi026032b; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; Inskeep WP, 2005, GEOBIOLOGY, V3, P297, DOI 10.1111/j.1472-4669.2006.00059.x; Inskeep WP, 2004, GEOCHIM COSMOCHIM AC, V68, P3141, DOI 10.1016/j.gca.2003.09.020; Ishikawa R, 2002, ARCH MICROBIOL, V179, P42, DOI 10.1007/s00203-002-0496-1; Itoh T, 1999, INT J SYST BACTERIOL, V49, P1157, DOI 10.1099/00207713-49-3-1157; Kawashima T, 2000, P NATL ACAD SCI USA, V97, P14257, DOI 10.1073/pnas.97.26.14257; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Komorowski L, 2002, BIOL CHEM, V383, P1791, DOI 10.1515/BC.2002.200; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kozubal M, 2008, APPL ENVIRON MICROB, V74, P942, DOI 10.1128/AEM.01200-07; Langner HW, 2001, ENVIRON SCI TECHNOL, V35, P3302, DOI 10.1021/es0105562; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu Q, 2008, BIOINFORMATICS, V24, P597, DOI 10.1093/bioinformatics/btn004; LUBBEN M, 1994, MOL MICROBIOL, V13, P327, DOI 10.1111/j.1365-2958.1994.tb00426.x; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P2263, DOI 10.1099/ijs.0.63708-0; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Pereira MM, 2004, J BIOENERG BIOMEMBR, V36, P93, DOI 10.1023/B:JOBB.0000019601.74394.67; Purschke WG, 1997, J BACTERIOL, V179, P1344, DOI 10.1128/jb.179.4.1344-1353.1997; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Reysenbach A.L., 2005, GEOTHERMAL BIOL GEOC, P129; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Santini JM, 2007, BBA-BIOENERGETICS, V1767, P189, DOI 10.1016/j.bbabio.2007.01.009; Schelert J, 2006, J BACTERIOL, V188, P7141, DOI 10.1128/JB.00558-06; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2001, J BACTERIOL, V183, P7027, DOI 10.1128/JB.183.24.7027-7036.2001; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Shock E. L., 2005, GEOTHERMAL BIOL GEOC, P95; Simbahan J, 2005, APPL ENVIRON MICROB, V71, P8836, DOI 10.1128/AEM.71.12.8836-8845.2005; STAUFFER RE, 1984, GEOCHIM COSMOCHIM AC, V48, P2547, DOI 10.1016/0016-7037(84)90305-3; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vadas A, 1999, J BIOL CHEM, V274, P36715, DOI 10.1074/jbc.274.51.36715; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Young M., 2005, GEOTHERMAL BIOL GEOC, P289, DOI DOI 10.1146/ANNUREV-MICRO-092412-155633	101	147	148	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9773	10.1371/journal.pone.0009773	http://dx.doi.org/10.1371/journal.pone.0009773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333304	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809700012
J	Oh, WJ; Westmoreland, JJ; Summers, R; Condie, BG				Oh, Won-Jong; Westmoreland, Joby J.; Summers, Ryan; Condie, Brian G.			Cleft Palate Is Caused by CNS Dysfunction in Gad1 and Viaat Knockout Mice	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; GREEN FLUORESCENT PROTEIN; ARTHROGRYPOSIS MULTIPLEX CONGENITA; MIDGESTATION MOUSE EMBRYOS; SYMPATHETIC-NERVOUS-SYSTEM; NEURAL PROGENITOR CELLS; TRANSGENIC MICE; TRANSPORTER GENE; BETA-3 SUBUNIT	Background: Previous studies have shown that disruption of GABA signaling in mice via mutations in the Gad1, Gabrb3 or Viaat genes leads to the development of non-neural developmental defects such as cleft palate. Studies of the Gabrb3 and Gad1 mutant mice have suggested that GABA function could be required either in the central nervous system or in the palate itself for normal palatogenesis. Methodology/Principal Findings: To further examine the role of GABA signaling in palatogenesis we used three independent experimental approaches to test whether Gad1 or Viaat function is required in the fetal CNS for normal palate development. We used oral explant cultures to demonstrate that the Gad1 and Viaat mutant palates were able to undergo palatogenesis in culture, suggesting that there is no defect in the palate tissue itself in these mice. In a second series of experiments we found that the GABA(A) receptor agonist muscimol could rescue the cleft palate phenotype in Gad1 and Viaat mutant embryos. This suggested that normal multimeric GABA(A) receptors in the CNS were necessary for normal palatogenesis. In addition, we showed that CNS-specific inactivation of Gad1 was sufficient to disrupt palate development. Conclusions/Significance: Our results are consistent with a role for Gad1 and Viaat in the central nervous system for normal development of the palate. We suggest that the alterations in GABA signaling lead to non-neural defects such as cleft palate as a secondary effect due to alterations in or elimination of fetal movements.	[Oh, Won-Jong; Summers, Ryan; Condie, Brian G.] Univ Georgia, Dept Genet, Dev Biol Grp, Athens, GA 30602 USA; [Oh, Won-Jong; Westmoreland, Joby J.] Med Coll Georgia, Inst Mol Med, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Oh, WJ (corresponding author), Univ Georgia, Dept Genet, Dev Biol Grp, Athens, GA 30602 USA.	bcondie@uga.edu		Summers, Ryan/0000-0002-3621-8664	National Institutes of Health [R01MH06479]; University of Georgia; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health award R01MH064794 (BGC) and lab startup funds from the University of Georgia (BGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Briner W, 2001, BMC Pharmacol, V1, P2, DOI 10.1186/1471-2210-1-2; Brown NL, 2003, DEV GROWTH DIFFER, V45, P153; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Choi DS, 1997, DEVELOPMENT, V124, P1745; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; CULIAT CT, 1995, NAT GENET, V11, P344, DOI 10.1038/ng1195-344; de Vries JIP, 2006, ULTRASOUND OBST GYN, V27, P701, DOI 10.1002/uog.2740; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Ferguson C, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-85; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hagiwara N, 2003, DEV BIOL, V254, P93, DOI 10.1016/S0012-1606(02)00030-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Heusner CL, 2008, GENESIS, V46, P357, DOI 10.1002/dvg.20405; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hooper SB, 2006, CLIN EXP PHARMACOL P, V33, P273, DOI 10.1111/j.1440-1681.2006.04358.x; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Inanlou MR, 2005, DEV DYNAM, V233, P772, DOI 10.1002/dvdy.20381; Iseki S, 2007, BIRTH DEFECTS RES A, V79, P688, DOI 10.1002/bdra.20400; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Kanno K, 2004, AM J MED GENET A, V127A, P11, DOI 10.1002/ajmg.a.20649; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Katarova Z, 1998, EUR J NEUROSCI, V10, P989, DOI 10.1046/j.1460-9568.1998.00109.x; Katarova Z, 2000, J COMP NEUROL, V424, P607, DOI 10.1002/1096-9861(20000904)424:4<607::AID-CNE4>3.0.CO;2-C; Klausberger T, 2001, J BIOL CHEM, V276, P16024, DOI 10.1074/jbc.M009508200; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Ma L, 1999, LEARN MEMORY, V6, P267; Maddox Dennis M., 2001, BMC Developmental Biology, V1, P1, DOI 10.1186/1471-213X-1-1; Makinae K, 2000, J NEUROCHEM, V75, P1429, DOI 10.1046/j.1471-4159.2000.0751429.x; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Moore-Scott BA, 2003, GENESIS, V35, P164, DOI 10.1002/gene.10179; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Mukhopadhyay P, 2004, BIRTH DEFECTS RES A, V70, P912, DOI 10.1002/bdra.20095; NAPOLITANO L, 1958, J BIOPHYS BIOCHEM CY, V4, P685, DOI 10.1083/jcb.4.6.685; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Oh WJ, 2005, GENE, V351, P39, DOI 10.1016/j.gene.2005.01.009; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Riemersma S, 1996, J CLIN INVEST, V98, P2358, DOI 10.1172/JCI119048; SADLER TW, 2005, LANGMANS ESSENTIAL M, P96; Scapoli L, 2002, HUM GENET, V110, P15, DOI 10.1007/s00439-001-0639-5; SHIOTA K, 1990, ACTA ANAT, V137, P59; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Te Pas AB, 2008, J PEDIATR-US, V152, P607, DOI 10.1016/j.jpeds.2007.10.041; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsunekawa N, 2005, EUR J NEUROSCI, V21, P173, DOI 10.1111/j.1460-9568.2004.03860.x; Vieira AR, 2008, AM J MED GENET A, V146A, P2828, DOI 10.1002/ajmg.a.32260; VINCENT A, 1995, LANCET, V346, P24, DOI 10.1016/S0140-6736(95)92652-6; Vogt J, 2008, AM J HUM GENET, V82, P222, DOI 10.1016/j.ajhg.2007.09.016; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WEE EL, 1986, J CRAN GENET DEV BIO, V6, P53; WEE EL, 1983, TERATOLOGY, V28, P15, DOI 10.1002/tera.1420280104; Wen PH, 2005, DEVELOPMENT, V132, P3873, DOI 10.1242/dev.01946; Westmoreland JJ, 2001, BIOCHEM BIOPH RES CO, V284, P674, DOI 10.1006/bbrc.2001.5031; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; ZIMMERMAN EF, 1989, TERATOLOGY, V40, P593, DOI 10.1002/tera.1420400607	77	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9758	10.1371/journal.pone.0009758	http://dx.doi.org/10.1371/journal.pone.0009758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333300	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809700008
J	Isodono, K; Takahashi, T; Imoto, H; Nakanishi, N; Ogata, T; Asada, S; Adachi, A; Ueyama, T; Oh, H; Matsubara, H				Isodono, Koji; Takahashi, Tomosaburo; Imoto, Hiroko; Nakanishi, Naohiko; Ogata, Takehiro; Asada, Satoshi; Adachi, Atsuo; Ueyama, Tomomi; Oh, Hidemasa; Matsubara, Hiroaki			PARM-1 Is an Endoplasmic Reticulum Molecule Involved in Endoplasmic Reticulum Stress-Induced Apoptosis in Rat Cardiac Myocytes	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; HEART-FAILURE; TRANSCRIPTION FACTOR; CARDIOMYOCYTE DEATH; CREB/ATF-FAMILY; ISCHEMIC-HEART; FAILING HEART; CELLS; ACTIVATION; DISEASE	To identify novel transmembrane and secretory molecules expressed in cardiac myocytes, signal sequence trap screening was performed in rat neonatal cardiac myocytes. One of the molecules identified was a transmembrane protein, prostatic androgen repressed message-1 (PARM-1). While PARM-1 has been identified as a gene induced in prostate in response to castration, its function is largely unknown. Our expression analysis revealed that PARM-1 was specifically expressed in hearts and skeletal muscles, and in the heart, cardiac myocytes, but not non-myocytes expressed PARM-1. Immunofluorescent staining showed that PARM-1 was predominantly localized in endoplasmic reticulum (ER). In Dahl salt-sensitive rats, high-salt diet resulted in hypertension, cardiac hypertrophy and subsequent heart failure, and significantly stimulated PARM-1 expression in the hearts, with a concomitant increase in ER stress markers such as GRP78 and CHOP. In cultured cardiac myocytes, PARM-1 expression was stimulated by proinflammatory cytokines, but not by hypertrophic stimuli. A marked increase in PARM-1 expression was observed in response to ER stress inducers such as thapsigargin and tunicamycin, which also induced apoptotic cell death. Silencing PARM-1 expression by siRNAs enhanced apoptotic response in cardiac myocytes to ER stresses. PARM-1 silencing also repressed expression of PERK and ATF6, and augmented expression of CHOP without affecting IRE-1 expression and JNK and Caspase-12 activation. Thus, PARM-1 expression is induced by ER stress, which plays a protective role in cardiac myocytes through regulating PERK, ATF6 and CHOP expression. These results suggested that PARM-1 is a novel ER transmembrane molecule involved in cardiac remodeling in hypertensive heart disease.	[Isodono, Koji; Takahashi, Tomosaburo; Imoto, Hiroko; Nakanishi, Naohiko; Ogata, Takehiro; Asada, Satoshi; Adachi, Atsuo; Ueyama, Tomomi; Oh, Hidemasa; Matsubara, Hiroaki] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Isodono, Koji; Takahashi, Tomosaburo; Imoto, Hiroko; Ogata, Takehiro; Asada, Satoshi; Adachi, Atsuo; Ueyama, Tomomi; Oh, Hidemasa; Matsubara, Hiroaki] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 606, Japan	Kyoto Prefectural University of Medicine; Kyoto University	Isodono, K (corresponding author), Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan.	ttaka@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Mitsubishi Pharma Research Foundation; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Mitsubishi Pharma Research Foundation and Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Blum A, 2001, ANNU REV MED, V52, P15, DOI 10.1146/annurev.med.52.1.15; Bruyninx M, 1999, ENDOCRINOLOGY, V140, P4789, DOI 10.1210/en.140.10.4789; Conraads VM, 2002, INT J CARDIOL, V85, P33, DOI 10.1016/S0167-5273(02)00232-2; Cornet AM, 2003, PROSTATE, V56, P220, DOI 10.1002/pros.10254; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Fisher SA, 2000, CIRC RES, V87, P856, DOI 10.1161/01.RES.87.10.856; Fladeby C, 2008, INT J CANCER, V122, P1229, DOI 10.1002/ijc.23185; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Harada K, 2008, J BIOL CHEM, V283, P26705, DOI 10.1074/jbc.M801485200; Horio T, 1998, ENDOCRINOLOGY, V139, P4576, DOI 10.1210/en.139.11.4576; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Klotz S, 2006, HYPERTENSION, V47, P901, DOI 10.1161/01.HYP.0000215579.81408.8e; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Ogata T, 2007, BIOCHEM BIOPH RES CO, V359, P341, DOI 10.1016/j.bbrc.2007.05.104; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	41	45	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9746	10.1371/journal.pone.0009746	http://dx.doi.org/10.1371/journal.pone.0009746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305782	Green Submitted, Green Published, gold			2022-12-27	WOS:000276456300003
J	Frak, V; Nazir, T; Goyette, M; Cohen, H; Jeannerod, M				Frak, Victor; Nazir, Tatjana; Goyette, Michel; Cohen, Henri; Jeannerod, Marc			Grip Force Is Part of the Semantic Representation of Manual Action Verbs	PLOS ONE			English	Article							MOTOR; LANGUAGE; BRAIN; PERCEPTION; MOVEMENTS; CORTEX; DAMAGE	Motor actions and action verbs activate similar cortical brain regions. A functional interference can be taken as evidence that there is a parallel treatment of these two types of information and would argue for the biological grounding of language in action. A novel approach examining the relationship between language and grip force is presented. With eyes closed and arm extended, subjects listened to words relating (verbs) or not relating (nouns) to a manual action while holding a cylinder with an integrated force sensor. There was a change in grip force when subjects heard verbs that related to manual action. Grip force increased from about 100 ms following the verb presentation, peaked at 380 ms and fell abruptly after 400 ms, signalling a possible inhibition of the motor simulation evoked by these words. These observations reveal the intimate relationship that exists between language and grasp and show that it is possible to elucidate online new aspects of sensorimotor interaction.	[Frak, Victor] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada; [Frak, Victor; Goyette, Michel] Univ Montreal, Inst Readaptat Gingras Lindsay Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Nazir, Tatjana; Jeannerod, Marc] Inst Cognit Sci, UMR 5015, CNRS, Bron, France; [Cohen, Henri] Univ Paris 05, UMR 8189, CNRS, Boulogne, France	University of Quebec; University of Quebec Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Frak, V (corresponding author), Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.	frak.victor@uqam.ca		Nazir, Tatjana/0000-0002-6313-9259; Frak, Victor/0000-0002-3311-777X	Fondation de l'Institut de Readaptation de Montreal, Canada	Fondation de l'Institut de Readaptation de Montreal, Canada	This work was aided by a grant from Fondation de l'Institut de Readaptation de Montreal, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Bourbonnais D, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-2; BROCA P, 1861, B SOC ANTHROPOL PAR, V2, P235; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Floel A, 2003, EUR J NEUROSCI, V18, P704, DOI 10.1046/j.1460-9568.2003.02774.x; Frak V, 2006, BRAIN COGNITION, V60, P43, DOI 10.1016/j.bandc.2005.09.010; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Goldenberg G, 2003, NEUROPSYCHOLOGIA, V41, P1565, DOI 10.1016/S0028-3932(03)00120-9; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grafton ST, 1998, J NEUROSCI, V18, P9420; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Johnson-Frey SH, 2004, BRAIN COGNITION, V55, P328, DOI 10.1016/j.bandc.2004.02.032; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Liepmann H., 1905, MUNCHEN MED WOCHEN, V49, P2375; Liepmann H. K., 1905, MUNCHEN MED WOCHEN, V49, P2322; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRICE CJ, 1994, BRAIN, V117, P1255, DOI 10.1093/brain/117.6.1255; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; [No title captured]	31	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9728	10.1371/journal.pone.0009728	http://dx.doi.org/10.1371/journal.pone.0009728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570ZC	20300535	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000275716400021
J	Morgan, OW; Bramley, A; Fowlkes, A; Freedman, DS; Taylor, TH; Gargiullo, P; Belay, B; Jain, S; Cox, C; Kamimoto, L; Fiore, A; Finelli, L; Olsen, SJ; Fry, AM				Morgan, Oliver W.; Bramley, Anna; Fowlkes, Ashley; Freedman, David S.; Taylor, Thomas H.; Gargiullo, Paul; Belay, Brook; Jain, Seema; Cox, Chad; Kamimoto, Laurie; Fiore, Anthony; Finelli, Lyn; Olsen, Sonja J.; Fry, Alicia M.			Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease	PLOS ONE			English	Article							H1N1 INFLUENZA; UNITED-STATES; OVERWEIGHT; PREVALENCE; MORTALITY	Background: Severe illness due to 2009 pandemic A(H1N1) infection has been reported among persons who are obese or morbidly obese. We assessed whether obesity is a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1), independent of chronic medical conditions considered by the Advisory Committee on Immunization Practices (ACIP) to increase the risk of influenza-related complications. Methodology/Principal Findings: We used a case-cohort design to compare cases of hospitalizations and deaths from 2009 pandemic A(H1N1) influenza occurring between April-July, 2009, with a cohort of the U. S. population estimated from the 2003-2006 National Health and Nutrition Examination Survey (NHANES); pregnant women and children < 2 years old were excluded. For hospitalizations, we defined categories of relative weight by body mass index (BMI, kg/m(2)); for deaths, obesity or morbid obesity was recorded on medical charts, and death certificates. Odds ratio (OR) of being in each BMI category was determined; normal weight was the reference category. Overall, 361 hospitalizations and 233 deaths included information to determine BMI category and presence of ACIP-recognized medical conditions. Among >= 20 year olds, hospitalization was associated with being morbidly obese (BMI >= 40) for individuals with ACIP-recognized chronic conditions (OR = 4.9, 95% Cl 2.4-9.9) and without ACIP-recognized chronic conditions (OR = 4.7, 95% Cl 1.3-17.2). Among 2-19 year olds, hospitalization was associated with being underweight (BMI <= 5(th) percentile) among those with (OR = 12.5, 95% Cl 3.4-45.5) and without (OR = 5.5, 95% Cl 1.3-22.5) ACIP-recognized chronic conditions. Death was not associated with BMI category among individuals 2-19 years old. Among individuals aged >= 20 years without ACIP-recognized chronic medical conditions death was associated with obesity (OR = 3.1, 95% Cl: 1.5-6.6) and morbid obesity (OR = 7.6, 95% Cl 2.1-27.9). Conclusions/Significance: Our findings support observations that morbid obesity may be associated with hospitalization and possibly death due to 2009 pandemic H1N1 infection. These complications could be prevented by early antiviral therapy and vaccination.	[Morgan, Oliver W.; Olsen, Sonja J.] Ctr Dis Control & Prevent, Div Emerging Infect, Atlanta, GA 30333 USA; [Morgan, Oliver W.; Olsen, Sonja J.] Ctr Dis Control & Prevent, Surveillance Serv, Atlanta, GA USA; [Bramley, Anna; Fowlkes, Ashley; Gargiullo, Paul; Jain, Seema; Cox, Chad; Kamimoto, Laurie; Fiore, Anthony; Finelli, Lyn; Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Freedman, David S.; Belay, Brook] Ctr Dis Control & Prevent, Div Nutr & Phys Activ & Obes, Atlanta, GA USA; [Taylor, Thomas H.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Morgan, OW (corresponding author), Ctr Dis Control & Prevent, Div Emerging Infect, Atlanta, GA 30333 USA.	afry@cdc.gov	Fiore, Anthony/AAO-8956-2020; Finelli, Lyn/AAK-2360-2020	Freedman, David/0000-0001-8014-0289				Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; CDC, 2009, CDC PROT REALT RTPCR; CDC, 2009, UPD INT REC US ANT M; CDC, SAS PROGR CDC GROWTH; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; KIRKWOOD BR, 2001, ESSENTIALS MED STAT; Knol MJ, 2008, AM J EPIDEMIOL, V168, P1073, DOI 10.1093/aje/kwn217; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LARUCHE GV, 2009, WEEKLY EPIDEMIOLOGIC, V84, P301; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO, 2009, PAND H1N1 2009 UPD; *WHO CONS OB, 2000, TECHN REP SER WHO CO, V894; Wolter K. M., 1985, INTRO VARIANCE ESTIM	25	303	315	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9694	10.1371/journal.pone.0009694	http://dx.doi.org/10.1371/journal.pone.0009694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300571	Green Submitted, Green Published, gold			2022-12-27	WOS:000275621000012
J	Pescador, N; Villar, D; Cifuentes, D; Garcia-Rocha, M; Ortiz-Barahona, A; Vazquez, S; Ordonez, A; Cuevas, Y; Saez-Morales, D; Garcia-Bermejo, ML; Landazuri, MO; Guinovart, J; del Peso, L				Pescador, Nuria; Villar, Diego; Cifuentes, Daniel; Garcia-Rocha, Mar; Ortiz-Barahona, Amaya; Vazquez, Silvia; Ordonez, Angel; Cuevas, Yolanda; Saez-Morales, David; Laura Garcia-Bermejo, Maria; Landazuri, Manuel O.; Guinovart, Joan; del Peso, Luis			Hypoxia Promotes Glycogen Accumulation through Hypoxia Inducible Factor (HIF)-Mediated Induction of Glycogen Synthase 1	PLOS ONE			English	Article							PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; MUSCLE CULTURES; HIF-ALPHA; FACTOR-I; INHIBITION; METABOLISM; EXPRESSION; MECHANISM; PATHWAY	When oxygen becomes limiting, cells reduce mitochondrial respiration and increase ATP production through anaerobic fermentation of glucose. The Hypoxia Inducible Factors (HIFs) play a key role in this metabolic shift by regulating the transcription of key enzymes of glucose metabolism. Here we show that oxygen regulates the expression of the muscle glycogen synthase (GYS1). Hypoxic GYS1 induction requires HIF activity and a Hypoxia Response Element within its promoter. GYS1 gene induction correlated with a significant increase in glycogen synthase activity and glycogen accumulation in cells exposed to hypoxia. Significantly, knockdown of either HIF1 alpha or GYS1 attenuated hypoxia-induced glycogen accumulation, while GYS1 overexpression was sufficient to mimic this effect. Altogether, these results indicate that GYS1 regulation by HIF plays a central role in the hypoxic accumulation of glycogen. Importantly, we found that hypoxia also upregulates the expression of UTP: glucose-1-phosphate urydylyltransferase (UGP2) and 1,4-alpha glucan branching enzyme (GBE1), two enzymes involved in the biosynthesis of glycogen. Therefore, hypoxia regulates almost all the enzymes involved in glycogen metabolism in a coordinated fashion, leading to its accumulation. Finally, we demonstrated that abrogation of glycogen synthesis, by knock-down of GYS1 expression, impairs hypoxic preconditioning, suggesting a physiological role for the glycogen accumulated during chronic hypoxia. In summary, our results uncover a novel effect of hypoxia on glucose metabolism, further supporting the central importance of metabolic reprogramming in the cellular adaptation to hypoxia.	[Pescador, Nuria; Villar, Diego; Ortiz-Barahona, Amaya; Cuevas, Yolanda; del Peso, Luis] Univ Autonoma Madrid, Dept Bioquim, Madrid, Spain; [Pescador, Nuria; Villar, Diego; Ortiz-Barahona, Amaya; Cuevas, Yolanda; del Peso, Luis] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Cifuentes, Daniel; Garcia-Rocha, Mar; Guinovart, Joan] Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Vazquez, Silvia; Landazuri, Manuel O.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Saez-Morales, David; Laura Garcia-Bermejo, Maria] Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid, Spain; [Ordonez, Angel] Hosp Ramon & Cajal, Serv Anat Patol, E-28034 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; Autonomous University of Madrid; Hospital de La Princesa; Hospital Universitario Ramon y Cajal	Pescador, N (corresponding author), Univ Autonoma Madrid, Dept Bioquim, Madrid, Spain.	luis.peso@uam.es	Pescador, Nuria/ABG-8337-2020; del Peso, Luis/K-9391-2014; Villar, Diego/K-8595-2017; García-Bermejo, María Laura/E-1542-2015	del Peso, Luis/0000-0003-4014-5688; Villar, Diego/0000-0002-8614-6232; García-Bermejo, María Laura/0000-0002-8167-2276; Vazquez Cuesta, Silvia Noemi/0000-0002-9065-9487; Garcia-Rocha, Mar/0000-0003-2467-2090; Cifuentes Buira, Daniel/0000-0001-5442-4843	Ministerio de Ciencia y Tecnologia/Ministerio de Ciencia e Innovacion [SAF2005-00180, SAF2008-03147, SAF2004-0824]; Red Cardiovascular (RECAVA); Comunidad Autonoma de Madrid [S-SAL-0311_2006]	Ministerio de Ciencia y Tecnologia/Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Cardiovascular (RECAVA); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by grants from Ministerio de Ciencia y Tecnologia/Ministerio de Ciencia e Innovacion (SAF2005-00180 and SAF2008-03147 to L. P. and SAF2004-0824 to M. O. L.), Red Cardiovascular (RECAVA) and Comunidad Autonoma de Madrid (S-SAL-0311_2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Gutmann I., 1974, METHODS ENZYMATIC AN; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KEIKO NT, 1997, EUROPEAN J BIOCH, V246, P486; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Mamedova LK, 2003, MOL CELL BIOCHEM, V250, P11, DOI 10.1023/A:1024980710799; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sridharan V, 2007, AM J PHYSIOL-CELL PH, V292, pC719, DOI 10.1152/ajpcell.00100.2006; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vigoda A, 2003, MOL CELL BIOCHEM, V254, P311, DOI 10.1023/A:1027302021428; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhao JH, 2004, TOXICOL APPL PHARM, V196, P404, DOI 10.1016/j.taap.2004.01.012	38	175	183	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9644	10.1371/journal.pone.0009644	http://dx.doi.org/10.1371/journal.pone.0009644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300197	Green Published, gold			2022-12-27	WOS:000275620900002
J	Le Jeune, A; Torelli, R; Sanguinetti, M; Giard, JC; Hartke, A; Auffray, Y; Benachour, A				Le Jeune, Andre; Torelli, Riccardo; Sanguinetti, Maurizio; Giard, Jean-Christophe; Hartke, Axel; Auffray, Yanick; Benachour, Abdellah			The Extracytoplasmic Function Sigma Factor SigV Plays a Key Role in the Original Model of Lysozyme Resistance and Virulence of Enterococcus faecalis	PLOS ONE			English	Article							PEPTIDOGLYCAN O-ACETYLTRANSFERASE; N-ACETYLGLUCOSAMINE DEACETYLASE; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; LACTOCOCCUS-LACTIS; TEICHOIC-ACIDS; ANTIMICROBIAL PEPTIDES; LIPOTEICHOIC ACID; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE	Background: Enterococcus faecalis is one of the leading agents of nosocomial infections. To cause diseases, pathogens or opportunistic bacteria have to adapt and survive to the defense systems encountered in the host. One of the most important compounds of the host innate defense response against invading microorganisms is lysozyme. It is found in a wide variety of body fluids, as well as in cells of the innate immune system. Lysozyme could act either as a muramidase and/or as a cationic antimicrobial peptide. Like Staphylococcus aureus, E. faecalis is one of the few bacteria that are completely lysozyme resistant. Results: This study revealed that oatA (O-acetyl transferase) and dlt (D-Alanylation of lipoteicoic acids) genes contribute only partly to the lysozyme resistance of E. faecalis and that a specific transcriptional regulator, the extracytoplasmic function SigV sigma factor plays a key role in this event. Indeed, the sigV single mutant is as sensitive as the oatA/dltA double mutant, and the sigV/oatA/dltA triple mutant displays the highest level of lysozyme sensitivity suggesting synergistic effects of these genes. In S. aureus, mutation of both oatA and dlt genes abolishes completely the lysozyme resistance, whereas this is not the case in E. faecalis. Interestingly SigV does not control neither oatA nor dlt genes. Moreover, the sigV mutants clearly showed a reduced capacity to colonize host tissues, as they are significantly less recovered than the parental JH2-2 strain from organs of mice subjected to intravenous or urinary tract infections. Conclusions: This work led to the discovery of an original model of lysozyme resistance mechanism which is obviously more complex than those described for other Gram positive pathogens. Moreover, our data provide evidences for a direct link between lysozyme resistance and virulence of E. faecalis.	[Le Jeune, Andre; Giard, Jean-Christophe; Hartke, Axel; Auffray, Yanick; Benachour, Abdellah] Univ Caen Basse Normandie, USC INRA 2017, EA956, Lab Microbiol Environm, Caen, France; [Torelli, Riccardo; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy	INRAE; Universite de Caen Normandie; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Le Jeune, A (corresponding author), Univ Caen Basse Normandie, USC INRA 2017, EA956, Lab Microbiol Environm, Caen, France.	abdellah.benachour@unicaen.fr	Torelli, Riccardo/K-8822-2018; Sanguinetti, Maurizio/A-1453-2019; Torelli, Riccardo/N-8813-2019	Torelli, Riccardo/0000-0001-7927-4343; Sanguinetti, Maurizio/0000-0002-9780-7059; giard, jean-christophe/0000-0001-8588-2732	Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche [ANR-06-PATHO-008-01]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	A. Le Jeune is funded by a thesis grant awarded by the Ministere de l'Enseignement Superieur et de la Recherche. This study was partly supported by grants of the Agence Nationale de la Recherche in the frame of a trans-national ERA-NET PathoGenomics program (ANR-06-PATHO-008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; BATISH VK, 1984, NEW ZEAL J DAIRY SCI, V19, P189; Benachour A, 2005, J BACTERIOL, V187, P1022, DOI 10.1128/JB.187.3.1022-1035.2005; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Binks MJ, 2005, J BIOL CHEM, V280, P20120, DOI 10.1074/jbc.M414194200; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Cox KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005366; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; DEVRIESE LA, 1992, J APPL BACTERIOL, V72, P29, DOI 10.1111/j.1365-2672.1992.tb04877.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Franz CMAP, 2003, INT J FOOD MICROBIOL, V88, P105, DOI 10.1016/S0168-1605(03)00174-0; FRERE J, 1993, CURR MICROBIOL, V27, P97, DOI 10.1007/BF01570865; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; Giaouris E, 2008, APPL ENVIRON MICROB, V74, P4764, DOI 10.1128/AEM.00078-08; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Ibrahim HR, 2002, CURR PHARM DESIGN, V8, P671, DOI 10.2174/1381612023395349; Kak V, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P355; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; LAIBLE NJ, 1985, INFECT IMMUN, V48, P720, DOI 10.1128/IAI.48.3.720-728.1985; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; MANSON JM, 2006, PATHOGENOMICS, P125; MASON DY, 1975, J CLIN PATHOL, V28, P124, DOI 10.1136/jcp.28.2.124; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; REED LJ, 1938, AM J HYG, V27; Sambrook J., 2002, MOL CLONING LAB MANU; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; YAGI Y, 1980, J BACTERIOL, V143, P966, DOI 10.1128/JB.143.2.966-970.1980; Yother J, 2002, J BACTERIOL, V184, P6085, DOI 10.1128/JB.184.22.6085-6092.2002	59	56	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9658	10.1371/journal.pone.0009658	http://dx.doi.org/10.1371/journal.pone.0009658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300180	Green Submitted, gold, Green Published			2022-12-27	WOS:000275620600013
J	Du, WG; Zhao, B; Shine, R				Du, Wei-Guo; Zhao, Bo; Shine, Richard			Embryos in the Fast Lane: High-Temperature Heart Rates of Turtles Decline After Hatching	PLOS ONE			English	Article							CHELYDRA-SERPENTINA; OXYGEN-CONSUMPTION; CHRYSEMYS-PICTA; LIZARD EMBRYOS; METABOLIC-RATE; INCUBATION; MECHANISMS; REPTILES; BASKING; SCRIPTA	In ectotherms such as turtles, the relationship between cardiovascular function and temperature may be subject to different selective pressures in different life-history stages. Because embryos benefit by developing as rapidly as possible, and can "afford" to expend energy to do so (because they have access to the yolk for nutrition), they benefit from rapid heart (and thus, developmental) rates. In contrast, hatchlings do not have a guaranteed food supply, and maximal growth rates may not enhance fitness-and so, we might expect a lower heart rate, especially at high temperatures where metabolic costs are greatest. Our data on two species of emydid turtles, Chrysemys picta, and Graptemys pseudogeographica kohnii, support these predictions. Heart rates of embryos and hatchlings were similar at low temperatures, but heart rates at higher temperatures were much greater before than after hatching.	[Du, Wei-Guo; Zhao, Bo] Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Du, Wei-Guo; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Hangzhou Normal University; University of Sydney	Du, WG (corresponding author), Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	dwghz@126.com	Du, Wei-Guo/K-1071-2014		Natural Science Foundation of China [30970362]; University of Sydney	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Sydney(University of Sydney)	Natural Science Foundation of China (30970362). The University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P573, DOI 10.1086/501062; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2001, ECOLOGY, V82, P3044, DOI 10.1890/0012-9658(2001)082[3044:TAPCOE]2.0.CO;2; Ar A, 1999, COMP BIOCHEM PHYS A, V124, P491, DOI 10.1016/S1095-6433(99)00142-7; Birchard GF, 1996, J COMP PHYSIOL B, V166, P461, DOI 10.1007/s003600050033; Birchard GF, 2000, J THERM BIOL, V25, P287, DOI 10.1016/S0306-4565(99)00100-X; BOBYN ML, 1994, CAN J ZOOL, V72, P28, DOI 10.1139/z94-005; Booth DT, 2000, AUST J ZOOL, V48, P369, DOI 10.1071/ZO00055; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Clark TD, 2006, FUNCT ECOL, V20, P105, DOI 10.1111/j.1365-2435.2006.01066.x; Coleman JL, 2008, CHELONIAN CONSERV BI, V7, P276, DOI 10.2744/CCB-0708.1; Crossley DA, 2003, J EXP BIOL, V206, P2703, DOI 10.1242/jeb.00476; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Dzialowski EM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P679, DOI 10.1086/322929; Ernst CH, 2009, TURTLES US CANADA; Ewert M.A., 1985, Biology of Reptilia, V14, P75; Galli G, 2004, J EXP BIOL, V207, P1471, DOI 10.1242/jeb.00912; GATTEN RE, 1974, COMP BIOCHEM PHYSIOL, V48, P619, DOI 10.1016/0300-9629(74)90606-9; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grayson KL, 2004, HERPETOLOGICA, V60, P325, DOI 10.1655/03-43; Huey R. B., 1996, ANIMALS TEMPERATURE, P205; Ji X, 2000, HERPETOL J, V10, P13; Morjan CL, 2003, BEHAV ECOL SOCIOBIOL, V53, P254, DOI 10.1007/s00265-002-0570-3; Nagle RD, 1998, COMP BIOCHEM PHYS B, V120, P145, DOI 10.1016/S0305-0491(98)10003-2; Nechaeva MV, 2007, COMP BIOCHEM PHYS A, V148, P599, DOI 10.1016/j.cbpa.2007.08.005; Olsson M, 2002, EVOLUTION, V56, P1867; Overgaard J, 2007, J EXP BIOL, V210, P1687, DOI 10.1242/jeb.001925; Pearson JT, 1999, J COMP PHYSIOL B, V169, P256, DOI 10.1007/s003600050219; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; Pough E. H., 1998, HERPETOLOGY; Radder R, 2006, BIOL LETTERS, V2, P415, DOI 10.1098/rsbl.2006.0495; Seebacher F, 2005, J COMP PHYSIOL B, V175, P533, DOI 10.1007/s00360-005-0007-1; Tazawa H, 2005, AVIAN POULT BIOL REV, V16, P123, DOI 10.3184/147020605783437977; VOIGT WG, 1975, COMP BIOCHEM PHYS A, V52, P527, DOI 10.1016/S0300-9629(75)80076-4; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9	35	13	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9557	10.1371/journal.pone.0009557	http://dx.doi.org/10.1371/journal.pone.0009557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224773	Green Published, gold			2022-12-27	WOS:000275328800008
J	Tang, JM; Malhotra, R; Song, W; Brill, I; Hu, LY; Farmer, PK; Mulenga, J; Allen, S; Hunter, E; Kaslow, RA				Tang, Jianming; Malhotra, Rakhi; Song, Wei; Brill, Ilene; Hu, Liangyuan; Farmer, Paul K.; Mulenga, Joseph; Allen, Susan; Hunter, Eric; Kaslow, Richard A.			Human Leukocyte Antigens and HIV Type 1 Viral Load in Early and Chronic Infection: Predominance of Evolving Relationships	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR HISTOCOMPATIBILITY COMPLEX; CELL-SURFACE EXPRESSION; CLASS-I ALLELES; HLA-C ALLELES; HETEROSEXUAL TRANSMISSION; DISCORDANT COUPLES; IMMUNOLOGICAL CONTROL; GAG; ASSOCIATION	Background: During untreated, chronic HIV-1 infection, plasma viral load (VL) is a relatively stable quantitative trait that has clinical and epidemiological implications. Immunogenetic research has established various human genetic factors, especially human leukocyte antigen (HLA) variants, as independent determinants of VL set-point. Methodology/Principal Findings: To identify and clarify HLA alleles that are associated with either transient or durable immune control of HIV-1 infection, we evaluated the relationships of HLA class I and class II alleles with VL among 563 seroprevalent Zambians (SPs) who were seropositive at enrollment and 221 seroconverters (SCs) who became seropositive during quarterly follow-up visits. After statistical adjustments for non-genetic factors (sex and age), two unfavorable alleles (A*3601 and DRB1*0102) were independently associated with high VL in SPs (p < 0.01) but not in SCs. In contrast, favorable HLA variants, mainly A*74, B*13, B*57 (or Cw*18), and one HLA-A and HLA-C combination (A*30+Cw*03), dominated in SCs; their independent associations with low VL were reflected in regression beta estimates that ranged from 20.47+/-0.23 to 20.92+/-0.32 log(10) in SCs (p < 0.05). Except for Cw*18, all favorable variants had diminishing or vanishing association with VL in SPs (p <= 0.86). Conclusions/Significance: Overall, each of the three HLA class I genes had at least one allele that might contribute to effective immune control, especially during the early course of HIV-1 infection. These observations can provide a useful framework for ongoing analyses of viral mutations induced by protective immune responses.	[Tang, Jianming; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Malhotra, Rakhi; Song, Wei; Brill, Ilene; Hu, Liangyuan; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Farmer, Paul K.; Hunter, Eric] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA; [Mulenga, Joseph; Allen, Susan] Rwanda Zambia HIV 1 Res Grp, Lusaka, Zambia; [Allen, Susan] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University	Tang, JM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	jtang@uab.edu; rkaslow@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486	National Institute of Allergy and Infectious Diseases (NIAID) [AI040951, AI071906, AI064060, AI76123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071906, R01AI040951, R01AI064060, K02AI076123] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID), through grants AI040951 (to S. A.), AI071906 (to R. A. K.), and AI064060 (to E. H). J.T. is the recipient of an Independent Scientist Award (AI76123) from NIAID. The funders had no role in study design, data collection, data analyses, decision to publish, or preparation of this manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brumme Z, 2009, CLIN INFECT DIS, V49, P956, DOI 10.1086/605503; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DORAK MT, 2002, ASS HLA B22 INCREASE; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; HANSEN JA, 2006, IMMUNOBIOLOGY HUMAN, P1551; Harrer EG, 2005, AIDS, V19, P734, DOI 10.1097/01.aids.0000166099.36638.56; Hendel H, 1999, J IMMUNOL, V162, P6942; Holdsworth R, 2009, TISSUE ANTIGENS, V73, P95, DOI 10.1111/j.1399-0039.2008.01183.x; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Honeyborne I, 2006, J IMMUNOL, V176, P4699, DOI 10.4049/jimmunol.176.8.4699; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hughes AL, 2002, IMMUNOL REV, V190, P161, DOI 10.1034/j.1600-065X.2002.19012.x; IDAGHDOUR Y, 2009, NAT GENET; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kulkarni S, 2008, AIDS RES HUM RETROV, V24, P1159, DOI 10.1089/aid.2007.0296; LAZARYAN A, 2010, J VIROL IN PRESS; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li YF, 2009, HUM GENET, V126, P685, DOI 10.1007/s00439-009-0720-z; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MacDonald KS, 2001, IMMUNOL LETT, V79, P151, DOI 10.1016/S0165-2478(01)00277-2; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mann DL, 1998, J INFECT DIS, V178, P1799, DOI 10.1086/314519; Marsh SGE, 2005, HUM IMMUNOL, V66, P571, DOI 10.1016/j.humimm.2005.02.002; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Pellegrin I, 1996, J ACQ IMMUN DEF SYND, V11, P438, DOI 10.1097/00042560-199604150-00003; Prado JG, 2009, J VIROL, V83, P1018, DOI 10.1128/JVI.01882-08; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramduth D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005013; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Romero V, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-14; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schreuder GMT, 2005, HUM IMMUNOL, V66, P170, DOI 10.1016/j.humimm.2004.09.017; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Smith WP, 2006, GENOMICS, V87, P561, DOI 10.1016/j.ygeno.2005.11.020; Song W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007157; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang Jianming, 2003, AIDS, V17 Suppl 4, pS51, DOI 10.1097/00002030-200317004-00006; Tang JM, 2004, J INFECT DIS, V189, P1696, DOI 10.1086/383280; Tang JM, 2002, AIDS, V16, P2275, DOI 10.1097/00002030-200211220-00007; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Treurnicht FK, 2010, VIROLOGY, V396, P213, DOI 10.1016/j.virol.2009.10.002; Yu XG, 2007, J VIROL, V81, P1619, DOI 10.1128/JVI.01580-06; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x	83	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9629	10.1371/journal.pone.0009629	http://dx.doi.org/10.1371/journal.pone.0009629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224785	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800024
J	Caron, JB; Morris, SC; Shu, DG				Caron, Jean-Bernard; Morris, Simon Conway; Shu, Degan			Tentaculate Fossils from the Cambrian of Canada (British Columbia) and China (Yunnan) Interpreted as Primitive Deuterostomes	PLOS ONE			English	Article							XENOTURBELLA-BOCKI; 18S RDNA; PHYLOGENY; ECHINODERMATA; HOLOTHUROIDEA; DIVERSITY; EVOLUTION; TUNICATE; ANIMALS; ORIGINS	Molecular and morphological evidence unite the hemichordates and echinoderms as the Ambulacraria, but their earliest history remains almost entirely conjectural. This is on account of the morphological disparity of the ambulacrarians and a paucity of obvious stem-groups. We describe here a new taxon Herpetogaster collinsi gen. et sp. nov. from the Burgess Shale (Middle Cambrian) Lagerstatte. This soft-bodied vermiform animal has a pair of elongate dendritic oral tentacles, a flexible stolon with an attachment disc, and a re-curved trunk with at least 13 segments that is directed dextrally. A differentiated but un-looped gut is enclosed in a sac suspended by mesenteries. It consists of a short pharynx, a conspicuous lenticular stomach, followed by a narrow intestine sub-equal in length. This new taxon, together with the Lower Cambrian Phlogites and more intriguingly the hitherto enigmatic discoidal eldoniids (Cambrian-Devonian), form a distinctive clade (herein the cambroernids). Although one hypothesis of their relationships would look to the lophotrochozoans (specifically the entoprocts), we suggest that the evidence is more consistent with their being primitive deuterostomes, with specific comparisons being made to the pterobranch hemichordates and pre-radial echinoderms. On this basis some of the earliest ambulacrarians are interpreted as soft-bodied animals with a muscular stalk, and possessing prominent tentacles.	[Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Shu, Degan] Northwest Univ, Early Life Inst & Key Lab Continental Dynam, Xian, Peoples R China	Royal Ontario Museum; University of Cambridge; Northwest University Xi'an	Caron, JB (corresponding author), Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada.	jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	Natural Sciences and Engineering Research Council of Canada Discovery; Evolutionary Biology Department at the University of Toronto; Royal Society, Cowper Reed Fund; St. John's College, Cambridge (SCM); Natural Science Foundation of China [40830208]	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Evolutionary Biology Department at the University of Toronto; Royal Society, Cowper Reed Fund(Royal Society of London); St. John's College, Cambridge (SCM); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by Natural Sciences and Engineering Research Council of Canada Discovery Grant (J-BC) through the Ecology and Evolutionary Biology Department at the University of Toronto, and the Royal Society, Cowper Reed Fund and St. John's College, Cambridge (SCM), and the Natural Science Foundation of China (Grant No. 40830208), MOST Special Fund from the State Key Laboratory of Continental Dynamics in Northwest University (DGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FE, 2004, J MOL EVOL, V58, P252, DOI 10.1007/s00239-003-2548-9; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Chen JY, 2009, INT J DEV BIOL, V53, P733, DOI 10.1387/ijdb.072513cj; Chen Jun-Yuan, 1995, Acta Palaeontologica Polonica, V40, P213; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; Clark AH, 1913, AM NAT, V47, P488, DOI 10.1086/279367; Clark HL, 1912, SCIENCE, V35, P274, DOI 10.1126/science.35.894.274-a; Cohen BL, 2005, ORG DIVERS EVOL, V5, P253, DOI 10.1016/j.ode.2004.12.002; DEVEREUX MG, 2001, THESIS U W ONTARIO, P196; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; DURHAM JW, 1974, J PALEONTOL, V48, P750; Dzik J., 1991, P47; Dzik J, 1997, PALAEONTOLOGY, V40, P385; Ehlers U, 1997, ZOOMORPHOLOGY, V117, P71; Fritzsch G, 2008, J EXP ZOOL PART B, V310B, P278, DOI 10.1002/jez.b.21208; Gilliland P.M., 1993, Special Papers in Palaeontology, V47, P1; Glenner H, 2004, CURR BIOL, V14, P1644, DOI 10.1016/j.cub.2004.09.027; Gould S. J., 1989, WONDERFUL LIFE BURGE; Halanych KM, 1996, BIOL BULL-US, V190, P1, DOI 10.2307/1542669; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hou GG, 2006, GFF, V128, P47; Hyman L.H., 1959, INVERTEBRATES; Israelsson O, 1999, P ROY SOC B-BIOL SCI, V266, P835, DOI 10.1098/rspb.1999.0713; Jenner RA, 2008, PHILOS T R SOC B, V363, P1503, DOI 10.1098/rstb.2007.2240; Kerr AM, 2001, ZOOL J LINN SOC-LOND, V133, P63, DOI 10.1006/zjls.2000.0280; LUO H., 1999, EARLY CAMBRIAN CHENG; MADSEN FJ, 1957, J PALEONTOL, V31, P281; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; MILLAR CI, 1990, FOREST ECOL MANAG, V35, P1, DOI 10.1016/0378-1127(90)90227-3; MORRIS S C, 1977, Palaeontology (Oxford), V20, P833; MORRIS SC, 1979, ANNU REV ECOL SYST, V10, P327, DOI 10.1146/annurev.es.10.110179.001551; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Perseke M, 2007, THEOR BIOSCI, V126, P35, DOI 10.1007/s12064-007-0007-7; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Rahman IA, 2009, ZOOL J LINN SOC-LOND, V157, P420, DOI 10.1111/j.1096-3642.2008.00517.x; REISINGER ERICH, 1960, ZEITSCHR WISS ZOOL, V164, P188; Rickards R. B., 2006, STUDIES PALAEOZOIC P, V25, P5; RUEDEMANN RUDOLF, 1931, PROC U S NATION MUS, V79, P1; Sato A, 2008, LETHAIA, V41, P303, DOI 10.1111/j.1502-3931.2008.00123.x; Shen X, 2009, GENE, V439, P79, DOI 10.1016/j.gene.2009.03.008; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu DG, 2003, SCIENCE, V299, P1380, DOI 10.1126/science.1079846; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; SMITH AB, 1988, ECHIPODEAN PHYLOGENY, P87; Smith AB, 2008, EVOL DEV, V10, P493, DOI 10.1111/j.1525-142X.2008.00260.x; Sroka Steven D., 1997, P270; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; TODD JA, 1992, NATURWISSENSCHAFTEN, V79, P311, DOI 10.1007/BF01138708; UBAGHS G, 1967, TREATISE INVERTEBRAT, pS565; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; Wasson K, 2002, T ROY SOC SOUTH AUST, V126, P1; Witek A, 2009, MOL PHYLOGENET EVOL, V53, P1037, DOI 10.1016/j.ympev.2009.07.031; Yokobori S, 2008, MOL PHYLOGENET EVOL, V47, P612, DOI 10.1016/j.ympev.2008.02.013; Zhu MY, 2002, GEOBIOS-LYON, V35, P165, DOI 10.1016/S0016-6995(02)00025-6	67	52	54	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A189	A201	e9586	10.1371/journal.pone.0009586	http://dx.doi.org/10.1371/journal.pone.0009586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221405	gold, Green Published			2022-12-27	WOS:000275328200018
J	Das, ND; Jung, KH; Chai, YG				Das, Nando Dulal; Jung, Kyoung Hwa; Chai, Young Gyu			The Role of NF-kappa B and H3K27me3 Demethylase, Jmjd3, on the Anthrax Lethal Toxin Tolerance of RAW 264.7 Cells	PLOS ONE			English	Article							HISTONE H3; MURINE MACROPHAGES; SIGNALING PATHWAY; UP-REGULATION; DIFFERENTIATION; SUSCEPTIBILITY; RESPONSES; RECEPTOR	Background: In Bacillus anthracis, lethal toxin (LeTx) is a critical virulence factor that causes immune suppression and toxic shock in the infected host. NF-kappa B is a key mediator of the inflammatory response and is crucial for the plasticity of first level immune cells such as macrophages, monocytes and neutrophils. In macrophages, this inflammatory response, mediated by NF-kappa B, can regulate host defense against invading pathogens. A Jumonji C family histone 3 lysine-27 (H3K27) demethylase, Jmjd3, plays a crucial role in macrophage plasticity and inflammation. Here we report that NF-kappa B and Jmjd3 can modulate the LeTx intoxication resistance of RAW 264.7 cells. Principal Findings: This study showed that a 2 h exposure of macrophages to LeTx caused substantial cell death with a survival rate of around 40%. The expression of the Jmjd3 gene was induced 8-fold in intoxication-resistant cells generated by treatment with lipopolysaccharides of RAW 264.7 cells. These intoxication-resistant cell lines (PLx intox and PLxL intox) were maintained for 8 passages and had a survival rate of around 100% on secondary exposure to LeTx and lipopolysaccharides. Analysis of NF-kappa B gene expression showed that the expression of p100, p50 and p65 was induced around 20, 7 and 4 fold, respectively, in both of the intoxication-resistant cell lines following a 2 h treatment with PLxL (0.1+0.1+1 mu g/ml). In contrast, these NF-kappa B genes were not induced following treatment with PLx treatment at the same concentrations. Conclusions: Although LeTx influences macrophage physiology and causes defects of some key signaling pathways such as GSK3b which contributes to cytotoxicity, these results indicate that modulation of NF-kappa B by p50, p100 and Jmjd3 could be vital for the recovery of murine macrophages from exposure to the anthrax lethal toxin.	[Das, Nando Dulal; Jung, Kyoung Hwa; Chai, Young Gyu] Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea	Hanyang University	Das, ND (corresponding author), Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea.	ygchai@hanyang.ac.kr		Das, Nando/0000-0001-7537-4021	Ministry of Education, Science and Technology, Republic of Korea [2009-0077023]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This project was performed under the Basic Science Research Program (2009-0077023) of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Baik SY, 2005, NEUROSCI LETT, V374, P53, DOI 10.1016/j.neulet.2004.10.047; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Comer JE, 2005, INFECT IMMUN, V73, P1879, DOI 10.1128/IAI.73.3.1879-1885.2005; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Ha SD, 2007, J BIOL CHEM, V282, P36230, DOI 10.1074/jbc.M707622200; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung KH, 2008, BBA-PROTEINS PROTEOM, V1784, P1501, DOI 10.1016/j.bbapap.2008.06.016; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rmali KA, 2004, INT J MOL MED, V14, P75; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Volmat V, 2001, J CELL SCI, V114, P3433; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Ziegler-Heitbrock L, 2001, J ENDOTOXIN RES, V7, P219, DOI 10.1177/09680519010070030401	34	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9913	10.1371/journal.pone.0009913	http://dx.doi.org/10.1371/journal.pone.0009913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360974	Green Published, Green Submitted, gold			2022-12-27	WOS:000276163100008
J	Jakobsson, HE; Jernberg, C; Andersson, AF; Sjolund-Karlsson, M; Jansson, JK; Engstrand, L				Jakobsson, Hedvig E.; Jernberg, Cecilia; Andersson, Anders F.; Sjolund-Karlsson, Maria; Jansson, Janet K.; Engstrand, Lars			Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; HELICOBACTER-PYLORI; INTESTINAL MICROFLORA; MACROLIDE RESISTANCE; CLARITHROMYCIN; GENES; POPULATIONS; PERSISTENCE; DIVERSITY	Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer. However, the long-term consequences of this treatment on the human indigenous microbiota are relatively unexplored. Here we studied short-and long-term effects of clarithromycin and metronidazole treatment, a commonly used therapy regimen against H. pylori, on the indigenous microbiota in the throat and in the lower intestine. The bacterial compositions in samples collected over a four-year period were monitored by analyzing the 16S rRNA gene using 454-based pyrosequencing and terminal-restriction fragment length polymorphism (T-RFLP). While the microbial communities of untreated control subjects were relatively stable over time, dramatic shifts were observed one week after antibiotic treatment with reduced bacterial diversity in all treated subjects in both locations. While the microbiota of the different subjects responded uniquely to the antibiotic treatment some general trends could be observed; such as a dramatic decline in Actinobacteria in both throat and feces immediately after treatment. Although the diversity of the microbiota subsequently recovered to resemble the pre treatment states, the microbiota remained perturbed in some cases for up to four years post treatment. In addition, four years after treatment high levels of the macrolide resistance gene erm(B) were found, indicating that antibiotic resistance, once selected for, can persist for longer periods of time than previously recognized. This highlights the importance of a restrictive antibiotic usage in order to prevent subsequent treatment failure and potential spread of antibiotic resistance.	[Jakobsson, Hedvig E.; Jernberg, Cecilia; Andersson, Anders F.; Sjolund-Karlsson, Maria; Engstrand, Lars] Swedish Inst Infect Dis, Dept Bacteriol, Solna, Sweden; [Jakobsson, Hedvig E.; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.] Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden; [Jansson, Janet K.] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Ecol, Berkeley, CA 94720 USA	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Uppsala University; Swedish University of Agricultural Sciences; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jakobsson, HE (corresponding author), Swedish Inst Infect Dis, Dept Bacteriol, Solna, Sweden.	lars.engstrand@smi.se	Andersson, Anders/J-9310-2019; Jansson, Janet/H-5478-2018	Andersson, Anders/0000-0002-3627-6899; Jansson, Janet/0000-0002-5487-4315	Ekhaga foundation; Soderberg foundation; U. S. Department of Energy [DE-AC02-05CH11231]	Ekhaga foundation; Soderberg foundation; U. S. Department of Energy(United States Department of Energy (DOE))	The Ekhaga foundation and the Soderberg foundation, and in part by the U. S. Department of Energy Contact DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Adamsson I, 1999, J ANTIMICROB CHEMOTH, V44, P629, DOI 10.1093/jac/44.5.629; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Buhling A, 2001, ALIMENT PHARM THER, V15, P1445, DOI 10.1046/j.1365-2036.2001.01033.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; Cresti S, 2002, ANTIMICROB AGENTS CH, V46, P1816, DOI 10.1128/AAC.46.6.1816-1822.2002; de Boer WA, 2000, BRIT MED J, V320, P31, DOI 10.1136/bmj.320.7226.31; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Donskey CJ, 2003, J MICROBIOL METH, V54, P249, DOI 10.1016/S0167-7012(03)00059-9; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Graham DY, 2000, GASTROENTEROLOGY, V118, pS2, DOI 10.1016/S0016-5085(00)70003-5; Guarner F, 2006, DIGESTION, V73, P5, DOI 10.1159/000089775; HAYEK LC, 1996, SURVEYING NATURAL PO; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Jakobsson H, 2007, SCAND J INFECT DIS, V39, P757, DOI 10.1080/00365540701299608; Jernberg C, 2005, APPL ENVIRON MICROB, V71, P501, DOI 10.1128/AEM.71.1.501-506.2005; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jonsson M, 2005, INT J ANTIMICROB AG, V25, P68, DOI 10.1016/j.ijantimicag.2004.08.011; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Krogius-Kurikka L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-68; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; ROUND JL, 2009, NAT REV IMMUNOL; Sjolund M, 2005, EMERG INFECT DIS, V11, P1389; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Tanaka J, 2005, J MED MICROBIOL, V54, P309, DOI 10.1099/jmm.0.45814-0; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMS JD, 1992, J ANTIMICROB CHEMOTH, V30, P27, DOI 10.1093/jac/30.1.27; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	45	710	757	4	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9836	10.1371/journal.pone.0009836	http://dx.doi.org/10.1371/journal.pone.0009836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352091	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894500009
J	Hadano, S; Otomo, A; Kunita, R; Suzuki-Utsunomiya, K; Akatsuka, A; Koike, M; Aoki, M; Uchiyama, Y; Itoyama, Y; Ikeda, JE				Hadano, Shinji; Otomo, Asako; Kunita, Ryota; Suzuki-Utsunomiya, Kyoko; Akatsuka, Akira; Koike, Masato; Aoki, Masashi; Uchiyama, Yasuo; Itoyama, Yasuto; Ikeda, Joh-E			Loss of ALS2/Alsin Exacerbates Motor wDysfunction in a SOD1(H46R)-Expressing Mouse ALS Model by Disturbing Endolysosomal Trafficking	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ASCENDING SPASTIC PARALYSIS; NUCLEOTIDE EXCHANGE FACTOR; INFANTILE-ONSET; SUPEROXIDE-DISMUTASE; ENDOSOME TRAFFICKING; NEURON DEGENERATION; BULBAR INVOLVEMENT; TRANSGENIC MICE; SITE MUTATION	Background: ALS2/alsin is a guanine nucleotide exchange factor for the small GTPase Rab5 and involved in macropinocytosis-associated endosome fusion and trafficking, and neurite outgrowth. ALS2 deficiency accounts for a number of juvenile recessive motor neuron diseases (MNDs). Recently, it has been shown that ALS2 plays a role in neuroprotection against MND-associated pathological insults, such as toxicity induced by mutant Cu/Zn superoxide dismutase (SOD1). However, molecular mechanisms underlying the relationship between ALS2-associated cellular function and its neuroprotective role remain unclear. Methodology/Principal Findings: To address this issue, we investigated the molecular and pathological basis for the phenotypic modification of mutant SOD1-expressing mice by ALS2 loss. Genetic ablation of Als2 in SOD1(H46R), but not SOD1(G93A), transgenic mice aggravated the mutant SOD1-associated disease symptoms such as body weight loss and motor dysfunction, leading to the earlier death. Light and electron microscopic examinations revealed the presence of degenerating and/or swollen spinal axons accumulating granular aggregates and autophagosome-like vesicles in early-and even pre-symptomatic SOD1(H46R) mice. Further, enhanced accumulation of insoluble high molecular weight SOD1, poly-ubiquitinated proteins, and macroautophagy-associated proteins such as polyubiquitin-binding protein p62/SQSTM1 and a lipidated form of light chain 3 (LC3-II), emerged in ALS2-deficient SOD1(H46R) mice. Intriguingly, ALS2 was colocalized with LC3 and p62, and partly with SOD1 on autophagosome/endosome hybrid compartments, and loss of ALS2 significantly lowered the lysosome-dependent clearance of LC3 and p62 in cultured cells. Conclusions/Significance: Based on these observations, although molecular basis for the distinctive susceptibilities to ALS2 loss in different mutant SOD1-expressing ALS models is still elusive, disturbance of the endolysosomal system by ALS2 loss may exacerbate the SOD1(H46R)-mediated neurotoxicity by accelerating the accumulation of immature vesicles and misfolded proteins in the spinal cord. We propose that ALS2 is implicated in endolysosomal trafficking through the fusion between endosomes and autophagosomes, thereby regulating endolysosomal protein degradation in vivo.	[Hadano, Shinji; Ikeda, Joh-E] Tokai Univ, Grad Sch Med, Neurodegenerat Dis Res Ctr, Kanagawa 2591100, Japan; [Hadano, Shinji; Otomo, Asako; Kunita, Ryota; Suzuki-Utsunomiya, Kyoko; Ikeda, Joh-E] Tokai Univ, Dept Mol Life Sci, Sch Med, Kanagawa 2591100, Japan; [Hadano, Shinji; Ikeda, Joh-E] Tokai Univ, Inst Med Sci, Kanagawa 2591100, Japan; [Akatsuka, Akira] Tokai Univ, Teaching & Res Support Ctr, Kanagawa 2591100, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 113, Japan; [Aoki, Masashi; Itoyama, Yasuto] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Ikeda, Joh-E] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	Tokai University; Tokai University; Tokai University; Tokai University; Juntendo University; Tohoku University; University of Ottawa; Children's Hospital of Eastern Ontario	Hadano, S (corresponding author), Tokai Univ, Grad Sch Med, Neurodegenerat Dis Res Ctr, Kanagawa 2591100, Japan.	shinji@is.icc.u-tokai.ac.jp; jei@m.med.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019; Koike, Masato/F-9584-2010; Hadano, Shinji/ABA-5052-2021	Otomo, Asako/0000-0002-7849-4309; Koike, Masato/0000-0002-3174-5684; Hadano, Shinji/0000-0002-4997-3968	Japan Society for the Promotion of Science; Japan Brain Foundation (SH), The Ichiro Kanehara Foundation; Tokai University School of Medicine Research Aid; Tokai University School of Medicine Project Research; Tokai University General Research Organization; Ministry of Health, Labour and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Brain Foundation (SH), The Ichiro Kanehara Foundation; Tokai University School of Medicine Research Aid; Tokai University School of Medicine Project Research; Tokai University General Research Organization; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (SH), Japan Brain Foundation (SH), The Ichiro Kanehara Foundation (SH), a Tokai University School of Medicine Research Aid (SH), a Tokai University School of Medicine Project Research (SH), and a Research Aid from the Tokai University General Research Organization ( SH). This work was also supported in part by the Ministry of Health, Labour and Welfare (JEI). AO, RK, and KSU receive support for a Tokai University School of Medicine Research Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; BENHAMIDA M, 1990, BRAIN, V113, P347; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cai HB, 2005, J NEUROSCI, V25, P7567, DOI 10.1523/JNEUROSCI.1645-05.2005; Cai HB, 2008, NEURODEGENER DIS, V5, P359, DOI 10.1159/000151295; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Deng HX, 2007, HUM MOL GENET, V16, P2911, DOI 10.1093/hmg/ddm251; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herzfeld T, 2009, NEUROGENETICS, V10, P59, DOI 10.1007/s10048-008-0148-y; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jacquier A, 2009, HUM MOL GENET, V18, P2127, DOI 10.1093/hmg/ddp136; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lai C, 2006, J NEUROSCI, V26, P11798, DOI 10.1523/JNEUROSCI.2084-06.2006; Lai C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-23; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; LermanSagie T, 1996, J CHILD NEUROL, V11, P54, DOI 10.1177/088307389601100114; Lin X, 2007, NEUROBIOL AGING, V28, P1628, DOI 10.1016/j.neurobiolaging.2006.07.014; Mintchev N, 2009, NEUROLOGY, V72, P28, DOI 10.1212/01.wnl.0000338530.77394.60; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otomo A, 2008, BIOCHEM BIOPH RES CO, V370, P87, DOI 10.1016/j.bbrc.2008.01.177; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perrin FE, 2006, J NEUROCHEM, V98, P1959, DOI 10.1111/j.1471-4159.2006.04024.x; Puttaparthi K, 2007, EXP NEUROL, V206, P53, DOI 10.1016/j.expneurol.2007.03.024; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P517, DOI 10.1097/01.jnen.0000263868.84188.3b; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Shirakawa K, 2009, NEUROLOGY, V73, P2124, DOI 10.1212/WNL.0b013e3181c67be0; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Sztriha L, 2008, CLIN GENET, V73, P591, DOI 10.1111/j.1399-0004.2008.00993.x; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Verschuuren-Bemelmans CC, 2008, EUR J HUM GENET, V16, P1407, DOI 10.1038/ejhg.2008.108; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	62	91	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9805	10.1371/journal.pone.0009805	http://dx.doi.org/10.1371/journal.pone.0009805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339559	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894300027
J	Raichlen, DA; Gordon, AD; Harcourt-Smith, WEH; Foster, AD; Haas, WR				Raichlen, David A.; Gordon, Adam D.; Harcourt-Smith, William E. H.; Foster, Adam D.; Haas, Wm. Randall, Jr.			Laetoli Footprints Preserve Earliest Direct Evidence of Human-Like Bipedal Biomechanics	PLOS ONE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HOMINID FOOTPRINTS; BENT-HIP; WALKING; LOCOMOTION; SPEED; COSTS	Background: Debates over the evolution of hominin bipedalism, a defining human characteristic, revolve around whether early bipeds walked more like humans, with energetically efficient extended hind limbs, or more like apes with flexed hind limbs. The 3.6 million year old hominin footprints at Laetoli, Tanzania represent the earliest direct evidence of hominin bipedalism. Determining the kinematics of Laetoli hominins will allow us to understand whether selection acted to decrease energy costs of bipedalism by 3.6 Ma. Methodology/Principal Findings: Using an experimental design, we show that the Laetoli hominins walked with weight transfer most similar to the economical extended limb bipedalism of humans. Humans walked through a sand trackway using both extended limb bipedalism, and more flexed limb bipedalism. Footprint morphology from extended limb trials matches weight distribution patterns found in the Laetoli footprints. Conclusions: These results provide us with the earliest direct evidence of kinematically human-like bipedalism currently known, and show that extended limb bipedalism evolved long before the appearance of the genus Homo. Since extended-limb bipedalism is more energetically economical than ape-like bipedalism, energy expenditure was likely an important selection pressure on hominin bipeds by 3.6 Ma.	[Raichlen, David A.; Foster, Adam D.; Haas, Wm. Randall, Jr.] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Gordon, Adam D.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Harcourt-Smith, William E. H.] Lehman Coll, Dept Anthropol, Bronx, NY USA; [Harcourt-Smith, William E. H.] Amer Museum Nat Hist, Div Vertebrate Paleontol, New York, NY 10024 USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Albany; City University of New York (CUNY) System; Lehman College (CUNY); American Museum of Natural History (AMNH)	Raichlen, DA (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	raichlen@email.arizona.edu	Gordon, Adam/AAB-9006-2019	Gordon, Adam/0000-0002-1807-4644; Haas, Randall/0000-0002-7742-2127; Foster, Adam/0000-0002-1265-8171	University of Arizona	University of Arizona	Funding was provided from the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1984, AM J PHYS ANTHROPOL, V63, P23, DOI 10.1002/ajpa.1330630105; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berge C, 2006, CR PALEVOL, V5, P561, DOI 10.1016/j.crpv.2005.09.001; Carey TS, 2005, J HUM EVOL, V48, P25, DOI 10.1016/j.jhevol.2004.10.001; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Crompton RH, 1998, J HUM EVOL, V35, P55, DOI 10.1006/jhev.1998.0222; D'Aout K, 2010, AM J PHYS ANTHROPOL, V141, P515, DOI 10.1002/ajpa.21169; Darwin C., 1871, DECENT MAN SELECTION; DAY MH, 1980, NATURE, V286, P385, DOI 10.1038/286385a0; DELOISON Y, 1992, CR ACAD SCI II, V315, P103; FEIBEL CS, 2005, EVOLUTIONARY ANTHR, V4, P149; HARCOURTSMITH WEH, 2005, AM J PHYS ANTHR S, V40, P116, DOI DOI 10.1002/AJPA.20217; HAY RL, 1982, SCI AM, V246, P50, DOI 10.1038/scientificamerican0282-50; HAY RL, 1987, LAETOLI PLIOCENE SIT, P23; Imhauser CW, 2004, CLIN BIOMECH, V19, P161, DOI 10.1016/j.clinbiomech.2003.10.007; Kullmer O, 2003, COUR FOR SEKENBG, V243, P85; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; LEAKEY M.D., 1987, LAETOLI PLIOCENE SIT; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1981, PHILOS T R SOC B, V292, P95, DOI 10.1098/rstb.1981.0017; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; MELDRUM D, 2007, CENOZOIC VERTEBRATE; MELDRUM DJ, 2004, J SCI EXPLOR, V18, P65; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Raichlen DA, 2008, J HUM EVOL, V54, P112, DOI 10.1016/j.jhevol.2007.07.005; Robbins L.M., 1987, P497; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Schmitt S, 2004, BIOMED TECH, V49, P61, DOI 10.1515/BMT.2004.012; Sellers WI, 2005, J R SOC INTERFACE, V2, P431, DOI 10.1098/rsif.2005.0060; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; TUTTLE R, 1991, BIPEDIE CHEZ HOMINID, P203; Tuttle R.H., 1985, P129; Tuttle R.H., 1987, P503; TUTTLE RH, 1996, THEY STAND TODAY KAU, V6, P97; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; WHITE TD, 1980, SCIENCE, V208, P175, DOI 10.1126/science.208.4440.175; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409	41	103	103	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9769	10.1371/journal.pone.0009769	http://dx.doi.org/10.1371/journal.pone.0009769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FR	20339543	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300013
J	Tiefenbach, J; Moll, PR; Nelson, MR; Hu, C; Baev, L; Kislinger, T; Krause, HM				Tiefenbach, Jens; Moll, Pamela R.; Nelson, Meryl R.; Hu, Chun; Baev, Lilia; Kislinger, Thomas; Krause, Henry M.			A Live Zebrafish-Based Screening System for Human Nuclear Receptor Ligand and Cofactor Discovery	PLOS ONE			English	Article							THYROID-HORMONE; IN-VIVO; N-COR; REPRESS TRANSCRIPTION; ESTROGEN-RECEPTOR; DRUG DISCOVERY; PROTEIN-KINASE; BETA GENE; PHOSPHORYLATION; ACTIVATION	Nuclear receptors (NRs) belong to a superfamily of transcription factors that regulate numerous homeostatic, metabolic and reproductive processes. Taken together with their modulation by small lipophilic molecules, they also represent an important and successful class of drug targets. Although many NRs have been targeted successfully, the majority have not, and one third are still orphans. Here we report the development of an in vivo GFP-based reporter system suitable for monitoring NR activities in all cells and tissues using live zebrafish (Danio rerio). The human NR fusion proteins used also contain a new affinity tag cassette allowing the purification of receptors with bound molecules from responsive tissues. We show that these constructs 1) respond as expected to endogenous zebrafish hormones and cofactors, 2) facilitate efficient receptor and cofactor purification, 3) respond robustly to NR hormones and drugs and 4) yield readily quantifiable signals. Transgenic lines representing the majority of human NRs have been established and are available for the investigation of tissue-and isoform-specific ligands and cofactors.	[Tiefenbach, Jens; Moll, Pamela R.; Nelson, Meryl R.; Hu, Chun; Baev, Lilia; Krause, Henry M.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada; [Tiefenbach, Jens; Nelson, Meryl R.; Krause, Henry M.] InDanio Biosci Inc, Toronto, ON, Canada; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kislinger, Thomas] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Kislinger, Thomas] Campbell Family Canc Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tiefenbach, J (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada.	h.krause@utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540; Krause, Henry/0000-0002-6182-7074	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors would like to thank the Canadian Institutes of Health Research for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanza C, 1998, J CELL BIOL, V141, P1301, DOI 10.1083/jcb.141.6.1301; Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chang IF, 2006, PROTEOMICS, V6, P6158, DOI 10.1002/pmic.200600225; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; Dias JM, 1998, ANAL BIOCHEM, V258, P96, DOI 10.1006/abio.1998.2583; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Luria A, 2004, P NATL ACAD SCI USA, V101, P8987, DOI 10.1073/pnas.0307053101; MACHUCA I, 1995, MOL ENDOCRINOL, V9, P96, DOI 10.1210/me.9.1.96; Maggi A, 2005, NAT REV DRUG DISCOV, V4, P249, DOI 10.1038/nrd1661; Messier N, 2000, MOL CELL ENDOCRINOL, V165, P57, DOI 10.1016/S0303-7207(00)00266-5; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Nagel SC, 2001, ENDOCRINOLOGY, V142, P4721, DOI 10.1210/en.142.11.4721; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Palanker L, 2006, DEVELOPMENT, V133, P3549, DOI 10.1242/dev.02512; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; SCHUELER PA, 1990, MOL ENDOCRINOL, V4, P227, DOI 10.1210/mend-4-2-227; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Shoji W, 1998, DEVELOPMENT, V125, P1275; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Taylor D, 2009, J MECH BEHAV BIOMED, V2, P1, DOI 10.1016/j.jmbbm.2008.10.001; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Ulisse S, 1996, P NATL ACAD SCI USA, V93, P1205, DOI 10.1073/pnas.93.3.1205; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Wegner GJ, 2002, ANAL CHEM, V74, P5161, DOI 10.1021/ac025922u; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yang L, 2006, EJC SUPPL, V4, P6, DOI 10.1016/j.ejcsup.2006.04.010; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P195, DOI 10.1080/10408440601123578	57	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9797	10.1371/journal.pone.0009797	http://dx.doi.org/10.1371/journal.pone.0009797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339547	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894300022
J	Waddell, SJ; Popper, SJ; Rubins, KH; Griffiths, MJ; Brown, PO; Levin, M; Relman, DA				Waddell, Simon J.; Popper, Stephen J.; Rubins, Kathleen H.; Griffiths, Michael J.; Brown, Patrick O.; Levin, Michael; Relman, David A.			Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; MICROARRAY ANALYSIS; ENDOTHELIAL-CELLS; GAMMA-RECEPTOR; HOST RESPONSE; ALPHA; CYTOKINES; INNATE; IFNS; IDENTIFICATION	Interferons are key modulators of the immune system, and are central to the control of many diseases. The response of immune cells to stimuli in complex populations is the product of direct and indirect effects, and of homotypic and heterotypic cell interactions. Dissecting the global transcriptional profiles of immune cell populations may provide insights into this regulatory interplay. The host transcriptional response may also be useful in discriminating between disease states, and in understanding pathophysiology. The transcriptional programs of cell populations in health therefore provide a paradigm for deconvoluting disease-associated gene expression profiles. We used human cDNA microarrays to (1) compare the gene expression programs in human peripheral blood mononuclear cells (PBMCs) elicited by 6 major mediators of the immune response: interferons alpha, beta, omega and gamma, IL12 and TNF alpha; and (2) characterize the transcriptional responses of purified immune cell populations (CD4(+) and CD8(+) T cells, B cells, NK cells and monocytes) to IFN gamma stimulation. We defined a highly stereotyped response to type I interferons, while responses to IFN gamma and IL12 were largely restricted to a subset of type I interferon-inducible genes. TNF alpha stimulation resulted in a distinct pattern of gene expression. Cell type-specific transcriptional programs were identified, highlighting the pronounced response of monocytes to IFN gamma, and emergent properties associated with IFN-mediated activation of mixed cell populations. This information provides a detailed view of cellular activation by immune mediators, and contributes an interpretive framework for the definition of host immune responses in a variety of disease settings.	[Waddell, Simon J.; Griffiths, Michael J.; Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Popper, Stephen J.; Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Rubins, Kathleen H.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Waddell, SJ (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	swaddell@sgul.ac.uk	Waddell, Simon J/A-9170-2013; Pacific-Southwest, RCE/B-6155-2009	Waddell, Simon J/0000-0002-3684-9116; Relman, David A./0000-0001-8331-1354; Levin, Michael/0000-0003-2767-6919	Burroughs Wellcome-Wellcome Trust; Horn Foundation; Thomas C. and Joan M. Merigan Endowed Professorship; Stanford University Digestive Diseases Center (National Institutes of Health) [P30 DK56339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	Burroughs Wellcome-Wellcome Trust(Burroughs Wellcome Fund); Horn Foundation; Thomas C. and Joan M. Merigan Endowed Professorship; Stanford University Digestive Diseases Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Burroughs Wellcome-Wellcome Trust Infectious Diseases Initiative Award to M. Levin, D. Beatty, and D.A. Relman. P.O. Brown and D. A. Relman were supported by the Horn Foundation. D. A. Relman was supported by the Thomas C. and Joan M. Merigan Endowed Professorship. This work includes data generated through the support of the Stanford University Digestive Diseases Center (National Institutes of Health P30 DK56339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2001, GENOMICS, V77, P50, DOI 10.1006/geno.2001.6623; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Baig E, 2008, ANTIVIR THER, V13, P409; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Daryadel A, 2009, J IMMUNOL, V182, P6527, DOI 10.4049/jimmunol.0803846; de Jong R, 1998, SCIENCE, V280, P1435; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kovarik P, 2007, IMMUNOBIOLOGY, V212, P895, DOI 10.1016/j.imbio.2007.09.011; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; ORTALDO JR, 1984, P NATL ACAD SCI-BIOL, V81, P4926, DOI 10.1073/pnas.81.15.4926; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Popper SJ, 2009, J INFECT DIS, V200, P657, DOI 10.1086/603538; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Schlaak JF, 2002, J BIOL CHEM, V277, P49428, DOI 10.1074/jbc.M205571200; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zimmerer JM, 2008, CLIN CANCER RES, V14, P5900, DOI 10.1158/1078-0432.CCR-08-0846	71	113	117	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9753	10.1371/journal.pone.0009753	http://dx.doi.org/10.1371/journal.pone.0009753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339534	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000275894300006
J	Kim, M; Long, TI; Arakawa, K; Wang, RW; Yu, MC; Laird, PW				Kim, Myungjin; Long, Tiffany I.; Arakawa, Kazuko; Wang, Renwei; Yu, Mimi C.; Laird, Peter W.			DNA Methylation as a Biomarker for Cardiovascular Disease Risk	PLOS ONE			English	Article							S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; EXPRESSION; HYPOMETHYLATION; ATHEROSCLEROSIS; PATTERNS; MICE	Background: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). Methodology/Principal Findings: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45-74 years recruited during 1993-1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P= 0.01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P= 0.03) but not in women (P= 0.53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5.8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P= 0.007). Conclusions/Significance: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese.	[Kim, Myungjin; Long, Tiffany I.; Arakawa, Kazuko; Laird, Peter W.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; [Kim, Myungjin; Long, Tiffany I.; Arakawa, Kazuko; Laird, Peter W.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Wang, Renwei; Yu, Mimi C.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Southern California; University of Southern California; University of Minnesota System; University of Minnesota Twin Cities	Kim, M (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Sch Biol Sci, Seoul, South Korea.	plaird@usc.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641	Ministry of Education, Science, and Technology (MEST) [KRF-2008-532-C00010]	Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (MEST) (KRF-2008-532-C00010) to M. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Castro R, 2005, J MOL MED, V83, P831, DOI 10.1007/s00109-005-0679-8; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Magliano DJ, 2006, ANN MED, V38, P34, DOI 10.1080/07853890500300311; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; Saw SM, 2001, AM J CLIN NUTR, V73, P232; Seow A, 2006, JNCI-J NATL CANCER I, V98, P135, DOI 10.1093/jnci/djj015; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Trinh BN, 2002, HUM GENET, V111, P299, DOI 10.1007/s00439-002-0779-2; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WHO, 2004, LANCET, V363, P902; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Yang TH, 2006, NUTR CANCER, V55, P224, DOI 10.1207/s15327914nc5502_14; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zhou Beifan, 2002, Obes Rev, V3, P147, DOI 10.1046/j.1467-789X.2002.00068.x	26	274	289	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9692	10.1371/journal.pone.0009692	http://dx.doi.org/10.1371/journal.pone.0009692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300621	gold, Green Submitted, Green Published			2022-12-27	WOS:000275621000010
J	Dotov, DG; Nie, L; Chemero, A				Dotov, Dobromir G.; Nie, Lin; Chemero, Anthony			A Demonstration of the Transition from Ready-to-Hand to Unready-to-Hand	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; TIMING ERRORS; 1/F NOISE; HEARTBEAT; SEQUENCES; COGNITION; DYNAMICS; BEHAVIOR	The ideas of continental philosopher Martin Heidegger have been influential in cognitive science and artificial intelligence, despite the fact that there has been no effort to analyze these ideas empirically. The experiments reported here are designed to lend empirical support to Heidegger's phenomenology and more specifically his description of the transition between ready-to-hand and unready-to-hand modes in interactions with tools. In experiment 1, we found that a smoothly coping cognitive system exhibits 1/f(beta) type positively correlated noise and that its correlated character is reduced when the system is perturbed. This indicates that the participant and tool constitute a self-assembled, extended device during smooth coping and this device is disrupted by the perturbation. In experiment 2, we examine the re-organization of awareness that occurs when a smoothly coping, self-assembled, extended cognitive system is perturbed. We found that the disruption is accompanied by a change in attention which interferes with participants' performance on a simultaneous cognitive task. Together these experiments show that a smoothly coping participant-tool system can be temporarily disrupted and that this disruption causes a change in the participant's awareness. Since these two events follow as predictions from Heidegger's work, our study offers evidence for the hypothesized transition from readiness-to-hand to unreadiness-to-hand.	[Dotov, Dobromir G.] Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA; [Nie, Lin; Chemero, Anthony] Franklin & Marshall Coll, Sci & Philosoph Studies Mind Program, Lancaster, PA 17604 USA	University of Connecticut; Franklin & Marshall College	Dotov, DG (corresponding author), Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA.	tony.chemero@fandm.edu	Dotov, Dobromir/HGF-2586-2022; Dotov, Dobromir G/J-8257-2015	Dotov, Dobromir G/0000-0002-5543-360X	University of Connecticut Research Foundation; Franklin & Marshall College Hackman Scholars Program	University of Connecticut Research Foundation; Franklin & Marshall College Hackman Scholars Program	Dobromir Dotov was supported by a grant from the University of Connecticut Research Foundation. Lin Nie was supported by the Franklin & Marshall College Hackman Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, P 6 NAT C ART INT, V278, P268; AGRE PE, 1995, ARTIF INTELL, V72, P1, DOI 10.1016/0004-3702(94)00054-5; [Anonymous], 2004, REALITY RES CHILDREN; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Blattner W., 2006, HEIDEGGERS BEING TIM; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Chen YQ, 2001, J MOTOR BEHAV, V33, P3, DOI 10.1080/00222890109601897; Clark A, 2008, SUPERSIZING MIND EMB; Clark A, 1998, BEING THERE PUTTING; Ding MZ, 2002, BRAIN COGNITION, V48, P98, DOI 10.1006/brcg.2001.1306; Dreyfus, 1991, BEING IN THE WORLD C; DREYFUS H, 1965, ALCHEMY ARTIFICIAL I, P3244; Dreyfus Hubert, 1979, WHAT COMPUTERS CANT; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Gallagher Shaun., 2021, PHENOMENOLOGICAL MIN, V3rd ed., DOI 10.4324/9780203086599; GOPHER D, 1982, J EXP PSYCHOL HUMAN, V8, P146, DOI 10.1037/0096-1523.8.1.146; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Holden JG, 2009, PSYCHOL REV, V116, P318, DOI 10.1037/a0014849; Ivanov PC, 2001, CHAOS, V11, P641, DOI 10.1063/1.1395631; Kahneman D., 1973, ATTENTION EFFORT; Leistedt S, 2007, CLIN NEUROPHYSIOL, V118, P940, DOI 10.1016/j.clinph.2007.01.003; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; McClamrock R., 1995, EXISTENTIAL COGNITIO; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; SPERLING G, 1978, ATTENTION PERFORM, V7, P675; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Treffner PJ, 1999, ECOL PSYCHOL, V11, P103, DOI 10.1207/s15326969eco1102_1; Turvey, 1987, INFORM NATURAL LAWS; Van Orden GC, 2005, J EXP PSYCHOL GEN, V134, P117, DOI 10.1037/0096-3445.134.1.117; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; VANGELDER T, 1995, J PHILOS, V92, P345, DOI 10.2307/2941061; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; WEST BJ, 1999, PHYSL PROMISCUITY PR; West BJ, 2006, ADV CHEM PHYS, V133, P1; Wheeler M., 1996, ROBOTS ROTHKO BRINGI, P209; WHEELER Michael, 2005, RECONSTRUCTING COGNI; Wickens C.D., 1991, MULTIPLE TASK PERFOR, V1991, P3, DOI [10.1201/9781003069447-2, DOI 10.1201/9781003069447-2]; Wilson RA., 2004, BOUNDARIES MIND INDI; Winograd T., 1986, UNDERSTANDING COMPUT	45	71	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9433	10.1371/journal.pone.0009433	http://dx.doi.org/10.1371/journal.pone.0009433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	565XA	20231883	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300005
J	Baur, F; Nau, K; Sadic, D; Allweiss, L; Elsasser, HP; Gillemans, N; de Wit, T; Kruger, I; Vollmer, M; Philipsen, S; Suske, G				Baur, Frank; Nau, Kerstin; Sadic, Dennis; Allweiss, Lena; Elsaesser, Hans-Peter; Gillemans, Nynke; de Wit, Ton; Krueger, Imme; Vollmer, Marion; Philipsen, Sjaak; Suske, Guntram			Specificity Protein 2 (Sp2) Is Essential for Mouse Development and Autonomous Proliferation of Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP3; BOX-BINDING-PROTEINS; CRE RECOMBINASE; EXPRESSION PATTERN; TRANSGENIC MOUSE; MAMMALIAN-CELLS; GENE-EXPRESSION; MICE; FAMILY; GROWTH	Background: The zinc finger protein Sp2 (specificity protein 2) is a member of the glutamine-rich Sp family of transcription factors. Despite its close similarity to Sp1, Sp3 and Sp4, Sp2 does not bind to DNA or activate transcription when expressed in mammalian cell lines. The expression pattern and the biological relevance of Sp2 in the mouse are unknown. Methodology/Principal Findings: Whole-mount in situ hybridization of mouse embryos between E7.5 and E9.5 revealed abundant expression in most embryonic and extra-embryonic tissues. In order to unravel the biological relevance of Sp2, we have targeted the Sp2 gene by a tri-loxP strategy. Constitutive Sp2null and conditional Sp2cko knockout alleles were obtained by crossings with appropriate Cre recombinase expressing mice. Constitutive disruption of the mouse Sp2 gene (Sp2null) resulted in severe growth retardation and lethality before E9.5. Mouse embryonic fibroblasts (MEFs) derived from Sp2null embryos at E9.5 failed to grow. Cre-mediated ablation of Sp2 in Sp2cko/cko MEFs obtained from E13.5 strongly impaired cell proliferation. Conclusions/Significance: Our results demonstrate that Sp2 is essential for early mouse development and autonomous proliferation of MEFs in culture. Comparison of the Sp2 knockout phenotype with the phenotypes of Sp1, Sp3 and Sp4 knockout strains shows that, despite their structural similarity and evolutionary relationship, all four glutamine-rich members of the Sp family of transcription factors have distinct non-redundant functions in vivo.	[Baur, Frank; Nau, Kerstin; Sadic, Dennis; Allweiss, Lena; Krueger, Imme; Vollmer, Marion; Suske, Guntram] Univ Marburg, Inst Mol Biol & Tumorforsch, D-3550 Marburg, Germany; [Elsaesser, Hans-Peter] Univ Marburg, Inst Zytobiol & Zytopathol, D-3550 Marburg, Germany; [Gillemans, Nynke; de Wit, Ton; Philipsen, Sjaak] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Philipps University Marburg; Philipps University Marburg; Erasmus University Rotterdam; Erasmus MC	Baur, F (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-3550 Marburg, Germany.	Suske@imt.uni-marburg.de		Suske, Guntram/0000-0002-4807-0513	Deutsche Forschungsgemeinschaft [GRK767]; Dutch Organisation for Scientific Research [DN 82-294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants of the Deutsche Forschungsgemeinschaft to GS (GRK767) and the Dutch Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) to SP (DN 82-294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; de Wit T, 1998, NUCLEIC ACIDS RES, V26, P676, DOI 10.1093/nar/26.2.676; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Moorefield KS, 2004, J BIOL CHEM, V279, P13911, DOI 10.1074/jbc.M313589200; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; St Amand TR, 2006, DEV BIOL, V291, P208, DOI 10.1016/j.ydbio.2005.10.018; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tewari R, 1996, DEVELOPMENT, V122, P3991; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van Loo,PF, 2007, MOL CELL BIOL, V27, P8571, DOI 10.1128/MCB.01350-07; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0	30	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A202	A212	e9587	10.1371/journal.pone.0009587	http://dx.doi.org/10.1371/journal.pone.0009587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221402	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200019
J	Cooper, WJ; Parsons, K; McIntyre, A; Kern, B; McGee-Moore, A; Albertson, RC				Cooper, W. James; Parsons, Kevin; McIntyre, Alyssa; Kern, Brittany; McGee-Moore, Alana; Albertson, R. Craig			Bentho-Pelagic Divergence of Cichlid Feeding Architecture Was Prodigious and Consistent during Multiple Adaptive Radiations within African Rift-Lakes	PLOS ONE			English	Article							COREGONUS-LAVARETUS L.; PHENOTYPIC PLASTICITY; MORPHOLOGICAL INTEGRATION; PUMPKINSEED SUNFISH; ARCTIC CHARR; ECOLOGICAL SPECIATION; FUNCTIONAL-MORPHOLOGY; TROPHIC POLYMORPHISM; PARALLEL EVOLUTION; NATURAL-SELECTION	Background: How particular changes in functional morphology can repeatedly promote ecological diversification is an active area of evolutionary investigation. The African rift-lake cichlids offer a calibrated time series of the most dramatic adaptive radiations of vertebrate trophic morphology yet described, and the replicate nature of these events provides a unique opportunity to test whether common changes in functional morphology have repeatedly facilitated their ecological success. Methodology/Principal Findings: Specimens from 87 genera of cichlid fishes endemic to Lakes Tanganyka, Malawi and Victoria were dissected in order to examine the functional morphology of cichlid feeding. We quantified shape using geometric morphometrics and compared patterns of morphological diversity using a series of analytical tests. The primary axes of divergence were conserved among all three radiations, and the most prevalent changes involved the size of the preorbital region of the skull. Even the fishes from the youngest of these lakes (Victoria), which exhibit the lowest amount of skull shape disparity, have undergone extensive preorbital evolution relative to other craniofacial traits. Such changes have large effects on feeding biomechanics, and can promote expansion into a wide array of niches along a bentho-pelagic ecomorphological axis. Conclusions/Significance: Here we show that specific changes in trophic anatomy have evolved repeatedly in the African rift lakes, and our results suggest that simple morphological alterations that have large ecological consequences are likely to constitute critical components of adaptive radiations in functional morphology. Such shifts may precede more complex shape changes as lineages diversify into unoccupied niches. The data presented here, combined with observations of other fish lineages, suggest that the preorbital region represents an evolutionary module that can respond quickly to natural selection when fishes colonize new lakes. Characterizing the changes in cichlid trophic morphology that have contributed to their extraordinary adaptive radiations has broad evolutionary implications, and such studies are necessary for directing future investigations into the proximate mechanisms that have shaped these spectacular phenomena.	[Cooper, W. James; Parsons, Kevin; Kern, Brittany; McGee-Moore, Alana; Albertson, R. Craig] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [McIntyre, Alyssa] Univ Connecticut, Sch Dent Med, Storrs, CT USA	Syracuse University; University of Connecticut	Cooper, WJ (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	wjcooper@syr.edu		Cooper, W. James/0000-0003-4204-4266	Department of Biology at Syracuse University; United States National Institute of Dental and Craniofacial Research [1R21DE019223]; United States National Institute on Aging [RO1AG031922]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031922] Funding Source: NIH RePORTER	Department of Biology at Syracuse University; United States National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funding from the Department of Biology at Syracuse University, grant 1R21DE019223 from the United States National Institute of Dental and Craniofacial Research (www.nidcr.nih.gov/), and grant RO1AG031922 from the United States National Institute on Aging (www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2004, BIOL J LINN SOC, V81, P611, DOI 10.1111/j.1095-8312.2004.00314.x; Adams CE, 2003, BIOL J LINN SOC, V78, P43, DOI 10.1046/j.1095-8312.2003.00126.x; Adams CE, 1998, J FISH BIOL, V52, P1259, DOI 10.1111/j.1095-8649.1998.tb00970.x; Albertson RC, 2007, DEV BIOL, V306, P505, DOI 10.1016/j.ydbio.2007.03.025; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Albertson RC, 2003, P NATL ACAD SCI USA, V100, P5252, DOI 10.1073/pnas.0930235100; Albertson RC, 2003, J HERED, V94, P291, DOI 10.1093/jhered/esg071; Amundsen PA, 2004, ANN ZOOL FENN, V41, P301; AVISE JC, 1990, NATURE, V347, P512, DOI 10.1038/347512a0; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Barlow G., 2002, CICHLID FISHES NATUR; Bernatchez L, 1999, BIOL J LINN SOC, V68, P173, DOI 10.1111/j.1095-8312.1999.tb01165.x; Boughman JW, 2005, EVOLUTION, V59, P361; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Bouton N, 2002, BIOL J LINN SOC, V77, P185, DOI 10.1046/j.1095-8312.2002.00093.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Collar DC, 2009, EVOLUTION, V63, P1557, DOI 10.1111/j.1558-5646.2009.00626.x; Collar DC, 2005, EVOLUTION, V59, P1783, DOI 10.1111/j.0014-3820.2005.tb01826.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cooper WJ, 2008, DEV BIOL, V321, P295, DOI 10.1016/j.ydbio.2008.06.025; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; Eschmeyer WN, 2009, CATALOG FISHES ELECT; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; Ferry-Graham LA, 2002, MAR BIOL, V141, P819, DOI 10.1007/s00227-002-0882-x; Ferry-Graham LA, 2001, J EXP MAR BIOL ECOL, V256, P167, DOI 10.1016/S0022-0981(00)00312-9; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Foster SA, 2004, TRENDS ECOL EVOL, V19, P456, DOI 10.1016/j.tree.2004.07.004; Fraser D, 1998, ECOL FRESHW FISH, V7, P184, DOI 10.1111/j.1600-0633.1998.tb00185.x; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gillespie GJ, 2003, J FISH BIOL, V62, P1099, DOI 10.1046/j.1095-8649.2003.00100.x; Greenwood PH, 1974, CICHLID FISHES LAKE; Grubich JR, 2008, ZOOLOGY, V111, P16, DOI 10.1016/j.zool.2007.05.003; Hegrenes S, 2001, ECOL FRESHW FISH, V10, P35, DOI 10.1034/j.1600-0633.2001.100105.x; Herrera CM, 2002, J EVOLUTION BIOL, V15, P108, DOI 10.1046/j.1420-9101.2002.00365.x; Hjelm J, 2001, OIKOS, V95, P311, DOI 10.1034/j.1600-0706.2001.950213.x; Holzman R, 2008, J EXP BIOL, V211, P3296, DOI 10.1242/jeb.020909; Holzman R, 2008, J R SOC INTERFACE, V5, P1445, DOI 10.1098/rsif.2008.0159; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; Jastrebski CJ, 2004, EVOL ECOL RES, V6, P285; Jonsson B, 2001, J FISH BIOL, V58, P605, DOI 10.1006/jfbi.2000.1515; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kammerer CF, 2006, J MORPHOL, V267, P1017, DOI 10.1002/jmor.10293; Kaufman L.S., 1982, Breviora, P1; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Konings A., 2001, MALAWI CICHLIDS THEI; Konings A, 2015, TANGANYIKA CICHLIDS; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Levin DA, 2004, SYST BOT, V29, P807, DOI 10.1600/0363644042451134; Loh YHE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r113; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; MALMQUIST HJ, 1992, OECOLOGIA, V92, P354, DOI 10.1007/BF00317461; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Morrison D.F., 2004, MULTIVARIATE STAT ME; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, J EVOLUTION BIOL, V18, P683, DOI 10.1111/j.1420-9101.2004.00844.x; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Parsons KJ, 2007, J EVOLUTION BIOL, V20, P673, DOI 10.1111/j.1420-9101.2006.01249.x; Parsons KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007957; Peres-Neto PR, 2004, OECOLOGIA, V140, P36, DOI 10.1007/s00442-004-1562-y; Rice AN, 2008, BIOL J LINN SOC, V93, P289, DOI 10.1111/j.1095-8312.2007.00915.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; Riopel C, 2008, ENVIRON BIOL FISH, V82, P409, DOI 10.1007/s10641-007-9303-9; Robinson BW, 2000, ECOLOGY, V81, P2799, DOI 10.1890/0012-9658(2000)081[2799:APAOCR]2.0.CO;2; ROBINSON BW, 1995, COPEIA, P294; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Robinson BW, 2002, CAN J FISH AQUAT SCI, V59, P1819, DOI 10.1139/F02-144; ROBINSON BW, 1993, EVOL ECOL, V7, P451, DOI 10.1007/BF01237641; Rohlf F.J., 2006, TPSDIG2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Ruzzante DE, 1998, BIOL J LINN SOC, V65, P191, DOI 10.1111/j.1095-8312.1998.tb00355.x; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shapiro MD, 2006, NATURE, V439, P1014, DOI 10.1038/nature04500; Stauffer JR, 2004, ANIM BIOL, V54, P137, DOI 10.1163/1570756041445191; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; Sturmbauer C, 2003, HYDROBIOLOGIA, V500, P51, DOI 10.1023/A:1024680201436; Terai Y, 2002, MOL BIOL EVOL, V19, P1628, DOI 10.1093/oxfordjournals.molbev.a004225; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; Turner GF., 1996, OFFSHORE CICHLIDS LA; Van Valen Leigh, 2005, P29, DOI 10.1016/B978-012088777-4/50005-3; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright PC, 2000, EXPTL BIOL REV, P207; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Walker JA, 2000, J ZOOL, V252, P293; Waltzek TB, 2003, J MORPHOL, V257, P96, DOI 10.1002/jmor.10111; West-Eberhard Mary Jane, 2003, pi; Westneat MW, 2006, FISH PHYSIOL, V23, P29, DOI 10.1016/S1546-5098(05)23002-9; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; Westneat MW, 1999, AM ZOOL, V39, p100A; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; WESTNEAT MW, 1995, SYST BIOL, V44, P361, DOI 10.2307/2413598; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740; Young NM, 2006, J ANAT, V209, P623, DOI 10.1111/j.1469-7580.2006.00639.x	121	115	115	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A38	A50	e9551	10.1371/journal.pone.0009551	http://dx.doi.org/10.1371/journal.pone.0009551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221400	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000275328200004
J	De la Fuente, IM; Vadillo, F; Perez-Samartin, AL; Perez-Pinilla, MB; Bidaurrazaga, J; Vera-Lopez, A				De la Fuente, Ildefonso M.; Vadillo, Fernando; Luis Perez-Samartin, Alberto; Perez-Pinilla, Martin-Blas; Bidaurrazaga, Joseba; Vera-Lopez, Antonio			Global Self-Regulation of the Cellular Metabolic Structure	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; PANCREATIC BETA-CELL; AUTONOMOUS OSCILLATIONS; WAVELET ANALYSIS; KINETIC-MODEL; TIME-SERIES; CYCLE; COMPARTMENTATION; ORGANIZATION; DYNAMICS	Background: Different studies have shown that cellular enzymatic activities are able to self-organize spontaneously, forming a metabolic core of reactive processes that remain active under different growth conditions while the rest of the molecular catalytic reactions exhibit structural plasticity. This global cellular metabolic structure appears to be an intrinsic characteristic common to all cellular organisms. Recent work performed with dissipative metabolic networks has shown that the fundamental element for the spontaneous emergence of this global self-organized enzymatic structure could be the number of catalytic elements in the metabolic networks. Methodology/Principal Findings: In order to investigate the factors that may affect the catalytic dynamics under a global metabolic structure characterized by the presence of metabolic cores we have studied different transitions in catalytic patterns belonging to a dissipative metabolic network. The data were analyzed using non-linear dynamics tools: power spectra, reconstructed attractors, long-term correlations, maximum Lyapunov exponent and Approximate Entropy; and we have found the emergence of self-regulation phenomena during the transitions in the metabolic activities. Conclusions/Significance: The analysis has also shown that the chaotic numerical series analyzed correspond to the fractional Brownian motion and they exhibit long-term correlations and low Approximate Entropy indicating a high level of predictability and information during the self-regulation of the metabolic transitions. The results illustrate some aspects of the mechanisms behind the emergence of the metabolic self-regulation processes, which may constitute an important property of the global structure of the cellular metabolism.	[De la Fuente, Ildefonso M.; Perez-Pinilla, Martin-Blas; Vera-Lopez, Antonio] Univ Basque Country, Dept Math, Vizcaya, Spain; [Vadillo, Fernando] Univ Basque Country, Dept Appl Math & Stat, Vizcaya, Spain; [Luis Perez-Samartin, Alberto] Univ Basque Country, Dept Neurosci, Vizcaya, Spain; [Bidaurrazaga, Joseba] Basque Govt, Dept Hlth, Vizcaya, Spain	University of Basque Country; University of Basque Country; University of Basque Country; Basque Government	De la Fuente, IM (corresponding author), Univ Basque Country, Dept Math, Vizcaya, Spain.	mtpmadei@ehu.es	Samartín, Alberto Pérez/AAB-6428-2019; Pérez-Pinillla, Martín-Blas/K-9042-2017; Samartín, Alberto Pérez/AAB-1336-2019; Vadillo, Fernando/AAW-5629-2021; Vera-López, Antonio/P-3022-2016	Pérez-Pinillla, Martín-Blas/0000-0002-3461-9990; Samartín, Alberto Pérez/0000-0003-0834-0424; Vadillo, Fernando/0000-0001-6524-360X; De la Fuente, Ildefonso/0000-0001-6548-7583; Vera-Lopez, Antonio/0000-0002-0351-2701	Spanish Ministry of Science and Education [MTM2007-62186, MTM2005-01504]; Basque Government [GIC07/151-IT-254-07, IT-305-07]	Spanish Ministry of Science and Education(Spanish Government); Basque Government(Basque Government)	This work was supported by the Spanish Ministry of Science and Education Grants with the projects MTM2007-62186 and MTM2005-01504 and by the Basque Government grants GIC07/151-IT-254-07 and IT-305-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Audit B, 2004, J BIOL PHYS, V30, P33, DOI 10.1023/B:JOBP.0000016438.86794.8e; BARIL EF, 1968, J NUTR, V95, P228, DOI 10.1093/jn/95.2.228; BASSINGTHWAIGHTE JB, 1995, ANN BIOMED ENG, V23, P491, DOI 10.1007/BF02584449; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; BLAKELY NJ, 2004, SYSTEMS PHYS REV LET, V92; BRODSKY VY, 1992, J CELL SCI, V103, P363; Cannon MJ, 1997, PHYSICA A, V241, P606, DOI 10.1016/S0378-4371(97)00252-5; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; CLEGG JS, 1984, AM J PHYSIOL, V246, pR133, DOI 10.1152/ajpregu.1984.246.2.R133; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; De la Fuente IM, 1998, FRACTALS, V6, P95, DOI 10.1142/S0218348X98000110; De la Fuentea IM, 1999, J BIOL SYST, V7, P113, DOI 10.1142/S0218339099000103; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE IM, 1995, BIOSYSTEMS, V35, P1, DOI 10.1016/0303-2647(94)01473-K; DIXON CJ, 1995, BIOCHEM J, V309, P145, DOI 10.1042/bj3090145; Dronov V, 2004, CHAOS, V14, P30, DOI 10.1063/1.1622352; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P237, DOI 10.3109/13813459409003936; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Futcher B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-107; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; Haimovich AD, 2006, J COMPUT BIOL, V13, P1289, DOI 10.1089/cmb.2006.13.1289; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hartig K, 2005, PLANT BIOLOGY, V7, P33, DOI 10.1055/s-2004-830474; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Hungerbuehler AK, 2007, EUKARYOT CELL, V6, P473, DOI 10.1128/EC.00273-06; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Jovanovic S, 2007, J MOL BIOL, V371, P349, DOI 10.1016/j.jmb.2007.05.081; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; Kantz H., 1997, NONLINEAR TIME SERIE; Kass L, 1996, J PHOTOCH PHOTOBIO B, V35, P105, DOI 10.1016/1011-1344(96)07301-0; Kazachenko VN, 2007, BIOCHEM MOSC SUPPL S, V1, P169, DOI 10.1134/S1990747807020109; KHOLODENKO BN, 1992, EUR J BIOCHEM, V210, P147, DOI 10.1111/j.1432-1033.1992.tb17402.x; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; KURGANOV BI, 1993, TRENDS BIOCHEM SCI, V18, P405, DOI 10.1016/0968-0004(93)90133-8; LANGE G, 2004, FEBS, V178, P61; LEBRUN P, 1985, BIOPHYS J, V48, P529, DOI 10.1016/S0006-3495(85)83809-1; Lee YK, 2007, J FLUID MECH, V575, P425, DOI 10.1017/S0022112006004289; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Lyubarev AE, 1997, BIOSYSTEMS, V42, P103, DOI 10.1016/S0303-2647(96)01698-X; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Mogilevskaya E, 2006, J BIOL PHYS, V32, P245, DOI 10.1007/s10867-006-9015-y; Moller AC, 1998, BIOPHYS CHEM, V72, P63, DOI 10.1016/S0301-4622(98)00123-9; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Nicolis G, 1977, SELF ORG NONEQUILIBR; Nielsen K, 1998, BIOPHYS CHEM, V72, P49, DOI 10.1016/S0301-4622(98)00122-7; Ott E., 1993, CHAOS DYNAMICAL SYST; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P83, DOI 10.1023/B:MCBI.0000009860.86969.72; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; OVADI J, 1995, J CELL ARCHITECTURE; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Raymond GM, 2003, PHYSICA A, V322, P169, DOI 10.1016/S0378-4371(02)01748-X; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Saks V, 2008, INT J MOL SCI, V9, P751, DOI 10.3390/ijms9050751; Saks V, 2009, INT J MOL SCI, V10, P1161, DOI 10.3390/ijms10031161; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; Shannon CE, 1997, MATH THEORY COMMUNIC; Shaul O, 1996, P NATL ACAD SCI USA, V93, P4868, DOI 10.1073/pnas.93.10.4868; SINAI YG, 1959, DOKL AKAD NAUK SSSR, V124, P768; Smrcinova M, 1998, INT J BIFURCAT CHAOS, V8, P2467, DOI 10.1142/S0218127498001984; Sprott JC, 2003, CHAOS TIME SERIES AN; SRERE PA, 1997, CHANNELING INTERMEDI; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tonozuka H, 2001, J BIOCHEM-TOKYO, V130, P589, DOI 10.1093/oxfordjournals.jbchem.a003023; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Viswanathan GM, 1997, BIOPHYS J, V72, P866, DOI 10.1016/S0006-3495(97)78721-6; WALTER H., 1999, INT REV CYTOLOGY, V192; WELCH GR, 1985, ORG MULTYENZYME SYST; WEST IC, 1997, CHANNELLING INTERMED; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200	113	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9484	10.1371/journal.pone.0009484	http://dx.doi.org/10.1371/journal.pone.0009484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209156	Green Published, gold, Green Submitted			2022-12-27	WOS:000275063300005
J	Filippone, C; Franssila, R; Kumar, A; Saikko, L; Kovanen, PE; Soderlund-Venermo, M; Hedman, K				Filippone, Claudia; Franssila, Rauli; Kumar, Arun; Saikko, Leena; Kovanen, Panu E.; Soderlund-Venermo, Maria; Hedman, Klaus			Erythroid Progenitor Cells Expanded from Peripheral Blood without Mobilization or Preselection: Molecular Characteristics and Functional Competence	PLOS ONE			English	Article							HUMAN PARVOVIRUS B19; CANDIDATE RECOMBINANT VACCINE; IN-VITRO; BONE-MARROW; PRODUCTIVE INFECTION; ANTIGEN-EXPRESSION; STEM-CELLS; REPLICATION; PROLIFERATION; DIFFERENTIATION	Background: Continued development of in-vitro procedures for expansion and differentiation of erythroid progenitor cells (EPC) is essential not only in hematology and stem cell research but also virology, in light of the strict erythrotropism of the clinically important human parvovirus B19. Methodology/Principal Findings: We cultured EPC directly from ordinary blood samples, without ex vivo stem cell mobilization or CD34+ cell in vitro preselection. Profound increase in the absolute cell number and clustering activity were observed during culture. The cells obtained expressed the EPC marker combination CD36, CD71 and glycophorin, but none of the lymphocyte, monocyte or NK markers. The functionality of the generated EPC was examined by an in vitro infection assay with human parvovirus B19, tropic for BFU-E and CFU-E cells. Following infection (i) viral DNA replication and mRNA production were confirmed by quantitative PCR, and (ii) structural and nonstructural proteins were expressed in >50% of the cells. As the overall cell number increased 100-200 fold, and the proportion of competent EPC (CD34+ to CD36+) rose from <0.5% to >50%, the in vitro culture procedure generated the EPC at an efficiency of >10 000-fold. Comparative culturing of unselected PBMC and ex vivo-preselected CD34+ cells produced qualitatively and quantitatively similar yields of EPC. Conclusions/Significance: This approach yielding EPC directly from unmanipulated peripheral blood is gratifyingly robust and will facilitate the study of myeloid infectious agents such as the B19 virus, as well as the examination of erythropoiesis and its cellular and molecular mechanisms.	[Filippone, Claudia; Franssila, Rauli; Kumar, Arun; Soderlund-Venermo, Maria; Hedman, Klaus] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Filippone, Claudia; Franssila, Rauli; Kumar, Arun; Soderlund-Venermo, Maria; Hedman, Klaus] Univ Helsinki, Lab Div, Helsinki, Finland; [Saikko, Leena; Kovanen, Panu E.] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Filippone, C (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	claudia.filippone@pasteur.fr	Söderlund-Venermo, Maria/AAX-2112-2020; Hedman, Klaus/D-5379-2009; Kumar, Arun/C-9466-2013	Kumar, Arun/0000-0003-4483-7585; Hedman, Klaus/0000-0003-1779-7960	Helsinki University Central Hospital Research and Education and Research and Development; Academy of Finland [1122539]; Sigrid Juselius Foundation; Medical Society of Finland; Centre for International Mobility (CIMO)	Helsinki University Central Hospital Research and Education and Research and Development; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Society of Finland; Centre for International Mobility (CIMO)	This work was supported by the Helsinki University Central Hospital Research and Education and Research and Development funds, the Academy of Finland (project 1122539), the Sigrid Juselius Foundation, the Medical Society of Finland (FLS), and the Centre for International Mobility (CIMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci E, 2003, STEM CELLS, V21, P33, DOI 10.1634/stemcells.21-1-33; Barrett L, 2007, J LEUKOCYTE BIOL, V82, P152, DOI 10.1189/jlb.0806521; Bonvicini F, 2006, VIROLOGY, V347, P447, DOI 10.1016/j.virol.2005.12.014; Bonvicini F, 2008, VIROLOGY, V381, P168, DOI 10.1016/j.virol.2008.09.002; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; BROWN KE, 1991, J GEN VIROL, V72, P741, DOI 10.1099/0022-1317-72-3-741; CORREA PN, 1991, BLOOD, V78, P2823; DEWOLF JTM, 1994, BLOOD, V84, P59, DOI 10.1182/blood.V84.1.59.bloodjournal84159; EMERSON SG, 1989, BLOOD, V74, P49; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FIBACH E, 1989, BLOOD, V73, P100; Franssila R, 2004, VACCINE, V22, P3809, DOI 10.1016/j.vaccine.2003.06.003; Franssila R, 2001, J INFECT DIS, V183, P805, DOI 10.1086/318819; Freyssinier JM, 1999, BRIT J HAEMATOL, V106, P912; Gallinella G, 2000, VIROLOGY, V278, P361, DOI 10.1006/viro.2000.0673; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Guo M, 1999, CYTOTHERAPY, V1, P183, DOI 10.1080/14653249910001591266; Hokynar K, 2004, J CLIN MICROBIOL, V42, P2013, DOI 10.1128/JCM.42.5.2013-2019.2004; Huh HY, 1996, BLOOD, V87, P2020; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; Kaikkonen L, 2001, J MED VIROL, V64, P360, DOI 10.1002/jmv.1059; Liu XL, 2007, J LEUKOCYTE BIOL, V82, P986, DOI 10.1189/jlb.0107014; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; Miller JL, 1999, EXP HEMATOL, V27, P624, DOI 10.1016/S0301-472X(98)00086-1; Miyagawa E, 1999, J VIROL METHODS, V83, P45, DOI 10.1016/S0166-0934(99)00105-6; MORTIMER PP, 1983, NATURE, V302, P426, DOI 10.1038/302426a0; NAKAHATA T, 1994, LEUKEMIA LYMPHOMA, V13, P401, DOI 10.3109/10428199409049629; NATHAN DG, 1978, J EXP MED, V147, P324, DOI 10.1084/jem.147.2.324; Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103; OKUMURA N, 1992, BLOOD, V80, P642; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Pierzchalska M, 2007, J PHYSIOL PHARMACOL, V58, P207; SATO N, 1993, BLOOD, V82, P3600; SCHWARZ TF, 1992, J VIROL, V66, P1273, DOI 10.1128/JVI.66.2.1273-1276.1992; SERKE S, 1991, BRIT J HAEMATOL, V79, P6, DOI 10.1111/j.1365-2141.1991.tb07999.x; SHIMOMURA S, 1992, BLOOD, V79, P18; SODERLUND M, 1995, J INFECT DIS, V171, P710, DOI 10.1093/infdis/171.3.710; SODERLUND M, 1995, J INFECT DIS, V172, P1431, DOI 10.1093/infdis/172.6.1431; SRIVASTAVA A, 1988, J VIROL, V62, P3059, DOI 10.1128/JVI.62.8.3059-3063.1988; SRIVASTAVA CH, 1992, VIROLOGY, V189, P456, DOI 10.1016/0042-6822(92)90569-B; Sugawara H, 2001, TRANSFUSION, V41, P456, DOI 10.1046/j.1537-2995.2001.41040456.x; TAKAHASHI T, 1990, BLOOD, V75, P603; WADA H, 1990, BLOOD, V75, P505, DOI 10.1182/blood.V75.2.505.505; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; YAEGASHI N, 1989, J VIROL, V63, P2422, DOI 10.1128/JVI.63.6.2422-2426.1989; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; ZUCKERMAN KS, 1981, J CLIN INVEST, V67, P702, DOI 10.1172/JCI110086	51	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9496	10.1371/journal.pone.0009496	http://dx.doi.org/10.1371/journal.pone.0009496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209110	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300012
J	Adams, BR; Golding, SE; Rao, RR; Valerie, K				Adams, Bret R.; Golding, Sarah E.; Rao, Raj R.; Valerie, Kristoffer			Dynamic Dependence on ATR and ATM for Double-Strand Break Repair in Human Embryonic Stem Cells and Neural Descendants	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION REPAIR; HISTONE H2AX; DNA-REPAIR; SELF-RENEWAL; DIFFERENTIATION; PROLIFERATION; APOPTOSIS; PATHWAYS; CLEAVAGE; ARREST	The DNA double-strand break (DSB) is the most toxic form of DNA damage. Studies aimed at characterizing DNA repair during development suggest that homologous recombination repair (HRR) is more critical in pluripotent cells compared to differentiated somatic cells in which nonhomologous end joining (NHEJ) is dominant. We have characterized the DNA damage response (DDR) and quality of DNA double-strand break (DSB) repair in human embryonic stem cells (hESCs), and in vitro-derived neural cells. Resolution of ionizing radiation-induced foci (IRIF) was used as a surrogate for DSB repair. The resolution of gamma-H2AX foci occurred at a slower rate in hESCs compared to neural progenitors (NPs) and astrocytes perhaps reflective of more complex DSB repair in hESCs. In addition, the resolution of RAD51 foci, indicative of active homologous recombination repair (HRR), showed that hESCs as well as NPs have high capacity for HRR, whereas astrocytes do not. Importantly, the ATM kinase was shown to be critical for foci formation in astrocytes, but not in hESCs, suggesting that the DDR is different in these cells. Blocking the ATM kinase in astrocytes not only prevented the formation but also completely disassembled preformed repair foci. The ability of hESCs to form IRIF was abrogated with caffeine and siRNAs targeted against ATR, implicating that hESCs rely on ATR, rather than ATM for regulating DSB repair. This relationship dynamically changed as cells differentiated. Interestingly, while the inhibition of the DNA-PKcs kinase (and presumably non-homologous endjoining [NHEJ]) in astrocytes slowed IRIF resolution it did not in hESCs, suggesting that repair in hESCs does not utilize DNA-PKcs. Altogether, our results show that hESCs have efficient DSB repair that is largely ATR-dependent HRR, whereas astrocytes critically depend on ATM for NHEJ, which, in part, is DNA-PKcs-independent.	[Adams, Bret R.; Golding, Sarah E.; Valerie, Kristoffer] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA; [Adams, Bret R.; Valerie, Kristoffer] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Rao, Raj R.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Valerie, Kristoffer] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Adams, BR (corresponding author), Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA.	KVALERIE@VCU.EDU	Valerie, Kristoffer/AAL-8299-2021; Rao, Raj/AAW-4308-2021		NIH [P01CA72955, R01NS064593, R21ES016636, T32CA085159, P30CA16059]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [T32CA085159, P30CA016059, P01CA072955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NIH P01CA72955, R01NS064593, and R21ES016636 (K. V.), NIH T32CA085159 (S. E. G.), and the American Brain Tumor Association (S. E. G.). The Massey Cancer Center Flow Cytometry and Imaging Facility is supported in part by NIH grant P30CA16059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Biton S, 2007, DNA REPAIR, V6, P128, DOI 10.1016/j.dnarep.2006.10.019; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Dhara SK, 2009, TISSUE ENG PT A, V15, P3621, DOI 10.1089/ten.tea.2009.0155; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Flygare J, 1998, FEBS LETT, V427, P247, DOI 10.1016/S0014-5793(98)00433-5; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; Hardcastle IR, 2005, J MED CHEM, V48, P7829, DOI 10.1021/jm050444b; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; POVIRK LF, 2007, NUCL ACIDS RES; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Short SC, 2007, NEURO-ONCOLOGY, V9, P404, DOI 10.1215/15228517-2007-030; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Suzuki K, 2006, RADIAT RES, V165, P499, DOI 10.1667/RR3542.1; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wilczynska KM, 2009, STEM CELLS, V27, P1173, DOI 10.1002/stem.35; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385	45	89	90	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10001	10.1371/journal.pone.0010001	http://dx.doi.org/10.1371/journal.pone.0010001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368801	Green Published, gold, Green Submitted			2022-12-27	WOS:000276419900005
J	Lin, HB; Fan, H; Zhang, F; Huang, XQ; Lin, KQ; Shi, L; Hu, SN; Chu, JY; Wang, DM				Lin, Hongbin; Fan, Hao; Zhang, Feng; Huang, Xiaoqin; Lin, Keqin; Shi, Lei; Hu, Songnian; Chu, Jiayou; Wang, Duen-Mei			Genetic Relationships of Ethnic Minorities in Southwest China Revealed by Microsatellite Markers	PLOS ONE			English	Article							Y-CHROMOSOME EVIDENCE; POPULATION-STRUCTURE; EAST-ASIA; PHYLOGENETIC TREES; BREEDS; DIVERSITY; HISTORY; DNA; RECONSTRUCTION; DISTANCES	Population migrations in Southwest and South China have played an important role in the formation of East Asian populations and led to a high degree of cultural diversity among ethnic minorities living in these areas. To explore the genetic relationships of these ethnic minorities, we systematically surveyed the variation of 10 autosomal STR markers of 1,538 individuals from 30 populations of 25 ethnic minorities, of which the majority were chosen from Southwest China, especially Yunnan Province. With genotyped data of the markers, we constructed phylogenies of these populations with both D-A and D-C measures and performed a principal component analysis, as well as a clustering analysis by structure. Results showed that we successfully recovered the genetic structure of analyzed populations formed by historical migrations. Aggregation patterns of these populations accord well with their linguistic affiliations, suggesting that deciphering of genetic relationships does in fact offer clues for study of ethnic differentiation.	[Fan, Hao; Huang, Xiaoqin; Lin, Keqin; Shi, Lei; Chu, Jiayou] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Lin, Hongbin; Zhang, Feng; Hu, Songnian; Wang, Duen-Mei] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Lin, Hongbin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Fan, Hao] Kunming Med Coll, Dept Biochem, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University	Chu, JY (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	chujy@imbcams.com.cn; wangdm@big.ac.cn	Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Science Foundation of China [30470946]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Science Foundation of China grants 30470946 (Dr. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; Benedict Paul King, 1972, SINO TIBETAN CONSPEC; Benedict Paul King, 1975, AUSTRO THAI LANGUAGE; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Chu J.-Y., 2008, INT J GENETICS, V31, P241; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; DAI Q, 1998, 20 CENTURY RES MINOR; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Guldin Gregory E., 1994, SAGA ANTHR CHINA MAL; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harrell S, 2001, WAYS BEING ETHNIC SW; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jin L., 2001, GENETIC LINGUISTIC A; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kim TH, 2005, J ANIM SCI, V83, P2255; Koskinen MT, 2004, HEREDITAS, V141, P61, DOI 10.1111/j.1601-5223.2004.01804.x; Li, 1977, HDB COMP TAI; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MANTEL N, 1967, CANCER RES, V27, P209; Minch E, 1998, MICROSAT COMPUTER PR; Moazami-Goudarzi K, 2002, GENETICS, V162, P473; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; Nei M., 2000, MOL EVOLUTION PHYLOG; Ota T, 1993, DISPAN GENETIC DISTA; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosenberg NA, 2001, GENETICS, V159, P699; RUIZOLINARES A, 1999, MICROSATELLITES RECO; SAGART L, 2005, PEOPLING E ASIA PUTT, P177; Sahoo S, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-4; Sanchez-Mazas A, 2005, PEOPLING E ASIA PUTT, P273; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Starosta Stanley, 2005, PEOPLING E ASIA PUTT, P182, DOI DOI 10.4324/9780203343685_CHAPTER_11; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Takezaki N, 1996, GENETICS, V144, P389; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Yang S.M., 2003, ETHNOGRAPHY CHINA; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	55	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9895	10.1371/journal.pone.0009895	http://dx.doi.org/10.1371/journal.pone.0009895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360948	Green Submitted, gold, Green Published			2022-12-27	WOS:000276163100005
J	Matynia, A; Ng, CH; Dansithong, W; Chiang, A; Silva, AJ; Reddy, S				Matynia, Anna; Ng, Carina Hoi; Dansithong, Warunee; Chiang, Andy; Silva, Alcino J.; Reddy, Sita			Muscleblind1, but Not Dmpk or Six5, Contributes to a Complex Phenotype of Muscular and Motivational Deficits in Mouse Models of Myotonic Dystrophy	PLOS ONE			English	Article							CTG REPEAT; REDUCES EXPRESSION; MICE LACKING; PROTEIN; EXPANSION; DISRUPTION; PROFILE; MEMORY; GENE	Assessment of molecular defects that underlie cognitive deficits observed in mendelian disorders provides a unique opportunity to identify key regulators of human cognition. Congenital Myotonic Dystrophy 1 (cDM1), a multi-system disorder is characterized by both cognitive deficits and a spectrum of behavioral abnormalities, which include visuo-spatial memory deficits, anxiety and apathy. Decreased levels of DMPK (Dystrophia Myotonica-protein kinase), SIX5, a transcription factor or MBNL1 (Muscleblind-like 1), an RNA splice regulator have been demonstrated to contribute to distinct features of cDM1. Mouse strains in which either Dmpk, Six5 or Mbnl1 are inactivated were therefore studied to determine the relative contribution of each gene to these cognitive functions. The open field and elevated plus maze tasks were used to examine anxiety, sucrose consumption was used to assess motivation, whereas the water maze and context fear conditioning were used to examine spatial learning and memory. Cognitive and behavioral abnormalities were observed only in Mbnl1 deficient mice, which demonstrate behavior consistent with motivational deficits in the Morris water maze, a complex visuo-spatial task and in the sucrose consumption test for anhedonia. All three models of cDM1 exhibit normal spatial learning and memory. These data identify MBNL1 as a potential regulator of emotional state with decreased MBNL1 levels underlying the motivational deficits observed in cDM1.	[Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Gonda Neurosci & Genet Ctr, Los Angeles, CA 90095 USA; [Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Matynia, Anna; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Ng, Carina Hoi; Dansithong, Warunee; Chiang, Andy; Reddy, Sita] Univ So Calif, Inst Med Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Matynia, A (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Gonda Neurosci & Genet Ctr, Los Angeles, CA 90095 USA.	sitaredd@usc.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558	Muscular Dystrophy Association; NIH [RO1 NS 050861]; NIMH [P50-MH0779720]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050861] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Muscular Dystrophy Association and the NIH (RO1 NS 050861) to SR, and from the NIMH (P50-MH0779720) to AJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Antonini G, 2006, J REHABIL MED, V38, P181, DOI 10.1080/16501970500477967; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; COLOMBO G, 1992, ITAL J NEUROL SCI, V13, P53, DOI 10.1007/BF02222889; COLOMBO G, 1992, ANN NY ACAD SCI, V654, P421, DOI 10.1111/j.1749-6632.1992.tb25986.x; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; EKSTROM AB, 2008, AM J MED GENET B; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Goossens E, 2000, GENET COUNSEL, V11, P317; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Logigian EL, 2005, MUSCLE NERVE, V32, P35, DOI 10.1002/mus.20339; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Matynia A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002121; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Rubinsztein JS, 1998, J NEUROL NEUROSUR PS, V64, P510, DOI 10.1136/jnnp.64.4.510; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; TURNPENNY P, 1994, J MED GENET, V31, P300, DOI 10.1136/jmg.31.4.300; Wakimoto H, 2002, J INTERV CARD ELECTR, V7, P127, DOI 10.1023/A:1020881520353; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118	34	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9857	10.1371/journal.pone.0009857	http://dx.doi.org/10.1371/journal.pone.0009857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360842	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500004
J	Eftychiou, E				Eftychiou, Eftychia			Routes to Lenition: An Acoustic Study	PLOS ONE			English	Article							FRICATIVE-VOWEL COARTICULATION; ANTICIPATORY LABIAL COARTICULATION; PERCEPTUAL EVIDENCE; VCV UTTERANCES; SPEECH; CHILDREN; ADULTS; IDENTIFICATION; FEATURES; SPOKEN	Background: Vowel lenition and its link with coarticulation have been the subject of extensive debate in the literature. The aims of the present paper are to demonstrate how vowel lenition and coarticulation are linked in Cypriot Greek (henceforth CG), to determine the nature of vowel lenition, and to illustrate how vowel lenition and coarticulation result from aerodynamic phenomena. Methodology/Principal Findings: Eight speakers were recorded producing utterances ending in either /i/ or /u/. Acoustic measures such as V(1)F2 and stop duration were employed to determine whether lenition of the vowels results in coarticulation with the preceding consonant. Results show that there is extensive stop-vowel coarticulation in CG and that stop production is as variable as vowel production, with full vowels never co-occurring with canonical consonants, indicating the existence of two routes to lenition in CG. Conclusions/Significance: These findings suggest that lenition in the final syllable is a consequence of the supralaryngeal articulation coupled with a marginal glottal setting.	Univ Cambridge, Phonet Lab, Cambridge, England	University of Cambridge	Eftychiou, E (corresponding author), Univ Cambridge, Phonet Lab, Cambridge, England.	eftychiou.e@gmail.com			A.G. Leventis Foundation; Cambridge Commonwealth Trust	A.G. Leventis Foundation; Cambridge Commonwealth Trust	The author was supported by the A.G. Leventis Foundation and the Cambridge Commonwealth Trust during the preparation of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adank P, 2004, J ACOUST SOC AM, V116, P3099, DOI 10.1121/1.1795335; AOYAGI M, 2007, PERCEPTUAL EFFECT VO, P785; AOYAGI M, 2006, PERCEPTUAL EFFECTS V; ARVANITI A, 1994, J PHONETICS, V22, P239, DOI 10.1016/S0095-4470(19)30203-7; ARVANITI A, 1991, PHONETICS MODERN GRE; Arvaniti Amalia., 1999, J INT PHON ASSOC, V29, P167, DOI [10.1017/S0025100300006538, DOI 10.1017/S0025100300006538]; Arvaniti Amalia., 1999, J INT PHON ASSOC, V29, P173, DOI [10.1017/S002510030000654S, DOI 10.1017/S002510030000654X]; Baltazani M., 2007, THEOR APPL LING 17 I, P31; Barbosa PlinioA., 2004, J INT PHON ASSOC, V34, P227, DOI [10.1017/S0025100304001756, DOI 10.1017/S0025100304001756]; Bauer L, 2008, J LINGUIST, V44, P605, DOI 10.1017/S0022226708005331; BECKMAN M, 1984, PHONETICA, V41, P61, DOI 10.1159/000261712; BECKMAN M, 1996, IS SYLLABLE NOT SYLL, P95; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Bonneau A, 2000, J PHONETICS, V28, P495, DOI 10.1006/jpho.2001.0130; Browman C., 1989, PHONOLOGY, V6, P201, DOI [10.1017/S0952675700001019, DOI 10.1017/S0952675700001019]; Browman Catherine, 1986, PHONOLOGY YB, V3, P219, DOI [DOI 10.1017/S0952675700000658, 10.1017/S0952675700000658]; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; CRYSTAL TH, 1982, J ACOUST SOC AM, V72, P705, DOI 10.1121/1.388251; Dauer R., 1980, J INT PHON ASSOC, V10, P17, DOI [10.1017/S0025100300002073, DOI 10.1017/S0025100300002073]; DAUER RM, 1980, STRESS RHYTHM MODERN; Davidson L, 2006, PHONETICA, V63, P79, DOI 10.1159/000095304; FARNETANI E, 1999, COARTICULATION MODEL; Gordon Matthew., 1998, BERKELEY LINGUISTIC, V24, P93; KLATT DH, 1975, J SPEECH HEAR RES, V18, P686, DOI 10.1044/jshr.1804.686; Lehiste I., 1970, SUPRASEGMENTALS; LOBANOV BM, 1971, J ACOUST SOC AM, V49, P606, DOI 10.1121/1.1912396; LOUKINA A, 2008, REGIONAL PHONETIC VA; MADDIESON I, 1997, PHONETIC UNIVERSALS; MCGOWAN RS, 1988, J ACOUST SOC AM, V83, P229, DOI 10.1121/1.396425; Mo Y, 2007, P 16 INT C PHON SCI, P445; Modarresi G, 2004, J PHONETICS, V32, P291, DOI 10.1016/j.wocn.2003.11.002; MOK P, 2006, INFLUENCES VOWEL TO; Newton B.E., 1972, CYPRIOT GREEK ITS PH; Nicolaidis K., 2001, J INT PHON ASSOC, V31, P67, DOI [10.1017/S0025100301001062, DOI 10.1017/S0025100301001062]; NITTROUER S, 1989, J SPEECH HEAR RES, V32, P120, DOI 10.1044/jshr.3201.120; NITTROUER S, 1989, J ACOUST SOC AM, V86, P1266, DOI 10.1121/1.398741; OHALA JJ, 1981, ARTICULATORY CONSTRA; OHALA JJ, 1983, ORIGIN SOUND PATTERN; OHMAN SEG, 1966, J ACOUST SOC AM, V39, P151, DOI 10.1121/1.1909864; Ostry DJ, 1996, J NEUROSCI, V16, P1570; PAYNE E, 2000, CONSONANT GEMINATION; PERKELL JS, 1992, J ACOUST SOC AM, V91, P2911, DOI 10.1121/1.403778; PRICE PJ, 1980, PHONETICA, V37, P327, DOI 10.1159/000260001; REPP BH, 1989, J ACOUST SOC AM, V85, P379, DOI 10.1121/1.397689; RODGERS J, 1998, VOWEL DEVOICING ENGL; SERENO JA, 1987, J ACOUST SOC AM, V81, P512, DOI 10.1121/1.394917; SMITH C, 2003, FRENCH LANGUAGE STUD, V13, P177; SOLI SD, 1981, J ACOUST SOC AM, V70, P976, DOI 10.1121/1.387032; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Trudgill Peter, 2003, J GREEK LINGUIST, V4, P45, DOI DOI 10.1075/JGL.4.04TRU; VARDEN JK, 1998, HIGH VOWEL DEVOICING; WHALEN DH, 1981, J ACOUST SOC AM, V69, P275, DOI 10.1121/1.385348; WINITZ H, 1972, J ACOUST SOC AM, V51, P1309, DOI 10.1121/1.1912976; YENIKOMSHIAN GH, 1981, J ACOUST SOC AM, V70, P966, DOI 10.1121/1.387031; [No title captured]	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9828	10.1371/journal.pone.0009828	http://dx.doi.org/10.1371/journal.pone.0009828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FS	20351788	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894400028
J	Wu, CY; Yeh, YC; Yang, YC; Chou, C; Liu, MT; Wu, HS; Chan, JT; Hsiao, PW				Wu, Chia-Ying; Yeh, Yi-Chun; Yang, Yu-Chih; Chou, Ching; Liu, Ming-Tsan; Wu, Ho-Sheng; Chan, Jia-Tsrong; Hsiao, Pei-Wen			Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus	PLOS ONE			English	Article							CONFERRED COMPLETE PROTECTION; HUMAN-PAPILLOMAVIRUS; IMMUNE-RESPONSES; MEMBRANE ASSOCIATION; HETEROLOGOUS STRAINS; GLYCAN ANALYSIS; MATRIX PROTEIN; M1 PROTEIN; VACCINE; HEMAGGLUTININ	Background: Influenza A viruses are major human and animal pathogens with huge economic and societal impact from illness, hospitalizations, and deaths. Virus-like particles (VLPs) of influenza virus have been suggested as a vaccine candidate offering improved safety and efficacy. To develop this concept further, we established a flexible platform to efficiently generate different subtypes of mammalian-expressed influenza VLPs. Here we demonstrate that these mammalian VLPs strongly resemble the authentic viruses in structure, particle size and composition of host factors, and even glycosylation of viral antigens. Methodology/Principal Findings: In this study, a mammalian VLP system was established by stable co-expression of four influenza structural proteins (HA, NA, M1, and M2) in a Vero cell line. By replacing the surface glycoproteins of HA and NA, we converted the H3N2-VLP subtype to H5N1-VLP. After centrifugation purification of conditioned media, the particle morphologies, average sizes, and hemagglutination abilities of secreted VLPs were characterized, and the VLP constituents were identified by LC/MS/MS. Protease protection assays demonstrated that specific cellular proteins that co-purified with influenza virions were integrated into mammalian VLPs. The glycosylation profiles of mammalian VLPs as revealed by deglycosylation assays were similar to that of progeny viruses produced from Vero cells. Vaccination of mice with 2.5 mg and above of H5N1-VLP elicited H5-specific IgG1 antibodies and resulted in full protection against lethal infection with homologous virus. These results provide compelling evidence that mammalian VLPs closely emulate the exterior of authentic virus particles not only in antigen presentation but also in biological properties and should provide promising vaccine candidates. Conclusions/Significance: This flexible mammalian influenza VLP system offers a superior alternative to the conventional reverse genetic vaccine platform without concerns over inadequate presentation of immune antigens or limitations imposed by the manipulation of real viruses.	[Wu, Chia-Ying; Yeh, Yi-Chun; Yang, Yu-Chih; Chou, Ching; Hsiao, Pei-Wen] Acad Sinica, Agr Biotech Res Ctr, Taipei 115, Taiwan; [Liu, Ming-Tsan; Wu, Ho-Sheng] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Chan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; Academia Sinica - Taiwan	Wu, CY (corresponding author), Acad Sinica, Agr Biotech Res Ctr, Taipei 115, Taiwan.	pwhsiao@gate.sinica.edu.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	National Science Council [NSC 95-2745-B-001-003]; Summit Project from Academia Sinica;  [NSC 98-3112-B-001-023]	National Science Council(Ministry of Science and Technology, Taiwan); Summit Project from Academia Sinica; 	This study was financially supported by a National Science Council grant (NSC 95-2745-B-001-003) and the Summit Project from Academia Sinica. Also, Core Facilities for Proteomics Research is supported by NSC 98-3112-B-001-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Blonder J, 2004, J INVEST DERMATOL, V123, P691, DOI 10.1111/j.0022-202X.2004.23421.x; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Evans TG, 2001, J INFECT DIS, V183, P1485, DOI 10.1086/320190; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Galarza JM, 2005, VIRAL IMMUNOL, V18, P365, DOI 10.1089/vim.2005.18.365; Galarza JM, 2005, VIRAL IMMUNOL, V18, P244, DOI 10.1089/vim.2005.18.244; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; GREGORIADES A, 1981, J VIROL, V40, P323, DOI 10.1128/JVI.40.1.323-328.1981; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; JOHANSSON BE, 1989, VIROLOGY, V171, P634, DOI 10.1016/0042-6822(89)90638-7; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Li N, 2004, PROTEOMICS, V4, P3156, DOI 10.1002/pmic.200400832; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; McMurry JA, 2008, HUM VACCINES, V4, P148, DOI 10.4161/hv.4.2.5169; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nicholson KG, 2009, EXPERT REV VACCINES, V8, P373, DOI 10.1586/ERV.09.17; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; PANDEY A, 2010, HUM VACCIN, V6; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; ROBERTSON JS, 1987, J GEN VIROL, V68, P1205, DOI 10.1099/0022-1317-68-4-1205; Romanova J, 2003, VIROLOGY, V307, P90, DOI 10.1016/S0042-6822(02)00064-8; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Sambhara S, 2009, EXPERT REV VACCINES, V8, P375, DOI [10.1586/erv.09.10, 10.1586/ERV.09.10]; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Schwarzer J, 2008, ELECTROPHORESIS, V29, P4203, DOI 10.1002/elps.200800042; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Tao P, 2009, VIRAL IMMUNOL, V22, P273, DOI 10.1089/vim.2009.0017; Trollfors B, 2006, ACTA PAEDIATR, V95, P774, DOI 10.1080/08035250600729126; von Haller PD, 2001, PROTEOMICS, V1, P1010; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	48	67	84	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9784	10.1371/journal.pone.0009784	http://dx.doi.org/10.1371/journal.pone.0009784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339535	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894300017
J	Webb, RL; Findlay, KA; Green, MA; Beckett, TL; Murphy, MP				Webb, Robin L.; Findlay, Kirk A.; Green, Michael A.; Beckett, Tina L.; Murphy, M. Paul			Efficient Activation of Reconstructed Rat Embryos by Cyclin-Dependent Kinase Inhibitors	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; ADULT SOMATIC-CELLS; OOCYTE ACTIVATION; FETAL FIBROBLASTS; AMINO-ACIDS; IN-VITRO; PREIMPLANTATION DEVELOPMENT; PARTHENOGENETIC ACTIVATION; MICROTUBULE ORGANIZATION; TRANSFECTED FETAL	Background: Over the last decade a number of species, from farm animals to rodents, have been cloned using somatic cell nuclear transfer technology (SCNT). This technique has the potential to revolutionize the way that genetically modified animals are made. In its current state, the process of SCNT is very inefficient (<5% success rate), with several technical and biological hurdles hindering development. Yet, SCNT provides investigators with powerful advantages over other approaches, such as allowing for prescreening for the desired level of transgene expression and eliminating the excess production of undesirable wild-type animals. The rat plays a significant role in biomedical research, but SCNT has been problematic for this species. In this study, we address one aspect of the problem by evaluating methods of activation in artificially constructed rat embryos. Principal Findings: We demonstrate that treatment with a calcium ionophore (ionomycin) combined with a variety of cyclin-dependent kinase inhibitors is an effective way to activate rat embryos. This is in contrast to methods developed for the mouse embryo, which tolerates much less specific chemical treatments. Methods developed to activate mouse embryos do not translate well to rat embryos. Conclusions: Activation methods developed for one species will not necessarily translate to another species, even if it is closely related. Further, the parthenogenic response to chemical activators is not always a reliable indicator of how reconstructed embryos will react to the same activation method. A better understanding of rat oocyte physiology, although essential for developing better models of disease, may also provide insights that will be useful for making the SCNT process more efficient.	[Webb, Robin L.; Murphy, M. Paul] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Webb, Robin L.; Beckett, Tina L.; Murphy, M. Paul] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Findlay, Kirk A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Green, Michael A.] Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA	University of Kentucky; University of Kentucky; Mayo Clinic; University of Kentucky	Webb, RL (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	mpmurp3@email.uky.edu			Alzheimer's Association [NIRG-04-1114]; National Institutes of Health (NIH) [R01 NS058382, P20 RR020171, P01 AG005119, P30 AG005144, T32 HL086341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005144, P01AG005119] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by Alzheimer's Association grant NIRG-04-1114 (to M. P. M.). Authors were also supported by National Institutes of Health (NIH) grants R01 NS058382, P20 RR020171, P01 AG005119, P30 AG005144, and T32 HL086341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2000, MOL REPROD DEV, V55, P422, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;422::AID-MRD10&gt;3.0.CO;2-C; Alberio R, 2001, MOL REPROD DEV, V59, P371, DOI 10.1002/mrd.1043; Alberio R, 2001, INT J DEV BIOL, V45, P797; Avery B, 1998, MOL REPROD DEV, V50, P334, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;334::AID-MRD10&gt;3.0.CO;2-4; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Colman A, 1999, Cloning, V1, P185; Ferber IA, 1996, J IMMUNOL, V156, P5; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; Galli C, 2008, REPROD DOMEST ANIM, V43, P331, DOI 10.1111/j.1439-0531.2008.01181.x; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hayes E, 2001, PHYSIOL GENOMICS, V5, P193, DOI 10.1152/physiolgenomics.2001.5.4.193; Heindryckx B, 2001, Cloning, V3, P41, DOI 10.1089/15204550152475545; HOLM S, 1979, SCAND J STAT, V6, P65; Iannaccone P, 2001, ZYGOTE, V9, P135, DOI 10.1017/S0967199401001149; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Katoh M, 2004, MUTAT RES-GEN TOX EN, V560, P199, DOI 10.1016/j.mrgentox.2004.03.003; Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849; Kishigami Satoshi, 2009, V518, P207, DOI 10.1007/978-1-59745-202-1_15; Koo OJ, 2009, ZYGOTE, V17, P37, DOI 10.1017/S096719940800498X; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Lane M, 1998, HUM REPROD, V13, P991, DOI 10.1093/humrep/13.4.991; Li ZY, 2006, DEV BIOL, V293, P439, DOI 10.1016/j.ydbio.2006.02.016; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Machaty Z, 1998, REPROD FERT DEVELOP, V10, P599, DOI 10.1071/RD98048; Matsumoto H, 1998, HUM REPROD, V13, P398, DOI 10.1093/humrep/13.2.398; Matsumoto Hiromichi, 1995, Journal of Reproduction and Development, V41, P263, DOI 10.1262/jrd.41.263; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Mizutani E, 2004, J REPROD DEVELOP, V50, P139, DOI 10.1262/jrd.50.139; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Otaegui P J, 1999, Cloning, V1, P111, DOI 10.1089/15204559950019997; OUHIBI N, 1995, MOL REPROD DEV, V40, P311, DOI 10.1002/mrd.1080400307; PANITCH HS, 1987, LANCET, V1, P893; Petr J, 2000, J EXP ZOOL, V287, P304, DOI 10.1002/1097-010X(20000901)287:4&lt;304::AID-JEZ5&gt;3.0.CO;2-6; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Roh S, 2003, REPROD FERT DEVELOP, V15, P135, DOI 10.1071/RD02096; Roh S, 2009, REPROD FERT DEVELOP, V21, P882, DOI 10.1071/RD09063; Ross PJ, 2006, CLONING STEM CELLS, V8, P275, DOI 10.1089/clo.2006.8.275; SCHLEGEL R, 1990, CELL GROWTH DIFFER, V1, P171; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Shinozawa T, 2004, MOL REPROD DEV, V68, P313, DOI 10.1002/mrd.20083; Siripattarapravat K, 2009, NAT METHODS, V6, P733, DOI [10.1038/NMETH.1369, 10.1038/nmeth.1369]; Tanuma N, 1999, J NEUROIMMUNOL, V96, P73, DOI 10.1016/S0165-5728(99)00018-1; Tao T, 2000, ZYGOTE, V8, P69, DOI 10.1017/S0967199400000848; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wall R J, 2001, Cloning Stem Cells, V3, P209, DOI 10.1089/15362300152725936; Wang WH, 1999, MOL REPROD DEV, V53, P99, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;99::AID-MRD12&gt;3.0.CO;2-G; WANI NA, 2009, BIOL REPROD; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 1997, NATURE, V386, P200, DOI 10.1038/386200a0; Yo JG, 2007, CLONING STEM CELLS, V9, P382, DOI 10.1089/clo.2006.0081; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098; ZHANG X, 1990, BIOL REPROD, V42, P662, DOI 10.1095/biolreprod42.4.662; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	67	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9799	10.1371/journal.pone.0009799	http://dx.doi.org/10.1371/journal.pone.0009799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333307	Green Submitted, Green Published, gold			2022-12-27	WOS:000275809700018
J	Berge, T; Sundvold-Gjerstad, V; Granum, S; Andersen, TCB; Holthe, GB; Claesson-Welsh, L; Andreotti, AH; Inngjerdingen, M; Spurkland, A				Berge, Tone; Sundvold-Gjerstad, Vibeke; Granum, Stine; Andersen, Thorny C. B.; Holthe, Gunn B.; Claesson-Welsh, Lena; Andreotti, Amy H.; Inngjerdingen, Marit; Spurkland, Anne			T Cell Specific Adapter Protein (TSAd) Interacts with Tec Kinase ITK to Promote CXCL12 Induced Migration of Human and Murine T Cells	PLOS ONE			English	Article							TYROSINE KINASE; CUTTING EDGE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION SITES; FUNCTIONAL-ACTIVITY; FACTOR-I; CHEMOKINE; ACTIVATION; RECEPTOR; DOMAIN	Background: The chemokine CXCL12/SDF-1 alpha interacts with its G-protein coupled receptor CXCR4 to induce migration of lymphoid and endothelial cells. T cell specific adapter protein (TSAd) has been found to promote migration of Jurkat T cells through interaction with the G protein beta subunit. However, the molecular mechanisms for how TSAd influences cellular migration have not been characterized in detail. Principal Findings: We show that TSAd is required for tyrosine phosphorylation of the Lck substrate IL2-inducible T cell kinase (Itk). Presence of Itk Y511 was necessary to boost TSAd's effect on CXCL12 induced migration of Jurkat T cells. In addition, TSAd's ability to promote CXCL12-induced actin polymerization and migration of Jurkat T lymphocytes was dependent on the Itk-interaction site in the proline-rich region of TSAd. Furthermore, TSAd-deficient murine thymocytes failed to respond to CXCL12 with increased Itk phosphorylation, and displayed reduced actin polymerization and cell migration responses. Conclusion: We propose that TSAd, through its interaction with both Itk and Lck, primes Itk for Lck mediated phosphorylation and thereby regulates CXCL12 induced T cell migration and actin cytoskeleton rearrangements.	[Berge, Tone; Sundvold-Gjerstad, Vibeke; Granum, Stine; Andersen, Thorny C. B.; Holthe, Gunn B.; Inngjerdingen, Marit; Spurkland, Anne] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Andreotti, Amy H.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Oslo; Uppsala University; Iowa State University	Berge, T (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	anne.spurkland@medisin.uio.no	Spurkland, Anne/L-3369-2019	Spurkland, Anne/0000-0003-4421-0766	Norwegian Research Council [177789/V40, 155329/310]; Norwegian Cancer Society; Novo Nordisk; University of Oslo EMBIO; University of Oslo; Anders Jahre Research Foundation; Unifor; Blix Family Foundation for Medical Research	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordisk(Novo Nordisk); University of Oslo EMBIO; University of Oslo; Anders Jahre Research Foundation; Unifor; Blix Family Foundation for Medical Research	The work was supported by grants from the Norwegian Research Council (grants no 177789/V40 and 155329/310), the Norwegian Cancer Society, Novo Nordisk, University of Oslo EMBIO, University of Oslo, Anders Jahre Research Foundation, Unifor and The Blix Family Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbal C, 1999, INT IMMUNOL, V11, P1451, DOI 10.1093/intimm/11.9.1451; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Choi YB, 1999, J IMMUNOL, V163, P5242; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dai KZ, 2004, J IMMUNOL, V172, P6144, DOI 10.4049/jimmunol.172.10.6144; Fischer AM, 2004, J BIOL CHEM, V279, P29816, DOI 10.1074/jbc.M312848200; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Ghosh MC, 2009, BLOOD, V113, P575, DOI 10.1182/blood-2008-04-151803; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Granum S, 2008, J BIOL CHEM, V283, P21909, DOI 10.1074/jbc.M800871200; Granum S, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-15; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; Kolltveit KM, 2008, MOL IMMUNOL, V45, P2380, DOI 10.1016/j.molimm.2007.11.005; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagel J. E., 2004, BMC Immunology, V5; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Onai N, 2000, BLOOD, V96, P2074; Park D, 2007, BLOOD, V109, P5122, DOI 10.1182/blood-2005-10-061838; Park E, 2009, EXP MOL MED, V41, P728, DOI 10.3858/emm.2009.41.10.079; Peacock JW, 1999, J IMMUNOL, V162, P215; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Spurkland A, 1998, J BIOL CHEM, V273, P4539, DOI 10.1074/jbc.273.8.4539; Sundvold V, 2000, J IMMUNOL, V165, P2927, DOI 10.4049/jimmunol.165.6.2927; Sundvold-Gjerstad V, 2005, EUR J IMMUNOL, V35, P1612, DOI 10.1002/eji.200425638; SUNDVOLDGJERSTA.V, 2007, LYMPHOCYTE ACTIVATIO, P211; Suzuki G, 1998, INT IMMUNOL, V10, P1049, DOI 10.1093/intimm/10.8.1049; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Taub Dennis D, 2004, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0629s61; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Wu LW, 2000, J BIOL CHEM, V275, P6059, DOI 10.1074/jbc.275.9.6059; Zamarchi R, 2002, CLIN EXP IMMUNOL, V127, P321, DOI 10.1046/j.1365-2249.2002.01775.x	55	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9761	10.1371/journal.pone.0009761	http://dx.doi.org/10.1371/journal.pone.0009761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305788	Green Published, gold, Green Submitted			2022-12-27	WOS:000276456300009
J	Gurley, ES; Rahman, M; Hossain, MJ; Nahar, N; Faiz, MA; Islam, N; Sultana, R; Khatun, S; Uddin, MZ; Haider, MS; Islam, MS; Ahmed, BN; Rahman, MW; Mondal, UK; Luby, SP				Gurley, Emily S.; Rahman, Mahmudur; Hossain, M. Jahangir; Nahar, Nazmun; Faiz, M. Abul; Islam, Nazrul; Sultana, Rebeca; Khatun, Selina; Uddin, Mohammad Zashim; Haider, M. Sabbir; Islam, M. Saiful; Ahmed, Be-Nazir; Rahman, Muhammad Waliur; Mondal, Utpal Kumar; Luby, Stephen P.			Fatal Outbreak from Consuming Xanthium strumarium Seedlings during Time of Food Scarcity in Northeastern Bangladesh	PLOS ONE			English	Article							WESTERN UTTAR-PRADESH; COCKLEBUR; CHILDREN; REDEFINITION; INTOXICATION; PRINCIPLE	Background: An outbreak characterized by vomiting and rapid progression to unconsciousness and death was reported in Sylhet Distrct in northeastern Bangladesh following destructive monsoon floods in November 2007. Methods and Findings: We identified cases presenting to local hospitals and described their clinical signs and symptoms. We interviewed patients and their families to collect illness histories and generate hypotheses about exposures associated with disease. An epidemiological study was conducted in two outbreak villages to investigate risk factors for developing illness. 76 patients were identified from 9 villages; 25% (19/76) died. Common presenting symptoms included vomiting, elevated liver enzymes, and altered mental status. In-depth interviews with 33 cases revealed that 31 (94%) had consumed ghagra shak, an uncultivated plant, in the hours before illness onset. Ghagra shak was consumed as a main meal by villagers due to inaccessibility of other foods following destructive monsoon flooding and rises in global food prices. Persons who ate this plant were 34.2 times more likely (95% CI 10.2 to 115.8, p-value<0.000) than others to develop vomiting and unconsciousness during the outbreak in our multivariate model. Ghagra shak is the local name for Xanthium strumarium, or common cocklebur. Conclusions: The consumption of Xanthium strumarium seedlings in large quantities, due to inaccessibility of other foods, caused this outbreak. The toxic chemical in the plant, carboxyatratyloside, has been previously described and eating X. strumarium seeds and seedlings has been associated with fatalities in humans and livestock. Unless people are able to meet their nutritional requirements with safe foods, they will continue to be at risk for poor health outcomes beyond undernutrition.	[Gurley, Emily S.; Hossain, M. Jahangir; Nahar, Nazmun; Sultana, Rebeca; Islam, M. Saiful; Rahman, Muhammad Waliur; Mondal, Utpal Kumar; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Programme Infect Dis & Vaccine Sci, Dhaka 1000, Bangladesh; [Rahman, Mahmudur; Khatun, Selina; Haider, M. Sabbir; Ahmed, Be-Nazir] Govt Bangladesh, Minist Hlth & Family Welf, IEDCR, Dhaka, Bangladesh; [Faiz, M. Abul] Govt Bangladesh, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Dhaka, Bangladesh; [Islam, Nazrul] Bangabandhu Sheikh Mujib Med Univ, Dept Virol, Dhaka, Bangladesh; [Uddin, Mohammad Zashim] Univ Dhaka, Dept Bot, Dhaka 1000, Bangladesh; [Luby, Stephen P.] Ctr Dis Control & Prevent, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU); University of Dhaka; Centers for Disease Control & Prevention - USA	Gurley, ES (corresponding author), Int Ctr Diarrhoeal Dis Res, Programme Infect Dis & Vaccine Sci, GPO Box 128, Dhaka 1000, Bangladesh.	egurley@icddrb.org		Sultana, Rebeca/0000-0002-4180-5679; Nahar, Nazmun/0000-0002-4530-6009	Centers for Disease Control and Prevention, USA (CDC) [U01 CI000298]; Government of the People's Republic of Bangladesh (GoB); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000298] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, USA (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Government of the People's Republic of Bangladesh (GoB); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by the Centers for Disease Control and Prevention, USA (CDC), cooperative agreement U01 CI000298, and by the Government of the People's Republic of Bangladesh (GoB). ICDDR, B acknowledges with gratitude the commitment of CDC and the GoB to the authors' research efforts. Co-authors on this paper include representatives from both the Centers for Disease Control and Prevention and the GoB, the two organizations who provided financial support for this work. These co-authors, and therefore CDC and the Government of Bangladesh, were both involved in hypothesis generation, study design, data interpretation, and review of the manuscript for publication.	Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; COLE RJ, 1980, J AGR FOOD CHEM, V28, P1330, DOI 10.1021/jf60232a043; FAO, 2008, SPEC REP FAO WFP CRO; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HATCH RC, 1982, AM J VET RES, V43, P111; Loewenberg S, 2008, LANCET, V372, P1209, DOI 10.1016/S0140-6736(08)61502-0; Mendez MD, 1998, VET HUM TOXICOL, V40, P144; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; STUART BP, 1981, VET PATHOL, V18, P368, DOI 10.1177/030098588101800310; Turgut M, 2005, ANN TROP PAEDIATR, V25, P125, DOI 10.1179/146532805X45728; Vashishtha VM, 2007, INDIAN J MED RES, V125, P756; Vashishtha VM, 2007, INDIAN J MED RES, V125, P523; Vashishtha VM, 2007, INDIAN PEDIATR, V44, P522; Witte S T, 1990, J Vet Diagn Invest, V2, P263	14	20	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9756	10.1371/journal.pone.0009756	http://dx.doi.org/10.1371/journal.pone.0009756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305785	Green Submitted, gold, Green Published			2022-12-27	WOS:000276456300007
J	He, ZS; Zhang, J; Shi, XH; Hu, LL; Kong, XY; Cai, YD; Chou, KC				He, Zhisong; Zhang, Jian; Shi, Xiao-He; Hu, Le-Le; Kong, Xiangyin; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN SUBCELLULAR LOCATION; SUPPORT VECTOR MACHINES; STRUCTURAL CLASS PREDICTION; ENZYME SUBFAMILY CLASSES; COUPLED RECEPTOR CLASSES; INFLUENZA-A VIRUS; APOPTOSIS PROTEINS; DOMAIN COMPOSITION; PERSONALIZED DRUG	Background: Study of drug-target interaction networks is an important topic for drug development. It is both time-consuming and costly to determine compound-protein interactions or potential drug-target interactions by experiments alone. As a complement, the in silico prediction methods can provide us with very useful information in a timely manner. Methods/Principal Findings: To realize this, drug compounds are encoded with functional groups and proteins encoded by biological features including biochemical and physicochemical properties. The optimal feature selection procedures are adopted by means of the mRMR (Maximum Relevance Minimum Redundancy) method. Instead of classifying the proteins as a whole family, target proteins are divided into four groups: enzymes, ion channels, G-protein-coupled receptors and nuclear receptors. Thus, four independent predictors are established using the Nearest Neighbor algorithm as their operation engine, with each to predict the interactions between drugs and one of the four protein groups. As a result, the overall success rates by the jackknife cross-validation tests achieved with the four predictors are 85.48%, 80.78%, 78.49%, and 85.66%, respectively. Conclusion/Significance: Our results indicate that the network prediction system thus established is quite promising and encouraging.	[He, Zhisong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Zhang, Jian] Yangpu Dist Cent Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Shi, Xiao-He; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiao-He; Kong, Xiangyin] SJTUSM, Shanghai, Peoples R China; [He, Zhisong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University	He, ZS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009; He, Zhisong/AAD-7727-2019	He, Zhisong/0000-0002-1502-4801; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2004CB518603]; CAS [KSCX2-YW-R-112]	National Basic Research Program of China(National Basic Research Program of China); CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This research is supported by the grant of National Basic Research Program of China (2004CB518603), grant from the Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baudin B, 2000, CLIN CHEM LAB MED, V38, P853, DOI 10.1515/CCLM.2000.123; BERESFORD AP, 1993, DRUG METAB REV, V25, P503, DOI 10.3109/03602539308993984; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2006, J THEOR BIOL, V238, P395, DOI 10.1016/j.jtbi.2005.05.035; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Chou K. C., 2006, EXCLI J, V5, P55; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; Chou KC, 2006, BIOCHEM BIOPH RES CO, V339, P1015, DOI 10.1016/j.bbrc.2005.10.196; Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a; Chou KC, 2005, J PROTEOME RES, V4, P1413, DOI 10.1021/pr050087t; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 2003, BIOCHEM BIOPH RES CO, V310, P675, DOI 10.1016/j.bbrc.2003.09.053; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; CHOU KC, 1995, PROTEIN SCI, V4, P1365, DOI 10.1002/pro.5560040712; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2006, CURR MED CHEM, V13, P3263, DOI 10.2174/092986706778773077; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Diao Y, 2008, AMINO ACIDS, V34, P111, DOI 10.1007/s00726-007-0550-z; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Gao Y, 2005, AMINO ACIDS, V28, P373, DOI 10.1007/s00726-005-0206-9; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Goto S, 1998, BIOINFORMATICS, V14, P591, DOI 10.1093/bioinformatics/14.7.591; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Johnson DE, 2000, DRUG DISCOV TODAY, V5, P445, DOI 10.1016/S1359-6446(00)01559-2; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Knowles J, 2003, NAT REV DRUG DISCOV, V2, P63, DOI 10.1038/nrd986; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2007, J COMPUT CHEM, V28, P1463, DOI 10.1002/jcc.20554; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057; Liu H, 2005, BIOCHEM BIOPH RES CO, V336, P737, DOI 10.1016/j.bbrc.2005.08.160; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mardia K.V., 1979, MULTIVARIATE ANAL, P322; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Mucchielli-Giorgi MH, 1999, BIOINFORMATICS, V15, P176, DOI 10.1093/bioinformatics/15.2.176; Nagamine N, 2007, BIOINFORMATICS, V23, P2004, DOI 10.1093/bioinformatics/btm266; Nagamine N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000397; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pan YX, 2003, J PROTEIN CHEM, V22, P395, DOI 10.1023/A:1025350409648; Pelkonen O, 2008, ARCH TOXICOL, V82, P667, DOI 10.1007/s00204-008-0332-8; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Vina D, 2009, MOL PHARMACEUT, V6, P825, DOI 10.1021/mp800102c; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2009, CURR MED CHEM, V16, P232, DOI 10.2174/092986709787002727; Wang JF, 2008, CURR TOP MED CHEM, V8, P1573, DOI 10.2174/156802608786786534; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Wang T, 2008, PROTEIN PEPTIDE LETT, V15, P915, DOI 10.2174/092986608785849308; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Xiao X, 2005, AMINO ACIDS, V28, P29, DOI 10.1007/s00726-004-0154-9; Xiao X, 2008, J THEOR BIOL, V254, P691, DOI 10.1016/j.jtbi.2008.06.016; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163; Xiao ZJ, 2006, LEUKEMIA RES, V30, P54, DOI 10.1016/j.leukres.2005.05.012; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	111	267	273	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9603	10.1371/journal.pone.0009603	http://dx.doi.org/10.1371/journal.pone.0009603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300175	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620600001
J	Richardson, TO; Robinson, EJH; Christensen, K; Jensen, HJ; Franks, NR; Sendova-Franks, AB				Richardson, Thomas O.; Robinson, Elva J. H.; Christensen, Kim; Jensen, Henrik J.; Franks, Nigel R.; Sendova-Franks, Ana B.			Record Dynamics in Ants	PLOS ONE			English	Article							INFORMATION; CORPULENCE	The success of social animals (including ourselves) can be attributed to efficiencies that arise from a division of labour. Many animal societies have a communal nest which certain individuals must leave to perform external tasks, for example foraging or patrolling. Staying at home to care for young or leaving to find food is one of the most fundamental divisions of labour. It is also often a choice between safety and danger. Here we explore the regulation of departures from ant nests. We consider the extreme situation in which no one returns and show experimentally that exiting decisions seem to be governed by fluctuating record signals and ant-ant interactions. A record signal is a new 'high water mark' in the history of a system. An ant exiting the nest only when the record signal reaches a level it has never perceived before could be a very effective mechanism to postpone, until the last possible moment, a potentially fatal decision. We also show that record dynamics may be involved in first exits by individually tagged ants even when their nest mates are allowed to re-enter the nest. So record dynamics may play a role in allocating individuals to tasks, both in emergencies and in everyday life. The dynamics of several complex but purely physical systems are also based on record signals but this is the first time they have been experimentally shown in a biological system.	[Richardson, Thomas O.; Sendova-Franks, Ana B.] Univ W England, Bristol Inst Technol, Dept Math & Stat, Bristol BS16 1QY, Avon, England; [Richardson, Thomas O.; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Robinson, Elva J. H.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Robinson, Elva J. H.] Univ York, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Christensen, Kim; Jensen, Henrik J.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England; [Christensen, Kim] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London, England; [Jensen, Henrik J.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England	University of West England; University of Bristol; University of York - UK; University of York - UK; Imperial College London; Imperial College London; Imperial College London	Richardson, TO (corresponding author), Univ W England, Bristol Inst Technol, Dept Math & Stat, Bristol BS16 1QY, Avon, England.	tom.richardson@bristol.ac.uk	Richardson, Thomas/H-9898-2019; Jensen, Henrik/D-2347-2010; Robinson, Elva J H/AAC-9785-2019; Franks, Nigel/AAG-8207-2019	Richardson, Thomas/0000-0002-0220-4897; Franks, Nigel/0000-0001-8139-9604; Christensen, Kim/0000-0002-7648-7332; Robinson, Elva/0000-0003-4914-9327	Engineering and Physical Sciences Research Council [EP/E061796/1]; EPSRC [EP/D076226/1]; Engineering and Physical Sciences Research Council [EP/D076226/1, EP/E061761/1] Funding Source: researchfish; EPSRC [EP/E061796/1, EP/E061761/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TOR and ABS-F gratefully acknowledge Engineering and Physical Sciences Research Council grant EP/E061796/1. NRF and EJHR gratefully acknowledge EPSRC grant EP/D076226/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PE, 2004, COMPLEXITY, V10, P49, DOI 10.1002/cplx.20049; Balankin AS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065106; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; CAMAZINE S, 2001, SELF ORG BIOL SYSTEM, P217; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; DENNY MW, 2008, J EXP BIOL, V31, P295; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; GLICK N, 1978, AM MATH MON, V85, P2, DOI 10.2307/2978044; Hall M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011904; Holldobler B., 1990, pi; Krug J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07001; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Nevzorov V. B., 2001, RECORDS MATH THEORY; Oliveira LP, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.104526; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Seeley T., 1995, WISDOM HIVE SOCIAL P; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; Sibani P, 2003, EUROPHYS LETT, V64, P8, DOI 10.1209/epl/i2003-00109-0; SIBANI P, 1993, PHYS REV LETT, V71, P1482, DOI 10.1103/PhysRevLett.71.1482; SIBANI P, 1995, PHYS REV LETT, V75, P2055, DOI 10.1103/PhysRevLett.75.2055	23	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9621	10.1371/journal.pone.0009621	http://dx.doi.org/10.1371/journal.pone.0009621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300174	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000275620600002
J	Manning, JA; Shalini, S; Risk, JM; Day, CL; Kumar, S				Manning, Jantina A.; Shalini, Sonia; Risk, Joanna M.; Day, Catherine L.; Kumar, Sharad			A Direct Interaction with NEDD1 Regulates gamma-Tubulin Recruitment to the Centrosome	PLOS ONE			English	Article							MICROTUBULE NUCLEATION; RING COMPLEX; SPINDLE; PROTEIN; LOCALIZATION; CEP192	The centrosome is the primary microtubule organizing centre of the cell. gamma-tubulin is a core component of the centrosome and is required for microtubule nucleation and centrosome function. The recruitment of gamma-tubulin to centrosomes is mediated by its interaction with NEDD1, a WD40-repeat containing protein. Here we demonstrate that NEDD1 is likely to be oligomeric in vivo and binds directly to gamma-tubulin through a small region of just 62 residues at the carboxyl-terminus of the protein. This carboxyl-terminal domain that binds gamma-tubulin has a helical structure and is a stable tetramer in solution. Mutation of residues in NEDD1 that disrupt binding to gamma-tubulin result in a mis-localization of gamma-tubulin away from the centrosome. Hence, this study defines the binding site on NEDD1 that is required for its interaction with gamma-tubulin, and shows that this interaction is required for the correct localization of gamma-tubulin.	[Manning, Jantina A.; Shalini, Sonia; Kumar, Sharad] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Manning, Jantina A.; Kumar, Sharad] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Risk, Joanna M.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin, New Zealand	Centre for Cancer Biology; SA Pathology; University of Adelaide; University of Otago	Manning, JA (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	sharad.kumar@health.sa.gov.au	Manning, Jantina/AAP-3810-2020; Kumar, Sharad/AAX-7787-2020; Risk, Joanna/A-1998-2010	Manning, Jantina/0000-0001-9142-6135; Kumar, Sharad/0000-0001-7126-9814; Shah, Sonia Shalini/0000-0002-9106-2324; Day, Catherine/0000-0003-1571-4367	Cancer Council of South Australia; Australian Postgraduate Award; National Health and Medical Research Council of Australia (NHMRC) [399300]	Cancer Council of South Australia(Cancer Council South Australia); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a grant from the Cancer Council of South Australia (http://www.cancersa.org.au/). JAM was supported by an Australian Postgraduate Award. SK is a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) (NHMRC Grant ID 399300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; KUMAR S, 1994, J BIOL CHEM, V269, P11318; Liu L, 2008, J CELL SCI, V121, P578, DOI 10.1242/jcs.018937; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; MANNING JA, 2010, CELL DEATH IN PRESS; Manning J, 2007, INT J BIOCHEM CELL B, V39, P7, DOI 10.1016/j.biocel.2006.08.012; Manning JA, 2008, HISTOCHEM CELL BIOL, V129, P751, DOI 10.1007/s00418-008-0392-0; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Tillement V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-10; Wiese C, 1999, CURR OPIN STRUC BIOL, V9, P250, DOI 10.1016/S0959-440X(99)80035-9; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zhu YH, 2009, J FOOD SAFETY, V29, P1, DOI 10.1111/j.1745-4565.2008.00144.x	24	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9618	10.1371/journal.pone.0009618	http://dx.doi.org/10.1371/journal.pone.0009618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224777	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000275328800016
J	Saari, S; Hilvo, M; Pan, PW; Gros, G; Hanke, N; Waheed, A; Sly, WS; Parkkila, S				Saari, Sina; Hilvo, Mika; Pan, Peiwen; Gros, Gerolf; Hanke, Nina; Waheed, Abdul; Sly, William S.; Parkkila, Seppo			The Most Recently Discovered Carbonic Anhydrase, CA XV, Is Expressed in the Thick Ascending Limb of Henle and in the Collecting Ducts of Mouse Kidney	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; H+-SECRETING CELLS; SUBCELLULAR-LOCALIZATION; INTERCALATED CELLS; PROXIMAL TUBULE; KNOCKOUT MICE; RAT-KIDNEY; WILD-TYPE; IV; MEMBRANE	Background: Carbonic anhydrases (CAs) are key enzymes for physiological pH regulation, including the process of urine acidification. Previous studies have identified seven cytosolic or membrane-bound CA isozymes in the kidney. Recently, we showed by in situ hybridization that the mRNA for the most novel CA isozyme, CA XV, is present in the renal cortex. CA XV is a unique isozyme among mammalian CAs, because it has become a pseudogene in primates even though expressed in several other species. Methodology/Principal Findings: In the present study, we raised a polyclonal antibody against recombinant mouse CA XV that was produced in a baculovirus/insect cell expression system, and the antibody was used for immunohistochemical analysis in different mouse tissues. Positive immunoreactions were found only in the kidney, where the enzyme showed a very limited distribution pattern. Parallel immunostaining experiments with several other anti-CA sera indicated that CA XV is mainly expressed in the thick ascending limb of Henle and collecting ducts, and the reactions were most prominent in the cortex and outer medulla. Conclusion/Significance: Although other studies have proposed a role for CA XV in cell proliferation, its tightly limited distribution may point to a specialized function in the regulation of acid-base homeostasis.	[Saari, Sina; Hilvo, Mika; Pan, Peiwen; Parkkila, Seppo] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Saari, Sina; Parkkila, Seppo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Hilvo, Mika; Pan, Peiwen; Parkkila, Seppo] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Hilvo, Mika] VTT Tech Res Ctr Finland, Espoo, Finland; [Gros, Gerolf; Hanke, Nina] Hannover Med Sch, Zentrum Physiol, D-30623 Hannover, Germany; [Waheed, Abdul; Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Tampere University; Tampere University; Tampere University; Tampere University Hospital; VTT Technical Research Center Finland; Hannover Medical School; Saint Louis University	Saari, S (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	seppo.parkkila@uta.fi	Wahhed, Abdul/AAA-3099-2020; Hilvo, Mika/AAC-7468-2020; Gros, Gerolf/K-8421-2012	Hilvo, Mika/0000-0003-0663-5843; Saari, Sina/0000-0003-4663-022X; Parkkila, Seppo/0000-0001-7323-8536	European Union; Tampere University Hospital [9L071]; Academy of Finland	European Union(European Commission); Tampere University Hospital; Academy of Finland(Academy of Finland)	This work was supported by the grants from the European Union FP6 Programme (DeZnIT), the Competitive Research Funding of the Tampere University Hospital (Grant 9L071), and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN RJ, 1985, AM J PHYSIOL, V248, pF272, DOI 10.1152/ajprenal.1985.248.2.F272; Brion LP, 1997, AM J PHYSIOL-RENAL, V273, pF234, DOI 10.1152/ajprenal.1997.273.2.F234; BROWN D, 1990, P NATL ACAD SCI USA, V87, P7457, DOI 10.1073/pnas.87.19.7457; BROWN D, 1982, HISTOCHEMISTRY, V75, P209, DOI 10.1007/BF00496012; BROWN D, 1983, AM J PHYSIOL, V245, pF110, DOI 10.1152/ajprenal.1983.245.1.F110; CAPASSO G, 1991, J CLIN INVEST, V88, P430, DOI 10.1172/JCI115322; CAPASSO G, 1994, KIDNEY INT, V45, P1543, DOI 10.1038/ki.1994.204; Cheval L, 2006, PHYSIOL GENOMICS, V27, P271, DOI 10.1152/physiolgenomics.00069.2006; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Fleming RE, 1995, J CLIN INVEST, V96, P2907, DOI 10.1172/JCI118362; Gailly P, 2008, KIDNEY INT, V74, P52, DOI 10.1038/sj.ki.5002794; Hilvo M, 2008, CURR PHARM DESIGN, V14, P672, DOI 10.2174/138161208783877811; Hilvo M, 2005, BIOCHEM J, V392, P83, DOI 10.1042/BJ20051102; Hilvo M, 2007, CURR TOP MED CHEM, V7, P893, DOI 10.2174/156802607780636672; Hilvo M, 2009, J MED CHEM, V52, P646, DOI 10.1021/jm801267c; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Kallio H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-22; KARHUKORPI EK, 1991, ACTA HISTOCHEM, V90, P11, DOI 10.1016/S0065-1281(11)80151-0; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Kyllonen MS, 2003, J HISTOCHEM CYTOCHEM, V51, P1217, DOI 10.1177/002215540305100912; Lehtonen J, 2004, J BIOL CHEM, V279, P2719, DOI 10.1074/jbc.M308984200; LONNERHOLM G, 1984, KIDNEY INT, V25, P886, DOI 10.1038/ki.1984.106; MCKINLEY DN, 1976, BIOCHIM BIOPHYS ACTA, V445, P780, DOI 10.1016/0005-2744(76)90128-5; OOSTERWIJK E, 1986, INT J CANCER, V38, P489, DOI 10.1002/ijc.2910380406; Parkkila S, 1996, HEPATOLOGY, V24, P1104; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; Parkkila S, 2000, J HISTOCHEM CYTOCHEM, V48, P1601, DOI 10.1177/002215540004801203; Parkkila Seppo, 2002, BMC Gastroenterol, V2, P13, DOI 10.1186/1471-230X-2-13; Premikumar L, 2005, P NATL ACAD SCI USA, V102, P7493, DOI 10.1073/pnas.0502829102; Purkerson JM, 2007, KIDNEY INT, V71, P407, DOI 10.1038/sj.ki.5002071; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Scheibe RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1379, DOI 10.1369/jhc.6A7003.2006; Schwartz GJ, 2002, J NEPHROL, V15, pS61; Schwartz GJ, 2000, AM J PHYSIOL-RENAL, V278, pF894, DOI 10.1152/ajprenal.2000.278.6.F894; Sender S, 1998, J HISTOCHEM CYTOCHEM, V46, P855, DOI 10.1177/002215549804600709; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Tamai S, 1996, P NATL ACAD SCI USA, V93, P13647, DOI 10.1073/pnas.93.24.13647; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Wetzel P, 2007, AM J PHYSIOL-CELL PH, V293, pC358, DOI 10.1152/ajpcell.00057.2007; WISTRAND PJ, 1977, PFLUG ARCH EUR J PHY, V370, P121, DOI 10.1007/BF00581684; ZHU XL, 1990, J BIOL CHEM, V265, P8795	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9624	10.1371/journal.pone.0009624	http://dx.doi.org/10.1371/journal.pone.0009624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224780	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800019
J	Xu, C; Lo, A; Yammanuru, A; Tallarico, ASC; Brady, K; Murakami, A; Barteneva, N; Zhu, Q; Marasco, WA				Xu, Chen; Lo, Agnes; Yammanuru, Anuradha; Tallarico, Aimee St. Clair; Brady, Kristen; Murakami, Akikazu; Barteneva, Natasha; Zhu, Quan; Marasco, Wayne A.			Unique Biological Properties of Catalytic Domain Directed Human Anti-CAIX Antibodies Discovered through Phage-Display Technology	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CARBONIC-ANHYDRASE-IX; DIAGNOSTIC BIOMARKER; IN-VITRO; CANCER; PROTEIN; THERAPY; IDENTIFICATION; EXPRESSION; KIDNEY	Carbonic anhydrase IX (CAIX, gene G250/MN-encoded transmembrane protein) is highly expressed in various human epithelial tumors such as renal clear cell carcinoma (RCC), but absent from the corresponding normal tissues. Besides the CA signal transduction activity, CAIX may serve as a biomarker in early stages of oncogenesis and also as a reliable marker of hypoxia, which is associated with tumor resistance to chemotherapy and radiotherapy. Although results from preclinical and clinical studies have shown CAIX as a promising target for detection and therapy for RCC, only a limited number of murine monoclonal antibodies (mAbs) and one humanized mAb are available for clinical testing and development. In this study, paramagnetic proteoliposomes of CAIX (CAIX-PMPLs) were constructed and used for anti-CAIX antibody selection from our 27 billion human single-chain antibody (scFv) phage display libraries. A panel of thirteen human scFvs that specifically recognize CAIX expressed on cell surface was identified, epitope mapped primarily to the CA domain, and affinity-binding constants (KD) determined. These human anti-CAIX mAbs are diverse in their functions including induction of surface CAIX internalization into endosomes and inhibition of the carbonic anhydrase activity, the latter being a unique feature that has not been previously reported for anti-CAIX antibodies. These human anti-CAIX antibodies are important reagents for development of new immunotherapies and diagnostic tools for RCC treatment as well as extending our knowledge on the basic structure-function relationships of the CAIX molecule.	[Xu, Chen; Lo, Agnes; Yammanuru, Anuradha; Tallarico, Aimee St. Clair; Brady, Kristen; Murakami, Akikazu; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xu, Chen; Lo, Agnes; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Xu, C (corresponding author), Beijing Tri Prime Genet Engn Corp Ltd, Beijing, Peoples R China.	quan_zhu@dfci.harvard.edu; wayne_marasco@dfci.harvard.edu	Barteneva, Natasha/B-9094-2017; Barteneva, Natalie/V-3826-2019	Barteneva, Natalie/0000-0002-8109-1754; Marasco, Wayne/0000-0003-3764-4611; Murakami, Akikazu/0000-0003-3064-3237	National Institutes of Health (NIH) [R21DK072282, 1S10RR23459-01]; Kidney SPORE [5P50CA101942]; PI; National Foundation for Cancer Research;  [R21AI058804]; NATIONAL CANCER INSTITUTE [P50CA101942] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072282] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidney SPORE; PI; National Foundation for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (NIH) grants R21DK072282 to WAM, in part by the Kidney SPORE grant 5P50CA101942 where WAM is a subcontract PI, and in part by R21AI058804 to QKZ. The Flow and Imaging Cytometry Resource (FICR) and Imagestream 100 instrument used in this study were funded, in part, under NIH grant 1S10RR23459-01. The FACS Calibur used for flow cytometric analysis performed in this study was funded through the National Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Atkins M, 2005, CLIN CANCER RES, V11, P3714, DOI 10.1158/1078-0432.CCR-04-2019; Atkins MB, 2009, CANCER-AM CANCER SOC, V115, P2327, DOI 10.1002/cncr.24231; Atkins MB, 2009, CANCER-AM CANCER SOC, V115, P2247, DOI 10.1002/cncr.24229; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Baselga J, 1998, CANCER RES, V58, P2825; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bleumer I, 2003, EUR UROL, V44, P65, DOI 10.1016/S0302-2838(03)00191-X; Bleumer I, 2004, BRIT J CANCER, V90, P985, DOI 10.1038/sj.bjc.6601617; Bleumer Ivar, 2006, Can J Urol, V13 Suppl 2, P57; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brouwers AH, 2002, NUCL MED COMMUN, V23, P229, DOI 10.1097/00006231-200203000-00005; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Davis Ian D, 2007, Cancer Immun, V7, P14; Davis Ian D, 2007, Cancer Immun, V7, P13; Divgi CR, 2007, LANCET ONCOL, V8, P304, DOI 10.1016/S1470-2045(07)70044-X; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Grabmaier K, 2000, INT J CANCER, V85, P865, DOI 10.1002/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q; Guilford P, 1999, MOL MED TODAY, V5, P172, DOI 10.1016/S1357-4310(99)01461-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; LIAO SY, 1994, AM J PATHOL, V145, P598; Liao SY, 1997, CANCER RES, V57, P2827; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Michael A, 2003, LANCET ONCOL, V4, P215, DOI 10.1016/S1470-2045(03)01044-1; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; MOSTFI FK, 1998, WHO INT HISTOLOGICAL; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 2000, J CLIN ONCOL, V18, P1928, DOI 10.1200/JCO.2000.18.9.1928; OOSTERWIJK E, 1986, INT J CANCER, V38, P489, DOI 10.1002/ijc.2910380406; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; Parkkila S, 2000, P NATL ACAD SCI USA, V97, P2220, DOI 10.1073/pnas.040554897; PASTOREK J, 1994, ONCOGENE, V9, P2877; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pinthus JH, 2003, CANCER RES, V63, P2470; Powles T, 2007, LANCET ONCOL, V8, P279, DOI 10.1016/S1470-2045(07)70080-3; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Schmitt A, 2009, INT J ONCOL, V34, P629, DOI 10.3892/ijo_00000188; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Stillebroer Alexander B, 2007, Cancer Imaging, V7, P179, DOI 10.1102/1470-7330.2007.0025; Surfus JE, 1996, J IMMUNOTHER, V19, P184, DOI 10.1097/00002371-199605000-00003; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Xu C, 2007, J IMMUNOL, V179, P2408, DOI 10.4049/jimmunol.179.4.2408; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111; ZAVADA J, 1993, INT J CANCER, V54, P268, DOI 10.1002/ijc.2910540218	54	33	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9625	10.1371/journal.pone.0009625	http://dx.doi.org/10.1371/journal.pone.0009625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224781	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328800020
J	Mkrtchyan, H; Gross, M; Hinreiner, S; Polytiko, A; Manvelyan, M; Mrasek, K; Kosyakova, N; Ewers, E; Nelle, H; Liehr, T; Volleth, M; Weise, A				Mkrtchyan, Hasmik; Gross, Madeleine; Hinreiner, Sophie; Polytiko, Anna; Manvelyan, Marina; Mrasek, Kristin; Kosyakova, Nadezda; Ewers, Elisabeth; Nelle, Heike; Liehr, Thomas; Volleth, Marianne; Weise, Anja			Early Embryonic Chromosome Instability Results in Stable Mosaic Pattern in Human Tissues	PLOS ONE			English	Article							COPY-NUMBER-VARIATION	The discovery of copy number variations (CNV) in the human genome opened new perspectives on the study of the genetic causes of inherited disorders and the aetiology of common diseases. Here, a single-cell-level investigation of CNV in different human tissues led us to uncover the phenomenon of mitotically derived genomic mosaicism, which is stable in different cell types of one individual. The CNV mosaic ratios were different between the 10 individuals studied. However, they were stable in the T lymphocytes, immortalized B lymphoblastoid cells, and skin fibroblasts analyzed in each individual. Because these cell types have a common origin in the connective tissues, we suggest that mitotic changes in CNV regions may happen early during embryonic development and occur only once, after which the stable mosaic ratio is maintained throughout the differentiated tissues. This concept is further supported by a unique study of immortalized B lymphoblastoid cell lines obtained with 20 year difference from two subjects. We provide the first evidence of somatic mosaicism for CNV, with stable variation ratios in different cell types of one individual leading to the hypothesis of early embryonic chromosome instability resulting in stable mosaic pattern in human tissues. This concept has the potential to open new perspectives in personalized genetic diagnostics and can explain genetic phenomena like diminished penetrance in autosomal dominant diseases. We propose that further genomic studies should focus on the single-cell level, to better understand the aetiology of aging and diseases mediated by somatic mutations.	[Mkrtchyan, Hasmik; Gross, Madeleine; Hinreiner, Sophie; Mrasek, Kristin; Kosyakova, Nadezda; Ewers, Elisabeth; Nelle, Heike; Liehr, Thomas; Weise, Anja] Jena Univ Hosp, Inst Human Genet & Anthropol, Jena, Germany; [Polytiko, Anna] Natl Med Ctr Mother & Child, Minsk, BELARUS; [Manvelyan, Marina] Yerevan State Univ, Dept Genet & Cytol, Yerevan 375049, Armenia; [Volleth, Marianne] Inst Human Genet, Magdeburg, Germany	Friedrich Schiller University of Jena; Yerevan State University	Mkrtchyan, H (corresponding author), Jena Univ Hosp, Inst Human Genet & Anthropol, Jena, Germany.	aweise@mti.uni-jena.de	Weise, Anja/H-6669-2019; Liehr, Thomas/H-2852-2019; Mkrtchyan, Hasmik/F-7635-2012	Weise, Anja/0000-0003-3988-8919; Liehr, Thomas/0000-0003-1672-3054; Manvelyan, Marine/0000-0002-8202-0341	University of Jena; IZKF Jena; Evangelische Studienwerk e. V. Villigst; DFG [436 ARM 17/2/04]; UICC [ICR/05/030]; Deutsche Krebshilfe/Mildred Scheel Stiftung fur Krebsforschung [70-3125-Li1]; Stiftung Leukamie; Stefan-Morsch Foundation; Monika Kutzner Foundation	University of Jena; IZKF Jena; Evangelische Studienwerk e. V. Villigst; DFG(German Research Foundation (DFG)); UICC; Deutsche Krebshilfe/Mildred Scheel Stiftung fur Krebsforschung(Deutsche Krebshilfe); Stiftung Leukamie; Stefan-Morsch Foundation; Monika Kutzner Foundation	This work was supported, in part, by a grant from the University of Jena, the IZKF Jena (Start-up S16), the Evangelische Studienwerk e. V. Villigst, the DFG (436 ARM 17/2/04), the UICC (ICR/05/030), the Deutsche Krebshilfe/Mildred Scheel Stiftung fur Krebsforschung (70-3125-Li1), the Stiftung Leukamie, the Stefan-Morsch Foundation and the Monika Kutzner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bergman Y, 1999, SEMIN IMMUNOL, V11, P319, DOI 10.1006/smim.1999.0188; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; DAVIS MM, 1988, NATURE, V335, P744, DOI 10.1038/335744b0; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Iourov IY, 2006, INT REV CYTOL, V249, P143, DOI 10.1016/S0074-7696(06)49003-3; Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; ODONOVAN MR, 1995, MUTAGENESIS, V10, P371, DOI 10.1093/mutage/10.4.371; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Polityko AD, 2009, EUR J MED GENET, V52, P207, DOI 10.1016/j.ejmg.2009.03.016; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; VERMA RS, 1989, HUMAN CHROMOSOMES MA; Weise A, 2008, INT J MOL MED, V21, P189; Wu D, 2009, NAT MED, V15, P215, DOI 10.1038/nm.1862; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	24	44	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9591	10.1371/journal.pone.0009591	http://dx.doi.org/10.1371/journal.pone.0009591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231887	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300009
J	Li, YW; Tao, W; Luo, LY; Huang, DQ; Kauper, K; Stabila, P; LaVail, MM; Laties, AM; Wen, R				Li, Yiwen; Tao, Weng; Luo, Lingyu; Huang, Deqiang; Kauper, Konrad; Stabila, Paul; LaVail, Matthew M.; Laties, Alan M.; Wen, Rong			CNTF Induces Regeneration of Cone Outer Segments in a Rat Model of Retinal Degeneration	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; ROD PHOTORECEPTORS; GANGLION-CELLS; PHOTOTRANSDUCTION MACHINERY; AXONAL REGENERATION; ANIMAL-MODELS; GENE-TRANSFER; SURVIVAL; DEATH; DIFFERENTIATION	Background: Cone photoreceptors are responsible for color and central vision. In the late stage of retinitis pigmentosa and in geographic atrophy associated with age-related macular degeneration, cone degeneration eventually causes loss of central vision. In the present work, we investigated cone degeneration secondary to rod loss in the S334ter-3 transgenic rats carrying the rhodopsin mutation S334ter. Methodology/Principal Findings: Recombinant human ciliary neurotrophic factor (CNTF) was delivered by intravitreal injection to the left eye of an animal, and vehicle to the right eye. Eyes were harvested 10 days after injection. Cone outer segments (COS), and cell bodies were identified by staining with peanut agglutinin and cone arrestin antibodies in whole-mount retinas. For long-term treatment with CNTF, CNTF secreting microdevices were implanted into the left eyes at postnatal day (PD) 20 and control devices into the right eyes. Cone ERG was recorded at PD 160 from implanted animals. Our results demonstrate that an early sign of cone degeneration is the loss of COS, which concentrated in many small areas throughout the retina and is progressive with age. Treatment with CNTF induces regeneration of COS and thus reverses the degeneration process in early stages of cone degeneration. Sustained delivery of CNTF prevents cones from degeneration and helps them to maintain COS and light-sensing function. Conclusions/Significance: Loss of COS is an early sign of secondary cone degeneration whereas cell death occurs much later. At early stages, degenerating cones are capable of regenerating outer segments, indicating the reversal of the degenerative process. Sustained delivery of CNTF preserves cone cells and their function. Long-term treatment with CNTF starting at early stages of degeneration could be a viable strategy for preservation of central vision for patients with retinal degenerations.	[Li, Yiwen; Luo, Lingyu; Huang, Deqiang; Wen, Rong] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [LaVail, Matthew M.] Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA; [Tao, Weng; Kauper, Konrad; Stabila, Paul] Neurotech USA, Lincoln, RI USA; [Laties, Alan M.] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Bascom Palmer Eye Institute; University of Miami; University of California System; University of California San Francisco; University of Pennsylvania	Li, YW (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rwen@med.miami.edu			National Institutes of Health (NIH) [R01EY015289, R01EY018586, R01EY001919, R01EY006842, P30EY14801, P30EY002162]; James and Esther King Biomedical Research Program of the State of Florida; Department of Defense [08192003]; Foundation Fighting Blindness; Research to Prevent Blindness Inc.; NATIONAL EYE INSTITUTE [R01EY006842, R01EY001919, P30EY014801, R01EY018586, P30EY002162, R01EY015289] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program of the State of Florida; Department of Defense(United States Department of Defense); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants R01EY015289 (RW), R01EY018586 (RW), R01EY001919 (MML), R01EY006842 (MML), Hope for Vision (RW), a grant from the James and Esther King Biomedical Research Program of the State of Florida (YL) and a grant from the Department of Defense (USAMRMC NO: 08192003, RW). It was also supported by NIH Core Grants P30EY14801 and P30EY002162, the Foundation Fighting Blindness (MML), and unrestricted grants from Research to Prevent Blindness Inc. to Bascom Palmer Eye Institute and Beckman Vision Center. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neurotech USA supplied the CNTF intraocular implants for this study. Neurotech USA is developing CNTF intraocular implants. As some of the authors are employed by Neurotech USA, this company had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; Bhattacharya S, 2004, MOL CELL NEUROSCI, V27, P32, DOI 10.1016/j.mcn.2004.05.004; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Chrysostomou V, 2009, INVEST OPHTH VIS SCI, V50, P3017, DOI 10.1167/iovs.08-3004; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; FUHRMANN S, 1995, DEVELOPMENT, V121, P2695; Goureau O, 2004, DEV NEUROSCI-BASEL, V26, P359, DOI 10.1159/000082278; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; HAGEMAN GS, 1986, J COMP NEUROL, V249, P499, DOI 10.1002/cne.902490406; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; Kirsch M, 1996, NEUROREPORT, V7, P697, DOI 10.1097/00001756-199602290-00004; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; Liu CD, 1999, J NEUROSCI, V19, P4778; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Schulz-Key S, 2002, INVEST OPHTH VIS SCI, V43, P3099; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; TAO W, 2006, INTRAOCULAR DRUG DEL; TAO W, 2007, RETINAL DEGENERATION; Tao Weng, 2006, Expert Opin Biol Ther, V6, P717, DOI 10.1517/14712598.6.7.717; VARON S, 1979, BRAIN RES, V173, P29, DOI 10.1016/0006-8993(79)91093-X; Weise J, 2000, NEUROBIOL DIS, V7, P212, DOI 10.1006/nbdi.2000.0285; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Xie HQ, 2000, INVEST OPHTH VIS SCI, V41, P4317; Zhu XM, 2002, MOL VIS, V8, P462	46	93	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9495	10.1371/journal.pone.0009495	http://dx.doi.org/10.1371/journal.pone.0009495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209167	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300011
J	Marongiu, M; Deiana, M; Meloni, A; Marcia, L; Puddu, A; Cao, A; Schlessinger, D; Crisponi, L				Marongiu, Mara; Deiana, Manila; Meloni, Alessandra; Marcia, Loredana; Puddu, Alessandro; Cao, Antonio; Schlessinger, David; Crisponi, Laura			The Forkhead Transcription Factor Foxl2 Is Sumoylated in Both Human and Mouse: Sumoylation Affects Its Stability, Localization, and Activity	PLOS ONE			English	Article							GRANULOSA-CELLS; SEX REVERSAL; EXPRESSION; RECEPTOR; PROTEIN; SUMO-1; SOX9; SPERMATOGENESIS; INDUCTION; REPRESSES	The FOXL2 forkhead transcription factor is expressed in ovarian granulosa cells, and mutated FOXL2 causes the blepharophimosis, ptosis and epicanthus inversus syndrome (BPES) and predisposes to premature ovarian failure. Inactivation of Foxl2 in mice demonstrated its indispensability for female gonadal sex determination and ovary development and revealed its antagonism of Sox9, the effector of male testis development. To help to define the regulatory activities of FOXL2, we looked for interacting proteins. Based on yeast two-hybrid screening, we found that FOXL2 interacts with PIAS1 and UBC9, both parts of the sumoylation machinery. We showed that human FOXL2 is sumoylated in transfected cell lines, and that endogenous mouse Foxl2 is comparably sumoylated. This modification changes its cellular localization, stability and transcriptional activity. It is intriguing that similar sumoylation and regulatory consequences have also been reported for SOX9, the male counterpart of FOXL2 in somatic gonadal tissues.	[Marongiu, Mara; Deiana, Manila; Meloni, Alessandra; Marcia, Loredana; Puddu, Alessandro; Cao, Antonio; Crisponi, Laura] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [Puddu, Alessandro] Univ Cagliari, Cagliari, Italy; [Schlessinger, David] NIA, NIH, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Marongiu, M (corresponding author), CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy.	laura.crisponi@inn.cnr.it	Marongiu, Mara/H-9437-2019; Crisponi, Laura/AAC-2642-2019	Marongiu, Mara/0000-0002-7321-2384; Crisponi, Laura/0000-0001-9128-8537; Puddu, Alessandro/0000-0002-9415-0477	Telethon Grant [GP0049Y01]; National Institute on Aging, National Institutes of Health (NIH); NATIONAL INSTITUTE ON AGING [ZIAAG000647] Funding Source: NIH RePORTER	Telethon Grant(Fondazione Telethon); National Institute on Aging, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Telethon Grant GP0049Y01 to LC and in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health (NIH) to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benayoun BA, 2008, PROTEOMICS, V8, P3118, DOI 10.1002/pmic.200800084; Crisponi L, 2004, GENOMICS, V83, P757, DOI 10.1016/j.ygeno.2003.11.010; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Oh HJ, 2007, MOL REPROD DEV, V74, P1446, DOI 10.1002/mrd.20737; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Ottolenghi C, 2007, BIOESSAYS, V29, P15, DOI 10.1002/bies.20515; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Shao RJ, 2006, MOL REPROD DEV, V73, P50, DOI 10.1002/mrd.20386; Shao RJ, 2004, ENDOCRINOLOGY, V145, P384, DOI 10.1210/en.2003-0527; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Vigodner M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1022, DOI 10.1152/ajpendo.00527.2005; Vigodner M, 2005, DEV BIOL, V282, P480, DOI 10.1016/j.ydbio.2005.03.034; Voet D., 2005, BIOCHEMISTRY-US; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	23	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9477	10.1371/journal.pone.0009477	http://dx.doi.org/10.1371/journal.pone.0009477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209145	Green Submitted, gold, Green Published			2022-12-27	WOS:000275063300004
J	Apri, M; Molenaar, J; de Gee, M; van Voorn, G				Apri, Mochamad; Molenaar, Jaap; de Gee, Maarten; van Voorn, George			Efficient Estimation of the Robustness Region of Biological Models with Oscillatory Behavior	PLOS ONE			English	Article							NETWORK; CELLS	Robustness is an essential feature of biological systems, and any mathematical model that describes such a system should reflect this feature. Especially, persistence of oscillatory behavior is an important issue. A benchmark model for this phenomenon is the Laub-Loomis model, a nonlinear model for cAMP oscillations in Dictyostelium discoideum. This model captures the most important features of biomolecular networks oscillating at constant frequencies. Nevertheless, the robustness of its oscillatory behavior is not yet fully understood. Given a system that exhibits oscillating behavior for some set of parameters, the central question of robustness is how far the parameters may be changed, such that the qualitative behavior does not change. The determination of such a "robustness region'' in parameter space is an intricate task. If the number of parameters is high, it may be also time consuming. In the literature, several methods are proposed that partially tackle this problem. For example, some methods only detect particular bifurcations, or only find a relatively small boxshaped estimate for an irregularly shaped robustness region. Here, we present an approach that is much more general, and is especially designed to be efficient for systems with a large number of parameters. As an illustration, we apply the method first to a well understood low-dimensional system, the Rosenzweig-MacArthur model. This is a predator-prey model featuring satiation of the predator. It has only two parameters and its bifurcation diagram is available in the literature. We find a good agreement with the existing knowledge about this model. When we apply the new method to the high dimensional Laub-Loomis model, we obtain a much larger robustness region than reported earlier in the literature. This clearly demonstrates the power of our method. From the results, we conclude that the biological system underlying is much more robust than was realized until now.	[Apri, Mochamad; Molenaar, Jaap; de Gee, Maarten; van Voorn, George] Wageningen Univ, Dept Math & Stat Methods, Wageningen, Netherlands; [Apri, Mochamad; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands	Wageningen University & Research	Apri, M (corresponding author), Wageningen Univ, Dept Math & Stat Methods, Wageningen, Netherlands.	mochamad.apri@wur.nl		Apri, Mochamad/0000-0001-7057-4323				Alon U., 2006, INTRO SYSTEMS BIOL D; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Boer MP, 2001, MATH BIOSCI, V169, P109, DOI 10.1016/S0025-5564(00)00058-4; Doedel E., 2007, CONTINUATION BIFURCA; Ghaemi R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-95; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kim J, 2006, IEE P SYST BIOL, V153, P96, DOI 10.1049/ip-syb:20050024; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KLEBANOFF A, 1994, J MATH BIOL, V32, P427, DOI 10.1007/BF00160167; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; Kuznetsov YA, 1996, MATH BIOSCI, V134, P1, DOI 10.1016/0025-5564(95)00104-2; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Ma L, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-38; Mattheij R, 2002, ORDINARY DIFFERENTIA; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nayfeh A.H., 2004, APPL NONLINEAR DYNAM; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Torrini G, 1998, CHAOS SOLITON FRACT, V9, P121, DOI 10.1016/S0960-0779(97)00055-6; Verhulst F. F., 1996, NONLINEAR DIFFERENTI, DOI 10.1007978-3-642-61453-8; Zhou K., 1996, ROBUST OPTIMAL CONTR	21	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9865	10.1371/journal.pone.0009865	http://dx.doi.org/10.1371/journal.pone.0009865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368983	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200005
J	Rey, JM				Rey, Jose-Manuel			A Mathematical Model of Sentimental Dynamics Accounting for Marital Dissolution	PLOS ONE			English	Article							DIVORCE; HAPPINESS; SIMILARITY; MARRIAGE	Background: Marital dissolution is ubiquitous in western societies. It poses major scientific and sociological problems both in theoretical and therapeutic terms. Scholars and therapists agree on the existence of a sort of second law of thermodynamics for sentimental relationships. Effort is required to sustain them. Love is not enough. Methodology/Principal Findings: Building on a simple version of the second law we use optimal control theory as a novel approach to model sentimental dynamics. Our analysis is consistent with sociological data. We show that, when both partners have similar emotional attributes, there is an optimal effort policy yielding a durable happy union. This policy is prey to structural destabilization resulting from a combination of two factors: there is an effort gap because the optimal policy always entails discomfort and there is a tendency to lower effort to non-sustaining levels due to the instability of the dynamics. Conclusions/Significance: These mathematical facts implied by the model unveil an underlying mechanism that may explain couple disruption in real scenarios. Within this framework the apparent paradox that a union consistently planned to last forever will probably break up is explained as a mechanistic consequence of the second law.	Univ Complutense, Dept Anal Econom, E-28040 Madrid, Spain	Complutense University of Madrid	Rey, JM (corresponding author), Univ Complutense, Dept Anal Econom, E-28040 Madrid, Spain.	j-man@ccee.ucm.es	Rey, Jose-Manuel/AAU-9668-2021		Ministerio de Ciencia e Innovacion (Spain) [MTM2006-02372, MTM2009-12672]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by Ministerio de Ciencia e Innovacion (Spain) through MTM2006-02372 and MTM2009-12672. The funders had no role in research design, decision to publish, or preparation of the manuscript.	Beck A.T., 1988, LOVE IS NEVER ENOUGH; Becker Gary Stanley, 1991, TREATISE FAMILY; BERSCHEID E, 1985, HDB SOCIAL PSYCHOL; Bramlett M. D., 2002, VITAL HLTH STAT, V23; Buston PM, 2003, P NATL ACAD SCI USA, V100, P8805, DOI 10.1073/pnas.1533220100; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; COOMBS RH, 1991, FAM RELAT, V40, P97, DOI 10.2307/585665; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Fisher H., 2005, WHY WE LOVE NATURE C; FREEDMAN J, 1978, HAPPY PEOPLE; GIGY L, 1992, J DIVORCE REMARRIAGE, V18, P169; Gonzaga GC, 2007, J PERS SOC PSYCHOL, V93, P34, DOI 10.1037/0022-3514.93.1.34; Gottman J.M., 2002, MATH MARRIAGE DYNAMI; *IFP, 2008, REP EV FAM EU27; Impett EA, 2005, J PERS SOC PSYCHOL, V89, P327, DOI 10.1037/0022-3514.89.3.327; Jacobson N.S., 1979, MARITAL THERAPY; Kreider R.M., 2002, CURRENT POPULATION R; MARTIN TC, 1989, DEMOGRAPHY, V26, P37, DOI 10.2307/2061492; Myers D.G., 1999, WELL BEING FDN HEDON; Pettijohn TF, 1996, PSYCHOL REP, V79, P759, DOI 10.2466/pr0.1996.79.3.759; Ruggles S, 1997, DEMOGRAPHY, V34, P455, DOI 10.2307/3038300; RUSHTON JP, 1989, BEHAV BRAIN SCI, V12, P503, DOI 10.1017/S0140525X00057320; Seierstad A., 1999, OPTIMAL CONTROL THEO; Stevenson B, 2007, J ECON PERSPECT, V21, P27, DOI 10.1257/jep.21.2.27; Strogatz S.H., 1988, MATH MAG, V61, P35, DOI [10.1080/0025570X.1988.11977342, DOI 10.1080/0025570X.1988.11977342, DOI 10.2307/2690328]; Stutzer A., 2006, J SOCIO EC, V35, P326, DOI [10.1016/j.socec.2005.11.043, DOI 10.1016/J.SOCEC.2005.11.043, DOI 10.1016/j.socec.2005.11.043]; Sweet J. A, 2002, NATL SURVEY FAMILIES; WHILTON S, 2002, ADV PERSONAL RELATIO, P156; Whyte MK., 1990, DATING MATING MARRIA; Zimmermann AC, 2006, POPUL DEV REV, V32, P511, DOI 10.1111/j.1728-4457.2006.00135.x	30	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9881	10.1371/journal.pone.0009881	http://dx.doi.org/10.1371/journal.pone.0009881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	576RA	20360987	Green Published, gold			2022-12-27	WOS:000276163200002
J	Neuman, RJ; Wasson, J; Atzmon, G; Wainstein, J; Yerushalmi, Y; Cohen, J; Barzilai, N; Blech, I; Glaser, B; Permutt, MA				Neuman, Rosalind J.; Wasson, Jon; Atzmon, Gil; Wainstein, Julio; Yerushalmi, Yair; Cohen, Joseph; Barzilai, Nir; Blech, Ilana; Glaser, Benjamin; Permutt, M. Alan			Gene-Gene Interactions Lead to Higher Risk for Development of Type 2 Diabetes in an Ashkenazi Jewish Population	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTIONS; EXCEPTIONAL LONGEVITY; COMMON VARIANTS; HUMAN-DISEASES; WFS1 GENE; EPISTASIS; KCNJ11; POLYMORPHISM	Background: Evidence has accumulated that multiple genetic and environmental factors play important roles in determining susceptibility to type 2 diabetes (T2D). Although variants from candidate genes have become prime targets for genetic analysis, few studies have considered their interplay. Our goal was to evaluate interactions among SNPs within genes frequently identified as associated with T2D. Methods/Principal Findings: Logistic regression was used to study interactions among 4 SNPs, one each from HNF4A[rs1884613], TCF7L2[rs12255372], WFS1[rs10010131], and KCNJ11[rs5219] in a case-control Ashkenazi sample of 974 diabetic subjects and 896 controls. Nonparametric multifactor dimensionality reduction (MDR) and generalized MDR (GMDR) were used to confirm findings from the logistic regression analysis. HNF4A and WFS1 SNPs were associated with T2D in logistic regression analyses [P<0.0001, P<0.0002, respectively]. Interaction between these SNPs were also strong using parametric or nonparametric methods: the unadjusted odds of being affected with T2D was 3 times greater in subjects with the HNF4A and WFS1 risk alleles than those without either (95% CI = [1.7-5.3]; P <= 0.0001). Although the univariate association between the TCF7L2 SNP and T2D was relatively modest [P = 0.02], when paired with the HNF4A SNP, the OR for subjects with risk alleles in both SNPs was 2.4 [95% CI = 1.7-3.4; P <= 0.0001]. The KCNJ11 variant reached significance only when paired with either the HNF4A or WFSI SNPs: unadjusted ORs were 2.0 [95% CI = 1.4-2.8; P <= 0.0001] and 2.3 [95% CI = 1.2-4.4; P <= 0.0001], respectively. MDR and GMDR results were consistent with the parametric findings. Conclusions: These results provide evidence of strong independent associations between T2D and SNPs in HNF4A and WFS1 and their interaction in our Ashkenazi sample. We also observed an interaction in the nonparametric analysis between the HNF4A and KCNJ11 SNPs (P <= 0.001), demonstrating that an independently non-significant variant may interact with another variant resulting in an increased disease risk.	[Neuman, Rosalind J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Neuman, Rosalind J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wasson, Jon; Permutt, M. Alan] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med & Genet, Inst Aging, New York, NY USA; [Blech, Ilana; Glaser, Benjamin] Hadassah Hebrew Univ, Endocrinol & Metab Serv, Med Ctr, Jerusalem, Israel; [Wainstein, Julio] E Wolfson Med Ctr, Diabet Unit, Holon, Israel; [Yerushalmi, Yair] Clalit Hlth Org, Endocrinol Unit, Tel Aviv, Israel; [Cohen, Joseph] Macabbi Hlth Serv, Diabet Clin, Tel Aviv, Israel	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Yeshiva University; Hebrew University of Jerusalem; Hadassah University Medical Center; Clalit Health Services	Neuman, RJ (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	rneuman@wustl.edu	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000	Israel Ministry of Health; Russell Berrie Foundation; Paul Beeson Physician Faculty Scholar in Aging Award; Ellison Medical Foundation Senior Scholar; National Institutes of Health [2R01DK49583-10A1, RO1s 18728-01A1 AG024391, AG7992, PO1 AG027734, M01-RR12248]; Diabetes Research and Training Cente [DK 20541]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR012248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK049583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024391, P01AG027734, R01AG007992] Funding Source: NIH RePORTER	Israel Ministry of Health; Russell Berrie Foundation; Paul Beeson Physician Faculty Scholar in Aging Award; Ellison Medical Foundation Senior Scholar; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Training Cente; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the chief scientist of the Israel Ministry of Health [B. G.], the Russell Berrie Foundation and D-Cure, Diabetes Care in Israel [B. G.], the Paul Beeson Physician Faculty Scholar in Aging Award, the Ellison Medical Foundation Senior Scholar Award, National Institutes of Health (NIH) 2R01DK49583-10A1 [M. A. P.], NIH RO1s 18728-01A1 AG024391, and AG7992, PO1 AG027734, Paul Beeson Physician Faculty Scholar in Aging Award, the Ellison Medical Foundation Senior Scholar Award, Glenn Award for Research in Biological Mechanisms of Aging, General Clinical Research Center [NIH M01-RR12248] and Diabetes Research and Training Center (DK 20541) [N. B.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmadi O, 2008, DIABETES-METAB RES, V24, P137, DOI 10.1002/dmrr.777; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Florez JC, 2008, DIABETOLOGIA, V51, P451, DOI 10.1007/s00125-007-0891-x; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Franks PW, 2008, DIABETOLOGIA, V51, P458, DOI 10.1007/s00125-007-0887-6; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant RW, 2009, DIABETES CARE, V32, P1107, DOI 10.2337/dc08-2171; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hanlon P, 2006, PHYSIOL GENOMICS, V26, P46, DOI 10.1152/physiolgenomics.00247.2005; Hansen SK, 2005, J CLIN ENDOCR METAB, V90, P3629, DOI 10.1210/jc.2004-1942; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jarvis JP, 2009, J EVOLUTION BIOL, V22, P1658, DOI 10.1111/j.1420-9101.2009.01776.x; JORDE LB, 1992, GENETIC DIVERSITY AMONG JEWS, P305; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Love-Gregory L, 2003, DIABETOLOGIA, V46, P136, DOI 10.1007/s00125-002-0947-x; Mensink Marco, 2005, Metabolic Syndrome and Related Disorders, V3, P26, DOI 10.1089/met.2005.3.26; Minton JAL, 2002, DIABETES, V51, P1287, DOI 10.2337/diabetes.51.4.1287; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; Qi L, 2007, DIABETIC MED, V24, P1187, DOI 10.1111/j.1464-5491.2007.02255.x; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Sparso T, 2009, DIABETOLOGIA, V52, P1308, DOI 10.1007/s00125-009-1362-3; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Wasson J, 2002, BIOTECHNIQUES, V32, P1144, DOI 10.2144/02325dd04; Weedon MN, 2007, DIABETIC MED, V24, P1062, DOI 10.1111/j.1464-5491.2007.02258.x; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202	46	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9903	10.1371/journal.pone.0009903	http://dx.doi.org/10.1371/journal.pone.0009903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361036	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600009
J	van Noort, SP; Nunes, MC; Weedall, GD; Hviid, L; Gomes, MGM				van Noort, Sander P.; Nunes, Marta C.; Weedall, Gareth D.; Hviid, Lars; Gomes, M. Gabriela M.			Immune Selection and Within-Host Competition Can Structure the Repertoire of Variant Surface Antigens in Plasmodium falciparum - A Mathematical Model	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; NATURALLY ACQUIRED-IMMUNITY; SEVERE CHILDHOOD MALARIA; VAR GENES; INFECTED ERYTHROCYTES; DIFFERENTIAL EXPRESSION; CLINICAL IMMUNITY; ANTIBODY-RESPONSE; HUMAN VOLUNTEERS; SEVERE DISEASE	Background: The evolutionary mechanisms structuring the expression pattern of variant surface antigen (VSA) families that allow pathogens to evade immune responses and establish chronic and repeated infections pose major challenges to theoretical research. In Plasmodium falciparum, the best-studied VSA family is erythrocyte membrane protein 1 (PfEMP1). Each parasite genome encodes about 60 PfEMP1 variants, which are important virulence factors and major targets of host antibody responses. Transcriptional switching is the basis of clonal PfEMP1 variation and immune evasion. A relatively conserved subset of PfEMP1 variants tends to dominate in non-immune patients and in patients with severe malaria, while more diverse subsets relate to uncomplicated infection and higher levels of pre-existing protective immunity. Methodology/Principal Findings: Here, we use the available molecular and serological evidence regarding VSAs, in particular PfEMP1, to formulate a mathematical model of the evolutionary mechanisms shaping VSA organization and expression patterns. The model integrates the transmission dynamics between hosts and the competitive interactions within hosts, based on the hypothesis that the VSAs can be organized into so-called dominance blocks, which characterize their competitive potential. The model reproduces immunological trends observed in field data, and predicts an evolutionary stable balance between inter-clonally conserved dominance blocks that are highly competitive within-host and diverse blocks that are favoured by immune selection at the population level. Conclusions/Significance: The application of a monotonic dominance profile to VSAs encoded by a gene family generates two opposing selective forces and, consequently, two distinct clusters of genes emerge in adaptation to naive and partially immune hosts, respectively.	[van Noort, Sander P.; Weedall, Gareth D.; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Nunes, Marta C.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Hviid, Lars] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Hviid, Lars] Rigshosp, DK-2100 Copenhagen, Denmark	Instituto Gulbenkian de Ciencia; University of Witwatersrand; University of Copenhagen; Rigshospitalet; University of Copenhagen	van Noort, SP (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	vnoort@igc.gulbenkian.pt	Hviid, Lars/G-3705-2012; Gomes, Gabriela/H-7218-2014	Hviid, Lars/0000-0002-1698-4927; Gomes, Gabriela/0000-0002-1454-4979; Weedall, Gareth/0000-0002-8927-1063; Nunes, Marta/0000-0003-3788-878X	Fundacion para a Ciencia e a Tecnologia (FCT); European Commission [MEXT-CT-2004-14338, EC-ICT-231807]	Fundacion para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by Fundacion para a Ciencia e a Tecnologia (FCT) and the European Commission (grants MEXT-CT-2004-14338 and EC-ICT-231807 (EPIWORK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Buckee CO, 2009, P ROY SOC B-BIOL SCI, V276, P477, DOI 10.1098/rspb.2008.1122; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kirchgessner AL, 2002, ENDOCR REV, V23, P1, DOI 10.1210/er.23.1.1; Krause DR, 2007, INFECT IMMUN, V75, P5967, DOI 10.1128/IAI.00327-07; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nielsen MA, 2005, J INFECT DIS, V192, P520, DOI 10.1086/431678; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Phiri H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-214; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-18; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Staalsoe T, 2002, J INFECT DIS, V186, P719, DOI 10.1086/342390; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; WARIMWE G, 2009, P NATL ACAD IN PRESS	49	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9778	10.1371/journal.pone.0009778	http://dx.doi.org/10.1371/journal.pone.0009778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339540	Green Submitted, gold, Green Published			2022-12-27	WOS:000275894300015
J	Cooper, J; Yazvenko, N; Peyvan, K; Maurer, K; Taitt, CR; Lyon, W; Danley, DL				Cooper, John; Yazvenko, Nina; Peyvan, Kia; Maurer, Karl; Taitt, Chris R.; Lyon, Wanda; Danley, David L.			Targeted Deposition of Antibodies on a Multiplex CMOS Microarray and Optimization of a Sensitive Immunoassay Using Electrochemical Detection	PLOS ONE			English	Article								Background: The CombiMatrix ElectraSense (R) microarray is a highly multiplex, complementary metal oxide semiconductor with 12,544 electrodes that are individually addressable. This platform is commercially available as a custom DNA microarray; and, in this configuration, it has also been used to tether antibodies (Abs) specifically on electrodes using complementary DNA sequences conjugated to the Abs. Methodology/Principal Findings: An empirical method is described for developing and optimizing immunoassays on the CombiMatrix ElectraSense (R) microarray based upon targeted deposition of polypyrrole (Ppy) and capture Ab. This process was automated using instrumentation that can selectively apply a potential or current to individual electrodes and also measure current generated at the electrodes by an enzyme-enhanced electrochemical (ECD) reaction. By designating groups of electrodes on the array for different Ppy deposition conditions, we determined that the sensitivity and specificity of a sandwich immunoassay for staphylococcal enterotoxin B (SEB) is influenced by the application of different voltages or currents and the application time. The sandwich immunoassay used a capture Ab adsorbed to the Ppy and a reporter Ab labeled for fluorescence detection or ECD, and results from these methods of detection were different. Conclusions/Significance: Using Ppy deposition conditions for optimum results, the lower limit of detection for SEB using the ECD assay was between 0.003 and 0.01 pg/ml, which represents an order of magnitude improvement over a conventional enzyme-linked immunosorbant assay. In the absence of understanding the variables and complexities that affect assay performance, this highly multiplexed electrode array provided a rapid, high throughput, and empirical approach for developing a sensitive immunoassay.	[Cooper, John; Yazvenko, Nina; Peyvan, Kia; Maurer, Karl; Danley, David L.] CombiMatrix Corp, Mukilteo, WA 98275 USA; [Taitt, Chris R.] USN, Res Lab, Washington, DC 20375 USA; [Lyon, Wanda] USAF, Res Lab, Dayton, OH USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Air Force	Cooper, J (corresponding author), CombiMatrix Corp, Mukilteo, WA 98275 USA.	ddanley@combimatrix.com		Taitt, Chris/0000-0002-0125-9239	Defense Threat Reduction Agency [W911SR-08-C-0055]; Air Force Research Laboratory [FA8650-09-C-6037]; CombiMatrix Corporation	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Air Force Research Laboratory; CombiMatrix Corporation	This study was funded by contract W911SR-08-C-0055 from the Defense Threat Reduction Agency, by contract FA8650-09-C-6037 from the Air Force Research Laboratory, and by CombiMatrix Corporation. CombiMatrix provided funds to conduct and administer this study for which it was reimbursed (materials, salaries, overhead, and profit) through the two government contracts. The Defense Threat Reduction Agency did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. W. L. is a consultant to the contracting officer's representative on the Air Force contract. CombiMatrix is a commercial for-profit company, and key investigators (J. C., N. Y., K. M., and D. L. D.) are employees of the company. Permission from supervisors was obtained to begin the study, and permission from the company's legal department was obtained to submit the manuscript. Scientific staff designed the study, collected and analyzed the data, and wrote the manuscript.	Bakker E, 2004, ANAL CHEM, V76, P3285, DOI 10.1021/ac049580z; Cosnier S, 1999, BIOSENS BIOELECTRON, V14, P443, DOI 10.1016/S0956-5663(99)00024-X; Diaz-Gonzalez M, 2005, ELECTROANAL, V17, P1901, DOI 10.1002/elan.200503357; Dill K, 2004, BIOSENS BIOELECTRON, V20, P736, DOI 10.1016/j.bios.2004.06.049; Dill K, 2004, J BIOCHEM BIOPH METH, V59, P181, DOI 10.1016/j.jbbm.2004.01.011; Dill K, 2001, ANAL CHIM ACTA, V444, P69, DOI 10.1016/S0003-2670(01)01155-2; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Labib M, 2009, ANAL BIOANAL CHEM, V393, P1539, DOI 10.1007/s00216-008-2559-x; Maurer K, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000034; Palmisano F, 2000, FRESEN J ANAL CHEM, V366, P586; Rahman MA, 2008, SENSORS-BASEL, V8, P118, DOI 10.3390/s8010118; Ramanaviciene A, 2002, CRIT REV ANAL CHEM, V32, P245, DOI 10.1080/10408340290765542; Ramanavicius A, 2006, ELECTROCHIM ACTA, V51, P6025, DOI 10.1016/j.electacta.2005.11.052; Roth KM, 2006, ELECTROANAL, V18, P1982, DOI 10.1002/elan.200603603; Sadik OA, 2003, MICROCHIM ACTA, V143, P187, DOI 10.1007/s00604-003-0057-6; Sadki S, 2000, CHEM SOC REV, V29, P283, DOI 10.1039/a807124a; Trojanowicz M, 2003, MICROCHIM ACTA, V143, P75, DOI 10.1007/s00604-003-0066-5; Vestergaard M, 2007, SENSORS-BASEL, V7, P3442, DOI 10.3390/s7123442; VIDAL JC, 2003, MICROCHIMICA ACTA, V143; Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2	20	11	12	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9781	10.1371/journal.pone.0009781	http://dx.doi.org/10.1371/journal.pone.0009781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333309	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809700016
J	Kang, J; Robinson, HPC; Feng, JF				Kang, Jing; Robinson, Hugh P. C.; Feng, Jianfeng			Diversity of Intrinsic Frequency Encoding Patterns in Rat Cortical Neurons-Mechanisms and Possible Functions	PLOS ONE			English	Article							FAST-SPIKING CELLS; PARAMETRIC WORKING-MEMORY; WEAKLY ELECTRIC FISH; PREFRONTAL CORTEX; GNATHONEMUS-PETERSII; SYNAPTIC INPUT; NEURAL CODES; MODEL; DISCRIMINATION; RESPONSES	Extracellular recordings of single neurons in primary and secondary somatosensory cortices of monkeys in vivo have shown that their firing rate can increase, decrease, or remain constant in different cells, as the external stimulus frequency increases. We observed similar intrinsic firing patterns (increasing, decreasing or constant) in rat somatosensory cortex in vitro, when stimulated with oscillatory input using conductance injection (dynamic clamp). The underlying mechanism of this observation is not obvious, and presents a challenge for mathematical modelling. We propose a simple principle for describing this phenomenon using a leaky integrate-and-fire model with sinusoidal input, an intrinsic oscillation and Poisson noise. Additional enhancement of the gain of encoding could be achieved by local network connections amongst diverse intrinsic response patterns. Our work sheds light on the possible cellular and network mechanisms underlying these opposing neuronal responses, which serve to enhance signal detection.	[Kang, Jing; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Robinson, Hugh P. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Warwick; Fudan University; University of Cambridge	Kang, J (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	hpcr@cam.ac.uk; Jianfeng.Feng@warwick.ac.uk		Kang, Jing/0000-0002-2770-1099; feng, jianfeng/0000-0002-9328-5732; Robinson, Hugh/0000-0002-5048-9954	Warwick Postgraduate Research Fellowship; Institute of Advance Study Early Career Fellowship; Engineering and Physical Sciences Research Council, United Kingdom; European Commission [012788]	Warwick Postgraduate Research Fellowship; Institute of Advance Study Early Career Fellowship; Engineering and Physical Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was funded by the Warwick Postgraduate Research Fellowship, Institute of Advance Study Early Career Fellowship, Code, Analysis, Repository and Modelling for e-Neuroscience (Engineering and Physical Sciences Research Council, United Kingdom), and European Commission Framework Program 6 Grant (Contract No. 012788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brown D, 1999, PHYS REV LETT, V82, P4731, DOI 10.1103/PhysRevLett.82.4731; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Destexhe A, 2009, DYNAMIC CLAMP PRINCI; Feng HF, 2001, NEURAL NETWORKS, V14, P955, DOI 10.1016/S0893-6080(01)00074-0; Feng JF, 2004, J COMPUT NEUROSCI, V16, P237, DOI 10.1023/B:JCNS.0000025687.78916.5a; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goenechea L, 2004, J COMP PHYSIOL A, V190, P907, DOI 10.1007/s00359-004-0548-x; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Miller P, 2006, P NATL ACAD SCI USA, V103, P201, DOI 10.1073/pnas.0508072103; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; SAKMANN B, 1995, SINGLE CHANNEL RECOR, V22; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Tateno T, 2006, J NEUROPHYSIOL, V95, P2650, DOI 10.1152/jn.00683.2005; Tateno T, 2009, J NEUROPHYSIOL, V101, P1056, DOI 10.1152/jn.91057.2008; VONDEREMDE G, 1992, J COMP PHYSIOL A, V171, P683, DOI 10.1007/BF00194116; VONDEREMDE G, 1994, J COMP PHYSIOL A, V175, P83, DOI 10.1007/BF00217439; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9608	10.1371/journal.pone.0009608	http://dx.doi.org/10.1371/journal.pone.0009608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333256	Green Published, Green Submitted, gold			2022-12-27	WOS:000275809700004
J	Tortosa, P; Charlat, S; Labbe, P; Dehecq, JS; Barre, H; Weill, M				Tortosa, Pablo; Charlat, Sylvain; Labbe, Pierrick; Dehecq, Jean-Sebastien; Barre, Helene; Weill, Mylene			Wolbachia Age-Sex-Specific Density in Aedes albopictus: A Host Evolutionary Response to Cytoplasmic Incompatibility?	PLOS ONE			English	Article							DROSOPHILA-SIMULANS; INFECTION; DIPTERA; CHIKUNGUNYA; CULICIDAE; POPULATIONS; EXPRESSION; DYNAMICS; LIFE	Background: Wolbachia bacteria have invaded many arthropod species by inducing Cytoplasmic Incompatibility (CI). These symbionts represent fascinating objects of study for evolutionary biologists, but also powerful potential biocontrol agents. Here, we assess the density dynamics of Wolbachia infections in males and females of the mosquito Aedes albopitcus, an important vector of human pathogens, and interpret the results within an evolutionary framework. Methodology/Principal Findings: Wolbachia densities were measured in natural populations and in age controlled mosquitoes using quantitative PCR. We show that the density dynamics of the wAlbA Wolbachia strain infecting Aedes albopictus drastically differ between males and females, with a very rapid decay of infection in males only. Conclusions/Significance: Theory predicts that Wolbachia and its hosts should cooperate to improve the transmission of infection to offspring, because only infected eggs are protected from the effects of CI. However, incompatible matings effectively lower the fertility of infected males, so that selection acting on the host genome should tend to reduce the expression of CI in males, for example, by reducing infection density in males before sexual maturation. The rapid decay of one Wolbachia infection in Aedes albopictus males, but not in females, is consistent with this prediction. We suggest that the commonly observed reduction in CI intensity with male age reflects a similar evolutionary process. Our results also highlight the importance of monitoring infection density dynamics in both males and females to assess the efficiency of Wolbachia-based control strategies.	[Tortosa, Pablo; Labbe, Pierrick; Weill, Mylene] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, Ste Clotilde, France; [Charlat, Sylvain] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Dehecq, Jean-Sebastien] Direct Reg Affaires Sanit & Sociales Reunion, St Denis, France; [Barre, Helene] Univ Corse, Lab Parasites & Ecosyst Mediterraneens, Corte, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Tortosa, P (corresponding author), Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France.	pablo.tortosa@ird.fr	Labbé, Pïerrick/AAL-5806-2020	Labbé, Pïerrick/0000-0003-0806-1919; Weill, Mylene/0000-0002-4043-1601; Tortosa, Pablo/0000-0002-7928-7264; Charlat, Sylvain/0000-0003-0760-0087; Barre-Cardi, Helene/0000-0003-1029-9256	ANR CHIKVENDOM Sante-Environnement; Region Languedoc Roussillon	ANR CHIKVENDOM Sante-Environnement(French National Research Agency (ANR)); Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France)	This work was funded by ANR CHIKVENDOM Sante-Environnement (Ministere delegue a la recherche); Region Reunion (http://www.regionreunion.com/fr/spip/spip.php?page=accueilv2); and Region Languedoc Roussillon (http://www.laregion.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahantarig A, 2008, J VECTOR ECOL, V33, P173, DOI 10.3376/1081-1710(2008)33[173:RWDOFA]2.0.CO;2; Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356; BINNINGTON KC, 1989, J INVERTEBR PATHOL, V54, P344, DOI 10.1016/0022-2011(89)90118-3; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Crawley M.J., 2007, R BOOK; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Dobson SL, 2002, GENETICS, V160, P1087; Duron O, 2007, HEREDITY, V98, P368, DOI 10.1038/sj.hdy.6800948; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Engelstadter J, 2007, J EVOLUTION BIOL, V20, P685, DOI 10.1111/j.1420-9101.2006.01257.x; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hornett EA, 2009, CURR BIOL, V19, P1628, DOI 10.1016/j.cub.2009.07.071; Jamnongluk W, 2000, J MED ENTOMOL, V37, P53, DOI 10.1603/0022-2585-37.1.53; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; Koehncke A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004425; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Noda H, 2001, INSECT BIOCHEM MOLEC, V31, P727, DOI 10.1016/S0965-1748(00)00180-6; Rasgon JL, 2003, GENETICS, V165, P2029; Riparbelli MG, 2007, MECH DEVELOP, V124, P699, DOI 10.1016/j.mod.2007.07.001; ROGERS SO, 1988, PLANT MOL BIOL MANUE; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	35	72	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9700	10.1371/journal.pone.0009700	http://dx.doi.org/10.1371/journal.pone.0009700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300514	Green Published, Green Submitted, gold			2022-12-27	WOS:000275716400005
J	Lin, P; Hartz, SM; Zhang, ZH; Saccone, SF; Wang, J; Tischfield, JA; Edenberg, HJ; Kramer, JR; Goate, AM; Bierut, LJ; Rice, JP				Lin, Peng; Hartz, Sarah M.; Zhang, Zhehao; Saccone, Scott F.; Wang, Jia; Tischfield, Jay A.; Edenberg, Howard J.; Kramer, John R.; Goate, Alison M.; Bierut, Laura J.; Rice, John P.		COGA Collaborators COGEND Collabor; GENEVA	A New Statistic to Evaluate Imputation Reliability	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; LARGE-SCALE; METAANALYSIS; REPLICATION; RISK	Background: As the amount of data from genome wide association studies grows dramatically, many interesting scientific questions require imputation to combine or expand datasets. However, there are two situations for which imputation has been problematic: (1) polymorphisms with low minor allele frequency (MAF), and (2) datasets where subjects are genotyped on different platforms. Traditional measures of imputation cannot effectively address these problems. Methodology/Principal Findings: We introduce a new statistic, the imputation quality score (IQS). In order to differentiate between well-imputed and poorly-imputed single nucleotide polymorphisms (SNPs), IQS adjusts the concordance between imputed and genotyped SNPs for chance. We first evaluated IQS in relation to minor allele frequency. Using a sample of subjects genotyped on the Illumina 1 M array, we extracted those SNPs that were also on the Illumina 550 K array and imputed them to the full set of the 1 M SNPs. As expected, the average IQS value drops dramatically with a decrease in minor allele frequency, indicating that IQS appropriately adjusts for minor allele frequency. We then evaluated whether IQS can filter poorly-imputed SNPs in situations where cases and controls are genotyped on different platforms. Randomly dividing the data into ``cases'' and ``controls'', we extracted the Illumina 550 K SNPs from the cases and imputed the remaining Illumina 1 M SNPs. The initial Q-Q plot for the test of association between cases and controls was grossly distorted (lambda = 1.15) and had 4016 false positives, reflecting imputation error. After filtering out SNPs with IQS < 0.9, the Q-Q plot was acceptable and there were no longer false positives. We then evaluated the robustness of IQS computed independently on the two halves of the data. In both European Americans and African Americans the correlation was > 0.99 demonstrating that a database of IQS values from common imputations could be used as an effective filter to combine data genotyped on different platforms. Conclusions/Significance: IQS effectively differentiates well-imputed and poorly-imputed SNPs. It is particularly useful for SNPs with low minor allele frequency and when datasets are genotyped on different platforms.	[Lin, Peng; Hartz, Sarah M.; Zhang, Zhehao; Saccone, Scott F.; Wang, Jia; Goate, Alison M.; Bierut, Laura J.; Rice, John P.] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Tischfield, Jay A.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Kramer, John R.] Univ Iowa, Dept Psychiat, Sch Med, Iowa City, IA 52242 USA	Washington University (WUSTL); Rutgers State University New Brunswick; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa	Lin, P (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	john@zork.wustl.edu	Bierut, Laura Jean/W-6806-2019; Hartz, Sarah/AAD-4073-2019; Hartz, Sarah M/AAD-7662-2020; Lin, P/G-7702-2014	Bierut, Laura Jean/0000-0002-9952-4810; Hartz, Sarah/0000-0002-5429-3799; Edenberg, Howard/0000-0003-0344-9690; Tischfield, Jay/0000-0003-3217-8287; Goate, Alison/0000-0002-0576-2472	NIH Genes, Environment and Health Initiative [GEI] [U01 HG004422, U01HG004438]; Gene Environment Association Studies (GENEVA) under GEI; GENEVA Coordinating Center [U01 HG004446]; Collaborative Study on the Genetics of Alcoholism [COGA; U10 AA008401]; Collaborative Genetic Study of Nicotine Dependence [COGEND; P01 CA089392]; Family Study of Cocaine Dependence [FSCD; R01 DA013423]; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; NIH [HHSN268200782096C]; National Institute of Mental Health Center [550K]; Pritzker Neuropsychiatric Disorders Research Fund; U. S. Public Health Service (USPHS) [U24MH68457, HHSN271200477471C, P01CA089392];  [K01DA024722]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004438, U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423, K01DA024722, R01DA019963] Funding Source: NIH RePORTER	NIH Genes, Environment and Health Initiative [GEI](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gene Environment Association Studies (GENEVA) under GEI; GENEVA Coordinating Center; Collaborative Study on the Genetics of Alcoholism; Collaborative Genetic Study of Nicotine Dependence; Family Study of Cocaine Dependence; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pritzker Neuropsychiatric Disorders Research Fund; U. S. Public Health Service (USPHS)(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding support for the Study of Addiction: Genetics and Environment (SAGE) was provided through the NIH Genes, Environment and Health Initiative [GEI] (U01 HG004422). SAGE is one of the genome-wide association studies funded as part of the Gene Environment Association Studies (GENEVA) under GEI. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by the Collaborative Study on the Genetics of Alcoholism (COGA; U10 AA008401), the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392), and the Family Study of Cocaine Dependence (FSCD; R01 DA013423). Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and the NIH contract ``High throughput genotyping for studying the genetic contributions to human disease'' (HHSN268200782096C). Genotyping of the control samples from the National Institute of Mental Health Center for Collaborative Genetic Studies on Mental Disorders using the Ilumina 550K array was conducted by the Pritzker Consortium and was supported by the Pritzker Neuropsychiatric Disorders Research Fund L. L. C. Part of the genotypes were obtained as part of a Genome-wide Association Study of Bipolar Disorder, which is supported in part by U. S. Public Health Service (USPHS) grants U24MH68457, HHSN271200477471C, P01CA089392. This work was also supported by K01DA024722 (S. F. Saccone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen J., 1960, COEFFICIENT AGREEMEN, P37; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DUPUIS J, 2010, NAT GENET; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; LAURIE C, GENOTYPE DATA UNPUB; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MCMAHON FJ, 2010, NAT GENET; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; PFEUFER A, 2010, NAT GENET; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Radstake T. R., 2010, NAT GENET; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	26	46	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9697	10.1371/journal.pone.0009697	http://dx.doi.org/10.1371/journal.pone.0009697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300623	Green Published, gold			2022-12-27	WOS:000275621000014
J	Bottoms, SE; Howell, JE; Reinhardt, AK; Evans, IC; McAnulty, RJ				Bottoms, Stephen E.; Howell, Jane E.; Reinhardt, Alistair K.; Evans, Iona C.; McAnulty, Robin J.			TGF-beta Isoform Specific Regulation of Airway Inflammation and Remodelling in a Murine Model of Asthma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BRONCHOALVEOLAR LAVAGE FLUID; SUBEPITHELIAL FIBROSIS; BRONCHIAL-ASTHMA; GENE-EXPRESSION; MESSENGER-RNA; PROTEOGLYCAN DEPOSITION; ALVEOLAR MACROPHAGES; TARGETED DISRUPTION; ALLERGEN CHALLENGE	The TGF-beta family of mediators are thought to play important roles in the regulation of inflammation and airway remodelling in asthma. All three mammalian isoforms of TGF-beta, TGF-beta(1-3), are expressed in the airways and TGF-beta(1) and -beta(2) are increased in asthma. However, there is little information on the specific roles of individual TGF-beta isoforms. In this study we assess the roles of TGF-beta(1) and TGF-beta(2) in the regulation of allergen-induced airway inflammation and remodelling associated with asthma, using a validated murine model of ovalbumin sensitization and challenge, and isoform specific TGF-beta neutralising antibodies. Antibodies to both isoforms inhibited TGF-beta mediated Smad signalling. Anti-TGF-beta(1) and anti-TGF-beta(2) inhibited ovalbumin-induced sub-epithelial collagen deposition but anti-TGF-beta(1) also specifically regulated airway and fibroblast decorin deposition by TGF-beta(1). Neither antibody affected the allergen-induced increase in sub-epithelial fibroblast-like cells. Anti-TGF-beta(1) also specifically inhibited ovalbumin-induced increases in monocyte/ macrophage recruitment. Whereas, both TGF-beta(1) and TGF-beta(2) were involved in regulating allergen-induced increases in eosinophil and lymphocyte numbers. These data show that TGF-beta(1) and TGF-beta(2) exhibit a combination of specific and shared roles in the regulation of allergen-induced airway inflammation and remodelling. They also provide evidence in support of the potential for therapeutic regulation of specific subsets of cells and extracellular matrix proteins associated with inflammation and remodelling in airway diseases such as asthma and COPD, as well as other fibroproliferative diseases.	[Bottoms, Stephen E.; Howell, Jane E.; Reinhardt, Alistair K.; Evans, Iona C.; McAnulty, Robin J.] UCL, Ctr Resp Res, Lung Pathobiol Grp, London, England	University of London; University College London	Bottoms, SE (corresponding author), UCL, Ctr Resp Res, Lung Pathobiol Grp, London, England.	r.mcanulty@ucl.ac.uk	McAnulty, Robin J/C-2502-2008	McAnulty, Robin J/0000-0003-1936-4245; Evans, Iona/0000-0002-0225-3154	Asthma UK [04/017]; Wellcome Trust [060109]	Asthma UK; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from Asthma UK www.asthma.org.uk (grant number 04/017) and the Wellcome Trust www.wellcome.ac.uk (grant number 060109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DH, 1991, J IMMUNOL, V147, P609; Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; AUBERT JD, 1994, THORAX, V49, P225, DOI 10.1136/thx.49.3.225; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BOULET LP, 1995, AM J RESP CRIT CARE, V152, P865, DOI 10.1164/ajrccm.152.3.7663797; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; Cabiling DS, 2007, PLAST RECONSTR SURG, V120, P614, DOI 10.1097/01.prs.0000270292.89388.a3; Carrington LM, 2006, INVEST OPHTH VIS SCI, V47, P1886, DOI 10.1167/iovs.05-0635; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Coker RK, 1996, EUR RESPIR J, V9, P2501, DOI 10.1183/09031936.96.09122501; Coker RK, 2001, THORAX, V56, P549, DOI 10.1136/thorax.56.7.549; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; FUKUSHIMA D, 1993, J BIOL CHEM, V268, P22710; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Gabbrielli S., 1994, Pathologica (Genoa), V86, P157; Hill C, 2001, J ENDOCRINOL, V170, P647, DOI 10.1677/joe.0.1700647; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Hoshino M, 1998, J ALLERGY CLIN IMMUN, V102, P783, DOI 10.1016/S0091-6749(98)70018-1; Howell JE, 2006, CURR DRUG TARGETS, V7, P547, DOI 10.2174/138945006776818692; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Leung SY, 2006, J PHARMACOL EXP THER, V319, P586, DOI 10.1124/jpet.106.109314; Luttmann W, 1998, SCAND J IMMUNOL, V47, P127; Magnan A, 1997, CLIN EXP ALLERGY, V27, P389; McAnulty R.J., 2002, ASTHMA COPD BASIC ME, P139; MCANULTY RJ, 2007, THERAPEUTIC STRATEGI, P15; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; PELTON RW, 1991, AM J RESP CELL MOL, V5, P522, DOI 10.1165/ajrcmb/5.6.522; Pini L, 2006, AM J PHYSIOL-LUNG C, V290, pL1052, DOI 10.1152/ajplung.00122.2005; Redington AE, 1998, J PATHOL, V186, P410, DOI 10.1002/(SICI)1096-9896(199812)186:4<410::AID-PATH198>3.0.CO;2-9; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Reinhardt AK, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-30; ROBERTS CR, 1995, CHEST, V107, pS111, DOI 10.1378/chest.107.3_Supplement.111S; ROCHE WR, 1989, LANCET, V1, P520; Rosendahl A, 2001, AM J RESP CELL MOL, V25, P60, DOI 10.1165/ajrcmb.25.1.4396; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SANTANA A, 1995, AM J RESP CELL MOL, V13, P34, DOI 10.1165/ajrcmb.13.1.7541221; Scherf W, 2005, EUR J IMMUNOL, V35, P198, DOI 10.1002/eji.200425209; SHAH M, 1995, J CELL SCI, V108, P985; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Torrego A, 2007, THORAX, V62, P307, DOI 10.1136/thx.2006.063487; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Vignola AM, 1996, CLIN EXP IMMUNOL, V106, P114, DOI 10.1046/j.1365-2249.1996.d01-811.x; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Zhang-Hoover J, 2000, IMMUNOLOGY, V101, P501, DOI 10.1046/j.1365-2567.2000.00143.x; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	65	61	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9674	10.1371/journal.pone.0009674	http://dx.doi.org/10.1371/journal.pone.0009674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300191	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900009
J	Azuaje, F; Devaux, Y; Wagner, DR				Azuaje, Francisco; Devaux, Yvan; Wagner, Daniel R.			Integrative Pathway-Centric Modeling of Ventricular Dysfunction after Myocardial Infarction	PLOS ONE			English	Article							GENE-EXPRESSION; BIOMARKER; BIOLOGY	Background: A significant proportion of myocardial infarction (MI) patients undergo complex, coordinated perturbations at the molecular level that may eventually drive the occurrence of ventricular dysfunction and heart failure. Despite advances in the elucidation of key processes implicated in this condition, traditional methods relying on gene expression data and the identification of individual biomarkers in isolation pose major limitations not only for improving prediction power, but also for model interpretability. Mechanisms underlying clinical responses after MI remain elusive and there is no biomarker with the capacity to accurately predict ventricular dysfunction after MI. This calls for the exploration of system-level modeling of ventricular dysfunction in post-MI patients. Within this discovery framework key perturbations and predictive patterns are characterized by the integrated biological activity levels observed in pathways, rather than in individual genes. Methodology/Principal Findings: Here we report an integrative approach to identifying pathways related with ventricular dysfunction post MI with potential prognostic and therapeutic value. We found that a diversity of pathway-level perturbations can be profiled in samples of patients with ventricular dysfunction post MI, most of which represent major reductions of gene expression. Highly perturbed pathways included those implicated in antigen-dependent B-cell activation and the synthesis of leucine. By analyzing patient-specific samples encoded with information derived from highly-perturbed pathways, it is possible to visualize differential prognostic patterns and to perform computational classification of patients with areas under the receiver operating characteristic curve above 0.75. We also demonstrate how the integration of the outcomes generated by different pathway-based analysis models may improve ventricular dysfunction prediction performance. Significance: This research offers an alternative, comprehensive view of key relationships and perturbations that may trigger the emergence or prevention of ventricular dysfunction post-MI.	[Azuaje, Francisco; Devaux, Yvan; Wagner, Daniel R.] Ctr Rech Publ Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Wagner, Daniel R.] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Azuaje, F (corresponding author), Ctr Rech Publ Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	Francisco.Azuaje@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020	Devaux, Yvan/0000-0002-5321-8543	Societe pour la Recherche sur les Maladies Cardiovasculaires; Ministere de la Culture, de l'Enseignement Superieur et de la Recherche; Fonds National de la Recherche of Luxembourg	Societe pour la Recherche sur les Maladies Cardiovasculaires; Ministere de la Culture, de l'Enseignement Superieur et de la Recherche; Fonds National de la Recherche of Luxembourg(Luxembourg National Research Fund)	This research was supported in part by grants from the Societe pour la Recherche sur les Maladies Cardiovasculaires; Ministere de la Culture, de l'Enseignement Superieur et de la Recherche; and Fonds National de la Recherche of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Azuaje F, 2009, BRIEF BIOINFORM, V10, P367, DOI 10.1093/bib/bbp008; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cleary JG, 1995, ED INN EC BUS ADM, P108; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Grivas PD, 2009, CELL ONCOL, V31, P235, DOI 10.3233/CLO-2009-0467; HABASHY HO, 2009, BREAST CANC IN PRESS; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; Kittleson MM, 2005, TRENDS CARDIOVAS MED, V15, P130, DOI 10.1016/j.tcm.2005.05.007; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; StatSoft Inc, 2008, STAT DAT AN SOFTW SY; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun S, 2010, J PROTEOME RES, V9, P70, DOI 10.1021/pr9002118; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Torabi A, 2008, EUR HEART J, V29, P859, DOI 10.1093/eurheartj/ehn096; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61	30	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9661	10.1371/journal.pone.0009661	http://dx.doi.org/10.1371/journal.pone.0009661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300185	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620600015
J	Miranda, KC; Karet, FE; Brown, D				Miranda, Kevin C.; Karet, Fiona E.; Brown, Dennis			An Extended Nomenclature for Mammalian V-ATPase Subunit Genes and Splice Variants	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; RENAL TUBULAR-ACIDOSIS; TISSUE-SPECIFIC ISOFORMS; MOLECULAR-CLONING; CHROMAFFIN GRANULES; LUMINAL ACIDIFICATION; MESSENGER-RNA; CDNA CLONING; C-SUBUNIT	The vacuolar-type H(+)-ATPase (V-ATPase) is a multisubunit proton pump that is involved in both intra-and extracellular acidification processes throughout the body. Multiple homologs and splice variants of V-ATPase subunits are thought to explain its varied spatial and temporal expression pattern in different cell types. Recently subunit nomenclature was standardized with a total of 22 subunit variants identified. However this standardization did not accommodate the existence of splice variants and is therefore incomplete. Thus, we propose here an extension of subunit nomenclature along with a literature and sequence database scan for additional V-ATPase subunits. An additional 17 variants were pulled from a literature search while 4 uncharacterized potential subunit variants were found in sequence databases. These findings have been integrated with the current V-ATPase knowledge base to create a new V-ATPase subunit catalogue. It is envisioned this catalogue will form a new platform on which future studies into tissue-and organelle-specific V-ATPase expression, localization and function can be based.	[Miranda, Kevin C.; Brown, Dennis] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA; [Miranda, Kevin C.; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Ctr Syst Biol, Boston, MA 02114 USA; [Miranda, Kevin C.; Brown, Dennis] Harvard Univ, Sch Med, Boston, MA USA; [Karet, Fiona E.] Univ Cambridge, Dept Med Genet, Cambridge, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge	Miranda, KC (corresponding author), Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA.	fek1000@cam.ac.uk; brown@receptor.mgh.harvard.edu		Karet, Fiona/0000-0002-2457-2869	National Kidney Foundation; Wellcome Trust; National Institutes of Health [DK42956]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042956, R01DK042956, P30DK043351] Funding Source: NIH RePORTER	National Kidney Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KCM is funded through a National Kidney Foundation Research Fellowship. FEK is funded through the Wellcome Trust, while DB is funded by a National Institutes of Health grant DK42956 (DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNASCONI P, 1990, J BIOL CHEM, V265, P17428; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Blake-Palmer KG, 2007, GENE, V393, P94, DOI 10.1016/j.gene.2007.01.020; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Brown D, 2000, J EXP BIOL, V203, P137; Crider BP, 1997, J BIOL CHEM, V272, P10721; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; FUJIWARA T, 1995, INT J RAPID PUBLICAT, V2, P107; Futai M, 2000, J EXP BIOL, V203, P107; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; Imai-Senga Y, 2002, GENE, V289, P7, DOI 10.1016/S0378-1119(02)00542-5; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2007, BIOCHEM BIOPH RES CO, V364, P1032, DOI 10.1016/j.bbrc.2007.10.118; Kennell JA, 2001, CYTOGENET CELL GENET, V92, P337, DOI 10.1159/000056924; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; NELSON H, 1990, J BIOL CHEM, V265, P20390; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Neville MJ, 1999, J IMMUNOL, V162, P4745; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishigori H, 1998, GENOMICS, V50, P222, DOI 10.1006/geno.1998.5310; PENG SB, 1994, J BIOL CHEM, V269, P17262; Peng SB, 1999, J BIOL CHEM, V274, P2549, DOI 10.1074/jbc.274.4.2549; Poea-Guyon S, 2006, J BIOL CHEM, V281, P17164, DOI 10.1074/jbc.M600927200; Ryan MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-313; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Smith AN, 2003, MOL CELL, V12, P801, DOI 10.1016/S1097-2765(03)00397-6; Smith AN, 2002, GENE, V297, P169, DOI 10.1016/S0378-1119(02)00884-3; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; Supekova L, 1996, J EXP BIOL, V199, P1147; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; WANG SY, 1988, J BIOL CHEM, V263, P17638; WANG ZQ, 1990, J BIOL CHEM, V265, P21957; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	44	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9531	10.1371/journal.pone.0009531	http://dx.doi.org/10.1371/journal.pone.0009531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224822	gold, Green Submitted, Green Published			2022-12-27	WOS:000275328800004
J	Kimmel, CB; DeLaurier, A; Ullmann, B; Dowd, J; McFadden, M				Kimmel, Charles B.; DeLaurier, April; Ullmann, Bonnie; Dowd, John; McFadden, Marcie			Modes of Developmental Outgrowth and Shaping of a Craniofacial Bone in Zebrafish	PLOS ONE			English	Article							NEURAL CREST; OSTEOBLAST DIFFERENTIATION; MANDIBULAR MORPHOLOGY; EPITHELIAL INFLUENCES; GENE-EXPRESSION; EMBRYONIC CHICK; HEAD SKELETON; EVOLUTION; ARCH; SKELETOGENESIS	The morphologies of individual bones are crucial for their functions within the skeleton, and vary markedly during evolution. Recent studies have begun to reveal the detailed molecular genetic pathways that underlie skeletal morphogenesis. On the other hand, understanding of the process of morphogenesis itself has not kept pace with the molecular work. We examined, through an extended period of development in zebrafish, how a prominent craniofacial bone, the opercle (Op), attains its adult morphology. Using high-resolution confocal imaging of the vitally stained Op in live larvae, we show that the bone initially appears as a simple linear spicule, or spur, with a characteristic position and orientation, and lined by osteoblasts that we visualize by transgenic labeling. The Op then undergoes a stereotyped sequence of shape transitions, most notably during the larval period occurring through three weeks postfertilization. New shapes arise, and the bone grows in size, as a consequence of anisotropic addition of new mineralized bone matrix along specific regions of the pre-existing bone surfaces. We find that two modes of matrix addition, spurs and veils, are primarily associated with change in shape, whereas a third mode, incremental banding, largely accounts for growth in size. Furthermore, morphometric analyses show that shape development and growth follow different trajectories, suggesting separate control of bone shape and size. New osteoblast arrangements are associated with new patterns of matrix outgrowth, and we propose that fine developmental regulation of osteoblast position is a critical determinant of the spatiotemporal pattern of morphogenesis.	[Kimmel, Charles B.; DeLaurier, April; Ullmann, Bonnie; Dowd, John; McFadden, Marcie] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Kimmel, CB (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	kimmel@uoneuro.uoregon.edu			National Institutes of Health [RO1DE13834, PO1HD22486, IF32DE019345]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE019345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by research grants RO1DE13834 and PO1HD22486 and a postdoctoral fellowship IF32DE019345 (AD) from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCHLEY WR, 1992, SYST BIOL, V41, P196, DOI 10.2307/2992521; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Atchley WR, 1993, SKULL, V1, P207; Bookstein F L, 1997, Med Image Anal, V1, P225; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; CHEVERUD JM, 1991, J CRAN GENET DEV BIO, V11, P122; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Fawcett D., 1994, TXB HISTOLOGY; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; Gregory W. K., 1933, FISH SKULLS STUDY EV; HALL B.K, 2005, BONES CARTILAGE; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; HALL BK, 1992, ANAT EMBRYOL, V186, P107; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; JONES SJ, 1976, CELL TISSUE RES, V166, P101, DOI 10.1007/BF00215129; Kimmel CB, 2003, DEVELOPMENT, V130, P1339, DOI 10.1242/dev.00338; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Miller CT, 2007, DEV BIOL, V308, P144, DOI 10.1016/j.ydbio.2007.05.018; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; NELSON E, 1949, J MORPHOL, V85, P229; PARENTI LR, 1986, ZOOL J LINN SOC-LOND, V87, P37, DOI 10.1111/j.1096-3642.1986.tb01329.x; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Raff R. A., 1996, SHAPE LIFE GENES DEV; ROHLF FJ, 2005, TPS DIG VERSION 2 04; ROHLF FJ, 2004, TPS THIN PLATE SPLIN; ROHLF FJ, 2005, TPS RELATIVE WARPS V; Rose C, 2009, BIOESSAYS, V31, P287, DOI 10.1002/bies.200800059; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; Smolyar IV, 2004, ICES J MAR SCI, V61, P992, DOI 10.1016/j.icesjms.2004.07.013; THOMPSON DW, 1942, GROWTH FORM NEW EDIT; TYLER MS, 1978, ANAT REC, V192, P225, DOI 10.1002/ar.1091920203; TYLER MS, 1977, ANAT REC, V188, P229, DOI 10.1002/ar.1091880208; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; WAGNER GP, 1996, AM ZOOL, V291, P116; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Walker MB, 2007, DEV BIOL, V304, P194, DOI 10.1016/j.ydbio.2006.12.027; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; WEISEL GF, 1967, J MORPHOL, V121, P1, DOI 10.1002/jmor.1051210102; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	53	92	97	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9475	10.1371/journal.pone.0009475	http://dx.doi.org/10.1371/journal.pone.0009475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221441	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197200002
J	Ding, SZ; Fischer, W; Kaparakis-Liaskos, M; Liechti, G; Merrell, DS; Grant, PA; Ferrero, RL; Crowe, SE; Haas, R; Hatakeyama, M; Goldberg, JB				Ding, Song-Ze; Fischer, Wolfgang; Kaparakis-Liaskos, Maria; Liechti, George; Merrell, D. Scott; Grant, Patrick A.; Ferrero, Richard L.; Crowe, Sheila E.; Haas, Rainer; Hatakeyama, Masanori; Goldberg, Joanna B.			Helicobacter pylori-Induced Histone Modification, Associated Gene Expression in Gastric Epithelial Cells, and Its Implication in Pathogenesis	PLOS ONE			English	Article							CAG PATHOGENICITY ISLAND; NF-KAPPA-B; VACUOLATING CYTOTOXIN; BETA-CATENIN; HOST-CELL; C-MET; PHOSPHORYLATION; ACTIVATION; RECEPTOR; INDUCTION	Histone modifications are critical in regulating gene expression, cell cycle, cell proliferation, and development. Relatively few studies have investigated whether Helicobacter pylori, the major cause of human gastric diseases, affects histone modification. We therefore investigated the effects of H. pylori infection on histone modifications in a global and promoter-specific manner in gastric epithelial cells. Infection of gastric epithelial cells by wild-type H. pylori induced time- and dose-dependent dephosphorylation of histone H3 at serine 10 (H3 Ser10) and decreased acetylation of H3 lysine 23, but had no effects on seven other specific modifications. Different cag pathogenicity island (PAI)-containing-clinical isolates showed similar abilities to induce H3 Ser10 dephosphorylation. Mutation of cagA, vacA, nonphosphorylateable CagA mutant cagA(EPISA), or disruption of the flagella showed no effects, while deletion of the entire cagPAI restored the H3 Ser10 phosphorylation to control levels. Analysis of 27 cagPAI mutants indicated that the genes that caused H3 Ser10 dephosphorylation were similar to those that were previously found to induce interleukin-8, irrespective of CagA translocation. This effect was independent of ERK or p38 pathways and type I interferon signaling. Additionally, c-Jun and hsp70 gene expression was associated with this histone modification. These results demonstrate that H. pylori alters histone modification and host response via a cagA-, vacA-independent, but cagPAI-dependent mechanisms, which contribute to its persistent infection and pathogenesis.	[Ding, Song-Ze; Liechti, George; Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22903 USA; [Fischer, Wolfgang; Haas, Rainer] Max Von Pettenkofer Inst, D-8000 Munich, Germany; [Fischer, Wolfgang; Haas, Rainer] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Kaparakis-Liaskos, Maria; Ferrero, Richard L.] Monash Inst Med Res, Ctr Innate Immunity & Infect Dis, Clayton, Vic, Australia; [Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Grant, Patrick A.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Crowe, Sheila E.] Univ Virginia Hlth Syst, Dept Med, Div Gastroenterol & Hepatol, Charlottesville, VA USA; [Ding, Song-Ze; Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido, Japan	University of Virginia; University of Munich; University of Munich; Monash University; Uniformed Services University of the Health Sciences - USA; University of Virginia; University of Virginia; Hokkaido University	Ding, SZ (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22903 USA.	jbg2b@virginia.edu	Kaparakis-Liaskos, Maria/I-6511-2013; Liechti, George/C-3129-2015; Kaparakis-Liaskos, Maria/R-9321-2019; Ferrero, Richard/U-1332-2017	Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Liechti, George/0000-0003-3028-8474; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Ferrero, Richard/0000-0001-6817-6211	NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051291, R01AI065529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK061769] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009109, 5T32 CA 009109] Funding Source: Medline; NIAID NIH HHS [R01 AI065529-05, R01-AI51291, R01 AI065529, R01-AI65529, R01 AI051291] Funding Source: Medline; NIDDK NIH HHS [P30 DK067629, R01 DK061769, R01-DK61769] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed A, 2000, MICROBES INFECT, V2, P1159, DOI 10.1016/S1286-4579(00)01270-3; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Churin Y, 2001, MOL MICROBIOL, V40, P815, DOI 10.1046/j.1365-2958.2001.02443.x; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; COVER TL, 1994, J BIOL CHEM, V269, P10566; Ding SZ, 2008, FEMS IMMUNOL MED MIC, V53, P385, DOI 10.1111/j.1574-695X.2008.00439.x; Ding SZ, 2008, J GASTROEN HEPATOL, V23, pE67, DOI 10.1111/j.1440-1746.2007.04912.x; Ding SZ, 2005, HELICOBACTER, V10, P193, DOI 10.1111/j.1523-5378.2005.00311.x; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; Fehri LF, 2009, EPIGENETICS-US, V4, P577, DOI 10.4161/epi.4.8.10217; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huang W, 2006, MOL CELL BIOL, V26, P1307, DOI 10.1128/MCB.26.4.1307-1317.2006; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lu H, 2005, CURR OPIN GASTROEN, V21, P653, DOI 10.1097/01.mog.0000181711.04529.d5; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mizzen CA, 2000, SCIENCE, V289, P2290, DOI 10.1126/science.289.5488.2290; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Pierzchalski P, 2006, HELICOBACTER, V11, P96, DOI 10.1111/j.1523-5378.2006.00383.x; Rokutan K, 2000, J GASTROEN HEPATOL, V15, pD12, DOI 10.1046/j.1440-1746.2000.02144.x; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Schmeck B, 2005, J IMMUNOL, V175, P2843, DOI 10.4049/jimmunol.175.5.2843; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Xia GQ, 2008, BIOCHEM BIOPH RES CO, V369, P526, DOI 10.1016/j.bbrc.2008.02.073; Yeo M, 2004, PROTEOMICS, V4, P3335, DOI 10.1002/pmic.200400951	48	94	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9875	10.1371/journal.pone.0009875	http://dx.doi.org/10.1371/journal.pone.0009875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368982	Green Submitted, gold, Green Published			2022-12-27	WOS:000276418200006
J	Joos, C; Marrama, L; Polson, HEJ; Corre, S; Diatta, AM; Diouf, B; Trape, JF; Tall, A; Longacre, S; Perraut, R				Joos, Charlotte; Marrama, Laurence; Polson, Hannah E. J.; Corre, Sandra; Diatta, Antoine-Marie; Diouf, Babacar; Trape, Jean-Francois; Tall, Adama; Longacre, Shirley; Perraut, Ronald			Clinical Protection from Falciparum Malaria Correlates with Neutrophil Respiratory Bursts Induced by Merozoites Opsonized with Human Serum Antibodies	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SURFACE PROTEIN-1; HOLOENDEMIC AREA; PHAGOCYTOSIS; MECHANISMS; BLOOD; VACCINE; IMMUNITY; GROWTH; STIMULATION	Background: Effective vaccines to combat malaria are urgently needed, but have proved elusive in the absence of validated correlates of natural immunity. Repeated blood stage infections induce antibodies considered to be the main arbiters of protection from pathology, but their essential functions have remained speculative. Methodology/Principal Findings: This study evaluated antibody dependent respiratory burst (ADRB) activity in polymorphonuclear neutrophils (PMN) induced by Plasmodium falciparum merozoites and antibodies in the sera of two different African endemic populations, and investigated its association with naturally acquired clinical protection. Respiratory bursts by freshly isolated PMN were quantified by chemiluminescence readout in the presence of isoluminol, which preferentially detects extra-cellular reactive oxygen species (ROS). Using a standardized, high throughput protocol, 230 sera were analyzed from individuals of all age groups living in meso-(Ndiop) or holo-endemic (Dielmo) Senegalese villages, and enrolled in a cross-sectional prospective study with intensive follow-up. Statistical significance was determined using non-parametric tests and Poisson regression models. The most important finding was that PMN ADRB activity was correlated with acquired clinical protection from malaria in both high and low transmission areas (P = 0.006 and 0.036 respectively). Strikingly, individuals in Dielmo with dichotomized high ADRB indexes were seventeen fold less susceptible to malaria attacks (P = 0.006). Complementary results showed that ADRB activity was (i) dependent on intact merozoites and IgG opsonins, but not parasitized erythrocytes, or complement, (ii) correlated with merozoite specific cytophilic IgG1 and IgG3 antibody titers (P < 0.001 for both), and (iii) stronger in antisera from a holo-endemic compared to a meso-endemic site (P = 0.002), and reduced in asymptomatic carriers (P < 0.001). Conclusions/Significance: This work presents the first clearly demonstrated functional antibody immune correlate of clinical protection from Plasmodium falciparum malaria, and begs the question regarding the importance of ADRB by PMN for immune protection against malaria in vivo.	[Joos, Charlotte; Corre, Sandra; Diatta, Antoine-Marie; Diouf, Babacar; Perraut, Ronald] Inst Pasteur, Unite Immunol, Dakar, Senegal; [Joos, Charlotte; Polson, Hannah E. J.; Longacre, Shirley] CNRS, Inst Pasteur, Lab Vaccinol Parasitaire, URA 1961, Paris, France; [Marrama, Laurence; Tall, Adama] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Trape, Jean-Francois] IRD, Lab Paludol Zool Med, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD)	Joos, C (corresponding author), Inst Pasteur, Unite Immunol, Dakar, Senegal.	longacre@pasteur.fr			Pasteur Institute Foundation; French Ministry of Research and Technology (VIHPAL Program); Pharmaciens Sans Frontieres Comite International; Agence Universitaire de la Francophonie; Sanofi Aventis/French Ministry of Higher Education and Research (Combating Parasitic Diseases program)	Pasteur Institute Foundation; French Ministry of Research and Technology (VIHPAL Program); Pharmaciens Sans Frontieres Comite International; Agence Universitaire de la Francophonie; Sanofi Aventis/French Ministry of Higher Education and Research (Combating Parasitic Diseases program)(Sanofi-Aventis)	This work was funded by the Pasteur Institute Foundation, the French Ministry of Research and Technology (VIHPAL Program), Pharmaciens Sans Frontieres Comite International, the Agence Universitaire de la Francophonie, Sanofi Aventis/French Ministry of Higher Education and Research (Combating Parasitic Diseases program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFSSAPS, 2006, FRENCH POST DRUGS DR; ALLISON AC, 1983, ANNU REV IMMUNOL, V1, P361, DOI 10.1146/annurev.iy.01.040183.002045; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; BROWN J, 1981, CLIN EXP IMMUNOL, V46, P106; Carvalho LJM, 2002, SCAND J IMMUNOL, V56, P327, DOI 10.1046/j.1365-3083.2002.01160.x; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; CELADA A, 1983, J PARASITOL, V69, P49, DOI 10.2307/3281273; CLARK IA, 1983, INFECT IMMUN, V39, P1; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Diouf B, 2002, Dakar Med, V47, P5; Giersing BK, 2006, VACCINE, V24, P4264, DOI 10.1016/j.vaccine.2006.01.005; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; KHUSMITH S, 1982, INFECT IMMUN, V35, P874, DOI 10.1128/IAI.35.3.874-879.1982; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; KUMARATILAKE LM, 1990, INFECT IMMUN, V58, P788, DOI 10.1128/IAI.58.3.788-793.1990; KUMARATILAKE LM, 1992, INFECT IMMUN, V60, P3731, DOI 10.1128/IAI.60.9.3731-3738.1992; Kumaratilake LM, 2000, CLIN DIAGN LAB IMMUN, V7, P9, DOI 10.1128/CDLI.7.1.9-13.2000; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Lensen AHW, 1997, INFECT IMMUN, V65, P3834, DOI 10.1128/IAI.65.9.3834-3837.1997; LUNEL F, 1989, INFECT IMMUN, V57, P2043, DOI 10.1128/IAI.57.7.2043-2049.1989; LUNEL F, 1990, ACTA TROP, V47, P61, DOI 10.1016/0001-706X(90)90068-B; MAGRISSO MJ, 1995, J BIOLUM CHEMILUM, V10, P77, DOI 10.1002/bio.1170100203; MALHOTRA K, 1988, CR SOC BIOL, V182, P270; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Miller LH, 1997, PARASITOL TODAY, V13, P46, DOI 10.1016/S0169-4758(96)20063-8; NNALUE NA, 1988, PARASITE IMMUNOL, V10, P47, DOI 10.1111/j.1365-3024.1988.tb00202.x; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Perraut R., 2005, Update in tropical immunology, P157; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Perraut R, 2003, J INFECT DIS, V188, P1940, DOI 10.1086/379838; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 2003, REV EPIDEMIOL SANTE, V51, P175; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; SALMON D, 1986, INFECT IMMUN, V51, P801, DOI 10.1128/IAI.51.3.801-806.1986; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; SUN T, 1985, ANN CLIN LAB SCI, V15, P465; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; *WHO, WHO INF SHEETS PRESC; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067	50	108	108	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9871	10.1371/journal.pone.0009871	http://dx.doi.org/10.1371/journal.pone.0009871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360847	gold, Green Published, Green Submitted			2022-12-27	WOS:000275969500010
J	Sierra, R; Rodriguez, LM; Chaves, D; Pinzon, A; Grajales, A; Rojas, A; Mutis, G; Cardenas, M; Burbano, D; Jimenez, P; Bernal, A; Restrepo, S				Sierra, Roberto; Rodriguez-R, Luis M.; Chaves, Diego; Pinzon, Andres; Grajales, Alejandro; Rojas, Alejandro; Mutis, Gabriel; Cardenas, Martha; Burbano, Daniel; Jimenez, Pedro; Bernal, Adriana; Restrepo, Silvia			Discovery of Phytophthora infestans Genes Expressed in Planta through Mining of cDNA Libraries	PLOS ONE			English	Article							LATE BLIGHT; RXLR EFFECTORS; POTATO GENES; DISEASE RESISTANCE; SEQUENCE; REVEALS; PROTEIN; ACTIVATION; GENERATION; TOMATO	Background: Phytophthora infestans (Mont.) de Bary causes late blight of potato and tomato, and has a broad host range within the Solanaceae family. Most studies of the Phytophthora - Solanum pathosystem have focused on gene expression in the host and have not analyzed pathogen gene expression in planta. Methodology/Principal Findings: We describe in detail an in silico approach to mine ESTs from inoculated host plants deposited in a database in order to identify particular pathogen sequences associated with disease. We identified candidate effector genes through mining of 22,795 ESTs corresponding to P. infestans cDNA libraries in compatible and incompatible interactions with hosts from the Solanaceae family. Conclusions/Significance: We annotated genes of P. infestans expressed in planta associated with late blight using different approaches and assigned putative functions to 373 out of the 501 sequences found in the P. infestans genome draft, including putative secreted proteins, domains associated with pathogenicity and poorly characterized proteins ideal for further experimental studies. Our study provides a methodology for analyzing cDNA libraries and provides an understanding of the plant - oomycete pathosystems that is independent of the host, condition, or type of sample by identifying genes of the pathogen expressed in planta.	[Sierra, Roberto; Rodriguez-R, Luis M.; Chaves, Diego; Pinzon, Andres; Grajales, Alejandro; Rojas, Alejandro; Mutis, Gabriel; Cardenas, Martha; Bernal, Adriana; Restrepo, Silvia] Univ Los Andes, Dept Ciencias Biol, Bogota Dist Capital, Colombia; [Burbano, Daniel] Univ Los Andes, Direcc Tecnol Informat, Bogota Dist Capital, Colombia; [Jimenez, Pedro] Univ Los Andes, Programa Biol Aplicada, Bogota Dist Capital, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Sierra, R (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.	srestrep@uniandes.edu.co	Rojas, J Alejandro/D-9273-2016; Restrepo, Silvia/G-1297-2010; Rojas, J Alejandro/AAH-7285-2019; Grajales, Alejandro/AAU-6606-2020; Rodriguez-R, Luis M./S-6996-2018	Rojas, J Alejandro/0000-0001-5492-5963; Rojas, J Alejandro/0000-0001-5492-5963; Grajales, Alejandro/0000-0003-3984-3323; Rodriguez-R, Luis M./0000-0001-7603-3093; Restrepo, Silvia/0000-0001-9016-1040; Cardenas, Martha/0000-0002-2009-4126; Pinzon, Andres/0000-0002-4133-810X; Bernal, Adriana/0000-0002-3557-697X; Sierra, Roberto/0000-0002-8657-1781				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beyer K, 2001, MOL PLANT PATHOL, V2, P125, DOI 10.1046/j.1364-3703.2001.00059.x; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Flinn B, 2005, PLANT MOL BIOL, V59, P407, DOI 10.1007/s11103-005-0185-y; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huitema E, 2003, METH MOL B, V236, P79; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Kamoun S, 2005, PLANT DIS, V89, P692, DOI 10.1094/PD-89-0692; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li YJ, 2009, PHYSIOL PLANTARUM, V136, P19, DOI 10.1111/j.1399-3054.2009.01209.x; MORGAN W, 2007, CURR OPIN MICROBIOL; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronning CM, 2003, PLANT PHYSIOL, V131, P419, DOI 10.1104/pp.013581; Ros B, 2004, MOL PLANT PATHOL, V5, P191, DOI [10.1111/j.1364-3703.2004.00221.x, 10.1111/J.1364-3703.2004.00221.X]; Ros B, 2008, PHYSIOL PLANTARUM, V133, P386, DOI 10.1111/j.1399-3054.2008.01048.x; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Tian ZD, 2006, PLANT CELL REP, V25, P1094, DOI 10.1007/s00299-006-0169-7; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang BL, 2005, PLANT SCI, V169, P1155, DOI 10.1016/j.plantsci.2005.07.020; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9847	10.1371/journal.pone.0009847	http://dx.doi.org/10.1371/journal.pone.0009847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352100	Green Submitted, gold, Green Published			2022-12-27	WOS:000275894500015
J	Cazorla, M; Jouvenceau, A; Rose, C; Guilloux, JP; Pilon, C; Dranovsky, A; Premont, J				Cazorla, Maxime; Jouvenceau, Anne; Rose, Christiane; Guilloux, Jean-Philippe; Pilon, Catherine; Dranovsky, Alex; Premont, Joel			Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC RECEPTOR TRKB; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; MOTOR-NEURONS; SOCIAL DEFEAT; BDNF FUNCTION; BRAIN; ACTIVATION	In the last decades, few mechanistically novel therapeutic agents have been developed to treat mental and neurodegenerative disorders. Numerous studies suggest that targeting BDNF and its TrkB receptor could be a promising therapeutic strategy for the treatment of brain disorders. However, the development of potent small ligands for the TrkB receptor has proven to be difficult. By using a peptidomimetic approach, we developed a highly potent and selective TrkB inhibitor, cyclotraxin-B, capable of altering TrkB-dependent molecular and physiological processes such as synaptic plasticity, neuronal differentiation and BDNF-induced neurotoxicity. Cyclotraxin-B allosterically alters the conformation of TrkB, which leads to the inhibition of both BDNF-dependent and -independent ( basal) activities. Finally, systemic administration of cyclotraxin-B to mice results in TrkB inhibition in the brain with specific anxiolytic-like behavioral effects and no antidepressant-like activity. This study demonstrates that cyclotraxin-B might not only be a powerful tool to investigate the role of BDNF and TrkB in physiology and pathology, but also represents a lead compound for the development of new therapeutic strategies to treat brain disorders.	[Cazorla, Maxime; Dranovsky, Alex] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY 10027 USA; [Cazorla, Maxime; Jouvenceau, Anne; Rose, Christiane; Guilloux, Jean-Philippe; Pilon, Catherine; Premont, Joel] Univ Paris 05, INSERM, UMR 894, Ctr Psychiat & Neurosci, Paris, France	Columbia University; New York State Psychiatry Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cazorla, M (corresponding author), Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY 10027 USA.	mc3195@columbia.edu	JP, Guilloux/Z-5069-2019; Cazorla, Maxime/M-6425-2014; Guilloux, Jean-Philippe/B-3726-2015; Jouvenceau, Anne/A-9694-2016; Dranovsky, Alex/P-4357-2018	JP, Guilloux/0000-0003-0982-3751; Cazorla, Maxime/0000-0002-8260-1154; Guilloux, Jean-Philippe/0000-0003-0982-3751; Dranovsky, Alex/0000-0001-7896-3243	INSERM; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH079088, R01MH091844] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; BRAHIMI F, 2009, PEPTIDES; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Durany N, 2004, EUR PSYCHIAT, V19, P326, DOI 10.1016/j.eurpsy.2004.06.020; Fletcher JM, 2008, J BIOL CHEM, V283, P33375, DOI 10.1074/jbc.M802789200; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Hu P, 2003, J NEUROCHEM, V84, P1421, DOI 10.1046/j.1471-4159.2003.01599.x; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Ibanez CF, 1998, TRENDS NEUROSCI, V21, P438, DOI 10.1016/S0166-2236(98)01266-1; IBANEZ CF, 1995, TRENDS BIOTECHNOL, V13, P217, DOI 10.1016/S0167-7799(00)88949-0; ILAG LL, 1994, J BIOL CHEM, V269, P19941; Ivanisevic L, 2007, J BIOL CHEM, V282, P16754, DOI 10.1074/jbc.M701996200; IWAKURA Y, 2008, J BIOL CHEM; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kim HJ, 2003, NEUROBIOL DIS, V14, P110, DOI 10.1016/S0969-9961(03)00103-7; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Marin P, 1997, J NEUROSCI, V17, P3445; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mojsilovic-Petrovic J, 2006, J NEUROSCI, V26, P9250, DOI 10.1523/JNEUROSCI.1856-06.2006; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; O'Leary PD, 1998, J NEUROCHEM, V70, P1712; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Pattarawarapan M, 2003, J MED CHEM, V46, P5277, DOI 10.1021/jm030221q; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Potier B, 2006, NEUROSCIENCE, V142, P187, DOI 10.1016/j.neuroscience.2006.06.040; Rantamaki T, 2008, EXPERT OPIN THER TAR, V12, P705, DOI [10.1517/14728222.12.6.705 , 10.1517/14728220802121472]; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sadick MD, 1997, EXP CELL RES, V234, P354, DOI 10.1006/excr.1997.3614; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Xie YM, 2000, J BIOL CHEM, V275, P29868, DOI 10.1074/jbc.M005071200; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zorner B, 2003, BIOL PSYCHIAT, V54, P972, DOI 10.1016/S0006-3223(03)00418-9; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	60	66	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9777	10.1371/journal.pone.0009777	http://dx.doi.org/10.1371/journal.pone.0009777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333308	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809700015
J	Lokesh, B; Rashmi, PR; Amruta, BS; Srisathiyanarayanan, D; Murthy, MRN; Savithri, HS				Lokesh, Bhushan; Rashmi, Panigrahi R.; Amruta, Bhat S.; Srisathiyanarayanan, Dharmaiah; Murthy, Mathur R. N.; Savithri, Handanahal S.			NSs Encoded by Groundnut Bud Necrosis Virus Is a Bifunctional Enzyme	PLOS ONE			English	Article							STIMULATED NUCLEOSIDE TRIPHOSPHATASE; COMPLETE NUCLEOTIDE-SEQUENCE; RNA HELICASE; MUTATIONAL ANALYSIS; S-RNA; GENOME ORGANIZATION; PROTEIN; DNA; TOSPOVIRUS; 5'-TRIPHOSPHATASE	Groundnut bud necrosis virus (GBNV), a member of genus Tospovirus in the family Bunyaviridae, infects a large number of leguminosae and solanaceae plants in India. With a view to elucidate the function of nonstructural protein, NSs encoded by the small RNA genome (S RNA), the NSs protein of GBNV-tomato (Karnataka) [1] was over-expressed in E. coli and purified by Ni-NTA chromatography. The purified rNSs protein exhibited an RNA stimulated NTPase activity. Further, this activity was metal ion dependent and was inhibited by adenosine 5' (beta, gamma imido) triphosphate, an ATP analog. The rNSs could also hydrolyze dATP. Interestingly, in addition to the NTPase and dATPase activities, the rNSs exhibited ATP independent 5' RNA/DNA phosphatase activity that was completely inhibited by AMP. The 5' alpha phosphate could be removed from ssDNA, ssRNA, dsDNA and dsRNA thus confirming that rNSs has a novel 5' alpha phosphatase activity. K189A mutation in the Walker motif A (GxxxxGKT) resulted in complete loss of ATPase activity, but the 5' phosphatase activity was unaffected. On the other hand, D159A mutation in the Walker motif B (DExx) resulted in partial loss of both the activities. These results demonstrate for the first time that NSs is a bifunctional enzyme, which could participate in viral movement, replication or in suppression of the host defense mechanism.	[Lokesh, Bhushan; Amruta, Bhat S.; Srisathiyanarayanan, Dharmaiah; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Rashmi, Panigrahi R.; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Lokesh, B (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in	Panigrahi, Rashmi/AAK-2432-2020; Dharmaiah, Srisathiyanarayanan/B-2887-2009	Panigrahi, Rashmi/0000-0002-1727-9269; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962	Department of Biotechnology and Department of Science and Technology New Delhi, India	Department of Biotechnology and Department of Science and Technology New Delhi, India	Department of Biotechnology and Department of Science and Technology New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram M, 2004, ANN APPL BIOL, V145, P285, DOI 10.1111/j.1744-7348.2004.tb00385.x; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bhat AI, 2002, CURR SCI INDIA, V82, P1389; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; BROYLES SS, 1987, J VIROL, V61, P1738, DOI 10.1128/JVI.61.5.1738-1742.1987; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; Gowda S, 1998, ARCH VIROL, V143, P2381, DOI 10.1007/s007050050468; GROSS CH, 1995, J VIROL, V69, P4727, DOI 10.1128/JVI.69.8.4727-4736.1995; Jain R. K., 2004, Indian Phytopathology, V57, P169; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kadare G, 1997, J VIROL, V71, P2583; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kim DW, 1997, J VIROL, V71, P9400, DOI 10.1128/JVI.71.12.9400-9409.1997; KORMELINK R, 1991, VIROLOGY, V181, P459, DOI 10.1016/0042-6822(91)90878-F; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; RICHARD M, 2009, VIRUSES, V1, P1003; Satyanarayana T, 1996, J GEN VIROL, V77, P2347, DOI 10.1099/0022-1317-77-9-2347; Satyanarayana T, 1996, ARCH VIROL, V141, P85, DOI 10.1007/BF01718590; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Umamaheswaran K., 2003, Indian Phytopathology, V56, P168; Venkat H, 2008, CURR SCI INDIA, V95, P952; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; Zhong WD, 1999, VIROLOGY, V261, P216, DOI 10.1006/viro.1999.9871; [No title captured]	43	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9757	10.1371/journal.pone.0009757	http://dx.doi.org/10.1371/journal.pone.0009757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305786	Green Submitted, Green Published, gold			2022-12-27	WOS:000276456300016
J	Schacht, A; Martin-Loeches, M; Casado, P; Rahman, RA; Sel, A; Sommer, W				Schacht, Annekathrin; Martin-Loeches, Manuel; Casado, Pilar; Rahman, Rasha Abdel; Sel, Alejandra; Sommer, Werner			How Is Sentence Processing Affected by External Semantic and Syntactic Information? Evidence from Event-Related Potentials	PLOS ONE			English	Article							BRAIN POTENTIALS; NEURAL BASIS; COMPREHENSION; LANGUAGE; AGREEMENT; INDEPENDENCE; PERSPECTIVE; HEURISTICS; N400	Background: A crucial question for understanding sentence comprehension is the openness of syntactic and semantic processes for other sources of information. Using event-related potentials in a dual task paradigm, we had previously found that sentence processing takes into consideration task relevant sentence-external semantic but not syntactic information. In that study, internal and external information both varied within the same linguistic domain-either semantic or syntactic. Here we investigated whether across-domain sentence-external information would impact within-sentence processing. Methodology: In one condition, adjectives within visually presented sentences of the structure [Det]-[Noun]-[Adjective]-[Verb] were semantically correct or incorrect. Simultaneously with the noun, auditory adjectives were presented that morphosyntactically matched or mismatched the visual adjectives with respect to gender. Findings: As expected, semantic violations within the sentence elicited N400 and P600 components in the ERP. However, these components were not modulated by syntactic matching of the sentence-external auditory adjective. In a second condition, syntactic within-sentence correctness-variations were combined with semantic matching variations between the auditory and the visual adjective. Here, syntactic within-sentence violations elicited a LAN and a P600 that did not interact with semantic matching of the auditory adjective. However, semantic mismatching of the latter elicited a frontocentral positivity, presumably related to an increase in discourse level complexity. Conclusion: The current findings underscore the open versus algorithmic nature of semantic and syntactic processing, respectively, during sentence comprehension.	[Schacht, Annekathrin; Rahman, Rasha Abdel; Sommer, Werner] Humboldt Univ, Dept Psychol, Berlin, Germany; [Martin-Loeches, Manuel; Casado, Pilar; Sel, Alejandra] UCM, ISCII, Ctr Human Evolut & Behav, Madrid, Spain; [Martin-Loeches, Manuel] Univ Complutense Madrid, Dept Psychobiol, Madrid, Spain	Humboldt University of Berlin; Complutense University of Madrid; Complutense University of Madrid	Schacht, A (corresponding author), Humboldt Univ, Dept Psychol, Berlin, Germany.	schachta@hu-berlin.de	Schacht, Annekathrin/B-2521-2014; Sommer, Werner/N-1945-2019; Rahman, Rasha Abdel/J-4687-2015; Martin-Loeches, Manuel/G-4288-2017; Casado, Pilar/GPX-1002-2022; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Rahman, Rasha Abdel/0000-0002-8438-1570; Martin-Loeches, Manuel/0000-0002-3487-8423; Sommer, Werner/0000-0001-5266-3445; Sel, Alex/0000-0002-1601-8833; Schacht, Anne/0000-0001-9471-3842; Lauwereyns, Jan/0000-0003-0551-2550; Casado, PILAR/0000-0002-3991-4155	German Academic Exchange Service; Spanish Ministerio de Education y Ciencia	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Ministerio de Education y Ciencia(Spanish Government)	This research was supported by a grant by the German Academic Exchange Service and the Spanish Ministerio de Education y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Berwick R.C., 1984, GRAMMATICAL BASIS LI; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; Filik R, 2008, J COGNITIVE NEUROSCI, V20, P1315, DOI 10.1162/jocn.2008.20090; FRAZIER L, 1987, ATTENTION PERFORM, P559; Friederici AD, 1996, J PSYCHOLINGUIST RES, V25, P157, DOI 10.1007/BF01708424; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Johnson-Laird, 1983, MENTAL MODELS; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1999, LANGUAGE DIVERSITY C; Kutas M., 2006, HDB PSYCHOLINGUISTIC; Marslen-Wilson William., 1987, MODULARITY KNOWLEDGE; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; Martin-Loeches M, 2009, J COGNITIVE NEUROSCI, V21, P1365, DOI 10.1162/jocn.2009.21106; McClelland JL, 1989, LANG COGNITIVE PROC, V4, pSI287, DOI 10.1080/01690968908406371; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Sebastian N., 2000, LEXESP LEXICO INFORM; Severens E, 2008, BRAIN RES, V1228, P135, DOI 10.1016/j.brainres.2008.05.092; Townsend D.J., 2001, SENTENCE COMPREHENSI; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vissers CTWM, 2007, BIOL PSYCHOL, V75, P8, DOI 10.1016/j.biopsycho.2006.10.004; Waters GS, 1996, PSYCHOL REV, V103, P761, DOI 10.1037/0033-295X.103.4.761	40	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9742	10.1371/journal.pone.0009742	http://dx.doi.org/10.1371/journal.pone.0009742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	572EG	20305820	Green Published, Green Accepted, gold			2022-12-27	WOS:000275809600014
J	Xu, ZJ; Xia, B; Gong, Q; Bailey, J; Groves, B; Radeke, M; Wood, SA; Szumlinski, KK; Ma, D				Xu, Zhuojin; Xia, Bin; Gong, Qiang; Bailey, Jeffrey; Groves, Benjamin; Radeke, Monte; Wood, Stephen A.; Szumlinski, Karen K.; Ma, Dzwokai			Identification of a Deubiquitinating Enzyme as a Novel AGS3-Interacting Protein	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; BETA-GAMMA-SUBUNITS; TETRATRICOPEPTIDE REPEAT; GOLGI MEMBRANES; REGULATOR AGS3; ALPHA-SUBUNITS; HT-29 CELLS; FAT FACETS; UBIQUITIN; ACTIVATOR	Activator of G protein Signaling 3 (AGS3) is a receptor-independent G protein activator that has been implicated in multiple biological events such as brain development, neuroplasticity and addiction, cardiac function, Golgi structure/function, macroautophagy and metabolism. However, how AGS3 is regulated is little known. We demonstrate here that AGS3 interacts with a ubiquitin specific protease USP9x, and this interaction is at least partially mediated through the C-terminal G protein regulatory domain of AGS3. Knockdown of USP9x causes a moderate reduction in the level of AGS3. In contrast, overexpression of either USP9x or its deubiquitinating domain UCH increases the amount of AGS3, whereas expression of the mutant UCH domain that lacks deubiquitinating activity does not have the same effect. As previously observed in AGS3 knockdown cells, the localization of several marker proteins of the late Golgi compartments is disturbed in cells depleted of USP9x. Taken together, our study suggests that USP9x can modulate the level of a subpopulation of AGS3, and this modulation plays a role in regulating the structure of the late Golgi compartments. Finally, we have found that levels of AGS3 and USP9x are co-regulated in the prefrontal cortex of rats withdrawn from repeated cocaine treatment. In conjunction with the above data, this observation indicates a potential role of USP9X in the regulation of the AGS3 level during cocaine-induced neuroplasticity.	[Xu, Zhuojin; Xia, Bin; Gong, Qiang; Bailey, Jeffrey; Groves, Benjamin; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Szumlinski, Karen K.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; [Xu, Zhuojin; Gong, Qiang; Bailey, Jeffrey; Groves, Benjamin; Radeke, Monte; Szumlinski, Karen K.; Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Xia, Bin] Sichuan Univ, Dept Pediat, W China Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Wood, Stephen A.] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cellular & Mol Therapies, Nathan, Qld 4111, Australia	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Sichuan University; Griffith University	Xu, ZJ (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	ma@lifesci.ucsb.edu	Gong, Qiang/D-5337-2009; Szumlinski, Karen K./J-9617-2015; Gong, Qiang/H-3234-2014; Wood, Stephen A/E-8357-2011	Szumlinski, Karen K./0000-0003-1078-1077; Wood, Stephen A/0000-0002-2576-7457; /0000-0002-6129-2938	American Heart Association (AHA) [07651554]; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024038] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the American Heart Association (AHA) award (# 07651554) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) 2008 Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Lanier SM, 2004, BIOL CELL, V96, P369, DOI 10.1016/j.biolcel.2004.03.012; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; SCHWICKART M, 2009, NATURE; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; VURAL A, 2010, MOL CELLULA IN PRESS; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546	43	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9725	10.1371/journal.pone.0009725	http://dx.doi.org/10.1371/journal.pone.0009725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305814	gold, Green Published			2022-12-27	WOS:000275809600002
J	Jiang, SX; Lee, BC; Fu, YG; Avraham, S; Lim, B; Avraham, HK				Jiang, Shuxian; Lee, Byeong-Chel; Fu, Yigong; Avraham, Shalom; Lim, Bing; Avraham, Hava Karsenty			Reconstitution of Mammary Epithelial Morphogenesis by Murine Embryonic Stem Cells Undergoing Hematopoietic Stem Cell Differentiation	PLOS ONE			English	Article							IN-VIVO; LIFE SPAN; GLAND; MICROENVIRONMENT; EXPRESSION; GROWTH; MODEL	Background: Mammary stem cells are maintained within specific microenvironments and recruited throughout lifetime to reconstitute de novo the mammary gland. Mammary stem cells have been isolated through the identification of specific cell surface markers and in vivo transplantation into cleared mammary fat pads. Accumulating evidence showed that during the reformation of mammary stem cell niches by dispersed epithelial cells in the context of the intact epithelium-free mammary stroma, non-mammary epithelial cells may be sequestered and reprogrammed to perform mammary epithelial cell functions and to adopt mammary epithelial characteristics during reconstruction of mammary epithelium in regenerating mammary tissue in vivo. Methodology/Principal Findings: To examine whether other types of progenitor cells are able to contribute to mammary branching morphogenesis, we examined the potential of murine embryonic stem (mES) cells, undergoing hematopoietic differentiation, to support mammary reconstitution in vivo. We observed that cells from day 14 embryoid bodies (EBs) under hematopoietic differentiation condition, but not supernatants derived from these cells, when transplanted into denuded mammary fat pads, were able to contribute to both the luminal and myoepithelial lineages in branching ductal structures resembling the ductal-alveolar architecture of the mammary tree. No teratomas were observed when these cells were transplanted in vivo. Conclusions/Significance: Our data provide evidence for the dominance of the tissue-specific mammary stem cell niche and its role in directing mES cells, undergoing hematopoietic differentiation, to reprogram into mammary epithelial cells and to promote mammary epithelial morphogenesis. These studies should also provide insights into regeneration of damaged mammary gland and the role of the mammary microenvironment in reprogramming cell fate.	[Jiang, Shuxian; Fu, Yigong; Avraham, Shalom; Avraham, Hava Karsenty] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA; [Jiang, Shuxian; Fu, Yigong; Avraham, Shalom; Lim, Bing; Avraham, Hava Karsenty] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Pittsburgh, PA USA; [Lim, Bing] Genome Inst Singapore, Singapore, Singapore	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Jiang, SX (corresponding author), Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA.	havraham@bidmc.harvard.edu		Avraham, Hava/0000-0002-7545-3640	National Institutes of Health [CA096805, CA13522]; Career Enhancement Award [K18 PAR-02-069, DK-47636]; NATIONAL CANCER INSTITUTE [R01CA096805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Enhancement Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (Grant CA 096805 and CA13522, H. A., Career Enhancement Award K18 PAR-02-069, H. A., and DK-47636, B. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2009, CELL CYCLE, V8, P1127, DOI 10.4161/cc.8.8.8189; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; DANIEL CW, 1965, SCIENCE, V149, P634, DOI 10.1126/science.149.3684.634; DANIEL CW, 1971, EXP CELL RES, V65, P27, DOI 10.1016/S0014-4827(71)80046-0; Daniel CW, 1999, J MAMMARY GLAND BIOL, V4, P3, DOI 10.1023/A:1018796301609; DEOME KB, 1959, CANCER RES, V19, P515; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SMITH GH, 1991, J VIROL, V65, P6365, DOI 10.1128/JVI.65.11.6365-6370.1991; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9	21	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9707	10.1371/journal.pone.0009707	http://dx.doi.org/10.1371/journal.pone.0009707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300573	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000275621000018
J	Katriel, G; Stone, L				Katriel, Guy; Stone, Lewi			Pandemic Dynamics and the Breakdown of Herd Immunity	PLOS ONE			English	Article							INFLUENZA EPIDEMICS	In this note we discuss the issues involved in attempting to model pandemic dynamics. More specifically, we show how it may be possible to make projections for the ongoing H1N1 pandemic as extrapolated from knowledge of seasonal influenza. We derive first-approximation parameter estimates for the SIR model to describe seasonal influenza, and then explore the implications of the existing classical epidemiological theory for the case of a pandemic virus. In particular, we note the dramatic nonlinear increase in attack rate as a function of the percentage of susceptibles initially present in the population. This has severe consequences for the pandemic, given the general lack of immunity in the global population.	[Katriel, Guy; Stone, Lewi] Tel Aviv Univ, George S Wise Fac Life Sci, Biomath Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University	Katriel, G (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Biomath Unit, IL-69978 Tel Aviv, Israel.	haggaika@yahoo.com		Katriel, Guy/0000-0001-7411-4789; Stone, Lewi/0000-0002-6465-579X	EU [FP7]; Israel Science Foundation; Israel Ministry of Health	EU(European Commission); Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health	The authors acknowledge the support of EU-FP7 grant Epiwork, the Israel Science Foundation, and the Israel Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; COX NJ, 2007, ANNU REV MED, V51, P407; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mccaw JM, 2009, SCIENCE, V325, P1071, DOI 10.1126/science.325_1071a; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; REVERE P, 2009, SWINE FLU THIS FALL; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	21	19	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9565	10.1371/journal.pone.0009565	http://dx.doi.org/10.1371/journal.pone.0009565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300617	Green Submitted, Green Published, gold			2022-12-27	WOS:000275621000001
J	Wright, B; Gibson, T; Spencer, J; Lovegrove, JA; Gibbins, JM				Wright, Bernice; Gibson, Trevor; Spencer, Jeremy; Lovegrove, Julie A.; Gibbins, Jonathan M.			Platelet-Mediated Metabolism of the Common Dietary Flavonoid, Quercetin	PLOS ONE			English	Article							O-METHYLTRANSFERASE ACTIVITY; ESSENTIAL COMPONENTS; ACTIVATION PATHWAY; SMALL-INTESTINE; IDENTIFICATION; INGESTION; RAT; BIOAVAILABILITY; PROCYANIDINS; FLAVAN-3-OLS	Background: Flavonoid metabolites remain in blood for periods of time potentially long enough to allow interactions with cellular components of this tissue. It is well-established that flavonoids are metabolised within the intestine and liver into methylated, sulphated and glucuronidated counterparts, which inhibit platelet function. Methodology/Principal Findings: We demonstrate evidence suggesting platelets which contain metabolic enzymes, as an alternative location for flavonoid metabolism. Quercetin and a plasma metabolite of this compound, 4'-O-methyl quercetin (tamarixetin) were shown to gain access to the cytosolic compartment of platelets, using confocal microscopy. High performance liquid chromatography (HPLC) and mass spectrometry (MS) showed that quercetin was transformed into a compound with a mass identical to tamarixetin, suggesting that the flavonoid was methylated by catechol-O-methyl transferase (COMT) within platelets. Conclusions/Significance: Platelets potentially mediate a third phase of flavonoid metabolism, which may impact on the regulation of the function of these cells by metabolites of these dietary compounds.	[Wright, Bernice; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England; [Gibson, Trevor] Univ Reading, Bioctr Facil, Reading, Berks, England; [Spencer, Jeremy; Lovegrove, Julie A.] Univ Reading, Sch Food & Nutr Sci, Reading, Berks, England; [Gibbins, Jonathan M.] King Saud Univ, Blood Transfus Res Grp, Riyadh, Saudi Arabia	University of Reading; University of Reading; University of Reading; King Saud University	Wright, B (corresponding author), Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England.	b.wright@rdg.ac.uk		Gibbins, Jonathan/0000-0002-0372-5352	Biotechnology and Biological Sciences Research Council [BBS/S/A/2004/10967]; Medical Research Council [G0400883]; British Heart Foundation [RG/05/007]; MRC [G0400883] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (grant code: BBS/S/A/2004/10967; URL: http://www.bbsrc.ac.uk/), Medical Research Council (grant code: G0400883; URL: http://www.mrc.ac.uk/index.htm) and British Heart Foundation (grant code: RG/05/007; URL: http://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crespy V, 1999, AM J PHYSIOL-GASTR L, V277, pG120, DOI 10.1152/ajpgi.1999.277.1.G120; Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441; DELUCA G, 1976, ITAL J BIOCHEM, V25, P213; Dingemanse J, 2000, EUR J PHARM SCI, V12, P159, DOI 10.1016/S0928-0987(00)00151-2; Donovan JL, 2001, J NUTR, V131, P1753, DOI 10.1093/jn/131.6.1753; Fiorani M, 2005, BRIT J NUTR, V94, P338, DOI 10.1079/BJN20051504; Fiorani M, 2002, FREE RADICAL BIO MED, V32, P64, DOI 10.1016/S0891-5849(01)00762-6; Frame LT, 2000, DRUG METAB DISPOS, V28, P1063; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; Guerrero JA, 2005, J THROMB HAEMOST, V3, P369, DOI 10.1111/j.1538-7836.2004.01099.x; Guerrero JA, 2007, BRIT J CLIN PHARMACO, V64, P133, DOI 10.1111/j.1365-2125.2007.02881.x; Harada M, 1999, BIOSCI BIOTECH BIOCH, V63, P973, DOI 10.1271/bbb.63.973; Heptinstall S, 2006, J CARDIOVASC PHARM, V47, pS197, DOI 10.1097/00005344-200606001-00015; Hollman PCH, 1997, BIOMED PHARMACOTHER, V51, P305, DOI 10.1016/S0753-3322(97)88045-6; Hollman PCH, 1996, ANAL CHEM, V68, P3511, DOI 10.1021/ac960461w; Hubbard GP, 2006, BRIT J NUTR, V96, P482, DOI 10.1079/BJN20061831; Hubbard GP, 2004, J THROMB HAEMOST, V2, P2138, DOI 10.1111/j.1538-7836.2004.01067.x; Kinouchi S, 2008, NEUROSCI LETT, V434, P124, DOI 10.1016/j.neulet.2008.01.039; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V277, P507, DOI 10.1006/bbrc.2000.3701; Masuda M, 2002, ANN CLIN BIOCHEM, V39, P589, DOI 10.1258/000456302760413379; Nowell SA, 1998, J BIOL CHEM, V273, P33342, DOI 10.1074/jbc.273.50.33342; PLOW EF, 2000, HEMATOLOGY BASIC PRI, P1741; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Spencer JPE, 2003, BIOCHEM J, V372, P173, DOI 10.1042/BJ20021972; Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558; Spencer JPE, 1999, FEBS LETT, V458, P224, DOI 10.1016/S0014-5793(99)01160-6; STRAMENTINOLI G, 1978, THROMB HAEMOSTASIS, V39, P238; Tsang C, 2005, BRIT J NUTR, V94, P170, DOI 10.1079/BJN20051480; Vafeiadou K, 2008, ARCH BIOCHEM BIOPHYS, V478, P195, DOI 10.1016/j.abb.2008.07.014; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yodogawa S, 2003, BIOL PHARM BULL, V26, P1120, DOI 10.1248/bpb.26.1120	33	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9673	10.1371/journal.pone.0009673	http://dx.doi.org/10.1371/journal.pone.0009673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300638	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000275620900008
J	Zhang, NX; Cannon, RD; Holland, BR; Patchett, ML; Schmid, J				Zhang, Ningxin; Cannon, Richard D.; Holland, Barbara R.; Patchett, Mark L.; Schmid, Jan			Impact of Genetic Background on Allele Selection in a Highly Mutable Candida albicans Gene, PNG2	PLOS ONE			English	Article							HUMAN COMMENSAL YEAST; ENDOPLASMIC-RETICULUM; ANTIGENIC VARIATION; EXPRESSION; SEQUENCE; GENOME; FUNGAL; CELL; PROTEINS; ADHESIN	In many microbes rapid mutation of highly mutable contingency genes continually replenishes a pool of variant alleles from which the most suitable are selected, assisting in rapid adaptation and evasion of the immune response. In some contingency genes mutability is achieved through DNA repeats within the coding region. The fungal human pathogen Candida albicans has 2600 repeat-containing ORFs. For those investigated (ALS genes, HYR1, HYR2, CEK1, RLM1) many protein variants with differing amino acid repeat regions exist, as expected for contingency genes. However, specific alleles dominate in different clades, which is unexpected if allele variation is used for short-term adaptation. Generation of new alleles of repeat-containing C. albicans ORFs has never been observed directly. Here we present evidence for restrictions on the emergence of new alleles in a highly mutable C. albicans repeat-containing ORF, PNG2, encoding a putative secreted or cell surface glycoamidase. In laboratory cultures new PNG2 alleles arose at a rate of 2.8 x 10(-5) (confidence interval 3.3 x 10(-6) -9.9 x 10(-5)) per cell per division, comparable to rates measured for contingency genes. Among 80 clinical isolates 17 alleles of different length and 23 allele combinations were distinguishable; sequence differences between repeat regions of identical size suggest the existence of 36 protein variants. Specific allele combinations predominated in different genetic backgrounds, as defined by DNA fingerprinting and multilocus sequence typing. Given the PNG2 mutation rate, this is unexpected, unless in different genetic backgrounds selection favors different alleles. Specific alleles or allele combinations were not preferentially associated with C. albicans isolates from particular body sites or geographical regions. Our results suggest that the mutability of PNG2 is not used for short-term adaptation or evasion of the immune system. Nevertheless the large number of alleles observed indicates that mutability of PNG2 may assist C. albicans strains from different genetic backgrounds optimize their interaction with the host in the long term.	[Zhang, Ningxin; Patchett, Mark L.; Schmid, Jan] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand; [Cannon, Richard D.] Univ Otago, Dept Oral Sci, Dunedin, New Zealand; [Holland, Barbara R.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	Massey University; University of Otago; Massey University	Zhang, NX (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	j.schmid@massey.ac.nz	Holland, Barbara/G-1646-2013; Schmid, Jan/A-6863-2011	Holland, Barbara/0000-0002-4628-7938; Schmid, Jan/0000-0001-8794-4175; Cannon, Richard/0000-0002-5398-2066	Royal Society of New Zealand [MAU 902]	Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by Marsden grant MAU 902 from the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1998, EUR J BIOCHEM, V252, P118, DOI 10.1046/j.1432-1327.1998.2520118.x; Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; FtouhiPaquin N, 1997, J BIOL CHEM, V272, P22960, DOI 10.1074/jbc.272.36.22960; Giblin L, 2001, GENE, V272, P157, DOI 10.1016/S0378-1119(01)00548-0; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Higy M, 2005, BIOCHEMISTRY-US, V44, P2039, DOI 10.1021/bi047976z; Holmes AR, 2006, MOL MICROBIOL, V62, P170, DOI 10.1111/j.1365-2958.2006.05357.x; HOYER LL, 1995, MOL MICROBIOL, V15, P39, DOI 10.1111/j.1365-2958.1995.tb02219.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; JEFFREY NW, 1998, MOL MICROBIOL, V30, P767; Jeng HW, 2005, MED MYCOL, V43, P209, DOI 10.1080/13693780410001731637; Lee REB, 2005, J ANTIMICROB CHEMOTH, V55, P655, DOI 10.1093/jac/dki105; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Lott TJ, 1999, MICROBIOL-UK, V145, P1137, DOI 10.1099/13500872-145-5-1137; Lott TJ, 2005, FUNGAL GENET BIOL, V42, P444, DOI 10.1016/j.fgb.2005.01.012; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Perfect SE, 1998, PLANT J, V15, P273, DOI 10.1046/j.1365-313X.1998.00196.x; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Sampaio P, 2009, ANTON LEEUW INT J G, V96, P395, DOI 10.1007/s10482-009-9352-5; Schmid J, 1999, MICROBIOL-UK, V145, P2405, DOI 10.1099/00221287-145-9-2405; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Sumita T, 2005, EUKARYOT CELL, V4, P1872, DOI 10.1128/EC.4.11.1872-1881.2005; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang NX, 2009, INFECT GENET EVOL, V9, P493, DOI 10.1016/j.meegid.2009.01.007; Zhang NX, 2003, GENOME RES, V13, P2005, DOI 10.1101/gr.1024903; Zhao XM, 2007, FUNGAL GENET BIOL, V44, P1298, DOI 10.1016/j.fgb.2007.05.004	48	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9614	10.1371/journal.pone.0009614	http://dx.doi.org/10.1371/journal.pone.0009614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231904	Green Published, gold			2022-12-27	WOS:000275328300022
J	Hou, YB; Zhang, H; Miranda, L; Lin, SJ				Hou, Yubo; Zhang, Huan; Miranda, Lilibeth; Lin, Senjie			Serious Overestimation in Quantitative PCR by Circular (Supercoiled) Plasmid Standard: Microalgal pcna as the Model Gene	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; PFIESTERIA-PISCICIDA; QUANTIFICATION; VALIDATION; EXPRESSION; EFFICIENCY	Quantitative real-time PCR (qPCR) has become a gold standard for the quantification of nucleic acids and microorganism abundances, in which plasmid DNA carrying the target genes are most commonly used as the standard. A recent study showed that supercoiled circular confirmation of DNA appeared to suppress PCR amplification. However, to what extent to which different structural types of DNA (circular versus linear) used as the standard may affect the quantification accuracy has not been evaluated. In this study, we quantitatively compared qPCR accuracies based on circular plasmid (mostly in supercoiled form) and linear DNA standards (linearized plasmid DNA or PCR amplicons), using proliferating cell nuclear gene (pcna), the ubiquitous eukaryotic gene, in five marine microalgae as a model gene. We observed that PCR using circular plasmids as template gave 2.65-4.38 more of the threshold cycle number than did equimolar linear standards. While the documented genome sequence of the diatom Thalassiosira pseudonana shows a single copy of pcna, qPCR using the circular plasmid as standard yielded an estimate of 7.77 copies of pcna per genome whereas that using the linear standard gave 1.02 copies per genome. We conclude that circular plasmid DNA is unsuitable as a standard, and linear DNA should be used instead, in absolute qPCR. The serious overestimation by the circular plasmid standard is likely due to the undetected lower efficiency of its amplification in the early stage of PCR when the supercoiled plasmid is the dominant template.	[Hou, Yubo; Zhang, Huan; Miranda, Lilibeth; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Hou, YB (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	yhou@wadsworth.org	zhang, yaqun/J-8478-2014; Guo, chentao/G-7320-2016; Lin, Senjie/A-7466-2011		National Science Foundation [OCE0452780]; National Oceanic and Atmospheric Administration Ecology and Oceanography of Harmful Algal Blooms [NA05NOS4781196]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Ecology and Oceanography of Harmful Algal Blooms	The work was supported by the National Science Foundation Grant OCE0452780 (to S.L.) and National Oceanic and Atmospheric Administration Ecology and Oceanography of Harmful Algal Blooms Grant NA05NOS4781196 ( to S.L. and H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Cooke JR, 2004, J BIOTECHNOL, V114, P239, DOI 10.1016/j.jbiotec.2004.06.011; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Lin SJ, 2003, APPL ENVIRON MICROB, V69, P343, DOI 10.1128/AEM.69.1.343-349.2003; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Nogva HK, 2004, BIOTECHNIQUES, V37, P246, DOI 10.2144/04372RR01; Pielberg G, 2003, GENOME RES, V13, P2171, DOI 10.1101/gr.1188203; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	23	173	176	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9545	10.1371/journal.pone.0009545	http://dx.doi.org/10.1371/journal.pone.0009545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221433	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197200007
J	Zhu, J; Braun, EL; Kohno, S; Antenos, M; Xu, EY; Cook, RW; Lin, SJ; Moore, BC; Guillette, LJ; Jardetzky, TS; Woodruff, TK				Zhu, Jie; Braun, Edward L.; Kohno, Satomi; Antenos, Monica; Xu, Eugene Y.; Cook, Robert W.; Lin, S. Jack; Moore, Brandon C.; Guillette, Louis J., Jr.; Jardetzky, Theodore S.; Woodruff, Teresa K.			Phylogenomic Analyses Reveal the Evolutionary Origin of the Inhibin alpha-Subunit, a Unique TGF beta Superfamily Antagonist	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ACTIVIN-A; POSITIVE SELECTION; GENOME DUPLICATION; GRANULOSA-CELLS; GENE-EXPRESSION; FEMALE RAT; 2 ROUNDS; PROTEINS; VERTEBRATE	Transforming growth factor-beta (TGF beta) homologues form a diverse superfamily that arose early in animal evolution and control cellular function through membrane-spanning, conserved serine-threonine kinases (RII and RI receptors). Activin and inhibin are related dimers within the TGF beta superfamily that share a common beta-subunit. The evolution of the inhibin alpha-subunit created the only antagonist within the TGF beta superfamily and the only member known to act as an endocrine hormone. This hormone introduced a new level of complexity and control to vertebrate reproductive function. The novel functions of the inhibin alpha-subunit appear to reflect specific insertion-deletion changes within the inhibin b-subunit that occurred during evolution. Using phylogenomic analysis, we correlated specific insertions with the acquisition of distinct functions that underlie the phenotypic complexity of vertebrate reproductive processes. This phylogenomic approach presents a new way of understanding the structure-function relationships between inhibin, activin, and the larger TGFb superfamily.	[Zhu, Jie; Antenos, Monica; Xu, Eugene Y.; Cook, Robert W.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Braun, Edward L.; Kohno, Satomi; Moore, Brandon C.; Guillette, Louis J., Jr.] Univ Florida, Dept Biol, Gainesville, FL USA; [Lin, S. Jack; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; State University System of Florida; University of Florida; Stanford University	Zhu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911; Kohno, Satomi/0000-0001-6184-3616; Braun, Edward/0000-0003-1643-5212; Woodruff, Teresa/0000-0002-1197-3399; Xu, Eugene/0000-0002-4344-6606	National Institutes of Health [R01HD37096, R21ES014053]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers R01HD37096 and R21ES014053 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbasi AA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-239; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Benner Steven A., 2007, V75, P1; BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2545, DOI 10.1210/en.133.6.2545; Braun Edward L, 2003, Appl Bioinformatics, V2, P13; Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chang H, 2001, MOL CELL ENDOCRINOL, V180, P39, DOI 10.1016/S0303-7207(01)00513-5; Chapman SC, 2003, ENDOCRINOLOGY, V144, P5640, DOI 10.1210/en.2003-0670; Cook RW, 2005, J BIOL CHEM, V280, P40177, DOI 10.1074/jbc.M504591200; CULLER MD, 1988, MOL CELL ENDOCRINOL, V58, P263, DOI 10.1016/0303-7207(88)90163-3; DAGOSTINO J, 1989, ENDOCRINOLOGY, V124, P310, DOI 10.1210/endo-124-1-310; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fang JM, 1996, BIOCHEM BIOPH RES CO, V228, P669, DOI 10.1006/bbrc.1996.1715; Fang JM, 1997, BIOCHEM BIOPH RES CO, V231, P655, DOI 10.1006/bbrc.1997.6162; Farnworth PG, 2007, ENDOCRINOLOGY, V148, P5355, DOI 10.1210/en.2007-0155; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Force A, 1999, GENETICS, V151, P1531; Ge W, 2000, CAN J PHYSIOL PHARM, V78, P1077, DOI 10.1139/cjpp-78-12-1077; GE W, 1993, BIOCHEM BIOPH RES CO, V193, P711, DOI 10.1006/bbrc.1993.1683; GE W, 1992, ENDOCRINOLOGY, V131, P1922, DOI 10.1210/en.131.4.1922; Grant T, 2007, MOL PHYLOGENET EVOL, V44, P483, DOI 10.1016/j.ympev.2006.11.027; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2009, MOL BIOL EVOL, V26, P463, DOI 10.1093/molbev/msn271; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hughes Austin L., 2003, Journal of Structural and Functional Genomics, V3, P85, DOI 10.1023/A:1022681600462; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Janke A, 1996, J MOL EVOL, V42, P153, DOI 10.1007/BF02198841; Johnson PA, 2005, GEN COMP ENDOCR, V141, P233, DOI 10.1016/j.ygcen.2005.01.006; JOHNSON PA, 1993, GEN COMP ENDOCR, V90, P43, DOI 10.1006/gcen.1993.1058; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kenny HA, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740085; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; Larhammar D, 2002, GENOME RES, V12, P1910, DOI 10.1101/gr.445702; Lebrun JJ, 1999, MOL ENDOCRINOL, V13, P15, DOI 10.1210/me.13.1.15; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li MD, 1998, J ENDOCRINOL, V156, P529, DOI 10.1677/joe.0.1560529; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Lovell TM, 2000, BIOL REPROD, V63, P213, DOI 10.1095/biolreprod63.1.213; Lovell TM, 2002, REPRODUCTION, V124, P649, DOI 10.1530/reprod/124.5.649; Lovell TM, 2001, BIOL REPROD, V64, P188, DOI 10.1095/biolreprod64.1.188; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; MANN GE, 1989, J ENDOCRINOL, V123, P383, DOI 10.1677/joe.0.1230383; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Muller GB, 2005, J EXP ZOOL PART B, V304B, P487, DOI 10.1002/jez.b.21081; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Ohno S., 1970, EVOLUTION GENE DUPLI; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pigliucci M, 2007, EVOLUTION, V61, P2743, DOI 10.1111/j.1558-5646.2007.00246.x; Piontkivska H, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-31; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; RIVIER C, 1987, HORM RES, V28, P104, DOI 10.1159/000180934; RIVIER C, 1987, ENDOCRINOLOGY, V120, P1688, DOI 10.1210/endo-120-4-1688; ROBERTSON DM, 1995, J ENDOCRINOL, V144, P261, DOI 10.1677/joe.0.1440261; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; Sassi SO, 2007, MOL BIOL EVOL, V24, P1012, DOI 10.1093/molbev/msm020; Satterlee DG, 2002, POULTRY SCI, V81, P519, DOI 10.1093/ps/81.4.519; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Silva JRV, 2004, J ENDOCRINOL, V183, P405, DOI 10.1677/joe.1.05756; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2004, MOL CELL ENDOCRINOL, V225, P9, DOI 10.1016/j.mce.2004.02.007; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Van der Zee M, 2008, DEV GENES EVOL, V218, P203, DOI 10.1007/s00427-007-0179-7; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wetterbom A, 2006, J MOL EVOL, V63, P682, DOI 10.1007/s00239-006-0045-7; WIATER E, 2009, MOL ENDOCRINOL; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; WOODRUFF TK, 1989, ENDOCRINOLOGY, V124, P2193, DOI 10.1210/endo-124-5-2193; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wu TT, 2000, BIOL REPROD, V62, P1585, DOI 10.1095/biolreprod62.6.1585; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	97	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9457	10.1371/journal.pone.0009457	http://dx.doi.org/10.1371/journal.pone.0009457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209104	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197100003
J	Miranda, C; Fumagalli, T; Anania, MC; Vizioli, MG; Pagliardini, S; Pierotti, MA; Greco, A				Miranda, Claudia; Fumagalli, Tiziana; Anania, Maria Chiara; Vizioli, Maria Grazia; Pagliardini, Sonia; Pierotti, Marco A.; Greco, Angela			Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes	PLOS ONE			English	Article							PAPILLARY THYROID-CARCINOMA; SERINE PHOSPHORYLATION; TYROSINE KINASE; CELLULAR-TRANSFORMATION; SIGNAL TRANSDUCER; GENE-REGULATION; ACTIVATION; TRANSCRIPTION-3; PROTEIN; CELLS	TRK oncoproteins are chimeric versions of the NTRK1/NGF receptor and display constitutive tyrosine kinase activity leading to transformation of NIH3T3 cells and neuronal differentiation of PC12 cells. Signal Transducer and Activator of Transcription (STAT) 3 is activated in response to cytokines and growth factors and it has been recently identified as a novel signal transducer for TrkA, mediating the functions of NGF in nervous system. In this paper we have investigated STAT3 involvement in signalling induced by TRK oncogenes. We showed that TRK oncogenes trigger STAT3 phosphorylation both on Y705 and S727 residues and STAT3 transcriptional activity. MAPK pathway was involved in the induction of STAT3 phosphorylation. Interestingly, we have shown reduced STAT3 protein level in NIH3T3 transformed foci expressing TRK oncogenes. Overall, we have unveiled a dual role for STAT3 in TRK oncogenes-induced NIH3T3 transformation: i) decreased STAT3 protein levels, driven by TRK oncoproteins activity, are associated to morphological transformation; ii) residual STAT3 transcriptional activity is required for cell growth.	[Miranda, Claudia; Fumagalli, Tiziana; Anania, Maria Chiara; Vizioli, Maria Grazia; Pagliardini, Sonia; Greco, Angela] Ist Nazl Tumori, Operat Unit Mol Mech, Dept Expt Oncol & Mol Med, IRCCS Fdn, I-20133 Milan, Italy; [Pierotti, Marco A.] Ist Nazl Tumori, IRCCS Fdn, Sci Directorate, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Miranda, C (corresponding author), Ist Nazl Tumori, Operat Unit Mol Mech, Dept Expt Oncol & Mol Med, IRCCS Fdn, Via Venezian 1, I-20133 Milan, Italy.	claudia.miranda@istitutotumori.mi.it; angela.greco@istitutotumori.mi.it	Anania, Maria Chiara/B-9339-2017; Pierotti, Marco Alessandro/AAC-4728-2022; Anania, Maria Chiara/N-4853-2019; Greco, Angela/C-1953-2017	Anania, Maria Chiara/0000-0003-4012-1870; Pierotti, Marco Alessandro/0000-0002-7431-8332; Anania, Maria Chiara/0000-0003-4012-1870; Greco, Angela/0000-0003-2994-0349	AIRC (Italian Association for Cancer Research); ACC (Alliance Against Cancer); Italian Ministry of Health	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); ACC (Alliance Against Cancer); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by AIRC (Italian Association for Cancer Research), ACC (Alliance Against Cancer), and Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; BONGARZONE I, 1989, ONCOGENE, V4, P1457; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; GAO SP, 2006, SCI STKE, pE30; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Greco A, 2004, CANC TREAT, V122, P207; GRECO A, 1995, MOL CELL BIOL, V15, P6118; GRECO A, 1992, ONCOGENE, V7, P237; GRECO A, 1993, CELL GROWTH DIFFER, V4, P539; GRECO A, 2004, MOL BASIS THYROID CA, P207; Gunning PT, 2008, CHEMBIOCHEM, V9, P2800, DOI 10.1002/cbic.200800291; Hwang JH, 2003, MOL ENDOCRINOL, V17, P1155, DOI 10.1210/me.2002-0401; Ishiyama T, 2006, NEC TECH J, V1, P47; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Liu HS, 2008, NEOPLASIA, V10, P52, DOI 10.1593/neo.07691; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; Miranda C, 2001, J CELL PHYSIOL, V186, P35; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Ranzi V, 2003, ENDOCRINOLOGY, V144, P922, DOI 10.1210/en.2002-221002; Roccato E, 2005, J BIOL CHEM, V280, P3382, DOI 10.1074/jbc.M407522200; Roccato E, 2002, BRIT J CANCER, V87, P645, DOI 10.1038/sj.bjc.6600544; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schubert WH, 2001, J HYDROMETEOROL, V2, P3, DOI 10.1175/1525-7541(2001)002<0005:>2.0.CO;2; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9446	10.1371/journal.pone.0009446	http://dx.doi.org/10.1371/journal.pone.0009446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209132	Green Submitted, Green Published, gold			2022-12-27	WOS:000275063400002
J	Livolsi, A; Niederhoffer, N; Dali-Youcef, N; Rambaud, C; Olexa, C; Mokni, W; Gies, JP; Bousquet, P				Livolsi, Angelo; Niederhoffer, Nathalie; Dali-Youcef, Nassim; Rambaud, Caroline; Olexa, Catherine; Mokni, Walid; Gies, Jean-Pierre; Bousquet, Pascal			Cardiac Muscarinic Receptor Overexpression in Sudden Infant Death Syndrome	PLOS ONE			English	Article							BRAIN-STEM; GUINEA-PIG; RISK; VICTIMS; BINDING; NUCLEUS; REFLEX; SIDS	Background: Sudden infant death syndrome (SIDS) remains the leading cause of death among infants less than 1 year of age. Disturbed expression of some neurotransmitters and their receptors has been shown in the central nervous system of SIDS victims but no biological abnormality of the peripheral vago-cardiac system has been demonstrated to date. The present study aimed to seek vago-cardiac abnormalities in SIDS victims. The cardiac level of expression of muscarinic receptors, as well as acetylcholinesterase enzyme activity were investigated. Methodology/Principal Findings: Left ventricular samples and blood samples were obtained from autopsies of SIDS and children deceased from non cardiac causes. Binding experiments performed with [H-3] NMS, a selective muscarinic ligand, in cardiac membrane preparations showed that the density of cardiac muscarinic receptors was increased as shown by a more than doubled B-max value in SIDS (n = 9 SIDS versus 8 controls). On average, the erythrocyte acetylcholinesterase enzyme activity was also significantly increased (n = 9 SIDS versus 11 controls). Conclusions: In the present study, it has been shown for the first time that cardiac muscarinic receptor overexpression is associated with SIDS. The increase of acetylcholinesterase enzyme activity appears as a possible regulatory mechanism.	[Livolsi, Angelo; Niederhoffer, Nathalie; Olexa, Catherine; Mokni, Walid; Bousquet, Pascal] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France; [Niederhoffer, Nathalie; Gies, Jean-Pierre] Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Dali-Youcef, Nassim] Univ Strasbourg, CNRS, INSERM, IGBMC, Illkirch Graffenstaden, France; [Dali-Youcef, Nassim] Hop Univ, Lab Biochim Gen & Specialisee, Strasbourg, France; [Rambaud, Caroline] Hop Raymond Poincare, Serv Anat Pathol & Med Legale, Garches, France; [Mokni, Walid; Bousquet, Pascal] Hop Univ, INSERM, Ctr Invest Clin, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Livolsi, A (corresponding author), Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France.	Pascal.Bousquet@medecine.u-strasbg.fr	Niederhoffer, Nathalie/AAF-1343-2020; DALI-YOUCEF, Nassim/O-2549-2016	DALI-YOUCEF, Nassim/0000-0001-6958-1331	French Ministery of Research	French Ministery of Research(Ministry of Research, France)	This study was funded by the French Ministery of Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM L, 1984, BRAIN RES, V323, P279, DOI 10.1016/0006-8993(84)90298-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Duncan JR, 2008, BRAIN PATHOL, V18, P21, DOI 10.1111/j.1750-3639.2007.00093.x; Duncan JR, 2009, J APPL PHYSIOL, V107, P1579, DOI 10.1152/japplphysiol.91629.2008; Edner A, 2000, ACTA PAEDIATR, V89, P1326, DOI 10.1080/080352500300002516; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; GIES JP, 1989, J PHARMACOL EXP THER, V250, P309; Gorini C, 2009, J NEUROPHYSIOL, V102, P1443, DOI 10.1152/jn.00287.2009; HADDAD EB, 1991, AM J PHYSIOL, V261, pL327, DOI 10.1152/ajplung.1991.261.4.L327; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Mallard C, 1999, J NEUROPATH EXP NEUR, V58, P255, DOI 10.1097/00005072-199903000-00005; Malloy MH, 2004, NEW ENGL J MED, V351, P957, DOI 10.1056/NEJMp048194; Matturri L, 2005, J CLIN PATHOL, V58, P77, DOI 10.1136/jcp.2004.020867; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Vennemann M, 2007, ARCH DIS CHILD, V92, P133, DOI 10.1136/adc.2006.101337	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9464	10.1371/journal.pone.0009464	http://dx.doi.org/10.1371/journal.pone.0009464			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209124	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997100011
J	Konstantinopoulos, PA; Fountzilas, E; Goldsmith, JD; Bhasin, M; Pillay, K; Francoeur, N; Libermann, TA; Gebhardt, MC; Spentzos, D				Konstantinopoulos, Panagiotis A.; Fountzilas, Elena; Goldsmith, Jeffrey D.; Bhasin, Manoj; Pillay, Kamana; Francoeur, Nancy; Libermann, Towia A.; Gebhardt, Mark C.; Spentzos, Dimitrios			Analysis of Multiple Sarcoma Expression Datasets: Implications for Classification, Oncogenic Pathway Activation and Chemotherapy Resistance	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; GENE-EXPRESSION; GROWTH-FACTOR; IMATINIB MESYLATE; TUMORS; SIGNATURES; CANCER; RECEPTOR; GUIDE; RNA	Background: Diagnosis of soft tissue sarcomas (STS) is challenging. Many remain unclassified (not-otherwise-specified, NOS) or grouped in controversial categories such as malignant fibrous histiocytoma (MFH), with unclear therapeutic value. We analyzed several independent microarray datasets, to identify a predictor, use it to classify unclassifiable sarcomas, and assess oncogenic pathway activation and chemotherapy response. Methodology/Principal Findings: We analyzed 5 independent datasets (325 tumor arrays). We developed and validated a predictor, which was used to reclassify MFH and NOS sarcomas. The molecular "match'' between MFH and their predicted subtypes was assessed using genome-wide hierarchical clustering and Subclass-Mapping. Findings were validated in 15 paraffin samples profiled on the DASL platform. Bayesian models of oncogenic pathway activation and chemotherapy response were applied to individual STS samples. A 170-gene predictor was developed and independently validated (80-85% accuracy in all datasets). Most MFH and NOS tumors were reclassified as leiomyosarcomas, liposarcomas and fibrosarcomas. "Molecular match'' between MFH and their predicted STS subtypes was confirmed both within and across datasets. This classification revealed previously unrecognized tissue differentiation lines (adipocyte, fibroblastic, smooth-muscle) and was reproduced in paraffin specimens. Different sarcoma subtypes demonstrated distinct oncogenic pathway activation patterns, and reclassified MFH tumors shared oncogenic pathway activation patterns with their predicted subtypes. These patterns were associated with predicted resistance to chemotherapeutic agents commonly used in sarcomas. Conclusions/Significance: STS profiling can aid in diagnosis through a predictor tracking distinct tissue differentiation in unclassified tumors, and in therapeutic management via oncogenic pathway activation and chemotherapy response assessment.	[Konstantinopoulos, Panagiotis A.; Fountzilas, Elena; Pillay, Kamana; Francoeur, Nancy; Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Konstantinopoulos, Panagiotis A.; Fountzilas, Elena; Goldsmith, Jeffrey D.; Bhasin, Manoj; Pillay, Kamana; Francoeur, Nancy; Libermann, Towia A.; Gebhardt, Mark C.; Spentzos, Dimitrios] Harvard Univ, Sch Med, Boston, MA USA; [Goldsmith, Jeffrey D.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.; Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Genom Ctr, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.; Spentzos, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Gebhardt, Mark C.] Beth Israel Deaconess Med Ctr, Dept Orthoped Surg, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Konstantinopoulos, PA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA.	dspentzo@bidmc.harvard.edu		Bhasin, Manoj/0000-0001-5172-420X; Libermann, Towia/0000-0002-4006-8179	Children's Hospital Molecular Genetics Core facility	Children's Hospital Molecular Genetics Core facility	We wish to thank Hal Schneider, PhD, Laboratory Supervisor, and the personnel of the Children's Hospital Molecular Genetics Core facility, for service and support provided in running the DASL microarray experiments.	Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Blay Jean-Yves, 2004, Cancer Treat Res, V120, P151; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Brenton JD, 2001, BREAST CANCER RES, V3, P77, DOI 10.1186/bcr274; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Dabney AR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001002; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; Dagher R, 2002, CLIN CANCER RES, V8, P3034; Daugaard S, 2004, EUR J CANCER, V40, P543, DOI 10.1016/j.ejca.2003.11.009; de Alava E, 2007, CLIN TRANSL ONCOL, V9, P130, DOI 10.1007/s12094-007-0027-2; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fletcher C D, 1997, Verh Dtsch Ges Pathol, V81, P318; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; FLETCHER CDM, 1992, AM J SURG PATHOL, V16, P213, DOI 10.1097/00000478-199203000-00001; Goldberg BR, 2007, ORTHOP NURS, V26, P4; Hegde U, 2001, Curr Oncol Rep, V3, P243, DOI 10.1007/s11912-001-0057-9; Henderson SR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r76; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; LAWRENCE W, 1987, ANN SURG, V205, P349, DOI 10.1097/00000658-198704000-00003; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nascimento AF, 2008, J SURG ONCOL, V97, P330, DOI 10.1002/jso.20972; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	42	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9747	10.1371/journal.pone.0009747	http://dx.doi.org/10.1371/journal.pone.0009747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368975	gold, Green Published, Green Submitted			2022-12-27	WOS:000276418200002
J	Velten, J; Cakir, C; Cazzonelli, CI				Velten, Jeff; Cakir, Cahid; Cazzonelli, Christopher I.			A Spontaneous Dominant-Negative Mutation within a 35S::AtMYB90 Transgene Inhibits Flower Pigment Production in Tobacco	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; R2R3-MYB GENE FAMILY; ANTHOCYANIN BIOSYNTHESIS; ZEA-MAYS; EXPRESSION ANALYSIS; MOLECULAR ANALYSIS; ACTIVATION DOMAIN; REGULATORY GENE; C1-I ALLELE; ARABIDOPSIS	Background: In part due to the ease of visual detection of phenotypic changes, anthocyanin pigment production has long been the target of genetic and molecular research in plants. Specific members of the large family of plant myb transcription factors have been found to play critical roles in regulating expression of anthocyanin biosynthetic genes and these genes continue to serve as important tools in dissecting the molecular mechanisms of plant gene regulation. Findings: A spontaneous mutation within the coding region of an Arabidopsis 35S::AtMYB90 transgene converted the activator of plant-wide anthocyanin production to a dominant-negative allele (PG-1) that inhibits normal pigment production within tobacco petals. Sequence analysis identified a single base change that created a premature nonsense codon, truncating the encoded myb protein. The resulting mutant protein lacks 78 amino acids from the wild type C-terminus and was confirmed as the source of the white-flower phenotype. A putative tobacco homolog of AtMYB90 (NtAN2) was isolated and found to be expressed in flower petals but not leaves of all tobacco plants tested. Using transgenic tobacco constitutively expressing the NtAN2 gene confirmed the NtAN2 protein as the likely target of PG-1-based inhibition of tobacco pigment production. Conclusions: Messenger RNA and anthocyanin analysis of PG-1Sh transgenic lines (and PG-1Sh x purple 35S:: NtAN2 seedlings) support a model in which the mutant myb transgene product acts as a competitive inhibitor of the native tobacco NtAN2 protein. This finding is important to researchers in the field of plant transcription factor analysis, representing a potential outcome for experiments analyzing in vivo protein function in test transgenic systems that over-express or mutate plant transcription factors.	[Velten, Jeff; Cakir, Cahid] USDA ARS, Plant Stress & Water Conservat Lab, Lubbock, TX USA; [Cazzonelli, Christopher I.] Australian Natl Univ, Res Sch Biol, Ctr Excellence Plant Energy Biol, Australian Res Council, Canberra, ACT, Australia	United States Department of Agriculture (USDA); Australian National University	Velten, J (corresponding author), USDA ARS, Plant Stress & Water Conservat Lab, Lubbock, TX USA.	VeltenLab@gmail.com	Cazzonelli, Christopher I/A-5347-2010	Cazzonelli, Christopher I/0000-0003-3096-3193	United States Department of Agriculture, Agricultural Research Service [6208-21000-016-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture, Agricultural Research Service (CRIS project number 6208-21000-016-00D), <http://www.ars.usda.gov/main/main.htm>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; Cazzonelli CI, 2004, PLANT MOL BIOL REP, V22, P347, DOI 10.1007/BF02772678; Chen BJ, 2004, MOL BIOTECHNOL, V26, P187, DOI 10.1385/MB:26:3:187; COE EH, 1962, GENETICS, V47, P779; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; D.P.S, PLANT MOL BIOL MANUA, P1, DOI 10.1007/978-94-009-0951-9; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; FRANKEN P, 1994, PLANT J, V6, P21, DOI 10.1046/j.1365-313X.1994.6010021.x; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; MALIGA P, 1975, NATURE, V255, P401, DOI 10.1038/255401a0; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Matousek J, 2006, J AGR FOOD CHEM, V54, P7606, DOI 10.1021/jf061785g; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Orzaez D, 2009, PLANT PHYSIOL, V150, P1122, DOI 10.1104/pp.109.139006; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; Pattanaik S, 2008, PLANTA, V227, P707, DOI 10.1007/s00425-007-0676-y; PAZARES J, 1990, EMBO J, V9, P315, DOI 10.1002/j.1460-2075.1990.tb08113.x; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rushton PJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-53; SABLOWSKI RWM, 1994, EMBO J, V13, P128, DOI 10.1002/j.1460-2075.1994.tb06242.x; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Sambrook J., 2001, MOL CLONING LAB MANU; Shen LY, 2006, MOL BREEDING, V18, P57, DOI 10.1007/s11032-006-9018-1; Singer T, 1998, GENET RES, V71, P127, DOI 10.1017/S0016672398003218; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; STADLER LJ, 1946, GENETICS, V31, P377; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Svab Zora, 1995, P55; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; VELTEN J, 1985, NUCLEIC ACIDS RES, V13, P6981, DOI 10.1093/nar/13.19.6981; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1235, DOI 10.1002/biot.200700184; Walker Clive H., 1994, P1; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x; Zuluaga DL, 2008, FUNCT PLANT BIOL, V35, P606, DOI 10.1071/FP08021	72	11	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9917	10.1371/journal.pone.0009917	http://dx.doi.org/10.1371/journal.pone.0009917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360951	Green Submitted, Green Published, gold			2022-12-27	WOS:000276163100010
J	Krause, A; Hoffmann, I				Krause, Annekatrin; Hoffmann, Ingrid			Polo-Like Kinase 2-Dependent Phosphorylation of NPM/B23 on Serine 4 Triggers Centriole Duplication	PLOS ONE			English	Article							CENTROSOME DUPLICATION; HUMAN-CELLS; BOX DOMAIN; SUBCELLULAR-LOCALIZATION; S-PHASE; NUCLEOPHOSMIN; MITOSIS; PLK1; BIOGENESIS; ACTIVATION	Duplication of the centrosome is well controlled during faithful cell division while deregulation of this process leads to supernumary centrosomes, chromosome missegregation and aneuploidy, a hallmark of many cancer cells. We previously reported that Polo-like kinase 2 (Plk2) is activated near the G1/S phase transition, and regulates the reproduction of centrosomes. In search for Plk2 interacting proteins we have identified NPM/B23 (Nucleophosmin) as a novel Plk2 binding partner. We find that Plk2 and NPM/B23 interact in vitro in a Polo-box dependent manner. An association between both proteins was also observed in vivo. Moreover, we show that Plk2 phosphorylates NPM/B23 on serine 4 in vivo in S-phase. Notably, expression of a non-phosphorylatable NPM/B23 S4A mutant interferes with centriole reduplication in S-phase arrested cells and leads to a dilution of centriole numbers in unperturbed U2OS cells. The corresponding phospho-mimicking mutants have the opposite effect and their expression leads to the accumulation of centrioles. These findings suggest that NPM/B23 is a direct target of Plk2 in the regulation of centriole duplication and that phosphorylation on serine 4 can trigger this process.	[Krause, Annekatrin; Hoffmann, Ingrid] German Canc Res Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krause, A (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	Ingrid.Hoffmann@dkfz.de			Deutsche Jose Carreras Leukamiestiftung	Deutsche Jose Carreras Leukamiestiftung	This work was supported in part by the Deutsche Jose Carreras Leukamiestiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bernard K, 2003, CANCER RES, V63, P6716; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; CHAN PK, 1990, BIOCHEM J, V270, P549, DOI 10.1042/bj2700549; Cizmecioglu O, 2008, CELL CYCLE, V7, P3548, DOI 10.4161/cc.7.22.7071; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lowery DM, 2004, CELL CYCLE, V3, P128; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nagano K, 2009, PROTEOMICS, V9, P2861, DOI 10.1002/pmic.200800667; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Paoletti A, 1996, J CELL SCI, V109, P3089; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Yao JH, 2004, FEBS LETT, V575, P112, DOI 10.1016/j.febslet.2004.08.047; Zatsepina OV, 1999, J CELL SCI, V112, P455; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	43	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9849	10.1371/journal.pone.0009849	http://dx.doi.org/10.1371/journal.pone.0009849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352051	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500017
J	Carroll, P; Schreuder, LJ; Muwanguzi-Karugaba, J; Wiles, S; Robertson, BD; Ripoll, J; Ward, TH; Bancroft, GJ; Schaible, UE; Parish, T				Carroll, Paul; Schreuder, Lise J.; Muwanguzi-Karugaba, Julian; Wiles, Siouxsie; Robertson, Brian D.; Ripoll, Jorge; Ward, Theresa H.; Bancroft, Gregory J.; Schaible, Ulrich E.; Parish, Tanya			Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; BACTERIAL-INFECTIONS; REAL-TIME; TUBERCULOSIS; PROMOTER; DYNAMICS; MARKER; INSTABILITY; PROGRESSION	Fluorescent reporter proteins have proven useful for imaging techniques in many organisms. We constructed optimized expression systems for several fluorescent proteins from the far-red region of the spectrum and analyzed their utility in several mycobacterial species. Plasmids expressing variants of the Discosoma Red fluorescent protein (DsRed) from the Mycobacterium bovis hsp60 promoter were unstable; in contrast expression from the Mycobacterium smegmatis rpsA promoter was stable. In Mycobacterium tuberculosis expression of several of the far-red reporters was readily visualised by eye and three reporters (mCherry, tdTomato, and Turbo-635) fluoresced at a high intensity. Strains expressing mCherry showed no fitness defects in vitro or in macrophages. Treatment of cells with antibiotics demonstrated that mCherry could also be used as a reporter for cell death, since fluorescence decreased in the presence of a bactericidal compound, but remained stable in the presence of a bacteriostatic compound. mCherry was functional under hypoxic conditions; using mCherry we demonstrated that the PmtbB is expressed early in hypoxia and progressively down-regulated. mCherry and other far-red fluorescent proteins will have multiple uses in investigating the biology of mycobacteria, particularly under non-replicating, or low cell density conditions, as well as providing a novel means of detecting cell death rapidly.	[Carroll, Paul; Schreuder, Lise J.; Muwanguzi-Karugaba, Julian; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Wiles, Siouxsie; Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Ripoll, Jorge] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Greece; [Ward, Theresa H.; Bancroft, Gregory J.; Schaible, Ulrich E.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; [Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Res, Borstel, Germany; [Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA	University of London; Queen Mary University London; Imperial College London; University of Auckland; Foundation for Research & Technology - Hellas (FORTH); University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel	Carroll, P (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	t.parish@qmul.ac.uk	Wiles, Siouxsie/E-1690-2011; Ward, Theresa H./E-9650-2013; Ripoll, Jorge/AAW-2245-2020; Schaible, Ulrich/C-7837-2011; Ripoll, Jorge/J-8134-2012	Wiles, Siouxsie/0000-0002-0467-0015; Ward, Theresa H./0000-0002-9881-8649; Ripoll, Jorge/0000-0001-8856-7738; Schaible, Ulrich/0000-0002-6638-7282; Ripoll, Jorge/0000-0001-8856-7738; Robertson, Brian D./0000-0001-5785-5307	Bill and Melinda Gates Foundation TB Drug Accelerator Programme; BBSRC [BB/E52708X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish	Bill and Melinda Gates Foundation TB Drug Accelerator Programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Bill and Melinda Gates Foundation TB Drug Accelerator Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Anilkumar G, 1998, GENE, V214, P7, DOI 10.1016/S0378-1119(98)00248-0; Barker LP, 1998, MOL MICROBIOL, V29, P1167, DOI 10.1046/j.1365-2958.1998.00996.x; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Brown AC, 2006, PLASMID, V55, P81, DOI 10.1016/j.plasmid.2005.06.005; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Coons AH, 1942, J IMMUNOL, V45, P159; Cosma CL, 2008, J INFECT DIS, V198, P1851, DOI 10.1086/593175; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; De Smet KAL, 1999, MICROBIOL-UK, V145, P3177, DOI 10.1099/00221287-145-11-3177; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Dunn KW, 2002, AM J PHYSIOL-CELL PH, V283, pC905, DOI 10.1152/ajpcell.00159.2002; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Gall K, 2006, FEMS MICROBIOL LETT, V255, P301, DOI 10.1111/j.1574-6968.2005.00078.x; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; KATZ MH, 2003, J SURG RES, P113; KREMER L, 1995, MOL MICROBIOL, V17, P913, DOI 10.1111/j.1365-2958.1995.mmi_17050913.x; LIM CR, 1995, J BIOCHEM-TOKYO, V118, P13, DOI 10.1093/oxfordjournals.jbchem.a124868; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Mansson LE, 2007, CELL MICROBIOL, V9, P2334, DOI 10.1111/j.1462-5822.2007.01019.x; Mansson LE, 2007, CELL MICROBIOL, V9, P413, DOI 10.1111/j.1462-5822.2006.00799.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Muller-Taubenberger A, 2007, APPL MICROBIOL BIOT, V77, P1, DOI 10.1007/s00253-007-1131-5; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; RALPH P, 1975, J IMMUNOL, V114, P898; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; SCHERBO D, 2009, BIOCHEM J, V418, P567; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Srivastava R, 1997, BIOCHEM BIOPH RES CO, V235, P602, DOI 10.1006/bbrc.1997.6837; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yamamoto N, 2004, CANCER RES, V64, P4251, DOI 10.1158/0008-5472.CAN-04-0643; Yamamoto N, 2003, CANCER RES, V63, P7785; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y	57	113	115	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9823	10.1371/journal.pone.0009823	http://dx.doi.org/10.1371/journal.pone.0009823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352111	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000275894400023
J	Han, JM; Kwon, NH; Lee, JY; Jeong, SJ; Jung, HJ; Kim, HR; Li, ZH; Kim, S				Han, Jung Min; Kwon, Nam Hoon; Lee, Jin Young; Jeong, Seung Jae; Jung, Hee Jung; Kim, Hyeong Rae; Li, Zihai; Kim, Sunghoon			Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CELL-SURFACE EXPRESSION; DENDRITIC CELLS; GOLGI-COMPLEX; KDEL RECEPTOR; LUPUS; HSP90; OLIGOMERIZATION; LOCALIZATION; INHIBITION	Heat shock proteins have been implicated as endogenous activators for dendritic cells (DCs). Chronic expression of heat shock protein gp96 on cell surfaces induces significant DC activations and systemic lupus erythematosus (SLE)-like phenotypes in mice. However, its potential as a therapeutic target against SLE remains to be evaluated. In this work, we conducted chemical approach to determine whether SLE-like phenotypes can be compromised by controlling surface translocation of gp96. From screening of chemical library, we identified a compound that binds and suppresses surface presentation of gp96 by facilitating its oligomerization and retrograde transport to endoplasmic reticulum. In vivo administration of this compound reduced maturation of DCs, populations of antigen presenting cells, and activated B and T cells. The chemical treatment also alleviated the SLE-associated symptoms such as glomerulonephritis, proteinuria, and accumulation of anti-nuclear and -DNA antibodies in the SLE model mice resulting from chronic surface exposure of gp96. These results suggest that surface translocation of gp96 can be chemically controlled and gp96 as a potential therapeutic target to treat autoimmune disease like SLE.	[Han, Jung Min; Kwon, Nam Hoon; Lee, Jin Young; Jeong, Seung Jae; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Seoul, South Korea; [Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Suwon, South Korea; [Han, Jung Min] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Jung, Hee Jung; Kim, Hyeong Rae] Korea Res Inst Chem Technol, Bioorgan Sci Div, Canc & Infect Dis Res Ctr, Taejon 305606, South Korea; [Li, Zihai] Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Chemical Technology (KRICT); University of Connecticut	Han, JM (corresponding author), Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Seoul, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Han, Jung Min/0000-0003-3372-7575; kim, sunghoon/0000-0002-1570-3230	Korean Government [NRF-2008-359-C00024]; Korean Ministry of Science and Technology [FPR08B1- 250]; Ministry of Education, Science, and Technology [R31-2008-000-10103-0]; Korea Science and Engineering Foundation	Korean Government(Korean Government); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2008-359-C00024), by FPR08B1- 250 of 21C Frontier Functional Proteomics Project from Korean Ministry of Science and Technology, by R31-2008-000-10103-0 from the WCU project of the Ministry of Education, Science, and Technology and the Korea Science and Engineering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Banerjee PP, 2002, J IMMUNOL, V169, P3507, DOI 10.4049/jimmunol.169.7.3507; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BERDEN JHM, 1983, J IMMUNOL, V130, P1699; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lee SW, 2008, EXPERT OPIN DRUG DIS, V3, P945, DOI 10.1517/17460441.3.8.945; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Li ZH, 2002, FRONT BIOSCI-LANDMRK, V7, pD731; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Monrad S, 2007, IMMUNOL RES, V37, P135, DOI 10.1007/BF02685895; Nagy G, 2005, CRIT REV IMMUNOL, V25, P123, DOI 10.1615/CritRevImmunol.v25.i2.30; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Robert J, 1999, J IMMUNOL, V163, P4133; Schur PH, 1995, LUPUS, V4, P425, DOI 10.1177/096120339500400603; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; SINGER GG, 1994, CURR OPIN IMMUNOL, V6, P913, DOI 10.1016/0952-7915(94)90013-2; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; VABULAS RM, 2002, J BIOL CHEM; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5	42	35	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9792	10.1371/journal.pone.0009792	http://dx.doi.org/10.1371/journal.pone.0009792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352117	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400011
J	D'Amico, G; Robinson, SD; Germain, M; Reynolds, LE; Thomas, GJ; Elia, G; Saunders, G; Fruttiger, M; Tybulewicz, V; Mavria, G; Hodivala-Dilke, KM				D'Amico, Gabriela; Robinson, Stephen D.; Germain, Mitchel; Reynolds, Louise E.; Thomas, Gareth J.; Elia, George; Saunders, Garry; Fruttiger, Marcus; Tybulewicz, Victor; Mavria, Georgia; Hodivala-Dilke, Kairbaan M.			Endothelial-Rac1 Is Not Required for Tumor Angiogenesis unless alpha v beta 3-Integrin Is Absent	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; CAPILLARY LUMEN FORMATION; ADVANCED SOLID TUMORS; GROWTH-FACTOR; PATHOLOGICAL ANGIOGENESIS; CILENGITIDE EMD-121974; VASCULAR DEVELOPMENT; INTEGRIN INHIBITORS; RAC1 ACTIVATION; CRE-RECOMBINASE	Endothelial cell migration is an essential aspect of tumor angiogenesis. Rac1 activity is needed for cell migration in vitro implying a requirement for this molecule in angiogenesis in vivo. However, a precise role for Rac1 in tumor angiogenesis has never been addressed. Here we show that depletion of endothelial Rac1 expression in adult mice, unexpectedly, has no effect on tumor growth or tumor angiogenesis. In addition, repression of Rac1 expression does not inhibit VEGF-mediated angiogenesis in vivo or ex vivo, nor does it affect chemotactic migratory responses to VEGF in 3-dimensions. In contrast, the requirement for Rac1 in tumor growth and angiogenesis becomes important when endothelial beta 3-integrin levels are reduced or absent: the enhanced tumor growth, tumor angiogenesis and VEGF-mediated responses in beta 3-null mice are all Rac1-dependent. These data indicate that in the presence of alpha v beta 3-integrin Rac1 is not required for tumor angiogenesis.	[D'Amico, Gabriela; Robinson, Stephen D.; Germain, Mitchel; Reynolds, Louise E.; Elia, George; Saunders, Garry; Hodivala-Dilke, Kairbaan M.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Adhes & Angiogenesis Lab, London, England; [Thomas, Gareth J.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Tumor Biol Ctr, London, England; [Fruttiger, Marcus] UCL, Inst Ophthalmol, London, England; [Tybulewicz, Victor] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Mavria, Georgia] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; MRC National Institute for Medical Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	D'Amico, G (corresponding author), Univ Helsinki, Biomedicum, Helsinki, Finland.	gabriela.damico@helsinki.fi; k.hodivala-dilke@qmul.ac.uk	D'Amico, Gabriela/H-6310-2011; D'Amico, Gabriela/AAD-1182-2020	Fruttiger, Marcus/0000-0002-6962-5485; Robinson, Stephen/0000-0002-6606-7588; Tybulewicz, Victor/0000-0003-2439-0798; D'Amico, Gabriela/0000-0002-5619-6749; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X	Cancer Research UK; Medical Research Council, Breast Cancer Campaign; The Association for International Cancer Research; The Health Foundation; MRC [G0501711, MC_U117527252] Funding Source: UKRI; Cancer Research UK [12007] Funding Source: researchfish; Medical Research Council [MC_U117527252, G0501711] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council, Breast Cancer Campaign(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Association for International Cancer Research; The Health Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Cancer Research UK, the Medical Research Council, Breast Cancer Campaign, The Association for International Cancer Research, and The Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Andrade SP, 1997, MICROVASC RES, V54, P253, DOI 10.1006/mvre.1997.2047; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Eskens FALM, 2003, EUR J CANCER, V39, P917, DOI 10.1016/S0959-8049(03)00057-1; Friess H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-285; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Gustafsson E, 2001, J CELL SCI, V114, P671; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Le Gat L, 2003, CELL COMMUN ADHES, V10, P129, DOI 10.1080/15419060390262543; Liu ZJ, 2003, FASEB J, V17, P1931, DOI 10.1096/fj.02-1171fje; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; MECHTERSHEIMER G, 1994, LAB INVEST, V70, P740; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nystrom ML, 2006, CANCER RES, V66, P10833, DOI 10.1158/0008-5472.CAN-06-1640; Oxboel J, 2009, ONCOL REP, V21, P769, DOI 10.3892/or_00000283; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; ROBINSON SD, 2009, J BIOL CHEM; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sato T, 2002, APMIS, V110, P347, DOI 10.1034/j.1600-0463.2002.100410.x; Sato T, 2001, ANTICANCER RES, V21, P643; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Soga N, 2001, CELL COMMUN ADHES, V8, P1, DOI 10.3109/15419060109080703; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200	68	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9766	10.1371/journal.pone.0009766	http://dx.doi.org/10.1371/journal.pone.0009766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339539	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000275894300010
J	Qiu, JZ; Wang, DC; Xiang, H; Feng, HH; Jiang, YSA; Xia, LJ; Dong, J; Lu, J; Yu, L; Deng, XM				Qiu, Jiazhang; Wang, Dacheng; Xiang, Hua; Feng, Haihua; Jiang, Youshuai; Xia, Lijie; Dong, Jing; Lu, Jing; Yu, Lu; Deng, Xuming			Subinhibitory Concentrations of Thymol Reduce Enterotoxins A and B and alpha-Hemolysin Production in Staphylococcus aureus Isolates	PLOS ONE			English	Article							VIRULENCE; EXPRESSION; TOXIN; EVOLUTION; GENES; SARA; ANTIVIRULENCE; CLINDAMYCIN; RESISTANCE; INFECTION	Background: Targeting bacterial virulence factors is now gaining interest as an alternative strategy to develop new types of anti-infective agents. It has been shown that thymol, when used at low concentrations, can inhibit the TSST-1 secretion in Staphylococcus aureus. However, there are no data on the effect of thymol on the production of other exotoxins (e. g., alpha-hemolysin and enterotoxins) by S. aureus. Methodology/Principal Findings: Secretion of alpha-hemolysin, SEA and SEB in both methicillin-sensitive and methicillin-resistant S. aureus isolates cultured with graded subinhibitory concentrations of thymol was detected by immunoblot analysis. Hemolysin and tumor necrosis factor (TNF) release assays were performed to elucidate the biological relevance of changes in a-hemolysin, SEA and SEB secretion induced by thymol. In addition, the influence of thymol on the transcription of hla, sea, and seb (the genes encoding alpha-hemolysin, SEA and SEB, respectively) was analyzed by quantitative RT-PCR. Thymol inhibited transcription of hla, sea and seb in S. aureus, resulting in a reduction of alpha-hemolysin, SEA and SEB secretion and, thus, a reduction in hemolytic and TNF-inducing activities. Conclusions/Significance: Subinhibitory concentrations of thymol decreased the production of alpha-hemolysin, SEA and SEB in both MSSA and MRSA in a dose-dependent manner. These data suggest that thymol may be useful for the treatment of S. aureus infections when used in combination with beta-lactams and glycopeptide antibiotics, which induce expression of alpha-hemolysin and enterotoxins at subinhibitory concentrations. Furthermore, the structure of thymol may potentially be used as a basic structure for development of drugs aimed against these bacterial virulence factors.	[Qiu, Jiazhang; Wang, Dacheng; Xiang, Hua; Feng, Haihua; Dong, Jing; Lu, Jing; Yu, Lu; Deng, Xuming] Jilin Univ, Inst Zoonoses, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Jiang, Youshuai] Heilongjiang August First Agr Univ, Coll Life Sci & Technol, Daqing, Heilongjiang, Peoples R China; [Xia, Lijie] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China	Jilin University; Yangzhou University	Qiu, JZ (corresponding author), Jilin Univ, Inst Zoonoses, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China.	yulu225@126.com; dengxm@jlu.edu.cn			973 programme of China [2006CB504402]	973 programme of China(National Basic Research Program of China)	The study was supported by a grant from 973 programme of China (2006CB504402). http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1994, FOOD CHEM TOXICOL, V32, P31, DOI 10.1016/0278-6915(84)90033-4; Alam K, 1999, PHARMACOL RES, V40, P159, DOI 10.1006/phrs.1999.0472; *APPL BIOS, 1997, US B APPL BIOS, V2; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; BI X, 2009, J APPL MICR IN PRESS; Blickwede M, 2005, FEMS MICROBIOL LETT, V252, P73, DOI 10.1016/j.femsle.2005.08.022; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PF, 1998, J BACTERIOL, V180, P6232; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; Didry N, 1994, Pharm Acta Helv, V69, P25, DOI 10.1016/0031-6865(94)90027-2; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Guo N, 2009, J MED MICROBIOL, V58, P1074, DOI 10.1099/jmm.0.008052-0; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Koszczol C, 2006, J ANTIMICROB CHEMOTH, V58, P564, DOI 10.1093/jac/dkl291; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McNamara PJ, 2009, ANTIMICROB AGENTS CH, V53, P1898, DOI 10.1128/AAC.01293-08; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nostro A, 2004, FEMS MICROBIOL LETT, V230, P191, DOI 10.1016/S0378-1097(03)00890-5; Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Robledo S, 2005, ANTIMICROB AGENTS CH, V49, P1652, DOI 10.1128/AAC.49.4.1652-1655.2005; ROWE GE, 1994, METHOD ENZYMOL, V235, P657; Sambanthamoorthy K, 2006, MICROBIOL-SGM, V152, P2559, DOI 10.1099/mic.0.29071-0; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; Smith-Palmer A, 2004, J MED MICROBIOL, V53, P1023, DOI 10.1099/jmm.0.45567-0; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRANTER HS, 1993, J APPL BACTERIOL, V74, P253, DOI 10.1111/j.1365-2672.1993.tb03023.x; Yoh K, 2000, NEPHROL DIAL TRANSPL, V15, P1170, DOI 10.1093/ndt/15.8.1170	39	104	110	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9736	10.1371/journal.pone.0009736	http://dx.doi.org/10.1371/journal.pone.0009736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305813	Green Submitted, Green Published, gold			2022-12-27	WOS:000275809600008
J	Romanowska, M; Reilly, L; Palmer, CNA; Gustafsson, MCU; Foerster, J				Romanowska, Malgorzata; Reilly, Louise; Palmer, Colin N. A.; Gustafsson, Mattias C. U.; Foerster, John			Activation of PPAR beta/delta Causes a Psoriasis-Like Skin Disease In Vivo	PLOS ONE			English	Article							QUALITY-OF-LIFE; METABOLIC SYNDROME; RISK-FACTORS; KAPPA-B; RECEPTORS; IL-1; DIFFERENTIATION; EXPRESSION; SYSTEM; CYP1A1	Background: Psoriasis is one of the most frequent skin diseases world-wide. The disease impacts enormously on affected patients and poses a huge financial burden on health care providers. Several lines of evidence suggest that the nuclear hormone receptor peroxisome proliferator activator (PPAR) beta/delta, known to regulate epithelial differentiation and wound healing, contributes to psoriasis pathogenesis. It is unclear, however, whether activation of PPAR beta/delta is sufficient to trigger psoriasis-like changes in vivo. Methodology/Principal Findings: Using immunohistochemistry, we define the distribution of PPAR beta/delta in the skin lesions of psoriasis. By expression profiling, we confirm that PPAR beta/delta is overexpressed in the vast majority of psoriasis patients. We further establish a transgenic model allowing inducible activation of PPAR beta/delta in murine epidermis mimicking its distribution in psoriasis lesions. Upon activation of PPAR beta/delta, transgenic mice sustain an inflammatory skin disease strikingly similar to psoriasis, featuring hyperproliferation of keratinocytes, dendritic cell accumulation, and endothelial activation. Development of this phenotype requires the activation of the Th17 subset of T cells, shown previously to be central to psoriasis. Moreover, gene dysregulation in the transgenic mice is highly similar to that in psoriasis. Key transcriptional programs activated in psoriasis, including IL1-related signalling and cholesterol biosynthesis, are replicated in the mouse model, suggesting that PPAR beta/delta regulates these transcriptional changes in psoriasis. Finally, we identify phosphorylation of STAT3 as a novel pathway activated by PPAR beta/delta and show that inhibition of STAT3 phosphorylation blocks disease development. Conclusions: Activation of PPAR beta/delta in the epidermis is sufficient to trigger inflammatory changes, immune activation, and signalling, and gene dysregulation characteristic of psoriasis.	[Romanowska, Malgorzata; Reilly, Louise; Foerster, John] Univ Dundee, Div Expt Med, Dundee, Scotland; [Palmer, Colin N. A.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Gustafsson, Mattias C. U.] Lund Univ, Dept Lab Med, Div Med Microbiol, Lund, Sweden	University of Dundee; University of Dundee; Lund University	Romanowska, M (corresponding author), Univ Dundee, Div Expt Med, Dundee, Scotland.	j.foerster@dundee.ac.uk	Palmer, Colin NA/C-7053-2008; Gustafsson, Mattias C. U./A-7451-2010	Palmer, Colin NA/0000-0002-6415-6560; Gustafsson, Mattias C. U./0000-0003-3260-0724	Cancer Research United Kingdom; Anonymous Trust; Tenovus Scotland	Cancer Research United Kingdom(Cancer Research UK); Anonymous Trust; Tenovus Scotland	The work presented here was in part funded by Cancer Research United Kingdom (role: fellowship for JF), the Anonymous Trust (role: provision of funds for consumables), and Tenovus Scotland (role: provision of funds for consumables). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Campbell SJ, 1996, J CELL SCI, V109, P2619; Chiaro CR, 2008, BIOCHEMISTRY-US, V47, P8445, DOI 10.1021/bi800712f; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Debets R, 1997, J IMMUNOL, V158, P2955; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di-Poi N, 2005, MOL CELL BIOL, V25, P1696, DOI 10.1128/MCB.25.5.1696-1712.2005; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; Gelfand JM, 2005, J AM ACAD DERMATOL, V52, P23, DOI 10.1016/j.jaad.2004.07.045; Gisondi P, 2008, AM J CLIN NUTR, V88, P1242, DOI 10.3945/ajcn.2008.26427; Hall JM, 2007, MOL ENDOCRINOL, V21, P1756, DOI 10.1210/me.2007-0060; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Kang Kihwa, 2007, Curr Atheroscler Rep, V9, P72, DOI 10.1007/BF02693931; Kaufman CK, 2002, MOL CELL BIOL, V22, P4293, DOI 10.1128/MCB.22.12.4293-4308.2002; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1238, DOI 10.1093/gerona/60.10.1238; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; PIQUERAS L, 2006, ARTERIOSCLER THROMB; Poikolainen K, 1999, ARCH DERMATOL, V135, P1490, DOI 10.1001/archderm.135.12.1490; ROBERTSON RW, 1994, NUCLEIC ACIDS RES, V22, P1741, DOI 10.1093/nar/22.9.1741; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Rosenfield RL, 1999, J INVEST DERMATOL, V112, P226, DOI 10.1046/j.1523-1747.1999.00487.x; Rowe JM, 2008, J INVEST DERMATOL, V128, P1866, DOI 10.1038/sj.jid.5701236; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schmitt JM, 2006, DERMATOLOGY, V213, P102, DOI 10.1159/000093848; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Short B, 2009, J CELL BIOL, V186, P769, DOI 10.1083/jcb.1866if; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Sun L, 2008, CHINESE MED J-PEKING, V121, P2305, DOI 10.1097/00029330-200811020-00017; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Trivedi NR, 2006, J INVEST DERMATOL, V126, P2002, DOI 10.1038/sj.jid.5700336; vanderVleuten CJM, 1996, ARCH DERMATOL RES, V288, P366, DOI 10.1007/s004030050065; Westergaard M, 2003, J INVEST DERMATOL, V121, P1104, DOI 10.1046/j.1523-1747.2003.12536.x; Wu Y, 2008, J DRUGS DERMATOL, V7, P373	56	67	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9701	10.1371/journal.pone.0009701	http://dx.doi.org/10.1371/journal.pone.0009701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300524	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400006
J	Buganim, Y; Goldstein, I; Lipson, D; Milyavsky, M; Polak-Charcon, S; Mardoukh, C; Solomon, H; Kalo, E; Madar, S; Brosh, R; Perelman, M; Navon, R; Goldfinger, N; Barshack, I; Yakhini, Z; Rotter, V				Buganim, Yosef; Goldstein, Ido; Lipson, Doron; Milyavsky, Michael; Polak-Charcon, Sylvie; Mardoukh, Corine; Solomon, Hilla; Kalo, Eyal; Madar, Shalom; Brosh, Ran; Perelman, Marina; Navon, Roy; Goldfinger, Naomi; Barshack, Iris; Yakhini, Zohar; Rotter, Varda			A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; ALZ-50 CLONE 1; CHROMOSOMAL-ABERRATIONS; DROSOPHILA-TRITHORAX; LUNG ADENOCARCINOMAS; PROSTATE-CANCER; ACUTE LEUKEMIAS; PHD FINGER; NEUROBLASTOMA; DNA	Partial gain of chromosome arm 17q is an abundant aberrancy in various cancer types such as lung and prostate cancer with a prominent occurrence and prognostic significance in neuroblastoma - one of the most common embryonic tumors. The specific genetic element/s in 17q responsible for the cancer-promoting effect of these aberrancies is yet to be defined although many genes located in 17q have been proposed to play a role in malignancy. We report here the characterization of a naturally-occurring, non-reciprocal translocation der(X)t(X;17) in human lung embryonal-derived cells following continuous culturing. This aberrancy was strongly correlated with an increased proliferative capacity and with an acquired ability to form colonies in vitro. The breakpoint region was mapped by fluorescence in situ hybridization (FISH) to the 17q24.3 locus. Further characterization by a custom-made comparative genome hybridization array (CGH) localized the breakpoint within the Bromodomain PHD finger Transcription Factor gene (BPTF), a gene involved in transcriptional regulation and chromatin remodeling. Interestingly, this translocation led to elevation in the mRNA levels of the endogenous BPTF. Knock-down of BPTF restricted proliferation suggesting a role for BPTF in promoting cellular growth. Furthermore, the BPTF chromosomal region was found to be amplified in various human tumors, especially in neuroblastomas and lung cancers in which 55% and 27% of the samples showed gain of 17q24.3, respectively. Additionally, 42% percent of the cancer cell lines comprising the NCI-60 had an abnormal BPTF locus copy number. We suggest that deregulation of BPTF resulting from the translocation may confer the cells with the observed cancer-promoting phenotype and that our cellular model can serve to establish causality between 17q aberrations and carcinogenesis.	[Buganim, Yosef; Goldstein, Ido; Milyavsky, Michael; Solomon, Hilla; Kalo, Eyal; Madar, Shalom; Brosh, Ran; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Lipson, Doron; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Polak-Charcon, Sylvie; Mardoukh, Corine; Perelman, Marina; Barshack, Iris] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Navon, Roy; Yakhini, Zohar] Agilent Technol, Tel Aviv, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Chaim Sheba Medical Center; Agilent Technologies	Buganim, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	varda.rotter@weizmann.ac.il	Brosh, Ran/H-7309-2019; Brosh, Ran/HDL-9562-2022; Goldstein, Ido/Y-6554-2019	Brosh, Ran/0000-0001-9714-8623; Goldstein, Ido/0000-0003-0139-1499; Yakhini, Zohar/0000-0002-0420-5412	Flight Attendant Medical Research Institute (FAMRI); EC [LSHC-CT-2004-503576]; Yad Abraham Center for Cancer Diagnosis and Therapy	Flight Attendant Medical Research Institute (FAMRI); EC(European CommissionEuropean Commission Joint Research Centre); Yad Abraham Center for Cancer Diagnosis and Therapy	This research was supported by a Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI), EC FP6 Grant LSHC-CT-2004-503576 and the Yad Abraham Center for Cancer Diagnosis and Therapy. This publication reflects the authors' views and not necessarily those of the European Community. The EC is not liable for any use that may be made of the information contained herein. VR is the incumbent of the Norman and Helen Asher Professorial Chair Cancer Research at the Weizmann Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Agilent Technologies (www.home.agilent.com) participated in the CGH study design and analysis but not in data collection, decision to publish, or preparation of the manuscript.	Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Beser AR, 2007, PATHOL ONCOL RES, V13, P180, DOI 10.1007/BF02893497; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Bown N, 2001, MED PEDIATR ONCOL, V36, P14, DOI 10.1002/1096-911X(20010101)36:1<14::AID-MPO1005>3.3.CO;2-7; Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0; Doerks T, 2001, TRENDS BIOCHEM SCI, V26, P145, DOI 10.1016/S0968-0004(00)01769-2; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; Jones MH, 2000, GENOMICS, V63, P35, DOI 10.1006/geno.1999.6070; Jordan-Sciutto KL, 1999, J BIOL CHEM, V274, P35262, DOI 10.1074/jbc.274.49.35262; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Lastowska M, 2002, GENE CHROMOSOME CANC, V34, P428, DOI 10.1002/gcc.10089; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lipson D, 2007, BIOINFORMATICS, V23, pE77, DOI 10.1093/bioinformatics/btl316; Meddeb M, 1996, GENE CHROMOSOME CANC, V17, P156, DOI 10.1002/(SICI)1098-2264(199611)17:3<156::AID-GCC3>3.0.CO;2-3; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Milyavsky M, 2003, CANCER RES, V63, P7147; Raidl M, 2004, J HEPATOL, V40, P660, DOI 10.1016/j.jhep.2003.12.020; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sun JL, 2008, PROSTATE, V68, P691, DOI 10.1002/pros.20754; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Van Roy N, 1997, EUR J CANCER, V33, P1974, DOI 10.1016/S0959-8049(97)00319-5; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yen CC, 2007, LUNG CANCER, V57, P292, DOI 10.1016/j.lungcan.2007.04.007; Zhu P, 1996, BBA-GENE STRUCT EXPR, V1309, P5, DOI 10.1016/S0167-4781(96)00127-3	35	43	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9657	10.1371/journal.pone.0009657	http://dx.doi.org/10.1371/journal.pone.0009657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300178	Green Submitted, Green Published, gold			2022-12-27	WOS:000275620600012
J	Chino, A; Watanabe, K; Moriya, H				Chino, Ayako; Watanabe, Kenji; Moriya, Hisao			Plasmid Construction Using Recombination Activity in the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; DNA	Background: Construction of plasmids is crucial in modern genetic manipulation. As of now, the common method for constructing plasmids is to digest specific DNA sequences with restriction enzymes and to ligate the resulting DNA fragments with DNA ligase. Another potent method to construct plasmids, known as gap-repair cloning (GRC), is commonly used in the budding yeast Saccharomyces cerevisiae. GRC makes use of the homologous recombination activity that occurs within the yeast cells. Due to its flexible design and efficiency, GRC has been frequently used for constructing plasmids with complex structures as well as genome-wide plasmid collections. Although there have been reports indicating GRC feasibility in the fission yeast Schizosaccharomyces pombe, this species is not commonly used for GRC as systematic studies of reporting GRC efficiency in S. pombe have not been performed till date. Methodology/Principal Findings: We investigated GRC efficiency in S. pombe in this study. We first showed that GRC was feasible in S. pombe by constructing a plasmid that contained the LEU2 auxotrophic marker gene in vivo and showed sufficient efficiency with short homology sequences (>25 bp). No preference was shown for the sequence length from the cut site in the vector plasmid. We next showed that plasmids could be constructed in a proper way using 3 DNA fragments with 70% efficiency without any specific selections being made. The GRC efficiency with 3 DNA fragments was dramatically increased >95% in lig4 Delta mutant cell, where non-homologous end joining is deficient. Following this approach, we successfully constructed plasmid vectors with leu1+, ade6+, his5+, and lys1+ markers with the low-copy stable plasmid pDblet as a backbone by applying GRC in S. pombe. Conclusions/Significance: We concluded that GRC was sufficiently feasible in S. pombe for genome-wide gene functional analysis as well as for regular plasmid construction. Plasmids with different markers constructed in this research are available from NBRP-yeast (http://yeast.lab.nig.ac.jp/).	[Chino, Ayako; Moriya, Hisao] Okayama Univ, Okayama 7008530, Japan; [Chino, Ayako; Moriya, Hisao] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1028666, Japan; [Watanabe, Kenji] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Okayama University; Japan Science & Technology Agency (JST); University of Shizuoka	Chino, A (corresponding author), Okayama Univ, Okayama 7008530, Japan.	hisaom@cc.okayama-u.ac.jp	Watanabe, Kenji/N-2012-2015; Moriya, Hisao/B-2424-2011	Watanabe, Kenji/0000-0002-0463-4831; Moriya, Hisao/0000-0001-7638-3640	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the PRESTO program, Japan Science and Technology Agency (HM); the Special Coordination Fund for Promoting Sciences and Technology, Ministry of Education, Culture, Sports, Science, and Technology (HM); a Grant-in-Aid for Scientific Research on Innovative Areas "The Physicochemical Field for Genetic Activities'', Ministry of Education, Culture, Sports, Science, and Technology (HM); and by a Grant for Industrial Technology Research Program, New Energy and Industrial Technology Development Organization (KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Amberg DC., 2005, METHODS YEAST GENETI; BRUN C, 1995, GENE, V164, P173, DOI 10.1016/0378-1119(95)00497-T; Egel R, 2004, MOL BIOL SCHIZOSACCH; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; SIKORSKI RS, 1989, GENETICS, V122, P19; Wang LL, 2004, METHODS, V33, P199, DOI 10.1016/j.ymeth.2003.11.014; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	14	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9652	10.1371/journal.pone.0009652	http://dx.doi.org/10.1371/journal.pone.0009652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300182	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620600008
J	King, MO; Owen, JP; Schwabl, HG				King, Marisa O.; Owen, Jeb P.; Schwabl, Hubert G.			Are Maternal Antibodies Really That Important? Patterns in the Immunologic Development of Altricial Passerine House Sparrows (Passer domesticus)	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; HUMORAL IMMUNE-RESPONSE; BURSAL DISEASE VIRUS; ESCHERICHIA-COLI; PASSIVE-IMMUNITY; CHICKEN EGGS; IMMUNOGLOBULINS; PROTECTION; BIRD; SIZE	Background: Maternal antibodies are believed to play an integral role in protecting immunologically immature wild-passerines from environmental antigens. This study comprehensively examines the early development of the adaptive immune system in an altricial-developing wild passerine species, the house sparrow (Passer domestics), by characterizing the half-life of maternal antibodies in nestling plasma, the onset of de novo synthesis of endogenous antibodies by nestlings, and the timing of immunological independence, where nestlings rely entirely on their own antibodies for immunologic protection. Methodology/Principal Findings: In an aviary study we vaccinated females against a novel antigen that these birds would not otherwise encounter in their natural environment, and measured both antigen-specific and total antibody concentration in the plasma of females, yolks, and nestlings. We traced the transfer of maternal antibodies from females to nestlings through the yolk and measured catabolisation of maternal antigen-specific antibodies in nestlings during early development. By utilizing measurements of non-specific and specific antibody levels in nestling plasma we were able to calculate the half-life of maternal antibodies in nestling plasma and the time point at which nestling were capable of synthesizing antibodies themselves. Based on the short half-life of maternal antibodies, the rapid production of endogenous antibodies by nestlings and the relatively low transfer of maternal antibodies to nestlings, our findings suggest that altricial-developing sparrows achieve immunologic independence much earlier than precocial birds. Conclusions/Significance: To our knowledge, this is the first in depth analyses performed on the adaptive immune system of a wild-passerine species. Our results suggest that maternal antibodies may not confer the immunologic protection or immune priming previously proposed in other passerine studies. Further research needs to be conducted on other altricial passerines to determine if the results of our study are a species-specific phenomenon or if they apply to all altricial-developing birds.	[King, Marisa O.; Schwabl, Hubert G.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Washington State University; Washington State University	King, MO (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	MOKing979@gmail.com		Owen, Jeb/0000-0002-2042-0526	The United States Environmental Protection Agency (EPA) under the Science to Achieve Results (STAR)	The United States Environmental Protection Agency (EPA) under the Science to Achieve Results (STAR)(United States Environmental Protection Agency)	The United States Environmental Protection Agency (EPA) under the Science to Achieve Results (STAR) Graduate Fellowship Program has funded the research described in this paper wholly. The EPA has not officially endorsed this publication and the views expressed herein may not reflect the views of the EPA. The EPA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AS, 2006, VET MICROBIOL, V114, P16, DOI 10.1016/j.vetmic.2005.10.037; Abou Elazab MF, 2009, J VET MED SCI, V71, P417, DOI 10.1292/jvms.71.417; ANDERSON RW, 1995, BIOSYSTEMS, V34, P87, DOI 10.1016/0303-2647(94)01444-C; Apanius V, 1998, AVIAN GROWTH DEV EVO, V8, P203; AR A, 1978, EVOLUTION, V32, P655, DOI 10.1111/j.1558-5646.1978.tb04610.x; Beam AL, 2009, J DAIRY SCI, V92, P3973, DOI 10.3168/jds.2009-2225; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Castinel A, 2008, J WILDLIFE DIS, V44, P8, DOI 10.7589/0090-3558-44.1.8; Chaffer M, 1997, AVIAN PATHOL, V26, P377, DOI 10.1080/03079459708419220; Cichon M, 2006, J EVOLUTION BIOL, V19, P1701, DOI 10.1111/j.1420-9101.2006.01110.x; DARBYSHIRE JH, 1985, RES VET SCI, V38, P14, DOI 10.1016/S0034-5288(18)31841-1; Dhondt AA, 2008, AVIAN PATHOL, V37, P635, DOI 10.1080/03079450802499100; FAHEY KJ, 1987, AUST VET J, V64, P203, DOI 10.1111/j.1751-0813.1987.tb15182.x; Forsman AM, 2008, MOL ECOL, V17, P3697, DOI 10.1111/j.1365-294X.2008.03860.x; Fouchet D, 2007, J R SOC INTERFACE, V4, P479, DOI 10.1098/rsif.2006.0189; Gasparini J, 2006, CAN J ZOOL, V84, P623, DOI 10.1139/Z06-024; Gasparini J, 2009, J AVIAN BIOL, V40, P271, DOI 10.1111/j.1600-048X.2008.04590.x; GLICK B, 1983, BIOSCIENCE, V33, P187, DOI 10.2307/1309273; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; Glick B, 1983, AVIAN BIOL, V7, P443; Goldammer A, 2002, BLOOD, V100, P353, DOI 10.1182/blood-2002-01-0128; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Hansen P, 1998, J IMMUNOL METHODS, V215, P1, DOI 10.1016/S0022-1759(98)00050-7; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; HELLER ED, 1990, AVIAN PATHOL, V19, P345, DOI 10.1080/03079459008418685; Huber SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008605; KALETA EF, 1977, BERL MUNCH TIERARZTL, V90, P131; Karell P, 2008, FUNCT ECOL, V22, P682, DOI 10.1111/j.1365-2435.2008.01425.x; KASPERS B, 1991, J VET MED A, V38, P73, DOI 10.1111/j.1439-0442.1991.tb00986.x; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; LAWRENCE EC, 1981, CLIN EXP IMMUNOL, V43, P450; LESLIE GA, 1969, J EXP MED, V130, P1337, DOI 10.1084/jem.130.6.1337; LESLIE GA, 1975, AM J VET RES, V36, P482; LESLIE GA, 1973, J IMMUNOL, V110; LOEKEN MR, 1983, IMMUNOLOGY, V49, P21; Lozano GA, 2002, CAN J ZOOL, V80, P918, DOI 10.1139/Z02-063; Lyche JL, 2006, J TOXICOL ENV HEAL A, V69, P139, DOI 10.1080/15287390500259418; MARTIN LN, 1973, P ROYAL SOC EXPT BIO, V143; Moller AP, 2007, FUNCT ECOL, V21, P363, DOI 10.1111/j.1365-2435.2006.01215.x; Mondal SP, 2001, VET IMMUNOL IMMUNOP, V79, P31, DOI 10.1016/S0165-2427(01)00248-3; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; PATTERSON R, 1962, J GEN PHYSL, V45; Pendleton AR, 2006, VIROLOGY, V345, P337, DOI 10.1016/j.virol.2005.09.069; POLSON A, 1990, IMMUNOL INVEST, V19, P253; Rose M.E., 1981, P341; Saino N, 1997, J ANIM ECOL, V66, P827, DOI 10.2307/5998; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Tizard I, 2002, SEMIN AVIAN EXOT PET, V11, P2, DOI 10.1053/saep.2002.28216; Tschirren B, 2009, IBIS, V151, P160, DOI 10.1111/j.1474-919X.2008.00880.x; Wang YW, 2004, POULTRY SCI, V83, P2039, DOI 10.1093/ps/83.12.2039; YAMAMOTO H, 1975, JPN J VET RES, V23, P131	54	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9639	10.1371/journal.pone.0009639	http://dx.doi.org/10.1371/journal.pone.0009639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300173	Green Published, gold, Green Submitted			2022-12-27	WOS:000275620600004
J	Potdar, AA; Jeon, J; Weaver, AM; Quaranta, V; Cummings, PT				Potdar, Alka A.; Jeon, Junhwan; Weaver, Alissa M.; Quaranta, Vito; Cummings, Peter T.			Human Mammary Epithelial Cells Exhibit a Bimodal Correlated Random Walk Pattern	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; WANDERING ALBATROSSES; SCALING LAWS; LEVY WALK; DISTRIBUTIONS; STRATEGIES; SIMULATION; MIGRATION; DISPERSAL; MOVEMENTS	Background: Organisms, at scales ranging from unicellular to mammals, have been known to exhibit foraging behavior described by random walks whose segments confirm to Levy or exponential distributions. For the first time, we present evidence that single cells (mammary epithelial cells) that exist in multi-cellular organisms (humans) follow a bimodal correlated random walk (BCRW). Methodology/Principal Findings: Cellular tracks of MCF-10A pBabe, neuN and neuT random migration on 2-D plastic substrates, analyzed using bimodal analysis, were found to reveal the BCRW pattern. We find two types of exponentially distributed correlated flights (corresponding to what we refer to as the directional and re-orientation phases) each having its own correlation between move step-lengths within flights. The exponential distribution of flight lengths was confirmed using different analysis methods (logarithmic binning with normalization, survival frequency plots and maximum likelihood estimation). Conclusions/Significance: Because of the presence of non-uniform turn angle distribution of move step-lengths within a flight and two different types of flights, we propose that the epithelial random walk is a BCRW comprising of two alternating modes with varying degree of correlations, rather than a simple persistent random walk. A BCRW model rather than a simple persistent random walk correctly matches the super-diffusivity in the cell migration paths as indicated by simulations based on the BCRW model.	[Potdar, Alka A.; Jeon, Junhwan; Cummings, Peter T.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37203 USA; [Potdar, Alka A.; Jeon, Junhwan; Weaver, Alissa M.; Quaranta, Vito; Cummings, Peter T.] Vanderbilt Integrat Canc Biol Ctr, Nashville, TN USA; [Weaver, Alissa M.; Quaranta, Vito] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Cummings, Peter T.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences	Potdar, AA (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37203 USA.	peter.cummings@vanderbilt.edu	Cummings, Peter T/B-8762-2013; Quaranta, Vito/G-6512-2016; Potdar, Alka/E-6882-2012	Cummings, Peter T/0000-0002-9766-2216; Quaranta, Vito/0000-0001-7491-8672; 	National Cancer Institute grant [5U54CA113007-02]; NATIONAL CANCER INSTITUTE [U54CA113007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075126] Funding Source: NIH RePORTER	National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Cancer Institute grant: Multiscale Mathematical Modeling of Cancer Invasion (grant number: 5U54CA113007-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Berg H C, 1974, Antibiot Chemother (1971), V19, P55; Berg H. C., 1983, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Bray D, 2001, CELL MOVEMENTS MOL M; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Byers JA, 2001, ECOLOGY, V82, P1680, DOI 10.2307/2679810; CAIN ML, 1985, ECOLOGY, V66, P876, DOI 10.2307/1940550; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; LEDOUARIN NM, 1984, CELL, V38, P353, DOI 10.1016/0092-8674(84)90490-2; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Potdar AA, 2009, ANN BIOMED ENG, V37, P230, DOI 10.1007/s10439-008-9592-y; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; SHIESINGER MF, 1986, GROWTH FORM FRACTAL, P279; Shlesinger M., 1995, LEVY FLIGHTS RELATED, Ved, DOI [10.1007/3-540-59222-9, DOI 10.1007/3-540-59222-9]; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; STOKES CL, 1991, J CELL SCI, V99, P419; Tsallis C, 1997, PHYS WORLD, V10, P42; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Van Haastert PJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006814; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011111; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	37	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9636	10.1371/journal.pone.0009636	http://dx.doi.org/10.1371/journal.pone.0009636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224792	gold, Green Published, Green Submitted			2022-12-27	WOS:000275328800030
J	Shirinian, M; Grabbe, C; Popovic, M; Varshney, G; Hugosson, F; Bos, H; Rehmann, H; Palmer, RH				Shirinian, Margret; Grabbe, Caroline; Popovic, Milica; Varshney, Gaurav; Hugosson, Fredrik; Bos, Hans; Rehmann, Holger; Palmer, Ruth H.			The Rap1 Guanine Nucleotide Exchange Factor C3G Is Required for Preservation of Larval Muscle Integrity in Drosophila melanogaster	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; REGULATES CELL-SHAPE; MYOBLAST FUSION; PDZ-GEF; MUSCULAR-DYSTROPHY; PROTEIN; ACTIVATION; CRK; CAVEOLIN-3; GTPASE	C3G is a guanine nucleotide exchange factor (GEF) and modulator of small G-protein activity, which primarily acts on members of the Rap GTPase subfamily. Via promotion of the active GTP bound conformation of target GTPases, C3G has been implicated in the regulation of multiple cellular and developmental events including proliferation, differentiation and apoptosis. The Drosophila C3G orthologue exhibits a domain organization similar to that of vertebrate C3G. Through deletion of the C3G locus, we have observed that loss of C3G causes semi-lethality, and that escaping adult flies are characterized by a reduction in lifespan and general fitness. In situ hybridization reveals C3G expression in the developing embryonic somatic and visceral muscles, and indeed analysis of C3G mutants suggests essential functions of C3G for normal body wall muscle development during larval stages. C3G mutants display abnormal muscle morphology and attachment, as well as failure to properly localize beta PS integrins to muscle attachment sites. Moreover, we show that C3G stimulates guanine nucleotide exchange on Drosophila Rap GTPases in vitro. Taken together, we conclude that Drosophila C3G is a Rap1-specific GEF with important functions in maintaining muscle integrity during larval stages.	[Shirinian, Margret; Grabbe, Caroline; Varshney, Gaurav; Hugosson, Fredrik; Palmer, Ruth H.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Popovic, Milica; Bos, Hans; Rehmann, Holger] Univ Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, Utrecht, Netherlands; [Popovic, Milica; Bos, Hans; Rehmann, Holger] Univ Med Ctr, Canc Genom Ctr, Utrecht, Netherlands	Umea University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Shirinian, M (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	Ruth.Palmer@ucmp.umu.se	Varshney, Gaurav/L-5261-2014	Varshney, Gaurav K./0000-0002-0429-1904	TI Pharma [T3-106]; Netherlands Organization for Scientific Research (NWO-CW); Swedish Research Council [621-2003-3399]; Swedish Cancer Research Society [09 0741]; Association for International Cancer Research	TI Pharma; Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Research Society; Association for International Cancer Research	MP was supported by TI Pharma Project T3-106 and HR by the Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW), RHP is a Swedish Cancer Foundation Research Fellow and was supported by the Swedish Research Council (621-2003-3399), the Swedish Cancer Research Society (09 0741) and the Association for International Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bloor JW, 1998, GENETICS, V148, P1127; Boettner B, 2007, MOL CELL BIOL, V27, P7966, DOI 10.1128/MCB.01275-07; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROWN NH, 1993, BIOESSAYS, V15, P383, DOI 10.1002/bies.950150604; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Dupuy AG, 2005, ONCOGENE, V24, P4509, DOI 10.1038/sj.onc.1208647; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Ishimaru S, 1999, EMBO J, V18, P145, DOI 10.1093/emboj/18.1.145; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee JH, 2002, MOL CELL BIOL, V22, P7658, DOI 10.1128/MCB.22.21.7658-7666.2002; LEISS D, 1988, DEVELOPMENT, V104, P525; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Okino K, 2006, INT J GYNECOL CANCER, V16, P763, DOI 10.1111/j.1525-1438.2006.00352.x; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; ROULIER EM, 1992, J CELL BIOL, V116, P911, DOI 10.1083/jcb.116.4.911; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; VOLK T, 1990, CELL, V63, P525, DOI 10.1016/0092-8674(90)90449-O; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Yagi R, 2001, EMBO REP, V2, P814, DOI 10.1093/embo-reports/kve178	54	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9403	10.1371/journal.pone.0009403	http://dx.doi.org/10.1371/journal.pone.0009403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209136	Green Submitted, Green Published, gold			2022-12-27	WOS:000275063400001
J	White, JR; Levy, T; Bishop, W; Beaty, JD				White, James Robert; Levy, Todd; Bishop, William; Beaty, James D.			Real-Time Decision Fusion for Multimodal Neural Prosthetic Devices	PLOS ONE			English	Article							PRIMATE MOTOR CORTEX; FREE ARM MOVEMENTS; 3-DIMENSIONAL SPACE; VISUAL TARGETS; BRAIN-TISSUE; DIRECTION; SIGNALS; ROBOT; SENSOR; EEG	Background: The field of neural prosthetics aims to develop prosthetic limbs with a brain-computer interface (BCI) through which neural activity is decoded into movements. A natural extension of current research is the incorporation of neural activity from multiple modalities to more accurately estimate the user's intent. The challenge remains how to appropriately combine this information in real-time for a neural prosthetic device. Methodology/Principal Findings: Here we propose a framework based on decision fusion, i.e., fusing predictions from several single-modality decoders to produce a more accurate device state estimate. We examine two algorithms for continuous variable decision fusion: the Kalman filter and artificial neural networks (ANNs). Using simulated cortical neural spike signals, we implemented several successful individual neural decoding algorithms, and tested the capabilities of each fusion method in the context of decoding 2-dimensional endpoint trajectories of a neural prosthetic arm. Extensively testing these methods on random trajectories, we find that on average both the Kalman filter and ANNs successfully fuse the individual decoder estimates to produce more accurate predictions. Conclusions: Our results reveal that a fusion-based approach has the potential to improve prediction accuracy over individual decoders of varying quality, and we hope that this work will encourage multimodal neural prosthetics experiments in the future.	[White, James Robert] Univ Maryland, Appl Math & Sci Computat Program, College Pk, MD 20742 USA; [Levy, Todd; Bishop, William; Beaty, James D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	White, JR (corresponding author), Univ Maryland, Appl Math & Sci Computat Program, College Pk, MD 20742 USA.	whitej@umd.edu			Defense Advanced Research Projects Agency (DARPA) [N66001-06-C-8005]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was funded by the Defense Advanced Research Projects Agency (DARPA) Revolutionizing Prosthetics program, contract N66001-06-C-8005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2008, IEEE T NEUR SYS REH, V16, P3, DOI 10.1109/TNSRE.2007.916289; Ahiskali M, 2009, IEEE ENG MED BIO, P2494, DOI 10.1109/IEMBS.2009.5335141; Andersen RA, 2004, P ANN INT IEEE EMBS, V26, P5352; Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; [Anonymous], 2006, P SIGGR COURS; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Ben-Yacoub S, 1999, IEEE T NEURAL NETWOR, V10, P1065, DOI 10.1109/72.788647; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cunningham JP, 2008, J NEUROPHYSIOL, V100, P3445, DOI 10.1152/jn.90833.2008; Dillingham TR, 2002, SOUTH MED J, V95, P875; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Gladwin TE, 2008, CORTEX, V44, P521, DOI 10.1016/j.cortex.2007.10.005; Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018; Guenther FH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008218; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; KETTNER RE, 1988, J NEUROSCI, V8, P2938; KIM J, 2007, C P IEEE ENG MED BIO, P5353; Kyriakoulis N, 2006, LECT NOTES COMPUT SC, V3955, P547; Lima PU, 2007, IEEE INSTRU MEAS MAG, V10, P22, DOI 10.1109/MIM.2007.4284255; Lin PC, 2006, IEEE T ROBOT, V22, P932, DOI 10.1109/TRO.2006.878954; Monwar MM, 2009, IEEE T SYST MAN CY B, V39, P867, DOI 10.1109/TSMCB.2008.2009071; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Morash V, 2008, CLIN NEUROPHYSIOL, V119, P2570, DOI 10.1016/j.clinph.2008.08.013; NAGATA K, 2006, C P IEEE ENG MED BIO, V1, P6193; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prasad S, 2008, IEEE ENG MED BIO, P3048, DOI 10.1109/IEMBS.2008.4649846; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Ribaric S, 2005, IEEE T PATTERN ANAL, V27, P1698, DOI 10.1109/TPAMI.2005.209; Rohlfing T, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P404; Rossi L, 2007, J NEURAL ENG, V4, P96, DOI 10.1088/1741-2560/4/2/010; Sanchez JC, 2008, J NEUROSCI METH, V167, P63, DOI 10.1016/j.jneumeth.2007.04.019; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Shenoy P, 2008, IEEE T BIO-MED ENG, V55, P273, DOI 10.1109/TBME.2007.903528; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; Wu W, 2004, P ANN INT IEEE EMBS, V26, P4126; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Wu W, 2008, IEEE T BIO-MED ENG, V55, P1733, DOI 10.1109/TBME.2008.919125; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006; Zhang H, 2006, IND ROBOT, V33, P451, DOI 10.1108/01439910610705626; Zhou DY, 2008, J SYST ENG ELECTRON, V19, P996, DOI 10.1016/S1004-4132(08)60187-5; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	49	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9493	10.1371/journal.pone.0009493	http://dx.doi.org/10.1371/journal.pone.0009493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209151	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300009
J	Liu, YX; Chen, WS; Liu, JK; Shi, SJ				Liu, Yingxiang; Chen, Weishan; Liu, Junkao; Shi, Shengjun			Actuating Mechanism and Design of a Cylindrical Traveling Wave Ultrasonic Motor Using Cantilever Type Composite Transducer	PLOS ONE			English	Article								Background: Ultrasonic motors (USM) are based on the concept of driving the rotor by a mechanical vibration excited on the stator via piezoelectric effect. USM exhibit merits such as simple structure, quick response, quiet operation, self-locking when power off, nonelectromagnetic radiation and higher position accuracy. Principal Findings: A cylindrical type traveling wave ultrasonic motor using cantilever type composite transducer was proposed in this paper. There are two cantilevers on the outside surface of cylinder, four longitudinal PZT ceramics are set between the cantilevers, and four bending PZT ceramics are set on each outside surface of cantilevers. Two degenerate flexural vibration modes spatially and temporally orthogonal to each other in the cylinder are excited by the composite transducer. In this new design, a single transducer can excite a flexural traveling wave in the cylinder. Thus, elliptical motions are achieved on the teeth. The actuating mechanism of proposed motor was analyzed. The stator was designed with FEM. The two vibration modes of stator were degenerated. Transient analysis was developed to gain the vibration characteristic of stator, and results indicate the motion trajectories of nodes on the teeth are nearly ellipses. Conclusions: The study results verify the feasibility of the proposed design. The wave excited in the cylinder isn't an ideal traveling wave, and the vibration amplitudes are inconsistent. The distortion of traveling wave is generated by the deformation of bending vibration mode of cylinder, which is caused by the coupling effect between the cylinder and transducer. Analysis results also prove that the objective motions of nodes on the teeth are three-dimensional vibrations. But, the vibration in axial direction is minute compared with the vibrations in circumferential and radial direction. The results of this paper can guide the development of this new type of motor.	[Liu, Yingxiang; Chen, Weishan; Liu, Junkao; Shi, Shengjun] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin 150006, Peoples R China	Harbin Institute of Technology	Liu, YX (corresponding author), Harbin Inst Technol, State Key Lab Robot & Syst, Harbin 150006, Peoples R China.	liuyingxiang868@163.com	liu, ying/GXF-4294-2022; liu, yingxiang/AFC-8987-2022; LIU, YING/GZL-7252-2022; Chen, Wei/GZK-7348-2022		National Natural Science Foundation of China [50875057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No. 50875057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WS, 2007, FERROELECTRICS, V350, P102, DOI 10.1080/00150190701369958; LIU YX, 2008, 3 S PIEZ AC WAV DEV, P246; Park JS, 2005, JPN J APPL PHYS 1, V44, P412, DOI 10.1143/JJAP.44.412; Ting Y, 2007, IEEE T ULTRASON FERR, V54, P847, DOI 10.1109/TUFFC.2007.318; Ueha S., 1993, ULTRASONIC MOTORS TH; Zhang F, 2005, IEEE T ULTRASON FERR, V52, P134, DOI 10.1109/TUFFC.2005.1397358; Zhao M, 2004, MED RES REV, V24, P1, DOI 10.1002/med.10056	7	47	48	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10020	10.1371/journal.pone.0010020	http://dx.doi.org/10.1371/journal.pone.0010020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368809	gold, Green Published, Green Submitted			2022-12-27	WOS:000276419900018
J	Wong, CH; Iskandar, KB; Yadav, SK; Hirpara, JL; Loh, T; Pervaiz, S				Wong, Chew Hooi; Iskandar, Kartini Bte; Yadav, Sanjiv Kumar; Hirpara, Jayshree L.; Loh, Thomas; Pervaiz, Shazib			Simultaneous Induction of Non-Canonical Autophagy and Apoptosis in Cancer Cells by ROS-Dependent ERK and JNK Activation	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; N-TERMINAL KINASE; INTRACELLULAR SUPEROXIDE; HYDROGEN-PEROXIDE; PROTEIN-KINASE; JNK1-MEDIATED PHOSPHORYLATION; TUMOR-SUPPRESSOR; T-CELLS; DEATH; NECROSIS	Background: Chemotherapy-induced reduction in tumor load is a function of apoptotic cell death, orchestrated by intracellular caspases. However, the effectiveness of these therapies is compromised by mutations affecting specific genes, controlling and/or regulating apoptotic signaling. Therefore, it is desirable to identify novel pathways of cell death, which could function in tandem with or in the absence of efficient apoptotic machinery. In this regard, recent evidence supports the existence of a novel cell death pathway termed autophagy, which is activated upon growth factor deprivation or exposure to genotoxic compounds. The functional relevance of this pathway in terms of its ability to serve as a stress response or a truly death effector mechanism is still in question; however, reports indicate that autophagy is a specialized form of cell death under certain conditions. Methodology/Principal Findings: We report here the simultaneous induction of non-canonical autophagy and apoptosis in human cancer cells upon exposure to a small molecule compound that triggers intracellular hydrogen peroxide (H(2)O(2)) production. Whereas, silencing of beclin1 neither inhibited the hallmarks of autophagy nor the induction of cell death, Atg 7 or Ulk1 knockdown significantly abrogated drug-induced H(2)O(2)-mediated autophagy. Furthermore, we provide evidence that activated extracellular regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) are upstream effectors controlling both autophagy and apoptosis in response to elevated intracellular H(2)O(2). Interestingly, inhibition of JNK activity reversed the increase in Atg7 expression in this system, thus indicating that JNK may regulate autophagy by activating Atg7. Of note, the small molecule compound triggered autophagy and apoptosis in primary cells derived from patients with lymphoma, but not in non-transformed cells. Conclusions/Significance: Considering that loss of tumor suppressor beclin 1 is associated with neoplasia, the ability of this small molecule compound to engage both autophagic and apoptotic machineries via ROS production and subsequent activation of ERK and JNK could have potential translational implications.	[Wong, Chew Hooi; Iskandar, Kartini Bte; Yadav, Sanjiv Kumar; Hirpara, Jayshree L.; Pervaiz, Shazib] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Wong, Chew Hooi; Pervaiz, Shazib] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117595, Singapore; [Loh, Thomas] Natl Univ Hosp Syst, Dept Otorhinolaryngol, Singapore, Singapore; [Pervaiz, Shazib] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Pervaiz, Shazib] Singapore MIT Alliance, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Wong, CH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	phssp@nus.edu.sg	Pervaiz, Shazib/C-4188-2015; Loh, Thomas/GYU-2298-2022		National Medical Research Council, Singapore; Biomedical Research Council, Singapore; Ministry of Education (MOE-Tier 2), Singapore; Duke-NUS Graduate Medical School, Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education (MOE-Tier 2), Singapore(Ministry of Education, Singapore); Duke-NUS Graduate Medical School, Singapore(National University of Singapore)	This work is supported by grants to S. P. from the National Medical Research Council, Singapore, the Biomedical Research Council, Singapore, the Ministry of Education (MOE-Tier 2), Singapore, and research funds from the Duke-NUS Graduate Medical School, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BODE AM, 2003, SCI STKE, pRE2; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Clement MV, 2003, CELL DEATH DIFFER, V10, P1273, DOI 10.1038/sj.cdd.4401302; Clement MV, 1999, FREE RADICAL RES, V30, P247, DOI 10.1080/10715769900300271; Clement MV, 2005, ANTIOXID REDOX SIGN, V7, P456, DOI 10.1089/ars.2005.7.456; Clement MV, 2001, REDOX REP, V6, P211, DOI 10.1179/135100001101536346; Clement MV, 1998, FEBS LETT, V440, P13, DOI 10.1016/S0014-5793(98)01410-0; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Pervaiz S, 2002, METHOD ENZYMOL, V352, P150; Pervaiz S, 2007, INT J BIOCHEM CELL B, V39, P1297, DOI 10.1016/j.biocel.2007.04.007; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; SCARLATTI F, 2008, CELL DEATH DIFFER; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Temkin V, 2007, IMMUNOL REV, V220, P8, DOI 10.1111/j.1600-065X.2007.00560.x; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yano K, 2007, AUTOPHAGY, V3, P215, DOI 10.4161/auto.3739; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	56	201	212	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e9996	10.1371/journal.pone.0009996	http://dx.doi.org/10.1371/journal.pone.0009996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368806	Green Published, gold			2022-12-27	WOS:000276419900003
J	Folli, F; Guzzi, V; Perego, L; Coletta, DK; Finzi, G; Placidi, C; La Rosa, S; Capella, C; Socci, C; Lauro, D; Tripathy, D; Jenkinson, C; Paroni, R; Orsenigo, E; Cighetti, G; Gregorini, L; Staudacher, C; Secchi, A; Bachi, A; Brownlee, M; Fiorina, P				Folli, Franco; Guzzi, Valeria; Perego, Lucia; Coletta, Dawn K.; Finzi, Giovanna; Placidi, Claudia; La Rosa, Stefano; Capella, Carlo; Socci, Carlo; Lauro, Davide; Tripathy, Devjit; Jenkinson, Christopher; Paroni, Rita; Orsenigo, Elena; Cighetti, Giuliana; Gregorini, Luisa; Staudacher, Carlo; Secchi, Antonio; Bachi, Angela; Brownlee, Michael; Fiorina, Paolo			Proteomics Reveals Novel Oxidative and Glycolytic Mechanisms in Type 1 Diabetic Patients' Skin Which Are Normalized by Kidney-Pancreas Transplantation	PLOS ONE			English	Article							GLYCOSYLATION END-PRODUCTS; AUTOXIDATIVE GLYCOSYLATION; ISLET TRANSPLANTATION; GLUCOSE AUTOXIDATION; POTENTIAL ROLE; PROTEIN; COMPLICATIONS; EXPRESSION; CELLS; HEAT-SHOCK-PROTEIN-27	Background: In type 1 diabetes (T1D) vascular complications such as accelerated atherosclerosis and diffused macro-/microangiopathy are linked to chronic hyperglycemia with a mechanism that is not yet well understood. End-stage renal disease (ESRD) worsens most diabetic complications, particularly, the risk of morbidity and mortality from cardiovascular disease is increased several fold. Methods and Findings: We evaluated protein regulation and expression in skin biopsies obtained from T1D patients with and without ESRD, to identify pathways of persistent cellular changes linked to diabetic vascular disease. We therefore examined pathways that may be normalized by restoration of normoglycemia with kidney-pancreas (KP) transplantation. Using proteomic and ultrastructural approaches, multiple alterations in the expression of proteins involved in oxidative stress (catalase, superoxide dismutase 1, Hsp27, Hsp60, ATP synthase delta chain, and flavin reductase), aerobic and anaerobic glycolysis (ACBP, pyruvate kinase muscle isozyme, and phosphoglycerate kinase 1), and intracellular signaling (stratifin-14-3-3, S100-calcyclin, cathepsin, and PPI rotamase) as well as endothelial vascular abnormalities were identified in T1D and T1D+ESRD patients. These abnormalities were reversed after KP transplant. Increased plasma levels of malondialdehyde were observed in T1D and T1D+ESRD patients, confirming increased oxidative stress which was normalized after KP transplant. Conclusions: Our data suggests persistent cellular changes of anti-oxidative machinery and of aerobic/anaerobic glycolysis are present in T1D and T1D+ESRD patients, and these abnormalities may play a key role in the pathogenesis of hyperglycemia-related vascular complications. Restoration of normoglycemia and removal of uremia with KP transplant can correct these abnormalities. Some of these identified pathways may become potential therapeutic targets for a new generation of drugs.	[Folli, Franco; Tripathy, Devjit; Jenkinson, Christopher] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Guzzi, Valeria; Perego, Lucia; Paroni, Rita; Gregorini, Luisa] Univ Milan, Dept Med, Milan, Italy; [Coletta, Dawn K.] Arizona State Univ, Sch Life Sci, Ctr Metab Biol, Tempe, AZ USA; [Finzi, Giovanna; Placidi, Claudia; La Rosa, Stefano; Capella, Carlo] Univ Insubria, Osped Circolo, Dept Pathol, Varese, Italy; [Finzi, Giovanna; Placidi, Claudia; La Rosa, Stefano; Capella, Carlo] Univ Insubria, Dept Human Morphol, Varese, Italy; [Socci, Carlo; Orsenigo, Elena; Staudacher, Carlo] Ist Sci San Raffaele, Dept Surg, I-20132 Milan, Italy; [Lauro, Davide; Cighetti, Giuliana] Univ Milan, Dept Clin Sci Luigi Sacco, Milan, Italy; [Secchi, Antonio] Ist Sci San Raffaele, Dept Med, I-20132 Milan, Italy; [Bachi, Angela] Univ Vita & Salute San Raffaele, Dept Oncol, Milan, Italy; [Brownlee, Michael] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Fiorina, Paolo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Childrens Hosp,Transplantat Res Ctr,Nephrol Div, Boston, MA 02115 USA	University of Texas System; University of Texas Health San Antonio; University of Milan; Arizona State University; Arizona State University-Tempe; Ospedale Circolo & Fondazione Macchi; University of Insubria; University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Luigi Sacco Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Yeshiva University; Yeshiva University; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard Medical School	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	folli@uthscsa.edu; paolo.fiorina@childrens.harvard.edu	folli, franco/J-2795-2018; La+Rosa, Stefano/AFH-8608-2022; La+Rosa, Stefano/AAF-3366-2022; PARONI, RITA/AAC-6265-2020; Coletta, Dawn/G-6382-2016; Lauro, Davide/K-4683-2018; bachi, angela/B-3527-2015; socci, carlo/AAN-7338-2020; PARONI, RITA/C-2955-2012; CIGHETTI, GIULIANA MARIA/E-8593-2017; Fiorina, Paolo/B-4532-2019	folli, franco/0000-0001-9824-5222; La+Rosa, Stefano/0000-0003-1941-2403; La+Rosa, Stefano/0000-0003-1941-2403; PARONI, RITA/0000-0002-3186-8860; bachi, angela/0000-0003-4842-6556; PARONI, RITA/0000-0002-3186-8860; tripathy, devjit/0000-0003-2797-0659; Lauro, Davide/0000-0002-8597-4415; CIGHETTI, GIULIANA MARIA/0000-0002-3428-8634; Fiorina, Paolo/0000-0002-1093-7724; Coletta, Dawn/0000-0001-5819-5152	American Society of Transplantation - Juvenile Diabetes Research Foundation; Italian Ministry of Health and the Italian Ministry of University and Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079195] Funding Source: NIH RePORTER	American Society of Transplantation - Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Italian Ministry of Health and the Italian Ministry of University and Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Paolo Fiorina is a recipient of an American Society of Transplantation - Juvenile Diabetes Research Foundation (AST-JDRF) Faculty Grant and a JDRF-Career Development Award. This work was supported by grants from JDF (P. F.) and grants from the Italian Ministry of Health and the Italian Ministry of University and Scientific Research (F. F., L. G. and A. S.) (http://www.a-s-t.org/index2.cfm?Section = research_funding&Sub1Section=ast_grants&content=past_grant_recipients.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2003, J CLIN INVEST, V112, P1788, DOI 10.1172/JCI200320501; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Cighetti G, 2009, FREE RADICAL BIO MED, V47, P307, DOI 10.1016/j.freeradbiomed.2009.05.007; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Eberl N, 2005, DIABETES-METAB RES, V21, P525, DOI 10.1002/dmrr.555; Fiorina P, 2004, DIABETES, V53, P2291, DOI 10.2337/diabetes.53.9.2291; Fiorina P, 2003, TRANSPLANTATION, V75, P1296, DOI 10.1097/01.TP.0000061788.32639.D9; Fiorina P, 2003, DIABETES CARE, V26, P1129, DOI 10.2337/diacare.26.4.1129; Fiorina P, 2001, DIABETES, V50, P496, DOI 10.2337/diabetes.50.3.496; Gruden G, 2008, DIABETES, V57, P1966, DOI 10.2337/db08-0009; Gulden E, 2008, FEBS LETT, V582, P2731, DOI 10.1016/j.febslet.2008.07.002; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; Iori E, 2008, BBA-MOL BASIS DIS, V1782, P627, DOI 10.1016/j.bbadis.2008.08.012; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; La Rocca E, 2000, CELL TRANSPLANT, V9, P929, DOI 10.1177/096368970000900621; La Rocca E, 2001, KIDNEY INT, V60, P1964, DOI 10.1046/j.1523-1755.2001.00008.x; Lee JP, 1999, P NATL ACAD SCI USA, V96, P3251, DOI 10.1073/pnas.96.6.3251; Macaulay IC, 2005, J CLIN INVEST, V115, P3370, DOI 10.1172/JCI26885; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nathan DM, 2003, NEW ENGL J MED, V348, P761; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oliveira HR, 1999, AM J PHYSIOL-CELL PH, V276, pC507, DOI 10.1152/ajpcell.1999.276.2.C507; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; PROPERZI G, 1995, J PATHOL, V175, P243, DOI 10.1002/path.1711750213; Quintana FJ, 2008, NOVART FDN SYMP, V291, P137; Quintana FJ, 2008, NOVART FDN SYMP, V291, P111; Quintana Francisco J, 2008, Novartis Found Symp, V291, P101; Schalkwijk CG, 2006, FEBS LETT, V580, P1565, DOI 10.1016/j.febslet.2006.01.086; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tessari P, 2007, J PROTEOME RES, V6, P976, DOI 10.1021/pr060443n; Vidal BC, 2005, CLIN SCI, V109, P421, DOI 10.1042/CS20050085; Vlassara H, 2003, MT SINAI J MED, V70, P232; VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	44	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9923	10.1371/journal.pone.0009923	http://dx.doi.org/10.1371/journal.pone.0009923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360867	Green Published, gold, Green Submitted			2022-12-27	WOS:000276163100016
J	Klevebring, D; Bjursell, M; Emanuelsson, O; Lundeberg, J				Klevebring, Daniel; Bjursell, Magnus; Emanuelsson, Olof; Lundeberg, Joakim			In-Depth Transcriptome Analysis Reveals Novel TARs and Prevalent Antisense Transcription in Human Cell Lines	PLOS ONE			English	Article							HUMAN PROMOTERS; HUMAN GENOME; RNA-SEQ; DNA	Several recent studies have indicated that transcription is pervasive in regions outside of protein coding genes and that short antisense transcripts can originate from the promoter and terminator regions of genes. Here we investigate transcription of fragments longer than 200 nucleotides, focusing on antisense transcription for known protein coding genes and intergenic transcription. We find that roughly 12% to 16% of all reads that originate from promoter and terminator regions, respectively, map antisense to the gene in question. Furthermore, we detect a high number of novel transcriptionally active regions (TARs) that are generally expressed at a lower level than protein coding genes. We find that the correlation between RNA-seq data and microarray data is dependent on the gene length, with longer genes showing a better correlation. We detect high antisense transcriptional activity from promoter, terminator and intron regions of protein-coding genes and identify a vast number of previously unidentified TARs, including putative novel EGFR transcripts. This shows that in-depth analysis of the transcriptome using RNA-seq is a valuable tool for understanding complex transcriptional events. Furthermore, the development of new algorithms for estimation of gene expression from RNA-seq data is necessary to minimize length bias.	[Klevebring, Daniel; Bjursell, Magnus; Emanuelsson, Olof; Lundeberg, Joakim] Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Div Gen Technol, Stockholm, Sweden	Royal Institute of Technology	Klevebring, D (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	joakim.lundeberg@biotech.kth.se		Klevebring, Daniel/0000-0002-9810-3838	Swedish Scientific Council; Knut and Alice Wallenberg Foundation	Swedish Scientific Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Scientific Council, and the Knut and Alice Wallenberg Foundation.	Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; EBISUYA M, 2008, NAT CELL BIOL; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KLEVEBRING D, 2009, J BIOMED BIOTECHNOL, P1; Lai CQ, 2008, DIABETES, V57, P809, DOI 10.2337/db07-1238; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; LINDBERG J, 2009, GENOMICS; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mortazavi A, 2008, NAT METH; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	24	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9762	10.1371/journal.pone.0009762	http://dx.doi.org/10.1371/journal.pone.0009762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360838	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969500002
J	Leibler, JH; Carone, M; Silbergeld, EK				Leibler, Jessica H.; Carone, Marco; Silbergeld, Ellen K.			Contribution of Company Affiliation and Social Contacts to Risk Estimates of Between-Farm Transmission of Avian Influenza	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANT ENTEROCOCCI; SWINE-FEEDING OPERATION; LOW-PATHOGENICITY; VIRUS INFECTIONS; POULTRY FARMS; COMMERCIAL POULTRY; A VIRUSES; H5N1; H7N2; EPIDEMIC	Background: Models of between-farm transmission of pathogens have identified service vehicles and social groups as risk factors mediating the spread of infection. Because of high levels of economic organization in much of the poultry industry, we examined the importance of company affiliation, as distinct from social contacts, in a model of the potential spread of avian influenza among broiler poultry farms in a poultry-dense region in the United States. The contribution of company affiliation to risk of between-farm disease transmission has not been previously studied. Methodology/Principal Findings: We obtained data on the nature and frequency of business and social contacts through a national survey of broiler poultry growers in the United States. Daily rates of contact were estimated using Monte Carlo analysis. Stochastic modeling techniques were used to estimate the exposure risk posed by a single infectious farm to other farms in the region and relative risk of exposure for farms under different scenarios. The mean daily rate of vehicular contact was 0.82 vehicles/day. The magnitude of exposure risk ranged from <1% to 25% under varying parameters. Risk of between-farm transmission was largely driven by company affiliation, with farms in the same company group as the index farm facing as much as a 5-fold increase in risk compared to farms contracted with different companies. Employment of part-time workers contributed to significant increases in risk in most scenarios, notably for farms who hired day-laborers. Social visits were significantly less important in determining risk. Conclusions/Significance: Biosecurity interventions should be based on information on industry structure and company affiliation, and include part-time workers as potentially unrecognized sources of viral transmission. Modeling efforts to understand pathogen transmission in the context of industrial food animal production should consider company affiliation in addition to geospatial factors and pathogen characteristics. Restriction of social contacts among farmers may be less useful in reducing between-farm transmission.	[Leibler, Jessica H.; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Carone, Marco] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Leibler, JH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	jleibler@jhsph.edu		Leibler, Jessica/0000-0002-0605-0928	Johns Hopkins Sommer Scholar program and the Johns Hopkins Center	Johns Hopkins Sommer Scholar program and the Johns Hopkins Center	This study was funded by the Johns Hopkins Sommer Scholar program and the Johns Hopkins Center for a Livable Future. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey BL, 2003, AVIAN DIS, V47, P1099, DOI 10.1637/0005-2086-47.s3.1099; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Bos MEH, 2007, VET RES, V38, P493, DOI 10.1051/vetres:2007008; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; *CORP, 2008, CRYST BALL FUS ED RE; Davison S, 1999, J AM VET MED ASSOC, V214, P1164; *DEL DEP TRANSP, 2008, TRAFF SUMM TRAFF COU; *DELM POULTR IND I, 2009, DELM US FACTS; Dent JE, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-27; Dunn PA, 2003, AVIAN DIS, V47, P812, DOI 10.1637/0005-2086-47.s3.812; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; Gerba CP, 2005, J ENVIRON QUAL, V34, P42; *GOOG INC, 2007, GOOG EARTH 4 2; Graham JP, 2009, SCI TOTAL ENVIRON, V407, P2701, DOI 10.1016/j.scitotenv.2008.11.056; Gray GC, 2009, POULTRY SCI, V88, P880, DOI 10.3382/ps.2008-00335; Guan J, 2009, AVIAN DIS, V53, P26, DOI 10.1637/8381-062008-Reg.1; Jalvingh AW, 1999, PREV VET MED, V42, P271, DOI 10.1016/S0167-5877(99)00080-X; Jeong OM, 2009, J VET SCI, V10, P53, DOI 10.4142/jvs.2009.10.1.53; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Ladman BS, 2008, AVIAN DIS, V52, P623, DOI 10.1637/8282-031208-Reg.1; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Lipatov AS, 2009, J INFECT DIS, V199, P717, DOI 10.1086/596740; Lu H, 2003, AVIAN DIS, V47, P1015, DOI 10.1637/0005-2086-47.s3.1015; MA W, 2009, ZOONOSES PUBLIC 0520; MARTINEZ SW, 1999, AER777 USDA EC RES S; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; *MICR CORP, 2007, MICR OFF EXC; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OIE, 2009, WAHID INT; Price LB, 2007, J OCCUP ENVIRON MED, V49, P748, DOI 10.1097/JOM.0b013e3180d09ec5; R Core Team, 2018, R LANG ENV STAT COMP; Rule Ana M, 2008, J Infect Public Health, V1, P33, DOI 10.1016/j.jiph.2008.08.001; Saito T, 2009, VET MICROBIOL, V133, P65, DOI 10.1016/j.vetmic.2008.06.020; Sanson RL, 2005, NEW ZEAL VET J, V53, P223, DOI 10.1080/00480169.2005.36550; Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P1040, DOI 10.1289/ehp.9770; Sawabe K, 2006, AM J TROP MED HYG, V75, P327, DOI 10.4269/ajtmh.2006.75.327; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; StataCorp, 2005, STAT STAT SOFTW REL; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Truscott J, 2007, P ROY SOC B-BIOL SCI, V274, P2287, DOI 10.1098/rspb.2007.0542; United States Department of Agriculture (USDA), 2007, CENS AGR; *US AN HLTH ASS, 2004, P ANN M US AN HLTH A; van der Goot JA, 2003, AVIAN DIS, V47, P939, DOI 10.1637/0005-2086-47.s3.939; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; Vieira AR, 2009, AVIAN DIS, V53, P55, DOI 10.1637/8364-051608-Reg.1; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Ziegler AF, 1999, AVIAN DIS, V43, P142, DOI 10.2307/1592774	57	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9888	10.1371/journal.pone.0009888	http://dx.doi.org/10.1371/journal.pone.0009888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360859	gold, Green Published, Green Submitted			2022-12-27	WOS:000275969500015
J	Sertich, JJW; Loewen, MA				Sertich, Joseph J. W.; Loewen, Mark A.			A New Basal Sauropodomorph Dinosaur from the Lower Jurassic Navajo Sandstone of Southern Utah	PLOS ONE			English	Article							EARLY EVOLUTION; THEROPOD; REMAINS; ORIGIN; ELLIOT; SKULL	Background: Basal sauropodomorphs, or 'prosauropods, 'are a globally widespread paraphyletic assemblage of terrestrial herbivorous dinosaurs from the Late Triassic and Early Jurassic. In contrast to several other landmasses, the North American record of sauropodomorphs during this time interval remains sparse, limited to Early Jurassic occurrences of a single well-known taxon from eastern North America and several fragmentary specimens from western North America. Methodology/Principal Findings: On the basis of a partial skeleton, we describe here a new basal sauropodomorph dinosaur from the Lower Jurassic Navajo Sandstone of southern Utah, Seitaad ruessi gen. et sp. nov. The partially articulated skeleton of Seitaad was likely buried post-mortem in the base of a collapsed dune foreset. The new taxon is characterized by a plate-like medial process of the scapula, a prominent proximal expansion of the deltopectoral crest of the humerus, a strongly inclined distal articular surface of the radius, and a proximally and laterally hypertrophied proximal metacarpal I. Conclusions/Significance: Phylogenetic analysis recovers Seitaad as a derived basal sauropodomorph closely related to plateosaurid or massospondylid 'prosauropods' and its presence in western North America is not unexpected for a member of this highly cosmopolitan clade. This occurrence represents one of the most complete vertebrate body fossil specimens yet recovered from the Navajo Sandstone and one of the few basal sauropodomorph taxa currently known from North America.	[Sertich, Joseph J. W.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Loewen, Mark A.] Utah Museum Nat Hist, Salt Lake City, UT USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sertich, JJW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	jsertich@ic.sunysb.edu			Utah Museum of Natural History	Utah Museum of Natural History	Funding for fieldwork was provided by the Utah Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attridge J., 1985, Journal of Vertebrate Paleontology, V5, P128; Bai Z.-Q., 1990, YUXIWENBO, V1, P14; Barrett Paul M., 2005, Palaeontologia Africana, V41, P123; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Barrett PM, 2004, S AFR J SCI, V100, P501; Blakey R.C., 1994, MESOZOIC SYSTEMS ROC, P273; BLAKEY RC, 1988, SEDIMENT GEOL, V56, P3, DOI 10.1016/0037-0738(88)90050-4; BONAPARTE J F, 1969, Zoological Journal of the Linnean Society, V48, P471, DOI 10.1111/j.1096-3642.1969.tb00725.x; Bonaparte J.F., 1986, P247; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Brady LF, 1936, AM J SCI, V31, P150; Brady LF, 1935, AM J SCI, V30, P210; Claessens LPAM, 2004, P ROY SOC B-BIOL SCI, V271, P1461, DOI 10.1098/rspb.2004.2743; Colbert E. H., 1964, American Museum Novitates, VNo. 2181, P1; COOPER M R, 1984, Palaeontologia Africana, V25, P203; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; CRUICKSHANK ARI, 1975, S AFR J SCI, V71, P89; Fedak T, 2006, J VERTEBR PALEONTOL, V26, p60A; Fedak TJ, 2007, SPEC PAP PALAEONTOL, P245; GALTON P M, 1971, Journal of Paleontology, V45, P781; GALTON P M, 1973, Palaeontologische Zeitschrift, V47, P229; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2007, Revue de Paleobiologie, V26, P505; GALTON PM, 1976, POSTILLA, V169, P1; Gauffre F-X, 1993, NEUES JB GEOLOGIE PA, V11, P648; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; GOW C E, 1990, Palaeontologia Africana, V27, P59; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Leal LA, 2004, ZOOTAXA, P1; Loewen M, 2005, J VERTEBR PALEONTOL, V25, p84A; Loope DB, 2003, J GEOL, V111, P223, DOI 10.1086/345843; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V29, P95; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Middleton L.T., 1983, EOLIAN SEDIMENTS PRO, P613; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PADIAN K, 1993, NEW MEXICO MUSEUM NA, V3, P379; Pol D, 2005, J VERTEBR PALEONTOL, V25, p100A; RMIS R.B., 2005, VERTEBRATE PALEONTOL, V11, P55; ROMER A, 1968, NOTES COMMENTS VERTE; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1989, J VERTEBR PALEONTOL, V9, pA38; SHUBIN NH, 1994, IN THE SHADOW OF THE DINOSAURS, P242; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; SMITH ND, 2007, 003 US GEOL SURV NAT, DOI DOI 10.3133/OF2007-1047.SRP003; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Tykoski R. S., 2005, MESA SOUTHWEST MUS B, V11, P72; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; *USGS, 2009, SO COL PLAT REG GEOL; van Heerden Jacques, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1, P39; von HUENE FRIEDRICH, 1929, PALAEONTOL ZEITSCHR, V11, P269; VONHUENE F, 1926, GEOLOGISCHE PALAEONT, P137; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yates A.M., 2004, GEOSCIENCE AFRICA, V2, P670; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2004, Postilla, V230, P1; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417; YATES AM, 2009, P ROYAL SOC LONDON B; Young C. C., 1941, Bulletin of the Geological Society of China, V21, P205; YOUNG C. C., 1947, PALEONTOL SINICA NEW SER, V12, P1; Young C. C., 1942, Bulletin of the Geological Society of China, V22, P63; Young C. C., 1941, Palaeontologia Sinica N S C, V7, P1; ZHANG Y, 1994, COMPLETE OSTEOLOGY P	77	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9789	10.1371/journal.pone.0009789	http://dx.doi.org/10.1371/journal.pone.0009789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352090	Green Published, gold			2022-12-27	WOS:000275894500005
J	Mishiba, K; Yamasaki, S; Nakatsuka, T; Abe, Y; Daimon, H; Oda, M; Nishihara, M				Mishiba, Kei-ichiro; Yamasaki, Satoshi; Nakatsuka, Takashi; Abe, Yoshiko; Daimon, Hiroyuki; Oda, Masayuki; Nishihara, Masahiro			Strict De Novo Methylation of the 35S Enhancer Sequence in Gentian	PLOS ONE			English	Article							MOSAIC VIRUS-35S PROMOTER; DNA METHYLATION; HERBICIDE-RESISTANCE; CYTOSINE METHYLATION; GENE-EXPRESSION; GENOME; PLANTS; AGROBACTERIUM; REGION; TRANSFORMATION	A novel transgene silencing phenomenon was found in the ornamental plant, gentian (Gentiana triflora x G. scabra), in which the introduced Cauliflower mosaic virus (CaMV) 35S promoter region was strictly methylated, irrespective of the transgene copy number and integrated loci. Transgenic tobacco having the same vector did not show the silencing behavior. Not only unmodified, but also modified 35S promoters containing a 35S enhancer sequence were found to be highly methylated in the single copy transgenic gentian lines. The 35S core promoter (290)-introduced transgenic lines showed a small degree of methylation, implying that the 35S enhancer sequence was involved in the methylation machinery. The rigorous silencing phenomenon enabled us to analyze methylation in a number of the transgenic lines in parallel, which led to the discovery of a consensus target region for de novo methylation, which comprised an asymmetric cytosine (CpHpH; H is A, C or T) sequence. Consequently, distinct footprints of de novo methylation were detected in each (modified) 35S promoter sequence, and the enhancer region (2148 to 285) was identified as a crucial target for de novo methylation. Electrophoretic mobility shift assay (EMSA) showed that complexes formed in gentian nuclear extract with the 2149 to 2124 and 2107 to 283 region probes were distinct from those of tobacco nuclear extracts, suggesting that the complexes might contribute to de novo methylation. Our results provide insights into the phenomenon of sequence-and species-specific gene silencing in higher plants.	[Mishiba, Kei-ichiro; Yamasaki, Satoshi; Daimon, Hiroyuki; Oda, Masayuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Nakatsuka, Takashi; Abe, Yoshiko; Nishihara, Masahiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan	Osaka Metropolitan University; Iwate Biotechnology Research Center	Mishiba, K (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan.	mishiba@plant.osakafu-u.ac.jp	Mishiba, Kei-ichiro/A-5844-2013	Mishiba, Kei-ichiro/0000-0002-3827-1020; Nishihara, Masahiro/0000-0002-1454-8785	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20780005]; Sumitomo Foundation [050356]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation	This work was supported by Grant-in-Aid for Scientific Research 20780005 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/), and by Grant for Basic Science Research Projects 050356 from The Sumitomo Foundation (http://www.sumitomo.or.jp/e/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annadana S, 2002, MOL BREEDING, V8, P335, DOI 10.1023/A:1015212312928; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; BENFEY PN, 1990, EMBO J, V9, P1677, DOI 10.1002/j.1460-2075.1990.tb08291.x; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dominguez A, 2002, MOL GENET GENOMICS, V267, P544, DOI 10.1007/s00438-002-0688-z; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOBBS SLA, 1990, PLANT MOL BIOL, V15, P851, DOI 10.1007/BF00039425; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Igasaki Tomohiro, 2002, Bulletin of the Forestry and Forest Products Research Institute, V1, P235; Kanazawa A, 2007, PLANT BIOLOGY, V9, P435, DOI 10.1055/s-2006-924633; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kobayashi H, 1998, PLANT SCI, V131, P173, DOI 10.1016/S0168-9452(97)00236-7; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; LAM E, 1990, J BIOL CHEM, V265, P9909; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; MATZKE AJM, 1994, MOL GEN GENET, V244, P219, DOI 10.1007/BF00285449; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; McCabe MS, 1999, THEOR APPL GENET, V99, P587, DOI 10.1007/s001220051272; Mette MF, 2002, EMBO J, V21, P461, DOI 10.1093/emboj/21.3.461; Mishiba K, 2005, PLANT J, V44, P541, DOI 10.1111/j.1365-313X.2005.02556.x; Mishiba K, 2009, BREEDING SCI, V59, P119, DOI 10.1270/jsbbs.59.119; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Nagaya S, 2005, PLANT CELL PHYSIOL, V46, P438, DOI 10.1093/pcp/pci039; Nakatsuka T, 2009, EUPHYTICA, V168, P113, DOI 10.1007/s10681-009-9899-2; NARAYAN RKJ, 1987, PLANT SYST EVOL, V157, P161, DOI 10.1007/BF00936195; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Singh A, 2008, PLANT J, V56, P814, DOI 10.1111/j.1365-313X.2008.03640.x; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; THOMPSON CJ, 1987, EMBO J, V6, P2519, DOI 10.1002/j.1460-2075.1987.tb02538.x; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; VANDERMEER IM, 1990, PLANT MOL BIOL, V15, P95, DOI 10.1007/BF00017727; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wada Y, 2005, PLANT BIOTECHNOL, V22, P71, DOI DOI 10.5511/plantbiotechnology.22.71; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	46	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9670	10.1371/journal.pone.0009670	http://dx.doi.org/10.1371/journal.pone.0009670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351783	Green Submitted, gold, Green Published			2022-12-27	WOS:000275894400006
J	Tizon, B; Sahoo, S; Yu, H; Gauthier, S; Kumar, AR; Mohan, P; Figliola, M; Pawlik, M; Grubb, A; Uchiyama, Y; Bandyopadhyay, U; Cuervo, AM; Nixon, RA; Levy, E				Tizon, Belen; Sahoo, Susmita; Yu, Haung; Gauthier, Sebastien; Kumar, Asok R.; Mohan, Panaiyur; Figliola, Matthew; Pawlik, Monika; Grubb, Anders; Uchiyama, Yasuo; Bandyopadhyay, Urmi; Cuervo, Ana Maria; Nixon, Ralph A.; Levy, Efrat			Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; ONSET ALZHEIMER-DISEASE; ENDOCYTIC PATHWAYS; GENE POLYMORPHISM; BETA-PROTEIN; CATHEPSIN-B; DEATH; INHIBITION; VACUOLES; BRAIN	Cystatin C (CysC) expression in the brain is elevated in human patients with epilepsy, in animal models of neurodegenerative conditions, and in response to injury, but whether up-regulated CysC expression is a manifestation of neurodegeneration or a cellular repair response is not understood. This study demonstrates that human CysC is neuroprotective in cultures exposed to cytotoxic challenges, including nutritional-deprivation, colchicine, staurosporine, and oxidative stress. While CysC is a cysteine protease inhibitor, cathepsin B inhibition was not required for the neuroprotective action of CysC. Cells responded to CysC by inducing fully functional autophagy via the mTOR pathway, leading to enhanced proteolytic clearance of autophagy substrates by lysosomes. Neuroprotective effects of CysC were prevented by inhibiting autophagy with beclin 1 siRNA or 3-methyladenine. Our findings show that CysC plays a protective role under conditions of neuronal challenge by inducing autophagy via mTOR inhibition and are consistent with CysC being neuroprotective in neurodegenerative diseases. Thus, modulation of CysC expression has therapeutic implications for stroke, Alzheimer's disease, and other neurodegenerative disorders.	[Tizon, Belen; Sahoo, Susmita; Gauthier, Sebastien; Kumar, Asok R.; Mohan, Panaiyur; Figliola, Matthew; Pawlik, Monika; Nixon, Ralph A.; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Nixon, Ralph A.; Levy, Efrat] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Levy, Efrat] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Nixon, Ralph A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Yu, Haung] Columbia Univ, Dept Pathol, Taub Inst, New York, NY USA; [Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo, Japan; [Bandyopadhyay, Urmi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol & Med, Bronx, NY 10467 USA	Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Columbia University; Lund University; Skane University Hospital; Juntendo University; Yeshiva University; Albert Einstein College of Medicine	Tizon, B (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Bandyopadhyay, Urmi/A-3944-2015	Bandyopadhyay, Urmi/0000-0003-3438-8923; Gauthier, Sebastien/0000-0002-5692-9260; Grubb, Anders/0000-0002-0125-3662; Yu, Wai Haung/0000-0001-7186-6731; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute on Aging (NIA) [AG017617]; National Institute on Neurological Disorders and Stroke (NINDS) [NS42029]; Alzheimer's Association [IIRG-07-59677]; Swedish Science Research Council [05196]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); Swedish Science Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by the National Institute on Aging (NIA) (AG017617), by the National Institute on Neurological Disorders and Stroke (NINDS) (NS42029), by the Alzheimer's Association IIRG-07-59677, and by the Swedish Science Research Council (05196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bernstein HG, 1996, MOL CHEM NEUROPATHOL, V27, P225, DOI 10.1007/BF02815106; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; BRUNK UT, 1995, FREE RADICAL BIO MED, V19, P813, DOI 10.1016/0891-5849(95)02001-Q; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; GLAUMANN H, 1981, INT REV CYTOL, V73, P149, DOI 10.1016/S0074-7696(08)61288-7; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; HAAN J, 1994, ACTA NEUROL SCAND, V89, P367; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; HALL A, 1993, BIOCHEM J, V291, P123, DOI 10.1042/bj2910123; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HORNUNG JP, 1989, J COMP NEUROL, V283, P425, DOI 10.1002/cne.902830310; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kato T, 2006, P NATL ACAD SCI USA, V103, P6019, DOI 10.1073/pnas.0509789103; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; LAWRENCE BP, 1992, J CELL SCI, V102, P515; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; NITATORI T, 1995, J NEUROSCI, V15, P1001; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Noto D, 2005, INT J CARDIOL, V101, P213, DOI 10.1016/j.ijcard.2004.03.018; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Perry SW, 2004, J NEUROSCI RES, V78, P485, DOI 10.1002/jnr.20272; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pirttila TJ, 2005, NEUROBIOL DIS, V20, P241, DOI 10.1016/j.nbd.2005.03.006; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; SUN Q, 1989, EXP CELL RES, V180, P150, DOI 10.1016/0014-4827(89)90219-X; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; TAVERA C, 1992, BIOCHEM BIOPH RES CO, V182, P1082, DOI 10.1016/0006-291X(92)91842-E; Tizon B., 2006, HDB NEUROCHEMISTRY M; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; VINTERS HV, 1990, AM J PATHOL, V137, P233; Yamada Toshiyuki, 2002, Rinsho Byori, V50, P613; YASUHARA O, 1993, BRAIN RES, V628, P85, DOI 10.1016/0006-8993(93)90941-F; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	72	95	106	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9819	10.1371/journal.pone.0009819	http://dx.doi.org/10.1371/journal.pone.0009819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352108	gold, Green Published			2022-12-27	WOS:000275894400020
J	Huijbers, IJ; Iravani, M; Popov, S; Robertson, D; Al-Sarraj, S; Jones, C; Isacke, CM				Huijbers, Ivo J.; Iravani, Marjan; Popov, Sergey; Robertson, David; Al-Sarraj, Safa; Jones, Chris; Isacke, Clare M.			A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion	PLOS ONE			English	Article							TGF-BETA; MANNOSE RECEPTOR; TRANSMEMBRANE GLYCOPROTEIN; MATRIX; EXPRESSION; BRAIN; GENE; UPARAP/ENDO180; PROLIFERATION; INHIBITOR	Background: Glioblastoma multiforme (GBM, WHO grade IV) is the most common and most malignant of astrocytic brain tumors, and is associated with rapid invasion into neighboring tissue. In other tumor types it is well established that such invasion involves a complex interaction between tumor cells and locally produced extracellular matrix. In GBMs, surprisingly little is known about the associated matrix components, in particular the fibrillar proteins such as collagens that are known to play a key role in the invasion of other tumor types. Methodology/Principal Findings: In this study we have used both the Masson's trichrome staining and a high resolution multiple immunofluorescence labeling method to demonstrate that intratumoral fibrillar collagens are an integral part of the extracellular matrix in a subset of GBMs. Correlated with this collagen deposition we observed high level expression of the collagen-binding receptor Endo180 (CD280) in the tumor cells. Further, interrogation of multiple expression array datasets identified Endo180 as one of the most highly upregulated transcripts in grade IV GBMs compared to grade III gliomas. Using promoter analysis studies we show that this increased expression is, in part, mediated via TGF-beta signaling. Functionally, we demonstrate that Endo180 serves as the major collagen internalization receptor in GBM cell lines and provide the first evidence that this activity is critical for the invasion of GBM cells through fibrillar collagen matrices. Conclusions/Significance: This study demonstrates, for the first time, that fibrillar collagens are extensively deposited in GBMs and that the collagen internalization receptor Endo180 is both highly expressed in these tumors and that it serves to mediate the invasion of tumor cells through collagen-containing matrices. Together these data provide important insights into the mechanism of GBM invasion and identify Endo180 as a potential target to limit matrix turnover by glioma cells and thereby restrict tumor progression.	[Huijbers, Ivo J.; Iravani, Marjan; Robertson, David; Isacke, Clare M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Popov, Sergey; Jones, Chris] Royal Marsden NHS Trust, Inst Canc Res, Sutton, Surrey, England; [Al-Sarraj, Safa] Kings Coll Hosp London, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; King's College Hospital NHS Foundation Trust; King's College Hospital	Huijbers, IJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	clare.isacke@icr.ac.uk	Huijbers, Ivo/I-3229-2019; Jones, Chris/ABE-6059-2021	Jones, Chris/0000-0001-8118-2296; Iravani, Marjan/0000-0002-8620-3073; Isacke, Clare/0000-0002-9222-3345	Breakthrough Breast Cancer [BC06/07]; Royal Marsden NHS Foundation Trust Charity; NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre	Breakthrough Breast Cancer; Royal Marsden NHS Foundation Trust Charity; NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was funded by Breakthrough Breast Cancer BC06/07 (IJH, MI, DR, CMI) and Royal Marsden NHS Foundation Trust Charity (SP). The authors acknowledge NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; CERDANICOLAS M, 1993, ACTA NEUROPATHOL, V85, P349, DOI 10.1007/BF00334444; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; GLADSON CL, 1995, J CELL SCI, V108, P947; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Knott JCA, 1998, INT J CANCER, V75, P864, DOI 10.1002/(SICI)1097-0215(19980316)75:6<864::AID-IJC8>3.0.CO;2-T; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luwor RB, 2008, J CLIN NEUROSCI, V15, P845, DOI 10.1016/j.jocn.2008.01.003; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; Ranuncolo SM, 2002, J SURG ONCOL, V79, P30, DOI 10.1002/jso.10045; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Sheikh H, 2000, J CELL SCI, V113, P1021; Simonavicius N, 2008, MODERN PATHOL, V21, P308, DOI 10.1038/modpathol.3801006; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Williams MJ, 2005, BRAIN RES, V1058, P62, DOI 10.1016/j.brainres.2005.07.078; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zamecnik J, 2004, NEUROPATH APPL NEURO, V30, P338, DOI 10.1046/j.1365-2990.2003.0541.x	44	148	153	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9808	10.1371/journal.pone.0009808	http://dx.doi.org/10.1371/journal.pone.0009808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339555	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300028
J	Lykidis, A; Perez-Pantoja, D; Ledger, T; Mavromatis, K; Anderson, IJ; Ivanova, NN; Hooper, SD; Lapidus, A; Lucas, S; Gonzalez, B; Kyrpides, NC				Lykidis, Athanasios; Perez-Pantoja, Danilo; Ledger, Thomas; Mavromatis, Kostantinos; Anderson, Iain J.; Ivanova, Natalia N.; Hooper, Sean D.; Lapidus, Alla; Lucas, Susan; Gonzalez, Bernardo; Kyrpides, Nikos C.			The Complete Multipartite Genome Sequence of Cupriavidus necator JMP134, a Versatile Pollutant Degrader	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; GENE-CLUSTER; TETRAHYDROFURFURYL ALCOHOL; MICROBIAL-METABOLISM; PLASMID PJP4; NITRIC-OXIDE; DEGRADATION; DEHYDROGENASE; BURKHOLDERIA; ACID	Background: Cupriavidus necator JMP134 is a Gram-negative beta-proteobacterium able to grow on a variety of aromatic and chloroaromatic compounds as its sole carbon and energy source. Methodology/ Principal Findings: Its genome consists of four replicons (two chromosomes and two plasmids) containing a total of 6631 protein coding genes. Comparative analysis identified 1910 core genes common to the four genomes compared (C. necator JMP134, C. necator H16, C. metallidurans CH34, R. solanacearum GMI1000). Although secondary chromosomes found in the Cupriavidus, Ralstonia, and Burkholderia lineages are all derived from plasmids, analyses of the plasmid partition proteins located on those chromosomes indicate that different plasmids gave rise to the secondary chromosomes in each lineage. The C. necator JMP134 genome contains 300 genes putatively involved in the catabolism of aromatic compounds and encodes most of the central ring-cleavage pathways. This strain also shows additional metabolic capabilities towards alicyclic compounds and the potential for catabolism of almost all proteinogenic amino acids. This remarkable catabolic potential seems to be sustained by a high degree of genetic redundancy, most probably enabling this catabolically versatile bacterium with different levels of metabolic responses and alternative regulation necessary to cope with a challenging environment. From the comparison of Cupriavidus genomes, it is possible to state that a broad metabolic capability is a general trait for Cupriavidus genus, however certain specialization towards a nutritional niche (xenobiotics degradation, chemolithoautotrophy or symbiotic nitrogen fixation) seems to be shaped mostly by the acquisition of "specialized" plasmids. Conclusions/Significance: The availability of the complete genome sequence for C. necator JMP134 provides the groundwork for further elucidation of the mechanisms and regulation of chloroaromatic compound biodegradation.	[Lykidis, Athanasios; Mavromatis, Kostantinos; Anderson, Iain J.; Ivanova, Natalia N.; Hooper, Sean D.; Lapidus, Alla; Lucas, Susan; Kyrpides, Nikos C.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Perez-Pantoja, Danilo; Ledger, Thomas; Gonzalez, Bernardo] Pontificia Univ Catolica Chile, NM PFG, NM EMBA,Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago, Chile; [Perez-Pantoja, Danilo; Ledger, Thomas; Gonzalez, Bernardo] Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; [Ledger, Thomas; Gonzalez, Bernardo] Univ Adolfo Ibanez, Fac Ingn & Ciencia, Santiago, Chile	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Adolfo Ibanez	Lykidis, A (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	alykidis@lbl.gov	González, Bernardo/AAW-9578-2021; Lapidus, Alla L/I-4348-2013; Kyrpides, Nikos C./A-6305-2014; Perez-Pantoja, Danilo/ABD-1286-2020; Pérez-Pantoja, Danilo/AAF-4197-2019; Ledger, Thomas/AAO-6775-2021	Lapidus, Alla L/0000-0003-0427-8731; Kyrpides, Nikos C./0000-0002-6131-0462; Pérez-Pantoja, Danilo/0000-0001-5720-2162; Ledger, Thomas/0000-0002-3109-2070; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy's Office of Science; University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]; FONDECYT [1070343]; Millennium Nuclei [P/04-007-F, P/06-009-F]; research program FONDAP [1501-0001];  [PBCT RED-12]	US Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nuclei; research program FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); 	The work presented in this article was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Livermore National Laboratory under contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional support from the FONDECYT grant 1070343; the Millennium Nuclei grants P/04-007-F and P/06-009-F; the research program FONDAP 1501-0001 and the grant PBCT RED-12 is acknowledged. D. P. P. is a CONICYT-DAAD PhD fellow.	Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Barrett CF, 2006, APPL ENVIRON MICROB, V72, P1198, DOI 10.1128/AEM.72.2.1198-1206.2006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; CLEMENT P, 1995, FEMS MICROBIOL LETT, V127, P51, DOI 10.1111/j.1574-6968.1995.tb07449.x; Copley SD, 2003, DEHALOGENATION: MICROBIAL PROCESSES AND ENVIRONMENTAL APPLICATIONS, P227; Cramm R, 1997, J BACTERIOL, V179, P6769, DOI 10.1128/jb.179.21.6769-6777.1997; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; DAUBARAS DL, 1995, APPL ENVIRON MICROB, V61, P1279, DOI 10.1128/AEM.61.4.1279-1289.1995; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; DON RH, 1981, J BACTERIOL, V145, P681, DOI 10.1128/JB.145.2.681-686.1981; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Egland PG, 2000, J BACTERIOL, V182, P100, DOI 10.1128/JB.182.1.100-106.2000; Ensign SA, 1998, ARCH MICROBIOL, V169, P179, DOI 10.1007/s002030050558; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Flavier AB, 1998, MOL MICROBIOL, V28, P475, DOI 10.1046/j.1365-2958.1998.00804.x; Garg RP, 2000, MOL MICROBIOL, V38, P359, DOI 10.1046/j.1365-2958.2000.02131.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; GHOSAL D, 1985, P NATL ACAD SCI USA, V82, P1638, DOI 10.1073/pnas.82.6.1638; Inoue H, 1997, J BACTERIOL, V179, P3956, DOI 10.1128/jb.179.12.3956-3962.1997; ITOH Y, 2007, HISTIDINE CATABOLISM, P371; JANSSEN DB, 2003, BACTERIAL GROWTH HAL, P207; JENNI B, 1988, SYST APPL MICROBIOL, V10, P126, DOI 10.1016/S0723-2020(88)80026-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laemmli CM, 2000, J BACTERIOL, V182, P4165, DOI 10.1128/JB.182.15.4165-4172.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Lu CD, 2004, J BACTERIOL, V186, P3855, DOI 10.1128/JB.186.12.3855-3861.2004; Lu CD, 2001, J BACTERIOL, V183, P490, DOI 10.1128/JB.183.2.490-499.2001; Lugtenberg BJJ, 2002, ANTON LEEUW INT J G, V81, P373, DOI 10.1023/A:1020596903142; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; MASSEY LK, 1976, BACTERIOL REV, V40, P42, DOI 10.1128/MMBR.40.1.42-54.1976; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Muller RH, 1996, APPL ENVIRON MICROB, V62, P147, DOI 10.1128/AEM.62.1.147-151.1996; Muller S, 1999, J BIOTECHNOL, V75, P81, DOI 10.1016/S0168-1656(99)00130-3; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Perez-Pantoja D, 2000, APPL ENVIRON MICROB, V66, P1602, DOI 10.1128/AEM.66.4.1602-1608.2000; Perez-Pantoja D, 2003, J BACTERIOL, V185, P1534, DOI 10.1128/JB.185.5.1534-1542.2003; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Plumeier I, 2002, J BACTERIOL, V184, P4054, DOI 10.1128/JB.184.15.4054-4064.2002; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; Rees E, 1997, APPL ENVIRON MICROB, V63, P800, DOI 10.1128/AEM.63.2.800-802.1997; Reinecke F, 2009, J MOL MICROB BIOTECH, V16, P91, DOI 10.1159/000142897; Revelles O, 2005, J BACTERIOL, V187, P7500, DOI 10.1128/JB.187.21.7500-7510.2005; Santana M, 2001, J BACTERIOL, V183, P687, DOI 10.1128/JB.183.2.687-699.2001; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; SCHLOMANN M, 1990, J BACTERIOL, V172, P5112, DOI 10.1128/jb.172.9.5112-5118.1990; SIDDIQUI RA, 1993, J BACTERIOL, V175, P5867, DOI 10.1128/JB.175.18.5867-5876.1993; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Sluis MK, 2002, J BACTERIOL, V184, P2969, DOI 10.1128/JB.184.11.2969-2977.2002; Stigter ECA, 1997, J MOL CATAL B-ENZYM, V2, P291, DOI 10.1016/S1381-1177(96)00030-6; Stoorvogel J, 1996, EUR J BIOCHEM, V235, P690, DOI 10.1111/j.1432-1033.1996.00690.x; TAYLOR DG, 1980, J GEN MICROBIOL, V118, P159; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Zarnt G, 2001, J BACTERIOL, V183, P1954, DOI 10.1128/JB.183.6.1954-1960.2001; Zarnt G, 1997, APPL ENVIRON MICROB, V63, P4891, DOI 10.1128/AEM.63.12.4891-4898.1997	66	74	359	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9729	10.1371/journal.pone.0009729	http://dx.doi.org/10.1371/journal.pone.0009729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339589	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894300005
J	Arvand, M; Raoult, D; Feil, EJ				Arvand, Mardjan; Raoult, Didier; Feil, Edward J.			Multi-Locus Sequence Typing of a Geographically and Temporally Diverse Sample of the Highly Clonal Human Pathogen Bartonella quintana	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ROCHALIMAEA-QUINTANA; GENETIC-VARIANTS; HENSELAE; ENDOCARDITIS; PCR; IDENTIFICATION; POPULATION; BACTEREMIA; PATIENT	Bartonella quintana is a re-emerging pathogen and the causative agent of a variety of disease manifestations in humans including trench fever. Various typing methods have been developed for B. quintana, but these tend to be limited by poor resolution and, in the case of gel-based methods, a lack of portability. Multilocus sequence typing (MLST) has been used to study the molecular epidemiology of a large number of pathogens, including B. henselae, a close relative of B. quintana. We developed a MLST scheme for B. quintana based on the 7 MLST loci employed for B. henselae with two additional loci to cover underrepresented regions of the B. quintana chromosome. A total of 16 B. quintana isolates spanning over 60 years and three continents were characterized. Allelic variation was detected in five of the nine loci. Although only 8/4270 (0.002%) of the nucleotide sites examined were variable over all loci, these polymorphisms resolved the 16 isolates into seven sequence types (STs). We also demonstrate that MLST can be applied on uncultured isolates by direct PCR from cardiac valve tissue, and suggest this method presents a promising approach for epidemiological studies in this highly clonal organism. Phylogenetic and clustering analyses suggest that two of the seven STs form a distinct lineage within the population.	[Arvand, Mardjan] Ctr Hlth Protect, Hesse State Hlth Off, Dillenburg, Germany; [Raoult, Didier] Univ Mediterranee, IFR 48, CNRS,Unite Rickettsies UMR 6020, Fac Med Marseille, Marseille, France; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Bath	Arvand, M (corresponding author), Ctr Hlth Protect, Hesse State Hlth Off, Dillenburg, Germany.	mardjan.arvand@hlpug.hessen.de	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; ANDERSON B, 1994, J CLIN MICROBIOL, V32, P942, DOI 10.1128/JCM.32.4.942-948.1994; Arvand M, 2006, MICROBES INFECT, V8, P1315, DOI 10.1016/j.micinf.2005.12.015; Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Arvand M, 2007, INT J MED MICROBIOL, V297, P255, DOI 10.1016/j.ijmm.2007.02.001; Berghoff J, 2007, MICROBIOL-SGM, V153, P2045, DOI 10.1099/mic.0.2007/006379-0; Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891; Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06; Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303; DRANCOURT M, 1995, NEW ENGL J MED, V332, P419, DOI 10.1056/NEJM199502163320702; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Foucault C, 2005, J CLIN MICROBIOL, V43, P41, DOI 10.1128/JCM.43.1.41-48.2005; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; Kelly P, 2006, EMERG INFECT DIS, V12, P1869; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; La VD, 2005, EMERG INFECT DIS, V11, P1287, DOI 10.3201/eid1108.050101; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015; Maurin M, 1996, CLIN MICROBIOL REV, V9, P273, DOI 10.1128/CMR.9.3.273; MAURIN M, 1994, J CLIN MICROBIOL, V32, P1166, DOI 10.1128/JCM.32.5.1166-1171.1994; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; MOOSER H, 1948, Schweiz Z Pathol Bakteriol, V11, P513; O'Rourke LG, 2005, EMERG INFECT DIS, V11, P1931, DOI 10.3201/eid1112.030045; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; RODRIGUEZBARRADAS MC, 1995, J CLIN MICROBIOL, V33, P1089, DOI 10.1128/JCM.33.5.1089-1093.1995; ROUX V, 1995, J CLIN MICROBIOL, V33, P1573, DOI 10.1128/JCM.33.6.1573-1579.1995; Sander A, 1999, J CLIN MICROBIOL, V37, P3097, DOI 10.1128/JCM.37.10.3097-3101.1999; Schmidt HU, 1996, EUR J CLIN MICROBIOL, V15, P736, DOI 10.1007/BF01691961; SPACH DH, 1995, NEW ENGL J MED, V332, P424, DOI 10.1056/NEJM199502163320703; Stothard P, 2005, NUCLEIC ACIDS RES, V33, pD317, DOI 10.1093/nar/gki075; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992; Woolley MW, 2007, J CLIN MICROBIOL, V45, P2040, DOI 10.1128/JCM.00175-07; Yerebakan C, 2008, ACTA CARDIOL, V63, P519, DOI 10.2143/AC.63.4.2033053; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101	37	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9765	10.1371/journal.pone.0009765	http://dx.doi.org/10.1371/journal.pone.0009765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333257	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809700009
J	Patarroyo, MA; Bermudez, A; Lopez, C; Yepes, G; Patarroyo, ME				Patarroyo, Manuel A.; Bermudez, Adriana; Lopez, Carolina; Yepes, Gloria; Patarroyo, Manuel E.			3D Analysis of the TCR/pMHCII Complex Formation in Monkeys Vaccinated with the First Peptide Inducing Sterilizing Immunity against Human Malaria	PLOS ONE			English	Article							T-CELL-RECEPTOR; MHC CLASS-II; NEW-WORLD MONKEYS; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; HLA-DR4 DRA-ASTERISK-0101; AOTUS-NANCYMAAE; AMINO-ACIDS; DIVERSITY	T-cell receptor gene rearrangements were studied in Aotus monkeys developing high antibody titers and sterilizing immunity against the Plasmodium falciparum malaria parasite upon vaccination with the modified synthetic peptide 24112, which was identified in the Merozoite Surface Protein 2 (MSP-2) and is known to bind to HLA-DR beta 1*0403 molecules with high capacity. Spectratyping analysis showed a preferential usage of V beta 12 and V beta 6 TCR gene families in 67% of HLA-DR beta 1*0403-like genotyped monkeys. Docking of peptide 24112 into the HLA-DR beta 1*0401-HA peptide-HA1.7TCR complex containing the VDJ rearrangements identified in fully protected monkeys showed a different structural signature compared to nonprotected monkeys. These striking results show the exquisite specificity of the TCR/pMHCII complex formation needed for inducing sterilizing immunity and provide important hints for a logical and rational methodology to develop multiepitopic, minimal subunit-based synthetic vaccines against infectious diseases, among them malaria.	[Patarroyo, Manuel A.; Bermudez, Adriana; Lopez, Carolina; Yepes, Gloria; Patarroyo, Manuel E.] Fdn Inst Inmunol Colombia, Bogota, Cundinamarca, Colombia; [Patarroyo, Manuel A.; Bermudez, Adriana; Lopez, Carolina] Univ Rosario, Bogota, Cundinamarca, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Bogota, Cundinamarca, Colombia	Universidad del Rosario; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia, Bogota, Cundinamarca, Colombia.	mepatarr@mail.com	Bermudez, Adriana/I-7935-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Patarroyo, Manuel A/I-8046-2016; López-Santana, Carolina/L-8580-2016	Bermudez, Adriana/0000-0003-2669-7259; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Patarroyo, Manuel A/0000-0002-4751-2500; López-Santana, Carolina/0000-0003-1313-7607	Asociacion para la Investigacion Solidaria SADAR (Pamplona, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID (Madrid, Spain)	Asociacion para la Investigacion Solidaria SADAR (Pamplona, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID (Madrid, Spain)	This research has been supported by the Asociacion para la Investigacion Solidaria SADAR (Pamplona, Spain 2009) and the Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID (Madrid, Spain 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bentley GA, 1996, ANNU REV IMMUNOL, V14, P563, DOI 10.1146/annurev.immunol.14.1.563; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cifuentes G, 2008, MED CHEM, V4, P278, DOI 10.2174/157340608784325160; Cifuentes G, 2003, J MED CHEM, V46, P2250, DOI 10.1021/jm020440w; Coppel RL, 2009, TRENDS PARASITOL, V25, P205, DOI 10.1016/j.pt.2009.02.006; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Dutta S, 2010, INFECT IMMUN, V78, P661, DOI 10.1128/IAI.00866-09; Favre N, 1998, IMMUNOGENETICS, V48, P253, DOI 10.1007/s002510050429; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kriener K, 2000, IMMUNOGENETICS, V51, P169, DOI 10.1007/s002510050028; Kriener K, 2001, HUM IMMUNOL, V62, P1, DOI 10.1016/S0198-8859(00)00233-0; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lu J, 2004, BLOOD, V103, P4588, DOI 10.1182/blood-2003-11-3959; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Moncada CA, 2005, IMMUNOGENETICS, V57, P42, DOI 10.1007/s00251-004-0758-y; Nino-Vasquez JJ, 2000, IMMUNOGENETICS, V51, P219, DOI 10.1007/s002510050035; Ocampo M, 2000, J PEPT RES, V55, P216, DOI 10.1034/j.1399-3011.2000.00174.x; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Patarroyo ME, 2004, CHEMBIOCHEM, V5, P1588, DOI 10.1002/cbic.200400116; Pico de Coana Y, 2004, CYTOKINE, V27, P129, DOI 10.1016/j.cyto.2004.04.004; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Prato S, 2005, EUR J IMMUNOL, V35, P681, DOI 10.1002/eji.200425771; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; RODRIGUEZ R, 1990, AM J TROP MED HYG, V43, P339, DOI 10.4269/ajtmh.1990.43.339; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0	46	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9771	10.1371/journal.pone.0009771	http://dx.doi.org/10.1371/journal.pone.0009771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333301	Green Published, Green Submitted, gold			2022-12-27	WOS:000275809700010
J	Nijland, R; Burgess, JG; Errington, J; Veening, JW				Nijland, Reindert; Burgess, J. Grant; Errington, Jeff; Veening, Jan-Willem			Transformation of Environmental Bacillus subtilis Isolates by Transiently Inducing Genetic Competence	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COMK; EXPRESSION; PROTOPLASTS; SPORULATION; INITIATION; STRAINS; PROTEIN; CYCLE	Domesticated laboratory strains of Bacillus subtilis readily take up and integrate exogenous DNA. In contrast, "wild'' ancestors or Bacillus strains recently isolated from the environment can only be genetically modified by phage transduction, electroporation or protoplast transformation. Such methods are laborious, have a variable yield or cannot efficiently be used to alter chromosomal DNA. A major disadvantage of using laboratory strains is that they have often lost, or do not display ecologically relevant physiologies such as the ability to form biofilms. Here we present a method that allows genetic transformation by natural competence in several environmental isolates of B. subtilis. Competence in these strains was established by expressing the B. subtilis competence transcription factor ComK from an IPTG-inducible promoter construct present on an unstable plasmid. This transiently activates expression of the genes required for DNA uptake and recombination in the host strain. After transformation, the comK encoding plasmid is lost easily because of its intrinsic instability and the transformed strain returns to its wild state. Using this method, we have successfully generated mutants and introduced foreign DNA into a number of environmental isolates and also B. subtilis strain NCIB3610, which is widely used to study biofilm formation. Application of the same method to strains of B. licheniformis was unsuccessful. The efficient and rapid approach described here may facilitate genetic studies in a wider array of environmental B. subtilis strains.	[Nijland, Reindert; Burgess, J. Grant] Univ Newcastle, Sch Marine Sci & Technol, Dove Marine Lab, N Shields, England; [Errington, Jeff; Veening, Jan-Willem] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Nijland, R (corresponding author), Univ Newcastle, Sch Marine Sci & Technol, Dove Marine Lab, N Shields, England.	rijnland@gmail.com	Nijland, Reindert/B-8206-2008; Errington, Jeff/G-1832-2011	Nijland, Reindert/0000-0003-0049-3768; Errington, Jeff/0000-0002-6977-9388; Veening, Jan-Willem/0000-0002-3162-6634	Intra-European Marie Curie; European Community's [MEIF-CT-2007-039139, PIEF-GA-2008-219592]	Intra-European Marie Curie(European Commission); European Community's(European Commission)	This research was funded by Intra-European Marie Curie Fellowships to JWV and RN from the European Community's Sixth and Seventh Framework Programmes, under grant agreements MEIF-CT-2007-039139 and PIEF-GA-2008-219592, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Duitman EH, 2007, APPL ENVIRON MICROB, V73, P3490, DOI 10.1128/AEM.02751-06; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; ISHIWA H, 1985, JAPANESE J GENETICS, V60, P8; JANDOVA Z, 1987, FOLIA MICROBIOL, V32, P82, DOI 10.1007/BF02877262; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kovacs AT, 2009, ENVIRON MICROBIOL, V11, P1911, DOI 10.1111/j.1462-2920.2009.01937.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; Niu DD, 2007, J IND MICROBIOL BIOT, V34, P357, DOI 10.1007/s10295-007-0204-x; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Romero D, 2006, J MICROBIOL METH, V66, P556, DOI 10.1016/j.mimet.2006.01.005; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Susanna KA, 2006, APPL ENVIRON MICROB, V72, P404, DOI 10.1128/AEM.72.1.404-411.2006; TAVARES P, 1992, J MOL BIOL, V225, P81, DOI 10.1016/0022-2836(92)91027-M; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; Turgay K, 1998, EMBO J, V17, P6730; Ussery DW, 2004, MICROBIOL-SGM, V150, P3519, DOI 10.1099/mic.0.27628-0; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Veening JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/j.1365-2672.2006.02911.x; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0	30	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9724	10.1371/journal.pone.0009724	http://dx.doi.org/10.1371/journal.pone.0009724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300532	gold, Green Published, Green Submitted			2022-12-27	WOS:000275716400022
J	Tibber, M; Saygin, AP; Grant, S; Melmoth, D; Rees, G; Morgan, M				Tibber, Marc; Saygin, Ayse Pinar; Grant, Simon; Melmoth, Dean; Rees, Geraint; Morgan, Michael			The Neural Correlates of Visuospatial Perceptual and Oculomotor Extrapolation	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; ILLUSORY CONTOURS; BOUNDARY COMPLETION; VOLITIONAL SACCADES; FMRI ACTIVATION; GLOBAL SHAPES; ATTENTION; INTERPOLATION; INTEGRATION; MOTION	The human visual system must perform complex visuospatial extrapolations (VSE) across space and time in order to extract shape and form from the retinal projection of a cluttered visual environment characterized by occluded surfaces and moving objects. Even if we exclude the temporal dimension, for instance when judging whether an extended finger is pointing towards one object or another, the mechanisms of VSE remain opaque. Here we investigated the neural correlates of VSE using functional magnetic resonance imaging in sixteen human observers while they judged the relative position of, or saccaded to, a (virtual) target defined by the extrapolated path of a pointer. Using whole brain and region of interest (ROI) analyses, we compared the brain activity evoked by these VSE tasks to similar control judgements or eye movements made to explicit (dot) targets that did not require extrapolation. The data show that activity in an occipitotemporal region that included the lateral occipital cortex (LOC) was significantly greater during VSE than during control tasks. A similar, though less pronounced, pattern was also evident in regions of the fronto-parietal cortex that included the frontal eye fields. However, none of the ROIs examined exhibited a significant interaction between target type (extrapolated/explicit) and response type (oculomotor/perceptual). These findings are consistent with a close association between visuoperceptual and oculomotor responses, and highlight a critical role for the LOC in the process of VSE.	[Tibber, Marc; Saygin, Ayse Pinar; Grant, Simon; Melmoth, Dean; Morgan, Michael] City Univ London, Dept Optometry & Visual Sci, Henry Wellcome Res Labs, London, England; [Saygin, Ayse Pinar; Rees, Geraint; Morgan, Michael] UCL, Inst Cognit Neurosci, London, England; [Saygin, Ayse Pinar; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Saygin, Ayse Pinar] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA	City University London; Wellcome Research Laboratories; University of London; University College London; University of London; University College London; University of California System; University of California San Diego	Tibber, M (corresponding author), City Univ London, Dept Optometry & Visual Sci, Henry Wellcome Res Labs, London, England.	mtibber@yahoo.com	Grant, Simon/H-3939-2019; Rees, Geraint/C-1493-2008; Saygin, Ayse Pinar/A-7126-2009	Rees, Geraint/0000-0002-9623-7007; Saygin, Ayse Pinar/0000-0002-0859-9500; Grant, Simon/0000-0001-6141-538X	Wellcome Trust [079766]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant no. 079766-www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2004, J COGNITIVE NEUROSCI, V16, P794, DOI 10.1162/089892904970825; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Angelucci A, 2002, J NEUROSCI, V22, P8633; Ashida H, 2004, NEUROPSYCHOLOGIA, V42, P1515, DOI 10.1016/j.neuropsychologia.2004.03.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craighero L, 2004, CURR BIOL, V14, P331, DOI 10.1016/j.cub.2004.01.054; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; de'Sperati C, 2006, VISION RES, V46, P2593, DOI 10.1016/j.visres.2005.12.019; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; FIELD D, 2001, VISUAL NEUROSCIENCES, P1069; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottesman CV, 1999, BEHAV RES METH INS C, V31, P86, DOI 10.3758/BF03207697; GREGORY RL, 1972, NATURE, V238, P51, DOI 10.1038/238051a0; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Hess RF, 2001, VISION RES, V41, P1023, DOI 10.1016/S0042-6989(01)00020-7; HIRSCH J, 1995, P NATL ACAD SCI USA, V92, P6469, DOI 10.1073/pnas.92.14.6469; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hoffman JE, 1998, ATTENTION, P119; Hu SY, 2009, EUR J NEUROSCI, V29, P2083, DOI 10.1111/j.1460-9568.2009.06757.x; Intraub H, 2008, PSYCHOL SCI, V19, P1007, DOI 10.1111/j.1467-9280.2008.02192.x; Intraub H, 2008, PERCEPT PSYCHOPHYS, V70, P1337, DOI 10.3758/PP.70.7.1337; Kellman PJ, 2007, PSYCHOL REV, V114, P488, DOI 10.1037/0033-295X.114.2.488; Kellman PJ, 2005, PSYCHOL REV, V112, P586, DOI 10.1037/0033-295X.112.3.586; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KELLMAN PJ, 2001, FRAGMENTS OBJECTS SE, P181; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2005, NEUROIMAGE, V28, P440, DOI 10.1016/j.neuroimage.2005.06.017; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Larsson J, 1999, EUR J NEUROSCI, V11, P4024, DOI 10.1046/j.1460-9568.1999.00805.x; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; Liu LC, 2006, NEUROSCIENCE, V141, P1585, DOI 10.1016/j.neuroscience.2006.04.062; Makin ADJ, 2008, VISION RES, V48, P1884, DOI 10.1016/j.visres.2008.05.023; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; McSorley E, 2005, VISION RES, V45, P2492, DOI 10.1016/j.visres.2005.04.012; McSorley E, 2004, EXP BRAIN RES, V155, P320, DOI 10.1007/s00221-003-1729-5; Melmoth DR, 2009, NEUROPSYCHOLOGIA, V47, P3217, DOI 10.1016/j.neuropsychologia.2009.07.024; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; MINGUZZI GF, 1986, PERCEPTION ILLUSORY, P71; Montaser-Kouhsari L, 2007, J NEUROSCI, V27, P2186, DOI 10.1523/JNEUROSCI.4173-06.2007; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Murray MM, 2004, J NEUROSCI, V24, P6898, DOI 10.1523/JNEUROSCI.1996-04.2004; Neppi-Modona M, 2004, CURR BIOL, V14, P1174, DOI 10.1016/j.cub.2004.06.047; Park S, 2007, NEURON, V54, P335, DOI 10.1016/j.neuron.2007.04.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Predebon J, 2004, PERCEPT MOTOR SKILL, V98, P47; Rauschenberger R, 2006, PSYCHOL SCI, V17, P358, DOI 10.1111/j.1467-9280.2006.01711.x; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Schneider WX, 2002, ATTENTION PERFORM, V19, P609; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Shipley TF, 2003, PERCEPTION, V32, P985, DOI 10.1068/p3420; Singh M, 2005, P NATL ACAD SCI USA, V102, P939, DOI 10.1073/pnas.0408444102; Singh M, 2007, VISION RES, V47, P783, DOI 10.1016/j.visres.2006.11.022; Smith DT, 2004, CURR BIOL, V14, P792, DOI 10.1016/j.cub.2004.04.035; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tibber MS, 2008, INVEST OPHTH VIS SCI, V49, P474, DOI 10.1167/iovs.07-0921; Tibber MS, 2009, J VISION, V9, DOI 10.1167/9.12.21; Tibber MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004585; TIBBER MS, 2008, J VIS, V8; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WATT RJ, 1984, VISION RES, V24, P1377, DOI 10.1016/0042-6989(84)90193-7	81	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9664	10.1371/journal.pone.0009664	http://dx.doi.org/10.1371/journal.pone.0009664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300627	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000275621000004
J	Roed, C; Omland, LH; Engsig, FN; Skinhoj, P; Obel, N				Roed, Casper; Omland, Lars Haukali; Engsig, Frederik Neess; Skinhoj, Peter; Obel, Niels			Long-Term Mortality in Patients Diagnosed with Meningococcal Disease: A Danish Nationwide Cohort Study	PLOS ONE			English	Article							BACTERIAL-MENINGITIS	Background: In contrast to the case fatality rate of patients diagnosed with meningococcal disease (MD) the long-term mortality in these patients is poorly documented. Methodology/Principal Findings: We performed a nationwide, population-based cohort study including all Danish patients diagnosed with MD from 1977 through 2006 and alive one year after diagnosis. Data was retrieved from the Danish National Hospital Register, the Danish Civil Registration System and the Danish Register of Causes of Death. For each patient four age-and gender-matched individuals were identified from the population cohort. The siblings of the MD patients and of the individuals from the population cohort were identified. We constructed Kaplan-Meier survival curves and used Cox regression analysis, cumulative incidence function and subdistribution hazard regression to estimate mortality rate ratios (MRR) and analyze causes of death. We identified 4,909 MD patients, 19,636 individuals from the population cohort, 8,126 siblings of MD patients and 31,140 siblings of the individuals from the population cohort. The overall MRR for MD patients was 1.27 (95% confidence interval (CI), 1.12-1.45), adjusted MRR, 1.21 (95% CI, 1.06-1.37). MD was associated with increased risk of death due to nervous system diseases (MRR 3.57 (95% CI, 1.82-7.00). No increased mortality due to infections, neoplasms or cardiovascular diseases was observed. The MRR for siblings of MD patients compared with siblings of the individuals from the population cohort was 1.17 (95% CI, 0.92-1.48). Conclusions: Patients surviving the acute phase of MD have increased long-term mortality, but the excess risk of death is small and stems mainly from nervous system diseases.	[Roed, Casper; Omland, Lars Haukali; Engsig, Frederik Neess; Skinhoj, Peter; Obel, Niels] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Roed, C (corresponding author), Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	casper.roed@rh.regionh.dk	Engsig, Frederik/GWM-4899-2022	Roed, Casper/0000-0001-8987-5230; Omland, Lars Haukali/0000-0002-5338-8948; Obel, Niels/0000-0002-5031-0045	Research Foundation at Copenhagen University Hospital, Rigshospitalet; Faculty of Health Science, Copenhagen University	Research Foundation at Copenhagen University Hospital, Rigshospitalet; Faculty of Health Science, Copenhagen University	The study was financed by The Research Foundation at Copenhagen University Hospital, Rigshospitalet and by The Faculty of Health Science, Copenhagen University. The funders had no role in the study design; in the collection, management, analysis, and interpretation of data; in the preparation, review, or approval of the manuscript, or in the decision to submit the article for publication.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], POPULATIONS ELECTION; Buysse CMP, 2008, ARCH PEDIAT ADOL MED, V162, P1036, DOI 10.1001/archpedi.162.11.1036; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hansen ABE, 2007, J INFECT DIS, V195, P230, DOI 10.1086/510246; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; HOGASEN K, 1993, SCAND J IMMUNOL, V37, P487, DOI 10.1111/j.1365-3083.1993.tb03323.x; Howitz M, 2009, EPIDEMIOL INFECT, V137, P1631, DOI 10.1017/S0950268809002428; Howitz MF, 2008, EPIDEMIOL INFECT, V136, P1088, DOI 10.1017/S0950268807009466; Juel K, 1999, DAN MED BULL, V46, P354; KJERSEM H, 1986, INFECTION, V14, P55, DOI 10.1007/BF01644442; Kleinbaum D, 2005, SURVIVAL ANAL SELF L, P391, DOI DOI 10.1007/0-387-29150-4; RIORDAN FAI, 1995, EUR J PEDIATR, V154, P472; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SAMUELSSON S, 1999, THESIS U SO DENMARK; Sorensen H T, 1995, Int J Risk Saf Med, V7, P179, DOI 10.3233/JRS-1995-7303; Sorensen HT, 1998, J CLIN EPIDEMIOL, V51, P717, DOI 10.1016/S0895-4356(98)00064-X; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	20	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9662	10.1371/journal.pone.0009662	http://dx.doi.org/10.1371/journal.pone.0009662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300639	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900003
J	Bragg, JG; Dutkiewicz, S; Jahn, O; Follows, MJ; Chisholm, SW				Bragg, Jason G.; Dutkiewicz, Stephanie; Jahn, Oliver; Follows, Michael J.; Chisholm, Sallie W.			Modeling Selective Pressures on Phytoplankton in the Global Ocean	PLOS ONE			English	Article							PROCHLOROCOCCUS ECOTYPES; MARINE SYNECHOCOCCUS; NITROGEN; BIOGEOGRAPHY; LINEAGES; DYNAMICS; GENOME; FORMS	Our view of marine microbes is transforming, as culture-independent methods facilitate rapid characterization of microbial diversity. It is difficult to assimilate this information into our understanding of marine microbe ecology and evolution, because their distributions, traits, and genomes are shaped by forces that are complex and dynamic. Here we incorporate diverse forces-physical, biogeochemical, ecological, and mutational-into a global ocean model to study selective pressures on a simple trait in a widely distributed lineage of picophytoplankton: the nitrogen use abilities of Synechococcus and Prochlorococcus cyanobacteria. Some Prochlorococcus ecotypes have lost the ability to use nitrate, whereas their close relatives, marine Synechococcus, typically retain it. We impose mutations for the loss of nitrogen use abilities in modeled picophytoplankton, and ask: in which parts of the ocean are mutants most disadvantaged by losing the ability to use nitrate, and in which parts are they least disadvantaged? Our model predicts that this selective disadvantage is smallest for picophytoplankton that live in tropical regions where Prochlorococcus are abundant in the real ocean. Conversely, the selective disadvantage of losing the ability to use nitrate is larger for modeled picophytoplankton that live at higher latitudes, where Synechococcus are abundant. In regions where we expect Prochlorococcus and Synechococcus populations to cycle seasonally in the real ocean, we find that model ecotypes with seasonal population dynamics similar to Prochlorococcus are less disadvantaged by losing the ability to use nitrate than model ecotypes with seasonal population dynamics similar to Synechococcus. The model predictions for the selective advantage associated with nitrate use are broadly consistent with the distribution of this ability among marine picocyanobacteria, and at finer scales, can provide insights into interactions between temporally varying ocean processes and selective pressures that may be difficult or impossible to study by other means. More generally, and perhaps more importantly, this study introduces an approach for testing hypotheses about the processes that underlie genetic variation among marine microbes, embedded in the dynamic physical, chemical, and biological forces that generate and shape this diversity.	[Bragg, Jason G.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Dutkiewicz, Stephanie; Jahn, Oliver; Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bragg, JG (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	mick@mit.edu; chisholm@mit.edu	Bragg, Jason/P-7675-2019; Bragg, Jason G/A-4473-2012; Bragg, Jason/R-5611-2016; Follows, Michael/G-9824-2011	Bragg, Jason/0000-0002-7621-7295; Bragg, Jason G/0000-0003-0093-4981; Bragg, Jason/0000-0002-7621-7295; Jahn, Oliver/0000-0002-0130-5186; Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foudation; United States Department of Energy; Center for Microbial Oceanography; United States National Science Foundation	Gordon and Betty Moore Foudation; United States Department of Energy(United States Department of Energy (DOE)); Center for Microbial Oceanography; United States National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the Gordon and Betty Moore Foudation, the United States Department of Energy, and the Center for Microbial Oceanography: Research and Education and Biological Oceanography Programs of the United States National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2006, APPL ENVIRON MICROB, V72, P7193, DOI 10.1128/AEM.00358-06; Aiken J, 2000, PROG OCEANOGR, V45, P257, DOI 10.1016/S0079-6611(00)00005-7; Casey JR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028725; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P685, DOI 10.4319/lo.1967.12.4.0685; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; EPPLEY RW, 1969, LIMNOL OCEANOGR, V14, P194, DOI 10.4319/lo.1969.14.2.0194; Flynn KJ, 1997, PHILOS T ROY SOC B, V352, P1625, DOI 10.1098/rstb.1997.0145; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Garcia-Fernandez JM, 2004, MICROBIOL MOL BIOL R, V68, P630, DOI 10.1128/MMBR.68.4.630-638.2004; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Ludwig CA, 1938, AM J BOT, V25, P448, DOI 10.2307/2436419; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Miller SR, 2001, APPL ENVIRON MICROB, V67, P3002, DOI 10.1128/AEM.67.7.3002-3009.2001; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Salihoglu B, 2007, J MAR RES, V65, P219; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; WROBLEWSKI JS, 1977, J MAR RES, V35, P357; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	31	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9569	10.1371/journal.pone.0009569	http://dx.doi.org/10.1371/journal.pone.0009569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224766	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800010
J	McCollum, ED; Preidis, GA; Kabue, MM; Singogo, EBM; Mwansambo, C; Kazembe, PN; Kline, MW				McCollum, Eric D.; Preidis, Geoffrey A.; Kabue, Mark M.; Singogo, Emmanuel B. M.; Mwansambo, Charles; Kazembe, Peter N.; Kline, Mark W.			Task Shifting Routine Inpatient Pediatric HIV Testing Improves Program Outcomes in Urban Malawi: A Retrospective Observational Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; INFECTED MOTHERS; FREE SURVIVAL; MORTALITY; INFANTS; CARE; PREVENTION; AIDS	Background: This study evaluated two models of routine HIV testing of hospitalized children in a high HIV-prevalence resource-constrained African setting. Both models incorporated "task shifting,'' or the allocation of tasks to the least-costly, capable health worker. Methods and Findings: Two models were piloted for three months each within the pediatric department of a referral hospital in Lilongwe, Malawi between January 1 and June 30, 2008. Model 1 utilized lay counselors for HIV testing instead of nurses and clinicians. Model 2 further shifted program flow and advocacy responsibilities from counselors to volunteer parents of HIV-infected children, called "patient escorts.'' A retrospective review of data from 6318 hospitalized children offered HIV testing between January-December 2008 was conducted. The pilot quarters of Model 1 and Model 2 were compared, with Model 2 selected to continue after the pilot period. There was a 2-fold increase in patients offered HIV testing with Model 2 compared with Model 1 (43.1% vs 19.9%, p < 0.001). Furthermore, patients in Model 2 were younger (17.3 vs 26.7 months, p < 0.001) and tested sooner after admission (1.77 vs 2.44 days, p < 0.001). There were no differences in test acceptance or enrollment rates into HIV care, and the program trends continued 6 months after the pilot period. Overall, 10244 HIV antibody tests (4779 maternal; 5465 child) and 453 DNA-PCR tests were completed, with 97.8% accepting testing. 19.6% of all mothers (n = 1112) and 8.5% of all children (n = 525) were HIV-infected. Furthermore, 6.5% of children were HIV-exposed (n = 405). Cumulatively, 72.9% (n = 678) of eligible children were evaluated in the hospital by a HIV-trained clinician, and 68.3% (n = 387) successfully enrolled into outpatient HIV care. Conclusions/Significance: The strategy presented here, task shifting from lay counselors alone to lay counselors and patient escorts, greatly improved program outcomes while only marginally increasing operational costs. The wider implementation of this strategy could accelerate pediatric HIV care access in high-prevalence settings.	[McCollum, Eric D.] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Lilongwe, Malawi; [Preidis, Geoffrey A.] Baylor Coll Med, Dept Pediat, Interdepartmental Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Kabue, Mark M.; Singogo, Emmanuel B. M.; Kazembe, Peter N.] Baylor Coll Med, Baylor Childrens Fdn Malawi, Lilongwe, Malawi; [Mwansambo, Charles] Kamuzu Cent Hosp, Dept Pediat, Lilongwe, Malawi; [Kline, Mark W.] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	McCollum, ED (corresponding author), Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Lilongwe, Malawi.	ericdmccollum@gmail.com	McCollum, Eric D./AAE-7120-2020; Kabue, Mark/ABD-3878-2021; Preidis, Geoffrey A./W-5538-2019	Kabue, Mark/0000-0002-4918-5558; Preidis, Geoffrey A./0000-0002-2206-6452; Singogo, Emmanuel/0000-0002-2015-335X	Baylor International Pediatric AIDS Initiative (BIPAI); Abbott Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	Baylor International Pediatric AIDS Initiative (BIPAI); Abbott Fund(Abbott Laboratories); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the PITC program and operational study was provided by Baylor International Pediatric AIDS Initiative (BIPAI) and the Abbott Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Cockcroft Anne, 2007, BMC Int Health Hum Rights, V7, P5, DOI 10.1186/1472-698X-7-5; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Diaz C, 1998, J ACQ IMMUN DEF SYND, V18, P221, DOI 10.1097/00042560-199807010-00004; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Fox MP, 2009, INT J EPIDEMIOL, V38, P569, DOI 10.1093/ije/dyn249; GEUBBELS E, 2006, MALAWI MED J, V3, P99; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kline MW, 2009, PEDIATRICS, V123, P134, DOI 10.1542/peds.2008-0402; Kline MW, 2006, PEDIATRICS, V117, P1388, DOI 10.1542/peds.2005-1348; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006059; Kuhn L, 2009, CURR OPIN PEDIATR, V21, P83, DOI 10.1097/MOP.0b013e328320d894; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; McPake B, 2008, LANCET, V372, P870, DOI 10.1016/S0140-6736(08)61375-6; *MIN HLTH MAL HIV, 2008, GUID PAED HIV TEST C; *MIN HLTH MAL HIV, 2008, ANN REP HIV UN 2008; Mofenson LM, 2009, JAIDS-J ACQ IMM DEF, V52, P305, DOI 10.1097/QAI.0b013e3181bbfe14; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Rogerson SR, 2004, T ROY SOC TROP MED H, V98, P544, DOI 10.1016/j.trstmh.2003.12.011; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; Spensley A, 2009, AM J PUBLIC HEALTH, V99, P631, DOI 10.2105/AJPH.2007.114421; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; TOVO PA, 1992, LANCET, V339, P1249, DOI 10.1016/0140-6736(92)91592-V; United Nations Children's Fund/ United Nations Programme on HIV/ AIDS/ World Health Organiza-tion/ United Nations Population Fund (UNICEF/ UNAIDS/ WHO/ UNFPA), 2008, CHILDR AIDS 3 STOCKT; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Waxman MJ, 2007, AIDS PATIENT CARE ST, V21, P981, DOI 10.1089/apc.2007.0075; Weigel R, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-80; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization, 2007, GUID PROV IN HIV TES; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	46	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9626	10.1371/journal.pone.0009626	http://dx.doi.org/10.1371/journal.pone.0009626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224782	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328800021
J	Shyu, C; Brown, CJ; Ytreberg, FM				Shyu, Conrad; Brown, Celeste J.; Ytreberg, F. Marty			Computational Study of Evolutionary Selection Pressure on Rainbow Trout Estrogen Receptors	PLOS ONE			English	Article							THERMODYNAMIC INTEGRATION; CRYSTALLOGRAPHY; SIMULATIONS; MECHANICS; EFFICIENT; ALPHA	Molecular dynamics simulations were used to determine the binding affinities between the hormone 17 beta-estradiol (E2) and different estrogen receptor (ER) isoforms in the rainbow trout, Oncorhynchus mykiss. Previous phylogenetic analysis indicates that a whole genome duplication prior to the divergence of ray-finned fish led to two distinct ER beta isoforms, ER beta 1 and ER beta 2, and the recent whole genome duplication in the ancestral salmonid created two ER alpha isoforms, ER alpha 1 and ER alpha 2. The objective of our computational studies is to provide insight into the underlying evolutionary pressures on these isoforms. For the ER alpha subtype our results show that E2 binds preferentially to ER alpha 1 over ER alpha 2. Tests of lineage specific dN/dS ratios indicate that the ligand binding domain of the ER alpha 2 gene is evolving under relaxed selection relative to all other ER alpha genes. Comparison with the highly conserved DNA binding domain suggests that ER alpha 2 may be undergoing neofunctionalization possibly by binding to another ligand. By contrast, both ER beta 1 and ER beta 2 bind similarly to E2 and the best fitting model of selection indicates that the ligand binding domain of all ERb genes are evolving under the same level of purifying selection, comparable to ER alpha 1.	[Shyu, Conrad; Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Brown, Celeste J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Shyu, C (corresponding author), Univ Idaho, Dept Phys, Moscow, ID USA.	ytreberg@uidaho.edu			Idaho NSF-EPSCoR; IBEST ( Initiative for Bioinformatics and Evolutionary Studies); NIH/NCRR [P20RR16448, P20RR016454]; BANTech; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448, P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM083827] Funding Source: NIH RePORTER	Idaho NSF-EPSCoR; IBEST ( Initiative for Bioinformatics and Evolutionary Studies); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BANTech; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Idaho NSF-EPSCoR (http://www.webs.uidaho.edu/epscor) and the IBEST ( Initiative for Bioinformatics and Evolutionary Studies) (http://www.ibest.uidaho.edu/home/home.php) at the University of Idaho. F. M. Y. and C. J. B. were supported by NIH/NCRR P20RR16448 and P20RR016454. Additional funding was provided by BANTech (http://www.phys.uidaho.edu/bantech) at the University of Idaho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Allendorf F.W., 1984, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Berendsen H., 1981, INTERMOLECULAR FORCE; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Broyden C. G., 1970, J I MATH ITS APPL, V6, P76, DOI [10.1093/imamat/6.1.76, DOI 10.1093/IMAMAT/6.1.76]; Chipot C., 2007, SPRINGER SERIES CHEM; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; DREAN Y, 1995, MOL CEL ENDORINOL, V109, P27; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; MITCHELL MJ, 1991, J COMPUT CHEM, V12, P271, DOI 10.1002/jcc.540120218; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030; Nagler JJ, 2000, J MOL ENDOCRINOL, V25, P243, DOI 10.1677/jme.0.0250243; Pakdel F, 2000, ENDOCRINOLOGY, V141, P571, DOI 10.1210/en.141.2.571; PETIT F, 1995, EUR J BIOCHEM, V233, P584, DOI 10.1111/j.1432-1033.1995.584_2.x; Ruff M, 2000, BREAST CANCER RES, V2, P353, DOI 10.1186/bcr80; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shirts MR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873592; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Shyu C, 2009, J COMPUT CHEM, V30, P2297, DOI 10.1002/jcc.21231; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	35	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9392	10.1371/journal.pone.0009392	http://dx.doi.org/10.1371/journal.pone.0009392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231885	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300003
J	Zhong, JX; Yang, P; Muta, K; Dong, R; Marrero, M; Gong, FL; Wang, CY				Zhong, Jixin; Yang, Ping; Muta, Kenjiro; Dong, Robert; Marrero, Mario; Gong, Feili; Wang, Cong-Yi			Loss of Jak2 Selectively Suppresses DC-Mediated Innate Immune Response and Protects Mice from Lethal Dose of LPS-Induced Septic Shock	PLOS ONE			English	Article							DENDRITIC CELL-DIFFERENTIATION; LISTERIA-MONOCYTOGENES; ADAPTIVE IMMUNITY; T-CELLS; MYELOID DIFFERENTIATION; CYTOKINE RECEPTORS; IL-2 PRODUCTION; SEVERE SEPSIS; IN-VIVO; INFECTION	Given the importance of Jak2 in cell signaling, a critical role for Jak2 in immune cells especially dendritic cells (DCs) has long been proposed. The exact function for Jak2 in DCs, however, remained poorly understood as Jak2 deficiency leads to embryonic lethality. Here we established Jak2 deficiency in adult Cre(+/+) Jak2(fl/fl) mice by tamoxifen induction. Loss of Jak2 significantly impaired DC development as manifested by reduced BMDC yield, smaller spleen size and reduced percentage of DCs in total splenocytes. Jak2 was also crucial for the capacity of DCs to mediate innate immune response. Jak2(-/) DCs were less potent in response to inflammatory stimuli and showed reduced capacity to secrete proinflammatory cytokines such as TNF alpha and IL-12. As a result, Jak2(-/-) mice were defective for the early clearance of Listeria after infection. However, their potency to mediate adaptive immune response was not affected. Unlike DCs, Jak2(-/-) macrophages showed similar capacity secretion of proinflammatory cytokines, suggesting that Jak2 selectively modulates innate immune response in a DC-dependent manner. Consistent with these results, Jak2(-/-) mice were remarkably resistant to lethal dose of LPS-induced septic shock, a deadly sepsis characterized by the excessive innate immune response, and adoptive transfer of normal DCs restored their susceptibility to LPS-induced septic shock. Mechanistic studies revealed that Jak2/SATA5 signaling is pivotal for DC development and maturation, while the capacity for DCs secretion of proinflammatory cytokines is regulated by both Jak2/STAT5 and Jak2/STAT6 signaling.	[Zhong, Jixin; Gong, Feili] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China; [Zhong, Jixin; Yang, Ping; Dong, Robert; Wang, Cong-Yi] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Yang, Ping] Huazhong Univ Sci & Technol, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China; [Muta, Kenjiro; Marrero, Mario] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA	Huazhong University of Science & Technology; University System of Georgia; Augusta University; Huazhong University of Science & Technology; University System of Georgia; Augusta University	Zhong, JX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China.	flgong@163.com; cwang@mcg.edu	Zhong, Jixin/ABE-3768-2020; Zhong, Jixin/G-5355-2012; Zhong, Jixin/A-3077-2012	Wang, Cong-Yi/0000-0001-7914-168X; Zhong, Jixin/0000-0002-3534-7480	Juvenile Diabetes Research Foundation (JDRF) [1-2007-181, 1-2007-192]; NIH/NIDDK [DK074957]; National Key Basic Research Program of China [2007CB512402]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074957] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Juvenile Diabetes Research Foundation (JDRF, 1-2007-181 and 1-2007-192) and NIH/NIDDK (DK074957) to CYW, and supported in part by the National Key Basic Research Program of China (2007CB512402) to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Carrillo-Esper Raul, 2003, Cir Cir, V71, P252; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Chiang PH, 2004, J IMMUNOL, V172, P1355, DOI 10.4049/jimmunol.172.3.1355; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Das UN, 2000, CRIT CARE, V4, P290, DOI 10.1186/cc711; Efron P, 2003, SHOCK, V20, P386, DOI 10.1097/01.SHK.0000092698.10326.6f; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Ferguson NR, 1999, INTENS CARE MED, V25, P106, DOI 10.1007/s001340050795; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Han JY, 2008, DIABETES, V57, P2118, DOI 10.2337/db07-1499; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Heymann WR, 2007, J AM ACAD DERMATOL, V57, P700, DOI 10.1016/j.jaad.2007.04.020; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; KHWANNIMIT B, 2009, EPIDEMIOL INFECT, P1; Kumar R, 1997, CANCER BIOTHER RADIO, V12, P333, DOI 10.1089/cbr.1997.12.333; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Lang CH, 2005, PEDIATR NEPHROL, V20, P306, DOI 10.1007/s00467-004-1607-9; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Nelson DP, 2009, AM J NURS, V109, P40, DOI 10.1097/01.NAJ.0000346928.90369.10; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Park WR, 2001, EUR J IMMUNOL, V31, P1456, DOI 10.1002/1521-4141(200105)31:5<1456::AID-IMMU1456>3.0.CO;2-A; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; RANE SG, 1994, ONCOGENE, V9, P2415; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sakr Y, 2007, SHOCK, V28, P636, DOI 10.1097/shk.0b013e3180cab855; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Sayyah J, 2009, CURR ONCOL REP, V11, P117, DOI 10.1007/s11912-009-0018-2; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shasby DM, 2004, AM J RESP CRIT CARE, V169, P144, DOI 10.1164/rccm.2311003; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Warner EA, 2008, FUTURE MICROBIOL, V3, P177, DOI 10.2217/17460913.3.2.177; Watanabe S, 1996, CURR OPIN GENET DEV, V6, P587, DOI 10.1016/S0959-437X(96)80088-8; Wen HT, 2008, J LEUKOCYTE BIOL, V83, P439, DOI 10.1189/jlb.0607357; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05; Yu G, 2008, J GENE MED, V10, P754, DOI 10.1002/jgm.1201	58	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9593	10.1371/journal.pone.0009593	http://dx.doi.org/10.1371/journal.pone.0009593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231889	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300011
J	Excoffon, KJDA; Gansemer, ND; Mobily, ME; Karp, PH; Parekh, KR; Zabner, J				Excoffon, Katherine J. D. A.; Gansemer, Nicholas D.; Mobily, Matthew E.; Karp, Philip H.; Parekh, Kalpaj R.; Zabner, Joseph			Isoform-Specific Regulation and Localization of the Coxsackie and Adenovirus Receptor in Human Airway Epithelia	PLOS ONE			English	Article							FIBROSIS TRANSMEMBRANE REGULATOR; HISTONE DEACETYLASE INHIBITOR; MEDIATED GENE-TRANSFER; CYSTIC-FIBROSIS; B VIRUS; BINDING AFFINITIES; TIGHT JUNCTIONS; APICAL SURFACE; CAR; DOMAIN	Adenovirus is an important respiratory pathogen. Adenovirus fiber from most serotypes co-opts the Coxsackie-Adenovirus Receptor (CAR) to bind and enter cells. However, CAR is a cell adhesion molecule localized on the basolateral membrane of polarized epithelia. Separation from the lumen of the airways by tight junctions renders airway epithelia resistant to inhaled adenovirus infection. Although a role for CAR in viral spread and egress has been established, the mechanism of initial respiratory infection remains controversial. CAR exists in several protein isoforms including two transmembrane isoforms that differ only at the carboxy-terminus (CAR(Ex7) and CAR(Ex8)). We found low-level expression of the CAR(Ex8) isoform in well-differentiated human airway epithelia. Surprisingly, in contrast to CAR(Ex7), CAR(Ex8) localizes to the apical membrane of epithelia where it augments adenovirus infection. Interestingly, despite sharing a similar class of PDZ-binding domain with CAR(Ex7), CAR(Ex8) differentially interacts with PICK1, PSD-95, and MAGI-1b. MAGI-1b appears to stoichiometrically regulate the degradation of CAR(Ex8) providing a potential mechanism for the apical localization of CAR(Ex8) in airway epithelial. In summary, apical localization of CAR(Ex8) may be responsible for initiation of respiratory adenoviral infections and this localization appears to be regulated by interactions with PDZ-domain containing proteins.	[Excoffon, Katherine J. D. A.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Gansemer, Nicholas D.; Mobily, Matthew E.; Karp, Philip H.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Parekh, Kalpaj R.] Univ Iowa, Dept Cardiothorac Surg, Iowa City, IA USA	University System of Ohio; Wright State University Dayton; University of Iowa; University of Iowa	Excoffon, KJDA (corresponding author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.	joseph-zabner@uiowa.edu	Parekh, Kalpaj/E-4966-2012; Excoffon, Katherine/ABC-5037-2021	Parekh, Kalpaj/0000-0001-6869-5441; Excoffon, Katherine/0000-0003-3945-0298; Zabner, Joseph/0000-0002-9606-1339	NIH [HL51670-11]; Roy J. Carver Charitable Trust; NHLBI; CFF; NIDDK; National Heart, Lung and Blood Institute; NIDDK [DK54759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Charitable Trust; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CFF; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a PPG grant from the NIH (HL51670-11). The Gene Transfer Vector Core is supported by the Roy J. Carver Charitable Trust, the NHLBI, CFF, and NIDDK. The In Vitro Cell Models Core is supported by the National Heart, Lung and Blood Institute and NIDDK [DK54759]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Bernal RM, 2002, CLIN CANCER RES, V8, P1915; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dorner A, 2006, J MOL MED, V84, P842, DOI 10.1007/s00109-006-0076-y; Dorner A, 2004, J BIOL CHEM, V279, P18497, DOI 10.1074/jbc.M311754200; Excoffon KJDA, 2007, J VIROL, V81, P5573, DOI 10.1128/JVI.02562-06; Excoffon KJDA, 2005, AM J RESP CELL MOL, V32, P498, DOI 10.1165/rcmb.2005-0031OC; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Excoffon KJDA, 2003, J VIROL, V77, P2559, DOI 10.1128/JVI.77.4.2559-2567.2003; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Goodfellow IG, 2005, J VIROL, V79, P12016, DOI 10.1128/JVI.79.18.12016-12024.2005; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kitazono M, 2001, CANCER RES, V61, P6328; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Pong RC, 2006, CANCER RES, V66, P8822, DOI 10.1158/0008-5472.CAN-05-4672; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Reimer D, 2007, INT J CANCER, V120, P2568, DOI 10.1002/ijc.22580; Segura-Pacheco Blanca, 2007, Genet Vaccines Ther, V5, P10, DOI 10.1186/1479-0556-5-10; Shaw CA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-42; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Thoelen I, 2001, BIOCHEM BIOPH RES CO, V287, P216, DOI 10.1006/bbrc.2001.5535; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Van't Hof W, 2001, HUM GENE THER, V12, P25, DOI 10.1089/104303401450933; Walters RW, 2001, J VIROL, V75, P7703, DOI 10.1128/JVI.75.16.7703-7711.2001; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Yanagawa B, 2004, J INFECT DIS, V189, P1431, DOI 10.1086/382598; Zabner J, 1996, GENE THER, V3, P458; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	45	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9909	10.1371/journal.pone.0009909	http://dx.doi.org/10.1371/journal.pone.0009909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361046	gold, Green Published			2022-12-27	WOS:000275969600015
J	Diedrich, CR; Mattila, JT; Klein, E; Janssen, C; Phuah, J; Sturgeon, TJ; Montelaro, RC; Lin, PL; Flynn, JL				Diedrich, Collin R.; Mattila, Joshua T.; Klein, Edwin; Janssen, Chris; Phuah, Jiayao; Sturgeon, Timothy J.; Montelaro, Ronald C.; Lin, Philana Ling; Flynn, JoAnne L.			Reactivation of Latent Tuberculosis in Cynomolgus Macaques Infected with SIV Is Associated with Early Peripheral T Cell Depletion and Not Virus Load	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HIV-1 REPLICATION; DISEASE PROGRESSION; LYMPHOID-TISSUES; MACROPHAGES; EXPRESSION; VACCINE; MANIFESTATIONS	HIV-infected individuals with latent Mycobacterium tuberculosis (Mtb) infection are at significantly greater risk of reactivation tuberculosis (TB) than HIV-negative individuals with latent TB, even while CD4 T cell numbers are well preserved. Factors underlying high rates of reactivation are poorly understood and investigative tools are limited. We used cynomolgus macaques with latent TB co-infected with SIVmac251 to develop the first animal model of reactivated TB in HIV-infected humans to better explore these factors. All latent animals developed reactivated TB following SIV infection, with a variable time to reactivation (up to 11 months post-SIV). Reactivation was independent of virus load but correlated with depletion of peripheral T cells during acute SIV infection. Animals experiencing reactivation early after SIV infection (<17 weeks) had fewer CD4 T cells in the periphery and airways than animals reactivating in later phases of SIV infection. Co-infected animals had fewer T cells in involved lungs than SIV-negative animals with active TB despite similar T cell numbers in draining lymph nodes. Granulomas from these animals demonstrated histopathologic characteristics consistent with a chronically active disease process. These results suggest initial T cell depletion may strongly influence outcomes of HIV-Mtb co-infection.	[Diedrich, Collin R.; Mattila, Joshua T.; Phuah, Jiayao; Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Klein, Edwin; Janssen, Chris] Univ Pittsburgh, Sch Med, Div Lab Anim Resources, Pittsburgh, PA 15213 USA; [Sturgeon, Timothy J.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15213 USA; [Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Diedrich, CR (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA.	joanne@pitt.edu	Flynn, JoAnne/ABC-7371-2020	Diedrich, Collin/0000-0002-7635-9699; , Joshua/0000-0002-6384-1291; Phuah, Jia Yao/0000-0003-2240-536X	NIH [RO1 HL075845-04, T32 AI060525-05, F32AI077183-01A1]; Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525, F32AI077183, R01AI050732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIH (RO1 HL075845-04 [JLF], T32 AI060525-05 [JLF, supporting CRD]), F32AI077183-01A1 [JTM]) and the Heiser Program for Research in Leprosy and Tuberculosis (JTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezuidenhout J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004228; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Croix DA, 2000, AIDS RES HUM RETROV, V16, P1895, DOI 10.1089/08892220050195856; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hertoghe T, 2000, CLIN EXP IMMUNOL, V122, P350, DOI 10.1046/j.1365-2249.2000.01385.x; Hoshino Y, 2004, J IMMUNOL, V172, P6251, DOI 10.4049/jimmunol.172.10.6251; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Law KF, 1996, AM J RESP CRIT CARE, V153, P1377, DOI 10.1164/ajrccm.153.4.8616569; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Lewinsohn DM, 2006, MICROBES INFECT, V8, P2587, DOI 10.1016/j.micinf.2006.07.007; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lopez-Gatell H, 2008, AIDS, V22, P1869, DOI 10.1097/QAD.0b013e32830e010c; LUCAS S, TUBERCULOSIS PATHOGE, P503; Mankatittham W, 2009, SE ASIAN J TROP MED, V40, P93; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; Nath BM, 2000, TRENDS MICROBIOL, V8, P426, DOI 10.1016/S0966-842X(00)01816-3; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Pawar SN, 2008, AIDS RES HUM RETROV, V24, P643, DOI 10.1089/aid.2007.0238; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8; Qin SL, 2008, J MED PRIMATOL, V37, P46, DOI 10.1111/j.1600-0684.2008.00327.x; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Safi H, 2003, AIDS RES HUM RETROV, V19, P585, DOI 10.1089/088922203322230950; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Silvestri G, 2008, J MED PRIMATOL, V37, P6, DOI 10.1111/j.1600-0684.2008.00328.x; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Vajdy M, 2001, J INFECT DIS, V184, P1007, DOI 10.1086/323615; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07	46	120	124	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9611	10.1371/journal.pone.0009611	http://dx.doi.org/10.1371/journal.pone.0009611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224771	Green Published, Green Accepted, gold			2022-12-27	WOS:000275328800014
J	Greganova, E; Heller, M; Butikofer, P				Greganova, Eva; Heller, Manfred; Buetikofer, Peter			A Structural Domain Mediates Attachment of Ethanolamine Phosphoglycerol to Eukaryotic Elongation Factor 1A in Trypanosoma brucei	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; BLOOD-STREAM FORMS; PROTEIN-SYNTHESIS; POSTTRANSLATIONAL MODIFICATION; SURFACE GLYCOPROTEIN; ACTIN CYTOSKELETON; ADP-RIBOSYLATION; H-3 ETHANOLAMINE; DIPHTHERIA-TOXIN; AMINO-ACID	Ethanolamine phosphoglycerol (EPG) represents a protein modification that so far has only been found in eukaryotic elongation factor 1A (eEF1A). In mammals and plants, EPG is covalently attached to two conserved glutamate residues located in domains II and III of eEF1A. In contrast, Trypanosoma brucei eEF1A contains a single EPG attached to Glu362 in domain III. The sequence and/or structural requirements for covalent linkage of EPG to eEF1A have not been determined for any organism. Using a combination of biosynthetic labelling of parasites with tritiated ethanolamine and mass spectrometry analyses, we demonstrate that replacement of Glu362 in T. brucei eEF1A by site-directed mutagenesis prevents EPG attachment, whereas single or multiple amino acid substitutions around the attachment site are not critical. In addition, by expressing a series of eEF1A deletion mutants in T. brucei procyclic forms, we demonstrate that a peptide consisting of 80 amino acids of domain III of eEF1A is sufficient for EPG attachment to occur. Furthermore, EPG addition also occurs if domain III of eEF1A is fused to a soluble reporter protein. To our knowledge, this is the first report addressing amino acid sequence, or structure, requirements for EPG modification of eEF1A in any organism. Using T. brucei as a model organism, we show that amino acid substitutions around the modification site are not critical for EPG attachment and that a truncated version of domain III of eEF1A is sufficient to mediate EPG addition.	[Greganova, Eva; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Heller, Manfred] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Greganova, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@mci.unibe.ch		Heller, Manfred/0000-0002-6364-7325	Swiss National Science Foundation [31003A-116627]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by Swiss National Science Foundation grant 31003A-116627 to P. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Anand M, 2006, J BIOL CHEM, V281, P32318, DOI 10.1074/jbc.M601899200; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Bunai F, 2006, J BIOCHEM, V140, P393, DOI 10.1093/jb/mvj169; Butikofer P, 1997, BIOCHEM J, V326, P415; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; DEVER TE, 1989, J BIOL CHEM, V264, P20518; Dinman JD, 1997, RNA, V3, P870; EDMONDS BT, 1995, J BIOL CHEM, V270, P15222, DOI 10.1074/jbc.270.25.15222; Edmonds BT, 1996, J CELL SCI, V109, P2705; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Gupta PK, 2008, CELL MICROBIOL, V10, P1687, DOI 10.1111/j.1462-5822.2008.01159.x; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; JOE YA, 1994, J BIOL CHEM, V269, P25916; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; KINZY TG, 1992, J BIOL CHEM, V267, P1623; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Merrick WC., 1996, TRANSLATION CONTROL, P31; Morita K, 2008, ZOOL SCI, V25, P22, DOI 10.2108/zsj.25.22; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; Ransom WD, 1998, PLANT PHYSIOL, V117, P949, DOI 10.1104/pp.117.3.949; RIFKIN MR, 1985, MOL BIOCHEM PARASIT, V15, P245, DOI 10.1016/0166-6851(85)90088-X; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; SHIBA T, 1971, BIOCHIM BIOPHYS ACTA, V244, P523, DOI 10.1016/0304-4165(71)90069-9; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Utz S, 2006, EUKARYOT CELL, V5, P1430, DOI 10.1128/EC.00067-06; VANNESS BG, 1980, J BIOL CHEM, V255, P717; vanOostveen I, 1997, ANAL BIOCHEM, V247, P310, DOI 10.1006/abio.1997.2052; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; WHITEHEART SW, 1994, ARCH BIOCHEM BIOPHYS, V309, P387, DOI 10.1006/abbi.1994.1128; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zhang Y, 2008, BIOCHEM J, V413, P163, DOI 10.1042/BJ20071083; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9486	10.1371/journal.pone.0009486	http://dx.doi.org/10.1371/journal.pone.0009486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209157	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300006
J	Carling, CLL; Kristoffersen, DT; Oxman, AD; Flottorp, S; Fretheim, A; Schunemann, HJ; Akl, EA; Herrin, J; MacKenzie, TD; Montori, VM				Carling, Cheryl L. L.; Kristoffersen, Doris Tove; Oxman, Andrew D.; Flottorp, Signe; Fretheim, Atle; Schuenemann, Holger J.; Akl, Elie A.; Herrin, Jeph; MacKenzie, Thomas D.; Montori, Victor M.			The Effect of How Outcomes Are Framed on Decisions about Whether to Take Antihypertensive Medication: A Randomized Trial	PLOS ONE			English	Article							RISK INFORMATION; HYPERTENSION; RECOMMENDATIONS; METAANALYSIS; BENEFITS; BEHAVIOR; CHOICE	Background: We conducted an Internet-based randomized trial comparing three valence framing presentations of the benefits of antihypertensive medication in preventing cardiovascular disease (CVD) for people with newly diagnosed hypertension to determine which framing presentation resulted in choices most consistent with participants' values. Methods and Findings: In this second in a series of televised trials in cooperation with the Norwegian Broadcasting Company, adult volunteers rated the relative importance of the consequences of taking antihypertensive medication using visual analogue scales (VAS). Participants viewed information (or no information) to which they were randomized and decided whether or not to take medication. We compared positive framing over 10 years (the number escaping CVD per 1000); negative framing over 10 years (the number that will have CVD) and negative framing per year over 10 years of the effects of antihypertensive medication on the 10-year risk for CVD for a 40 year-old man with newly diagnosed hypertension without other risk factors. Finally, all participants were shown all presentations and detailed patient information about hypertension and were asked to decide again. We calculated a relative importance score (RIS) by subtracting the VAS-scores for the undesirable consequences of antihypertensive medication from the VAS-score for the benefit of CVD risk reduction. We used logistic regression to determine the association between participants' RIS and their choice. 1,528 participants completed the study. The statistically significant differences between the groups in the likelihood of choosing to take antihypertensive medication in relation to different values (RIS) increased as the RIS increased. Positively framed information lead to decisions most consistent with those made by everyone for the second, more fully informed decision. There was a statistically significant decrease in deciding to take antihypertensives on the second decision, both within groups and overall. Conclusions: For decisions about taking antihypertensive medication for people with a relatively low baseline risk of CVD (70 per 1000 over 10 years), both positive and negative framing resulted in significantly more people deciding to take medication compared to what participants decided after being shown all three of the presentations.	[Carling, Cheryl L. L.; Kristoffersen, Doris Tove; Oxman, Andrew D.; Flottorp, Signe; Fretheim, Atle] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Schuenemann, Holger J.] Italian Natl Canc Inst Regina Elena, Clin Res & INFORMAt Translat Unit, Rome, Italy; [Schuenemann, Holger J.] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, Rome, Italy; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Herrin, Jeph] Yale Univ, Div Cardiol, New Haven, CT USA; [MacKenzie, Thomas D.] Denver Hlth & Hosp Author, Dept Internal Med, Denver, CO USA; [MacKenzie, Thomas D.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Montori, Victor M.] Mayo Clin, Coll Med, Div Endocrinol & Internal Med, Knowledge & Encounter Res Unit, Rochester, MN USA	Norwegian Knowledge Centre for Health Services; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Mayo Clinic	Carling, CLL (corresponding author), Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway.	cheryl.carling@kunnskapssenteret.no	Kristoffersen, Doris Tove/GWQ-3158-2022; Oxman, Andrew/Y-3004-2019; Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Oxman, Andrew/0000-0002-5608-5061; Akl, Elie A/0000-0002-3444-8618; Schunemann, Holger/0000-0003-3211-8479; Flottorp, Signe/0000-0003-2961-7461	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by the Norwegian Research Council (http://www.forskningsradet.no/en/Home+page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; BENSON J, 2002, BMJ-BRIT MED J, V225, P873; BLOCK LG, 1995, J MARKETING RES, V32, P192, DOI 10.2307/3152047; Carling C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003693; Carling CLL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000140; Carling CLL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000134; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Covey J, 2007, MED DECIS MAKING, V27, P638, DOI 10.1177/0272989x07306783; Detweiler JB, 1999, HEALTH PSYCHOL, V18, P189, DOI 10.1037/0278-6133.18.2.189; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Elliott C.S., 1998, J SOCIO-ECON, V27, P229, DOI [DOI 10.1016/S1053-5357(99)80086-9, 10.1016/S1053-5357(99)80086-9]; Fretheim A, 2002, J FAM PRACTICE, V51, P963; Fretheim Atle, 2002, Tidsskr Nor Laegeforen, V122, P2277; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; HOLLNAGEL H, 1996, PRACTICUS, V116, P237; Holmes-Rovner M, 1999, MED CARE, V37, P270, DOI 10.1097/00005650-199903000-00007; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KASSIRER JP, 1981, NEW ENGL J MED, V305, P1465, DOI 10.1056/NEJM198112103052409; Kuhberger A, 1998, ORGAN BEHAV HUM DEC, V75, P23, DOI 10.1006/obhd.1998.2781; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Linville Patricia W., 1993, P5; LLEWELLYNTHOMAS H, 1988, PROFESSIONAL JUDGMEN, P395; McGettigan P, 1999, J GEN INTERN MED, V14, P633, DOI 10.1046/j.1525-1497.1999.09038.x; Misselbrook D, 2001, BRIT J GEN PRACT, V51, P276; Moxey A, 2003, J GEN INTERN MED, V18, P948, DOI 10.1046/j.1525-1497.2003.20928.x; O'Connor A. M., 2005, IPDAS COLLABORATION; O'Connor AM, 2003, BMJ-BRIT MED J, V327, P736, DOI 10.1136/bmj.327.7417.736; OCONNOR AM, 2003, COCHRANE DATABASE SY; OMEARA JJ, 1994, NEW ENGL J MED, V330, P1864, DOI 10.1056/NEJM199406303302605; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; *STAT NORW, ED TAB 06217 PEOPL 1; *STAT NORW, POP TABL 03026 POP S; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Wallis EJ, 2002, HEART, V88, P306, DOI 10.1136/heart.88.3.306; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Wills CE, 2003, PATIENT EDUC COUNS, V50, P285, DOI 10.1016/S0738-3991(03)00051-X; Wiseman DB, 1996, ORGAN BEHAV HUM DEC, V66, P241, DOI 10.1006/obhd.1996.0053; [No title captured]	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9469	10.1371/journal.pone.0009469	http://dx.doi.org/10.1371/journal.pone.0009469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	561RT	20209127	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000274997100015
J	Gai, ZH; Wang, XY; Liu, XR; Tai, C; Tang, HZ; He, XF; Wu, G; Deng, ZX; Xu, P				Gai, Zhonghui; Wang, Xiaoyu; Liu, Xiaorui; Tai, Cui; Tang, Hongzhi; He, Xiaofei; Wu, Geng; Deng, Zixin; Xu, Ping			The Genes Coding for the Conversion of Carbazole to Catechol Are Flanked by IS6100 Elements in Sphingomonas sp Strain XLDN2-5	PLOS ONE			English	Article							CATABOLIC GENES; DIOXIN DIOXYGENASE; PLASMID PCAR3; DEGRADATION; SEQUENCE; CELLS; 1,9A-DIOXYGENASE; PAUCIMOBILIS; ORGANIZATION; EXPRESSION	Background: Carbazole is a recalcitrant compound with a dioxin-like structure and possesses mutagenic and toxic activities. Bacteria respond to a xenobiotic by recruiting exogenous genes to establish a pathway to degrade the xenobiotic, which is necessary for their adaptation and survival. Usually, this process is mediated by mobile genetic elements such as plasmids, transposons, and insertion sequences. Findings: The genes encoding the enzymes responsible for the degradation of carbazole to catechol via anthranilate were cloned, sequenced, and characterized from a carbazole-degrading Sphingomonas sp. strain XLDN2-5. The car gene cluster (carRAaBaBbCAc) and fdr gene were accompanied on both sides by two copies of IS6100 elements, and organized as IS6100::ISSsp1-ORF1-carRAaBaBbCAc-ORF8-IS6100-fdr-IS6100. Carbazole was converted by carbazole 1,9a-dioxygenase (CARDO, CarAaAcFdr), meta-cleavage enzyme (CarBaBb), and hydrolase (CarC) to anthranilate and 2-hydroxypenta-2,4-dienoate. The fdr gene encoded a novel ferredoxin reductase whose absence resulted in lower transformation activity of carbazole by CarAa and CarAc. The ant gene cluster (antRAcAdAbAa) which was involved in the conversion of anthranilate to catechol was also sandwiched between two IS6100 elements as IS6100-antRAcAdAbAa-IS6100. Anthranilate 1,2-dioxygenase (ANTDO) was composed of a reductase (AntAa), a ferredoxin (AntAb), and a two-subunit terminal oxygenase (AntAcAd). Reverse transcription-PCR results suggested that carAaBaBbCAc gene cluster, fdr, and antRAcAdAbAa gene cluster were induced when strain XLDN2-5 was exposed to carbazole. Expression of both CARDO and ANTDO in Escherichia coli required the presence of the natural reductases for full enzymatic activity. Conclusions/Significance: We predict that IS6100 might play an important role in the establishment of carbazole-degrading pathway, which endows the host to adapt to novel compounds in the environment. The organization of the car and ant genes in strain XLDN2-5 was unique, which showed strong evolutionary trail of gene recruitment mediated by IS6100 and presented a remarkable example of rearrangements and pathway establishments.	[Gai, Zhonghui] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gai, ZH (corresponding author), Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn			National High Technology Research and Development Program of China [2007AA10Z401]; National Basic Research Program of China [2009CB118906]; National Natural Science Foundation of China [20977061, 20777051]; Shanghai Key Basic Research Program of China [09JC1407700]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Program of China	This work was partially supported by the grants from National High Technology Research and Development Program of China (grant number 2007AA10Z401), from National Basic Research Program of China (grant number 2009CB118906), and from National Natural Science Foundation of China (grant numbers 20977061 and 20777051). The authors also acknowledge the financial support from Shanghai Key Basic Research Program of China (grant number 09JC1407700). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 1998, J BACTERIOL, V180, P3954, DOI 10.1128/JB.180.15.3954-3966.1998; Armengaud J, 1998, EUR J BIOCHEM, V253, P437, DOI 10.1046/j.1432-1327.1998.2530437.x; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Cai M, 2002, J BACTERIOL, V184, P4672, DOI 10.1128/JB.184.17.4672-4680.2002; Chang HK, 2003, J BACTERIOL, V185, P5871, DOI 10.1128/JB.185.19.5871-5881.2003; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dogra C, 2004, J BACTERIOL, V186, P2225, DOI 10.1128/JB.186.8.2225-2235.2004; Gai ZH, 2007, APPL ENVIRON MICROB, V73, P2832, DOI 10.1128/AEM.02704-06; Gai ZH, 2008, MICROBIOL-SGM, V154, P3804, DOI 10.1099/mic.0.2008/023176-0; HALL RM, 1994, J BACTERIOL, V176, P6286, DOI 10.1128/jb.176.20.6286-6294.1994; Herman PL, 2005, J BIOL CHEM, V280, P24759, DOI 10.1074/jbc.M500597200; Jha AM, 2002, MUTAT RES-FUND MOL M, V500, P97, DOI 10.1016/S0027-5107(01)00303-7; KATO K, 1994, J BACTERIOL, V176, P1197, DOI 10.1128/JB.176.4.1197-1200.1994; Kilbane JJ, 2002, BIOCHEM BIOPH RES CO, V297, P242, DOI 10.1016/S0006-291X(02)02183-6; Kirimura K, 1999, BIOSCI BIOTECH BIOCH, V63, P1563, DOI 10.1271/bbb.63.1563; Li L, 2006, APPL MICROBIOL BIOT, V73, P941, DOI 10.1007/s00253-006-0530-3; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; Nagata Y, 1999, J IND MICROBIOL BIOT, V23, P380, DOI 10.1038/sj.jim.2900736; Nojiri H, 1999, J BACTERIOL, V181, P3105, DOI 10.1128/JB.181.10.3105-3113.1999; Nojiri H, 2001, J BACTERIOL, V183, P3663, DOI 10.1128/JB.183.12.3663-3679.2001; Ouchiyama N, 1998, J GEN APPL MICROBIOL, V44, P57, DOI 10.2323/jgam.44.57; PETERSON JA, 1990, J BIOL CHEM, V265, P6066; Pinyakong O, 2003, J GEN APPL MICROBIOL, V49, P1, DOI 10.2323/jgam.49.1; Providenti MA, 2006, APPL ENVIRON MICROB, V72, P2651, DOI 10.1128/AEM.72.4.2651-2660.2006; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Sambrook J., 2001, MOL CLONING LAB MANU; Sato SI, 1997, J BACTERIOL, V179, P4850, DOI 10.1128/jb.179.15.4850-4858.1997; Shepherd JM, 1998, BIOCHEM BIOPH RES CO, V247, P129, DOI 10.1006/bbrc.1998.8750; Shintani M, 2007, J BACTERIOL, V189, P2007, DOI 10.1128/JB.01486-06; SUNDIN GW, 1995, APPL ENVIRON MICROB, V61, P2891, DOI 10.1128/AEM.61.8.2891-2897.1995; Tauch A, 2002, PLASMID, V48, P117, DOI 10.1016/S0147-619X(02)00120-8; Urata M, 2006, APPL ENVIRON MICROB, V72, P3198, DOI 10.1128/AEM.72.5.3198-3205.2006; Wang X, 2007, APPL ENVIRON MICROB, V73, P6421, DOI 10.1128/AEM.01051-07; Zylstra GJ, 1997, J IND MICROBIOL BIOT, V19, P408, DOI 10.1038/sj.jim.2900475	35	17	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10018	10.1371/journal.pone.0010018	http://dx.doi.org/10.1371/journal.pone.0010018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368802	Green Published, gold, Green Submitted			2022-12-27	WOS:000276419900017
J	Hobbs, WO; Telford, RJ; Birks, HJB; Saros, JE; Hazewinkel, RRO; Perren, BB; Saulnier-Talbot, E; Wolfe, AP				Hobbs, William O.; Telford, Richard J.; Birks, H. John B.; Saros, Jasmine E.; Hazewinkel, Roderick R. O.; Perren, Bianca B.; Saulnier-Talbot, Emilie; Wolfe, Alexander P.			Quantifying Recent Ecological Changes in Remote Lakes of North America and Greenland Using Sediment Diatom Assemblages	PLOS ONE			English	Article							REGIONAL PALEOLIMNOLOGICAL ASSESSMENT; ATMOSPHERIC NITROGEN DEPOSITION; RECENT ENVIRONMENTAL-CHANGES; MOUNTAIN NATIONAL-PARK; CLIMATE-CHANGE; ALPINE LAKES; EUTROPHICATION; ISLAND; COMMUNITIES; ECOSYSTEM	Background: Although arctic lakes have responded sensitively to 20(th)-century climate change, it remains uncertain how these ecological transformations compare with alpine and montane-boreal counterparts over the same interval. Furthermore, it is unclear to what degree other forcings, including atmospheric deposition of anthropogenic reactive nitrogen (Nr), have participated in recent regime shifts. Diatom-based paleolimnological syntheses offer an effective tool for retrospective assessments of past and ongoing changes in remote lake ecosystems. Methodology/Principal Findings: We synthesized 52 dated sediment diatom records from lakes in western North America and west Greenland, spanning broad latitudinal and altitudinal gradients, and representing alpine (n = 15), arctic (n = 20), and forested boreal-montane (n = 17) ecosystems. Diatom compositional turnover (beta-diversity) during the 20(th) century was estimated using Detrended Canonical Correspondence Analysis (DCCA) for each site and compared, for cores with sufficiently robust chronologies, to both the 19(th) century and the prior similar to 250 years (Little Ice Age). For both arctic and alpine lakes, beta-diversity during the 20(th) century is significantly greater than the previous 350 years, and increases with both latitude and altitude. Because no correlation is apparent between 20(th)-century diatom beta-diversity and any single physical or limnological parameter (including lake and catchment area, maximum depth, pH, conductivity, [NO3-], modeled Nr deposition, ambient summer and winter air temperatures, and modeled temperature trends 1948-2008), we used Principal Components Analysis (PCA) to summarize the amplitude of recent changes in relationship to lake pH, lake: catchment area ratio, modeled Nr deposition, and recent temperature trends. Conclusions/Significance: The ecological responses of remote lakes to post-industrial environmental changes are complex. However, two regions reveal concentrations of sites with elevated 20(th)-century diatom beta-diversity: the Arctic where temperatures are increasing most rapidly, and mid-latitude alpine lakes impacted by high Nr deposition rates. We predict that remote lakes will continue to shift towards new ecological states in the Anthropocene, particularly in regions where these two forcings begin to intersect geographically.	[Hobbs, William O.; Wolfe, Alexander P.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Telford, Richard J.; Birks, H. John B.] Univ Bergen, Dept Biol, Bergen, Norway; [Telford, Richard J.; Birks, H. John B.] Bjerknes Ctr Climate Res, Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London, England; [Saros, Jasmine E.] Univ Maine, Sch Biol & Ecol, Orono, ME USA; [Hazewinkel, Roderick R. O.] Alberta Environm, Edmonton, AB, Canada; [Perren, Bianca B.] Univ Toronto, Dept Geol, Toronto, ON, Canada; [Saulnier-Talbot, Emilie] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Alberta; University of Bergen; Bjerknes Centre for Climate Research; University of London; University College London; University of Maine System; University of Maine Orono; University of Toronto; McGill University	Hobbs, WO (corresponding author), Sci Museum Minnesota, St Croix Watershed Res Stn, Marine St Croix, MN USA.	awolfe@ualberta.ca	Telford, Richard/AAD-2249-2019; Telford, Richard/C-1668-2008; Wolfe, Alexander P/G-6867-2011; Birks, John B/C-3103-2008; Hobbs, William/P-1110-2016	Telford, Richard/0000-0001-9826-3076; Telford, Richard/0000-0001-9826-3076; Birks, John B/0000-0002-5891-9859; Hobbs, William/0000-0001-7321-0779; Perren, Bianca/0000-0001-6089-6468	Alberta Ingenuity Centre for Water Research; Natural Sciences and Engineering Research Council of Canada; U.S. National Science Foundation; U.S. Department of the Interior; Faculty of Graduate Studies and Research; University of Alberta	Alberta Ingenuity Centre for Water Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of the Interior; Faculty of Graduate Studies and Research; University of Alberta(University of Alberta)	Funding was provided by the Alberta Ingenuity Centre for Water Research, the Natural Sciences and Engineering Research Council of Canada, the U.S. National Science Foundation, and the U.S. Department of the Interior. W. O. H. received a travel grant from the Faculty of Graduate Studies and Research, University of Alberta, for the visit to the University of Bergen from which this paper emerged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades D, 2005, J PALEOLIMNOL, V33, P349, DOI 10.1007/s10933-004-6611-3; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Balmaseda M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030452; Baron JS, 2006, ECOL APPL, V16, P433, DOI 10.1890/1051-0761(2006)016[0433:HNDTDA]2.0.CO;2; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Battarbee RW, 2002, J PALEOLIMNOL, V28, P1, DOI 10.1023/A:1020342316326; BATTARBEE RW, 1984, T R SOC LONDON B, V305, P415; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Bennion H, 1996, ENVIRON SCI TECHNOL, V30, P2004, DOI 10.1021/es9508030; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Birks HJB, 2007, VEG HIST ARCHAEOBOT, V16, P197, DOI 10.1007/s00334-006-0079-1; Box JE, 2002, INT J CLIMATOL, V22, P1829, DOI 10.1002/joc.852; BRADBURY J P, 1988, Journal of Paleolimnology, V1, P115; Bradley RS, 2003, GLO CH IGBP, P105; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Dentener F.J, 2006, GLOBAL MAPS ATMOSPHE; Enders SK, 2008, LIMNOL OCEANOGR, V53, P1468, DOI 10.4319/lo.2008.53.4.1468; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Glew Jr, 2002, DEV PALEOENVIRON RES, V1, P73; Hazewinkel RRO, 2008, CAN J FISH AQUAT SCI, V65, P1554, DOI 10.1139/F08-074; Heegaard E, 2006, J PALEOLIMNOL, V35, P507, DOI 10.1007/s10933-005-3239-x; Hobbs WO, 2008, J PALEOLIMNOL, V40, P295, DOI 10.1007/s10933-007-9161-7; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Keatley BE, 2006, HYDROBIOLOGIA, V553, P15, DOI 10.1007/s10750-005-1737-5; Laird K, 2001, CAN J FISH AQUAT SCI, V58, P479, DOI 10.1139/cjfas-58-3-479; Laird K, 2001, CAN J FISH AQUAT SCI, V58, P492, DOI 10.1139/cjfas-58-3-492; Lean JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038932; Luckman BH, 2005, CLIM DYNAM, V24, P131, DOI 10.1007/s00382-004-0511-0; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Michelutti N, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000396; Michelutti N, 2006, QUATERNARY RES, V65, P421, DOI 10.1016/j.yqres.2006.02.001; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; Moser KA, 2002, J PALEOLIMNOL, V28, P269, DOI 10.1023/A:1021635024757; Nanus L, 2008, ENVIRON SCI TECHNOL, V42, P6487, DOI 10.1021/es800739e; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Parker BR, 2008, P NATL ACAD SCI USA, V105, P12927, DOI 10.1073/pnas.0806481105; Perren BB, 2003, ARCT ANTARCT ALP RES, V35, P271, DOI 10.1657/1523-0430(2003)035[0271:RLRTRH]2.0.CO;2; Perren BB, 2009, J PALEOLIMNOL, V42, P233, DOI 10.1007/s10933-008-9273-8; R Core Team, 2021, R LANGUAGE ENV STAT; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Saros JE, 2005, CAN J FISH AQUAT SCI, V62, P1681, DOI 10.1139/F05-077; Saros JE, 2003, ARCT ANTARCT ALP RES, V35, P18, DOI 10.1657/1523-0430(2003)035[0018:RCITDC]2.0.CO;2; SAULNIERTALBOT E, 2007, THESIS U LAVAL QUEBE; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Ter Braak C. J. F., 2002, CANOCO SOFTWARE CANO; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams MW, 1996, ENVIRON SCI TECHNOL, V30, P640, DOI 10.1021/es950383e; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; Wolfe AP, 2006, ARCT ANTARCT ALP RES, V38, P465, DOI 10.1657/1523-0430(2006)38[465:ACROAN]2.0.CO;2; Wolfe AP, 2003, GEOBIOLOGY, V1, P153, DOI 10.1046/j.1472-4669.2003.00012.x; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI [10.1130/GSAT01802A.1, DOI 10.1130/GSAT01802A.1]	60	89	91	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10026	10.1371/journal.pone.0010026	http://dx.doi.org/10.1371/journal.pone.0010026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368811	Green Published, gold, Green Submitted			2022-12-27	WOS:000276419900020
J	Kalcounis-Rueppell, MC; Petric, R; Briggs, JR; Carney, C; Marshall, MM; Willse, JT; Rueppell, O; Ribble, DO; Crossland, JP				Kalcounis-Rueppell, Matina C.; Petric, Radmila; Briggs, Jessica R.; Carney, Catherine; Marshall, Matthew M.; Willse, John T.; Rueppell, Olav; Ribble, David O.; Crossland, Janet P.			Differences in Ultrasonic Vocalizations between Wild and Laboratory California Mice (Peromyscus californicus)	PLOS ONE			English	Article							MOUSE; AGGRESSION; ENCOUNTER; RESPONSES; CAPTIVITY; BEHAVIOR; CALLS; PAIN	Background: Ultrasonic vocalizations (USVs) emitted by muroid rodents, including laboratory mice and rats, are used as phenotypic markers in behavioral assays and biomedical research. Interpretation of these USVs depends on understanding the significance of USV production by rodents in the wild. However, there has never been a study of muroid rodent ultrasound function in the wild and comparisons of USVs produced by wild and laboratory rodents are lacking to date. Here, we report the first comparison of wild and captive rodent USVs recorded from the same species, Peromyscus californicus. Methodology and Principal Findings: We used standard ultrasound recording techniques to measure USVs from California mice in the laboratory ( Peromyscus Genetic Stock Center, SC, USA) and the wild ( Hastings Natural History Reserve, CA, USA). To determine which California mouse in the wild was vocalizing, we used a remote sensing method that used a 12-microphone acoustic localization array coupled with automated radio telemetry of all resident Peromyscus californicus in the area of the acoustic localization array. California mice in the laboratory and the wild produced the same types of USV motifs. However, wild California mice produced USVs that were 2-8 kHz higher in median frequency and significantly more variable in frequency than laboratory California mice. Significance: The similarity in overall form of USVs from wild and laboratory California mice demonstrates that production of USVs by captive Peromyscus is not an artifact of captivity. Our study validates the widespread use of USVs in laboratory rodents as behavioral indicators but highlights that particular characteristics of laboratory USVs may not reflect natural conditions.	[Kalcounis-Rueppell, Matina C.; Petric, Radmila; Briggs, Jessica R.; Carney, Catherine; Marshall, Matthew M.; Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Willse, John T.] Univ N Carolina, Dept Educ Res & Methodol, Greensboro, NC 27412 USA; [Ribble, David O.] Trinity Univ, Dept Biol, San Antonio, TX 78212 USA; [Crossland, Janet P.] Univ S Carolina, Peromyscus Genet Stock Ctr, Columbia, SC 29208 USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; Trinity University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kalcounis-Rueppell, MC (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	mckalcounisrueppell@gmail.com	Kalcounis-Rueppell, Matina C/G-2649-2010; Rueppell, Olav/G-2679-2010	Kalcounis-Rueppell, Matina C/0000-0003-0964-2125; Rueppell, Olav/0000-0001-5370-4229	HNHR	HNHR	Support for field work was provided at HNHR. Assistance for this study was provided by E. Gonzalez, K. Thomas, D. Kinsey, M. Miller, J. Szewczak, R. Specht, A. Walker and E. Walters. An earlier version of this manuscript was improved by B. H. Blake, J. J. Lepri, Christine Portfors, D. K. Riskin and an anonymous reviewer.	Augustsson H, 2005, PHYSIOL BEHAV, V84, P265, DOI 10.1016/j.physbeh.2004.12.002; Bester-Meredith JK, 2005, AGGRESSIVE BEHAV, V31, P189, DOI 10.1002/ab.20075; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; Botten J, 2001, COMPARATIVE MED, V51, P314; Bradbury Jack W., 1998, pi; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; BRIGGS J, 2009, THESIS U N CAROLINA; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brunelli SA, 1997, DEV PSYCHOBIOL, V31, P255, DOI 10.1002/(SICI)1098-2302(199712)31:4<255::AID-DEV3>3.0.CO;2-Q; Calvino B, 1996, NEUROREPORT, V7, P581, DOI 10.1097/00001756-199601310-00049; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; Fuxjager MJ, 2009, HORM BEHAV, V56, P214, DOI 10.1016/j.yhbeh.2009.04.009; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; GUTTINGER HR, 1985, BEHAVIOUR, V94, P254, DOI 10.1163/156853985X00226; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Kalcounis-Rueppell Matina C, 2006, Front Zool, V3, P3, DOI 10.1186/1742-9994-3-3; Kalcounis-Ruppell MC, 2002, J MAMMAL, V83, P614, DOI 10.1644/1545-1542(2002)083<0614:POSFAT>2.0.CO;2; Kirkland G.L. Jr, 1989, P1; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Kunzl C, 2003, HORM BEHAV, V43, P187, DOI 10.1016/S0018-506X(02)00017-X; Lee AW, 2007, PHYSIOL BEHAV, V92, P617, DOI 10.1016/j.physbeh.2007.05.008; McPhee ME, 2004, J MAMMAL, V85, P1130, DOI 10.1644/BPR-017.1; MERRITT J F, 1978, Mammalian Species, V85, P1; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; *NAT RES COUNC, 1996, GUID CAR US LAB AN, P125; PANSKEPP J, 2007, PLOS ONE, V2, pE651; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; R Core Team, 2018, R LANG ENV STAT COMP; RIBBLE DO, 1992, ECOLOGY, V73, P859, DOI 10.2307/1940163; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; SMITH WJ, 1979, AM ZOOL, V19, P531; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; Trainor BC, 2008, HORM BEHAV, V53, P200, DOI 10.1016/j.yhbeh.2007.09.017; Trainor BC, 2008, HORM BEHAV, V53, P192, DOI 10.1016/j.yhbeh.2007.09.016; Vieira ML, 2003, DEV PSYCHOBIOL, V42, P246, DOI 10.1002/dev.10097; Vieira ML, 2002, BEHAV PROCESS, V59, P147, DOI 10.1016/S0376-6357(02)00089-X; Vivian JA, 1999, PSYCHOPHARMACOLOGY, V146, P153, DOI 10.1007/s002130051101; Wohr M, 2008, BEHAV GENET, V38, P579, DOI 10.1007/s10519-008-9221-4; Wolff JO, 2003, BIOSCIENCE, V53, P421, DOI 10.1641/0006-3568(2003)053[0421:LSWRFO]2.0.CO;2; Wright SL, 2004, BEHAV PROCESS, V65, P155, DOI 10.1016/j.beproc.2003.09.004; [No title captured]	43	54	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9705	10.1371/journal.pone.0009705	http://dx.doi.org/10.1371/journal.pone.0009705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368980	Green Published, gold			2022-12-27	WOS:000276418200001
J	Feverati, G; Lesieur, C				Feverati, Giovanni; Lesieur, Claire			Oligomeric Interfaces Under the Lens: Gemini	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACES; THERMUS-THERMOPHILUS HB8; FLY-CASTING MECHANISM; QUATERNARY STRUCTURE; CRYSTAL-STRUCTURE; ASSEMBLIES; DATABASE; DESIGN; LENGTH; CRYSTALLIZATION	The assembly of subunits in protein oligomers is an important topic to study as a vast number of proteins exists as stable or transient oligomer and because it is a mechanism used by some protein oligomers for killing cells (e. g., perforin from the human immune system, pore-forming toxins from bacteria, phage, amoeba, protein misfolding diseases, etc.). Only a few of the amino acids that constitute a protein oligomer seem to regulate the capacity of the protein to assemble (to form interfaces), and some of these amino acids are localized at the interfaces that link the different chains. The identification of the residues of these interfaces is rather difficult. We have developed a series of programs, under the common name of Gemini, that can select the subset of the residues that is involved in the interfaces of a protein oligomer of known atomic structure, and generate a 2D interaction network (or graph) of the subset. The graphs generated for several oligomers demonstrate the accuracy of the selection of subsets that are involved in the geometrical and the chemical properties of interfaces. The results of the Gemini programs are in good agreement with those of similar programs with an advantage that Gemini programs can perform the residue selection much more rapidly. Moreover, Gemini programs can also perform on a single protein oligomer without the need of comparison partners. The graphs are extremely useful for comparative studies that would help in addressing questions not only on the sequence specificity of protein interfaces but also on the mechanism of the assembly of unrelated protein oligomers.	[Feverati, Giovanni; Lesieur, Claire] Univ Savoie, Phys Theor Lab, CNRS, UMR 5108, Annecy Le Vieux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Savoie	Feverati, G (corresponding author), Univ Savoie, Phys Theor Lab, CNRS, UMR 5108, BP 110, Annecy Le Vieux, France.	lesieur@lapp.in2p3.fr	Feverati, Giovanni/L-8248-2013					Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bascos N, 2004, PROTEIN SCI, V13, P1317, DOI 10.1110/ps.03559504; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Calladine CR, 2001, J MOL BIOL, V305, P603, DOI 10.1006/jmbi.2000.4320; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; Elcock AH, 2001, P NATL ACAD SCI USA, V98, P2990, DOI 10.1073/pnas.061411798; Fischer TB, 2003, BIOINFORMATICS, V19, P1453, DOI 10.1093/bioinformatics/btg163; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Guidry Jesse J, 2003, BMC Biochem, V4, P14, DOI 10.1186/1471-2091-4-14; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luke K, 2006, J MOL BIOL, V363, P729, DOI 10.1016/j.jmb.2006.08.058; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Numoto N, 2005, PROTEINS, V58, P498, DOI 10.1002/prot.20317; Pastor MT, 2008, J MOL BIOL, V375, P695, DOI 10.1016/j.jmb.2007.08.012; Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004; Perham M, 2005, J AM CHEM SOC, V127, P16402, DOI 10.1021/ja055574o; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Roberts MM, 1999, ACTA CRYSTALLOGR D, V55, P910, DOI 10.1107/S0907444998018447; Schulze-Kremer S, 2000, METH MOL B, V143, P175; Shakhnovich EI, 1999, NAT STRUCT BIOL, V6, P99, DOI 10.1038/5785; Shimamura T, 2003, ACTA CRYSTALLOGR D, V59, P1632, DOI 10.1107/S0907444903013660; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Teyra J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-104; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; Zhu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001926	59	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9897	10.1371/journal.pone.0009897	http://dx.doi.org/10.1371/journal.pone.0009897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360856	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969500017
J	Billard, JM				Billard, Jean-marie			Long-Term Depression in the Hippocampal CA1 Area of Aged Rats, Revisited: Contribution of Temporal Constraints Related to Slice Preparation	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; NEUROMODULATOR D-SERINE; SYNAPTIC PLASTICITY; IN-VIVO; INCREASED SUSCEPTIBILITY; CA2+ HOMEOSTASIS; MEMORY; POTENTIATION; INDUCTION; LTD	Background: The effects of low-frequency conditioning stimulation (LFS, 900 pulses at 1 Hz) of glutamatergic afferents in CA1 hippocampal area using slices from two different strains of adult (3-5 month-old) and aged (23-27 month-old) rats were reinvestigated regarding the discrepancies in the literature concerning the expression of long-term depression (LTD) in the aging brain. Methodology/Principal Findings: N-methyl-D-aspartate receptor (NMDA-R) dependent LTD was examined in both adult (n = 21) and aged (n = 22) Sprague-Dawley rats. While equivalent amounts of LTD could be obtained in both ages, there was significant variability depending upon the time between the slices were made and when they were tested. LTD was not apparent if slices were tested within 3 hours of dissection. The amount of LTD increased over the next three hours but more in adult than in aged rats. This age-related impairment was abolished by exogenous D-serine, thus reflecting the reduced activation of the NMDA-R glycine-binding site by the endogenous agonist in aged rats. Then, the amount of LTD reached asymptote at 5-7 hours following dissection. Similar temporal profiles of LTD expression were seen in young and aged Wistar rats. Conclusions/Significance: Taken together, these results sound a cautionary note regarding the existence of an experimental "window of opportunity'' for studying the effects of aging on LTD expression in hippocampal slice preparation.	Univ Paris 05, Fac Med Rene Descartes, Ctr Psychiat & Neurosci, UMR894, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Billard, JM (corresponding author), Univ Paris 05, Fac Med Rene Descartes, Ctr Psychiat & Neurosci, UMR894, Paris, France.	jean-marie.billard@inserm.fr	Billard, Jean-Marie/ABD-4987-2020		Institut National de la Sante et de la Recherche Scientifique (INSERM)	Institut National de la Sante et de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Institut National de la Sante et de la Recherche Scientifique (INSERM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billard JM, 2006, MAGNESIUM RES, V19, P199; Billard JM, 2007, EUR J NEUROSCI, V25, P2260, DOI 10.1111/j.1460-9568.2007.05488.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Braunewell KH, 2001, REV NEUROSCIENCE, V12, P121; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; BURKE JP, 1994, J NEUROSCI, V14, P5120; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Doyle CA, 1997, NEUROSCIENCE, V77, P75, DOI 10.1016/S0306-4522(96)00427-7; Eichenbaum H, 1996, LEARN MEMORY, V3, P61, DOI 10.1101/lm.3.2-3.61; ERRINGTON ML, 1995, J NEUROPHYSIOL, V74, P1793, DOI 10.1152/jn.1995.74.4.1793; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Foster TC, 1998, TRENDS NEUROSCI, V21, P286, DOI 10.1016/S0166-2236(98)01259-4; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Foy MR, 2008, BEHAV NEUROSCI, V122, P301, DOI 10.1037/0735-7044.122.2.301; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Hansel C, 1996, J PHYSIOLOGY-PARIS, V90, P317, DOI 10.1016/S0928-4257(97)87906-5; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Hsu KS, 2002, HIPPOCAMPUS, V12, P787, DOI 10.1002/hipo.10032; Junjaud G, 2006, J NEUROCHEM, V98, P1159, DOI 10.1111/j.1471-4159.2006.03944.x; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Kollen M, 2010, NEUROBIOL AGING, V31, P129, DOI 10.1016/j.neurobiolaging.2008.03.010; Kumar A, 2005, BRAIN RES, V1031, P125, DOI 10.1016/j.brainres.2004.10.023; Kumar A, 2007, J NEUROPHYSIOL, V98, P594, DOI 10.1152/jn.00249.2007; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Manahan-Vaughan D, 2000, CEREB CORTEX, V10, P482, DOI 10.1093/cercor/10.5.482; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Norris CM, 1998, J NEUROSCI, V18, P3171; Norris CM, 1996, J NEUROSCI, V16, P5382; Roman FS, 1999, PROG NEUROBIOL, V58, P61, DOI 10.1016/S0301-0082(98)00076-8; Schuchmann S, 2000, J NEUROPHYSIOL, V83, P1710, DOI 10.1152/jn.2000.83.3.1710; Taubenfeld SM, 2002, J NEUROCHEM, V81, P1348, DOI 10.1046/j.1471-4159.2002.00936.x; Thiels E, 1996, HIPPOCAMPUS, V6, P43, DOI 10.1002/(SICI)1098-1063(1996)6:1<43::AID-HIPO8>3.0.CO;2-8; Toescu EC, 2004, J CELL MOL MED, V8, P181, DOI 10.1111/j.1582-4934.2004.tb00273.x; Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001; van Dam EJM, 2004, EUR J NEUROSCI, V19, P112, DOI 10.1111/j.1460-9568.2004.03103.x; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Vouimba RM, 2000, BRAIN RES BULL, V53, P783, DOI 10.1016/S0361-9230(00)00377-4; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; Xiong H, 2004, NEUROBIOL AGING, V25, P349, DOI 10.1016/S0197-4580(03)00123-4; Xiong J, 2002, J NEUROSCI, V22, P10761; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9843	10.1371/journal.pone.0009843	http://dx.doi.org/10.1371/journal.pone.0009843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352095	Green Published, gold			2022-12-27	WOS:000275894500012
J	Tarazona-Santos, E; Fabbri, C; Yeager, M; Magalhaes, WC; Burdett, L; Crenshaw, A; Pettener, D; Chanock, SJ				Tarazona-Santos, Eduardo; Fabbri, Cristina; Yeager, Meredith; Magalhaes, Wagner C.; Burdett, Laurie; Crenshaw, Andrew; Pettener, Davide; Chanock, Stephen J.			Diversity in the Glucose Transporter-4 Gene (SLC2A4) in Humans Reflects the Action of Natural Selection along the Old-World Primates Evolution	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; HUMAN GENOME; RECOMBINATION HOTSPOTS; GLUCOSE-TRANSPORTER; POPULATION-GENETICS; HAPLOTYPE STRUCTURE; POSITIVE SELECTION; POLYMORPHISM; MODEL; ASSOCIATION	Background: Glucose is an important source of energy for living organisms. In vertebrates it is ingested with the diet and transported into the cells by conserved mechanisms and molecules, such as the trans-membrane Glucose Transporters (GLUTs). Members of this family have tissue specific expression, biochemical properties and physiologic functions that together regulate glucose levels and distribution. GLUT4-coded by SLC2A4 (17p13) is an insulin-sensitive transporter with a critical role in glucose homeostasis and diabetes pathogenesis, preferentially expressed in the adipose tissue, heart muscle and skeletal muscle. We tested the hypothesis that natural selection acted on SLC2A4. Methodology/Principal Findings: We re-sequenced SLC2A4 and genotyped 104 SNPs along a similar to 1 Mb region flanking this gene in 102 ethnically diverse individuals. Across the studied populations (African, European, Asian and Latin-American), all the eight common SNPs are concentrated in the N-terminal region upstream of exon 7 (similar to 3700 bp), while the C-terminal region downstream of intron 6 (similar to 2600 bp) harbors only 6 singletons, a pattern that is not compatible with neutrality for this part of the gene. Tests of neutrality based on comparative genomics suggest that: (1) episodes of natural selection (likely a selective sweep) predating the coalescent of human lineages, within the last 25 million years, account for the observed reduced diversity downstream of intron 6 and, (2) the target of natural selection may not be in the SLC2A4 coding sequence. Conclusions: We propose that the contrast in the pattern of genetic variation between the N-terminal and C-terminal regions are signatures of the action of natural selection and thus follow-up studies should investigate the functional importance of differnet regions of the SLC2A4 gene.	[Tarazona-Santos, Eduardo; Fabbri, Cristina; Magalhaes, Wagner C.; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Tarazona-Santos, Eduardo; Magalhaes, Wagner C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Fabbri, Cristina; Pettener, Davide] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Bologna, Italy; [Yeager, Meredith; Burdett, Laurie; Crenshaw, Andrew] NCI, Intramural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA; [Yeager, Meredith; Burdett, Laurie; Crenshaw, Andrew] NCI, Core Genotype Facil, NIH, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal de Minas Gerais; University of Bologna; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tarazona-Santos, E (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	edutars@icb.ufmg.br	Tarazona-Santos, Eduardo/AAF-1110-2019; Yeager, Meredith/AAA-5322-2020; Fripp, Jurgen/A-8763-2011; Chetelat, Gael/G-2316-2015; Bourgeat, Pierrick T/A-1419-2010; Pettener, Davide/E-1576-2017; Magalhaes, Wagner CS/D-8822-2015; Salvado, Olivier/C-8910-2009; IBL, A/C-8408-2013	Fripp, Jurgen/0000-0001-9705-0079; Bourgeat, Pierrick T/0000-0002-2605-4766; Salvado, Olivier/0000-0002-2720-8739; Tarazona, Eduardo/0000-0003-3508-3160	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; University of Bologna; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil); Brazilian Ministry of Education (Agency for the Development of Graduate Education-CAPES)	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Bologna; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Ministry of Education (Agency for the Development of Graduate Education-CAPES)	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. CF and DP were supported by the University of Bologna, ET-S by NIH, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) and Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil) and WCSM by Brazilian Ministry of Education (Agency for the Development of Graduate Education-CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; BANDELT HJ, 1995, GENETICS, V141, P743; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand-Miller Jennie, 2007, Curr Atheroscler Rep, V9, P479, DOI 10.1007/s11883-007-0064-x; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; FU YX, 1993, GENETICS, V133, P693; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes AL, 2008, GENOMICS, V92, P1, DOI 10.1016/j.ygeno.2008.03.005; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li N, 2003, GENETICS, V165, P2213; McDonald JH, 1998, MOL BIOL EVOL, V15, P377, DOI 10.1093/oxfordjournals.molbev.a025934; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Oshel KM, 2000, J BIOL CHEM, V275, P23666, DOI 10.1074/jbc.M001452200; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Suh SH, 2007, MOL CELLS, V23, P272; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tarazona-Santos E, 2005, GENES IMMUN, V6, P53, DOI 10.1038/sj.gene.6364149; Tarazona-Santos E, 2008, HUM MUTAT, V29, P623, DOI 10.1002/humu.20667; Teran-Garcia M, 2008, J APPL PHYSIOL, V105, P988, DOI 10.1152/japplphysiol.00070.2008; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang Z., 2007, HDB STAT GENETICS, V1, P377; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9827	10.1371/journal.pone.0009827	http://dx.doi.org/10.1371/journal.pone.0009827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352120	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400027
J	Tissot, AC; Renhofa, R; Schmitz, N; Cielens, I; Meijerink, E; Ose, V; Jennings, GT; Saudan, P; Pumpens, P; Bachmann, MF				Tissot, Alain C.; Renhofa, Regina; Schmitz, Nicole; Cielens, Indulis; Meijerink, Edwin; Ose, Velta; Jennings, Gary T.; Saudan, Philippe; Pumpens, Paul; Bachmann, Martin F.			Versatile Virus-Like Particle Carrier for Epitope Based Vaccines	PLOS ONE			English	Article							INFLUENZA-A VACCINE; ADVANCED PROSTATE-CANCER; PHASE-I SAFETY; AUTOIMMUNE ARTHRITIS; EXTRACELLULAR DOMAIN; PRECLINICAL EFFICACY; ACTIVE IMMUNIZATION; COAT PROTEIN; PHAGE; IMMUNOGENICITY	Background: Recombinant proteins and in particular single domains or peptides are often poorly immunogenic unless conjugated to a carrier protein. Virus-like-particles are a very efficient means to confer high immunogenicity to antigens. We report here the development of virus-like-particles (VLPs) derived from the RNA bacteriophage AP205 for epitope-based vaccines. Methodology/Principal Findings: Peptides of angiotensin II, S. typhi outer membrane protein (D2), CXCR4 receptor, HIV1 Nef, gonadotropin releasing hormone (GnRH), Influenza A M2-protein were fused to either N-or C-terminus of AP205 coat protein. The A205-peptide fusions assembled into VLPs, and peptides displayed on the VLP were highly immunogenic in mice. GnRH fused to the C-terminus of AP205 induced a strong antibody response that inhibited GnRH function in vivo. Exposure of the M2-protein peptide at the N-terminus of AP205 resulted in a strong M2-specific antibody response upon immunization, protecting 100% of mice from a lethal influenza infection. Conclusions/Significance: AP205 VLPs are therefore a very efficient and new vaccine system, suitable for complex and long epitopes, of up to at least 55 amino acid residues in length. AP205 VLPs confer a high immunogenicity to displayed epitopes, as shown by inhibition of endogenous GnRH and protective immunity against influenza infection.	[Tissot, Alain C.; Schmitz, Nicole; Meijerink, Edwin; Jennings, Gary T.; Saudan, Philippe; Bachmann, Martin F.] Cytos Biotechnol AG, Zurich, Switzerland; [Renhofa, Regina; Cielens, Indulis; Ose, Velta; Pumpens, Paul] Latvian Biomed Res & Study Ctr, Riga, Latvia	Latvian Biomedical Research & Study Centre	Tissot, AC (corresponding author), Cytos Biotechnol AG, Zurich, Switzerland.	paul@biomed.lu.lv; martin.bachmann@cytos.com	Pumpens, Paul/A-2163-2008		Cytos Biotechnology AG	Cytos Biotechnology AG	The work was funded by Cytos Biotechnology AG. The authors of the manuscript were employees or collaborators of the funder at the time of performance of the work. The funding source supported financially the performance of the experiments. Data analysis and interpretation was performed exclusively by the authors.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Armstrong EP, 2007, J MANAGE CARE PHARM, V13, pS12; Bachmann MF, 1999, CURR OPIN IMMUNOL, V11, P332, DOI 10.1016/S0952-7915(99)80053-3; Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284; Chackerian B, 2004, J VIROL, V78, P4037, DOI 10.1128/JVI.78.8.4037-4047.2004; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Cielens I, 2000, FEBS LETT, V482, P261, DOI 10.1016/S0014-5793(00)02061-5; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Hsu CT, 2000, CANCER RES, V60, P3701; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Klovins J, 2002, J GEN VIROL, V83, P1523, DOI 10.1099/0022-1317-83-6-1523; Kozlovska TM, 1996, INTERVIROLOGY, V39, P9, DOI 10.1159/000150469; KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Labrie F, 2004, J ANDROL, V25, P305; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; Meinke A, 2005, VACCINE, V23, P2035, DOI 10.1016/j.vaccine.2005.01.005; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; O'Hagan DT, 2004, DRUG DISCOV TODAY, V9, P846, DOI 10.1016/S1359-6446(04)03234-9; Parkinson RJ, 2004, EUR UROL, V45, P171, DOI 10.1016/j.eururo.2003.10.007; Pumpens P, 2002, INTERVIROLOGY, V45, P24, DOI 10.1159/000050084; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; PUSHKO P, 1993, PROTEIN ENG, V6, P883, DOI 10.1093/protein/6.8.883; PUSHKO P, 1994, VIROLOGY, V202, P912, DOI 10.1006/viro.1994.1413; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Simms MS, 2000, BRIT J CANCER, V83, P443, DOI 10.1054/bjoc.2000.1315; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450; TALWAR GP, 1992, INT J IMMUNOPHARMACO, V14, P511, DOI 10.1016/0192-0561(92)90183-L; Tars K, 2000, ACTA CRYSTALLOGR D, V56, P398, DOI 10.1107/S0907444900001232; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	41	129	145	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9809	10.1371/journal.pone.0009809	http://dx.doi.org/10.1371/journal.pone.0009809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352110	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894400014
J	Li, S; Rao, LL; Bai, XW; Zheng, R; Ren, XP; Li, JZ; Wang, ZJ; Liu, H; Zhang, K				Li, Shu; Rao, Li-Lin; Bai, Xin-Wen; Zheng, Rui; Ren, Xiao-Peng; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan; Zhang, Kan			Progression of the "Psychological Typhoon Eye" and Variations Since the Wenchuan Earthquake	PLOS ONE			English	Article								Background: In 2008 after a massive earthquake jolted Wenchuan, China, we reported an effect that we termed a "Psychological Typhoon Eye'': the closer to the center of the devastated area, the lower the level of concern felt by residents about safety and health. We now report on the progression of this effect and the development of new variations after the quake as well as investigating potential explanations. Methodology/Principal Findings: We conducted two sequential surveys of 5,216 residents in non-devastated and devastated areas in September-October 2008 and April-May 2009. Respondents were asked five questions to assess their concerns about safety and health. A MANCOVA showed a significant inverse effect of residential devastation level on the estimated number of medical and psychological workers needed, the estimated probability of an epidemic outbreak, and the estimated number of self-protective behaviors needed (Ps < 0.001), in spite of the passage of one year. The level of post-earthquake concern decreased significantly with an increase in the residential devastation level. Additionally, we observed two variations in the "Psychological Typhoon Eye'' effect, in that the respondents' concern decreased with increasing relational distance between a respondent and victims who had suffered either physical or economic damage. Conclusions/Significance: The previously reported effect of a "Psychological Typhoon Eye'' remains robust over a 1-year period. We found that the "psychological immunization'' theory did not provide a satisfactory explanation for these intriguing results. Our findings may be useful in understanding how people become resilient to threats.	[Li, Shu; Rao, Li-Lin; Bai, Xin-Wen; Zheng, Rui; Ren, Xiao-Peng; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Rao, Li-Lin; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, S (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	lishu@psych.ac.cn; zhangk@psych.ac.cn	Xinwen, Bai/A-3827-2014	Xinwen, Bai/0000-0002-4750-4164; li, shu/0000-0003-4402-1674	Chinese Academy of Sciences [KSCX2-YW-R-130, KKCX1-YW-05]; National Natural Science Foundation of China [70871110]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-130; KKCX1-YW-05) and the National Natural Science Foundation of China (No. 70871110). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAPLOW T, 1982, AM SOCIOL REV, V47, P383, DOI 10.2307/2094994; Festinger L., 1957, THEORY COGNITIVE DIS, V2; HENDERSON AS, 1972, LANCET, V1, P1111; Li S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004964; SILVERMAN RA, 1987, J CRIM LAW CRIM, V78, P272, DOI 10.2307/1143450; *XINH NEWS AG, 2009, CHIN AL PREV SWIN FL; *XINH NEWS AG, 2009, DEATH TOLL CHIN MAY; *XINH NEWS AG, 2009, CHIN REP SUSP CAS A; 2009, NATURE, V459, P139	9	22	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9727	10.1371/journal.pone.0009727	http://dx.doi.org/10.1371/journal.pone.0009727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	572EG	20305817	gold, Green Submitted, Green Published			2022-12-27	WOS:000275809600003
J	Boscolo, S; Lorenzon, A; Sblattero, D; Florian, F; Stebel, M; Marzari, R; Not, T; Aeschlimann, D; Ventura, A; Hadjivassiliou, M; Tongiorgi, E				Boscolo, Sabrina; Lorenzon, Andrea; Sblattero, Daniele; Florian, Fiorella; Stebel, Marco; Marzari, Roberto; Not, Tarcisio; Aeschlimann, Daniel; Ventura, Alessandro; Hadjivassiliou, Marios; Tongiorgi, Enrico			Anti Transglutaminase Antibodies Cause Ataxia in Mice	PLOS ONE			English	Article							TISSUE-TYPE TRANSGLUTAMINASE; CELIAC-DISEASE; GLUTEN ATAXIA; CEREBELLAR-ATAXIA; INTRAVENOUS IMMUNOGLOBULIN; HUMAN BRAIN; IN-VIVO; AUTOANTIBODIES; IDENTIFICATION; CONSTRUCTION	Background: Celiac disease (CD) is an autoimmune gastrointestinal disorder characterized by the presence of anti-transglutaminase 2 (TG2) and anti-gliadin antibodies. Amongst the neurological dysfunctions associated with CD, ataxia represents the most common one. Methods: We analyzed by immunohistochemistry, the anti-neural reactivity of the serum from 20 CD patients. To determine the role of anti-TG2 antibodies in ataxia, two anti-TG2 single chain variable fragments (scFv), isolated from a phage-display IgA antibody library, were characterized by immunohistochemistry and ELISA, and injected in mice to study their effects on motor coordination. We found that 75% of the CD patient population without evidence of neurological involvement, has circulating anti-neural IgA and/or IgG antibodies. Two anti-TG2 scFvs, cloned from one CD patient, stained blood vessels but only one reacted with neurons. This anti-TG2 antibody showed cross reactivity with the transglutaminase isozymes TG3 and TG6. Intraventricular injection of the anti-TG2 or the anti-TG2/3/6 cross-reactive scFv provoked transient, equally intensive ataxia in mice. Conclusion: The serum from CD patients contains anti-TG2, TG3 and TG6 antibodies that may potentially cause ataxia.	[Boscolo, Sabrina; Tongiorgi, Enrico] Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy; [Lorenzon, Andrea; Stebel, Marco] Univ Trieste, CSPA, Trieste, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Not, Tarcisio; Ventura, Alessandro] Univ Trieste, Inst Childhood Dis, IRCCS Burlo Garofolo, Dept Reprod & Dev Sci, Trieste, Italy; [Aeschlimann, Daniel] Cardiff Univ, Sch Dent, Matrix Biol & Tissue Repair Res Unit, Cardiff, S Glam, Wales; [Hadjivassiliou, Marios] Royal Hallamshire Hosp, Dept Clin Neurol, Sheffield S10 2JF, S Yorkshire, England	University of Trieste; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; IRCCS Burlo Garofolo; University of Trieste; Cardiff University; University of Sheffield	Boscolo, S (corresponding author), Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy.	sboscolo@units.it	ghebretinsae, selamawit/B-1448-2012; Not, Tarcisio/K-2616-2018	Not, Tarcisio/0000-0003-1059-3009; Lorenzon, Andrea/0000-0002-5766-9034; Ventura, Alessandro/0000-0002-4657-1760; Aeschlimann, Daniel/0000-0003-0930-7706; Sblattero, Daniele/0000-0003-4309-242X; Tongiorgi, Enrico/0000-0003-0485-0603	Telethon Foundation [E. 1270, E. 1141]; Fondazione Cassa di Risparmio di Trieste; National Ataxia Foundation; Bardhan Research and Education Trust of Rotherham; Ryder Briggs Trust	Telethon Foundation(Fondazione Telethon); Fondazione Cassa di Risparmio di Trieste; National Ataxia Foundation; Bardhan Research and Education Trust of Rotherham; Ryder Briggs Trust	This study was supported by Telethon Foundation (http://www.telethon.it/Pagine/homepage.aspx) grants E. 1270 to A. V. and E. T. and E. 1141 to D. S., Fondazione Cassa di Risparmio di Trieste to E. T., R. M. and A. V., National Ataxia Foundation (http://www.ataxia.org/) award to E. T., and grants from the Bardhan Research and Education Trust of Rotherham and the Ryder Briggs Trust to D. A., N. W. and M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CDC, 2004, MOL CELL NEUROSCI, V25, P493, DOI 10.1016/j.mcn.2003.11.016; Bakker ENTP, 2005, CIRC RES, V96, P119, DOI 10.1161/01.RES.0000151333.56089.66; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Baumgartner W, 2007, J VASC RES, V44, P234, DOI 10.1159/000100422; Boscolo S, 2006, J IMMUNOL METHODS, V309, P139, DOI 10.1016/j.jim.2005.11.020; Boscolo S, 2007, ANN NY ACAD SCI, V1107, P319, DOI 10.1196/annals.1381.034; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Cannistraci C, 2007, J EUR ACAD DERMATOL, V21, P509, DOI 10.1111/j.1468-3083.2006.02017.x; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Festoff BW, 2002, J NEUROCHEM, V81, P708, DOI 10.1046/j.1471-4159.2002.00850.x; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Hadjivassiliou M, 2006, NEUROLOGY, V66, P373, DOI 10.1212/01.wnl.0000196480.55601.3a; Hadjivassiliou M, 1998, LANCET, V352, P1582, DOI 10.1016/S0140-6736(98)05342-2; Hadjivassiliou M, 2002, NEUROLOGY, V58, P1221, DOI 10.1212/WNL.58.8.1221; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Luostarinen L, 2001, EUR NEUROL, V46, P187, DOI 10.1159/000050802; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Nanri K, 2009, INTERNAL MED, V48, P783, DOI 10.2169/internalmedicine.48.1802; OHASHI H, 1995, J BIOCHEM-TOKYO, V118, P1271, DOI 10.1093/oxfordjournals.jbchem.a125018; Picarelli A, 1996, LANCET, V348, P1065, DOI 10.1016/S0140-6736(96)03060-7; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Pratesi R, 1998, SCAND J GASTROENTERO, V33, P817; Sander HW, 2003, LANCET, V362, P1548, DOI 10.1016/S0140-6736(03)14743-5; Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253; Sblattero D, 2004, J AUTOIMMUN, V22, P65, DOI 10.1016/j.jaut.2003.09.004; Sblattero D, 2002, EUR J BIOCHEM, V269, P5175, DOI 10.1046/j.1432-1033.2002.03215.x; Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Sblattero Daniele, 2000, Human Antibodies, V9, P199; Schrodl D, 2004, J AUTOIMMUN, V22, P335, DOI 10.1016/j.jaut.2004.02.001; Souayah N, 2008, EUR J NEUROL, V15, P1300, DOI 10.1111/j.1468-1331.2008.02305.x; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603	41	65	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9698	10.1371/journal.pone.0009698	http://dx.doi.org/10.1371/journal.pone.0009698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300628	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000275621000015
J	Zhou, Q; Gheiratmand, L; Chen, YX; Lim, TK; Zhang, J; Li, SW; Xia, NS; Liu, BH; Lin, QS; He, CY				Zhou, Qing; Gheiratmand, Ladan; Chen, Yixin; Lim, Teck Kwang; Zhang, Jun; Li, Shaowei; Xia, Ningshao; Liu, Binghai; Lin, Qingsong; He, Cynthia Y.			A Comparative Proteomic Analysis Reveals a New Bi-Lobe Protein Required for Bi-Lobe Duplication and Cell Division in Trypanosoma brucei	PLOS ONE			English	Article							FLAGELLUM ATTACHMENT; AFRICAN TRYPANOSOMES; GOLGI DUPLICATION; CYTOKINESIS; SEGREGATION; MEMBRANE; CYTOSKELETAL; EXPRESSION; DYNAMICS; CENTRIN	A Golgi-associated bi-lobed structure was previously found to be important for Golgi duplication and cell division in Trypanosoma brucei. To further understand its functions, comparative proteomics was performed on extracted flagellar complexes (including the flagellum and flagellum-associated structures such as the basal bodies and the bi-lobe) and purified flagella to identify new bi-lobe proteins. A leucine-rich repeats containing protein, TbLRRP1, was characterized as a new bi-lobe component. The anterior part of the TbLRRP1-labeled bi-lobe is adjacent to the single Golgi apparatus, and the posterior side is tightly associated with the flagellar pocket collar marked by TbBILBO1. Inducible depletion of TbLRRP1 by RNA interference inhibited duplication of the bi-lobe as well as the adjacent Golgi apparatus and flagellar pocket collar. Formation of a new flagellum attachment zone and subsequent cell division were also inhibited, suggesting a central role of bi-lobe in Golgi, flagellar pocket collar and flagellum attachment zone biogenesis.	[Zhou, Qing; Gheiratmand, Ladan; Lim, Teck Kwang; Liu, Binghai; Lin, Qingsong; He, Cynthia Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chen, Yixin; Zhang, Jun; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China	National University of Singapore; Xiamen University	Zhou, Q (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyc@nus.edu.sg	Lin, Qingsong/H-9794-2012; Xia, NS/G-4647-2010; Chen, YX/G-3937-2010; Zhang, Jun/G-4598-2010; Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019; He, Cynthia/H-9789-2012	Lin, Qingsong/0000-0001-9117-8514; Zhang, Jun/0000-0002-6601-9180; Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Xia, Ningshao/0000-0003-0179-5266	Singapore Biomedical Research Council [07/1/21/19/515]; Singapore National Research Foundation	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation(National Research Foundation, Singapore)	This study is supported by Singapore Biomedical Research Council (grant number: 07/1/21/19/515). CYH is a research fellow of the Singapore National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bastin P, 1999, J CELL SCI, V112, P3769; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Fevre EM, 2006, ADV PARASIT, V61, P167, DOI 10.1016/S0065-308X(05)61005-6; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; ISMACH R, 1989, J PROTOZOOL, V36, P617, DOI 10.1111/j.1550-7408.1989.tb01105.x; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; MCKEITHAN TW, 1981, J CELL BIOL, V91, P352, DOI 10.1083/jcb.91.2.352; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; RUBEN L, 1983, BIOCHIM BIOPHYS ACTA, V758, P104, DOI 10.1016/0304-4165(83)90290-8; Salisbury JL, 2007, J CELL PHYSIOL, V213, P420, DOI 10.1002/jcp.21226; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; SILVA NLD, 1989, MOL BIOCHEM PARASIT, V37, P129, DOI 10.1016/0166-6851(89)90109-6; Tan HT, 2008, MOL CELL PROTEOMICS, V7, P1174, DOI 10.1074/mcp.M700483-MCP200; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yelinek JT, 2009, TRAFFIC, V10, P300, DOI 10.1111/j.1600-0854.2008.00873.x	37	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9660	10.1371/journal.pone.0009660	http://dx.doi.org/10.1371/journal.pone.0009660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300570	gold, Green Published, Green Submitted			2022-12-27	WOS:000275621000003
J	Chatagnon, A; Ballestar, E; Esteller, M; Dante, R				Chatagnon, Amandine; Ballestar, Esteban; Esteller, Manel; Dante, Robert			A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2/TFF1 Gene	PLOS ONE			English	Article							CANCER-CELL-LINES; DNA METHYLATION; BREAST-CANCER; PS2 GENE; CHROMATIN-STRUCTURE; EPIGENETIC REGULATION; ACTIVE CHROMATIN; PROMOTER DNA; EXPRESSION; TRANSCRIPTION	Background: In human Estrogen Receptor alpha (ER alpha)-positive breast cancers, 59 end dense methylation of the estrogen-regulated pS2/TFF1 gene correlates with its transcriptional inhibition. However, in some ER alpha-rich biopsies, pS2 expression is observed despite the methylation of its TATA-box region. Herein, we investigated the methylation-dependent mechanism of pS2 regulation. Methodology/Principal Findings: We observed interplay between Methyl-CpG Binding Domain protein 2 (MBD2) transcriptional repressor and ER alpha transactivator: (i) the pS2 gene is poised for transcription upon demethylation limited to the enhancer region containing the estrogen responsive element (ERE); (ii) MBD2-binding sites overlapped with the methylation status of the pS2 59 end; (iii) MBD2 depletion elevated pS2 expression and ectopic expression of ER alpha partially overcame the inhibitory effect of MBD2 when the ERE is unmethylated. Furthermore, serial chromatin immunoprecipitation assays indicated that MBD2 and ER alpha could simultaneously occupy the same pS2 DNA molecule; (iv) concomitant ectopic ER alpha expression and MBD2 depletion resulted in synergistic transcriptional stimulation, while the pS2 promoter remains methylated. Conclusions/Significance: MBD2 and ER alpha drive opposite effects on pS2 expression, which are associated with specific steady state levels of histone H3 acetylation and methylation marks. Thus, epigenetic silencing of pS2 could be dependent on balance of the relative intracellular concentrations of ER alpha and MBD2.	[Chatagnon, Amandine; Dante, Robert] INSERM, U590, F-69008 Lyon, France; [Ballestar, Esteban; Esteller, Manel] ICO IDIBELL, PEBC, Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Chatagnon, A (corresponding author), INSERM, U590, F-69008 Lyon, France.	dante@univ-lyon1.f	Esteller, Manel/L-5956-2014; Ballestar, Esteban/ABG-8561-2020	Esteller, Manel/0000-0003-4490-6093; Ballestar, Esteban/0000-0002-1400-2440	Ligue Nationale contre le Cancer (Comite du Rhene and Comite de la Loire); Institut National contre le Cancer (EpiPro and CircBio)	Ligue Nationale contre le Cancer (Comite du Rhene and Comite de la Loire); Institut National contre le Cancer (EpiPro and CircBio)	The present work was supported by the Ligue Nationale contre le Cancer (Comite du Rhene and Comite de la Loire), the Institut National contre le Cancer (EpiPro and CircBio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; Auriol E, 2005, NUCLEIC ACIDS RES, V33, P4243, DOI 10.1093/nar/gki729; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; HUANG LH, 1984, NATURE, V308, P293, DOI 10.1038/308293a0; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Martin V, 1998, BIOL CHEM, V379, P409, DOI 10.1515/bchm.1998.379.4-5.409; Martin V, 1997, J CELL BIOCHEM, V65, P95, DOI 10.1002/(SICI)1097-4644(199704)65:1<95::AID-JCB10>3.0.CO;2-G; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; METZGER D, 1995, MOL ENDOCRINOL, V9, P579, DOI 10.1210/me.9.5.579; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pao MM, 2001, HUM MOL GENET, V10, P903, DOI 10.1093/hmg/10.9.903; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243; Sahar S, 2007, CELL CYCLE, V6, P1329, DOI 10.4161/cc.6.11.4295; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9665	10.1371/journal.pone.0009665	http://dx.doi.org/10.1371/journal.pone.0009665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300195	Green Published, Green Submitted, gold			2022-12-27	WOS:000275620900005
J	Conte, D; MacWilliams, HK; Ceccarelli, A				Conte, Daniele; MacWilliams, Harry K.; Ceccarelli, Adriano			BTG Interacts with Retinoblastoma to Control Cell Fate in Dictyostelium	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PC3/BTG/TOB FAMILY; GENE-EXPRESSION; DIFFERENTIATION; DISCOIDEUM; GROWTH; VECTORS; PROTEIN; MEMBER; CAMP	Background: In the genesis of many tissues, a phase of cell proliferation is followed by cell cycle exit and terminal differentiation. The latter two processes overlap: genes involved in the cessation of growth may also be important in triggering differentiation. Though conceptually distinct, they are often causally related and functional interactions between the cell cycle machinery and cell fate control networks are fundamental to coordinate growth and differentiation. A switch from proliferation to differentiation may also be important in the life cycle of single-celled organisms, and genes which arose as regulators of microbial differentiation may be conserved in higher organisms. Studies in microorganisms may thus contribute to understanding the molecular links between cell cycle machinery and the determination of cell fate choice networks. Methodology/Principal Findings: Here we show that in the amoebozoan D. discoideum, an ortholog of the metazoan antiproliferative gene btg controls cell fate, and that this function is dependent on the presence of a second tumor suppressor ortholog, the retinoblastoma-like gene product. Specifically, we find that btg-overexpressing cells preferentially adopt a stalk cell (and, more particularly, an Anterior-Like Cell) fate. No btg-dependent preference for ALC fate is observed in cells in which the retinoblastoma-like gene has been genetically inactivated. Dictyostelium btg is the only example of non-metazoan member of the BTG family characterized so far, suggesting that a genetic interaction between btg and Rb predated the divergence between dictyostelids and metazoa. Conclusions/Significance: While the requirement for retinoblastoma function for BTG antiproliferative activity in metazoans is known, an interaction of these genes in the control of cell fate has not been previously documented. Involvement of a single pathway in the control of mutually exclusive processes may have relevant implication in the evolution of multicellularity.	[Conte, Daniele; Ceccarelli, Adriano] Univ Turin, Dipartimento Sci Clin & Biol, Orbassano, Italy; [MacWilliams, Harry K.] Univ Munich, Dept Biol 2, Biozentrum, Munich, Germany	University of Turin; University of Munich	Conte, D (corresponding author), Univ Turin, Dipartimento Sci Clin & Biol, Orbassano, Italy.	adriano.ceccarelli@unito.it			Italian Ministry of University and Scientific Research	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant to A. C. from the Italian Ministry of University and Scientific Research (prin 2006-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Ceccarelli A, 2000, DIFFERENTIATION, V66, P189, DOI 10.1046/j.1432-0436.2000.660405.x; Coyne C, 1999, DEV GENES EVOL, V209, P63, DOI 10.1007/s004270050228; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; ESCH RK, 1991, GENE DEV, V5, P9, DOI 10.1101/gad.5.1.9; FAIX J, 1992, J CELL SCI, V102, P203; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fukuzawa M, 2006, DEVELOPMENT, V133, P1715, DOI 10.1242/dev.02327; Gaudet P, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e5; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; HARWOOD AJ, 1990, NUCLEIC ACIDS RES, V18, P4292, DOI 10.1093/nar/18.14.4292; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Keller T, 2008, DEVELOPMENT, V135, P1635, DOI 10.1242/dev.020883; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; MacWilliams H, 2006, DEVELOPMENT, V133, P1287, DOI 10.1242/dev.02287; MacWilliams H, 2001, DIFFERENTIATION, V67, P12, DOI 10.1046/j.1432-0436.2001.067001012.x; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Muller-Taubenberger A, 2009, CELL MOTIL CYTOSKEL, V66, P929, DOI 10.1002/cm.20386; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; SIVE H, EARLY DEV XENOPUS LE, P249; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; Thompson CRL, 2000, DEV BIOL, V227, P56, DOI 10.1006/dbio.2000.9877; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tsujioka M, 2007, EUKARYOT CELL, V6, P568, DOI 10.1128/EC.00373-06; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171	30	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9676	10.1371/journal.pone.0009676	http://dx.doi.org/10.1371/journal.pone.0009676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300194	gold, Green Published, Green Submitted			2022-12-27	WOS:000275620900010
J	Bruyere, F; Melen-Lamalle, L; Blacher, S; Detry, B; Masset, A; Lecomte, J; Lambert, V; Maillard, C; Hoyer-Hansen, G; Lund, LR; Foidart, JM; Noel, A				Bruyere, Francoise; Melen-Lamalle, Laurence; Blacher, Silvia; Detry, Benoit; Masset, Anne; Lecomte, Julie; Lambert, Vincent; Maillard, Catherine; Hoyer-Hansen, Gunilla; Lund, Leif R.; Foidart, Jean-Michel; Noel, Agnes			Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; BREAST-CANCER; TUMOR-GROWTH; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; TYPE-1; MICE; VASCULARIZATION; MORPHOGENESIS	The purpose of this study is to explore the function of plasminogen activator inhibitor-1 (PAI-1) during pathological lymphangiogenesis. PAI-1, the main physiological inhibitor of plasminogen activators is involved in pathological angiogenesis at least by controlling extracellular proteolysis and by regulating endothelial cell survival and migration. Protease system's role in lymphangiogenesis is unknown yet. Thus, based on its important pro-angiogenic effect, we hypothesized that PAI-1 may regulate lymphangiogenesis associated at least with metastatic dissemination of cancer cells. To address this issue, we studied the impact of PAI-1 deficiency in various murine models of tumoral lymphangiogenesis. Wild-type PAI-1 proficient mice were used as controls. We provide for the first time evidence that PAI-1 is dispensable for tumoral lymphangiogenesis associated with breast cancers either induced by mammary carcinoma cell injection or spontaneously appearing in transgenic mice expressing the polyomavirus middle T antigen (PymT) under the control of a mouse mammary tumor virus long-terminal repeat promoter (MMTV-LTR). We also investigated inflammation-related lymphatic vessel recruitment by using two inflammatory models. PAI-1 deficiency did neither affect the development of lymphangioma nor burn-induced corneal lymphangiogenesis. These novel data suggest that vascular remodelling associated with lymphangiogenesis and angiogenesis involve different molecular determinants. PAI-1 does not appear as a potential therapeutic target to counteract pathological lymphangiogenesis.	[Bruyere, Francoise; Melen-Lamalle, Laurence; Blacher, Silvia; Detry, Benoit; Masset, Anne; Lecomte, Julie; Lambert, Vincent; Maillard, Catherine; Foidart, Jean-Michel; Noel, Agnes] Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, Liege, Belgium; [Lambert, Vincent] Ctr Hosp Univ, Dept Ophthalmol, Liege, Belgium; [Hoyer-Hansen, Gunilla; Lund, Leif R.] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Foidart, Jean-Michel] Ctr Hosp Univ, Dept Gynecol, Liege, Belgium	University of Liege; University of Liege; Rigshospitalet; University of Copenhagen; University of Liege	Bruyere, F (corresponding author), Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, Liege, Belgium.	agnes.noel@ulg.ac.be		Noel, Agnes/0000-0002-7670-6179	European Union [FP7-2007-2011, 201279]; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (F.N.R.S., Belgium); Fondation contre le Cancer; Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); "Region Wallonne"; Televie-FNRS	European Union(European Commission); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (F.N.R.S., Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer; Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); "Region Wallonne"; Televie-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the European Union Framework Program projects (FP7-2007-2011 "MICROENVIMET'' No 201279), the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), the Fondation contre le Cancer, the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the D.G.T.R.E. from the "Region Wallonne", the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium). FB, BD, AM and JL are recipients of a Televie-FNRS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Aurora AB, 2005, J IMMUNOL, V175, P6319, DOI 10.4049/jimmunol.175.10.6319; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Blacher S, 2009, EXP EYE RES, V89, P274, DOI 10.1016/j.exer.2009.02.021; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Chuang-Tsai S, 2003, AM J PATHOL, V163, P445, DOI 10.1016/S0002-9440(10)63674-7; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; FENTON BM, 1979, MICROVASC RES, V18, P153, DOI 10.1016/0026-2862(79)90025-6; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Gutierrez LS, 2000, CANCER RES, V60, P5839; HENNO A, 2008, BR J DERMATOL; Hojilla CV, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1980; Jost M, 2007, AM J PATHOL, V171, P1369, DOI 10.2353/ajpath.2007.070074; Karpanen T, 2001, CANCER RES, V61, P1786; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Lambert V, 2003, INVEST OPHTH VIS SCI, V44, P2791, DOI 10.1167/iovs.02-1179; Lambert V, 2001, FASEB J, V15, P1021, DOI 10.1096/fj.00-0393com; Lee C.-C., 2004, J CANC MOL, V1, P25, DOI 10.29685/JCM.200510.0003; Leik CE, 2006, J THROMB HAEMOST, V4, P2710, DOI 10.1111/j.1538-7836.2006.02244.x; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Maillard C, 2005, NEOPLASIA, V7, P57, DOI 10.1593/neo.04406; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Nakamura ES, 2004, CANCER SCI, V95, P25, DOI 10.1111/j.1349-7006.2004.tb03166.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; PHILIPJOET F, 1995, EUR RESPIR J, V8, P1352, DOI 10.1183/09031936.95.08081352; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Thiele W, 2006, J BIOTECHNOL, V124, P224, DOI 10.1016/j.jbiotec.2006.01.007; Tsuchiya Hiroyuki, 1995, General and Diagnostic Pathology, V141, P41; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	41	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9653	10.1371/journal.pone.0009653	http://dx.doi.org/10.1371/journal.pone.0009653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300183	Green Submitted, Green Published, gold			2022-12-27	WOS:000275620600009
J	Dalkic, E; Wang, XW; Wright, N; Chan, C				Dalkic, Ertugrul; Wang, Xuewei; Wright, Neil; Chan, Christina			Cancer-Drug Associations: A Complex System	PLOS ONE			English	Article							FDA APPROVED DRUGS; NETWORK; TARGETS	Background: Network analysis has been performed on large-scale medical data, capturing the global topology of drugs, targets, and disease relationships. A smaller-scale network is amenable to a more detailed and focused analysis of the individual members and their interactions in a network, which can complement the global topological descriptions of a network system. Analysis of these smaller networks can help address questions, i.e., what governs the pairing of the different cancers and drugs, is it driven by molecular findings or other factors, such as death statistics. Methodology/Principal Findings: We defined global and local lethality values representing death rates relative to other cancers vs. within a cancer. We generated two cancer networks, one of cancer types that share Food and Drug Administration (FDA) approved drugs (FDA cancer network), and another of cancer types that share clinical trials of FDA approved drugs (clinical trial cancer network). Breast cancer is the only cancer type with significant weighted degree values in both cancer networks. Lung cancer is significantly connected in the FDA cancer network, whereas ovarian cancer and lymphoma are significantly connected in the clinical trial cancer network. Correlation and linear regression analyses showed that global lethality impacts the drug approval and trial numbers, whereas, local lethality impacts the amount of drug sharing in trials and approvals. However, this effect does not apply to pancreatic, liver, and esophagus cancers as the sharing of drugs for these cancers is very low. We also collected mutation target information to generate cancer type associations which were compared with the cancer type associations derived from the drug target information. The analysis showed a weak overlap between the mutation and drug target based networks. Conclusions/Significance: The clinical and FDA cancer networks are differentially connected, with only breast cancer significantly connected in both networks. The networks of cancer-drug associations are moderately affected by the death statistics. A strong overlap does not exist between the cancer-drug associations and the molecular information. Overall, this analysis provides a systems level view of cancer drugs and suggests that death statistics (i.e. global vs. local lethality) have a differential impact on the number of approvals, trials and drug sharing.	[Dalkic, Ertugrul; Wang, Xuewei; Wright, Neil; Chan, Christina] Michigan State Univ, Ctr Syst Biol, E Lansing, MI 48824 USA; [Dalkic, Ertugrul; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, Cellular & Mol Biol Lab, E Lansing, MI 48824 USA; [Dalkic, Ertugrul; Chan, Christina] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Wang, Xuewei; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Wright, Neil] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Dalkic, E (corresponding author), Michigan State Univ, Ctr Syst Biol, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Wright, Neil/AAB-7092-2019; wang, xuewei/C-7773-2009	Wang, Xuewei/0000-0003-3679-7421	National Institutes of Health [R01GM079688-01, R21CA126136-01, R21RR024439, P42 ES004911]; Michigan Universities Commercialization Initiative (MUCI); Michigan State University Foundation; Center for Systems Biology; Michigan State University Quantitative Biology and Modeling Initiative Fellowship; NATIONAL CANCER INSTITUTE [R21CA126136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Universities Commercialization Initiative (MUCI); Michigan State University Foundation; Center for Systems Biology; Michigan State University Quantitative Biology and Modeling Initiative Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by the National Institutes of Health (R01GM079688-01, R21CA126136-01, R21RR024439, P42 ES004911), Michigan Universities Commercialization Initiative (MUCI) and the Michigan State University Foundation and the Center for Systems Biology. E. D. is supported in part by Michigan State University Quantitative Biology and Modeling Initiative Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2001, AM CANC SOC 2001 200; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Sakharkar MK, 2008, INT J BIOL SCI, V4, P15; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; TESTA JR, 1992, CANCER RES, V52, pS2702; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; YOKOTA J, 1986, LANCET, V1, P765	15	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10031	10.1371/journal.pone.0010031	http://dx.doi.org/10.1371/journal.pone.0010031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368808	Green Published, Green Submitted, gold			2022-12-27	WOS:000276419900022
J	Zhou, XX; Han, PW; Li, JM; Zhang, X; Huang, B; Ruan, HQ; Chen, C				Zhou, Xixi; Han, Peiwei; Li, Jiangmei; Zhang, Xu; Huang, Bo; Ruan, Hong-Qiang; Chen, Chang			ESNOQ, Proteomic Quantification of Endogenous S-Nitrosation	PLOS ONE			English	Article							NITROSYLATED PROTEINS; MASS-SPECTROMETRY; CELL-CULTURE; NITRIC-OXIDE; AMINO-ACIDS; SILAC; IDENTIFICATION; SITES	S-nitrosation is a post-translational protein modification and is one of the most important mechanisms of NO signaling. Endogenous S-nitrosothiol (SNO) quantification is a challenge for detailed functional studies. Here we developed an ESNOQ (Endogenous SNO Quantification) method which combines the stable isotope labeling by amino acids in cell culture (SILAC) technique with the detergent-free biotin-switch assay and LC-MS/MS. After confirming the accuracy of quantification in this method, we obtained an endogenous S-nitrosation proteome for LPS/IFN-gamma induced RAW264.7 cells. 27 S-nitrosated protein targets were confirmed and using our method we were able to obtain quantitative information on the level of S-nitrosation on each modified Cys. With this quantitative information, over 15 more S-nitrosated targets were identified than in previous studies. Based on the quantification results, we found that the S-nitrosation levels of different cysteines varied within one protein, providing direct evidence for differences in the sensitivity of cysteine residues to reactive nitrosative stress and that S-nitrosation is a site-specific modification. Gene ontology clustering shows that S-nitrosation targets in the LPS/IFN-gamma induced RAW264.7 cell model were functionally enriched in protein translation and glycolysis, suggesting that S-nitrosation may function by regulating multiple pathways. The ESNOQ method described here thus provides a solution for quantification of multiple endogenous S-nitrosation events, and makes it possible to elucidate the network of relationships between endogenous S-nitrosation targets involved in different cellular processes.	[Zhou, Xixi; Han, Peiwei; Li, Jiangmei; Zhang, Xu; Huang, Bo; Chen, Chang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Ruan, Hong-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, XX (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	changchen@moon.ibp.ac.cn	Zhou, Xixi/F-1760-2011; HUANG, Bo/ABG-2966-2021; huang, bo/B-4649-2008; Zhou, Xixi/F-6474-2013	Zhou, Xixi/0000-0003-4202-8821; huang, bo/0000-0001-5945-7601; chen, chang/0000-0003-1008-1062; , Xu/0000-0002-8103-8486	National Basic Research Program of China [2006CB911001, 2005CB522804]; National Natural Science Foundation of China [30270352, 30770512]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (2006CB911001, 2005CB522804), and the National Natural Science Foundation of China (30270352 and 30770512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gao CJ, 2005, NITRIC OXIDE-BIOL CH, V12, P121, DOI 10.1016/j.niox.2004.11.006; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Han P, 2008, RAPID COMMUN MASS SP, V22, P1137, DOI 10.1002/rcm.3476; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Sandau K, 1996, CELL SIGNAL, V8, P173, DOI 10.1016/0898-6568(95)02051-9; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; THOMPSON J, 1973, J EXP MED, V137, P10, DOI 10.1084/jem.137.1.10; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016	23	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10015	10.1371/journal.pone.0010015	http://dx.doi.org/10.1371/journal.pone.0010015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368813	Green Published, Green Submitted, gold			2022-12-27	WOS:000276419900015
J	Nishida, H; Motoyama, T; Suzuki, Y; Yamamoto, S; Aburatani, H; Osada, H				Nishida, Hiromi; Motoyama, Takayuki; Suzuki, Yutaka; Yamamoto, Shogo; Aburatani, Hiroyuki; Osada, Hiroyuki			Genome-Wide Maps of Mononucleosomes and Dinucleosomes Containing Hyperacetylated Histones of Aspergillus fumigatus	PLOS ONE			English	Article							HIGH-RESOLUTION; CHROMATIN-STRUCTURE; NUCLEOSOME; YEAST; TRANSCRIPTION; DEACETYLASES; NIDULANS; CODE	It is suggested that histone modifications and/or histone variants influence the nucleosomal DNA length. We sequenced both ends of mononucleosomal and dinucleosomal DNA fragments of the filamentous fungus Aspergillus fumigatus, after treatment with the histone deacetylase inhibitor trichostatin A (TSA). After mapping the DNA fragments to the genome, we identified >7 million mononucleosome positions and >7 million dinucleosome positions. We showed that the distributions of the lengths of the mononucleosomal DNA fragments after 15-min and 30-min treatments with micrococcal nuclease (MNase) showed a single peak at 168 nt and 160 nt, respectively. The distributions of the lengths of the dinucleosomal DNA fragments after 15-min-and 30-min-treatment with MNase showed a single peak at 321 nt and 306 nt, respectively. The nucleosomal DNA fragments obtained from the TSA-treated cells were significantly longer than those obtained from the untreated cells. On the other hand, most of the genes did not undergo any change after treatment. Between the TSA-treated and untreated cells, only 77 genes had >= 2-fold change in expression levels. In addition, our results showed that the locations where mononucleosomes were frequently detected were conserved between the TSA-treated cells and untreated cells in the gene promoters (lower density of the nucleosomes). However, these locations were less conserved in the bodies (higher density of the nucleosomes) of genes with >= 2-fold changes. Our findings indicate that TSA influences the nucleosome positions, especially of the regions with high density of the nucleosomes by elongation of the nucleosomal DNA. However, most of the nucleosome positions are conserved in the gene promoters, even after treatment with TSA, because of the low density of nucleosomes in the gene promoters.	[Nishida, Hiromi] Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan; [Motoyama, Takayuki; Osada, Hiroyuki] RIKEN, Chem Biol Core Facil, Adv Sci Inst, Wako, Saitama, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Yamamoto, Shogo; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	University of Tokyo; RIKEN; University of Tokyo; University of Tokyo	Nishida, H (corresponding author), Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan.	hnishida@iu.a.u-tokyo.ac.jp	Motoyama, Takayuki/D-2646-2017; Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Nishida, Hiromi/B-1635-2008		Institute for Fermentation, Osaka, Japan; Ministry of Education, Culture, Sports, Science and Technology [20221009]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research grant from the Institute for Fermentation, Osaka, Japan to HN, Grants-in-Aid for Scientific Research (S) 20221009 from the Ministry of Education, Culture, Sports, Science and Technology to HA, and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Gonzalez R, 1997, NUCLEIC ACIDS RES, V25, P3955, DOI 10.1093/nar/25.19.3955; Graessle S, 2000, BBA-GENE STRUCT EXPR, V1492, P120, DOI 10.1016/S0167-4781(00)00093-2; IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Nishida H., 2009, OPEN ACCESS BIOINFOR, V1, P1; Nishida H, 2009, BIOINFORMATICS, V25, P2295, DOI 10.1093/bioinformatics/btp413; Nishida H, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/379317; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Song JS, 2008, GENOME RES, V18, P1064, DOI 10.1101/gr.075374.107; Suzuki Yutaka, 2003, Methods Mol Biol, V221, P73; Tribus M, 2010, MOL BIOL CELL, V21, P345, DOI 10.1091/mbc.E09-08-0750; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	29	9	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9916	10.1371/journal.pone.0009916	http://dx.doi.org/10.1371/journal.pone.0009916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361043	Green Published, gold, Green Submitted			2022-12-27	WOS:000275969600017
J	Cheng, Y; Li, HJ; Ren, XC; Niu, TK; Hait, WN; Yang, JM				Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Hait, William N.; Yang, Jinming			Cytoprotective Effect of the Elongation Factor-2 Kinase-Mediated Autophagy in Breast Cancer Cells Subjected to Growth Factor Inhibition	PLOS ONE			English	Article							ANTI-HER2 MONOCLONAL-ANTIBODY; RESISTANCE; DEATH; PHOSPHORYLATION; ACTIVATION; RADIATION; CAPACITY; RECEPTOR; MCF-7	Background: Autophagy is a highly conserved and regulated cellular process employed by living cells to degrade proteins and organelles as a response to metabolic stress. We have previously reported that eukaryotic elongation factor-2 kinase (eEF-2 kinase, also known as Ca2+/calmodulin-dependent protein kinase III) can positively modulate autophagy and negatively regulate protein synthesis. The purpose of the current study was to determine the role of the eEF-2 kinase-regulated autophagy in the response of breast cancer cells to inhibitors of growth factor signaling. Methodology/Principal Findings: We found that nutrient depletion or growth factor inhibitors activated autophagy in human breast cancer cells, and the increased activity of autophagy was associated with a decrease in cellular ATP and an increase in activities of AMP kinase and eEF-2 kinase. Silencing of eEF-2 kinase relieved the inhibition of protein synthesis, led to a greater reduction of cellular ATP, and blunted autophagic response. We further showed that suppression of eEF-2 kinase-regulated autophagy impeded cell growth in serum/nutrient-deprived cultures and handicapped cell survival, and enhanced the efficacy of the growth factor inhibitors such as trastuzumab, gefitinib, and lapatinib. Conclusion/Significance: The results of this study provide new evidence that activation of eEF-2 kinase-mediated autophagy plays a protective role for cancer cells under metabolic stress conditions, and that targeting autophagic survival may represent a novel approach to enhancing the effectiveness of growth factor inhibitors.	[Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Yang, Jinming] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Yang, Jinming] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA USA; [Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Yang, Jinming] Milton S Hershey Med Ctr, Hershey, PA USA; [Yang, Jinming] Soochow Univ, Sch Med, Dept Pharmacol, Suzhou, Peoples R China; [Hait, William N.] OrthoBiotech Res & Dev, Raritan, NJ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Soochow University - China	Cheng, Y (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA.	jyang2@hmc.psu.edu			Department of Defense [BC050789]; National Cancer Institute [CA 135038]; NATIONAL CANCER INSTITUTE [R01CA135038] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the Department of Defense BC050789 and from the National Cancer Institute CA 135038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; KROEMER G, 2005, LYSOSOMES AUTOPHAGY; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li B, 2003, CANCER RES, V63, P7443; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Paglin S, 2001, CANCER RES, V61, P439; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rexer BN, 2009, CELL CYCLE, V8, P18, DOI 10.4161/cc.8.1.7324; Rez G, 1999, CARCINOGENESIS, V20, P1893, DOI 10.1093/carcin/20.10.1893; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Toth S, 2001, ACTA BIOL HUNG, V52, P393; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; WELSH GI, 1992, BIOCHEM J, V284, P19, DOI 10.1042/bj2840019; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yang XH, 2001, CANCER RES, V61, P348; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378	38	63	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9715	10.1371/journal.pone.0009715	http://dx.doi.org/10.1371/journal.pone.0009715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300520	gold, Green Published, Green Submitted			2022-12-27	WOS:000275716400013
J	Rahman, MJ; Degano, IR; Singh, M; Fernandez, C				Rahman, Muhammad Jubayer; Degano, Irene Roman; Singh, Mahavir; Fernandez, Carmen			Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model	PLOS ONE			English	Article							T-CELL; NEWBORN MICE; EARLY-LIFE; B-CELL; RESPONSES; IMMUNIZATION; VACCINE; HEMAGGLUTININ; INTRANASAL; SENSITIZATION	Background: It has been proposed that the immune system could be primed as early as during the fetal life and this might have an impact on postnatal vaccination. Therefore, we addressed in murine models whether gestational treatment with mycobacterial antigens could induce better immune responses in the postnatal life. Methods/Findings: BALB/c mice were treated subcutaneously (s.c.) at the second week of gestation with antigen (Ag)85A or heparin-binding hemagglutinin (HBHA) in the absence of adjuvant. Following birth, offspring mice were immunized intranasally (i.n.) with the same antigens formulated with the adjuvant cholera toxin (CT) at week 1 and week 4. One week after the last immunization, we assessed antigen-specific recall interferon gamma (IFN-c) responses by in vitro restimulation of lung-derived lymphocytes. Protection against infection was assessed by challenge with high dose Mycobacterium bovis Bacille Calmette-Guerin (BCG) given i.n. We found that recall IFN-c responses were higher in the offspring born to the treated mother compared to the untreated-mother. More importantly, we observed that the offspring born to the treated mother controlled infection better than the offspring born to the untreated mother. Since the gestational treatment was done in absence of adjuvant, essentially there was no antibody production observed in the pregnant mice and therefore no influence of maternal antibodies was expected. We hypothesized that the effect of maternal treatment with antigen on the offspring occurred due to antigen transportation through placenta. To trace the antigens, we conjugated fluorescent nanocrystals with Ag85A (Qdot-ITK-Ag85A). After inoculation in the pregnant mice, Qdot-ITK-Ag85A conjugates were detected in the liver, spleen of pregnant females and in all the fetuses and placentas examined. Conclusion: The fetal immune system could be primed in utero by mycobacterial antigens transported through the placenta.	[Rahman, Muhammad Jubayer; Degano, Irene Roman; Fernandez, Carmen] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Singh, Mahavir] Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany	Stockholm University; Lionex Diagnostics & Therapeutics GmbH	Rahman, MJ (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden.	jubayer.rahman@imun.su.se	Degano, Irene/ABG-5341-2020; Degano, Irene Roman/C-1826-2012	Degano, Irene R./0000-0003-1914-6934	European Commission [LSHP-CT-2005 018736]; Boehringer Ingelheim Fonds	European Commission(European CommissionEuropean Commission Joint Research Centre); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This study has been supported by a grant from the European Commission, Sixth Framework Program, LSHP-CT-2005 018736. IRD received partial support from Boehringer Ingelheim Fonds. None of the commercial funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 1999, IMMUNOL TODAY, V20, P330, DOI 10.1016/S0167-5699(99)01473-5; Bjarnarson SP, 2005, EUR J IMMUNOL, V35, P1037, DOI 10.1002/eji.200425850; CARLIER Y, 1980, AM J TROP MED HYG, V29, P74, DOI 10.4269/ajtmh.1980.29.74; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Devereux G, 2001, CLIN EXP ALLERGY, V31, P1686, DOI 10.1046/j.1365-2222.2001.01215.x; GILL TJ, 1983, J CLIN INVEST, V72, P987, DOI 10.1172/JCI111071; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Giri PK, 2006, FEMS IMMUNOL MED MIC, V47, P233, DOI 10.1111/j.1574-695X.2006.00087.x; Herz U, 2001, INT ARCH ALLERGY IMM, V124, P193, DOI 10.1159/000053708; Herz U, 2000, AM J RESP CRIT CARE, V162, pS62, DOI 10.1164/ajrccm.162.supplement_2.ras-1; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; IGUCHI T, 1993, BIOL REPROD, V48, P188, DOI 10.1095/biolreprod48.1.188; IVANYI L, 1977, CLIN EXP IMMUNOL, V30, P252; Jakobsen H, 2002, INFECT IMMUN, V70, P1443, DOI 10.1128/IAI.70.3.1443-1452.2002; Jones AC, 1996, PEDIATR ALLERGY IMMU, V7, P109, DOI 10.1111/j.1399-3038.1996.tb00117.x; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; LEE CJ, 1980, IMMUNOLOGY, V41, P45; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Pravieux JJ, 2007, J COMP PATHOL, V137, pS32, DOI 10.1016/j.jcpa.2007.04.009; Rahman MJ, 2009, VACCINE, V27, P4038, DOI 10.1016/j.vaccine.2009.04.027; ROCKLIN RE, 1979, ANNU REV MED, V30, P375, DOI 10.1146/annurev.me.30.020179.002111; Rodriguez A, 2003, VACCINE, V21, P458, DOI 10.1016/S0264-410X(02)00478-4; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	39	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9699	10.1371/journal.pone.0009699	http://dx.doi.org/10.1371/journal.pone.0009699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300629	Green Published, Green Submitted, gold			2022-12-27	WOS:000275621000016
J	Heupel, MR; Simpfendorfer, CA; Fitzpatrick, R				Heupel, Michelle R.; Simpfendorfer, Colin A.; Fitzpatrick, Richard			Large-Scale Movement and Reef Fidelity of Grey Reef Sharks	PLOS ONE			English	Article							NEGAPRION-BREVIROSTRIS; LEMON SHARKS; BIOENERGETICS; POPULATIONS; TELEMETRY; PATTERNS; ISLANDS; BRAZIL	Despite an Indo-Pacific wide distribution, the movement patterns of grey reef sharks (Carcharhinus amblyrhynchos) and fidelity to individual reef platforms has gone largely unstudied. Their wide distribution implies that some individuals have dispersed throughout tropical waters of the Indo-Pacific, but data on large-scale movements do not exist. We present data from nine C. amblyrhynchos monitored within the Great Barrier Reef and Coral Sea off the coast of Australia. Shark presence and movements were monitored via an array of acoustic receivers for a period of six months in 2008. During the course of this monitoring few individuals showed fidelity to an individual reef suggesting that current protective areas have limited utility for this species. One individual undertook a large-scale movement (134 km) between the Coral Sea and Great Barrier Reef, providing the first evidence of direct linkage of C. amblyrhynchos populations between these two regions. Results indicate limited reef fidelity and evidence of large-scale movements within northern Australian waters.	[Heupel, Michelle R.; Simpfendorfer, Colin A.] James Cook Univ, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld, Australia; [Fitzpatrick, Richard] Reef Channel, Cairns, Qld, Australia	James Cook University	Heupel, MR (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld, Australia.	michelle.heupel@jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332	Digital Dimensions, Townsville, Australia	Digital Dimensions, Townsville, Australia	Funding for this research was made available by Digital Dimensions, Townsville, Australia through the production of the documentary 'Mysteries of the Shark Coast' for Discovery Channel. The Reef Channel (employer of co-author Fitzpatrick) is a division of Digital Dimensions. Consequently, the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; RANDALL JE, 1977, PAC SCI, V31, P143; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sundstrom LF, 1998, HYDROBIOLOGIA, V372, P241; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920	12	104	107	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9650	10.1371/journal.pone.0009650	http://dx.doi.org/10.1371/journal.pone.0009650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224793	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000275328800035
J	Kim, JH; Park, JM; Yea, K; Kim, HW; Suh, PG; Ryu, SH				Kim, Jong Hyun; Park, Ji-Man; Yea, Kyungmoo; Kim, Hyun Wook; Suh, Pann-Ghill; Ryu, Sung Ho			Phospholipase D1 Mediates AMP-Activated Protein Kinase Signaling for Glucose Uptake	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; RICH TYROSINE KINASE-2; SKELETAL-MUSCLE; AS160 PHOSPHORYLATION; PHOSPHATIDIC-ACID; REGULATED KINASE; PLASMA-MEMBRANE; CONTRACTION; INSULIN; ENERGY	Background: Glucose homeostasis is maintained by a balance between hepatic glucose production and peripheral glucose utilization. In skeletal muscle cells, glucose utilization is primarily regulated by glucose uptake. Deprivation of cellular energy induces the activation of regulatory proteins and thus glucose uptake. AMP-activated protein kinase (AMPK) is known to play a significant role in the regulation of energy balances. However, the mechanisms related to the AMPK-mediated control of glucose uptake have yet to be elucidated. Methodology/Principal Findings: Here, we found that AMPK-induced phospholipase D1 (PLD1) activation is required for C-14-glucose uptake in muscle cells under glucose deprivation conditions. PLD1 activity rather than PLD2 activity is significantly enhanced by glucose deprivation. AMPK-wild type (WT) stimulates PLD activity, while AMPK-dominant negative (DN) inhibits it. AMPK regulates PLD1 activity through phosphorylation of the Ser-505 and this phosphorylation is increased by the presence of AMP. Furthermore, PLD1-S505Q, a phosphorylation-deficient mutant, shows no changes in activity in response to glucose deprivation and does not show a significant increase in C-14-glucose uptake when compared to PLD1-WT. Taken together, these results suggest that phosphorylation of PLD1 is important for the regulation of C-14-glucose uptake. In addition, extracellular signal-regulated kinase (ERK) is stimulated by AMPK-induced PLD1 activation through the formation of phosphatidic acid (PA), which is a product of PLD. An ERK pharmacological inhibitor, PD98059, and the PLD inhibitor, 1-BtOH, both attenuate C-14-glucose uptake in muscle cells. Finally, the extracellular stresses caused by glucose deprivation or aminoimidazole carboxamide ribonucleotide (AICAR; AMPK activator) regulate C-14-glucose uptake and cell surface glucose transport (GLUT) 4 through ERK stimulation by AMPK-mediated PLD1 activation. Conclusions/Significance: These results suggest that AMPK-mediated PLD1 activation is required for C-14-glucose uptake through ERK stimulation. We propose that the AMPK-mediated PLD1 pathway may provide crucial clues to understanding the mechanisms involved in glucose uptake.	[Kim, Jong Hyun; Park, Ji-Man; Yea, Kyungmoo; Kim, Hyun Wook; Suh, Pann-Ghill; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Kim, Jong Hyun] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, JH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010	Ryu, Sung Ho/0000-0003-0913-3048	Ministry of Science and Technology in the Republic of Korea; National Institutes of Health (NIH) [GM 68849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	Ministry of Science and Technology in the Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the 21st Frontier Proteomics Research of the Ministry of Science and Technology in the Republic of Korea and National Institutes of Health (NIH) grant GM 68849 (W. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Barnes BR, 2005, CURR MOL MED, V5, P341, DOI 10.2174/1566524053766103; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Itani SI, 2003, DIABETES, V52, P1635, DOI 10.2337/diabetes.52.7.1635; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Kim JH, 2006, J BIOL CHEM, V281, P15747, DOI 10.1074/jbc.M509844200; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; MUSI N, 2003, AM J PHYSIOL-ENDOC M, V280, P677; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Pelletier A, 2005, ENDOCRINOLOGY, V146, P2285, DOI 10.1210/en.2004-1565; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Sajan MP, 2002, BIOCHEM J, V362, P665, DOI 10.1042/0264-6021:3620665; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9600	10.1371/journal.pone.0009600	http://dx.doi.org/10.1371/journal.pone.0009600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231899	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328300016
J	Schwartz, MS; Benci, JL; Selote, DS; Sharma, AK; Chen, AGY; Dang, H; Fares, H; Vatamaniuk, OK				Schwartz, Marc S.; Benci, Joseph L.; Selote, Devarshi S.; Sharma, Anuj K.; Chen, Andy G. Y.; Dang, Hope; Fares, Hanna; Vatamaniuk, Olena K.			Detoxification of Multiple Heavy Metals by a Half-Molecule ABC Transporter, HMT-1, and Coelomocytes of Caenorhabditis elegans	PLOS ONE			English	Article							PHYTOCHELATIN SYNTHASE; GAMMA-GLUTAMYLCYSTEINE; CADMIUM TOLERANCE; BINDING PEPTIDES; ARABIDOPSIS; GLUTATHIONE; MEMBRANE; IDENTIFICATION; TRANSFORMATION; ENDOCYTOSIS	Background: Developing methods for protecting organisms in metal-polluted environments is contingent upon our understanding of cellular detoxification mechanisms. In this regard, half-molecule ATP-binding cassette (ABC) transporters of the HMT-1 subfamily are required for cadmium (Cd) detoxification. HMTs have conserved structural architecture that distinguishes them from other ABC transporters and allows the identification of homologs in genomes of different species including humans. We recently discovered that HMT-1 from the simple, unicellular organism, Schizosaccharomyces pombe, SpHMT1, acts independently of phytochelatin synthase (PCS) and detoxifies Cd, but not other heavy metals. Whether HMTs from multicellular organisms confer tolerance only to Cd or also to other heavy metals is not known. Methodology/Principal Findings: Using molecular genetics approaches and functional in vivo assays we showed that HMT1 from a multicellular organism, Caenorhabditis elegans, functions distinctly from its S. pombe counterpart in that in addition to Cd it confers tolerance to arsenic (As) and copper (Cu) while acting independently of pcs-1. Further investigation of hmt-1 and pcs-1 revealed that these genes are expressed in different cell types, supporting the notion that hmt-1 and pcs-1 operate in distinct detoxification pathways. Interestingly, pcs-1 and hmt-1 are co-expressed in highly endocytic C. elegans cells with unknown function, the coelomocytes. By analyzing heavy metal and oxidative stress sensitivities of the coelomocyte-deficient C. elegans strain we discovered that coelomocytes are essential mainly for detoxification of heavy metals, but not of oxidative stress, a by-product of heavy metal toxicity. Conclusions/Significance: We established that HMT-1 from the multicellular organism confers tolerance to multiple heavy metals and is expressed in liver-like cells, the coelomocytes, as well as head neurons and intestinal cells, which are cell types that are affected by heavy metal poisoning in humans. We also showed that coelomocytes are involved in detoxification of heavy metals. Therefore, the HMT-1-dependent detoxification pathway and coelomocytes of C. elegans emerge as novel models for studies of heavy metal-promoted diseases.	[Schwartz, Marc S.; Benci, Joseph L.; Selote, Devarshi S.; Sharma, Anuj K.; Chen, Andy G. Y.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Dang, Hope; Fares, Hanna] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Cornell University; University of Arizona	Schwartz, MS (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Selote, Devarshi/F-1560-2015; Sharma, Anuj/G-3043-2011	Sharma, Anuj/0000-0001-5061-9731; Benci, Joseph/0000-0002-1759-4621	National Science Foundation [MCB-0923731]; President's Council of Cornell Women Affinito/Stewart Program	National Science Foundation(National Science Foundation (NSF)); President's Council of Cornell Women Affinito/Stewart Program	This work was co-funded by Cornell Start-up, National Science Foundation (MCB-0923731) and President's Council of Cornell Women (PCCW) Affinito/Stewart Program grants awarded to O.K.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; DELANGE RJ, 1979, J BIOL CHEM, V254, P5838; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Fernandez SBM, 2002, J BIOL CHEM, V277, P31048, DOI 10.1074/jbc.M204267200; FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hanikenne M, 2001, FEMS MICROBIOL LETT, V196, P107; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; Hyman MH, 2004, ALTERN THER HEALTH M, V10, P70; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; MADURO M, 1995, GENETICS, V141, P977; Mason DL, 2002, MOL BIOL CELL, V13, P4443, DOI 10.1091/mbc.E02-07-0405; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Romanyuk ND, 2006, PLANT PHYSIOL, V141, P858, DOI 10.1104/pp.106.082131; Schaheen L, 2006, DEVELOPMENT, V133, P3939, DOI 10.1242/dev.02575; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Uriu-Adams Janet Y., 2005, Molecular Aspects of Medicine, V26, P268, DOI 10.1016/j.mam.2005.07.015; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vatamaniuk OK, 2004, J BIOL CHEM, V279, P22449, DOI 10.1074/jbc.M313142200; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zhao ZY, 2004, J MOL BIOL, V344, P409, DOI 10.1016/j.jmb.2004.09.052	41	46	51	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9564	10.1371/journal.pone.0009564	http://dx.doi.org/10.1371/journal.pone.0009564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221439	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197200014
J	Sunagawa, S; Woodley, CM; Medina, M				Sunagawa, Shinichi; Woodley, Cheryl M.; Medina, Monica			Threatened Corals Provide Underexplored Microbial Habitats	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; DIVERSITY; BACTERIA; EVOLUTION; MUCUS; COMMUNITIES; WORLDS; TREE	Contemporary in-depth sequencing of environmental samples has provided novel insights into microbial community structures, revealing that their diversity had been previously underestimated. Communities in marine environments are commonly composed of a few dominant taxa and a high number of taxonomically diverse, low-abundance organisms. However, studying the roles and genomic information of these "rare'' organisms remains challenging, because little is known about their ecological niches and the environmental conditions to which they respond. Given the current threat to coral reef ecosystems, we investigated the potential of corals to provide highly specialized habitats for bacterial taxa including those that are rarely detected or absent in surrounding reef waters. The analysis of more than 350,000 small subunit ribosomal RNA (16S rRNA) sequence tags and almost 2,000 nearly full-length 16S rRNA gene sequences revealed that rare seawater biosphere members are highly abundant or even dominant in diverse Caribbean corals. Closely related corals (in the same genus/family) harbored similar bacterial communities. At higher taxonomic levels, however, the similarities of these communities did not correlate with the phylogenetic relationships among corals, opening novel questions about the evolutionary stability of coral-microbial associations. Large proportions of OTUs (28.7-49.1%) were unique to the coral species of origin. Analysis of the most dominant ribotypes suggests that many uncovered bacterial taxa exist in coral habitats and await future exploration. Our results indicate that coral species, and by extension other animal hosts, act as specialized habitats of otherwise rare microbes in marine ecosystems. Here, deep sequencing provided insights into coral microbiota at an unparalleled resolution and revealed that corals harbor many bacterial taxa previously not known. Given that two of the coral species investigated are listed as threatened under the U.S. Endangered Species Act, our results add an important microbial diversity-based perspective to the significance of conserving coral reefs.	[Sunagawa, Shinichi; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Woodley, Cheryl M.] NOAA, Hollings Marine Lab, Ctr Coastal Environm Hlth & Biomol Res, Natl Ocean Serv, Charleston, SC USA	University of California System; University of California Merced; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Sunagawa, S (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	mmedina@ucmerced.edu	Sunagawa, Shinichi/Q-5950-2019	Sunagawa, Shinichi/0000-0003-3065-0314	International Census of Marine Microbes; W.M. Keck Foundation award to the Marine Biological Laboratory in Woods Hole, MA; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program; Coral Disease and Health Consortium [1939-2009]; Sigma Xi Grant; National Science Foundation [IOS-0644438, OCE-0313708]; Division Of Integrative Organismal Systems [1402065] Funding Source: National Science Foundation	International Census of Marine Microbes; W.M. Keck Foundation award to the Marine Biological Laboratory in Woods Hole, MA; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Coral Disease and Health Consortium; Sigma Xi Grant; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by the International Census of Marine Microbes and the W.M. Keck Foundation award to the Marine Biological Laboratory in Woods Hole, MA, the National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program, Coral Disease and Health Consortium Project 1939-2009 to C. M. W., a Sigma Xi Grant to S. S., and National Science Foundation grants IOS-0644438 and OCE-0313708 to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Geffen Y, 2009, FEMS MICROBIOL LETT, V295, P103, DOI 10.1111/j.1574-6968.2009.01590.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	56	222	225	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9554	10.1371/journal.pone.0009554	http://dx.doi.org/10.1371/journal.pone.0009554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221265	Green Submitted, Green Published, gold			2022-12-27	WOS:000275197200009
J	Tanaka, S; Honda, M				Tanaka, Susumu; Honda, Makoto			IgG Abnormality in Narcolepsy and Idiopathic Hypersomnia	PLOS ONE			English	Article							HYPOCRETIN; ANTIBODIES; SLEEP; IMMUNOGLOBULINS; AUTOANTIBODIES; CATAPLEXY; IMMUNITY; SERIES; RISK	Background: A close association between narcolepsy and the Human Leukocyte Antigen (HLA)-DQB1*0602 allele suggests the involvement of the immune system, or possibly an autoimmune process. We investigated serum IgG levels in narcolepsy. Methodology/Principal Findings: We measured the serum total IgG levels in 159 Japanese narcolepsy-cataplexy patients positive for the HLA-DQB1*0602 allele, 28 idiopathic hypersomnia patients with long sleep time, and 123 healthy controls (the HLA-DQB1*0602 allele present in 45 subjects). The serum levels of each IgG subclass were subsequently measured. The distribution of serum IgG was significantly different among healthy controls negative for the HLA-DQB1*0602 allele (11.66 +/- 3.55 mg/ml), healthy controls positive for the HLA-DQB1*0602 allele (11.45 +/- 3.43), narcolepsy patients (9.67 +/- 3.38), and idiopathic hypersomnia patients (13.81 +/- 3.80). None of the following clinical variables, age, disease duration, Epworth Sleepiness Scale, smoking habit and BMI at the time of blood sampling, were associated with IgG levels in narcolepsy or idiopathic hypersomnia. Furthermore we found the decrease in IgG1 and IgG2 levels, stable expression of IgG3, and the increase in the proportion of IgG4 in narcolepsy patients with abnormally low IgG levels. The increase in the proportion of IgG4 levels was also found in narcolepsy patients with normal serum total IgG levels. Idiopathic hypersomnia patients showed a different pattern of IgG subclass distribution with high IgG3 and IgG4 level, low IgG2 level, and IgG1/IgG2 imbalance. Conclusions/Significance: Our study is the first to determine IgG abnormalities in narcolepsy and idiopathic hypersomnia by measuring the serum IgG levels in a large number of hypersomnia patients. The observed IgG abnormalities indicate humoral immune alterations in narcolepsy and idiopathic hypersomnia. Different IgG profiles suggest immunological differences between narcolepsy and idiopathic hypersomnia.	[Tanaka, Susumu; Honda, Makoto] Tokyo Inst Psychiat, Tokyo, Japan	Tokyo Institute of Psychiatry	Tanaka, S (corresponding author), Tokyo Inst Psychiat, Tokyo, Japan.	stanaka@prit.go.jp	Tanaka, Susumu/AAC-4739-2019	Tanaka, Susumu/0000-0003-4804-7839	Ministry of Education, Science and Culture of Japan [20790868, 19390310]; Mitsubishi Pharma Research Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation	This work was supported by Grants-in-Aid for Scientific Research (no. 20790868 to S. Tanaka, no. 19390310 to M. Honda) from the Ministry of Education, Science and Culture of Japan, and in part by grants from the Mitsubishi Pharma Research Foundation (to S. Tanaka), and on Priority Areas "Comprehensive Genomics'' from the Ministry of Education, Science and Culture of Japan (to M. Honda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DISO; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Baba T, 2009, J NEUROL, V256, P287, DOI 10.1007/s00415-009-0139-4; Bassetti C, 1997, BRAIN, V120, P1423, DOI 10.1093/brain/120.8.1423; Billiard M, 1998, PSYCHIAT CLIN NEUROS, V52, P125, DOI 10.1111/j.1440-1819.1998.tb00987.x; Black JL, 2005, BIOL PSYCHIAT, V58, P504, DOI 10.1016/j.biopsych.2005.04.026; Black JL, 2005, SLEEP, V28, P427, DOI 10.1093/sleep/28.4.427; Carlander B, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.135228; CEJKA J, 1974, CLIN CHEM, V20, P656; Dauvilliers Y, 2006, ANN NEUROL, V60, P153, DOI 10.1002/ana.20892; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; FRENCH MAH, 1984, CLIN EXP IMMUNOL, V56, P473; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; Honda Y, 1998, Nihon Rinsho, V56, P371; Hui L, 2007, BRAIN BEHAV IMMUN, V21, P308, DOI 10.1016/j.bbi.2006.09.005; Ichihara K, 2008, CLIN CHEM, V54, P356, DOI 10.1373/clinchem.2007.091843; Jackson MW, 2008, J NEUROSCI, V28, P13303, DOI 10.1523/JNEUROSCI.4489-08.2008; Knudsen S, 2007, NEUROREPORT, V18, P77, DOI 10.1097/WNR.0b013e328010baad; Lange T, 2006, ARCH INTERN MED, V166, P1695, DOI 10.1001/archinte.166.16.1695; Martinez-Rodriguez JE, 2007, SLEEP, V30, P27, DOI 10.1093/sleep/30.1.27; MIGNOT E, 1994, SLEEP, V17, pS68, DOI 10.1093/sleep/17.suppl_8.S68; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nozaki H, 2009, SLEEP MED, V10, P253, DOI 10.1016/j.sleep.2007.11.022; Overeem S, 2006, J NEUROIMMUNOL, V174, P187, DOI 10.1016/j.jneuroim.2006.02.010; OXELIUS VA, 1984, AM J MED, V76, P7, DOI 10.1016/0002-9343(84)90314-0; Singh SM, 1996, J CLIN IMMUNOL, V16, P208, DOI 10.1007/BF01541226; Tanaka S, 2006, SLEEP, V29, P633, DOI 10.1093/sleep/29.5.633; Tanaka S, 2009, SLEEP BIOL RHYTHMS, V7, P66, DOI 10.1111/j.1479-8425.2009.00387.x; Ton TGN, 2009, NEUROEPIDEMIOLOGY, V32, P114, DOI 10.1159/000177037; Valko PO, 2008, J NEUROL, V255, P1900, DOI 10.1007/s00415-008-0996-2; Vernet C, 2009, SLEEP, V32, P753, DOI 10.1093/sleep/32.6.753; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007; ZALCMAN S, 1991, BEHAV NEUROSCI, V105, P669, DOI 10.1037/0735-7044.105.5.669	33	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9555	10.1371/journal.pone.0009555	http://dx.doi.org/10.1371/journal.pone.0009555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221267	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197200010
J	Oyane, NM; Ursin, R; Pallesen, S; Holsten, F; Bjorvatn, B				Oyane, Nicolas M.; Ursin, Reidun; Pallesen, Stale; Holsten, Fred; Bjorvatn, Bjorn			Increased Health Risk in Subjects with High Self-Reported Seasonality	PLOS ONE			English	Article							PATTERN ASSESSMENT QUESTIONNAIRE; CORONARY HEART-DISEASE; AFFECTIVE-DISORDER; CARDIOVASCULAR-DISEASE; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; METABOLIC SYNDROME; SERUM-CHOLESTEROL; WINTER DEPRESSION; HORDALAND HEALTH	Background: Seasonal variations in mood and behaviour, termed seasonality, are commonly reported in the general population. As a part of a large cross-sectional health survey in Hordaland, Norway, we investigated the relationship between seasonality, objective health measurements and health behaviours. Methodology/Principal Findings: A total of 11,545 subjects between 40-44 years old participated, completing the Global Seasonality Score, measuring seasonality. Waist/hip circumference, BMI and blood pressure were measured, and blood samples were analyzed for total cholesterol, HDL cholesterol, triglycerides and glucose. Subjects also completed a questionnaire on miscellaneous health behaviours (exercise, smoking, alcohol consumption). Hierarchical linear regression analyses were used to investigate associations between seasonality and objective health measurements, while binary logistic regression was used for analysing associations between seasonality and health behaviours. Analyses were adjusted for sociodemographic factors, month of questionnaire completion and sleep duration. Seasonality was positively associated with high waist-hip-ratio, BMI, triglyceride levels, and in men high total cholesterol. Seasonality was negatively associated with HDL cholesterol. In women seasonality was negatively associated with prevalence of exercise and positively associated with daily cigarette smoking. Conclusions/Significance: High seasonality was associated with objective health risk factors and in women also with health behaviours associated with an increased risk for cardiovascular disease.	[Oyane, Nicolas M.; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Ursin, Reidun] Univ Bergen, Dept Biomed, Bergen, Norway; [Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Holsten, Fred] Univ Bergen, Dept Psychiat, Bergen, Norway; [Oyane, Nicolas M.; Ursin, Reidun; Pallesen, Stale; Holsten, Fred; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Oyane, NM (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.	Nicolas.Oyane@isf.uib.no			University of Bergen	University of Bergen	This work was supported by the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon SL, 2009, THROMB HAEMOSTASIS, V101, P452, DOI 10.1160/TH08-10-0630; BOOKER JM, 1992, AM J PSYCHIAT, V149, P1176; BROWN SL, 1994, BRIT MED J, V308, P1328, DOI 10.1136/bmj.308.6940.1328; Dam H, 1998, ACTA PSYCHIAT SCAND, V97, P1, DOI 10.1111/j.1600-0447.1998.tb09954.x; Davidovic Lazar B, 2005, World J Surg Oncol, V3, P10, DOI 10.1186/1477-7819-3-10; Eagles JM, 1999, BRIT J PSYCHIAT, V175, P472, DOI 10.1192/bjp.175.5.472; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P507, DOI 10.1093/oxfordjournals.aje.a117465; GLUECK CJ, 1994, AM J MED SCI, V308, P218; Goldfinger Tedd M., 2003, Cardiology Clinics, V21, P449, DOI 10.1016/S0733-8651(03)00081-X; Hansen V, 2001, AM J EPIDEMIOL, V154, P891, DOI 10.1093/aje/154.10.891; HARDIN TA, 1991, J PSYCHIAT RES, V25, P75, DOI 10.1016/0022-3956(91)90001-Q; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Lam RW, 2001, J AFFECT DISORDERS, V63, P123, DOI 10.1016/S0165-0327(00)00196-8; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Lavie CJ, 2006, ARCH INTERN MED, V166, P1878, DOI 10.1001/archinte.166.17.1878; Magnusson A, 1996, J AFFECT DISORDERS, V40, P121, DOI 10.1016/0165-0327(96)00036-5; Mersch PPA, 1999, BIOL PSYCHIAT, V45, P1013, DOI 10.1016/S0006-3223(98)00220-0; Miller TD, 1997, ANN BEHAV MED, V19, P220, DOI 10.1007/BF02892287; MORGAN RE, 1993, LANCET, V341, P75, DOI 10.1016/0140-6736(93)92556-9; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Nakao M, 2004, TOHOKU J EXP MED, V204, P273, DOI 10.1620/tjem.204.273; Oyane NMF, 2008, J AFFECT DISORDERS, V105, P147, DOI 10.1016/j.jad.2007.05.002; Oyane NMF, 2005, EUR J EPIDEMIOL, V20, P929, DOI 10.1007/s10654-005-2952-0; Patberg WR, 2004, J RHEUMATOL, V31, P1327; Pjrek E, 2007, EUR ARCH PSY CLIN N, V257, P197, DOI 10.1007/s00406-006-0706-y; REICHBORNKJENNE.T, 2001, SEASONAL AFFECTIVE D, P19; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; ROSEN LN, 1990, PSYCHIAT RES, V31, P131, DOI 10.1016/0165-1781(90)90116-M; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; SELTZER CC, 1973, NEW ENGL J MED, V288, P1186; Sher L, 2001, MED HYPOTHESES, V56, P104, DOI 10.1054/mehy.2000.1122; Storms WW, 2003, MED SCI SPORT EXER, V35, P1464, DOI 10.1249/01.MSS.0000084533.75912.B4; Terao T, 2000, ACTA PSYCHIAT SCAND, V101, P231; THOMPSON C, 1988, J AFFECT DISORDERS, V14, P257, DOI 10.1016/0165-0327(88)90043-2; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206; YOUNG MA, 1991, J AFFECT DISORDERS, V22, P191, DOI 10.1016/0165-0327(91)90065-Z	39	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9498	10.1371/journal.pone.0009498	http://dx.doi.org/10.1371/journal.pone.0009498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209129	Green Submitted, gold, Green Published			2022-12-27	WOS:000275063400008
J	Schokraie, E; Hotz-Wagenblatt, A; Warnken, U; Mali, B; Frohme, M; Forster, F; Dandekar, T; Hengherr, S; Schill, RO; Schnolzer, M				Schokraie, Elham; Hotz-Wagenblatt, Agnes; Warnken, Uwe; Mali, Brahim; Frohme, Marcus; Foerster, Frank; Dandekar, Thomas; Hengherr, Steffen; Schill, Ralph O.; Schnoelzer, Martina			Proteomic Analysis of Tardigrades: Towards a Better Understanding of Molecular Mechanisms by Anhydrobiotic Organisms	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MILNESIUM-TARDIGRADUM; DESICCATION TOLERANCE; RICHTERSIUS-CORONIFER; ARABIDOPSIS-THALIANA; ARTEMIA-FRANCISCANA; BRINE SHRIMP; HEAT-SHOCK; PROTEIN; TREHALOSE	Background: Tardigrades are small, multicellular invertebrates which are able to survive times of unfavourable environmental conditions using their well-known capability to undergo cryptobiosis at any stage of their life cycle. Milnesium tardigradum has become a powerful model system for the analysis of cryptobiosis. While some genetic information is already available for Milnesium tardigradum the proteome is still to be discovered. Principal Findings: Here we present to the best of our knowledge the first comprehensive study of Milnesium tardigradum on the protein level. To establish a proteome reference map we developed optimized protocols for protein extraction from tardigrades in the active state and for separation of proteins by high resolution two-dimensional gel electrophoresis. Since only limited sequence information of M. tardigradum on the genome and gene expression level is available to date in public databases we initiated in parallel a tardigrade EST sequencing project to allow for protein identification by electrospray ionization tandem mass spectrometry. 271 out of 606 analyzed protein spots could be identified by searching against the publicly available NCBInr database as well as our newly established tardigrade protein database corresponding to 144 unique proteins. Another 150 spots could be identified in the tardigrade clustered EST database corresponding to 36 unique contigs and ESTs. Proteins with annotated function were further categorized in more detail by their molecular function, biological process and cellular component. For the proteins of unknown function more information could be obtained by performing a protein domain annotation analysis. Our results include proteins like protein member of different heat shock protein families and LEA group 3, which might play important roles in surviving extreme conditions. Conclusions: The proteome reference map of Milnesium tardigradum provides the basis for further studies in order to identify and characterize the biochemical mechanisms of tolerance to extreme desiccation. The optimized proteomics workflow will enable application of sensitive quantification techniques to detect differences in protein expression, which are characteristic of the active and anhydrobiotic states of tardigrades.	[Schokraie, Elham; Hotz-Wagenblatt, Agnes; Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Mali, Brahim; Frohme, Marcus] Univ Appl Sci Wildau, Dept Mol Biol & Funct Genom, Wildau, Germany; [Foerster, Frank; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Wurzburg, Germany; [Hengherr, Steffen; Schill, Ralph O.] Univ Stuttgart, Dept Zool, Stuttgart, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Applied Sciences Wildau; University of Wurzburg; University of Stuttgart	Schokraie, E (corresponding author), German Canc Res Ctr, D-6900 Heidelberg, Germany.	m.schnoelzer@dkfz.de	Dandekar, Thomas/A-4431-2017; Förster, Frank/A-2181-2010; Mondragon, Angel/F-3972-2017; Frohme, Marcus/HCH-4031-2022	Dandekar, Thomas/0000-0003-1886-7625; Förster, Frank/0000-0003-4166-5423; Mondragon, Angel/0000-0002-6721-2054; 	German Federal Ministry of Education and Research; BMBF; FUNCRYPTA [FKY 0313838D]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); FUNCRYPTA	This work was supported by the German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA (FKY 0313838D). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; BAUMANN H, 1922, ANABIOSE TARDIGRADEN, P501; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019; CLEGG JS, 1992, FEBS LETT, V303, P45, DOI 10.1016/0014-5793(92)80474-U; CLEGG JS, 1964, J EXP BIOL, V41, P879; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTE FP, 1977, J EXP ZOOL, V202, P339, DOI 10.1002/jez.1402020306; del Val C, 2007, NUCLEIC ACIDS RES, V35, pW444, DOI 10.1093/nar/gkm364; DUMAS C, 1993, J BIOL CHEM, V268, P21599; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Haslekas C, 1998, PLANT MOL BIOL, V36, P833, DOI 10.1023/A:1005900832440; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; HENGHERR S, 2008, J ZOOLOGY L IN PRESS; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Kato Y, 2004, GENE, V334, P157, DOI 10.1016/j.gene.2004.03.030; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; KIM KW, 1988, J BIOL CHEM, V263, P4704; KUZMICH S, 1991, INT J PEPT PROT RES, V37, P565; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; LEPRINCE O, 1994, PLANT PHYSIOL, V104, P1333, DOI 10.1104/pp.104.4.1333; Leprince O., 1993, Seed Science Research, V3, P231, DOI 10.1017/S0960258500001859; Martin RM, 1997, INT J PARASITOL, V27, P1561, DOI 10.1016/S0020-7519(97)00146-X; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miyata S, 1997, DEV GROWTH DIFFER, V39, P111; Mommsen T.P., 1988, P347; Morrison J. F., 1973, ENZYMES, V8, P457, DOI 10.1016/S1874-6047; Mulder N.J., 2008, CURR PROTOC BIOINFOR, V2, P2, DOI DOI 10.1002/0471250953.BI0207S21; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; RAMLOV H, 1992, CRYOBIOLOGY, V29, P125, DOI 10.1016/0011-2240(92)90012-Q; Salinas AE, 1999, CURR MED CHEM, V6, P279; Schill RO, 2008, J ZOOL, V276, P103, DOI 10.1111/j.1469-7998.2008.00474.x; Schill RO, 2004, J EXP BIOL, V207, P1607, DOI 10.1242/jeb.00935; Seki K, 1998, NATURE, V395, P853, DOI 10.1038/27576; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Suzuki AC, 2003, ZOOL SCI, V20, P49, DOI 10.2108/zsj.20.49; Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; WARNER AH, 1995, CELL TISSUE RES, V282, P21; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8	59	46	47	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9502	10.1371/journal.pone.0009502	http://dx.doi.org/10.1371/journal.pone.0009502			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20224743	Green Published, gold, Green Submitted			2022-12-27	WOS:000275063400010
J	Masseck, OA; Forster, S; Hoffmann, KP				Masseck, Olivia Andrea; Foerster, Sascha; Hoffmann, Klaus-Peter			Sensitivity of the Goldfish Motion Detection System Revealed by Incoherent Random Dot Stimuli: Comparison of Behavioural and Neuronal Data	PLOS ONE			English	Article							PRIMATE SUPERIOR COLLICULUS; DIRECTION-SELECTIVE NEURONS; ACCESSORY OPTIC-SYSTEM; EYE-MOVEMENTS; ELECTRICAL MICROSTIMULATION; OPTOKINETIC RESPONSE; PERCEPTION; NUCLEUS; ZEBRAFISH; PRETECTUM	Background: Global motion detection is one of the most important abilities in the animal kingdom to navigate through a 3-dimensional environment. In the visual system of teleost fish direction-selective neurons in the pretectal area (APT) are most important for global motion detection. As in all other vertebrates these neurons are involved in the control of slow phase eye movements during gaze stabilization. In contrast to mammals cortical pathways that might influence motion detection abilities of the optokinetic system are missing in teleost fish. Results: To test global motion detection in goldfish we first measured the coherence threshold of random dot patterns to elicit horizontal slow phase eye movements. In addition, the coherence threshold of the optomotor response was determined by the same random dot patterns. In a second approach the coherence threshold to elicit a direction selective response in neurons of the APT was assessed from a neurometric function. Behavioural thresholds and neuronal thresholds to elicit slow phase eye movements were very similar, and ranged between 10% and 20% coherence. In contrast to these low thresholds for the optokinetic reaction and APT neurons the optomotor response could only be elicited by random dot patterns with coherences above 40%. Conclusion: Our findings suggest a high sensitivity for global motion in the goldfish optokinetic system. Comparison of neuronal and behavioural thresholds implies a nearly one-to-one transformation of visual neuron performance to the visuomotor output. In addition, we assume that the optomotor response is not mediated by the optokinetic system, but instead by other motion detection systems with higher coherence thresholds.	[Masseck, Olivia Andrea; Foerster, Sascha; Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, Bochum, Germany	Ruhr University Bochum	Masseck, OA (corresponding author), Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, Bochum, Germany.	kph@neurobiologie.rub.de		Masseck, Olivia Andrea/0000-0002-1541-2388				Bischof WF, 1999, PERCEPT PSYCHOPHYS, V61, P1089, DOI 10.3758/BF03207616; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Carpenter RRHS, 1988, MOVEMENTS EYE; COLLEWIJN H, 1975, BRAIN RES, V100, P489, DOI 10.1016/0006-8993(75)90154-7; Damjanovic I, 2009, J INTEGR NEUROSCI, V8, P77, DOI 10.1142/S021963520900206X; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; DIERINGER N, 1992, BRAIN BEHAV EVOLUT, V39, P289, DOI 10.1159/000114126; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; EASTER SS, 1972, VISION RES, V12, P673, DOI 10.1016/0042-6989(72)90161-7; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; Guillaume A, 2006, J PHYSIOL-LONDON, V577, P779, DOI 10.1113/jphysiol.2006.113720; Herrero L, 1998, EXP BRAIN RES, V120, P291, DOI 10.1007/s002210050403; Hoffmann KP, 2009, EUR J NEUROSCI, V29, P411, DOI 10.1111/j.1460-9568.2008.06585.x; HOFFMANN KP, 1981, EXP BRAIN RES, V42, P146; Huang YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1899, DOI 10.2741/2810; Huang YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006550; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hupfeld D, 2006, VISION RES, V46, P2941, DOI 10.1016/j.visres.2006.02.020; KATTE O, 1980, J COMP PHYSIOL, V140, P53, DOI 10.1007/BF00613747; Keng MJ, 1997, BRAIN BEHAV EVOLUT, V49, P214, DOI 10.1159/000112993; Klar M, 2002, BRAIN RES BULL, V57, P431, DOI 10.1016/S0361-9230(01)00706-7; MASINO T, 1993, J NEUROSCI, V13, P351; Masseck OA, 2008, J NEUROPHYSIOL, V99, P200, DOI 10.1152/jn.00926.2007; Masseck OA, 2009, J NEUROPHYSIOL, V102, P2781, DOI 10.1152/jn.00415.2009; Masseck OA, 2009, ANN NY ACAD SCI, V1164, P430, DOI 10.1111/j.1749-6632.2009.03854.x; MONTGOMERY N, 1982, BRAIN BEHAV EVOLUT, V21, P137, DOI 10.1159/000121622; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; NAKAYAMA K, 1983, SPATIAL ORIENTED BEH, P223; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Roeser T, 2003, J NEUROSCI, V23, P3726; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; Saitoh K, 2007, J NEUROPHYSIOL, V97, P3093, DOI 10.1152/jn.00639.2006; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; SOODAK RE, 1988, J NEUROPHYSIOL, V60, P2037, DOI 10.1152/jn.1988.60.6.2037; SPRINGER AD, 1977, BRAIN RES, V128, P393, DOI 10.1016/0006-8993(77)90166-4; STENGRILLNER, 2008, BRAIN RES REV, V57, P2; Stuphorn V, 2007, J NEUROPHYSIOL, V98, P1847, DOI 10.1152/jn.00665.2007; Walton MMG, 2007, J NEUROPHYSIOL, V98, P2022, DOI 10.1152/jn.00258.2007; YEOMANS JS, 1988, BRAIN RES REV, V13, P235, DOI 10.1016/0165-0173(88)90008-2	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9461	10.1371/journal.pone.0009461	http://dx.doi.org/10.1371/journal.pone.0009461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209165	Green Submitted, gold, Green Published			2022-12-27	WOS:000274997100008
J	Shao, W; Wu, J; Chen, J; Lee, DM; Tishkina, A; Harris, TJC				Shao, Wei; Wu, Johnny; Chen, Jeyla; Lee, Donghoon M.; Tishkina, Alisa; Harris, Tony J. C.			A Modifier Screen for Bazooka/PAR-3 Interacting Genes in the Drosophila Embryo Epithelium	PLOS ONE			English	Article							FUNCTIONAL GENOMIC SCREEN; CELL POLARITY; ADHERENS JUNCTIONS; PAR PROTEINS; ZONULA ADHERENS; E-CADHERIN; ESTABLISHMENT; REVEALS; APKC; CRUMBS	Background: The development and homeostasis of multicellular organisms depends on sheets of epithelial cells. Bazooka (Baz; PAR-3) localizes to the apical circumference of epithelial cells and is a key hub in the protein interaction network regulating epithelial structure. We sought to identify additional proteins that function with Baz to regulate epithelial structure in the Drosophila embryo. Methodology/Principal Findings: The baz zygotic mutant cuticle phenotype could be dominantly enhanced by loss of known interaction partners. To identify additional enhancers, we screened molecularly defined chromosome 2 and 3 deficiencies. 37 deficiencies acted as strong dominant enhancers. Using deficiency mapping, bioinformatics, and available single gene mutations, we identified 17 interacting genes encoding known and predicted polarity, cytoskeletal, transmembrane, trafficking and signaling proteins. For each gene, their loss of function enhanced adherens junction defects in zygotic baz mutants during early embryogenesis. To further evaluate involvement in epithelial polarity, we generated GFP fusion proteins for 15 of the genes which had not been found to localize to the apical domain previously. We found that GFP fusion proteins for Drosophila ASAP, Arf79F, CG11210, Septin 5 and Sds22 could be recruited to the apical circumference of epithelial cells. Nine of the other proteins showed various intracellular distributions, and one was not detected. Conclusions/Significance: Our enhancer screen identified 17 genes that function with Baz to regulate epithelial structure in the Drosophila embryo. Our secondary localization screen indicated that some of the proteins may affect epithelial cell polarity by acting at the apical cell cortex while others may act through intracellular processes. For 13 of the 17 genes, this is the first report of a link to baz or the regulation of epithelial structure.	[Shao, Wei; Wu, Johnny; Chen, Jeyla; Lee, Donghoon M.; Tishkina, Alisa; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Shao, W (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca		Lee, Donghoon/0000-0002-1078-6655	Canadian Institutes of Health Research (CIHR) [MOP-82829]; Natural Science and Engineering Research Council (NSERC) of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by Canadian Institutes of Health Research (CIHR) Operating grant number MOP-82829 to T. Harris (http://www.cihr-irsc.gc.ca/e/193.html). W. Shao was supported by a University of Toronto Connaught Scholarship and a Ning Po Residents Association Scholarship. J. Wu and J. Chen were supported by the Work-Study program at the University of Toronto. J. Chen was also awarded a Natural Science and Engineering Research Council (NSERC) of Canada Undergraduate Research Award. A. Tishkina was awarded a University of Toronto Excellence Award for Undergraduate Research. T. Harris holds a Tier 2 Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2002, GENE, V297, P69, DOI 10.1016/S0378-1119(02)00887-9; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Beers M, 2006, DEVELOPMENT, V133, P3745, DOI 10.1242/dev.02544; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Grawe F, 1996, DEVELOPMENT, V122, P951; Grusche FA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-14; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Magie Craig R., 2002, Development (Cambridge), V129, P3771; MCGILL MA, 2009, J CELL BIOL; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Raghu P, 2009, J CELL BIOL, V185, P129, DOI 10.1083/jcb.200807027; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zhang Y, 2004, CELL CYCLE, V3, P391	80	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9938	10.1371/journal.pone.0009938	http://dx.doi.org/10.1371/journal.pone.0009938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368978	Green Submitted, gold, Green Published			2022-12-27	WOS:000276418200015
J	Weisrock, DW; Rasoloarison, RM; Fiorentino, I; Ralison, JM; Goodman, SM; Kappeler, PM; Yoder, AD				Weisrock, David W.; Rasoloarison, Rodin M.; Fiorentino, Isabella; Ralison, Jose M.; Goodman, Steven M.; Kappeler, Peter M.; Yoder, Anne D.			Delimiting Species without Nuclear Monophyly in Madagascar's Mouse Lemurs	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE TREES; MICROCEBUS; DNA; BIODIVERSITY; DIVERSITY; EVOLUTION; PATTERNS; LOCI; DELIMITATION	Background: Speciation begins when populations become genetically separated through a substantial reduction in gene flow, and it is at this point that a genetically cohesive set of populations attain the sole property of species: the independent evolution of a population-level lineage. The comprehensive delimitation of species within biodiversity hotspots, regardless of their level of divergence, is important for understanding the factors that drive the diversification of biota and for identifying them as targets for conservation. However, delimiting recently diverged species is challenging due to insufficient time for the differential evolution of characters-including morphological differences, reproductive isolation, and gene tree monophyly-that are typically used as evidence for separately evolving lineages. Methodology: In this study, we assembled multiple lines of evidence from the analysis of mtDNA and nDNA sequence data for the delimitation of a high diversity of cryptically diverged population-level mouse lemur lineages across the island of Madagascar. Our study uses a multi-faceted approach that applies phylogenetic, population genetic, and genealogical analysis for recognizing lineage diversity and presents the most thoroughly sampled species delimitation of mouse lemur ever performed. Conclusions: The resolution of a large number of geographically defined clades in the mtDNA gene tree provides strong initial evidence for recognizing a high diversity of population-level lineages in mouse lemurs. We find additional support for lineage recognition in the striking concordance between mtDNA clades and patterns of nuclear population structure. Lineages identified using these two sources of evidence also exhibit patterns of population divergence according to genealogical exclusivity estimates. Mouse lemur lineage diversity is reflected in both a geographically fine-scaled pattern of population divergence within established and geographically widespread taxa, as well as newly resolved patterns of microendemism revealed through expanded field sampling into previously poorly and well-sampled regions.	[Weisrock, David W.; Fiorentino, Isabella; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC USA; [Rasoloarison, Rodin M.; Kappeler, Peter M.] German Primate Ctr, Dept Behav Ecol & Sociobiol, Gottingen, Germany; [Rasoloarison, Rodin M.; Ralison, Jose M.] Univ Antananarivo, Dept Biol Anim, Antananarivo, Madagascar; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Vahatra, Antananarivo, Madagascar; [Yoder, Anne D.] Duke Univ, Duke Lemur Ctr, Durham, NC USA	Duke University; Deutsches Primatenzentrum (DPZ); University Antananarivo; Field Museum of Natural History (Chicago); Duke University	Weisrock, DW (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40536 USA.	dweis2@uky.edu	Weisrock, David W./G-3587-2015; Kappeler, Peter/B-6825-2012	Weisrock, David/0000-0002-6187-5623	National Science Foundation [DEB 0516276]; John D. and Catherine T. MacArthur Foundation; German Primate Center (DPZ); Deutsche Forschungsgemeinschaft [Ka 1082-8]; Volkswagen Foundation	National Science Foundation(National Science Foundation (NSF)); John D. and Catherine T. MacArthur Foundation; German Primate Center (DPZ); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This project was supported by grant DEB 0516276 from the National Science Foundation, and by funding from the John D. and Catherine T. MacArthur Foundation, the German Primate Center (DPZ), the Deutsche Forschungsgemeinschaft (grant Ka 1082-8), and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS RM, 1994, J MOL EVOL, V38, P215; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; Andriantompohavana Rambinintsoa, 2006, Occasional Papers Museum of Texas Tech University, V259, P1; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Caparroz R, 2009, AUK, V126, P359, DOI 10.1525/auk.2009.07183; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2005, EVOLUTION, V59, P24; Duminil J, 2006, MOL ECOL, V15, P3505, DOI 10.1111/j.1365-294X.2006.03040.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fichtel C, 2007, AM J PRIMATOL, V69, P611, DOI 10.1002/ajp.20363; Fredsted T, 2005, MOL ECOL, V14, P2363, DOI 10.1111/j.1365-294X.2005.02596.x; FU YX, 1993, GENETICS, V133, P693; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goodman S.M., 1997, FIELDIANA ZOOL, V87, P1; Groeneveld LF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-30; Groves CP, 2000, INT J PRIMATOL, V21, P943, DOI 10.1023/A:1005559012637; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckman KL, 2007, MOL PHYLOGENET EVOL, V43, P353, DOI 10.1016/j.ympev.2007.03.005; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Hudson RR, 2003, EVOLUTION, V57, P182; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Kappeler P.M., 2005, Primate Report, V71, P3; Louis EE, 2006, INT J PRIMATOL, V27, P347, DOI 10.1007/s10764-006-9036-1; Louis Edward E. Jr, 2008, Primate Conservation, V23, P19, DOI 10.1896/052.023.0103; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; Mayden R. L., 1997, V54, P381; Mayden RL, 1999, J NEMATOL, V31, P95; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Olivieri G, 2007, MOL PHYLOGENET EVOL, V43, P309, DOI 10.1016/j.ympev.2006.10.026; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pritchard JK, 2000, GENETICS, V155, P945; Radespiel U, 2008, AM J PRIMATOL, V70, P1033, DOI 10.1002/ajp.20592; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Thalmann U, 2007, FOLIA PRIMATOL, V78, P420, DOI 10.1159/000105153; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Weisrock DW, 2006, MOL ECOL, V15, P2489, DOI 10.1111/j.1365-294X.2006.02961.x; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wimmer B, 2002, BEHAV ECOL SOCIOBIOL, V52, P166, DOI 10.1007/s00265-002-0497-8; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102; Yoder AD, 2002, INT J PRIMATOL, V23, P1335, DOI 10.1023/A:1021187106641	69	119	119	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9883	10.1371/journal.pone.0009883	http://dx.doi.org/10.1371/journal.pone.0009883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360988	gold, Green Published, Green Submitted			2022-12-27	WOS:000276163200003
J	Cabanski, CR; Qi, Y; Yin, XY; Bair, E; Hayward, MC; Fan, C; Li, JY; Wilkerson, MD; Marron, JS; Perou, CM; Hayes, DN				Cabanski, Christopher R.; Qi, Yuan; Yin, Xiaoying; Bair, Eric; Hayward, Michele C.; Fan, Cheng; Li, Jianying; Wilkerson, Matthew D.; Marron, J. S.; Perou, Charles M.; Hayes, D. Neil			SWISS MADE: Standardized WithIn Class Sum of Squares to Evaluate Methodologies and Dataset Elements	PLOS ONE			English	Article							MICROARRAY DATA-ANALYSIS; GENE-EXPRESSION; ARRAY DATA; EXPERIMENTAL-DESIGN; NORMALIZATION; REPRODUCIBILITY; QUALITY; RNA; CLASSIFICATION; MODELS	Contemporary high dimensional biological assays, such as mRNA expression microarrays, regularly involve multiple data processing steps, such as experimental processing, computational processing, sample selection, or feature selection (i.e. gene selection), prior to deriving any biological conclusions. These steps can dramatically change the interpretation of an experiment. Evaluation of processing steps has received limited attention in the literature. It is not straightforward to evaluate different processing methods and investigators are often unsure of the best method. We present a simple statistical tool, Standardized WithIn class Sum of Squares (SWISS), that allows investigators to compare alternate data processing methods, such as different experimental methods, normalizations, or technologies, on a dataset in terms of how well they cluster a priori biological classes. SWISS uses Euclidean distance to determine which method does a better job of clustering the data elements based on a priori classifications. We apply SWISS to three different gene expression applications. The first application uses four different datasets to compare different experimental methods, normalizations, and gene sets. The second application, using data from the MicroArray Quality Control (MAQC) project, compares different microarray platforms. The third application compares different technologies: a single Agilent two-color microarray versus one lane of RNA-Seq. These applications give an indication of the variety of problems that SWISS can be helpful in solving. The SWISS analysis of one-color versus two-color microarrays provides investigators who use two-color arrays the opportunity to review their results in light of a single-channel analysis, with all of the associated benefits offered by this design. Analysis of the MACQ data shows differential intersite reproducibility by array platform. SWISS also shows that one lane of RNA-Seq clusters data by biological phenotypes as well as a single Agilent two-color microarray.	[Cabanski, Christopher R.; Marron, J. S.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA; [Qi, Yuan; Yin, Xiaoying; Hayward, Michele C.; Fan, Cheng; Li, Jianying; Wilkerson, Matthew D.; Marron, J. S.; Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yin, Xiaoying] Univ N Carolina, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC USA; [Bair, Eric] Univ N Carolina, Sch Dent, Chapel Hill, NC USA; [Bair, Eric] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cabanski, CR (corresponding author), Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA.	hayes@med.unc.edu	Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247; Bair, Eric/0000-0001-8733-7869; Hayes, D. Neil/0000-0001-6203-7771	United States National Institutes of Health [U24CA126554, P50CA58223, KL2 RR025746]; Thomas G. Labrecque Foundation; Joan's Legacy Foundation; NIH [F32CA142039]; National Cancer Institute; NATIONAL CANCER INSTITUTE [U24CA126554, P50CA058223, F32CA142039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas G. Labrecque Foundation; Joan's Legacy Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the following grants from the United States National Institutes of Health: U24CA126554, P50CA58223, and KL2 RR025746. This study was also supported by the Thomas G. Labrecque Foundation, through Joan's Legacy Foundation. MDW was supported by NIH grant F32CA142039 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF TECHN NOT, 2010, GUID PROB LOG INT ER; Armstrong NJ, 2004, CELL ONCOL, V26, P279; Bilban Martin, 2002, Current Issues in Molecular Biology, V4, P57; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Fan JQ, 2006, CLIN CANCER RES, V12, P4469, DOI 10.1158/1078-0432.CCR-06-1033; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Fierro AC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-1; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giancarlo R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-462; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Grant GR, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB1906S77; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hu ZY, 2005, BIOTECHNIQUES, V38, P121, DOI 10.2144/05381MT02; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaluria P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-4; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MEYERSON M, 2005, MOL DIAGNOSTICS CLIN, P121; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Raychaudhuri S, 2001, TRENDS BIOTECHNOL, V19, P189, DOI 10.1016/S0167-7799(01)01599-2; Ressom HW, 2008, FRONT BIOSCI-LANDMRK, V13, P691, DOI 10.2741/2712; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosa GJM, 2006, PHYSIOL GENOMICS, V28, P15, DOI 10.1152/physiolgenomics.00106.2006; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simon R, 2002, GENET EPIDEMIOL, V23, P21, DOI 10.1002/gepi.202; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stoyanova R, 2004, BIOINFORMATICS, V20, P1772, DOI 10.1093/bioinformatics/bth170; TEMPELMAN RJ, 2008, INT J PLANT GENOMICS; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; WILKERSON MD, 2010, BIOINFORMATICS UNPUB; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; 2010, GUIDE PROBE LOGARITH; TECHNOLOGIES FEATURE	47	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9905	10.1371/journal.pone.0009905	http://dx.doi.org/10.1371/journal.pone.0009905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360852	gold, Green Submitted, Green Published			2022-12-27	WOS:000275969600011
J	Simmen, B; Bayart, F; Rasamimanana, H; Zahariev, A; Blanc, S; Pasquet, P				Simmen, Bruno; Bayart, Francoise; Rasamimanana, Hanta; Zahariev, Alexandre; Blanc, Stephane; Pasquet, Patrick			Total Energy Expenditure and Body Composition in Two Free-Living Sympatric Lemurs	PLOS ONE			English	Article							RING-TAILED LEMURS; PROPITHECUS-VERREAUXI-COQUERELI; FIELD METABOLIC-RATE; EULEMUR-FULVUS; VARECIA-VARIEGATA; HAPALEMUR-GRISEUS; BASAL-METABOLISM; MOUSE LEMUR; PRIMATE; WILD	Background: Evolutionary theories that account for the unusual socio-ecological traits and life history features of group-living prosimians, compared with other primates, predict behavioral and physiological mechanisms to conserve energy. Low energy output and possible fattening mechanisms are expected, as either an adaptive response to drastic seasonal fluctuations of food supplies in Madagascar, or persisting traits from previously nocturnal hypometabolic ancestors. Free ranging ring-tailed lemurs (Lemur catta) and brown lemurs (Eulemur sp.) of southern Madagascar have different socio-ecological characteristics which allow a test of these theories: Both gregarious primates have a phytophagous diet but different circadian activity rhythms, degree of arboreality, social systems, and slightly different body size. Methodology and Results: Daily total energy expenditure and body composition were measured in the field with the doubly labeled water procedure. High body fat content was observed at the end of the rainy season, which supports the notion that individuals need to attain a sufficient physical condition prior to the long dry season. However, ring-tailed lemurs exhibited lower water flux rates and energy expenditure than brown lemurs after controlling for body mass differences. The difference was interpreted to reflect higher efficiency for coping with seasonally low quality foods and water scarcity. Daily energy expenditure of both species was much less than the field metabolic rates predicted by various scaling relationships found across mammals. Discussion: We argue that low energy output in these species is mainly accounted for by low basal metabolic rate and reflects adaptation to harsh, unpredictable environments. The absence of observed sex differences in body weight, fat content, and daily energy expenditure converge with earlier investigations of physical activity levels in ring-tailed lemurs to suggest the absence of a relationship between energy constraints and the evolution of female dominance over males among lemurs. Nevertheless, additional seasonal data are required to provide a definitive conclusion.	[Simmen, Bruno; Bayart, Francoise; Pasquet, Patrick] CNRS, UMR 7206, Brunoy, France; [Simmen, Bruno; Bayart, Francoise; Pasquet, Patrick] Museum Natl Hist Nat, Brunoy, France; [Rasamimanana, Hanta] Univ Antananarivo, Ecole Normale Super, Antananarivo, Madagascar; [Zahariev, Alexandre; Blanc, Stephane] Univ Strasbourg, Strasbourg, France; [Zahariev, Alexandre; Blanc, Stephane] CNRS, Inst Pluridisciplinaire Hubert Curien, UMR 7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); University Antananarivo; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Simmen, B (corresponding author), CNRS, UMR 7206, Brunoy, France.	simmen@mnhn.fr	Simmen, Bruno/G-9916-2014	Patrick, Pasquet/0000-0002-7017-3068; Simmen, Bruno/0000-0002-5867-1646	National Museum of Natural History in Paris; CNRS [7206]	National Museum of Natural History in Paris; CNRS(Centre National de la Recherche Scientifique (CNRS))	The study was funded by a BQR from the National Museum of Natural History in Paris and by CNRS (UMR 7206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; Blanc S, 2005, J MED PRIMATOL, V34, P130, DOI 10.1111/j.1600-0684.2005.00106.x; Campbell JL, 2000, AM J PRIMATOL, V52, P133, DOI 10.1002/1098-2345(200011)52:3<133::AID-AJP2>3.0.CO;2-#; Campbell JL, 2004, AM J PRIMATOL, V64, P323, DOI 10.1002/ajp.20081; Clutton-Brock T. H, 1977, P557; DANIELS HL, 1984, J MAMMAL, V65, P584, DOI 10.2307/1380841; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; Drack S, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P83; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Ganzhorn Jorg U., 2003, P132; Garcia C, 2004, J MED PRIMATOL, V33, P146, DOI 10.1111/j.1600-0684.2004.00064.x; Genoud M, 1997, AM J PRIMATOL, V41, P229, DOI 10.1002/(SICI)1098-2345(1997)41:3<229::AID-AJP5>3.0.CO;2-Z; Goodman SM, 1997, REV ECOL-TERRE VIE, V52, P321; Goodman Steven M., 2006, P3, DOI 10.1007/978-0-387-34126-2_1; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Hladik A., 1980, P3; Hladik C.-M., 1981, P215; Jolly A., 1966, LEMUR BEHAV MADAGASC; Jolly A., 1984, FEMALE PRIMATES STUD, P197; Jolly Alison, 2006, P3; KAPPELER PM, 1991, FOLIA PRIMATOL, V57, P132, DOI 10.1159/000156575; KARASOV WH, 1992, AM ZOOL, V32, P238, DOI 10.1093/icb/32.2.238; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; KODAMA AM, 1970, J APPL PHYSIOL, V29, P260, DOI 10.1152/jappl.1970.29.2.260; Koyama N, 2008, PRIMATES, V49, P9, DOI 10.1007/s10329-007-0051-4; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; MILTON K, 1976, NATURE, V259, P459, DOI 10.1038/259459a0; MILTON K, 1979, J MAMMAL, V60, P373, DOI 10.2307/1379809; Milton K., 1980, FORAGING STRATEGIES; NAGY KA, 1979, ECOLOGY, V60, P475, DOI 10.2307/1936066; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; OVERDORFF DJ, 1993, INT J PRIMATOL, V14, P721, DOI 10.1007/BF02192188; Overdorff DJ, 1996, AM J PHYS ANTHROPOL, V100, P487; Pereira ME, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P93; PEREIRA ME, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P205; Perret M, 1998, COMP BIOCHEM PHYS A, V119, P981, DOI 10.1016/S1095-6433(98)00015-4; Pinkus Susan, 2006, P119, DOI 10.1007/978-0-387-34126-2_9; Power RA, 2001, COMPARATIVE MED, V51, P218; Pride E, 2005, BEHAV ECOL, V16, P550, DOI 10.1093/beheco/ari025; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; RASAMIMANANA H, 2004, THESIS NATL MUSEUM N; Rasamimanana Hantanirina, 2006, P271, DOI 10.1007/978-0-387-34126-2_16; RASAMIMANANA HR, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P123; Richard AF, 2000, J HUM EVOL, V39, P381, DOI 10.1006/jhev.2000.0427; RICHARD AF, 1987, AM J PRIMATOL, V12, P309, DOI 10.1002/ajp.1350120308; RICHARD AF, 1991, ANNU REV ECOL SYST, V22, P145, DOI 10.1146/annurev.es.22.110191.001045; Roeder JJ, 2002, AGGRESSIVE BEHAV, V28, P62, DOI 10.1002/ab.90006; Sapolsky RM, 1998, AM J PRIMATOL, V44, P155, DOI 10.1002/(SICI)1098-2345(1998)44:2&lt;155::AID-AJP6&gt;3.0.CO;2-V; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Sauther ML, 1998, FOLIA PRIMATOL, V69, P309; Schmid J, 2000, J COMP PHYSIOL B, V170, P633, DOI 10.1007/s003600000146; Schmid J, 1996, AM J PRIMATOL, V38, P169, DOI 10.1002/(SICI)1098-2345(1996)38:2<169::AID-AJP5>3.0.CO;2-X; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; Simmen B, 2003, INT J PRIMATOL, V24, P948; Simmen B, 2007, INT J PRIMATOL, V28, P1253, DOI 10.1007/s10764-007-9217-6; Simmen Bruno, 2006, P55, DOI 10.1007/978-0-387-34126-2_5; Speakman J.R., 1997, DOUBLY LABELLED WATE; Sussman R.W., 1974, P75; vanSchaik CP, 1996, ETHOLOGY, V102, P915; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7	68	39	41	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2010	5	3							e9860	10.1371/journal.pone.0009860	http://dx.doi.org/10.1371/journal.pone.0009860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DS	20360848	gold, Green Published, Green Submitted			2022-12-27	WOS:000275969500006
J	Davenport, CF; Tummler, B				Davenport, Colin F.; Tuemmler, Burkhard			Abundant Oligonucleotides Common to Most Bacteria	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; A-TRACT; DINUCLEOTIDE STEPS; BENT DNA; EVOLUTIONARY IMPLICATIONS; NUCLEOSOME ORGANIZATION; GENOMES; SEQUENCES; CHROMOSOMES; SIGNATURES	Background: Bacteria show a bias in their genomic oligonucleotide composition far beyond that dictated by G+C content. Patterns of over-and underrepresented oligonucleotides carry a phylogenetic signal and are thus diagnostic for individual species. Patterns of short oligomers have been investigated by multiple groups in large numbers of bacteria genomes. However, global distributions of the most highly overrepresented mid-sized oligomers have not been assessed across all prokaryotes to date. We surveyed overrepresented mid-length oligomers across all prokaryotes and normalised for base composition and embedded oligomers using zero and second order Markov models. Principal Findings: Here we report a presumably ancient set of oligomers conserved and overrepresented in nearly all branches of prokaryotic life, including Archaea. These oligomers are either adenine rich homopurines with one to three guanine nucleosides, or homopyridimines with one to four cytosine nucleosides. They do not show a consistent preference for coding or non-coding regions or aggregate in any coding frame, implying a role in DNA structure and as polypeptide binding sites. Structural parameters indicate these oligonucleotides to be an extreme and rigid form of B-DNA prone to forming triple stranded helices under common physiological conditions. Moreover, the narrow minor grooves of these structures are recognised by DNA binding and nucleoid associated proteins such as HU. Conclusion: Homopurine and homopyrimidine oligomers exhibit distinct and unusual structural features and are present at high copy number in nearly all prokaryotic lineages. This fact suggests a non-neutral role of these oligonucleotides for bacterial genome organization that has been maintained throughout evolution.	[Davenport, Colin F.; Tuemmler, Burkhard] Hannover Med Sch, Hannover, Lower Saxony, Germany	Hannover Medical School	Davenport, CF (corresponding author), Hannover Med Sch, Hannover, Lower Saxony, Germany.	davenport.colin@mh-hannover.de		Davenport, Colin/0000-0002-4764-6963	Deutsche Forschungsgemeinschaft [653/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grant 653/3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P865, DOI 10.1093/bioinformatics/16.10.865; BEUTEL BA, 1992, J MOL BIOL, V228, P803, DOI 10.1016/0022-2836(92)90865-H; Bohlin J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000057; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Chor B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r108; Cohanim AB, 2009, NUCLEIC ACIDS RES, V37, P6466, DOI 10.1093/nar/gkp689; Coker C, 2000, J BACTERIOL, V182, P2649, DOI 10.1128/JB.182.9.2649-2653.2000; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davenport CF, 2009, ENVIRON MICROBIOL, V11, P1092, DOI 10.1111/j.1462-2920.2008.01839.x; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; ELHASSAN MA, 1995, J MOL BIOL, V251, P648, DOI 10.1006/jmbi.1995.0462; ElHassan MA, 1996, ENDEAVOUR, V20, P61, DOI 10.1016/0160-9327(96)10016-8; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; Greenwood P. E., 1996, GUIDE CHISQUARED TES; Hampson S, 2002, BIOINFORMATICS, V18, P513, DOI 10.1093/bioinformatics/18.4.513; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HARAN TE, 1989, BIOCHEMISTRY-US, V28, P2763, DOI 10.1021/bi00433a003; HOEBEKE M, RMES FINDING EXCEPTI; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karlin S, 1996, NUCLEIC ACIDS RES, V24, P4263, DOI 10.1093/nar/24.21.4263; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEROY JL, 1988, BIOCHEMISTRY-US, V27, P8894, DOI 10.1021/bi00425a004; Mrazek J, 2002, NUCLEIC ACIDS RES, V30, P4216, DOI 10.1093/nar/gkf534; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P5127, DOI 10.1073/pnas.0700429104; NADEAU JG, 1989, P NATL ACAD SCI USA, V86, P2622, DOI 10.1073/pnas.86.8.2622; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; R Core Team, 2018, R LANG ENV STAT COMP; RAJAGOPAL P, 1989, NATURE, V339, P637, DOI 10.1038/339637a0; Reva ON, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-90; Roberts RW, 1996, P NATL ACAD SCI USA, V93, P4320, DOI 10.1073/pnas.93.9.4320; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sandstrom K, 2002, J MOL BIOL, V315, P737, DOI 10.1006/jmbi.2001.5249; Schbath S, 2000, J COMPUT BIOL, V7, P193, DOI 10.1089/10665270050081469; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Tolstorukov MY, 2005, NUCLEIC ACIDS RES, V33, P3907, DOI 10.1093/nar/gki699; van Passel MWJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-26; Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021; WATERHOUSE AM, 2009, JALVIEW VERSION 2 MU; Woods KK, 2004, J AM CHEM SOC, V126, P15330, DOI 10.1021/ja045207x	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9841	10.1371/journal.pone.0009841	http://dx.doi.org/10.1371/journal.pone.0009841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352124	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400034
J	Yadav, N; Joglekar, H; Rao, RPN; Vahia, MN; Adhikari, R; Mahadevan, I				Yadav, Nisha; Joglekar, Hrishikesh; Rao, Rajesh P. N.; Vahia, Mayank N.; Adhikari, Ronojoy; Mahadevan, Iravatham			Statistical Analysis of the Indus Script Using n-Grams	PLOS ONE			English	Article								The Indus script is one of the major undeciphered scripts of the ancient world. The small size of the corpus, the absence of bilingual texts, and the lack of definite knowledge of the underlying language has frustrated efforts at decipherment since the discovery of the remains of the Indus civilization. Building on previous statistical approaches, we apply the tools of statistical language processing, specifically n-gram Markov chains, to analyze the syntax of the Indus script. We find that unigrams follow a Zipf-Mandelbrot distribution. Text beginner and ender distributions are unequal, providing internal evidence for syntax. We see clear evidence of strong bigram correlations and extract significant pairs and triplets using a log-likelihood measure of association. Highly frequent pairs and triplets are not always highly significant. The model performance is evaluated using information-theoretic measures and cross-validation. The model can restore doubtfully read texts with an accuracy of about 75%. We find that a quadrigram Markov chain saturates information theoretic measures against a held-out corpus. Our work forms the basis for the development of a stochastic grammar which may be used to explore the syntax of the Indus script in greater detail.	[Yadav, Nisha; Vahia, Mayank N.] Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India; [Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Adhikari, Ronojoy] Inst Math Sci, Chennai 600113, Tamil Nadu, India; [Mahadevan, Iravatham] Indus Res Ctr, Roja Muthiah Res Lib, Chennai, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); University of Washington; University of Washington Seattle; Institute of Mathematical Sciences (IMSc) India	Yadav, N (corresponding author), Tata Inst Fundamental Res, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	y_nisha@tifr.res.in; rjoy@imsc.res.in	Adhikari, Ronojoy/B-7157-2011	Rao, Rajesh P. N./0000-0003-0682-8952	Jamsetji Tata Trust; National Science Foundation; Packard Foundation; Department of Atomic Energy, Government of India	Jamsetji Tata Trust; National Science Foundation(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was supported in part by the Jamsetji Tata Trust (N. Y. and M. N. V.), by the National Science Foundation and the Packard Foundation (R. P. N. R.) and the Project for Interdisciplinary Science and Modelling from the Department of Atomic Energy, Government of India (R. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S., 2003, P 4 INT C INT TEXT P; Chen S F, 1998, TR1098 HARV U COMP S; Crystal D., 1995, CAMBRIDGE ENCY ENGLI; Dunning T., 1993, Computational Linguistics, V19, P61; Jurafsky D., 2019, SPEECH LANGUAGE PROC, V3rd; Kenoyer J.M, 1998, ANCIENT CITIES INDUS; Mahadevan I., 1977, MEMOIRS ARCHAEOLOGIC; MAHADEVAN I, 2002, ELECT J VEDIC STUDIE, V2, P1; Mandelbrot B., 1953, INFORM THEORY STAT S; Manning C.D., 1999, FDN STAT NATURAL LAN; Markov A., 1906, IZVESTIYA FIZIKOMATE, V2, P135; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Parpola Asko, 2005, 50 ICES TOK SESS; Pedersen T, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P455; Possehl Gregory, 1996, INDUS AGE WRITING SY; Possehl Gregory L., 2002, INDUS CIVILIZATION C; Rao RPN, 2009, P NATL ACAD SCI USA, V106, P13685, DOI 10.1073/pnas.0906237106; Rao RPN, 2009, SCIENCE, V324, P1165, DOI 10.1126/science.1170391; Rao S. R., 1982, DECIPHERMENT INDUS S; Sinha S., 2009, P 2009 WORKSH GRAPH, P5; SIROMONEY G, 1979, INDUS SCRIPT CHALLEN; Stolcke A., 2002, SRILM EXTENSIBLE LAN; SUBBARAYAPPA BV, 1997, INDUS SCRIPT ITS NAT; TONG H, 1975, J APPL PROBAB, V12, P488, DOI 10.2307/3212863; WELLS BK, 2006, EPIGRAPHIC APPROACHE; YADAV N, 2008, INT J DRAVIDIAN LING, V37, P53; Yadav N., 2008, INT J DRAVIDIAN LING, V37, P39; Zipf GeorgeKingsley., 1936, PSYCHOBIOLOGY LANGUA	29	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9506	10.1371/journal.pone.0009506	http://dx.doi.org/10.1371/journal.pone.0009506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333254	Green Published, gold, Green Submitted			2022-12-27	WOS:000275809700001
J	Necchi, V; Sommi, P; Ricci, V; Solcia, E				Necchi, Vittorio; Sommi, Patrizia; Ricci, Vittorio; Solcia, Enrico			In Vivo Accumulation of Helicobacter pylori Products, NOD1, Ubiquitinated Proteins and Proteasome in a Novel Cytoplasmic Structure	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; VACUOLATING CYTOTOXIN; ENDOPLASMIC-RETICULUM; 26S PROTEASOME; CAGA; EXPRESSION; AUTOPHAGY; PATHWAY; SYSTEM; MUCOSA	In Cell internalization and intracellular fate of H. pylori products/virulence factors in vivo by human gastric epithelium, the main target of H. pylori-induced pathologies (i.e., peptic ulcer and cancer), are still largely unknown. Investigating gastric endoscopic biopsies from dyspeptic patients by means of ultrastructural immunocytochemistry, here we show that, in human superficial-foveolar epithelium and its metaplastic or dysplastic foci, H. pylori virulence factors accumulated in a discrete cytoplasmic structure characterized by 13-nm-thick cylindrical particles of regular punctate-linear substructure resembling the proteasome complex in size and structure. Inside this particle-rich cytoplasmic structure (PaCS) we observed colocalization of VacA, CagA, urease and outer membrane proteins with NOD1 receptor, ubiquitin-activating enzyme E1, polyubiquitinated proteins, proteasome components and potentially oncogenic proteins like SHP2 and ERKs in human gastric epithelium. By means of electron and confocal microscopy, we demonstrate that the in vivo findings were reproduced in vitro by incubating human epithelial cell lines with H. pylori products/virulence factors. PaCSs differed from VacA-induced vacuoles, phagosomes, aggresomes or related bodies. Our data suggest that PaCS is a novel, proteasome-enriched structure arising in ribosome-rich cytoplasm at sites of H. pylori products accumulation. As a site of selective concentration of bacterial virulence factors, the ubiquitin-proteasome system and interactive proteins, PaCS is likely to modulate immune-inflammatory and proliferative responses of the gastric epithelium of potential pathologic relevance.	[Necchi, Vittorio; Solcia, Enrico] Univ Pavia, Dept Human Pathol, Sch Med, I-27100 Pavia, Italy; [Sommi, Patrizia; Ricci, Vittorio] Univ Pavia, Sch Med, Dept Physiol, I-27100 Pavia, Italy; [Sommi, Patrizia; Solcia, Enrico] Policlin San Matteo, Fdn IRCCS, Serv Anat Pathol, I-27100 Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo	Necchi, V (corresponding author), Univ Pavia, Dept Human Pathol, Sch Med, Via Palestro 3, I-27100 Pavia, Italy.	vricci@unipv.it			Italian Ministry of Health to the Fondazione IRCCS Policlinico San Matteo; University of Pavia	Italian Ministry of Health to the Fondazione IRCCS Policlinico San Matteo; University of Pavia	This investigation was supported in part by grants from the Italian Ministry of Health to the Fondazione IRCCS Policlinico San Matteo and from the University of Pavia (Fondo di Ateneo per la Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Barrera CA, 2001, HUM IMMUNOL, V62, P1081, DOI 10.1016/S0198-8859(01)00281-6; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLASER MJ, 1995, CANCER RES, V55, P2111; Brooks P, 2000, BIOCHEM J, V352, P611, DOI 10.1042/0264-6021:3520611; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; CHAN WY, 1992, HISTOPATHOLOGY, V21, P521, DOI 10.1111/j.1365-2559.1992.tb00439.x; CORREA P, 1988, CANCER RES, V48, P3554; COVER TL, 1992, HUM PATHOL, V23, P1004, DOI 10.1016/0046-8177(92)90261-Z; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; ENGSTRAND L, 1989, INFECT IMMUN, V57, P827, DOI 10.1128/IAI.57.3.827-832.1989; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; FIOCCA R, 1994, SCAND J GASTROENTERO, V29, P11, DOI 10.3109/00365529409091404; Galmiche A, 2000, EMBO J, V19, P6361, DOI 10.1093/emboj/19.23.6361; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Munro P, 2007, CURR OPIN MICROBIOL, V10, P39, DOI 10.1016/j.mib.2006.11.002; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Necchi V, 2009, HELICOBACTER, V14, P208, DOI 10.1111/j.1523-5378.2009.00679.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Ricci V, 1997, J PATHOL, V183, P453; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Solcia E, 1996, AM J SURG PATHOL, V20, pS8; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958	54	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9716	10.1371/journal.pone.0009716	http://dx.doi.org/10.1371/journal.pone.0009716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300534	gold, Green Submitted, Green Published			2022-12-27	WOS:000275716400014
J	Pereira-Rodrigues, N; Poleni, PE; Guimard, D; Arakawa, Y; Sakai, Y; Fujii, T				Pereira-Rodrigues, Nazare; Poleni, Paul-Emile; Guimard, Denis; Arakawa, Yasuhiko; Sakai, Yasuyuki; Fujii, Teruo			Modulation of Hepatocarcinoma Cell Morphology and Activity by Parylene-C Coating on PDMS	PLOS ONE			English	Article							SCANNING ELECTROCHEMICAL MICROSCOPY; ADSORBED COLLAGEN; PROTEIN ADSORPTION; SANDWICH CULTURE; LIVING CELLS; ADHESION; LIVER; HEPATOCYTES; ORGANIZATION; EXPRESSION	Background: The ability to understand and locally control the morphogenesis of mammalian cells is a fundamental objective of cell and developmental biology as well as tissue engineering research. We present parylene-C (ParC) deposited on polydimethylsiloxane (PDMS) as a new substratum for in vitro advanced cell culture in the case of Human Hepatocarcinoma (HepG2) cells. Principal Findings: Our findings establish that the intrinsic properties of ParC-coated PDMS (ParC/PDMS) influence and modulate initial extracellular matrix (ECM; here, type-I collagen) surface architecture, as compared to non-coated PDMS substratum. Morphological changes induced by the presence of ParC on PDMS were shown to directly affect liver cell metabolic activity and the expression of transmembrane receptors implicated in cell adhesion and cell-cell interaction. These changes were characterized by atomic force microscopy (AFM), which elucidated differences in HepG2 cell adhesion, spreading, and reorganization into two-or three-dimensional structures by neosynthesis of ECM components. Local modulation of cell aggregation was successfully performed using ParC/PDMS micropatterns constructed by simple microfabrication. Conclusion/Significance: We demonstrated for the first time the modulation of HepG2 cells' behavior in relation to the intrinsic physical properties of PDMS and ParC, enabling the local modulation of cell spreading in a 2D or 3D manner by simple microfabrication techniques. This work will provide promising insights into the development of cell-based platforms that have many applications in the field of in vitro liver tissue engineering, pharmacology and therapeutics.	[Pereira-Rodrigues, Nazare; Poleni, Paul-Emile; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, CIRMM, Meguro Ku, Tokyo, Japan; [Poleni, Paul-Emile; Sakai, Yasuyuki; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, LIMMS, CNRS,Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Pereira-Rodrigues, N (corresponding author), Univ Tokyo, Inst Ind Sci, CIRMM, Meguro Ku, Tokyo, Japan.	poleni2003@yahoo.fr			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was sponsored by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japanese Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2002, SEMIN CELL DEV BIOL, V13, P447, DOI 10.1016/S1084952102001337; [Anonymous], 2004, DEKKER ENCY NANOSCIE; ARMSTRONG PB, 1989, CRIT REV BIOCHEM MOL, V24, P119, DOI 10.3109/10409238909086396; Bard A.J., 2001, SCANNING ELECTROCHEM; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bi YA, 2006, DRUG METAB DISPOS, V34, P1658, DOI 10.1124/dmd.105.009118; Carloni V, 2001, HEPATOLOGY, V34, P42, DOI 10.1053/jhep.2001.25224; Chan C, 2004, LIVER TRANSPLANT, V10, P1331, DOI 10.1002/lt.20229; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Daniels E, 1996, DEV DYNAM, V206, P272, DOI 10.1002/(SICI)1097-0177(199607)206:3<272::AID-AJA5>3.3.CO;2-U; Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o; Du Y, 2008, BIOMATERIALS, V29, P290, DOI 10.1016/j.biomaterials.2007.09.016; Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z; Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29; Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; GERLACH JC, 2008, BIOARTIFICIAL LIVER, P575; Grant MA, 2005, COLD SH Q B, V70, P399, DOI 10.1101/sqb.2005.70.017; Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009; Kojima Takashi, 2003, Medical Electron Microscopy, V36, P157, DOI 10.1007/s00795-003-0220-5; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467; Liu B, 2000, P NATL ACAD SCI USA, V97, P9855, DOI 10.1073/pnas.97.18.9855; Liu B, 2001, J ELECTROANAL CHEM, V500, P590, DOI 10.1016/S0022-0728(00)00436-8; LOEB GE, 1977, J BIOMED MATER RES, V11, P195, DOI 10.1002/jbm.820110206; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Omstead DR, 1998, TISSUE ENG, V4, P239, DOI 10.1089/ten.1998.4.239; Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012; PARSONSWINGERTER PA, 1993, BIOTECHNOL PROGR, V9, P600, DOI 10.1021/bp00024a006; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; PESHWA MV, 1994, BIOTECHNOL PROGR, V10, P460, DOI 10.1021/bp00029a002; Pinkse GGM, 2005, J HEPATOL, V42, P87, DOI 10.1016/j.jhep.2004.09.010; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; Pirone DM, 2004, J MAMMARY GLAND BIOL, V9, P405, DOI 10.1007/s10911-004-1410-z; Powers MJ, 1997, BIOTECHNOL BIOENG, V53, P415, DOI 10.1002/(SICI)1097-0290(19970220)53:4<415::AID-BIT10>3.3.CO;2-3; Powers MJ, 1996, BIOTECHNOL BIOENG, V50, P392, DOI 10.1002/(SICI)1097-0290(19960520)50:4<392::AID-BIT6>3.0.CO;2-G; Raghavan S, 2004, ADV MATER, V16, P1303, DOI 10.1002/adma.200400594; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAKAI Y, 2004, LAB CHIPS CELLOMICS; Sharma NS, 2006, BIOTECHNOL BIOENG, V94, P1053, DOI 10.1002/bit.20936; Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010; SPRAY DC, 1987, J CELL BIOL, V105, P541, DOI 10.1083/jcb.105.1.541; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011; Xu JS, 2003, TOXICOL APPL PHARM, V189, P100, DOI 10.1016/S0041-008X(03)00089-9; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	64	15	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9667	10.1371/journal.pone.0009667	http://dx.doi.org/10.1371/journal.pone.0009667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300511	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400003
J	Zhang, QB; Fan, HL; Shen, JK; Hoffman, RM; Xing, HR				Zhang, Qingbei; Fan, Hanli; Shen, Jikun; Hoffman, Robert M.; Xing, H. Rosie			Human Breast Cancer Cell Lines Co-Express Neuronal, Epithelial, and Melanocytic Differentiation Markers In Vitro and In Vivo	PLOS ONE			English	Article							MDA-MB-435 CELLS; EXPRESSION; MELANOMA; GENE	Differentiation programs are aberrant in cancer cells allowing them to express differentiation markers in addition to their tissue of origin. In the present study, we demonstrate the multi-lineage differentiation potential of breast cancer cell lines to express multiple neuronal/glial lineage-specific markers as well as mammary epithelial and melanocytic-specific markers. Multilineage expression was detected in luminal (MCF-7 and SKBR3) and basal (MDA-MB-231) types of human breast cancer cell lines. We also observed comparable co-expression of these three cell lineage markers in MDA-MB-435 cells in vitro, in MDA-MB-435 primary tumors derived from parental and single cell clones and in lung metastases in vivo. Furthermore, ectoderm multi-lineage transdifferentiation was also found in human melanoma (Ul-MeL) and glioblastoma cell lines (U87 and D54). These observations indicate that aberrant multi-lineage transdifferentiation or lineage infidelity may be a wide spread phenomenon in cancer.	[Zhang, Qingbei; Fan, Hanli; Shen, Jikun; Xing, H. Rosie] Univ Chicago, Dept Pathol Cellular & Radiat Oncol, Chicago, IL 60637 USA; [Xing, H. Rosie] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	University of Chicago; University of Chicago; Anti Cancer Inc; University of California System; University of California San Diego	Zhang, QB (corresponding author), Univ Chicago, Dept Pathol Cellular & Radiat Oncol, Chicago, IL 60637 USA.	hxing@bsd.uchicago.edu			University of Chicago	University of Chicago(University of Chicago)	This work is supported by the start-up fund provided to H. R. X. by the University of Chicago. AntiCancer provided the GFP-labeled breast cancer line used in the study as scientific collaboration and contributed to the preparation of the manuscript. The funders had no role in study design, data collection and analysis, or decision to publish.	CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; HOWLETT AR, 1994, J NATL CANCER I, V86, P1838, DOI 10.1093/jnci/86.24.1838; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Quiros I, 2009, INT J CANCER, V125, P1497, DOI 10.1002/ijc.24501; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; You HH, 2001, CELL GROWTH DIFFER, V12, P471	14	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9712	10.1371/journal.pone.0009712	http://dx.doi.org/10.1371/journal.pone.0009712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300523	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400010
J	Yoshihara, K; Tajima, A; Yahata, T; Kodama, S; Fujiwara, H; Suzuki, M; Onishi, Y; Hatae, M; Sueyoshi, K; Fujiwara, H; Kudo, Y; Kotera, K; Masuzaki, H; Tashiro, H; Katabuchi, H; Inoue, I; Tanaka, K				Yoshihara, Kosuke; Tajima, Atsushi; Yahata, Tetsuro; Kodama, Shoji; Fujiwara, Hiroyuki; Suzuki, Mitsuaki; Onishi, Yoshitaka; Hatae, Masayuki; Sueyoshi, Kazunobu; Fujiwara, Hisaya; Kudo, Yoshiki; Kotera, Kohei; Masuzaki, Hideaki; Tashiro, Hironori; Katabuchi, Hidetaka; Inoue, Ituro; Tanaka, Kenichi			Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; C-MYC GENE; PROGNOSTIC-FACTOR; DATA SETS; MICROARRAY; CHEMOTHERAPY; PACLITAXEL; SIGNATURE; CARCINOMA; CYCLOPHOSPHAMIDE	Background: Advanced-stage ovarian cancer patients are generally treated with platinum/taxane-based chemotherapy after primary debulking surgery. However, there is a wide range of outcomes for individual patients. Therefore, the clinicopathological factors alone are insufficient for predicting prognosis. Our aim is to identify a progression-free survival (PFS)-related molecular profile for predicting survival of patients with advanced-stage serous ovarian cancer. Methodology/Principal Findings: Advanced-stage serous ovarian cancer tissues from 110 Japanese patients who underwent primary surgery and platinum/taxane-based chemotherapy were profiled using oligonucleotide microarrays. We selected 88 PFS-related genes by a univariate Cox model (p < 0.01) and generated the prognostic index based on 88 PFS-related genes after adjustment of regression coefficients of the respective genes by ridge regression Cox model using 10-fold cross-validation. The prognostic index was independently associated with PFS time compared to other clinical factors in multivariate analysis [hazard ratio (HR), 3.72; 95% confidence interval (CI), 2.66-5.43; p < 0.0001]. In an external dataset, multivariate analysis revealed that this prognostic index was significantly correlated with PFS time (HR, 1.54; 95% CI, 1.20-1.98; p = 0.0008). Furthermore, the correlation between the prognostic index and overall survival time was confirmed in the two independent external datasets (log rank test, p = 0.0010 and 0.0008). Conclusions/Significance: The prognostic ability of our index based on the 88-gene expression profile in ridge regression Cox hazard model was shown to be independent of other clinical factors in predicting cancer prognosis across two distinct datasets. Further study will be necessary to improve predictive accuracy of the prognostic index toward clinical application for evaluation of the risk of recurrence in patients with advanced-stage serous ovarian cancer.	[Yoshihara, Kosuke; Yahata, Tetsuro; Tanaka, Kenichi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Tajima, Atsushi; Inoue, Ituro] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Kodama, Shoji] Niigata Canc Ctr Hosp, Dept Gynecol, Niigata, Japan; [Fujiwara, Hiroyuki; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Japan; [Onishi, Yoshitaka; Hatae, Masayuki] Kagoshima City Hosp, Dept Obstet & Gynecol, Kagoshima, Japan; [Sueyoshi, Kazunobu] Kagoshima City Hosp, Dept Pathol, Kagoshima, Japan; [Fujiwara, Hisaya; Kudo, Yoshiki] Hiroshima Univ, Dept Obstet & Gynecol, Grad Sch Biomed Sci, Hiroshima, Japan; [Kotera, Kohei] Nagasaki Municipal Hosp, Dept Obstet & Gynecol, Nagasaki, Japan; [Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 852, Japan; [Tashiro, Hironori; Katabuchi, Hidetaka] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Gynecol, Kumamoto, Japan	Niigata University; Tokai University; Jichi Medical University; Kagoshima City Hospital; Kagoshima City Hospital; Hiroshima University; Nagasaki University; Kumamoto University	Yoshihara, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan.	tanaken@med.niigata-u.ac.jp	Yoshihara, Kosuke/AAU-9874-2020; Tajima, Atsushi/C-1053-2008	Yoshihara, Kosuke/0000-0002-2254-3378; Tajima, Atsushi/0000-0001-6808-5491	Ministry of Health, Labor and Welfare, Japan; Tokai University Educational System General Research Organization	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Tokai University Educational System General Research Organization	This work was supported in part by a Grant-in-Aid for the Third- term Cancer Control Strategy Program from the Ministry of Health, Labor and Welfare, Japan (KT), and 2009 Research and Study Program of Tokai University Educational System General Research Organization (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, CURR OPIN PHARMACOL, V6, P345, DOI 10.1016/j.coph.2006.02.007; [Anonymous], 1971, Acta Obstet Gynecol Scand, V50, P1; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berchuck A, 2009, CLIN CANCER RES, V15, P2448, DOI 10.1158/1078-0432.CCR-08-2430; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Darcy KM, 2009, GYNECOL ONCOL, V114, P472, DOI 10.1016/j.ygyno.2009.05.012; Denkert C, 2009, J PATHOL, V218, P273, DOI 10.1002/path.2547; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; FIGO Cancer Committee, 1986, GYNECOL ONCOL, V25, P383; Goodman MT, 2003, CANCER, V97, P2676, DOI 10.1002/cncr.11349; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Iba T, 2004, CANCER SCI, V95, P418, DOI 10.1111/j.1349-7006.2004.tb03225.x; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kommoss S, 2009, VIRCHOWS ARCH, V454, P249, DOI 10.1007/s00428-009-0725-y; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; McGuire V, 2002, GYNECOL ONCOL, V84, P399, DOI 10.1006/gyno.2001.6536; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Motoori M, 2005, INT J CANCER, V114, P963, DOI 10.1002/ijc.20808; Okada H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040026; Ozols RF, 2005, INT J GYNECOL CANCER, V15, P3, DOI 10.1111/j.1525-1438.2005.15351.x; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Reimer D, 2007, CLIN CANCER RES, V13, P144, DOI 10.1158/1078-0432.CCR-06-0780; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schramm A, 2005, ONCOGENE, V24, P7902, DOI 10.1038/sj.onc.1208936; Silverberg SG, 2000, INT J GYNECOL PATHOL, V19, P7, DOI 10.1097/00004347-200001000-00003; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; TAWASSOLI FA, 2003, PATHOLOGY GENETICS T; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Woo HG, 2008, CLIN CANCER RES, V14, P2056, DOI 10.1158/1078-0432.CCR-07-1473; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x	52	99	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9615	10.1371/journal.pone.0009615	http://dx.doi.org/10.1371/journal.pone.0009615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300634	Green Submitted, gold, Green Published			2022-12-27	WOS:000275620900001
J	Greenhill, SJ; Drummond, AJ; Gray, RD				Greenhill, Simon J.; Drummond, Alexei J.; Gray, Russell D.			How Accurate and Robust Are the Phylogenetic Estimates of Austronesian Language Relationships?	PLOS ONE			English	Article							DIVERGENCE TIMES; SPEAKING; EXPANSION; POLYNESIA; IMPACT; MTDNA	We recently used computational phylogenetic methods on lexical data to test between two scenarios for the peopling of the Pacific. Our analyses of lexical data supported a pulse-pause scenario of Pacific settlement in which the Austronesian speakers originated in Taiwan around 5,200 years ago and rapidly spread through the Pacific in a series of expansion pulses and settlement pauses. We claimed that there was high congruence between traditional language subgroups and those observed in the language phylogenies, and that the estimated age of the Austronesian expansion at 5,200 years ago was consistent with the archaeological evidence. However, the congruence between the language phylogenies and the evidence from historical linguistics was not quantitatively assessed using tree comparison metrics. The robustness of the divergence time estimates to different calibration points was also not investigated exhaustively. Here we address these limitations by using a systematic tree comparison metric to calculate the similarity between the Bayesian phylogenetic trees and the subgroups proposed by historical linguistics, and by re-estimating the age of the Austronesian expansion using only the most robust calibrations. The results show that the Austronesian language phylogenies are highly congruent with the traditional subgroupings, and the date estimates are robust even when calculated using a restricted set of historical calibrations.	[Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Greenhill, Simon J.; Drummond, Alexei J.] Univ Auckland, Computat Evolut Grp, Auckland, New Zealand	University of Auckland; University of Auckland	Greenhill, SJ (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.		Greenhill, Simon/A-9555-2010; Greenhill, Simon/I-3554-2019; Drummond, Alexei J/A-3209-2010; Gray, Russell/H-2078-2015; Greenhill, Simon J/B-3114-2011	Greenhill, Simon/0000-0001-7832-6156; Drummond, Alexei J/0000-0003-4454-2576; Gray, Russell/0000-0002-9858-0191; Greenhill, Simon J/0000-0001-7832-6156	Royal Society of New Zealand; Bright Futures doctoral scholarship	Royal Society of New Zealand(Royal Society of New Zealand); Bright Futures doctoral scholarship	Funding was provided by the Royal Society of New Zealand Marsden Fund and a Bright Futures doctoral scholarship to S. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaar A, 2005, OCEAN LINGUIST, V44, P357, DOI 10.1353/ol.2005.0027; ADELAAR KA, 2005, AUSTRONESIAN LANGUAG, P1; BATEMAN R, 1990, CURR ANTHROPOL, V31, P1, DOI 10.1086/203800; Bellwood P, 1988, ASIAN PERSPECT, V26, P107; Bellwood Peter, 1997, PREHISTORY INDOMALAY; BLUST R, 1995, J WORLD PREHIST, V9, P453, DOI 10.1007/BF02221119; BLUST R, 1978, 2 INT C AUSTR LING P, P181; BLUST R, 1993, OCEAN LINGUIST, V32, P241, DOI DOI 10.2307/3623195; Blust Robert, 2009, AUSTRONESIAN LANGUAG; Blust Robert, 1999, 8 INT C AUSTR LING, P31; Blust Robert A., 1991, OCEAN LINGUIST, V30, P73; Burnham K. P., 1998, MODEL SELECTION INFE; Campbell L, 2008, LANGUAGE, V84, P636; Christiansen C, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-16; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; DAY WHE, 1986, SYST ZOOL, V35, P325, DOI 10.2307/2413385; Donohue M, 2008, OCEAN LINGUIST, V47, P223; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Green RC., 1991, B INDOPACIFIC PREHIS, V11, P295, DOI [10.7152/bippa.v11i0.11393, DOI 10.7152/BIPPA.V11I0.11393]; GREEN RC, 2002, NZ ARCHAEOLOGICAL AS, V25, P21; GREEN RC, 2003, PACIFIC ARCHAEOLOGY; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Hage P., 1999, ASIAN PERSPECT, V38, P200; HAMMERSTROM H, 2005, REV ETHNOLOGUE; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; HO SY, 2005, SYST BIOL, V56, P515; Hurles ME, 2003, AM J HUM GENET, V72, P1282, DOI 10.1086/374827; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kirch P., 2001, HAWAIKI ANCESTRAL PO; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; LEWIS PM, 2009, ETHNOLOGUE LANGUAGES; Lynch J., 2002, OCEANIC LANGUAGES; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; MOORE JH, 1994, AM ANTHROPOL, V96, P925, DOI 10.1525/aa.1994.96.4.02a00110; Oppenheimer S, 2004, WORLD ARCHAEOL, V36, P591, DOI 10.1080/0043824042000303773; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; Pawley, 2009, AUSTRONESIAN HIST LI, P375; PAWLEY A, 2002, EXAMINING FARMING LA, P251; Pawley A., 1994, AUSTRONESIAN TERMINO, P329; Pawley A, 2007, TERRA AUSTRALIS, V26, P17; ROSS M, 1998, LEXICON PROTOOCEANIC, V1; Ross Malcolm, 1988, PROTOOCEANIC AUSTRON; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sneddon JamesNeil., 1993, OCEAN LINGUIST, V32, P1, DOI [10.2307/3623095, DOI 10.2307/3623095]; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; STEEL MA, 1993, SYST BIOL, V42, P126, DOI 10.2307/2992536; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thurgood G., 1999, ANCIENT CHAM MODERN; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; VOORHOEVE CL, 1989, IRIAN, V17, P106; [No title captured]	58	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9573	10.1371/journal.pone.0009573	http://dx.doi.org/10.1371/journal.pone.0009573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	565XE	20224774	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800011
J	Quaia, C; Ying, HS; Optican, LM				Quaia, Christian; Ying, Howard S.; Optican, Lance M.			The Viscoelastic Properties of Passive Eye Muscle in Primates. III: Force Elicited by Natural Elongations	PLOS ONE			English	Article							MODEL; TISSUE	We have recently shown that in monkey passive extraocular muscles the force induced by a stretch does not depend on the entire length history, but to a great extent is only a function of the last elongation applied. This led us to conclude that Fung's quasi-linear viscoelastic (QLV) model, and more general nonlinear models based on a single convolution integral, cannot faithfully mimic passive eye muscles. Here we present additional data about the mechanical properties of passive eye muscles in deeply anesthetized monkeys. We show that, in addition to the aforementioned failures, previous models also grossly overestimate the force exerted by passive eye muscles during smooth elongations similar to those experienced during normal eye movements. Importantly, we also show that the force exerted by a muscle following an elongation is largely independent of the elongation itself, and it is mostly determined by the final muscle length. These additional findings conclusively rule out the use of classical viscoelastic models to mimic the mechanical properties of passive eye muscles. We describe here a new model that extends previous ones using principles derived from research on thixotropic materials. This model is able to account reasonably well for our data, and could thus be incorporated into models of the eye plant.	[Quaia, Christian; Optican, Lance M.] NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; [Ying, Howard S.] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine	Quaia, C (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.	quaiac@nei.nih.gov			National Eye Institute (CQ, LMO); National Institutes of Health (NIH) [EY19347, EY15025]; Knights Templar Eye Foundation Young Investigator Award; Research to Prevent Blindness Core Grant; NATIONAL EYE INSTITUTE [ZIAEY000302, K12EY015025, R01EY019347] Funding Source: NIH RePORTER	National Eye Institute (CQ, LMO)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation Young Investigator Award; Research to Prevent Blindness Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute (CQ, LMO), by National Institutes of Health (NIH) grants NIH EY19347 and NIH EY15025 (HSY), the Knights Templar Eye Foundation Young Investigator Award (HSY), and Research to Prevent Blindness Core Grant (HSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIERNO D, 1976, J NON-NEWTON FLUID, V1, P125, DOI 10.1016/0377-0257(76)80012-2; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Collins C.C., 1971, CONTROL EYE MOVEMENT, P283; Doehring TC, 2004, ANN BIOMED ENG, V32, P223, DOI 10.1023/B:ABME.0000012742.01261.b0; Fung Y.-C., 2004, BIOMECHANICS MECH PR; Fung Y.C.B, 1971, BIOMECHANICS ITS FDN, P181; KAPOULA Z, 1989, J NEUROPHYSIOL, V61, P879, DOI 10.1152/jn.1989.61.5.879; Marmarelis VZ, 2004, NONLINEAR DYNAMIC MO; Mujumdar A, 2002, J NON-NEWTON FLUID, V102, P157, DOI 10.1016/S0377-0257(01)00176-8; Nekouzadeh A, 2008, J BIOMECH, V41, P2964, DOI 10.1016/j.jbiomech.2008.07.033; Nekouzadeh A, 2007, J BIOMECH, V40, P3070, DOI 10.1016/j.jbiomech.2007.03.019; NEUBERT HKP, 1963, AERONAUT QUART, V14, P187, DOI 10.1017/S0001925900002754; OPTICAN LM, 1985, J NEUROPHYSIOL, V54, P940, DOI 10.1152/jn.1985.54.4.940; PIPKIN AC, 1968, J MECH PHYS SOLIDS, V16, P59, DOI 10.1016/0022-5096(68)90016-1; Popper K.R., 1959, LOGIC SCI DISCOVERY; Pryse KM, 2003, ANN BIOMED ENG, V31, P1287, DOI 10.1114/1.1615571; Quaia C, 2000, EXP BRAIN RES, V132, P39, DOI 10.1007/s002219900324; Quaia Christian, 2003, Strabismus, V11, P17, DOI 10.1076/stra.11.1.17.14088; Quaia C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006480; Quaia C, 2008, PROG BRAIN RES, V171, P47, DOI 10.1016/S0079-6123(08)00607-9; Quaia C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004850; Robinson D.A., 1981, MODELS OCULOMOTOR BE, P21; ROBINSON DA, 1975, INVEST OPHTH VISUAL, V14, P801; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2612, DOI 10.1167/iovs.06-1318; Yoo L, 2009, INVEST OPHTH VIS SCI, V50, P3721, DOI 10.1167/iovs.08-3245	26	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A236	A254	e9595	10.1371/journal.pone.0009595	http://dx.doi.org/10.1371/journal.pone.0009595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221406	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328200022
J	Quintana, FJ; Iglesias, AH; Farez, MF; Caccamo, M; Burns, EJ; Kassam, N; Oukka, M; Weiner, HL				Quintana, Francisco J.; Iglesias, Antonio H.; Farez, Mauricio F.; Caccamo, Mario; Burns, Evan J.; Kassam, Nasim; Oukka, Mohamed; Weiner, Howard L.			Adaptive Autoimmunity and Foxp3-Based Immunoregulation in Zebrafish	PLOS ONE			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; FOXP3; EVOLUTION; EXPRESSION; TOLERANCE; SYSTEM; GENE; ENTEROPATHY; VERTEBRATES	Background: Jawed vertebrates generate their immune-receptor repertoire by a recombinatorial mechanism that has the potential to produce harmful autoreactive lymphocytes. In mammals, peripheral tolerance to self-antigens is enforced by Foxp3(+) regulatory T cells. Recombinatorial mechanisms also operate in teleosts, but active immunoregulation is thought to be a late incorporation to the vertebrate lineage. Methods/Principal Findings: Here we report the characterization of adaptive autoimmunity and Foxp3-based immunoregulation in the zebrafish. We found that zebrafish immunization with an homogenate of zebrafish central nervous system (zCNS) triggered CNS inflammation and specific antibodies. We cloned the zebrafish ortholog for mammalian Foxp3 (zFoxp3) which induced a regulatory phenotype on mouse T cells and controlled IL-17 production in zebrafish embryos. Conclusions/Significance: Our findings demonstrate the acquisition of active mechanisms of self-tolerance early in vertebrate evolution, suggesting that active regulatory mechanisms accompany the development of the molecular potential for adaptive autoimmunity. Moreover, they identify the zebrafish as a tool to study the molecular pathways controlling adaptive immunity.	[Quintana, Francisco J.; Iglesias, Antonio H.; Farez, Mauricio F.; Burns, Evan J.; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Caccamo, Mario] European Bioinformat Inst, EMBL Outstn Hinxton, Cambridge, England; [Kassam, Nasim; Oukka, Mohamed] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		National Institutes of Health [AI435801, NS38037, R01AI073542-01, AI075285-01A2]; National Multiple Sclerosis Society [RG-3882-A-1, RG4111A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R00AI075285, R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants AI435801 and NS38037 from the National Institutes of Health to HLW, R01AI073542-01 from the National Institutes of Health and RG-3882-A-1 from the National Multiple Sclerosis Society to MO, and AI075285-01A2 from the National Institutes of Health and RG4111A1 from the National Multiple Sclerosis Society to FJQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Amemiya CT, 2007, CURR OPIN IMMUNOL, V19, P535, DOI 10.1016/j.coi.2007.08.003; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Boehm T, 2006, NAT REV IMMUNOL, V6, P79, DOI 10.1038/nri1749; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Flores MV, 2007, GENE EXPR PATTERNS, V7, P535, DOI 10.1016/j.modgep.2007.02.001; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saltis M, 2008, IMMUNOGENETICS, V60, P105, DOI 10.1007/s00251-007-0268-9; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stekel D, 2003, MICROARRAY BIOINFORM; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Takizawa F, 2008, MOL IMMUNOL, V45, P127, DOI 10.1016/j.molimm.2007.05.005; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	47	61	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9478	10.1371/journal.pone.0009478	http://dx.doi.org/10.1371/journal.pone.0009478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221429	Green Submitted, Green Published, gold			2022-12-27	WOS:000275197200004
J	Fard, SS; Kele, J; Vilar, M; Paratcha, G; Ledda, F				Fard, Shahrzad Shirazi; Kele, Julianna; Vilar, Marcal; Paratcha, Gustavo; Ledda, Fernanda			Tiam1 as a Signaling Mediator of Nerve Growth Factor-Dependent Neurite Outgrowth	PLOS ONE			English	Article							SCHWANN-CELL MIGRATION; RAC1 EXCHANGE FACTOR; RHO-GTPASES; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GUANOSINE TRIPHOSPHATASES; MENTAL-RETARDATION; RAS ACTIVATION; PROTEIN; PATHWAY	Nerve Growth Factor (NGF)-induced neuronal differentiation requires the activation of members of the Rho family of small GTPases. However, the molecular mechanisms through which NGF regulates cytoskeletal changes and neurite outgrowth are not totally understood. In this work, we identify the Rac1-specific guanine exchange factor (GEF) Tiam1 as a novel mediator of NGF/TrkA-dependent neurite elongation. In particular, we report that knockdown of Tiam1 causes a significant reduction in Rac1 activity and neurite outgrowth induced by NGF. Physical interaction between Tiam1 and active Ras (Ras-GTP), but not tyrosine phosphorylation of Tiam1, plays a central role in Rac1 activation by NGF. In addition, our findings indicate that Ras is required to associate Tiam1 with Rac1 and promote Rac1 activation upon NGF stimulation. Taken together, these findings define a novel molecular mechanism through which Tiam1 mediates TrkA signaling and neurite outgrowth induced by NGF.	[Fard, Shahrzad Shirazi; Kele, Julianna; Paratcha, Gustavo; Ledda, Fernanda] Karolinska Inst, Dept Neurosci, Mol & Cellular Neurosci Lab, Stockholm, Sweden; [Paratcha, Gustavo; Ledda, Fernanda] Univ Buenos Aires, Sch Med, CONICET,Div Mol & Cellular Neurosci, Inst Cellular Biol & Neurosci Prof Dr E De Robert, Buenos Aires, DF, Argentina; [Vilar, Marcal] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	Karolinska Institutet; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Valencia	Fard, SS (corresponding author), Karolinska Inst, Dept Neurosci, Mol & Cellular Neurosci Lab, Stockholm, Sweden.	fernanda.ledda@ki.se	Vilar, Marçal/B-4581-2016	Vilar, Marçal/0000-0002-9376-6544; Paratcha, Gustavo/0000-0002-0804-4433; Kele, Julianna/0000-0003-3418-1412	Swedish Medical Research Council [33P-15416-01A, 33SX-14773-01A, K2007-68X-20483-01-3, 33PS-14809-01A]; Karolinska Institute [2006FoBi0639, 2006FoBi0977]; Royal Swedish Academy of Science, Argentine Agency for Promotion of Science and Technology [ANPCyT-PICT2007-01034]; Argentine Medical Research Council (CONICET); ParkinsonFonden, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); Royal Swedish Academy of Science, Argentine Agency for Promotion of Science and Technology; Argentine Medical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ParkinsonFonden, Sweden	Financial support was obtained from the Swedish Medical Research Council (33P-15416-01A, 33SX-14773-01A and K2007-68X-20483-01-3), Karolinska Institute (2006FoBi0639 and 2006FoBi0977), Royal Swedish Academy of Science, Argentine Agency for Promotion of Science and Technology (ANPCyT-PICT2007-01034) and Argentine Medical Research Council (CONICET). F. L. was supported by an assistant researcher position from the Swedish Medical Research Council (33P-15416-01A), and G. P. was supported by an assistant researcher position from the Swedish Medical Research Council (33PS-14809-01A) and Karolinska Institute. JKO was supported by ParkinsonFonden, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kita Y, 1998, J CELL SCI, V111, P907; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	48	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9647	10.1371/journal.pone.0009647	http://dx.doi.org/10.1371/journal.pone.0009647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333299	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809700006
J	Hernandez-Vargas, H; Lambert, MP; Le Calvez-Kelm, F; Gouysse, G; McKay-Chopin, S; Tavtigian, SV; Scoazec, JY; Herceg, Z				Hernandez-Vargas, Hector; Lambert, Marie-Pierre; Le Calvez-Kelm, Florence; Gouysse, Geraldine; McKay-Chopin, Sandrine; Tavtigian, Sean V.; Scoazec, Jean-Yves; Herceg, Zdenko			Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; CPG ISLAND HYPERMETHYLATION; GENE-EXPRESSION PROFILES; MICROARRAY DATA; MOLECULAR PATHOGENESIS; INCREASED RISK; HEPATITIS; CANCER; POLYMORPHISMS; HEPATOCARCINOGENESIS	Background: Hepatocellular carcinoma (HCC) is characterized by late detection and fast progression, and it is believed that epigenetic disruption may be the cause of its molecular and clinicopathological heterogeneity. A better understanding of the global deregulation of methylation states and how they correlate with disease progression will aid in the design of strategies for earlier detection and better therapeutic decisions. Methods and Findings: We characterized the changes in promoter methylation in a series of 30 HCC tumors and their respective surrounding tissue and identified methylation signatures associated with major risk factors and clinical correlates. A wide panel of cancer-related gene promoters was analyzed using Illumina bead array technology, and CpG sites were then selected according to their ability to classify clinicopathological parameters. An independent series of HCC tumors and matched surrounding tissue was used for validation of the signatures. We were able to develop and validate a signature of methylation in HCC. This signature distinguished HCC from surrounding tissue and from other tumor types, and was independent of risk factors. However, aberrant methylation of an independent subset of promoters was associated with tumor progression and etiological risk factors (HBV or HCV infection and alcohol consumption). Interestingly, distinct methylation of an independent panel of gene promoters was strongly correlated with survival after cancer therapy. Conclusion: Our study shows that HCC tumors exhibit specific DNA methylation signatures associated with major risk factors and tumor progression stage, with potential clinical applications in diagnosis and prognosis.	[Hernandez-Vargas, Hector; Lambert, Marie-Pierre; Herceg, Zdenko] IARC, Epigenet Grp, Lyon, France; [Le Calvez-Kelm, Florence; McKay-Chopin, Sandrine; Tavtigian, Sean V.] IARC, Genet Canc Susceptibil Grp, Lyon, France; [Gouysse, Geraldine; Scoazec, Jean-Yves] Edouard Herriot Hosp Lyon, Serv Anat Pathol, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon	Hernandez-Vargas, H (corresponding author), IARC, Epigenet Grp, Lyon, France.	herceg@iarc.fr		Lambert, Marie-Pierre/0000-0002-4468-5203; Hernandez-Vargas, Hector/0000-0001-6045-2103; Le Calvez-Kelm, Florence/0000-0003-0063-5068	Ligue Nationale (Francaise) Contre le Cancer; l'Association pour le Recherche Contre le Cancer (l'ARC); l'Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France); National Institutes of Health/National Cancer Institute, USA; Swiss Bridge Award	Ligue Nationale (Francaise) Contre le Cancer(Ligue nationale contre le cancer); l'Association pour le Recherche Contre le Cancer (l'ARC); l'Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France)(ANRS); National Institutes of Health/National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss Bridge Award	This work was supported by la Ligue Nationale (Francaise) Contre le Cancer, l'Association pour le Recherche Contre le Cancer (l'ARC), l'Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France), National Institutes of Health/National Cancer Institute, USA, and Swiss Bridge Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 1996, PHARMACOGENETICS, V6, P501; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; Flanagan JM, 2007, BRIT J CANCER, V96, P183, DOI 10.1038/sj.bjc.6603516; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; Kinoshita M, 2002, HEPATOLOGY, V36, P433, DOI 10.1053/jhep.2002.34851; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kong SY, 2008, CANCER SCI, V99, P340, DOI 10.1111/j.1349-7006.2007.00693.x; Korn EL, 2007, STAT MED, V26, P4428, DOI 10.1002/sim.2865; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Tang KS, 2008, BIOCHEM BIOPH RES CO, V366, P643, DOI 10.1016/j.bbrc.2007.11.125; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; VAISSIERE T, 2008, CANC RES IN PRESS; Wang Y, 2004, CLIN CANCER RES, V10, P2441, DOI 10.1158/1078-0432.CCR-1187-3; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29; Yu MW, 2000, GUT, V47, P703, DOI 10.1136/gut.47.5.703; Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076; Zhang YJ, 2007, CLIN CANCER RES, V13, P2378, DOI 10.1158/1078-0432.CCR-06-1900; Zhong S, 2003, CLIN CANCER RES, V9, P3376; Zhu JD, 2006, J HEPATO-BILIARY-PAN, V13, P265, DOI 10.1007/s00534-005-1054-4	44	153	159	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9749	10.1371/journal.pone.0009749	http://dx.doi.org/10.1371/journal.pone.0009749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305825	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809600018
J	Massen, JJM; van den Berg, LM; Spruijt, BM; Sterck, EHM				Massen, Jorg J. M.; van den Berg, Lisette M.; Spruijt, Berry M.; Sterck, Elisabeth H. M.			Generous Leaders and Selfish Underdogs: Pro-Sociality in Despotic Macaques	PLOS ONE			English	Article							LONG-TAILED MACAQUES; FOOD; EVOLUTION; CHIMPANZEES; ALTRUISM; COST; RANK	Actively granting food to a companion is called pro-social behavior and is considered to be part of altruism. Recent findings show that some non-human primates behave pro-socially. However, pro-social behavior is not expected in despotic species, since the steep dominance hierarchy will hamper pro-sociality. We show that some despotic long-tailed macaques do grant others access to food. Moreover, their dominance hierarchy determines pro-social behavior in an unexpected way: high-ranking individuals grant, while low-ranking individuals withhold their partner access to food. Surprisingly, pro-social behavior is not used by subordinates to obtain benefits from dominants, but by dominants to emphasize their dominance position. Hence, Machiavellian macaques rule not through "fear above love'', but through "be feared when needed and loved when possible''.	[Massen, Jorg J. M.; van den Berg, Lisette M.; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Utrecht, Netherlands; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Rijswijk, Netherlands	Utrecht University	Massen, JJM (corresponding author), Univ Utrecht, Utrecht, Netherlands.	E.H.M.Sterck@uu.nl	Massen, Jorg/F-1190-2011; Spruijt, Berry/C-2122-2011; Sterck, Elisabeth/C-1063-2011	Sterck, Elisabeth/0000-0003-1101-6027; Massen, Jorg/0000-0002-1630-9606	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by an Evolution and Behaviour grant from the Netherlands Organization for Scientific Research (NWO, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; CHANCE M R A, 1977, Primates, V18, P611, DOI 10.1007/BF02383139; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; DOVIDIO JF, 1981, SOC PSYCHOL QUART, V44, P192, DOI 10.2307/3033833; Dugatkin L.A., 1997, COOPERATION ANIMALS; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hill D. A., 1996, P459; Hrdy S.B., 2005, ATTACHMENT BONDING N, P9, DOI DOI 10.1016/J.GLOENVCHA.2013.12.001; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; MASSEN JJM, INEQUITY AVERS UNPUB; Mast MS, 1999, Z PSYCHOL, V207, P1; MOORE J, 1984, ETHOL SOCIOBIOL, V5, P5, DOI 10.1016/0162-3095(84)90031-1; NOE R, 1991, ETHOLOGY, V87, P97; Schaub H, 1996, INT J PRIMATOL, V17, P445, DOI 10.1007/BF02736631; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; SILK JB, 1986, PRIMATE SOC, P318; Thierry Bernard, 2000, P106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; Van Noordwijk MA, 2001, BEHAVIOUR, V138, P359, DOI 10.1163/15685390152032505; VANNOORDWIJK MA, 1987, ANIM BEHAV, V35, P577, DOI 10.1016/S0003-3472(87)80284-1; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Zahavi A, 2004, BEHAV BRAIN SCI, V27, P570, DOI 10.1017/S0140525X04330128; ZAHAVI A, 1997, EVOLUTIONARY ECOLOGY, P253	35	77	79	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9734	10.1371/journal.pone.0009734	http://dx.doi.org/10.1371/journal.pone.0009734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305812	Green Published, Green Submitted, gold			2022-12-27	WOS:000275809600007
J	Wilting, A; Cord, A; Hearn, AJ; Hesse, D; Mohamed, A; Traeholdt, C; Cheyne, SM; Sunarto, S; Jayasilan, MA; Ross, J; Shapiro, AC; Sebastian, A; Dech, S; Breitenmoser, C; Sanderson, J; Duckworth, JW; Hofer, H				Wilting, Andreas; Cord, Anna; Hearn, Andrew J.; Hesse, Deike; Mohamed, Azlan; Traeholdt, Carl; Cheyne, Susan M.; Sunarto, Sunarto; Jayasilan, Mohd-Azlan; Ross, Joanna; Shapiro, Aurelie C.; Sebastian, Anthony; Dech, Stefan; Breitenmoser, Christine; Sanderson, Jim; Duckworth, J. W.; Hofer, Heribert			Modelling the Species Distribution of Flat-Headed Cats (Prionailurus planiceps), an Endangered South-East Asian Small Felid	PLOS ONE			English	Article							CONSERVATION STATUS; SAMPLE-SIZE; PALM OIL; FOREST; BENGALENSIS; BIODIVERSITY; PERFORMANCE; MOVEMENTS; IMPROVE; NUMBERS	Background: The flat-headed cat (Prionailurus planiceps) is one of the world's least known, highly threatened felids with a distribution restricted to tropical lowland rainforests in Peninsular Thailand/Malaysia, Borneo and Sumatra. Throughout its geographic range large-scale anthropogenic transformation processes, including the pollution of fresh-water river systems and landscape fragmentation, raise concerns regarding its conservation status. Despite an increasing number of camera-trapping field surveys for carnivores in South-East Asia during the past two decades, few of these studies recorded the flat-headed cat. Methodology/Principal Findings: In this study, we designed a predictive species distribution model using the Maximum Entropy (MaxEnt) algorithm to reassess the potential current distribution and conservation status of the flat-headed cat. Eighty-eight independent species occurrence records were gathered from field surveys, literature records, and museum collections. These current and historical records were analysed in relation to bioclimatic variables (WorldClim), altitude (SRTM) and minimum distance to larger water resources (Digital Chart of the World). Distance to water was identified as the key predictor for the occurrence of flat-headed cats (>50% explanation). In addition, we used different land cover maps (GLC2000, GlobCover and SarVision LLC for Borneo), information on protected areas and regional human population density data to extract suitable habitats from the potential distribution predicted by the MaxEnt model. Between 54% and 68% of suitable habitat has already been converted to unsuitable land cover types (e. g. croplands, plantations), and only between 10% and 20% of suitable land cover is categorised as fully protected according to the IUCN criteria. The remaining habitats are highly fragmented and only a few larger forest patches remain. Conclusion/Significance: Based on our findings, we recommend that future conservation efforts for the flat-headed cat should focus on the identified remaining key localities and be implemented through a continuous dialogue between local stakeholders, conservationists and scientists to ensure its long-term survival. The flat-headed cat can serve as a flagship species for the protection of several other endangered species associated with the threatened tropical lowland forests and surface fresh-water sources in this region.	[Wilting, Andreas; Hofer, Heribert] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Cord, Anna; Dech, Stefan] Univ Wurzburg, Inst Geog, Dept Remote Sensing, Wurzburg, Germany; [Cord, Anna; Dech, Stefan] German Aerosp Ctr DLR, German Remote Sensing Data Ctr, DFD, Wessling, Germany; [Hearn, Andrew J.; Ross, Joanna] Global Canopy Programme, Oxford, England; [Hearn, Andrew J.; Cheyne, Susan M.; Ross, Joanna] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England; [Hesse, Deike] German Inst Human Nutr, Dept Expt Diabet, Potsdam, Germany; [Mohamed, Azlan] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Malaysia; [Mohamed, Azlan] WWF Malaysia, Selangor, Malaysia; [Traeholdt, Carl] Copenhagen Zoo, Dept Res & Conservat, Frederiksberg, Denmark; [Cheyne, Susan M.] Univ Palangka Raya, Orang Utan Trop Peatland Project, Kalimantan, Indonesia; [Sunarto, Sunarto] Virginia Tech, Dept Fisheries & Wildlife Sci, Blacksburg, VA USA; [Sunarto, Sunarto] WWF Indonesia, Pekanbaru, Indonesia; [Jayasilan, Mohd-Azlan] Fac Resource Sci & Technol, Dept Zool, Kota Samarahan, Sarawak, Malaysia; [Jayasilan, Mohd-Azlan] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia; [Shapiro, Aurelie C.] WWF US, Conservat Sci Program, Washington, DC USA; [Sebastian, Anthony] Aonyx Environm, Kuching, Sarawak, Malaysia; [Breitenmoser, Christine] KORA, IUCN, SSC Cat Specialist Grp, Muri, Switzerland; [Sanderson, Jim] Wildlife Conservat Network, Small Wild Cat Conservat Fdn, Los Altos, CA USA; [Duckworth, J. W.] Wildlife Conservat Soc Asia Program, New York, NY USA	Leibniz Institut fur Zoo und Wildtierforschung; University of Wurzburg; Helmholtz Association; German Aerospace Centre (DLR); University of Oxford; University of Oxford; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Universiti Malaysia Sabah; World Wildlife Fund; Universitas Palangka Raya (UPR); Virginia Polytechnic Institute & State University; World Wildlife Fund; Charles Darwin University; World Wildlife Fund; Wildlife Conservation Society	Wilting, A (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	a.wilting@gmx.de	Cheyne, Susan M/C-9856-2013; Wilting, Andreas/B-1644-2010; Cheyne, Susan M/P-2404-2019; Hesse, Deike/F-5716-2018; Hofer, Heribert/AAF-7854-2021	Cheyne, Susan M/0000-0002-9180-3356; Cheyne, Susan M/0000-0002-9180-3356; Hesse, Deike/0000-0001-5915-8003; Hofer, Heribert/0000-0002-2813-7442; Wilting, Andreas/0000-0001-5073-9186; Cord, Anna F./0000-0003-3183-8482; Shapiro, Aurelie/0000-0001-9693-9394; Mohamed, Azlan/0000-0003-3788-4383; Breitenmoser, Christine/0000-0002-5228-2957	Clouded Leopard Project and Point Defiance Zoo and Aquarium; Panthera Foundation; WWF-Germany; WWF-Malaysia; Minnesota Zoo; Cleveland MetroParks; Houston Zoo; Association for Wild Cat Conservation; Society for the Conservation of Species and Populations; Deutsche Forschungsgemeinschaft [Fi-698/5-1]; Darwin Initiative; Felidae Conservation Fund; International Trust for Nature Conservation; Wild About Cats; HDH Wills 1965 Charitable Trust; Cat Action Treasury	Clouded Leopard Project and Point Defiance Zoo and Aquarium; Panthera Foundation; WWF-Germany; WWF-Malaysia; Minnesota Zoo; Cleveland MetroParks; Houston Zoo; Association for Wild Cat Conservation; Society for the Conservation of Species and Populations; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Darwin Initiative; Felidae Conservation Fund; International Trust for Nature Conservation; Wild About Cats; HDH Wills 1965 Charitable Trust; Cat Action Treasury	The different field work projects of the authors were supported by the Clouded Leopard Project and Point Defiance Zoo and Aquarium, the Panthera Foundation, WWF-Germany, WWF-Malaysia, Minnesota Zoo, Cleveland MetroParks, Houston Zoo, Association for Wild Cat Conservation, the Society for the Conservation of Species and Populations, Deutsche Forschungsgemeinschaft (grant Fi-698/5-1), the Darwin Initiative, Felidae Conservation Fund, International Trust for Nature Conservation, Wild About Cats, HDH Wills 1965 Charitable Trust and the Cat Action Treasury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AW, 1987, US FISH WILDLIFE SER, V82, P47; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; AZLAN MJ, 2007, CAT NEWS, P47; Bezuijen Mark R., 2003, Cat News, V38, P26; Bezuijen MR, 2000, ORYX, V34, P222, DOI 10.1017/S0030605300031227; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Cerioli A, 1997, BIOMETRICS, V53, P619, DOI 10.2307/2533962; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; CHEYNE SM, 2009, CAT NEWS, V51, P16; Cliff A. D., 1981, SPATIAL PROCESSES MO; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FAO,, 2022, STAT WORLDS FOR 2022; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2275, DOI 10.1023/A:1021302930424; Gaubert P, 2006, BIOL CONSERV, V130, P106, DOI 10.1016/j.biocon.2005.12.006; Grassman LI, 2000, ACTA THERIOL, V45, P421, DOI 10.4098/AT.arch.00-41; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Haining R., 2003, SPATIAL DATA ANAL TH; HEARN A, 2008, IUCN 2009 IUCN RED L; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLMES D, 1999, BIRDS BORNEO; Hughes JB, 2003, J BIOGEOGR, V30, P569, DOI 10.1046/j.1365-2699.2003.00847.x; IZAWA M, 1990, WILDL CONSERV, P140; Jackson P., 1996, BIOL CONSERVATION; KHAN M, 1986, CAT NEWS, V5, P11; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Lekagul B., 1977, MAMMALS THAILAND; Lim BK, 2002, BIODIVERS CONSERV, V11, P1237, DOI 10.1023/A:1016038501986; LIM BL, 1970, J MAMMAL, V51, P806, DOI 10.2307/1378310; LIM BL, 1961, MALAYS NAT HIST J, V15, P8; LYDEKKER R, 1895, HDB CARNIVORA 1; MEDWAY L, 1965, MAMMALS BORNEO FIELD; MEIJAARD E, 1997, CAT NEWS, V27; Meijaard Erik, 2005, Cat News, V43, P24; MIVART G, 1892, CAT; Mohamed A, 2009, CAT NEWS, V51, P12; Mohd-Azlan J, 2007, ORYX, V41, P394, DOI 10.1017/S0030605307000516; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; PAYNE J, 1985, FIELD GUIDE MAMMALS; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Povey K, 2009, CLOUDED LEOPARD SMAL; PRB (Population Reference Bureau), 2007, 2007 WORLD POP DAT S; RABINOWITZ A, 1990, BIOTROPICA, V22, P397, DOI 10.2307/2388557; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Rautner M, 2005, BORNEO TREASURE ISLA; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Sanchez-Cordero V, 2008, ECOGRAPHY, V31, P757, DOI 10.1111/j.1600-0587.2008.05327.x; Shepherd P.A., 1997, BIODIVESITY SUSTAINA, P191; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sunquist M, 2009, HDB MAMMALS WORLD, VI, P54; Sunquist ME, 2002, WILD CATS WORLD; Sunquist Mel, 1994, Oryx, V28, P67; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; Tonkin B.A., 1979, CAT BEHAV PREDATORY; *UNESCO IUCN, 2004, TROP RAINF HER SUM I; Uryu Y, 2008, DEFORESTATION FOREST; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; YASUDA M, 2007, CAT NEWS, V47, P12; YASUMA S, 1994, PUSREHUT SPECIAL PUB, V3, P176; Zheng BY, 2000, STAT MED, V19, P1771, DOI 10.1002/1097-0258(20000715)19:13<1771::AID-SIM485>3.3.CO;2-G	68	88	101	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9612	10.1371/journal.pone.0009612	http://dx.doi.org/10.1371/journal.pone.0009612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305809	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000275809600001
J	Suwannakarn, K; Chieochansin, T; Thongmee, C; Makkoch, J; Praianantathavorn, K; Theamboonlers, A; Sreevatsan, S; Poovorawan, Y				Suwannakarn, Kamol; Chieochansin, Thaweesak; Thongmee, Chitima; Makkoch, Jarika; Praianantathavorn, Kesmanee; Theamboonlers, Apiradee; Sreevatsan, Srinand; Poovorawan, Yong			Molecular Evolution of Human H1N1 and H3N2 Influenza A Virus in Thailand, 2006-2009	PLOS ONE			English	Article							RECEPTOR-BINDING; NUCLEOPROTEIN	Background: Annual seasonal influenza outbreaks are associated with high morbidity and mortality. Objective: To index and document evolutionary changes among influenza A H1N1 and H3N2 viruses isolated from Thailand during 2006-2009, using complete genome sequences. Methods: Nasopharyngeal aspirates were collected from patients diagnosed with respiratory illness in Thailand during 2006-2009. All samples were screened for Influenza A virus. A total of 13 H1N1 and 21 H3N2 were confirmed and whole genome sequenced for the evolutionary analysis using standard phylogenetic approaches. Results: Phylogenetic analysis of HA revealed a clear diversification of seasonal from vaccine strain lineages. H3N2 seasonal clusters were closely related to the WHO recommended vaccine strains in each season. Most H1N1 isolates could be differentiated into 3 lineages. The A/Brisbane/59/2007 lineage, a vaccine strain for H1N1 since 2008, is closely related with the H1N1 subtypes circulating in 2009. HA sequences were conserved at the receptor-binding site. Amino acid variations in the antigenic site resulted in a possible N-linked glycosylation motif. Recent H3N2 isolates had higher genetic variations compared to H1N1 isolates. Most substitutions in the NP protein were clustered in the T-cell recognition domains. Conclusion: In this study we performed evolutionary genetic analysis of influenza A viruses in Thailand between 2006-2009. Although the current vaccine strain is efficient for controlling the circulating outbreak subtypes, surveillance is necessary to provide unambiguous information on emergent viruses. In summary, the findings of this study contribute the understanding of evolution in influenza A viruses in humans and is useful for routine surveillance and vaccine strain selection.	[Suwannakarn, Kamol; Chieochansin, Thaweesak; Thongmee, Chitima; Makkoch, Jarika; Praianantathavorn, Kesmanee; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sreevatsan, Srinand] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	Chulalongkorn University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Suwannakarn, K (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Poovorawan, Yong/0000-0002-2337-6807	Thailand Research Fund; Commission on Higher Education, King Chulalongkorn Memorial Hospital; Center of Excellence in Clinical Virology and CU Centenary Academic Development Project; Chulalongkorn University, Bangkok, Thailand; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN266200700007C]	Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education, King Chulalongkorn Memorial Hospital(Office of Higher Education Commission (OHEC)); Center of Excellence in Clinical Virology and CU Centenary Academic Development Project; Chulalongkorn University, Bangkok, Thailand(Chulalongkorn University); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services	This research was supported by the Thailand Research Fund, the Commission on Higher Education, King Chulalongkorn Memorial Hospital, the Center of Excellence in Clinical Virology and CU Centenary Academic Development Project, Chulalongkorn University, Bangkok, Thailand. This work was also funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chutinimitkul S, 2008, VIRUS RES, V132, P122, DOI 10.1016/j.virusres.2007.11.007; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Gupta R., 2004, RESEARCHGATE; Hampson AW, 2002, PERSP MED V, V7, P49; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Lin YP, 2004, VIRUS RES, V103, P47, DOI 10.1016/j.virusres.2004.02.011; Lindstrom S, 1996, ARCH VIROL, V141, P1349, DOI 10.1007/BF01718836; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2009, REC COMP INFL VIR VA; *WHO, 2009, WHO EP PAND AL RESP; WINTER G, 1981, VIROLOGY, V114, P423, DOI 10.1016/0042-6822(81)90223-3; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	22	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9717	10.1371/journal.pone.0009717	http://dx.doi.org/10.1371/journal.pone.0009717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300536	gold, Green Published			2022-12-27	WOS:000275716400015
J	Schwartz, RS; Mueller, RL				Schwartz, Rachel S.; Mueller, Rachel Lockridge			Variation in DNA Substitution Rates among Lineages Erroneously Inferred from Simulated Clock-Like Data	PLOS ONE			English	Article							ESTIMATING DIVERGENCE TIMES; EVOLUTIONARY RATE VARIATION; BRANCH-LENGTH ESTIMATION; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; PHYLOGENETIC ANALYSIS; GENERATION TIME; RELATIVE RATES; ABSOLUTE RATES; GENE-SEQUENCES	Background: The observation of variation in substitution rates among lineages has led to (1) a general rejection of the molecular clock model, and (2) the suggestion that a number of biological characteristics of organisms can cause rate variation. Accurate estimates of rate variation, and thus accurate inferences regarding the causes of rate variation, depend on accurate estimates of substitution rates. However, theory suggests that even when the substitution process is clock-like, variable numbers of substitutions can occur among lineages because the substitution process is stochastic. Furthermore, substitution rates along lineages can be misestimated, particularly when multiple substitutions occur at some sites. Although these potential causes of error in rate estimation are well understood in theory, such error has not been examined in detail; consequently, empirical studies that estimate rate variation among lineages have been unable to determine whether their results could be impacted by estimation error. Methodology/Principal Findings: To evaluate the extent to which error in rate estimation could erroneously suggest rate variation among lineages, we examined rate variation estimated for datasets simulated under a molecular clock on trees with equal and variable branch lengths. Thus, any apparent rate variation in these datasets reflects error in rate estimation rather than true differences in the underlying substitution process. We observed substantial rate variation among lineages in our simulations; however, we did not observe rate variation when average substitution rates were compared between different clades. Conclusions/Significance: Our results confirm previous theoretical work suggesting that observations of among lineage rate variation in empirical data may be due to the stochastic substitution process and error in the estimation of substitution rates, rather than true differences in the underlying substitution process among lineages. However, conclusions regarding rate variation drawn from rates averaged across multiple branches are likely due to real, systematic variation in rates between groups.	[Schwartz, Rachel S.; Mueller, Rachel Lockridge] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University	Schwartz, RS (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	Rachel.Schwartz@colostate.edu		Schwartz, Rachel/0000-0001-7414-9893	Colorado State University; National Science Foundation [DBI 0906004]	Colorado State University; National Science Foundation(National Science Foundation (NSF))	Funding was provided by Colorado State University and by a National Science Foundation (http://www.nsf.gov) Postdoctoral Research Fellowship in Biology to RSS (DBI 0906004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2006, GENE, V380, P21, DOI 10.1016/j.gene.2006.04.019; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Davies TJ, 2006, EVOLUTION, V60, P476; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FITCH WM, 1987, MOL BIOL EVOL, V4, P381; Galtier N, 2001, MOL BIOL EVOL, V18, P866, DOI 10.1093/oxfordjournals.molbev.a003868; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; GILLESPIE JH, 1986, ANNU REV ECOL SYST, V17, P637; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huelsenbeck JP, 2002, MOL BIOL EVOL, V19, P698, DOI 10.1093/oxfordjournals.molbev.a004128; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, EVOLUTION, V61, P2293, DOI 10.1111/j.1558-5646.2007.00188.x; Jordan IK, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-22; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; LI P, 1992, MOL BIOL EVOL, V9, P1185; Li W. H, 1997, MOL EVOLUTION; LI WH, 1987, MOL BIOL EVOL, V4, P74; LI WH, 1985, MOL BIOL EVOL, V2, P150; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; MUSE SV, 1992, GENETICS, V132, P269; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; Schwartz RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-5; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1993, GENETICS, V135, P599; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; Tuffley C, 1998, MATH BIOSCI, V147, P63, DOI 10.1016/S0025-5564(97)00081-3; Wang HC, 2007, MOL BIOL EVOL, V24, P294, DOI 10.1093/molbev/msl155; Wang YF, 2001, GENETICS, V158, P1311; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; ZUCKERKANDL EMILE, 1965, P97	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9649	10.1371/journal.pone.0009649	http://dx.doi.org/10.1371/journal.pone.0009649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300176	Green Submitted, Green Published, gold			2022-12-27	WOS:000275620600006
J	Joyner, TA; Lukhnova, L; Pazilov, Y; Temiralyeva, G; Hugh-Jones, ME; Aikimbayev, A; Blackburn, JK				Joyner, Timothy Andrew; Lukhnova, Larissa; Pazilov, Yerlan; Temiralyeva, Gulnara; Hugh-Jones, Martin E.; Aikimbayev, Alim; Blackburn, Jason K.			Modeling the Potential Distribution of Bacillus anthracis under Multiple Climate Change Scenarios for Kazakhstan	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; PREDICTING DISTRIBUTIONS; GEOGRAPHIC DISTRIBUTIONS; SNOW ACCUMULATION; NORTHERN EURASIA; COUPLED MODEL; NICHE; GARP; RANGE; POPULATION	Anthrax, caused by the bacterium Bacillus anthracis, is a zoonotic disease that persists throughout much of the world in livestock, wildlife, and secondarily infects humans. This is true across much of Central Asia, and particularly the Steppe region, including Kazakhstan. This study employed the Genetic Algorithm for Rule-set Prediction (GARP) to model the current and future geographic distribution of Bacillus anthracis in Kazakhstan based on the A2 and B2 IPCC SRES climate change scenarios using a 5-variable data set at 55 km(2) and 8 km(2) and a 6-variable BioClim data set at 8 km(2). Future models suggest large areas predicted under current conditions may be reduced by 2050 with the A2 model predicting similar to 14-16% loss across the three spatial resolutions. There was greater variability in the B2 models across scenarios predicting similar to 15% loss at 55 km 2, similar to 34% loss at 8 km 2, and similar to 30% loss with the BioClim variables. Only very small areas of habitat expansion into new areas were predicted by either A2 or B2 in any models. Greater areas of habitat loss are predicted in the southern regions of Kazakhstan by A2 and B2 models, while moderate habitat loss is also predicted in the northern regions by either B2 model at 8 km(2). Anthrax disease control relies mainly on livestock vaccination and proper carcass disposal, both of which require adequate surveillance. In many situations, including that of Kazakhstan, vaccine resources are limited, and understanding the geographic distribution of the organism, in tandem with current data on livestock population dynamics, can aid in properly allocating doses. While speculative, contemplating future changes in livestock distributions and B. anthracis spore promoting environments can be useful for establishing future surveillance priorities. This study may also have broader applications to global public health surveillance relating to other diseases in addition to B. anthracis.	[Joyner, Timothy Andrew; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Joyner, Timothy Andrew; Blackburn, Jason K.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Lukhnova, Larissa; Pazilov, Yerlan; Temiralyeva, Gulnara; Aikimbayev, Alim] Kazakh Sci Ctr Quarantine & Zoonot Dis, Alma Ata, Kazakhstan; [Hugh-Jones, Martin E.] Louisiana State Univ, Sch Coast & Environm, Dept Environm Sci, Baton Rouge, LA 70803 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Louisiana State University System; Louisiana State University	Joyner, TA (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	jkblackburn@ufl.edu	Lukhnova, Larissa/ABE-5682-2021; Blackburn, Jason/AAV-9445-2020	Blackburn, Jason/0000-0003-0928-4831; Luhnova, Larisa/0000-0002-5818-8021; Joyner, Timothy/0000-0003-2790-6817	Defense Threat Reduction Agency's Biological Threat Reduction Program under the Cooperative Biological Research Projec [KZ-1]	Defense Threat Reduction Agency's Biological Threat Reduction Program under the Cooperative Biological Research Projec	This study was funded by the Defense Threat Reduction Agency's Biological Threat Reduction Program under the Cooperative Biological Research Project KZ-1 to the participating institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian JCZ, 2006, J MED ENTOMOL, V43, P93, DOI 10.1603/0022-2585(2006)043[0093:AOGAFR]2.0.CO;2; AIKEMBAYEV A, 2010, EMERGING IN IN PRESS; Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; ATZMANSTORFER K, 2007, GEOINFORMATION DEV B; Baettig MB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028159; BAKER BB, 1993, CLIMATIC CHANGE, V25, P97, DOI 10.1007/BF01661200; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; BLACKBURN KJ, 2010, SCI PEACE S IN PRESS; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Carlson JK, 2003, FISH RES, V60, P405, DOI 10.1016/S0165-7836(02)00135-2; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dragon DC, 1999, J APPL MICROBIOL, V87, P208, DOI 10.1046/j.1365-2672.1999.00872.x; Dragon DC, 2001, J APPL MICROBIOL, V91, P435, DOI 10.1046/j.1365-2672.2001.01389.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESRI, 2007, ARCGIS 9 2; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; GAINER RS, 1989, CAN VET J, V30, P953; GATES CC, 1995, CAN J VET RES, V59, P256; Giorgi F, 2001, GEOPHYS RES LETT, V28, P3317, DOI 10.1029/2001GL013150; Gordon H B, 2002, 60 CSIRO; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Grinnell J., 1917, Auk Cambridge Mass, V34; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IPCC, 2000, SPECIAL REPORT EMISS; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; KAUFMANN AF, 1990, SALISBURY MED B S, V68, P16; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kimoto M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023383; Lal M, 2001, J METEOROL SOC JPN, V79, P219, DOI 10.2151/jmsj.79.219; MacArthur R.H., 1972, pvii; McNyset KM, 2005, ECOL FRESHW FISH, V14, P243, DOI 10.1111/j.1600-0633.2005.00101.x; McNyset KM, 2006, DIVERS DISTRIB, V12, P782, DOI [10.1111/j.1472-4642.2006.00281.x, 10.1111/j.1366-9516.2006.00281.x]; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Parkinson R, 2003, CAN VET J, V44, P315; Parra-Olea G, 2005, BIOTROPICA, V37, P202, DOI 10.1111/j.1744-7429.2005.00027.x; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; *PSSS, 2008, SPSS V 16 0; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Saito K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016341; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Smith KL, 1999, J APPL MICROBIOL, V87, P204, DOI 10.1046/j.1365-2672.1999.00871.x; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockman AK, 2006, DIVERS DISTRIB, V12, P81, DOI 10.1111/j.1366-9516.2006.00225.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sweeney AW, 2006, J MED ENTOMOL, V43, P1068, DOI 10.1603/0022-2585(2006)43[1068:EFAWDA]2.0.CO;2; Terribile LC, 2009, ACTA OECOL, V35, P163, DOI 10.1016/j.actao.2008.09.006; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Turner AJ, 1999, J APPL MICROBIOL, V87, P294, DOI 10.1046/j.1365-2672.1999.00894.x; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Watanabe M, 1999, J CLIMATE, V12, P494, DOI 10.1175/1520-0442(1999)012<0494:DCITAC>2.0.CO;2; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wilson RT, 1997, MT RES DEV, V17, P57, DOI 10.2307/3673914; Woods CW, 2004, AM J TROP MED HYG, V71, P48, DOI 10.4269/ajtmh.2004.71.48; Ye HC, 1998, J CLIMATE, V11, P856, DOI 10.1175/1520-0442(1998)011<0856:TCIRWS>2.0.CO;2; Ye HC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016873; Ye HC, 2001, J CLIMATE, V14, P4573, DOI 10.1175/1520-0442(2001)014<4573:QBAQDV>2.0.CO;2; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5	85	57	61	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9596	10.1371/journal.pone.0009596	http://dx.doi.org/10.1371/journal.pone.0009596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231894	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300013
J	Martinez-Poveda, B; Verotta, L; Bombardelli, E; Quesada, AR; Medina, MA				Martinez-Poveda, Beatriz; Verotta, Luisella; Bombardelli, Ezio; Quesada, Ana R.; Angel Medina, Miguel			Tetrahydrohyperforin and Octahydrohyperforin Are Two New Potent Inhibitors of Angiogenesis	PLOS ONE			English	Article							ST-JOHNS-WORT; IN-VITRO; HYPERFORIN ANALOGS; EFFICACY; CANCER	Background: We have previously shown that hyperforin, a phloroglucinol derivative found in St. John's wort, behaves as a potent anti-angiogenic compound. To identify the reactive group(s) mainly involved in this anti-angiogenic effect, we have investigated the anti-angiogenic properties of a series of stable derivatives obtained by oxidative modification of the natural product. In addition, in the present work we have studied the role of the four carbonyl groups present in hyperforin by investigating the potential of some other chemically stable derivatives. Methodology/Principal Findings: The experimental procedures included the analysis of the effects of treatment of endothelial cells with these compounds in cell growth, cell viability, cell migration and zymographic assays, as well as the tube formation assay on Matrigel. Our study with hyperforin and eight derivatives shows that the enolized beta-dicarbonyl system contained in the structure of hyperforin has a dominant role in its antiangiogenic activity. On the other hand, two of the tested hyperforin derivatives, namely, tetrahydrohyperforin and octahydrohyperforin, behave as potent inhibitors of angiogenesis. Additional characterization of these compounds included a cell specificity study of their effects on cell growth, as well as the in vivo Matrigel plug assay. Conclusions/Significance: These observations could be useful for the rational design and chemical synthesis of more effective hyperforin derivatives as anti-angiogenic drugs. Altogether, the results indicate that octahydrohyperforin is a more specific and slightly more potent antiangiogenic compound than hyperforin.	[Martinez-Poveda, Beatriz; Quesada, Ana R.; Angel Medina, Miguel] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain; [Verotta, Luisella] Univ Milan, Dipartimento Chim Organ & Ind, Milan, Italy; [Bombardelli, Ezio] Indena SPA, I-20141 Milan, Italy; [Quesada, Ana R.; Angel Medina, Miguel] CIBER Enfermedades Raras, Unidad 741, Malaga, Spain	Universidad de Malaga; University of Milan; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martinez-Poveda, B (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain.	luisella.verotta@unimi.it; medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Verotta, Luisella/O-5953-2016; Martinez-Poveda, Beatriz/T-6973-2017	Medina, Miguel Ángel/0000-0001-7275-6462; Verotta, Luisella/0000-0002-5739-6291; Martinez-Poveda, Beatriz/0000-0003-3927-3877; Rodriguez Quesada, Ana Maria/0000-0002-6419-8867	EEC [018834]; Spanish Ministry of Science and Innovation [CTQ2006-15279-C03-03/BQU, PS09/02216, TRACE PT2008-0145]; Fundacion Ramon Areces [PIE CTS-3759, P07-CVI-02999]; Andalusian Government [BIO-267]	EEC; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Andalusian Government	Work supported in part by EEC (Contract 018834: Antimal), as well as grants CTQ2006-15279-C03-03/BQU, PS09/02216 and TRACE PT2008-0145 (Spanish Ministry of Science and Innovation), Fundacion Ramon Areces and PIE CTS-3759, P07-CVI-02999 and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras'' is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilia AR, 2002, LIFE SCI, V70, P3077, DOI 10.1016/S0024-3205(02)01566-7; Cabrelle A, 2008, J LEUKOCYTE BIOL, V83, P212, DOI 10.1189/jlb.0707469; Cardenas C, 2006, CELL MOL LIFE SCI, V63, P3083, DOI 10.1007/s00018-006-6399-6; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dell'Aica I, 2007, J PHARMACOL EXP THER, V321, P492, DOI 10.1124/jpet.106.116459; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Feisst Christian, 2005, Med Chem, V1, P287, DOI 10.2174/1573406053765503; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lee J, 2006, PHYTOCHEMISTRY, V67, P2550, DOI 10.1016/j.phytochem.2006.09.018; MARTINEZPOVEDA B, 2005, INT J CANC, V117; Medina MA, 2006, LIFE SCI, V79, P105, DOI 10.1016/j.lfs.2005.12.027; Mennini T, 2004, LIFE SCI, V75, P1021, DOI 10.1016/j.lfs.2004.04.005; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Rothley M, 2009, INT J CANCER, V125, P34, DOI 10.1002/ijc.24295; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Verotta L, 2000, J NAT PROD, V63, P412, DOI 10.1021/np9903752; Verotta L, 2004, J ORG CHEM, V69, P7869, DOI 10.1021/jo048857s; Verotta L, 2003, CURR TOP MED CHEM, V3, P187, DOI 10.2174/1568026033392589; Verotta L, 2002, J NAT PROD, V65, P433, DOI 10.1021/np0105681; Verotta L, 1999, J NAT PROD, V62, P770, DOI 10.1021/np980470v; Verotta L, 2007, BIOORG MED CHEM LETT, V17, P1544, DOI 10.1016/j.bmcl.2006.12.100; Verotta Luisella, 2002, Phytochemistry Reviews, V1, P389, DOI 10.1023/A:1026069624278; Verotta L, 2006, EUR J ORG CHEM, V2006, P5479, DOI 10.1002/ejoc.200600644; Wolfender JL, 2003, PHYTOCHEM ANALYSIS, V14, P290, DOI 10.1002/pca.718	27	14	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9558	10.1371/journal.pone.0009558	http://dx.doi.org/10.1371/journal.pone.0009558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20224821	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300006
J	Ye, L; Wang, X; Metzger, DS; Riedel, E; Montaner, LJ; Ho, WZ				Ye, Li; Wang, Xu; Metzger, David S.; Riedel, Eric; Montaner, Luis J.; Ho, Wenzhe			Upregulation of SOCS-3 and PIAS-3 Impairs IL-12-Mediated Interferon-Gamma Response in CD56(+) T Cells in HCV-Infected Heroin Users	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; BLOOD MONONUCLEAR-CELLS; NATURAL-KILLER-CELLS; DRUG-USERS; HUMAN LIVER; HEPATOCELLULAR-CARCINOMA; SIGNAL-TRANSDUCTION; INDUCED EXPRESSION; ALPHA EXPRESSION; IMMUNE-SYSTEM	Background: CD56(+) T cells are abundant in liver and play an important role in host innate immunity against viral infections, including hepatitis C virus (HCV) infection, a common infection among heroin abusers. We thus investigated the in vivo impact of heroin use or heroin use plus HCV infection on the CD56(+) T cell frequency and function. Methodology/Principal Findings: A total of 37 heroin users with (17) or without (20) HCV infection and 17 healthy subjects were included in the study. Although there was no significant difference in CD56+ T cell frequency in PBMCs among three study groups, CD56(+) T cells isolated from the heroin users had significantly lower levels of constitutive interferon-gamma (IFN-gamma) expression than those from the normal subjects. In addition, when stimulated by interleukin (IL)-12, CD56(+) natural T cells from HCV-infected heroin users produced significantly lower levels of IFN-gamma than those from the normal subjects. This diminished ability to produce IFN-gamma by CD56(+) T cells was associated with the increased plasma HCV viral loads in the HCV-infected heroin users. Investigation of the mechanisms showed that although heroin use or heroin use plus HCV infection had little impact on the expression of the key positive regulators (IL-12 receptors, STAT-1, 3, 4, 5, JAK-2, and TYK-2) in IL-12 pathway, heroin use or heroin use plus HCV infection induced the expression of suppressor of cytokine signaling protein-3 (SOCS-3) and protein inhibitors of activated STAT-3 (PIAS-3), two key inhibitors of IL-12 pathway. Conclusion/Significance: These findings provide compelling in vivo evidence that heroin use or heroin use plus HCV infection impairs CD56(+) T cell-mediated innate immune function, which may account for HCV infection and persistence in liver.	[Ye, Li; Wang, Xu; Ho, Wenzhe] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Wang, Xu] Temple Univ, Sch Med, Ctr Studies Addict, Dept Psychiat, Philadelphia, PA 19122 USA; [Riedel, Eric] Childrens Hosp Philadelphia, Dept Pediat, Res Inst Jr, Philadelphia, PA 19104 USA; [Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute	Ye, L (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.	wenzheho@temple.edu			National Institutes of Health [DA 22177, 12815, AI 073219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022177, R01DA012815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants (http://projectreporter.nih.gov/reporter.cfm) DA 22177(to Wenzhe Ho), DA 12815 (to Wenzhe Ho), AI 073219 (to Luis J. Montaner). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backmund M, 2003, EUR J EPIDEMIOL, V18, P563, DOI 10.1023/A:1024603517136; Bassani S, 2004, MED CLIN-BARCELONA, V122, P570, DOI 10.1157/13060891; Byrnes AA, 2007, J LEUKOCYTE BIOL, V81, P825, DOI 10.1189/jlb.1006622; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Day C, 2003, DRUG ALCOHOL REV, V22, P317, DOI 10.1080/0959523031000154463; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Doherty DG, 1999, J IMMUNOL, V163, P2314; Edlin BR, 2001, NEW ENGL J MED, V345, P211, DOI 10.1056/NEJM200107193450311; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Homan JW, 2002, J ACQ IMMUN DEF SYND, V30, P9, DOI 10.1097/00126334-200205010-00002; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jin YD, 1998, HUM IMMUNOL, V59, P352, DOI 10.1016/S0198-8859(98)00030-5; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Li Y, 2005, J INFECT DIS, V192, P1093, DOI 10.1086/432957; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Li Y, 2007, J INFECT DIS, V196, P719, DOI 10.1086/520093; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; LU PH, 1994, J IMMUNOL, V153, P1687; McCarthy JJ, 2001, J ADDICT DIS, V20, P19, DOI 10.1300/J069v20n01_03; Ohkawa T, 2001, IMMUNOLOGY, V103, P281, DOI 10.1046/j.1365-2567.2001.01248.x; Okumura A, 2005, HEPATOL RES, V32, P213, DOI 10.1016/j.hepres.2005.02.008; Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P1107, DOI 10.1590/S0100-879X1999000900009; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; PETERSON PK, 1987, J CLIN INVEST, V80, P824, DOI 10.1172/JCI113140; Quaglio G, 2003, CLIN INFECT DIS, V37, P33, DOI 10.1086/375566; Sacerdote P, 2006, PALLIATIVE MED, V20, pS9, DOI 10.1191/0269216306pm1124oa; Sacerdote P, 2001, INT IMMUNOPHARMACOL, V1, P713, DOI 10.1016/S1567-5769(01)00005-4; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; SCHMIDT RE, 1986, J EXP MED, V164, P351, DOI 10.1084/jem.164.1.351; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Smyth BP, 2005, INT J EPIDEMIOL, V34, P166, DOI 10.1093/ije/dyh347; StollKeller F, 1997, INT J IMMUNOPHARMACO, V19, P95, DOI 10.1016/S0192-0561(97)00017-9; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Vitale M, 2000, CYTOMETRY, V39, P189, DOI 10.1002/(SICI)1097-0320(20000301)39:3<189::AID-CYTO3>3.0.CO;2-C; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V310, P1188, DOI 10.1016/j.bbrc.2003.09.140; Yang JH, 2002, J VIROL METHODS, V102, P119, DOI 10.1016/S0166-0934(02)00007-1; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854	54	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9602	10.1371/journal.pone.0009602	http://dx.doi.org/10.1371/journal.pone.0009602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231901	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328300018
J	Baker, SS; Baker, RD; Liu, WS; Nowak, NJ; Zhu, LX				Baker, Susan S.; Baker, Robert D.; Liu, Wensheng; Nowak, Norma J.; Zhu, Lixin			Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY LIVER-DISEASE; FACTOR-ALPHA PRODUCTION; INSULIN-RESISTANCE; ETHANOL-PRODUCTION; DEHYDROGENASE; ACTIVATION; SYSTEM; CELLS; RAT	Background: Non-alcoholic steatohepatitis (NASH) is a serious form of non-alcoholic fatty liver disease (NAFLD), associated with obesity and insulin resistance. Previous studies suggested that intestinal bacteria produced more alcohol in obese mice than lean animals. Methodology/Principal Findings: To investigate whether alcohol is involved in the pathogenesis of NASH, the expression of inflammation, fibrosis and alcohol metabolism related genes in the liver tissues of NASH patients and normal controls (NCs) were examined by microarray (NASH, n = 7; NC, n = 4) and quantitative real-time PCR (NASH, n = 6; NC, n = 6). Genes related to liver inflammation and fibrosis were found to be elevated in NASH livers compared to normal livers. The most striking finding is the increased gene transcription of alcohol dehydrogenase (ADH) genes, genes for catalase and cytochrome P450 2E1, and aldehyde dehydrogenase genes. Immunoblot analysis confirmed the increased expression of ADH1 and ADH4 in NASH livers (NASH, n = 9; NC, n = 4). Conclusions/Significance: The augmented activity of all the available genes of the pathways for alcohol catabolism suggest that 1) alcohol concentration was elevated in the circulation of NASH patients; 2) there was a high priority for the NASH livers to scavenge alcohol from the circulation. Our data is the first human evidence that suggests alcohol may contribute to the development of NAFLD.	[Baker, Susan S.; Baker, Robert D.; Liu, Wensheng; Zhu, Lixin] SUNY Buffalo, Dept Pediat, Digest Dis & Nutr Ctr, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Nowak, Norma J.] Roswell Pk Canc Inst, Microarray & Genom Facil, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Baker, SS (corresponding author), SUNY Buffalo, Dept Pediat, Digest Dis & Nutr Ctr, Buffalo, NY 14260 USA.	lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, New York	Peter and Tommy Fund, Inc., Buffalo, New York	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, New York. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAONA E, 1986, GASTROENTEROLOGY, V90, P103, DOI 10.1016/0016-5085(86)90081-8; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Bode C, 2005, ALCOHOL CLIN EXP RES, V29, p166S, DOI 10.1097/01.alc.0000189280.19073.28; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; HONCHEL R, 1992, ALCOHOL CLIN EXP RES, V16, P665, DOI 10.1111/j.1530-0277.1992.tb00656.x; Kawaratani H, 2008, WORLD J GASTROENTERO, V14, P6655, DOI 10.3748/wjg.14.6655; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCLAIN CJ, 1989, HEPATOLOGY, V9, P349, DOI 10.1002/hep.1840090302; NELSON S, 1989, LIFE SCI, V44, P673, DOI 10.1016/0024-3205(89)90472-4; Nosova T, 1996, ALCOHOL ALCOHOLISM, V31, P555; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Szabo G, 2005, ALCOHOL CLIN EXP RES, V29, p140S, DOI 10.1097/01.alc.0000189287.83544.33; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121; YOKOYAMA H, 1994, BIOCHEM BIOPH RES CO, V203, P219, DOI 10.1006/bbrc.1994.2170; YOKOYAMA S, 1994, FEBS LETT, V351, P411, DOI 10.1016/0014-5793(94)00895-7; Zhang Z, 2001, ALCOHOL CLIN EXP RES, V25, P444, DOI 10.1097/00000374-200103000-00018; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200	35	121	126	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A82	A92	e9570	10.1371/journal.pone.0009570	http://dx.doi.org/10.1371/journal.pone.0009570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221393	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328200008
J	Woc-Colburn, L; Smultea, L; Ramachandra, L; Canaday, DH				Woc-Colburn, Laila; Smultea, Lavinia; Ramachandra, Lakshmi; Canaday, David H.			Preserved MHC Class II Antigen Processing in Monocytes from HIV-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD MONOCYTES; T-CELL HYBRIDOMAS; COMPLEX CLASS-II; HLA-DR; SURFACE EXPRESSION; INTERFERON-GAMMA; LANGERHANS CELLS; DENDRITIC CELLS; TYPE-1	Background: MHC-II restricted CD4+ T cells are dependent on antigen presenting cells (APC) for their activation. APC dysfunction in HIV-infected individuals could accelerate or exacerbate CD4+ T cell dysfunction and may contribute to increased levels of immunodeficiency seen in some patients regardless of their CD4+ T cell numbers. Here we test the hypothesis that APC from HIV-infected individuals have diminished antigen processing and presentation capacity. Methodology/Principal Findings: Monocytes (MN) were purified by immuno-magnetic bead isolation techniques from HLA-DR1.01+ or DR15.01+ HIV-infected and uninfected individuals. MN were analyzed for surface MHC-II expression and for antigen processing and presentation capacity after overnight incubation with soluble antigen or peptide and HLA-DR matched T cell hybridomas. Surface expression of HLA-DR was 20% reduced (p < 0.03) on MN from HIV-infected individuals. In spite of this, there was no significant difference in antigen processing and presentation by MN from 14 HIV-infected donors (8 HLA-DR1.01+ and 6 HLA-DR15.01+) compared to 24 HIV-uninfected HLA-matched subjects. Conclusions/Significance: We demonstrated that MHC class II antigen processing and presentation is preserved in MN from HIV-infected individuals. This further supports the concept that this aspect of APC function does not further contribute to CD4+ T cell dysfunction in HIV disease.	[Woc-Colburn, Laila; Smultea, Lavinia; Canaday, David H.] Case Western Reserve Univ, Sch Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Ramachandra, Lakshmi] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Canaday, David H.] Cleveland Vet Affairs, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Geriatric Research Education & Clinical Center	Woc-Colburn, L (corresponding author), Case Western Reserve Univ, Sch Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA.	dxc44@case.edu	Woc-Colburn, Laila/U-7357-2019	Woc-Colburn, Laila/0000-0003-2888-7806	Cleveland Veterans Affairs Geriatric Research Education; Clinical Center (Canaday); Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research [AI-36219]; National Institutes of Health Pulmonary training [HL-07889];  [AI-73217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073217, P30AI036219] Funding Source: NIH RePORTER	Cleveland Veterans Affairs Geriatric Research Education; Clinical Center (Canaday); Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research; National Institutes of Health Pulmonary training; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI-73217 and Cleveland Veterans Affairs Geriatric Research Education and Clinical Center (Canaday) and Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research, AI-36219. LWC is supported by National Institutes of Health Pulmonary training grant HL-07889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAUVELT A, 1995, J IMMUNOL, V154, P3506; Blauvelt A, 1996, J CLIN INVEST, V97, P1550, DOI 10.1172/JCI118578; BORN W, 1988, IMMUNOL RES, V7, P279, DOI 10.1007/BF02935533; Canaday DH, 2006, CELL IMMUNOL, V243, P96, DOI 10.1016/j.cellimm.2007.01.003; Canaday DH, 2003, J IMMUNOL METHODS, V281, P129, DOI 10.1016/j.jim.2003.07.004; Fidler SJ, 1996, IMMUNOLOGY, V89, P46, DOI 10.1046/j.1365-2567.1996.d01-715.x; Gascon RL, 2002, J ACQ IMMUN DEF SYND, V30, P146, DOI [10.1097/01.QA1.0000017720.31903.6E, 10.1097/00042560-200206010-00002]; HEAGY W, 1984, J CLIN INVEST, V74, P2089, DOI 10.1172/JCI111633; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Jones L, 2007, AIDS RES HUM RETROV, V23, P812, DOI 10.1089/aid.2006.0280; KOETHE SM, 1989, J MED VIROL, V29, P82, DOI 10.1002/jmv.1890290203; LOCHER C, 1994, CLIN EXP IMMUNOL, V98, P115, DOI 10.1111/j.1365-2249.1994.tb06616.x; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; McIlroy D, 1996, RES VIROLOGY, V147, P115, DOI 10.1016/0923-2516(96)80225-1; PETIT AJC, 1988, J IMMUNOL, V140, P1485; Polyak S, 1997, J IMMUNOL, V159, P2177; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; WASSERMAN K, 1994, CHEST, V105, P1324, DOI 10.1378/chest.105.5.1324; ZWILLING BS, 1990, CLIN EXP IMMUNOL, V82, P553, DOI 10.1111/j.1365-2249.1990.tb05489.x	21	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9491	10.1371/journal.pone.0009491	http://dx.doi.org/10.1371/journal.pone.0009491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209134	Green Published, gold, Green Submitted			2022-12-27	WOS:000275063400006
J	Ravoori, M; Czaplinska, AJ; Sikes, C; Han, L; Johnson, EM; Qiao, W; Ng, C; Cody, DD; Murphy, WA; Do, KA; Navone, NM; Kundra, V				Ravoori, Murali; Czaplinska, Aneta J.; Sikes, Charles; Han, Lin; Johnson, Evan M.; Qiao, Wei; Ng, Chaan; Cody, Dianna D.; Murphy, William A., Jr.; Do, Kim-Anh; Navone, Nora M.; Kundra, Vikas			Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo mu CT and Non-Destructive Ex Vivo mu CT and DXA in a Mouse Model	PLOS ONE			English	Article							METASTASIS; GROWTH; CELLS; TOMOGRAPHY; ESTABLISHMENT; OSTEOCLASTS; RESOLUTION; INJECTION; RECEPTOR; THERAPY	Background: To compare nondestructive in vivo and ex vivo micro-computed tomography (mu CT) and ex vivo dual-energy-X-ray-absorptiometry (DXA) in characterizing mineralized cortical and trabecular bone response to prostate cancer involving the skeleton in a mouse model. Methodology/Principal Findings: In vivo mu CT was performed before and 10 weeks after implantation of human prostate cancer cells (MDA-PCa-2b) or vehicle into SCID mouse femora. After resection, femora were imaged by nondestructive ex vivo specimen mu CT at three voxel sizes (31 mu, 16 mu, 8 mu) and DXA, and then sectioned for histomorphometric analysis of mineralized bone. Bone mineral density (BMD), trabecular parameters (number, TbN; separation, TbSp; thickness, TbTh) and mineralized bone volume/total bone volume (BV/TV) were compared and correlated among imaging methods and histomorphometry. Statistical tests were considered significant if P<0.05. Ten weeks post inoculation, diaphyseal BMD increased in the femur with tumor compared to the opposite femur by all modalities (p<0.005, n = 11). Diaphyseal BMD by in vivo mu CT correlated with ex vivo 31 and 16 mu m mu CT and histomorphometry BV/TV (r = 0.91-0.94, P<0.001, n = 11). DXA BMD correlated less with bone histomorphometry (r = 0.73, P<0.001, n = 11) and DXA did not distinguish trabeculae from cortex. By in vivo and ex vivo mu CT, trabecular BMD decreased (P<0.05, n = 11) as opposed to the cortex. Unlike BMD, trabecular morphologic parameters were threshold-dependent and when using "fixed-optimal-thresholds," all except TbTh demonstrated trabecular loss with tumor and correlated with histomorphometry (r = 0.73-0.90, P>0.05, n = 11). Conclusions/Significance: Prostate cancer involving the skeleton can elicit a host bone response that differentially affects the cortex compared to trabeculae and that can be quantified noninvasively in vivo and nondestructively ex vivo.	[Ravoori, Murali; Han, Lin; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Czaplinska, Aneta J.; Sikes, Charles; Navone, Nora M.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol Res, Houston, TX 77030 USA; [Johnson, Evan M.; Cody, Dianna D.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Qiao, Wei; Do, Kim-Anh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Ng, Chaan; Murphy, William A., Jr.; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ravoori, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA.	vkundra@mdanderson.org		Copeland, Margaret/0000-0002-9664-9335	National Institutes of Health/National Cancer Institute [P50 CA090270]; University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program; UT MDACC Core [P30CA16672]; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672, P50CA090270] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program; UT MDACC Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute P50 CA090270, University of Texas M. D. Anderson Cancer Center Prostate Cancer Research Program, UT MDACC Core grant P30CA16672 and John S. Dunn, Sr., Distinguished Chair in Diagnostic Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Imran, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000689; American Cancer Society, 2009, CANC FACTS FIG 2009; AVIOLI, 1998, METABOLIC BONE DIS C; Barou O, 2002, INVEST RADIOL, V37, P40, DOI 10.1097/00004424-200201000-00008; Bauer JS, 2007, AM J ROENTGENOL, V188, P1294, DOI 10.2214/AJR.06.1006; BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Cho MH, 2005, PHYSIOL MEAS, V26, P667, DOI 10.1088/0967-3334/26/5/008; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; DAMBACHER MA, 2004, J MINER STOFFWECHS, V11, P13; Degeorges A, 1999, CANCER RES, V59, P2787; Dong Z, 2005, AM J PATHOL, V166, P1173, DOI 10.1016/S0002-9440(10)62337-1; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; GOLDSTEIN SA, 1990, MECH REMODELING PROP, P61; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Henry MD, 2005, PROSTATE, V65, P347, DOI 10.1002/pros.20300; JACOBS SC, 1983, UROLOGY, V21, P337, DOI 10.1016/0090-4295(83)90147-4; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KESSLER RM, 1984, J COMPUT ASSIST TOMO, V8, P514, DOI 10.1097/00004728-198406000-00028; KINNEY JH, 1995, J BONE MINER RES, V10, P264; Kundra V, 2007, PROSTATE, V67, P50, DOI 10.1002/pros.20494; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Navone NM, 2000, CLIN CANCER RES, V6, P1190; Nemeth JA, 1999, CANCER RES, V59, P1987; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Peyrin F, 1998, Technol Health Care, V6, P391; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; RUEGSEGGER, 1995, OSTEOPOROSIS INT, V5, P287; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; THALMANN GN, 1994, CANCER RES, V54, P2577; Uchiyama T, 1997, CALCIFIED TISSUE INT, V61, P493, DOI 10.1007/s002239900373; Uehara H, 2003, J NATL CANCER I, V95, P458, DOI 10.1093/jnci/95.6.458; Williams SA, 2007, JNCI-J NATL CANCER I, V99, P376, DOI 10.1093/jnci/djk065; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yang M, 1999, CANCER RES, V59, P781; Yonou H, 2004, PROSTATE, V58, P406, DOI 10.1002/pros.10349; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9854	10.1371/journal.pone.0009854	http://dx.doi.org/10.1371/journal.pone.0009854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360964	Green Submitted, Green Published, gold			2022-12-27	WOS:000276163100003
J	Zvuloni, A; van Woesik, R; Loya, Y				Zvuloni, Assaf; van Woesik, Robert; Loya, Yossi			Diversity Partitioning of Stony Corals Across Multiple Spatial Scales Around Zanzibar Island, Tanzania	PLOS ONE			English	Article							SPECIES-DIVERSITY; SCLERACTINIAN CORALS; REEF; COMMUNITIES; PATTERNS; CONSERVATION; BIODIVERSITY; BUTTERFLIES; COMPETITION; RICHNESS	Background: The coral reefs of Zanzibar Island (Unguja, Tanzania) encompass a considerable proportion of the global coral-reef diversity and are representative of the western Indian Ocean region. Unfortunately, these reefs have been recently subjected to local and regional disturbances. The objectives of this study were to determine whether there are potentially non-random processes forcing the observed coral diversity patterns, and highlight where and at which spatial scales these processes might be most influential. Methodology/Principal Findings: A hierarchical (nested) sampling design was employed across three spatial scales, ranging from transects (<= 20 m), stations (<100 m), to sites (<1000 m), to examine coral diversity patterns. Two of the four sites, Chumbe and Mnemba, were located within Marine Protected Areas (MPAs), while the other two sites, Changuu and Bawe, were not protected. Additive partitioning of coral diversity was used to separate regional (total) diversity (gamma) into local alpha diversity and among-sample beta diversity components. Individual-based null models were used to identify deviations from random distribution across the three spatial scales. We found that Chumbe and Mnemba had similar diversity components to those predicted by the null models. However, the diversity at Changuu and Bawe was lower than expected at all three spatial scales tested. Consequently, the relative contribution of the among-site diversity component was significantly greater than expected. Applying partitioning analysis for each site separately revealed that the within-transect diversity component in Changuu was significantly lower than the null expectation. Conclusions/Significance: The non-random outcome of the partitioning analyses helped to identify the among-sites scale (i.e., 10's of kilometers) and the within-transects scale (i.e., a few meters; especially at Changuu) as spatial boundaries within which to examine the processes that may interact and disproportionately differentiate coral diversity. In light of coral community compositions and diversity patterns we strongly recommend that Bawe be declared a MPA.	[Zvuloni, Assaf; Loya, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Zvuloni, Assaf] Interuniv Inst Marine Sci Eilat, H Steinitz Marine Biol Lab, Elat, Israel; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Tel Aviv University; Florida Institute of Technology	Zvuloni, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	zvolonia@post.tau.ac.il	Loya, Yossi/J-3039-2012; Loya, Joseph/AAJ-9014-2020	Loya, Yossi/0000-0001-6870-9444; 	World Bank and the Global Environmental Facility (GEF); Coral Bleaching and Local Environmental Responses working group; Raynor Chair for Environmental Conservation Research	World Bank and the Global Environmental Facility (GEF); Coral Bleaching and Local Environmental Responses working group; Raynor Chair for Environmental Conservation Research	This work was supported by the World Bank and the Global Environmental Facility (GEF) through the Coral Reef Targeted Research and Capacity Building for Management program, Coral Bleaching and Local Environmental Responses working group, (RvW and YL) and the Raynor Chair for Environmental Conservation Research to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bjork M, 1995, AMBIO, V24, P502; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; BUSS LW, 1979, AM NAT, V113, P223, DOI 10.1086/283381; Carlon DB, 2002, J EXP MAR BIOL ECOL, V268, P33, DOI 10.1016/S0022-0981(01)00369-0; Clarke KR, 1994, CHANGE MARINE COMMUN; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Done TJ, 1983, CORAL ZONATION ITS N, P107; DULVY NK, 1995, AMBIO, V24, P358; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; GAUDIAN G, 1990, ZANZIBAR ENV STUDY S, V9; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guard M, 1997, MAR POLLUT BULL, V34, P758, DOI 10.1016/S0025-326X(97)00095-7; Hillebrand H, 2002, OECOLOGIA, V132, P479, DOI 10.1007/s00442-002-0988-3; Houk P, 2010, MAR ECOL-EVOL PERSP, V31, P318, DOI 10.1111/j.1439-0485.2009.00301.x; Hubbell Stephen P., 2001, V32, pi; Jiddawi N, 1997, P NAT C COR REEFS, P22; Johnstone RW, 1998, AMBIO, V27, P700; Karlson RH, 2004, NATURE, V429, P867, DOI 10.1038/nature02685; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LANG J, 1973, B MAR SCI, V23, P260; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; Mbije NE, 2002, AMBIO, V31, P609, DOI 10.1639/0044-7447(2002)031[0609:PITDAA]2.0.CO;2; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; MUHANDO C, 1998, CORAL REEFS VALUES T, P15; Muhando CA, 2002, AMBIO, V31, P558, DOI 10.1639/0044-7447(2002)031[0558:EEOTDO]2.0.CO;2; MUHANDO CA, 1997, P NAT C COR REEFS; Mundy C, 2000, MAR ECOL PROG SER, V198, P109, DOI 10.3354/meps198109; NGOILE MAK, 1988, ECOLOGY BIOPRODUCTIV, P93; NGOILE MAK, 1990, ZNZ ENV STUDY SER, V9; Nzali LM, 1998, AMBIO, V27, P717; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Semmens BX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008895; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Srivastava DS, 1999, J ANIM ECOL, V68, P1, DOI 10.1046/j.1365-2656.1999.00266.x; Summerville KS, 2003, CONSERV BIOL, V17, P1045, DOI 10.1046/j.1523-1739.2003.02059.x; THOMAS CD, 1985, BIOL CONSERV, V33, P95, DOI 10.1016/0006-3207(85)90098-9; *UNEP, 1989, UNEP REG SEAS REP; van Woesik R., 2002, Comments on Theoretical Biology, V7, P201, DOI 10.1080/08948550214054; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veron J. E. N., 2000, CORALS WORLD, V2; VERON JEN, 1995, CORALS SPACE TIME BI; WAGNER GM, 1997, P NAT C COR REEFS ZA, P38; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3; Zvuloni A, 2008, LIMNOL OCEANOGR-METH, V6, P144, DOI 10.4319/lom.2008.6.144	58	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9941	10.1371/journal.pone.0009941	http://dx.doi.org/10.1371/journal.pone.0009941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360956	Green Published, gold, Green Submitted			2022-12-27	WOS:000276163100023
J	Davis, JL; Worodria, W; Kisembo, H; Metcalfe, JZ; Cattamanchi, A; Kawooya, M; Kyeyune, R; den Boon, S; Powell, K; Okello, R; Yoo, S; Huang, L				Davis, J. Lucian; Worodria, William; Kisembo, Harriet; Metcalfe, John Z.; Cattamanchi, Adithya; Kawooya, Michael; Kyeyune, Rachel; den Boon, Saskia; Powell, Krista; Okello, Richard; Yoo, Samuel; Huang, Laurence			Clinical and Radiographic Factors Do Not Accurately Diagnose Smear-Negative Tuberculosis in HIV-infected Inpatients in Uganda: A Cross-Sectional Study	PLOS ONE			English	Article							ACID-FAST BACILLI; CHEST-X-RAY; PULMONARY TUBERCULOSIS; FLUORESCENCE MICROSCOPY; RECORDING-SYSTEM; SPUTUM SMEARS; SENSITIVITY; PERFORMANCE; SPECIFICITY; OPPORTUNITY	Background: Although World Health Organization guidelines recommend clinical judgment and chest radiography for diagnosing tuberculosis in HIV-infected adults with unexplained cough and negative sputum smears for acid-fast bacilli, the diagnostic performance of this approach is unknown. Therefore, we sought to assess the accuracy of symptoms, physical signs, and radiographic findings for diagnosing tuberculosis in this population in a low-income country with a high incidence of tuberculosis. Methodology: We performed a cross-sectional study enrolling consecutive HIV-infected inpatients with unexplained cough and negative sputum smears for acid-fast bacilli at Mulago Hospital in Kampala, Uganda. Trained medical officers prospectively collected data on standard symptoms and signs of systemic respiratory illness, and two radiologists interpreted chest radiographs in a standardized fashion. We calculated positive-and negative-likelihood ratios of these factors for diagnosing pulmonary tuberculosis (defined when mycobacterial cultures of sputum or bronchoalveolar lavage fluid were positive). We used both conventional and novel regression techniques to develop multivariable prediction models for pulmonary tuberculosis. Principal Findings: Among 202 enrolled HIV-infected adults with negative sputum smears for acid-fast bacilli, 72 (36%) had culture-positive pulmonary tuberculosis. No single factor, including respiratory symptoms, physical findings, CD4+ T-cell count, or chest radiographic abnormalities, substantially increased or decreased the likelihood of pulmonary tuberculosis. After exhaustive testing, we were also unable to identify any combination of factors which reliably predicted bacteriologically confirmed tuberculosis. Conclusions and Significance: Clinical and radiographic criteria did not help diagnose smear-negative pulmonary tuberculosis among HIV-infected patients with unexplained cough in a low-income setting. Enhanced diagnostic methods for smear-negative tuberculosis are urgently needed.	[Davis, J. Lucian; Metcalfe, John Z.; Cattamanchi, Adithya; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Davis, J. Lucian; Metcalfe, John Z.; Cattamanchi, Adithya; Powell, Krista; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Davis, J. Lucian; Metcalfe, John Z.; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Francis J Curry Natl TB Ctr, San Francisco, CA USA; [Kisembo, Harriet; Kawooya, Michael; Okello, Richard] Makerere Univ, Dept Radiol, Mulago Hosp, Kampala, Uganda; [Worodria, William; Yoo, Samuel] Makerere Univ, Dept Med, Mulago Hosp, Kampala, Uganda; [Davis, J. Lucian; Worodria, William; Cattamanchi, Adithya; Kyeyune, Rachel; den Boon, Saskia; Yoo, Samuel; Huang, Laurence] Makerere Univ, Univ California San Francisco Res Collaborat, Mulago Hosp, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital	Davis, JL (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	lucian.davis@ucsf.edu	Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Metcalfe, John/0000-0002-2279-7036	National Institutes of Health [K23 HL094141, K23 AI080147, K24 HL087713, R01HL090335]; National Center for Research Resources [KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Foundation for Innovative New Diagnostics (www.finddiagnostics.org) provided some funding which supported this study. In addition, the following authors have received support for this research from the National Institutes of Health (www.nih.gov): Adithya Cattamanchi, K23 HL094141; J. Lucian Davis, K23 AI080147; Laurence Huang, K24 HL087713, R01HL090335. This work was also supported by the National Center for Research Resources (KL2 RR024130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript for this study.	[Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Bock NN, 1996, AM J RESP CRIT CARE, V154, P1468, DOI 10.1164/ajrccm.154.5.8912766; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2008, J CLIN MICROBIOL, V46, P3325, DOI 10.1128/JCM.01175-08; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Cummings P, 2003, ARCH PEDIAT ADOL MED, V157, P321, DOI 10.1001/archpedi.157.4.321; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; El-Solh AA, 1999, CHEST, V116, P968, DOI 10.1378/chest.116.4.968; ElSolh A, 1997, AM J RESP CRIT CARE, V155, P1711, DOI 10.1164/ajrccm.155.5.9154881; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Harries AD, 1998, INT J TUBERC LUNG D, V2, P999; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; McGee S, 2002, J GEN INTERN MED, V17, P646; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Newman TB, 2009, EVIDENCE-BASED DIAGNOSIS, P1, DOI 10.1017/CBO9780511759512; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; Selwyn PA, 1998, AIDS, V12, P885, DOI 10.1097/00002030-199808000-00011; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Shea YR, 2009, J CLIN MICROBIOL, V47, P1553, DOI 10.1128/JCM.00348-09; Sinisi SE, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1069; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Were W, 2009, INT J TUBERC LUNG D, V13, P47; *WHO, 2005, INT MAN AD AD ILLN G; Wilkinson D, 2000, INT J TUBERC LUNG D, V4, P513; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471	43	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9859	10.1371/journal.pone.0009859	http://dx.doi.org/10.1371/journal.pone.0009859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20361038	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600001
J	Darmstadt, GL; Choi, Y; Arifeen, SE; Bari, S; Rahman, SM; Mannan, I; Seraji, HR; Winch, PJ; Saha, SK; Ahmed, ASMNU; Ahmed, S; Begum, N; Lee, ACC; Black, RE; Santosham, M; Crook, D; Baqui, AH				Darmstadt, Gary L.; Choi, Yoonjoung; Arifeen, Shams E.; Bari, Sanwarul; Rahman, Syed M.; Mannan, Ishtiaq; Seraji, Habibur Rahman; Winch, Peter J.; Saha, Samir K.; Ahmed, A. S. M. Nawshad Uddin; Ahmed, Saifuddin; Begum, Nazma; Lee, Anne C. C.; Black, Robert E.; Santosham, Mathuram; Crook, Derrick; Baqui, Abdullah H.		Bangladesh Projahnmo-2 Mirzapur St	Evaluation of a Cluster-Randomized Controlled Trial of a Package of Community-Based Maternal and Newborn Interventions in Mirzapur, Bangladesh	PLOS ONE			English	Article							NEONATAL-MORTALITY; PRETERM INFANTS; SYLHET DISTRICT; HEALTH WORKERS; CARE; INFECTIONS; MANAGEMENT; STRATEGIES; IMPACT; BIRTH	Background: To evaluate a delivery strategy for newborn interventions in rural Bangladesh. Methods: A cluster-randomized controlled trial was conducted in Mirzapur, Bangladesh. Twelve unions were randomized to intervention or comparison arm. All women of reproductive age were eligible to participate. In the intervention arm, community health workers identified pregnant women; made two antenatal home visits to promote birth and newborn care preparedness; made four postnatal home visits to negotiate preventive care practices and to assess newborns for illness; and referred sick neonates to a hospital and facilitated compliance. Primary outcome measures were antenatal and immediate newborn care behaviours, knowledge of danger signs, care seeking for neonatal complications, and neonatal mortality. Findings: A total of 4616 and 5241 live births were recorded from 9987 and 11153 participants in the intervention and comparison arm, respectively. High coverage of antenatal (91% visited twice) and postnatal (69% visited on days 0 or 1) home visitations was achieved. Indicators of care practices and knowledge of maternal and neonatal danger signs improved. Adjusted mortality hazard ratio in the intervention arm, compared to the comparison arm, was 1.02 (95% CI: 0.80-1.30) at baseline and 0.87 (95% CI: 0.68-1.12) at endline. Primary causes of death were birth asphyxia (49%) and prematurity (26%). No adverse events associated with interventions were reported. Conclusion: Lack of evidence for mortality impact despite high program coverage and quality assurance of implementation, and improvements in targeted newborn care practices suggests the intervention did not adequately address risk factors for mortality. The level and cause-structure of neonatal mortality in the local population must be considered in developing interventions. Programs must ensure skilled care during childbirth, including management of birth asphyxia and prematurity, and curative postnatal care during the first two days of life, in addition to essential newborn care and infection prevention and management.	[Darmstadt, Gary L.; Choi, Yoonjoung; Mannan, Ishtiaq; Winch, Peter J.; Lee, Anne C. C.; Black, Robert E.; Santosham, Mathuram; Baqui, Abdullah H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Arifeen, Shams E.; Bari, Sanwarul; Rahman, Syed M.; Mannan, Ishtiaq; Seraji, Habibur Rahman; Begum, Nazma; Baqui, Abdullah H.] Int Ctr Diarrhoeal Dis Res, Div Publ Hlth Sci, Dhaka 1000, Bangladesh; [Saha, Samir K.] Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh; [Ahmed, A. S. M. Nawshad Uddin] Kumudini Womens Med Coll, Dept Pediat, Mirzapur, Tangail, Bangladesh; [Ahmed, Saifuddin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD USA; [Crook, Derrick] Univ Oxford, John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford	Darmstadt, GL (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	gary.darmstadt@gatesfoundation.org	Rahman, Syed Moshfiqur/AAH-9000-2019; Darmstadt, Gary/AAU-7488-2020	Rahman, Syed Moshfiqur/0000-0002-9441-0590; Darmstadt, Gary/0000-0002-7522-5824; Black, Robert/0000-0001-9926-7984; Arifeen, Shams/0000-0002-5372-5932	Wellcome Trust - Burroughs Wellcome Fund Infectious Disease Initiative; Office of Health, Infectious Diseases and Nutrition, Global Health Bureau, United States Agency for International Development (USAID) [HRN-A-00-96-90006-00]; Johns Hopkins Bloomberg School of Public Health [HRN-A-00-96-90006-00]; Bill & Melinda Gates Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Wellcome Trust - Burroughs Wellcome Fund Infectious Disease Initiative(Burroughs Wellcome FundWellcome Trust); Office of Health, Infectious Diseases and Nutrition, Global Health Bureau, United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Johns Hopkins Bloomberg School of Public Health(Johns Hopkins University); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Wellcome Trust - Burroughs Wellcome Fund Infectious Disease Initiative 2000 and the Office of Health, Infectious Diseases and Nutrition, Global Health Bureau, United States Agency for International Development (USAID) through the Global Research Activity Cooperative agreement with the Johns Hopkins Bloomberg School of Public Health (award HRN-A-00-96-90006-00). Support for data analysis and manuscript preparation was provided by the Saving Newborn Lives program through a grant by the Bill & Melinda Gates Foundation to Save the Children-US. The sponsors had no role in study design, study implementation, data analysis or interpretation, or in the decision to publish the paper.	ARIFEEN S, 2010, RESULTS DEMOGR UNPUB; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS82, DOI 10.1038/sj.jp.7211275; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bangash FK, 2003, J CHEM SOC PAKISTAN, V25, P1; Baqui AH, 2007, INDIAN J PEDIATR, V74, P241, DOI 10.1007/s12098-007-0038-6; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2007, J HEALTH POPUL NUTR, V25, P179; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Bari S, 2006, J HEALTH POPUL NUTR, V24, P519; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Barnett S, 2006, J HEALTH POPUL NUTR, V24, P394; BASSIOUNY MR, 1994, J TROP PEDIATRICS, V40, P341, DOI 10.1093/tropej/40.6.341; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2008, PEDIATRICS, V121, P522, DOI 10.1542/peds.2007-0213; Darmstadt GL, 2009, J INFECT DIS, V200, P906, DOI 10.1086/605473; Darmstadt GL, 2009, B WORLD HEALTH ORGAN, V87, P12, DOI 10.2471/BLT.07.050666; Darmstadt GL, 2005, LANCET, V365, P1039, DOI 10.1016/S0140-6736(05)74228-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Darmstadt GL, 2004, PEDIATR INFECT DIS J, V23, P719, DOI 10.1097/01.inf.0000133047.50836.6f; Darmstadt GL, 2000, PEDIATR INFECT DIS J, V19, P739, DOI 10.1097/00006454-200008000-00014; DARMSTADT GL, 2009, INT J GYNAECOL OBSTE; DARMSTADT GL, 2009, HLTH POLICY PLAN; DARMSTADT GL, 2008, VALIDATION CLI UNPUB; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P273; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Ganzach Y, 2000, ORGAN RES METHODS, V3, P237, DOI 10.1177/109442810033002; *GOV IND MIN HLTH, 2009, JAN SUR YOJ GUID IMP; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Koyamaibole L, 2006, J TROP PEDIATRICS, V52, P249, DOI 10.1093/tropej/fmi109; KUMAR R, 1994, T ROY SOC TROP MED H, V88, P159, DOI 10.1016/0035-9203(94)90274-7; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; LEFEVRE A, 2010, B WHO IN PRESS; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mercer A, 2006, HEALTH POLICY PLANN, V21, P432, DOI 10.1093/heapol/czl024; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; National Institute of Population Research and Training Mitra and Associates & Macro International, 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training Mitra and Associates & ORC Macro, 2001, BANGL DEM HLTH SURV; Sack DA, 2008, J HEALTH POPUL NUTR, V26, P251; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; WINCH PJ, 2003, PROJECT ADV HLTH NEW, V2; Zaman K., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P99	58	81	83	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9696	10.1371/journal.pone.0009696	http://dx.doi.org/10.1371/journal.pone.0009696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FT	20352087	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500003
J	Wang, DQ; Xia, XM; Weiss, RE; Refetoff, S; Yen, PM				Wang, Dongqing; Xia, Xianmin; Weiss, Roy E.; Refetoff, Samuel; Yen, Paul M.			Distinct and Histone-Specific Modifications Mediate Positive versus Negative Transcriptional Regulation of TSH alpha Promoter	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; STIMULATING HORMONE; COREPRESSOR COMPLEX; MOLECULAR-BASIS; SUBUNIT GENE; IN-VIVO; ACETYLATION; RECRUITMENT; METHYLATION; RESISTANCE	Background: Hormonally-regulated histone modifications that govern positive versus negative transcription of target genes are poorly characterized despite their importance for normal and pathological endocrine function. There have been only a few studies examining chromatin modifications on target gene promoters by nuclear hormone receptors. Moreover, these studies have focused on positively-regulated target genes. TSH alpha, a heterodimer partner for thyrotropin (TSH), is secreted by the pituitary gland. T(3) negatively regulates TSH alpha gene expression via thyroid hormone receptors (TRs) which belong to the nuclear hormone receptor superfamily, whereas thyrotropin releasing hormone (TRH) positively regulates via the TRH receptor, a G protein-coupled receptor. Methodology/Principal Findings: We studied regulation of the TSH alpha gene by cAMP and T(3) using chromatin immunoprecipitation (ChIP) assays in stably-transfected rat pituitary cells containing the human TSH alpha promoter. Interestingly, cAMP selectively increased histone H4 acetylation whereas, as previously reported, T(3) induced histone H3 acetylation. In particular, cAMP increased H4K5 and H4K8 acetylation and decreased H4K20 trimethylation, modifications associated with transcriptional activation. T(3) increased H3K9 and H3K18 acetylation and H3K4 trimethylation; however, it also decreased H3K27 acetylation and increased H3K27 trimethylation which are associated with transcriptional repression. Of note, cAMP recruited pCREB, CBP/p300, and PCAF to the promoter whereas T(3) caused dissociation of NCoR/SMRT and HDAC3. Overexpression of a dominant negative mutant thyroid hormone receptor (TR) from a patient with resistance to thyroid hormone (RTH) led to less T(3)-dependent negative regulation and partially blocked histone H3 modifications of the TSH alpha promoter. Conclusions/Significance: Our findings show that non-overlapping and specific histone modifications determine positive versus negative transcriptional regulation, and integrate opposing hormonal and intracellular signals at the TSH alpha promoter. A mutant TR from a patient with RTH exerted dominant negative activity by blocking the histone modifications induced by T(3) on the TSH alpha promoter and likely contributes to the inappropriate TSH production observed in RTH.	[Wang, Dongqing; Yen, Paul M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21205 USA; [Yen, Paul M.] Duke Natl Univ Singapore, Grad Sch Med, Lab Hormonal Regulat, Cardiovasc & Metab Dis Program, Singapore, Singapore; [Xia, Xianmin] DJ Biotech, Changzhou, Peoples R China; [Weiss, Roy E.; Refetoff, Samuel] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Weiss, Roy E.; Refetoff, Samuel] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	Johns Hopkins University; National University of Singapore; University of Chicago; University of Chicago	Wang, DQ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21205 USA.	paul.yen@duke-nus.edu.sg	Refetoff, Samuel/ABB-1263-2021; Yen, Paul M/V-9857-2019	Refetoff, Samuel/0000-0003-0164-8231; Yen, Paul/0000-0002-3790-8114	National Institutes of Health [5R01DK69899, 4R37DK15070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069899, R37DK015070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health 5R01DK69899 (P. M. Y.) and NIH 4R37DK15070 (S. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; Hayashi Y, 1996, MOL ENDOCRINOL, V10, P100, DOI 10.1210/me.10.1.100; HAYASHI Y, 1994, J BIOL CHEM, V269, P23872; HOLLENBERG AN, 1995, J BIOL CHEM, V270, P14272; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KIM DS, 1994, MOL ENDOCRINOL, V8, P528, DOI 10.1210/me.8.4.528; LADENSON PW, 1983, J CLIN ENDOCR METAB, V56, P1252, DOI 10.1210/jcem-56-6-1252; Lee KC, 2003, MOL ENDOCRINOL, V17, P908, DOI 10.1210/me.2002-0308; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; SAKURAI A, 1989, P NATL ACAD SCI USA, V86, P8977, DOI 10.1073/pnas.86.22.8977; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Tagami T, 1999, J BIOL CHEM, V274, P22345, DOI 10.1074/jbc.274.32.22345; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Wang DQ, 2009, MOL ENDOCRINOL, V23, P600, DOI 10.1210/me.2008-0389; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	34	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9853	10.1371/journal.pone.0009853	http://dx.doi.org/10.1371/journal.pone.0009853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352046	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894500020
J	Ochsner, M; Textor, M; Vogel, V; Smith, ML				Ochsner, Mirjam; Textor, Marcus; Vogel, Viola; Smith, Michael L.			Dimensionality Controls Cytoskeleton Assembly and Metabolism of Fibroblast Cells in Response to Rigidity and Shape	PLOS ONE			English	Article							GENE-EXPRESSION; MATRIX; STIFFNESS; CULTURE; FIBRONECTIN; GROWTH; ARCHITECTURE; ADHESIONS; PHENOTYPE; TENSION	Background: Various physical parameters, including substrate rigidity, size of adhesive islands and micro-and nano-topographies, have been shown to differentially regulate cell fate in two-dimensional (2-D) cell cultures. Cells anchored in a three-dimensional (3-D) microenvironment show significantly altered phenotypes, from altered cell adhesions, to cell migration and differentiation. Yet, no systematic analysis has been performed that studied how the integrated cellular responses to the physical characteristics of the environment are regulated by dimensionality (2-D versus 3-D). Methodology/Principal Findings: Arrays of 5 or 10 mm deep microwells were fabricated in polydimethylsiloxane (PDMS). The actin cytoskeleton was compared for single primary fibroblasts adhering either to microfabricated adhesive islands (2-D) or trapped in microwells (3-D) of controlled size, shape, and wall rigidity. On rigid substrates (Young's Modulus = 1 MPa), cytoskeleton assembly within single fibroblast cells occurred in 3-D microwells of circular, rectangular, square, and triangular shapes with 2-D projected surface areas (microwell bottom surface area) and total surface areas of adhesion (microwell bottom plus wall surface area) that inhibited stress fiber assembly in 2-D. In contrast, cells did not assemble a detectable actin cytoskeleton in soft 3-D microwells (20 kPa), regardless of their shapes, but did so on flat, 2-D substrates. The dependency on environmental dimensionality was also reflected by cell viability and metabolism as probed by mitochondrial activities. Both were upregulated in 3-D cultured cells versus cells on 2-D patterns when surface area of adhesion and rigidity were held constant. Conclusion/Significance: These data indicate that cell shape and rigidity are not orthogonal parameters directing cell fate. The sensory toolbox of cells integrates mechanical (rigidity) and topographical (shape and dimensionality) information differently when cell adhesions are confined to 2-D or occur in a 3-D space.	[Ochsner, Mirjam; Textor, Marcus] Swiss Fed Inst Technol, Surface Sci & Technol Lab, BioInterface Grp, Zurich, Switzerland; [Vogel, Viola; Smith, Michael L.] Swiss Fed Inst Technol, Lab Biol Oriented Mat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ochsner, M (corresponding author), ASTAR, Inst Mat Res & Engn, Singapore, Singapore.	msmith@bu.edu	Vogel, Viola/O-8025-2015; Textor, Marcus/A-6200-2012	Vogel, Viola/0000-0003-2898-7671; Textor, Marcus/0000-0002-0178-1801	ETH Zurich; Swiss National Science Foundation [FN 205321-112323/1]; Swiss Competence Centre for Materials Science and Technology (CCMX); International Human Frontier Science Program Organization (MLS)	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Competence Centre for Materials Science and Technology (CCMX); International Human Frontier Science Program Organization (MLS)(Human Frontier Science Program)	This study was supported by ETH Zurich, the Swiss National Science Foundation (Project FN 205321-112323/1), the Swiss Competence Centre for Materials Science and Technology (CCMX) and the International Human Frontier Science Program Organization (MLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; BOTTARO DP, 2002, MOL SIGNALING BIOENG, P961; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Dusseiller MR, 2006, BIOINTERPHASES, V1, pP1, DOI 10.1116/1.2190698; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Fringer J, 2001, J BIOL CHEM, V276, P31047, DOI 10.1074/jbc.M101898200; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; JIANG G, 2009, BIOPHYS J, V90, P1804; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; KUBOW KE, 2009, INTEGR BIOL IN PRESS; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	50	72	73	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9445	10.1371/journal.pone.0009445	http://dx.doi.org/10.1371/journal.pone.0009445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351781	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894400004
J	Gengler, S; Hamilton, A; Holscher, C				Gengler, Simon; Hamilton, Alison; Hoelscher, Christian			Synaptic Plasticity in the Hippocampus of a APP/PS1 Mouse Model of Alzheimer's Disease Is Impaired in Old but Not Young Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; SEIZURES; AMYLOIDOSIS; MODULATION	Background: Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We have investigated synaptic plasticity in area CA1 in a novel AD mouse model (APPPS1-21) which expresses the Swedish mutation of APP and the L166P mutation of human PS-1. This model shows initial plaque formation at 2 months in the neocortex and 4 months in the hippocampus and displays beta-amyloid-associated pathologies and learning impairments. Methodology/Principal Findings: We tested long-term potentiation (LTP) and short term potentiation (paired-pulse facilitation, PPF) of synaptic transmission in vivo in area CA1 of the hippocampus. There was no difference in LTP or PPF at 4-5 months of age in APPPS1-21 mice compared to littermate controls. At 6 months of age there was also no difference in LTP but APPPS1-21 mice showed slightly increased PPF (p<0.03). In 8 months old mice, LTP was greatly impaired in APPPS-21 animals (p<0.0001) while PPF was not changed. At 15 months of age, APPPS1-21 mice showed again impaired LTP compared to littermate controls (p<0.005), and PPF was also significantly reduced at 80 ms (p<0.005) and 160 ms (p<0.01) interstimulus interval. Immunohistological analysis showed only modest amyloid deposition in the hippocampus at 4 and 6 months with a robust increase up to 15 months of age. Conclusions: Our results suggest that increased formation and aggregation of beta amyloid with aging is responsible for the impaired LTP with aging in this mouse model, while the transient increase of PPF at 6 months of age is caused by some other mechanism.	[Gengler, Simon; Hamilton, Alison; Hoelscher, Christian] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Gengler, S (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	christian_Holscher@mac.com		Holscher, Christian/0000-0002-8159-3260	Alzheimer Research Trust	Alzheimer Research Trust	Alzheimer Research Trust project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; ASHE KH, 2005, MECH MEMORY LOSS ABE, P591; BLISS TVP, 1993, NATURE, V31, P361, DOI DOI 10.1038/361031A0.[; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen Y, 1996, NEUROSCI LETT, V218, P204, DOI 10.1016/S0304-3940(96)13149-9; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cummings BJ, 2002, NEUROBIOL AGING, V23, P161, DOI 10.1016/S0197-4580(01)00316-5; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Dema A, 1998, Rom J Morphol Embryol, V44, P93; Dewachter I, 2008, NEUROBIOL AGING, V29, P639, DOI 10.1016/j.neurobiolaging.2006.11.019; Dewachter I, 2002, J NEUROSCI, V22, P3445; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Holscher C, 2005, REV NEUROSCIENCE, V16, P181; Holscher C, 2001, NEURONAL MECHANISMS OF MEMORY FORMATION, P146; Kalaria RN, 1996, NEURODEGENERATION, V5, P497, DOI 10.1006/neur.1996.0069; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Priller C, 2009, NEUROBIOL AGING, V30, P1227, DOI 10.1016/j.neurobiolaging.2007.10.016; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Roder S, 2003, NEUROSCIENCE, V120, P705, DOI 10.1016/S0306-4522(03)00381-6; SCHULZ PE, 1995, J PHYSIOLOGY-PARIS, V89, P3, DOI 10.1016/0928-4257(96)80546-8; STURCHLERPIERRA.C, 2000, PATHOGENIC MECH ALZH, P134; Tsai ML, 2008, EPILEPSY RES, V79, P187, DOI 10.1016/j.eplepsyres.2008.02.001; Tsai ML, 2006, EPILEPSIA, V47, P277, DOI 10.1111/j.1528-1167.2006.00419.x; VOLIANSKIS A, 2008, NEUROBIOL AGING; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; WILCOX R, 2005, INTRO R ESTIMATION H; Wiley CA, 2009, ARCH NEUROL-CHICAGO, V66, P60, DOI 10.1001/archneurol.2008.511; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.2307/2334299	34	114	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9764	10.1371/journal.pone.0009764	http://dx.doi.org/10.1371/journal.pone.0009764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339537	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000275894300009
J	Roy, N; Nageshan, RK; Pallavi, R; Chakravarthy, H; Chandran, S; Kumar, R; Gupta, AK; Singh, RK; Yadav, SC; Tatu, U				Roy, Nainita; Nageshan, Rishi Kumar; Pallavi, Rani; Chakravarthy, Harshini; Chandran, Syama; Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra; Tatu, Utpal			Proteomics of Trypanosoma evansi Infection in Rodents	PLOS ONE			English	Article							PARAFLAGELLAR ROD PROTEINS; PROTECTIVE IMMUNITY; OLIGOPEPTIDASE-B; BLOOD-STREAM; DRUG TARGETS; CRUZI; BRUCEI; EQUIPERDUM; PEPTIDASE; RESPONSES	Background: Trypanosoma evansi infections, commonly called 'surra', cause significant economic losses to livestock industry. While this infection is mainly restricted to large animals such as camels, donkeys and equines, recent reports indicate their ability to infect humans. There are no World Animal Health Organization (WAHO) prescribed diagnostic tests or vaccines available against this disease and the available drugs show significant toxicity. There is an urgent need to develop improved methods of diagnosis and control measures for this disease. Unlike its related human parasites T. brucei and T. cruzi whose genomes have been fully sequenced T. evansi genome sequence remains unavailable and very little efforts are being made to develop improved methods of prevention, diagnosis and treatment. With a view to identify potential diagnostic markers and drug targets we have studied the clinical proteome of T. evansi infection using mass spectrometry (MS). Methodology/Principal Findings: Using shot-gun proteomic approach involving nano-lc Quadrupole Time Of Flight (QTOF) mass spectrometry we have identified over 160 proteins expressed by T. evansi in mice infected with camel isolate. Homology driven searches for protein identification from MS/MS data led to most of the matches arising from related Trypanosoma species. Proteins identified belonged to various functional categories including metabolic enzymes; DNA metabolism; transcription; translation as well as cell-cell communication and signal transduction. TCA cycle enzymes were strikingly missing, possibly suggesting their low abundances. The clinical proteome revealed the presence of known and potential drug targets such as oligopeptidases, kinases, cysteine proteases and more. Conclusions/Significance: Previous proteomic studies on Trypanosomal infections, including human parasites T. brucei and T. cruzi, have been carried out from lab grown cultures. For T. evansi infection this is indeed the first ever proteomic study reported thus far. In addition to providing a glimpse into the biology of this neglected disease, our study is the first step towards identification of diagnostic biomarkers, novel drug targets as well as potential vaccine candidates to fight against T. evansi infections.	[Roy, Nainita; Nageshan, Rishi Kumar; Pallavi, Rani; Chakravarthy, Harshini; Chandran, Syama; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra] Natl Res Ctr Equines, Hisar, Haryana, India	Indian Institute of Science (IISC) - Bangalore; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Roy, N (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in	Bhowmick, Nainita Roy/AAS-2908-2021; Pallavi, Rani/AAR-7824-2020	Tatu, Utpal/0000-0003-0404-8872; Nageshan, Rishi Kumar/0000-0003-1592-4452; Singh, Rajkumar/0000-0003-4649-2015	Department of Biotechnology, New Delhi, India; Roche; United Grants Commission/Council of Scientific and Industrial Research	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Roche(Roche Holding); United Grants Commission/Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	UT would like to thank Department of Biotechnology, New Delhi, India for financial support. UT would also like to thank the funding support from Roche made available from University of Bern. NR, RK and RP would like to thank United Grants Commission/Council of Scientific and Industrial Research for their scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; GILL B S, 1971, Tropical Animal Health and Production, V3, P195, DOI 10.1007/BF02359579; Graefe SEB, 2002, EUKARYOT CELL, V1, P936, DOI 10.1128/EC.1.6.936-943.2002; Gruszynski AE, 2003, J BIOL CHEM, V278, P24665, DOI 10.1074/jbc.M301497200; Hoare C. A, 1972, TRYPANOSOMES MAMMALS, P288, DOI DOI 10.1017/S003118200900554X; Holzmuller P, 2008, ANN NY ACAD SCI, V1149, P337, DOI 10.1196/annals.1428.097; Hong YC, 2006, FEBS LETT, V580, P603, DOI 10.1016/j.febslet.2005.12.075; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Kaminsky R, 1998, ANTIMICROB AGENTS CH, V42, P2858, DOI 10.1128/AAC.42.11.2858; Krauth-Siegel RL, 2003, PARASITOL RES, V90, pS77, DOI 10.1007/s00436-002-0771-8; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Li SQ, 2009, PARASITOL RES, V104, P429, DOI 10.1007/s00436-008-1216-9; LUCKINS AG, 1988, PARASITOL TODAY, V4, P137, DOI 10.1016/0169-4758(88)90188-3; LUMSDEN WHR, 1973, TECHNIQUES TRYPANOSO, P57; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Marcipar IS, 2005, J CLIN MICROBIOL, V43, P5498, DOI 10.1128/JCM.43.11.5498-5503.2005; Michailowsky V, 2003, INFECT IMMUN, V71, P3165, DOI 10.1128/IAI.71.6.3165-3171.2003; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Nogueira F, 2009, PARASITOL RES, V104, P835, DOI 10.1007/s00436-008-1264-1; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Pinto APA, 2003, BBA-PROTEINS PROTEOM, V1652, P107, DOI 10.1016/j.bbapap.2003.08.008; Scory Stefan, 2007, Kinetoplastid Biol Dis, V6, P2, DOI 10.1186/1475-9292-6-2; SILVA RAMS, 1995, VET PARASITOL, V60, P167, DOI 10.1016/0304-4017(94)00757-4; Subramanya S, 2009, BIOCHEM J, V417, P685, DOI 10.1042/BJ20080167; Tsuji A, 2006, J PEPT SCI, V12, P65, DOI 10.1002/psc.683; Tuntasuvan D, 2003, VET PARASITOL, V110, P227, DOI 10.1016/S0304-4017(02)00304-7; Uzcategui NL, 2007, ANTIMICROB AGENTS CH, V51, P3960, DOI 10.1128/AAC.00423-07; WRIGHTSMAN RA, 1995, INFECT IMMUN, V63, P122, DOI 10.1128/IAI.63.1.122-125.1995; Wrightsman RA, 2000, VACCINE, V18, P1419, DOI 10.1016/S0264-410X(99)00380-1	39	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9796	10.1371/journal.pone.0009796	http://dx.doi.org/10.1371/journal.pone.0009796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339546	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300021
J	Franberg, J; Karlstrom, H; Winblad, B; Tjernberg, LO; Frykman, S				Franberg, Jenny; Karlstrom, Helena; Winblad, Bengt; Tjernberg, Lars O.; Frykman, Susanne			gamma-Secretase Dependent Production of Intracellular Domains Is Reduced in Adult Compared to Embryonic Rat Brain Membranes	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; P75 NEUROTROPHIN RECEPTOR; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; IN-VIVO; NOTCH; PRESENILIN; CLEAVAGE; MICE; DEFICIENCY	Background: gamma-Secretase is an intramembrane aspartyl protease whose cleavage of the amyloid precursor protein (APP) generates the amyloid beta-peptide (A beta) and the APP intracellular domain. A beta is widely believed to have a causative role in Alzheimer's disease pathogenesis, and therefore modulation of gamma-secretase activity has become a therapeutic goal. Besides APP, more than 50 substrates of gamma-secretase with different cellular functions during embryogenesis as well as adulthood have been revealed. Prior to gamma-secretase cleavage, substrates are ectodomain shedded, producing membrane bound C-terminal fragments (CTFs). Principal Findings: Here, we investigated gamma-secretase cleavage of five substrates; APP, Notch1, N-cadherin, ephrinB and p75 neurotrophin receptor (p75-NTR) in membranes isolated from embryonic, young or old adult rat brain by analyzing the release of the corresponding intracellular domains (ICDs) or A beta 40 by western blot analysis and ELISA respectively. The highest levels of all ICDs and A beta were produced by embryonic membranes. In adult rat brain only cleavage of APP and Notch1 could be detected and the A beta 40 and ICD production from these substrates was similar in young and old adult rat brain. The CTF levels of Notch1, N-cadherin, ephrinB and p75-NTR were also clearly decreased in the adult brain compared to embryonic brain, whereas the APP CTF levels were only slightly decreased. Conclusions: In summary our data suggests that gamma-secretase dependent ICD production is down-regulated in the adult brain compared to embryonic brain. In addition, the present approach may be useful for evaluating the specificity of gamma-secretase inhibitors.	[Franberg, Jenny; Karlstrom, Helena; Winblad, Bengt; Tjernberg, Lars O.; Frykman, Susanne] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Alzheimers Dis Res Ctr, Huddinge, Sweden	Karolinska Institutet	Franberg, J (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Alzheimers Dis Res Ctr, Huddinge, Sweden.	jenny.franberg@ki.se		Karlstrom, Helena/0000-0002-0498-2473	Socialstyrelsen [2009-22304]; Karolinska Institutets Foundation for Geriatric Research; Demensfonden [33/09]; Gun och Bertil Stohne's Foundation; Foundation for Gamla Tjanarinnor; Foundation for Alzheimer's and Dementia Research (SADF) [1613/09]; H. K. by Swedish Brain Power [2004-00160]	Socialstyrelsen; Karolinska Institutets Foundation for Geriatric Research; Demensfonden; Gun och Bertil Stohne's Foundation; Foundation for Gamla Tjanarinnor; Foundation for Alzheimer's and Dementia Research (SADF); H. K. by Swedish Brain Power	This study was supported by Socialstyrelsen (2009-22304), Karolinska Institutets Foundation for Geriatric Research (2008 Alde0036), Demensfonden (33/09), Gun och Bertil Stohne's Foundation (J. F.) and the Foundation for Gamla Tjanarinnor (S. F.). J. F. was supported by the Foundation for Alzheimer's and Dementia Research (SADF, 1613/09) and H. K. by Swedish Brain Power (2004-00160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Franberg J, 2007, BIOCHEMISTRY-US, V46, P7647, DOI 10.1021/bi0621258; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Teranishi Y., 2009, J CELL MOL MED; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004	60	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9772	10.1371/journal.pone.0009772	http://dx.doi.org/10.1371/journal.pone.0009772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333303	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809700011
J	Diehl, F; Brown, MA; van Amerongen, MJ; Novoyatleva, T; Wietelmann, A; Harriss, J; Ferrazzi, F; Bottger, T; Harvey, RP; Tucker, PW; Engel, FB				Diehl, Florian; Brown, Mark A.; van Amerongen, Machteld J.; Novoyatleva, Tatyana; Wietelmann, Astrid; Harriss, June; Ferrazzi, Fulvia; Boettger, Thomas; Harvey, Richard P.; Tucker, Philip W.; Engel, Felix B.			Cardiac Deletion of Smyd2 Is Dispensable for Mouse Heart Development	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; GENE-EXPRESSION; CARDIOMYOCYTE PROLIFERATION; MICE LACKING; PROTEIN; CHROMATIN; H3; METHYLATION; HOMOLOG; CELLS	Chromatin modifying enzymes play a critical role in cardiac differentiation. Previously, it has been shown that the targeted deletion of the histone methyltransferase, Smyd1, the founding member of the SET and MYND domain containing (Smyd) family, interferes with cardiomyocyte maturation and proper formation of the right heart ventricle. The highly related paralogue, Smyd2 is a histone 3 lysine 4- and lysine 36-specific methyltransferase expressed in heart and brain. Here, we report that Smyd2 is differentially expressed during cardiac development with highest expression in the neonatal heart. To elucidate the functional role of Smyd2 in the heart, we generated conditional knockout (cKO) mice harboring a cardiomyocyte-specific deletion of Smyd2 and performed histological, functional and molecular analyses. Unexpectedly, cardiac deletion of Smyd2 was dispensable for proper morphological and functional development of the murine heart and had no effect on global histone 3 lysine 4 or 36 methylation. However, we provide evidence for a potential role of Smyd2 in the transcriptional regulation of genes associated with translation and reveal that Smyd2, similar to Smyd3, interacts with RNA Polymerase II as well as to the RNA helicase, HELZ.	[Diehl, Florian; van Amerongen, Machteld J.; Novoyatleva, Tatyana; Wietelmann, Astrid; Boettger, Thomas; Engel, Felix B.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Hessen, Germany; [Brown, Mark A.; Harriss, June; Tucker, Philip W.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Brown, Mark A.; Harriss, June; Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Harvey, Richard P.] Victor Chang Cardiac Res Inst, Dev Biol Div, Darlinghurst, NSW, Australia; [Ferrazzi, Fulvia] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Lombardia, Italy	Max Planck Society; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Victor Chang Cardiac Research Institute; University of Pavia	Diehl, F (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Hessen, Germany.	felix.engel@mpi-bn.mpg.de	Ferrazzi, Fulvia/C-1161-2008; Boettger, Thomas/E-3406-2012; van Amerongen, Machteld/C-5032-2008; Engel, Felix/A-1767-2008	Ferrazzi, Fulvia/0000-0003-4011-4638; Boettger, Thomas/0000-0003-4280-8449; Engel, Felix/0000-0003-2605-3429; Harvey, Richard/0000-0002-9950-9792	Alexander von Humboldt-Foundation; Excellence Cluster Cardio-Pulmonary System; NIH (PWT); Marie Betzer Morrow Centennial Endowment (PWT)	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); NIH (PWT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Betzer Morrow Centennial Endowment (PWT)	This work was supported by the Alexander von Humboldt-Foundation (Bonn, Germany; Sofja Kovalevskaja Award to FBE), the Excellence Cluster Cardio-Pulmonary System (Giessen, Germany), the NIH (PWT) and the Marie Betzer Morrow Centennial Endowment (PWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; DENNIS G, 2003, DAVID DATABASE ANNOT; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Holbert MA, 2005, CURR OPIN STRUC BIOL, V15, P673, DOI 10.1016/j.sbi.2005.10.006; Hotta Y, 2008, DEV DYNAM, V237, P2947, DOI 10.1002/dvdy.21726; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; IWASAWA M, 2009, J CLIN INVEST; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; LI D, 2009, NUCL ACIDS RES; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Rossi DJ, 2001, EMBO J, V20, P2844, DOI 10.1093/emboj/20.11.2844; RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Shirai M, 2002, J CLIN INVEST, V110, P177, DOI 10.1172/JCI200214839; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Sobral RA, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-27; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001; Xiong SB, 2007, CIRCULATION, V115, P2925, DOI 10.1161/CIRCULATIONAHA.107.689901	61	54	58	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9748	10.1371/journal.pone.0009748	http://dx.doi.org/10.1371/journal.pone.0009748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305823	Green Published, Green Submitted, gold			2022-12-27	WOS:000275809600017
J	Fan, JS; Zeller, K; Chen, YC; Watkins, T; Barnes, KC; Becker, KG; Dang, CV; Cheadle, C				Fan, JinShui; Zeller, Karen; Chen, Yu-Chi; Watkins, Tonya; Barnes, Kathleen C.; Becker, Kevin G.; Dang, Chi V.; Cheadle, Chris			Time-Dependent c-Myc Transactomes Mapped by Array-Based Nuclear Run-On Reveal Transcriptional Modules in Human B Cells	PLOS ONE			English	Article							GENE-EXPRESSION; GENOMIC TARGETS; RNA; ACTIVATION	Background: The definition of transcriptional networks through measurements of changes in gene expression profiles and mapping of transcription factor binding sites is limited by the moderate overlap between binding and gene expression changes and the inability to directly measure global nuclear transcription (coined ``transactome''). Methodology/Principal Findings: We developed a method to measure nascent nuclear gene transcription with an Arraybased Nuclear Run-On (ANRO) assay using commercial microarray platforms. This strategy provides the missing component, the transactome, to fully map transcriptional networks. ANRO measurements in an inducible c-Myc expressing human P4936 B cell model reveals time-dependent waves of transcription, with a transactome early after c-Myc induction that does not persist at a late, steady-state phase, when genes that are regulated by c-Myc and E2F predominate. Gene set matrix analysis further uncovers functionally related groups of genes putatively regulated by waves of transcription factor motifs following Myc induction, starting with AP1 and CREB that are followed by EGR1, NFkB and STAT, and ending with E2F, Myc and ARNT/HIF motifs. Conclusions/Significance: By coupling ANRO with previous global mapping of c-Myc binding sites by chromatin immunoprecipitation (ChIP) in P493-6 cells, we define a set of transcriptionally regulated direct c-Myc target genes and pave the way for the use of ANRO to comprehensively map any transcriptional network.	[Fan, JinShui; Chen, Yu-Chi; Watkins, Tonya; Barnes, Kathleen C.; Cheadle, Chris] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol & Allergy,Lowe Family Genom Core, Baltimore, MD 21205 USA; [Zeller, Karen; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Becker, Kevin G.] NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fan, JS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol & Allergy,Lowe Family Genom Core, Baltimore, MD 21205 USA.	cvdang@jhmi.edu; ccheadl1@jhmi.edu	Dang, Chi/Y-3375-2019	Becker, Kevin/0000-0002-6794-6656; Dang, Chi/0000-0002-4031-2522	National Institute on Aging, NIH [R01CA57341, R01CA51497]; Maryland Stem Cell Research Fund [2007-MSCRFE-0167-00, 2008-MSCRFE-0156-00]; Mary Beryl Patch Turnbull Scholar Program; NATIONAL CANCER INSTITUTE [R01CA057341, R01CA051497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Maryland Stem Cell Research Fund; Mary Beryl Patch Turnbull Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported in part by the Intramural Research Program of the NIH, National Institute on Aging, NIH grants R01CA57341 and R01CA51497 and Maryland Stem Cell Research Fund grants 2007-MSCRFE-0167-00 and 2008-MSCRFE-0156-00. KCB was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheadle C, 2007, MOL CELL PROBE, V21, P35, DOI 10.1016/j.mcp.2006.07.004; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan JS, 2006, NUCLEIC ACIDS RES, V34, P1492, DOI 10.1093/nar/gkj510; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Ponzielli R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn735; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	27	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9691	10.1371/journal.pone.0009691	http://dx.doi.org/10.1371/journal.pone.0009691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300622	Green Submitted, Green Published, gold			2022-12-27	WOS:000275621000009
J	Bannasch, D; Young, A; Myers, J; Truve, K; Dickinson, P; Gregg, J; Davis, R; Bongcam-Rudloff, E; Webster, MT; Lindblad-Toh, K; Pedersen, N				Bannasch, Danika; Young, Amy; Myers, Jeffrey; Truve, Katarina; Dickinson, Peter; Gregg, Jeffrey; Davis, Ryan; Bongcam-Rudloff, Eric; Webster, Matthew T.; Lindblad-Toh, Kerstin; Pedersen, Niels			Localization of Canine Brachycephaly Using an Across Breed Mapping Approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DOMESTIC DOG; COAT COLOR; MUTATION; GENE; LINKAGE; TISSUE; SMOC-2; SPARC; FGF4	The domestic dog, Canis familiaris, exhibits profound phenotypic diversity and is an ideal model organism for the genetic dissection of simple and complex traits. However, some of the most interesting phenotypes are fixed in particular breeds and are therefore less tractable to genetic analysis using classical segregation-based mapping approaches. We implemented an across breed mapping approach using a moderately dense SNP array, a low number of animals and breeds carefully selected for the phenotypes of interest to identify genetic variants responsible for breed-defining characteristics. Using a modest number of affected (10-30) and control (20-60) samples from multiple breeds, the correct chromosomal assignment was identified in a proof of concept experiment using three previously defined loci; hyperuricosuria, white spotting and chondrodysplasia. Genome-wide association was performed in a similar manner for one of the most striking morphological traits in dogs: brachycephalic head type. Although candidate gene approaches based on comparable phenotypes in mice and humans have been utilized for this trait, the causative gene has remained elusive using this method. Samples from nine affected breeds and thirteen control breeds identified strong genome-wide associations for brachycephalic head type on Cfa 1. Two independent datasets identified the same genomic region. Levels of relative heterozygosity in the associated region indicate that it has been subjected to a selective sweep, consistent with it being a breed defining morphological characteristic. Genotyping additional dogs in the region confirmed the association. To date, the genetic structure of dog breeds has primarily been exploited for genome wide association for segregating traits. These results demonstrate that non-segregating traits under strong selection are equally tractable to genetic analysis using small sample numbers.	[Bannasch, Danika; Young, Amy; Myers, Jeffrey] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Truve, Katarina; Bongcam-Rudloff, Eric] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, S-75007 Uppsala, Sweden; [Dickinson, Peter] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Gregg, Jeffrey; Davis, Ryan] Univ Calif Davis, Sch Med, Dept Pathol, Davis, CA 95616 USA; [Webster, Matthew T.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst Harvard, Cambridge, MA USA; [Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02139 USA; [Pedersen, Niels] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; Swedish University of Agricultural Sciences; University of California System; University of California Davis; University of California System; University of California Davis; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis	Bannasch, D (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	dlbannasch@ucdavis.edu	Bannasch, Danika/GZL-8044-2022; Dickinson, Peter/GPT-0703-2022	Truve, Katarina/0000-0002-2449-8283; Davis, Ryan/0000-0001-7439-6683; Webster, Matthew/0000-0003-1141-2863; Bannasch, Danika/0000-0002-7614-7207; Young, Amy/0000-0002-4181-4233; Bongcam-Rudloff, Erik/0000-0002-1947-8288	Center for Companion Animal Health; Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California Davis; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R21 DK074954]; Swedish Research Council; National Cancer Institute (NCI) [3 P30 CA093373]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074954] Funding Source: NIH RePORTER	Center for Companion Animal Health; Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California Davis(University of California System); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Center for Companion Animal Health and the Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California Davis and in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R21 DK074954), the Swedish Research Council and a Cancer Center Support Grant from the National Cancer Institute (NCI) (3 P30 CA093373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; American Kennel Club, 2006, COMPL DOG BOOK, Vtwentieth; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bannasch D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000246; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Ellis JL, 2009, J ANAT, V214, P362, DOI 10.1111/j.1469-7580.2008.01042.x; Foley CW, 1979, ABNORMALITIES COMPAN, P119; Haworth KE, 2001, MAMM GENOME, V12, P622, DOI 10.1007/s00335-001-3011-0; HAYES HM, 1975, INT J CANCER, V15, P39, DOI 10.1002/ijc.2910150106; Hedan Benoit, 2006, BMC Vet Res, V2, P9, DOI 10.1186/1746-6148-2-9; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Hunemeier T, 2009, ANIM GENET, V40, P357, DOI 10.1111/j.1365-2052.2008.01838.x; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; KARMI N, 2009, VALIDATION URINE TES; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LIUP LJ, 2008, MOL BIOL CELL, V19, P248; LUGINBUHL H., 1965, ACTA NEUROCHIR SUPPL, V10, P173; Neff MW, 2004, P NATL ACAD SCI USA, V101, P11725, DOI 10.1073/pnas.0402374101; NELSON RW, 2003, SMALL ANIMAL INTERNA, P248; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; NOLLER G, 2002, NEW ASPECTS BRACHYCE; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Philipp U, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-34; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; Smith FO, 2007, THERIOGENOLOGY, V68, P348, DOI 10.1016/j.theriogenology.2007.04.041; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zedda M, 2006, ANAT HISTOL EMBRYOL, V35, P319, DOI 10.1111/j.1439-0264.2006.00687.x	40	76	76	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9632	10.1371/journal.pone.0009632	http://dx.doi.org/10.1371/journal.pone.0009632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224736	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328800026
J	Rodriguez-Carres, M; Findley, K; Sun, S; Dietrich, FS; Heitman, J				Rodriguez-Carres, Marianela; Findley, Keisha; Sun, Sheng; Dietrich, Fred S.; Heitman, Joseph			Morphological and Genomic Characterization of Filobasidiella depauperata: A Homothallic Sibling Species of the Pathogenic Cryptococcus Species Complex	PLOS ONE			English	Article							MATING-TYPE LOCI; BASIDIOMYCETOUS YEAST; SEXUAL REPRODUCTION; NEOFORMANS; EVOLUTION; DNA; REARRANGEMENTS; ORGANIZATION; ASSOCIATION; DYNAMICS	The fungal species Cryptococcus neoformans and Cryptococcus gattii cause respiratory and neurological disease in animals and humans following inhalation of basidiospores or desiccated yeast cells from the environment. Sexual reproduction in C. neoformans and C. gattii is controlled by a bipolar system in which a single mating type locus (MAT) specifies compatibility. These two species are dimorphic, growing as yeast in the asexual stage, and producing hyphae, basidia, and basidiospores during the sexual stage. In contrast, Filobasidiella depauperata, one of the closest related species, grows exclusively as hyphae and it is found in association with decaying insects. Examination of two available strains of F. depauperata showed that the life cycle of this fungal species shares features associated with the unisexual or same-sex mating cycle in C. neoformans. Therefore, F. depauperata may represent a homothallic and possibly an obligately sexual fungal species. RAPD genotyping of 39 randomly isolated progeny from isolate CBS7855 revealed a new genotype pattern in one of the isolated basidiospores progeny, therefore suggesting that the homothallic cycle in F. depauperata could lead to the emergence of new genotypes. Phylogenetic analyses of genes linked to MAT in C. neoformans indicated that two of these genes in F. depauperata, MYO2 and STE20, appear to form a monophyletic clade with the MATa alleles of C. neoformans and C. gattii, and thus these genes may have been recruited to the MAT locus before F. depauperata diverged. Furthermore, the ancestral MATa locus may have undergone accelerated evolution prior to the divergence of the pathogenic Cryptococcus species since several of the genes linked to the MATa locus appear to have a higher number of changes and substitutions than their MATa counterparts. Synteny analyses between C. neoformans and F. depauperata showed that genomic regions on other chromosomes displayed conserved gene order. In contrast, the genes linked to the MAT locus of C. neoformans showed a higher number of chromosomal translocations in the genome of F. depauperata. We therefore propose that chromosomal rearrangements appear to be a major force driving speciation and sexual divergence in these closely related pathogenic and saprobic species.	[Rodriguez-Carres, Marianela; Findley, Keisha; Sun, Sheng; Dietrich, Fred S.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA	Duke University	Rodriguez-Carres, M (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021		National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI50113, RO1 AI063443]; Molecular Mycology Pathogenesis Training Program [2T32-AI052080-06A1]; National Institutes of Health (NIH) [5R01-AI063443-04 S1, 1-P30]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063443, R01AI050113, T32AI052080] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Molecular Mycology Pathogenesis Training Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) RO1 grants AI50113 and AI063443. Marianela Rodriguez-Carres was supported by Molecular Mycology Pathogenesis Training Program grant 2T32-AI052080-06A1. Keisha Findley was supported by National Institutes of Health (NIH) Minority Supplement grant 5R01-AI063443-04 S1 Sub no. 1-P30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Chung SY, 2002, EUKARYOT CELL, V1, P432, DOI 10.1128/EC.1.3.432-439.2002; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fries BC, 1999, INFECT IMMUN, V67, P6076, DOI 10.1128/IAI.67.11.6076-6083.1999; Fries BC, 2002, MICROBES INFECT, V4, P1345, DOI 10.1016/S1286-4579(02)00006-0; Fries BC, 1996, J CLIN MICROBIOL, V34, P1531, DOI 10.1128/JCM.34.6.1531-1534.1996; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garcia-Hermoso D, 2004, INFECT IMMUN, V72, P3359, DOI 10.1128/IAI.72.6.3359-3365.2004; GORDON D, 2004, CURRENT PROTOCOLS BI; Gunde-Cimerman Nina, 2006, Reviews in Environmental Science and Bio/Technology, V5, P323, DOI 10.1007/s11157-006-9105-0; Hsueh YP, 2008, EUKARYOT CELL, V7, P1847, DOI 10.1128/EC.00271-08; Hsueh YP, 2006, PLOS GENET, V2, P1702, DOI 10.1371/journal.pgen.0020184; Hull CM, 2005, EUKARYOT CELL, V4, P526, DOI 10.1128/EC.4.3.526-535.2005; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; KAHMANN R, 1995, CURR OPIN GENET DEV, V5, P559, DOI 10.1016/0959-437X(95)80023-9; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Kent CR, 2008, APPL ENVIRON MICROB, V74, P6248, DOI 10.1128/AEM.00970-08; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; KwonChung KJ, 1995, STUD MYCOL, P67; KWONCHUNG KJ, 1976, J BACTERIOL, V126, P524, DOI 10.1128/JB.126.1.524-528.1976; KwonChung KJ, 1997, MYCOLOGIA, V89, P244, DOI 10.2307/3761078; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lin Xiaorong, 2007, P35; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; MADDISON WP, 2003, MACCLADE, V4; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; MCLAUGHLIN DJ, 1995, STUD MYCOL, V38, P87; MITCHELL TG, 1992, J MED VET MYCOL, V30, P207; MOORE RT, 1962, AM J BOT, V49, P86, DOI 10.2307/2439393; Onofri S, 2007, ADV SPACE RES, V40, P1657, DOI 10.1016/j.asr.2007.06.004; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Poggeler S, 1997, GENETICS, V147, P567; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; SAMSON RA, 1983, A VAN LEEUW J MICROB, V49, P447; Sivakumaran S, 2003, MYCOPATHOLOGIA, V156, P157, DOI 10.1023/A:1023309311643; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tesler G, 2002, J COMPUT SYST SCI, V65, P587, DOI 10.1016/S0022-0000(02)00011-9; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velegraki A, 1999, MED MYCOL, V37, P69; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; [No title captured]	65	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9620	10.1371/journal.pone.0009620	http://dx.doi.org/10.1371/journal.pone.0009620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224779	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800017
J	Uthman, OA; Popoola, TA; Uthman, MMB; Aremu, O				Uthman, Olalekan A.; Popoola, Taiwo Aderemi; Uthman, Mubashir M. B.; Aremu, Olatunde			Economic Evaluations of Adult Male Circumcision for Prevention of Heterosexual Acquisition of HIV in Men in Sub-Saharan Africa: A Systematic Review	PLOS ONE			English	Review							SEXUALLY-TRANSMITTED INFECTIONS; COST-EFFECTIVENESS; NEONATAL CIRCUMCISION; DECISION-MAKING; HEALTH; RISK; STRATEGIES; HIV/AIDS; RAKAI; TRANSMISSION	Background: There is conclusive evidence from observational data and three randomized controlled trials that circumcised men have a significantly lower risk of becoming infected with the human immunodeficiency virus (HIV). The aim of this study was to systematically review economic evaluations on adult male circumcision (AMC) for prevention of heterosexual acquisition of HIV in men. Methods and Findings: Studies were identified from the following bibliographic databases: MEDLINE (Ovid), EMBASE (Ovid), Cochrane Library (Wiley's internet version), NHS EED and DARE Office of Health Economics HEED. The searches were conducted in November 2009. The Drummond 10-point checklist was used for methodological critique of the economic evaluations. Cost data were inflated and converted to 2008 US dollars (US$). Of 264 identified papers, only five met the inclusion criteria and were included in the review. The studies were published between 2006 and 2009. Most of the studies were carried out from the perspective of government healthcare payer. The time horizon ranged from 10 to 20 years. All studies reported that AMC is cost-effective. The reported cost per HIV infection averted ranged from US$174 to US$2808. The key driver of the cost-effectiveness models was circumcision efficacy. Conclusions: All published economic evaluations offered the same conclusion that AMC is cost-effective and potentially cost-saving for prevention of heterosexual acquisition of HIV in men. On these grounds, AMC may be seen as a promising new form of strategy for prevention of HIV and should be implemented in conjunction with other evidence-based prevention methods.	[Uthman, Olalekan A.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, WMHTAC, Birmingham, W Midlands, England; [Popoola, Taiwo Aderemi] Ctr Evidence Based Global Hlth, Birmingham, W Midlands, England; [Uthman, Mubashir M. B.] Univ Ilorin, Dept Epidemiol & Community Hlth, Ilorin, Kwara State, Nigeria; [Aremu, Olatunde] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden	University of Birmingham; University of Birmingham; University of Ilorin; Karolinska Institutet	Uthman, OA (corresponding author), Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, WMHTAC, Birmingham, W Midlands, England.	uthlekan@yahoo.com	Uthman, Olalekan/N-5584-2019; Aremu, Olatunde/AAD-1995-2019	Uthman, Olalekan/0000-0002-8567-3081; Aremu, Olatunde/0000-0002-5832-2403				Anderson J, 2009, J INFECT DIS, V200, P1803, DOI 10.1086/648472; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertozzi S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P331; *BLS, OV BLS STAT INFL PRI; Bollinger LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-7; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8310; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Cohen DA, 2004, JAIDS-J ACQ IMM DEF, V37, P1404, DOI 10.1097/01.qai.0000123271.76723.96; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Drummond MF, 2015, METHODS EC EVALUATIO; Fieno JV, 2008, AIDS CARE, V20, P515, DOI 10.1080/09540120701867149; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; GANIATS TG, 1991, MED DECIS MAKING, V11, P282, DOI 10.1177/0272989X9101100406; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; HOGAN DR, 2005, BRIT MED J, V331, P1431, DOI DOI 10.1136/BMJ.38643.368692.68; Jayanthi VR, 1999, J UROLOGY, V161, P1301, DOI 10.1016/S0022-5347(01)61674-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kim HH, 2009, NAT CLIN PRACT UROL, V6, P64, DOI 10.1038/ncpuro1279; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McAllister R. G., 2008, International Journal of Men's Health, V7, P307, DOI 10.3149/jmh.0703.307; McKinlay RJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-67; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; MOSES S, 1994, SEX TRANSM DIS, V21, P201, DOI 10.1097/00007435-199407000-00004; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; O'Farrell N, 2000, INT J STD AIDS, V11, P137, DOI 10.1258/0956462001915480; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RAJA V, 2007, J ONE DAY SURG, V17; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Royle P., 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7340; Schoen EJ, 2006, J UROLOGY, V175, P1111, DOI 10.1016/S0022-5347(05)00399-X; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; SIEGFRIED N, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003362; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; *UNAIDS, 2008, 2007 REP GLOB AIDS E; *UNAIDS, 2005, 9 UNAIDS; Van Howe RS, 1999, INT J STD AIDS, V10, P8, DOI 10.1258/0956462991913015; Van Howe RS, 2004, MED DECIS MAKING, V24, P584, DOI 10.1177/0272989X04271039; Walker D, 2003, HEALTH POLICY PLANN, V18, P4, DOI 10.1093/heapol/18.1.4; Wamai RG., 2008, FUTURE HIV THER, V2, P399; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406	55	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9628	10.1371/journal.pone.0009628	http://dx.doi.org/10.1371/journal.pone.0009628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	565XE	20224784	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328800023
J	Wang, V; Davis, DA; Veeranna, RP; Haque, M; Yarchoan, R				Wang, Victoria; Davis, David A.; Veeranna, Ravindra P.; Haque, Muzammel; Yarchoan, Robert			Characterization of the Activation of Protein Tyrosine Phosphatase, Receptor-Type, Z Polypeptide 1 (PTPRZ1) by Hypoxia Inducible Factor-2 Alpha	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; TRANSCRIPTION FACTORS; HIF-2-ALPHA PROMOTES; ENDOTHELIAL-CELLS; RESPONSE ELEMENTS; BINDING-SITES; BETA-CATENIN; C-MYC; GENE; EXPRESSION	Background: Hypoxia inducible factors (HIFs) are the principal means by which cells upregulate genes in response to hypoxia and certain other stresses. There are two major HIFs, HIF-1 and HIF-2. We previously found that certain genes are preferentially activated by HIF-2. One was protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1). PTPRZ1 is overexpressed in a number of tumors and has been implicated in glioblastoma pathogenesis. Methodology/Principal Findings: To understand the preferential activation of PTPRZ1 by HIF-2, we studied the PTPRZ1 promoter in HEK293T cells and Hep3B cells. Through deletion and mutational analysis, we identified the principal hypoxia response element. This element bound to both HIF-1 and HIF-2. We further identified a role for ELK1, an E26 transformation-specific (Ets) factor that can bind to HIF-2 alpha but not HIF-1 alpha, in the HIF-2 responsiveness. Knock-down experiments using siRNA to ELK1 decreased HIF-2 activation by over 50%. Also, a deletion mutation of one of the two Ets binding motifs located near the principal hypoxia response element similarly decreased activation of the PTPRZ1 promoter by HIF-2. Finally, chromatin immunoprecipitation assays showed binding of HIF and ELK1 to the PTPRZ1 promoter region. Conclusions/Significance: These results identify HIF-binding and Ets-binding motifs on the PTPRZ1 promoter and provide evidence that preferential activation of PTPRZ1 by HIF-2 results at least in part from cooperative binding of HIF-2 and ELK1 to nearby sites on the PTPRZ1 promoter region. These results may have implications in tumor pathogenesis and in understanding neurobiology, and may help inform the development of novel tumor therapy.	[Wang, Victoria] NCI, HIV, NIH, Bethesda, MD 20892 USA; NCI, AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, V (corresponding author), NCI, HIV, NIH, Bethesda, MD 20892 USA.	yarchoan@helix.nih.gov		Veeranna, Ravindra/0000-0003-4228-1843	National Institutes of Heath, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010885] Funding Source: NIH RePORTER	National Institutes of Heath, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Research Program of the National Institutes of Heath, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; De Zhu J, 2006, CELL RES, V16, P780, DOI 10.1038/sj.cr.7310092; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Foehr ED, 2006, CANCER RES, V66, P2271, DOI 10.1158/0008-5472.CAN-05-1221; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Haque M, 2003, J VIROL, V77, P6761, DOI 10.1128/JVI.77.12.6761-6768.2003; Haque M, 2006, J VIROL, V80, P7037, DOI 10.1128/JVI.00553-06; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Liu YT, 2007, AM J PATHOL, V171, P1978, DOI 10.2353/ajpath.2007.070741; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Muller S, 2004, EXPERT OPIN THER TAR, V8, P211, DOI 10.1517/14728222.8.3.211; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Ohradanova A, 2008, BRIT J CANCER, V99, P1348, DOI 10.1038/sj.bjc.6604685; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richard DE, 1999, BIOCHEM BIOPH RES CO, V266, P718, DOI 10.1006/bbrc.1999.1889; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANN NY ACAD SCI, V874, P262, DOI 10.1111/j.1749-6632.1999.tb09241.x; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Ulbricht U, 2003, J NEUROPATH EXP NEUR, V62, P1265, DOI 10.1093/jnen/62.12.1265; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046	45	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9641	10.1371/journal.pone.0009641	http://dx.doi.org/10.1371/journal.pone.0009641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224786	gold, Green Published, Green Submitted			2022-12-27	WOS:000275328800032
J	Tsuji, T; Du, W; Nishioka, T; Chen, LH; Yamamoto, D; Chen, CY				Tsuji, Takanori; Du, Wei; Nishioka, Takashi; Chen, Lihua; Yamamoto, Daisuke; Chen, Chang Yan			Phellinus Linteus Extract Sensitizes Advanced Prostate Cancer Cells to Apoptosis in Athymic Nude Mice	PLOS ONE			English	Article							PATHWAYS; POLYSACCHARIDES; MUSHROOMS; GROWTH	Phellinus linteus (PL) mushroom possesses anti-tumor property. We previously reported that the treatment with PL caused cultured human prostate cancer cells to undergo apoptosis. To further studying the mechanisms of PL-mediated apoptosis, we performed xenograft assay, together with in vitro assays, to evaluate the effect of PL on the genesis and progression of the tumors formed from the inoculation of prostate cancer PC3 or DU145 cells. After the inoculation, nude mice were injected with PL every two days for 12 days. Although PL treatment did not prevent the formation of the inoculated tumors, the growth rate of the tumors after PL treatment was dramatically attenuated. We then tested the effect of PL on the tumors 12 days after the inoculation. After inoculated tumors reached a certain size, PL was administrated to the mice by subcutaneous injection. The histochemistry or immunochemistry analysis showed that apoptosis occurred with the activation of caspase 3 in the tumors formed by inoculating prostate cancer DU145 or PC3 cells. The data was in a good agreement with that from cultured cells. Thus, our in vivo study suggests that PL not only is able to attenuate tumor growth, but also to cause tumor regression by inducing apoptosis.	[Tsuji, Takanori; Du, Wei; Nishioka, Takashi; Chen, Lihua; Yamamoto, Daisuke; Chen, Chang Yan] Harvard Univ, Sch Med, Dept Radiat Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsuji, T (corresponding author), Harvard Univ, Sch Med, Dept Radiat Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	cchen6@bidmc.harvard.edu		Nishioka, Takashi/0000-0002-1144-3881	JCRT Foundation	JCRT Foundation	This work is supported by funding from JCRT Foundation to CYC. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers AT, 1999, P SOC EXP BIOL MED, V221, P281, DOI 10.1046/j.1525-1373.1999.d01-86.x; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; CHIHARA G, 1969, Nature (London), V222, P687; Collins L, 2006, BRIT J CANCER, V95, P282, DOI 10.1038/sj.bjc.6603277; Guo JJ, 2007, MOL CARCINOGEN, V46, P144, DOI 10.1002/mc.20275; Han SB, 1999, IMMUNOPHARMACOLOGY, V41, P157, DOI 10.1016/S0162-3109(98)00063-0; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Song KS, 1995, CHEM PHARM BULL, V43, P2105, DOI 10.1248/cpb.43.2105; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Zhu T, 2007, BRIT J CANCER, V96, P583, DOI 10.1038/sj.bjc.6603595	16	20	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9885	10.1371/journal.pone.0009885	http://dx.doi.org/10.1371/journal.pone.0009885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360989	gold, Green Published, Green Submitted			2022-12-27	WOS:000276163200004
J	Zhou, X; Sumazin, P; Rajbhandari, P; Califano, A				Zhou, Xiang; Sumazin, Pavel; Rajbhandari, Presha; Califano, Andrea			A Systems Biology Approach to Transcription Factor Binding Site Prediction	PLOS ONE			English	Article							EXPECTATION MAXIMIZATION; REGULATORY ELEMENTS; GENE-EXPRESSION; HUMAN GENOME; B-CELLS; DISCOVERY; IDENTIFICATION; VERTEBRATE; SEQUENCE; MOTIFS	Background: The elucidation of mammalian transcriptional regulatory networks holds great promise for both basic and translational research and remains one the greatest challenges to systems biology. Recent reverse engineering methods deduce regulatory interactions from large-scale mRNA expression profiles and cross-species conserved regulatory regions in DNA. Technical challenges faced by these methods include distinguishing between direct and indirect interactions, associating transcription regulators with predicted transcription factor binding sites (TFBSs), identifying non-linearly conserved binding sites across species, and providing realistic accuracy estimates. Methodology/Principal Findings: We address these challenges by closely integrating proven methods for regulatory network reverse engineering from mRNA expression data, linearly and non-linearly conserved regulatory region discovery, and TFBS evaluation and discovery. Using an extensive test set of high-likelihood interactions, which we collected in order to provide realistic prediction-accuracy estimates, we show that a careful integration of these methods leads to significant improvements in prediction accuracy. To verify our methods, we biochemically validated TFBS predictions made for both transcription factors (TFs) and co-factors; we validated binding site predictions made using a known E2F1 DNA-binding motif on E2F1 predicted promoter targets, known E2F1 and JUND motifs on JUND predicted promoter targets, and a de novo discovered motif for BCL6 on BCL6 predicted promoter targets. Finally, to demonstrate accuracy of prediction using an external dataset, we showed that sites matching predicted motifs for ZNF263 are significantly enriched in recent ZNF263 ChIP-seq data. Conclusions/Significance: Using an integrative framework, we were able to address technical challenges faced by state of the art network reverse engineering methods, leading to significant improvement in direct-interaction detection and TFBS-discovery accuracy. We estimated the accuracy of our framework on a human B-cell specific test set, which may help guide future methodological development.	[Zhou, Xiang; Califano, Andrea] Columbia Univ, Dept Biomed Informat DBMI, New York, NY 10027 USA; [Sumazin, Pavel; Rajbhandari, Presha; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Zhou, X (corresponding author), Columbia Univ, Dept Biomed Informat DBMI, New York, NY 10027 USA.	califano@c2b2.columbia.edu	Califano, Andrea/F-7239-2012; Sumazin, Pavel/AAE-6607-2020	Sumazin, Pavel/0000-0002-1215-4977; Califano, Andrea/0000-0003-4742-3679	National Center: Multi-Scale Study - Cellular Networks [U54-CA121852-05]; National Centers for Biomedical Computing NIH Roadmap; Multi-Scale Study - Cellular Networks [U54-CA121852-05]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	National Center: Multi-Scale Study - Cellular Networks; National Centers for Biomedical Computing NIH Roadmap; Multi-Scale Study - Cellular Networks; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Center: Multi-Scale Study - Cellular Networks (RMI) grant (U54-CA121852-05) from the National Centers for Biomedical Computing NIH Roadmap initiative. XZ is supported by Multi-Scale Study - Cellular Networks (RMI) grant (U54-CA121852-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; BAILEY TL, 1993, MACH LEARN, V21, P51; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Blanchette M, 2001, Bioinformatics, V17 Suppl 1, pS30; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Brazma A, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P34; Califano A, 2000, BIOINFORMATICS, V16, P341, DOI 10.1093/bioinformatics/16.4.341; CARRO M, 2009, NATURE; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; KAWAMATA N, 1994, BIOCHEM BIOPH RES CO, V204, P366, DOI 10.1006/bbrc.1994.2468; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; SADLER JR, 1983, NUCLEIC ACIDS RES, V11, P2221, DOI 10.1093/nar/11.7.2221; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100114; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Sosinsky A, 2007, P NATL ACAD SCI USA, V104, P6305, DOI 10.1073/pnas.0701614104; Sumazin P, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bth471; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; XIE D, 2008, GENOME RES; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; YOSEPH B, 2001, P 1 INT WORKSH ALG B; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu Z, 2002, J MOL BIOL, V318, P71, DOI 10.1016/S0022-2836(02)00026-8	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9878	10.1371/journal.pone.0009878	http://dx.doi.org/10.1371/journal.pone.0009878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360861	Green Submitted, gold, Green Published			2022-12-27	WOS:000275969600003
J	Seifert, EL; Fiehn, O; Bezaire, V; Bickel, DR; Wohlgemuth, G; Adams, SH; Harper, ME				Seifert, Erin L.; Fiehn, Oliver; Bezaire, Veronic; Bickel, David R.; Wohlgemuth, Gert; Adams, Sean H.; Harper, Mary-Ellen			Long-Chain Fatty Acid Combustion Rate Is Associated with Unique Metabolite Profiles in Skeletal Muscle Mitochondria	PLOS ONE			English	Article							INSULIN-RESISTANCE; TRIGLYCERIDE SYNTHESIS; UNCOUPLING PROTEIN-3; CHRONIC EXPOSURE; MALONYL-COA; IN-VIVO; OXIDATION; CYCLE; CITRATE; OBESITY	Background/Aim: Incomplete or limited long-chain fatty acid (LCFA) combustion in skeletal muscle has been associated with insulin resistance. Signals that are responsive to shifts in LCFA beta-oxidation rate or degree of intramitochondrial catabolism are hypothesized to regulate second messenger systems downstream of the insulin receptor. Recent evidence supports a causal link between mitochondrial LCFA combustion in skeletal muscle and insulin resistance. We have used unbiased metabolite profiling of mouse muscle mitochondria with the aim of identifying candidate metabolites within or effluxed from mitochondria and that are shifted with LCFA combustion rate. Methodology/Principal Findings: Large-scale unbiased metabolomics analysis was performed using GC/TOF-MS on buffer and mitochondrial matrix fractions obtained prior to and after 20 min of palmitate catabolism (n = 7 mice/condition). Three palmitate concentrations (2, 9 and 19 mu M; corresponding to low, intermediate and high oxidation rates) and 9 mu M palmitate plus tricarboxylic acid (TCA) cycle and electron transport chain inhibitors were each tested and compared to zero palmitate control incubations. Paired comparisons of the 0 and 20 min samples were made by Student's t-test. False discovery rate were estimated and Type I error rates assigned. Major metabolite groups were organic acids, amines and amino acids, free fatty acids and sugar phosphates. Palmitate oxidation was associated with unique profiles of metabolites, a subset of which correlated to palmitate oxidation rate. In particular, palmitate oxidation rate was associated with distinct changes in the levels of TCA cycle intermediates within and effluxed from mitochondria. Conclusions/Significance: This proof-of-principle study establishes that large-scale metabolomics methods can be applied to organelle-level models to discover metabolite patterns reflective of LCFA combustion, which may lead to identification of molecules linking muscle fat metabolism and insulin signaling. Our results suggest that future studies should focus on the fate of effluxed TCA cycle intermediates and on mechanisms ensuring their replenishment during LCFA metabolism in skeletal muscle.	[Seifert, Erin L.; Bezaire, Veronic; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Fiehn, Oliver; Wohlgemuth, Gert] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Bickel, David R.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Adams, Sean H.] Univ Calif Davis, ARS, Obes & Metab Res Unit, USDA,Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of Ottawa; University of California System; University of California Davis; University of Ottawa; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis	Seifert, EL (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	sean.h.adams@ars.usda.gov; Maryellen.Harper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009; Bickel, David/F-9370-2010; Bickel, David/ABF-7206-2021; ADAMS, SEAN/N-9262-2018	Bickel, David/0000-0002-9623-3946; Bickel, David/0000-0002-9623-3946; ADAMS, SEAN/0000-0002-9515-2319; Harper, Mary-Ellen/0000-0003-3864-5886	United States Department of Agriculture Agricultural Research Service (USDA-ARS) [530651530-016-00D]; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [R01DK078328]; Canadian Institutes for Health Research [57810]; Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER	United States Department of Agriculture Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part through intramural United States Department of Agriculture Agricultural Research Service (USDA-ARS) Project 530651530-016-00D (S. H. A.) and National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) R01DK078328 (S. H. A. and M-E. H.) and by the Canadian Institutes for Health Research (Nutrition, Metabolism and Diabetes (57810); M-E. H.). E. L. S. was the recipient of a fellowship from the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Bangsbo J, 2006, PFLUG ARCH EUR J PHY, V452, P737, DOI 10.1007/s00424-006-0075-4; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; BICKEL DR, 2004, STAT APPL GENET MOL, V3; Bland JM, 1996, BRIT MED J, V312, P770; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; BRUCE CR, 2008, DIABETES; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; FINK G, 1988, J BIOL CHEM, V263, P18036; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; GUILLAUMEGENTIL C, 1993, DIABETOLOGIA, V36, P899, DOI 10.1007/BF02374470; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600; Khairallah M, 2004, AM J PHYSIOL-HEART C, V286, pH1461, DOI 10.1152/ajpheart.00942.2003; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; LYSIAK W, 1988, J BIOL CHEM, V263, P1151; MAILLOUX RJ, 2010, FASEB J IN PRESS; MAIZELS EZ, 1977, BIOCHEM J, V162, P557, DOI 10.1042/bj1620557; MAKOWSKI L, 2008, FASEB J; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; Messer JI, 2004, AM J PHYSIOL-CELL PH, V286, pC565, DOI 10.1152/ajpcell.00146.2003; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Mourtzakis M, 2008, J APPL PHYSIOL, V105, P547, DOI 10.1152/japplphysiol.90394.2008; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; NOSADINI R, 1985, AM J PHYSIOL, V248, pR611, DOI 10.1152/ajpregu.1985.248.5.R611; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pelletier A, 2007, MOL CELL BIOCHEM, V296, P97, DOI 10.1007/s11010-006-9303-7; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Poirier M, 2002, AM J PHYSIOL-HEART C, V283, pH1379, DOI 10.1152/ajpheart.00244.2002; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Saha AK, 1997, AM J PHYSIOL-ENDOC M, V272, pE641, DOI 10.1152/ajpendo.1997.272.4.E641; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tardif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE1205, DOI 10.1152/ajpendo.2001.281.6.E1205; Tretter L, 2000, J NEUROSCI, V20, P8972; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521; Vincent GV, 2004, AM J PHYSIOL-HEART C, V286, pH257, DOI 10.1152/ajpheart.00717.2003; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	64	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9834	10.1371/journal.pone.0009834	http://dx.doi.org/10.1371/journal.pone.0009834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352092	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894500008
J	Siddharthan, R				Siddharthan, Rahul			Dinucleotide Weight Matrices for Predicting Transcription Factor Binding Sites: Generalizing the Position Weight Matrix	PLOS ONE			English	Article							NONADDITIVITY; SEQUENCES; DATABASE; CODE	Background: Identifying transcription factor binding sites (TFBS) in silico is key in understanding gene regulation. TFBS are string patterns that exhibit some variability, commonly modelled as "position weight matrices" (PWMs). Though convenient, the PWM has significant limitations, in particular the assumed independence of positions within the binding motif; and predictions based on PWMs are usually not very specific to known functional sites. Analysis here on binding sites in yeast suggests that correlation of dinucleotides is not limited to near-neighbours, but can extend over considerable gaps. Methodology/Principal Findings: I describe a straightforward generalization of the PWM model, that considers frequencies of dinucleotides instead of individual nucleotides. Unlike previous efforts, this method considers all dinucleotides within an extended binding region, and does not make an attempt to determine a priori the significance of particular dinucleotide correlations. I describe how to use a "dinucleotide weight matrix" (DWM) to predict binding sites, dealing in particular with the complication that its entries are not independent probabilities. Benchmarks show, for many factors, a dramatic improvement over PWMs in precision of predicting known targets. In most cases, significant further improvement arises by extending the commonly defined "core motifs" by about 10bp on either side. Though this flanking sequence shows no strong motif at the nucleotide level, the predictive power of the dinucleotide model suggests that the "signature" in DNA sequence of protein-binding affinity extends beyond the core protein-DNA contact region. Conclusion/Significance: While computationally more demanding and slower than PWM-based approaches, this dinucleotide method is straightforward, both conceptually and in implementation, and can serve as a basis for future improvements.	Inst Math Sci, Madras 600113, Tamil Nadu, India	Institute of Mathematical Sciences (IMSc) India	Siddharthan, R (corresponding author), Inst Math Sci, Madras 600113, Tamil Nadu, India.	rsidd@imsc.res.in			Department of Biotechnology, Government of India [BT/PR7521/BRB/10/482/2006]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the PRISM project at the author's institution, and (particularly for computational support) by the Department of Biotechnology, Government of India (BT/PR7521/BRB/10/482/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARASH Y, 2003, P 7 ANN INT C RES CO; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; BUTLER G, 1991, MOL CELL BIOL, V11, P476, DOI 10.1128/MCB.11.1.476; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Durbin R., 1998, BIOL SEQUENCE ANAL P; Faiger H, 2007, NUCLEIC ACIDS RES, V35, P4409, DOI 10.1093/nar/gkm451; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lusk Richard W, 2008, Pac Symp Biocomput, P489; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; O'Flanagan RA, 2005, BIOINFORMATICS, V21, P2254, DOI 10.1093/bioinformatics/bti361; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siddharthan R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000156; Sinha S, 2006, NUCLEIC ACIDS RES, V34, pW555, DOI 10.1093/nar/gkl224; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	32	57	58	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9722	10.1371/journal.pone.0009722	http://dx.doi.org/10.1371/journal.pone.0009722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339533	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300004
J	David, M; Wannecq, E; Descotes, F; Jansen, S; Deux, B; Ribeiro, J; Serre, CM; Gres, S; Bendriss-Vermare, N; Bollen, M; Saez, S; Aoki, J; Saulnier-Blache, JS; Clezardin, P; Peyruchaud, O				David, Marion; Wannecq, Estelle; Descotes, Francoise; Jansen, Silvia; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Gres, Sandra; Bendriss-Vermare, Nathalie; Bollen, Mathieu; Saez, Simone; Aoki, Junken; Saulnier-Blache, Jean-Sebastien; Clezardin, Philippe; Peyruchaud, Olivier			Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts	PLOS ONE			English	Article							MOTILITY-STIMULATING PROTEIN; BREAST-CANCER; LYSOPHOSPHOLIPASE-D; IDENTIFICATION; RECEPTOR; GENE; BISPHOSPHONATES; DIFFERENTIATION; PHENOTYPE; CARCINOMA	Background: Bone metastases are highly frequent complications of breast cancers. Current bone metastasis treatments using powerful anti-resorbtive agents are only palliative indicating that factors independent of bone resorption control bone metastasis progression. Autotaxin (ATX/NPP2) is a secreted protein with both oncogenic and pro-metastatic properties. Through its lysosphospholipase D (lysoPLD) activity, ATX controls the level of lysophosphatidic acid (LPA) in the blood. Platelet-derived LPA promotes the progression of osteolytic bone metastases of breast cancer cells. We asked whether ATX was involved in the bone metastasis process. We characterized the role of ATX in osteolytic bone metastasis formation by using genetically modified breast cancer cells exploited on different osteolytic bone metastasis mouse models. Methodology/Principal Findings: Intravenous injection of human breast cancer MDA-B02 cells with forced expression of ATX (MDA-B02/ATX) to inmmunodeficiency BALB/C nude mice enhanced osteolytic bone metastasis formation, as judged by increased bone loss, tumor burden, and a higher number of active osteoclasts at the metastatic site. Mouse breast cancer 4T1 cells induced the formation of osteolytic bone metastases after intracardiac injection in immunocompetent BALB/C mice. These cells expressed active ATX and silencing ATX expression inhibited the extent of osteolytic bone lesions and decreased the number of active osteoclasts at the bone metastatic site. In vitro, osteoclast differentiation was enhanced in presence of MDA-B02/ATX cell conditioned media or recombinant autotaxin that was blocked by the autotaxin inhibitor vpc8a202. In vitro, addition of LPA to active charcoal-treated serum restored the capacity of the serum to support RANK-L/MCSF-induced osteoclastogenesis. Conclusion/Significance: Expression of autotaxin by cancer cells controls osteolytic bone metastasis formation. This work demonstrates a new role for LPA as a factor that stimulates directly cancer growth and metastasis, and osteoclast differentiation. Therefore, targeting the autotaxin/LPA track emerges as a potential new therapeutic approach to improve the outcome of patients with bone metastases.	[David, Marion; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Clezardin, Philippe; Peyruchaud, Olivier] INSERM, U664, F-69008 Lyon, France; [David, Marion; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Clezardin, Philippe; Peyruchaud, Olivier] Univ Lyon 1, Villeurbanne, France; [Wannecq, Estelle; Gres, Sandra; Saulnier-Blache, Jean-Sebastien] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France; [David, Marion; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Clezardin, Philippe; Peyruchaud, Olivier] Fac Med Laennec, Lyon, France; [Descotes, Francoise; Saez, Simone] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France; [Jansen, Silvia; Bollen, Mathieu] Univ Louvain, Dept Mol Cell Biol, Lab Biosignaling & Therapeut, Louvain, Belgium; [Bendriss-Vermare, Nathalie] INSERM, U590, F-69008 Lyon, France; [Bendriss-Vermare, Nathalie] Ctr Leon Berard, F-69373 Lyon, France; [Aoki, Junken] Tohoku Univ, Sendai, Miyagi 980, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Tohoku University	David, M (corresponding author), INSERM, U664, F-69008 Lyon, France.	Olivier.peyruchaud@inserm.fr	Bendriss-Vermare, Nathalie/M-9197-2018; Clezardin, Philippe/M-8071-2014; Saulnier-Blache, Jean Sebastien/X-7729-2018	Bendriss-Vermare, Nathalie/0000-0002-8771-3585; Clezardin, Philippe/0000-0003-0149-4463; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723; Aoki, Junken/0000-0001-9435-1896; Peyruchaud, Olivier/0000-0002-5393-4945	INSERM; Comite departemental de la Loire de la Ligue Nationale contre le Cancer; French National Institute of Cancer, INCA [0610-3D1616-102/PL 2006]; French Association pour la Recherche sur le Cancer, ARC; Ligue Nationale contre le Cancer; Research Foundation-Flanders (FWO)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Comite departemental de la Loire de la Ligue Nationale contre le Cancer; French National Institute of Cancer, INCA(Institut National du Cancer (INCA) France); French Association pour la Recherche sur le Cancer, ARC(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Research Foundation-Flanders (FWO)(FWO)	This study was supported by grants from the INSERM (O. P. and P. C.), the Comite departemental de la Loire de la Ligue Nationale contre le Cancer (O. P.), the French National Institute of Cancer, INCA (O. P., contract 0610-3D1616-102/PL 2006) and the French Association pour la Recherche sur le Cancer, ARC (O. P.). M. D. was a recipient of fellowship from the Ligue Nationale contre le Cancer. J. S. holds a postdoctoral fellowship of the Research Foundation-Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bellahcene A, 2007, BREAST CANCER RES TR, V101, P135, DOI 10.1007/s10549-006-9279-8; Boissier S, 2000, CANCER RES, V60, P2949; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Cui P, 2007, BIOORG MED CHEM LETT, V17, P1634, DOI 10.1016/j.bmcl.2006.12.114; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; Gidley J, 2006, PROSTAG OTH LIPID M, V80, P46, DOI 10.1016/j.prostaglandins.2006.04.001; Grey A, 2001, ENDOCRINOLOGY, V142, P1098, DOI 10.1210/en.142.3.1098; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hillner BE, 2000, J CLIN ONCOL, V18, P1378, DOI 10.1200/JCO.2000.18.6.1378; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karagiosis SA, 2007, BIOCHEM BIOPH RES CO, V357, P194, DOI 10.1016/j.bbrc.2007.03.121; Kawagoe H, 1997, CANCER RES, V57, P2516; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Lee HY, 1996, BIOCHEM BIOPH RES CO, V218, P714, DOI 10.1006/bbrc.1996.0127; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; MURATA J, 1994, J BIOL CHEM, V269, P30479; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Peyruchaud O, 2009, BONE AND CANCER, P73, DOI 10.1007/978-1-84882-019-7_5; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Singh AD, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.116947; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Taghavi P, 2008, ONCOGENE, V27, P6806, DOI 10.1038/onc.2008.294; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhang GX, 1999, CHINESE MED J-PEKING, V112, P330; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216	52	83	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9741	10.1371/journal.pone.0009741	http://dx.doi.org/10.1371/journal.pone.0009741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305819	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000275809600013
J	Hines, WC; Bazarov, AV; Mukhopadhyay, R; Yaswen, P				Hines, William C.; Bazarov, Alexey V.; Mukhopadhyay, Rituparna; Yaswen, Paul			BORIS (CTCFL) Is Not Expressed in Most Human Breast Cell Lines and High Grade Breast Carcinomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANCER-TESTIS GENE; FREQUENT AMPLIFICATION; METHYLATION; EPIGENETICS; DEREPRESSION; CTCFL/BORIS; REGULATOR; MELANOMA; MAGE-A1	BORIS (CTCFL) is the only known paralog of the versatile regulatory protein CTCF, a multifunctional DNA binding protein that mediates distinct gene regulatory functions involved in cell growth, differentiation, and apoptosis. Unlike CTCF, the expression of BORIS is normally restricted to specific cells in testes (the only cells where CTCF is not expressed), where it may play a role in reprogramming the methylation pattern of male germ line DNA. Frequent amplification of the 20q13.2 region, which contains the BORIS gene, and expression of BORIS transcripts in diverse human tumors and cell lines have led to the hypothesis that aberrant expression of BORIS may play a role in tumorigenesis by interfering with CTCF functions. However, recent studies using more quantitative methods indicate low frequency of BORIS expression in melanoma, ovarian, prostate, and bladder carcinomas. To investigate the relationship between chromosome 20q13 amplification and BORIS mRNA levels within breast cancer cell lines and tissues, we developed a quantitative RT-PCR assay to measure the levels of BORIS mRNA. Endpoint RT-PCR assays were also used to investigate the possible expression of alternatively spliced variants. Using multiple primer sets and controls, we found that neither mature BORIS transcripts nor spliced variants are commonly expressed at detectable levels in malignant breast cells or tissues, although endogenous BORIS transcripts can be induced in MCF-7 cells following 5-aza-29-deoxycytidine treatment. In conclusion, in most breast cancer cells, endogenous BORIS is unlikely to be expressed at sufficient levels to interfere with CTCF functions. Thus it is improbable that aberrant BORIS expression plays a role in most human breast cancers.	[Hines, William C.; Mukhopadhyay, Rituparna; Yaswen, Paul] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Bazarov, Alexey V.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Hines, WC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	P_Yaswen@lbl.gov		Hines, William/0000-0002-0707-3160	California Breast Cancer Research Program [9WB-0193]; Department of Defense Breast Cancer Research Program [W81XWH-04-1-0283]; Office of Health and Environmental Research, Health Effects Division, United States Department of Energy [DE-AC02-05CH11231]; Komen Foundation [PDF0707408, BCTR0707231]; Flight Attendant Medical Research Institute [032122]	California Breast Cancer Research Program; Department of Defense Breast Cancer Research Program(United States Department of Defense); Office of Health and Environmental Research, Health Effects Division, United States Department of Energy(United States Department of Energy (DOE)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Flight Attendant Medical Research Institute	This work was funded by grants from the California Breast Cancer Research Program (9WB-0193), the Department of Defense Breast Cancer Research Program (W81XWH-04-1-0283), and by the Office of Health and Environmental Research, Health Effects Division, United States Department of Energy (contract no. DE-AC02-05CH11231). W. C. Hines and A. Bazarov received support from the Komen Foundation (fellowship PDF0707408 & grant BCTR0707231) and the Flight Attendant Medical Research Institute (032122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Darcy V, 2006, CLIN CANCER RES, V12, P5978, DOI 10.1158/1078-0432.CCR-05-2731; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Tanner MM, 1995, CLIN CANCER RES, V1, P1455; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	29	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9738	10.1371/journal.pone.0009738	http://dx.doi.org/10.1371/journal.pone.0009738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305816	Green Published, Green Submitted, gold			2022-12-27	WOS:000275809600010
J	Ramana, J; Gupta, D				Ramana, Jayashree; Gupta, Dinesh			FaaPred: A SVM-Based Prediction Method for Fungal Adhesins and Adhesin-Like Proteins	PLOS ONE			English	Article							BLASTOMYCES-DERMATITIDIS; IDENTIFICATION; LOCALIZATION; PROGRAM; BINDING; ACID	Adhesion constitutes one of the initial stages of infection in microbial diseases and is mediated by adhesins. Hence, identification and comprehensive knowledge of adhesins and adhesin-like proteins is essential to understand adhesin mediated pathogenesis and how to exploit its therapeutic potential. However, the knowledge about fungal adhesins is rudimentary compared to that of bacterial adhesins. In addition to host cell attachment and mating, the fungal adhesins play a significant role in homotypic and xenotypic aggregation, foraging and biofilm formation. Experimental identification of fungal adhesins is labor- as well as time-intensive. In this work, we present a Support Vector Machine (SVM) based method for the prediction of fungal adhesins and adhesin-like proteins. The SVM models were trained with different compositional features, namely, amino acid, dipeptide, multiplet fractions, charge and hydrophobic compositions, as well as PSI-BLAST derived PSSM matrices. The best classifiers are based on compositional properties as well as PSSM and yield an overall accuracy of 86%. The prediction method based on best classifiers is freely accessible as a world wide web based server at http://bioinfo.icgeb.res.in/faap. This work will aid rapid and rational identification of fungal adhesins, expedite the pace of experimental characterization of novel fungal adhesins and enhance our knowledge about role of adhesins in fungal infections.	[Ramana, Jayashree; Gupta, Dinesh] ICGEB, Struct & Computat Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Ramana, J (corresponding author), ICGEB, Struct & Computat Biol Grp, Aruna Asaf Ali Marg, New Delhi, India.	dinesh@icgeb.res.in	Ramana, Jayashree/GQQ-5678-2022; Gupta, Dinesh/AAW-4243-2020; Gupta, Dinesh/C-1079-2009	Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835	Department of Biotechnology (DBT, India)	Department of Biotechnology (DBT, India)(Department of Biotechnology (DBT) India)	Department of Biotechnology (DBT, India) grant for Bioinformatics infrastructure Facility at ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM AF, 2008, PROTEIN-STRUCT FUNCT, V70, P659; Andreotti PF, 2005, MICROBES INFECT, V7, P875, DOI 10.1016/j.micinf.2005.02.005; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Brandhorst T, 2000, J BIOL CHEM, V275, P7925, DOI 10.1074/jbc.275.11.7925; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guo J, 2006, BIOINFORMATICS, V22, P1784, DOI 10.1093/bioinformatics/btl180; Halperin SA, 2003, VACCINE, V21, P2298, DOI 10.1016/S0264-410X(03)00173-7; ITZHAK O, 2003, FEMS IMMUNOLOGY MED, V38, P181; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linder T, 2008, FUNGAL GENET BIOL, V45, P485, DOI 10.1016/j.fgb.2007.08.002; MANISH K, 2008, PROTEIN-STRUCT FUNCT, V71, P189; MARK ES, 2009, FEMS MICROBIOLOGY LE, V299, P1; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; PAULA S, 2002, CELLULAR MICROBIOLOG, V4, P461; Prinz C, 2003, TRENDS MICROBIOL, V11, P134, DOI 10.1016/S0966-842X(03)00024-6; Ramana J, 2009, BIOINFORMATICS, V25, P1568, DOI 10.1093/bioinformatics/btp258; Rapola S, 2003, VACCINE, V21, P3608, DOI 10.1016/S0264-410X(03)00409-2; Sachdeva G, 2005, BIOINFORMATICS, V21, P483, DOI 10.1093/bioinformatics/bti028; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Stanley MS, 2002, PHYTOPATHOLOGY, V92, P378, DOI 10.1094/PHYTO.2002.92.4.378; Upadhyay SK, 2009, J MED MICROBIOL, V58, P714, DOI 10.1099/jmm.0.005991-0; Vapnik N., 1998, STAT LEARNING THEORY; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wuthrich M, 2000, INFECT IMMUN, V68, P7172, DOI 10.1128/IAI.68.12.7172-7174.2000; Yin QY, 2008, TRENDS MICROBIOL, V16, P20, DOI 10.1016/j.tim.2007.10.011	36	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9695	10.1371/journal.pone.0009695	http://dx.doi.org/10.1371/journal.pone.0009695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300572	Green Published, gold, Green Submitted			2022-12-27	WOS:000275621000013
J	Schuster-Bockler, B; Conrad, D; Bateman, A				Schuster-Bockler, Benjamin; Conrad, Donald; Bateman, Alex			Dosage Sensitivity Shapes the Evolution of Copy-Number Varied Regions	PLOS ONE			English	Article							GENE-REGULATION; COMPENSATION; DUPLICATIONS; RESOURCE; BALANCE; CONSEQUENCES; DATABASE; ORIGIN; SERIES; FATES	Dosage sensitivity is an important evolutionary force which impacts on gene dispensability and duplicability. The newly available data on human copy-number variation (CNV) allow an analysis of the most recent and ongoing evolution. Provided that heterozygous gene deletions and duplications actually change gene dosage, we expect to observe negative selection against CNVs encompassing dosage sensitive genes. In this study, we make use of several sources of population genetic data to identify selection on structural variations of dosage sensitive genes. We show that CNVs can directly affect expression levels of contained genes. We find that genes encoding members of protein complexes exhibit limited expression variation and overlap significantly with a manually derived set of dosage sensitive genes. We show that complexes and other dosage sensitive genes are underrepresented in CNV regions, with a particular bias against frequent variations and duplications. These results suggest that dosage sensitivity is a significant force of negative selection on regions of copy-number variation.	[Schuster-Bockler, Benjamin] Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain; [Conrad, Donald; Bateman, Alex] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Schuster-Bockler, B (corresponding author), Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain.	agb@sanger.ac.uk	Bateman, Alex/E-6518-2011; Bateman, Alex/H-2861-2019; Schuster-Böckler, Benjamin/H-8339-2019	Bateman, Alex/0000-0002-6982-4660; Schuster-Böckler, Benjamin/0000-0002-8892-5133	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust [grant number WT077044/Z/05/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENE ONTOLOGY ANNOTA; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; BIRCHLER JA, 1981, GENETICS, V97, P625; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; BIRCHLER JA, 1979, GENETICS, V92, P1211; BIRCHLER JA, 1981, GENETICS, V99, P247; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DEVLIN RH, 1982, P NATL ACAD SCI-BIOL, V79, P1200, DOI 10.1073/pnas.79.4.1200; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Hahn A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-112; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; ORR HA, 1991, P NATL ACAD SCI USA, V88, P11413, DOI 10.1073/pnas.88.24.11413; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Platzer P, 2002, CANCER RES, V62, P1134; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; R Development Core Team, 2006, R LANG ENV STAT COMP; REDON, CNV DATA; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Van Dongen SM, 2000, THESIS U UTRECHT NET; Veitia RA, 2005, TRENDS GENET, V21, P33, DOI 10.1016/j.tig.2004.11.002; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100; DATABASE GENETIC VAR; SEGMENTAL DUPLICATIO; GENE EXPRESSION VARI	58	69	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9474	10.1371/journal.pone.0009474	http://dx.doi.org/10.1371/journal.pone.0009474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224824	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328800001
J	Xu, PJ; Lu, ZL; Wang, XP; Dosher, B; Zhou, JN; Zhang, DR; Zhou, YF				Xu, Pengjing; Lu, Zhong-Lin; Wang, Xiaoping; Dosher, Barbara; Zhou, Jiangning; Zhang, Daren; Zhou, Yifeng			Category and Perceptual Learning in Subjects with Treated Wilson's Disease	PLOS ONE			English	Article							EXTERNAL NOISE; DISCRIMINATION; ORIENTATION; DEFICITS; SYSTEMS; IMPROVEMENT; MECHANISMS; ATTENTION; DISPLAYS; V1	To explore the relationship between category and perceptual learning, we examined both category and perceptual learning in patients with treated Wilson's disease (WD), whose basal ganglia, known to be important in category learning, were damaged by the disease. We measured their learning rate and accuracy in rule-based and information-integration category learning, and magnitudes of perceptual learning in a wide range of external noise conditions, and compared the results with those of normal controls. The WD subjects exhibited deficits in both forms of category learning and in perceptual learning in high external noise. However, their perceptual learning in low external noise was relatively spared. There was no significant correlation between the two forms of category learning, nor between perceptual learning in low external noise and either form of category learning. Perceptual learning in high external noise was, however, significantly correlated with information-integration but not with rule-based category learning. The results suggest that there may be a strong link between information-integration category learning and perceptual learning in high external noise. Damage to brain structures that are important for information-integration category learning may lead to poor perceptual learning in high external noise, yet spare perceptual learning in low external noise. Perceptual learning in high and low external noise conditions may involve separate neural substrates.	[Xu, Pengjing; Wang, Xiaoping; Zhou, Jiangning; Zhang, Daren; Zhou, Yifeng] Univ Sci & Technol China, Dept Neurobiol & Biophys, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Univ So Calif, Dept Biomed Engn, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Dosher, Barbara] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Zhou, Yifeng] Chinese Acad Sci, Inst Biophys, Visual Informat Proc Lab, Beijing 100080, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, PJ (corresponding author), Univ Sci & Technol China, Dept Neurobiol & Biophys, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	zhonglin@usc.edu	XU, PENGJING/GZM-8511-2022	Lu, Zhong-Lin/0000-0002-7295-727X; Zhou, Jiang-Ning/0000-0003-1225-2873	National Natural Science Foundation of China [30128006]; Foundation of Chinese Academy of Sciences [KSCX2-SW-217]; US National Institute of Mental Health [1 R01 MH61834]; National Science Foundation [BCS-9911801]; National Eye Institute [9 R01 EY017491]; NATIONAL EYE INSTITUTE [R01EY017491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061834] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Natural Science Foundation of China (30128006), Foundation of Chinese Academy of Sciences (KSCX2-SW-217), US National Institute of Mental Health (1 R01 MH61834), National Science Foundation (BCS-9911801), and National Eye Institute (9 R01 EY017491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; CUMMINGS JL, 1986, BRIT J PSYCHIAT, V149, P682, DOI 10.1192/bjp.149.6.682; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 2005, P NATL ACAD SCI USA, V102, P5286, DOI 10.1073/pnas.0500492102; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Dosher Barbara Anne, 2009, Learn Percept, V1, P37; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gajda J, 1994, J NEUROL S, V1, P161; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; GIBSON JJ, 1967, PRINCIPLES PERCEPTUA; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; HAWKINS RA, 1987, NEUROLOGY, V37, P1707, DOI 10.1212/WNL.37.11.1707; HINTZMAN DL, 1986, PSYCHOL REV, V93, P411, DOI 10.1037/0033-295X.93.4.411; JOANNA S, 2002, MOVEMENT DISORD, V17, P1077; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KNEHR CA, 1956, J NERV MENT DIS, V124, P251, DOI 10.1097/00005053-195609000-00005; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Lu ZL, 2006, VISION RES, V46, P2315, DOI 10.1016/j.visres.2006.01.012; Lu ZL, 2010, VISION RES, V50, P375, DOI 10.1016/j.visres.2009.08.027; Lu Zhong-Lin, 2009, Learn Percept, V1, P19; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; NOSOFSKY RM, 1984, J EXP PSYCHOL LEARN, V10, P104, DOI 10.1037/0278-7393.10.1.104; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; REBER PJ, 1994, LEARN MEMORY, V1, P217; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schacter D., 2000, OXFORD HDB MEMORY; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Smith EE, 1981, CATEGORIES CONCEPTS; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; STAROSTARUBINSTEIN S, 1987, ARCH NEUROL-CHICAGO, V44, P365, DOI 10.1001/archneur.1987.00520160007005; WALSHE JM, 1986, WILSON DIS, P223; Wilson SAK, 1911, BRAIN, V34, P295; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9635	10.1371/journal.pone.0009635	http://dx.doi.org/10.1371/journal.pone.0009635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	565XE	20224790	Green Published, gold			2022-12-27	WOS:000275328800029
J	Barlow, J; Gardner, TA; Louzada, J; Peres, CA				Barlow, Jos; Gardner, Toby A.; Louzada, Julio; Peres, Carlos A.			Measuring the Conservation Value of Tropical Primary Forests: The Effect of Occasional Species on Estimates of Biodiversity Uniqueness	PLOS ONE			English	Article							ATLANTIC FOREST; ABUNDANCE DISTRIBUTIONS; PLANTATION FORESTS; UNCERTAIN FUTURE; LAND MANAGEMENT; PATTERNS; ASSEMBLAGES; SIMILARITY; SECONDARY; RARITY	Background: Developing effective conservation plans for multi-functional landscapes requires an accurate knowledge of the relative conservation value of different land-uses. A growing number of tropical ecologists have evaluated conservation value using the number (or proportion) of species that are unique to primary or old-growth forests. However, estimates of the conservation value of modified land-uses may be inflated by the presence of occasional species (e. g. singletons and doubletons) that may be unable to exist as viable populations in isolation. Methodology/Principal Findings: We use a unique 15-taxa dataset from a mixed-use forest landscape in the Brazilian Amazon to test the hypothesis that the removal of occasional species from sample data can increase estimates of the value of primary forest for biodiversity conservation. Conclusions/Significance: Estimates of conservation value that are based on the proportion of species that are unique to tropical primary or old-growth forests are highly sensitive to decisions researchers make regarding the inclusion or exclusion of occasional species. By removing singletons from modified forest samples, and considering only those species known to occur in primary forest, we almost double estimates of the conservation value of tropical primary forests.	[Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Gardner, Toby A.; Louzada, Julio] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Gardner, Toby A.] Univ Cambridge, Dept Zool, Cambridge, England; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Lancaster University; Universidade Federal de Lavras; University of Cambridge; University of East Anglia	Barlow, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	josbarlow@gmail.com	Peres, Carlos A./ABE-8361-2020; Peres, Carlos Augusto/N-8275-2019; Barlow, Jos/E-7861-2014; Bioterra Amazonia, Inct/J-9890-2013; Louzada, Julio/F-1265-2010; Gardner, Toby/B-7516-2008; Peres, Carlos A./B-1276-2013; Barlow, Jos/HGE-9486-2022	Peres, Carlos A./0000-0002-1588-8765; Louzada, Julio/0000-0002-1481-3112; Peres, Carlos A./0000-0002-1588-8765; 	UK Darwin Initiative [162/12/014]; Center for Applied Biodiversity Science of Conservation International; Natural Environment Research Council (NERC); National Geographic Society; Conservation Food and Health Foundation; FAPEMIG [CRA-000343/07]; Instituto Nacional de Ciencia e Tecnologia-Biodiversidade e Uso da Terra na Amazonia (CNPq) [574008/2008-0]; Natural Environmental Research Council [NE/F01614X/1]; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010, NE/F01614X/1] Funding Source: researchfish; NERC [NE/F01614X/1] Funding Source: UKRI	UK Darwin Initiative; Center for Applied Biodiversity Science of Conservation International; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic Society(National Geographic Society); Conservation Food and Health Foundation; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia-Biodiversidade e Uso da Terra na Amazonia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by a UK Darwin Initiative grant 162/12/014, with additional support from the Center for Applied Biodiversity Science of Conservation International, the Natural Environment Research Council (NERC), the National Geographic Society, the Conservation Food and Health Foundation, FAPEMIG CRA-000343/07, and the Instituto Nacional de Ciencia e Tecnologia-Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0). TAG also thanks the Natural Environmental Research Council (NE/F01614X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Bennett AF, 2007, CONSERV SCI PRACT, V1, P201; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; CHAZDON RL, 2009, CONSERVATION BIOL; Clarke KR, 1994, CHANGE MARINE COMMUN; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; DENT DH, BIOL CONSER IN PRESS; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Drake P, 1999, SCI TOTAL ENVIRON, V242, P271, DOI 10.1016/S0048-9697(99)00395-2; Duffy-Anderson JT, 2006, FISH OCEANOGR, V15, P80, DOI 10.1111/j.1365-2419.2005.00348.x; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Faria D, 2007, BIODIVERS CONSERV, V16, P2335, DOI 10.1007/s10531-007-9189-z; FERRIER S, USING GEN DISSIMILAR, P252; GARDNER TA, 2008, ECOLOGY LETT, V11; GARDNER TA, 2008, UNDERSTANDING CONSEQ; Gardner TA, 2007, BIOTROPICA, V39, P25, DOI 10.1111/j.1744-7429.2006.00228.x; Gaston K.J., 1994, RARITY, P1; Goerck JM, 1997, CONSERV BIOL, V11, P112, DOI 10.1046/j.1523-1739.1997.95314.x; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Marchese MR, 2005, RIVER RES APPL, V21, P485, DOI 10.1002/rra.814; Meijaard E, 2007, BIODIVERS CONSERV, V16, P3053, DOI 10.1007/s10531-007-9161-y; Norris K, 2008, CONSERV LETT, V1, P2, DOI 10.1111/j.1755-263X.2008.00007.x; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Pilgrim ES, 2004, BIOL CONSERV, V120, P161, DOI 10.1016/j.biocon.2004.02.008; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Possingham HP, 2007, CONSERV SCI PRACT, V1, P546, DOI 10.1002/9780470692400.ch45; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Sodhi NS, 2008, BASIC APPL ECOL, V9, P93, DOI 10.1016/j.baae.2007.11.001; TERBORGH J, 1969, Ecology (Washington D C), V50, P765, DOI 10.2307/1933691; Ulrich W, 2004, DIVERS DISTRIB, V10, P263, DOI 10.1111/j.1366-9516.2004.00082.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Wright SJ, 2006, BIOTROPICA, V38, P443, DOI 10.1111/j.1744-7429.2006.00177.x	38	55	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9609	10.1371/journal.pone.0009609	http://dx.doi.org/10.1371/journal.pone.0009609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231897	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000275328300021
J	Everaerts, C; Farine, JP; Cobb, M; Ferveur, JF				Everaerts, Claude; Farine, Jean-Pierre; Cobb, Matthew; Ferveur, Jean-Francois			Drosophila Cuticular Hydrocarbons Revisited: Mating Status Alters Cuticular Profiles	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; CONTACT SEX-PHEROMONE; CIS-VACCENYL ACETATE; COURTSHIP BEHAVIOR; CHEMICAL COMMUNICATION; MELANOGASTER; IDENTIFICATION; PERCEPTION; QUEENS; BIOSYNTHESIS	Most living organisms use pheromones for inter-individual communication. In Drosophila melanogaster flies, several pheromones perceived either by contact/at a short distance (cuticular hydrocarbons, CHs), or at a longer distance (cis-vaccenyl acetate, cVA), affect courtship and mating behaviours. However, it has not previously been possible to precisely identify all potential pheromonal compounds and simultaneously monitor their variation on a time scale. To overcome this limitation, we combined Solid Phase Micro-Extraction with gas-chromatography coupled with mass-spectrometry. This allowed us (i) to identify 59 cuticular compounds, including 17 new CHs; (ii) to precisely quantify the amount of each compound that could be detected by another fly, and (iii) to measure the variation of these substances as a function of aging and mating. Sex-specific variation appeared with age, while mating affected cuticular compounds in both sexes with three possible patterns: variation was (i) reciprocal in the two sexes, suggesting a passive mechanical transfer during mating, (ii) parallel in both sexes, such as for cVA which strikingly appeared during mating, or (iii) unilateral, presumably as a result of sexual interaction. We provide a complete reassessment of all Drosophila CHs and suggest that the chemical conversation between male and female flies is far more complex than is generally accepted. We conclude that focusing on individual compounds will not provide a satisfactory understanding of the evolution and function of chemical communication in Drosophila.	[Everaerts, Claude; Farine, Jean-Pierre; Ferveur, Jean-Francois] Univ Bourgogne, INRA, CNRS, Ctr Sci Gout & Alimentat,UMR 6265,UMR 1324, Dijon, France; [Cobb, Matthew] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Manchester	Everaerts, C (corresponding author), Univ Bourgogne, INRA, CNRS, Ctr Sci Gout & Alimentat,UMR 6265,UMR 1324, Dijon, France.	Claude.Everaerts@u-bourgogne.fr		Cobb, Matthew/0000-0002-8258-4913	CNRS; Burgundy Regional Council; ANR (INSAVEL)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR))	This work was partly funded by grants from the CNRS, Burgundy Regional Council, and ANR (INSAVEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2007, XLSTAT 2007 DAT AN S; [Anonymous], 2014, PHEROMONES ANIMAL BE; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Augusto F, 2002, TRAC-TREND ANAL CHEM, V21, P428, DOI 10.1016/S0165-9936(02)00602-7; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Bland JM, 2001, J CHROMATOGR A, V932, P119, DOI 10.1016/S0021-9673(01)01239-0; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Chertemps T, 2006, INSECT MOL BIOL, V15, P465, DOI 10.1111/j.1365-2583.2006.00658.x; Cobb M, 1995, BEHAV PROCESS, V35, P35, DOI 10.1016/0376-6357(95)00052-6; Cochran WG., 1963, SAMPLING TECHNIQUES; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Foley B, 2007, GENETICS, V175, P1465, DOI 10.1534/genetics.106.065771; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Ginzel MD, 2006, J CHEM ECOL, V32, P435, DOI 10.1007/s10886-005-9010-y; Ginzel MD, 2003, CHEMOECOLOGY, V13, P135, DOI 10.1007/s00049-003-0239-z; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Kent C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000962; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Moneti G, 1997, RAPID COMMUN MASS SP, V11, P857; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; PECHINE JM, 1988, J CHEM ECOL, V14, P1071, DOI 10.1007/BF01019336; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Roux E, 2002, J CHEM ECOL, V28, P1221, DOI 10.1023/A:1016237918662; Said I, 2005, J INSECT PHYSIOL, V51, P1384, DOI 10.1016/j.jinsphys.2005.09.001; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; SCOTT D, 1986, P NATL ACAD SCI USA, V83, P8429, DOI 10.1073/pnas.83.21.8429; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Sledge MF, 2001, P ROY SOC B-BIOL SCI, V268, P2253, DOI 10.1098/rspb.2001.1799; Sledge MF, 2000, J CHROMATOGR A, V873, P73, DOI 10.1016/S0021-9673(99)01176-0; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Starostina E, 2009, J BIOL CHEM, V284, P585, DOI 10.1074/jbc.M806474200; Subchev M, 2001, ARCH INSECT BIOCHEM, V47, P35, DOI 10.1002/arch.1033; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; TEAL PEA, 1988, J CHEM ECOL, V14, P2131, DOI 10.1007/BF01014254; Tentschert J, 2001, NATURWISSENSCHAFTEN, V88, P175, DOI 10.1007/s001140100218; Theodoridis G, 2000, J CHROMATOGR B, V745, P49, DOI 10.1016/S0378-4347(00)00203-6; TOMPKINS L, 1983, GENETICS, V103, P179; Turillazzi S, 1998, ETHOL ECOL EVOL, V10, P293, DOI 10.1080/08927014.1998.9522859; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Yew JY, 2008, P NATL ACAD SCI USA, V105, P7135, DOI 10.1073/pnas.0802692105; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	63	201	201	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9607	10.1371/journal.pone.0009607	http://dx.doi.org/10.1371/journal.pone.0009607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231905	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328300020
J	Kedar, VP; Darby, MK; Williams, JG; Blackshear, PJ				Kedar, Vishram P.; Darby, Martyn K.; Williams, Jason G.; Blackshear, Perry J.			Phosphorylation of Human Tristetraprolin in Response to Its Interaction with the CbI Interacting Protein CIN85	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA DECAY; ZINC-FINGER PROTEINS; GROWTH-FACTOR RECEPTORS; MAP KINASE PATHWAY; AU-RICH ELEMENTS; DOWN-REGULATION; TRANSCRIPTION FACTOR; DEFICIENCY SYNDROME; SIGNALING PATHWAY	Background: Tristetraprolin (TTP) is the prototype member of a family of CCCH tandem zinc finger proteins and is considered to be an anti-inflammatory protein in mammals. TTP plays a critical role in the decay of tumor necrosis factor alpha (TNF) mRNA, among others, by binding AU-rich RNA elements in the 3'-untranslated regions of this transcript and promoting its deadenylation and degradation. Methodology/Principal Findings: We used yeast two-hybrid analysis to identify potential protein binding partners for human TTP (hTTP). Various regions of hTTP recovered 31 proteins that fell into 12 categories based on sequence similarities. Among these, the interactions between hTTP and CIN85, cytoplasmic poly (A) binding protein (PABP), nucleolin and heat shock protein 70 were confirmed by co-immunoprecipitation experiments. CIN85 and hTTP co-localized in the cytoplasm of cells as determined by confocal microscopy. CIN85 contains three SH3 domains that specifically bind a unique proline-arginine motif (PXXXPR) found in several CIN85 effectors. We found that the SH3 domains of CIN85 bound to a PXXXPR motif located near the C-terminus of hTTP. Co-expression of CIN85 with hTTP resulted in the increased phosphorylation of hTTP at serine residues in positions 66 and 93, possibly due in part to the demonstrated association of mitogen-activated protein kinase kinase kinase 4 (MEKK4) to both proteins. The presence of CIN85 did not appear to alter hTTP's binding to RNA probes or its stimulated breakdown of TNF mRNA. Conclusions/Significance: These studies describe interactions between hTTP and nucleolin, cytoplasmic PABP, heat shock protein 70 and CIN85; these interactions were initially discovered by two-hybrid analysis, and confirmed by coimmunoprecipitation. We found that CIN85 binding to a C-terminal motif within hTTP led to the increased phosphorylation of hTTP, possibly through enhanced association with MEKK4. The functional consequences to each of the members of this putative complex remain to be determined.	[Kedar, Vishram P.; Darby, Martyn K.; Blackshear, Perry J.] Natl Inst Environm Hlth Sci, Lab Signal Transduct, Res Triangle Pk, NC USA; [Williams, Jason G.] Natl Inst Environm Hlth Sci, Prot Microcharacterizat Core Facil, Res Triangle Pk, NC USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Kedar, VP (corresponding author), Natl Inst Environm Hlth Sci, Lab Signal Transduct, Res Triangle Pk, NC USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NIH; NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102488, ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was entirely supported by the Intramural Research Program of the NIH, NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Aissouni Y, 2005, BIOCHEM BIOPH RES CO, V338, P808, DOI 10.1016/j.bbrc.2005.10.032; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bettinger BT, 2007, J CELL BIOCHEM, V101, P34, DOI 10.1002/jcb.21289; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; DeGrado-Warren J, 2008, BIOTECHNIQUES, V44, P265, DOI 10.2144/000112674; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; FREDERICK ED, 2008, J BIOL CHEM; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Ginisty H, 1999, J CELL SCI, V112, P761; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Horner TJ, 2009, MOL CELL BIOL, V29, P1999, DOI 10.1128/MCB.00982-08; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Laroia G, 2002, P NATL ACAD SCI USA, V99, P1842, DOI 10.1073/pnas.042575699; LISCHWE MA, 1981, EXP CELL RES, V136, P101, DOI 10.1016/0014-4827(81)90041-0; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Narita T, 2005, EXP CELL RES, V304, P256, DOI 10.1016/j.yexcr.2004.11.005; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	78	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A213	A227	e9588	10.1371/journal.pone.0009588	http://dx.doi.org/10.1371/journal.pone.0009588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221403	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328200020
J	Morita, M; Morokami, S; Morita, H				Morita, Masahiko; Morokami, Shigemitsu; Morita, Hiromi			Attribute Pair-Based Visual Recognition and Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; BINDING PROBLEM; FEATURE-INTEGRATION; BINOCULAR-RIVALRY; OBJECT; ATTENTION; HYPOTHESIS; CAPACITY; INFORMATION; NEURONS	Background: In the human visual system, different attributes of an object, such as shape, color, and motion, are processed separately in different areas of the brain. This raises a fundamental question of how are these attributes integrated to produce a unified perception and a specific response. This "binding problem'' is computationally difficult because all attributes are assumed to be bound together to form a single object representation. However, there is no firm evidence to confirm that such representations exist for general objects. Methodology/Principal Findings: Here we propose a paired-attribute model in which cognitive processes are based on multiple representations of paired attributes. In line with the model's prediction, we found that multiattribute stimuli can produce an illusory perception of a multiattribute object arising from erroneous integration of attribute pairs, implying that object recognition is based on parallel perception of paired attributes. Moreover, in a change-detection task, a feature change in a single attribute frequently caused an illusory perception of change in another attribute, suggesting that multiple pairs of attributes are stored in memory. Conclusions/Significance: The paired-attribute model can account for some novel illusions and controversial findings on binocular rivalry and short-term memory. Our results suggest that many cognitive processes are performed at the level of paired attributes rather than integrated objects, which greatly facilitates the binding problem and provides simpler solutions for it.	[Morita, Masahiko] Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Intelligent Interact Technol, Tsukuba, Ibaraki, Japan; [Morokami, Shigemitsu] Aichi Shukutoku Univ, Fac Letters, Aichi, Japan; [Morita, Hiromi] Univ Tsukuba, Grad Sch Lib Informat & Media Studies, Tsukuba, Ibaraki, Japan	University of Tsukuba; Aichi Shukutoku University; University of Tsukuba	Morita, M (corresponding author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Intelligent Interact Technol, Tsukuba, Ibaraki, Japan.	mor@bcl.esys.tsukuba.ac.jp	Morita, Masahiko/R-6324-2019	Morita, Hiromi/0000-0003-4571-7315	Japan Society for the Promotion of Science [19650059]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21013007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research for Challenging Exploratory Research (19650059) from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research on Priority Areas (21013007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Bonneh Y, 2001, VISION RES, V41, P981, DOI 10.1016/S0042-6989(01)00013-X; Davis G, 2005, MEM COGNITION, V33, P185, DOI 10.3758/BF03195307; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MCLEAN JP, 1983, Q J EXP PSYCHOL-A, V35, P171, DOI 10.1080/14640748308402123; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Olson IR, 2002, PERCEPT PSYCHOPHYS, V64, P1055, DOI 10.3758/BF03194756; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SUEMITSU A, 2006, P IJCNN 06, P293; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treisman A, 1999, NEURON, V24, P105, DOI 10.1016/S0896-6273(00)80826-0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; von der Malsburg C., 1994, MODELS NEURAL NETWOR, P95, DOI [DOI 10.1007/978-1-4612-4320-5_2, 10.1007/978-1-4612-4320-5_2]; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9571	10.1371/journal.pone.0009571	http://dx.doi.org/10.1371/journal.pone.0009571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	564EX	20221425	Green Published, gold			2022-12-27	WOS:000275197200017
J	Tocchetti, A; Soppo, CBE; Zani, F; Bianchi, F; Gagliani, MC; Pozzi, B; Rozman, J; Elvert, R; Ehrhardt, N; Rathkolb, B; Moerth, C; Horsch, M; Fuchs, H; Gailus-Durner, V; Beckers, J; Klingenspor, M; Wolf, E; de Angelis, MH; Scanziani, E; Tacchetti, C; Scita, G; Di Fiore, PP; Offenhauser, N				Tocchetti, Arianna; Soppo, Charlotte Blanche Ekalle; Zani, Fabio; Bianchi, Fabrizio; Gagliani, Maria Cristina; Pozzi, Benedetta; Rozman, Jan; Elvert, Ralf; Ehrhardt, Nicole; Rathkolb, Birgit; Moerth, Corinna; Horsch, Marion; Fuchs, Helmut; Gailus-Durner, Valerie; Beckers, Johannes; Klingenspor, Martin; Wolf, Eckhard; de Angelis, Martin Hrabe; Scanziani, Eugenio; Tacchetti, Carlo; Scita, Giorgio; Di Fiore, Pier Paolo; Offenhaeuser, Nina			Loss of the Actin Remodeler Eps8 Causes Intestinal Defects and Improved Metabolic Status in Mice	PLOS ONE			English	Article							MECHANISMS LINKING OBESITY; ADIPOSE-TISSUE; MICROARRAY DATA; CARDIOVASCULAR-DISEASE; CALORIE RESTRICTION; DIETARY RESTRICTION; BODY-TEMPERATURE; INSULIN-RECEPTOR; BRUSH-BORDER; LIFE-SPAN	Background: In a variety of organisms, including mammals, caloric restriction improves metabolic status and lowers the incidence of chronic-degenerative diseases, ultimately leading to increased lifespan. Methodology/Principal Findings: Here we show that knockout mice for Eps8, a regulator of actin dynamics, display reduced body weight, partial resistance to age-or diet-induced obesity, and overall improved metabolic status. Alteration in the liver gene expression profile, in behavior and metabolism point to a calorie restriction-like phenotype in Eps8 knockout mice. Additionally, and consistent with a calorie restricted metabolism, Eps8 knockout mice show increased lifespan. The metabolic alterations in Eps8 knockout mice correlated with a significant reduction in intestinal fat absorption presumably caused by a 25% reduction in intestinal microvilli length. Conclusions/Significance: Our findings implicate actin dynamics as a novel variable in the determination of longevity. Additionally, our observations suggest that subtle differences in energy balance can, over time, significantly affect bodyweight and metabolic status in mice.	[Tocchetti, Arianna; Soppo, Charlotte Blanche Ekalle; Zani, Fabio; Bianchi, Fabrizio; Gagliani, Maria Cristina; Pozzi, Benedetta; Tacchetti, Carlo; Scita, Giorgio; Di Fiore, Pier Paolo; Offenhaeuser, Nina] Fdn Inst FIRC Oncol Mol, Milan, Italy; [Bianchi, Fabrizio; Scita, Giorgio; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg Odontoiatria, Milan, Italy; [Gagliani, Maria Cristina; Tacchetti, Carlo] Univ Genoa, Dept Expt Med, Genoa, Italy; [Rozman, Jan; Elvert, Ralf; Ehrhardt, Nicole; Rathkolb, Birgit; Moerth, Corinna; Horsch, Marion; Fuchs, Helmut; Gailus-Durner, Valerie; Beckers, Johannes; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Munich, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, D-8050 Freising Weihenstephan, Germany; [Rathkolb, Birgit; Moerth, Corinna; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Scanziani, Eugenio] Univ Milan, Fac Med Vet, Milan, Italy; [Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Genoa; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Milan; IRCCS European Institute of Oncology (IEO)	Tocchetti, A (corresponding author), KtedoGen Srl, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; nina.offenhauser@ifom-ieo-campus.it	Rathkolb, Birgit/F-7041-2013; Gailus-Durner, Valerie/M-7337-2014; Di Fiore, Pier Paolo/K-2130-2012; Bianchi, Fabrizio/B-5995-2017; Beckers, Johannes/K-7237-2012; Klingenspor, Martin/K-5033-2019; Soppo, Charlotte Blanche Ekalle/ABI-1362-2020; Klingenspor, Martin/D-6930-2011; Scita, Giorgio/J-9670-2012; Bianchi, Fabrizio/W-7037-2019; Rozman, Jan/A-2540-2010; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Scanziani, Eugenio/G-8046-2017	Di Fiore, Pier Paolo/0000-0002-2252-0950; Bianchi, Fabrizio/0000-0001-7412-8638; Beckers, Johannes/0000-0001-7874-3822; Klingenspor, Martin/0000-0002-4502-6664; Bianchi, Fabrizio/0000-0001-7412-8638; Rozman, Jan/0000-0002-8035-8904; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Scita, Giorgio/0000-0001-7984-1889; TACCHETTI, CARLO/0000-0003-4602-000X; Scanziani, Eugenio/0000-0003-3996-5048; gagliani, maria cristina/0000-0002-2902-2719; Offenhauser, Nina/0000-0002-3316-3047; Wolf, Eckhard/0000-0002-0430-9510; Tocchetti, Arianna/0000-0001-7004-7582	Associazione Italiana per la Ricerca sul Cancro [4874]; European Community; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Cariplo Foundation; Ferrari Foundation; Monzino Foundation; Bundesministerium fuer Bildung und Forschung [01GS0869, 01GS0851, 01GS0850];  [LSHG-2006-037188]	Associazione Italiana per la Ricerca sul Cancro; European Community; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Cariplo Foundation; Ferrari Foundation; Monzino Foundation; Bundesministerium fuer Bildung und Forschung; 	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro to PPDF, NO (4874) and GS (http://www.airc.it/); the European Community (VI Framework) to PPDF and LSHG-2006-037188 to the German Mouse Clinic (http://ec.europa.eu/grants/index_en.htm); the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to PPDF and GS (http://www.miur.it/DefaultDesktop.aspx); the Cariplo Foundation to PPDF and NO (http://www.fondazionecariplo.it/portal/page148a.do&link=oln643a.redirect&seu311a.oid.set=26); the Ferrari Foundation and the Monzino Foundation to PPDF; the Bundesministerium fuer Bildung und Forschung to MK (01GS0869), EW (01GS0851), and to JB and MHA (01GS0850) (http://www.bmbf.de/de/99.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Arellano C, 2004, J CHROMATOGR B, V807, P263, DOI 10.1016/j.jchromb.2004.04.015; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chu G., 2002, SAM SIGNIFICANCE ANA; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Duivenvoorden I, 2006, AM J CLIN NUTR, V84, P312; Ferguson M, 2007, MECH AGEING DEV, V128, P539, DOI 10.1016/j.mad.2007.07.005; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Grimm-Gunter EMS, 2009, MOL BIOL CELL, V20, P2549, DOI 10.1091/mbc.E08-10-1030; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016; HERTZOG M, 2009, DEADLY EMBRACE UNPUB; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Pohjanvirta R, 2008, TOXICOL APPL PHARM, V230, P41, DOI 10.1016/j.taap.2008.02.002; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; QUARRIE JK, 2004, SCI AGING KNOWLEDGE, pRE5; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Selman C, 2005, MECH AGEING DEV, V126, P783, DOI 10.1016/j.mad.2005.02.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	48	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9468	10.1371/journal.pone.0009468	http://dx.doi.org/10.1371/journal.pone.0009468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209148	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063300003
J	Genesca, M; McChesney, MB; Miller, CJ				Genesca, Meritxell; McChesney, Michael B.; Miller, Christopher J.			Depo-Provera (R) Treatment Does Not Abrogate Protection from Intravenous SIV Challenge in Female Macaques Immunized with an Attenuated AIDS Virus	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS-INDUCED PROTECTION; RHESUS MACAQUES; PATHOGENIC SIVMAC239; INTRAVAGINAL CHALLENGE; DISEASE PROGRESSION; VAGINAL CHALLENGE; VIRAL REPLICATION; SEX-HORMONES; DEPO-PROVERA	Background: In a previous study, progesterone treatment of female monkeys immunized with live, attenuated SHIV89.6 abrogated the generally consistent protection from vaginal simian immunodeficiency virus (SIV) challenge. The mechanisms responsible for the loss of protection remain to be defined. The objective of the present study was to determine whether Depo-Provera (R) administration alters protection from intravenous SIV challenge in SHIV-immunized female macaques. Methods and Findings: Two groups of female macaques were immunized with attenuated SHIV89.6 and then challenged intravenously with SIVmac239. Four weeks before challenge, one animal group was treated with Depo-Provera (R), a commonly used injectable contraceptive progestin. As expected, SHIV-immunized monkeys had significantly lower peak and set-point plasma viral RNA levels compared to naive controls, but in contrast to previously published findings with vaginal SIV challenge, the Depo-Provera (R) SHIV-immunized animals controlled SIV replication to a similar, or even slightly greater, degree than did the untreated SHIV-immunized animals. Control of viral replication from week 4 to week 20 after challenge was more consistent in the progesterone-treated, SHIV-immunized animals than in untreated, SHIV-immunized animals. Although levels of interferon-gamma production were similar, the SIV-specific CD8(+) T cells of progesterone-treated animals expressed more functions than the anti-viral CD8(+) T cells from untreated animals. Conclusions: Depo-Provera (R) did not diminish the control of viral replication after intravenous SIV challenge in female macaques immunized with a live-attenuated lentivirus. This result contrasts with the previously reported effect of DepoProvera (R) on protection from vaginal SIV challenge and strongly implies that the decreased protection from vaginal challenge is due to effects of progesterone on the genital tract rather than to systemic effects. Further, these results demonstrate that the effects of hormonal contraceptives on vaccine efficacy need to be considered in the context of testing and use of an AIDS vaccine.	[Genesca, Meritxell; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Genesca, Meritxell; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Med, Div Infect Dis, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Genesca, M (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Genescà, Meritxell/AFT-2336-2022	Genescà, Meritxell/0000-0001-6413-3812	National Institutes of Health (NIH) [RR00169, AI066314, AI44480]; James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044480, P01AI066314] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants RR00169, AI066314, AI44480 and a gift from the James B. Pendleton Charitable Trust. These agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed are solely those of the authors.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Asin SN, 2008, AIDS RES HUM RETROV, V24, P701, DOI 10.1089/aid.2007.0108; Baeten JM, 2007, CLIN INFECT DIS, V45, P360, DOI 10.1086/519432; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Bulterys M, 2007, AIDS, V21, P97, DOI 10.1097/QAD.0b013e3280117cb5; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Genesca M, 2007, J MED PRIMATOL, V36, P266, DOI 10.1111/j.1600-0684.2007.00244.x; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Liang J, 2006, INT IMMUNOPHARMACOL, V6, P830, DOI 10.1016/j.intimp.2005.12.002; MANNEL DN, 1990, IMMUNOL LETT, V26, P89, DOI 10.1016/0165-2478(90)90181-O; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Mauck C, 2005, JAIDS-J ACQ IMM DEF, V38, pS11, DOI 10.1097/01.qai.0000167026.95406.93; McChesney MB, 1998, J VIROL, V72, P10029, DOI 10.1128/JVI.72.12.10029-10035.1998; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Munoz LDA, 2007, J INFECT DIS, V195, P1294, DOI 10.1086/513434; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Pantaleo G, 2008, LANCET INFECT DIS, V8, P82, DOI 10.1016/S1473-3099(07)70266-9; Stone M, 2009, VIROLOGY, V392, P260, DOI 10.1016/j.virol.2009.06.052; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	27	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9814	10.1371/journal.pone.0009814	http://dx.doi.org/10.1371/journal.pone.0009814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352116	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400016
J	Latifi-Navid, S; Ghorashi, SA; Siavoshi, F; Linz, B; Massarrat, S; Khegay, T; Salmanian, AH; Shayesteh, AA; Masoodi, M; Ghanadi, K; Ganji, A; Suerbaum, S; Achtman, M; Malekzadeh, R; Falush, D				Latifi-Navid, Saeid; Ghorashi, Seyed Ali; Siavoshi, Farideh; Linz, Bodo; Massarrat, Sadegh; Khegay, Tanya; Salmanian, Ali-Hatef; Shayesteh, Ali Akbar; Masoodi, Mohsen; Ghanadi, Koroush; Ganji, Azita; Suerbaum, Sebastian; Achtman, Mark; Malekzadeh, Reza; Falush, Daniel			Ethnic and Geographic Differentiation of Helicobacter pylori within Iran	PLOS ONE			English	Article							RECOMBINATION; POPULATIONS; PREVALENCE; INFERENCE; HUMANS	The bacterium Helicobacter pylori colonizes the human stomach, with individual infections persisting for decades. The spread of the bacterium has been shown to reflect both ancient and recent human migrations. We have sequenced housekeeping genes from H. pylori isolated from 147 Iranians with well-characterized geographical and ethnic origins sampled throughout Iran and compared them with sequences from strains from other locations. H. pylori from Iran are similar to others isolated from Western Eurasia and can be placed in the previously described HpEurope population. Despite the location of Iran at the crossroads of Eurasia, we found no evidence that the region been a major source of ancestry for strains across the continent. On a smaller scale, we found genetic affinities between the H. pylori isolated from particular Iranian populations and strains from Turks, Uzbeks, Palestinians and Israelis, reflecting documented historical contacts over the past two thousand years.	[Latifi-Navid, Saeid; Ghorashi, Seyed Ali] Natl Inst Genet Engn & Biotechnol, Dept Bacteriol & Virol, Tehran, Iran; [Latifi-Navid, Saeid; Massarrat, Sadegh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Siavoshi, Farideh] Univ Tehran, Coll Sci, Sch Biol, Dept Microbiol, Tehran, Iran; [Linz, Bodo] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Khegay, Tanya] Uzbek Acad Sci, Inst Immunol, Tashkent 700135, Uzbekistan; [Salmanian, Ali-Hatef] Natl Inst Genet Engn & Biotechnol, Dept Plant Mol Biol, Tehran, Iran; [Shayesteh, Ali Akbar] Ahvaz Jundishapur Univ Med Sci, Imam Khomeini Hosp, Dept Internal Med, Ahvaz, Iran; [Masoodi, Mohsen] Iran Univ Med Sci, GILDRC, Dept Internal Med, Tehran, Iran; [Masoodi, Mohsen] Hormozgan Univ Med Sci, Trop & Infect Dis Res Ctr, Bandar Abbas, Iran; [Ghanadi, Koroush] Lorestan Univ Med Sci, Khorramabad, Iran; [Ganji, Azita] MUMS, Imam Reza Hosp, Dept Gastroenterol, Mashhad, Iran; [Suerbaum, Sebastian] Hannover Med Sch, Inst Med Mikrobiol, D-30623 Hannover, Germany; [Suerbaum, Sebastian] Krankenhaushyg, Hannover, Germany; [Achtman, Mark; Falush, Daniel] Univ Coll Cork, Environm Res Inst, Dept Microbiol, Cork, Ireland	Tehran University of Medical Sciences; University of Tehran; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Academy of Sciences of Uzbekistan; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Iran University of Medical Sciences; Lorestan University of Medical Sciences; Mashhad University Medical Science; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University College Cork	Latifi-Navid, S (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Bacteriol & Virol, Tehran, Iran.	D.Falush@ucc.ie	shayesteh, ali akbar/R-1791-2017; ghanadi, kourosh/P-2513-2016; Masoodi, Mohsen/AAM-6102-2020; Ghorashi, Seyed A/C-1529-2016; Ganji, Azita/AAW-7769-2020; salmanian, ali hatef/ABC-6202-2021; Malekzadeh, Reza/U-1382-2017; Guttman, David S/A-7839-2011; Latifi-Navid, Saeid/Q-1680-2016	shayesteh, ali akbar/0000-0002-7636-1369; ghanadi, kourosh/0000-0002-0990-9590; Masoodi, Mohsen/0000-0001-8471-9220; Ghorashi, Seyed A/0000-0002-9820-5308; Ganji, Azita/0000-0002-8161-6629; salmanian, ali hatef/0000-0002-9984-7441; Malekzadeh, Reza/0000-0002-9820-6335; Guttman, David S/0000-0001-8479-3869; Latifi-Navid, Saeid/0000-0002-6838-9425; Achtman, Mark/0000-0001-6815-0070; Hegay, Tatyana/0000-0003-4764-0841; Malekzadeh, Reza/0000-0003-1043-3814	research council of Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences [301/166]; Science Foundation of Ireland [05/FE1/B882]; Volkswagen Foundation	research council of Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences(Tehran University of Medical Sciences); Science Foundation of Ireland(Science Foundation Ireland); Volkswagen Foundation(Volkswagen)	This study was funded by the research council of Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences grant 301/166 and by Science Foundation of Ireland grant 05/FE1/B882 and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Jackson Peter, 1986, CAMBRIDGE HIST IRAN; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu YZ, 2002, APPL ENVIRON MICROB, V68, P1436, DOI 10.1128/AEM.68.3.1436-1439.2002; Malekzadeh R, 2004, J CLIN PATHOL, V57, P37, DOI 10.1136/jcp.57.1.37; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; MASSARRAT S, 1995, EUR J GASTROEN HEPAT, V7, P427; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; MORONY M, 2006, CTR IRANIAN STUDIES; Nasidze I, 2008, ANN HUM GENET, V72, P241, DOI 10.1111/j.1469-1809.2007.00413.x; Nouraie M, 2009, HELICOBACTER, V14, P40, DOI 10.1111/j.1523-5378.2009.00657.x; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; SAVORY RM, 1980, IRAN UNDER SAFAVIDS; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101	26	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9645	10.1371/journal.pone.0009645	http://dx.doi.org/10.1371/journal.pone.0009645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339588	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894300001
J	Middelbos, IS; Boler, BMV; Qu, A; White, BA; Swanson, KS; Fahey, GC				Middelbos, Ingmar S.; Boler, Brittany M. Vester; Qu, Ani; White, Bryan A.; Swanson, Kelly S.; Fahey, George C., Jr.			Phylogenetic Characterization of Fecal Microbial Communities of Dogs Fed Diets with or without Supplemental Dietary Fiber Using 454 Pyrosequencing	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SMALL-INTESTINE; GUT MICROBIOME; DIVERSITY; OBESITY; METAGENOMICS; POPULATIONS; IMBALANCES; DIGESTA; ENERGY	Background: Dogs suffer from many of the same maladies as humans that may be affected by the gut microbiome, but knowledge of the canine microbiome is incomplete. This work aimed to use 16S rDNA tag pyrosequencing to phylogenetically characterize hindgut microbiome in dogs and determine how consumption of dietary fiber affects community structure. Principal Findings: Six healthy adult dogs were used in a crossover design. A control diet without supplemental fiber and a beet pulp-supplemented (7.5%) diet were fed. Fecal DNA was extracted and the V3 hypervariable region of the microbial 16S rDNA gene amplified using primers suitable for 454-pyrosequencing. Microbial diversity was assessed on random 2000-sequence subsamples of individual and pooled DNA samples by diet. Our dataset comprised 77,771 reads with an average length of 141 nt. Individual samples contained approximately 129 OTU, with Fusobacteria (23-40% of reads), Firmicutes (14 -28% of reads) and Bacteroidetes (31-34% of reads) being co- dominant phyla. Feeding dietary fiber generally decreased Fusobacteria and increased Firmicutes, but these changes were not equally apparent in all dogs. UniFrac analysis revealed that structure of the gut microbiome was affected by diet and Firmicutes appeared to play a strong role in by-diet clustering. Conclusions: Our data suggest three co- dominant bacterial phyla in the canine hindgut. Furthermore, a relatively small amount of dietary fiber changed the structure of the gut microbiome detectably. Our data are among the first to characterize the healthy canine gut microbiome using pyrosequencing and provide a basis for studies focused on devising dietary interventions for microbiome-associated diseases.	[Middelbos, Ingmar S.; Boler, Brittany M. Vester; Qu, Ani; White, Bryan A.; Swanson, Kelly S.; Fahey, George C., Jr.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [White, Bryan A.; Swanson, Kelly S.; Fahey, George C., Jr.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Qu, Ani; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Middelbos, IS (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	gcfahey@illinois.edu		Swanson, Kelly/0000-0001-5518-3076	Illinois Agricultural Experiment Station	Illinois Agricultural Experiment Station	This work was funded by the Illinois Agricultural Experiment Station (http://home.aces.uiuc.edu/ACES_Research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; DAVIS CP, 1977, APPL ENVIRON MICROB, V34, P194, DOI 10.1128/AEM.34.2.194-206.1977; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAHEY GC, 1990, J ANIM SCI, V68, P4221; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; SUCHODOLSKI JS, 2005, THESIS TEXAS A M U C; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YQ, 2009, AUTOMAT SOFTW ENG, V16, P3, DOI 10.1007/s10515-008-0042-8; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	44	169	176	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9768	10.1371/journal.pone.0009768	http://dx.doi.org/10.1371/journal.pone.0009768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339542	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894300012
J	Vellutini, BC; Migotto, AE				Vellutini, Bruno C.; Migotto, Alvaro E.			Embryonic, Larval, and Juvenile Development of the Sea Biscuit Clypeaster subdepressus (Echinodermata: Clypeasteroida)	PLOS ONE			English	Article							SAND DOLLAR; ECHINOIDS; EVOLUTION; URCHIN; METAMORPHOSIS; GASTRULATION; ORIGIN; PERIOD	Sea biscuits and sand dollars diverged from other irregular echinoids approximately 55 million years ago and rapidly dispersed to oceans worldwide. A series of morphological changes were associated with the occupation of sand beds such as flattening of the body, shortening of primary spines, multiplication of podia, and retention of the lantern of Aristotle into adulthood. To investigate the developmental basis of such morphological changes we documented the ontogeny of Clypeaster subdepressus. We obtained gametes from adult specimens by KCl injection and raised the embryos at 26 degrees C. Ciliated blastulae hatched 7.5 h after sperm entry. During gastrulation the archenteron elongated continuously while ectodermal red-pigmented cells migrated synchronously to the apical plate. Pluteus larvae began to feed in 3 d and were similar to 20 d old at metamorphosis; starved larvae died 17 d after fertilization. Postlarval juveniles had neither mouth nor anus nor plates on the aboral side, except for the remnants of larval spicules, but their bilateral symmetry became evident after the resorption of larval tissues. Ossicles of the lantern were present and organized in 5 groups. Each group had 1 tooth, 2 demipyramids, and 2 epiphyses with a rotula in between. Early appendages consisted of 15 spines, 15 podia (2 types), and 5 sphaeridia. Podial types were distributed in accordance to Loven's rule and the first podium of each ambulacrum was not encircled by the skeleton. Seven days after metamorphosis juveniles began to feed by rasping sand grains with the lantern. Juveniles survived in laboratory cultures for similar to 9 months and died with <500 mu m wide, a single open sphaeridium per ambulacrum, aboral anus, and no differentiated food grooves or petaloids. Tracking the morphogenesis of early juveniles is a necessary step to elucidate the developmental mechanisms of echinoid growth and important groundwork to clarify homologies between irregular urchins.	[Vellutini, Bruno C.; Migotto, Alvaro E.] Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil; [Vellutini, Bruno C.; Migotto, Alvaro E.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Vellutini, BC (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil.	organelas@gmail.com	Migotto, Alvaro E/D-3748-2011; Vellutini, Bruno C./H-3831-2019	Migotto, Alvaro E/0000-0003-3887-1947; Vellutini, Bruno C./0000-0002-0000-9465	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/01898-7]; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [305608/2006-1]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Master's degree scholarship to BCV funded by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo http://www.fapesp.br/ (06/01898-7) and CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior http://www.capes.gov.br/. AEM is funded by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://www.cnpq.br/ (305608/2006-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, SEA STARS SEA URCHIN; BURKE RD, 1980, J EXP MAR BIOL ECOL, V47, P223, DOI 10.1016/0022-0981(80)90040-4; CALDWELL JW, 1972, THESIS U FLORIDA; CAMERON RA, 1982, MAR BIOL, V71, P197, DOI 10.1007/BF00394630; CHIA FS, 1977, J EXP MAR BIOL ECOL, V27, P187, DOI 10.1016/0022-0981(77)90138-1; DAVID B, 1995, P 4 EUR C ECH LOND R, P155; EMLET RB, 1986, J EXP MAR BIOL ECOL, V95, P183, DOI 10.1016/0022-0981(86)90202-9; Gordon I, 1926, PHILOS T R SOC LON B, V214, P259, DOI 10.1098/rstb.1926.0007; Gordon I, 1929, PHILOS T R SOC LON B, V217, P289, DOI 10.1098/rstb.1929.0005; GORDON ISABELLA, 1926, PHIL TRANS ROY SOC LONDON B, V215, P255; Gosselin P, 1998, ZOOMORPHOLOGY, V118, P31, DOI 10.1007/s004350050054; Hart MW, 2002, EVOL DEV, V4, P62, DOI 10.1046/j.1525-142x.2002.01052.x; KIER P M, 1977, Paleobiology, V3, P168; KIER PM, 1982, PALAEONTOLOGY, V25, P1; Miller BA, 1999, J EXP MAR BIOL ECOL, V235, P67, DOI 10.1016/S0022-0981(98)00164-6; Miner BG, 2005, J EXP MAR BIOL ECOL, V321, P135, DOI 10.1016/j.jembe.2005.01.008; MOOI R, 1990, PALEOBIOLOGY, V16, P25, DOI 10.1017/S0094837300009714; MOOI R, 1994, ECHINODERMS THROUGH TIME, P87; MOOI R, 1986, ZOOMORPHOLOGY, V106, P75, DOI 10.1007/BF00312110; Mortensen T, 1948, MONOGRAPH ECHINOIDEA; Netto LF, 2005, REV BIOL TROP, V53, P207; Nunes CDP, 2007, ZOOMORPHOLOGY, V126, P103, DOI 10.1007/s00435-007-0032-6; Pearse John S., 1991, P513; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Rasband W., 2006, IMAGEJ; Reitzel AM, 2007, EVOL ECOL RES, V9, P109; Saucede T, 2007, GEOL MAG, V144, P333, DOI 10.1017/S0016756806003001; Smith AB, 2001, PALEOBIOLOGY, V27, P392, DOI 10.1666/0094-8373(2001)027<0392:PTCOOC>2.0.CO;2; Smith MS, 2007, BIOESSAYS, V29, P566, DOI 10.1002/bies.20579; Strathmann MF, 1987, REPROD DEV MARINE IN; Takata H, 2004, ZOOL SCI, V21, P1025, DOI 10.2108/zsj.21.1025; Takata H, 2004, DEV GROWTH DIFFER, V46, P23; TELFORD M, 1987, BIOL BULL, V172, P324, DOI 10.2307/1541712; TOMMASI L. R., 1966, CONTRIB AVULSAS INST OCEANOGR [SAO PAULA], V11, P1; Wray Gregory A., 1997, P309; Zigler KS, 2008, BIOL BULL-US, V215, P191, DOI 10.2307/25470700	36	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9654	10.1371/journal.pone.0009654	http://dx.doi.org/10.1371/journal.pone.0009654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339592	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894300002
J	Rapaport, D; Lugassy, Y; Sprecher, E; Horowitz, M				Rapaport, Debora; Lugassy, Yevgenia; Sprecher, Eli; Horowitz, Mia			Loss of SNAP29 Impairs Endocytic Recycling and Cell Motility	PLOS ONE			English	Article							EARLY ENDOSOMAL TRANSPORT; MEMBRANE-FUSION; SYNAPTIC-TRANSMISSION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; SNARE PROTEIN; EHD PROTEINS; C-ELEGANS; TRAFFICKING; MIGRATION	Intracellular membrane trafficking depends on the ordered formation and consumption of transport intermediates and requires that membranes fuse with each other in a tightly regulated and highly specific manner. Membrane anchored SNAREs assemble into SNARE complexes that bring membranes together to promote fusion. SNAP29 is a ubiquitous synaptosomal-associated SNARE protein. It interacts with several syntaxins and with the EH domain containing protein EHD1. Loss of functional SNAP29 results in CEDNIK syndrome (Cerebral Dysgenesis, Neuropathy, Ichthyosis and Keratoderma). Using fibroblast cell lines derived from CEDNIK patients, we show that SNAP29 mediates endocytic recycling of transferrin and beta 1-integrin. Impaired beta 1-integrin recycling affected cell motility, as reflected by changes in cell spreading and wound healing. No major changes were detected in exocytosis of VSVG protein from the Golgi apparatus, although the Golgi system acquired a dispersed morphology in SNAP29 deficient cells. Our results emphasize the importance of SNAP29 mediated membrane fusion in endocytic recycling and consequently, in cell motility.	[Rapaport, Debora; Horowitz, Mia] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel; [Sprecher, Eli] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-69978 Tel Aviv, Israel; [Lugassy, Yevgenia; Sprecher, Eli] Rappaport Inst, Ctr Translat Genet, Haifa, Israel; [Lugassy, Yevgenia; Sprecher, Eli] Technion Israel Inst Technol, Haifa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Rapaport, D (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	horwitzm@post.tau.ac.il			Foundation for Ichthiosis and Related Skin Disorders (FIRST); Israeli Ministry of Health; Jacqueline Seroussi Foundation	Foundation for Ichthiosis and Related Skin Disorders (FIRST); Israeli Ministry of Health; Jacqueline Seroussi Foundation	This work was supported by grants from the Foundation for Ichthiosis and Related Skin Disorders (FIRST) and from the Israeli Ministry of Health, and by a grant from the Jacqueline Seroussi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; ETAIN B, 2009, MOL PSYCHIAT; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; HENDERSON IC, 1974, CELL, V3, P65, DOI 10.1016/0092-8674(74)90041-5; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Houben E, 2007, SKIN PHARMACOL PHYS, V20, P122, DOI 10.1159/000098163; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Pan PY, 2005, J BIOL CHEM, V280, P25769, DOI 10.1074/jbc.M502356200; Pierini LM, 2000, BLOOD, V95, P2471; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Sakai K, 2007, EXP DERMATOL, V16, P920, DOI 10.1111/j.1600-0625.2007.00614.x; Schardt A, 2009, J NEUROSCI RES, V87, P3465, DOI 10.1002/jnr.22005; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	54	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9759	10.1371/journal.pone.0009759	http://dx.doi.org/10.1371/journal.pone.0009759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305790	Green Published, Green Submitted, gold			2022-12-27	WOS:000276456300008
J	Tendulkar, AV; Krallinger, M; de la Torre, V; Lopez, G; Wangikar, PP; Valencia, A				Tendulkar, Ashish V.; Krallinger, Martin; de la Torre, Victor; Lopez, Gonzalo; Wangikar, Pramod P.; Valencia, Alfonso			FragKB: Structural and Literature Annotation Resource of Conserved Peptide Fragments and Residues	PLOS ONE			English	Article							DATABASE; PROTEINS; LOOPS	Background: FragKB (Fragment Knowledge-base) is a repository of clusters of structurally similar fragments from proteins. Fragments are annotated with information at the level of sequence, structure and function, integrating biological descriptions derived from multiple existing resources and text mining. Methodology: FragKB contains approximately 400,000 conserved fragments from 4,800 representative proteins from PDB. Literature annotations are extracted from more than 1,700 articles and are available for over 12,000 fragments. The underlying systematic annotation workflow of FragKB ensures efficient update and maintenance of this database. The information in FragKB can be accessed through a web interface that facilitates sequence and structural visualization of fragments together with known literature information on the consequences of specific residue mutations and functional annotations of proteins and fragment clusters. FragKB is accessible online at http://ubio.bioinfo.cnio.es/biotools/fragkb/. Significance: The information presented in FragKB can be used for modeling protein structures, for designing novel proteins and for functional characterization of related fragments. The current release is focused on functional characterization of proteins through inspection of conservation of the fragments.	[Tendulkar, Ashish V.; Krallinger, Martin; de la Torre, Victor; Lopez, Gonzalo; Valencia, Alfonso] Spanish Natl Canc Ctr, Struct Biol & Biocomp Programme, Madrid, Spain; [Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India	Centro Nacional de Investigaciones Oncologicas (CNIO); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Tendulkar, AV (corresponding author), Spanish Natl Canc Ctr, Struct Biol & Biocomp Programme, Madrid, Spain.	avtendulkar@cnio.es	Krallinger, Martin/I-2599-2015; Valencia, Alfonso/I-3127-2015; Lopez, Gonzalo/AAG-1169-2019	Valencia, Alfonso/0000-0002-8937-6789; Lopez, Gonzalo/0000-0002-5092-1284; Krallinger, Martin/0000-0002-2646-8782	Spanish projects CONSOLIDER [CSD2007-00050, RED ISCIII: RD07/0067/0014, BIO2007-66855]; Spanish Bioinformatics Institute	Spanish projects CONSOLIDER; Spanish Bioinformatics Institute	This work was funded by the Spanish projects CONSOLIDER: CSD2007-00050, RED ISCIII: RD07/0067/0014 and BIO2007-66855 2007 - 2012. Several of the services used are supported by the Spanish Bioinformatics Institute (www.inab.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Ausiello G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-182; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Burke DF, 2000, BIOINFORMATICS, V16, P513, DOI 10.1093/bioinformatics/16.6.513; BURNS G, 2009, NATURE PRECEDINGS; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Espadaler J, 2004, NUCLEIC ACIDS RES, V32, pD185, DOI 10.1093/nar/gkh002; HULO N, 2008, NUCLEIC ACIDS RES, V245, P20; Karuppasamy M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r52; Kasuya A, 1999, J MOL BIOL, V286, P1673, DOI 10.1006/jmbi.1999.2581; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pD219, DOI 10.1093/nar/gkl897; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; OLDFIELD TJ, 1994, PROTEINS, V18, P324, DOI 10.1002/prot.340180404; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P197, DOI 10.1093/nar/24.1.197; Tendulkar AV, 2005, BIOINFORMATICS, V21, P3622, DOI 10.1093/bioinformatics/bti621; Tendulkar AV, 2004, J MOL BIOL, V338, P611, DOI 10.1016/j.jmb.2004.02.047; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Velankar S, 2005, NUCLEIC ACIDS RES, V33, pD262, DOI 10.1093/nar/gki058	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9679	10.1371/journal.pone.0009679	http://dx.doi.org/10.1371/journal.pone.0009679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305778	Green Submitted, gold, Green Published			2022-12-27	WOS:000276456300002
J	Vroom, PS; Braun, CL				Vroom, Peter S.; Braun, Cristi L.			Benthic Composition of a Healthy Subtropical Reef: Baseline Species-Level Cover, with an Emphasis on Algae, in the Northwestern Hawaiian Islands	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; CORAL-REEFS; COMMUNITY STRUCTURE; PHASE-SHIFTS; ASSEMBLAGES; SCALE; DEGRADATION; HERBIVORY; ABUNDANCE; TURNOVER	The Northwestern Hawaiian Islands (NWHI) are considered to be among the most pristine coral reef ecosystems remaining on the planet. These reefs naturally contain a high percent cover of algal functional groups with relatively low coral abundance and exhibit thriving fish communities dominated by top predators. Despite their highly protected status, these reefs are at risk from both direct and indirect anthropogenic sources. This study provides the first comprehensive data on percent coverage of algae, coral, and non-coral invertebrates at the species level, and investigates spatial diversity patterns across the archipelago to document benthic communities before further environmental changes occur in response to global warming and ocean acidification. Monitoring studies show that non-calcified macroalgae cover a greater percentage of substrate than corals on many high latitude reef sites. Forereef habitats in atoll systems often contain high abundances of the green macroalga Microdictyon setchellianum and the brown macroalga Lobophora variegata, yet these organisms were uncommon in forereefs of non-atoll systems. Species of the brown macroalgal genera Padina, Sargassum, and Stypopodium and the red macroalgal genus Laurencia became increasingly common in the two northernmost atolls of the island chain but were uncommon components of more southerly islands. Conversely, the scleractinian coral Porites lobata was common on forereefs at southern islands but less common at northern islands. Currently accepted paradigms of what constitutes a "healthy'' reef may not apply to the subtropical NWHI, and metrics used to gauge reef health (e. g., high coral cover) need to be reevaluated.	[Vroom, Peter S.; Braun, Cristi L.] NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA	Vroom, PS (corresponding author), NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA.	Peter.Vroom@noaa.gov			National Oceanic and Atmospheric Administration (NOAA); Pacific Island Fisheries Science Center (PIFSC); Coral Reef Ecosystem Division (CRED)	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Pacific Island Fisheries Science Center (PIFSC); Coral Reef Ecosystem Division (CRED)	Funding to the National Oceanic and Atmospheric Administration (NOAA) Pacific Island Fisheries Science Center (PIFSC) Coral Reef Ecosystem Division (CRED) for scientific expeditions to the Northwestern Hawai'ian Islands was provided through NOAA's Coral Reef Conservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2003, CORAL REEFS, V22, P256, DOI 10.1007/s00338-003-0309-2; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Boland Raymond, 2006, Atoll Research Bulletin, P461; BRAINARD R, 2008, PIFSC SPECIAL PUBLIC; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Budd AF, 1998, PALAIOS, V13, P170, DOI 10.2307/3515488; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHENEY DP, 1977, J PHYCOL, V13, P12; Coyer J, 1999, GUIDE METHODS UNDERW; Dameron OJ, 2007, MAR POLLUT BULL, V54, P423, DOI 10.1016/j.marpolbul.2006.11.019; Diaz-Pulido G, 2002, BOT MAR, V45, P284, DOI 10.1515/BOT.2002.028; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; FRIEDLANDER A, 2008, STATE CORAL REEF ECO, P263; Friedlander A. M., 2004, STATUS CORAL REEFS W, V2, P411; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Galtsoff P. S., 1933, Bulletin Bishop Museum Honolulu, Vno. 107, P1; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; HOEKE R, 2006, P 10 INT COR REEF S, V1, P718; Hoeke Ronald, 2006, Atoll Research Bulletin, P489; HOLZWARTH S, 2006, P 10 INT COR REEF S, V1, P1131; Holzwarth Stephani R., 2006, Atoll Research Bulletin, P257; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JOHANSSON CL, MAR ECOL PR IN PRESS; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel P.L., 2006, P 10 INT COR REEF S, P390; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kenyon JC, 2006, PAC SCI, V60, P153, DOI 10.1353/psc.2006.0006; KENYON JC, 2007, ATOLL RES B, V549, P1; KENYON JC, 2007, ATOLL RES B, V550, P1; Kenyon Jean C., 2008, Atoll Research Bulletin, V559, P1; Kenyon Jean C., 2008, Atoll Research Bulletin, V558, P1; Kenyon Jean C., 2006, Atoll Research Bulletin, P505; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Leichter JJ, 1999, CONT SHELF RES, V19, P911, DOI 10.1016/S0278-4343(99)00004-7; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; MacCaughey V, 1916, AM J BOT, V3, P474, DOI 10.2307/2435240; MacCaughey V, 1918, BOT GAZ, V65, P42, DOI 10.1086/332188; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; McClanaban TR, 1999, CORAL REEFS, V18, P195, DOI 10.1007/s003380050181; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; *NAT MAR FISH SERV, 2005, CR05012 NAT MAR FISH; PAGE KN, 2006, THESIS U HAWAII; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Rooney John J., 2008, V1, P519, DOI 10.1007/978-1-4020-6847-8_13; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; SICILIANO D, 2005, THESIS U CALIFORNIA; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Vroom PS, 2009, J PHYCOL, V45, P337, DOI 10.1111/j.1529-8817.2009.00666.x; Vroom Peter S., 2006, Atoll Research Bulletin, P533; Vroom PS, 2006, PAC SCI, V60, P81, DOI 10.1353/psc.2005.0063; Vroom PS, 2005, CORAL REEFS, V24, P574, DOI 10.1007/s00338-005-0028-y; Wilkinson C., 2004, STATUS CORAL REEFS W; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; [No title captured]	66	44	45	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9733	10.1371/journal.pone.0009733	http://dx.doi.org/10.1371/journal.pone.0009733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305808	Green Published, Green Submitted, gold			2022-12-27	WOS:000275809600006
J	Mines, MA; Yuskaitis, CJ; King, MK; Beurel, E; Jope, RS				Mines, Marjelo A.; Yuskaitis, Christopher J.; King, Margaret K.; Beurel, Eleonore; Jope, Richard S.			GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FMR1 KNOCKOUT MOUSE; LITHIUM; MICE; PHOSPHORYLATION; EXPRESSION; CHILDREN; FEATURES	Background: Nearly 1% of children in the United States exhibit autism spectrum disorders, but causes and treatments remain to be identified. Mice with deletion of the fragile X mental retardation 1 (Fmr1) gene are used to model autism because loss of Fmr1 gene function causes Fragile X Syndrome (FXS) and many people with FXS exhibit autistic-like behaviors. Glycogen synthase kinase-3 (GSK3) is hyperactive in brains of Fmr1 knockout mice, and inhibition of GSK3 by lithium administration ameliorates some behavioral impairment in these mice. We extended our studies of this association by testing whether GSK3 contributes to socialization behaviors. This used two mouse models with disrupted regulation of GSK3, Fmr1 knockout mice and GSK3 knockin mice, in which inhibitory serines of the two isoforms of GSK3, GSK3 alpha and GSK3 beta, are mutated to alanines, leaving GSK3 fully active. Methodology/Principal Findings: To assess sociability, test mice were introduced to a restrained stimulus mouse (S1) for 10 min, followed by introduction of a second restrained stimulus mouse (S2) for 10 min, which assesses social preference. Fmr1 knockout and GSK3 knockin mice displayed no deficit in sociability with the S1 mouse, but unlike wild-type mice neither demonstrated social preference for the novel S2 mouse. Fmr1 knockout mice displayed more anxiety-related behaviors during social interaction (grooming, rearing, and digging) than wild-type mice, which was ameliorated by inhibition of GSK3 with chronic lithium treatment. Conclusions/Significance: These results indicate that impaired inhibitory regulation of GSK3 in Fmr1 knockout mice may contribute to some socialization deficits and that lithium treatment can ameliorate certain socialization impairments. As discussed in the present work, these results suggest a role for GSK3 in social behaviors and implicate inhibition of GSK3 as a potential therapeutic.	[Mines, Marjelo A.; Yuskaitis, Christopher J.; King, Margaret K.; Beurel, Eleonore; Jope, Richard S.] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Mines, MA (corresponding author), Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	jope@uab.edu			FRAXA Research Foundation; National Institutes of Health [MH38752]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038752, R56MH038752] Funding Source: NIH RePORTER	FRAXA Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by grants from the FRAXA Research Foundation and the National Institutes of Health (MH38752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Berry-Kravis E, 2008, J DEV BEHAV PEDIATR, V29, P293, DOI 10.1097/DBP.0b013e31817dc447; Bitterman A, 2008, J AUTISM DEV DISORD, V38, P1509, DOI 10.1007/s10803-007-0531-9; Brodkin ES, 2008, BEHAV NEUROSCI, V122, P483, DOI 10.1037/0735-7044.122.2.483; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagerman RJ, 2005, CURR OPIN PSYCHIATR, V18, P490, DOI 10.1097/01.yco.0000179485.39520.b0; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Jope R. S., 2006, GLYCOGEN SYNTHASE KI, P223; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kau ASM, 2004, AM J MED GENET A, V126A, P9, DOI 10.1002/ajmg.a.20218; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koukoui SD, 2007, BRAIN RES REV, V53, P27, DOI 10.1016/j.brainresrev.2006.06.001; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P105, DOI 10.1080/09297040802112564; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rhoades Rachel A, 2007, BMC Pediatr, V7, P37, DOI 10.1186/1471-2431-7-37; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spencer CA, 2008, BEHAV NEUROSCI, V122, P710, DOI 10.1037/0735-7044.122.3.710; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sullivan K, 2006, AM J MED GENET A, V140A, P2275, DOI 10.1002/ajmg.a.31388; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yuskaitis CJ, 2010, BIOCHEM PHARMACOL, V79, P632, DOI 10.1016/j.bcp.2009.09.023	38	165	174	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9706	10.1371/journal.pone.0009706	http://dx.doi.org/10.1371/journal.pone.0009706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570ZC	20300527	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400007
J	Solberg, R; Enot, D; Deigner, HP; Koal, T; Scholl-Burgi, S; Saugstad, OD; Keller, M				Solberg, Ronnaug; Enot, David; Deigner, Hans-Peter; Koal, Therese; Scholl-Buergi, Sabine; Saugstad, Ola D.; Keller, Matthias			Metabolomic Analyses of Plasma Reveals New Insights into Asphyxia and Resuscitation in Pigs	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; ROOM-AIR RESUSCITATION; 100-PERCENT OXYGEN; L-CARNITINE; NEWBORN-INFANTS; NEONATAL ENCEPHALOPATHY; TERM INFANTS; BRAIN-INJURY; METAANALYSIS; CHOLESTEROL	Background: Currently, a limited range of biochemical tests for hypoxia are in clinical use. Early diagnostic and functional biomarkers that mirror cellular metabolism and recovery during resuscitation are lacking. We hypothesized that the quantification of metabolites after hypoxia and resuscitation would enable the detection of markers of hypoxia as well as markers enabling the monitoring and evaluation of resuscitation strategies. Methods and Findings: Hypoxemia of different durations was induced in newborn piglets before randomization for resuscitation with 21% or 100% oxygen for 15 min or prolonged hyperoxia. Metabolites were measured in plasma taken before and after hypoxia as well as after resuscitation. Lactate, pH and base deficit did not correlate with the duration of hypoxia. In contrast to these, we detected the ratios of alanine to branched chained amino acids (Ala/BCAA; R-2. adj = 0.58, qvalue, 0.001) and of glycine to BCAA (Gly/BCAA; R-2.adj = 0.45, q-value, 0.005), which were highly correlated with the duration of hypoxia. Combinations of metabolites and ratios increased the correlation to R-2 adjust = 0.92. Reoxygenation with 100% oxygen delayed cellular metabolic recovery. Reoxygenation with different concentrations of oxygen reduced lactate levels to a similar extent. In contrast, metabolites of the Krebs cycle (which is directly linked to mitochondrial function) including alpha keto-glutarate, succinate and fumarate were significantly reduced at different rates depending on the resuscitation, showing a delay in recovery in the 100% reoxygenation groups. Additional metabolites showing different responses to reoxygenation include oxysterols and acylcarnitines (n = 8-11, q<0.001). Conclusions: This study provides a novel strategy and set of biomarkers. It provides biochemical in vivo data that resuscitation with 100% oxygen delays cellular recovery. In addition, the oxysterol increase raises concerns about the safety of 100% O-2 resuscitation. Our biomarkers can be used in a broad clinical setting for evaluation or the prediction of damage in conditions associated with low tissue oxygenation in both infancy and adulthood. These findings have to be validated in human trials.	[Solberg, Ronnaug; Saugstad, Ola D.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0316 Oslo, Norway; [Solberg, Ronnaug] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Surg Res, N-0316 Oslo, Norway; [Enot, David; Deigner, Hans-Peter; Koal, Therese] BIOCRATES Life Sci AG, Innsbruck, Austria; [Scholl-Buergi, Sabine] Innsbruck Med Univ, Dept Pediat 4, Div Neuropediatr & Inherited Metab Disorders, Innsbruck, Austria; [Keller, Matthias] Univ Essen Gesamthsch, Dept Pediat 1, Essen, Germany	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Medical University of Innsbruck; University of Duisburg Essen	Solberg, R (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0316 Oslo, Norway.	Matthias.Keller@uk-essen.de	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254; Scholl-Burgi, Sabine/0000-0002-2529-4231	South-Eastern Norway Regional Health Authority; Norwegian SIDS; Stillbirth Society	South-Eastern Norway Regional Health Authority; Norwegian SIDS; Stillbirth Society	Financial support was provided by the South-Eastern Norway Regional Health Authority and the Norwegian SIDS and Stillbirth Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binienda ZK, 2003, ANN NY ACAD SCI, V993, P289, DOI 10.1111/j.1749-6632.2003.tb07536.x; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Briddon A, 1996, ANN CLIN BIOCHEM, V33, P227, DOI 10.1177/000456329603300309; Cai C, 2008, J HUAZHONG U SCI-MED, V28, P207, DOI 10.1007/s11596-008-0224-4; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Chace DH, 2003, PEDIATR RES, V53, P823, DOI 10.1203/01.PDR.0000059220.39578.3D; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; DE V, 1990, BIOL NEONATE S, V58, P54; GEHRKE I, 1990, LUNG, V168, P79, DOI 10.1007/BF02719678; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Groenendaal F, 2000, Semin Neonatol, V5, P17, DOI 10.1053/siny.1999.0119; HASTIE T, 2009, SPRINGER SERIES STAT; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Helton E, 2000, PEDIATRICS, V105, P1260; International Liaison Committee on Resuscitation, 2005, Resuscitation, V67, P293; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Markham EA, 2007, STAND, V7, P62; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; McGuire William, 2006, Clin Evid, P511; Meyburg J, 2001, PEDIATR RES, V49, P125, DOI 10.1203/00006450-200101000-00024; Odd DE, 2009, LANCET, V373, P1615, DOI 10.1016/S0140-6736(09)60244-0; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; REZNICK AZ, 1992, ARCH BIOCHEM BIOPHYS, V296, P394, DOI 10.1016/0003-9861(92)90589-O; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saugstad OD, 2003, PEDIATRICS, V112, P296, DOI 10.1542/peds.112.2.296; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Smith J, 2000, BRIT J OBSTET GYNAEC, V107, P461, DOI 10.1111/j.1471-0528.2000.tb13262.x; Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P498, DOI 10.1007/s10545-009-1126-8; Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077; Thoresen M, 2000, Semin Neonatol, V5, P61, DOI 10.1053/siny.1999.0118; TODO G, 1986, INVEST RADIOL, V21, P689, DOI 10.1097/00004424-198609000-00003; Touma EH, 2001, ARCH DIS CHILD, V84, P58, DOI 10.1136/adc.84.1.58; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Wainwright MS, 2006, STROKE, V37, P524, DOI 10.1161/01.STR.0000198892.15269.f7; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; *WHO, 2005, WORLD HTLH REP 2005; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	50	92	100	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9606	10.1371/journal.pone.0009606	http://dx.doi.org/10.1371/journal.pone.0009606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231903	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300019
J	Appledorn, DM; Aldhamen, YA; DePas, W; Seregin, SS; Liu, CJJ; Schuldt, N; Quach, D; Quiroga, D; Godbehere, S; Zlatkin, I; Kim, S; McCormick, JJ; Amalfitano, A				Appledorn, Daniel M.; Aldhamen, Yasser A.; DePas, William; Seregin, Sergey S.; Liu, Chyong-Jy J.; Schuldt, Nathan; Quach, Darin; Quiroga, Dionisia; Godbehere, Sarah; Zlatkin, Igor; Kim, Sungjin; McCormick, J. Justin; Amalfitano, Andrea			A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; IN-VIVO; ACTIVATION; EXPANSION; EFFICACY; PROTEIN; CD4; NK	Background: Adenoviral based vectors remain promising vaccine platforms for use against numerous pathogens, including HIV. Recent vaccine trials utilizing Adenovirus based vaccines expressing HIV antigens confirmed induction of cellular immune responses, but these responses failed to prevent HIV infections in vaccinees. This illustrates the need to develop vaccine formulations capable of generating more potent T-cell responses to HIV antigens, such as HIV-Gag, since robust immune responses to this antigen correlate with improved outcomes in long-term non-progressor HIV infected individuals. Methodology/Principal Findings: In this study we designed a novel vaccine strategy utilizing an Ad-based vector expressing a potent TLR agonist derived from Eimeria tenella as an adjuvant to improve immune responses from a [E1-]Ad-based HIV-Gag vaccine. Our results confirm that expression of rEA elicits significantly increased TLR mediated innate immune responses as measured by the influx of plasma cytokines and chemokines, and activation of innate immune responding cells. Furthermore, our data show that the quantity and quality of HIV-Gag specific CD8(+) and CD8(-) T-cell responses were significantly improved when coupled with rEA expression. These responses also correlated with a significantly increased number of HIV-Gag derived epitopes being recognized by host T cells. Finally, functional assays confirmed that rEA expression significantly improved antigen specific CTL responses, in vivo. Moreover, we show that these improved responses were dependent upon improved TLR pathway interactions. Conclusion/Significance: The data presented in this study illustrate the potential utility of Ad-based vectors expressing TLR agonists to improve clinical outcomes dependent upon induction of robust, antigen specific immune responses.	[Appledorn, Daniel M.; Aldhamen, Yasser A.; DePas, William; Seregin, Sergey S.; Liu, Chyong-Jy J.; Schuldt, Nathan; Quach, Darin; Quiroga, Dionisia; Godbehere, Sarah; Kim, Sungjin; McCormick, J. Justin; Amalfitano, Andrea] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Zlatkin, Igor; McCormick, J. Justin] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Appledorn, DM (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	amalfit1@msu.edu	Quiroga, Dionisia/ABH-7893-2020	Quiroga, Dionisia/0000-0003-3388-7069; Aldhamen, Yasser/0000-0002-9560-8013; Quach, Darin/0000-0002-3244-5376; Schuldt, Nathan/0000-0001-7692-4814; DePas, William/0000-0001-8532-2567	National Institutes of Health [RO1DK-069884, P01 CA078673]; Michigan State University (MSU) Foundation; Osteopathic Heritage Foundation; Michigan State University Center; National Institute of Environmental Health Sciences [T32ES007255]; NATIONAL CANCER INSTITUTE [P01CA078673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University (MSU) Foundation; Osteopathic Heritage Foundation; Michigan State University Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	A. A. was supported by the National Institutes of Health grants RO1DK-069884 and P01 CA078673, the Michigan State University (MSU) Foundation, as well the Osteopathic Heritage Foundation. D. M. A. was supported by the Michigan State University Center for Integrative Toxicology (MSU-CIT) program through award number T32ES007255 from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2008, GENE THER, V15, P885, DOI 10.1038/gt.2008.18; Appledorn DM, 2009, J INNATE IMMUN, V1, P376, DOI 10.1159/000207194; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Dyer WB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-112; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gowen BB, 2006, ANTIMICROB AGENTS CH, V50, P2023, DOI 10.1128/AAC.01473-05; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hedhli D, 2009, VACCINE, V27, P2274, DOI 10.1016/j.vaccine.2009.01.100; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kalinski P, 2006, IMMUNOL RES, V36, P137, DOI 10.1385/IR:36:1:137; Karan D, 2007, INT J CANCER, V121, P1520, DOI 10.1002/ijc.22873; KUMAR H, 2009, BIOCH BIOPHYS RES CO; Lee Y, 2004, EUR J BIOCHEM, V271, P1094, DOI 10.1111/j.1432-1033.2004.04011.x; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Ng Philip, 2002, Methods Mol Med, V69, P389; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Rader JS, 2008, CLIN CANCER RES, V14, P3089, DOI 10.1158/1078-0432.CCR-07-4250; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wolska A, 2009, CELL MOL BIOL LETT, V14, P248, DOI 10.2478/s11658-008-0048-z; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhu JA, 2008, MOL THER, V16, P1300, DOI 10.1038/mt.2008.88	30	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A130	A139	e9579	10.1371/journal.pone.0009579	http://dx.doi.org/10.1371/journal.pone.0009579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221448	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328200012
J	Gomard, T; Michaud, HA; Tempe, D; Thiolon, K; Pelegrin, M; Piechaczyk, M				Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc			An NF-kappa B-Dependent Role for JunB in the Induction of Proinflammatory Cytokines in LPS-Activated Bone Marrow-Derived Dendritic Cells	PLOS ONE			English	Article							C-JUN; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; DOWN-REGULATION; AP-1; LIPOPOLYSACCHARIDE; FOS; MATURATION	Background: Dendritic cells (DCs) play a key role in the induction of adaptive and memory immune responses. Upon encounter with pathogens, they undergo a complex maturation process and migrate toward lymphoid organs where they stimulate immune effector cells. This process is associated with dramatic transcriptome changes, pointing to a paramount role for transcription factors in DC activation and function. The regulation and the role of these transcription factors are however ill-defined and require characterization. Among those, AP-1 is a family of dimeric transcription complexes with an acknowledged role in the control of immunity. However, it has not been studied in detail in DCs yet. Methodology/Principal Findings: Here, we have investigated the regulation and function of one of its essential components, JunB, in primary bone marrow-derived DCs induced to maturate upon stimulation by Escherichia coli lipopolysaccharide (LPS). Our data show fast and transient NF-kappa B-dependent transcriptional induction of the junb gene correlating with the induction of the TNF alpha, IL-6, and IL-12 proinflammatory cytokines. Inhibition of JunB protein induction by RNA interference hampered the transcriptional activation of the TNF-alpha, IL-6, and IL-12p40 genes. Consistently, chromatin immunoprecipitation experiments showed LPS-inducible binding of JunB at AP-1-responsive sites found in promoter regions of these genes. Concomitant LPS-inducible NF-kappa B/p65 binding to these promoters was also observed. Conclusions/Significance: We identified a novel role for JunB-that is, induction of proinflammatory cytokines in LPS-activated primary DCs with NF-kappa B acting not only as an inducer of JunB, but also as its transcriptional partner.	[Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc] CNRS, Inst Genet Mol, Montpellier, France; [Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc] Univ Montpellier 2, Montpellier, France; [Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc] Univ Montpellier 1, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Gomard, T (corresponding author), CNRS, Inst Genet Mol, Montpellier, France.	marc.piechaczyk@igmm.cnrs.fr	PIECHACZYK, Marc/E-7896-2013; Michaud, Henri-Alexandre/Z-1417-2019	PIECHACZYK, Marc/0000-0003-1367-2597; Pelegrin, Mireia/0000-0002-0117-2010; Michaud, Henri-Alexandre/0000-0002-6165-1929	French Ligue Nationale contre le Cancer; Programme Blanc of the French Agence Nationale pour la Recherche (ANR)	French Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Programme Blanc of the French Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	MP's laboratory is funded by the French Ligue Nationale contre le Cancer. This work was also supported by the CNRS and a grant from the Programme Blanc of the French Agence Nationale pour la Recherche (ANR). TG is recipient of a fellowship from the Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrecht S, 2002, J BIOL CHEM, V277, P35961, DOI 10.1074/jbc.M202847200; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Brown RT, 1995, J BIOL CHEM, V270, P31129, DOI 10.1074/jbc.270.52.31129; Casals C, 2007, J IMMUNOL, V178, P6307, DOI 10.4049/jimmunol.178.10.6307; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Frazier-Jessen MR, 2002, FEBS LETT, V513, P203, DOI 10.1016/S0014-5793(02)02295-0; Fujihara M, 1998, J IMMUNOL, V161, P3659; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Granucci F, 2005, ADV IMMUNOL, V88, P193, DOI 10.1016/S0065-2776(05)88006-X; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hu XT, 2001, CANCER RES, V61, P6290; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MALNOU CE, 2010, J BIOL CHEM; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Mannucci Pier M, 2002, Hematology Am Soc Hematol Educ Program, P1; Meixner A, 2008, NAT CELL BIOL, V10, P1003, DOI 10.1038/ncb1761; Mizumoto N, 2005, J INVEST DERMATOL, V124, P718, DOI 10.1111/j.0022-202X.2005.23616.x; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Scaife CL, 2002, CANCER RES, V62, P6870; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Shen ZH, 1997, J IMMUNOL, V158, P2723; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Textor B, 2007, J IMMUNOL, V179, P6873, DOI 10.4049/jimmunol.179.10.6873; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	52	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A178	A188	e9585	10.1371/journal.pone.0009585	http://dx.doi.org/10.1371/journal.pone.0009585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221401	Green Submitted, Green Published, gold			2022-12-27	WOS:000275328200017
J	Wang, JL; Wang, JT; Chen, SY; Chen, YC; Chang, SC				Wang, Jiun-Ling; Wang, Jann-Tay; Chen, Shey-Ying; Chen, Yee-Chun; Chang, Shan-Chwen			Distribution of Staphylococcal Cassette Chromosome mec Types and Correlation with Comorbidity and Infection Type in Patients with MRSA Bacteremia	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SCCMEC TYPE-IV; METHICILLIN-RESISTANT; AUREUS INFECTION; COMMUNITY; CLONES; EMERGENCE; CHILDREN; STRAINS; TAIWAN	Background: Molecular epidemiological definitions that are based on staphylococcal cassette chromosome mec (SCCmec) typing and phylogenetic analysis of methicillin-resistant Staphylococcus aureus (MRSA) isolates are considered a reliable way to distinguish between healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA). However, there is little information regarding the clinical features and outcomes of bacteremia patients with MRSA carrying different SCCmec types. Methods: From January 1 through December 31, 2006, we recorded the demographic data and outcomes of 159 consecutive adult MRSA bacteremia patients from whom isolates for SCCmec analysis were collected. All participants were patients at a tertiary care center in Taiwan. Principal Findings: The following SCCmec types were identified in MRSA isolates: 30 SCCmec II (18.9%), 87 SCCmec III (54.7%), 22 SCCmec IV (13.8%), and 20 SCCmec V (12.6%). The time from admission to the first MRSA-positive blood culture for patients infected with isolates with the SCCmec III element (mean/median, 50.7/26 days) was significantly longer than for patients infected with isolates carrying SCCmec IV or V (mean/median, 6.7/3 days for SCCmec IV; 11.1/10.5 days for SCCmec V) (P < 0.05). In univariate analysis, community onset, soft tissue infection, and deep-seated infection were predictors for SCCmec IV/V. In multivariate analysis, length of stay before index culture, diabetes mellitus, and being bedridden were independent risk factors associated with SCCmec II/III. Conclusions: These findings are in agreement with previous studies of the genetic characteristics of CA-MRSA. MRSA bacteremia with SCCmec II/III isolates occurred more among patients with serious comorbidities and prolonged hospitalization. Community onset, skin and soft tissue infection, and deep-seated infection best predicted SCCmec IV/V MRSA bacteremia.	[Wang, Jiun-Ling; Wang, Jann-Tay; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Wang, Jiun-Ling] I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung Cty, Taiwan; [Chen, Shey-Ying] Natl Taiwan Univ, Dept Emergency Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital	Wang, JL (corresponding author), Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan.	dtmed111wang@ntu.edu.tw; changsc@ntu.edu.tw	Chen, Yee-Chun/AGW-7535-2022; Wang, 竣令王 Jiun-Ling/L-9627-2015	Chen, Yee-Chun/0000-0002-1816-9010; Wang, 竣令王 Jiun-Ling/0000-0002-9465-8692; CHANG, SHAN-CHWEN/0000-0001-6505-4139; WANG, JANN-TAY/0000-0002-0924-3469; CHEN, SHEY-YING/0000-0002-5855-6170	National Science Council in Taiwan [96-2314-B-002-031]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council (96-2314-B-002-031-) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Bannerman TM, 2003, MANUAL CLIN MICROBIO, P384; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Chen FJ, 2005, EMERG INFECT DIS, V11, P1761, DOI 10.3201/eid1111.050367; Davis SL, 2006, INFECT CONT HOSP EP, V27, P1025, DOI 10.1086/507918; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Seybold U, 2007, CLIN INFECT DIS, V44, P502, DOI 10.1086/511047; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	38	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9489	10.1371/journal.pone.0009489	http://dx.doi.org/10.1371/journal.pone.0009489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221428	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197200005
J	Humbert, M; Casteran, N; Letard, S; Hanssens, K; Iovanna, J; Finetti, P; Bertucci, F; Bader, T; Mansfield, CD; Moussy, A; Hermine, O; Dubreuil, P				Humbert, Martine; Casteran, Nathalie; Letard, Sebastien; Hanssens, Katia; Iovanna, Juan; Finetti, Pascal; Bertucci, Francois; Bader, Thomas; Mansfield, Colin D.; Moussy, Alain; Hermine, Olivier; Dubreuil, Patrice			Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model	PLOS ONE			English	Article							CANCER; INHIBITION; EXPRESSION; CARCINOMA; GROWTH; PROGRESSION; METASTASIS; SURVIVAL; THERAPY	Background: Tyrosine kinases are attractive targets for pancreatic cancer therapy because several are over-expressed, including PDGFR alpha/beta, FAK, Src and Lyn. A critical role of mast cells in the development of pancreatic cancer has also been reported. Masitinib is a tyrosine kinase inhibitor that selectively targets c-Kit, PDGFR alpha/beta, Lyn, and to a lesser extent the FAK pathway, without inhibiting kinases of known toxicities. Masitinib is particularly efficient in controlling the proliferation, differentiation and degranulation of mast cells. This study evaluates the therapeutic potential of masitinib in pancreatic cancer, as a single agent and in combination with gemcitabine. Methodology/Findings: Proof-of-concept studies were performed in vitro on human pancreatic tumour cell lines and then in vivo using a mouse model of human pancreatic cancer. Molecular mechanisms were investigated via gene expression profiling. Masitinib as a single agent had no significant antiproliferative activity while the masitinib/gemcitabine combination showed synergy in vitro on proliferation of gemcitabine-refractory cell lines Mia Paca2 and Panc1, and to a lesser extent in vivo on Mia Paca2 cell tumour growth. Specifically, masitinib at 10 mu M strongly sensitised Mia Paca2 cells to gemcitabine (> 400-fold reduction in IC50); and moderately sensitised Panc1 cells (10-fold reduction). Transcriptional analysis identified the Wnt/beta-catenin signalling pathway as down-regulated in the cell lines resensitised by the masitinib/gemcitabine combination. Conclusions: These data establish proof-of-concept that masitinib can sensitise gemcitabine-refractory pancreatic cancer cell lines and warrant further in vivo investigation. Indeed, such an effect has been recently observed in a phase 2 clinical study of patients with pancreatic cancer who received a masitinib/gemcitabine combination.	[Humbert, Martine; Casteran, Nathalie; Hanssens, Katia; Bader, Thomas; Mansfield, Colin D.; Moussy, Alain] AB Sci SA, Paris, France; [Letard, Sebastien; Dubreuil, Patrice] Ctr Reference Mastocytoses, Ctr Rech Cancerol Marseille Signalisat Hematopoie, INSERM, U891, Marseille, France; [Letard, Sebastien; Finetti, Pascal; Bertucci, Francois; Dubreuil, Patrice] Univ Mediterranee, Marseille, France; [Iovanna, Juan] INSERM, U624, F-13258 Marseille, France; [Finetti, Pascal; Bertucci, Francois] Inst J Paoli I Calmettes, Dept Med Oncol, Dept Mol Oncol, Ctr Rech Cancerol Marseille,INSERM,U891, F-13009 Marseille, France; [Hermine, Olivier] Univ Paris 05, CNRS, UMR 8147, Ctr Reference Mastocytoses,Serv Hematol,Hop Necke, F-75270 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Humbert, M (corresponding author), AB Sci SA, Paris, France.	olivier.hermine@nck.aphp.fr; patrice.dubreuil@inserm.fr	Hermine, Olivier/Q-7072-2018; Dubreuil, Patrice/V-4816-2019; Iovanna, Juan/M-9805-2017; dubreuil, patrice/F-5346-2011; Finetti, Pascal/O-8669-2017	Dubreuil, Patrice/0000-0003-1155-1150; Iovanna, Juan/0000-0003-1822-2237; dubreuil, patrice/0000-0003-1155-1150; Bertucci, Francois/0000-0002-0157-0959; Hermine, Olivier/0000-0003-2574-3874; LETARD, Sebastien/0000-0002-6508-7376; Finetti, Pascal/0000-0002-2674-3123	la Ligue Nationale Contre le Cancer; equipe labellisee; INCa; Institut National du Cancer; Agence Nationale pour la Recherche; AB Science, S. A., Paris, France	la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); equipe labellisee; INCa(Institut National du Cancer (INCA) France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); AB Science, S. A., Paris, France	This work was supported in part by funds from: INSERM (Institut National de la Sante de la Recherche Medicale), la Ligue Nationale Contre le Cancer, equipe labellisee (P. D. and J. I.); INCa (Institut National du Cancer - PACA in PACA project), Institut National du Cancer (O. H. and P. D.); and the Agence Nationale pour la Recherche, RIB project (P. D.). This study was financially supported by AB Science, S. A., Paris, France. The sponsor was involved in the study design, data analysis and interpretation, manuscript preparation and in the decision to submit the manuscript.	Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chen J, 2006, CANCER LETT, V233, P328, DOI 10.1016/j.canlet.2005.03.027; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Duxbury MS, 2004, J AM COLL SURGEONS, V198, P953, DOI 10.1016/j.jamcollsurg.2004.01.037; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V311, P786, DOI 10.1016/j.bbrc.2003.10.060; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Giroux V, 2006, CLIN CANCER RES, V12, P235, DOI 10.1158/1078-0432.CCR-05-1700; Hahn KA, 2008, J VET INTERN MED, V22, P1301, DOI 10.1111/j.1939-1676.2008.0190.x; Hammel P, 2009, J CLIN ONCOL, V27; Hammond JR, 1999, J PHARMACOL EXP THER, V288, P1185; Hwang RF, 2003, CLIN CANCER RES, V9, P6534; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murtaugh L Charles, 2008, Organogenesis, V4, P81; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; Saif MW, 2006, J PANCREAS, V7, P337; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sultana A, 2007, BRIT J CANCER, V96, P1183, DOI 10.1038/sj.bjc.6603719; Sultana A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-192; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tebib J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2740; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokoi K, 2005, CANCER RES, V65, P10371, DOI 10.1158/0008-5472.CAN-05-1698	30	57	59	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9430	10.1371/journal.pone.0009430	http://dx.doi.org/10.1371/journal.pone.0009430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209107	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197100002
J	Fernandes, JMO; Ruangsri, J; Kiron, V				Fernandes, Jorge M. O.; Ruangsri, Jareeporn; Kiron, Viswanath			Atlantic Cod Piscidin and Its Diversification through Positive Selection	PLOS ONE			English	Article							AMINO-ACID SITES; ANTIMICROBIAL PEPTIDES; ONCORHYNCHUS-MYKISS; MAXIMUM-LIKELIHOOD; PHYLOGENETIC ANALYSIS; SKIN SECRETIONS; IMMUNE-SYSTEM; RAINBOW-TROUT; FISH; GENES	Piscidins constitute a family of cationic antimicrobial peptides that are thought to play an important role in the innate immune response of teleosts. On the one hand they show a remarkable diversity, which indicates that they are shaped by positive selection, but on the other hand they are ancient and have specific targets, suggesting that they are constrained by purifying selection. Until now piscidins had only been found in fish species from the superorder Acanthopterygii but we have recently identified a piscidin gene in Atlantic cod (Gadus morhua), thus showing that these antimicrobial peptides are not restricted to evolutionarily modern teleosts. Nucleotide diversity was much higher in the regions of the piscidin gene that code for the mature peptide and its pro domain than in the signal peptide. Maximum likelihood analyses with different evolution models revealed that the piscidin gene is under positive selection. Charge or hydrophobicity-changing amino acid substitutions observed in positively selected sites within the mature peptide influence its amphipathic structure and can have a marked effect on its function. This diversification might be associated with adaptation to new habitats or rapidly evolving pathogens.	[Fernandes, Jorge M. O.; Ruangsri, Jareeporn; Kiron, Viswanath] Bodo Univ Coll, Fac Biosci & Aquaculture, Bodo, Nordland, Norway	Nord University	Fernandes, JMO (corresponding author), Bodo Univ Coll, Fac Biosci & Aquaculture, Bodo, Nordland, Norway.	Jorge.fernandes@hibo.no	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; Viswanath, Kiron/0000-0003-4640-1910	Research Council of Norway; Prince of Songkla University (Thailand)	Research Council of Norway(Research Council of Norway); Prince of Songkla University (Thailand)	This study was partially funded by a research grant to VK from the Research Council of Norway (Ref. 184703/S40). JR was supported by a PhD fellowship from the Prince of Songkla University (Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLY JE, 1991, VET IMMUNOL IMMUNOP, V28, P365, DOI 10.1016/0165-2427(91)90127-X; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Fernandes JMO, 2004, DEV COMP IMMUNOL, V28, P127, DOI 10.1016/S0145-305X(03)00120-4; Fernandes JMO, 2004, FISH SHELLFISH IMMUN, V16, P1, DOI 10.1016/S1050-4648(03)00027-5; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAWKES JW, 1974, CELL TISSUE RES, V149, P147, DOI 10.1007/BF00222270; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017; Padhi A, 2007, MOL DIVERS, V11, P119, DOI 10.1007/s11030-007-9066-4; Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Smith Valerie J., 2008, P241; Sun BJ, 2007, J FISH DIS, V30, P335, DOI 10.1111/j.1365-2761.2007.00789.x; Sung WS, 2008, BIOCHEM BIOPH RES CO, V371, P551, DOI 10.1016/j.bbrc.2008.04.107; Swofford D.L., 2003, PAUP VERSION 4 0B10; Tennessen JA, 2005, J MOL EVOL, V61, P445, DOI 10.1007/s00239-004-0330-2; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	36	79	82	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9501	10.1371/journal.pone.0009501	http://dx.doi.org/10.1371/journal.pone.0009501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209162	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000275063300015
J	Stroh, T; Erben, U; Kuhl, AA; Zeitz, M; Siegmund, B				Stroh, Thorsten; Erben, Ulrike; Kuehl, Anja A.; Zeitz, Martin; Siegmund, Britta			Combined Pulse Electroporation - A Novel Strategy for Highly Efficient Transfection of Human and Mouse Cells	PLOS ONE			English	Article							GENE ELECTROTRANSFER; NUCLEOFECTION; EXPRESSION; MEMBRANES; COMBINATIONS; ADIPOCYTES; PEPTIDES; DELIVERY; MUSCLE	The type of a nucleic acid and the type of the cell to be transfected generally affect the efficiency of electroporation, the versatile method of choice for gene regulation studies or for recombinant protein expression. We here present a combined square pulse electroporation strategy to reproducibly and efficiently transfect eukaryotic cells. Cells suspended in a universal buffer system received an initial high voltage pulse that was continuously combined with a subsequent low voltage pulse with independently defined electric parameters of the effective field and the duration of each pulse. At comparable viable cell recoveries and transfection efficiencies of up to 95% of all cells, a wide variety of cells especially profited from this combined pulse strategy by high protein expression levels of individual cells after transfection. Long-term silencing of gene expression by transfected small interfering RNA was most likely due to the uptake of large nucleic acid amounts as shown by direct detection of fluorochromated small interfering RNA. The highly efficient combined pulse electroporation strategy enables for external regulation of the number of naked nucleic acid molecules taken up and can be easily adapted for cells considered difficult to transfect.	[Stroh, Thorsten; Erben, Ulrike; Kuehl, Anja A.; Zeitz, Martin; Siegmund, Britta] Charite, Med Klin 2, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stroh, T (corresponding author), Charite, Med Klin 2, D-13353 Berlin, Germany.		Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X; Kuhl, Anja/0000-0003-2293-5387	Deutsche Forschungsgemeinschaft [Si 749/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the following grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.html): Si 749/5-1 "Histone acetylation - epigenetic modification as regulator of the intestinal effector Th response" (to B. S.), as well as TP 12 "Mesenteric adipose tissue and the regulatory function in intestinal inflammation" (to B. S.) and Z 1 "Development of systematic morphological methods for the evaluation of mucosal inflammations and the in-situdetection of defined cell populations" (to M. Z.) of the Collaborative Research Center 633 "Induction and modulation of T cell-mediated immune response in the gastrointestinal tract". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1978, DOKL AKAD NAUK SSSR+, V240, P733; Andre FM, 2008, HUM GENE THER, V19, P1261, DOI [10.1089/hum.2008.060, 10.1089/hgt.2008.060]; Batra A, 2007, AM J PATHOL, V170, P1931, DOI 10.2353/ajpath.2007.060699; Chenuet Sebastien, 2009, V518, P99, DOI 10.1007/978-1-59745-202-1_8; Coonrod A, 1997, GENE THER, V4, P1313, DOI 10.1038/sj.gt.3300536; COSTER HGL, 1965, BIOPHYS J, V5, P669, DOI 10.1016/S0006-3495(65)86745-5; FREEMAN SA, 1994, BIOPHYS J, V67, P42, DOI 10.1016/S0006-3495(94)80453-9; Helledie T, 2008, STEM CELLS DEV, V17, P837, DOI 10.1089/scd.2007.0209; Hojman P, 2008, HUM GENE THER, V19, P1249, DOI 10.1089/hum.2008.059; Isakari Y, 2007, INT J PHARMACEUT, V338, P157, DOI 10.1016/j.ijpharm.2007.01.042; Kanduser M, 2009, BIOELECTROCHEMISTRY, V74, P265, DOI 10.1016/j.bioelechem.2008.09.002; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; KLENCHIN VA, 1991, BIOPHYS J, V60, P804, DOI 10.1016/S0006-3495(91)82115-4; Lundberg P, 2007, FASEB J, V21, P2664, DOI 10.1096/fj.06-6502com; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Martinet W, 2003, BIOTECHNOL LETT, V25, P1025, DOI 10.1023/A:1024157508492; MCGEHEE RE, 1993, MOL ENDOCRINOL, V7, P551, DOI 10.1210/me.7.4.551; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Oliveira S, 2007, INT J PHARM, V331, P211, DOI 10.1016/j.ijpharm.2006.11.050; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rols MP, 1998, BIOPHYS J, V75, P1415, DOI 10.1016/S0006-3495(98)74060-3; Schakowski Frank, 2004, Genet Vaccines Ther, V2, P1, DOI 10.1186/1479-0556-2-1; SUKHAREV SI, 1992, BIOPHYS J, V63, P1320, DOI 10.1016/S0006-3495(92)81709-5; Thiel Corinna, 2006, V129, P255; Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891; van Baalen CA, 2005, J INFECT DIS, V192, P1183, DOI 10.1086/444546; WEAVER JC, 1993, J CELL BIOCHEM, V51, P426, DOI 10.1002/jcb.2400510407; WINTERBOURNE DJ, 1988, BIOCHEM J, V251, P427, DOI 10.1042/bj2510427	28	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9488	10.1371/journal.pone.0009488	http://dx.doi.org/10.1371/journal.pone.0009488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209146	gold, Green Published, Green Submitted			2022-12-27	WOS:000275063300008
J	Cunningham, TM; Koehl, JL; Summers, JS; Haydel, SE				Cunningham, Tanya M.; Koehl, Jennifer L.; Summers, Jack S.; Haydel, Shelley E.			pH-Dependent Metal Ion Toxicity Influences the Antibacterial Activity of Two Natural Mineral Mixtures	PLOS ONE			English	Article							ESCHERICHIA-COLI; CLAY-MINERALS; HYDROGEN-PEROXIDE; ADSORPTION; GROWTH; SOILS; ACID; MICROORGANISMS; INACTIVATION; BIOCHEMISTRY	Background: Recent studies have demonstrated that several mineral products sold for medicinal purposes demonstrate antimicrobial activity, but little is known about the physicochemical properties involved in antibacterial activity. Methodology/Principal Findings: Using in vitro mineral suspension testing, we have identified two natural mineral mixtures, arbitrarily designated BY07 and CB07, with antibacterial activity against a broad-spectrum of bacterial pathogens. Mineral-derived aqueous leachates also exhibited antibacterial activity, revealing that chemical, not physical, mineral characteristics were responsible for the observed activity. The chemical properties essential for bactericidal activity against Escherichia coli were probed by testing antibacterial activity in the presence of metal chelators, the hydroxyl radical scavenger, thiourea, and varying pH levels. Chelation of the BY07 minerals with EDTA or desferrioxamine eliminated or reduced BY07 toxicity, respectively, suggesting a role of an acid-soluble metal species, particularly Fe(3+) or other sequestered metal cations, in mineral toxicity. This conclusion was supported by NMR relaxation data, which indicated that BY07 and CB07 leachates contained higher concentrations of chemically accessible metal ions than leachates from non-bactericidal mineral samples. Conclusions/Significance: We conclude that the acidic environment of the hydrated minerals significantly contributes to antibacterial activity by increasing the availability and toxicity of metal ions. These findings provide impetus for further investigation of the physiological effects of mineral products and their applications in complementary antibacterial therapies.	[Cunningham, Tanya M.; Koehl, Jennifer L.; Haydel, Shelley E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Cunningham, Tanya M.; Haydel, Shelley E.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ USA; [Summers, Jack S.] Western Carolina Univ, Dept Chem, Cullowhee, NC 28723 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; Western Carolina University	Cunningham, TM (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Shelley.Haydel@asu.edu		Haydel, Shelley/0000-0001-5542-5469	Public Health Service [AT004690, AT003618]; NIH National Center for Complementary and Alternative Medicine; Howard Hughes Medical Institute through the Undergraduate Science Education Program; ASU School of Life Sciences; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004690] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003618] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Howard Hughes Medical Institute through the Undergraduate Science Education Program(Howard Hughes Medical Institute); ASU School of Life Sciences; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by Public Health Service grants AT004690 and AT003618 to S. E. Haydel from the NIH National Center for Complementary and Alternative Medicine (http://nccam.nih.gov/) and in part by funds from the Howard Hughes Medical Institute through the Undergraduate Science Education Program (http://www.hhmi.org/) and from the ASU School of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1950, J BACTERIOL, V60, P401, DOI 10.1128/JB.60.4.401-413.1950; ANTONIADIS V, 2006, TRACE ELEMENTS ENV, P39; ASAD NR, 1991, J BACTERIOL, V173, P2562, DOI 10.1128/jb.173.8.2562-2568.1991; BABICH H, 1977, APPL ENVIRON MICROB, V33, P696, DOI 10.1128/AEM.33.3.696-705.1977; BABICH H, 1983, AQUAT TOXICOL, V3, P195, DOI 10.1016/0166-445X(83)90040-1; BLUNDELL MR, 1969, BIOCHEM J, V115, P213, DOI 10.1042/bj1150213; Braun S., 1998, 150 MORE BASIC NMR E; Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0; Cherny RA, 2000, J STRUCT BIOL, V130, P209, DOI 10.1006/jsbi.2000.4285; CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2827, DOI 10.1021/bi00835a020; Collins Y. E., 1989, METAL IONS BACTERIA, P31; Eberl D.D., 2003, OPEN FILE REPORT 03, P1; Falkinham JO, 2009, APPL ENVIRON MICROB, V75, P2735, DOI 10.1128/AEM.00104-09; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Gupta C. K., 2003, CHEM METALLURGY, P811; Haydel SE, 2008, J ANTIMICROB CHEMOTH, V61, P353, DOI 10.1093/jac/dkm468; Hu CH, 2005, VET MICROBIOL, V109, P83, DOI 10.1016/j.vetmic.2005.04.021; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Jucker BA, 1997, COLLOID SURFACE B, V9, P331, DOI 10.1016/S0927-7765(97)00038-6; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kiipli T, 2000, OIL SHALE, V17, P215; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LIPSON SM, 1984, APPL ENVIRON MICROB, V48, P525, DOI 10.1128/AEM.48.3.525-530.1984; Lo IMC, 1999, WATER AIR SOIL POLL, V109, P219, DOI 10.1023/A:1005000520321; Magana SM, 2008, J MOL CATAL A-CHEM, V281, P192, DOI 10.1016/j.molcata.2007.10.024; MCLAREN AD, 1963, SCIENCE, V141, P1141, DOI 10.1126/science.141.3586.1141; Mpuchane SF, 2008, FRESEN ENVIRON BULL, V17, P547; NESSE W, 2000, SILICATES INTRO MINE, P183; NESSE W, 2000, SHEET SILICATES INTR, P235; Smith B, 2000, J GEOL SOC LONDON, V157, P885, DOI 10.1144/jgs.157.4.885; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Summers JS, 2008, J AM CHEM SOC, V130, P1727, DOI 10.1021/ja077193b; SWIFT TJ, 1962, J CHEM PHYS, V37, P307, DOI 10.1063/1.1701321; Top A, 2004, APPL CLAY SCI, V27, P13, DOI 10.1016/j.clay.2003.12.002; Velde B., 1995, Origin and mineralogy of clays: clays and the environment., P8; VERMEER DE, 1985, SCIENCE, V227, P634, DOI 10.1126/science.3969552; World Health Organization, 2002, 5 WHO ADV GROUP M BU; Wypych F, 2002, ENCY SURFACE COLLOID, P995; Yee N, 2000, GEOCHIM COSMOCHIM AC, V64, P609, DOI 10.1016/S0016-7037(99)00342-7; Yoshida N., 2004, J BIOL SCI, V4, P532; Yu TS, 2004, J MICROBIOL, V42, P47; Ziegler JL, 1997, TROP MED INT HEALTH, V2, P609, DOI 10.1046/j.1365-3156.1997.d01-359.x	45	30	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9456	10.1371/journal.pone.0009456	http://dx.doi.org/10.1371/journal.pone.0009456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209160	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997100006
J	Jewett, A; Arasteh, A; Tseng, HC; Behel, A; Arasteh, H; Yang, W; Cacalano, NA; Paranjpe, A				Jewett, Anahid; Arasteh, Aida; Tseng, Han-Ching; Behel, Armin; Arasteh, Hobie; Yang, Wendy; Cacalano, Nicholas A.; Paranjpe, Avina			Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ORAL TUMOR-CELLS; CLASS-I ANTIGENS; FACTOR-KAPPA-B; STROMAL CELLS; BONE-MARROW; TNF-ALPHA; PROLIFERATION; IMMUNOSUPPRESSION; SECRETION	Background: The aim of this paper is to study the function of allogeneic and autologous NK cells against Dental Pulp Stem Cells (DPSCs) and Mesenchymal Stem Cells (MSCs) and to determine the function of NK cells in a three way interaction with monocytes and stem cells. Methodology/Principal Findings: We demonstrate here that freshly isolated untreated or IL-2 treated NK cells are potent inducers of cell death in DPSCs and MSCs, and that anti-CD16 antibody which induces functional split anergy and apoptosis in NK cells inhibits NK cell mediated lysis of DPSCs and MSCs. Monocytes co-cultured with either DPSCs or MSCs decrease lysis of stem cells by untreated or IL-2 treated NK cells. Monocytes also prevent NK cell apoptosis thereby raising the overall survival and function of NK cells, DPSCs or MSCs. Both total population of monocytes and those depleted of CD16(+) subsets were able to prevent NK cell mediated lysis of MSCs and DPSCs, and to trigger an increased secretion of IFN-gamma by IL-2 treated NK cells. Protection of stem cells from NK cell mediated lysis was also seen when monocytes were sorted out from stem cells before they were added to NK cells. However, this effect was not specific to monocytes since the addition of T and B cells to stem cells also protected stem cells from NK cell mediated lysis. NK cells were found to lyse monocytes, as well as T and B cells. Conclusion/Significance: By increasing the release of IFN-gamma and decreasing the cytotoxic function of NK cells monocytes are able to shield stem cells from killing by the NK cells, resulting in an increased protection and differentiation of stem cells. More importantly studies reported in this paper indicate that anti-CD16 antibody can be used to prevent NK cell induced rejection of stem cells.	[Jewett, Anahid; Arasteh, Aida; Tseng, Han-Ching; Behel, Armin; Arasteh, Hobie; Yang, Wendy; Paranjpe, Avina] Univ Calif Los Angeles, Sch Med & Dent, Div Oral Biol & Med, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA; [Cacalano, Nicholas A.] Univ Calif Los Angeles, Sch Med & Dent, Dept Radiat Oncol, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Jewett, A (corresponding author), Univ Calif Los Angeles, Sch Med & Dent, Div Oral Biol & Med, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.	ajewett@ucla.edu			University of California Los Angeles Academic Senate	University of California Los Angeles Academic Senate(University of California System)	Funding was received from the University of California Los Angeles Academic Senate grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ALGE DL, J TISSUE ENG REGEN M, V4, P73; Cacalano N, 2008, APOPTOSIS, V13, P1439, DOI 10.1007/s10495-008-0270-1; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Jewett A, 2006, CANCER IMMUNOL IMMUN, V55, P1052, DOI 10.1007/s00262-005-0093-7; Jewett A, 2006, CLIN CANCER RES, V12, P1994, DOI 10.1158/1078-0432.CCR-05-2306; Jewett A, 1996, J IMMUNOL, V156, P907; Jewett A, 2003, HUM IMMUNOL, V64, P505, DOI 10.1016/S0198-8859(03)00039-9; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; JEWETT A, 1995, J CLIN IMMUNOL, V15, P35, DOI 10.1007/BF01489488; Jewett A, 1997, J IMMUNOL, V159, P4815; Jewett A, 2000, CLIN IMMUNOL, V96, P19, DOI 10.1006/clim.2000.4871; Jewett A, 2008, CANCER IMMUNOL IMMUN, V57, P1053, DOI 10.1007/s00262-007-0437-6; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nasef A, 2008, CELL IMMUNOL, V253, P16, DOI 10.1016/j.cellimm.2008.06.002; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; PARANJPE A, 2009, TOXICOL SCI; Paranjpe A, 2007, FREE RADICAL BIO MED, V43, P1394, DOI 10.1016/j.freeradbiomed.2007.07.011; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Vuk-Pavlovic S, 2008, BLOOD CELL MOL DIS, V40, P94, DOI 10.1016/j.bcmd.2007.06.025; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhao ZG, 2008, IMMUNOL INVEST, V37, P726, DOI 10.1080/08820130802349940	31	48	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2010	5	3							e9874	10.1371/journal.pone.0009874	http://dx.doi.org/10.1371/journal.pone.0009874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576RA	20360990	Green Submitted, gold, Green Published			2022-12-27	WOS:000276163200001
J	Higuchi, A; Takahashi, K; Hirashima, M; Kawakita, T; Tsubota, K				Higuchi, Akihiro; Takahashi, Kazuhiko; Hirashima, Masaki; Kawakita, Tetsuya; Tsubota, Kazuo			Selenoprotein P Controls Oxidative Stress in Cornea	PLOS ONE			English	Article							DRY EYE; CELL-DEATH; GLUTATHIONE-PEROXIDASE; SERUM APPLICATION; EPITHELIAL-CELLS; LACRIMAL GLAND; SELENIUM; PROTEIN; SELENOCYSTEINE; HYDROPEROXIDE	The ocular surface is always attacked by oxidative stress, and cornea epithelial cells are supposed to have their own recovery system against oxidative stress. Therefore we hypothesized that tears supply key molecules for preventing oxidative stress in cornea. The potential target key molecule we focused is selenoprotein P (SeP). SeP is a carrier of selenium, which is an essential trace element for many animals, for oxidative stress metabolism in the organism, and was extremely expressed in lacrimal gland. An experiment was performed with SeP eye drops in a rat dry eye model, prepared by removing the lacrimal glands. The anticipated improvement in corneal dry eye index and the suppression of oxidative stress markers were observed in SeP eye drop group. Furthermore, the concentration of SeP was significantly higher in dry eye patients compared with normal volunteers. Collectively, we concluded that tear SeP is a key molecule to protect the ocular surface cells against environmental oxidative stress.	[Higuchi, Akihiro; Tsubota, Kazuo] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Takahashi, Kazuhiko] Hokkaido Pharmaceut Univ, Sch Pharm, Dept Nutr Biochem, Sapporo, Hokkaido, Japan; [Hirashima, Masaki] Chemoserotherapeut Res Inst, Res Dept 1, Kumamoto, Japan; [Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University; Keio University	Higuchi, A (corresponding author), Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan.	ahiguchi@sc.itc.keio.ac.jp			Kowa Company, Ltd.	Kowa Company, Ltd.	The study reported in the present article was supported by grants from Kowa Company, Ltd. (4-14-3 Nihonbashihoncho, Chuo-Ku, Tokyo, Japan). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R, 2005, J TRACE ELEM MED BIO, V19, P141, DOI 10.1016/j.jtemb.2005.09.003; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; AUGUSTIN AJ, 1995, GRAEF ARCH CLIN EXP, V233, P694, DOI 10.1007/BF00164671; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Cekic O, 2002, AM J OPHTHALMOL, V134, P75, DOI 10.1016/S0002-9394(02)01472-1; Craig JP, 2000, EYE, V14, P635, DOI 10.1038/eye.2000.156; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Higuchi A, 2006, BRIT J OPHTHALMOL, V90, P760, DOI 10.1136/bjo.2005.088203; Higuchi A, 2007, CURR EYE RES, V32, P83, DOI 10.1080/02713680601147690; Hirashima M, 2003, BIOL PHARM BULL, V26, P794; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; KUIZENGA A, 1991, INVEST OPHTH VIS SCI, V32, P381; Lemp Michael A., 1995, CLAO Journal, V21, P221; MCKEEHAN WL, 1976, P NATL ACAD SCI USA, V73, P2023, DOI 10.1073/pnas.73.6.2023; Modis L, 1998, GRAEF ARCH CLIN EXP, V236, P86, DOI 10.1007/s004170050047; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; Nakamura S, 2003, INVEST OPHTH VIS SCI, V44, P4682, DOI 10.1167/iovs.03-0198; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Saito Y, 2004, BIOCHEM J, V381, P841, DOI 10.1042/BJ20040328; Saito Y, 2002, EUR J BIOCHEM, V269, P5746, DOI 10.1046/j.1432-1033.2002.03298.x; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Sharif NA, 1998, INVEST OPHTH VIS SCI, V39, P2562; Shimmura S, 2003, BRIT J OPHTHALMOL, V87, P1279, DOI 10.1136/bjo.87.10.1279; Shisler JL, 1998, SCIENCE, V279, P102, DOI 10.1126/science.279.5347.102; Tsubota K, 2000, INT OPHTHALMOL CLIN, V40, P113, DOI 10.1097/00004397-200010000-00009; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; UBELS JL, 1986, INVEST OPHTH VIS SCI, V27, P1261; Wilson SE, 1999, INVEST OPHTH VIS SCI, V40, P2185; ZUCLICH JA, 1976, INVEST OPHTH VISUAL, V15, P760	36	51	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9911	10.1371/journal.pone.0009911	http://dx.doi.org/10.1371/journal.pone.0009911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20360971	Green Published, gold, Green Submitted			2022-12-27	WOS:000276163100006
J	Iaboli, L; Caselli, L; Filice, A; Russi, G; Belletti, E				Iaboli, Luca; Caselli, Luana; Filice, Angelina; Russi, Gianpaolo; Belletti, Eleonora			The Unbearable Lightness of Health Science Reporting: A Week Examining Italian Print Media	PLOS ONE			English	Article							NEWSPAPER COVERAGE; FINANCIAL INTEREST; NEWS MEDIA; DISCLOSURE; JOURNALISTS; INFORMATION; INTERESTS; BENEFITS; STORIES	Background: Although being an important source of science news information to the public, print news media have often been criticized in their credibility. Health-related content of press media articles has been examined by many studies underlining that information about benefits, risks and costs are often incomplete or inadequate and financial conflicts of interest are rarely reported. However, these studies have focused their analysis on very selected science articles. The present research aimed at adopting a wider explorative approach, by analysing all types of health science information appearing on the Italian national press in one-week period. Moreover, we attempted to score the balance of the articles. Methodology/Principal Findings: We collected 146 health science communication articles defined as articles aiming at improving the reader's knowledge on health from a scientific perspective. Articles were evaluated by 3 independent physicians with respect to different divulgation parameters: benefits, costs, risks, sources of information, disclosure of financial conflicts of interest and balance. Balance was evaluated with regard to exaggerated or non correct claims. The selected articles appeared on 41 Italian national daily newspapers and 41 weekly magazines, representing 89% of national circulation copies: 97 articles (66%) covered common medical treatments or basic scientific research and 49 (34%) were about new medical treatments, procedures, tests or products. We found that only 6/49 (12%) articles on new treatments, procedures, tests or products mentioned costs or risks to patients. Moreover, benefits were always maximized and in 16/49 cases (33%) they were presented in relative rather than absolute terms. The majority of stories (133/146, 91%) did not report any financial conflict of interest. Among these, 15 were shown to underreport them (15/146, 9.5%), as we demonstrated that conflicts of interest did actually exist. Unbalanced articles were 27/146 (18%). Specifically, the probability of unbalanced reporting was significantly increased in stories about a new treatment, procedure, test or product (22/49, 45%), compared to stories covering common treatments or basic scientific research (5/97, 5%) (risk ratio, 8.72). Conclusions/Significance: Consistent with prior research on health science communication in other countries, we report undisclosed costs and risks, emphasized benefits, unrevealed financial conflicts of interest and exaggerated claims in Italian print media. In addition, we show that the risk for a story about a new medical approach to be unbalanced is almost 9 times higher with respect to stories about any other kind of health science-related topics. These findings raise again the fundamental issue whether popular media is detrimental rather than useful to public health.	[Iaboli, Luca] Santa Maria Nuova Hosp, Dept Emergency Med, Reggio Emilia, Italy; [Caselli, Luana] Univ Ferrara, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy; [Filice, Angelina] Santa Maria Nuova Hosp, Dept Nucl Med, Reggio Emilia, Italy; [Russi, Gianpaolo] Santa Maria Nuova Hosp, Dept Transfus Med, Reggio Emilia, Italy; [Belletti, Eleonora] St Anna Hosp, Hlth Sci Lib, Ferrara, Italy	IRCCS Arcispedale S. Maria Nuova; University of Ferrara; IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; University of Ferrara; Arcispedale Sant'Anna	Iaboli, L (corresponding author), Santa Maria Nuova Hosp, Dept Emergency Med, Reggio Emilia, Italy.	luana.caselli@unife.it	Caselli, Luana/AGA-7498-2022	Caselli, Luana/0000-0001-7058-7570				Allan GM, 2007, PLOS MED, V4, P1486, DOI 10.1371/journal.pmed.0040283; [Anonymous], 2009, LANCET, V373, P604, DOI 10.1016/S0140-6736(09)60375-5; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Cook DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001266; Covey J, 2007, MED DECIS MAKING, V27, P638, DOI 10.1177/0272989x07306783; Dutta-Bergman MJ, 2004, HEALTH COMMUN, V16, P273, DOI 10.1207/S15327027HC1603_1; ENTWISTLE V, 1995, BRIT MED J, V310, P920, DOI 10.1136/bmj.310.6984.920; Entwistle V., 1992, PUBLIC UNDERST SCI, V1, P367, DOI DOI 10.1088/0963-6625/1/4/002; Goldacre B, 2007, BRIT MED J, V335, P480, DOI 10.1136/bmj.39328.450000.59; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Gross CP, 2003, BRIT MED J, V326, P526, DOI 10.1136/bmj.326.7388.526; Hochman M, 2008, JAMA-J AM MED ASSOC, V300, P1544, DOI 10.1001/jama.300.13.1544; Kline KN, 2006, J HEALTH COMMUN, V11, P43, DOI 10.1080/10810730500461067; Krimsky S, 1998, JAMA-J AM MED ASSOC, V280, P225, DOI 10.1001/jama.280.3.225; LANDIS JR, 1977, BIOMETRICS, V33, P174; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Moynihan R, 2000, MED J AUSTRALIA, V173, P631, DOI 10.5694/j.1326-5377.2000.tb139366.x; OSTERWEIL N, 2009, FDA NOT EFFECTIVELY; Rains SA, 2007, J HEALTH COMMUN, V12, P667, DOI 10.1080/10810730701619992; Schwartz LM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2535; Schwartz RS, 2008, NEW ENGL J MED, V358, P1850, DOI 10.1056/NEJMe0802618; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; *THOMS SCI, 2007, J CIT REP 2006 JCR S; Weinfurt KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002128; WHITE C, 2003, BRIT MED J, V327, P348, DOI DOI 10.1136/BMJ.327.7410.348; Wilson PM, 2008, J ROY SOC MED, V101, P125, DOI 10.1258/jrsm.2007.070115; 2006, ACCERTAMENTI DIFFUSI	32	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9829	10.1371/journal.pone.0009829	http://dx.doi.org/10.1371/journal.pone.0009829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FT	20352089	Green Submitted, gold, Green Published			2022-12-27	WOS:000275894500007
J	Bob, NS; Diop, BM; Renaud, F; Marrama, L; Durand, P; Tall, A; Ka, B; Ekala, MT; Bouchier, C; Mercereau-Puijalon, O; Jambou, R				Bob, Ndeye Sakha; Diop, Bernard Marcel; Renaud, Francois; Marrama, Laurence; Durand, Patrick; Tall, Adama; Ka, Boubacar; Ekala, Marie Therese; Bouchier, Christiane; Mercereau-Puijalon, Odile; Jambou, Ronan			Parasite Polymorphism and Severe Malaria in Dakar (Senegal): A West African Urban Area	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; GENETIC DIVERSITY; MICROSATELLITE; TRANSMISSION; POPULATION; LINKAGE; EPIDEMIOLOGY; PATTERNS; MARKERS; ALLELE	Background: Transmission of malaria in West African urban areas is low and healthcare facilities are well organized. However, malaria mortality remains high. We conducted a survey in Dakar with the general objective to establish who died from severe malaria (SM) in urban areas (particularly looking at the age-groups) and to compare parasite isolates associated with mild or severe malaria. Methodology/Principal Findings: The current study included mild-(MM) and severe malaria (SM) cases, treated in dispensaries (n = 2977) and hospitals (n = 104), We analysed Pfdhfr/Pfcrt-exon2 and nine microsatellite loci in 102 matched cases of SM and MM. Half of the malaria cases recorded at the dispensaries and 87% of SM cases referred to hospitals, occurred in adults, although adults only accounted for 26% of all dispensary consultations. This suggests that, in urban settings, whatever the reason for this adult over-representation, health-workers are forced to take care of increasing numbers of malaria cases among adults. Inappropriate self treatment and mutations in genes associated with drug resistance were found associated with SM in adults. SM was also associated with a specific pool of isolates highly polymorphic and different from those associated with MM. Conclusion: In this urban setting, adults currently represent one of the major groups of patients attending dispensaries for malaria treatment. For these patients, despite the low level of transmission, SM was associated with a specific and highly polymorphic pool of parasites which may have been selected by inappropriate treatment.	[Bob, Ndeye Sakha; Marrama, Laurence; Tall, Adama; Jambou, Ronan] Inst Pasteur, Dakar, Senegal; [Diop, Bernard Marcel] CHU Fann, Clin Malad Infectieuses, Dakar, Senegal; [Renaud, Francois; Durand, Patrick] CNRS, IRD, GEMI, UMR 2724, Montpellier, France; [Ka, Boubacar] Hop Principal Dakar, Dakar, Senegal; [Ekala, Marie Therese; Mercereau-Puijalon, Odile] Inst Pasteur, CNRS, URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bob, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	rjambou@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020; JAMBOU, RONAN/CAG-3718-2022		Louis D. Foundation; Ministere francais des Affaires etrangeres; European Commission [QLK2-CT20021-1503-ResMalChip]; FSP-RAI	Louis D. Foundation; Ministere francais des Affaires etrangeres; European Commission(European CommissionEuropean Commission Joint Research Centre); FSP-RAI	This study was supported by the Louis D. Foundation (Academies des Sciences, Paris, France), the Ministere francais des Affaires etrangeres (Fond Solidarite Prioritaire, FSP-RAI) and the European Commission (contract QLK2-CT20021-1503-ResMalChip) project. NS Bob was supported by a grant from FSP-RAI. The funders had no role in study design data collection and analysis, decision to publish or preparation of this manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; CONTAMIN H, 1995, J CLIN MICROBIOL, V33, P944, DOI 10.1128/JCM.33.4.944-951.1995; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Diallo S, 2000, Sante, V10, P221; Diallo S, 1998, B SOC PATHOL EXOT, V91, P208; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; Durand R, 2008, TROP MED INT HEALTH, V13, P1392, DOI 10.1111/j.1365-3156.2008.02156.x; Faye O., 1995, Cahiers d'Etudes et de Recherches Francophones/Sante, V5, P299; Ferreira MU, 2002, J CLIN MICROBIOL, V40, P1854, DOI 10.1128/JCM.40.5.1854-1857.2002; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Henry M, 2006, AM J TROP MED HYG, V75, P146, DOI 10.4269/ajtmh.2006.75.146; Ibrahim ML, 2007, MICROBES INFECT, V9, P599, DOI 10.1016/j.micinf.2007.02.003; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Leclerc MC, 2002, MICROBES INFECT, V4, P685, DOI 10.1016/S1286-4579(02)01587-3; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Ndiaye P, 2006, Med Trop (Mars), V66, P74; NEI M, 1985, MOL BIOL EVOL, V2, P189; Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Nzila AM, 2002, INT J PARASITOL, V32, P1469, DOI 10.1016/S0020-7519(02)00164-9; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Prothero RM, 2001, HEALTH RISK SOC, V3, P19, DOI 10.1080/713670171; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; Schleiermacher D, 2001, AM J TROP MED HYG, V64, P303, DOI 10.4269/ajtmh.2001.64.303; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Soumare M, 2008, Bull Soc Pathol Exot, V101, P20; Soumare M, 2005, MED MALADIES INFECT, V35, P383, DOI 10.1016/j.medmal.2005.03.009; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; TRAORE S, 1996, MIGRATIONS AFRIQUE O; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; United Nations, 2004, WORLD URB PROSP 2003; World Health Organization, 2008, WORLD MAL REP	37	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9817	10.1371/journal.pone.0009817	http://dx.doi.org/10.1371/journal.pone.0009817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352101	Green Published, gold			2022-12-27	WOS:000275894400019
J	House, JS; Zhu, SY; Ranjan, R; Linder, K; Smart, RC				House, John S.; Zhu, Songyun; Ranjan, Rakesh; Linder, Keith; Smart, Robert C.			C/EBP alpha and C/EBP beta Are Required for Sebocyte Differentiation and Stratified Squamous Differentiation in Adult Mouse Skin	PLOS ONE			English	Article							ENHANCER-BINDING-PROTEIN; TRANSCRIPTION FACTORS C/EBP; SEBACEOUS GLAND; STEM-CELLS; GENE-EXPRESSION; MAMMARY-GLAND; GROWTH ARREST; ONCOGENIC RAS; IN-VIVO; C-MYC	C/EBP alpha and C/EBP beta are bZIP transcription factors that are highly expressed in the interfollicular epidermis and sebaceous glands of skin and yet germ line deletion of either family member alone has only mild or no effect on keratinocyte biology and their role in sebocyte biology has never been examined. To address possible functional redundancies and reveal functional roles of C/EBP alpha and C/EBP beta in postnatal skin, mouse models were developed in which either family member could be acutely ablated alone or together in the epidermis and sebaceous glands of adult mice. Acute removal of either C/EBP alpha or C/EBP beta alone in adult mouse skin revealed modest to no discernable changes in epidermis or sebaceous glands. In contrast, co-ablation of C/EBP alpha and C/EBP beta in postnatal epidermis resulted in disruption of stratified squamous differentiation characterized by hyperproliferation of basal and suprabasal keratinocytes and a defective basal to spinous keratinocyte transition involving an expanded basal compartment and a diminished and delayed spinous compartment. Acute co-ablation of C/EBP alpha and C/EBP beta in sebaceous glands resulted in severe morphological defects, and sebocyte differentiation was blocked as determined by lack of sebum production and reduced expression of stearoyl-CoA desaturase (SCD3) and melanocortin 5 receptor (MC5R), two markers of terminal sebocyte differentiation. Specialized sebocytes of Meibomian glands and preputial glands were also affected. Our results indicate that in adult mouse skin, C/EBP alpha and C/EBP beta are critically involved in regulating sebocyte differentiation and epidermal homeostasis involving the basal to spinous keratinocyte transition and basal cell cycle withdrawal.	[House, John S.; Zhu, Songyun; Ranjan, Rakesh; Smart, Robert C.] N Carolina State Univ, Dept Environm & Mol Toxicol, Cell Signaling & Canc Grp, Raleigh, NC 27695 USA; [Linder, Keith] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	House, JS (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Cell Signaling & Canc Grp, Raleigh, NC 27695 USA.	rcsmart@ncsu.edu	House, John S/A-1933-2013	House, John S/0000-0002-8447-7871; Smart, Robert/0000-0002-6767-6756	National Cancer Institute [CA046637]; National Institute of Environmental Health Sciences [ES012473, ES007046]; NATIONAL CANCER INSTITUTE [R29CA046637, R01CA046637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046, R01ES012473] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Cancer Institute (CA046637), a grant from the National Institute of Environmental Health Sciences (ES012473) and a training grant from the National Institute of Environmental Health Sciences (ES007046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2003, AM J PATHOL, V163, P2173, DOI 10.1016/S0002-9440(10)63574-2; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Chen WC, 2003, J INVEST DERMATOL, V121, P441, DOI 10.1046/j.1523-1747.2003.12411.x; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; DOUGHERTY JM, 1986, INVEST OPHTH VIS SCI, V27, P486; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; LOPEZ RG, 2009, NAT CELL BIOL; Maytin EV, 1999, DEV BIOL, V216, P164, DOI 10.1006/dbio.1999.9460; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; NATSUKA S, 1992, BLOOD, V79, P460; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shim M, 2005, CANCER RES, V65, P861; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STEWART ME, 1992, SEMIN DERMATOL, V11, P100; Swart GWM, 1997, BIOL CHEM, V378, P373, DOI 10.1515/bchm.1997.378.5.373; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	45	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9837	10.1371/journal.pone.0009837	http://dx.doi.org/10.1371/journal.pone.0009837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352127	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894400032
J	Sitkiewicz, I; Green, NM; Guo, N; Bongiovanni, AM; Witkin, SS; Musser, JM				Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Bongiovanni, Ann M.; Witkin, Steven S.; Musser, James M.			Adaptation of Group A Streptococcus to Human Amniotic Fluid	PLOS ONE			English	Article							BACTERIAL-GROWTH INHIBITION; CHEMICALLY-DEFINED MEDIUM; GROUP-B STREPTOCOCCUS; HUMAN BLOOD; EPITHELIAL-CELLS; GENE-EXPRESSION; PYOGENES; VIRULENCE; TRANSCRIPTOME; INFECTIONS	Background: For more than 100 years, group A Streptococcus has been identified as a cause of severe and, in many cases, fatal infections of the female urogenital tract. Due to advances in hospital hygiene and the advent of antibiotics, this type of infection has been virtually eradicated. However, within the last three decades there has been an increase in severe intra-and post-partum infections attributed to GAS. Methodology: We hypothesized that GAS alters its transcriptome to survive in human amniotic fluid (AF) and cause disease. To identify genes that were up or down regulated in response to growth in AF, GAS was grown in human AF or standard laboratory media (THY) and samples for expression microarray analysis were collected during mid-logarithmic, late-logarithmic, and stationary growth phases. Microarray analysis was performed using a custom Affymetrix chip and normalized hybridization values derived from three biological replicates were collected at each growth point. Ratios of AF/THY above a 2-fold change and P-value <0.05 were considered significant. Principal Findings: The majority of changes in the GAS transcriptome involved down regulation of multiple adhesins and virulence factors and activation of the stress response. We observed significant changes in genes involved in the arginine deiminase pathway and in the nucleotide de novo synthesis pathway. Conclusions/Significance: Our work provides new insight into how pathogenic bacteria respond to their environment to establish infection and cause disease.	[Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Musser, James M.] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA; [Bongiovanni, Ann M.; Witkin, Steven S.; Musser, James M.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Sitkiewicz, I (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmhs.org	Witkin, Steven/AAF-3812-2019; Witkin, Steven/AAW-8602-2021; Sitkiewicz, Izabela/G-5058-2011	Witkin, Steven/0000-0002-3502-3929; Sitkiewicz, Izabela/0000-0001-8228-9917; Bongiovanni, Ann Marie/0000-0001-9801-570X	Methodist Hospital Research Institute	Methodist Hospital Research Institute	The project was internally funded by The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2004, J KOREAN MED SCI, V19, P333, DOI 10.3346/jkms.2004.19.3.333; BECK A, 1969, J BACTERIOL, V100, P1204, DOI 10.1128/JB.100.3.1204-1207.1969; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chuang I, 2002, CLIN INFECT DIS, V35, P665, DOI 10.1086/342062; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; Eidelman Arthur I, 2002, J Perinatol, V22, P467, DOI 10.1038/sj.jp.7210774; EVANS HE, 1977, OBSTET GYNECOL, V49, P35; GALASK RP, 1970, AM J OBSTET GYNECOL, V106, P59, DOI 10.1016/0002-9378(70)90126-2; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Kreikemeyer B, 2002, MICROBIOL-SGM, V148, P1501, DOI 10.1099/00221287-148-5-1501; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; LARSEN B, 1974, AM J OBSTET GYNECOL, V119, P492, DOI 10.1016/0002-9378(74)90207-5; LARSEN B, 1974, AM J OBSTET GYNECOL, V119, P497, DOI 10.1016/0002-9378(74)90208-7; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Modena Alberto Bacchi, 2004, Acta Biomed, V75 Suppl 1, P11; Mylvaganam H, 2009, CLIN MICROBIOL INFEC, V15, P245, DOI 10.1111/j.1469-0691.2008.02664.x; Nair S, 2003, MICROBIOL-SGM, V149, P407, DOI 10.1099/mic.0.25783-0; Nilsson S, 2004, J PROTEOME RES, V3, P884, DOI 10.1021/pr0499545; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; Pasteur L., 1879, B ACAD NATL MED, VVIII, P271; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; PIERCE WILLIAM A., 1955, JOUR BACT, V69, P230; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; POMMERENKE W T, 1953, Ann Ostet Ginecol, V75, P891; Purushothaman SS, 2004, INDIAN J MED RES, V119, P44; Quivey RG, 2001, CRIT REV ORAL BIOL M, V12, P301, DOI 10.1177/10454411010120040201; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sitkiewicz I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006114; SOZANSKII A, 1961, B EXP BIOL MED+, V51, P323, DOI 10.1007/BF00783508; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Steiner K, 2002, INFECT IMMUN, V70, P3627, DOI 10.1128/IAI.70.7.3627-3636.2002; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tran SH, 2003, AM J OBSTET GYNECOL, V189, P746, DOI 10.1067/S0002-9378(03)00767-1; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Voyich JM, 2003, P NATL ACAD SCI USA, V100, P1996, DOI 10.1073/pnas.0337370100	52	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9785	10.1371/journal.pone.0009785	http://dx.doi.org/10.1371/journal.pone.0009785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352104	gold, Green Submitted, Green Published			2022-12-27	WOS:000275894400009
J	Ang, CW; Dijkstra, JR; de Klerk, MA; Endtz, HP; van Doorn, PA; Jacobs, BC; Jeurissen, SHM; Wagenaar, JA				Ang, C. Wim; Dijkstra, Jeroen R.; de Klerk, Marcel A.; Endtz, Hubert Ph; van Doorn, Pieter A.; Jacobs, Bart C.; Jeurissen, Suzan H. M.; Wagenaar, Jaap A.			Host Factors Determine Anti-GM1 Response Following Oral Challenge of Chickens with Guillain-Barre Syndrome Derived Campylobacter jejuni Strain GB11	PLOS ONE			English	Article							LIPOPOLYSACCHARIDES; ANTIBODIES; COLONIZATION; GANGLIOSIDES; INFECTION	Background: Anti-ganglioside antibodies with a pathogenic potential are present in C. jejuni-associated Guillain-Barre syndrome (GBS) patients and are probably induced by molecular mimicry. Immunization studies in rabbits and mice have demonstrated that these anti-ganglioside antibodies can be induced using purified lipo-oligosaccharides (LOS) from C. jejuni in a strong adjuvant. Methodology/Principal Findings: To investigate whether natural colonization of chickens with a ganglioside-mimicking C. jejuni strain induces an anti-ganglioside response, and to investigate the diversity in anti-ganglioside response between and within genetically different chicken lines, we orally challenged chickens with different C. jejuni strains. Oral challenge of chickens with a C. jejuni strain from a GBS patient, containing a LOS that mimics ganglioside GM1, induced specific IgM and IgG anti-LOS and anti-GM1 antibodies. Inoculation of chickens with the Penner HS:3 serostrain, without a GM1-like structure, induced anti-LOS but no anti-ganglioside antibodies. We observed different patterns of anti-LOS/ganglioside response between and within the five strains of chickens. Conclusions: Natural infection of chickens with C. jejuni induces anti-ganglioside antibodies. The production of antibodies is governed by both microbial and host factors.	[Ang, C. Wim] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Ang, C. Wim; de Klerk, Marcel A.; van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ang, C. Wim; de Klerk, Marcel A.; Jacobs, Bart C.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Ang, C. Wim; Endtz, Hubert Ph] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Endtz, Hubert Ph] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Dijkstra, Jeroen R.; Jeurissen, Suzan H. M.; Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] WHO Collaborating Ctr Campylobacter, OIE Reference Lab Campylobacteriosis, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; International Centre for Diarrhoeal Disease Research (ICDDR); Wageningen University & Research; Utrecht University	Ang, CW (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	w.ang@vumc.nl	Dijkstra, Jeroen R/N-4383-2015; Jacobs, Bart/ABE-2210-2021					Ang CW, 2000, J NEUROIMMUNOL, V111, P229, DOI 10.1016/S0165-5728(00)00369-6; Ang CW, 2000, J NEUROIMMUNOL, V104, P133, DOI 10.1016/S0165-5728(99)00279-9; Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Ang CW, 2001, INFECT IMMUN, V69, P2462, DOI 10.1128/IAI.69.4.2462-2469.2001; ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; Gilbert M, 2004, INFECT IMMUN, V72, P1162, DOI 10.1128/IAI.72.2.1162-1165.2004; Gilbert M, 2008, CAMPYLOBACTER, 3RD EDITION, P483; Godschalk PCR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-32; Goodyear CS, 1999, J CLIN INVEST, V104, P697, DOI 10.1172/JCI6837; Jacobs BC, 1997, J NEUROIMMUNOL, V79, P62, DOI 10.1016/S0165-5728(97)00110-0; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; KRAMER J, 2003, THESIS ERASMUS U ROT; Li CY, 1996, J NEUROL NEUROSUR PS, V61, P279, DOI 10.1136/jnnp.61.3.279; Nachamkin I, 1997, ANN NEUROL, V42, pM80; Phongsisay V, 2006, INFECT IMMUN, V74, P1368, DOI 10.1128/IAI.74.2.1368-1372.2006; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Usuki S, 2006, EXP NEUROL, V200, P50, DOI 10.1016/j.expneurol.2006.01.011; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Willison HJ, 2006, ACTA NEUROL SCAND, V113, P14, DOI 10.1111/j.1600-0404.2006.00607.x; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9820	10.1371/journal.pone.0009820	http://dx.doi.org/10.1371/journal.pone.0009820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339556	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894300032
J	Mednick, SC; Christakis, NA; Fowler, JH				Mednick, Sara C.; Christakis, Nicholas A.; Fowler, James H.			The Spread of Sleep Loss Influences Drug Use in Adolescent Social Networks	PLOS ONE			English	Article							PEER PRESSURE; SUSCEPTIBILITY; DETERIORATION; ASSOCIATION; PERFORMANCE; MEDIATION; PATTERNS; VALIDITY; SMOKING; NIGHT	Troubled sleep is a commonly cited consequence of adolescent drug use, but it has rarely been studied as a cause. Nor have there been any studies of the extent to which sleep behavior can spread in social networks from person to person to person. Here we map the social networks of 8,349 adolescents in order to study how sleep behavior spreads, how drug use behavior spreads, and how a friend's sleep behavior influences one's own drug use. We find clusters of poor sleep behavior and drug use that extend up to four degrees of separation (to one's friends' friends' friends' friends) in the social network. Prospective regression models show that being central in the network negatively influences future sleep outcomes, but not vice versa. Moreover, if a friend sleeps <= 7 hours, it increases the likelihood a person sleeps <= 7 hours by 11%. If a friend uses marijuana, it increases the likelihood of marijuana use by 110%. Finally, the likelihood that an individual uses drugs increases by 19% when a friend sleeps <= 7 hours, and a mediation analysis shows that 20% of this effect results from the spread of sleep behavior from one person to another. This is the first study to suggest that the spread of one behavior in social networks influences the spread of another. The results indicate that interventions should focus on healthy sleep to prevent drug use and targeting specific individuals may improve outcomes across the entire social network.	[Mednick, Sara C.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Christakis, Nicholas A.] Harvard Univ, Dept Med, Boston, MA 02115 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Harvard University; University of California System; University of California San Diego	Mednick, SC (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	smednick@ucsd.edu	Fowler, James H/C-2750-2008; Christakis, Nicholas A/C-3205-2009	Fowler, James H/0000-0001-7795-1638; mednick, sara/0000-0002-0906-3097	National Institute of Mental Health (NIMH) [K01MH080992]; Christakis and Fowler by National Institute on Aging (NIA) [P01AG031093]; Pioneer Portfolio of the Robert Wood Johnson Foundation [58729]; National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Christakis and Fowler by National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pioneer Portfolio of the Robert Wood Johnson Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Mednick was supported by National Institute of Mental Health (NIMH) grant K01MH080992, Christakis and Fowler by National Institute on Aging (NIA) grant P01AG031093 and by grant # 58729 from the Pioneer Portfolio of the Robert Wood Johnson Foundation; the National Longitudinal Study of Adolescent Health was originally funded by National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER I, 1981, J STUD ALCOHOL, V42, P701, DOI 10.15288/jsa.1981.42.701; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARRATT ES, 1974, BIOL PSYCHIAT, V8, P47; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; BOLLA KI, 2008, SLEEP, V31; Bollen K. A., 1990, SOCIOLOGICAL METHODO, P115; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; BONACICH P, 1971, J MATH SOCIOL, V92, P1170; Burke CK, 2008, J SUBST ABUSE TREAT, V35, P328, DOI 10.1016/j.jsat.2007.10.003; CACIOPPO JT, 2009, J PERSONALI IN PRESS; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Califano J., 2007, WASTING BEST BRIGHTE; CARSKADON M A, 1990, Pediatrician, V17, P5; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; COHENZION M, ADDIC BEHAV IN PRESS; Crum RM, 2004, ALCOHOL CLIN EXP RES, V28, P1533, DOI 10.1097/01.ALC.0000141915.56236.40; DIELMAN TE, 1992, J SCHOOL HEALTH, V62, P233, DOI 10.1111/j.1746-1561.1992.tb01233.x; DIELMAN TE, 1987, HEALTH EDUC QUART, V14, P207, DOI 10.1177/109019818701400207; FEINBERG I, 1976, CLIN PHARM THERAPEUT, V19; Foundation NS, 2006, SLEEP AM POLL, P2006; FOWLER JH, 2010, P NATL ACAD IN PRESS; Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447; Hayashi M, 1999, INT J PSYCHOPHYSIOL, V32, P173, DOI 10.1016/S0167-8760(99)00009-4; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Kamada T., 1989, INFORM PROCESSING LE, V31; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mednick SC, 2008, BEHAV BRAIN RES, V193, P79, DOI 10.1016/j.bbr.2008.04.028; Mednick SC, 2008, BEHAV NEUROSCI, V122, P267, DOI 10.1037/0735-7044.122.2.267; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; MEDNICK SC, 2009, VISION RES; Murphy DA, 2000, AM J EPIDEMIOL, V152, P805, DOI 10.1093/aje/152.9.805; National Instituteon Drug Abuse (NIDA), 2007, NIH PUBL; O'Donnell J A, 1982, Chem Depend, V4, P229; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; PHILIP G, 2002, J SLEEP RES, V11, P229; Rosenquist J. N., 2010, ANN INTERNAL MED, V152; ROSENQUIST JN, 2010, MOL PSYCHIAT, V15; Schulenberg, 2007, MONITORING FUTURE NA; Schwartz SJ, 2009, YOUTH SOC, V40, P541, DOI 10.1177/0044118X08327506; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; SZABO G, NETWORK EFFECTS SERV; Tubman J G, 1991, J Subst Abuse, V3, P405; Udry J.R, 2003, NATL LONGITUDINAL ST; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Wong MM, 2009, SLEEP MED, V10, P787, DOI 10.1016/j.sleep.2008.06.015	55	147	151	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9775	10.1371/journal.pone.0009775	http://dx.doi.org/10.1371/journal.pone.0009775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	572EH	20333306	Green Published, gold			2022-12-27	WOS:000275809700014
J	Crabb, DP; Smith, ND; Rauscher, FG; Chisholm, CM; Barbur, JL; Edgar, DF; Garway-Heath, DF				Crabb, David P.; Smith, Nicholas D.; Rauscher, Franziska G.; Chisholm, Catharine M.; Barbur, John L.; Edgar, David F.; Garway-Heath, David F.			Exploring Eye Movements in Patients with Glaucoma When Viewing a Driving Scene	PLOS ONE			English	Article							VISUAL-FIELD LOSS; FIXATION STABILITY; MACULAR DEGENERATION; VISION; PERFORMANCE; FITNESS; SCOTOMAS; DRIVERS; WALKING; SEARCH	Background: Glaucoma is a progressive eye disease and a leading cause of visual disability. Automated assessment of the visual field determines the different stages in the disease process: it would be desirable to link these measurements taken in the clinic with patient's actual function, or establish if patients compensate for their restricted field of view when performing everyday tasks. Hence, this study investigated eye movements in glaucomatous patients when viewing driving scenes in a hazard perception test (HPT). Methodology/Principal Findings: The HPT is a component of the UK driving licence test consisting of a series of short film clips of various traffic scenes viewed from the driver's perspective each containing hazardous situations that require the camera car to change direction or slow down. Data from nine glaucomatous patients with binocular visual field defects and ten age-matched control subjects were considered (all experienced drivers). Each subject viewed 26 different films with eye movements simultaneously monitored by an eye tracker. Computer software was purpose written to pre-process the data, co-register it to the film clips and to quantify eye movements and point-of-regard (using a dynamic bivariate contour ellipse analysis). On average, and across all HPT films, patients exhibited different eye movement characteristics to controls making, for example, significantly more saccades (P<0.001; 95% confidence interval for mean increase: 9.2 to 22.4%). Whilst the average region of 'point-of-regard' of the patients did not differ significantly from the controls, there were revealing cases where patients failed to see a hazard in relation to their binocular visual field defect. Conclusions/Significance: Characteristics of eye movement patterns in patients with bilateral glaucoma can differ significantly from age-matched controls when viewing a traffic scene. Further studies of eye movements made by glaucomatous patients could provide useful information about the definition of the visual field component required for fitness to drive.	[Crabb, David P.; Smith, Nicholas D.; Rauscher, Franziska G.; Barbur, John L.; Edgar, David F.] City Univ London, Dept Optometry & Visual Sci, London, England; [Chisholm, Catharine M.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Garway-Heath, David F.] Moorfields Eye Hosp, NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Garway-Heath, David F.] UCL Inst Ophthalmol, London, England	City University London; University of Bradford; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Crabb, DP (corresponding author), City Univ London, Dept Optometry & Visual Sci, London, England.	David.Crabb.1@city.ac.uk	Rauscher, Franziska/AAV-8222-2021	Rauscher, Franziska/0000-0003-0183-0340; Barbur, John/0000-0002-2187-5004; Crabb, David/0000-0001-8754-3902; Garway-Heath, David/0000-0003-2907-6992	Moorfields Eye Hospital Special Trustees; UK Department for Transport; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology	Moorfields Eye Hospital Special Trustees; UK Department for Transport; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital(National Institute for Health Research (NIHR)); UCL Institute of Ophthalmology	Nicholas Smith was supported by unrestricted funding from the Moorfields Eye Hospital Special Trustees. The authors acknowledge the UK Department for Transport financial support for the project that secured the HPT data in patients with glaucoma. One of the authors (DGH) has received a proportion of his funding from the Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altangerel U, 2006, OPHTHAL EPIDEMIOL, V13, P67, DOI 10.1080/09286580500428500; Ang GS, 2007, EYE, V21, P604, DOI 10.1038/sj.eye.6702284; Bellmann C, 2004, OPHTHALMOLOGY, V111, P2265, DOI 10.1016/j.ophtha.2004.06.019; Bhargava JS, 2006, INVEST OPHTH VIS SCI, V47, P2885, DOI 10.1167/iovs.05-1244; Cheong AMY, 2008, OPTOMETRY VISION SCI, V85, P26, DOI 10.1097/OPX.0b013e31815ed6fd; Chisholm CM, 2008, BRIT J OPHTHALMOL, V92, P225, DOI 10.1136/bjo.2007.129726; Coeckelbergh TRM, 2002, VISION RES, V42, P669, DOI 10.1016/S0042-6989(01)00297-8; Cornelissen FW, 2005, OPTOMETRY VISION SCI, V82, P27; Crabb DP, 2005, GRAEF ARCH CLIN EXP, V243, P210, DOI 10.1007/s00417-004-0984-x; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; Crossland MD, 2006, VISION RES, V46, P590, DOI 10.1016/j.visres.2005.05.015; Crossland MD, 2002, OPTOMETRY VISION SCI, V79, P735, DOI 10.1097/00006324-200211000-00011; Friedman DS, 2007, OPHTHALMOLOGY, V114, P2232, DOI 10.1016/j.ophtha.2007.02.001; Geruschat DR, 2006, OPTOMETRY VISION SCI, V83, P550, DOI 10.1097/01.opx.0000232219.23362.a6; Goldstein RB, 2007, COMPUT BIOL MED, V37, P957, DOI 10.1016/j.compbiomed.2006.08.018; Gonzalez EG, 2006, CAN J OPHTHALMOL, V41, P333, DOI 10.1139/I06-019; Grayson G, 2002, TRL558; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; HEALY HJR, 1972, APPL STAT, V21, P202; Henderson JM, 1997, PERCEPT PSYCHOPHYS, V59, P323, DOI 10.3758/BF03211901; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Jampel HD, 2002, INVEST OPHTH VIS SCI, V43, P1059; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Kotecha A, 2008, BRIT MED BULL, V87, P163, DOI 10.1093/bmb/ldn028; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; Nelson P, 2003, J GLAUCOMA, V12, P139, DOI 10.1097/00061198-200304000-00009; Noe G, 2003, CLIN EXP OPHTHALMOL, V31, P482, DOI 10.1046/j.1442-9071.2003.00712.x; Owen VMF, 2008, INVEST OPHTH VIS SCI, V49, P2449, DOI 10.1167/iovs.07-0877; RAUSCHER F, 79 UK DEP TRANSP; SMITH ND, 2007, EYE MOVEMENT ANAL GL; STAMPE DM, 1993, BEHAV RES METH INSTR, V25, P137, DOI 10.3758/BF03204486; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Turano KA, 2001, OPTOMETRY VISION SCI, V78, P667, DOI 10.1097/00006324-200109000-00012; Underwood G, 2005, OPHTHAL PHYSL OPT, V25, P346, DOI 10.1111/j.1475-1313.2005.00290.x; Underwood G, 2003, ERGONOMICS, V46, P629, DOI 10.1080/0014013031000090116; Underwood G., 2002, TRANSPORT RES F-TRAF, V5, P87, DOI DOI 10.1016/S1369-8478(02)00008-6; van der Geest JN, 2002, J NEUROSCI METH, V114, P185, DOI 10.1016/S0165-0270(01)00527-1; Vargas-Martin F, 2006, INVEST OPHTH VIS SCI, V47, P5295, DOI 10.1167/iovs.05-1043; Viswanathan AC, 1999, ARCH OPHTHALMOL-CHIC, V117, P450; Westlake W, 2000, BRIT MED J, V321, P972, DOI 10.1136/bmj.321.7267.972; White Stuart C, 2006, Gend Med, V3, P110, DOI 10.1016/S1550-8579(06)80200-7; [No title captured]	45	99	99	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9710	10.1371/journal.pone.0009710	http://dx.doi.org/10.1371/journal.pone.0009710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300522	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000275716400008
J	He, MA; Guo, H; Yang, XB; Zhou, L; Zhang, XM; Cheng, LX; Zeng, HS; Hu, FB; Tanguay, RM; Wu, TC				He, Meian; Guo, Huan; Yang, Xiaobo; Zhou, Li; Zhang, Xiaomin; Cheng, Longxian; Zeng, Hesong; Hu, Frank B.; Tanguay, Robert M.; Wu, Tangchun			Genetic Variations in HSPA8 Gene Associated with Coronary Heart Disease Risk in a Chinese Population	PLOS ONE			English	Article							APOPTOSIS; SHOCK; HEAT-SHOCK-PROTEIN-70; MECHANISMS; PROTECTION; HSP70; ATHEROSCLEROSIS; OVEREXPRESSION; CHAPERONES; PROTEINS	Background: There is ample evidence that Hsp70 takes part in the progress of coronary heart disease (CHD). This implies that genetic variants of Hsp70 genes such as HSPA8 (HSC70) gene might contribute to the development of CHD. The present study aimed to investigate whether certain genetic variants of HSPA8 gene are associated with CHD in Han Chinese people. Methodology/Principal Findings: A total of 2006 subjects (1003 CHD cases and 1003 age-and sex-matched healthy controls) were recruited. Genetic variants in the HSPA8 gene were identified by sequencing of the gene in 60 unrelated Chinese. Four tag single nucleotide polymorphisms (tagSNPs) (rs2236659, rs2276077, rs10892958, and rs1461496) were selected and genotyped. The function of the significant SNP was evaluated using luciferase reporter assays in two cell lines. By sequencing the promoter and all exons and introns of the HSPA8 gene, 23 genetic variants were identified. One promoter SNP rs2236659 was associated with susceptibility to CHD. Carriers of the "C'' allele of rs2236659 had decreased CHD risk with odds ratio (OR) of 0.78 (95% CI: 0.62, 0.98; P = 0.033) after adjustment for conventional risk factors. Haplotype analyses indicated that haplotype GCGC contributed to a lower CHD risk (OR = 0.78, 95% CI: 0.65, 0.93; P = 0.006) compared with the common haplotype AGGT. In a transfection assay, the C allele of rs2236659 showed a 37-40% increase in luciferase expression of the reporter gene luciferase in endothelial and non-endothelial cells compared with the T allele. Conclusions/Significance: These findings suggest that genetic variants in HSPA8 gene (especially promoter SNP rs2236659) contribute to the CHD susceptibility by affecting its expression level.	[He, Meian; Guo, Huan; Yang, Xiaobo; Zhou, Li; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [He, Meian; Guo, Huan; Yang, Xiaobo; Zhou, Li; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll,Minist Educ, Wuhan 430074, Peoples R China; [He, Meian; Cheng, Longxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430074, Peoples R China; [Zeng, Hesong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan 430074, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tanguay, Robert M.] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Lab Cellular & Dev Genet, Quebec City, PQ G1K 7P4, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Laval University	He, MA (corresponding author), Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Zhang, Xiaomin/F-3206-2018		National Natural Science Foundation [NSFC-30525031, NSFC-30430590, NSFC-30711120579]; Canadian Institutes of Health Research (CIHR); American Heart Association Established Investigator Award	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); American Heart Association Established Investigator Award(American Heart Association)	This work was supported by grants from the National Natural Science Foundation (grant NSFC-30525031 and NSFC-30430590) and a China-Canada Joint Health Research Grant of the Canadian Institutes of Health Research (CIHR) and the National Natural Science Foundation (grant NSFC-30711120579) to RMT and TW. FBH's work was supported in part by the American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolla MK, 1998, DIS MARKERS, V13, P227, DOI 10.1155/1998/235151; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chong KY, 1998, J MOL CELL CARDIOL, V30, P599, DOI 10.1006/jmcc.1997.0623; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de la Rosa EJ, 1998, P NATL ACAD SCI USA, V95, P9950, DOI 10.1073/pnas.95.17.9950; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Ding KY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-38; Ding KY, 2003, BIOINFORMATICS, V19, P2147, DOI 10.1093/bioinformatics/btg276; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; He MA, 2008, CELL STRESS CHAPERON, V13, P231, DOI 10.1007/s12192-008-0025-5; He MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004851; JOHNSON AD, 1995, ARTERIOSCL THROM VAS, V15, P27, DOI 10.1161/01.ATV.15.1.27; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mugge A, 1998, Z KARDIOL, V87, P851, DOI 10.1007/s003920050241; Steinberg D, 1999, J CLIN INVEST, V103, P1487, DOI 10.1172/JCI7298; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Su CY, 1998, J MOL CELL CARDIOL, V30, P587, DOI 10.1006/jmcc.1997.0622; Suzuki K, 2000, BASIC RES CARDIOL, V95, P397, DOI 10.1007/s003950070039; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Yun JK, 1997, P NATL ACAD SCI USA, V94, P13903, DOI 10.1073/pnas.94.25.13903	26	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9684	10.1371/journal.pone.0009684	http://dx.doi.org/10.1371/journal.pone.0009684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300519	gold, Green Published, Green Submitted			2022-12-27	WOS:000275716400004
J	Samengo, I; Montemurro, MA				Samengo, Ines; Montemurro, Marcelo A.			Conversion of Phase Information into a Spike-Count Code by Bursting Neurons	PLOS ONE			English	Article							EVOKED-POTENTIALS; IN-VIVO; OSCILLATIONS; PRECESSION; MODULATION; POPULATIONS; FREQUENCY; DYNAMICS; CORTEX	Single neurons in the cerebral cortex are immersed in a fluctuating electric field, the local field potential (LFP), which mainly originates from synchronous synaptic input into the local neural neighborhood. As shown by recent studies in visual and auditory cortices, the angular phase of the LFP at the time of spike generation adds significant extra information about the external world, beyond the one contained in the firing rate alone. However, no biologically plausible mechanism has yet been suggested that allows downstream neurons to infer the phase of the LFP at the soma of their pre-synaptic afferents. Therefore, so far there is no evidence that the nervous system can process phase information. Here we study a model of a bursting pyramidal neuron, driven by a time-dependent stimulus. We show that the number of spikes per burst varies systematically with the phase of the fluctuating input at the time of burst onset. The mapping between input phase and number of spikes per burst is a robust response feature for a broad range of stimulus statistics. Our results suggest that cortical bursting neurons could play a crucial role in translating LFP phase information into an easily decodable spike count code.	[Samengo, Ines] Ctr Atom Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Samengo, Ines] Inst Balseiro, San Carlos De Bariloche, Rio Negro, Argentina; [Montemurro, Marcelo A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; University of Manchester	Samengo, I (corresponding author), Ctr Atom Bariloche, San Carlos De Bariloche, Rio Negro, Argentina.	M.Montemurro@manchester.ac.uk	Samengo, Ines/AAY-7605-2020	Montemurro, Marcelo/0000-0003-0893-8530	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Comision Nacional de Energi-a Atomica; Agencia Nacional de Promocion Cienti-fica y Tecnologica; Universidad Nacional de Cuyo of Argentina; UK Medical Research Council (MRC); Royal Society; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/C010841/1]; MRC [G0600164] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish; Medical Research Council [G0600164] Funding Source: researchfish	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Comision Nacional de Energi-a Atomica; Agencia Nacional de Promocion Cienti-fica y Tecnologica(ANPCyT); Universidad Nacional de Cuyo of Argentina; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Ines Samengo acknowledges support from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Comision Nacional de Energi-a Atomica, Agencia Nacional de Promocion Cienti-fica y Tecnologica and Universidad Nacional de Cuyo of Argentina (IS). Marcelo A. Montenurro was supported by the UK Medical Research Council (MRC), the Royal Society, and UK Engineering and Physical Sciences Research Council (EPSRC) grant EP/C010841/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFKEN GB, 1999, MATH METHODS PHYS; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; BUCHWALD JS, 1965, NATURE, V205, P1012, DOI 10.1038/2051012a0; Buonviso N, 2006, CHEM SENSES, V31, P145, DOI 10.1093/chemse/bjj010; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cang JH, 2003, J NEUROSCI, V23, P4108; Coombes S, 1999, PHYS REV E, V60, P2086, DOI 10.1103/PhysRevE.60.2086; Coombes S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041914; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 2006, EU J NEUROSCI, V2, P588; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; FROMM GH, 1967, ELECTROEN CLIN NEURO, V22, P159, DOI 10.1016/0013-4694(67)90156-3; FROMM GH, 1964, ELECTROEN CLIN NEURO, V17, P520, DOI 10.1016/0013-4694(64)90182-8; Gollisch T, 2005, PLOS BIOL, V3, P144, DOI 10.1371/journal.pbio.0030008; Gollisch T, 2002, J NEUROSCI, V22, P10434; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Juergens E, 1999, EXP BRAIN RES, V129, P247, DOI 10.1007/s002210050895; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Kepecs A, 2002, J NEUROSCI, V22, P9053; Latham PE, 2008, CURR BIOL, V18, pR349, DOI 10.1016/j.cub.2008.02.062; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MARSAN CA, 1965, ISRAEL J MED SCI, V1, P104; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nadasdy Z, 1998, NEURONAL ENSEMBLES: STRATEGIES FOR RECORDING AND DECODING, P17; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; WANG XJ, 1994, NEUROSCIENCE, V59, P21, DOI 10.1016/0306-4522(94)90095-7; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	45	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9669	10.1371/journal.pone.0009669	http://dx.doi.org/10.1371/journal.pone.0009669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300632	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000275620900006
J	Lauterbach, H; Kassub, R; Patzold, J; Korner, J; Bruckel, M; Verschoor, A; Chaplin, P; Suter, M; Hochrein, H				Lauterbach, Henning; Kassub, Ronny; Paetzold, Juliane; Koerner, Jana; Brueckel, Michael; Verschoor, Admar; Chaplin, Paul; Suter, Mark; Hochrein, Hubertus			Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; POXVIRUS INFECTION; VIRUS ANKARA; PROTECTIVE IMMUNITY; GENETIC-RESISTANCE; ECTROMELIA-VIRUS; CUTTING EDGE; IN-VIVO; B-CELLS; VACCINATION	Current prophylactic vaccines work via the induction of B and T cell mediated memory that effectively control further replication of the pathogen after entry. In the case of therapeutic or post-exposure vaccinations the situation is far more complex, because the pathogen has time to establish itself in the host, start producing immune-inhibitory molecules and spread into distant organs. So far it is unclear which immune parameters have to be activated in order to thwart an existing lethal infection. Using the mousepox model, we investigated the immunological mechanisms responsible for a successful post-exposure immunization with modified vaccinia Ankara (MVA). In contrast to intranasal application of MVA, we found that intravenous immunization fully protected mice infected with ectromelia virus (ECTV) when applied three days after infection. Intravenous MVA immunization induced strong innate and adaptive immune responses in lethally infected mice. By using various gene-targeted and transgenic mouse strains we show that NK cells, CD4 T cells, CD8 T cells and antibodies are essential for the clearance of ECTV after post-exposure immunization. Post-exposure immunization with MVA is an effective measure in a murine model of human smallpox. MVA activates innate and adaptive immune parameters and only a combination thereof is able to purge ECTV from its host. These data not only provide a basis for therapeutic vaccinations in the case of the deliberate release of pathogenic poxviruses but possibly also for the treatment of chronic infections and cancer.	[Lauterbach, Henning; Kassub, Ronny; Paetzold, Juliane; Chaplin, Paul; Suter, Mark; Hochrein, Hubertus] Bavarian Nord GmbH, Dept Res, Martinsried, Germany; [Koerner, Jana; Brueckel, Michael] Bavarian Nord GmbH, Preclin Dev Dept, Martinsried, Germany; [Verschoor, Admar] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Suter, Mark] Univ Zurich, Zurich, Switzerland	Bavarian Nordic; Bavarian Nordic; Technical University of Munich; University of Zurich	Lauterbach, H (corresponding author), Bavarian Nord GmbH, Dept Res, Martinsried, Germany.	henning.lauterbach@bavarian-nordic.com	Hochrein, Hubertus/L-3697-2013	Hochrein, Hubertus/0000-0001-9904-1934; Lauterbach, Henning/0000-0002-6062-5163	Bavarian Nordic GmbH	Bavarian Nordic GmbH	Bavarian Nordic GmbH is the funder of this study. All authors except Admar Verschoor are employees of Bavarian Nordic GmbH. The authors, as employees of Bavarian Nordic GmbH, designed the study, collected and analyzed data, decided to publish and prepared the manuscript.	ANDREWES CH, 1948, BRIT J EXP PATHOL, V29, P329; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; BURNET FM, 1946, J IMMUNOL, V53, P1; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; FENNER F, 1949, AUST J EXP BIOL MED, V27, P19, DOI 10.1038/icb.1949.2; FENNER F, 1949, J IMMUNOL, V63, P341; FENNER F, 1947, AUST J EXP BIOL MED, V25, P257, DOI 10.1038/icb.1947.38; Garza NL, 2009, VACCINE, V27, P5496, DOI 10.1016/j.vaccine.2009.06.105; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Hanke T, 1998, J GEN VIROL, V79, P83, DOI 10.1099/0022-1317-79-1-83; JACOBY RO, 1989, ARCH VIROL, V108, P49, DOI 10.1007/BF01313742; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Jones T, 2008, CURR OPIN MOL THER, V10, P407; KARUPIAH G, 1993, J VIROL, V67, P4214, DOI 10.1128/JVI.67.7.4214-4226.1993; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Lehmann MH, 2009, J VIROL, V83, P2540, DOI 10.1128/JVI.01884-08; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Marchal J, 1930, J PATHOL BACTERIOL, V33, P713, DOI 10.1002/path.1700330317; MCCARTHY K, 1948, BRIT J EXP PATHOL, V29, P501; Merrick AE, 2009, CURR OPIN INVEST DR, V10, P1372; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Panchanathan V, 2005, P NATL ACAD SCI USA, V102, P12921, DOI 10.1073/pnas.0505180102; PANCHANATHAN V, 2010, IMMUNOL CELL BIOL; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Paran N, 2009, J INFECT DIS, V199, P39, DOI 10.1086/595565; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Parker S, 2009, VIROLOGY, V385, P11, DOI 10.1016/j.virol.2008.11.015; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Prieur E, 2004, P NATL ACAD SCI USA, V101, P290, DOI 10.1073/pnas.0307158101; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Smith VP, 2000, J VIROL, V74, P8460, DOI 10.1128/JVI.74.18.8460-8471.2000; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Wang Y, 2009, J IMMUNOL, V183, P3324, DOI 10.4049/jimmunol.0803985; WERNER GT, 1980, ARCH VIROL, V64, P247, DOI 10.1007/BF01322704; *WHO, 1980, 4 WHO; Zaunders JJ, 2006, J VIROL, V80, P10151, DOI 10.1128/JVI.02670-05	57	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9659	10.1371/journal.pone.0009659	http://dx.doi.org/10.1371/journal.pone.0009659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300179	Green Submitted, gold, Green Published			2022-12-27	WOS:000275620600014
J	Goehler, H; Droge, A; Lurz, R; Schnoegl, S; Chernoff, YO; Wanker, EE				Goehler, Heike; Droege, Anja; Lurz, Rudi; Schnoegl, Sigrid; Chernoff, Yury O.; Wanker, Erich E.			Pathogenic Polyglutamine Tracts Are Potent Inducers of Spontaneous Sup35 and Rnq1 Amyloidogenesis	PLOS ONE			English	Article							AMYLOID-LIKE FIBRILS; PRION-LIKE FACTOR; YEAST PSI+ PRION; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASE; GLUTAMINE-RICH; IN-VITRO; COMMON MECHANISM; ASPARAGINE-RICH; PROTEIN	The glutamine/asparagine (Q/N)-rich yeast prion protein Sup35 has a low intrinsic propensity to spontaneously self-assemble into ordered, beta-sheet-rich amyloid fibrils. In yeast cells, de novo formation of Sup35 aggregates is greatly facilitated by high protein concentrations and the presence of preformed Q/N-rich protein aggregates that template Sup35 polymerization. Here, we have investigated whether aggregation-promoting polyglutamine (polyQ) tracts can stimulate the de novo formation of ordered Sup35 protein aggregates in the absence of Q/N-rich yeast prions. Fusion proteins with polyQ tracts of different lengths were produced and their ability to spontaneously self-assemble into amlyloid structures was analyzed using in vitro and in vivo model systems. We found that Sup35 fusions with pathogenic (>= 54 glutamines), as opposed to non-pathogenic (19 glutamines) polyQ tracts efficiently form seeding-competent protein aggregates. Strikingly, polyQ-mediated de novo assembly of Sup35 protein aggregates in yeast cells was independent of pre-existing Q/N-rich protein aggregates. This indicates that increasing the content of aggregation-promoting sequences enhances the tendency of Sup35 to spontaneously self-assemble into insoluble protein aggregates. A similar result was obtained when pathogenic polyQ tracts were linked to the yeast prion protein Rnq1, demonstrating that polyQ sequences are generic inducers of amyloidogenesis. In conclusion, long polyQ sequences are powerful molecular tools that allow the efficient production of seeding-competent amyloid structures.	[Goehler, Heike; Droege, Anja; Schnoegl, Sigrid; Wanker, Erich E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lurz, Rudi] Max Planck Inst Mol Genet, Berlin, Germany; [Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Chernoff, Yury O.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Goehler, H (corresponding author), Protagen AG, Dortmund, Germany.	ewanker@mdc-berlin.de	Chernoff, Yury O/J-2833-2014	Chernoff, Yury/0000-0002-8934-9051; Wanker, Erich/0000-0001-8072-1630	HDSA, DFG [WA1151/5-1]; BMBF [NGFN1/2, 01GS08170, 0311853]; National Institutes of Health [R01GM58763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058763] Funding Source: NIH RePORTER	HDSA, DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from HDSA, DFG (WA1151/5-1) and BMBF (NGFN1/2 and NGFNplus 01GS08170 as well as the BioFuture project 0311853) to EEW. YOC was supported by grant R01GM58763 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bousset L, 2008, CURR ALZHEIMER RES, V5, P251, DOI 10.2174/156720508784533303; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Holz C, 2001, GENOME RES, V11, P1730, DOI 10.1101/gr.181501; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pellarin R, 2007, J MOL BIOL, V374, P917, DOI 10.1016/j.jmb.2007.09.090; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TERAVANESYAN MD, 1994, GENETICS, V137, P671; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wu YX, 2005, P NATL ACAD SCI USA, V102, P12789, DOI 10.1073/pnas.0506384102	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9642	10.1371/journal.pone.0009642	http://dx.doi.org/10.1371/journal.pone.0009642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224794	gold, Green Accepted, Green Published			2022-12-27	WOS:000275328800033
J	Hong, JH; Min, CH; Jeong, B; Kojiya, T; Morioka, E; Nagai, T; Ikeda, M; Lee, KJ				Hong, Jin Hee; Min, Cheol Hong; Jeong, Byeongha; Kojiya, Tomoyoshi; Morioka, Eri; Nagai, Takeharu; Ikeda, Masayuki; Lee, Kyoung J.			Intracellular Calcium Spikes in Rat Suprachiasmatic Nucleus Neurons Induced by BAPTA-Based Calcium Dyes	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; CLOCK; CA2+; MODULATION; EXPRESSION; CHANNELS; CELLS; TRANSIENTS; CALBINDIN; DYNAMICS	Background: Circadian rhythms in spontaneous action potential (AP) firing frequencies and in cytosolic free calcium concentrations have been reported for mammalian circadian pacemaker neurons located within the hypothalamic suprachiasmatic nucleus (SCN). Also reported is the existence of "Ca2+ spikes" (i.e., [Ca2+](c) transients having a bandwidth of 10,100 seconds) in SCN neurons, but it is unclear if these SCN Ca2+ spikes are related to the slow circadian rhythms. Methodology/Principal Findings: We addressed this issue based on a Ca2+ indicator dye (fluo-4) and a protein Ca2+ sensor (yellow cameleon). Using fluo-4 AM dye, we found spontaneous Ca2+ spikes in 18% of rat SCN cells in acute brain slices, but the Ca2+ spiking frequencies showed no day/night variation. We repeated the same experiments with rat (and mouse) SCN slice cultures that expressed yellow cameleon genes for a number of different circadian phases and, surprisingly, spontaneous Ca2+ spike was barely observed (< 3%). When fluo-4 AM or BAPTA-AM was loaded in addition to the cameleon-expressing SCN cultures, however, the number of cells exhibiting Ca2+ spikes was increased to 13 similar to 14%. Conclusions/Significance: Despite our extensive set of experiments, no evidence of a circadian rhythm was found in the spontaneous Ca2+ spiking activity of SCN. Furthermore, our study strongly suggests that the spontaneous Ca2+ spiking activity is caused by the Ca2+ chelating effect of the BAPTA-based fluo-4 dye. Therefore, this induced activity seems irrelevant to the intrinsic circadian rhythm of [Ca2+](c) in SCN neurons. The problems with BAPTA based dyes are widely known and our study provides a clear case for concern, in particular, for SCN Ca2+ spikes. On the other hand, our study neither invalidates the use of these dyes as a whole, nor undermines the potential role of SCN Ca2+ spikes in the function of SCN.	[Hong, Jin Hee; Min, Cheol Hong; Jeong, Byeongha; Lee, Kyoung J.] Korea Univ, Ctr Cell Dynam, Seoul, South Korea; [Hong, Jin Hee; Min, Cheol Hong; Jeong, Byeongha; Lee, Kyoung J.] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Kojiya, Tomoyoshi; Morioka, Eri; Ikeda, Masayuki] Toyama Univ, Grad Sch Innovat Life Sci, Toyama 930, Japan; [Nagai, Takeharu] Hokkaido Univ, Lab Nanosyst Physiol, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Korea University; Korea University; University of Toyama; Hokkaido University	Hong, JH (corresponding author), Korea Univ, Ctr Cell Dynam, Seoul, South Korea.	kyoung@korea.ac.kr		Nagai, Takeharu/0000-0003-2650-9895	Korea Ministry of Science and Technology [R17-2007-017-01000-0]; Ministry of Education, Culture, Sports, Science and Technology Japan [16300104, 18021012]; Brain Science Foundation	Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain Science Foundation	This research was supported by the Acceleration Project (R17-2007-017-01000-0) of the Korea Ministry of Science and Technology (K. L.) and by a grant-in-aid for scientific research (16300104 and 18021012) from the Ministry of Education, Culture, Sports, Science and Technology Japan (M. I.) and a grant from the Brain Science Foundation (M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Roblero R, 2007, EUR J NEUROSCI, V26, P575, DOI 10.1111/j.1460-9568.2007.05679.x; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; EILERS J, 2005, IMAGING NEUROSCIENCE, P277; Grant SK, 2001, ANAL BIOCHEM, V294, P27, DOI 10.1006/abio.2001.5157; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Haak LL, 1999, J NEUROPHYSIOL, V81, P1308, DOI 10.1152/jn.1999.81.3.1308; Hamada T, 2003, J NEUROSCI, V23, P8820; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Honma S, 2003, TRENDS NEUROSCI, V26, P650, DOI 10.1016/j.tins.2003.09.012; Ikeda M, 2004, NEUROSCIENTIST, V10, P315, DOI 10.1177/10738584031262149; Ikeda M, 2003, EUR J NEUROSCI, V17, P1111, DOI 10.1046/j.1460-9568.2003.02515.x; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Ikeda M, 2003, EUR J NEUROSCI, V17, P58, DOI 10.1046/j.1460-9568.2003.02427.x; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Irwin RP, 2007, J NEUROSCI, V27, P11748, DOI 10.1523/JNEUROSCI.1840-07.2007; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Laemle LK, 2002, BRAIN RES, V953, P73, DOI 10.1016/S0006-8993(02)03272-9; LeSauter J, 1999, J NEUROSCI, V19, P5574; Mahoney MM, 2000, NEUROSCIENCE, V99, P565, DOI 10.1016/S0306-4522(00)00212-8; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Obrietan K, 1996, J NEUROSCI, V16, P3521; Park D, 2003, NAT NEUROSCI, V6, P337, DOI 10.1038/nn1033; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; REGEHR WD, 1992, CURR OPIN NEUROBIOL, V4, P373; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Sugiyama T, 2004, BIOCHEM BIOPH RES CO, V323, P479, DOI 10.1016/j.bbrc.2004.08.126; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; VANDENPOL AN, 1992, J NEUROSCI, V12, P2648; Wang Z, 1997, J NEUROSCI, V17, P7359; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057	42	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9634	10.1371/journal.pone.0009634	http://dx.doi.org/10.1371/journal.pone.0009634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224788	Green Published, gold			2022-12-27	WOS:000275328800028
J	Jemal, A; Ward, E; Thun, M				Jemal, Ahmedin; Ward, Elizabeth; Thun, Michael			Declining Death Rates Reflect Progress against Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; PROSTATE-CANCER; UNITED-STATES; RISK-FACTORS; LUNG-CANCER; GASTROESOPHAGEAL-REFLUX; COLORECTAL-CANCER; TOBACCO USE; MORTALITY; TRENDS	Background: The success of the "war on cancer'' initiated in 1971 continues to be debated, with trends in cancer mortality variably presented as evidence of progress or failure. We examined temporal trends in death rates from all-cancer and the 19 most common cancers in the United States from 1970-2006. Methodology/Principal Findings: We analyzed trends in age-standardized death rates (per 100,000) for all cancers combined, the four most common cancers, and 15 other sites from 1970-2006 in the United States using joinpoint regression model. The age-standardized death rate for all-cancers combined in men increased from 249.3 in 1970 to 279.8 in 1990, and then decreased to 221.1 in 2006, yielding a net decline of 21% and 11% from the 1990 and 1970 rates, respectively. Similarly, the all-cancer death rate in women increased from 163.0 in 1970 to 175.3 in 1991 and then decreased to 153.7 in 2006, a net decline of 12% and 6% from the 1991 and 1970 rates, respectively. These decreases since 1990/91 translate to preventing of 561,400 cancer deaths in men and 205,700 deaths in women. The decrease in death rates from all-cancers involved all ages and racial/ethnic groups. Death rates decreased for 15 of the 19 cancer sites, including the four major cancers, with lung, colorectum and prostate cancers in men and breast and colorectum cancers in women. Conclusions/Significance: Progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The downturn in cancer death rates since 1990 result mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers. Continued and increased investment in cancer prevention and control, access to high quality health care, and research could accelerate this progress.	[Jemal, Ahmedin; Thun, Michael] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA	American Cancer Society	Jemal, A (corresponding author), Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA.	ajemal@cancer.org			American Cancer Society	American Cancer Society(American Cancer Society)	The American Cancer Society funded this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; ANDERSON R, 1998, NATL VITAL STAT REPO, V47, P16; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Balis FM, 2002, PRINCIPLES PRACTICE, V4th, P237; BEGLEY S, 2008, NEWSWEEK, V151, P42; BEGLEY S, 2008, NEWSWEEK, V152, P46; Begley Sharon, 2008, Newsweek, V152, P57; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; BOFFETTA P, 1993, INT J EPIDEMIOL, V22, P377, DOI 10.1093/ije/22.3.377; Bray FI, 2010, INT J CANCER, V126, P1454, DOI 10.1002/ijc.24855; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Chu KC, 2003, CANCER, V97, P2853, DOI 10.1002/cncr.11411; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; CHU KC, 1991, JNCI-J NATL CANCER I, V83, P1636, DOI 10.1093/jnci/83.22.1636; Cole P, 1996, CANCER, V78, P2045, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2045::AID-CNCR3>3.0.CO;2-N; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; EDWARDS BK, 2009, CANCER; Edwards BK, 2009, CANCER, V116, P544, DOI DOI 10.1002/CNCR.24760; Einhorn L H, 1977, Urol Clin North Am, V4, P407; EINHORN LH, 1977, J UROLOGY, V117, P65, DOI 10.1016/S0022-5347(17)58338-X; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Eltom MA, 2002, J NATL CANCER I, V94, P1204, DOI 10.1093/jnci/94.16.1204; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Feuer EJ, 2002, CANCER-AM CANCER SOC, V95, P870, DOI 10.1002/cncr.10726; Feuer EJ, 1999, JNCI-J NATL CANCER I, V91, P1025, DOI 10.1093/jnci/91.12.1025; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; GILES GG, 1991, AUST J PUBLIC HEALTH, V15, P245; HARRIS G, 2009, NEW YORK TIMES  0915; HOEL DG, 1993, JNCI-J NATL CANCER I, V85, P1063, DOI 10.1093/jnci/85.13.1063; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2003, J NATL CANCER I, V95, P1727, DOI 10.1093/jnci/djg116; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KOLATA G, 2009, ADV ELUSIVE LONG DRI; KOSS LG, 1989, JAMA-J AM MED ASSOC, V261, P737, DOI 10.1001/jama.261.5.737; Leaf C, 2004, FORTUNE, V149, P76; Levi F, 2005, EUR J CANCER PREV, V14, P497, DOI 10.1097/00008469-200512000-00002; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; *NAT CACN I SURV R, 2009, SEER STAT SOFTW; National Center for Health Statistics, 2009, HLTH US 2008; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Oliver SE, 2001, INT J CANCER, V92, P893, DOI 10.1002/ijc.1260; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; Robles Sylvia C., 1996, Boletin de la Oficina Sanitaria Panamericana, V121, P478; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; *SEER, 2009, SEER CAUS DEATH REC; SEER Program, 2009, SEER STAT DAT MORT A; Shafey O, 2003, TOBACCO CONTROL COUN; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; SILVERMAN DT, 1994, JNCI-J NATL CANCER I, V86, P1510, DOI 10.1093/jnci/86.20.1510; SIMONE J, 2010, CANCER, P263; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Tarone RE, 1997, JNCI-J NATL CANCER I, V89, P251, DOI 10.1093/jnci/89.3.251; Taylor RJ, 2001, J EPIDEMIOL COMMUN H, V55, P782, DOI 10.1136/jech.55.11.782; Thun M.J., 2006, CANCER MED-US, V7th, P339; Thun MJ, 2006, TOB CONTROL, V15, P345, DOI 10.1136/tc.2006.017749; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; 2005, MMWR MORB MORTAL WKL, V54, P625	78	165	174	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9584	10.1371/journal.pone.0009584	http://dx.doi.org/10.1371/journal.pone.0009584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231893	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328300007
J	Lindstrom, MS; Nister, M				Lindstrom, Mikael S.; Nister, Monica			Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; HUMAN-MALIGNANT GLIOMA; P53-DEPENDENT CHECKPOINT; CYCLE ARREST; NUCLEOLAR DISRUPTION; DOWN-REGULATION; DNA-DAMAGE; MDM2; L11; DEGRADATION	Background: Disruption of the nucleolus often leads to activation of the p53 tumor suppressor pathway through inhibition of MDM2 that is mediated by a limited set of ribosomal proteins including RPL11 and RPL5. The effects of ribosomal protein loss in cultured mammalian cells have not been thoroughly investigated. Here we characterize the cellular stress response caused by depletion of ribosomal protein S9 (RPS9). Methodology/Principal Findings: Depletion of RPS9 impaired production of 18S ribosomal RNA and induced p53 activity. It promoted p53-dependent morphological differentiation of U343MGa Cl2:6 glioma cells as evidenced by intensified expression of glial fibrillary acidic protein and profound changes in cell shape. U2OS osteosarcoma cells displayed a limited senescence response with increased expression of DNA damage response markers, whereas HeLa cervical carcinoma cells underwent cell death by apoptosis. Knockdown of RPL11 impaired p53-dependent phenotypes in the different RPS9 depleted cell cultures. Importantly, knockdown of RPS9 or RPL11 also markedly inhibited cell proliferation through p53-independent mechanisms. RPL11 binding to MDM2 was retained despite decreased levels of RPL11 protein following nucleolar stress. In these settings, RPL11 was critical for maintaining p53 protein stability but was not strictly required for p53 protein synthesis. Conclusions: p53 plays an important role in the initial restriction of cell proliferation that occurs in response to decreased level of RPS9. Our results do not exclude the possibility that other nucleolar stress sensing molecules act upstream or in parallel to RPL11 to activate p53. Inhibiting the expression of certain ribosomal proteins, such as RPS9, could be one efficient way to reinitiate differentiation processes or to induce senescence or apoptosis in rapidly proliferating tumor cells.	[Lindstrom, Mikael S.; Nister, Monica] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Lindstrom, MS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	mikael.lindstrom@ki.se	Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	Ake Wiberg's foundation; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden); Swedish Cancer Society; Cancer Society in Stockholm; Swedish Research Council; Swedish Childhood Cancer Foundation; Karolinska University Hospital FoUU	Ake Wiberg's foundation; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Karolinska University Hospital FoUU	This study was made possible with the financial support to ML from Ake Wiberg's foundation, Karolinska Institutet funds and the Magnus Bergvall's foundation. ML is a recipient of a fellowship award from the Swedish Cancer Society (Cancerfonden). Work was carried out in the laboratory of MN, supported by the Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, the Swedish Childhood Cancer Foundation and Karolinska University Hospital FoUU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Badhai J, 2009, FEBS LETT, V583, P2049, DOI 10.1016/j.febslet.2009.05.023; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Flygare J, 2005, BLOOD, V105, P4627, DOI 10.1182/blood-2004-08-3115; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Langlois A, 2002, GLIA, V40, P85, DOI 10.1002/glia.10127; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; NISTER M, 1986, CANCER RES, V46, P332; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Svechnikova I, 2008, INT J ONCOL, V32, P821; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; WESTERMARK B, 1973, INT J CANCER, V12, P438, DOI 10.1002/ijc.2910120215; WESTERMARK B, 1982, J NEUROSCI RES, V8, P491, DOI 10.1002/jnr.490080236; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	70	63	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A116	A129	e9578	10.1371/journal.pone.0009578	http://dx.doi.org/10.1371/journal.pone.0009578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221446	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200011
J	Ng, SK; Lo, WS; Pun, FW; Zhao, CY; Yu, ZL; Chen, JH; Tong, KL; Xu, ZW; Tsang, SY; Yang, Q; Yu, WC; Nimgaonkar, V; Stober, G; Harano, M; Xue, H				Ng, Siu-Kin; Lo, Wing-Sze; Pun, Frank W.; Zhao, Cunyou; Yu, Zhiliang; Chen, Jianhuan; Tong, Ka-Lok; Xu, Zhiwen; Tsang, Shui-Ying; Yang, Qiang; Yu, Weichuan; Nimgaonkar, Vishwajit; Stoeber, Gerald; Harano, Mutsuo; Xue, Hong			A Recombination Hotspot in a Schizophrenia-Associated Region of GABRB2	PLOS ONE			English	Article							RECEPTOR BETA(2) GENE; HUMAN GENOME; NUCLEOTIDE SUBSTITUTIONS; LINKAGE-DISEQUILIBRIUM; MEIOTIC RECOMBINATION; POSITIVE SELECTION; POPULATION; SUBUNIT; SITES; POLYMORPHISMS	Background: Schizophrenia is a major disorder with complex genetic mechanisms. Earlier, population genetic studies revealed the occurrence of strong positive selection in the GABRB2 gene encoding the beta(2) subunit of GABA(A) receptors, within a segment of 3,551 bp harboring twenty-nine single nucleotide polymorphisms (SNPs) and containing schizophrenia-associated SNPs and haplotypes. Methodology/Principal Findings: In the present study, the possible occurrence of recombination in this `S1-S29' segment was assessed. The occurrence of hotspot recombination was indicated by high resolution recombination rate estimation, haplotype diversity, abundance of rare haplotypes, recurrent mutations and torsos in haplotype networks, and experimental haplotyping of somatic and sperm DNA. The sub-segment distribution of relative recombination strength, measured by the ratio of haplotype diversity (H(d)) over mutation rate (theta), was indicative of a human specific Alu-Yi6 insertion serving as a central recombining sequence facilitating homologous recombination. Local anomalous DNA conformation attributable to the Alu-Yi6 element, as suggested by enhanced DNase I sensitivity and obstruction to DNA sequencing, could be a contributing factor of the increased sequence diversity. Linkage disequilibrium (LD) analysis yielded prominent low LD points that supported ongoing recombination. LD contrast revealed significant dissimilarity between control and schizophrenic cohorts. Among the large array of inferred haplotypes, H26 and H73 were identified to be protective, and H19 and H81 risk-conferring, toward the development of schizophrenia. Conclusions/Significance: The co-occurrence of hotspot recombination and positive selection in the S1-S29 segment of GABRB2 has provided a plausible contribution to the molecular genetics mechanisms for schizophrenia. The present findings therefore suggest that genome regions characterized by the co-occurrence of positive selection and hotspot recombination, two interacting factors both affecting genetic diversity, merit close scrutiny with respect to the etiology of common complex disorders.	[Ng, Siu-Kin; Lo, Wing-Sze; Pun, Frank W.; Zhao, Cunyou; Chen, Jianhuan; Xu, Zhiwen; Tsang, Shui-Ying; Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Ng, Siu-Kin; Lo, Wing-Sze; Pun, Frank W.; Zhao, Cunyou; Yu, Zhiliang; Chen, Jianhuan; Tong, Ka-Lok; Xu, Zhiwen; Tsang, Shui-Ying; Yang, Qiang; Yu, Weichuan; Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Fok Ying Tung Grad Sch, Hong Kong, Hong Kong, Peoples R China; [Chen, Jianhuan; Tong, Ka-Lok; Yang, Qiang; Yu, Weichuan; Xue, Hong] Hong Kong Univ Sci & Technol, HKH Bioinformat Ctr, Hong Kong, Hong Kong, Peoples R China; [Yang, Qiang] Hong Kong Univ Sci & Technol, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Yu, Weichuan] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Dept Human Genet, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Stoeber, Gerald] Univ Wurzburg, Dept Psychiat & Psychotherapy, Wurzburg, Germany; [Harano, Mutsuo] Kurume Univ, Sch Med, Dept Neuropsychiat, Fukuoka, Japan	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wurzburg; Kurume University	Ng, SK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	hxue@ust.hk	Chen, Jian-Huan/ABB-9660-2021; Lo, Cario Wing Sze/DGZ-8810-2022; yang, qiang/GYJ-0971-2022; ZHAO, Cunyou/Q-5076-2016; Chen, Jian-Huan/L-7188-2017	Chen, Jian-Huan/0000-0001-8714-2543; ZHAO, Cunyou/0000-0001-6116-4584; Chen, Jian-Huan/0000-0001-8714-2543; Yu, Weichuan/0000-0002-5510-6916; Yang, Qiang/0000-0001-5059-8360; Xue, Hong/0000-0002-8133-9828	Fok Ying Tung Foundation; University Grants Council; Innovation and Technology Fund of Hong Kong Special Administrative Region Government	Fok Ying Tung Foundation(Fok Ying Tung Education Foundation); University Grants Council; Innovation and Technology Fund of Hong Kong Special Administrative Region Government	This work was supported by the fundings from the Fok Ying Tung Foundation, the University Grants Council, and the Innovation and Technology Fund of Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berchowitz LE, 2009, GENOME RES, V19, P2245, DOI 10.1101/gr.096297.109; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Freudenberg J, 2007, EUR J HUM GENET, V15, P1071, DOI 10.1038/sj.ejhg.5201876; Freudenberg J, 2007, BIOINFORMATICS, V23, P1441, DOI 10.1093/bioinformatics/btm137; GOTTESMAN II, 1989, SCHIZOPHRENIA BULL, V15, P5, DOI 10.1093/schbul/15.1.5; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Leonhard K., 1999, CLASSIFICATION ENDOG, V2nd; Li N, 2003, GENETICS, V165, P2213; Liu JX, 2005, BIOCHEM BIOPH RES CO, V334, P817, DOI 10.1016/j.bbrc.2005.06.167; Lo WS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000462; Lo WS, 2007, BIOL PSYCHIAT, V61, P653, DOI 10.1016/j.biopsych.2006.05.003; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Lupski JR, 2008, NATURE, V455, P178, DOI 10.1038/455178a; McGuffin Peter, 2003, Curr Psychiatry Rep, V5, P121, DOI 10.1007/s11920-003-0028-y; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2006, BIOCHEM SOC T, V34, P526, DOI 10.1042/BST0340526; NEI M, 1983, GENETICS, V105, P207; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Ng SK, 2006, GENE, V368, P110, DOI 10.1016/j.gene.2005.10.034; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Otto SP, 1997, GENETICS, V147, P879; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Purcell SM, 2009, NATURE; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; STEFANSSON H, 2009, NATURE; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yu ZL, 2006, CLIN BIOCHEM, V39, P210, DOI 10.1016/j.clinbiochem.2006.01.009; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; ZHANG Y, 2009, HDB ANAL HUMAN GENET, P25; Zhao C, 2006, MOL PSYCHIATR, V11, P1092, DOI 10.1038/sj.mp.4001899	45	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A18	A30	e9547	10.1371/journal.pone.0009547	http://dx.doi.org/10.1371/journal.pone.0009547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221451	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000275328200002
J	Stevens, JC; Chia, R; Hendriks, WT; Bros-Facer, V; van Minnen, J; Martin, JE; Jackson, GS; Greensmith, L; Schiavo, G; Fisher, EMC				Stevens, James C.; Chia, Ruth; Hendriks, William T.; Bros-Facer, Virginie; van Minnen, Jan; Martin, Joanne E.; Jackson, Graham S.; Greensmith, Linda; Schiavo, Giampietro; Fisher, Elizabeth M. C.			Modification of Superoxide Dismutase 1 (SOD1) Properties by a GFP Tag - Implications for Research into Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							FAMILIAL ALS; MUTANT SOD1; HUMAN-CELLS; MUTATIONS; PROTEIN; ULTRACENTRIFUGATION; DEATH; MODEL; GENE; MICE	Background: Since the discovery that mutations in the enzyme SOD1 are causative in human amyotrophic lateral sclerosis (ALS), many strategies have been employed to elucidate the toxic properties of this ubiquitously expressed mutant protein, including the generation of GFP-SOD1 chimaeric proteins for studies in protein localization by direct visualization using fluorescence microscopy. However, little is known about the biochemical and physical properties of these chimaeric proteins, and whether they behave similarly to their untagged SOD1 counterparts. Methodology/Principal Findings: Here we compare the physicochemical properties of SOD1 and the effects of GFP-tagging on its intracellular behaviour. Immunostaining demonstrated that SOD1 alone and GFP-SOD1 have an indistinguishable intracellular distribution in PC12 cells. Cultured primary motor neurons expressing GFP or GFP-SOD1 showed identical patterns of cytoplasmic expression and of movement within the axon. However, GFP tagging of SOD1 was found to alter some of the intrinsic properties of SOD1, including stability and specific activity. Evaluation of wildtype and mutant SOD1, tagged at either the N- or C-terminus with GFP, in PC12 cells demonstrated that some chimaeric proteins were degraded to the individual proteins, SOD1 and GFP. Conclusions/Significance: Our findings indicate that most, but not all, properties of SOD1 remain the same with a GFP tag.	[Stevens, James C.; Chia, Ruth; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Hendriks, William T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA USA; [Bros-Facer, Virginie; Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Sci & Movement Disorders, London, England; [van Minnen, Jan] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB, Canada; [Martin, Joanne E.] Queen Mary Univ London, ICMS Pathol Grp, London, England; [Jackson, Graham S.] UCL Inst Neurol, MRC Prion Unit, London, England; [Schiavo, Giampietro] Canc Res UK, Mol Neuropathobiol Lab, London, England	University of London; University College London; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of London; University College London; University of Calgary; University of London; Queen Mary University London; University of London; University College London; Cancer Research UK	Stevens, JC (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Fisher, Elizabeth MC/C-2168-2008	Chia, Ruth/0000-0002-4709-7423; Fisher, Elizabeth MC/0000-0003-2850-9936; Jackson, Graham/0000-0002-3125-2011; Schiavo, Giampietro/0000-0002-4319-8745	Ipsen Fund; UK Motor Neurone Disease Association; Research Advisory Board of St Bartholomew's and the Royal London Charitable Foundation [RAB04/F7]; Brain Research Trust; Biotechnology and Biological Sciences Research Council; Cancer Research UK; EU FP6 NEST [12702]; Medical Research Council [MC_U123170362, G0601943B, G0500288, G0601943] Funding Source: researchfish; MRC [G0601943, G0500288, MC_U123170362] Funding Source: UKRI	Ipsen Fund(Ipsen); UK Motor Neurone Disease Association; Research Advisory Board of St Bartholomew's and the Royal London Charitable Foundation; Brain Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); EU FP6 NEST(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by research grants from The Ipsen Fund, the UK Motor Neurone Disease Association, the Research Advisory Board of St Bartholomew's and the Royal London Charitable Foundation (RAB04/F7), The Brain Research Trust, the Biotechnology and Biological Sciences Research Council, Cancer Research UK and EU FP6 NEST grant 12702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; CHIA R, 2008, THESIS U COLL LONDON; CHIA R, 2010, PRION LIKE PRO UNPUB; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAYES DB, 2003, SEDNTERP SEDIMENTIAT; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	26	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A8	A17	e9541	10.1371/journal.pone.0009541	http://dx.doi.org/10.1371/journal.pone.0009541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221404	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328200001
J	Slominski, AT; Janjetovic, Z; Fuller, BE; Zmijewski, MA; Tuckey, RC; Nguyen, MN; Sweatman, T; Li, W; Zjawiony, J; Miller, D; Chen, TC; Lozanski, G; Holick, MF				Slominski, Andrzej T.; Janjetovic, Zorica; Fuller, Brian E.; Zmijewski, Michal A.; Tuckey, Robert C.; Nguyen, Minh N.; Sweatman, Trevor; Li, Wei; Zjawiony, Jordan; Miller, Duane; Chen, Tai C.; Lozanski, Gerard; Holick, Michael F.			Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity	PLOS ONE			English	Article							KAPPA-B ACTIVITY; ERYTHROID-DIFFERENTIATION; D ANALOGS; LEUKEMIA; RECEPTOR; INDUCTION; PATHWAY; SYSTEM; D3; PROLIFERATION	Background: Cytochrome P450scc metabolizes vitamin D3 to 20-hydroxyvitamin D3 (20(OH) D3) and 20,23(OH)(2)D3, as well as 1-hydroxyvitamin D3 to 1 alpha,20-dihydroxyvitamin D3 (1,20(OH)(2)D3). It also cleaves the side chain of 7-dehydrocholesterol producing 7-dehydropregnenolone (7DHP), which can be transformed to 20(OH)7DHP. UVB induces transformation of the steroidal 5,7-dienes to pregnacalciferol (pD) and a lumisterol-like compounds (pL). Methods and Findings: To define the biological significance of these P450scc-initiated pathways, we tested the effects of their 5,7-diene precursors and secosteroidal products on leukemia cell differentiation and proliferation in comparison to 1 alpha,25-dihydroxyvitamin D3 (1,25(OH)(2)D3). These secosteroids inhibited proliferation and induced erythroid differentiation of K562 human chronic myeloid and MEL mouse leukemia cells with 20(OH)D3 and 20,23(OH)(2)D3 being either equipotent or slightly less potent than 1,25(OH)(2)D3, while 1,20(OH)(2)D3, pD and pL compounds were slightly or moderately less potent. The compounds also inhibited proliferation and induced monocytic differentiation of HL-60 promyelocytic and U937 promonocytic human leukemia cells. Among them 1,25(OH)(2)D3 was the most potent, 20(OH)D3, 20,23(OH)(2)D3 and 1,20(OH)(2)D3 were less active, and pD and pL compounds were the least potent. Since it had been previously proven that secosteroids without the side chain (pD) have no effect on systemic calcium levels we performed additional testing in rats and found that 20(OH)D3 had no calcemic activity at concentration as high as 1 mg/kg, whereas, 1,20(OH)(2)D3 was slightly to moderately calcemic and 1,25(OH)(2)D3 had strong calcemic activity. Conclusions: We identified novel secosteroids that are excellent candidates for anti-leukemia therapy with 20(OH)D3 deserving special attention because of its relatively high potency and lack of calcemic activity.	[Slominski, Andrzej T.; Janjetovic, Zorica; Fuller, Brian E.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Zmijewski, Michal A.] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol Enzymol, PL-80952 Gdansk, Poland; [Zmijewski, Michal A.] Med Univ Gdansk, Gdansk, Poland; [Tuckey, Robert C.; Nguyen, Minh N.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia; [Sweatman, Trevor] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Sweatman, Trevor] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Li, Wei; Miller, Duane] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Zjawiony, Jordan] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA; [Zjawiony, Jordan] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, University, MS 38677 USA; [Chen, Tai C.; Holick, Michael F.] Boston Univ, Sch Med, Dept Med, Div Endocrinol, Boston, MA 02118 USA; [Lozanski, Gerard] Ohio State Univ, Dept Pathol & Lab Med, Columbus, OH 43210 USA	University of Tennessee System; University of Tennessee Health Science Center; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Western Australia; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Mississippi; University of Mississippi; Boston University; University System of Ohio; Ohio State University	Slominski, AT (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.	aslominski@uthsc.edu	Tuckey, Robert/H-5983-2014	Holick, Michael/0000-0001-6023-9062; Zmijewski, Michal/0000-0003-2206-3531; Li, Wei/0000-0002-9522-4474; Tuckey, Robert/0000-0002-5022-4729; Slominski, Andrzej/0000-0001-8963-3995; Zjawiony, Jordan/0000-0001-5242-2799; Chen, Tai/0000-0002-5704-5694	NIH [R01A052190]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH grant R01A052190 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2000, LEUKEMIA, V14, P2176, DOI 10.1038/sj.leu.2401950; Bar M, 2007, J INVEST DERMATOL, V127, P206, DOI 10.1038/sj.jid.5700493; Bikle DD, 2007, CURR OPIN RHEUMATOL, V19, P383, DOI 10.1097/BOR.0b013e32818e9d58; BIKLE DD, 1986, J CLIN INVEST, V78, P557, DOI 10.1172/JCI112609; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Fabiani R, 2006, J NUTR, V136, P614, DOI 10.1093/jn/136.3.614; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; GALLAGHER R, 1979, BLOOD, V54, P713; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOLICK MF, 1975, J BIOL CHEM, V250, P226; HOLICK MF, 1978, FED PROC, V37, P2567; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; James SY, 1999, GEN PHARMACOL, V32, P143, DOI 10.1016/S0306-3623(98)00098-6; Janjetovic Z, 2010, J CELL PHYSIOL, V223, P36, DOI 10.1002/jcp.21992; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Kamradt J, 2003, RECENT RESULTS CANC, V164, P259; Mahdavi M, 2007, ARCH PHARM RES, V30, P177, DOI 10.1007/BF02977692; Masuda S, 2006, MOL CANCER THER, V5, P797, DOI 10.1158/1535-7163.MCT-05-0539; MEYSKENS FL, 1995, LEUKEMIA RES, V19, P605, DOI 10.1016/0145-2126(95)00032-J; Mukai H, 2006, NEUROENDOCRINOLOGY, V84, P255, DOI 10.1159/000097747; Munker R, 1996, BLOOD, V88, P2201, DOI 10.1182/blood.V88.6.2201.bloodjournal8862201; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nakagawa K, 2005, CARCINOGENESIS, V26, P1044, DOI 10.1093/carcin/bgi049; NILSSON K, 1974, INT J CANCER, V13, P808, DOI 10.1002/ijc.2910130609; Pisarchik A V, 2001, Mol Gen Mikrobiol Virusol, P15; Qiao SJ, 2009, ENDOCRINOLOGY, V150, P4163, DOI 10.1210/en.2009-0195; REDDY PMS, 1993, MOL CELL BIOL, V13, P1093, DOI 10.1128/MCB.13.2.1093; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Schwartz GG, 2006, J NATL CANCER I, V98, P428, DOI 10.1093/jnci/djj127; Sicinski RR, 1998, J MED CHEM, V41, P4662, DOI 10.1021/jm9802618; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; Slominski A, 2006, J CELL PHYSIOL, V206, P780, DOI 10.1002/jcp.20530; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004309; Spina CS, 2007, J STEROID BIOCHEM, V103, P757, DOI 10.1016/j.jsbmb.2006.12.040; Spina CS, 2006, ANTICANCER RES, V26, P2515; Srivastava MD, 2004, LEUKEMIA LYMPHOMA, V45, P2119, DOI 10.1080/1042819032000159924; TANG E, 2010, J STEROID B IN PRESS; Teplyuk NM, 2009, J CELL BIOCHEM, V107, P144, DOI 10.1002/jcb.22108; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; TUCKEY RC, 2008, J STEROID BIOCH MOL; TUCKEY RC, 2008, INT J BIOCH CELL BIO; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Wu-Wong JR, 2006, LEUKEMIA LYMPHOMA, V47, P727, DOI 10.1080/10428190500398898; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72; Zmijewski MA, 2009, STEROIDS, V74, P218, DOI 10.1016/j.steroids.2008.10.017; Zmijewski MA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1570, DOI 10.1039/b809005j	54	125	126	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2010	5	3							e9907	10.1371/journal.pone.0009907	http://dx.doi.org/10.1371/journal.pone.0009907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574DT	20360850	Green Published, Green Submitted, gold			2022-12-27	WOS:000275969600013
J	De Toni-Costes, F; Despeaux, M; Bertrand, J; Bourogaa, E; Ysebaert, L; Payrastre, B; Racaud-Sultan, C				De Toni-Costes, Fabienne; Despeaux, Mathieu; Bertrand, Jessica; Bourogaa, Ezzeddine; Ysebaert, Loic; Payrastre, Bernard; Racaud-Sultan, Claire			A New alpha(5)beta(1) Integrin-Dependent Survival Pathway Through GSK3 beta Activation in Leukemic Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN PHOSPHATASE 2A; FACTOR-KAPPA-B; ACUTE MYELOID-LEUKEMIA; FOCAL ADHESION KINASE; SIGNALING PATHWAYS; COLORECTAL-CANCER; APOPTOSIS; GROWTH; RECEPTOR	Background: Cell survival mediated by integrin engagement has been implicated in cell adhesion-mediated drug resistance. We have recently demonstrated that the activation of glycogen synthase kinase 3 beta (GSK3 beta) is a new pathway supporting the chemoresistance of leukemic cells adhered to fibronectin. Methodology and Principal Findings: We show here that in conditions of serum starvation, the fibronectin receptor alpha(5)beta(1) integrin, but not alpha(4)beta(1), induced activation of GSK3 beta through Ser-9 dephosphorylation in adherent U937 cells. The GSK3 beta-dependent survival pathway occurred in adherent leukemic cells from patients but not in the HL-60 and KG1 cell lines. In adhesion, activated GSK3 beta was found in the cytosol/plasma membrane compartment and was co-immunoprecipitated with alpha(5) integrin, the phosphatase PP2A and the scaffolding protein RACK1. PP2A and its regulatory subunit B' regulated the Ser-9 phosphorylation of GSK3 beta. In adherent leukemic cells, alpha(5)beta(1) integrin but not alpha(4)beta(1) upregulated the resistance to TNF alpha-induced apoptosis. Both extrinsic and intrinsic apoptotic pathways were under the control of alpha(5)beta(1) and GSK3 beta. Conclusions and Significance: Our data show that, upon serum starvation, alpha(5)beta(1) integrin engagement could regulate specific pro-survival functions through the activation of GSK3 beta.	[De Toni-Costes, Fabienne; Despeaux, Mathieu; Bertrand, Jessica; Bourogaa, Ezzeddine; Ysebaert, Loic; Payrastre, Bernard; Racaud-Sultan, Claire] Fac Med Toulouse, INSERM, U563, F-31073 Toulouse, France; [De Toni-Costes, Fabienne; Despeaux, Mathieu; Bertrand, Jessica; Bourogaa, Ezzeddine; Ysebaert, Loic; Payrastre, Bernard; Racaud-Sultan, Claire] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France; [Ysebaert, Loic] Hop Purpan, CHU Toulouse, Serv Hematol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	De Toni-Costes, F (corresponding author), Fac Med Toulouse, INSERM, U563, U317, F-31073 Toulouse, France.	claire.racaud@inserm.fr	Payrastre, Bernard/M-5295-2014; Ysebaert, Loic/H-1554-2016	Ysebaert, Loic/0000-0001-8478-5623; Racaud-Sultan, Claire/0000-0002-6549-1088; , Bernard/0000-0002-8693-0190	Association de Recherche contre le Cancer [Nu3638, Nu8407]; Institut National du Cancer [Nu07/3D1616/IABC-23-8/NC-NG]; Conseil Regional de Midi-Pyrenees; DGRSRT/INSERM Franco-Tunisian cooperation	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Conseil Regional de Midi-Pyrenees(Region Occitanie); DGRSRT/INSERM Franco-Tunisian cooperation	Financial support was obtained from the Association de Recherche contre le Cancer (Nu3638, Nu8407), the Institut National du Cancer (Nu07/3D1616/IABC-23-8/NC-NG), the Conseil Regional de Midi-Pyrenees and the DGRSRT/INSERM Franco-Tunisian cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Ayala F, 2009, LEUKEMIA, V23, P2233, DOI 10.1038/leu.2009.175; Bao Wenjie, 2002, Biological Procedures Online, V4, P81, DOI 10.1251/bpo37; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Chetoui N, 2006, MOL IMMUNOL, V43, P1687, DOI 10.1016/j.molimm.2005.09.010; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Liao XB, 2003, MOL CANCER THER, V2, P1215; Mourtacla-Maarabouni M, 2005, J LEUKOCYTE BIOL, V78, P503, DOI 10.1189/jlb.0205070; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tcherkasowa AE, 2002, J IMMUNOL, V169, P5161, DOI 10.4049/jimmunol.169.9.5161; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Viquez NM, 2006, J NEUROSCI, V26, P9293, DOI 10.1523/JNEUROSCI.1740-06.2006	37	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9807	10.1371/journal.pone.0009807	http://dx.doi.org/10.1371/journal.pone.0009807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352103	gold, Green Published, Green Submitted			2022-12-27	WOS:000275894400013
J	Barber, MJ; Mangravite, LM; Hyde, CL; Chasman, DI; Smith, JD; McCarty, CA; Li, XH; Wilke, RA; Rieder, MJ; Williams, PT; Ridker, PM; Chatterjee, A; Rotter, JI; Nickerson, DA; Stephens, M; Krauss, RM				Barber, Mathew J.; Mangravite, Lara M.; Hyde, Craig L.; Chasman, Daniel I.; Smith, Joshua D.; McCarty, Catherine A.; Li, Xiaohui; Wilke, Russell A.; Rieder, Mark J.; Williams, Paul T.; Ridker, Paul M.; Chatterjee, Aurobindo; Rotter, Jerome I.; Nickerson, Deborah A.; Stephens, Matthew; Krauss, Ronald M.			Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; LOCI; GENE; THERAPY; POLYMORPHISMS; PROTEIN; RISK; PHARMACOGENOMICS; STRATIFICATION; TRIGLYCERIDES	Background: Stains effectively lower total and plasma LDL-cholesterol, but the magnitude of decrease varies among individuals. To identify single nucleotide polymorphisms (SNPs) contributing to this variation, we performed a combined analysis of genome-wide association (GWA) results from three trials of statin efficacy. Methods and Principal Findings: Bayesian and standard frequentist association analyses were performed on untreated and statin-mediated changes in LDL-cholesterol, total cholesterol, HDL-cholesterol, and triglyceride on a total of 3932 subjects using data from three studies: Cholesterol and Pharmacogenetics (40 mg/day simvastatin, 6 weeks), Pravastatin/Inflammation CRP Evaluation (40 mg/day pravastatin, 24 weeks), and Treating to New Targets (10 mg/day atorvastatin, 8 weeks). Genotype imputation was used to maximize genomic coverage and to combine information across studies. Phenotypes were normalized within each study to account for systematic differences among studies, and fixed-effects combined analysis of the combined sample were performed to detect consistent effects across studies. Two SNP associations were assessed as having posterior probability greater than 50%, indicating that they were more likely than not to be genuinely associated with statin-mediated lipid response. SNP rs8014194, located within the CLMN gene on chromosome 14, was strongly associated with statin-mediated change in total cholesterol with an 84% probability by Bayesian analysis, and a p-value exceeding conventional levels of genome- wide significance by frequentist analysis (P = 1.8x10(-8)). This SNP was less significantly associated with change in LDL-cholesterol (posterior probability = 0.16, P = 4.0x10(-6)). Bayesian analysis also assigned a 51% probability that rs4420638, located in APOC1 and near APOE, was associated with change in LDL-cholesterol. Conclusions and Significance: Using combined GWA analysis from three clinical trials involving nearly 4,000 individuals treated with simvastatin, pravastatin, or atorvastatin, we have identified SNPs that may be associated with variation in the magnitude of statin-mediated reduction in total and LDL-cholesterol, including one in the CLMN gene for which statistical evidence for association exceeds conventional levels of genome-wide significance.	[Barber, Mathew J.; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Mangravite, Lara M.; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Hyde, Craig L.; Chatterjee, Aurobindo] Pfizer Global Res & Dev, Stat Applicat, Groton, CT USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Joshua D.; Rieder, Mark J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Li, Xiaohui; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA USA; [Wilke, Russell A.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Wilke, Russell A.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Williams, Paul T.] Ernest Orlando Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pfizer; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Medical College of Wisconsin; Medical College of Wisconsin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Chicago	Barber, MJ (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	rkrauss@chori.org	Rotter, Jerome/AAY-6598-2021	McCarty, Catherine/0000-0003-1089-0142; Mangravite, Lara/0000-0001-7841-3612; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health [U01 HL69757, R01 HG002585, U01 HL084689]; Cedars-Sinai board of governors' chair in medical genetics, NCRR [MO1-RR00425]; DERC [DK063491]; Donald W. Reynolds Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, U01HL084689] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai board of governors' chair in medical genetics, NCRR; DERC; Donald W. Reynolds Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the National Institutes of Health, U01 HL69757. Additional support was provided by National Institutes of Health grants R01 HG002585 and U01 HL084689 (MS), by the Cedars-Sinai board of governors' chair in medical genetics, NCRR grant MO1-RR00425, and DERC grant DK063491 (JR) and by a grant from the Donald W. Reynolds Foundation (PR and DC). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Treating to New Targets Study (TNT) was funded by Pfizer and CH and AC are full time employees of Pfizer and were involved in analysis and interpretation of the data, as well as revisions to the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Clee SM, 2001, CIRCULATION, V103, P1198; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldberg IJ, 1996, J LIPID RES, V37, P693; Grundy SM, 2002, AM J CARDIOL, V90, p11I; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hirosawa M, 1999, DNA Res, V6, P329, DOI 10.1093/dnares/6.5.329; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P449, DOI 10.1016/j.jacc.2007.10.017; Ishisaki Z, 2001, GENOMICS, V74, P172, DOI 10.1006/geno.2001.6544; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Krauss RM, 2008, CIRCULATION, V117, P1537, DOI 10.1161/CIRCULATIONAHA.107.708388; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Mangravite LM, 2006, PHARMACOGENOMICS J, V6, P360, DOI 10.1038/sj.tpj.6500384; Mangravite LM, 2008, CURR OPIN MOL THER, V10, P555; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Senn SS, 2008, STAT ISSUES DRUG DEV; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899	40	178	181	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9763	10.1371/journal.pone.0009763	http://dx.doi.org/10.1371/journal.pone.0009763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339536	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894300008
J	Kirkham, JJ; Altman, DG; Williamson, PR				Kirkham, Jamie J.; Altman, Doug G.; Williamson, Paula R.			Bias Due to Changes in Specified Outcomes during the Systematic Review Process	PLOS ONE			English	Article								Background: Adding, omitting or changing outcomes after a systematic review protocol is published can result in bias because it increases the potential for unacknowledged or post hoc revisions of the planned analyses. The main objective of this study was to look for discrepancies between primary outcomes listed in protocols and in the subsequent completed reviews published on the Cochrane Library. A secondary objective was to quantify the risk of bias in a set of meta-analyses where discrepancies between outcome specifications in protocols and reviews were found. Methods and Findings: New reviews from three consecutive issues of the Cochrane Library were assessed. For each review, the primary outcome(s) listed in the review protocol and the review itself were identified and review authors were contacted to provide reasons for any discrepancies. Over a fifth (64/288, 22%) of protocol/review pairings were found to contain a discrepancy in at least one outcome measure, of which 48 (75%) were attributable to changes in the primary outcome measure. Where lead authors could recall a reason for the discrepancy in the primary outcome, there was found to be potential bias in nearly a third (8/28, 29%) of these reviews, with changes being made after knowledge of the results from individual trials. Only 4(6%) of the 64 reviews with an outcome discrepancy described the reason for the change in the review, with no acknowledgment of the change in any of the eight reviews containing potentially biased discrepancies. Outcomes that were promoted in the review were more likely to be significant than if there was no discrepancy ( relative risk 1.66 95% CI (1.10, 2.49), p = 0.02). Conclusion: In a review, making changes after seeing the results for included studies can lead to biased and misleading interpretation if the importance of the outcome ( primary or secondary) is changed on the basis of those results. Our assessment showed that reasons for discrepancies with the protocol are not reported in the review, demonstrating an under-recognition of the problem. Complete transparency in the reporting of changes in outcome specification is vital; systematic reviewers should ensure that any legitimate changes to outcome specification are reported with reason in the review.	[Kirkham, Jamie J.; Williamson, Paula R.] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England; [Altman, Doug G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Liverpool; University of Oxford	Kirkham, JJ (corresponding author), Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England.	jjk@liv.ac.uk	Kirkham, Jamie/AAD-4490-2019; Altman, Douglas G/A-9714-2012; Williamson, Paula R/B-6425-2016	Kirkham, Jamie/0000-0003-2579-9325; Williamson, Paula R/0000-0001-9802-6636	Medical Research Council [G0500952]; MRC [G0500952] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project was funded by the Medical Research Council (Grant Number G0500952). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.	BIESTER K, 2005, 13 COCHR C MELB 22 2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M., 2001, SYSTEMATIC REV HLTH; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; KIRKHAM JJ, 2010, BMJ-BRIT MED J, V340; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; PARMELLI E, 2007, 15 COCHR C SAO PAUL; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; SMYTH R, 2009, BMJ UNPUB; Straus S, 2010, CAN MED ASSOC J, V182, P13, DOI 10.1503/cmaj.081849	14	97	100	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9810	10.1371/journal.pone.0009810	http://dx.doi.org/10.1371/journal.pone.0009810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339557	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894300029
J	Redondo, S; Ruiz, E; Gordillo-Moscoso, A; Navarro-Dorado, J; Ramajo, M; Carnero, M; Reguillo, F; Rodriguez, E; Tejerina, T				Redondo, Santiago; Ruiz, Emilio; Gordillo-Moscoso, Antonio; Navarro-Dorado, Jorge; Ramajo, Marta; Carnero, Manuel; Reguillo, Fernando; Rodriguez, Enrique; Tejerina, Teresa			Role of TGF-beta 1 and MAP Kinases in the Antiproliferative Effect of Aspirin in Human Vascular Smooth Muscle Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROLIFERATION; CLOPIDOGREL; INHIBITION; APOPTOSIS; ATHEROSCLEROSIS; THERAPY; ANGINA	Background: We aimed to test the antiproliferative effect of acetylsalicylic acid (ASA) on vascular smooth muscle cells (VSMC) from bypass surgery patients and the role of transforming growth factor beta 1 (TGF-beta 1). Methodology/Principal Findings: VSMC were isolated from remaining internal mammary artery from patients who underwent bypass surgery. Cell proliferation and DNA fragmentation were assessed by ELISA. Protein expression was assessed by Western blot. ASA inhibited BrdU incorporation at 2 mM. Anti-TGF-beta 1 was able to reverse this effect. ASA (2 mM) induced TGF-beta 1 secretion; however it was unable to induce Smad activation. ASA increased p38(MAPK) phosphorylation in a TGF-beta 1-independent manner. Anti-CD105 (endoglin) was unable to reverse the antiproliferative effect of ASA. Pre-surgical serum levels of TGF-b1 in patients who took at antiplatelet doses ASA were assessed by ELISA and remained unchanged. Conclusions/Significance: In vitro antiproliferative effects of aspirin (at antiinflammatory concentration) on human VSMC obtained from bypass patients are mediated by TGF-beta 1 and p38(MAPK). Pre-surgical serum levels of TGF-beta 1 from bypass patients who took aspirin at antiplatelet doses did not change.	[Redondo, Santiago; Ruiz, Emilio; Gordillo-Moscoso, Antonio; Navarro-Dorado, Jorge; Ramajo, Marta; Tejerina, Teresa] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain; [Carnero, Manuel; Reguillo, Fernando; Rodriguez, Enrique] Hosp Clin Univ San Carlos, Serv Cirugia Cardiaca, Madrid, Spain	Complutense University of Madrid	Redondo, S (corresponding author), Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain.	teje@med.ucm.es	Carnero, Manuel/AAF-4073-2021; Stefanadis, Christodoulos/ABH-2232-2020	Carnero, Manuel/0000-0001-5045-5765; Stefanadis, Christodoulos/0000-0001-5974-6454; Navarro-Dorado, Jorge/0000-0002-4643-3528; REGUILLO, FERNANDO/0000-0001-5610-1335; Carnero Alcazar, Manuel/0000-0002-3536-5996	Fondo de Investigaciones Sanitarias FIS [PI080920]; Red Tematica de Investigacion Cardiovascular RECAVA [RD/06/0014/1007]	Fondo de Investigaciones Sanitarias FIS(Instituto de Salud Carlos III); Red Tematica de Investigacion Cardiovascular RECAVA	This work was funded by Fondo de Investigaciones Sanitarias FIS PI080920 (Health Research Fund from the Spanish Ministry of Health) and by Red Tematica de Investigacion Cardiovascular RECAVA RD/06/0014/1007 (Instituto de Salud Carlos III, Spanish Ministry of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Amann R, 2002, EUR J PHARMACOL, V447, P1, DOI 10.1016/S0014-2999(02)01828-9; Ansari HR, 2009, AM J PHYSIOL-HEART C, V297, pH1032, DOI 10.1152/ajpheart.00374.2009; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Ivanov VO, 1998, ATHEROSCLEROSIS, V140, P25, DOI 10.1016/S0021-9150(98)00102-6; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kropf J, 1997, CLIN CHEM, V43, P1965; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Okrainec K, 2005, J AM COLL CARDIOL, V45, P177, DOI 10.1016/j.jacc.2004.09.065; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; RANKE C, 1993, CIRCULATION, V87, P1873, DOI 10.1161/01.CIR.87.6.1873; RANKE C, 1994, CLIN INVESTIGATOR, V72, P673, DOI 10.1007/BF00212985; Redondo S, 2005, DIABETES, V54, P811, DOI 10.2337/diabetes.54.3.811; Redondo S, 2003, CIRCULATION, V107, P626, DOI 10.1161/01.CIR.0000045664.75269.A5; Redondo S, 2007, CYTOKINE GROWTH F R, V18, P279, DOI 10.1016/j.cytogfr.2007.04.005; Redondo S, 2007, EUR J PHARMACOL, V556, P36, DOI 10.1016/j.ejphar.2006.10.060; Refson JS, 1998, CIRCULATION, V97, P2506, DOI 10.1161/01.CIR.97.25.2506; Ruiz E, 2007, J PHARMACOL EXP THER, V321, P431, DOI 10.1124/jpet.106.114934; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schmidt-Weber CB, 2005, INT IMMUNOL, V17, P921, DOI 10.1093/intimm/dxh272; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Siegert A, 1999, J MOL MED-JMM, V77, P437, DOI 10.1007/s001090050374; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57	31	11	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9800	10.1371/journal.pone.0009800	http://dx.doi.org/10.1371/journal.pone.0009800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339548	Green Submitted, Green Published, gold			2022-12-27	WOS:000275894300023
J	Stromberg, SP; Carlson, JM				Stromberg, Sean P.; Carlson, Jean M.			The Suppression of Immune System Disorders by Passive Attrition	PLOS ONE			English	Article							HAY-FEVER; T-CELLS; MEMORY; AUTOIMMUNE; HOMEOSTASIS; INFECTIONS; RESISTANCE; CHILDREN; DISEASE; HYGIENE	Exposure to infectious diseases has an unexpected benefit of inhibiting autoimmune diseases and allergies. This is one of many fundamental fitness tradeoffs associated with immune system architecture. The immune system attacks pathogens, but also may (inappropriately) attack the host. Exposure to pathogens can suppress the deleterious response, at the price of illness and the decay of immunity to previous diseases. This "hygiene hypothesis'' has been associated with several possible underlying biological mechanisms. This study focuses on physiological constraints that lead to competition for survival between immune system cell types. Competition maintains a relatively constant total number of cells within each niche. The constraint implies that adding cells conferring new immunity requires loss (passive attrition) of some cells conferring previous immunities. We consider passive attrition as a mechanism to prevent the initial proliferation of autoreactive cells, thus preventing autoimmune disease. We see that this protection is a general property of homeostatic regulation and we look specifically at both the IL-15 and IL-7 regulated niches to make quantitative predictions using a mathematical model. This mathematical model yields insight into the dynamics of the "Hygiene Hypothesis,'' and makes quantitative predictions for experiments testing the ability of passive attrition to suppress immune system disorders. The model also makes a prediction of an anti-correlation between prevalence of immune system disorders and passive attrition rates.	[Stromberg, Sean P.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Stromberg, Sean P.; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Emory University; University of California System; University of California Santa Barbara	Stromberg, SP (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	stromberg@emory.edu			David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies through United States Army research [W911NF-09-D-0001]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies through United States Army research	This work was supported by the David and Lucile Packard Foundation and the Institute for Collaborative Biotechnologies through United States Army research grant W911NF-09-D-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Bach JF, 2005, CELL IMMUNOL, V233, P158, DOI 10.1016/j.cellimm.2005.04.006; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Calcinaro F, 1997, IMMUNOL CELL BIOL, V75, P467, DOI 10.1038/icb.1997.72; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Zorzella SFC, 2007, MEM I OSWALDO CRUZ, V102, P931, DOI 10.1590/S0074-02762007000800007; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Kurtzke JF, 2000, J NEUROVIROL, V6, pS134; LIKE AA, 1991, DIABETES, V40, P259, DOI 10.2337/diabetes.40.2.259; Pross H F, 1974, Adv Immunol, V18, P133, DOI 10.1016/S0065-2776(08)60309-0; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Stromberg SP, 2006, PLOS COMPUT BIOL, V2, P1475, DOI 10.1371/journal.pcbi.0020160; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Utzny C, 2001, J THEOR BIOL, V211, P393, DOI 10.1006/jtbi.2001.2352; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9648	10.1371/journal.pone.0009648	http://dx.doi.org/10.1371/journal.pone.0009648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300517	gold, Green Submitted, Green Published			2022-12-27	WOS:000275716400002
J	Murray, LA; Rosada, R; Moreira, AP; Joshi, A; Kramer, MS; Hesson, DP; Argentieri, RL; Mathai, S; Gulati, M; Herzog, EL; Hogaboam, CM				Murray, Lynne A.; Rosada, Rogerio; Moreira, Ana Paula; Joshi, Amrita; Kramer, Michael S.; Hesson, David P.; Argentieri, Rochelle L.; Mathai, Susan; Gulati, Mridu; Herzog, Erica L.; Hogaboam, Cory M.			Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; ALTERNATIVE ACTIVATION; BLOOD MONOCYTES; INHIBITION; RECEPTOR; CELLS; LUNG; FIBROBLASTS; DIFFERENTIATION; INTERLEUKIN-13	Macrophages promote tissue remodeling but few mechanisms exist to modulate their activity during tissue fibrosis. Serum amyloid P (SAP), a member of the pentraxin family of proteins, signals through Fc gamma receptors which are known to affect macrophage activation. We determined that IPF/UIP patients have increased protein levels of several alternatively activated pro-fibrotic (M2) macrophage-associated proteins in the lung and monocytes from these patients show skewing towards an M2 macrophage phenotype. SAP therapeutically inhibits established bleomycin-induced pulmonary fibrosis, when administered systemically or locally to the lungs. The reduction in aberrant collagen deposition was associated with a reduction in M2 macrophages in the lung and increased IP10/CXCL10. These data highlight the role of macrophages in fibrotic lung disease, and demonstrate a therapeutic action of SAP on macrophages which may extend to many fibrotic indications caused by over-exuberant pro-fibrotic macrophage responses.	[Murray, Lynne A.; Kramer, Michael S.; Hesson, David P.; Argentieri, Rochelle L.] Promedior Inc, Malvern, PA USA; [Rosada, Rogerio; Moreira, Ana Paula; Joshi, Amrita; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Mathai, Susan; Gulati, Mridu; Herzog, Erica L.] Yale Univ, Sch Med, Internal Med Pulm & Crit Care Div, New Haven, CT USA	University of Michigan System; University of Michigan; Yale University	Murray, LA (corresponding author), Promedior Inc, Malvern, PA USA.	MurrayL@MedImmune.com	Rosada, Rogerio/B-1396-2010; Hogaboam, Cory M./AAI-1433-2021; Murray, Lynne/AAB-1793-2020; hogaboam, cory/M-3578-2014	Hogaboam, Cory M./0000-0003-3366-4850; Murray, Lynne/0000-0003-4879-966X; 	Promedior, Inc.	Promedior, Inc.	This study was sponsored by Promedior, Inc. LAM, MSK, DPH, and RLA are employees of Promedior and Promedior is supportive of publishing this manuscript. LAM conceived, designed, analyzed and wrote the paper and provided reagents. MSK provided reagents. DPH conceived and designed experiments and provided reagents, RLA performed experiments and analyzed the data.	Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Jakubzick C, 2004, AM J PATHOL, V164, P1989, DOI 10.1016/S0002-9440(10)63759-5; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Keane MP, 1999, J IMMUNOL, V163, P5686; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425; LU J, 2008, STRUCTURAL RECOGNITI; Luzina IG, 2008, J LEUKOCYTE BIOL, V83, P237, DOI 10.1189/jlb.0707504; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Murray LA, 2008, INT J BIOCHEM CELL B, V40, P2174, DOI 10.1016/j.biocel.2008.02.016; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90	26	148	154	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9683	10.1371/journal.pone.0009683	http://dx.doi.org/10.1371/journal.pone.0009683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300636	gold, Green Published, Green Submitted			2022-12-27	WOS:000275620900016
J	McDonald, CJ; Jones, MK; Wallace, DF; Summerville, L; Nawaratna, S; Subramaniam, VN				McDonald, Cameron J.; Jones, Malcolm K.; Wallace, Daniel F.; Summerville, Lesa; Nawaratna, Sujeevi; Subramaniam, V. Nathan			Increased Iron Stores Correlate with Worse Disease Outcomes in a Mouse Model of Schistosomiasis Infection	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; HELMINTH INFECTIONS; YOUNG-ADULTS; ANEMIA; HEPCIDIN; JAPONICUM; HEMOCHROMATOSIS; INFLAMMATION; TRANSFERRIN; PHILIPPINES	Schistosomiasis is a significant parasitic infection creating disease burden throughout many of the world's developing nations. Iron deficiency anemia is also a significant health burden resulting from both nutritional deficit as well as parasitic infection in these countries. In this study we investigated the relationships between the disease outcomes of Schistosoma japonicum infection and iron homeostasis. We aimed to determine if host iron status has an effect on schistosome maturation or egg production, and to investigate the response of iron regulatory genes to chronic schistosomiasis infection. Wild-type C57BL/6 and Transferrin Receptor 2 null mice were infected with S. japonicum, and sacrificed at the onset of chronic disease. Transferrin Receptor 2 null mice are a model of type 3 hereditary hemochromatosis and develop significant iron overload providing increased iron stores at the onset of infection. The infectivity of schistosomes and egg production was assessed along with the subsequent development of granulomas and fibrosis. The response of the iron regulatory gene Hepcidin to infection and the changes in iron status were assessed by real-time PCR and Western blotting. Our results show that Hepcidin levels responded to the changing iron status of the animals, but were not significantly influenced by the inflammatory response. We also show that with increased iron availability at the time of infection there was greater development of fibrosis around granulomas. In conclusion, our studies indicate that chronic inflammation may not be the primary cause of the anemia seen in schistosomiasis, and suggest that increased availability of iron, such as through iron supplementation, may actually lead to increased disease severity.	[McDonald, Cameron J.; Wallace, Daniel F.; Summerville, Lesa; Subramaniam, V. Nathan] Queensland Inst Med Res, Div Canc & Cell Biol, Membrane Transport Lab, Brisbane, Qld 4006, Australia; [Jones, Malcolm K.; Nawaratna, Sujeevi] Queensland Inst Med Res, Div Infect Dis & Immunol, Parasite Cell Biol Lab, Brisbane, Qld 4006, Australia; [Jones, Malcolm K.; Nawaratna, Sujeevi] Queensland Inst Med Res, Sch Vet Sci, Brisbane, Qld 4006, Australia; [Subramaniam, V. Nathan] Univ Queensland, Sch Med, Liver Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland	McDonald, CJ (corresponding author), Queensland Inst Med Res, Div Canc & Cell Biol, Membrane Transport Lab, Brisbane, Qld 4006, Australia.	Nathan.Subramaniam@qimr.edu.au	Jones, Malcolm K/A-1097-2009; McDonald, Cameron/M-9928-2016; Subramaniam, V. Nathan/A-1901-2010; Wallace, Daniel F/D-2638-2009	Jones, Malcolm K/0000-0002-0035-6141; McDonald, Cameron/0000-0001-7904-6797; Subramaniam, V. Nathan/0000-0002-4583-7790; Wallace, Daniel F/0000-0002-6019-9424	National Health and Medical Research Council (NHMRC) of Australia [339400]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Program Grant from the National Health and Medical Research Council (NHMRC) of Australia (339400) to VNS. DFW is the recipient of an NHMRC R. D. Wright Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Chang D, 2006, ACTA TROP, V97, P318, DOI 10.1016/j.actatropica.2005.12.006; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; CLEMENS LE, 1989, J PARASITOL, V75, P417, DOI 10.2307/3282599; Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; de Mast Q, 2009, BRIT J HAEMATOL, V145, P657, DOI 10.1111/j.1365-2141.2009.07664.x; Denic S, 2007, NUTRITION, V23, P603, DOI 10.1016/j.nut.2007.05.002; Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006; Ezeamama AE, 2005, J INFECT DIS, V192, P2160, DOI 10.1086/498219; Fleck A, 1985, ACUTE PHASE RESPONSE, P249; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Friis H, 2003, EUR J CLIN NUTR, V57, P573, DOI 10.1038/sj.ejcn.1601568; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Kanzaria HK, 2005, AM J TROP MED HYG, V72, P115, DOI 10.4269/ajtmh.2005.72.115; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Leenstra T, 2006, AM J CLIN NUTR, V83, P371; Leenstra T, 2006, INFECT IMMUN, V74, P6398, DOI 10.1128/IAI.00757-06; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Ramm GA, 1997, J HEPATOL, V26, P584, DOI 10.1016/S0168-8278(97)80424-2; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Stavitsky AB, 2004, INFECT IMMUN, V72, P1, DOI 10.1128/IAI.72.1.1-12.2004; Steinmann P, 2007, ACTA TROP, V104, P38, DOI 10.1016/j.actatropica.2007.07.003; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Wallace DF, 2007, WORLD J GASTROENTERO, V13, P4690, DOI 10.3748/wjg.v13.i35.4690; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	33	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9594	10.1371/journal.pone.0009594	http://dx.doi.org/10.1371/journal.pone.0009594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231891	Green Published, gold, Green Submitted			2022-12-27	WOS:000275328300012
J	Abhary, S; Burdon, KP; Kuot, A; Javadiyan, S; Whiting, MJ; Kasmeridis, N; Petrovsky, N; Craig, JE				Abhary, Sotoodeh; Burdon, Kathryn P.; Kuot, Abraham; Javadiyan, Shahrbanou; Whiting, Malcolm J.; Kasmeridis, Nicholas; Petrovsky, Nikolai; Craig, Jamie E.			Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ASYMMETRIC DIMETHYLARGININE ADMA; ENDOTHELIAL-CELLS; INSULIN-RESISTANCE; DIMETHYLAMINOHYDROLASE; DYSFUNCTION; RETINOPATHY; APOPTOSIS; PATHWAY; PLASMA	Background: Asymmetric dimethylarginine (ADMA), present in human serum, is an endogenous inhibitor of nitric oxide synthase and contributes to vascular disease. Dimethylarginine dimethylaminohydrolase (DDAH) is an ADMA degrading enzyme that has two isoforms: DDAHI and DDAHII. We sought to determine whether serum ADMA levels in type 2 diabetes are influenced by common polymorphisms in the DDAH1 and DDAH2 genes. Methodology/Principal Findings: Relevant clinical parameters were measured and peripheral whole blood obtained for serum and genetic analysis on 343 participants with type 2 diabetes. Serum ADMA concentrations were determined by mass spectroscopy. Twenty six tag SNPs in the DDAH1 and 10 in the DDAH2 gene were genotyped in all subjects and tested for association with serum ADMA levels. Several SNPs and haplotypes in the DDAH genes were strongly associated with ADMA levels. Most significantly in the DDAH1 gene, rs669173 (p = 2.96 x 10(-7)), rs7521189 (p = 6.40 x 10(-7)), rs2474123 (p = 0.00082) and rs13373844 (p = 0.00027), and in the DDAH2 gene, rs3131383 (p = 0.0029) and the TGCCCAGGAG haplotype (p = 0.0012) were significantly associated with ADMA levels. Sub-analysis by diabetic retinopathy (DR) status revealed these variants were associated with ADMA levels predominantly in participants without DR. Combined analysis of the most strongly associated SNPs in DDAH1 (rs669173) and DDAH2 (rs3131383) revealed an additive effect (p = 1.37 x 10(-8)) on ADMA levels. Conclusions/Significance: Genetic variation in the DDAH1 and 2 genes is significantly associated with serum ADMA levels. Further studies are required to determine the pathophysiological significance of elevated serum ADMA in type 2 diabetes and to better understand how DDAH gene variation influences ADMA levels.	[Abhary, Sotoodeh; Burdon, Kathryn P.; Kuot, Abraham; Javadiyan, Shahrbanou; Craig, Jamie E.] Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA, Australia; [Abhary, Sotoodeh; Burdon, Kathryn P.; Kuot, Abraham; Javadiyan, Shahrbanou; Kasmeridis, Nicholas; Petrovsky, Nikolai; Craig, Jamie E.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Kasmeridis, Nicholas; Petrovsky, Nikolai] Flinders Med Ctr, Dept Endocrinol, Adelaide, SA, Australia; [Whiting, Malcolm J.] SA Pathol, Chem Pathol Lab, Adelaide, SA, Australia	Flinders Medical Centre; Flinders University South Australia; Flinders Medical Centre; SA Pathology	Abhary, S (corresponding author), Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA, Australia.	sotoodeh.abhary@health.sa.gov.au	Burdon, Kathryn/AAD-2334-2022; Burdon, Kathryn/A-5026-2009; Petrovsky, Nikolai/P-1912-2017; Kuot, Abraham/W-7246-2019	Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Petrovsky, Nikolai/0000-0002-1580-5245; Craig, Jamie/0000-0001-9955-9696	Ophthalmic Research Institute of Australia	Ophthalmic Research Institute of Australia	This research was supported by a grant from the Ophthalmic Research Institute of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; ABHARY S, 2009, DIABETES CARE; Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Connell P, 2007, ENDOTHELIUM-J ENDOTH, V14, P17, DOI 10.1080/10623320601177213; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Ducharme G, 2007, EUR J NEUROSCI, V26, P2119, DOI 10.1111/j.1460-9568.2007.05802.x; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; El-Asrar AM, 2001, AM J OPHTHALMOL, V132, P551, DOI 10.1016/S0002-9394(01)01127-8; Fanucchi S, 2008, BIOCHEMISTRY-US, V47, P11674, DOI 10.1021/bi801147r; Forbes SP, 2008, BIOCHEMISTRY-US, V47, P1819, DOI 10.1021/bi701659n; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GRADON JD, 1991, PEDIATR INFECT DIS J, V10, P786; Hanai K, 2009, NEPHROL DIAL TRANSPL, V24, P1884, DOI 10.1093/ndt/gfn716; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jones LC, 2003, BIOCHEM BIOPH RES CO, V310, P836, DOI 10.1016/j.bbrc.2003.09.097; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Makino N, 2005, J DIABETES COMPLICAT, V19, P347, DOI 10.1016/j.jdiacomp.2005.04.002; Malecki MT, 2007, DIABETES CARE, V30, P2899, DOI 10.2337/dc07-1138; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakurada M, 2008, HYPERTENSION, V52, P903, DOI 10.1161/HYPERTENSIONAHA.108.114207; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; STAMLER J, 1989, CIRC RES, V65, P789, DOI 10.1161/01.RES.65.3.789; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Sugai M, 2007, ENDOCR J, V54, P303, DOI 10.1507/endocrj.K06-140; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Tsai DC, 2003, OPHTHALMOLOGICA, V217, P342, DOI 10.1159/000071349; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Wang BY, 1999, CIRCULATION, V99, P1236, DOI 10.1161/01.CIR.99.9.1236; Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395; Yuan Ai-hua, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P454	45	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9462	10.1371/journal.pone.0009462	http://dx.doi.org/10.1371/journal.pone.0009462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209122	Green Published, gold, Green Submitted			2022-12-27	WOS:000274997100009
J	Rout, N; Else, JG; Yue, S; Connole, M; Exley, MA; Kaur, A				Rout, Namita; Else, James G.; Yue, Simon; Connole, Michelle; Exley, Mark A.; Kaur, Amitinder			Paucity of CD4(+) Natural Killer T (NKT) Lymphocytes in Sooty Mangabeys Is Associated with Lack of NKT Cell Depletion after SIV Infection	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HERPES-SIMPLEX-VIRUS; TCR ALPHA-CHAIN; RHESUS MACAQUE SPLEEN; HEPATITIS-B-VIRUS; IN-VIVO; PERIPHERAL-BLOOD; HIV-1 INFECTION; DENDRITIC CELLS; CYTOKINE PRODUCTION	Lack of chronic immune activation in the presence of persistent viremia is a key feature that distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection in natural hosts from pathogenic SIV and HIV infection. To elucidate novel mechanisms downmodulating immune activation in natural hosts of SIV infection, we investigated natural killer T (NKT) lymphocytes in sooty mangabeys. NKT lymphocytes are a potent immunoregulatory arm of the innate immune system that recognize glycolipid antigens presented on the nonpolymorphic MHC-class I-like CD1d molecules. In a cross-sectional analysis of 50 SIV-negative and 50 naturally SIV-infected sooty mangabeys, ligand alpha-galactosylceramide loaded CD1d tetramers co-staining with V alpha 24-positive invariant NKT lymphocytes were detected at frequencies >= 0.002% of circulating T lymphocytes in approximately half of the animals. In contrast to published reports in Asian macaques, sooty mangabey NKT lymphocytes consisted of CD8(+) and CD4/CD8 double-negative T lymphocytes that were CXCR3-positive and CCR5-negative suggesting that they trafficked to sites of inflammation without being susceptible to SIV infection. Consistent with these findings, there was no difference in the frequency or phenotype of NKT lymphocytes between SIV-negative and SIV-infected sooty mangabeys. On stimulation with a-galactosylceramide loaded on human CD1d molecules, sooty mangabey NKT lymphocytes underwent degranulation and secreted IFN-gamma, TNF-alpha, IL-2, IL-13, and IL-10, indicating the presence of both effector and immunoregulatory functional capabilities. The unique absence of CD4(+) NKT lymphocytes in sooty mangabeys, combined with their IL-10 cytokine-secreting ability and preservation following SIV infection, raises the possibility that NKT lymphocytes might play a role in downmodulating immune activation in SIV-infected sooty mangabeys.	[Rout, Namita; Connole, Michelle; Kaur, Amitinder] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Else, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Yue, Simon; Exley, Mark A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Emory University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rout, N (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA.	amitinder_kaur@hms.harvard.edu		Exley, Mark/0000-0002-5088-1032	Public Health Service [RR00168, RR00165, DK066917, AI049809, AI084810]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000165, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084810, R01AI049809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066917] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grants RR00168, RR00165, DK066917, AI049809 and AI084810. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; Chen YG, 2005, J IMMUNOL, V174, P1196, DOI 10.4049/jimmunol.174.3.1196; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Dieli F, 2003, J IMMUNOL, V171, P1961, DOI 10.4049/jimmunol.171.4.1961; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; EXLEY MA, 2003, CURR PROTOC IMMUNOL, pCH14; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fleuridor R, 2003, IMMUNOLOGY, V108, P3, DOI 10.1046/j.1365-2567.2003.01560.x; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gansuvd B, 2003, J IMMUNOL, V171, P2904, DOI 10.4049/jimmunol.171.6.2904; Gansuvd B, 2008, J MED PRIMATOL, V37, P1, DOI 10.1111/j.1600-0684.2007.00222.x; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Grubor-Bauk B, 2008, J VIROL, V82, P11073, DOI 10.1128/JVI.00205-08; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jiang SP, 2005, EUR J IMMUNOL, V35, P1193, DOI 10.1002/eji.200425899; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kashiwase K, 2003, IMMUNOGENETICS, V54, P776, DOI 10.1007/s00251-002-0527-8; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lederer S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000296; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; Moll M, 2006, BLOOD, V107, P3081, DOI 10.1182/blood-2005-09-3636; Moll M, 2009, EUR J IMMUNOL, V39, P902, DOI 10.1002/eji.200838780; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Roelofs-Haarhuis K, 2004, J IMMUNOL, V173, P1043, DOI 10.4049/jimmunol.173.2.1043; Sandberg JK, 2002, J VIROL, V76, P7528, DOI 10.1128/JVI.76.15.7528-7534.2002; Shaulov A, 2008, EXP HEMATOL, V36, P464, DOI 10.1016/j.exphem.2007.12.010; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sonoda KH, 2001, J IMMUNOL, V166, P42, DOI 10.4049/jimmunol.166.1.42; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Unutmaz D, 2003, MICROBES INFECT, V5, P1041, DOI 10.1016/S1286-4579(03)00185-0; van der Vliet HJJ, 2006, J IMMUNOL, V177, P5775, DOI 10.4049/jimmunol.177.9.5775; van der Vliet HJJ, 2002, J IMMUNOL, V168, P1490, DOI 10.4049/jimmunol.168.3.1490; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Vasan S, 2007, INT IMMUNOL, V19, P943, DOI 10.1093/intimm/dxm055; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; Wang ZC, 2006, J VIROL, V80, P2771, DOI 10.1128/JVI.80.6.2771-2783.2006; Watte CM, 2008, J LEUKOCYTE BIOL, V83, P928, DOI 10.1189/jlb.0807579; Yang OO, 2007, AIDS RES HUM RETROV, V23, P913, DOI 10.1089/aid.2006.0253	84	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9787	10.1371/journal.pone.0009787	http://dx.doi.org/10.1371/journal.pone.0009787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352088	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894500004
J	van Es, ACGM; van der Grond, J; ten Dam, VH; de Craen, AJM; Blauw, GJ; Westendorp, RGJ; Admiraal-Behloul, F; van Buchem, MA				van Es, Adriaan C. G. M.; van der Grond, Jeroen; ten Dam, V. Hester; de Craen, Anton J. M.; Blauw, Gerard J.; Westendorp, Rudi G. J.; Admiraal-Behloul, Faiza; van Buchem, Mark A.		PROSPER Study Grp	Associations between Total Cerebral Blood Flow and Age Related Changes of the Brain	PLOS ONE			English	Article							WHITE-MATTER LESIONS; INTERNAL CAROTID-ARTERY; CONTRAST MR-ANGIOGRAPHY; VOLUME MEASUREMENT; VASCULAR DEMENTIA; ELDERLY-PEOPLE; LEUKOARAIOSIS; HYPERINTENSITIES; ATROPHY; DISEASE	Background and Purpose: Although total cerebral blood flow (tCBF) is known to be related to age, less is known regarding the associations between tCBF and the morphologic changes of the brain accompanying cerebral aging. The purpose of this study was to investigate whether total cerebral blood flow (tCBF) is related to white matter hyperintensity (WMH) volume and/or cerebral atrophy. Furthermore, we investigate whether tCBF should be expressed in mL/min, as was done in all previous MR studies, or in mL/100 mL/min, which yielded good results in precious SPECT, PET and perfusion MRI studies investigating regional cerebral blood flow. Materials and Methods: Patients were included from the nested MRI sub-study of the PROSPER study. Dual fast spin echo and FLAIR images were obtained in all patients. In addition, single slice phase contrast MR angiography was used for flow measurements in the internal carotids and vertebral arteries. tCBF was expressed in both mL/min and mL/100 mL/min. Results: We found a significant correlation between tCBF in mL/min and both age (r = -.124; p = p <=.001) and parenchymal volume (r = 0.430; p <=.001). We found no association between tCBF in mL/min and %-atrophy (r = -.077; p <=.103) or total WMH volume (r = -.069; p =.148). When tCBF was expressed in mL/100 mL/min the correlation between tCBF and age was no longer found (r = -.001; p =.985). Multivariate regression analyses corrected for age showed a significant correlation between tCBF in mL/100 mL/min and WMH volume (r = -.106; p =.044). No significant association between tCBF in mL/100 mL/min and %- atrophy was found. Conclusion: From this study we conclude that, when evaluating tCBF alterations due to various pathologies, tCBF should in mL/100 mL/min instead of mL/min. Furthermore, changes or differences in WMH volume should be accounted for.	[van Es, Adriaan C. G. M.; Admiraal-Behloul, Faiza] Leiden Univ, Med Ctr, Dept Radiol, Sect Image Proc LKEB, Leiden, Netherlands; [ten Dam, V. Hester; de Craen, Anton J. M.; Blauw, Gerard J.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gen Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Es, ACGM (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Sect Image Proc LKEB, Leiden, Netherlands.	A.C.G.M.van_Es@LUMC.nl	Blauw, Gerard/GWD-1079-2022; van Buchem, Mark/AAC-9843-2022; Blauw, Gerard/AAW-7904-2021; Sweeney, Brian J/D-2569-2013	van Buchem, Mark/0000-0003-1881-1998; 	Leiden University Medical Center	Leiden University Medical Center	The study was funded with internal funds from the Leiden University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher E, 2003, J VASC SURG, V37, P769, DOI 10.1067/mva.2003.231; Bakker CJG, 1995, MAGN RESON IMAGING, V13, P959, DOI 10.1016/0730-725X(95)02005-E; Bisschops RHC, 2004, J NEUROL, V251, P1481, DOI 10.1007/s00415-004-0569-y; BOTS ML, 1993, LANCET, V341, P1232, DOI 10.1016/0140-6736(93)91144-B; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H; de Leeuw FE, 2000, STROKE, V31, P425, DOI 10.1161/01.STR.31.2.425; DeCarli C, 1999, STROKE, V30, P529, DOI 10.1161/01.STR.30.3.529; den Heijer T, 2003, NEUROBIOL AGING, V24, P307, DOI 10.1016/S0197-4580(02)00088-X; Firbank MJ, 2004, AM J GERIAT PSYCHIAT, V12, P606, DOI 10.1176/appi.ajgp.12.6.606; Hatazawa J, 1997, STROKE, V28, P1944, DOI 10.1161/01.STR.28.10.1944; Hendrikse J, 2005, RADIOLOGY, V235, P184, DOI 10.1148/radiol.2351031799; Hendrikse J, 2003, NEUROSURGERY, V53, P858, DOI 10.1227/01.NEU.0000083552.45265.46; Ho SSY, 2000, STROKE, V31, P1342, DOI 10.1161/01.STR.31.6.1342; ISAKA Y, 1994, STROKE, V25, P375, DOI 10.1161/01.STR.25.2.375; Isaka Y, 1997, STROKE, V28, P354, DOI 10.1161/01.STR.28.2.354; Kato T, 2002, AM J NEURORADIOL, V23, P1346; KAWAMURA J, 1991, STROKE, V22, P609, DOI 10.1161/01.STR.22.5.609; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Marstrand JR, 2002, STROKE, V33, P972, DOI 10.1161/01.STR.0000012808.81667.4B; MEGURO K, 1990, ANN NEUROL, V28, P378, DOI 10.1002/ana.410280313; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Rutgers DR, 2000, STROKE, V31, P3021, DOI 10.1161/01.STR.31.12.3021; Sakakibara R, 1999, J NEUROL NEUROSUR PS, V67, P658, DOI 10.1136/jnnp.67.5.658; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Swan GE, 2000, NEUROLOGY, V54, P2108, DOI 10.1212/WNL.54.11.2108; TarvonenSchroder S, 1996, J NEUROL NEUROSUR PS, V60, P431, DOI 10.1136/jnnp.60.4.431; van der Flier WM, 2004, NEUROLOGY, V62, P1862, DOI 10.1212/01.WNL.0000125337.65553.8A; van der Geest RJ, 1998, J COMPUT ASSIST TOMO, V22, P904, DOI 10.1097/00004728-199811000-00013; van Gijn J, 1998, NEUROLOGY, V51, pS3, DOI 10.1212/WNL.51.3_Suppl_3.S3; WASSERMAN BA, 1995, RADIOLOGY, V194, P681, DOI 10.1148/radiology.194.3.7862962; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7; Yamauchi H, 1999, NEUROLOGY, V53, P1833, DOI 10.1212/WNL.53.8.1833; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009	38	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9825	10.1371/journal.pone.0009825	http://dx.doi.org/10.1371/journal.pone.0009825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20352115	Green Published, Green Submitted, gold			2022-12-27	WOS:000275894400025
J	Liu, LC; Ioannides, AA				Liu, Lichan; Ioannides, Andreas A.			Emotion Separation Is Completed Early and It Depends on Visual Field Presentation	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; SINGLE TRIAL ANALYSIS; HUMAN NEURAL SYSTEM; FACIAL EXPRESSIONS; TIME-COURSE; SPATIOTEMPORAL DYNAMICS; OCCIPITOTEMPORAL CORTEX; AFFECT RECOGNITION	It is now apparent that the visual system reacts to stimuli very fast, with many brain areas activated within 100 ms. It is, however, unclear how much detail is extracted about stimulus properties in the early stages of visual processing. Here, using magnetoencephalography we show that the visual system separates different facial expressions of emotion well within 100 ms after image onset, and that this separation is processed differently depending on where in the visual field the stimulus is presented. Seven right-handed males participated in a face affect recognition experiment in which they viewed happy, fearful and neutral faces. Blocks of images were shown either at the center or in one of the four quadrants of the visual field. For centrally presented faces, the emotions were separated fast, first in the right superior temporal sulcus (STS; 35-48 ms), followed by the right amygdala (57-64 ms) and medial pre-frontal cortex (83-96 ms). For faces presented in the periphery, the emotions were separated first in the ipsilateral amygdala and contralateral STS. We conclude that amygdala and STS likely play a different role in early visual processing, recruiting distinct neural networks for action: the amygdala alerts sub-cortical centers for appropriate autonomic system response for fight or flight decisions, while the STS facilitates more cognitive appraisal of situations and links appropriate cortical sites together. It is then likely that different problems may arise when either network fails to initiate or function properly.	[Liu, Lichan; Ioannides, Andreas A.] RIKEN, Brain Sci Inst, Lab Human Brain Dynam, Wako, Saitama, Japan; [Liu, Lichan; Ioannides, Andreas A.] AAI Sci Cultural Serv Ltd, Lab Human Brain Dynam, Nicosia, Cyprus	RIKEN	Liu, LC (corresponding author), RIKEN, Brain Sci Inst, Lab Human Brain Dynam, Wako, Saitama, Japan.	l.liu@humanbraindynamics.com			Research Promotion Foundation, Cyprus [0308/02]	Research Promotion Foundation, Cyprus	The MEG data of the present study was collected from the Laboratory for Human Brain Dynamics in RIKEN Brain Science Institute, Japan. The data was analyzed in the Laboratory for Human Brain Dynamics, AAI Scientific Cultural Services Ltd., Cyprus. A grant from Research Promotion Foundation, Cyprus, "Upgrading Information System" (no. 0308/02), provided the computer hardware for data storage and analysis, but this grant funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABU BA, 2008, HUM BRAIN MAPP, V29, P1313; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; ARMONY JL, 1995, BEHAV NEUROSCI, V109, P246, DOI 10.1037/0735-7044.109.2.246; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BARBAS H, 1990, J COMP NEUROL, V300, P549, DOI 10.1002/cne.903000409; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; BRYDEN MP, 1990, BEHAV BRAIN SCI, V13, P547, DOI 10.1017/S0140525X00080079; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Christamn SD, 1997, CEREBRAL ASYMMETRIES, P263; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Debruille JB, 1998, NEUROREPORT, V9, P3349, DOI 10.1097/00001756-199810260-00002; EFRON R, 1990, DECLINE FALL HEMISPH; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Glascher J, 2003, J NEUROSCI, V23, P10274; GUR RC, 1994, BRAIN COGNITION, V25, P271, DOI 10.1006/brcg.1994.1036; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hanawalt NG, 1944, J GEN PSYCHOL, V31, P23, DOI 10.1080/00221309.1944.10545217; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Indersmitten T, 2003, J NEUROSCI, V23, P3820; Ioannides AA, 2000, HUM BRAIN MAPP, V11, P77, DOI 10.1002/1097-0193(200010)11:2<77::AID-HBM20>3.0.CO;2-0; Ioannides AA, 1995, INT J PSYCHOPHYSIOL, V20, P161, DOI 10.1016/0167-8760(95)00031-3; Ioannides AA, 2005, J NEUROSCI, V25, P7950, DOI 10.1523/JNEUROSCI.1091-05.2005; Ioannides AA, 2004, NEUROIMAGE, V23, P473, DOI 10.1016/j.neuroimage.2004.06.023; Ioannides AA, 2001, CLIN ELECTROENCEPHAL, V32, P98, DOI 10.1177/155005940103200304; IOANNIDES AA, 1990, INVERSE PROBL, V6, P523, DOI 10.1088/0266-5611/6/4/005; IOANNIDES AA, 2002, 5215 SOC NEUR; Ioannides AA, 2006, NEUROSCIENTIST, V12, P524, DOI 10.1177/1073858406293696; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; JAHN O, 1999, RECENT ADV BIOMAGNET, P224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kato Y, 2004, NEUROREPORT, V15, P225, DOI 10.1097/00001756-200402090-00002; KRAVITZ DJ, 2008, 2008 NEUR M PLANN WA; Kravitz DJ, 2008, TRENDS COGN SCI, V12, P114, DOI 10.1016/j.tics.2007.12.006; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Liu LC, 2006, NEUROIMAGE, V31, P1726, DOI 10.1016/j.neuroimage.2006.02.009; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Lyons M, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P200, DOI 10.1109/AFGR.1998.670949; Maruyama M, 2009, HUM BRAIN MAPP, V30, P147, DOI 10.1002/hbm.20495; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Meeren HKM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003503; Moradi F, 2003, NEUROIMAGE, V18, P595, DOI 10.1016/S1053-8119(02)00053-8; MORAWETZ C, 2008, 2008 NEUR M PLANN WA; Morgan MA, 1999, NEUROBIOL LEARN MEM, V72, P244, DOI 10.1006/nlme.1999.3907; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nelson CA, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P79; OJEMANN JG, 1992, BRAIN, V115, P1, DOI 10.1093/brain/115.1.1; Okazaki Y, 2008, NEUROSCIENCE, V152, P1130, DOI 10.1016/j.neuroscience.2008.01.056; Peyk P, 2008, BRAIN TOPOGR, V20, P205, DOI 10.1007/s10548-008-0052-7; Pizzagalli D, 1999, NEUROREPORT, V10, P2691, DOI 10.1097/00001756-199909090-00001; Poghosyan V, 2008, NEURON, V58, P802, DOI 10.1016/j.neuron.2008.04.013; Poghosyan V, 2007, NEUROIMAGE, V35, P759, DOI 10.1016/j.neuroimage.2006.11.052; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; PREVIC FH, 1993, VISION RES, V33, P2697, DOI 10.1016/0042-6989(93)90229-P; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Ross ED, 2007, NEUROSCIENTIST, V13, P433, DOI 10.1177/1073858407305618; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Rudrauf D, 2008, J NEUROSCI, V28, P2793, DOI 10.1523/JNEUROSCI.3476-07.2008; SALK L, 1973, SCI AM, V228, P24, DOI 10.1038/scientificamerican0573-24; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; Sato W, 2008, SOC COGN AFFECT NEUR, V3, P224, DOI 10.1093/scan/nsn016; Schweinberger SR, 1998, J EXP PSYCHOL HUMAN, V24, P1748, DOI 10.1037/0096-1523.24.6.1748; Sieratzki JS, 1996, LANCET, V347, P1746, DOI 10.1016/S0140-6736(96)90813-2; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Streit M, 2001, AM J PSYCHIAT, V158, P1429, DOI 10.1176/appi.ajp.158.9.1429; Szabo CA, 2001, AM J NEURORADIOL, V22, P1342; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor JG, 1999, IEEE T MED IMAGING, V18, P151, DOI 10.1109/42.759120; Tzelepi A, 2001, NEUROIMAGE, V13, P702, DOI 10.1006/nimg.2000.0735; Vauclair J, 2009, INFANT CHILD DEV, V18, P106, DOI 10.1002/icd.594; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; YOUNG AW, 1986, PSYCHOL RES-PSYCH FO, V48, P63, DOI 10.1007/BF00309318	106	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9790	10.1371/journal.pone.0009790	http://dx.doi.org/10.1371/journal.pone.0009790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FR	20339549	Green Published, gold, Green Submitted			2022-12-27	WOS:000275894300018
J	Mullin, CA; Frazier, M; Frazier, JL; Ashcraft, S; Simonds, R; vanEngelsdorp, D; Pettis, JS				Mullin, Christopher A.; Frazier, Maryann; Frazier, James L.; Ashcraft, Sara; Simonds, Roger; vanEngelsdorp, Dennis; Pettis, Jeffery S.			High Levels of Miticides and Agrochemicals in North American Apiaries: Implications for Honey Bee Health	PLOS ONE			English	Article							APIS-MELLIFERA L; COLONY LOSSES; PESTICIDE-RESIDUES; PYRETHROID INSECTICIDE; SYSTEMIC INSECTICIDES; ACARICIDE RESIDUES; POLLEN; HYMENOPTERA; RESISTANCE; TOXICITY	Background: Recent declines in honey bees for crop pollination threaten fruit, nut, vegetable and seed production in the United States. A broad survey of pesticide residues was conducted on samples from migratory and other beekeepers across 23 states, one Canadian province and several agricultural cropping systems during the 2007-08 growing seasons. Methodology/Principal Findings: We have used LC/MS-MS and GC/MS to analyze bees and hive matrices for pesticide residues utilizing a modified QuEChERS method. We have found 121 different pesticides and metabolites within 887 wax, pollen, bee and associated hive samples. Almost 60% of the 259 wax and 350 pollen samples contained at least one systemic pesticide, and over 47% had both in-hive acaricides fluvalinate and coumaphos, and chlorothalonil, a widely-used fungicide. In bee pollen were found chlorothalonil at levels up to 99 ppm and the insecticides aldicarb, carbaryl, chlorpyrifos and imidacloprid, fungicides boscalid, captan and myclobutanil, and herbicide pendimethalin at 1 ppm levels. Almost all comb and foundation wax samples (98%) were contaminated with up to 204 and 94 ppm, respectively, of fluvalinate and coumaphos, and lower amounts of amitraz degradates and chlorothalonil, with an average of 6 pesticide detections per sample and a high of 39. There were fewer pesticides found in adults and brood except for those linked with bee kills by permethrin (20 ppm) and fipronil (3.1 ppm). Conclusions/Significance: The 98 pesticides and metabolites detected in mixtures up to 214 ppm in bee pollen alone represents a remarkably high level for toxicants in the brood and adult food of this primary pollinator. This represents over half of the maximum individual pesticide incidences ever reported for apiaries. While exposure to many of these neurotoxicants elicits acute and sublethal reductions in honey bee fitness, the effects of these materials in combinations and their direct association with CCD or declining bee health remains to be determined.	[Mullin, Christopher A.; Frazier, Maryann; Frazier, James L.; Ashcraft, Sara] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Simonds, Roger] Agr Mkt Serv, Natl Sci Lab, USDA, Gastonia, NC USA; [vanEngelsdorp, Dennis] Penn Dept Agr, Harrisburg, PA USA; [Pettis, Jeffery S.] ARS, Bee Res Lab, USDA, Beltsville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Mullin, CA (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	camullin@psu.edu	vanEngelsdorp, Dennis/E-7934-2010		Florida State Beekeepers; National Honey Board; Penn State College of Agriculture Sciences; Project Apis mellifera (PAm); Tampa Bay Beekeepers; The Foundation for the Preservation of Honey Bees; United States Department of Agriculture	Florida State Beekeepers; National Honey Board; Penn State College of Agriculture Sciences; Project Apis mellifera (PAm); Tampa Bay Beekeepers; The Foundation for the Preservation of Honey Bees; United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding was received from the Florida State Beekeepers, National Honey Board, Penn State College of Agriculture Sciences, Project Apis mellifera (PAm), Tampa Bay Beekeepers, The Foundation for the Preservation of Honey Bees, and the United States Department of Agriculture Critical Issues program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder L, 2006, MASS SPECTROM REV, V25, P838, DOI 10.1002/mas.20091; ALDRIDGE WN, 1969, BIOCHEM J, V115, P147, DOI 10.1042/bj1150147; ANDERSON JF, 1986, J ECON ENTOMOL, V79, P1200, DOI 10.1093/jee/79.5.1200; ATKINS EL, 1986, J APICULT RES, V25, P242, DOI 10.1080/00218839.1986.11100725; ATKINS EL, 1981, U CALIF DIV AGR SCI, V2883; *BAT CONS INT, 2009, WHAT WE DO WHIT NOS; *BFR, 2009, PAR DET PEST RES; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; Bogdanov S, 2004, BEE WORLD, V85, P46, DOI 10.1080/0005772X.2004.11099623; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; DeGrandi-Hoffman G, 2009, AM BEE J, V149, P583; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ellis MD, 1997, APIDOLOGIE, V28, P123, DOI 10.1051/apido:19970303; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Everich R, 2009, J ECON ENTOMOL, V102, P20, DOI 10.1603/029.102.0104; Everts S, 2008, CHEM ENG NEWS, V86, P10, DOI 10.1021/cen-v086n021.p010a; Faucon JP, 2002, BEE WORLD, V83, P14, DOI 10.1080/0005772X.2002.11099532; Ferrer I, 2007, J CHROMATOGR A, V1175, P24, DOI 10.1016/j.chroma.2007.09.092; Finley J, 1996, AM BEE J, V136, P805; Fox JE, 2007, P NATL ACAD SCI USA, V104, P10282, DOI 10.1073/pnas.0611710104; Frazier M, 2008, AM BEE J, V148, P521; Ghini S, 2004, ARCH ENVIRON CON TOX, V47, P479, DOI 10.1007/s00244-003-3219-y; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Graham J.M., 1999, HIVE HONEY BEE; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Halmer P., 2000, SEED TECHNOLOGY ITS, P257; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; JOHANSEN CA, 1984, ENVIRON ENTOMOL, V13, P1386, DOI 10.1093/ee/13.5.1386; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kindemba Vicky, 2009, IMPACT NEONICOTINOID; Kubik M, 1999, APIDOLOGIE, V30, P521, DOI 10.1051/apido:19990607; Ladurner E, 2005, APIDOLOGIE, V36, P449, DOI 10.1051/apido:2005032; Lehotay SJ, 2005, J AOAC INT, V88, P615; Lodesani M, 2005, BEE WORLD, V86, P102, DOI 10.1080/0005772X.2005.11417324; LODESANI M, 1992, APIDOLOGIE, V23, P257, DOI 10.1051/apido:19920309; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Martin SJ, 2004, BEE WORLD, V85, P67, DOI 10.1080/0005772X.2004.11099632; Maude, 1996, SEEDBORNE DIS THEIR, P114; Mineau P, 2008, ENVIRON ENTOMOL, V37, P546, DOI 10.1603/0046-225X(2008)37[546:UROBMI]2.0.CO;2; Mullin CA, 2005, ENVIRON ENTOMOL, V34, P1626, DOI 10.1603/0046-225X-34.6.1626; MUNN MD, 2001, 014077 US GEOL SURV; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Pettis JS, 1998, AM BEE J, V138, P538; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Rohr JR, 2008, ECOL APPL, V18, P1743, DOI 10.1890/07-1429.1; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Tierney KB, 2008, ENVIRON SCI TECHNOL, V42, P4996, DOI 10.1021/es800240u; Tremolada P, 2004, ECOTOXICOLOGY, V13, P589, DOI 10.1023/B:ECTX.0000037193.28684.05; *USDA AMS, 2008, PEST DAT PROGR ANN S; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; WALLNER K, 1995, AM BEE J, V135, P817; Walorczyk S, 2009, J CHROMATOGR A, V1216, P6522, DOI 10.1016/j.chroma.2009.07.045; WHEELOCK CE, 1959, J AM CHEM SOC, V81, P1348, DOI 10.1021/ja01515a021	75	902	927	14	676	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9754	10.1371/journal.pone.0009754	http://dx.doi.org/10.1371/journal.pone.0009754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333298	Green Published, gold			2022-12-27	WOS:000275809700007
J	Barelier, S; Linard, D; Pons, J; Clippe, A; Knoops, B; Lancelin, JM; Krimm, I				Barelier, Sarah; Linard, Dominique; Pons, Julien; Clippe, Andre; Knoops, Bernard; Lancelin, Jean-Marc; Krimm, Isabelle			Discovery of Fragment Molecules That Bind the Human Peroxiredoxin 5 Active Site	PLOS ONE			English	Article							LIGAND-BINDING; AUTOMATED DOCKING; CRYSTAL-STRUCTURE; DRUG DESIGN; NMR; EFFICIENCY; AFFINITY; GENERATION; PROTEINS; ENZYME	The search for protein ligands is a crucial step in the inhibitor design process. Fragment screening represents an interesting method to rapidly find lead molecules, as it enables the exploration of a larger portion of the chemical space with a smaller number of compounds as compared to screening based on drug-sized molecules. Moreover, fragment screening usually leads to hit molecules that form few but optimal interactions with the target, thus displaying high ligand efficiencies. Here we report the screening of a homemade library composed of 200 highly diverse fragments against the human Peroxiredoxin 5 protein. Peroxiredoxins compose a family of peroxidases that share the ability to reduce peroxides through a conserved cysteine. The three-dimensional structures of these enzymes ubiquitously found throughout evolution have been extensively studied, however, their biological functions are still not well understood and to date few inhibitors have been discovered against these enzymes. Six fragments from the library were shown to bind to the Peroxiredoxin 5 active site and ligand-induced chemical shift changes were used to drive the docking of these small molecules into the protein structure. The orientation of the fragments in the binding pocket was confirmed by the study of fragment homologues, highlighting the role of hydroxyl functions that hang the ligands to the Peroxiredoxin 5 protein. Among the hit fragments, the small catechol molecule was shown to significantly inhibit Peroxiredoxin 5 activity in a thioredoxin peroxidase assay. This study reports novel data about the ligand-Peroxiredoxin interactions that will help considerably the development of potential Peroxiredoxin inhibitors.	[Barelier, Sarah; Pons, Julien; Lancelin, Jean-Marc; Krimm, Isabelle] Univ Lyon 1, CNRS, Analyt Sci Lab, CNRS,UMR 5180, F-69622 Villeurbanne, France; [Linard, Dominique; Clippe, Andre; Knoops, Bernard] Catholic Univ Louvain, Cell Biol Lab, Inst Sci Vie, B-3000 Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain	Barelier, S (corresponding author), Univ Lyon 1, CNRS, Analyt Sci Lab, CNRS,UMR 5180, Bat ESCPE Lyon, F-69622 Villeurbanne, France.	isabelle.krimm@univ-lyon1.fr	Krimm, Isabelle/O-4972-2014; Lancelin, Jean-marc/AAC-5686-2019	Krimm, Isabelle/0000-0002-5981-109X; 	"Fonds National de la Recherche Scientifique''; "Fonds pour la formation la Recherche dans L'Industrie et dans l'Agriculture''	"Fonds National de la Recherche Scientifique''(Fonds de la Recherche Scientifique - FNRS); "Fonds pour la formation la Recherche dans L'Industrie et dans l'Agriculture''(Fonds de la Recherche Scientifique - FNRS)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D. L. and B. K. are financially supported by the "Fonds National de la Recherche Scientifique'' (F. N. R. S.) and by the "Fonds pour la formation la Recherche dans L'Industrie et dans l'Agriculture'' (F. R. I. A.).	Bemis GW, 1999, J MED CHEM, V42, P5095, DOI 10.1021/jm9903996; Bretonnet AS, 2007, J MED CHEM, V50, P1865, DOI 10.1021/jm061460r; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Cioffi M, 2008, J MED CHEM, V51, P2512, DOI 10.1021/jm701194r; Ciulli A, 2007, CURR OPIN BIOTECH, V18, P489, DOI 10.1016/j.copbio.2007.09.003; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Congreve M, 2007, ANNU REP MED CHEM, V42, P431, DOI 10.1016/S0065-7743(07)42028-0; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Erlanson DA, 2006, CURR OPIN BIOTECH, V17, P643, DOI 10.1016/j.copbio.2006.10.007; Fejzo J, 1999, CHEM BIOL, V6, P755, DOI 10.1016/S1074-5521(00)80022-8; Flohe Leopold, 2007, V44, P1; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jhoti H, 2007, CURR OPIN CHEM BIOL, V11, P485, DOI 10.1016/j.cbpa.2007.07.010; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karplus P. Andrew, 2007, V44, P41; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Knoops Bernard, 2007, V44, P27; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Liu G, 2010, CHEMMEDCHEM, V5, P41, DOI 10.1002/cmdc.200900391; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McCoy MA, 2000, J BIOMOL NMR, V18, P189, DOI 10.1023/A:1026508025631; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Pellecchia M, 2008, NAT REV DRUG DISCOV, V7, P738, DOI 10.1038/nrd2606; Pintacuda G, 2007, ACCOUNTS CHEM RES, V40, P206, DOI 10.1021/ar050087z; Poole Leslie B., 2007, V44, P61; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rosenfeld RJ, 2003, J COMPUT AID MOL DES, V17, P525, DOI 10.1023/B:JCAM.0000004604.87558.02; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Stark J, 2008, J AM CHEM SOC, V130, P535, DOI 10.1021/ja0737974; Theys N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006110; Trujillo Madia, 2007, V44, P83; Verdonk ML, 2008, CHEMMEDCHEM, V3, P1179, DOI 10.1002/cmdc.200800132	46	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9744	10.1371/journal.pone.0009744	http://dx.doi.org/10.1371/journal.pone.0009744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305821	gold, Green Published, Green Submitted			2022-12-27	WOS:000275809600016
J	Song, ES; Rodgers, DW; Hersh, LB				Song, Eun Suk; Rodgers, David W.; Hersh, Louis B.			A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties	PLOS ONE			English	Article							IN-VIVO; INSULYSIN; GENE; ATP; RECOGNITION; DEGRADATION; DISEASE; TARGET	Background: Insulin degrading enzyme (IDE) is a key enzyme in the metabolism of both insulin and amyloid beta peptides. IDE is unique in that it is subject to allosteric activation which is hypothesized to occur through an oligomeric structuture. Methodology/Principal Findings: IDE is known to exist as an equilibrium mixture of monomers, dimers, and higher oligomers, with the dimer being the predominant form. Based on the crystal structure of IDE we deleted the putative dimer interface in the C-terminal region, which resulted in a monomeric variant. Monomeric IDE retained enzymatic activity, however instead of the allosteric behavior seen with wild type enzyme it displayed Michaelis-Menten kinetic behavior. With the substrate Abz-GGFLRKHGQ-EDDnp, monomeric IDE retained similar to 25% of the wild type activity. In contrast with the larger peptide substrates beta-endorphin and amyloid beta peptide 1-40, monomeric IDE retained only 1 to 0.25% of wild type activity. Unlike wild type IDE neither bradykinin nor dynorphin B-9 activated the monomeric variant of the enzyme. Similarly, monomeric IDE was not activated by polyphosphates under conditions in which the activity of wild type enzyme was increased more than 50 fold. Conclusions/Significance: These findings serve to establish the dimer interface in IDE and demonstrate the requirement for an oligomeric form of the enzyme for its regulatory properties. The data support a mechanism where the binding of activators to oligomeric IDE induces a conformational change that cannot occur in the monomeric variant. Since a conformational change from a closed to a more open structure is likely the rate-determining step in the IDE reaction, the subunit induced conformational change likely shifts the structure of the oligomeric enzyme to a more open conformation.	[Song, Eun Suk] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Song, ES (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	lhersh@uky.edu			NIH [DA02243, NS046517, DA016176, P20RR20171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R01DA002243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA02243, NS046517, DA016176, and P20RR20171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GOLDSTEIN BJ, 1981, METABOLISM, V30, P825, DOI 10.1016/0026-0495(81)90030-5; Gu HF, 2004, DIABETES, V53, P2137, DOI 10.2337/diabetes.53.8.2137; HARI J, 1987, ENDOCRINOLOGY, V120, P829, DOI 10.1210/endo-120-2-829; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Vepsalainen S, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048470; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; YONEZAWA K, 1986, ENDOCRINOLOGY, V118, P1989, DOI 10.1210/endo-118-5-1989	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9719	10.1371/journal.pone.0009719	http://dx.doi.org/10.1371/journal.pone.0009719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300529	Green Published, gold, Green Submitted			2022-12-27	WOS:000275716400017
J	Ayenew, A; Leykun, A; Colebunders, R; Deribew, A				Ayenew, Animut; Leykun, Abenet; Colebunders, Robert; Deribew, Amare			Predictors of HIV Testing among Patients with Tuberculosis in North West Ethiopia: A Case-Control Study	PLOS ONE			English	Article							JOGJAKARTA; INDONESIA; SUSPECTS	Background: The acceptance of HIV testing among patients with tuberculosis (TB) is low in Ethiopia. The purpose of this study was to assess predictors of acceptance of HIV testing among patients with TB in North Ethiopia. Methods: A case control study was conducted in eight randomly selected health facilities in North Ethiopia from February 5 to March 11, 2009. A total of 282 participants (188 controls and 94 cases) were included in the study. Cases were TB patients who refused to be tested for HIV. We used quantitative and qualitative methods of data collection. For the quantitative survey, cases and controls were interviewed by trained nurses using a pre-tested and structured questionnaire. In-depth interviews were conducted with 5 nurse counselors and 15 TB patients. Bivariate and multivariate analysis was done using SPSS 16.0 statistical software. Results: The uptake of HIV testing among TB patients in the study health facilities was 70.6%. The rate of TB/HIV co-infection in those who were tested was 36.2%. From the source population, a total of 282 participants were included in the study. TB patients who had formal education [OR = 2.35, (95% Cl: 1.33, 4.13)], high awareness about the benefits of HIV counseling and testing [OR = 3.14, 95% Cl: 1.77, 5.50)], and a low stigmatized attitude [OR = 3.16, 95% Cl: 1.79, 5.59)] were more likely to accept HIV testing. The qualitative study also revealed that low awareness and stigma were the major reasons for nonacceptance of HIV testing. Conclusion: ``Knowledge and attitude'' factors were the major barriers for HIV testing. Tailored training should be given to TB patients and the community concerning the benefits of HIV testing. During counseling sessions, health workers should focus on barriers of uptake of HIV testing such as stigma and discrimination.	[Ayenew, Animut] Fed Minist Hlth, Addis Ababa, Ethiopia; [Leykun, Abenet] Private Sector Partnership Ethiopia, Addis Ababa, Ethiopia; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert; Deribew, Amare] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Deribew, Amare] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia	Federal Ministry of Health - Ethiopia (FMOH); Institute of Tropical Medicine (ITM); University of Antwerp; Jimma University	Ayenew, A (corresponding author), Fed Minist Hlth, Addis Ababa, Ethiopia.	amare_deribew@yahoo.com		Deribew, Amare/0000-0003-2031-6080	Ethiopian Public Health Association (EPHA)	Ethiopian Public Health Association (EPHA)	The study was funded by Ethiopian Public Health Association (EPHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKLILU A, 2004, THESIS A ABABA U; Central Statistical Agency Ethiopia and ORC Macro, 2006, ETH DEM HLTH SURV; Demissie A, 2009, ETHIOP J HEALTH DEV, V23, P141; Demissie M., 2000, Ethiopian Journal of Health Development, V14, P277; Jerene Degu, 2007, BMC Int Health Hum Rights, V7, P4, DOI 10.1186/1472-698X-7-4; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Mahendradhata Y, 2008, T ROY SOC TROP MED H, V102, P1003, DOI 10.1016/j.trstmh.2008.04.042; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-385; MARU M, 2007, THESIS A ABABA U; Mawar N, 2005, INDIAN J MED RES, V122, P471; *MIN HLTH FED DEM, 2008, TB HIV IMPL GUID; *MIN HLTH FED DEM, 2008, GUID LAB HIV TEST BL; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; NIGUSSU N, 2009, THESIS JIMMA U; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Van Rie A, 2008, INT J TUBERC LUNG D, V12, pS73; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2009, WHOHTMTB2009411; *WHO UNAIDS, 2004, WHOHTMTB2004330 UNAI; Worku Getachew, 2007, Ethiop Med J, V45, P1; World Health Organization, 2006, WHOHTMTB2006368	23	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9702	10.1371/journal.pone.0009702	http://dx.doi.org/10.1371/journal.pone.0009702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300574	gold, Green Published, Green Submitted			2022-12-27	WOS:000275621000017
J	Courter, D; Cao, HB; Kwok, S; Kong, C; Banh, A; Kuo, PW; Bouley, DM; Vice, C; Brustugun, OT; Denko, NC; Koong, AC; Giaccia, A; Le, QT				Courter, Donald; Cao, Hongbin; Kwok, Shirley; Kong, Christina; Banh, Alice; Kuo, Peiwen; Bouley, Donna M.; Vice, Carmen; Brustugun, Odd Terje; Denko, Nicholas C.; Koong, Albert C.; Giaccia, Amato; Le, Quynh-Thu			The RGD Domain of Human Osteopontin Promotes Tumor Growth and Metastasis through Activation of Survival Pathways	PLOS ONE			English	Article							MUSCLE-CELL-MIGRATION; INTEGRIN MONOCLONAL-ANTIBODY; PROMATRIX METALLOPROTEINASE-2; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; BREAST-CANCER; NULL MICE; EXPRESSION; BINDING; ALPHA-V-BETA-3	Background: Human osteopontin (OPN), a known tumor associated protein, exists in different isoforms, whose function is unclear. It also possesses a RGD domain, which has been implicated in diverse function. Here, we use genetic approaches to systematically investigate the function of the RGD domain in different OPN isoforms on tumor progression and metastasis for 2 different solid tumor models. Methodology/Principal Findings: Using isoform-specific qRT-PCR, we found that OPN-A and B were the main isoforms overexpressed in evaluated human tumors, which included 4 soft tissue sarcomas, 24 lung and 30 head and neck carcinomas. Overexpression of either OPN-A or B in two different cell types promoted local tumor growth and lung metastasis in SCID mouse xenografts. However, expression of either isoform with the RGD domain either mutated or deleted decreased tumor growth and metastasis, and resulted in increased apoptosis by TUNEL staining. In vitro, whereas mutation of the RGD domain did not affect cell-cell adhesion, soft agar growth or cell migration, it increased apoptosis under hypoxia and serum starvation. This effect could be mitigated when the RGD mutant cells were treated with condition media containing WT OPN. Mechanistically, the RGD region of OPN inhibited apoptosis by inducing NF-kappa B activation and FAK phosphorylation. Inhibition of NF-kappa B (by siRNA to the p65 subunit) or FAK activation (by a inhibitor) significantly increased apoptosis under hypoxia in WT OPN cells, but not in RGD mutant cells. Conclusion/Significance: Unlike prior reports, our data suggest that the RGD domain of both OPN-A and B promote tumor growth and metastasis mainly by protecting cells against apoptosis under stressed conditions and not via migration or invasion. Future inhibitors directed against OPN should target multiple isoforms and should inhibit cell survival mechanisms that involve the RGD domain, FAK phosphorylation and NF-kappa B activation.	[Courter, Donald; Cao, Hongbin; Banh, Alice; Kuo, Peiwen; Vice, Carmen; Denko, Nicholas C.; Koong, Albert C.; Giaccia, Amato; Le, Quynh-Thu] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Kwok, Shirley; Kong, Christina] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Brustugun, Odd Terje] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Stanford University; Stanford University; Stanford University; University of Oslo	Courter, D (corresponding author), Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.	Qle@stanford.edu	denko, nicholas/F-8444-2010	Koong, Albert/0000-0001-9824-1643; Le, Quynh Thu/0000-0002-3682-1439	Public Health Service [CA09302]; National Cancer Institute, Department of Health and Human Services [P01-CA67166]; NATIONAL CANCER INSTITUTE [P01CA067166, T32CA009302] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by Public Health Service Grant Number CA09302 (DC) and P01-CA67166 (QTL, AB, HC, DC, PK, NCD, AK, AJG) awarded by the National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; BLASBERG JD, 2009, J THORAC CARDIOVASC; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Cao ZG, 2008, MOL IMMUNOL, V45, P3683, DOI 10.1016/j.molimm.2008.06.008; Chae S, 2009, INT J ONCOL, V35, P1409, DOI 10.3892/ijo_00000458; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Cui R, 2007, LUNG CANCER, V57, P302, DOI 10.1016/j.lungcan.2007.03.019; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fan KX, 2008, ARTHRITIS RHEUM-US, V58, P2041, DOI 10.1002/art.23490; FONG YC, 2008, LUNG CANC; Furger KA, 2003, MOL CANCER RES, V1, P810; Geissinger E, 2002, CANCER RES, V62, P4820; GONG M, 2008, CANC LETT; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Graves EE, 2007, TECHNOL CANCER RES T, V6, P111, DOI 10.1177/153303460700600207; Gu T, 2009, LUNG CANCER, V66, P176, DOI 10.1016/j.lungcan.2009.02.004; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsieh YH, 2006, CANCER RES, V66, P7119, DOI 10.1158/0008-5472.CAN-06-1002; HU DD, 1995, ANN NY ACAD SCI, V760, P312, DOI 10.1111/j.1749-6632.1995.tb44644.x; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ivanov SV, 2009, BIOCHEM BIOPH RES CO, V382, P514, DOI 10.1016/j.bbrc.2009.03.042; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Khan SA, 2002, J CELL BIOCHEM, V85, P728, DOI 10.1002/jcb.10170; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P15326, DOI 10.1073/pnas.0903704106; Le QT, 2003, CLIN CANCER RES, V9, P59; Le QT, 2007, INT J RADIAT ONCOL, V69, P167, DOI 10.1016/j.ijrobp.2007.01.071; Li JJ, 2007, BIOCHEM BIOPH RES CO, V356, P13, DOI 10.1016/j.bbrc.2007.02.092; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Loster K, 1997, ANAL BIOCHEM, V244, P96, DOI 10.1006/abio.1996.9883; Martin PL, 2005, CLIN CANCER RES, V11, P6959, DOI 10.1158/1078-0432.CCR-04-2623; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; NASU K, 1995, BIOCHEM J, V307, P257, DOI 10.1042/bj3070257; Ning SC, 2008, MOL CANCER THER, V7, P1569, DOI 10.1158/1535-7163.MCT-08-0288; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Rice J, 2006, J VASC RES, V43, P422, DOI 10.1159/000094884; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Rittling SR, 2002, J BIOL CHEM, V277, P9175, DOI 10.1074/jbc.M109028200; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Trikha M, 2004, INT J CANCER, V110, P326, DOI 10.1002/ijc.20116; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; YUE TL, 1994, EXP CELL RES, V214, P459, DOI 10.1006/excr.1994.1282; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025; ZHU Y, 2005, ONCOGENE; Zohar R, 2004, AM J PHYSIOL-HEART C, V287, pH1730, DOI 10.1152/ajpheart.00098.2004	65	44	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9633	10.1371/journal.pone.0009633	http://dx.doi.org/10.1371/journal.pone.0009633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224789	Green Published, Green Submitted, gold			2022-12-27	WOS:000275328800027
J	Collins, SC; Coffee, B; Benke, PJ; Berry-Kravis, E; Gilbert, F; Oostra, B; Halley, D; Zwick, ME; Cutler, DJ; Warren, ST				Collins, Stephen C.; Coffee, Brad; Benke, Paul J.; Berry-Kravis, Elizabeth; Gilbert, Fred; Oostra, Ben; Halley, Dicky; Zwick, Michael E.; Cutler, David J.; Warren, Stephen T.			Array-Based FMR1 Sequencing and Deletion Analysis in Patients with a Fragile X Syndrome-Like Phenotype	PLOS ONE			English	Article							MENTAL-RETARDATION; POINT MUTATION; GENE; REGION	Background: Fragile X syndrome (FXS) is caused by loss of function mutations in the FMR1 gene. Trinucleotide CGG-repeat expansions, resulting in FMR1 gene silencing, are the most common mutations observed at this locus. Even though the repeat expansion mutation is a functional null mutation, few conventional mutations have been identified at this locus, largely due to the clinical laboratory focus on the repeat tract. Methodology/Principal Findings: To more thoroughly evaluate the frequency of conventional mutations in FXS-like patients, we used an array-based method to sequence FMR1 in 51 unrelated males exhibiting several features characteristic of FXS but with normal CGG-repeat tracts of FMR1. One patient was identified with a deletion in FMR1, but none of the patients were found to have other conventional mutations. Conclusions/Significance: These data suggest that missense mutations in FMR1 are not a common cause of the FXS phenotype in patients who have normal-length CGG-repeat tracts. However, screening for small deletions of FMR1 may be of clinically utility.	[Collins, Stephen C.; Coffee, Brad; Zwick, Michael E.; Cutler, David J.; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Benke, Paul J.] Joe DiMaggio Childrens Hosp, Hollywood, FL USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gilbert, Fred] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Oostra, Ben; Halley, Dicky] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Rush University; Rush University; Cornell University; Erasmus University Rotterdam; Emory University; Emory University	Collins, SC (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012		National Institutes of Heath [HD020521, HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD020521] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institutes of Heath HD020521 and HD024064 to STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castellvi-Bel S, 1999, AM J MED GENET, V84, P262, DOI 10.1002/(SICI)1096-8628(19990528)84:3<262::AID-AJMG18>3.0.CO;2-V; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; CHIURAZZI P, 1994, AM J MED GENET, V51, P309, DOI 10.1002/ajmg.1320510405; Coffee B, 2008, AM J MED GENET A, V146A, P1358, DOI 10.1002/ajmg.a.32261; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEGRAAFF E, 1995, HUM MOL GENET, V4, P45; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Gronskov K, 1998, HUM GENET, V102, P440, DOI 10.1007/s004390050718; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Reyniers E, 1996, AM J MED GENET, V64, P408, DOI 10.1002/(SICI)1096-8628(19960809)64:2<408::AID-AJMG35>3.3.CO;2-L; Shinahara Kumi, 2004, Journal of Medical Investigation, V51, P52, DOI 10.2152/jmi.51.52; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vincent JB, 1996, MOL PSYCHIATR, V1, P227; Wang YC, 1997, HUM MUTAT, V10, P393, DOI 10.1002/(SICI)1098-1004(1997)10:5<393::AID-HUMU10>3.3.CO;2-Q; WOHRLE D, 1992, AM J HUM GENET, V51, P299	20	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9476	10.1371/journal.pone.0009476	http://dx.doi.org/10.1371/journal.pone.0009476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221430	Green Published, gold			2022-12-27	WOS:000275197200003
J	Meik, JM; Lawing, AM; Pires-daSilva, A				Meik, Jesse M.; Lawing, A. Michelle; Pires-daSilva, Andre			Body Size Evolution in Insular Speckled Rattlesnakes (Viperidae: Crotalus mitchellii)	PLOS ONE			English	Article							ISLAND RULE; MAINLAND POPULATIONS; BAJA-CALIFORNIA; TIGER SNAKES; NOTECHIS; MAMMALS; AREA; BIOGEOGRAPHY; DIMORPHISM; SELECTION	Background: Speckled rattlesnakes (Crotalus mitchellii) inhabit multiple islands off the coast of Baja California, Mexico. Two of the 14 known insular populations have been recognized as subspecies based primarily on body size divergence from putative mainland ancestral populations; however, a survey of body size variation from other islands occupied by these snakes has not been previously reported. We examined body size variation between island and mainland speckled rattlesnakes, and the relationship between body size and various island physical variables among 12 island populations. We also examined relative head size among giant, dwarfed, and mainland speckled rattlesnakes to determine whether allometric differences conformed to predictions of gape size (and indirectly body size) evolving in response to shifts in prey size. Methodology/Principal Findings: Insular speckled rattlesnakes show considerable variation in body size when compared to mainland source subspecies. In addition to previously known instances of gigantism on Angel de la Guarda and dwarfism on El Muerto, various degrees of body size decrease have occurred frequently in this taxon, with dwarfed rattlesnakes occurring mostly on small, recently isolated, land-bridge islands. Regression models using the Akaike information criterion (AIC) showed that mean SVL of insular populations was most strongly correlated with island area, suggesting the influence of selection for different body size optima for islands of different size. Allometric differences in head size of giant and dwarf rattlesnakes revealed patterns consistent with shifts to larger and smaller prey, respectively. Conclusions/Significance: Our data provide the first example of a clear relationship between body size and island area in a squamate reptile species; among vertebrates this pattern has been previously documented in few insular mammals. This finding suggests that selection for body size is influenced by changes in community dynamics that are related to graded differences in area over what are otherwise similar bioclimatic conditions. We hypothesize that in this system shifts to larger prey, episodic saturation and depression of primary prey density, and predator release may have led to insular gigantism, and that shifts to smaller prey and increased reproductive efficiency in the presence of intense intraspecific competition may have led to insular dwarfism.	[Meik, Jesse M.; Pires-daSilva, Andre] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Lawing, A. Michelle] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	University of Texas System; University of Texas Arlington; Indiana University System; Indiana University Bloomington	Meik, JM (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	jmeik@uta.edu	Silva, André/HHN-2071-2022; da Silva, Andre Pires/B-1066-2008; Lawing, Michelle/F-7453-2019	da Silva, Andre Pires/0000-0002-0741-7197; Lawing, Michelle/0000-0003-4041-6177	TE Inc; California Academy of Sciences	TE Inc; California Academy of Sciences	Partial funding for this research was provided by a grant from T&E Inc. and by a Stearns Grants-in-Aid of Herpetological Research from the California Academy of Sciences to JMM, and a Phi Sigma Biological Honor Society Grant to AML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2002, EVOLUTION, V56, P1045; Aubret F, 2004, NATURE, V431, P261, DOI 10.1038/431261a; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Boback SM, 2006, COPEIA, P261, DOI 10.1643/0045-8511(2006)6[261:AMCOIA]2.0.CO;2; Boback SM, 2003, EVOLUTION, V57, P345; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BURNHAM KP, 2002, MODEL SELECTION MULT, pR26; CALDER WA, 1996, SIZE FUNCTION LIFE H, pR16; CAMPBELL JA, 2004, VENOMOUS REPTILES W, pR18; Carreno Ana Luisa, 2002, P14; Case Ted J., 2002, P221; CASE TJ, 1978, ECOLOGY, V59, P1, DOI 10.2307/1936628; CASE TJ, 2002, NEW ISLAND BIOGEOGRA, pR17; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; DARWIN CR, 1845, VOYAGE BEAGLE; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; DUNHAM AE, 1978, ECOLOGY, V59, P1230, DOI 10.2307/1938236; FORSMAN A, 1991, J ANIM ECOL, V60, P253, DOI 10.2307/5458; FORSMAN A, 1993, FUNCT ECOL, V7, P183, DOI 10.2307/2389885; Grant Peter R., 1998; GRISMER LL, 2002, AMPHIBIANS REPTILES, pR13; Harmon LJ, 2006, EVOLUTION, V60, P2622; Hasegawa M., 1989, P414; Hasegawa Masami, 2008, South American Journal of Herpetology, V3, P145, DOI 10.2994/1808-9798(2008)3[145:DAGISG]2.0.CO;2; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Jaeger RG, 1998, HERPETOLOGICA, V54, pS64; Keogh JS, 2005, EVOLUTION, V59, P226; King RB, 2002, FUNCT ECOL, V16, P766, DOI 10.1046/j.1365-2435.2002.00678.x; Klauber L. M., 1963, Transactions of the San Diego Society for Natural History, V13, P73; Klauber L. M., 1938, Occasional Papers of the San Diego Society of Natural History, VNo. 4, P1; KLAUBER LAURENCE M, 1940, OCCAS PAPERS SAN DIEGO SOC NAT HIST, V6, P1; KLAUBER LM, 1949, T SAN DIEGO SOC NAT, V13, P73; LAWLOR TE, 1982, AM NAT, V119, P54, DOI 10.1086/283890; Lawlor Timothy E., 2002, P326; LEVITON AE, 1985, COPEIA, P802; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; LONDSDALE P, 1989, E PACIFIC OCEAN HAWA, P449; MAC ARTHUR ROBERT H., 1967; Meiri S, 2005, ECOL LETT, V8, P1211, DOI 10.1111/j.1461-0248.2005.00825.x; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P702, DOI 10.1111/j.1466-8238.2007.00327.x; MELTON R H, 1982, Evolutionary Theory, V6, P113; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; MILLIMAN JD, 1968, SCIENCE, V162, P1121, DOI 10.1126/science.162.3858.1121; Murphy Robert W., 2002, P181; Murphy Robert W., 2002, P447; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Palkovacs EP, 2003, OIKOS, V103, P37, DOI 10.1034/j.1600-0706.2003.12502.x; Pergams ORW, 1999, EVOLUTION, V53, P1573, DOI 10.1111/j.1558-5646.1999.tb05420.x; Petren K, 1997, EVOLUTION, V51, P206, DOI 10.1111/j.1558-5646.1997.tb02402.x; Schillaci MA, 2009, J BIOGEOGR, V36, P362, DOI 10.1111/j.1365-2699.2008.01984.x; SCHWANER TD, 1988, J HERPETOL, V22, P24, DOI 10.2307/1564353; SCHWANER TD, 1990, J HERPETOL, V24, P320, DOI 10.2307/1564405; SHINE R, 1987, HERPETOLOGICA, V43, P233; SMITH FA, 1992, FUNCT ECOL, V6, P265, DOI 10.2307/2389516; SOULE M, 1970, American Naturalist, V104, P85, DOI 10.1086/282642; SOULE M, 1966, AM NAT, V100, P47, DOI 10.1086/282399; STOCK JM, 1989, TECTONICS, V8, P99, DOI 10.1029/TC008i001p00099; Sun LX, 2002, J ZOOL, V256, P511, DOI 10.1017/S095283692000560; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; Wallace AR, 1880, ISLAND LIFE; White TA, 2007, J BIOGEOGR, V34, P356, DOI 10.1111/j.1365-2699.2006.01599.x; WILCOX BA, 1978, SCIENCE, V199, P996, DOI 10.1126/science.199.4332.996	67	24	28	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9524	10.1371/journal.pone.0009524	http://dx.doi.org/10.1371/journal.pone.0009524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209105	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100010
